Citrus Sinensis ID: 035930
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 857 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFA2 | 934 | Serine/threonine-protein | yes | no | 0.535 | 0.491 | 0.663 | 0.0 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.522 | 0.760 | 0.598 | 1e-164 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.522 | 0.760 | 0.598 | 1e-164 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.478 | 0.673 | 0.651 | 1e-158 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.435 | 0.645 | 0.638 | 1e-144 | |
| O64682 | 438 | Protein kinase PINOID OS= | no | no | 0.428 | 0.837 | 0.508 | 1e-107 | |
| Q64FQ2 | 525 | Protein kinase PINOID 2 O | no | no | 0.471 | 0.769 | 0.458 | 1e-107 | |
| Q94E49 | 493 | Protein kinase PINOID 2 O | no | no | 0.429 | 0.746 | 0.480 | 1e-102 | |
| Q2QM77 | 484 | Protein kinase PINOID OS= | no | no | 0.409 | 0.725 | 0.483 | 1e-102 | |
| P93025 | 915 | Phototropin-2 OS=Arabidop | no | no | 0.385 | 0.360 | 0.449 | 2e-95 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 644 bits (1660), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/475 (66%), Positives = 375/475 (78%), Gaps = 16/475 (3%)
Query: 396 AIVTKVDERSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWD 455
A+V K E S EK EFS SSK S+G+YS STSISE+S LS S G++PHMS D+RW+
Sbjct: 463 AMVEKETENPTSSEKFEFSLSSKDSLGDYSRSTSISEESNLSRFS-CGNKPHMSMDVRWE 521
Query: 456 AIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP 515
AI+ ++ Q+G +G+RHF L KKLGCGDIGTVYLAELIGT+CLFA+KVMDN+FL RKK P
Sbjct: 522 AIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKSP 581
Query: 516 RAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAAR 575
RAQ EREI++MLDHPFLPTL+A FT++ SCLVMEYCPGGDLHVLRQKQ R F E AAR
Sbjct: 582 RAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQLGRCFPEPAAR 641
Query: 576 FYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPV 635
FYVAE+LLALEYLHMLG++YRDLKPENILVREDGHIML+DFDLSLRCAVNP +V+S+SP
Sbjct: 642 FYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCAVNPTLVRSNSPP 701
Query: 636 EEPPPKKASSPCSEASCIEPFCL-HPSWQVSCFTPRLLSVAAKSRKIK-----SDLAAQV 689
+ P + S P + ++CI+PFC+ PS QVSCF+PRL S + RK K S +
Sbjct: 702 GK-DPARISGPYNTSNCIQPFCITEPSCQVSCFSPRLSSNQQQGRKPKRGDHLSKTQQHL 760
Query: 690 S-PMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFK 748
S +PQLV EPT ARSNSFVGTHEYLAPEIIKGEGHG++VDWWTFG+ L+ELLYG+TPFK
Sbjct: 761 SRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVLLYELLYGKTPFK 820
Query: 749 GSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808
G NDETL+NVV Q+L+FP P+VSF A+DLIRGLLVKEP+NRLG+ KG+ EIK+HPFFE
Sbjct: 821 GYNNDETLANVVLQNLKFPDSPLVSFQAKDLIRGLLVKEPENRLGSEKGSVEIKRHPFFE 880
Query: 809 GLNWALIRCAVPPELPR------SCDAVIGSQKKESTKCEESKGAADEHVEFEMF 857
GLNWALIRCA+PPELP +A S + + E K D H+EFE+F
Sbjct: 881 GLNWALIRCAIPPELPDFYEYGGGPEAAADSPGGSNNRYLECKAIGD-HLEFELF 934
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 580 bits (1496), Expect = e-164, Method: Compositional matrix adjust.
Identities = 277/463 (59%), Positives = 350/463 (75%), Gaps = 15/463 (3%)
Query: 404 RSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQ 463
RS + E+G FS SS S+S+ +S++S S S ++PH +ND RW+AI+ ++ +
Sbjct: 133 RSETGERG-FS----SSRCRPSTSSDVSDESACSSIS-SVTKPHKANDSRWEAIQMIRTR 186
Query: 464 HGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI 523
G +G+ HFKL KKLGCGDIG+VYL+EL GT FA+KVMD L RKK+ RAQTE+EI
Sbjct: 187 DGILGLSHFKLLKKLGCGDIGSVYLSELSGTKSYFAMKVMDKASLASRKKLLRAQTEKEI 246
Query: 524 MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLL 583
+Q LDHPFLPTL+ HF T+KFSCLVME+CPGGDLH LRQ+Q ++F EQA +FYVAE+LL
Sbjct: 247 LQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILL 306
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKA 643
A+EYLHMLG++YRDLKPEN+LVREDGHIMLSDFDLSLRCAV+P +++SS+P E K
Sbjct: 307 AMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALRKNN 366
Query: 644 SSPCSEASCIEPFCL-HPSWQ--VSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700
+ C + +C+EP C+ PS +CF PR S + K RK K ++ QVSP P+L+ EP+
Sbjct: 367 QAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPELIAEPS 426
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
ARS SFVGTHEYLAPEIIKGEGHGS+VDWWTFGIFL+ELL+G+TPFKGSGN TL NV+
Sbjct: 427 DARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVI 486
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVP 820
Q LRFP YPVVSF ARDLIRGLLVKEP RLG +GA EIKQHPFFEG+NWALIRCA P
Sbjct: 487 GQPLRFPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALIRCASP 546
Query: 821 PELPRSCD------AVIGSQKKESTKCEESKGAADEHVEFEMF 857
PE+PR + + + + + + ++ ++D ++EF+ F
Sbjct: 547 PEVPRPVEIERPPKQPVSTSEPAAAPSDAAQKSSDSYLEFDFF 589
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 580 bits (1496), Expect = e-164, Method: Compositional matrix adjust.
Identities = 277/463 (59%), Positives = 350/463 (75%), Gaps = 15/463 (3%)
Query: 404 RSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQ 463
RS + E+G FS SS S+S+ +S++S S S ++PH +ND RW+AI+ ++ +
Sbjct: 133 RSETGERG-FS----SSRCRPSTSSDVSDESACSSIS-SVTKPHKANDSRWEAIQMIRTR 186
Query: 464 HGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI 523
G +G+ HFKL KKLGCGDIG+VYL+EL GT FA+KVMD L RKK+ RAQTE+EI
Sbjct: 187 DGILGLSHFKLLKKLGCGDIGSVYLSELNGTKSYFAMKVMDKASLASRKKLLRAQTEKEI 246
Query: 524 MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLL 583
+Q LDHPFLPTL+ HF T+KFSCLVME+CPGGDLH LRQ+Q ++F EQA +FYVAE+LL
Sbjct: 247 LQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILL 306
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKA 643
A+EYLHMLG++YRDLKPEN+LVREDGHIMLSDFDLSLRCAV+P +++SS+P E K
Sbjct: 307 AMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALRKNN 366
Query: 644 SSPCSEASCIEPFCL-HPSWQ--VSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700
+ C + +C+EP C+ PS +CF PR S + K RK K ++ QVSP P+L+ EP+
Sbjct: 367 QAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPELIAEPS 426
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
ARS SFVGTHEYLAPEIIKGEGHGS+VDWWTFGIFL+ELL+G+TPFKGSGN TL NV+
Sbjct: 427 DARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVI 486
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVP 820
Q LRFP YPVVSF ARDLIRGLLVKEP RLG +GA EIKQHPFFEG+NWALIRCA P
Sbjct: 487 GQPLRFPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALIRCASP 546
Query: 821 PELPRSCD------AVIGSQKKESTKCEESKGAADEHVEFEMF 857
PE+PR + + + + + + ++ ++D ++EF+ F
Sbjct: 547 PEVPRPVEIERPPKQPVSTSEPAAAPSDAAQKSSDSYLEFDFF 589
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 559 bits (1441), Expect = e-158, Method: Compositional matrix adjust.
Identities = 273/419 (65%), Positives = 329/419 (78%), Gaps = 9/419 (2%)
Query: 412 EFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRH 471
+F++S K+SI S+ + S++S S S +PH +ND+RW+AI+ V+ + G + MRH
Sbjct: 169 DFNESRKTSICRASTGSDASDESSTSSLSSVLYKPHKANDIRWEAIQAVRTRDGMLEMRH 228
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F+L KKLGCGDIG+VYLAEL GT FA+KVM+ L RKK+ RAQTEREI+Q LDHPF
Sbjct: 229 FRLLKKLGCGDIGSVYLAELSGTRTSFAMKVMNKTELANRKKLLRAQTEREILQSLDHPF 288
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
LPTL+ HF TE FSCLVME+CPGGDLH LRQ+QP ++FSE A RFYVAEVLL+LEYLHML
Sbjct: 289 LPTLYTHFETEIFSCLVMEFCPGGDLHALRQRQPGKYFSEHAVRFYVAEVLLSLEYLHML 348
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEAS 651
G++YRDLKPEN+LVREDGHIMLSDFDLSLRC+V+P +VKSS+ ++ K+S C + S
Sbjct: 349 GIIYRDLKPENVLVREDGHIMLSDFDLSLRCSVSPTLVKSSNNLQ----TKSSGYCVQPS 404
Query: 652 CIEPFC-LHPS-WQVSCFTPRLL---SVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706
CIEP C + P + SCFTPR L S K K K+D+ QV+P+P+L+ EPT ARS S
Sbjct: 405 CIEPTCVMQPDCIKPSCFTPRFLSGKSKKDKKSKPKNDMHNQVTPLPELIAEPTNARSMS 464
Query: 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF 766
FVGTHEYLAPEIIKGEGHGS+VDWWTFGIFL+ELL+GRTPFKGS N TL NV+ Q LRF
Sbjct: 465 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGRTPFKGSANRATLFNVIGQPLRF 524
Query: 767 PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPR 825
P P VSF ARDLIRGLLVKEP +RL +GA EIKQHPFF+ +NWALIRCA PPE+PR
Sbjct: 525 PESPTVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQHPFFQNVNWALIRCATPPEVPR 583
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 513 bits (1320), Expect = e-144, Method: Compositional matrix adjust.
Identities = 249/390 (63%), Positives = 301/390 (77%), Gaps = 17/390 (4%)
Query: 445 RPHM-SNDLRWDAIRCVQKQHGC-MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKV 502
+PH +ND RW AI+ V+ + G + + FKL KKLG GDIG VYLAELIGT FA+KV
Sbjct: 153 KPHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVSFAVKV 212
Query: 503 MDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQ 562
M+ + RKK+ RAQTE+EI+Q LDHPFLPTL++HF TE SCLVME+CPGGDLH LRQ
Sbjct: 213 MEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLHSLRQ 272
Query: 563 KQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622
KQ ++F EQAARFYVAEVLLA+EYLHMLG++YRDLKPEN+LVREDGHIMLSDFDLSLRC
Sbjct: 273 KQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 332
Query: 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASC-------IEPFCLHPSWQVSCFTPRLLSVA 675
AV+P +V+ ++ E K+SS C + +C ++P C+ P CFTPR LS
Sbjct: 333 AVSPTLVRFAAITLE---SKSSSYCIQPTCVDQSSCIVQPDCIQP----VCFTPRFLS-K 384
Query: 676 AKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGI 735
K RK +D++ Q+ P+P+L+ EPT ARS SFVGTHEYLAPEIIKGEGHGS+VDWWTFGI
Sbjct: 385 GKHRKKSNDMSRQIRPLPELIAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGI 444
Query: 736 FLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV 795
FL+ELL+G TPF+G N TL NVV Q LRFP +P VSF ARDLIRGLLVKEP +RL
Sbjct: 445 FLYELLFGITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARDLIRGLLVKEPQHRLAYR 504
Query: 796 KGAAEIKQHPFFEGLNWALIRCAVPPELPR 825
+GA EIKQHPFF+ +NWALIRC PP++P+
Sbjct: 505 RGATEIKQHPFFQSVNWALIRCTSPPQIPQ 534
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64682|PID_ARATH Protein kinase PINOID OS=Arabidopsis thaliana GN=PID PE=1 SV=1 | Back alignment and function description |
|---|
Score = 391 bits (1005), Expect = e-107, Method: Compositional matrix adjust.
Identities = 209/411 (50%), Positives = 264/411 (64%), Gaps = 44/411 (10%)
Query: 427 STSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTV 486
ST E+S LS +PH S+D + IR +KQ + R F+L +++G GDIGTV
Sbjct: 38 STIPEEESFLS------LKPHRSSDFAYAEIRRRKKQ--GLTFRDFRLMRRIGAGDIGTV 89
Query: 487 YLAELIGT-----SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541
YL L G S FA+KV+D + L +KKM RA+ E+ I++MLDHPFLPTL+A F
Sbjct: 90 YLCRLAGDEEESRSSYFAMKVVDKEALALKKKMHRAEMEKTILKMLDHPFLPTLYAEFEA 149
Query: 542 EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPE 601
FSC+VMEYC GGDLH LR +QP R FS +ARFY AEVL+ALEYLHMLG++YRDLKPE
Sbjct: 150 SHFSCIVMEYCSGGDLHSLRHRQPHRRFSLSSARFYAAEVLVALEYLHMLGIIYRDLKPE 209
Query: 602 NILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPS 661
NILVR DGHIMLSDFDLSL C+ + V+SSS P ++ SP
Sbjct: 210 NILVRSDGHIMLSDFDLSL-CSDSIAAVESSS--SSPENQQLRSP--------------- 251
Query: 662 WQVSCFT--PRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEII 719
FT RL +S+K+++ + P V EP ARS SFVGTHEY+APE+
Sbjct: 252 ---RRFTRLARLFQRVLRSKKVQT-----LEPTRLFVAEPVTARSGSFVGTHEYVAPEVA 303
Query: 720 KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP-GYPVVSF--HA 776
G HG++VDWW FG+FL+E++YG+TPF ND L N+V + L FP P F HA
Sbjct: 304 SGGSHGNAVDWWAFGVFLYEMIYGKTPFVAPTNDVILRNIVKRQLSFPTDSPATMFELHA 363
Query: 777 RDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSC 827
R+LI GLL K+P RLG+ +GAAE+K HPFF+GLN+ALIR PPE+P S
Sbjct: 364 RNLISGLLNKDPTKRLGSRRGAAEVKVHPFFKGLNFALIRTLTPPEIPSSV 414
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Acts as a positive regulator of cellular auxin efflux and regulates organ development by enhancing polar auxin transport. Phosphorylates conserved serine residues in the PIN auxin efflux carriers. Phosphorylation of PIN proteins is required and sufficient for apical-basal PIN polarity that enables directional intercellular auxin fluxes, which mediate differential growth, tissue patterning and organogenesis. Acts in association with PIN1 to control the establishment of bilateral symmetry and promotion of cotyledon outgrowth. Regulates root gravitropism through modulation of PIN2-dependent basipetal auxin transport. Required for polarization of PIN3-dependent auxin transport for hypocotyl gravitropic response. The protein kinase activity of PID is essential for its auxin efflux regulatory function. PID kinase and PP2A phosphatase activities antagonistically regulate phosphorylation of PIN proteins, affecting PIN sorting. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q64FQ2|PID2_ARATH Protein kinase PINOID 2 OS=Arabidopsis thaliana GN=PID2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 390 bits (1001), Expect = e-107, Method: Compositional matrix adjust.
Identities = 208/454 (45%), Positives = 286/454 (62%), Gaps = 50/454 (11%)
Query: 419 SSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHG-CMGMRHFKLHKK 477
SS S +SIS S +S S+PH +N + W+A+ +++ G +G+ HF+L K+
Sbjct: 33 SSFTASPSCSSISHLSNHGLNSYNQSKPHKANQVAWEAMARLRRCCGRAVGLEHFRLLKR 92
Query: 478 LGCGDIGTVYLAELIGT--SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTL 535
LG GDIG+VYL ++ G+ + +A+KV+D + + +KK+ RA+ E++I+ MLDHPF PTL
Sbjct: 93 LGSGDIGSVYLCQIRGSPETAFYAMKVVDKEAVAVKKKLGRAEMEKKILGMLDHPFCPTL 152
Query: 536 FAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVY 595
+A F +S LVMEYCPGGDL+ +R +QPS+ F+ + RFY AE L+ALEYLHM+G+VY
Sbjct: 153 YAAFEASHYSFLVMEYCPGGDLYAVRLRQPSKRFTISSTRFYAAETLVALEYLHMMGIVY 212
Query: 596 RDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV----KSSSPVEEPPPKKASSPCSEAS 651
RDLKPEN+L+REDGH+MLSDFDLS +C V P + + E+ CS S
Sbjct: 213 RDLKPENVLIREDGHVMLSDFDLSFKCDVVPQFLSDNDRDRGHQEDDDDISIRRKCSTPS 272
Query: 652 CIEPFCLHPSWQVSCFTP-----RLLSV---------AAKSRKIKSDLAAQV---SP--- 691
C L+P +SCF+P R +V A S +KS+ ++ SP
Sbjct: 273 CTTT-PLNPV--ISCFSPTSSRRRKKNVVTTTIHENAAGTSDSVKSNDVSRTFSRSPSSC 329
Query: 692 -------------MPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLF 738
P + EP ARS SFVGTHEYLAPE+I G+GHGS+VDWWT+GIFL+
Sbjct: 330 SRVSNGLRDISGGCPSIFAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTYGIFLY 389
Query: 739 ELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVS-------FHARDLIRGLLVKEPDNR 791
E+++GRTPFKG N++TL N++ L FP V S +A+DLI LLVK P R
Sbjct: 390 EMIFGRTPFKGDNNEKTLVNILKAPLTFPKVIVNSPKEYEDMVNAQDLIIKLLVKNPKKR 449
Query: 792 LGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPR 825
LG++KG+ EIK+H FFEG+NWALIR PP +P+
Sbjct: 450 LGSLKGSIEIKRHEFFEGVNWALIRSIKPPWVPK 483
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Plays a minor role in the regulation of cellular auxin efflux and cotyledon organogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94E49|PID2_ORYSJ Protein kinase PINOID 2 OS=Oryza sativa subsp. japonica GN=PID2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 374 bits (960), Expect = e-102, Method: Compositional matrix adjust.
Identities = 194/404 (48%), Positives = 256/404 (63%), Gaps = 36/404 (8%)
Query: 445 RPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAEL-----------IG 493
+PH +N W+AIR ++ G +G+ HF+L ++LG GD+G VYL L
Sbjct: 53 KPHKANQAEWEAIRRLRAGAGRVGLEHFRLVRRLGSGDLGNVYLCRLREPWSSSSMTTTA 112
Query: 494 TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCP 553
CL+A+KV+D D L RKK+ RA+ ER+I++ LDHPFLPTL+A F ++CLVME+CP
Sbjct: 113 GGCLYAMKVVDKDALAFRKKLRRAEVERDILRTLDHPFLPTLYADFEASHYACLVMEFCP 172
Query: 554 GGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML 613
GGDLHV RQ+QP R F+ + RFYVAE +LALEYLHM+GVVYRDLKPEN+LVR DGHIML
Sbjct: 173 GGDLHVARQRQPGRRFTVSSTRFYVAETVLALEYLHMMGVVYRDLKPENVLVRGDGHIML 232
Query: 614 SDFDLSLRCAVNPMVVKSSSPVEE------PPPKKASSPCSE--ASCIEPF-----CLHP 660
SDFDLSL+C V P +++ + PPP P + SCI F C H
Sbjct: 233 SDFDLSLKCDVVPKLLRPARSAAAGGKPPLPPPSSCVPPTIQPVLSCI--FRGVHKCHHA 290
Query: 661 SWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIK 720
+ + + + +VVEP ARS SFVGTHEYLAPE+I
Sbjct: 291 --KECAGGGAAAGNNGDGDGNDEEAETETAEPEVVVVEPVAARSKSFVGTHEYLAPEVIS 348
Query: 721 GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFH----- 775
G+GHGS+VDWWT G+F++E+LYGRTPFKG N++TL N++ Q + FP +
Sbjct: 349 GQGHGSAVDWWTLGVFMYEMLYGRTPFKGESNEKTLINIIKQPVTFPRLAGAAAAGEWEE 408
Query: 776 ---ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIR 816
A+DL+ LL K P RLG+ G+AE+K+HPFF+G+NWAL+R
Sbjct: 409 MKTAQDLMLQLLAKNPKKRLGSTMGSAEVKRHPFFKGVNWALVR 452
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QM77|PID_ORYSJ Protein kinase PINOID OS=Oryza sativa subsp. japonica GN=PID PE=2 SV=1 | Back alignment and function description |
|---|
Score = 372 bits (956), Expect = e-102, Method: Compositional matrix adjust.
Identities = 189/391 (48%), Positives = 244/391 (62%), Gaps = 40/391 (10%)
Query: 445 RPHMSNDLRWDAIRCVQKQHGC-MGMRHFKLHKKLGCGDIGTVYLAELIGTS-----CLF 498
RPH S D+ W AIR +G R FKL +++G GDIGTVYL L + C++
Sbjct: 83 RPHRSGDVAWAAIRAASTTSAAPLGPRDFKLVRRIGGGDIGTVYLCRLRSSPERESPCMY 142
Query: 499 ALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHF-TTEKFSCLVMEYCPGGDL 557
A+KV+D + ++K+ RA E+ I++ LDHPFLPTLFA F T FSC VME+CPGGDL
Sbjct: 143 AMKVVDRRAVARKQKLGRAAAEKRILRQLDHPFLPTLFADFDATPHFSCAVMEFCPGGDL 202
Query: 558 HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFD 617
H LR + PSR F +ARFY AEVLLA+EYLHM+G+VYRDLKPEN+L+R DGHIML+DFD
Sbjct: 203 HSLRHRMPSRRFPLPSARFYAAEVLLAIEYLHMMGIVYRDLKPENVLIRADGHIMLTDFD 262
Query: 618 LSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAK 677
LSL+ +P + + +E S SCF LL
Sbjct: 263 LSLQSTTSPSLDGDTDTDDE----------------------ASGGASCFPDHLL----- 295
Query: 678 SRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFL 737
+ K A +P P+ V EP ARS SFVGTHEY+APE+ G HG++VDWW +G+FL
Sbjct: 296 --RFKRRRNAVAAPRPRFVAEPVDARSCSFVGTHEYVAPEVASGGAHGAAVDWWAYGVFL 353
Query: 738 FELLYGRTPFKGSGNDETLSNVVSQSLRFPGYP----VVSFHARDLIRGLLVKEPDNRLG 793
+EL+YGRTPF G+ N+ TL N+V + L FP ARDLI LL K+P RLG
Sbjct: 354 YELIYGRTPFAGATNEATLRNIVRRPLAFPSGSGSCGPADADARDLIARLLAKDPAARLG 413
Query: 794 AVKGAAEIKQHPFFEGLNWALIRCAVPPELP 824
+ +GAA++K HPFF+ LN AL+R + PP +P
Sbjct: 414 SRRGAADVKSHPFFKSLNLALLRSSRPPVVP 444
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. May control polar auxin transport and probably plays a role in the pattern formation and organogenesis in the rice shoot. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93025|PHOT2_ARATH Phototropin-2 OS=Arabidopsis thaliana GN=PHOT2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 350 bits (899), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 170/378 (44%), Positives = 225/378 (59%), Gaps = 48/378 (12%)
Query: 446 PHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDN 505
PH W AI+ +Q +G+ HFK K LG GD G+V+L EL GT L+A+K M+
Sbjct: 551 PHNKESTSWKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAMKAMEK 610
Query: 506 DFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQP 565
++ R K RA EREI+ +LDHPFLPTL+A F T CL+ ++CPGG+L L +QP
Sbjct: 611 TMMLNRNKAHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFALLDRQP 670
Query: 566 SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625
+ +E +ARFY AEV++ LEYLH LG+VYRDLKPENIL+++DGHI+L+DFDLS
Sbjct: 671 MKILTEDSARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSFMTTCT 730
Query: 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDL 685
P ++ ++P +K R+ KS
Sbjct: 731 PQLIIPAAP-----------------------------------------SKRRRSKS-- 747
Query: 686 AAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRT 745
P+P V EP+ +SNSFVGT EY+APEII G GH S++DWW GI L+E+LYGRT
Sbjct: 748 ----QPLPTFVAEPS-TQSNSFVGTEEYIAPEIITGAGHTSAIDWWALGILLYEMLYGRT 802
Query: 746 PFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHP 805
PF+G +T +N++ + L FP VS R LI LL ++P +RLG+ GA EIKQH
Sbjct: 803 PFRGKNRQKTFANILHKDLTFPSSIPVSLVGRQLINTLLNRDPSSRLGSKGGANEIKQHA 862
Query: 806 FFEGLNWALIRCAVPPEL 823
FF G+NW LIR PP L
Sbjct: 863 FFRGINWPLIRGMSPPPL 880
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 857 | ||||||
| 255576361 | 847 | serine/threonine protein kinase, putativ | 0.970 | 0.982 | 0.676 | 0.0 | |
| 225436305 | 879 | PREDICTED: serine/threonine-protein kina | 0.991 | 0.967 | 0.686 | 0.0 | |
| 356515408 | 830 | PREDICTED: serine/threonine-protein kina | 0.953 | 0.984 | 0.632 | 0.0 | |
| 356508158 | 827 | PREDICTED: uncharacterized protein LOC10 | 0.949 | 0.984 | 0.625 | 0.0 | |
| 449496264 | 844 | PREDICTED: serine/threonine-protein kina | 0.971 | 0.986 | 0.571 | 0.0 | |
| 449456106 | 844 | PREDICTED: serine/threonine-protein kina | 0.971 | 0.986 | 0.571 | 0.0 | |
| 357456077 | 840 | Protein kinase [Medicago truncatula] gi| | 0.926 | 0.945 | 0.557 | 0.0 | |
| 225440934 | 864 | PREDICTED: serine/threonine-protein kina | 0.968 | 0.960 | 0.571 | 0.0 | |
| 297734827 | 687 | unnamed protein product [Vitis vinifera] | 0.786 | 0.981 | 0.587 | 0.0 | |
| 356570839 | 868 | PREDICTED: serine/threonine-protein kina | 0.973 | 0.960 | 0.553 | 0.0 |
| >gi|255576361|ref|XP_002529073.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223531485|gb|EEF33317.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1111 bits (2874), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/872 (67%), Positives = 684/872 (78%), Gaps = 40/872 (4%)
Query: 1 MDGPSSTCEIVESIEELEFASKRNEKAKKHSLPKSGNKYSIEDDINRLFEAIDVKTSAKN 60
MD ST EIVES EEL+F K +E A KHS P SGN+YSIEDDINRLFEAID++TS K
Sbjct: 1 MDALPSTSEIVESTEELDFDLKMDENAGKHSYPLSGNRYSIEDDINRLFEAIDIRTSTKG 60
Query: 61 L--------DALRKSALKRPIRVSSSQALGIGISEPVNLKQALRGLCISQAAEMAAMKRL 112
L D+LRK A+KRPIRV S Q GIGISEPV+LKQALRGLCISQA+EMAAMKRL
Sbjct: 61 LGLTHESSKDSLRKKAMKRPIRVGSPQMSGIGISEPVSLKQALRGLCISQASEMAAMKRL 120
Query: 113 SKPSGSSRSSEAGTIKRLYRAVVVEANESGIPLNEGKGNLVEISLVPENITSNSSEKVHE 172
S+P+ SS +SEAGTIKRLYRAVVVEAN SG+PLN+G GNLVEISLVPE + SNSSEK E
Sbjct: 121 SRPATSSGASEAGTIKRLYRAVVVEANGSGLPLNDGNGNLVEISLVPERVASNSSEKC-E 179
Query: 173 SQQVPRAESSRHAAHHSPPLDIVTKPKAIPSKLPSLDQVVPLVT-EFEEKPKAEHHNLNS 231
S Q+ +++ AH S DQ VPL T E PKAE+ L
Sbjct: 180 SSQMDKSQFLYQNAHSSQ------------------DQAVPLHTVPITEIPKAENKRLQP 221
Query: 232 PE-SSSVPFTREVEEVEIIAPSSVEVLVNSPVSDKGQKSKLHPGSSLSSSSNGSRLTKCG 290
+ SS + ++ EV+ + +S++V P+ + GQ++ LH S+ S +
Sbjct: 222 TDFPSSSHASEKLPEVDEKSSASIKVYSKPPLPE-GQRNHLHTAYLPSNCSPVGVVNSSA 280
Query: 291 SNSQRLVKPVFRSKGFVRRKVKQDSTSASSSCTPCDVSASNDPGPSTSYLDVHMHNCTVN 350
NS R +KP+FR+K F+++KVKQ+ SS C +ND PSTS D +CT
Sbjct: 281 CNSPRFMKPIFRNKSFLKKKVKQELPPVSSISNLCRGKVNNDQDPSTSNSDPC--DCTPE 338
Query: 351 NERKENMKTTPAPSGTNMSTDVNSSVGDSSSSKPGFSLNCGNRNKAIVTKVDERSRSREK 410
+E+MK++PA S N + NS + + +SS S N R K+I+TKVDERSRSREK
Sbjct: 339 VVSQESMKSSPASSAMNHIIECNSGI-EETSSSKLGSSNSDYRTKSILTKVDERSRSREK 397
Query: 411 GEFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMR 470
GEFSQSSKSSIG+YSSSTS+SEDS LSGSSR G+RPHMS DLRW+AIR VQ+QHG +G++
Sbjct: 398 GEFSQSSKSSIGDYSSSTSVSEDSNLSGSSRCGTRPHMSRDLRWEAIRQVQRQHGRLGLK 457
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
HFKL KKLGCGDIG+VYLAEL GT+CLFALKVMDN+FL RKKM RA+TEREI+QMLDHP
Sbjct: 458 HFKLIKKLGCGDIGSVYLAELTGTNCLFALKVMDNEFLASRKKMSRAETEREILQMLDHP 517
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
FLPTL+AHF +++FSCLVME+C GGDLHVLRQKQPSR FSEQAARFYVAEVLLALEYLHM
Sbjct: 518 FLPTLYAHFVSDRFSCLVMEHCSGGDLHVLRQKQPSRSFSEQAARFYVAEVLLALEYLHM 577
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEA 650
LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP++V+S+SPVEE P KK SSPCSEA
Sbjct: 578 LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPILVQSASPVEE-PTKKMSSPCSEA 636
Query: 651 SCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710
SCI+PFCLHP+WQVSCFTPRLLSVAAKSRK+KSDLAAQVSP+PQLVVEPT ARSNSFVGT
Sbjct: 637 SCIDPFCLHPAWQVSCFTPRLLSVAAKSRKLKSDLAAQVSPLPQLVVEPTNARSNSFVGT 696
Query: 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYP 770
HEYLAPEIIKG+GHGS+VDWWTFGIFLFELLYGRTPFKGSGN+ETLSNVVS+SL+FP P
Sbjct: 697 HEYLAPEIIKGDGHGSAVDWWTFGIFLFELLYGRTPFKGSGNEETLSNVVSRSLKFPSSP 756
Query: 771 VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCDAV 830
+VSFHARDLIRGLL+KEP+NRLG+ KGAAEIKQH FFEGLNWALIRCA+PPE+P+ CD
Sbjct: 757 IVSFHARDLIRGLLIKEPENRLGSAKGAAEIKQHSFFEGLNWALIRCAIPPEMPKLCDTG 816
Query: 831 IG-----SQKKESTKCEESKGAADEHVEFEMF 857
IG SQ KE TKC+ESKG D + EFEMF
Sbjct: 817 IGTTTTFSQNKEGTKCKESKGTED-YTEFEMF 847
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225436305|ref|XP_002269994.1| PREDICTED: serine/threonine-protein kinase KIPK-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1105 bits (2859), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 602/877 (68%), Positives = 693/877 (79%), Gaps = 27/877 (3%)
Query: 5 SSTCEIVESIEELEFASKRNEKAKKHSLPKSGNKYSIEDDINRLFEAIDVKTSAK----- 59
+ T EIVES EEL+ K N+ A +H L K G YSIEDDIN+LFEAID++ S +
Sbjct: 6 AGTSEIVESAEELDSELKMNDIAGRHRLLKPGQNYSIEDDINQLFEAIDIRCSGRVSGTS 65
Query: 60 ---NLDALRKSALKRPIRVSSSQALGIGISEPVNLKQALRGLCISQAAEMAAMKRLSKPS 116
+ DA RKSA+KRPIRVSS Q+ GIGISE V+LKQALRGLCISQA+EMAAMKRLSKP+
Sbjct: 66 HQVSKDAFRKSAMKRPIRVSSPQSSGIGISESVSLKQALRGLCISQASEMAAMKRLSKPA 125
Query: 117 GSSRSSEAGTIKRLYRAVVVEANESGIPLNEGKGNLVEISLVPENITSNSSEKVHESQQV 176
G S SSEAGTIKRLYRAVVV+A+ESG+P NEGKGNLVEISLVPE TS+ EKV ES QV
Sbjct: 126 GLSGSSEAGTIKRLYRAVVVDASESGLPFNEGKGNLVEISLVPEKSTSSFYEKVPESLQV 185
Query: 177 PRAESSRHAAHHSPPLDIVTKPKAIPSKLPSLDQVVPLVTEF-EEKPKAE--HHNLNSPE 233
P+AE S+ A P+ T K++ P+ D++VPL E EK KAE + P
Sbjct: 186 PKAELSQQCAPSCNPVADATTAKSMLPITPAQDEIVPLPAEIGREKSKAELEQNGKRKPV 245
Query: 234 SS--SVPFTREVEEVEIIAPSSVEVLVNSPVSDKGQKSKLHPGSSLSSSSNGSRLTKCGS 291
S SV + ++E I P+ EV + DKGQK KLH SSL S+S+GS+++K GS
Sbjct: 246 HSLLSVDAGERLPKLEKIVPTLNEVASKTSTLDKGQKGKLHSASSLPSASSGSKVSKSGS 305
Query: 292 NSQRLVKPVFRSKGFVRRKVKQDSTSASS--SCTPCDVSASNDPGPSTSYLDVHMHNCTV 349
S L+KPVFRSK FV++KVK DS AS+ P + + +ND PSTS L +N T+
Sbjct: 306 YSPHLIKPVFRSKNFVKKKVKLDSALASTPAGSNPRNGTINNDLDPSTSKLVFQTYNYTL 365
Query: 350 NNERKENMKTTPAPSGTNMSTDVNSSVGDSSSSKPGFSLNCGNRNKAIVTKVDERSRSRE 409
NE KEN K +PA SG N+S +V+SSV DS +SKPGF NC NR + VTK DERSRS E
Sbjct: 366 KNETKENEKASPASSGRNVSIEVSSSVVDSDASKPGFGSNCSNRTRG-VTKGDERSRSSE 424
Query: 410 KGEFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGM 469
KGEFSQSSKSSIG+YSSSTSISE+S +SGSSR G+RPHMS DLRW+AI VQKQH G+
Sbjct: 425 KGEFSQSSKSSIGQYSSSTSISEESNVSGSSRSGNRPHMSKDLRWEAIHHVQKQHETFGL 484
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH 529
R+FKL K+LGCGDIGTVYL EL GT+CLFALKVMDN+FL RKKMPRAQTEREI+QMLDH
Sbjct: 485 RNFKLLKRLGCGDIGTVYLVELTGTNCLFALKVMDNEFLATRKKMPRAQTEREILQMLDH 544
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
PFLPTL+AHFTT+K SCLVMEYCPGGDLHVLRQKQPSR FSEQAARFY AEVLLALEYLH
Sbjct: 545 PFLPTLYAHFTTDKLSCLVMEYCPGGDLHVLRQKQPSRSFSEQAARFYAAEVLLALEYLH 604
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSE 649
MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM++KS+SPV E P KKASSPC++
Sbjct: 605 MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMLLKSASPVVE-PTKKASSPCTD 663
Query: 650 ASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709
+SCI PFCL PSWQV CFTPRLLS AKSRK+KSDLA QV+P+PQLV EPT ARSNSFVG
Sbjct: 664 SSCIHPFCLQPSWQVPCFTPRLLSTTAKSRKLKSDLATQVTPLPQLVAEPTSARSNSFVG 723
Query: 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGY 769
THEYLAPEIIKGEGHGS+VDWWTFGIFL+ELLYG+TPFKGSGN++TL++VVS SL+FP
Sbjct: 724 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLYGKTPFKGSGNEDTLASVVSHSLKFPES 783
Query: 770 PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCDA 829
P+VSFHARDLIRGLLVKEP+NRLG+VKGA EIKQH FFEGLNWALIRCA+PPE+P+ CDA
Sbjct: 784 PMVSFHARDLIRGLLVKEPENRLGSVKGATEIKQHSFFEGLNWALIRCAIPPEMPKLCDA 843
Query: 830 VIGS-------QKKESTK--CEESKGAADEHVEFEMF 857
GS QKKES K C++ K E VEFE+F
Sbjct: 844 GTGSTVMSMSVQKKESAKSDCKDMKDTT-ECVEFELF 879
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356515408|ref|XP_003526392.1| PREDICTED: serine/threonine-protein kinase KIPK-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 987 bits (2552), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 550/870 (63%), Positives = 653/870 (75%), Gaps = 53/870 (6%)
Query: 1 MDGPSSTCEIVESIEELEFASKRNEKAKKHSLPKSGNKYSIEDDINRLFEAIDVKTSAKN 60
MD +TCEIVES EE+ K +EK + KSG KYSIEDDIN+LF+AI++K+S+++
Sbjct: 1 MDTSGNTCEIVESREEIISEFKMDEKPESSCAHKSGKKYSIEDDINQLFQAIEIKSSSRS 60
Query: 61 LDA--LRKSALKRPIRVSSSQALGIGISEPVNLKQALRGLCISQAAEMAAMKRLSKPSGS 118
+ L+KSALKRPI+V+SSQA GIGISEPV+LKQALRGLCISQA+EMAA+KRL+KP S
Sbjct: 61 RSSSSLQKSALKRPIKVTSSQASGIGISEPVSLKQALRGLCISQASEMAALKRLTKPCSS 120
Query: 119 SRSSEAGTIKRLYRAVVVEANESGIPLNEGKGNLVEISLVPENITSNSSEKVHESQQVPR 178
SR SEAGTIKRLY AVV +EGKGNLVEISLVPE S S+K+
Sbjct: 121 SRVSEAGTIKRLYTAVV----------DEGKGNLVEISLVPE--ISAPSDKLS------G 162
Query: 179 AESSRHAAHHSPPLDIVTKPKAIPSKLPSLDQVVPLVTEFE-EKP-----KAEHHNLNSP 232
S +HS PL TKPK I + S D++V E E EKP K NL SP
Sbjct: 163 VTISSSIDNHSSPLVDATKPKEIITGFSSQDRIVSPPLEVEGEKPIMGIGKPILANL-SP 221
Query: 233 ESSSVPFTREVEEVEIIAPSSVEVLVNSPVSDKGQKSKLHPGSSLSSSSNGSRLTKCGSN 292
+S+ + EV EV + SS + + S +SDKG ++ GS SSS G+ K S+
Sbjct: 222 VASA---SEEVPEVRMDPASSSKASLGSSMSDKGHEANFPSGSCPPSSSTGNGADKYTSS 278
Query: 293 SQRLVKPVFRSKGFVRRKVKQDSTSASSSCTPCDVSASNDPGPSTSYLDVHMHNCTVNNE 352
+ L KP+F + F+++KVKQD +SA+S TPC TS LD N +E
Sbjct: 279 NTCLSKPIFNNLNFLKKKVKQDLSSAASCSTPC-----------TSNLDKEGGNSDFKHE 327
Query: 353 RKENMKTTPAPSGTNMSTDVNSSVGDSSSSKPGFSLNCGNRNKAIVTKVDERSRSREKGE 412
K+N K +P S N S +VNS G + SSK GFSLNC R K +VTKVDE+SRS+EKGE
Sbjct: 328 MKDNAKQSPCSS--NHSIEVNSINGGTDSSKSGFSLNCNKRTKFLVTKVDEKSRSKEKGE 385
Query: 413 FSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHF 472
+SQSSKSSIGEYSSSTSISE+S LS SSRGG RPHMS LRW+A+R VQ+QHG + ++HF
Sbjct: 386 YSQSSKSSIGEYSSSTSISEESSLSSSSRGGHRPHMSKHLRWEAVRAVQQQHGNLNLKHF 445
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532
KL ++LG GDIGTVYLAELIGTSCLFALKVMDN+FL RKKM R+QTEREI+QMLDHPFL
Sbjct: 446 KLLRRLGSGDIGTVYLAELIGTSCLFALKVMDNEFLASRKKMFRSQTEREILQMLDHPFL 505
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592
PTL++H ++K SCLVMEYCPGGDLHVLRQ+Q + FSEQAARFYVAEVLLALEYLHMLG
Sbjct: 506 PTLYSHIASDKLSCLVMEYCPGGDLHVLRQRQSYKSFSEQAARFYVAEVLLALEYLHMLG 565
Query: 593 VVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASC 652
VVYRDLKPENILVREDGHIML+DFDLSLRC+VNPM+VKSSSP + KK SSPCSEASC
Sbjct: 566 VVYRDLKPENILVREDGHIMLTDFDLSLRCSVNPMLVKSSSP-DTDATKKTSSPCSEASC 624
Query: 653 IEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHE 712
I PFCL P WQVSCFTP LLS AKSRK+K+D+A+Q P+PQLVVEPT ARSNSFVGT+E
Sbjct: 625 IHPFCLQPDWQVSCFTPILLSAGAKSRKMKADIASQAGPLPQLVVEPTSARSNSFVGTYE 684
Query: 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVV 772
YLAPEIIKGEGHGS+VDWWTFGIFLFELLYG+TPFKG N++TL+NVVSQSL+FPG P+V
Sbjct: 685 YLAPEIIKGEGHGSAVDWWTFGIFLFELLYGKTPFKGQSNEDTLANVVSQSLKFPGTPIV 744
Query: 773 SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCD---- 828
SFHARDLIRGLL+K+P+NRLG+VKGAAEIKQHPFFEGLNWALIRCA PPELP+ D
Sbjct: 745 SFHARDLIRGLLIKDPENRLGSVKGAAEIKQHPFFEGLNWALIRCAAPPELPKFLDFGSS 804
Query: 829 -AVIGSQKKESTKCEESKGAADEHVEFEMF 857
+ + K+ + E+ ++ EFE+F
Sbjct: 805 APSVAANKENANDLED----IEDCEEFELF 830
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508158|ref|XP_003522827.1| PREDICTED: uncharacterized protein LOC100789339 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 975 bits (2521), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 544/870 (62%), Positives = 650/870 (74%), Gaps = 56/870 (6%)
Query: 1 MDGPSSTCEIVESIEELEFASKRNEKAKKHSLPKSGNKYSIEDDINRLFEAIDVKTSAKN 60
MD +TCEIVES EE+ K +EK + KSG KYSIEDDIN+LF+AI++K+S+++
Sbjct: 1 MDTSGNTCEIVESREEIISEFKMDEKPESSCAHKSGKKYSIEDDINQLFQAIEIKSSSRS 60
Query: 61 LDA--LRKSALKRPIRVSSSQALGIGISEPVNLKQALRGLCISQAAEMAAMKRLSKPSGS 118
+ L+KSALKRPI+V+SSQA GIGISEPV+LKQALRGLCISQA+EMAA+KRL+KP S
Sbjct: 61 RSSSRLQKSALKRPIKVTSSQASGIGISEPVSLKQALRGLCISQASEMAALKRLTKPCSS 120
Query: 119 SRSSEAGTIKRLYRAVVVEANESGIPLNEGKGNLVEISLVPENITSNSSEKVHESQQVPR 178
SR SEAGTIKRLY AVV +EGKGNLVEISLVPE S S+K+
Sbjct: 121 SRVSEAGTIKRLYTAVV----------DEGKGNLVEISLVPE--ISAPSDKLS------G 162
Query: 179 AESSRHAAHHSPPLDIVTKPKAIPSKLPSLDQVVPLVTEFEEKP------KAEHHNLNSP 232
S + +H+ PL TKPK + + S Q+VPL E E + K NL SP
Sbjct: 163 VTISSSSDNHASPLVDATKPKEMITGFASQYQIVPLPLEVEGEELITGTGKPILANL-SP 221
Query: 233 ESSSVPFTREVEEVEIIAPSSVEVLVNSPVSDKGQKSKLHPGSSLSSSSNGSRLTKCGSN 292
+S+ + EV E + SS + + S + DKG ++ L S SSS G+ K S+
Sbjct: 222 VASA---SEEVPEARMHHASSSKASLGSSLPDKGHEANLPSASCPPSSSTGNGADKSTSS 278
Query: 293 SQRLVKPVFRSKGFVRRKVKQDSTSASSSCTPCDVSASNDPGPSTSYLDVHMHNCTVNNE 352
+ L KP+F + F+++KVKQD +SASS TPC TS LD N + ++
Sbjct: 279 NTCLSKPIFNNLNFLKKKVKQDLSSASSCSTPC-----------TSNLDKEGGNSDLKHD 327
Query: 353 RKENMKTTPAPSGTNMSTDVNSSVGDSSSSKPGFSLNCGNRNKAIVTKVDERSRSREKGE 412
K N K +P S +N S +VNS G + SSK GFSLNC R K +VTKVDE+SRS+EKGE
Sbjct: 328 VKHNEKQSP--SSSNHSIEVNSINGGTDSSKSGFSLNCNKRTKFLVTKVDEKSRSKEKGE 385
Query: 413 FSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHF 472
+SQSSKSSIGEYSSSTSISE+S LSGSSR G RPHMS LRW+A+R VQ+QHG + ++HF
Sbjct: 386 YSQSSKSSIGEYSSSTSISEESSLSGSSRSGHRPHMSKHLRWEAVRAVQQQHGSLNLKHF 445
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532
KL ++LG GDIGTVYLAELIGTSCLFALKVMD++FL RKKM RAQTEREI+QMLDHPFL
Sbjct: 446 KLLRRLGSGDIGTVYLAELIGTSCLFALKVMDSEFLASRKKMFRAQTEREILQMLDHPFL 505
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592
PTL++H T+K SCL+MEYCPGGDLHVLRQ+QP + FSEQA RFYVAEVLLALEYLHMLG
Sbjct: 506 PTLYSHIATDKLSCLIMEYCPGGDLHVLRQRQPYKSFSEQATRFYVAEVLLALEYLHMLG 565
Query: 593 VVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASC 652
VVYRDLKPENILVREDGHIML+DFDLSLRC+VNPM+VKSSSP E K SSPCSEASC
Sbjct: 566 VVYRDLKPENILVREDGHIMLTDFDLSLRCSVNPMLVKSSSPDTE----KTSSPCSEASC 621
Query: 653 IEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHE 712
I PFCL P WQVSCFTP LLS KSRK+K+D+A+ V P+PQLVVEPT ARSNSFVGT+E
Sbjct: 622 IHPFCLQPDWQVSCFTPILLSAGVKSRKMKADIASHVGPLPQLVVEPTSARSNSFVGTYE 681
Query: 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVV 772
YLAPEIIKGEGHGS+VDWWTFGIFLFELLYG+TPFKG N++TL+NVVSQSL+FPG P+V
Sbjct: 682 YLAPEIIKGEGHGSAVDWWTFGIFLFELLYGKTPFKGQSNEDTLANVVSQSLKFPGTPIV 741
Query: 773 SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPR-----SC 827
SFHARDLIRGLL+K+P+NRLG+VKGAAEIKQHPFFEGLNWALIRCA PPELP+ S
Sbjct: 742 SFHARDLIRGLLIKDPENRLGSVKGAAEIKQHPFFEGLNWALIRCAAPPELPKFRDFGST 801
Query: 828 DAVIGSQKKESTKCEESKGAADEHVEFEMF 857
+ + K+ + E+ ++ EFE+F
Sbjct: 802 APSVAANKENANDLED----IEDCEEFELF 827
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449496264|ref|XP_004160088.1| PREDICTED: serine/threonine-protein kinase KIPK-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 918 bits (2372), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/868 (57%), Positives = 609/868 (70%), Gaps = 35/868 (4%)
Query: 1 MDGPSSTCEIVESIEELEFASKRNEKAKKHSLPKSGNKYSIEDDINRLFEAIDVKTSAK- 59
M +ST EIVES EE + +EKA G K+SIEDDINRLF+AID+++ K
Sbjct: 1 MTTLASTSEIVESTEEFD-----SEKAGTSYGLHVGKKFSIEDDINRLFQAIDIRSLRKR 55
Query: 60 -------NLDALRKSALKRPIRVSSSQALGIGISEPVNLKQALRGLCISQAAEMAAMKRL 112
+ DALRKSA+KRP+RV S GIGISEP +LKQALRGLCISQAAEMAA KRL
Sbjct: 56 SGQQREADKDALRKSAMKRPVRVGPSHMAGIGISEPASLKQALRGLCISQAAEMAASKRL 115
Query: 113 SKPSGSSRSSEAGTIKRLYRAVVVEANESGIPLNEGKGNLVEISLVPENITSNSSEKVHE 172
++ S R SEAGTIKRLYRAVVVEAN G+P+NE K NLVEIS+V E + S K+ E
Sbjct: 116 TRSVASPRISEAGTIKRLYRAVVVEANGFGVPVNESKANLVEISIVSERLMSTFQNKMPE 175
Query: 173 SQQVPRAESSRHAAHHSPPLDIVTKPKAIPSKLPSLDQVVPLVTEFEEKPKAEHHNLNSP 232
A+ A S + +A +++ S++ P E L SP
Sbjct: 176 LLHKNEADIPNQGAESSSFKNTGVSEEAT-TEVASIE------------PPGEVGKLKSP 222
Query: 233 ESSSVPFTREVEEVEIIAPSSVEVLVNSPVSDKGQKSKLHPGSSLSSSSNGSRLTKCGSN 292
S P + +A SS E L + V +K +K + SSLSSS + R K +
Sbjct: 223 --SFTPSGEKDLAANSMAISSNEDLARNSVPEK-EKGTMSCLSSLSSSGSAVRPNKTAFS 279
Query: 293 SQRLVKPVFRSKGFVRRKVKQDSTSASSSCTPCDVSASNDPGPSTSYLDVHMHNCTVNNE 352
+ R +KP+FR+K FV++K K ++ S+ S C V+A + G + M +E
Sbjct: 280 NTRFIKPIFRTKNFVKKKAKLETNSSPSIFDVCTVTADTNLGTIAEKTENQMPENAQLHE 339
Query: 353 RKENMKTTPAPSGTNMSTDVNSSVGDSSSSKPGFSLNCGNRNKAIVTKVDERSRSREKGE 412
KE + + +V+ +V ++ SS+PG SLNC NRN+ + DERSRSREKG
Sbjct: 340 IKEEDIGSSVSCNITLGVEVSGNVVNTESSRPGTSLNCFNRNRPTIMASDERSRSREKGM 399
Query: 413 FSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHF 472
FSQSSKSS+GE SSS SIS +SILSGSSR G RPHMS DL+W+AI +Q QH C+G R+F
Sbjct: 400 FSQSSKSSVGECSSSPSISGESILSGSSRSGVRPHMSKDLKWEAIHNLQDQHKCLGSRNF 459
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532
KL ++LG GDIGTVYL+EL +SCLFA+KVMD +FL RKK+ RAQTEREI+QMLDHPFL
Sbjct: 460 KLLRRLGLGDIGTVYLSELCDSSCLFAMKVMDKEFLESRKKILRAQTEREILQMLDHPFL 519
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592
PTL+AHF T+K CLVM+YCP GDLHVLRQKQPS+ FSE+A RFYVAEVLLALEYLHMLG
Sbjct: 520 PTLYAHFETDKHLCLVMDYCPSGDLHVLRQKQPSKSFSERAVRFYVAEVLLALEYLHMLG 579
Query: 593 VVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASC 652
VVYRDLKPEN+LVREDGHIML+DFDLSLRCAVNP +++SS PV E K+ +PC E+SC
Sbjct: 580 VVYRDLKPENVLVREDGHIMLTDFDLSLRCAVNPTLLQSSFPVVE-STKRTLNPCDESSC 638
Query: 653 IEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHE 712
I+PFCLHPSWQVSCFTP++LS KSR+ K+D Q S +PQL+VEPTGARSNSFVGTHE
Sbjct: 639 IDPFCLHPSWQVSCFTPKVLSAPYKSRRTKADY--QASLLPQLIVEPTGARSNSFVGTHE 696
Query: 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVV 772
YLAPEI+KGE HGS+VDWWT+GIFLFELLYGRTPFKGS N++TL+N+VSQ+L+FP P+V
Sbjct: 697 YLAPEIVKGESHGSAVDWWTYGIFLFELLYGRTPFKGSANEDTLTNIVSQTLKFPDCPLV 756
Query: 773 SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCDAVIG 832
SFHARDLIR LL KEP+NRLG+ KGA EIKQHPFFEGLNWALIRCA PPELP+ D
Sbjct: 757 SFHARDLIRCLLTKEPENRLGSTKGAVEIKQHPFFEGLNWALIRCATPPELPKFFDGATS 816
Query: 833 S---QKKESTKCEESKGAADEHVEFEMF 857
+ E+TK + + + F++F
Sbjct: 817 TMPVDSGENTKRRDLENIETDAAMFDLF 844
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449456106|ref|XP_004145791.1| PREDICTED: serine/threonine-protein kinase KIPK-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 917 bits (2370), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/868 (57%), Positives = 609/868 (70%), Gaps = 35/868 (4%)
Query: 1 MDGPSSTCEIVESIEELEFASKRNEKAKKHSLPKSGNKYSIEDDINRLFEAIDVKTSAK- 59
M +ST EIVES EE + +EKA G K+SIEDDINRLF+AID+++ K
Sbjct: 1 MTTLASTSEIVESTEEFD-----SEKAGTSYGLHVGKKFSIEDDINRLFQAIDIRSLRKR 55
Query: 60 -------NLDALRKSALKRPIRVSSSQALGIGISEPVNLKQALRGLCISQAAEMAAMKRL 112
+ DALRKSA+KRP+RV S GIGISEP +LKQALRGLCISQAAEMAA KRL
Sbjct: 56 SGQQREADKDALRKSAMKRPVRVGPSHMAGIGISEPASLKQALRGLCISQAAEMAASKRL 115
Query: 113 SKPSGSSRSSEAGTIKRLYRAVVVEANESGIPLNEGKGNLVEISLVPENITSNSSEKVHE 172
++ S R SEAGTIKRLYRAVVVEAN G+P+NE K NLVEIS+V E + S K+ E
Sbjct: 116 TRSVASPRISEAGTIKRLYRAVVVEANGFGVPVNESKANLVEISIVSERLMSTFQNKMPE 175
Query: 173 SQQVPRAESSRHAAHHSPPLDIVTKPKAIPSKLPSLDQVVPLVTEFEEKPKAEHHNLNSP 232
A+ A S + +A +++ S++ P E L SP
Sbjct: 176 LLHKNEADIPNQGAESSSFKNTGVSEEAT-TEVASIE------------PPGEVGKLKSP 222
Query: 233 ESSSVPFTREVEEVEIIAPSSVEVLVNSPVSDKGQKSKLHPGSSLSSSSNGSRLTKCGSN 292
S P + +A SS E L + V +K +K + SSLSSS + R K +
Sbjct: 223 --SFTPSGEKDLAANSMAISSNEDLARNSVPEK-EKGTMSCLSSLSSSGSAVRPNKTAFS 279
Query: 293 SQRLVKPVFRSKGFVRRKVKQDSTSASSSCTPCDVSASNDPGPSTSYLDVHMHNCTVNNE 352
+ R +KP+FR+K FV++K K ++ S+ S C V+A + G + M +E
Sbjct: 280 NTRFIKPIFRTKNFVKKKAKLETNSSPSIFDVCTVTADTNLGTIAEKSENQMPENAQLHE 339
Query: 353 RKENMKTTPAPSGTNMSTDVNSSVGDSSSSKPGFSLNCGNRNKAIVTKVDERSRSREKGE 412
KE + + +V+ +V ++ SS+PG SLNC NRN+ + DERSRSREKG
Sbjct: 340 IKEEDIGSSVSCNITLGVEVSGNVVNTESSRPGTSLNCFNRNRPTIMASDERSRSREKGM 399
Query: 413 FSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHF 472
FSQSSKSS+GE SSS SIS +SILSGSSR G RPHMS DL+W+AI +Q QH C+G R+F
Sbjct: 400 FSQSSKSSVGECSSSPSISGESILSGSSRSGVRPHMSKDLKWEAIHNLQDQHKCLGSRNF 459
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532
KL ++LG GDIGTVYL+EL +SCLFA+KVMD +FL RKK+ RAQTEREI+QMLDHPFL
Sbjct: 460 KLLRRLGLGDIGTVYLSELCDSSCLFAMKVMDKEFLESRKKILRAQTEREILQMLDHPFL 519
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592
PTL+AHF T+K CLVM+YCP GDLHVLRQKQPS+ FSE+A RFYVAEVLLALEYLHMLG
Sbjct: 520 PTLYAHFETDKHLCLVMDYCPSGDLHVLRQKQPSKSFSERAVRFYVAEVLLALEYLHMLG 579
Query: 593 VVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASC 652
VVYRDLKPEN+LVREDGHIML+DFDLSLRCAVNP +++SS PV E K+ +PC E+SC
Sbjct: 580 VVYRDLKPENVLVREDGHIMLTDFDLSLRCAVNPTLLQSSFPVVE-STKRTLNPCDESSC 638
Query: 653 IEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHE 712
I+PFCLHPSWQVSCFTP++LS KSR+ K+D Q S +PQL+VEPTGARSNSFVGTHE
Sbjct: 639 IDPFCLHPSWQVSCFTPKVLSAPYKSRRTKADY--QASLLPQLIVEPTGARSNSFVGTHE 696
Query: 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVV 772
YLAPEI+KGE HGS+VDWWT+GIFLFELLYGRTPFKGS N++TL+N+VSQ+L+FP P+V
Sbjct: 697 YLAPEIVKGESHGSAVDWWTYGIFLFELLYGRTPFKGSANEDTLTNIVSQTLKFPDCPLV 756
Query: 773 SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCDAVIG 832
SFHARDLIR LL KEP+NRLG+ KGA EIKQHPFFEGLNWALIRCA PPELP+ D
Sbjct: 757 SFHARDLIRCLLTKEPENRLGSTKGAVEIKQHPFFEGLNWALIRCATPPELPKFFDGATS 816
Query: 833 S---QKKESTKCEESKGAADEHVEFEMF 857
+ E+TK + + + F++F
Sbjct: 817 TMPVDSGENTKRRDLENIETDAAMFDLF 844
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357456077|ref|XP_003598319.1| Protein kinase [Medicago truncatula] gi|355487367|gb|AES68570.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 905 bits (2339), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/903 (55%), Positives = 612/903 (67%), Gaps = 109/903 (12%)
Query: 1 MDGPSSTCEIVESIEELEFASKRNEKAKKHSLPKSGNKYSIEDDINRLFEAIDVKTSAKN 60
M+ S+TCEIVE EE+ + +EK + KSG +YSIE DI+RLF+AI++K+S++
Sbjct: 1 MNASSNTCEIVEYREEIFPEFETDEKPQSSCSYKSGKRYSIEADIDRLFKAIEIKSSSRG 60
Query: 61 LDALR--KSALKRPIRVSSSQALGIGISEPVNLKQALRGLCISQAAEMAAMKRLSKPSGS 118
R +S+LKRPI+V SQA GIGI+EPV+LKQALRGLCISQA+EMAA+KR+SK S
Sbjct: 61 HSTSRSQQSSLKRPIKVCPSQASGIGIAEPVSLKQALRGLCISQASEMAALKRVSKQCSS 120
Query: 119 SRSSEAGTIKRLYRAVVVEANESGIPLNEGKGNLVEISLVPENITSNSSEKVHESQQVPR 178
SR SE GT+K+L VEISLVPE T S + P
Sbjct: 121 SRVSEVGTVKKL----------------------VEISLVPEISTL--------SGKFPV 150
Query: 179 AESSRHAAHHSPPLDIVTKPKAIPSKLPSLDQVVPLVTEFEEKPKAEHHNLNSPESSSVP 238
S +A+HS P+ T+ + ++ S DQ+VPL E E A L
Sbjct: 151 VAISSSSANHSIPVVSATRLTEMTTRFVSQDQIVPLPPEVE----AGKQTLQ-------- 198
Query: 239 FTREVEEVEIIAPSSVEVLVNSPVSDKGQKSKLHPGSSLSSSSNGSRLTKCGSNSQRLVK 298
T EV EV + ++ + ++S + DK ++ H S SSSN S + K S S L K
Sbjct: 199 -TEEVLEVRMNPATTSKSCLSSSMPDKDREKNFHCASCPPSSSNDSGVGKNSSLSTCLAK 257
Query: 299 PVFRSKGFVRRKVKQDSTSASSSCTPCDVSASNDPGPSTSYLDVHMHNCTVNNERKENMK 358
P+F + F+++KVK+D SASS +TS + N + ++ KEN
Sbjct: 258 PIFNNMNFLKKKVKKDQCSASSC--------------ATSSFNKENGNSDLKHDIKEN-D 302
Query: 359 TTPAPSGTNMSTDVNSSVGDSSSSKPGFSLNCGNRNKAIVTKVDERSRSREKGEFSQSSK 418
P+P +N S +VNS SSKPGFSLN + K +VTKVDE+SRS+EKGEFSQSSK
Sbjct: 303 DKPSPCSSNHSIEVNSINVSRDSSKPGFSLNFSKKTKFLVTKVDEKSRSKEKGEFSQSSK 362
Query: 419 SSIGEYSSSTSISEDSI-LSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKK 477
SS+GEYS+S++ + LSGSSR G RPHMS RW+AIR +Q+QHG + +RHF+L +K
Sbjct: 363 SSMGEYSTSSTSISEESNLSGSSRSGQRPHMSKHSRWEAIRAIQQQHGNLNLRHFRLIRK 422
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFA 537
LG GDIGTVYLAELIGTSCLFALKVMDN+FL RKK R QTEREI+QMLDHPFLPTL++
Sbjct: 423 LGSGDIGTVYLAELIGTSCLFALKVMDNEFLASRKKTFRVQTEREILQMLDHPFLPTLYS 482
Query: 538 HFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAAR---------------------- 575
H TT K SCLVMEYCPGGDLHVLRQKQ + FSEQAAR
Sbjct: 483 HITTTKLSCLVMEYCPGGDLHVLRQKQTYKSFSEQAARDGRSWESPREINHVENFKIALI 542
Query: 576 ----------------FYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
FYVAEVLLALEYLHM+GVVYRDLKPENILVREDGHIML+DFDLS
Sbjct: 543 NVAKIIVFMHLQLSRMFYVAEVLLALEYLHMMGVVYRDLKPENILVREDGHIMLTDFDLS 602
Query: 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSR 679
LRC+VN M+VK+SSP + KK SSPCS ASCI PFCL P WQVSCF P LLS AKSR
Sbjct: 603 LRCSVNAMLVKTSSP-DADAAKKTSSPCSGASCIHPFCLQPDWQVSCFAPILLSPGAKSR 661
Query: 680 KIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFE 739
K+K+D+AAQV P+PQLVVEPT ARSNSFVGT+EYLAPEIIK EGHG++VDWWTFGIFLFE
Sbjct: 662 KMKADIAAQVGPLPQLVVEPTNARSNSFVGTYEYLAPEIIKSEGHGNAVDWWTFGIFLFE 721
Query: 740 LLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAA 799
LLYG+TPFKG ND+TLSNVVS+SL+FPG P+VSFHARDLIRGLL+K+P+NRLG++KGAA
Sbjct: 722 LLYGKTPFKGPSNDDTLSNVVSESLKFPGTPIVSFHARDLIRGLLIKDPENRLGSIKGAA 781
Query: 800 EIKQHPFFEGLNWALIRCAVPPELPRSCD-----AVIGSQKKESTKCEESKGAADEHVEF 854
EIKQHPFFEGLNWALIRCA PPELP+ D + +QK+ + E+ D+ EF
Sbjct: 782 EIKQHPFFEGLNWALIRCAAPPELPKFRDFGTSAPSMAAQKENANDLED----IDDCEEF 837
Query: 855 EMF 857
E+F
Sbjct: 838 ELF 840
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225440934|ref|XP_002277025.1| PREDICTED: serine/threonine-protein kinase KIPK-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2331), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/879 (57%), Positives = 630/879 (71%), Gaps = 49/879 (5%)
Query: 7 TCEIVESIEELEFAS------------KRNEKAKKHSLPKSGNKYSIEDDINRLFEAIDV 54
+CEIVES E+ A K ++K +K + K G+ S+EDD+NR+FEAI++
Sbjct: 7 SCEIVESSEDPSLAQLSRGIHRPKSGVKVDDKVRKPPILKLGHDSSLEDDLNRIFEAINL 66
Query: 55 KTSAK--------NLDALRKSALKRPIRVSSSQALGIGISEPVNLKQALRGLCISQAAEM 106
K ++K D+ K+ALK+PI VS S + IGISEP LKQALRGLCISQA+EM
Sbjct: 67 KNASKVWGLPHQVGTDSPSKNALKKPITVSGSHSPRIGISEPATLKQALRGLCISQASEM 126
Query: 107 AAMKRLSKPSGSSRSSEAGTIKRLYRAVVVEANESGIPLNEGKGNLVEISLVPENITSNS 166
AA+KRLSK S +SEAG IK L+ VVVEA + G+ L GKG + EISL PE TSN+
Sbjct: 127 AAVKRLSKSGSYSGASEAGRIKSLFSTVVVEARQPGMSL--GKGGIAEISLFPEESTSNA 184
Query: 167 SEKVHESQQVPRAESSRHAAHHSPPLDIVTKPKAIPSKLPSLDQVVPLVTEFEEKP---- 222
SEKV + VP+ +SS +AH SP + ++ P ++VP+ TE +
Sbjct: 185 SEKVTQYLHVPKVKSSSQSAHSSPRFAVGATQLGTTARSPQ-SEIVPVSTEISNQTSKTV 243
Query: 223 -KAEHHNLNSPESSSVPFTREVEEVEIIAPSSVEVLVNSPVSDKGQKSKLHPGSSLSSSS 281
K +H ++ + ++ + E+ +S + + G+K +L S S +S
Sbjct: 244 QKEKHTSVTALSGANT--DDNMLELGTTGHASTKSANRASALKPGRKGRLQNVPSSSVNS 301
Query: 282 NGSRLTKCGSNSQRLVKPVFRSKGFVRRKVKQDSTSASSSCTPCDVSASNDPGPSTSYLD 341
+ + + N+QR+VKP+ R+K FV++KVKQDS SA+S+ C +++ PSTS L
Sbjct: 302 SKASKST--KNTQRVVKPILRNKNFVKKKVKQDSNSATSTSNTCS-EVNDEMDPSTSQLV 358
Query: 342 VHMHNCTVNNERKENMKTTPAPSGTNMSTDVNSSVGDSSSSKPGFSLNCGNRNKAIVTKV 401
+C + + RKE + +P + ++ST+ + S +S ++KPG S N NR+KAI K
Sbjct: 359 CQRCHCALKDARKELSQDSPTSNLKSLSTEASFSNMNSVANKPGISSNSYNRHKAIFVKA 418
Query: 402 DERSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQ 461
++ ++SREKGE SQSSKSS GEYSSSTSISE+SILSGSS G+RPHMS DLRW+AIR VQ
Sbjct: 419 NKNAKSREKGELSQSSKSSRGEYSSSTSISEESILSGSS-CGNRPHMSKDLRWEAIRQVQ 477
Query: 462 KQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTER 521
Q G +G+RHF L KKLG GDIGTVYLAELIGT CLFA+KVMDNDFL RKKMPRAQTER
Sbjct: 478 MQQGVLGLRHFNLLKKLGGGDIGTVYLAELIGTCCLFAIKVMDNDFLARRKKMPRAQTER 537
Query: 522 EIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEV 581
EI++MLDHPFLPTL+A FT++ SCLVMEYCPGGDLHVLRQKQP R F EQAARFYVAEV
Sbjct: 538 EILRMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQPGRNFPEQAARFYVAEV 597
Query: 582 LLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPK 641
LLALEYLHMLGVVYRDLKPENILVREDGHIML+DFDLSLRC VNP ++KSSS E P +
Sbjct: 598 LLALEYLHMLGVVYRDLKPENILVREDGHIMLTDFDLSLRCNVNPTLLKSSSSTME-PTR 656
Query: 642 KASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701
S PC E+SCI+P C+ PS +V CF+PR L AA++RK+KS+LAAQV +PQLV EPT
Sbjct: 657 MMSGPCKESSCIDPLCIEPSCEVPCFSPRFLPAAARTRKLKSELAAQVRSLPQLVAEPTD 716
Query: 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS 761
ARSNSFVGTHEYLAPEIIKGEGHGS+VDWWTFG+FL+ELLYG+TPFKGSGNDETL+NVV
Sbjct: 717 ARSNSFVGTHEYLAPEIIKGEGHGSAVDWWTFGVFLYELLYGKTPFKGSGNDETLANVVL 776
Query: 762 QSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPP 821
QSL+FP P++SF ARDLIRGLL+KEP+NRLG+ +GAAEIKQHPFFEGLNWALIRC +PP
Sbjct: 777 QSLKFPDNPIISFQARDLIRGLLMKEPENRLGSERGAAEIKQHPFFEGLNWALIRCTIPP 836
Query: 822 ELPRSCD---AVIGSQKKESTKCEESKGAADEHVEFEMF 857
ELP + + SQ+KES +++EFE+F
Sbjct: 837 ELPEFGEFGLMTVASQQKES-----------KYLEFELF 864
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297734827|emb|CBI17061.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 898 bits (2320), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 506/861 (58%), Positives = 576/861 (66%), Gaps = 187/861 (21%)
Query: 5 SSTCEIVESIEELEFASKRNEKAKKHSLPKSGNKYSIEDDINRLFEAIDVKTSAK----- 59
+ T EIVES EEL+ K N+ A +H L K G YSIEDDIN+LFEAID++ S +
Sbjct: 6 AGTSEIVESAEELDSELKMNDIAGRHRLLKPGQNYSIEDDINQLFEAIDIRCSGRVSGTS 65
Query: 60 ---NLDALRKSALKRPIRVSSSQALGIGISEPVNLKQALRGLCISQAAEMAAMKRLSKPS 116
+ DA RKSA+KRPIRVSS Q+ GIGISE V+LKQALRGLCISQA+EMAAMKRLSKP+
Sbjct: 66 HQVSKDAFRKSAMKRPIRVSSPQSSGIGISESVSLKQALRGLCISQASEMAAMKRLSKPA 125
Query: 117 GSSRSSEAGTIKRLYRAVVVEANESGIPLNEGKGNLVEISLVPENITSNSSEKVHESQQV 176
G S SSEAGTIKRLYRAVVV+A+ESG+P NEGKGNLVEISLVPE TS+ EKV ES Q
Sbjct: 126 GLSGSSEAGTIKRLYRAVVVDASESGLPFNEGKGNLVEISLVPEKSTSSFYEKVPESLQK 185
Query: 177 PRAESSRHAAHHSPPLDIVTKPKAIPSKLPSLDQVVPLVTEFEEKPKAEHHNLNSPESSS 236
+AE ++ K K H L+
Sbjct: 186 SKAELEQNG-----------------------------------KRKPVHSLLSVDAGER 210
Query: 237 VPFTREVEEVEIIAPSSVEVLVNSPVSDKGQKSKLHPGSSLSSSSNGSRLTKCGSNSQRL 296
+P ++E I P+ EV + DKGQK
Sbjct: 211 LP------KLEKIVPTLNEVASKTSTLDKGQK---------------------------- 236
Query: 297 VKPVFRSKGFVRRKVKQDSTSASSSCTPCDVSASNDPGPSTSYLDVHMHNCTVNNERKEN 356
VFRSK FV++KVK DS AS+
Sbjct: 237 ---VFRSKNFVKKKVKLDSALAST------------------------------------ 257
Query: 357 MKTTPAPSGTNMSTDVNSSVGDSSSSKPGFSLNCGNRNKAIVTKVDERSRSREKGEFSQS 416
P+G+N ++SSV DS +SKPGF NC NR + VTK DERSRS EKGEFSQS
Sbjct: 258 ------PAGSN---PLSSSVVDSDASKPGFGSNCSNRTRG-VTKGDERSRSSEKGEFSQS 307
Query: 417 SKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHK 476
SKSSIG+YSSSTSISE+S +SGSSR G+RPHMS DLRW+AI VQKQH G+R+FKL K
Sbjct: 308 SKSSIGQYSSSTSISEESNVSGSSRSGNRPHMSKDLRWEAIHHVQKQHETFGLRNFKLLK 367
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLF 536
+LGCGDIGTVYL EL GT+CLFALKVMDN+FL RKKMPRAQTEREI+QMLDHPFLPTL+
Sbjct: 368 RLGCGDIGTVYLVELTGTNCLFALKVMDNEFLATRKKMPRAQTEREILQMLDHPFLPTLY 427
Query: 537 AHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYR 596
AHFTT+K SCLVMEYCPGGDLHVLRQKQPSR FSEQAARFY AEVLLALEYLHMLGVVYR
Sbjct: 428 AHFTTDKLSCLVMEYCPGGDLHVLRQKQPSRSFSEQAARFYAAEVLLALEYLHMLGVVYR 487
Query: 597 DLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPF 656
DLKPENILVREDGHIMLSDFDLSLRCAVNPM++KS+SPV
Sbjct: 488 DLKPENILVREDGHIMLSDFDLSLRCAVNPMLLKSASPV--------------------- 526
Query: 657 CLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAP 716
+KSDLA QV+P+PQLV EPT ARSNSFVGTHEYLAP
Sbjct: 527 ------------------------LKSDLATQVTPLPQLVAEPTSARSNSFVGTHEYLAP 562
Query: 717 EIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHA 776
EIIKGEGHGS+VDWWTFGIFL+ELLYG+TPFKGSGN++TL++VVS SL+FP P+VSFHA
Sbjct: 563 EIIKGEGHGSAVDWWTFGIFLYELLYGKTPFKGSGNEDTLASVVSHSLKFPESPMVSFHA 622
Query: 777 RDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCDAVIGSQKK 836
RDLIRGLLVKEP+NRLG+VKGA EIKQH FFEGLNWALIRCA+PPE+P+ CDA GS
Sbjct: 623 RDLIRGLLVKEPENRLGSVKGATEIKQHSFFEGLNWALIRCAIPPEMPKLCDAGTGST-- 680
Query: 837 ESTKCEESKGAADEHVEFEMF 857
C VEFE+F
Sbjct: 681 ----C----------VEFELF 687
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356570839|ref|XP_003553591.1| PREDICTED: serine/threonine-protein kinase KIPK-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 859 bits (2219), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/891 (55%), Positives = 609/891 (68%), Gaps = 57/891 (6%)
Query: 1 MDGPSSTCEIVESIEELEFASKR-------------NEKAKKHSLPKSGNKYSIEDDINR 47
M S TCEIVE+ EE E +++ +EK +K S+ K G K ++DDIN+
Sbjct: 1 MGSFSGTCEIVEAREE-ELNTRKAPGVYQSSSECSTSEKNQKFSVLKLGYKDDLDDDINK 59
Query: 48 LFEAIDVKTSAKNLDALR-------KSALKRPIRVSSSQALGIGISEPVNLKQALRGLCI 100
LFE+I +K+S+++L + KSALK+PI + ++ +G SEP NLKQALR LCI
Sbjct: 60 LFESIALKSSSRDLSLFQDGTSPRLKSALKKPITMGIPRSPRVGTSEPANLKQALRDLCI 119
Query: 101 SQAAEMAAMKRLSKPSGSS-RSSEAGTIKRLYRAVVVEANESGIPLNEGKGNLVEISLVP 159
S+A+EMAAMKRLSK + +S R SE G I+ LY +VV E + SG E G +EISLVP
Sbjct: 120 SKASEMAAMKRLSKSTTASPRLSEVGKIQTLYNSVVAETSRSGSSFVESNGRQIEISLVP 179
Query: 160 ENITSNSSEKVHESQQVP----RAESSRHAAHHSPPLD-----IVTKPKAIPSKLPSLDQ 210
E S S EK +S Q+ SSR A + D I + SK+ Q
Sbjct: 180 EKGKSLSLEKTSQSSQIALLSRNIHSSREIAVATTKYDAGTSLIQSDLAGSSSKVGIQSQ 239
Query: 211 -VVPLVTEFEEKPKAEHHNLNSPESSSVPFTREVEEVEIIAPSSVEVLVNSPVSDKGQKS 269
VVP+ TE E + +SP + + EV A S ++ + VS+ G+K
Sbjct: 240 RVVPVETE-------EQASASSPSLYNTSGCKS--EVPKNASSPKKLGNKTSVSNTGKKG 290
Query: 270 KLHPGSSLSSSSNGSRLTKCGSNSQRLVKPVFRSKGFVRRKVKQDSTSASSSCTPCDVSA 329
+L SS S++ NG+R+ K ++ VK V ++K ++K K+DS S TP +V
Sbjct: 291 RLQTVSS-SNAVNGNRVNKPPRHAPWTVKSVIKNKNLSKKKQKEDSCSTLCGPTPNEV-- 347
Query: 330 SNDPGPSTSYLDVHMHNCTVNNERKENMKTTPAPSGTNMSTDVNSSVGDSSSSKPGFSLN 389
N P P T L C + N +E + A T+ VN S S S+KPG +
Sbjct: 348 -NKPVPGTPRLICERCRCALENTSEEKNQDIVALDSTSPENGVNLSNVHSGSNKPGLVSS 406
Query: 390 CGNRNKAIVTKVDERSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMS 449
N++K V KV + ++ +E+ EFSQSSKSS GEYSSSTS S++S +SGSSR +RPHMS
Sbjct: 407 SVNKSKT-VAKV-KNTKLKEQIEFSQSSKSSQGEYSSSTSTSDESNVSGSSRS-TRPHMS 463
Query: 450 NDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV 509
D+RW AIR Q QHG +G+RHF L KKLGCGDIGTVYLAELIGTSCLFA+KVMDN+FL
Sbjct: 464 KDVRWAAIRHAQVQHGVLGLRHFNLLKKLGCGDIGTVYLAELIGTSCLFAIKVMDNEFLE 523
Query: 510 GRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFF 569
RKKMPRAQTEREI+++LDHPFLPT++A FT++ SCLVMEYCPGGDLHVLRQKQ R+F
Sbjct: 524 RRKKMPRAQTEREILRILDHPFLPTMYAQFTSDNLSCLVMEYCPGGDLHVLRQKQLGRYF 583
Query: 570 SEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629
SE AARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML+DFDLSLRCAVNPM++
Sbjct: 584 SEPAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLTDFDLSLRCAVNPMLL 643
Query: 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQV 689
KSS + P K S ++ASCIEPFC+ PS QV CF+PRLL AAK+RK+K DLAAQV
Sbjct: 644 KSS----DVDPAKISGLSAQASCIEPFCIEPSCQVPCFSPRLLPTAAKARKLKVDLAAQV 699
Query: 690 SPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKG 749
+PQLV EPT ARSNSFVGTHEYLAPEIIK EGHG++VDWWTFG+FL+ELLYGRTPFKG
Sbjct: 700 RSLPQLVAEPTDARSNSFVGTHEYLAPEIIKEEGHGAAVDWWTFGVFLYELLYGRTPFKG 759
Query: 750 SGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
S N+ETL+NVV LRFP +P VSF A+DLIRGLLVKEP+NRLG+ KGAAEIKQHPFFEG
Sbjct: 760 SNNEETLANVVLLGLRFPEHPNVSFQAKDLIRGLLVKEPENRLGSEKGAAEIKQHPFFEG 819
Query: 810 LNWALIRCAVPPELPRSCDAVIGSQKKESTKCEESK---GAADEHVEFEMF 857
LNWALIRCA+PPELP D G +++C+ +K EHVEFE+F
Sbjct: 820 LNWALIRCAMPPELPDFYD--FGVSDMMNSQCKGAKYLECKVGEHVEFELF 868
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 857 | ||||||
| TAIR|locus:2049485 | 949 | AT2G36350 [Arabidopsis thalian | 0.478 | 0.432 | 0.653 | 1.9e-171 | |
| TAIR|locus:2085191 | 934 | KIPK "KCBP-interacting protein | 0.630 | 0.578 | 0.538 | 3.6e-168 | |
| TAIR|locus:2144598 | 926 | AT5G03640 [Arabidopsis thalian | 0.477 | 0.441 | 0.649 | 4.2e-161 | |
| TAIR|locus:2160922 | 586 | D6PKL2 "D6 protein kinase like | 0.478 | 0.699 | 0.634 | 4.8e-142 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.477 | 0.808 | 0.619 | 6.2e-142 | |
| TAIR|locus:2178388 | 498 | D6PK "D6 protein kinase" [Arab | 0.479 | 0.825 | 0.616 | 1.9e-138 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.434 | 0.531 | 0.657 | 5.2e-136 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.435 | 0.487 | 0.627 | 2.2e-128 | |
| TAIR|locus:2091443 | 578 | ATPK7 [Arabidopsis thaliana (t | 0.437 | 0.648 | 0.626 | 2.7e-128 | |
| TAIR|locus:2174885 | 499 | AT5G40030 [Arabidopsis thalian | 0.471 | 0.809 | 0.591 | 1.1e-126 |
| TAIR|locus:2049485 AT2G36350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1432 (509.1 bits), Expect = 1.9e-171, Sum P(3) = 1.9e-171
Identities = 274/419 (65%), Positives = 326/419 (77%)
Query: 446 PHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDN 505
PHMS D+RW+A++ V+ Q+G +G+RHF L KKLGCGDIGTVYLAEL+GT+CLFA+KVMDN
Sbjct: 533 PHMSMDVRWEAVKHVKLQYGSLGLRHFNLLKKLGCGDIGTVYLAELVGTNCLFAIKVMDN 592
Query: 506 DFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQP 565
+FL RKK PRAQ ER I++MLDHPFLPTL+A FT++ SCLVMEYCPGGDLHVLRQKQ
Sbjct: 593 EFLARRKKTPRAQAERAILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQL 652
Query: 566 SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625
SR FSE A RFYVAE+LLALEYLHMLGV+YRDLKPENILVREDGHIML+DFDLSLRCAVN
Sbjct: 653 SRCFSEPATRFYVAEILLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCAVN 712
Query: 626 PMXXXXXXXXXXXXXXXXXXXXXXXXXIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD- 684
P I+P C+ PS +V CF+PRLLS A+++K +
Sbjct: 713 P-TLLRSTSPPEKDPARMSGPYSTSNCIQPLCIEPSCRVPCFSPRLLSTQARNQKPRKPK 771
Query: 685 ----LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFEL 740
L Q +PQLV EPT ARSNSFVGTHEYLAPEIIKGEGHG++VDWWTFG+ L+EL
Sbjct: 772 RPDLLTQQFRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVLLYEL 831
Query: 741 LYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAE 800
LYG+TPFKG N+ETLSNVV Q+L+FP P+VSF A++LIR LLVK+P++RLG+ KGAAE
Sbjct: 832 LYGKTPFKGYDNEETLSNVVYQNLKFPDSPLVSFQAKELIRRLLVKDPESRLGSEKGAAE 891
Query: 801 IKQHPFFEGLNWALIRCAVPPELPRSCD--AVIGSQKKESTKCEESKGAADEHVEFEMF 857
IK+HPFFEGLNWALIRCA+PPELP D A + + + + E K D H+EFE+F
Sbjct: 892 IKRHPFFEGLNWALIRCAIPPELPDIYDNGATEATSPEGNNRYLECKAIGD-HLEFELF 949
|
|
| TAIR|locus:2085191 KIPK "KCBP-interacting protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1431 (508.8 bits), Expect = 3.6e-168, Sum P(3) = 3.6e-168
Identities = 303/563 (53%), Positives = 358/563 (63%)
Query: 314 DSTSASSSCTPCDVS---ASNDPGPSTSYLDVHMHN-CTVNNERKENMKTTPAPSGTNMX 369
DS++ C C S S D P SY H CT + N + +
Sbjct: 376 DSSANQLLCQRCHCSLKSTSIDDNPP-SYTSSHNPKICTDSLSSVSNKEAHQGSDENSSG 434
Query: 370 XXXXXXXXXXXXXXXXXXLNCGNRNK--AIVTKVDERSRSREKGEFXXXXXXXXXXXXXX 427
++ N + A+V K E S EK EF
Sbjct: 435 SCNVSQSSEADIVIMKQDVSSSNNSGIGAMVEKETENPTSSEKFEFSLSSKDSLGDYSRS 494
Query: 428 XXXXXXXXXXXXXXXXXXPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVY 487
PHMS D+RW+AI+ ++ Q+G +G+RHF L KKLGCGDIGTVY
Sbjct: 495 TSISEESNLSRFSCGNK-PHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVY 553
Query: 488 LAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547
LAELIGT+CLFA+KVMDN+FL RKK PRAQ EREI++MLDHPFLPTL+A FT++ SCL
Sbjct: 554 LAELIGTNCLFAIKVMDNEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCL 613
Query: 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE 607
VMEYCPGGDLHVLRQKQ R F E AARFYVAE+LLALEYLHMLG++YRDLKPENILVRE
Sbjct: 614 VMEYCPGGDLHVLRQKQLGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVRE 673
Query: 608 DGHIMLSDFDLSLRCAVNPMXXXXXXXXXXXXXXXXXXXXXXXXXIEPFCL-HPSWQVSC 666
DGHIML+DFDLSLRCAVNP I+PFC+ PS QVSC
Sbjct: 674 DGHIMLTDFDLSLRCAVNP-TLVRSNSPPGKDPARISGPYNTSNCIQPFCITEPSCQVSC 732
Query: 667 FTPRLLSVAAKSRKIK-----SDLAAQVS-PMPQLVVEPTGARSNSFVGTHEYLAPEIIK 720
F+PRL S + RK K S +S +PQLV EPT ARSNSFVGTHEYLAPEIIK
Sbjct: 733 FSPRLSSNQQQGRKPKRGDHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIK 792
Query: 721 GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLI 780
GEGHG++VDWWTFG+ L+ELLYG+TPFKG NDETL+NVV Q+L+FP P+VSF A+DLI
Sbjct: 793 GEGHGAAVDWWTFGVLLYELLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVSFQAKDLI 852
Query: 781 RGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPR------SCDAVIGSQ 834
RGLLVKEP+NRLG+ KG+ EIK+HPFFEGLNWALIRCA+PPELP +A S
Sbjct: 853 RGLLVKEPENRLGSEKGSVEIKRHPFFEGLNWALIRCAIPPELPDFYEYGGGPEAAADSP 912
Query: 835 KKESTKCEESKGAADEHVEFEMF 857
+ + E K D H+EFE+F
Sbjct: 913 GGSNNRYLECKAIGD-HLEFELF 934
|
|
| TAIR|locus:2144598 AT5G03640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1397 (496.8 bits), Expect = 4.2e-161, Sum P(3) = 4.2e-161
Identities = 271/417 (64%), Positives = 320/417 (76%)
Query: 446 PHMSNDLRWDAIRCVQKQHGC--MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM 503
PHMS D+RW+AI+ ++ QHG +G+RHF L KKLGCGDIGTVYLAEL GT+CLFA+KVM
Sbjct: 513 PHMSKDVRWEAIQHIRAQHGLGSLGLRHFNLLKKLGCGDIGTVYLAELTGTNCLFAIKVM 572
Query: 504 DNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQK 563
DN+FL R KM RAQTE++I++MLDHPFLPTL+AHFT++ SCLVME CPGGDLHVLRQK
Sbjct: 573 DNEFLERRNKMSRAQTEKDILKMLDHPFLPTLYAHFTSDNLSCLVMECCPGGDLHVLRQK 632
Query: 564 QPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623
QP R+F E AARFYVAEVLLALEYLHMLGV+YRDLKPENILVR+DGHIM++DFDLSLRC
Sbjct: 633 QPGRWFPEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRDDGHIMVTDFDLSLRCT 692
Query: 624 VNPMXXXXXXXXXXXXXXXXXXXXXXXXXIEPFCLHPSWQVSCFTPRLLSVAAKS--RKI 681
V+P IEP C P P+ + +K+
Sbjct: 693 VSPTLLNSSSPLHADAMRLSSGSRTGSNCIEPSCFRPKLSRGS-GPKKKGKQHRMMMKKL 751
Query: 682 K-SDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFEL 740
K SDL A+ +PQLV EPT ARSNSFVGTHEYLAPEIIKGEGHG++VDWWTFGIFL+EL
Sbjct: 752 KKSDLIARFKSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYEL 811
Query: 741 LYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAE 800
LYG+TPFKG+ N+ET++NVV QSL+FP P VSF A+DLIRGLLVKEP+NRLG KGAAE
Sbjct: 812 LYGKTPFKGATNEETIANVVLQSLKFPDNPNVSFQAKDLIRGLLVKEPENRLGTEKGAAE 871
Query: 801 IKQHPFFEGLNWALIRCAVPPELPRSCDAVIGSQKKESTKCEESKGAADEHVEFEMF 857
IK+H FFEGLNWALIRCA+PPELP D + +Q+ +S + K A EH+EFE+F
Sbjct: 872 IKRHAFFEGLNWALIRCAIPPELPDFYDYGVPNQEGKSNYLD-CK-AVGEHLEFELF 926
|
|
| TAIR|locus:2160922 D6PKL2 "D6 protein kinase like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1389 (494.0 bits), Expect = 4.8e-142, P = 4.8e-142
Identities = 269/424 (63%), Positives = 317/424 (74%)
Query: 446 PHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDN 505
PH +NDLRW+AI+ V+ + G +G+ HF+L K+LGCGDIG+VYL+EL GT C FA+KVMD
Sbjct: 165 PHKANDLRWEAIQAVRVRDGLLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDK 224
Query: 506 DFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQP 565
L RKK+ RAQTEREI+Q LDHPFLPTL+ HF TEKFSCLVME+CPGGDLH LRQ+QP
Sbjct: 225 TSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQRQP 284
Query: 566 SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625
+ FSEQA +FY+AE LLALEYLHMLG+VYRDLKPEN+LVREDGHIMLSDFDLSLRC V+
Sbjct: 285 GKHFSEQAVKFYIAESLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCLVS 344
Query: 626 PMXXXXXXXXXXXXXXXXXXXXXXXXXIEPFCLHPSWQV--SCFTPRLLSVAAKS-RKIK 682
P IEP C+ PS V +CF+PRL S +K RK K
Sbjct: 345 P--TLVKSAAIESDPLRKNVYCVQPACIEPSCIQPSCTVPTTCFSPRLFSSKSKKDRKPK 402
Query: 683 SDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY 742
+D A QV P+P+LV EPT ARS SFVGTHEYLAPEIIKGEGHGS+VDWWTFGIFL+ELL+
Sbjct: 403 NDTANQVRPLPELVAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF 462
Query: 743 GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIK 802
GRTPFKGSGN +TL NVV Q LRFP PVVSF ARDLIRGLL+KEP RLG +GA E+K
Sbjct: 463 GRTPFKGSGNRQTLFNVVGQPLRFPETPVVSFAARDLIRGLLMKEPQQRLGFKRGATEVK 522
Query: 803 QHPFFEGLNWALIRCAVPPELPRSCDAVIG---------SQKKESTKCEESKGAADEHVE 853
QHPFFEG+NWALIRCA PPE+P+ + G SQK + ++ +D ++E
Sbjct: 523 QHPFFEGVNWALIRCATPPEIPKPVELEKGAVSVAEAPSSQKTAAGLVLNAQKGSDNYLE 582
Query: 854 FEMF 857
F+ F
Sbjct: 583 FDFF 586
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1364 (485.2 bits), Expect = 6.2e-142, Sum P(2) = 6.2e-142
Identities = 256/413 (61%), Positives = 309/413 (74%)
Query: 446 PHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDN 505
PH +ND+RW+AI+ V+ +HG +G+ HF+L K+LGCGDIGTV+LAEL GT C FA+KVMD
Sbjct: 97 PHKANDVRWEAIQAVRTKHGVLGLNHFRLLKRLGCGDIGTVHLAELHGTRCFFAMKVMDK 156
Query: 506 DFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQP 565
L RKK+ RAQTEREI+Q LDHPFLPTL++HF TEKFSCLVME+CPGGDLH LRQ+QP
Sbjct: 157 GALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQP 216
Query: 566 SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625
+ FSEQAA+FYVAEVLLA+EYLHMLG++YRDLKPEN+LVR+DGH+MLSDFDLSLRC V+
Sbjct: 217 GKRFSEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTVS 276
Query: 626 PMXXXXXXXXXXXXXXXXXXXXXXXXXIEPFCLHPSWQVSCFTPRLLSVAAKS-RKIKSD 684
P +P C+ S +CF+PR S +K +K+K++
Sbjct: 277 PTVVRSTVLASEGQKNSGYCAQPACIQ-QPSCI--SAPTTCFSPRYFSSKSKKDKKMKNE 333
Query: 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGR 744
QVSP+P+LV EPT ARS SFVGTHEYLAPEIIKGEGHGS+VDWWTFGIFL+ELL+G+
Sbjct: 334 TGNQVSPLPELVAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGK 393
Query: 745 TPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804
TPFKGSGN TL NVV Q LRFP PVVSF ARDLIR LLVKEP +RL +GA E+KQH
Sbjct: 394 TPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRSLLVKEPQHRLAYKRGATEMKQH 453
Query: 805 PFFEGLNWALIRCAVPPELPRSCDAVIGSQKKESTKCEESKGAADEHVEFEMF 857
PFFEG+NWAL+RCA PPE+P+ D + K ++EF+ F
Sbjct: 454 PFFEGVNWALVRCASPPEIPKPVDYESAPATPAAATSTSVKSDQSNYLEFDFF 506
|
|
| TAIR|locus:2178388 D6PK "D6 protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1339 (476.4 bits), Expect = 1.9e-138, Sum P(2) = 1.9e-138
Identities = 257/417 (61%), Positives = 311/417 (74%)
Query: 446 PHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDN 505
PH +ND+RW+AI+ V+ +HG +G+ HF+L K+LGCGDIGTV+LAEL GT C FA+KVMD
Sbjct: 83 PHKANDVRWEAIQAVRTKHGGLGLNHFRLLKRLGCGDIGTVHLAELNGTRCYFAMKVMDK 142
Query: 506 DFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQP 565
L RKK+ RAQTEREI+Q LDHPFLPTL++HF TEKFSCLVME+CPGGDLH LRQ+QP
Sbjct: 143 TALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQP 202
Query: 566 SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625
+ F+EQAA+FYVAEVLLA+EYLHMLG++YRDLKPEN+LVR+DGH+MLSDFDLSLRC V+
Sbjct: 203 GKRFTEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTVS 262
Query: 626 PMXXXXXXXXXXXXXXXXXXXXXXXXXIE-PFCLHPSWQVSCFTPRLLSVAAKS-RKIKS 683
I+ P C+ + SCF PR S +K +K K+
Sbjct: 263 LSIVRSANVGSEGLSKNSVSCSQQPACIQQPSCISMA-PTSCFGPRFFSSKSKKDKKPKT 321
Query: 684 DLAA-QVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY 742
+ QV+P+P+LV EPTGARS SFVGTHEYLAPEIIKGEGHGS+VDWWTFGIFL+ELL+
Sbjct: 322 ENGNHQVTPLPELVAEPTGARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF 381
Query: 743 GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIK 802
G+TPFKGSGN TL NVV Q LRFP PVVSF ARDLIR LLVKEP +RL +GA EIK
Sbjct: 382 GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRSLLVKEPQHRLAYKRGATEIK 441
Query: 803 QHPFFEGLNWALIRCAVPPELPRSCDAVIGSQKKESTKCEESKGAADE--HVEFEMF 857
QHPFFEG+NWAL+RCA PPE+P+ D + S +D+ ++EF+ F
Sbjct: 442 QHPFFEGVNWALVRCASPPEIPKPVDLEALNPTPTVPAAASSSVRSDQSNYLEFDFF 498
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 1332 (473.9 bits), Expect = 5.2e-136, P = 5.2e-136
Identities = 253/385 (65%), Positives = 292/385 (75%)
Query: 446 PHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDN 505
PH ND RW AI ++ + G +GM HFKL K+LGCGDIG+VYL+EL GT C FA+KVMD
Sbjct: 282 PHKGNDPRWKAILAIRARDGILGMSHFKLLKRLGCGDIGSVYLSELSGTRCYFAMKVMDK 341
Query: 506 DFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQP 565
L RKK+ RAQTEREI+Q+LDHPFLPTL+ HF T++FSCLVMEYCPGGDLH LRQ+QP
Sbjct: 342 ASLASRKKLTRAQTEREILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQP 401
Query: 566 SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625
+ FSE AARFY AEVLLALEYLHMLGVVYRDLKPEN+LVR+DGHIMLSDFDLSLRCAV+
Sbjct: 402 GKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVS 461
Query: 626 PMXXXXXXXXXXXXXXXXXXXXXXXXXIEPFCLHPS---WQVSCFTPRLLSVAAKSR--K 680
P ++P C+ P+ Q +CF PRL +K + K
Sbjct: 462 P--------TLIRISSDDPSKRGAAFCVQPACIEPTTVCMQPACFLPRLFPQKSKKKTPK 513
Query: 681 IKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFEL 740
++D Q + MP+LV EPT ARS SFVGTHEYLAPEIIKGEGHGS+VDWWTFGIFL EL
Sbjct: 514 PRADSGFQANSMPELVAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLHEL 573
Query: 741 LYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAE 800
LYG+TPFKGSGN TL NVV Q L+FP P S+ +RDLIRGLLVKEP NRLG +GA E
Sbjct: 574 LYGKTPFKGSGNRATLFNVVGQQLKFPDSPATSYASRDLIRGLLVKEPQNRLGVKRGATE 633
Query: 801 IKQHPFFEGLNWALIRCAVPPELPR 825
IKQHPFFEG+NWALIRC+ PPE+PR
Sbjct: 634 IKQHPFFEGVNWALIRCSTPPEVPR 658
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1260 (448.6 bits), Expect = 2.2e-128, P = 2.2e-128
Identities = 246/392 (62%), Positives = 289/392 (73%)
Query: 446 PHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDN 505
PH ND W+AI ++ + G +GM HFKL K+LGCGDIG+VYLAEL GT C FA+KVMD
Sbjct: 337 PHKGNDPWWNAILAIRTRDGILGMSHFKLLKRLGCGDIGSVYLAELSGTRCHFAVKVMDK 396
Query: 506 DFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQP 565
L RKK+ RAQTER+I+Q+LDHPFLPTL+ HF T++FSCLVMEYCPGGDLH LRQ+QP
Sbjct: 397 ASLEDRKKLNRAQTERDILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQP 456
Query: 566 SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625
+ FSE AARFY AEVLLALEYLHMLGVVYRDLKPEN+LVR+DGHIMLSDFDLSLRCAV+
Sbjct: 457 GKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVS 516
Query: 626 PMXXXXXXXXXXXXXXXXXXXXXXXXXIEPFCLHPSW----QVSCFTPRLL----SVAAK 677
P ++P C+ P+ Q SCF PR + + K
Sbjct: 517 P---------TLIKTFDSDPSRRGAFCVQPACMEPTSACIIQPSCFLPRSIFPNKNKKNK 567
Query: 678 SRKIKSDLAAQVS-PMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIF 736
SRK ++D S +P+LV EP RS SFVGTHEYLAPEIIKGEGHGS+VDWWTFGIF
Sbjct: 568 SRKTQADFFKSHSGSLPELVAEPN-TRSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIF 626
Query: 737 LFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVK 796
+ ELLYG+TPFKGSGN TL NVV + L+FP P S+ RDLI+ LLVK+P NRLG +
Sbjct: 627 VHELLYGKTPFKGSGNRATLFNVVGEQLKFPESPATSYAGRDLIQALLVKDPKNRLGTKR 686
Query: 797 GAAEIKQHPFFEGLNWALIRCAVPPELPRSCD 828
GA EIKQHPFFEG+NWALIRC+ PPE+PR +
Sbjct: 687 GATEIKQHPFFEGVNWALIRCSTPPEVPRQME 718
|
|
| TAIR|locus:2091443 ATPK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1237 (440.5 bits), Expect = 2.7e-128, Sum P(2) = 2.7e-128
Identities = 242/386 (62%), Positives = 286/386 (74%)
Query: 446 PHM-SNDLRWDAIRCVQKQHGC-MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM 503
PH +ND RW AI+ V+ + G + + FKL KKLG GDIG VYLAELIGT FA+KVM
Sbjct: 154 PHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVSFAVKVM 213
Query: 504 DNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQK 563
+ + RKK+ RAQTE+EI+Q LDHPFLPTL++HF TE SCLVME+CPGGDLH LRQK
Sbjct: 214 EKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLHSLRQK 273
Query: 564 QPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623
Q ++F EQAARFYVAEVLLA+EYLHMLG++YRDLKPEN+LVREDGHIMLSDFDLSLRCA
Sbjct: 274 QRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 333
Query: 624 VNPMXXXXXXXXXXXXXXXX----XXXXXXXXXIEPFCLHPSWQVSCFTPRLLSVAAKSR 679
V+P ++P C+ P CFTPR LS K R
Sbjct: 334 VSPTLVRFAAITLESKSSSYCIQPTCVDQSSCIVQPDCIQPV----CFTPRFLS-KGKHR 388
Query: 680 KIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFE 739
K +D++ Q+ P+P+L+ EPT ARS SFVGTHEYLAPEIIKGEGHGS+VDWWTFGIFL+E
Sbjct: 389 KKSNDMSRQIRPLPELIAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYE 448
Query: 740 LLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAA 799
LL+G TPF+G N TL NVV Q LRFP +P VSF ARDLIRGLLVKEP +RL +GA
Sbjct: 449 LLFGITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARDLIRGLLVKEPQHRLAYRRGAT 508
Query: 800 EIKQHPFFEGLNWALIRCAVPPELPR 825
EIKQHPFF+ +NWALIRC PP++P+
Sbjct: 509 EIKQHPFFQSVNWALIRCTSPPQIPQ 534
|
|
| TAIR|locus:2174885 AT5G40030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1244 (443.0 bits), Expect = 1.1e-126, P = 1.1e-126
Identities = 249/421 (59%), Positives = 303/421 (71%)
Query: 446 PHMSNDLRWDAIRCVQ-KQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMD 504
PH NDLRWDAI+ V+ ++ +G+ HF+L KKLGCGDIG+VYLAEL C FA+KVMD
Sbjct: 87 PHKGNDLRWDAIQNVKCSKNEDLGLGHFRLLKKLGCGDIGSVYLAELREMGCFFAMKVMD 146
Query: 505 NDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQ 564
L+GRKK+ RAQTEREI+ +LDHPFLPTL++HF TEKFSCL+ME+C GGDLH+LRQKQ
Sbjct: 147 KGMLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEKFSCLLMEFCSGGDLHILRQKQ 206
Query: 565 PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624
P + FSE AARFY +EVLLALEYLHM+GVVYRDLKPEN++VREDGHIMLSDFDLSL+ V
Sbjct: 207 PGKHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENVMVREDGHIMLSDFDLSLQSFV 266
Query: 625 NPMXXXXXXXXXXXXXXXXXXXXXXXXXIEPFCLHP--SWQVSCFTPRLLSVAAKSRKIK 682
+P I+P C P Q SCF PR L+ K RK K
Sbjct: 267 SP----TLIQSTSQPSCHIASYCIQPPCIDPSCKLPVACIQPSCFKPRFLN--NKPRKAK 320
Query: 683 SDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY 742
++ A S +P L+ EPT ARS SFVGTHEYLAPEII+G+GHGSSVDWWTFGIFL+ELL
Sbjct: 321 TEKAGSDS-LPMLIAEPTAARSMSFVGTHEYLAPEIIRGDGHGSSVDWWTFGIFLYELLT 379
Query: 743 GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIK 802
G+TPFKG+GN ETL NVV Q L+FP + SF A+DLIRGLL K+P RLG KGA EIK
Sbjct: 380 GKTPFKGNGNRETLFNVVGQPLKFPEGSI-SFAAKDLIRGLLTKDPKKRLGFKKGATEIK 438
Query: 803 QHPFFEGLNWALIRCAVPPELPRSCD-AVIGSQKKESTK-----CEESKGAADEHVEFEM 856
QHPFF +NWALIR PPE+P+ D +++ K S + ++S ++ +++FE
Sbjct: 439 QHPFFNNVNWALIRSTTPPEIPKPIDLSILNETLKSSVQQQGKHSKQSDSSSGPYLDFEF 498
Query: 857 F 857
F
Sbjct: 499 F 499
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00021642001 | SubName- Full=Chromosome chr8 scaffold_23, whole genome shotgun sequence; (857 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 857 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-167 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-79 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-76 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-55 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-54 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-53 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-53 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-45 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-42 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-41 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-41 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-38 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-37 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-37 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-36 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-35 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-34 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-33 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-33 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-32 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-32 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-32 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-32 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-31 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-31 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-31 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-30 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-30 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-30 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-30 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-29 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-29 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-29 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-29 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-29 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-29 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-28 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-27 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-27 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-27 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-27 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-27 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-26 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-26 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-26 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-26 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-26 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-26 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-26 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-26 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-26 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-26 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-26 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-26 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-26 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-26 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-25 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-25 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-25 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-25 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-25 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-25 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-25 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-24 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-24 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-24 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-24 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-24 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-23 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-23 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-23 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-23 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-23 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-23 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-23 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-23 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-22 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-22 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-22 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-22 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-22 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-22 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-22 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-22 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-22 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-21 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-21 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-21 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-21 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-21 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-21 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-21 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-21 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-21 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-20 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-20 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-20 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-19 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-19 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-18 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-18 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-17 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-17 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-16 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-13 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-10 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-10 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-09 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-08 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-08 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-08 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-08 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-07 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-07 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-07 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-06 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-06 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-06 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-05 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-05 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-05 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-04 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-04 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-04 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 3e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-04 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-04 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 0.001 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.001 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.001 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.001 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 0.001 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.001 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 0.001 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.001 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.002 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.002 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 0.002 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.002 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.002 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.002 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.002 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 0.003 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.004 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 0.004 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.004 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.004 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.004 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 487 bits (1256), Expect = e-167
Identities = 187/356 (52%), Positives = 224/356 (62%), Gaps = 46/356 (12%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH 529
+HFK K LG GD+G V+L L GT LFALKV+D ++ R K+ R TE+EI+ LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
PFLPTL+A F TE + CLVM+YCPGG+L L Q+QP + SE+ ARFY AEVLLALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSE 649
+LG+VYRDLKPENIL+ E GHIMLSDFDLS + V P V + S P
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP--- 177
Query: 650 ASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709
+ E RSNSFVG
Sbjct: 178 -------------------------------------------SETFSEEPSFRSNSFVG 194
Query: 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGY 769
T EY+APE+I G+GHGS+VDWWT GI L+E+LYG TPFKGS DET SN++ + + FPG
Sbjct: 195 TEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGS 254
Query: 770 PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPR 825
P VS ARDLIR LLVK+P RLG+ +GAAEIKQHPFF G+NWALIR PP +PR
Sbjct: 255 PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPR 310
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 257 bits (660), Expect = 1e-79
Identities = 108/339 (31%), Positives = 161/339 (47%), Gaps = 64/339 (18%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HP 530
FK K +G G TV LA+ T+ +A+K++D L+ KK+ + E+E++ L+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 531 FLPTLFAHFTTEKFSCL--VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
+ L+ F E L V+EY P G+L L+ + E+ RFY AE+LLALEYL
Sbjct: 63 GIIKLYYTFQDE--ENLYFVLEYAPNGEL--LQYIRKYGSLDEKCTRFYAAEILLALEYL 118
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCS 648
H G+++RDLKPENIL+ +D HI ++DF ++ V +P S+
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFG--------------TAKVLDPNSSPESNKGD 164
Query: 649 EASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708
+ +E R SFV
Sbjct: 165 ATNIDSQ-----------------------------------------IEKNRRRFASFV 183
Query: 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG 768
GT EY++PE++ + G S D W G ++++L G+ PF+GS T ++ FP
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFP- 242
Query: 769 YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
P A+DLI LLV +P +RLG +G E+K HPFF
Sbjct: 243 -PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 9e-76
Identities = 121/357 (33%), Positives = 188/357 (52%), Gaps = 58/357 (16%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F++ K +G G G V+L T ++A+KV+ ++ R ++ + ER+I+ D P+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ L+ F E+ LVMEY PGGDL ++R+ F E+ ARFY+AE++LAL+ +H
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV----FPEETARFYIAELVLALDSVH 118
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSE 649
LG ++RD+KP+NIL+ DGHI L+DF L + KA
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKM------------------NKAKDR--- 157
Query: 650 ASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709
+ L+ S + L+ ++ R+NS VG
Sbjct: 158 -----EYYLNDSHNLLFRDNVLVRRRDHKQRRV--------------------RANSTVG 192
Query: 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QSLRFP 767
T +Y+APE+++G +G DWW+ G+ L+E+LYG PF ET + +++ +SLRFP
Sbjct: 193 TPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFP 252
Query: 768 GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELP 824
P VS A DLI LL +P++RLG+ + EIK HPFF+G++W +R PP +P
Sbjct: 253 PDPPVSPEAIDLICRLLC-DPEDRLGSFE---EIKSHPFFKGIDWENLRETKPPFVP 305
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 8e-55
Identities = 108/357 (30%), Positives = 177/357 (49%), Gaps = 47/357 (13%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F+ K +G G G V L + T ++A+K + ++ ++++ + ER+I+ D+P+
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ L+ F E + L+MEY PGGD+ L K+ + F+E+ RFY+AE +LA++ +H L
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKL 120
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLS--LRCAVNPMVVKSSSPVEEPPPKKASSPCSE 649
G ++RD+KP+N+L+ GHI LSDF L L+ + + S P
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS--HALPSNFLDFISKP 178
Query: 650 ASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709
S +W+ ++R+ A S VG
Sbjct: 179 MSSKRKA---ETWK-------------RNRRAL-------------------AYST--VG 201
Query: 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QSLRFP 767
T +Y+APE+ G+ DWW+ G+ ++E+L G PF ET +++ ++L+FP
Sbjct: 202 TPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFP 261
Query: 768 GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELP 824
+S A+DLI+ L E + RLG G EIK HPFF+G++W IR P +P
Sbjct: 262 DEVPLSPEAKDLIKRLCC-EAERRLG-NNGVNEIKSHPFFKGVDWEHIRERPAPIIP 316
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 8e-54
Identities = 110/364 (30%), Positives = 171/364 (46%), Gaps = 51/364 (14%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
F K +G G G V L + T+ L+A+K + ++ R + + ER+I+ D+
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
++ L+ F + VM+Y PGGD+ L + F E ARFY+AE+ A+E +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK 119
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDL--SLRCAVNPMVVKSSSPVE----EPPPKKAS 644
+G ++RD+KP+NIL+ DGHI L+DF L R + + EP +
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE--- 176
Query: 645 SPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704
++ + L K R+ + LA
Sbjct: 177 ----------------WSEIDRCRLKPLERRRK-RQHQRCLA------------------ 201
Query: 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--Q 762
+S VGT Y+APE++ G+ DWW+ G+ L+E+L G+ PF ET V++
Sbjct: 202 HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWET 261
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA-LIRCAVPP 821
+L P +S A DLI L ++RLG GA EIK HPFF+G+++A LIR P
Sbjct: 262 TLHIPSQAKLSREASDLILR-LCCGAEDRLGK-NGADEIKAHPFFKGIDFASLIRRQKAP 319
Query: 822 ELPR 825
+P+
Sbjct: 320 YIPK 323
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 6e-53
Identities = 67/148 (45%), Positives = 92/148 (62%), Gaps = 4/148 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+++ +KLG G G VYLA T L A+KV+ + ++ R E +I++ L HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRE--RILREIKILKKLKHPN 58
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ L+ F E LVMEYC GGDL L +K+ SE ARFY+ ++L ALEYLH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLHSK 116
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLS 619
G+V+RDLKPENIL+ EDGH+ L+DF L+
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLA 144
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 9e-53
Identities = 69/142 (48%), Positives = 92/142 (64%), Gaps = 2/142 (1%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFA 537
LG G G V L T L+A+KV+ ++ RK++ TER I+ ++HPF+ L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 538 HFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRD 597
F TE+ LV+EY PGG+L K+ FSE+ ARFY AE++LALEYLH LG++YRD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGR--FSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 598 LKPENILVREDGHIMLSDFDLS 619
LKPENIL+ DGHI L+DF L+
Sbjct: 119 LKPENILLDADGHIKLTDFGLA 140
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 66/146 (45%), Positives = 89/146 (60%), Gaps = 4/146 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F+ K LG G G V L G+ +ALK++ +V K++ E+ I+Q + HPF
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
L L+ F + LVMEY PGG+L LR+ S F E ARFY A+V+LALEYLH
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHS 119
Query: 591 LGVVYRDLKPENILVREDGHIMLSDF 616
L +VYRDLKPEN+L+ DG+I ++DF
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 2e-44
Identities = 111/357 (31%), Positives = 171/357 (47%), Gaps = 43/357 (12%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTL 535
K LG G G V LA + T L+A+K + ++ R ++ + ER+I+ D+ ++ L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 536 FAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVY 595
+ F + VM+Y PGGD+ L + F E ARFY+AE+ LA+E +H +G ++
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIH 124
Query: 596 RDLKPENILVREDGHIMLSDFDL--SLRCAVNPMVVKSSSPVEEPP--PKKASSPCSEAS 651
RD+KP+NIL+ DGHI L+DF L R N + S + + P S
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184
Query: 652 CIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711
C + RL ++ ++ K A +S VGT
Sbjct: 185 CGD---------------RLKTLEQRATKQHQRCLA-----------------HSLVGTP 212
Query: 712 EYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QSLRFPGY 769
Y+APE++ +G+ DWW+ G+ LFE+L G+ PF ET V++ +L P
Sbjct: 213 NYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQ 272
Query: 770 PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL-IRCAVPPELPR 825
+S A DLI L + RLG GA +IK HPFF ++++ IR P +P+
Sbjct: 273 VKLSPEAVDLI-TKLCCSAEERLGR-NGADDIKAHPFFSEVDFSSDIRTQPAPYVPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 5e-42
Identities = 59/149 (39%), Positives = 86/149 (57%), Gaps = 5/149 (3%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
++L +KLG G GTVY A+ GT + A+K++ +K A+ E I++ L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQ-TARREIRILRRLSHPN 59
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
+ L F + LVMEYC GGDL L + P SE A+ ++L LEYLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHS 116
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLS 619
G+++RDLKPENIL+ E+G + ++DF L+
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLA 145
|
Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 60/157 (38%), Positives = 93/157 (59%), Gaps = 2/157 (1%)
Query: 481 GDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFT 540
G G V+LA+ T ++A+KV+ ++ + ++ + TER+I+ P++ L+ F
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 541 TEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKP 600
+K LVMEY PGGDL L + S E AR Y+AE++LALEYLH G+++RDLKP
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGS--LDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121
Query: 601 ENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEE 637
+NIL+ +GH+ L+DF LS V + + E+
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 54/108 (50%), Positives = 72/108 (66%), Gaps = 3/108 (2%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
G+R+N+F GT EYLAPE++ G+G+G +VDWW+ G+ L+E+L G+ PF E +
Sbjct: 146 EGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205
Query: 760 VSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+ LRFP +S ARDLI GLL K+P RLG+ GA EIK HPFF
Sbjct: 206 LKDPLRFP--EFLSPEARDLISGLLQKDPTKRLGS-GGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-38
Identities = 104/343 (30%), Positives = 165/343 (48%), Gaps = 40/343 (11%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTL 535
K LG G G V LA + T L+A+K + ++ R ++ + ER+I+ D+ ++ L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 536 FAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVY 595
+ F + VM+Y PGGD+ L + F E ARFY+AE+ A+E +H +G ++
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIH 124
Query: 596 RDLKPENILVREDGHIMLSDFDL--SLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCI 653
RD+KP+NIL+ DGHI L+DF L R + +S V + ++ A+C
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184
Query: 654 EPFCLHP-SWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHE 712
L P + +R+ + LA + P +
Sbjct: 185 CGDRLKPLERRA-------------ARQHQRCLAHSLVGTPNYI---------------- 215
Query: 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QSLRFPGYP 770
APE++ G+ DWW+ G+ L+E+L G+ PF ET V++ SL P
Sbjct: 216 --APEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQA 273
Query: 771 VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813
+S A DLI L + P++RLG GA EIK HPFF+ ++++
Sbjct: 274 KLSPEASDLIIK-LCRGPEDRLGK-NGADEIKAHPFFKTIDFS 314
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 57/140 (40%), Positives = 86/140 (61%), Gaps = 4/140 (2%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFA 537
LG G G V L ++ + FALK + +V + +E+EI++ +HPF+ L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 538 HFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYR 596
F +K+ ++MEYC GG+L +LR + F E ARFY+A V+LA EYLH G++YR
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRG---LFDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 597 DLKPENILVREDGHIMLSDF 616
DLKPEN+L+ +G++ L DF
Sbjct: 118 DLKPENLLLDSNGYVKLVDF 137
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 6e-37
Identities = 55/143 (38%), Positives = 79/143 (55%), Gaps = 4/143 (2%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFA 537
LG G GTVYLA T A+K++ + + E EI++ L+HP + L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE--ELLREIEILKKLNHPNIVKLYG 58
Query: 538 HFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRD 597
F E LVMEYC GG L L ++ + SE + ++L LEYLH G+++RD
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 598 LKPENILV-REDGHIMLSDFDLS 619
LKPENIL+ ++G + L+DF LS
Sbjct: 118 LKPENILLDSDNGKVKLADFGLS 140
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 50/120 (41%), Positives = 73/120 (60%), Gaps = 5/120 (4%)
Query: 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG 768
GT EYLAPEII +G+G +VDWW GI ++E+L G PF + ++ +RFP
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS 219
Query: 769 YPVVSFHARDLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLNW-ALIRCAV-PPELPR 825
+ S A+DLIR LL + RLG +K G +IK HP+F G++W AL++ + P +P+
Sbjct: 220 F--FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPK 277
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 5e-35
Identities = 61/145 (42%), Positives = 87/145 (60%), Gaps = 3/145 (2%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPT 534
K LG G G V LAEL GT L+A+KV+ D ++ + TE+ ++ + HPFL
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
L + F T+ VMEY GGDL + Q S F E ARFY AE++L L++LH G++
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 595 YRDLKPENILVREDGHIMLSDFDLS 619
YRDLK +N+L+ +GHI ++DF +
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 51/119 (42%), Positives = 71/119 (59%), Gaps = 1/119 (0%)
Query: 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND 753
Q+ + VGT +Y+APE+I G+GH +VDWW+ G L+E L G PF G +
Sbjct: 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
Query: 754 ETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812
E N+++ + +P VS A DLI LLV +P+ RLGA K EIK HPFF+G++W
Sbjct: 208 EIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGA-KSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 61/152 (40%), Positives = 83/152 (54%), Gaps = 10/152 (6%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD--- 528
F+ LG G G V LAE T L+A+K + ++ R ++ E+ I + +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALE 586
HPFL LFA F TE C VMEY GGDL H+ FSE A FY A V+L L+
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV-----FSEPRAVFYAACVVLGLQ 115
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618
YLH +VYRDLK +N+L+ +G + ++DF L
Sbjct: 116 YLHENKIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 47/130 (36%), Positives = 80/130 (61%), Gaps = 5/130 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
G +++F GT +Y+APEI+ + +G +VDWW G+ L+E+L G++PF+G DE +++
Sbjct: 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV-KGAAEIKQHPFFEGLNW-ALIRCA 818
+R+P + +S A+ +++ L K P+ RLG + G +IK HPFF ++W L R
Sbjct: 210 EDEVRYPRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKE 267
Query: 819 V-PPELPRSC 827
+ PP P+
Sbjct: 268 IKPPFKPKIK 277
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 57/146 (39%), Positives = 84/146 (57%), Gaps = 4/146 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+ K +G G G V+L + +ALKVM ++ K+ E+ +++ + HPF
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
+ LF ++F ++MEY PGG+L LR S FS FY +E++ ALEYLH
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS 119
Query: 591 LGVVYRDLKPENILVREDGHIMLSDF 616
+VYRDLKPENIL+ ++GHI L+DF
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 50/117 (42%), Positives = 74/117 (63%), Gaps = 7/117 (5%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND--ETLSN 758
G ++ +F GT EY+APEII +G+ SVD+W+ GI L+ELL GR PF D E ++
Sbjct: 146 GQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND 205
Query: 759 VVSQS--LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLNW 812
++ + L FP Y + A+DLI+ LL + P+ RLG +K G +IK+H +F G +W
Sbjct: 206 ILKGNGKLEFPNY--IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 57/151 (37%), Positives = 95/151 (62%), Gaps = 6/151 (3%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
HF+L + +G G G V + + T +FA+K M+ V + + ER I+Q L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
FL L+ F E+ LV++ GGDL H+ ++ + FSE+ +F++ E++LALEYL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK----FSEEQVKFWICEIVLALEYL 116
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
H G+++RD+KP+NIL+ E GH+ ++DF+++
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIA 147
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 66/142 (46%), Positives = 85/142 (59%), Gaps = 3/142 (2%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM-LDHPFLPT 534
K LG G G V LAEL GT ++A+KV+ D ++ + TE+ I+ + HPFL
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
L F T+ VMEY GGDL + Q Q SR F E +RFY AEV LAL +LH GV+
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 595 YRDLKPENILVREDGHIMLSDF 616
YRDLK +NIL+ +GH L+DF
Sbjct: 119 YRDLKLDNILLDAEGHCKLADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 9e-32
Identities = 63/126 (50%), Positives = 82/126 (65%), Gaps = 9/126 (7%)
Query: 703 RSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS 761
R+ SF GT EY+APEII+G+ GHG +VDWW+ GI +FELL G +PF G T S V
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
Query: 762 QSLR----FPGYPVVSFHARDLIRGLLVKEPDNRLGA-VKGAAEIKQHPFFEGLNW-ALI 815
+ L+ FP + A+DL+ LL K+P RLGA +GA+EIK+HPFF+GL+W AL
Sbjct: 222 RILKCDPPFP--SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALA 279
Query: 816 RCAVPP 821
V P
Sbjct: 280 LRKVNP 285
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 60/154 (38%), Positives = 96/154 (62%), Gaps = 9/154 (5%)
Query: 472 FKLHKKLGCGDIGTVYLAELIG---TSCLFALKVMDNDFLVGRKK-MPRAQTEREIMQML 527
F+L + LG G G V+L +G L+A+KV+ +V + K +TER++++ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 528 DH-PFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYVAEVLLAL 585
PFL TL F T+ L+++Y GG+L L Q++ F+E R Y+AE++LAL
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLAL 118
Query: 586 EYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++LH LG++YRD+K ENIL+ +GH++L+DF LS
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 61/145 (42%), Positives = 84/145 (57%), Gaps = 6/145 (4%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTL 535
K LG G G V L T +A+K++ + ++ + ++ TE ++Q HPFL L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 536 FAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
F T C VMEY GG+L H+ R+ R FSE ARFY AE++ AL YLH V
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 594 VYRDLKPENILVREDGHIMLSDFDL 618
VYRDLK EN+++ +DGHI ++DF L
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 47/110 (42%), Positives = 65/110 (59%), Gaps = 6/110 (5%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
G + +FVGT EY+APE++ G+G+G +VD W+ G+ L+ELL G+ PF G L
Sbjct: 149 PGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKK 208
Query: 760 VSQSLRFPGYPV--VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+ + P +S A+DLIR LLVK+P+ RL A E QHPFF
Sbjct: 209 IGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL----TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 55/155 (35%), Positives = 88/155 (56%), Gaps = 3/155 (1%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPT 534
K + G G+VYLA+ T FA+KV+ ++ + ++ + ER IM + + P++
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
L+ F ++ + LVMEY GGD L + E A+ Y+AEV+L +E LH G++
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGII 119
Query: 595 YRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629
+RD+KPEN+L+ + GH+ L+DF LS N V
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 48/151 (31%), Positives = 85/151 (56%), Gaps = 3/151 (1%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+++ K++G G G VYL L+ LK +D + +++ A E +I++ L+HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-EDALNEVKILKKLNHP 59
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
+ + F + C+VMEY GGDL + +QK+ + F E+ + ++ LAL+YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
H +++RD+KP+NI + +G + L DF +S
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGIS 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 57/133 (42%), Positives = 79/133 (59%), Gaps = 6/133 (4%)
Query: 694 QLVVEPTGARSNSFVGTHEYLAPEIIKG--EGHGSSVDWWTFGIFLFELLYGRTPFKGSG 751
+ + R+ SF GT EY+APE+I+G GH +VDWW+ G+ FELL G +PF G
Sbjct: 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
Query: 752 NDETLSNVVSQSLR-FPGYP-VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
+ S + + L+ P +P +S ARD I+ LL K+P RLGA GA EIK HPFF+G
Sbjct: 213 EQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGA-NGADEIKNHPFFQG 271
Query: 810 LNW-ALIRCAVPP 821
++W L +P
Sbjct: 272 IDWDDLAAKRIPA 284
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 59/148 (39%), Positives = 87/148 (58%), Gaps = 2/148 (1%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F+ K + G G VYL T FA+K ++ L+ R ++ + ER+I+ ++PF
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ ++F F T++ C+VMEY GGD L + + AR Y AE +LALEYLH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLHNY 120
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLS 619
G+V+RDLKP+N+L+ GHI L+DF LS
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 62/167 (37%), Positives = 95/167 (56%), Gaps = 2/167 (1%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F + +G G G V + T ++A+KVM L+ ++ + + ER+I+ + + P+
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+P L F + LVMEY PGGDL L + +F E A+FY+AE++LA+ +H +
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF-DEDMAQFYLAELVLAIHSVHQM 121
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEP 638
G V+RD+KPEN+L+ GHI L+DF + R N MV S PV P
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN-SKLPVGTP 167
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 8e-30
Identities = 58/149 (38%), Positives = 81/149 (54%), Gaps = 2/149 (1%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
F++ ++G G G V+LA+ T + ALK M L ++ TER+I+
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
+L L F +++ L MEY PGGD L SE ARFY+AE+ A++ LH
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHE 119
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLS 619
LG ++RDLKPEN L+ GHI L+DF LS
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 50/124 (40%), Positives = 72/124 (58%), Gaps = 4/124 (3%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
R+ + GT EYLAPE+I+ +GHG +VDWWT G+ L+E + G PF +++
Sbjct: 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG 230
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLNW-ALIRCAVP 820
L+FP + ARDL++GLL + RLG +K G A++K HP+F G NW L P
Sbjct: 231 RLKFPNW--FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYP 288
Query: 821 PELP 824
+P
Sbjct: 289 APIP 292
|
Length = 329 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 53/154 (34%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQMLDH 529
+ + LG G G+VYLA T L A+K ++ L G + EREI + L H
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVE---LSGDSEEELEALEREIRILSSLQH 58
Query: 530 PFLPTLFAHFTTEKFSCL--VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
P + + E+ + L +EY GG L L +K E R Y ++L L Y
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--LPEPVIRKYTRQILEGLAY 116
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621
LH G+V+RD+K NILV DG + L+DF + R
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKR 150
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 63/147 (42%), Positives = 94/147 (63%), Gaps = 6/147 (4%)
Query: 476 KKLGCGDIGTVYLA-ELIGTSC--LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532
K LG G G V+L ++ G L+A+KV+ L R ++ R + ER+I+ ++HPF+
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVNHPFI 60
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592
L F TE L++++ GGDL K+ F+E+ +FY+AE+ LAL++LH LG
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG 118
Query: 593 VVYRDLKPENILVREDGHIMLSDFDLS 619
++YRDLKPENIL+ E+GHI L+DF LS
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLS 145
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 65/154 (42%), Positives = 94/154 (61%), Gaps = 9/154 (5%)
Query: 472 FKLHKKLGCGDIGTVYLAELIG---TSCLFALKVMDNDFLVGRKK-MPRAQTEREIMQML 527
F+L K LG G G V+L + T L+A+KV+ LV + K + +TER +++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 528 -DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYVAEVLLAL 585
PFL TL F TE L+++Y GG++ L Q+ FSE RFY E++LAL
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILAL 118
Query: 586 EYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
E+LH LG+VYRD+K ENIL+ +GH++L+DF LS
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 6e-29
Identities = 60/145 (41%), Positives = 86/145 (59%), Gaps = 6/145 (4%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTL 535
K LG G G V L T +A+K++ + ++ + ++ TE ++Q HPFL L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 536 FAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
F T C VMEY GG+L H+ R+ R F+E+ ARFY AE++ ALEYLH V
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRDV 116
Query: 594 VYRDLKPENILVREDGHIMLSDFDL 618
VYRD+K EN+++ +DGHI ++DF L
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 62/144 (43%), Positives = 87/144 (60%), Gaps = 7/144 (4%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM-LDHPFLPT 534
K LG G G V LAEL GT+ FA+K + D ++ + ER ++ + +HPFL
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 535 LFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592
LF F T++ VMEY GGDL H+ Q S F E ARFY AE++ L++LH G
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHI----QSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 593 VVYRDLKPENILVREDGHIMLSDF 616
++YRDLK +N+L+ +DGHI ++DF
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 48/121 (39%), Positives = 80/121 (66%), Gaps = 6/121 (4%)
Query: 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS 761
++++F GT +Y+APEI+KG+ + SVDWW+FG+ L+E+L G++PF G DE ++++
Sbjct: 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
Query: 762 QSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI-RCAVP 820
FP + +S A+D + L ++P RLG V G +I+QHPFF G++W + + +P
Sbjct: 211 DRPHFPRW--ISKEAKDCLSKLFERDPTKRLG-VDG--DIRQHPFFRGIDWERLEKREIP 265
Query: 821 P 821
P
Sbjct: 266 P 266
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 44/123 (35%), Positives = 76/123 (61%), Gaps = 4/123 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
G R+++F GT E+LAPE++ + +VDWW G+ ++E+L G +PF G +E ++V
Sbjct: 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV 214
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA-VKGAAEIKQHPFFEGLNW-ALIRCA 818
+ +R+P + +S A ++R LL + P+ RLG+ K A ++K+ PFF +NW L+
Sbjct: 215 NDEVRYPRF--LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARK 272
Query: 819 VPP 821
+ P
Sbjct: 273 IKP 275
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 58/144 (40%), Positives = 84/144 (58%), Gaps = 3/144 (2%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPT 534
K LG G G V+LAEL GT+ FA+K + D ++ + E+ ++ + +HPFL
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
L+ F T++ VMEY GGDL + Q F A FY AE++ L++LH G+V
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 595 YRDLKPENILVREDGHIMLSDFDL 618
YRDLK +NIL+ DGHI ++DF +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 54/129 (41%), Positives = 85/129 (65%), Gaps = 13/129 (10%)
Query: 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS 761
A++ +F GT +Y+APEI+ G+ + +SVDWW+FG+ L+E+L G++PF G +E
Sbjct: 151 AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF----- 205
Query: 762 QSLRF--PGYP-VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI--R 816
QS+R P YP ++ A+D++ L V+EP+ RLG VKG +I+QHPFF ++W+ + R
Sbjct: 206 QSIRMDNPCYPRWLTREAKDILVKLFVREPERRLG-VKG--DIRQHPFFREIDWSALEER 262
Query: 817 CAVPPELPR 825
PP P+
Sbjct: 263 EIEPPFKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 55/130 (42%), Positives = 77/130 (59%), Gaps = 5/130 (3%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
++N+F GT EYLAPE++ G G+ +VDWWT G+ L+E+L G PF +E ++ +
Sbjct: 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA--LIRCAVP 820
LRFP A+DL+ GLL ++P RLG GA EIK HPFF L+W L++ P
Sbjct: 209 PLRFPDG--FDRDAKDLLIGLLSRDPTRRLG-YNGAQEIKNHPFFSQLSWKKLLMKGIQP 265
Query: 821 PELPRSCDAV 830
P P A+
Sbjct: 266 PFKPAVSSAI 275
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 60/145 (41%), Positives = 84/145 (57%), Gaps = 5/145 (3%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ---MLDHPFLPT 534
+G G G VY T ++A+KV+ +V +K++ ER I+ + + PF+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
L F T+ LV +Y GG+L QK+ FSE A+FY+AE++LALE+LH +V
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 595 YRDLKPENILVREDGHIMLSDFDLS 619
YRDLKPENIL+ GHI L DF LS
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLS 143
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 47/126 (37%), Positives = 75/126 (59%), Gaps = 5/126 (3%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
R+ + GT EYLAPE+I+ +GH +VDWW GI ++E+L G PF +++
Sbjct: 154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLNWALI--RCAV 819
L FP + + +A+DLI+ LLV + RLG +K GA ++K H +F+ ++W + R
Sbjct: 214 KLEFPRH--LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLK 271
Query: 820 PPELPR 825
PP +P+
Sbjct: 272 PPIVPK 277
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 49/114 (42%), Positives = 62/114 (54%), Gaps = 3/114 (2%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
G + FVGT +YLAPE I G G DWW+ G +FE L+G PF D N++
Sbjct: 147 GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL 206
Query: 761 SQSLRFPGYPV--VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812
S+ + +P S A DLI LL +P RLGA G EIK HPFF+ +NW
Sbjct: 207 SRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGA-NGYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 51/110 (46%), Positives = 66/110 (60%), Gaps = 3/110 (2%)
Query: 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP- 767
GT EY+APE+I +G+G VDWW GI L+E L G PF G +E V+S + +P
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237
Query: 768 GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW-ALIR 816
G + A+DLI LL + P RLG GA E+KQH FF GL+W L+R
Sbjct: 238 GDEALPADAQDLISRLLRQNPLERLGT-GGAFEVKQHRFFLGLDWNGLLR 286
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 51/151 (33%), Positives = 84/151 (55%), Gaps = 4/151 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F++ + LG G G V +A+ GT +A+K + ++ K++ E+ I+ L HPF
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
+ + F E ++E+ GG+L LR+ F A+FY AE++LA EYLH
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR---FPNDVAKFYHAELVLAFEYLHS 136
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLSLR 621
++YRDLKPEN+L+ GH+ ++DF + +
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167
|
Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 59/142 (41%), Positives = 82/142 (57%), Gaps = 3/142 (2%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLF 536
LG G G V LA L + L+A+KV+ D ++ + TE+ I+ + +HPFL L+
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 537 AHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYR 596
F T VME+ GGDL QK SR F E ARFY AE+ AL +LH G++YR
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 597 DLKPENILVREDGHIMLSDFDL 618
DLK +N+L+ +GH L+DF +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 55/148 (37%), Positives = 88/148 (59%), Gaps = 2/148 (1%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F K +G G G V L + T ++A+K + + + ++ + ER+++ D P+
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ +L+ F ++ L+ME+ PGGDL + K + FSE RFY+AE +LA+E +H L
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKL 120
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLS 619
G ++RD+KP+NIL+ GHI LSDF LS
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 52/122 (42%), Positives = 71/122 (58%), Gaps = 4/122 (3%)
Query: 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QS 763
S VGT +Y+APEI +G+G DWW+ G +FE L G PF + ET +++ ++
Sbjct: 207 STVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET 266
Query: 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPEL 823
L FP +S A DLIR L+ +NRLG GA EIK HPFF G++W IR P +
Sbjct: 267 LYFPDDIHLSVEAEDLIRRLIT-NAENRLGR-GGAHEIKSHPFFRGVDWDTIRQIRAPFI 324
Query: 824 PR 825
P+
Sbjct: 325 PQ 326
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 58/146 (39%), Positives = 83/146 (56%), Gaps = 7/146 (4%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM-QMLDHPFLPT 534
K +G G G V LA+ +A+KV+ ++ +K+ ER ++ + + HPFL
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 535 LFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592
L F T V++Y GG+L H+ R+ R F E ARFY AE+ AL YLH L
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSLN 116
Query: 593 VVYRDLKPENILVREDGHIMLSDFDL 618
++YRDLKPENIL+ GH++L+DF L
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 48/130 (36%), Positives = 78/130 (60%), Gaps = 10/130 (7%)
Query: 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV- 760
+NS VG+ +Y+APE+++G+G+ +VD+W+ G L+E L G PF GS +ET N+
Sbjct: 153 TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212
Query: 761 -SQSLRFPGY----PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI 815
++L+ P Y +S A DLI L+ +P R G+++ +IK HPFF+ ++W +
Sbjct: 213 WKETLQRPVYDDPRFNLSDEAWDLITKLI-NDPSRRFGSLE---DIKNHPFFKEVDWNEL 268
Query: 816 RCAVPPELPR 825
R PP +P
Sbjct: 269 RELKPPFVPE 278
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 51/121 (42%), Positives = 74/121 (61%), Gaps = 4/121 (3%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
++ SF GT EY+APE++ GH S DWW+FG+ +FE+L G PF+G ET++ ++
Sbjct: 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA-VKGAAEIKQHPFFEGLNW-ALIRCAVP 820
L P + +S A+ L+R L + P NRLGA G EIK+HPFF ++W L R +
Sbjct: 214 KLGMPQF--LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIK 271
Query: 821 P 821
P
Sbjct: 272 P 272
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 62/146 (42%), Positives = 86/146 (58%), Gaps = 7/146 (4%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTL 535
K LG G G V L + T +A+K++ + +V + ++ TE ++Q HPFL L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 536 FAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LG 592
F T C VMEY GG+L H+ R+ R FSE ARFY AE++ AL+YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 593 VVYRDLKPENILVREDGHIMLSDFDL 618
VVYRDLK EN+++ +DGHI ++DF L
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGL 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 52/127 (40%), Positives = 76/127 (59%), Gaps = 5/127 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
G +++F GT EY+APEI+ GHG +VDWW+ G ++++L G PF +T+ ++
Sbjct: 154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKG-AAEIKQHPFFEGLNW--ALIRC 817
L P Y ++ ARDL++ LL + P +RLGA G AAE++ HPFF +NW L R
Sbjct: 214 KGKLNLPPY--LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARK 271
Query: 818 AVPPELP 824
PP P
Sbjct: 272 VEPPFKP 278
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 59/149 (39%), Positives = 85/149 (57%), Gaps = 10/149 (6%)
Query: 476 KKLGCGDIGTVYLAE-LIGTSC--LFALKVMDNDFLV-GRKKMPRAQTEREIMQMLDHPF 531
K LG G G V+ + G +FA+KV+ +V +K + ER I++ + HPF
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ L F T L++EY GG+L H+ R+ F E A FY++E+ LALE+LH
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLH 117
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDL 618
G++YRDLKPENIL+ GH+ L+DF L
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGL 146
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (279), Expect = 2e-26
Identities = 59/152 (38%), Positives = 84/152 (55%), Gaps = 6/152 (3%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+++ +KLG G G VYLA ALKV+ K++ R E +I+ L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 531 -FLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
+ L+ F E LVMEY GG L +L++ SE A F +A++L ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 589 HMLGVVYRDLKPENILVREDGH-IMLSDFDLS 619
H G+++RD+KPENIL+ DG + L DF L+
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149
|
Length = 384 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 59/156 (37%), Positives = 97/156 (62%), Gaps = 11/156 (7%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIG---TSCLFALKVMDNDFLVGRKKMPR-AQTEREIMQM 526
+F+L K LG G G V+L + + L+A+KV+ +V + K +TER++++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 527 LDH-PFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLL 583
+ PFL TL F T+ L+++Y GG+L H+ ++++ F EQ + Y E++L
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVL 116
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
ALE+LH LG++YRD+K ENIL+ +GH++L+DF LS
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 51/142 (35%), Positives = 76/142 (53%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFA 537
LG G G V ++ T ++A K +D L RK A E++I++ + F+ +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 538 HFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRD 597
F T+ CLVM GGDL F E A FY A+++ LE+LH +VYRD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 598 LKPENILVREDGHIMLSDFDLS 619
LKPEN+L+ + G++ +SD L+
Sbjct: 121 LKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 55/140 (39%), Positives = 82/140 (58%), Gaps = 3/140 (2%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM-QMLDHPFLPTLF 536
+G G V L EL T ++A+KV+ + + + + QTE+ + +HPFL L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 537 AHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYR 596
+ F TE V+E+ GGDL Q+Q R E+ ARFY AE+ LAL +LH G++YR
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 597 DLKPENILVREDGHIMLSDF 616
DLK +N+L+ +GHI L+D+
Sbjct: 121 DLKLDNVLLDAEGHIKLTDY 140
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 52/130 (40%), Positives = 75/130 (57%), Gaps = 10/130 (7%)
Query: 703 RSNSFVGTHEYLAPEIIK----GEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS 757
+SN VGT +Y++PEI++ G+G G DWW+ G+ ++E+LYG TPF ET
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 758 NVVSQSLRF---PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814
+++ F P VS A+DLIR L+ P+ RLG G + K HPFFEG++W
Sbjct: 219 KIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGR-NGLQDFKDHPFFEGIDWDN 276
Query: 815 IRCAVPPELP 824
IR + P +P
Sbjct: 277 IRNSTAPYVP 286
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 48/126 (38%), Positives = 74/126 (58%), Gaps = 4/126 (3%)
Query: 702 ARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
+N+F GT EYLAPE++ E G+ VD+W+ G+ +FE+ G +PF + N+
Sbjct: 151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA 210
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI--RCA 818
+RFP V+S R ++GLL + P +RLGA + A E+K+HPFF ++W L+ +
Sbjct: 211 FGKVRFPK-NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQI 269
Query: 819 VPPELP 824
PP P
Sbjct: 270 TPPFKP 275
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 57/145 (39%), Positives = 86/145 (59%), Gaps = 6/145 (4%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTL 535
K LG G G V L + +A+K++ + ++ + ++ TE +++ HPFL +L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 536 FAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
F T+ C VMEY GG+L H+ R+ R FSE RFY AE++ AL+YLH +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 594 VYRDLKPENILVREDGHIMLSDFDL 618
VYRDLK EN+++ +DGHI ++DF L
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 51/131 (38%), Positives = 72/131 (54%), Gaps = 5/131 (3%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
+E + S +F GT EYLAPE+++ + + +VDWW G L+E+LYG PF E
Sbjct: 147 IEHSKTTS-TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY 205
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA--L 814
N++++ LR P +S AR L+ GLL K+ RLGA EIK H FF +NW +
Sbjct: 206 DNILNKPLRLK--PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLV 263
Query: 815 IRCAVPPELPR 825
+ PP P
Sbjct: 264 NKKITPPFNPN 274
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 58/144 (40%), Positives = 83/144 (57%), Gaps = 3/144 (2%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM-QMLDHPFLPT 534
K +G G G V LA+ +A+KV+ ++ +K+ ER ++ + L HPFL
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
L F T + V++Y GG+L Q++ R F E ARFY AEV A+ YLH L ++
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 595 YRDLKPENILVREDGHIMLSDFDL 618
YRDLKPENIL+ GH++L+DF L
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 48/130 (36%), Positives = 74/130 (56%), Gaps = 5/130 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
G + +F GT +Y+APEII + +G SVDWW FG+ L+E+L G+ PF G DE +++
Sbjct: 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA-VKGAAEIKQHPFFEGLNWALI--RC 817
++ +P +S A + +GLL K P RLG G +I++H FF ++W + R
Sbjct: 215 EHNVSYP--KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERRE 272
Query: 818 AVPPELPRSC 827
PP P+
Sbjct: 273 IQPPFKPKVK 282
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 50/130 (38%), Positives = 69/130 (53%), Gaps = 10/130 (7%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGH----GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN 758
R ++ VGT +Y++PE++K +G G DWW+ G+FL+E+L G TPF T S
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 759 VVSQ--SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF--EGLNWAL 814
++ SL FP +S A+DLI L RLG G EIK HPFF + +
Sbjct: 259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDREV-RLGR-NGVDEIKSHPFFKNDQWTFDN 316
Query: 815 IRCAVPPELP 824
IR V P +P
Sbjct: 317 IRETVAPVVP 326
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 51/121 (42%), Positives = 76/121 (62%), Gaps = 5/121 (4%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKG--EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE 754
E R+ SF GT EY+AP+I++G GH +VDWW+ G+ ++ELL G +PF G
Sbjct: 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215
Query: 755 TLSNVVSQSLRF-PGYPV-VSFHARDLIRGLLVKEPDNRLGA-VKGAAEIKQHPFFEGLN 811
+ + + + L+ P YP +S A+D+I+ LL+K+P RLG A EIK+HPFF+ +N
Sbjct: 216 SQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275
Query: 812 W 812
W
Sbjct: 276 W 276
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 49/153 (32%), Positives = 78/153 (50%), Gaps = 4/153 (2%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
F++ +K+G G G VY A T A+KV+ L ++K + E +I++ HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHP 57
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
+ + + + +VME+C GG L L + Q A + E+L LEYLH
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIA-YVCKELLKGLEYLHS 116
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623
G+++RD+K NIL+ DG + L DF LS + +
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 58/167 (34%), Positives = 97/167 (58%), Gaps = 2/167 (1%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F++ K +G G G V + ++ T ++A+K+++ ++ R + + ER+++ D +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ L F E LVM+Y GGDL L K R E ARFY+AE++LA++ +H L
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYLAEMVLAIDSVHQL 121
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEP 638
G V+RD+KP+N+L+ ++GHI L+DF LR + V+S+ V P
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTP 167
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-25
Identities = 60/178 (33%), Positives = 98/178 (55%), Gaps = 5/178 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F + K + G G VYL S L+A+KV+ ++ + + + Q ER+ + + PF
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ L+ + LVMEY GGD+ L +F E+ A Y++EV LAL+YLH
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH 123
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLS---LRCAVNPMVVKSSSPVEEPPPKKASSP 646
G+++RDLKP+N+L+ +GHI L+DF LS L +N M + ++ + +P + +P
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSRTP 181
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 53/146 (36%), Positives = 78/146 (53%), Gaps = 3/146 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP- 530
F LG G G V LAE GT L+A+K++ D ++ + E+ ++ + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
FL L + F T VMEY GGDL + Q F E A FY AE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 591 LGVVYRDLKPENILVREDGHIMLSDF 616
G++YRDLK +N+++ +GHI ++DF
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADF 145
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 57/172 (33%), Positives = 93/172 (54%), Gaps = 4/172 (2%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
M F + K +G G G V L + ++A+K++ ++ R ER+IM
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99
Query: 527 LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
+ ++ L F +K+ +VMEY PGGDL L + E+ ARFY AEV+LAL+
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAEVVLALD 156
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEP 638
+H +G ++RD+KP+N+L+ + GH+ L+DF ++ N M V+ + V P
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTP 207
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 45/125 (36%), Positives = 77/125 (61%), Gaps = 7/125 (5%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
R+++F GT +Y+APEI++G + SVDWW+FG+ L+E+L G++PF G DE ++
Sbjct: 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD 211
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI--RCAVP 820
+ +P + ++ ++D++ L ++P RLG V I+ HPFF+ +NW + R P
Sbjct: 212 TPHYPRW--ITKESKDILEKLFERDPTRRLGVV---GNIRGHPFFKTINWTALEKRELDP 266
Query: 821 PELPR 825
P P+
Sbjct: 267 PFKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 45/129 (34%), Positives = 75/129 (58%), Gaps = 6/129 (4%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
G +++F GT +Y+APEI++ +G SVDWW G+ L+E+L G PF+ D+ ++
Sbjct: 150 GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVK--GAAEIKQHPFFEGLNWALI--R 816
+ + +P + +S A D+++ + K P RLG++ G I +HPFF+ L+W + R
Sbjct: 210 NDEVVYPTW--LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRR 267
Query: 817 CAVPPELPR 825
PP PR
Sbjct: 268 QIEPPFRPR 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 51/131 (38%), Positives = 79/131 (60%), Gaps = 5/131 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
G + +F GT +Y+APEII + +G SVDWW FG+ L+E+L G+ PF+G DE +++
Sbjct: 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLG-AVKGAAEIKQHPFFEGLNW-ALIRCA 818
++ +P +S A + +GL+ K P RLG +G +IK+H FF ++W L R
Sbjct: 215 EHNVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 272
Query: 819 V-PPELPRSCD 828
V PP P++C
Sbjct: 273 VQPPYKPKACG 283
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 57/144 (39%), Positives = 83/144 (57%), Gaps = 3/144 (2%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM-QMLDHPFLPT 534
K +G G G V LA+ +A+KV+ ++ RK+ ER ++ + + HPFL
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
L F T + V+++ GG+L Q++ R F E ARFY AE+ AL YLH + +V
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 595 YRDLKPENILVREDGHIMLSDFDL 618
YRDLKPENIL+ GH++L+DF L
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKK--MPRAQTEREIMQMLD 528
+++L +G G G VY + T A+K + L K+ + E ++++ L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQIS---LEKIKEEALKSIMQEIDLLKNLK 57
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
HP + T +++EY G L + K+ F A YV +VL L YL
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQI-IKKFGPFPESLVAV-YVYQVLQGLAYL 115
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEP----PPKKAS 644
H GV++RD+K NIL +DG + L+DF ++ + +N + +S V P P
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 645 SPCSEASCIEPFCLHPSWQVSC 666
S S AS I W + C
Sbjct: 174 SGASTASDI--------WSLGC 187
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 45/123 (36%), Positives = 73/123 (59%), Gaps = 4/123 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
GA +F GT EYLAPE+++ +G +VDWW G+ ++E++ GR PF +++ ++
Sbjct: 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLNW-ALIRCA 818
+ +RFP +S A+ L+ GLL K+P RLG A EI +H FF +NW +++
Sbjct: 209 MEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKK 266
Query: 819 VPP 821
+ P
Sbjct: 267 LEP 269
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 59/144 (40%), Positives = 82/144 (56%), Gaps = 3/144 (2%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM-QMLDHPFLPT 534
K +G G G V LA +A+KV+ ++ +K+ +ER ++ + + HPFL
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
L F T V++Y GG+L Q++ R F E ARFY AE+ AL YLH L +V
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 595 YRDLKPENILVREDGHIMLSDFDL 618
YRDLKPENIL+ GHI+L+DF L
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 57/142 (40%), Positives = 83/142 (58%), Gaps = 3/142 (2%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM-QMLDHPFLPTLF 536
+G G V L L T ++A+KV+ + + + + QTE+ + Q +HPFL L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 537 AHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYR 596
+ F TE V+EY GGDL Q+Q R E+ ARFY AE+ LAL YLH G++YR
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 597 DLKPENILVREDGHIMLSDFDL 618
DLK +N+L+ +GHI L+D+ +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 55/152 (36%), Positives = 84/152 (55%), Gaps = 4/152 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F+ ++ LG G G V ++ T ++A K ++ + RK A E++I++ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ L + T+ CLV+ GGDL H+ P F E+ A FY AE+L LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLEDLH 119
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621
VYRDLKPENIL+ + GHI +SD L+++
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRISDLGLAVK 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 54/152 (35%), Positives = 84/152 (55%), Gaps = 4/152 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F+ ++ LG G G V ++ T ++A K ++ + RK A E++I++ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ +L + T+ CLV+ GGDL H+ P F E+ A FY AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDLH 119
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621
+VYRDLKPENIL+ + GHI +SD L++
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVE 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 57/149 (38%), Positives = 80/149 (53%), Gaps = 7/149 (4%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL-PTLF 536
+G G G V T ++ALK + +V R ++ ER ++ ++ PF+ P F
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 537 AHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYR 596
+ + EK LV+ + GG+L Q++ F ARFY AE+L ALE LH V+YR
Sbjct: 61 SFQSPEKLY-LVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 597 DLKPENILVREDGHIMLSDFDLSLRCAVN 625
DLKPENIL+ GHI L DF L C +N
Sbjct: 118 DLKPENILLDYQGHIALCDFGL---CKLN 143
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 46/128 (35%), Positives = 74/128 (57%), Gaps = 5/128 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
GA +F GT EYLAPE+++ +G +VDWW G+ ++E++ GR PF ++ ++
Sbjct: 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRL-GAVKGAAEIKQHPFFEGLNW--ALIRC 817
+ +RFP +S A+ L+ GLL K+P RL G A E+ +H FF +NW + +
Sbjct: 209 MEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 266
Query: 818 AVPPELPR 825
+PP P+
Sbjct: 267 LLPPFKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 48/138 (34%), Positives = 76/138 (55%), Gaps = 10/138 (7%)
Query: 695 LVVE-PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG-- 751
L VE G + GT Y+APE+++GE + SVDW+ G L+E++ GR+PF+
Sbjct: 141 LAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK 200
Query: 752 --NDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAA-EIKQHPFFE 808
+E + ++ +P S A+DL LL K+P+ RLG G+A E+++HP F+
Sbjct: 201 VEKEELKRRTLEMAVEYPDK--FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
Query: 809 GLNWALIRCAV--PPELP 824
LNW + + PP +P
Sbjct: 259 DLNWRRLEAGMLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-23
Identities = 55/162 (33%), Positives = 90/162 (55%), Gaps = 3/162 (1%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
M +++ K +G G G V L T ++A+K++ ++ R ER+IM
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 527 LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
+ P++ LF F +++ +VMEY PGGDL L E+ ARFY AEV+LAL+
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALD 156
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628
+H +G ++RD+KP+N+L+ + GH+ L+DF ++ MV
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 53/153 (34%), Positives = 76/153 (49%), Gaps = 17/153 (11%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVM---DNDFLVGRKKMPRAQTEREIMQMLDHPFL 532
K+G G G VY A + T L A+K + DND K + E +++++L HP L
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND----PKTIKEIADEMKVLELLKHPNL 61
Query: 533 PTLFA---HFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
+ H EK + MEYC GG L +L R E R Y ++L L YL
Sbjct: 62 VKYYGVEVH--REKV-YIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYL 115
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621
H G+V+RD+KP NI + +G I L DF +++
Sbjct: 116 HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 9e-23
Identities = 47/130 (36%), Positives = 76/130 (58%), Gaps = 5/130 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
G + +F GT +Y+APEII + +G SVDWW +G+ L+E+L G+ PF G DE +++
Sbjct: 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLG-AVKGAAEIKQHPFFEGLNWALI--RC 817
++ +P +S A + +GL+ K P RLG +G +I++H FF ++W + R
Sbjct: 215 EHNVSYP--KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENRE 272
Query: 818 AVPPELPRSC 827
PP P+ C
Sbjct: 273 IQPPFKPKVC 282
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 1e-22
Identities = 47/128 (36%), Positives = 77/128 (60%), Gaps = 5/128 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
A +F GT EYLAPE+++ +G +VDWW G+ ++E++ GR PF +++ ++
Sbjct: 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRL-GAVKGAAEIKQHPFFEGLNWALI--RC 817
+ ++FP +S A+ L+ GLL+K+P+ RL G A EI +H FF G+NW + +
Sbjct: 209 MEDIKFP--RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKK 266
Query: 818 AVPPELPR 825
VPP P+
Sbjct: 267 LVPPFKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 54/142 (38%), Positives = 81/142 (57%), Gaps = 3/142 (2%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM-QMLDHPFLPTLF 536
+G G V L L ++A+KV+ + + + + QTE+ + Q +PFL L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 537 AHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYR 596
+ F T LV+EY GGDL Q+Q R E+ ARFY AE+ +AL +LH G++YR
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 597 DLKPENILVREDGHIMLSDFDL 618
DLK +N+L+ DGHI L+D+ +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 41/113 (36%), Positives = 59/113 (52%), Gaps = 10/113 (8%)
Query: 701 GARSNSFVGTHEYLAPEIIK-GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND---ETL 756
+ +FVGT Y+APE++ G G+G VD W+ G+ L+ELL G+ PF G + +
Sbjct: 152 SSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
Query: 757 SNVVSQSLRFPGYPVVSFH--ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
++ L F S A+DLI+ L K+P R A EI QHP+F
Sbjct: 212 RRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP----TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-22
Identities = 54/162 (33%), Positives = 90/162 (55%), Gaps = 3/162 (1%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
M + + K +G G G V L + ++A+K++ ++ R ER+IM
Sbjct: 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 527 LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
+ P++ LF F +K+ +VMEY PGGDL L E+ A+FY AEV+LAL+
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLALD 156
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628
+H +G+++RD+KP+N+L+ + GH+ L+DF ++ MV
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-22
Identities = 50/147 (34%), Positives = 91/147 (61%), Gaps = 2/147 (1%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F+ K +G G G V L + T ++A+K++ ++ ++++ + ER+I+ D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ +F F ++ L+ME+ PGGD+ L K+ + SE+A +FY+AE +LA++ +H L
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQL 120
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDL 618
G ++RD+KP+N+L+ GH+ LSDF L
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 3e-22
Identities = 49/138 (35%), Positives = 76/138 (55%), Gaps = 15/138 (10%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-------- 752
G +++F GT Y+APEI++GE +G SVDWW G+ +FE++ GR+PF G
Sbjct: 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT 209
Query: 753 -DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLG--AVKGAAEIKQHPFFEG 809
D ++ + +R P +S A +++G L K+P RLG G +IK HPFF
Sbjct: 210 EDYLFQVILEKQIRIPRS--LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267
Query: 810 LNWALI--RCAVPPELPR 825
++W L+ + +PP P
Sbjct: 268 IDWDLLEQKQVLPPYKPN 285
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 3e-22
Identities = 50/116 (43%), Positives = 67/116 (57%), Gaps = 3/116 (2%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
VEP S +F GT EYLAPE+++ E + +VDWW G L+E+LYG PF +
Sbjct: 147 VEPEETTS-TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY 205
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812
N++ + L+ PG V+ A DL+ GLL K+ RLGA EIK H FF +NW
Sbjct: 206 DNILHKPLQLPGGKTVA--ACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 4e-22
Identities = 49/128 (38%), Positives = 75/128 (58%), Gaps = 5/128 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
GA +F GT EYLAPE+++ +G +VDWW G+ ++E++ GR PF +++ ++
Sbjct: 150 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRL-GAVKGAAEIKQHPFFEGLNWALI--RC 817
+ +RFP +S A+ L+ GLL K+P RL G A EI QH FF G+ W + +
Sbjct: 210 MEEIRFP--RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKK 267
Query: 818 AVPPELPR 825
VPP P+
Sbjct: 268 LVPPFKPQ 275
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 6e-22
Identities = 46/125 (36%), Positives = 73/125 (58%), Gaps = 13/125 (10%)
Query: 708 VGTHEYLAPEI---IKGEG---HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS 761
VGT +Y+APE+ + G+G +G DWW+ G+ +E++YGR+PF + +T +N+++
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN 223
Query: 762 --QSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAV 819
+ L+FP P VS DLI+ LL RL G + HPFF ++W IR ++
Sbjct: 224 FQRFLKFPEDPKVSSDFLDLIQSLLCG-QKERL----GYEGLCCHPFFSKIDWNNIRNSL 278
Query: 820 PPELP 824
PP +P
Sbjct: 279 PPFVP 283
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 6e-22
Identities = 53/146 (36%), Positives = 82/146 (56%), Gaps = 7/146 (4%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPT 534
K LG G G V LAEL G FA+K + D ++ + E+ ++ + ++PFL
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 535 LFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592
L+ F T++ VME+ GGDL H+ Q F A FY AE++ L++LH G
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 593 VVYRDLKPENILVREDGHIMLSDFDL 618
++YRDLK +N+++ DGHI ++DF +
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 7e-22
Identities = 52/145 (35%), Positives = 79/145 (54%), Gaps = 2/145 (1%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFA 537
LG G G V ++ T L+A K ++ L RK A E+ I+ + F+ +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 538 HFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVY 595
F T+ CLVM GGDL H+ + + F E A FY A+++ LE+LH ++Y
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 596 RDLKPENILVREDGHIMLSDFDLSL 620
RDLKPEN+L+ DG++ +SD L++
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAV 145
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 7e-22
Identities = 57/163 (34%), Positives = 73/163 (44%), Gaps = 30/163 (18%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLF----ALKVMDNDFLVGRKKMPRAQTE--RE--IM 524
L KKLG G G VY L G A+K + D + E RE IM
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED------ASEQQIEEFLREARIM 55
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRF-------FSEQAARF 576
+ LDHP + L T E+ +VMEY PGGDL LR+ +P F+ Q AR
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR- 114
Query: 577 YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+EYL ++RDL N LV E+ + +SDF LS
Sbjct: 115 -------GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-21
Identities = 44/130 (33%), Positives = 76/130 (58%), Gaps = 7/130 (5%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
G + +F GT +Y+APEI++ +G SVDWW G+ ++E++ G+ PF+ D+ +++
Sbjct: 150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV---KGAAEIKQHPFFEGLNWALI-- 815
+ +P + +S A +++ + K P+ RLG V G IKQHPFF+ ++W L+
Sbjct: 210 HDDVLYPVW--LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQ 267
Query: 816 RCAVPPELPR 825
R PP P+
Sbjct: 268 RKIKPPFKPK 277
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 47/116 (40%), Positives = 66/116 (56%), Gaps = 3/116 (2%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
+E G S +F GT EYLAPE++ + + +VDWW G L+E+LYG PF E
Sbjct: 147 IEHNGTTS-TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 205
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812
N++++ L+ P ++ AR L+ GLL K+ RLGA EIK H FF +NW
Sbjct: 206 DNILNKPLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-21
Identities = 48/147 (32%), Positives = 89/147 (60%), Gaps = 2/147 (1%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F+ K +G G G V L + T ++A+K++ ++ ++++ + ER+I+ D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ +F F + L+ME+ PGGD+ L K+ + +E+ +FY+AE +LA++ +H L
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIHQL 120
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDL 618
G ++RD+KP+N+L+ GH+ LSDF L
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-21
Identities = 47/119 (39%), Positives = 69/119 (57%), Gaps = 3/119 (2%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS 763
+ +F GT EYLAPE+I+ + + ++VDWW G L+E+LYG PF E N++ +
Sbjct: 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212
Query: 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA-LIRCAVPP 821
L P S A ++ LL K+ RLGA + EI++HPFFE L+W L + +PP
Sbjct: 213 LVL--RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 56/150 (37%), Positives = 80/150 (53%), Gaps = 15/150 (10%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQT----EREIMQML---DHP 530
+G G G VY T ++A+K +D R KM + +T ER ++ ++ D P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKK----RIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
F+ + F T +++ GGDLH L Q FSE RFY AE++L LE++H
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMH 114
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
VVYRDLKP NIL+ E GH+ +SD L+
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 35/110 (31%), Positives = 53/110 (48%), Gaps = 3/110 (2%)
Query: 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN 758
+ S GT Y+APE++ +G+ +VDWW+ G+ +E L G+ P++G
Sbjct: 151 TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210
Query: 759 VVSQSLRFPGYPVV-SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
Q YP S A D I LL ++P RLG ++K HP+F
Sbjct: 211 RAKQETADVLYPATWSTEAIDAINKLLERDPQKRLG--DNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-21
Identities = 53/144 (36%), Positives = 81/144 (56%), Gaps = 7/144 (4%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP-FLPTLF 536
LG G G V LAE GT L+A+K++ D ++ + E+ ++ + D P FL L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 537 AHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
+ F T VMEY GGDL H+ + + F E A FY AE+ + L +LH G++
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGK----FKEPQAVFYAAEISVGLFFLHRRGII 123
Query: 595 YRDLKPENILVREDGHIMLSDFDL 618
YRDLK +N+++ +GHI ++DF +
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 9/152 (5%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-- 528
+ K LG G G VY T ++ALK V + R Q RE+ +
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKK----IHVDGDEEFRKQLLRELKTLRSCE 57
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
P++ + F E +V+EY GG L L +K E + ++L L+YL
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYL 115
Query: 589 H-MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
H +++RD+KP N+L+ G + ++DF +S
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 4e-21
Identities = 49/137 (35%), Positives = 77/137 (56%), Gaps = 15/137 (10%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-------- 752
G +++F GT Y+APEI++GE +G SVDWW G+ +FE++ GR+PF G+
Sbjct: 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 209
Query: 753 -DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV--KGAAEIKQHPFFEG 809
D ++ + +R P +S A +++ L K+P RLG G A+I+ HPFF
Sbjct: 210 EDYLFQVILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267
Query: 810 LNWALI--RCAVPPELP 824
++W L+ + VPP P
Sbjct: 268 VDWDLMEQKQVVPPFKP 284
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 4e-21
Identities = 58/167 (34%), Positives = 94/167 (56%), Gaps = 2/167 (1%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F++ K +G G G V + ++ T ++A+K+++ ++ R + + ER ++ D +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ TL F E + LVM+Y GGDL L K R E ARFY+AE++LA+ +H L
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYIAEMVLAIHSIHQL 121
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEP 638
V+RD+KP+N+L+ +GHI L+DF L+ V+SS V P
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLK-MNQDGTVQSSVAVGTP 167
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 4e-21
Identities = 51/159 (32%), Positives = 84/159 (52%), Gaps = 3/159 (1%)
Query: 462 KQHGCMGMRHFKLHKKLGCGDIGTVYLAELI-GTSCLFALKVMDNDFLVGRKKMPRAQTE 520
K+ M F + LG G G V LA A+K + ++ +K++ +E
Sbjct: 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE 81
Query: 521 REIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAE 580
R+I+ ++HPF L+ F E + LV+E+ GG+ ++ ++ F FY A+
Sbjct: 82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQ 139
Query: 581 VLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++L EYL L +VYRDLKPEN+L+ +DG I ++DF +
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178
|
Length = 340 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 5e-21
Identities = 54/148 (36%), Positives = 80/148 (54%), Gaps = 3/148 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP- 530
F LG G G V LAE GT L+A+K++ D ++ + E+ ++ + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
FL L + F T VMEY GGDL + Q Q F E A FY AE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDL 618
G++YRDLK +N+++ +GHI ++DF +
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 5e-21
Identities = 47/139 (33%), Positives = 80/139 (57%), Gaps = 13/139 (9%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN-- 758
G +++F GT Y+APEI++GE +G SVDWW G+ +FE++ GR+PF ++ ++
Sbjct: 150 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED 209
Query: 759 -----VVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA--VKGAAEIKQHPFFEGLN 811
++ + +R P + +S A +++G L K+P RLG G ++IK H FF ++
Sbjct: 210 YLFQVILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267
Query: 812 WALI--RCAVPPELPRSCD 828
W L+ + PP P+ D
Sbjct: 268 WDLLEKKQVTPPFKPQITD 286
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 9e-21
Identities = 59/167 (35%), Positives = 96/167 (57%), Gaps = 2/167 (1%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F++ K +G G G V + +L +FA+K+++ ++ R + + ER+++ D+ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ TL F E LVM+Y GGDL L K R E ARFY+AE+++A++ +H L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYLAEMVIAIDSVHQL 121
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEP 638
V+RD+KP+NIL+ +GHI L+DF L+ + V+SS V P
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTP 167
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-20
Identities = 53/130 (40%), Positives = 74/130 (56%), Gaps = 10/130 (7%)
Query: 703 RSNSFVGTHEYLAPEIIKGEG----HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN 758
R ++ VGT +Y++PE++K +G +G DWW+ G+FLFE+L G TPF T S
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK 258
Query: 759 VVSQ--SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG--LNWAL 814
++ SL FP +S HA++LI L + + RLG G EIKQHPFF+ NW
Sbjct: 259 IMDHKNSLNFPEDVEISKHAKNLICAFLT-DREVRLGR-NGVEEIKQHPFFKNDQWNWDN 316
Query: 815 IRCAVPPELP 824
IR P +P
Sbjct: 317 IRETAAPVVP 326
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 50/148 (33%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+K +K+G G G VY A T A+K M + ++ E IM+ HP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHP 75
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVA-EVLLALEYL 588
+ + + +VMEY GG L ++ Q R Q A YV EVL LEYL
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-FVRMNEPQIA--YVCREVLQGLEYL 132
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDF 616
H V++RD+K +NIL+ +DG + L+DF
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 53/151 (35%), Positives = 83/151 (54%), Gaps = 4/151 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F+ ++ LG G G V ++ T ++A K ++ + RK A E++I++ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ +L + T+ CLV+ GGDL H+ + F E A FY AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLH 119
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSL 620
+VYRDLKPENIL+ + GHI +SD L++
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLAV 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 17/157 (10%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTE-----REI-- 523
++L + +G G VY A + + A+K +D + + QT +E+
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRID---------LEKCQTSVDELRKEVQA 52
Query: 524 MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGD-LHVLRQKQPSRFFSEQAARFYVAEVL 582
M +HP + + F LVM Y GG L +++ P E + EVL
Sbjct: 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
LEYLH G ++RD+K NIL+ EDG + ++DF +S
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS 149
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 56/162 (34%), Positives = 73/162 (45%), Gaps = 29/162 (17%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLF----ALKVMDNDFLVGRKKMPRAQTE--RE--IM 524
L KKLG G G VY +L G A+K + D + E RE IM
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED------ASEQQIEEFLREARIM 55
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPS------RFFSEQAARFY 577
+ LDHP + L T E+ +VMEY GGDL LR+ +P F+ Q AR
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR-- 113
Query: 578 VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+EYL ++RDL N LV E+ + +SDF LS
Sbjct: 114 ------GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-20
Identities = 54/152 (35%), Positives = 83/152 (54%), Gaps = 4/152 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F+ ++ LG G G V ++ T ++A K ++ + RK A E+ I++ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ +L + T+ CLV+ GGDL H+ P F EQ A FY AE+ LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLEDLQ 119
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621
+VYRDLKPENIL+ + GHI +SD L+++
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQ 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 7e-20
Identities = 52/138 (37%), Positives = 80/138 (57%), Gaps = 12/138 (8%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEIIK----GEG-HGSSVDWWTFGIFLFELLYGRTPFKGS 750
++E +S+ VGT +Y++PEI++ G+G +G DWW+ G+ ++E+LYG TPF
Sbjct: 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
Query: 751 GNDETLSNVVSQSLRFPGYPV----VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
ET +++ RF +P VS A+DLIR L+ ++RLG G + KQHPF
Sbjct: 212 SLVETYGKIMNHKERFQ-FPAQVTDVSEDAKDLIRRLICSR-EHRLGQ-NGIEDFKQHPF 268
Query: 807 FEGLNWALIRCAVPPELP 824
F G++W IR P +P
Sbjct: 269 FTGIDWDNIRNCEAPYIP 286
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-20
Identities = 54/149 (36%), Positives = 80/149 (53%), Gaps = 13/149 (8%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQT----EREIMQML---DHP 530
+G G G VY T ++A+K +D R KM + +T ER ++ ++ D P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKK----RIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
F+ + F T C +++ GGDLH + FSE+ RFY E++L LE++H
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHN 115
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLS 619
VVYRDLKP NIL+ E GH+ +SD L+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 50/142 (35%), Positives = 71/142 (50%), Gaps = 18/142 (12%)
Query: 695 LVVE-PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND 753
L VE P G VGT Y+APE++K E + S DWW G ++E++ G++PF+
Sbjct: 148 LAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207
Query: 754 ---ETLSNVVSQ-----SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA-VKGAAEIKQH 804
E + V + S +F S AR + R LL K+P RLG +GA E+K H
Sbjct: 208 VKREEVERRVKEDQEEYSEKF------SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261
Query: 805 PFFEGLNWALIRCAV--PPELP 824
PFF N+ + + PP P
Sbjct: 262 PFFRTANFKRLEAGMLEPPFCP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 49/157 (31%), Positives = 67/157 (42%), Gaps = 17/157 (10%)
Query: 472 FKLHKKLGCGDIGTVYLAELIG----TSCLFALKVMDNDFLVGRKKMPRAQTE--RE--I 523
+L KKLG G G VY L G T A+K + + E E I
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA------SEEEREEFLEEASI 54
Query: 524 MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYVAEVL 582
M+ L HP + L T + +V EY PGGDL LR+ + + ++
Sbjct: 55 MKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIA 112
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+EYL V+RDL N LV E+ + +SDF LS
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 45/150 (30%), Positives = 78/150 (52%), Gaps = 3/150 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
FK+ KKLG G G+VY + + + +ALK +D + +++ A E I+ ++HP
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE-DAVNEIRILASVNHPN 60
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLH--VLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ + F C+VMEY P GDL + ++K+ + EQ ++L L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+++RDLK NIL+ + + + D +S
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGIS 150
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-19
Identities = 49/131 (37%), Positives = 75/131 (57%), Gaps = 12/131 (9%)
Query: 703 RSNSFVGTHEYLAPEIIK----GEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS 757
+S+ VGT +Y++PEI++ G G +G DWW+ G+ ++E+LYG TPF ET
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 758 NVVSQSLRFPGYPV----VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813
+++ RF +P VS A+DLI+ L+ + RLG G + K+H FFEG++W
Sbjct: 219 KIMNHEERFQ-FPSHITDVSEEAKDLIQRLICSR-ERRLGQ-NGIEDFKKHAFFEGIDWE 275
Query: 814 LIRCAVPPELP 824
IR P +P
Sbjct: 276 NIRNLEAPYIP 286
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 20/157 (12%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM----DNDFLVGRKKMPRAQTEREIMQM 526
++L +++G G G VY A I T L A+KV+ +DF + Q E +++
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-------IQQEISMLKE 56
Query: 527 LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL----HVLRQKQPSRFFSEQAARFYVAEVL 582
HP + F + +VMEYC GG L V R SE + E L
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-----GPLSELQIAYVCRETL 111
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L YLH G ++RD+K NIL+ EDG + L+DF +S
Sbjct: 112 KGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 45/124 (36%), Positives = 72/124 (58%), Gaps = 9/124 (7%)
Query: 708 VGTHEYLAPEII-KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS---NVVSQS 763
VGTH Y+APE++ KG + SS DW++ G LF+LL G +PF+ + ++ +
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 215
Query: 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV-KGAAEIKQHPFFEGLNWALI--RCAVP 820
+ P S R L+ GLL ++ + RLG + +GA E+K+HPFF L+W ++ + P
Sbjct: 216 VELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273
Query: 821 PELP 824
P +P
Sbjct: 274 PLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 8/151 (5%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE---IMQMLD 528
+K+ K+LG G G+VYLA T L A+K M F RE + ++ +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF----YSWEECMNLREVKSLRKLNE 56
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
HP + L F V EY G +L+ L + + + FSE R + ++L L ++
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
H G +RDLKPEN+LV + ++DF L+
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-18
Identities = 48/123 (39%), Positives = 71/123 (57%), Gaps = 7/123 (5%)
Query: 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QS 763
S VGT +Y+APE+ G+ DWW+ G+ ++E+L G PF ET V++ ++
Sbjct: 195 STVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKET 254
Query: 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIR---CAVP 820
L FP +S A+DLI + +NR+G+ G EIK HPFFEG++W IR A+P
Sbjct: 255 LVFPPEVPISEKAKDLILRFCT-DSENRIGS-NGVEEIKSHPFFEGVDWGHIRERPAAIP 312
Query: 821 PEL 823
E+
Sbjct: 313 IEI 315
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 37/124 (29%), Positives = 66/124 (53%), Gaps = 7/124 (5%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG----NDETLSN 758
++ + GT ++APE+++GE + SVD++ G+ L+E++ R PF+ G N E
Sbjct: 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR 212
Query: 759 VVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGA-AEIKQHPFFEGLNWALIRC 817
+++ S+ +P S ++ LL K+P+ RLG G ++ HP F LNW +
Sbjct: 213 ILNDSVTYPDK--FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEA 270
Query: 818 AVPP 821
+ P
Sbjct: 271 GMLP 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-18
Identities = 49/130 (37%), Positives = 74/130 (56%), Gaps = 10/130 (7%)
Query: 703 RSNSFVGTHEYLAPEIIKGEG----HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN 758
R ++ VGT +Y++PE++K +G +G DWW+ G+FL+E+L G TPF T S
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 759 VVSQ--SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL-- 814
+++ SL FP +S A++LI L + + RLG G EIK+H FF+ WA
Sbjct: 259 IMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLGR-NGVEEIKRHLFFKNDQWAWET 316
Query: 815 IRCAVPPELP 824
+R V P +P
Sbjct: 317 LRDTVAPVVP 326
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 20/155 (12%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKV--MDNDFLVGRKKMPRAQTEREI--MQML 527
F + +KLG G G+VY A T + A+KV ++ D + +EI ++
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---------EIIKEISILKQC 55
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGG---DLHVLRQKQPSRFFSEQAARFYVAEVLLA 584
D P++ + + +VMEYC G D+ + K +E+ + + L
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT----LTEEEIAAILYQTLKG 111
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
LEYLH ++RD+K NIL+ E+G L+DF +S
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 9e-18
Identities = 51/155 (32%), Positives = 70/155 (45%), Gaps = 14/155 (9%)
Query: 476 KKLGCGDIGTVYLAEL---IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532
KKLG G G VY +L G + A+K + D +K E +M+ L HP +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD--FLKEARVMKKLGHPNV 58
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFF-------SEQAARFYVAEVLLA 584
L T E+ LV+EY GGDL LR+ +P + F ++
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF-AIQIAKG 117
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+EYL V+RDL N LV ED + +SDF LS
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 52/161 (32%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPR---AQTE-REI--MQMLDH 529
KKLG G VY A T + A+K + +G +K + T REI +Q L H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIK----LGERKEAKDGINFTALREIKLLQELKH 61
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
P + L F + LV E+ DL V++ K S + + Y+ L LEYL
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYL 118
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629
H +++RDLKP N+L+ DG + L+DF L+ +P
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRK 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 50/146 (34%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKV--MDNDFLVGRKKMPRAQTEREI--MQMLDHPFLP 533
LG G G+VY + FA+K + +D G++ + Q E+EI + L HP +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAV--KQLEQEIALLSKLQHPNIV 65
Query: 534 TLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
E + +E PGG L L +K S F E R Y ++LL LEYLH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 594 VYRDLKPENILVREDGHIMLSDFDLS 619
V+RD+K NILV +G + L+DF ++
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMA 149
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-17
Identities = 39/111 (35%), Positives = 64/111 (57%), Gaps = 3/111 (2%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
R+ + GT EY+APEI+ GHG + DWWT GIF++E+L G PF + ++
Sbjct: 184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG 243
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV-KGAAEIKQHPFFEGLNW 812
+ FP + + + + L++ LL + R G + KGA +K+HP+F ++W
Sbjct: 244 IIYFPKF--LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292
|
Length = 340 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 51/153 (33%), Positives = 79/153 (51%), Gaps = 13/153 (8%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRK--KMPRAQTEREI--MQML 527
+K+ ++G G G V+ A+ T ALK + + R +P Q REI +Q
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKV----ALRRLEGGIPN-QALREIKALQAC 56
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALE 586
HP++ L F LVMEY P DL VLR ++ R E + Y+ +L +
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEE--RPLPEAQVKSYMRMLLKGVA 113
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
Y+H G+++RDLKP N+L+ DG + ++DF L+
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM--QMLDHPFLP 533
++G G G VY A T L ALK + + ++ P REI Q L HP +
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPI-TAIREIKLLQKLRHPNIV 61
Query: 534 TL----FAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
L + + +V EY DL +L P F+E + Y+ ++L L+YL
Sbjct: 62 RLKEIVTSKGKGSIY--MVFEYMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYL 116
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDL 618
H G+++RD+K NIL+ DG + L+DF L
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGL 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-17
Identities = 47/122 (38%), Positives = 71/122 (58%), Gaps = 13/122 (10%)
Query: 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET----LSNVVSQS 763
+GT +YLAPE++ G+ HG +VDWW G+ LFE L G PF NDET N++++
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPF----NDETPQQVFQNILNRD 596
Query: 764 LRFP-GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPE 822
+ +P G +S +A++ I LL +P R G E+KQHP F G++W ++ P
Sbjct: 597 IPWPEGEEKLSVNAQNAIEILLTMDPTKR----AGLKELKQHPLFHGVDWENLQNQTMPF 652
Query: 823 LP 824
+P
Sbjct: 653 IP 654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 45/144 (31%), Positives = 73/144 (50%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFA 537
LG G G V ++ T ++A K +D L + A E+EI++ ++ PF+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 538 HFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRD 597
F ++ CLVM GGDL R + Y A++ + +LH + +VYRD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 598 LKPENILVREDGHIMLSDFDLSLR 621
+KPEN+L+ + G+ LSD L++
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVE 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-16
Identities = 48/123 (39%), Positives = 71/123 (57%), Gaps = 7/123 (5%)
Query: 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QS 763
S VGT +Y+APE+ G+ DWW+ G+ ++E+L G PF ET V++ ++
Sbjct: 195 STVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKET 254
Query: 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIR---CAVP 820
L FP +S A+DLI E ++R+GA G EIK +PFFEG++W IR A+P
Sbjct: 255 LIFPPEVPISEKAKDLILRFCC-EWEHRIGA-PGVEEIKTNPFFEGVDWEHIRERPAAIP 312
Query: 821 PEL 823
E+
Sbjct: 313 IEI 315
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 44/133 (33%), Positives = 64/133 (48%), Gaps = 9/133 (6%)
Query: 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN----DE 754
P G VGT Y+APE+I E + S DWW G ++E++ G++PF+ +E
Sbjct: 153 PEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE 212
Query: 755 TLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV-KGAAEIKQHPFFEGLNWA 813
V + S A+ + R LL K P RLG GAA +KQHP F+ +N+
Sbjct: 213 VDRRVKEDQEEYS--EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270
Query: 814 LIRCAV--PPELP 824
+ + PP P
Sbjct: 271 RLEANMLEPPFCP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 5/131 (3%)
Query: 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN 758
P G VGT Y+APE++ + + S D+W G ++E++ G++PF+G
Sbjct: 153 PEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212
Query: 759 VVSQSLRFPGYPVVSF--HARDLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLNWALI 815
V + L F A+ + + LL K+P RLG + GA E+K+HPFF +N+ +
Sbjct: 213 VDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL 272
Query: 816 RCAV--PPELP 824
+ PP +P
Sbjct: 273 EAGMLDPPFVP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 53/154 (34%), Positives = 77/154 (50%), Gaps = 8/154 (5%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQMLDHPFLP 533
+KLG G G VY A T + ALK + D + +P + REI ++ L HP +
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIP-STALREISLLKELKHPNIV 61
Query: 534 TLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
L TE+ LV EYC DL K+P S + + ++L L Y H +
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPL-SPNLIKSIMYQLLRGLAYCHSHRI 119
Query: 594 VYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627
++RDLKP+NIL+ DG + L+DF L+ R P+
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLA-RAFGIPL 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 52/162 (32%), Positives = 78/162 (48%), Gaps = 33/162 (20%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTE-----REIMQM 526
F L + +G G G VY A T+ + A+KV+D + A+ E +EI
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE---------EAEDEIEDIQQEIQ-- 51
Query: 527 LDHPFLPTLFAHFTTEKFSC--------LVMEYCPGGD-LHVLRQKQPSRFFSEQAARFY 577
FL + + T+ + ++MEYC GG L +L+ E F
Sbjct: 52 ----FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFI 103
Query: 578 VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ EVLL LEYLH G ++RD+K NIL+ E+G + L+DF +S
Sbjct: 104 LREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 7/148 (4%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE--IMQMLDH 529
F++ K+G G G V+ ++A+K +D L + R + E ++ LD
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQID---LSKMNRREREEAIDEARVLAKLDS 58
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSE-QAARFYVAEVLLALEYL 588
++ + F + +VMEY GDLH L + Q R E Q RF++ ++LL L +L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHL 117
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDF 616
H +++RD+K N+ + ++ + D
Sbjct: 118 HSKKILHRDIKSLNLFLDAYDNVKIGDL 145
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 38/103 (36%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS----QSL 764
GT +Y +PE IKG + S DWW G+ +ELL G+ PFK DE L ++ S Q
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED-EDEEL-DLESLLKRQQK 225
Query: 765 RFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+ P VS +A D ++ +L + RL EI +HPF
Sbjct: 226 KLPFIKNVSKNANDFVQSMLKYNINYRLTNYN---EIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 41/138 (29%), Positives = 73/138 (52%), Gaps = 8/138 (5%)
Query: 695 LVVE-PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGS--- 750
L VE G GT+ Y+APEI+K E + VDW+ G ++E++ GRTPFK
Sbjct: 141 LAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200
Query: 751 -GNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
+E + ++F + + ++D+ R L K+P++RLG+ + + ++H FF+
Sbjct: 201 VAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259
Query: 810 LNWALIRCAV--PPELPR 825
+N+ + + PP +P
Sbjct: 260 INFPRLEAGLIPPPFVPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 41/145 (28%), Positives = 77/145 (53%), Gaps = 2/145 (1%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTL 535
+ +G G G V+L L +K + + + + + AQ E +++++L HP +
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEY 64
Query: 536 FAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVY 595
+ +F +K +VMEY PGG L QK+ + E + ++LLAL ++H +++
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILH 124
Query: 596 RDLKPENILVREDGHIM-LSDFDLS 619
RDLK +NIL+ + ++ + DF +S
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGIS 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 42/115 (36%), Positives = 68/115 (59%), Gaps = 7/115 (6%)
Query: 703 RSNSFVGTHEYLAPEII-KGEGHGSSVDWWTFGIFLFELLYGRTPF---KGSGNDETLSN 758
+ ++ VGTH Y+APE++ KG + SS DW++ G LF+LL G +PF K E
Sbjct: 151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
Query: 759 VVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV-KGAAEIKQHPFFEGLNW 812
++ ++ P S + L+ GLL ++ RLG + +GA E+K+H FF+G++W
Sbjct: 211 TLTVNVELPD--SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFL-VGRKKMPRAQTEREI--MQMLDHPFL 532
K+G G G VY A T + A+K + F G K REI ++ L+HP +
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKT----ALREIKLLKELNHPNI 60
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592
L F + LV E+ +++ +Q R E + Y+ ++L L + H G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 593 VVYRDLKPENILVREDGHIMLSDFDL 618
+++RDLKPEN+L+ +G + L+DF L
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGL 144
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 4e-15
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDF--LVGRKKMPRAQTEREIMQMLD 528
++L K +G G G V A T A+K + N F L+ K++ R E ++++ L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR---EIKLLRHLR 57
Query: 529 HPF---LPTLFAHFTTEKFS--CLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVL 582
H L + + E F+ +V E DLH V++ QP ++ ++++ ++L
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQP---LTDDHIQYFLYQIL 113
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L+YLH V++RDLKP NILV + + + DF L+
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 53/150 (35%), Positives = 76/150 (50%), Gaps = 11/150 (7%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALK-VMDNDFLVGRKKMPRAQT------EREIMQMLDHP 530
+G G G VYLA + T + A+K V + GR + E E ++ LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ TTE++ + +EY PGG + LR F EQ RF+ +VL L YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYLH 125
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
G+++RDLK +N+LV DG +SDF +S
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGIS 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 28/167 (16%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE-------- 522
+++ + +G G GTV + K +D M TE+E
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG------NM----TEKEKQQLVSEV 50
Query: 523 -IMQMLDHPFLPTLFAHF--TTEKFSCLVMEYCPGGDLHVL--RQKQPSRFFSEQAARFY 577
I++ L HP + + + + +VMEYC GGDL L + K+ ++ E+
Sbjct: 51 NILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRI 110
Query: 578 VAEVLLALEYLHMLG-----VVYRDLKPENILVREDGHIMLSDFDLS 619
+ ++LLAL H V++RDLKP NI + + ++ L DF L+
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 48/137 (35%), Positives = 70/137 (51%), Gaps = 17/137 (12%)
Query: 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPF---KGSGNDET 755
P G VGT Y+APE++K E + S DWW G L+E++ G++PF K E
Sbjct: 153 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212
Query: 756 LSNVVSQ-----SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV-KGAAEIKQHPFFEG 809
+ +V + S +F S AR L + LL K+P RLG GA E+K+HP F+
Sbjct: 213 VERLVKEVQEEYSEKF------SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266
Query: 810 LNWALIRCAV--PPELP 824
+N+ + + PP P
Sbjct: 267 INFKRLEAGMLEPPFKP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHP 530
F+L + +G G G VY A T L A+K+MD + + E I++ +HP
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII----EDEEEEIKEEYNILRKYSNHP 63
Query: 531 FLPTLFAHFTTEKFSC------LVMEYCPGG---DLHVLRQKQPSRFFSEQAARFYVAEV 581
+ T + F + LVME C GG DL +K+ R E A + + E
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-YILRET 122
Query: 582 LLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L L YLH V++RD+K +NIL+ ++ + L DF +S
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 45/145 (31%), Positives = 78/145 (53%), Gaps = 4/145 (2%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLF 536
+LG G G VY A+ T L A KV++ +++ E EI+ +HP++ L
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 537 AHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYR 596
F + +++E+CPGG + + + R +E + ++L AL+YLH + +++R
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAI-MLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHR 134
Query: 597 DLKPENILVREDGHIMLSDFDLSLR 621
DLK N+L+ DG I L+DF +S +
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 43/147 (29%), Positives = 66/147 (44%), Gaps = 8/147 (5%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE--IMQMLDHPFLP 533
+LG G+ G V T + A+K + + + + Q RE I+ + P++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTI----RLEINEAIQKQILRELDILHKCNSPYIV 62
Query: 534 TLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH-MLG 592
+ F + MEY GG L + ++ R + VA VL L YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA-VLKGLTYLHEKHK 121
Query: 593 VVYRDLKPENILVREDGHIMLSDFDLS 619
+++RD+KP NILV G I L DF +S
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVS 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 9/156 (5%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELI----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ 525
RH K K+LG G G V L T A+K +++ + + E EI++
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS--GEEQHRSDFEREIEILR 61
Query: 526 MLDHPFLPTL--FAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLL 583
LDH + + L+MEY P G L Q+ + ++ F ++
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS-QICK 120
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++YL ++RDL NILV + + +SDF L+
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 14/152 (9%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI-----MQMLDHPFL 532
+G G GTVY A + T ALK + + + +P + T REI ++ +HP +
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLS-TLREIALLKQLESFEHPNI 63
Query: 533 PTLF----AHFTTEKFSC-LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
L T + LV E+ DL K P + + + ++L +++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
LH +V+RDLKP+NILV DG + ++DF L+
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 18/149 (12%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMD-------NDFLVGRKKMPRAQTEREIMQMLDHP 530
LG G G VY A+ T A K++ DF+V E +I+ HP
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV----------EIDILSECKHP 62
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
+ L+ + E +++E+C GG L + + R +E R+ ++L AL +LH
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLS 619
V++RDLK NIL+ DG + L+DF +S
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 34/108 (31%), Positives = 59/108 (54%)
Query: 512 KKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSE 571
K+ A E I+ +L HP + + HF + + MEY GG L+ +Q + F E
Sbjct: 41 KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE 100
Query: 572 QAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ +Y+ +++ A+ Y+H G+++RD+K NI + + G I L DF +S
Sbjct: 101 EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 11/149 (7%)
Query: 474 LHKKL---GCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
L+++L G G G VY + + T + ALK+++ D + Q E ++ L
Sbjct: 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD--TPDDDVSDIQREVALLSQLRQS 59
Query: 531 FLPTL---FAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
P + + + ++MEY GG + L + P +E+ + EVL+AL+Y
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVALKY 116
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDF 616
+H +GV++RD+K NILV G++ L DF
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDF 145
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 53/174 (30%), Positives = 82/174 (47%), Gaps = 21/174 (12%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMD----NDFLVGRKKMPRAQTEREIMQML 527
F+L +++G G G VY A + T L A+KV+ DF V ++EI+ M
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV---------VQQEIIMMK 61
Query: 528 D--HPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLA 584
D H + F + + ME+C GG L + P SE + E L
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQG 118
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEP 638
L YLH G ++RD+K NIL+ ++GH+ L+DF +S + + + K S + P
Sbjct: 119 LYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKSFIGTP 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 8/154 (5%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFL----VGRKKMPRAQTEREI--MQMLDHPF 531
+G G G+VYL + L A+K ++ + RK+ REI ++ L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ + +EY PGG + L + F E R +V ++L L YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNR 125
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625
G+++RD+K NILV G I +SDF +S + N
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 44/146 (30%), Positives = 78/146 (53%), Gaps = 2/146 (1%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+++ KK+G G G +YLA+ S +K +D + ++K ++ E ++ + HP
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMKHPN 60
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ T FA F +VMEYC GGDL +Q FSE + ++ L L+++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 592 GVVYRDLKPENILVREDGHIM-LSDF 616
+++RD+K +NI + ++G + L DF
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDF 146
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 88/390 (22%), Positives = 134/390 (34%), Gaps = 128/390 (32%)
Query: 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALK--VMDNDFLVGRKKMP-RAQTER 521
GC +R +++ KLG G G VY A I T + ALK +M N+ + P A E
Sbjct: 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE----KDGFPITALREI 58
Query: 522 EIMQMLDHP-FLPTL---FAHFTTEKFSCLV-------MEYCPGGDLHVLRQKQPSRFFS 570
+I++ L HP +P + K M++ G L PS +
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-----NPSVKLT 113
Query: 571 EQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630
E + Y+ ++L + YLH +++RD+K NIL+ G + ++DF L
Sbjct: 114 ESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL------------ 161
Query: 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVS 690
+ P + PPP +RK +
Sbjct: 162 -ARPYDGPPPNPKGGG----------------------------GGGTRKYTN------- 185
Query: 691 PMPQLVVEPTGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKG 749
LVV T Y PE++ GE + ++VD W G E+ R +G
Sbjct: 186 ----LVV------------TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229
Query: 750 SG---------------NDETLSNVVSQSLRFPGYPVVSFHAR----------------- 777
+ET +SL PG V
Sbjct: 230 KSDIDQLHLIFKLCGTPTEETWPG--WRSL--PGCEGVHSFTNYPRTLEERFGKLGPEGL 285
Query: 778 DLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
DL+ LL +P RL A +HP+F
Sbjct: 286 DLLSKLLSLDPYKRLTASDA----LEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 39/114 (34%), Positives = 54/114 (47%), Gaps = 7/114 (6%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-- 753
V+E T + N+FVGT Y++PE I+GE + + D W+ G+ L E G+ PF G
Sbjct: 149 VLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF 208
Query: 754 -ETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
E + + S RD I L K+P R AAE+ QHPF
Sbjct: 209 FELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRP----SAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 50/142 (35%), Positives = 72/142 (50%), Gaps = 8/142 (5%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFA 537
LG G+ GTVY A + T + A+KV+ D V +K + +E EI+ D P++ +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK--QIMSELEILYKCDSPYIIGFYG 66
Query: 538 HFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRD 597
F E + E+ GG L V R K P R VA V+ L YL L +++RD
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYR-KIPEHVL----GRIAVA-VVKGLTYLWSLKILHRD 120
Query: 598 LKPENILVREDGHIMLSDFDLS 619
+KP N+LV G + L DF +S
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVS 142
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 43/183 (23%), Positives = 68/183 (37%), Gaps = 15/183 (8%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQ---------TE 520
R+ + LG G G V A T + A+K + + R T
Sbjct: 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 521 RE--IMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYV 578
RE IM + H + L + F LVM+ V+ +K +E + +
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI---RLTESQVKCIL 125
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEP 638
++L L LH ++RDL P NI + G ++DF L+ R P + S E
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA-RRYGYPPYSDTLSKDETM 184
Query: 639 PPK 641
+
Sbjct: 185 QRR 187
|
Length = 335 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 50/147 (34%), Positives = 74/147 (50%), Gaps = 8/147 (5%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLF 536
+LG G G VY A+ T L A KV+D +++ E +I+ DHP + L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 537 AHFTTEKFSCLVMEYCPGG--DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
F E +++E+C GG D +L ++P +E R + L AL YLH ++
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYLHENKII 125
Query: 595 YRDLKPENILVREDGHIMLSDFDLSLR 621
+RDLK NIL DG I L+DF +S +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAK 152
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
+ +FK+ KK+G G VY A + + ALK + ++ K E ++++ LD
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDL-----HVLRQKQPSRFFSEQAARFYVAEVLL 583
HP + A F +V+E GDL H +QK R E+ Y ++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQK---RLIPERTIWKYFVQLCS 117
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618
ALE++H +++RD+KP N+ + G + L D L
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 7/151 (4%)
Query: 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKK---MPRAQTEREIMQMLDHP 530
L ++LG G GTVYL + LKV+ + VG +A E +++ LDHP
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVL-KEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
+ A F C++ EYC G DL + K + SE + ++LL + Y+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
H +++RDLK +NI ++ + + + DF +S
Sbjct: 123 HQRRILHRDLKAKNIFLKNN-LLKIGDFGVS 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 10/113 (8%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
+ T AR N+ VGT ++APE+I G+ + D W+ GI EL G+ P+ + L
Sbjct: 148 LSDTKAR-NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL 206
Query: 757 SNVVSQSLRFPGYP---VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
+ + PG S +D ++ L K P+ R A ++ +HPF
Sbjct: 207 FKIATNG--PPGLRNPEKWSDEFKDFLKKCLQKNPEKRP----TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 49/149 (32%), Positives = 72/149 (48%), Gaps = 22/149 (14%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE-------IMQMLD 528
K+G G G V +A T A+K MD R Q RE IM+
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMD----------LRKQQRRELLFNEVVIMRDYQ 74
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
HP + +++ + +VME+ GG L ++ +R EQ A +A VL AL +
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLA-VLKALSF 130
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDF 616
LH GV++RD+K ++IL+ DG + LSDF
Sbjct: 131 LHAQGVIHRDIKSDSILLTSDGRVKLSDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 47/149 (31%), Positives = 67/149 (44%), Gaps = 10/149 (6%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE--IMQMLDHPFLPT 534
+LG G G+V L T +FALK + + Q RE I + P++
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSCKSPYIVK 63
Query: 535 LFAHFTTEKFSCL--VMEYCPGGDLHVLRQKQPSR--FFSEQAARFYVAEVLLALEYLHM 590
+ F E S + MEYC GG L + +K R E+ VL L YLH
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLS 619
+++RD+KP NIL+ G + L DF +S
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVS 152
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 6/153 (3%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVM--DNDFLVGRKKMPRAQTEREIMQMLDH 529
++ K LG G G VYL + T A+K + D D +K++ + E ++++ L H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
+ + ++ + MEY PGG + L+ +E R Y ++L +EYL
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYL 120
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621
H +V+RD+K NIL G++ L DF S R
Sbjct: 121 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 4e-12
Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 17/151 (11%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDF--LVGRKKMPRAQTEREIMQMLDHPFLPTL 535
+G G G V A T A+K + F + K R E +++ +DH + L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK---RTYRELRLLKHMDHENVIGL 79
Query: 536 FAHFTT----EKFS--CLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
FT E F LV G DL+ +++ ++ S+ +F V ++L L+Y+
Sbjct: 80 LDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQK----LSDDHIQFLVYQILRGLKYI 134
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
H G+++RDLKP NI V ED + + DF L+
Sbjct: 135 HSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 45/198 (22%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+ + + +G G G L + + + +A+K + + ++ E ++ + HP
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR--LPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ F + +VMEYC GGDL + Q + F E + ++ L ++++H
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSS---SPVEEPPPKKASSPCS 648
V++RD+K +NI + ++G + L DF S R +P + +P PP + P +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFG-SARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 649 EASCIEPFCLHPSWQVSC 666
S I W + C
Sbjct: 179 NKSDI--------WSLGC 188
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 521 REI--MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYV 578
RE+ ++ L H + L F + LV EY L +L + P A R Y+
Sbjct: 49 REVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELL-EASPGGL-PPDAVRSYI 106
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616
++L A+ Y H +++RD+KPENILV E G + L DF
Sbjct: 107 WQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 48/148 (32%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE--IMQMLDHPFLP 533
LG G+ G+V + I T + A KV+ +G K R Q RE IM P++
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVV----HIGAKSSVRKQILRELQIMHECRSPYIV 66
Query: 534 TLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYLH-ML 591
+ + F E C+ ME+ G L + ++ P E + VA V+ L YL+ +
Sbjct: 67 SFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPV--EILGKIAVA-VVEGLTYLYNVH 123
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLS 619
+++RD+KP NILV G I L DF +S
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 42/152 (27%), Positives = 75/152 (49%), Gaps = 2/152 (1%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
+ +F++ KK+G G VY A + ALK + L+ K E ++++ L+
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQ-KQPSRFFSEQAARFYVAEVLLALE 586
HP + +A F + +V+E GDL +++ K+ R E+ Y ++ ALE
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618
++H V++RD+KP N+ + G + L D L
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 41/148 (27%), Positives = 61/148 (41%), Gaps = 10/148 (6%)
Query: 476 KKLGCGDIGTV---YLAELIGTSCLFALKVMDNDFLVGRKK-MPRAQTEREIMQMLDHPF 531
K+LG G+ G+V G A+K + + + KK R E +M LDHP
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHPC 57
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ L E LVME P G L +K+ + +V + + YL
Sbjct: 58 IVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRRE--IPVSDLKELAHQVAMGMAYLESK 114
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLS 619
V+RDL N+L+ +SDF +S
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 52/174 (29%), Positives = 80/174 (45%), Gaps = 18/174 (10%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQ---TEREIMQM 526
+ + +K+G G GTVY A + T A+K M+ ++ P+ + E +M+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN------LQQQPKKELIINEILVMRE 72
Query: 527 LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLAL 585
HP + + +VMEY GG L V+ + E E L AL
Sbjct: 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQAL 128
Query: 586 EYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA-VNPMVVKSSSPVEEP 638
E+LH V++RD+K +NIL+ DG + L+DF CA + P K S+ V P
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF---CAQITPEQSKRSTMVGTP 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 45/142 (31%), Positives = 67/142 (47%), Gaps = 7/142 (4%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALK--VMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPT 534
K+G G G V+ T + A+K V D V +K R E +++ L HP L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR---EIRMLKQLKHPNLVN 64
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
L F ++ LV EYC L+ L + R E + + + L A+ + H +
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCI 122
Query: 595 YRDLKPENILVREDGHIMLSDF 616
+RD+KPENIL+ + G I L DF
Sbjct: 123 HRDVKPENILITKQGQIKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 5/146 (3%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTL 535
KK+G G G L + + +K + N + K+ ++ E ++ + HP +
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEI-NISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 536 FAHFTTEKFSCL--VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
F E+ L VM+YC GGDL+ Q F E + ++ LAL+++H +
Sbjct: 65 QESF--EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI 122
Query: 594 VYRDLKPENILVREDGHIMLSDFDLS 619
++RD+K +NI + +DG I L DF ++
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIA 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 20/164 (12%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMD---NDFLVGRKKMPRAQTEREIMQML 527
+ ++LG G + Y A + T L A+K + N + + + E +M L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 528 DHPFLPTLF------AHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAE 580
+HP + + +HF L +E+ GG + H+L + F E Y +
Sbjct: 61 NHPHIIRMLGATCEDSHFN------LFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQ 111
Query: 581 VLLALEYLHMLGVVYRDLKPENILVREDGHIM-LSDFDLSLRCA 623
+L L YLH +++RD+K N+L+ G + ++DF + R A
Sbjct: 112 LLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 44/150 (29%), Positives = 76/150 (50%), Gaps = 12/150 (8%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQML-D 528
+K+ K+G G V A+ T +A+K M F K + + REI ++ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF----KSLEQVNNLREIQALRRLSP 56
Query: 529 HPFLPTLFAHFTTEKFSC--LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
HP + L K LV E +L+ L + + R E+ + Y+ ++L +L+
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGR-KRPLPEKRVKSYMYQLLKSLD 114
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDF 616
++H G+ +RD+KPENIL+++D + L+DF
Sbjct: 115 HMHRNGIFHRDIKPENILIKDD-ILKLADF 143
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 50/155 (32%), Positives = 70/155 (45%), Gaps = 5/155 (3%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTL 535
+++G G G VY A + T+ + A+K M +K E +Q L HP
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 536 FAHFTTEKFSCLVMEYCPGGDLHVLR-QKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
+ E + LVMEYC G +L K+P + E AA L L YLH +
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEV-EIAA--ICHGALQGLAYLHSHERI 137
Query: 595 YRDLKPENILVREDGHIMLSDF-DLSLRCAVNPMV 628
+RD+K NIL+ E G + L+DF SL N V
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 27/143 (18%)
Query: 509 VGRKKMPRA--------QTERE--IMQMLDHPFLPTLFAHFTTE----KFSCLVMEYCPG 554
V KK+P A +T RE I++ H + + K +VM+
Sbjct: 33 VAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-E 91
Query: 555 GDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML 613
DLH ++ QP +E+ R+++ ++L L+Y+H V++RDLKP N+LV ED + +
Sbjct: 92 SDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRI 148
Query: 614 SDFDLSLRCAVNPMVVKSSSPVE 636
DF ++ R SSSP E
Sbjct: 149 GDFGMA-RGL-------SSSPTE 163
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 23/172 (13%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSC--LFALKVMDNDFLVGRKKMPRAQTEREIMQML- 527
++L K+LG G G V A TS A+K + N F KK+ + RE+ +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF---SKKILAKRALRELKLLRH 57
Query: 528 --DHPFLPTLFAH--FTTEKFSCL-----VMEYCPGGDLH-VLRQKQPSRFFSEQAARFY 577
H + L+ F+ L +ME DLH ++R QP ++ + +
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEA----DLHQIIRSGQP---LTDAHFQSF 110
Query: 578 VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629
+ ++L L+Y+H V++RDLKP N+LV D + + DF L+ + NP
Sbjct: 111 IYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 62.8 bits (151), Expect = 3e-10
Identities = 39/124 (31%), Positives = 55/124 (44%), Gaps = 18/124 (14%)
Query: 699 PTGARSNSFVGTHEYLAPEIIKGEGH---GSSVDWWTFGIFLFELLYGRTPFKGSGNDET 755
A ++ VGT Y+APE++ G SS D W+ GI L+ELL G PF+G N
Sbjct: 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA 219
Query: 756 LSNVVSQSLRFP-----------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804
S + L P ++S A DL++ LL K+P NRL ++ H
Sbjct: 220 TSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL----SSSSDLSH 275
Query: 805 PFFE 808
Sbjct: 276 DLLA 279
|
Length = 384 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 3e-10
Identities = 44/157 (28%), Positives = 69/157 (43%), Gaps = 20/157 (12%)
Query: 470 RHFKLHKKLG--CGDIGTVYLAELIGTSCLFALKVMDND-FLVGRKKMPRAQTEREIM-- 524
++ ++ KKL G G V + + T LF K++ F E M
Sbjct: 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-----------NAIEPMVH 62
Query: 525 -QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLL 583
M D+P L+ TT K L+M+Y GDL L +K+ SE + + +++
Sbjct: 63 QLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVE 120
Query: 584 ALEYLHMLGVVYRDLKPENIL-VREDGHIMLSDFDLS 619
AL LH +++ D+K EN+L R I L D+ L
Sbjct: 121 ALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157
|
Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 50/153 (32%), Positives = 71/153 (46%), Gaps = 6/153 (3%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFA 537
LG G G VY A + T A+K + R P + E + L H +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHE-EIALHSYLKHRNIVQYLG 72
Query: 538 HFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYR 596
+ F + ME PGG L +LR K +EQ FY ++L L+YLH +V+R
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 597 DLKPENILVRE-DGHIMLSDFDLSLRCA-VNPM 627
D+K +N+LV G + +SDF S R A +NP
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 5e-10
Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 23/107 (21%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKG------ 749
V+ T + + VGT YL+PE+ + + + D W+ G L+EL + PF+G
Sbjct: 152 VLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL 211
Query: 750 -----SGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791
G + + S L R+L+ LL K+P+ R
Sbjct: 212 ALKILKGQYPPIPSQYSSEL------------RNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMD----NDFLVGRKKMPRAQTEREIMQML 527
++L +++G G G VY A + T L A+K++ +DF + Q E +++
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-------IQQEIFMVKEC 63
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALE 586
H + F + + + + MEYC GG L + P SE + E L L
Sbjct: 64 KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLA 120
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEP 638
YLH G ++RD+K NIL+ ++G + L+DF ++ + + + K S + P
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGTP 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALK--VMD-NDFLVGRKKMPRAQTEREIMQMLDHPFLPT 534
LG G GTVY L L A+K +D ++ L K+ + Q E ++++ L H +
Sbjct: 8 LGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 535 LFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
+ + ME+ PGG + +L + P E Y ++L + YLH V
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 594 VYRDLKPENILVREDGHIMLSDFDLSLRCA 623
V+RD+K N+++ +G I L DF + R A
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 41/99 (41%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKG--SG-NDETLSNVVSQSLRFPGY 769
Y APE+ + DWW+ G LFELL G+T + SG N T +L P +
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHT-------TLNIPEW 200
Query: 770 PVVSFHARDLIRGLLVKEPDNRLGA-VKGAAEIKQHPFF 807
VS AR L++ LL P RLGA V G +IK HPFF
Sbjct: 201 --VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTE-------REI- 523
F+ +K+G G G VY A T + ALK + D +TE REI
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAIREIS 51
Query: 524 -MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVL 582
++ L+HP + L TE LV E+ DL P + Y+ ++L
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLL 110
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L + H V++RDLKP+N+L+ +G I L+DF L+
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 11/155 (7%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F+L + +G G G VY + T L A+KVMD V + + E +++ H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73
Query: 532 -LPTLFAHFTTEKFS------CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLA 584
+ T + F + LVME+C G + L + E + E+L
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L +LH V++RD+K +N+L+ E+ + L DF +S
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 5/109 (4%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
TG + S GT ++APE+I+GE +G + D W+ G + E+ G+ P+ GN
Sbjct: 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK 215
Query: 760 VSQSLRFPGYPV-VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+ S P P +S A+D +R L ++P R A E+ QHPF
Sbjct: 216 IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRP----TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 9/154 (5%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F+L + +G G G VY + T L A+KVMD + G ++ Q + + H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRN 64
Query: 532 LPTLFAHFTTEKFS------CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLAL 585
+ T + F + LVME+C G + L + E+ + E+L L
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 586 EYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+LH V++RD+K +N+L+ E+ + L DF +S
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 47/166 (28%), Positives = 71/166 (42%), Gaps = 21/166 (12%)
Query: 473 KLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML 527
+ ++LG G G VY EL G ++ A+K + + K + E E+M L
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDL 65
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH--VLRQKQPSRFFSEQAARFY-------- 577
HP + L T E+ +C++ EY GDLH ++R S +E
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 578 ----VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++ +EYL V+RDL N LV E + +SDF LS
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 6/89 (6%)
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
P + L + +E LV+++ GG L H+ + E+ + + AE+++AL+
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN----IPEECVKRWAAEMVVALDA 100
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDF 616
LH G+V RDL P NIL+ + GHI L+ F
Sbjct: 101 LHREGIVCRDLNPNNILLDDRGHIQLTYF 129
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 55/165 (33%), Positives = 81/165 (49%), Gaps = 14/165 (8%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD--HPFLPT 534
K+G G G V +A + + L A+K MD RK+ R E++ M D H +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
++ + +VME+ GG L + +R EQ A +A VL AL LH GV+
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLA-VLKALSVLHAQGVI 138
Query: 595 YRDLKPENILVREDGHIMLSDFDLSLRCA-VNPMVVKSSSPVEEP 638
+RD+K ++IL+ DG + LSDF CA V+ V + S V P
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGF---CAQVSKEVPRRKSLVGTP 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 45/153 (29%), Positives = 67/153 (43%), Gaps = 12/153 (7%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
FK +KLG G TVY T + ALK + D G A E +M+ L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPST--AIREISLMKELKHEN 59
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGG-----DLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
+ L TE LV EY D H +R + + ++L +
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDP-----NTVKSFTYQLLKGIA 114
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ H V++RDLKP+N+L+ + G + L+DF L+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 18/167 (10%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI-----MQMLDHPF 531
++G G GTVY A + ALK + +P + T RE+ ++ DHP
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVR--VQTNEDGLPLS-TVREVALLKRLEAFDHPN 63
Query: 532 LPTLF-----AHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
+ L + E LV E+ DL K P + + + + L L+
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDL----SLRCAVNPMVV 629
+LH +V+RDLKPENILV G + L+DF L S + A+ P+VV
Sbjct: 123 FLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 36/146 (24%), Positives = 64/146 (43%), Gaps = 15/146 (10%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH--PFLP 533
K L G VYL + LK R+K + E I+Q+L +P
Sbjct: 4 KLLKGGLTNRVYLLGTKDED--YVLK-----INPSREKGADREREVAILQLLARKGLPVP 56
Query: 534 TLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
+ A ++ +S L+ME+ G L + +++ + +AE+L L L +L +
Sbjct: 57 KVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ------LAELLAKLHQLPLLVL 110
Query: 594 VYRDLKPENILVREDGHIMLSDFDLS 619
+ DL P NILV + + + D++ +
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 31/106 (29%), Positives = 49/106 (46%), Gaps = 5/106 (4%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
R S VGT ++APE+I +G+ VD W+ GI + E++ G P+ + + +
Sbjct: 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230
Query: 763 SLRFPGYPV-VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
VS R + +LV++P R AAE+ HPF
Sbjct: 231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQR----ATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 21/157 (13%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFA 537
LG G GTV A+ + FA+KV+D + + K RAQ E + +L+ F +
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKN-RAQAE--VCCLLNCDFFSIVKC 96
Query: 538 HFTTEKFS-------------CLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVL 582
H E F+ LV++Y GDL + + + +R F E A +VL
Sbjct: 97 H---EDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
LA+ ++H +++RD+K NIL+ +G + L DF S
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190
|
Length = 496 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 4e-09
Identities = 46/142 (32%), Positives = 70/142 (49%), Gaps = 4/142 (2%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTL 535
+++G G G VY A + T+ + A+K M +K E + +Q + HP
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 536 FAHFTTEKFSCLVMEYCPGGDLHVLR-QKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
+ E + LVMEYC G +L K+P + E AA + A L L YLH ++
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-EIAAITHGA--LQGLAYLHSHNMI 147
Query: 595 YRDLKPENILVREDGHIMLSDF 616
+RD+K NIL+ E G + L+DF
Sbjct: 148 HRDIKAGNILLTEPGQVKLADF 169
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 2/152 (1%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
+ +F++ KK+G G VY A + ALK + ++ K E ++++ L+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLH--VLRQKQPSRFFSEQAARFYVAEVLLALE 586
HP + F + +V+E GDL + K+ R E+ Y ++ A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618
++H V++RD+KP N+ + G + L D L
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 57/165 (34%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD--HPFLPT 534
K+G G G V +A T A+K MD RK+ R E++ M D H +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
++ + +VME+ GG L + +R EQ A ++ VL AL YLH GV+
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLS-VLRALSYLHNQGVI 140
Query: 595 YRDLKPENILVREDGHIMLSDFDLSLRCA-VNPMVVKSSSPVEEP 638
+RD+K ++IL+ DG I LSDF CA V+ V K S V P
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGF---CAQVSKEVPKRKSLVGTP 182
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 36/138 (26%), Positives = 62/138 (44%), Gaps = 1/138 (0%)
Query: 479 GCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAH 538
D+ V+LA+ T+ L A+K ++ D ++ + Q E + L HP +
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 539 FTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDL 598
F + +V G L + E A F + +VL AL+Y+H G ++R +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127
Query: 599 KPENILVREDGHIMLSDF 616
K +IL+ DG ++LS
Sbjct: 128 KASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 7e-09
Identities = 43/142 (30%), Positives = 59/142 (41%), Gaps = 39/142 (27%)
Query: 702 ARSNS-----FVGTHEYLAPEIIKGEGHGS-SVDWWTFGIFLFELLYGRTPFKGSG---- 751
AR +V T Y APEI+ H + +VD W+ G + ELL G+T F GS
Sbjct: 165 ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ 224
Query: 752 -----------NDETLSNVVSQSLR-----FPGYPVVSFH---------ARDLIRGLLVK 786
++E L + S+S R P P F A DL+ +LV
Sbjct: 225 LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVL 284
Query: 787 EPDNRLGAVKGAAEIKQHPFFE 808
+PD R+ AAE HP+
Sbjct: 285 DPDKRI----TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 22/154 (14%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVM---DNDFLVGRKKMPRAQTEREIMQM-LDHPFLP 533
+G G G VY T + A+K M N +++ R + +++ D P++
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-----KEENKRILMDLDVVLKSHDCPYIV 77
Query: 534 TLFAHFTTEK--FSCL-VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL-- 588
+ +F T+ F C+ +M C D + R + P E ++ AL YL
Sbjct: 78 KCYGYFITDSDVFICMELMSTC--LDKLLKRIQGP---IPEDILGKMTVAIVKALHYLKE 132
Query: 589 -HMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621
H GV++RD+KP NIL+ G++ L DF +S R
Sbjct: 133 KH--GVIHRDVKPSNILLDASGNVKLCDFGISGR 164
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 7e-09
Identities = 43/113 (38%), Positives = 60/113 (53%), Gaps = 13/113 (11%)
Query: 517 AQ-TEREIM---QMLDHPFLPTLFAHFTTE--KFSCLVMEYCPGGDLH-VLRQKQPSRFF 569
AQ T REIM ++ DHP + L E K LV EY DLH V+R
Sbjct: 50 AQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRAN----IL 104
Query: 570 SEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622
+ R+ + ++L AL+Y+H V++RDLKP NIL+ D + L+DF L+ R
Sbjct: 105 EDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA-RS 156
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 8e-09
Identities = 47/142 (33%), Positives = 67/142 (47%), Gaps = 4/142 (2%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTL 535
+++G G G VY A + S + A+K M +K E +Q L HP
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 536 FAHFTTEKFSCLVMEYCPGGDLHVLR-QKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
+ E + LVMEYC G +L K+P + E AA + A L L YLH ++
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-EIAAVTHGA--LQGLAYLHSHNMI 137
Query: 595 YRDLKPENILVREDGHIMLSDF 616
+RD+K NIL+ E G + L DF
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 26/66 (39%), Positives = 42/66 (63%), Gaps = 3/66 (4%)
Query: 554 GGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML 613
G DLH L +P +Q ++++ ++L L+Y+H GVV+RDLKP NIL+ E+ + +
Sbjct: 93 GTDLHRLLTSRP---LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKI 149
Query: 614 SDFDLS 619
DF L+
Sbjct: 150 CDFGLA 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 44/167 (26%), Positives = 67/167 (40%), Gaps = 23/167 (13%)
Query: 476 KKLGCGDIGTVYLAE---LIGTSCLFALKVMDND--FLVGRKKM-------PRAQTEREI 523
+KLG G G V+L E L S + + D LV K + R +E+
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 524 MQM--LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAE 580
+ L P + L T + C++MEY GDL L++ ++
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 581 VLL--------ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
LL + YL L V+RDL N LV ++ I ++DF +S
Sbjct: 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 15/101 (14%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND---------- 753
+++FVGT Y++PE I+G + D W+ GI + EL G+ PF S D
Sbjct: 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI 218
Query: 754 -ETLSNVVSQSLRFPGYPVVSF--HARDLIRGLLVKEPDNR 791
+ L +V + P P F RD + L+K+P R
Sbjct: 219 LDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDPTER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 47/143 (32%), Positives = 67/143 (46%), Gaps = 3/143 (2%)
Query: 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLP 533
LH+ +G G G VY A T+ + A+K M +K E + +Q L HP
Sbjct: 26 LHE-IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 534 TLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
+ E + LVMEYC G +L + E AA + A L L YLH +
Sbjct: 85 EYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGA--LQGLAYLHSHNM 142
Query: 594 VYRDLKPENILVREDGHIMLSDF 616
++RD+K NIL+ E G + L+DF
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADF 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 11/109 (10%)
Query: 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-----ETLSNV 759
+FVGT Y+APE I+G + D W+ G+ L EL GR P+ + E L +
Sbjct: 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
Query: 760 VSQ-SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
V++ R P S +D + L+K+P R E+ +HPF
Sbjct: 217 VNEPPPRLPSGK-FSPDFQDFVNLCLIKDPRER----PSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 30/108 (27%), Positives = 49/108 (45%), Gaps = 6/108 (5%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
TG +S GT +++PE+I GEG+G D W+ G + E+L + P+ + +
Sbjct: 162 TGMKS--VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 219
Query: 760 VSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+Q VS AR+ +R V+ R A E+ +H F
Sbjct: 220 ATQPTNPQLPSHVSPDARNFLRRTFVENAKKR----PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 5/148 (3%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F +K+G G G V+ T + A+K++D + ++ Q E ++ D P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPY 63
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ + + + ++MEY GG L + P E + E+L L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSE 120
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLS 619
++RD+K N+L+ E G + L+DF ++
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 6/155 (3%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM--DNDFLVGRKKMPRAQTEREIMQMLD 528
+++L K LG G G VYL T A+K + D + K++ + E ++++ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 529 HPFLPTLFAHF--TTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
H + + E+ + ME+ PGG + Q + +E R Y ++L +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK--DQLKSYGALTENVTRKYTRQILEGVS 120
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621
YLH +V+RD+K NIL G++ L DF S R
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKR 155
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 31/110 (28%), Positives = 46/110 (41%), Gaps = 13/110 (11%)
Query: 705 NSFVGTHEYLAPEIIK-GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS 763
+FVGT ++APE+++ G+ D W+FGI EL G P+ + L +
Sbjct: 164 KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND 223
Query: 764 LRFPGYP------VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
P S R +I L K+P R A E+ +H FF
Sbjct: 224 --PPSLETGADYKKYSKSFRKMISLCLQKDPSKR----PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 48/143 (33%), Positives = 74/143 (51%), Gaps = 12/143 (8%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD--HPFLPT 534
K+G G G V +A + A+K+MD RK+ R E++ M D H +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHQNVVE 82
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAE-VLLALEYLHMLGV 593
++ + + ++ME+ GG L + + +R EQ A V E VL AL YLH GV
Sbjct: 83 MYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIAT--VCESVLQALCYLHSQGV 138
Query: 594 VYRDLKPENILVREDGHIMLSDF 616
++RD+K ++IL+ DG + LSDF
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 51/153 (33%), Positives = 77/153 (50%), Gaps = 14/153 (9%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKV--MDNDFLVGRKKMPRAQTEREIM--QMLD 528
KL++ +G G G VY A + + ALK MDN+ R +P + REI L
Sbjct: 11 KLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNE----RDGIP-ISSLREITLLLNLR 64
Query: 529 HPFLPTLFAHFTTEKFSC--LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
HP + L + LVMEYC DL L P+ F SE + + ++L L+
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPF-SESQVKCLMLQLLRGLQ 122
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
YLH +++RDLK N+L+ + G + ++DF L+
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 47/169 (27%), Positives = 61/169 (36%), Gaps = 38/169 (22%)
Query: 476 KKLGCGDIGTVYLAEL---------IGTSCLFALKVMDN--DFLVGRKKMPRAQTEREIM 524
KKLG G G V E + CL + K+ D DFL E IM
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK----------EAAIM 50
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRF-------FSEQAARF 576
LDH L L+ T +V E P G L LR+ F ++ Q A
Sbjct: 51 HSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIAN- 108
Query: 577 YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625
+ YL ++RDL NIL+ D + + DF L N
Sbjct: 109 -------GMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 35/174 (20%)
Query: 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALK--VMDNDFLVGRKKMP-RAQTERE 522
C + ++ K+G G G V+ A T + ALK +M+N+ ++ P A E +
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE----KEGFPITALREIK 63
Query: 523 IMQMLDHP----------FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQ 572
I+Q+L H T + + + LV E+C H L + S +
Sbjct: 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFY--LVFEFCE----HDL-----AGLLSNK 112
Query: 573 AARFYVAEV-------LLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+F ++E+ L L Y+H +++RD+K NIL+ +DG + L+DF L+
Sbjct: 113 NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 6/155 (3%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM--DNDFLVGRKKMPRAQTEREIMQMLD 528
+++L K LG G G VYL T A+K + D D K++ + E ++++ L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 529 HPFLPTLFAHFT--TEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
H + + EK + +EY PGG + Q + +E R Y ++L +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS--IKDQLKAYGALTENVTRRYTRQILQGVS 120
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621
YLH +V+RD+K NIL G++ L DF S R
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 18/150 (12%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVM------DNDFLVGRKKMPRAQTEREIMQMLDH 529
K+LG G G V+L + G A+K++ ++DF+ E ++M L H
Sbjct: 10 KELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFI----------EEAKVMMKLSH 58
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
P L L+ T ++ +V EY G L +++ + +E ++V A+EYL
Sbjct: 59 PNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM-CSDVCEAMEYLE 117
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
G ++RDL N LV ED + +SDF L+
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 50/158 (31%), Positives = 70/158 (44%), Gaps = 16/158 (10%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQT---EREI 523
+ M+ KL + +G G+ G V L + G A+K + ND AQ E +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKND--------ATAQAFLAEASV 52
Query: 524 MQMLDHPFLPTLFAHFTTEKFSC-LVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEV 581
M L H L L EK +V EY G L LR + S + +F + +V
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DV 111
Query: 582 LLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
A+EYL V+RDL N+LV ED +SDF L+
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP-RAQTEREIMQMLDHPFLPT 534
+KLG G TVY + L ALKV+ L + P A E +++ L H +
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLKHANIVL 67
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
L T++ LV EY DL K P E + ++ ++L L Y+H ++
Sbjct: 68 LHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENV-KLFLFQLLRGLSYIHQRYIL 125
Query: 595 YRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVE--EPPPKKASSPCSEASC 652
+RDLKP+N+L+ + G + L+DF L+ R P S+ V PP ++C
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 653 IEPFCLHPSWQVSC-FTPRLLSVAA 676
++ W V C F + VAA
Sbjct: 185 LD------MWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 38/150 (25%), Positives = 69/150 (46%), Gaps = 5/150 (3%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH 529
F +++G G G VY T + A+K++D + ++ Q E ++ D
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDS 61
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
P++ + + ++MEY GG L + P E + E+L L+YLH
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLH 118
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++RD+K N+L+ E G + L+DF ++
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 27/103 (26%), Positives = 41/103 (39%), Gaps = 38/103 (36%)
Query: 704 SNSFVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
+ VGT Y+APE++ G+G+ D W+ G+ L+EL
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------- 187
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHP 805
+DLIR +L K+P+ R A EI +H
Sbjct: 188 -----------PELKDLIRKMLQKDPEKRP----SAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 30/109 (27%), Positives = 49/109 (44%), Gaps = 11/109 (10%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
+ + +GT Y+APE+ KG + D W+ G L+E+ PF+ + L
Sbjct: 154 KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-LRYK 212
Query: 760 VSQSLRFPGYPVVSFHARDL---IRGLLVKEPDNRLGAVKGAAEIKQHP 805
V Q ++P P+ +++DL IR +L +P R K I P
Sbjct: 213 V-QRGKYP--PIPPIYSQDLQNFIRSMLQVKPKLRPNCDK----ILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 4/90 (4%)
Query: 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG-NDETLSNVVSQSL 764
S VGT Y++PE I G+ D W+ G L+E+ ++PF G N +L + +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC- 223
Query: 765 RFPGYPVVSFHA--RDLIRGLLVKEPDNRL 792
+P P + RDL+ + +P+ R
Sbjct: 224 DYPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 46/150 (30%), Positives = 69/150 (46%), Gaps = 6/150 (4%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVM--DNDFLVGRKKMPRAQTEREIMQMLDHPFLP 533
K LG G G VYL + T A K + D + K++ + E ++++ L H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 534 TLFAHFT--TEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ EK + MEY PGG V Q + +E R Y ++L + YLH
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGS--VKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLSLR 621
+V+RD+K NIL G++ L DF S R
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKR 155
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 6e-08
Identities = 34/132 (25%), Positives = 50/132 (37%), Gaps = 39/132 (29%)
Query: 710 THE-----YLAPEIIKGEGH-GSSVDWWTFG-IFLFELLYGRTPFKGSGNDETL------ 756
THE Y APEI+ G H ++VD W+ G IF E++ G+ F G + L
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFA-EMITGKPLFPGDSEIDQLFKIFQI 214
Query: 757 ------------SNVVSQSLRFPGYPVVSFH---------ARDLIRGLLVKEPDNRLGAV 795
+ + FP +P DL+ +L P R+
Sbjct: 215 LGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI--- 271
Query: 796 KGAAEIKQHPFF 807
A E +HP+F
Sbjct: 272 -SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 20/158 (12%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALK----VMDNDFLVGRKKMPRAQTEREIMQMLDH-P 530
+K+G G G VY A T L ALK MD + + P A E ++QML
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP-----PTALREISLLQMLSESI 61
Query: 531 FLPTLFAHFTTEKFS-----CLVMEYCPGGDLH---VLRQKQPSRFFSEQAARFYVAEVL 582
++ L E+ + LV EY DL + P R + + ++ ++L
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIM-LSDFDLS 619
+ + H GV++RDLKP+N+LV + ++ ++D L
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 5/148 (3%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F +++G G G V+ T + A+K++D + ++ Q E ++ D P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPY 63
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ + + ++MEY GG L + P F E + E+L L+YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSE 120
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLS 619
++RD+K N+L+ E G + L+DF ++
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 34/112 (30%), Positives = 51/112 (45%), Gaps = 11/112 (9%)
Query: 701 GARSNSFVGTHEYLAPEIIKG---EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS 757
G S GT Y+APE+I G +GHG + D W+ G + E+ G+ P+ N+ +
Sbjct: 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216
Query: 758 NVVSQSLRFPGYP---VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
V + P P +S +D + L +P R A E+ QHPF
Sbjct: 217 FHVGAGHK-PPIPDSLQLSPEGKDFLDRCLESDPKKRPTAS----ELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 35/119 (29%), Positives = 55/119 (46%), Gaps = 7/119 (5%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV-S 761
+ S VGT ++APE+I +G+ VD W+ GI + E++ G P+ + + + S
Sbjct: 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 232
Query: 762 QSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVP 820
+ +S RD + +L +EP R A E+ HPF L L C VP
Sbjct: 233 PPPKLKNAHKISPVLRDFLERMLTREPQER----ATAQELLDHPFL--LQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 14/161 (8%)
Query: 472 FKLHKKLGCGDIGTVYLAEL---IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
KL K LG G+ G+V +L G+ A+K M D + ++ +E M+ D
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-IHTYSEIEEFLSEAACMKDFD 59
Query: 529 HPFLPTL----FAHFTTEKFS--CLVMEYCPGGDLHVL----RQKQPSRFFSEQAARFYV 578
HP + L F + +K +++ + GDLH R Q ++
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++ L +EYL ++RDL N ++RED + ++DF LS
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 49/172 (28%), Positives = 69/172 (40%), Gaps = 33/172 (19%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRK---------KMPRAQT------- 519
+KLG G G V+L E G K MD DF + KM R
Sbjct: 11 EKLGEGQFGEVHLCEAEGM-----EKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 520 ---EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQP--------SR 567
E +IM L P + L A T C++ EY GDL+ L + +P
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 568 FFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
S F ++ ++YL L V+RDL N LV ++ I ++DF +S
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 46/158 (29%), Positives = 64/158 (40%), Gaps = 20/158 (12%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDND------FLVGRKKMPRAQTERE 522
+ KL +G G+ G V L + G A+K + +D FL E
Sbjct: 5 SKELKLGATIGKGEFGDVMLGDYRGQKV--AVKCLKDDSTAAQAFL----------AEAS 52
Query: 523 IMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEV 581
+M L HP L L +V EY G L LR + + Q F + +V
Sbjct: 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL-DV 111
Query: 582 LLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+EYL V+RDL N+LV ED +SDF L+
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 45/154 (29%), Positives = 79/154 (51%), Gaps = 25/154 (16%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALK--VMDNDFLVGRKKMPRAQTEREI--MQMLDHPFL 532
K+G G GTV+ A+ T + ALK +D+D + +P + REI ++ L H +
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDD----DEGVP-SSALREICLLKELKHKNI 61
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSE-------QAARFYVAEVLLAL 585
L+ ++K LV EYC DL ++F + + ++ ++L L
Sbjct: 62 VRLYDVLHSDKKLTLVFEYC-DQDL--------KKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 586 EYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ H V++RDLKP+N+L+ ++G + L+DF L+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 26/161 (16%)
Query: 476 KKLGCGDIGTVYLAELIGTSC--LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLP 533
+ LGCG G V+ A + + C A+K + L + + A E +I++ LDH +
Sbjct: 11 RPLGCGSNGLVFSA--VDSDCDKRVAVKKI---VLTDPQSVKHALREIKIIRRLDHDNIV 65
Query: 534 TLF------AHFTTEKFS--------CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVA 579
++ TE +V EY DL + ++ P SE+ AR ++
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGP---LSEEHARLFMY 121
Query: 580 EVLLALEYLHMLGVVYRDLKPENILVR-EDGHIMLSDFDLS 619
++L L+Y+H V++RDLKP N+ + ED + + DF L+
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 14/161 (8%)
Query: 472 FKLHKKLGCGDIGTVY-LAELIGTSCLFALK-VMDNDFLVGRKKMPRAQTEREIM----- 524
+ + + LG G G VY + + L ALK + ++ G+ K R ++ +I+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 525 --QMLDHPFLPTLFAHFTTEKFSCLVMEY---CPGGDLHVLRQKQPSRFFSEQAARFYVA 579
+ L HP + + F +VM+ P G+ H K+ + F+E+
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFV 120
Query: 580 EVLLALEYLHMLG-VVYRDLKPENILVREDGHIMLSDFDLS 619
+++LAL YLH +V+RDL P NI++ ED + ++DF L+
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 3e-07
Identities = 25/103 (24%), Positives = 44/103 (42%), Gaps = 7/103 (6%)
Query: 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL 764
++VGT Y++PE + + D W+ G ++EL PF + S + +
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI--KEG 225
Query: 765 RFPGYPVV-SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
+F P S ++I+ +L +PD R E+ Q P
Sbjct: 226 KFRRIPYRYSSELNEVIKSMLNVDPDKR----PSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 47/146 (32%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP-RAQTEREIMQMLDHPFLPTL 535
KLG G TVY T L ALK + L + P A E +++ L H + TL
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 536 FAHFTTEKFSCLVMEYCPGGDLHVLRQ--KQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
TEK LV EY L+Q + + ++ ++L L Y H V
Sbjct: 70 HDIIHTEKSLTLVFEYLDKD----LKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 594 VYRDLKPENILVREDGHIMLSDFDLS 619
++RDLKP+N+L+ E G + L+DF L+
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 10/170 (5%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH 529
+ + +K+G G GTVY A I T A+K M+ L + K E +M+ +
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENKN 75
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
P + + +VMEY GG L + + E E L AL++LH
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLH 132
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA-VNPMVVKSSSPVEEP 638
V++RD+K +NIL+ DG + L+DF CA + P K S+ V P
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGF---CAQITPEQSKRSTMVGTP 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 6/144 (4%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP-RAQTEREIMQMLDHPFLPTL 535
KLG G TV+ T L ALK + L + P A E +++ L H + TL
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIR---LEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 536 FAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVY 595
TE+ LV EY L S + ++ ++L L Y H +++
Sbjct: 69 HDIIHTERCLTLVFEYLDSDLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126
Query: 596 RDLKPENILVREDGHIMLSDFDLS 619
RDLKP+N+L+ E G + L+DF L+
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 16/173 (9%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQ---TEREIMQM 526
+ + ++K+G G GTV+ A + T A+K ++ +K P+ + E +M+
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN------LQKQPKKELIINEILVMKE 72
Query: 527 LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
L +P + F +VMEY GG L + + E E L ALE
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALE 129
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA-VNPMVVKSSSPVEEP 638
+LH V++RD+K +N+L+ DG + L+DF CA + P K S+ V P
Sbjct: 130 FLHANQVIHRDIKSDNVLLGMDGSVKLTDFGF---CAQITPEQSKRSTMVGTP 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 40/142 (28%), Positives = 66/142 (46%), Gaps = 4/142 (2%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFA 537
LG G+ G V+ L + + A+K D K + +E I++ DHP + L
Sbjct: 3 LGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIG 59
Query: 538 HFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRD 597
T + +VME PGGD +K+ ++Q +F + + + YL ++RD
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL-DAAAGMAYLESKNCIHRD 118
Query: 598 LKPENILVREDGHIMLSDFDLS 619
L N LV E+ + +SDF +S
Sbjct: 119 LAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 50/148 (33%), Positives = 69/148 (46%), Gaps = 7/148 (4%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP-RAQTEREIMQMLDHPF 531
KL K LG G TVY T L ALK + L + P A E +++ L H
Sbjct: 9 KLDK-LGEGSYATVYKGRSKLTGQLVALKEIR---LEHEEGAPFTAIREASLLKDLKHAN 64
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ TL T+K LV EY DL S R ++ ++L L Y H
Sbjct: 65 IVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLS 619
V++RDLKP+N+L+ E G + L+DF L+
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 4e-07
Identities = 45/163 (27%), Positives = 62/163 (38%), Gaps = 61/163 (37%)
Query: 679 RKIKSD----------------LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGE 722
R IKSD AAQ++ + NS VGT ++APE+IK +
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--------KRNSVVGTPYWMAPEVIKRK 191
Query: 723 GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP-----------GYPV 771
+G VD W+ GI E+ G P+ LR P G P
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPY----------------LREPPLRALFLITTKGIPP 235
Query: 772 ------VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808
S +D + LVK+P+ R A E+ QHPF +
Sbjct: 236 LKNPEKWSPEFKDFLNKCLVKDPEKR----PSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 41/149 (27%), Positives = 57/149 (38%), Gaps = 7/149 (4%)
Query: 474 LHKKLGCGDIGTVYLA---ELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
L + +G G G VY A+K N ++ + E IM+ DHP
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVRE--KFLQEAYIMRQFDHP 67
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
+ L TE +VME P G+L Q Y ++ AL YL
Sbjct: 68 HIVKLIG-VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLI-LYSYQLSTALAYLES 125
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLS 619
V+RD+ N+LV + L DF LS
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 10/170 (5%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH 529
+ + +K+G G GTVY A + T A++ M+ L + K E +M+ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKN 76
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
P + + +VMEY GG L + + E E L ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH 133
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA-VNPMVVKSSSPVEEP 638
V++RD+K +NIL+ DG + L+DF CA + P K S+ V P
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGF---CAQITPEQSKRSTMVGTP 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 38/108 (35%), Positives = 56/108 (51%), Gaps = 8/108 (7%)
Query: 513 KMPRAQTEREI--MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLR--QKQPSRF 568
KM + REI ++ L H L L F +K LV E+ D VL +K P+
Sbjct: 41 KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV---DHTVLDDLEKYPNGL 97
Query: 569 FSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616
E R Y+ ++L +E+ H +++RD+KPENILV + G + L DF
Sbjct: 98 -DESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 10/147 (6%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP-RAQTEREIMQMLDHPFLPT 534
+KLG G TV+ T L ALK + L + P A E +++ L H + T
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPS--RFFSEQAARFYVAEVLLALEYLHMLG 592
L T+K LV EY L+Q S + ++ ++L L Y H
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKD----LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 593 VVYRDLKPENILVREDGHIMLSDFDLS 619
V++RDLKP+N+L+ E G + L+DF L+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 45/163 (27%), Positives = 69/163 (42%), Gaps = 24/163 (14%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELI----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ 525
RH K ++LG G+ G+V L T + A+K + + + + + E EI++
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILK 60
Query: 526 MLDHPFLPTLFAHFTTEKFSC---------LVMEYCPGGDLHVLRQKQPSRFFSEQAARF 576
L H + K C LVMEY P G L QK R +
Sbjct: 61 SLQHDNI-------VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL-L 112
Query: 577 YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
Y +++ +EYL V+RDL NILV + + + DF L+
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 48/190 (25%), Positives = 70/190 (36%), Gaps = 51/190 (26%)
Query: 471 HFKLHKKLGCGDIGTVYLAELI----------------GTSCLFALKVMD--------ND 506
H +KLG G G V+L E++ G L A+K++ ND
Sbjct: 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND 65
Query: 507 FLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL------HVL 560
FL E +I+ L P + L E C++ EY GDL H L
Sbjct: 66 FL----------KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHL 115
Query: 561 RQKQ-PSRFFSEQAARFYV----------AEVLLALEYLHMLGVVYRDLKPENILVREDG 609
K+ A ++ ++YL L V+RDL N LV E+
Sbjct: 116 DDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENL 175
Query: 610 HIMLSDFDLS 619
I ++DF +S
Sbjct: 176 TIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 15/104 (14%)
Query: 519 TEREIMQMLDHPFLPTLFAHFTTEKFSCLVME------YCPGGDLHVLRQKQPSRFFSEQ 572
TE I++ ++HP + L FT KF+CL++ YC L R + +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCY---LAAKRNIAICDILAIE 188
Query: 573 AARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616
+ VL A++YLH +++RD+K ENI + G + L DF
Sbjct: 189 RS------VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226
|
Length = 391 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 35/120 (29%), Positives = 58/120 (48%), Gaps = 15/120 (12%)
Query: 692 MPQLVVEPTGARSNSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGS 750
M + VVE + A+S F G+ ++APE+I +G +G + D W+ G + E+ G+ P+
Sbjct: 148 MAKQVVEFSFAKS--FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205
Query: 751 GNDETLSNVVSQSLRFPGYPVVSFH----ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
+ + R P + H A+D I L ++P R AAE+ +HPF
Sbjct: 206 EGVAAVFKIG----RSKELPPIPDHLSDEAKDFILKCLQRDPSLRP----TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 30/115 (26%), Positives = 53/115 (46%), Gaps = 15/115 (13%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
G +GT ++APE+++GE +G S D W+ G + E+ + P+ N E SN
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW----NAEKHSNH 216
Query: 760 VSQSLRFP---GYPVVSFH----ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
++ + P + H RD+ L +P++R + E+ +HP F
Sbjct: 217 LALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSR----ELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 7/107 (6%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
TG RS GT +++PE+I GEG+G D W+ G + E+L + P+ + +
Sbjct: 164 TGIRS--VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221
Query: 760 VSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
+Q +S HARD + + V E +R A E+ +HPF
Sbjct: 222 ATQPTNPQLPSHISEHARDFLGCIFV-EARHR----PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 28/110 (25%), Positives = 56/110 (50%), Gaps = 1/110 (0%)
Query: 511 RKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK-FSCLVMEYCPGGDLHVLRQKQPSRFF 569
R++ A+ E +++ L HP + + E +VM +C GGDL+ ++Q +
Sbjct: 40 RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLL 99
Query: 570 SEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
E + ++ +AL+YLH +++RDLK +N+ + I + D ++
Sbjct: 100 PENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIA 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 4/144 (2%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTL 535
+K+G G+ G VY L + A+K + L K Q E EI++ DHP + L
Sbjct: 1 EKIGKGNFGDVYKGVL-KGNTEVAVKTCRST-LPPDLKRKFLQ-EAEILKQYDHPNIVKL 57
Query: 536 FAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVY 595
++ +VME PGG L +K+ +R ++ + + +EYL ++
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQM-SLDAAAGMEYLESKNCIH 116
Query: 596 RDLKPENILVREDGHIMLSDFDLS 619
RDL N LV E+ + +SDF +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 40/147 (27%), Positives = 65/147 (44%), Gaps = 10/147 (6%)
Query: 477 KLGCGDIGTVY--LAELIGTSCLFALKVMDNDFLVGRKKMPRAQ--TEREIMQMLDHPFL 532
+LG G+ G V + ++ A+KV+ N +K R + E EIM LD+P++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKN----ENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592
+ E LVME GG L+ + + +V + ++YL
Sbjct: 58 VRMIGVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVEL-MHQVSMGMKYLEGKN 115
Query: 593 VVYRDLKPENILVREDGHIMLSDFDLS 619
V+RDL N+L+ + +SDF LS
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 26/73 (35%), Positives = 40/73 (54%), Gaps = 5/73 (6%)
Query: 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR 606
LVM Y + QK SE ++ V ++L L+Y+H G+++RDLKP N+ V
Sbjct: 97 LVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN 151
Query: 607 EDGHIMLSDFDLS 619
ED + + DF L+
Sbjct: 152 EDCELKILDFGLA 164
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDF---LVGRKKMPRAQTEREIMQMLDHPFL 532
K++G G GTV A T A+K + F L + RA E +++ + H +
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAK----RAYRELRLLKHMKHENV 76
Query: 533 PTLFAHFTTE----KFS--CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
L FT + +F LVM + G DL L + + SE +F V ++L L+
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK---LSEDRIQFLVYQMLKGLK 132
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
Y+H G+++RDLKP N+ V ED + + DF L+
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 33/110 (30%), Positives = 48/110 (43%), Gaps = 10/110 (9%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
T ++ N+FVGT ++APE+IK G+ D W+ GI EL G P L +
Sbjct: 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210
Query: 760 VSQ---SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
SL + S +D + L K+P R A E+ +H F
Sbjct: 211 PKNNPPSLEGNKF---SKPFKDFVSLCLNKDPKERP----SAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 7/106 (6%)
Query: 704 SNSFVGTHEYLAPEII-KG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS 761
+ +F GT +Y+APE+I KG G+G+ D W+ G + E+ G+ PF G + V
Sbjct: 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG 225
Query: 762 QSLRFPGYP-VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
P P +S A++ I +PD R A ++ Q PF
Sbjct: 226 MFKIHPEIPESLSAEAKNFILRCFEPDPDKR----ASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 6/120 (5%)
Query: 502 VMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VL 560
VM ND ++ A++E + DH + F F ++ L+MEY GGDL+ +
Sbjct: 101 VMLND----ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI 156
Query: 561 RQKQPSRF-FSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+Q+ F E +++LAL+ +H +++RDLK NI + G I L DF S
Sbjct: 157 KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS 216
|
Length = 478 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 31/89 (34%), Positives = 47/89 (52%), Gaps = 3/89 (3%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS 763
++SF GT YLAPE+ + + + D W+ G+ L+ELL PFKG E + V+
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG- 286
Query: 764 LRFPGYPV-VSFHARDLIRGLLVKEPDNR 791
++ +P VS + L+ LL K P R
Sbjct: 287 -KYDPFPCPVSSGMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-06
Identities = 36/130 (27%), Positives = 54/130 (41%), Gaps = 6/130 (4%)
Query: 494 TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE-KFSCLVMEYC 552
T A+K++ D + R + E + L HP + L V EY
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 553 PGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG--- 609
PG L + + E + +VL AL H G+V+RDLKP+NI+V + G
Sbjct: 62 PGRTLREVLAADGALPAGETGR--LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 610 HIMLSDFDLS 619
H + DF +
Sbjct: 120 HAKVLDFGIG 129
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVM------DNDFLVGRKKMPRAQTEREIMQMLDH 529
K+LG G G V+L + A+K + + DF+ E ++M L H
Sbjct: 10 KELGSGQFGVVHLGKW-RAQIKVAIKAINEGAMSEEDFI----------EEAKVMMKLSH 58
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
P L L+ T +K +V E+ G L + LRQ+Q S+ +V +EYL
Sbjct: 59 PKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK--LSKDMLLSMCQDVCEGMEYL 116
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSS---PVEEPPPK 641
++RDL N LV G + +SDF ++ R ++ SS PV+ PP+
Sbjct: 117 ERNSFIHRDLAARNCLVSSTGVVKVSDFGMT-RYVLDDEYTSSSGAKFPVKWSPPE 171
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 41/146 (28%), Positives = 75/146 (51%), Gaps = 12/146 (8%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVM--DNDFLVGRKKMPRAQTEREIMQMLDHPFLP 533
++G G GTVY T L+ALKV+ +++ V R+++ R E EI++ ++HP +
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV-RRQICR---EIEILRDVNHPNVV 135
Query: 534 TLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
F +++E+ GG L + + EQ ++L + YLH +
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSL------EGTHIADEQFLADVARQILSGIAYLHRRHI 189
Query: 594 VYRDLKPENILVREDGHIMLSDFDLS 619
V+RD+KP N+L+ ++ ++DF +S
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVS 215
|
Length = 353 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 42/148 (28%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 476 KKLGCGDIGTVY--LAELIGTSCLFALKVM--DNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+LG G+ GTV + ++ + A+K++ DN+ + ++ R E +MQ LD+P+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR---EANVMQQLDNPY 57
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ + E + LVME G L+ QK ++ +E+ V +V + ++YL
Sbjct: 58 IVRMIGICEAESW-MLVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEET 114
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLS 619
V+RDL N+L+ + +SDF LS
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 24/153 (15%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTE---------REI--MQ 525
K+G G G VY A T + ALK + R +TE REI ++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI------------RLETEDEGVPSTAIREISLLK 53
Query: 526 MLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLAL 585
L+HP + L +E LV E+ DL P + Y+ ++L +
Sbjct: 54 ELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 586 EYLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618
Y H V++RDLKP+N+L+ +G + L+DF L
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 42/150 (28%), Positives = 65/150 (43%), Gaps = 12/150 (8%)
Query: 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE--IMQMLDHPF 531
+ KLG G G VY S A+K + D M + +E +M+ + HP
Sbjct: 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPN 63
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVA-EVLLALEYLH 589
L L T E ++ E+ G+L LR+ Y+A ++ A+EYL
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQISSAMEYLE 121
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++RDL N LV E+ + ++DF LS
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLS 151
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 40/129 (31%), Positives = 51/129 (39%), Gaps = 33/129 (25%)
Query: 708 VGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS----- 761
V T Y APE++ G VD W G ELL G F G + E L+ V
Sbjct: 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTP 220
Query: 762 --------------QSLRFPG---------YPVVSFHARDLIRGLLVKEPDNRLGAVKGA 798
+ FP +P S A DL++GLLV +P RL A
Sbjct: 221 NEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL----SA 276
Query: 799 AEIKQHPFF 807
AE +HP+F
Sbjct: 277 AEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 29/101 (28%), Positives = 44/101 (43%), Gaps = 5/101 (4%)
Query: 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR 765
+ VGT Y++PE+ +G + D W G L+ELL + F + N L + Q
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-NPLNLVVKIVQGNY 218
Query: 766 FPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
P V S L+ LL ++P+ R A E+ P
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKR----PTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 47/161 (29%), Positives = 72/161 (44%), Gaps = 25/161 (15%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQT-EREIMQMLD 528
+ +KL +G G G VY A I TS A+K + D P+ + E IM+ L+
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--------PQYKNRELLIMKNLN 117
Query: 529 HPFLPTLFAHFTTEKFS--------CLVMEYCPGG----DLHVLRQKQPSRFFSEQAARF 576
H + L ++ TE F +VME+ P H R F +
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF---LVKL 174
Query: 577 YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIM-LSDF 616
Y ++ AL Y+H + +RDLKP+N+L+ + H + L DF
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215
|
Length = 440 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 43/166 (25%), Positives = 66/166 (39%), Gaps = 44/166 (26%)
Query: 681 IKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFEL 740
+KSD ++ T +V T Y APE+I G G+ +VD W+ G + EL
Sbjct: 156 VKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
Query: 741 LYGRTPFKGSGNDETLSNVVSQ----SLRF---------------PGYPVVSF------- 774
+ G F+G+ + + + V+ Q S F P YP +SF
Sbjct: 216 VKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDW 275
Query: 775 --------------HARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
ARDL+ +LV +PD R+ E +HP+
Sbjct: 276 IFPSESERDKLKTSQARDLLSKMLVIDPDKRI----SVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 34/121 (28%), Positives = 51/121 (42%), Gaps = 30/121 (24%)
Query: 703 RSNSFVGTHEYLAPEII-----KGEGHGSSVDWWTFGIFLFELLYGRTP----------F 747
+ ++F+GT ++APE++ K + D W+ GI L EL P
Sbjct: 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL 218
Query: 748 K-GSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
K TL P SF+ D ++ LVK+PD+R AAE+ +HPF
Sbjct: 219 KILKSEPPTLDQ--------PSKWSSSFN--DFLKSCLVKDPDDRP----TAAELLKHPF 264
Query: 807 F 807
Sbjct: 265 V 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 42/154 (27%), Positives = 66/154 (42%), Gaps = 17/154 (11%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMD------NDFLVGRKKMPRAQTEREIMQ 525
KL +KLG G G V++ GT+ + A+K + FL E +IM+
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTMSPEAFL----------QEAQIMK 56
Query: 526 MLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLAL 585
L H L L+A + E+ +V EY G L + + A++ +
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 586 EYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
YL ++RDL NILV E+ ++DF L+
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 7/175 (4%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F L +KLG G G V+ L A+K++ +D L+ K Q E + ++ L H
Sbjct: 8 FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKH 63
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
L +LFA + + ++ E G L + + + +V + YL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSS--PVEEPPPKKAS 644
++RDL NILV ED ++DF L+ R + + S P + P+ AS
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLA-RLIKEDVYLSSDKKIPYKWTAPEAAS 177
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 5/107 (4%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV-S 761
+ S VGT ++APE+I +G+ VD W+ GI + E++ G P+ + + + +
Sbjct: 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN 233
Query: 762 QSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808
R VS R + +LV+EP R A E+ QHPF +
Sbjct: 234 LPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQ----ELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 38/150 (25%), Positives = 63/150 (42%), Gaps = 12/150 (8%)
Query: 476 KKLGCGDIGTVY----LAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
K LG G GTVY + E A+KV+ + K E +M +DHP
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAYVMASVDHPH 70
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ L + + L+ + P G L +V + Q + ++ + YL
Sbjct: 71 VVRLLGICLSSQV-QLITQLMPLGCLLDYV---RNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+V+RDL N+LV+ H+ ++DF L+
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 39/126 (30%), Positives = 55/126 (43%), Gaps = 20/126 (15%)
Query: 513 KMPRAQTEREIM--------------QMLDHPFLPTLFAHFTTEKFS-----CLVMEYCP 553
K R QT E M + +HP + LF T + LV E+
Sbjct: 33 KRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV- 91
Query: 554 GGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML 613
DL K P + + + ++L L++LH VV+RDLKP+NILV G I L
Sbjct: 92 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 151
Query: 614 SDFDLS 619
+DF L+
Sbjct: 152 ADFGLA 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 53/180 (29%), Positives = 78/180 (43%), Gaps = 20/180 (11%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQT---EREI 523
+ ++ L + +G G+ G V E G A+K + D AQ E +
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKV--AVKNIKCDV--------TAQAFLEETAV 52
Query: 524 MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVL 582
M L H L L +VME G+L + LR + + Q +F + +V
Sbjct: 53 MTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL-DVA 110
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSS-PVEEPPPK 641
+EYL +V+RDL NILV EDG +SDF L+ V M V +S PV+ P+
Sbjct: 111 EGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPE 167
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 19/168 (11%)
Query: 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKV--MDNDFLVGRKKMP-RAQTER 521
G + F + ++G G G VY A T L ALK +DN+ ++ P A E
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE----KEGFPITAIREI 57
Query: 522 EIMQMLDHPFLPTLFAHFTTEKFSC----------LVMEYCPGGDLHVLRQKQPSRFFSE 571
+I++ L+H + L T ++ + LV EY + +L FSE
Sbjct: 58 KILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH--FSE 115
Query: 572 QAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ ++ ++L L Y H ++RD+K NIL+ G I L+DF L+
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 32/120 (26%), Positives = 53/120 (44%), Gaps = 27/120 (22%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
T A+ N+ +GT ++APE+I+ G+ + D W+ GI E+ G+ P S++
Sbjct: 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP---------YSDI 202
Query: 760 ------------VSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+L P S D ++ LVK+P+ R A ++ QHPF
Sbjct: 203 HPMRAIFMIPNKPPPTLSDPEK--WSPEFNDFVKKCLVKDPEER----PSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 31/115 (26%), Positives = 53/115 (46%), Gaps = 9/115 (7%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
+ P ++ ++ VGT ++APE++ + +G VD W+ GI E++ G P+ L
Sbjct: 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
Query: 757 SNVVSQ---SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808
+ + L+ P F RD + L + D R A E+ QHPF +
Sbjct: 225 YLIATNGTPELQNPERLSAVF--RDFLNRCLEMDVDRR----GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 11/109 (10%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS--NVV 760
R S VGT ++APE+I +G VD W+ GI + E++ G P+ N+ L ++
Sbjct: 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF---NEPPLKAMKMI 228
Query: 761 SQSL--RFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+L + VS + + LLV++P R AAE+ +HPF
Sbjct: 229 RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR----ATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 43/147 (29%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 476 KKLGCGDIGTVY--LAELIGTSCLFALKVMDNDFLVGRKKMP-RAQTEREIMQMLDHPFL 532
+KLG G TVY ++ + G L ALKV+ + + +P A E +++ L H +
Sbjct: 11 EKLGEGSYATVYKGISRINGQ--LVALKVIS---MKTEEGVPFTAIREASLLKGLKHANI 65
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592
L T++ V EY DL + P R ++ ++L L Y+H
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNV-RLFMFQLLRGLAYIHGQH 123
Query: 593 VVYRDLKPENILVREDGHIMLSDFDLS 619
+++RDLKP+N+L+ G + L+DF L+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 33/131 (25%), Positives = 50/131 (38%), Gaps = 35/131 (26%)
Query: 707 FVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGND--------ETL- 756
+V T Y APE++ G +G+ + VD W+ G ELL R F G ++ TL
Sbjct: 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK-SEIDQLFKIFRTLG 216
Query: 757 -----------SNVVSQSLRFPGYPVVSFH---------ARDLIRGLLVKEPDNRLGAVK 796
S + FP + A DL+ +L +P R+ A +
Sbjct: 217 TPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276
Query: 797 GAAEIKQHPFF 807
HP+F
Sbjct: 277 AL----AHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 46/153 (30%), Positives = 66/153 (43%), Gaps = 17/153 (11%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKV-----MD-NDFLVGRKKMPRAQTEREIMQM 526
+L +KLG G G V+ T+ + A+K MD DFL E +IM+
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTMDPKDFL----------AEAQIMKK 57
Query: 527 LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
L HP L L+A T E+ +V E G L Q R A+V +
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
YL ++RDL N+LV E+ ++DF L+
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 46/181 (25%), Positives = 75/181 (41%), Gaps = 22/181 (12%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM------DNDFLVGRKKMPRAQTEREI 523
+ K+LG G G V + G + A+K++ +++F+ E ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFI----------EEAKV 52
Query: 524 MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVL 582
M L H L L+ T ++ +V EY G L + LR+ + F +V
Sbjct: 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVC 110
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV--VKSSSPVEEPPP 640
+ YL ++RDL N LV + G + +SDF LS + V S PV PP
Sbjct: 111 EGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 641 K 641
+
Sbjct: 171 E 171
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 1e-05
Identities = 34/130 (26%), Positives = 49/130 (37%), Gaps = 34/130 (26%)
Query: 708 VGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSG--------------- 751
V T Y PE++ G G VD W+ G L EL G+ F+GS
Sbjct: 162 VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP 221
Query: 752 NDETLSNVVS----QSLRFP-GYP---------VVSFHARDLIRGLLVKEPDNRLGAVKG 797
DE V ++L+ Y ++ A DL+ LL +P R+
Sbjct: 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI----S 277
Query: 798 AAEIKQHPFF 807
A + QH +F
Sbjct: 278 ADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 1e-05
Identities = 32/134 (23%), Positives = 48/134 (35%), Gaps = 34/134 (25%)
Query: 707 FVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSG-------------- 751
+V T Y APE++ ++D W+ G ELL + F G
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225
Query: 752 -NDETLSNVVSQSLR-----FPGYPVVSFH---------ARDLIRGLLVKEPDNRLGAVK 796
++E L + S+ R P P A DL+ +LV +P R+
Sbjct: 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI---- 281
Query: 797 GAAEIKQHPFFEGL 810
A E HP+ L
Sbjct: 282 TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 42/182 (23%)
Query: 470 RHFKLHKKLGCGDIGTVYL------AELIGTSC--------LFALKVMD--------NDF 507
+ +L +KLG G G V+L AE +G L A+K++ NDF
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 508 LVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPS 566
L E +IM L +P + L ++ C++ EY GDL+ L Q++
Sbjct: 65 L----------KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIE 114
Query: 567 RFF---------SEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFD 617
F S + ++ ++YL L V+RDL N LV I ++DF
Sbjct: 115 STFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFG 174
Query: 618 LS 619
+S
Sbjct: 175 MS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-05
Identities = 27/65 (41%), Positives = 37/65 (56%), Gaps = 7/65 (10%)
Query: 580 EVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDF----DLSLRCAVNP---MVVKSS 632
+VL L LH +G+V+RD+KPEN+LV DG + + DF D+ NP M+
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376
Query: 633 SPVEE 637
SP EE
Sbjct: 377 SPPEE 381
|
Length = 507 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 19/40 (47%), Positives = 29/40 (72%), Gaps = 1/40 (2%)
Query: 581 VLLALEYLH-MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++ ALEYLH L V++RD+KP N+L+ +G + L DF +S
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 21/65 (32%), Positives = 40/65 (61%), Gaps = 4/65 (6%)
Query: 556 DLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLS 614
DLH ++R Q S+ ++++ ++L L+Y+H V++RDLKP N+L+ + + +
Sbjct: 94 DLHQIIRSSQT---LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 150
Query: 615 DFDLS 619
DF L+
Sbjct: 151 DFGLA 155
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 34/112 (30%), Positives = 50/112 (44%), Gaps = 15/112 (13%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPF-KGSGND------ETL 756
+ ++VGT+ Y+APE I GE +G D W+ GI EL GR P+ + N + L
Sbjct: 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209
Query: 757 SNVVSQSLRFPGYPVVSFHAR--DLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
+V + P PV F + I + K+P R + HPF
Sbjct: 210 QCIVDEDP--PVLPVGQFSEKFVHFITQCMRKQPKERP----APENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 37/132 (28%), Positives = 54/132 (40%), Gaps = 34/132 (25%)
Query: 707 FVGTHEYLAPEI-IKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG-------------- 751
+V T Y APEI + + + ++D W+ G L ELL + FKG
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228
Query: 752 -NDETLSNVVSQSLR-----FPGYPVVSF---------HARDLIRGLLVKEPDNRLGAVK 796
++ETLS + S + P P F A DL+ LL +P R+ V+
Sbjct: 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS-VE 287
Query: 797 GAAEIKQHPFFE 808
A E HP+
Sbjct: 288 EALE---HPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 29/111 (26%), Positives = 47/111 (42%), Gaps = 14/111 (12%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
+G S GT +++PE+I GEG+G D W+ G + E+L + P+ + +
Sbjct: 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 221
Query: 760 VSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810
+Q P VS H RD ++ + V E K P + L
Sbjct: 222 ATQPTNPVLPPHVSDHCRDFLKRIFV--------------EAKLRPSADEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 23/66 (34%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 554 GGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML 613
G DL+ + + Q S++ +F + ++L L+Y+H G+++RDLKP N+ V ED + +
Sbjct: 103 GADLNNIVKCQK---LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRI 159
Query: 614 SDFDLS 619
DF L+
Sbjct: 160 LDFGLA 165
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 38/145 (26%), Positives = 64/145 (44%), Gaps = 4/145 (2%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLF 536
+LG G+ G+VY T A+K + + + K + E +I+ P++ +
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 537 AHFTTEKFSCLVMEYCPGGDLHVLR-QKQPSRFFSEQAARFYVAEVLLALEYL-HMLGVV 594
F E + MEY G L L + E R V+ L++L ++
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 595 YRDLKPENILVREDGHIMLSDFDLS 619
+RD+KP N+LV +G + L DF +S
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 35/141 (24%), Positives = 65/141 (46%), Gaps = 19/141 (13%)
Query: 493 GTSCLFALKVMDNDFLVGRKKMP--------RAQTEREIMQMLDHPFLPTLFAHFTTEKF 544
G C V+D + + + P RA E +M+ ++H + +L FT +K
Sbjct: 31 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS 90
Query: 545 ------SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDL 598
LVME V++ + + + + ++L +++LH G+++RDL
Sbjct: 91 LEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 145
Query: 599 KPENILVREDGHIMLSDFDLS 619
KP NI+V+ D + + DF L+
Sbjct: 146 KPSNIVVKSDCTLKILDFGLA 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 18/43 (41%), Positives = 27/43 (62%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTP 746
+NSFVGT Y++PE ++G + D W+ G+ L E+ GR P
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 5/107 (4%)
Query: 516 RAQTERE--IMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQA 573
R Q RE ++ + P++ + F ++ + ME+ GG L + K+ R
Sbjct: 43 RNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGRIPENIL 101
Query: 574 ARFYVAEVLLALEYLH-MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ +A VL L YL +++RD+KP NILV G I L DF +S
Sbjct: 102 GKISIA-VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 34/117 (29%), Positives = 52/117 (44%), Gaps = 15/117 (12%)
Query: 518 QTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH---VLRQKQPSRFFS---- 570
Q E +M L HP + L T E+ C++ EY GDLH ++R S
Sbjct: 55 QQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114
Query: 571 -------EQAARFYVA-EVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ ++A ++ +EYL V++DL NIL+ E H+ +SD LS
Sbjct: 115 GTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 42/148 (28%), Positives = 63/148 (42%), Gaps = 8/148 (5%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532
L +++G G G V+L L KV G E ++M L HP L
Sbjct: 7 TLVQEIGSGQFGLVWLG-----YWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKL 61
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
L+ T CLV E+ G L LR ++ FS++ +V + YL
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVCEGMAYLESS 119
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLS 619
V++RDL N LV E+ + +SDF ++
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 32/111 (28%), Positives = 56/111 (50%), Gaps = 10/111 (9%)
Query: 518 QTEREIMQML-DHPFLPTLFAHFTTEKFSC-----LVMEYCPGGDLHVLRQ---KQPSRF 568
+ E I++ L DHP + + + + LV+E C GG + L + K+ R
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121
Query: 569 FSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
E + + E L+ L++LH+ ++RD+K NIL+ +G + L DF +S
Sbjct: 122 -EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 38/131 (29%), Positives = 55/131 (41%), Gaps = 34/131 (25%)
Query: 707 FVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGN------------- 752
+V T Y APEI+ H +VD W+ G + ELL GRT F G+ +
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236
Query: 753 --DETLSNVVSQSLR-----FPGYPVVSF---------HARDLIRGLLVKEPDNRLGAVK 796
E L + S+S R P ++F A DL+ +LV + D R+
Sbjct: 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI---- 292
Query: 797 GAAEIKQHPFF 807
AA+ H +F
Sbjct: 293 TAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 3e-05
Identities = 38/130 (29%), Positives = 52/130 (40%), Gaps = 33/130 (25%)
Query: 707 FVGTHEYLAPEII-KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS---- 761
+V T Y APEI+ + + S VD W G + EL R F GS + L + S
Sbjct: 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGT 217
Query: 762 -------------QSL--RFPGYPVVSFH---------ARDLIRGLLVKEPDNRLGAVKG 797
L RFP + S H A DLI+ +L +P R
Sbjct: 218 PTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP----T 273
Query: 798 AAEIKQHPFF 807
A++ QHP+F
Sbjct: 274 ASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 38/139 (27%), Positives = 59/139 (42%), Gaps = 34/139 (24%)
Query: 702 ARSNSFVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
A +V T Y APE+I H +VD W+ G + E+L G+T FKG + L+ ++
Sbjct: 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228
Query: 761 S----------------------QSL-RFPG------YPVVSFHARDLIRGLLVKEPDNR 791
+SL ++P +P S A DL+ +L + D R
Sbjct: 229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKR 288
Query: 792 LGAVKGAAEIKQHPFFEGL 810
L A E +HP+F+
Sbjct: 289 L----TATEALEHPYFDSF 303
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 39/149 (26%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDF--LVGRKKMPRAQTEREIMQMLDHPFLPTL 535
+G G G+V A T A+K + F ++ K+ R E +++ + H + L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR---ELRLLKHMKHENVIGL 81
Query: 536 FAHFTT----EKFS-CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
FT E+F+ ++ + G DL+ + + Q ++ +F + ++L L+Y+H
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHS 138
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLS 619
+++RDLKP N+ V ED + + DF L+
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLA 167
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 44/167 (26%), Positives = 63/167 (37%), Gaps = 27/167 (16%)
Query: 474 LHKKLGCGDIGTVYLAEL-----IGTSCLFALKVM----DNDFLVGRKKMPRAQTEREIM 524
L ++LG G G V+L E L A+K + ND RK R E E++
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND---ARKDFER---EAELL 62
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQP--SRFFSEQAARFYVAEV 581
H + + T +V EY GDL+ LR P + S + +
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 582 LL---------ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L + YL V+RDL N LV D + + DF +S
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 7/148 (4%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532
KL KKLG G G V++ S A+K + G + E +M+ L H L
Sbjct: 9 KLVKKLGAGQFGEVWMG-YYNNSTKVAVKTLKP----GTMSVQAFLEEANLMKTLQHDKL 63
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
L+A T E+ ++ EY G L L+ + + + F A++ + Y+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF-SAQIAEGMAYIERK 122
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLS 619
++RDL+ N+LV E ++DF L+
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 33/111 (29%), Positives = 52/111 (46%), Gaps = 14/111 (12%)
Query: 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-----ETLSNVV 760
+F GT Y+APE I+G+ + + D W+ G+ L E+ R PF G E LS +V
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV 221
Query: 761 SQSLRF----PGYPVV-SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
+ PG + S +D I+ L K+P R ++ +HP+
Sbjct: 222 NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR----PTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 32/119 (26%), Positives = 59/119 (49%), Gaps = 11/119 (9%)
Query: 516 RAQTEREIMQMLDHPFLPTLFAHFTTEK----FS--CLVMEYCPGGDLHVLRQKQPSRFF 569
RA E +++ ++H + +L FT +K F LVME V+ +
Sbjct: 66 RAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME-----L 120
Query: 570 SEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628
+ + + ++L +++LH G+++RDLKP NI+V+ D + + DF L+ N M+
Sbjct: 121 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM 179
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 45/157 (28%), Positives = 65/157 (41%), Gaps = 20/157 (12%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVM-DNDFLVGRKKMPRAQTERE--------- 522
K+ K +G G+ G V C LK+ + V K + TE++
Sbjct: 7 KIEKVIGAGEFGEV---------CSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEAS 57
Query: 523 IMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVL 582
IM DHP + L T K +V EY G L +K +F Q + +
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGM-LRGIA 116
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++YL +G V+RDL NILV + +SDF LS
Sbjct: 117 SGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 22/73 (30%), Positives = 41/73 (56%), Gaps = 4/73 (5%)
Query: 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR 606
+V E DL+ L + Q S ++++ ++L L+Y+H V++RDLKP N+L+
Sbjct: 85 IVQELMET-DLYKLIKTQH---LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 140
Query: 607 EDGHIMLSDFDLS 619
+ + + DF L+
Sbjct: 141 TNCDLKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 28/105 (26%), Positives = 47/105 (44%), Gaps = 7/105 (6%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS-Q 762
S VGT ++APE+I+ G ++ D W+ G + ELL G P+ L +V
Sbjct: 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD 215
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
P +S +D + K+P+ R A ++ +HP+
Sbjct: 216 HPPLP--EGISPELKDFLMQCFQKDPNLR----PTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 32/110 (29%), Positives = 56/110 (50%), Gaps = 11/110 (10%)
Query: 516 RAQTEREIMQMLDHPFLPTLFAHFTTEK----FS--CLVMEYCPGGDLHVLRQKQPSRFF 569
RA E +M++++H + L FT +K F LVME V++
Sbjct: 61 RAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERM 120
Query: 570 SEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
S + + ++L +++LH G+++RDLKP NI+V+ D + + DF L+
Sbjct: 121 S-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 10/158 (6%)
Query: 473 KLHKKLGCG--DIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+L ++G G ++ +VYLA T L +++ D + + + Q E + HP
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN-CTEEHLKALQNEVVLSHFFRHP 59
Query: 531 FLPTLFAHFTTEKFSCLV---MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
+ T + FTT + ++ M Y G +L+ P SE + L L Y
Sbjct: 60 NIMTSWTVFTTGSWLWVISPFMAY--GSANSLLKTYFPEGM-SEALIGNILFGALRGLNY 116
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625
LH G ++R++K +IL+ DG + LS L V
Sbjct: 117 LHQNGYIHRNIKASHILISGDGLVSLSGLS-HLYSLVR 153
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-05
Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 27/172 (15%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALK-----VMDNDFLVGRKKMPRAQTEREI 523
M+ + + + +G G +G VYLA S ALK + +N L +K+ R E +I
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLL--KKRFLR---EAKI 55
Query: 524 MQMLDHP-FLPTLFAHFTTEKFSCLV---MEYCPGGDL-HVLRQ-KQPSRFFSEQAARFY 577
L HP +P ++ V M Y G L +L+ Q E A +
Sbjct: 56 AADLIHPGIVPV----YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTS 111
Query: 578 VAEVL-------LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622
V L +EY+H GV++RDLKP+NIL+ G +++ D+ ++
Sbjct: 112 VGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163
|
Length = 932 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 30/125 (24%), Positives = 54/125 (43%), Gaps = 13/125 (10%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
+ P ++ ++ VGT ++APE++ + +G VD W+ GI E++ G P+ L
Sbjct: 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
Query: 757 SNVVSQSL-RFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI 815
+ + +S RD + L + + R A E+ QHPF +
Sbjct: 225 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR----GSAKELLQHPF--------L 272
Query: 816 RCAVP 820
+ A P
Sbjct: 273 KIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 6e-05
Identities = 28/89 (31%), Positives = 49/89 (55%), Gaps = 7/89 (7%)
Query: 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL- 764
+F GT Y+APEI + + + D ++ G+ L+ELL + PF G E + V+ ++L
Sbjct: 204 TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG----ENMEEVMHKTLA 259
Query: 765 -RF-PGYPVVSFHARDLIRGLLVKEPDNR 791
R+ P P +S ++++ LL +P R
Sbjct: 260 GRYDPLPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 6e-05
Identities = 30/115 (26%), Positives = 53/115 (46%), Gaps = 9/115 (7%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
+ P ++ ++ VGT ++APE++ + +G VD W+ GI E++ G P+ L
Sbjct: 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
Query: 757 SNVVSQ---SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808
+ + L+ P F RD + L + + R A E+ QHPF +
Sbjct: 225 YLIATNGTPELQNPEKLSPIF--RDFLNRCLEMDVEKR----GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 34/109 (31%), Positives = 47/109 (43%), Gaps = 11/109 (10%)
Query: 705 NSFVGTHEYLAPEII-----KGEGHGSSVDWWTFGIFLFELLYGRTPFKGS--GNDETLS 757
NS VGT Y++PE I G G + D W+ G+ + E GR PF G+ +L
Sbjct: 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM 285
Query: 758 NVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
+ S S R I L +EP R A++ + QHPF
Sbjct: 286 CAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQ----LLQHPF 330
|
Length = 353 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 23/155 (14%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTE---------REI--M 524
+K+G G G VY T + A+K + R ++E REI +
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKI------------RLESEEEGVPSTAIREISLL 53
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLA 584
+ L HP + L E L+ E+ L ++ + + Y+ ++L
Sbjct: 54 KELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQG 113
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ + H V++RDLKP+N+L+ G I L+DF L+
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 22/51 (43%), Positives = 34/51 (66%), Gaps = 1/51 (1%)
Query: 575 RFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625
+F++ ++L AL+Y+H V +RDLKP+NIL D + + DF L+ R A N
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFN 155
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 37/149 (24%), Positives = 64/149 (42%), Gaps = 13/149 (8%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP-----RAQTEREIMQMLDHP 530
+++G G+ G V+ L + A+K R+ +P + E I++ HP
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSC-------RETLPPDLKAKFLQEARILKQYSHP 53
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
+ L T ++ +VME GGD + + R ++ + V +EYL
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM-VENAAAGMEYLES 112
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLS 619
++RDL N LV E + +SDF +S
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMS 141
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 48/175 (27%), Positives = 66/175 (37%), Gaps = 43/175 (24%)
Query: 478 LGCGDIGTVYLAELIGT-----SCLFALKV--------MDNDFLVGRKKMPRAQTEREIM 524
+G G G V+ A G + A+K+ M DF Q E +M
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF----------QREAALM 62
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQK----QPSRFFSEQAARFY-- 577
DHP + L K CL+ EY GDL+ LR + Q S S +AR
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 578 -------------VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+V + YL V+RDL N LV E+ + ++DF LS
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 34/115 (29%), Positives = 47/115 (40%), Gaps = 14/115 (12%)
Query: 700 TGARSNSFVGTHEYLAPEII---KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
T A+ SF+GT ++APE+ + G+ D W GI EL + P L
Sbjct: 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL 213
Query: 757 -----SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
SN L+ FH D I+ L K+P R A ++ QHPF
Sbjct: 214 FLISKSNFPPPKLKDKEKWSPVFH--DFIKKCLTKDPKKR----PTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 8e-05
Identities = 43/184 (23%), Positives = 69/184 (37%), Gaps = 45/184 (24%)
Query: 472 FKLHKKLGCGDIGTVYLAELI--GTSCLFALKVMDNDFLVGRKKMPRAQTE-------RE 522
+++ +G G G VY A+ +A+K K + Q RE
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF---------KGDKEQYTGISQSACRE 52
Query: 523 IMQM--LDHPFLPTL---FAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFY 577
I + L H + +L F + L+ +Y +++ F QA R
Sbjct: 53 IALLRELKHENVVSLVEVFLEHADKSVY-LLFDYAEHDLWQIIK-------FHRQAKRVS 104
Query: 578 VAE---------VLLALEYLHMLGVVYRDLKPENILV----REDGHIMLSDFDLSLRCAV 624
+ +L + YLH V++RDLKP NILV E G + + D L+ R
Sbjct: 105 IPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA-RLFN 163
Query: 625 NPMV 628
P+
Sbjct: 164 APLK 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 42/150 (28%), Positives = 69/150 (46%), Gaps = 12/150 (8%)
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLF 536
+G G G VY L A+K++D V + + E I+Q L +HP + +
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE----IEAEYNILQSLPNHPNVVKFY 85
Query: 537 AHF-TTEKFS----CLVMEYCPGGDLHVLRQK--QPSRFFSEQAARFYVAEVLLALEYLH 589
F +K LV+E C GG + L + + E + + LL L++LH
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+++RD+K NIL+ +G + L DF +S
Sbjct: 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 41/169 (24%), Positives = 69/169 (40%), Gaps = 29/169 (17%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP-RAQTEREIM--QMLDH 529
+ ++LG G VY L GT+ + + L + + P R + + E M L H
Sbjct: 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH 67
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLH---VLRQK-----------------QPSRFF 569
P + L T E+ ++ YC DLH V+R +P+ F
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 570 SEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618
V ++ +E+L VV++DL N+LV + ++ +SD L
Sbjct: 128 H------IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 9e-05
Identities = 36/128 (28%), Positives = 50/128 (39%), Gaps = 31/128 (24%)
Query: 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTP-FKGSGNDETLS------- 757
S V T Y APE++ + + VD W+ G E L+ R P F+G+ + L
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAE-LFRRRPLFRGTSEADQLDKIFDVIG 223
Query: 758 ---------NVVSQSLRFPGYPVVSF---------HARDLIRGLLVKEPDNRLGAVKGAA 799
NV FP Y SF DL++ +L P R+ A
Sbjct: 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI----SAF 279
Query: 800 EIKQHPFF 807
E QHP+F
Sbjct: 280 EALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 33/101 (32%), Positives = 42/101 (41%), Gaps = 15/101 (14%)
Query: 715 APEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETLSNVVSQSLRFPGYPVVS 773
APE D W+FGI L E++ YGR P+ G N E L V Q R P P
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ-VDQGYRMPCPPGCP 230
Query: 774 FHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814
D++ ++PD+R P FE L W L
Sbjct: 231 KELYDIMLDCWKEDPDDR-------------PTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 12/106 (11%)
Query: 695 LVVEPTGARSNSFVGTHEYLAPEII-KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND 753
L+ + + RS +FVGT ++APE+I +G+ + + D W+ GI ++E+ G P+ +D
Sbjct: 150 LLNQNSSKRS-TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY----SD 204
Query: 754 ETLSNVV-----SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794
+ S+ R S R+ + L +EP RL A
Sbjct: 205 VDAFRAMMLIPKSKPPRLEDNG-YSKLLREFVAACLDEEPKERLSA 249
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 35/107 (32%), Positives = 45/107 (42%), Gaps = 13/107 (12%)
Query: 709 GTHEYLAPEIIKGEGH--GSSV--DWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVSQS 763
G Y+APE I E + G V D W+ GI + EL GR P+ + L VV +
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP 224
Query: 764 LRFPGYPVVSFHA--RDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808
P P F +D + L K R E+ QHPFFE
Sbjct: 225 S--PQLPAEKFSPEFQDFVNKCLKKNYKER----PNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 42/168 (25%), Positives = 64/168 (38%), Gaps = 21/168 (12%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTS-----CLFALKVMDNDFLVGRKKMPRAQTEREIM 524
R L +LG G G V+LAE L A+K + R+ Q E E++
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF---QREAELL 61
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARF------- 576
+L H + + T + +V EY GDL+ LR P
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 577 -----YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+++ + YL L V+RDL N LV + + + DF +S
Sbjct: 122 GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 43/174 (24%), Positives = 77/174 (44%), Gaps = 8/174 (4%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+L KLG G G V++ GT+ + A+K + + + AQ +M+ L H
Sbjct: 8 LRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQ----VMKKLRHEK 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
L L+A + E +V EY G L + + ++ A++ + Y+ +
Sbjct: 63 LVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSS--PVEEPPPKKA 643
V+RDL+ NILV E+ ++DF L+ N + + P++ P+ A
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 16/152 (10%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532
KL KKLG G G V++ G + + A+K + G E +M+ L HP L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQ----GSMSPEAFLAEANLMKQLQHPRL 63
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRF----FSEQAARFYVAEVLLALEY 587
L+A T E ++ EY G L L+ + + + AA+ +AE + +
Sbjct: 64 VRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ--IAE---GMAF 117
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ ++RDL+ NILV E ++DF L+
Sbjct: 118 IERKNYIHRDLRAANILVSETLCCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE--IMQMLDHPFLPT 534
+LG G+ G V + + + A K++ + K R Q RE ++ + P++
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVG 67
Query: 535 LFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYL-HMLG 592
+ F ++ + ME+ GG L VL K+ R E + +A VL L YL
Sbjct: 68 FYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIA-VLRGLAYLREKHQ 124
Query: 593 VVYRDLKPENILVREDGHIMLSDFDLS 619
+++RD+KP NILV G I L DF +S
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 40/163 (24%), Positives = 65/163 (39%), Gaps = 25/163 (15%)
Query: 470 RHFKLHKKLGCGDIGTV----YLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ 525
R+ K + LG G G V Y GT + A+K + + G++ + E I++
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILK 61
Query: 526 MLDHPFLPTLFAHFTTEKFSC---------LVMEYCPGGDLHVLRQKQPSRFFSEQAARF 576
L H + K C L+MEY P G L R P +
Sbjct: 62 TLYH-------ENIVKYKGCCSEQGGKGLQLIMEYVPLGSL---RDYLPKHKLNLAQLLL 111
Query: 577 YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ ++ + YLH ++RDL N+L+ D + + DF L+
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 31/112 (27%), Positives = 52/112 (46%), Gaps = 16/112 (14%)
Query: 704 SNSFVGTHEYLAPEII--KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV-- 759
+ S G+ ++APE+I +G+ + VD W+ G + E+ GR P+ ++E ++ +
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW---SDEEAIAAMFK 223
Query: 760 VSQSLRFPGYP-----VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
+ P P +S A D + PDNR A E+ QHPF
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNR----PTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 29/110 (26%), Positives = 46/110 (41%), Gaps = 8/110 (7%)
Query: 701 GARSN---SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS 757
G SN S GT ++APE+I G+G D W+ G +FE+ G+ P +
Sbjct: 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218
Query: 758 NVVSQSLRFPGYP-VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
+ + P P S A D + L ++ R A ++ +H F
Sbjct: 219 YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHER----PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 34/118 (28%), Positives = 54/118 (45%), Gaps = 11/118 (9%)
Query: 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGR 744
LA Q P +L S VGT Y PEI+K E +G D W FG L+++ +
Sbjct: 160 LAKQKQPESKL---------TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210
Query: 745 TPFKGSGNDETLSNVVSQSLRFP-GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEI 801
PF S N +L+ + +++ P + S D+I L + + R ++ +A I
Sbjct: 211 PPFY-STNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 16/51 (31%), Positives = 31/51 (60%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPF 747
+ P ++ ++ VGT ++APE++ + +G VD W+ GI E++ G P+
Sbjct: 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 19/43 (44%), Positives = 27/43 (62%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTP 746
+NSFVGT Y++PE ++G + D W+ G+ L EL GR P
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 30/110 (27%), Positives = 56/110 (50%), Gaps = 11/110 (10%)
Query: 516 RAQTEREIMQMLDHPFLPTLFAHFTTEK----FSCL--VMEYCPGGDLHVLRQKQPSRFF 569
RA E +M+ ++H + L FT +K F + VME V++ +
Sbjct: 69 RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----L 123
Query: 570 SEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ + + ++L +++LH G+++RDLKP NI+V+ D + + DF L+
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 24/168 (14%)
Query: 474 LHKKLGCGDIGTVYLAELIGT-------SCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
L K LG G G V +AE +G + A+K++ +D K + +E E+M+M
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKM 76
Query: 527 L-DHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQP---------SRFFSEQAA- 574
+ H + L T + +++EY G+L LR ++P +R EQ
Sbjct: 77 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 575 RFYVA---EVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ V+ +V +EYL ++RDL N+LV E+ + ++DF L+
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 184
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 28/97 (28%), Positives = 46/97 (47%)
Query: 518 QTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFY 577
Q E + ++ +HP + A F + +V + G L SE A +
Sbjct: 47 QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYI 106
Query: 578 VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLS 614
+ VL AL+Y+H +G V+R +K +IL+ DG + LS
Sbjct: 107 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 41/158 (25%), Positives = 61/158 (38%), Gaps = 22/158 (13%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTS---CLFALKVMDN--------DFLVGRKKMPRAQTER 521
+ K +G G+ G V L A+K + DFL TE
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL----------TEA 56
Query: 522 EIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEV 581
IM DHP + L T + ++ EY G L ++ +F Q + +
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM-LRGI 115
Query: 582 LLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++YL + V+RDL NILV + +SDF LS
Sbjct: 116 ASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 29/84 (34%), Positives = 40/84 (47%), Gaps = 1/84 (1%)
Query: 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP 767
VGT YL+PEI + + + D W+ G L+EL + PF+G+ N L + Q P
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFAP 221
Query: 768 GYPVVSFHARDLIRGLLVKEPDNR 791
P S R LI L P +R
Sbjct: 222 ISPNFSRDLRSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 37/137 (27%), Positives = 57/137 (41%), Gaps = 33/137 (24%)
Query: 699 PTGARSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS 757
P SN V T Y AP+++ G + +S+D W+ G + E++ GR F G+ N++ L
Sbjct: 153 PVNTFSNEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211
Query: 758 NV--------------VSQS----LRFPGYPVVSFH---------ARDLIRGLLVKEPDN 790
+ +SQ FP YP DL+ LL P+
Sbjct: 212 KIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPEL 271
Query: 791 RLGAVKGAAEIKQHPFF 807
R+ A + QHP+F
Sbjct: 272 RI----SAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG-NDETLSNVVSQ 762
++S VGT Y++PE I G+ D W+ G L+E+ ++PF G N +L + Q
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ 222
Query: 763 SLRFPGYPVVSFHA--RDLIRGLLVKEPDNR 791
+P P + R+L+ + +PD R
Sbjct: 223 C-DYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 29/108 (26%), Positives = 50/108 (46%), Gaps = 7/108 (6%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
+G S GT +++PE+I GEG+G D W+ + E+L + P+ + +
Sbjct: 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI 221
Query: 760 VSQSLRFPGYPV-VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
+Q + P P VS RD ++ + V+E A + +HPF
Sbjct: 222 ATQPTK-PMLPDGVSDACRDFLKQIFVEEK-----RRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 33/117 (28%), Positives = 53/117 (45%), Gaps = 22/117 (18%)
Query: 702 ARSNSFVGTHEYLAPEIIKGEG------HGSSVDWWTFGIFLFELLYGRTPFKGSGNDET 755
A++N +G Y+APE IK G + D W+ G+ + E+ GR P+ ET
Sbjct: 158 AKTN--IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP----PET 211
Query: 756 LSNVVSQSLRF-----PGYPV-VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
+N+ +Q P P S A+D + L K P+ R A++ +HP+
Sbjct: 212 YANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR----PTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 34/132 (25%), Positives = 53/132 (40%), Gaps = 34/132 (25%)
Query: 707 FVGTHEYLAPEI-IKGEGHGSSVDWWTFGIFLFELLYGRTPFK---------------GS 750
+V T Y APEI + +G+ ++D W+ G L E+L R F G+
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228
Query: 751 GNDETLSNVVSQSLR-----FPGYPVVSFH---------ARDLIRGLLVKEPDNRLGAVK 796
+ E L+ ++S R P P V ++ A DL+ +L P R+
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI---- 284
Query: 797 GAAEIKQHPFFE 808
E HP+ E
Sbjct: 285 TVEEALAHPYLE 296
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 35/200 (17%)
Query: 442 GGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTS------ 495
G S + D RW+ R L K LG G G V +AE IG
Sbjct: 1 GVSEYELPEDPRWEVPR-----------DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNR 49
Query: 496 -CLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCLVMEYCP 553
A+K++ +D K + +E E+M+M+ H + L T + +++EY
Sbjct: 50 VTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 107
Query: 554 GGDL-HVLRQKQP-------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLK 599
G+L LR ++P S + +V +EYL ++RDL
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167
Query: 600 PENILVREDGHIMLSDFDLS 619
N+LV ED + ++DF L+
Sbjct: 168 ARNVLVTEDNVMKIADFGLA 187
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 11/90 (12%)
Query: 547 LVMEYCPGGDLHVL--RQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604
+VMEY DL L KQP F + + + ++L + +LH +++RDLK N+L
Sbjct: 83 MVMEYVEH-DLKSLMETMKQP---FLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLL 138
Query: 605 VREDGHIMLSDFDLSLRCAVN-----PMVV 629
+ G + + DF L+ +VV
Sbjct: 139 LNNRGILKICDFGLAREYGSPLKPYTQLVV 168
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 31/99 (31%), Positives = 48/99 (48%), Gaps = 6/99 (6%)
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVM-EYCPGGDLHVLRQKQPSRFFSEQAARFYV 578
E +++ L HP + L +CLV+ +Y DL+ + Q V
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYLGARLRPLGLAQVTA--V 265
Query: 579 AEVLL-ALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616
A LL A++Y+H G+++RD+K EN+LV I L DF
Sbjct: 266 ARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDF 304
|
Length = 461 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 8/174 (4%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+L KKLG G G V++ G + + A+K + + + AQ IM+ L H
Sbjct: 8 LQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLEEAQ----IMKKLRHDK 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
L L+A + E +V EY G L + R A+V + Y+ +
Sbjct: 63 LVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSS--PVEEPPPKKA 643
++RDL+ NILV + ++DF L+ N + + P++ P+ A
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 46/178 (25%), Positives = 69/178 (38%), Gaps = 46/178 (25%)
Query: 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTER---------EIM 524
L K LG G G V AE +G + V K + TE+ E+M
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDN------PNETSTVAVKMLKDDATEKDLSDLVSEMEMM 69
Query: 525 QML-DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRF-------------- 568
+M+ H + L T E +V+EY G+L LR ++P
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 569 -------FSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
F+ Q AR +E+L ++RDL N+LV ED + ++DF L+
Sbjct: 130 TQKDLVSFAYQVAR--------GMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 15/103 (14%)
Query: 517 AQTEREIMQMLDHPF---LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQA 573
A+ E E +Q L +P +P A +VMEY G +L+ LR E
Sbjct: 156 AEREFEALQRL-YPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRLDV------ENP 204
Query: 574 ARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616
++L + + G+V+ DL NILV EDG I++ D+
Sbjct: 205 DEIL-DKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 39/171 (22%), Positives = 74/171 (43%), Gaps = 13/171 (7%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+ + K L G G V++A G LK+ G+K E ++Q ++HP
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI-------GQK--GTTLIEAMLLQNVNHPS 118
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ + + +C+V+ + DL+ K+ +QA ++L L YLH
Sbjct: 119 VIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQAL-IIEKQILEGLRYLHAQ 176
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN-PMVVKSSSPVEEPPPK 641
+++RD+K ENI + + + + D + + V P + + VE P+
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPE 226
|
Length = 357 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 38/141 (26%), Positives = 53/141 (37%), Gaps = 35/141 (24%)
Query: 698 EPTGARSNSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
+ +V T Y APE++ G+ +G VD W G + ELL G F G + + L
Sbjct: 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211
Query: 757 -------------------SNVVSQSLRFPG----------YPV-VSFHARDLIRGLLVK 786
SN + FP YP VS A D ++ L
Sbjct: 212 YLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRM 271
Query: 787 EPDNRLGAVKGAAEIKQHPFF 807
+P RL E+ QHP+F
Sbjct: 272 DPKERL----TCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 20/47 (42%), Positives = 27/47 (57%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTP 746
T + N+FVGT ++APE+IK + S D W+ GI EL G P
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 22/65 (33%), Positives = 39/65 (60%), Gaps = 4/65 (6%)
Query: 556 DLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLS 614
DLH ++ QP S + ++ ++L L+YLH G+++RD+KP N+LV + + +
Sbjct: 89 DLHKIIVSPQP---LSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKIC 145
Query: 615 DFDLS 619
DF L+
Sbjct: 146 DFGLA 150
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 41/148 (27%), Positives = 63/148 (42%), Gaps = 8/148 (5%)
Query: 476 KKLGCGDIGTVY----LAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
K LG G GTVY + E A+K+++ G K E IM +DHP
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TGPKANVEFMDEALIMASMDHPH 70
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
L L + LV + P G L + S+ + V ++ + YL
Sbjct: 71 LVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV-QIAKGMMYLEER 128
Query: 592 GVVYRDLKPENILVREDGHIMLSDFDLS 619
+V+RDL N+LV+ H+ ++DF L+
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 37/158 (23%), Positives = 69/158 (43%), Gaps = 13/158 (8%)
Query: 474 LHKKLGCGDIGTVYLAELIGTSCLF--ALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP- 530
L K LG G+ G+V +L + A+K M + R +M +E M+ DHP
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 531 ---FLPTLFAHFTTEKFSC--LVMEYCPGGDLHVL----RQKQPSRFFSEQAARFYVAEV 581
+ +E + +++ + GDLH R ++ Q ++ ++
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 582 LLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+EYL ++RDL N ++ E+ ++ ++DF LS
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 25/83 (30%), Positives = 38/83 (45%), Gaps = 12/83 (14%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTP------------FKGSG 751
+NSFVGT Y++PE ++G + D W+ G+ L E+ GR P F
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPV 218
Query: 752 NDETLSNVVSQSLRFPGYPVVSF 774
+ + S R PG P+ S+
Sbjct: 219 EGDPAESETSPRPRPPGRPLSSY 241
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 4e-04
Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 12/148 (8%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
+ +++ KK+G G G V+L + T F K + L R+K + E +M+ L
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEVNVMRELK 70
Query: 529 HPFLPTLFAHFTTEKFSCL--VMEYCPGGDLHVLRQKQPSRF--FSEQAARFYVAEVLLA 584
H + F + L +ME+C GDL QK F E A ++L A
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 585 LEYLHMLG-------VVYRDLKPENILV 605
L Y H L V++RDLKP+NI +
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFL 158
|
Length = 1021 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 5e-04
Identities = 37/132 (28%), Positives = 51/132 (38%), Gaps = 34/132 (25%)
Query: 707 FVGTHEYLAPEIIKGEGHGS-SVDWWTFGIFLFELLYGRTPFKG---------------- 749
+V T Y APEI+ G + VD W+ G L E+L G+ F G
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231
Query: 750 ----------SGNDETLSNVVSQSLRFP---GYPVVSFHARDLIRGLLVKEPDNRLGAVK 796
S T+ + + R P P S A DL++ LLV P+ RL A
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAE- 290
Query: 797 GAAEIKQHPFFE 808
E +HP+
Sbjct: 291 ---EALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 35/141 (24%), Positives = 58/141 (41%), Gaps = 34/141 (24%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGS-SVDWWTFGIFLFELLYGRTPFKGSGNDETLSN 758
T + +V T Y APE+I H + +VD W+ G + E+L G+ FKG + + L
Sbjct: 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME 227
Query: 759 VVS-------------QSLRFPGY----------------PVVSFHARDLIRGLLVKEPD 789
++ QS Y P + A +++ +LV + +
Sbjct: 228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAE 287
Query: 790 NRLGAVKGAAEIKQHPFFEGL 810
+R+ AAE HP+FE
Sbjct: 288 SRI----TAAEALAHPYFEEF 304
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 19/47 (40%), Positives = 27/47 (57%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTP 746
T + N+FVGT ++APE+I+ + S D W+ GI EL G P
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 24/168 (14%)
Query: 474 LHKKLGCGDIGTVYLAELIG-------TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
L K LG G G V +AE IG A+K++ +D K + +E E+M+M
Sbjct: 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKM 73
Query: 527 L-DHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRF-FSEQAARF------- 576
+ H + L T + +++EY G+L LR ++P +S +
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 577 -----YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+V +EYL ++RDL N+LV ED + ++DF L+
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 11/152 (7%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE--IMQMLDH 529
F+ +LG G+ G V+ + + A K++ + K R Q RE ++ +
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNS 62
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
P++ + F ++ + ME+ GG L VL K+ R + + +A V+ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIA-VIKGLTYL 119
Query: 589 -HMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+++RD+KP NILV G I L DF +S
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 43/175 (24%), Positives = 79/175 (45%), Gaps = 10/175 (5%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRA-QTEREIMQMLDHP 530
+L KLG G G V++ GT+ + A+K + + MP A E +IM+ L H
Sbjct: 8 LRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTLKPGTM-----MPEAFLQEAQIMKKLRHD 61
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
L L+A + E +V E+ G L ++ ++ A++ + Y+
Sbjct: 62 KLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSS--PVEEPPPKKA 643
+ ++RDL+ NILV ++ ++DF L+ N + + P++ P+ A
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 19/48 (39%), Positives = 26/48 (54%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPF 747
T + N+FVGT ++APE+IK + D W+ GI EL G P
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 45/169 (26%), Positives = 70/169 (41%), Gaps = 22/169 (13%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTS-----CLFALKVMDNDFLVGRKKMPRAQTEREIM 524
R L ++LG G G V+LAE S L A+K + + L RK Q E E++
Sbjct: 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF---QREAELL 61
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-----------VLRQKQPSRFFSEQ- 572
L H + + +V EY GDL+ +L QP + E
Sbjct: 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 573 -AARFYVA-EVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ ++A ++ + YL V+RDL N LV + + + DF +S
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 24/95 (25%), Positives = 44/95 (46%), Gaps = 7/95 (7%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
+ +++ + VGT Y++PE+ +G+ + D W G L+EL + F+ L +
Sbjct: 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA----ANLPAL 209
Query: 760 VSQSLRFPGYPV---VSFHARDLIRGLLVKEPDNR 791
V + + P+ S R LI +L +P R
Sbjct: 210 VLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 34/142 (23%), Positives = 55/142 (38%), Gaps = 34/142 (23%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE 754
++ G +V T Y APE++ G+ +G VD W G ELL G+ + G + +
Sbjct: 149 ILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD 208
Query: 755 TL--------------SNVVSQSLRFPG---------------YPVVSFHARDLIRGLLV 785
L + S + F G +P +S A ++G L
Sbjct: 209 QLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQ 268
Query: 786 KEPDNRLGAVKGAAEIKQHPFF 807
+P RL E+ +HP+F
Sbjct: 269 MDPTERL----SCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 38/141 (26%), Positives = 55/141 (39%), Gaps = 34/141 (24%)
Query: 699 PTGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL- 756
PT SN V T Y P+I+ G + + +D W G +E+ GR F GS +E L
Sbjct: 157 PTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH 215
Query: 757 ------------------SNVVSQSLRFPGY---PVVSFHAR------DLIRGLLVKEPD 789
SN +S +P Y + + R +L+ LL E
Sbjct: 216 FIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGR 275
Query: 790 NRLGAVKGAAEIKQHPFFEGL 810
R+ A E +HP+F L
Sbjct: 276 KRI----SAEEAMKHPYFHCL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 29/87 (33%), Positives = 37/87 (42%), Gaps = 15/87 (17%)
Query: 729 DWWTFGIFLFELL-YGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787
D W+FGI L E++ YGR P+ G N E L V + R P P DL+ K+
Sbjct: 186 DVWSFGILLTEIVTYGRVPYPGMTNREVLEQ-VERGYRMPRPPNCPEELYDLMLQCWDKD 244
Query: 788 PDNRLGAVKGAAEIKQHPFFEGLNWAL 814
P+ R P FE L L
Sbjct: 245 PEER-------------PTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 22/75 (29%), Positives = 39/75 (52%), Gaps = 3/75 (4%)
Query: 674 VAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTF 733
+AA++ + D A+VS V G ++ ++ APE +K + S D W++
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL--PVKWTAPEALKHKKFSSKSDVWSY 183
Query: 734 GIFLFELL-YGRTPF 747
G+ L+E+ YGR P+
Sbjct: 184 GVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 44/162 (27%), Positives = 67/162 (41%), Gaps = 19/162 (11%)
Query: 474 LHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
L ++LG G G V+LAE L A+K + + RK R E E++ L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLTNLQ 65
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSE---------QAARFYV 578
H + + +V EY GDL+ LR P Q+ ++
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 579 AEVLLA-LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
A+ + A + YL V+RDL N LV E+ + + DF +S
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 29/165 (17%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTE-------- 520
M ++ +K+G G G VY A T+ ALK + R + E
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI------------RLEQEDEGVPSTA 48
Query: 521 -REI--MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSE--QAAR 575
REI ++ + H + L +EK LV EY DL + + S F++ + +
Sbjct: 49 IREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIK 105
Query: 576 FYVAEVLLALEYLHMLGVVYRDLKPENILV-REDGHIMLSDFDLS 619
Y+ ++L + Y H V++RDLKP+N+L+ R + L+DF L+
Sbjct: 106 TYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150
|
Length = 294 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 28/108 (25%), Positives = 47/108 (43%), Gaps = 8/108 (7%)
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQP-----SRFFSEQA 573
E +M+ + + L +T + + +VME GDL LR ++P
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118
Query: 574 ARFY--VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+F AE+ + YL V+RDL N +V ED + + DF ++
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 1/94 (1%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
GA + ++VGT Y+ PEI + + + D W+ G L+EL + PF+ + + V
Sbjct: 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC 213
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794
S + P S+ R LI+ + + P +R A
Sbjct: 214 QGSYK-PLPSHYSYELRSLIKQMFKRNPRSRPSA 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 32/109 (29%), Positives = 49/109 (44%), Gaps = 13/109 (11%)
Query: 704 SNSFVGTHEYLAPEIIKG--EGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
+NSFVGT ++APE+I EG VD W+ GI EL + P L ++
Sbjct: 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227
Query: 761 ---SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
S +L + S + R+ + L K P +R + E+ +H F
Sbjct: 228 QNDSPTLSSNDW---SDYFRNFVDSCLQKIPQDR----PSSEELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 38/141 (26%), Positives = 54/141 (38%), Gaps = 37/141 (26%)
Query: 699 PTGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGN----- 752
P+ SN V T Y P+++ G + +S+D W G +E+ GR F GS +
Sbjct: 156 PSKTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL 214
Query: 753 -----------DETLSNVVS----QSLRFPGYPVVSF-----------HARDLIRGLLVK 786
+ET V S + FP YP H +L L
Sbjct: 215 HKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQY 274
Query: 787 EPDNRLGAVKGAAEIKQHPFF 807
EP R+ AAE +HP+F
Sbjct: 275 EPKKRI----SAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 45/190 (23%), Positives = 74/190 (38%), Gaps = 40/190 (21%)
Query: 701 GARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
G RS S++ + Y APE++ G + + +D W+ G + E++ G F G + + L +
Sbjct: 224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283
Query: 760 VS-------QSLRF--PGYPVVSF------------------HARDLIRGLLVKEPDNRL 792
+ L+ P Y + F A + I L EP RL
Sbjct: 284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL 343
Query: 793 GAVKGAAEIKQHPFFEGLNWALIRCAVP------PELPRSCDAVIGSQKKESTKCEESKG 846
++ A+ PFF+ L I+ +P P+L CDA I + K
Sbjct: 344 NPIEALAD----PFFDDLRDPCIK--LPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPKC 397
Query: 847 AADEHVEFEM 856
+ + EF M
Sbjct: 398 TYEAYKEFLM 407
|
Length = 440 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 19/57 (33%), Positives = 31/57 (54%), Gaps = 2/57 (3%)
Query: 712 EYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETLSNVVSQSLRFP 767
++ APE I D W+FGI L+E++ YG+ P+ G N + +S + + R P
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS-ALQRGYRMP 224
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 35/141 (24%), Positives = 55/141 (39%), Gaps = 45/141 (31%)
Query: 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-------------- 752
+V T Y APE+I G G+ +VD W+ G + E++ G F G+ +
Sbjct: 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP 236
Query: 753 --------DETLSNVVSQSLRFPGYPV------VSF-------------HARDLIRGLLV 785
T+ N V ++ GY V F ARDL+ +LV
Sbjct: 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV 296
Query: 786 KEPDNRLGAVKGAAEIKQHPF 806
+P+ R+ + QHP+
Sbjct: 297 IDPEKRISVD----DALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 43/184 (23%), Positives = 68/184 (36%), Gaps = 44/184 (23%)
Query: 681 IKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFEL 740
+KSD ++ T +V T Y APE+I G G+ +VD W+ G + E+
Sbjct: 159 VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 741 LYGRTPFKGSGNDETLSNVVSQ----------------------SLRFPGY--------- 769
+ G F G+ + + + V+ Q ++ GY
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDV 278
Query: 770 --PVVSFH-------ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVP 820
P S H ARDL+ +LV + R+ E QHP+ A P
Sbjct: 279 LFPADSEHNKLKASQARDLLSKMLVIDASKRI----SVDEALQHPYINVWYDPSEAEAPP 334
Query: 821 PELP 824
P++P
Sbjct: 335 PKIP 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 584 ALEYL-HMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
AL YL L +++RD+KP NIL+ +G+I L DF +S
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 23/70 (32%), Positives = 41/70 (58%), Gaps = 2/70 (2%)
Query: 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR 606
LV EY L +L ++ P+ E+ R Y+ +++ A+ + H +V+RD+KPEN+L+
Sbjct: 77 LVFEYVEKNMLELL-EEMPNGVPPEKV-RSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS 134
Query: 607 EDGHIMLSDF 616
+ + L DF
Sbjct: 135 HNDVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 20/73 (27%), Positives = 37/73 (50%), Gaps = 1/73 (1%)
Query: 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR 606
L+ME+ P G L + ++ +Q + Y ++ ++YL V+RDL N+LV
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQICKGMDYLGSRQYVHRDLAARNVLVE 143
Query: 607 EDGHIMLSDFDLS 619
+ + + DF L+
Sbjct: 144 SEHQVKIGDFGLT 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 472 FKLHKKLGCGDIGTVY----LAELIGTSCLFALKVMDNDFLVGRKKMPRAQTE----REI 523
FK K LG G GTVY + E A+K + P+A E +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR------EATSPKANKEILDEAYV 62
Query: 524 MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLL 583
M +D+P + L T L+ + P G L ++ S+ + V ++
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV-QIAK 120
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ YL +V+RDL N+LV+ H+ ++DF L+
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP 767
+GT YL+PEI + + + D W G L+E+ + F+ +GN + N+V + +R
Sbjct: 162 IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE-AGN---MKNLVLKIIR-G 216
Query: 768 GYPVVSFH----ARDLIRGLLVKEPDNR 791
YP VS H R+L+ L + P +R
Sbjct: 217 SYPPVSSHYSYDLRNLVSQLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 4/91 (4%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG-NDETLSNVVSQ 762
++S VGT Y++PE I G+ D W+ G L+E+ ++PF G N +L + Q
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 222
Query: 763 SLRFPGYPV--VSFHARDLIRGLLVKEPDNR 791
+P P S R L+ + +P+ R
Sbjct: 223 C-DYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 30/111 (27%), Positives = 44/111 (39%), Gaps = 11/111 (9%)
Query: 702 ARSNSFVGTHEYLAPEIIKGEGHGSS----VDWWTFGIFLFELLYGRTPFKGSGND-ETL 756
A++ S G Y+APE I D W+ GI L EL G+ P+K + E L
Sbjct: 170 AKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228
Query: 757 SNVVSQSL-RFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
+ ++ + P S + L K+ R E+ QHPF
Sbjct: 229 TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKR----PKYRELLQHPF 275
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 36/131 (27%), Positives = 53/131 (40%), Gaps = 36/131 (27%)
Query: 710 THE-----YLAPEIIKGEGHGSS-VDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV--- 760
THE Y APE++ G H S+ VD W+ G E+ + F G + L ++
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228
Query: 761 ----SQS------LR----FP---------GYPVVSFHARDLIRGLLVKEPDNRLGAVKG 797
Q LR FP P +S DL++ +L +P R+ A K
Sbjct: 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA-KA 287
Query: 798 AAEIKQHPFFE 808
A HP+F+
Sbjct: 288 AL---THPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 34/133 (25%), Positives = 52/133 (39%), Gaps = 35/133 (26%)
Query: 708 VGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETL---------- 756
V T Y APEI+ G H S+VD W+ G ELL R F+ + L
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224
Query: 757 -------------SNVVSQSLRFPGYPVVSFH-------ARDLIRGLLVKEPDNRLGAVK 796
++++ + P PV+ A L+ +LV +PD R+
Sbjct: 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI---- 280
Query: 797 GAAEIKQHPFFEG 809
AA+ HP+ +
Sbjct: 281 SAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 34/124 (27%), Positives = 50/124 (40%), Gaps = 30/124 (24%)
Query: 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL- 756
E + A +V T Y +PE++ G +G +VD W+ G L EL G+ F G + L
Sbjct: 152 EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211
Query: 757 ------------------SNVVSQSLRFPG--YP---------VVSFHARDLIRGLLVKE 787
SN LRFP +P ++S DL++ LL
Sbjct: 212 TIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLN 271
Query: 788 PDNR 791
P +R
Sbjct: 272 PTDR 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 18/42 (42%), Positives = 26/42 (61%), Gaps = 1/42 (2%)
Query: 576 FYVAEVLL-ALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616
+ LL AL YLH G+++RD+K ENI + E + +L DF
Sbjct: 188 ITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDF 229
|
Length = 392 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 857 | |||
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.03 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.96 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.95 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.7 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.54 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.51 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.44 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.22 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.21 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.09 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.91 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.89 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.82 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.8 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.8 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.78 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.76 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.6 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.58 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.53 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.37 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.37 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.33 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.3 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.22 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.17 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.16 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.1 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.88 | |
| PLN02236 | 344 | choline kinase | 96.55 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.53 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.51 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.35 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.31 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.14 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.96 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.9 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.86 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.47 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.2 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.6 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.53 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.49 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.45 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.26 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.11 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.97 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.55 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-78 Score=654.97 Aligned_cols=372 Identities=69% Similarity=1.209 Sum_probs=343.6
Q ss_pred CCCCCCCCCCccchhHHHHhh-hccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHH
Q 035930 441 RGGSRPHMSNDLRWDAIRCVQ-KQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQT 519 (857)
Q Consensus 441 ~g~s~p~~~~d~~~~~~~~~~-~~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~ 519 (857)
.....|+..++.+|+.+..+. .+.+.+++++|++++.||.|..|+||++++.++++.+|+||+++..+..++.+.+++.
T Consensus 47 ~~~~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~t 126 (459)
T KOG0610|consen 47 SSGNKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQT 126 (459)
T ss_pred cccCCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHH
Confidence 456789999999999987666 5778899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCC
Q 035930 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLK 599 (857)
Q Consensus 520 EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLK 599 (857)
|.+||.+++||++++||..|+.+++.|||||||+||+|+.++++++.+.|++..+++|+++|+.||+|||.+|||+||||
T Consensus 127 E~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLK 206 (459)
T KOG0610|consen 127 EREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLK 206 (459)
T ss_pred HHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhh
Q 035930 600 PENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSR 679 (857)
Q Consensus 600 PeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~ 679 (857)
||||||.++|||+|+||+|+.+|.+.|.++..+++...+. .+.|.. ++..||+|++.....+.+
T Consensus 207 PENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~--------------~~~~~~--~~~s~f~~r~~~~~~~~~ 270 (459)
T KOG0610|consen 207 PENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGS--------------QPSCRS--RQPSCFSPRCLSSSKKRK 270 (459)
T ss_pred cceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCC--------------Cccccc--ccccccccchhccccccc
Confidence 9999999999999999999999999999887765543322 344444 577899998776654433
Q ss_pred hhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHH
Q 035930 680 KIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759 (857)
Q Consensus 680 ~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~I 759 (857)
+ .+.... ...|.++.++++.++++|+||..|+|||+|.|.+|+.++|||+|||+|||||+|..||+|.++.+++.+|
T Consensus 271 k--~~~~~~-~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI 347 (459)
T KOG0610|consen 271 K--KDESAS-RSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI 347 (459)
T ss_pred c--cccccc-ccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH
Confidence 3 333333 7889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCCCcccc
Q 035930 760 VSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCDAVI 831 (857)
Q Consensus 760 v~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~~~~~~ 831 (857)
+.+.+.||..+.++..++|||++||.+||.+|+++.++|+||++||||+++||+|||+..||++|+..+.+.
T Consensus 348 v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~~ 419 (459)
T KOG0610|consen 348 VGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGGL 419 (459)
T ss_pred hcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccCc
Confidence 999999999999999999999999999999999999999999999999999999999999999999988865
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-59 Score=503.48 Aligned_cols=284 Identities=40% Similarity=0.762 Sum_probs=257.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
...++|+++++||.|+||+||+++.+.+++.||+|++++..+...........|..||..++||+||.++..|++.+.+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 45678999999999999999999999999999999999998888888889999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
||+||+.||.|..++++... |+|..+++|+++|+.||.|||++||||||||||||||+.+||++|+||||++...
T Consensus 102 lVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--- 176 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--- 176 (357)
T ss_pred EEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc---
Confidence 99999999999999987654 9999999999999999999999999999999999999999999999999984310
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
..+..+.+
T Consensus 177 ------------------------------------------------------------------------~~~~~t~t 184 (357)
T KOG0598|consen 177 ------------------------------------------------------------------------KDGDATRT 184 (357)
T ss_pred ------------------------------------------------------------------------cCCCcccc
Confidence 01223456
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
+|||+.|||||++.+.+|+.++||||||+++|||++|.+||.+.+..+++.+|+.+....+. ..++.++++||+++|.+
T Consensus 185 fcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p-~~ls~~ardll~~LL~r 263 (357)
T KOG0598|consen 185 FCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP-GYLSEEARDLLKKLLKR 263 (357)
T ss_pred ccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC-ccCCHHHHHHHHHHhcc
Confidence 89999999999999999999999999999999999999999999999999999988744432 34899999999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCCCCCChhhh--ccCCCCCCCCCCc
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFEGLNWALI--RCAVPPELPRSCD 828 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~~ 828 (857)
||++|++...++++|.+||||.++||+.+ +...||+.|....
T Consensus 264 dp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~ 307 (357)
T KOG0598|consen 264 DPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTG 307 (357)
T ss_pred CHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCC
Confidence 99999976667999999999999999865 5678999997533
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-57 Score=507.27 Aligned_cols=333 Identities=34% Similarity=0.609 Sum_probs=269.8
Q ss_pred hhccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeee
Q 035930 461 QKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFT 540 (857)
Q Consensus 461 ~~~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~ 540 (857)
..+...++.++|.++++||+|+||.||+|+-+.||..||+|++++..+........++.|..||...++|+||+||..|+
T Consensus 132 R~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 132 RLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred HhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 33444688999999999999999999999999999999999999998888888999999999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
+.+++||||||++||++..++.+.. .|+++.+++|+++++.|++.||++|||||||||+|+|||..||+||+||||+.
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence 9999999999999999999998764 49999999999999999999999999999999999999999999999999984
Q ss_pred hcccCcccccC-CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCc--ccccccchhhHHHhhhhhhhhhhcccCCCCcccc
Q 035930 621 RCAVNPMVVKS-SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQ--VSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVV 697 (857)
Q Consensus 621 r~~~~~~l~~~-ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~--~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~ 697 (857)
-+........- ......... . + ...+.+. ..+.. +...+.....+ .
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~---~----~-------~~~~~~~~~~~~~~------~~~~~~~~~~w-----------~ 338 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINL---S----E-------AKPSDFPKFNTPRS------TMSRREQLQTW-----------K 338 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhh---c----c-------CCCccccccccccc------hhhHHHHHHHH-----------H
Confidence 33221110000 000000000 0 0 0000000 00000 00000000000 0
Q ss_pred cCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc--ccCCCCCCCCHH
Q 035930 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS--LRFPGYPVVSFH 775 (857)
Q Consensus 698 ~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~--~~~p~~~~is~~ 775 (857)
........+.+|||.|||||++.+.+|+..+||||||||+||||.|.+||.+.+..+++++|+.-. +.+|....++++
T Consensus 339 ~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~e 418 (550)
T KOG0605|consen 339 RNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDE 418 (550)
T ss_pred hhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHH
Confidence 011122346899999999999999999999999999999999999999999999999999998744 788888889999
Q ss_pred HHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCCCc
Q 035930 776 ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCD 828 (857)
Q Consensus 776 l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~~~ 828 (857)
++|||.+||+ ||++|++ ..+++||.+||||++++|+-|+...||++|...+
T Consensus 419 A~DLI~rll~-d~~~RLG-~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~ 469 (550)
T KOG0605|consen 419 AKDLITRLLC-DPENRLG-SKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNS 469 (550)
T ss_pred HHHHHHHHhc-CHHHhcC-cccHHHHhcCCccccCCcchhhcCCCCCCCCCCC
Confidence 9999999999 9999999 6889999999999999999999999999998644
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-57 Score=512.64 Aligned_cols=285 Identities=39% Similarity=0.766 Sum_probs=261.4
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCC
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEK 543 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~ 543 (857)
+.+.+++|.++++||+|.||+|+++..+++++.||||+++++.+..+...+..+.|..|+.... ||++++|+..|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4578899999999999999999999999999999999999999999999999999999999886 999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
++|+||||+.||++..+++. +.|++..+++|+++|+.||.|||++||||||||.+|||||.+|++||+||||++...
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999999996544433 349999999999999999999999999999999999999999999999999975310
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
-.+.+
T Consensus 520 ---------------------------------------------------------------------------~~g~~ 524 (694)
T KOG0694|consen 520 ---------------------------------------------------------------------------GQGDR 524 (694)
T ss_pred ---------------------------------------------------------------------------CCCCc
Confidence 02335
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~ 783 (857)
+.+|||||.|||||++.+..|+.++|||+|||+|||||.|..||.|.+.++++..|+.....+|.+ ++.++.+||++|
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~--ls~ea~~il~~l 602 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF--LSKEAIAIMRRL 602 (694)
T ss_pred cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCc--ccHHHHHHHHHH
Confidence 678999999999999999999999999999999999999999999999999999999999999977 999999999999
Q ss_pred ccCCcCCcCCch-hhHHHHHcCCCCCCCChhhh--ccCCCCCCCCCCcc
Q 035930 784 LVKEPDNRLGAV-KGAAEIKQHPFFEGLNWALI--RCAVPPELPRSCDA 829 (857)
Q Consensus 784 L~~DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~~~ 829 (857)
|.++|++|+++. ..+++|++||||+.|+|..| +...||++|+-...
T Consensus 603 l~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~ 651 (694)
T KOG0694|consen 603 LRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGP 651 (694)
T ss_pred hccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCCh
Confidence 999999999974 46899999999999999876 57889999986443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-57 Score=473.89 Aligned_cols=276 Identities=39% Similarity=0.778 Sum_probs=257.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
..+.+|++++.||.|+||+|.+++.+.+|..||+|++++..+..-+..+...+|..+|+.+.||++++|++.|.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 66789999999999999999999999999999999999988877788888999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
|||||++||.|..++++.. .|++..+++|++||++||+|||.++||||||||||||+|.+|++||+|||+|+++.
T Consensus 121 mvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred EEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 9999999999999998764 39999999999999999999999999999999999999999999999999997632
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.++-+
T Consensus 196 ---------------------------------------------------------------------------~rT~T 200 (355)
T KOG0616|consen 196 ---------------------------------------------------------------------------GRTWT 200 (355)
T ss_pred ---------------------------------------------------------------------------CcEEE
Confidence 12346
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
.||||.|+|||++...+|+.++|||+|||++|||+.|.+||...+...++.+|+.+.++||.. ++.+++|||+++|+.
T Consensus 201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~--fs~~~kdLl~~LL~v 278 (355)
T KOG0616|consen 201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY--FSSDAKDLLKKLLQV 278 (355)
T ss_pred ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc--cCHHHHHHHHHHHhh
Confidence 799999999999999999999999999999999999999999999999999999999999975 999999999999999
Q ss_pred CcCCcCCchh-hHHHHHcCCCCCCCChhhh--ccCCCCCCC
Q 035930 787 EPDNRLGAVK-GAAEIKQHPFFEGLNWALI--RCAVPPELP 824 (857)
Q Consensus 787 DPe~Rpt~~~-~a~ELL~HPfF~~l~w~li--~~~~pp~~P 824 (857)
|-.+|.+..+ +..+|.+||||.+++|..+ +...||+.|
T Consensus 279 D~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 279 DLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred hhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence 9999987755 8999999999999999866 457788888
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-56 Score=493.60 Aligned_cols=288 Identities=38% Similarity=0.655 Sum_probs=257.0
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCe
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~ 544 (857)
.....+|.+++.||+|+|++|++|+++.+++.|||||+.+..+..++..+-+.+|.++|.+| +||.|++||..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 46678999999999999999999999999999999999999999888888999999999999 79999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|+|+||+++|+|..++.+.. .|++..+|+|++||+.||+|||.+||||||||||||||+.||++||+|||-|+.+..
T Consensus 149 LYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999999999874 499999999999999999999999999999999999999999999999998865422
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
... .... +. .......+.
T Consensus 227 ~~~--------------~~~~------~~------------------------------------------~~~~a~s~~ 244 (604)
T KOG0592|consen 227 SQK--------------SQEN------PV------------------------------------------DPNQASSRR 244 (604)
T ss_pred hhc--------------cccC------cc------------------------------------------CcccccCcc
Confidence 110 0000 00 000011224
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
.+|+||-.|.+||+|.+...+..+|||+||||||.|+.|.+||.+.+...++++|+.-.+.||. .+++.++|||+++|
T Consensus 245 ~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~--~fp~~a~dLv~KLL 322 (604)
T KOG0592|consen 245 SSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE--GFPEDARDLIKKLL 322 (604)
T ss_pred cceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC--CCCHHHHHHHHHHH
Confidence 6899999999999999999999999999999999999999999999999999999998888885 49999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCC
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPEL 823 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~ 823 (857)
..||.+|+| +.+|.+||||.+|+|.-|+...||.+
T Consensus 323 v~dp~~Rlt----~~qIk~HpFF~~Vdw~nlw~~~PP~l 357 (604)
T KOG0592|consen 323 VRDPSDRLT----SQQIKAHPFFEGVDWENLWQQTPPKL 357 (604)
T ss_pred ccCcccccc----HHHHhhCcccccCChhhhhhcCCCcc
Confidence 999999999 89999999999999998887777655
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-54 Score=466.04 Aligned_cols=261 Identities=32% Similarity=0.507 Sum_probs=230.6
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccccc----chhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRK----KMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~----~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
.+.|.+.+.||.|+||.|-+|..+.+|+.||||++++....... ....+++|++||++|+|||||+++++|+..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35789999999999999999999999999999999887665422 34457899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC---CcEEEecccchhh
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED---GHIMLSDFDLSLR 621 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d---g~iKL~DFGLA~r 621 (857)
.||||||+.||+|.+.+-.... +.++..+.+++||+.||.|||++||+||||||+|||+..+ ..+||+|||||+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999998877643 8899999999999999999999999999999999999765 7899999999853
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
.. ..
T Consensus 329 ~g----------------------------------------------------------------------------~~ 332 (475)
T KOG0615|consen 329 SG----------------------------------------------------------------------------EG 332 (475)
T ss_pred cc----------------------------------------------------------------------------cc
Confidence 11 12
Q ss_pred CccccccCCCCccChhhhcCCCC---CcccceehhhHHHHHHhhCCCCCCCCCChh-hhHHHhhccccC--CCCCCCCHH
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGH---GSSVDWWTFGIFLFELLYGRTPFKGSGNDE-TLSNVVSQSLRF--PGYPVVSFH 775 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~---s~ksDVWSLGvILyELLtGk~PF~g~~~~e-~l~~Iv~~~~~~--p~~~~is~~ 775 (857)
....++||||.|.|||++.+.++ ..++|||||||+||-+|+|.+||.+...+. ...+|.++.+.| +.+..++.+
T Consensus 333 sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Isee 412 (475)
T KOG0615|consen 333 SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEE 412 (475)
T ss_pred eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHH
Confidence 34568899999999999987664 458899999999999999999999887666 778888887765 457889999
Q ss_pred HHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 776 ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 776 l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
+++||.+||..||++||+ ++|+|+||||....
T Consensus 413 a~dlI~~mL~VdP~~R~s----~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 413 ALDLINWMLVVDPENRPS----ADEALNHPWFKDAP 444 (475)
T ss_pred HHHHHHHhhEeCcccCcC----HHHHhcChhhhccc
Confidence 999999999999999999 99999999999664
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-53 Score=478.97 Aligned_cols=258 Identities=32% Similarity=0.602 Sum_probs=242.5
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
.+|..++.||+|||++||.+++..+|..||+|++.+..+......+++.+|++|.+.|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 67999999999999999999999999999999999998888888999999999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|+|..++|..++.++ +.++|.+++.+++||+.||.|||+++|||||||..||||+++.++||+|||||.++
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l------- 168 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQL------- 168 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeee-------
Confidence 999999999888854 34999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
+..+++..++||
T Consensus 169 --------------------------------------------------------------------e~~~Erk~TlCG 180 (592)
T KOG0575|consen 169 --------------------------------------------------------------------EYDGERKKTLCG 180 (592)
T ss_pred --------------------------------------------------------------------cCcccccceecC
Confidence 223456678999
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
||.|+|||++...+|++.+||||+||+||-||+|++||...+-.+++..|....+.+|. .++.+++|||++||..||.
T Consensus 181 TPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~~P~ 258 (592)
T KOG0575|consen 181 TPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS--HLSAEAKDLIRKLLRPNPS 258 (592)
T ss_pred CCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc--ccCHHHHHHHHHHhcCCcc
Confidence 99999999999999999999999999999999999999999999999999999999987 5999999999999999999
Q ss_pred CcCCchhhHHHHHcCCCC-CCC
Q 035930 790 NRLGAVKGAAEIKQHPFF-EGL 810 (857)
Q Consensus 790 ~Rpt~~~~a~ELL~HPfF-~~l 810 (857)
+||+ +++||.|+|| .+.
T Consensus 259 ~Rps----l~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 259 ERPS----LDEVLDHPFFKSGF 276 (592)
T ss_pred cCCC----HHHHhcCHhhhCCC
Confidence 9999 9999999999 443
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-52 Score=457.11 Aligned_cols=298 Identities=34% Similarity=0.611 Sum_probs=265.8
Q ss_pred CCCccchhHHHHhhhccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc
Q 035930 448 MSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML 527 (857)
Q Consensus 448 ~~~d~~~~~~~~~~~~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L 527 (857)
+..+.+|.++.. ..+....|+..++||.|+||.||.|+.+.||+.||+|.+.+.++..+.......+|..||.++
T Consensus 168 f~rFlQWK~lE~-----qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV 242 (591)
T KOG0986|consen 168 FTRFLQWKWLEL-----QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV 242 (591)
T ss_pred HHHHHHHHHHHh-----hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh
Confidence 445667877653 236677899999999999999999999999999999999999888888888999999999999
Q ss_pred CCCCccccceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc
Q 035930 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE 607 (857)
Q Consensus 528 ~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~ 607 (857)
+.++||.|-.+|++.+.+||||..|+||+|+.++.+...+.|++..+++|+++|+.||++||..+||+|||||+|||+|+
T Consensus 243 ~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd 322 (591)
T KOG0986|consen 243 SSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDD 322 (591)
T ss_pred ccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeecc
Confidence 99999999999999999999999999999998888777677999999999999999999999999999999999999999
Q ss_pred CCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhc
Q 035930 608 DGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAA 687 (857)
Q Consensus 608 dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~ 687 (857)
.||++|+|+|||..+..
T Consensus 323 ~GhvRISDLGLAvei~~--------------------------------------------------------------- 339 (591)
T KOG0986|consen 323 HGHVRISDLGLAVEIPE--------------------------------------------------------------- 339 (591)
T ss_pred CCCeEeeccceEEecCC---------------------------------------------------------------
Confidence 99999999999954321
Q ss_pred ccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC----ChhhhHHHhhcc
Q 035930 688 QVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG----NDETLSNVVSQS 763 (857)
Q Consensus 688 ~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~----~~e~l~~Iv~~~ 763 (857)
+......+||.+|||||++.+..|++.+|||+|||+||||+.|+.||.... .+++-+.++...
T Consensus 340 -------------g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~ 406 (591)
T KOG0986|consen 340 -------------GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP 406 (591)
T ss_pred -------------CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch
Confidence 112234589999999999999999999999999999999999999998653 346666777777
Q ss_pred ccCCCCCCCCHHHHHHHHhhccCCcCCcCCch-hhHHHHHcCCCCCCCChhhhc--cCCCCCCCCCCc
Q 035930 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV-KGAAEIKQHPFFEGLNWALIR--CAVPPELPRSCD 828 (857)
Q Consensus 764 ~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~~~ 828 (857)
..++ ..+++++++|++.+|++||.+|++++ .++.++.+||||+.+||..+. ...||++|++..
T Consensus 407 ~ey~--~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~a 472 (591)
T KOG0986|consen 407 EEYS--DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGA 472 (591)
T ss_pred hhcc--cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccc
Confidence 7787 46999999999999999999999997 689999999999999999885 688999998743
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=437.44 Aligned_cols=258 Identities=30% Similarity=0.484 Sum_probs=225.4
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC-eEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK-FSC 546 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~-~l~ 546 (857)
...+++.++.||+|..|+||+++|+.+++.||+|++..+ ......+.+.+|++||+.++|||||.+|+.|..++ .++
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 345667789999999999999999999999999999543 33455677899999999999999999999999999 499
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+||+|+.++... +.++|..+-.++.+|++||.|||+ ++||||||||+|||++..|.|||||||.+..+.
T Consensus 155 I~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv-- 230 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV-- 230 (364)
T ss_pred eehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh--
Confidence 999999999999998876 349999999999999999999995 999999999999999999999999999874321
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
+...+
T Consensus 231 ---------------------------------------------------------------------------nS~a~ 235 (364)
T KOG0581|consen 231 ---------------------------------------------------------------------------NSIAN 235 (364)
T ss_pred ---------------------------------------------------------------------------hhhcc
Confidence 11346
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCC-----CChhhhHHHhhccc-cCCCCCCCCHHHHHH
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGS-----GNDETLSNVVSQSL-RFPGYPVVSFHARDL 779 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~-----~~~e~l~~Iv~~~~-~~p~~~~is~~l~dL 779 (857)
+++||..|||||.+.|..|+.++||||||++|+||++|+.||... +..+.+..|+.+.. ++|. ..+++++++|
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~-~~fS~ef~~F 314 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE-GEFSPEFRSF 314 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc-ccCCHHHHHH
Confidence 889999999999999999999999999999999999999999875 34566677776433 3333 2599999999
Q ss_pred HHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 780 IRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
|..||++||.+|++ +.+|++|||+....
T Consensus 315 V~~CL~Kdp~~R~s----~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 315 VSCCLRKDPSERPS----AKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHhcCCcccCCC----HHHHhcCHHHhhcc
Confidence 99999999999999 99999999998654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-51 Score=481.38 Aligned_cols=285 Identities=39% Similarity=0.712 Sum_probs=258.1
Q ss_pred cccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 464 HGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 464 ~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
...+..++|.++++||.|+||.|.+++++.+++.||+|++++.....+.....|..|.+||..-+.+-|++|+.+|.++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34467789999999999999999999999999999999999876666666777899999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
++|||||||+||+|-.++.+.. .+++..+++|+++|+.||.-||+.|+|||||||+|||||..|||||+|||-+.++.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 9999999999999999998876 49999999999999999999999999999999999999999999999999886654
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.+.+ .+
T Consensus 227 ~dG~--------------------------------------------------------------------------V~ 232 (1317)
T KOG0612|consen 227 ADGT--------------------------------------------------------------------------VR 232 (1317)
T ss_pred CCCc--------------------------------------------------------------------------EE
Confidence 3221 12
Q ss_pred cccccCCCCccChhhhc----C-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhc--cccCCCCCCCCHHH
Q 035930 704 SNSFVGTHEYLAPEIIK----G-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ--SLRFPGYPVVSFHA 776 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~----g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~--~~~~p~~~~is~~l 776 (857)
+...+|||.|++||++. + ..|+..+|||||||++||||+|.+||+..+--++|.+|+.. .+.||....+|.++
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeea 312 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEA 312 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHH
Confidence 34558999999999995 3 45899999999999999999999999999999999999875 78888777899999
Q ss_pred HHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCC
Q 035930 777 RDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRS 826 (857)
Q Consensus 777 ~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~ 826 (857)
+|||+++|+ +|+.|++ +.|++++.+||||.+++|+-||...||.+|..
T Consensus 313 kdLI~~ll~-~~e~RLg-rngiedik~HpFF~g~~W~~iR~~~pP~vPev 360 (1317)
T KOG0612|consen 313 KDLIEALLC-DREVRLG-RNGIEDIKNHPFFEGIDWDNIRESVPPVVPEV 360 (1317)
T ss_pred HHHHHHHhc-Chhhhcc-cccHHHHHhCccccCCChhhhhhcCCCCCCcC
Confidence 999999997 7999998 77899999999999999999999999999985
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-51 Score=430.80 Aligned_cols=282 Identities=38% Similarity=0.715 Sum_probs=257.9
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
.+.+++|.++++||.|.||.|.+|+.+.+++.||||+++++.+..+........|-++|+...||++..|...|+..+++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 36778999999999999999999999999999999999999888888888889999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||++||.|..++.+. +.|+++.+++|-.+|+.||.|||+++||+||||.+|+|+|+||||||+||||++.-.
T Consensus 244 CFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred EEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc--
Confidence 9999999999998877764 459999999999999999999999999999999999999999999999999974310
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.-+....
T Consensus 320 -------------------------------------------------------------------------~~g~t~k 326 (516)
T KOG0690|consen 320 -------------------------------------------------------------------------KYGDTTK 326 (516)
T ss_pred -------------------------------------------------------------------------cccceec
Confidence 0133456
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
+|||||.|+|||++....|+.++|||.+||++|||++|+.||+..+.+..+.-|+-..++||.. ++++++.|+.++|.
T Consensus 327 TFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~--ls~eAktLLsGLL~ 404 (516)
T KOG0690|consen 327 TFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRT--LSPEAKTLLSGLLK 404 (516)
T ss_pred cccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCcc--CCHHHHHHHHHHhh
Confidence 8999999999999999999999999999999999999999999999999999999999999965 99999999999999
Q ss_pred CCcCCcCCchh-hHHHHHcCCCCCCCChhhh--ccCCCCCCCCC
Q 035930 786 KEPDNRLGAVK-GAAEIKQHPFFEGLNWALI--RCAVPPELPRS 826 (857)
Q Consensus 786 ~DPe~Rpt~~~-~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~ 826 (857)
+||.+|++..+ .+.||.+|+||.++||.-. +...||+-|..
T Consensus 405 kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqV 448 (516)
T KOG0690|consen 405 KDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQV 448 (516)
T ss_pred cChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCc
Confidence 99999998754 5899999999999999743 46778888875
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=426.86 Aligned_cols=267 Identities=36% Similarity=0.745 Sum_probs=235.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
....+|.+.+.||.|+||+||+|++..+++.||||++.............+.+|+.+|+.++||||++++++|.+++.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999997654444455667889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred EEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 9999999999998887653 489999999999999999999999999999999999999999999999998743100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
....
T Consensus 171 ----------------------------------------------------------------------------~~~~ 174 (329)
T PTZ00263 171 ----------------------------------------------------------------------------RTFT 174 (329)
T ss_pred ----------------------------------------------------------------------------Ccce
Confidence 0113
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
.+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......+|.. ++..+++||.+||..
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~L~~ 252 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW--FDGRARDLVKGLLQT 252 (329)
T ss_pred ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCC--CCHHHHHHHHHHhhc
Confidence 468999999999999999999999999999999999999999887777888887777666643 899999999999999
Q ss_pred CcCCcCCch-hhHHHHHcCCCCCCCChhhh
Q 035930 787 EPDNRLGAV-KGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 787 DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li 815 (857)
||.+|+++. ..+++|+.||||.+.+|..+
T Consensus 253 dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~ 282 (329)
T PTZ00263 253 DHTKRLGTLKGGVADVKNHPYFHGANWDKL 282 (329)
T ss_pred CHHHcCCCCCCCHHHHhcCCccCCCCHHHH
Confidence 999999742 34799999999999999865
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=425.41 Aligned_cols=282 Identities=32% Similarity=0.667 Sum_probs=242.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCC-eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTS-CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg-~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
+..++|.+.+.||.|+||.||+|.+..++ ..||+|++.............+.+|+.+|+.++||||++++++|.+++.+
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 45578999999999999999999877655 78999999765444445566788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+++|+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 99999999999999987654 389999999999999999999999999999999999999999999999998732100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
...
T Consensus 184 -----------------------------------------------------------------------------~~~ 186 (340)
T PTZ00426 184 -----------------------------------------------------------------------------RTY 186 (340)
T ss_pred -----------------------------------------------------------------------------Ccc
Confidence 011
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
..+||+.|||||++.+..++.++|||||||++|||++|..||.+.+....+..+......+|. .++..+++||++||.
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~ 264 (340)
T PTZ00426 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK--FLDNNCKHLMKKLLS 264 (340)
T ss_pred eecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHcc
Confidence 346899999999999999999999999999999999999999988777778888877766664 489999999999999
Q ss_pred CCcCCcCCc-hhhHHHHHcCCCCCCCChhhhc--cCCCCCCCCCCccc
Q 035930 786 KEPDNRLGA-VKGAAEIKQHPFFEGLNWALIR--CAVPPELPRSCDAV 830 (857)
Q Consensus 786 ~DPe~Rpt~-~~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~~~~~ 830 (857)
.||++|++. .++++++++||||.+++|..+. ...+|..|+..+..
T Consensus 265 ~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~~ 312 (340)
T PTZ00426 265 HDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVF 312 (340)
T ss_pred cCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCCc
Confidence 999999742 2349999999999999998653 56678888865543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=430.59 Aligned_cols=327 Identities=34% Similarity=0.585 Sum_probs=243.2
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+++.||+|+||+||++.+..+++.||||++.+...........+.+|+++|+.++||||++++++|.+.+++||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997654444455667889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999998887653 48999999999999999999999999999999999999999999999999985432110000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
... .......+..+............. . ..... ... ..............+|
T Consensus 159 ------~~~------~~~~~~~~~~~~~~~~~~~~~~~~--~---~~~~~---~~~--------~~~~~~~~~~~~~~~g 210 (377)
T cd05629 159 ------YYQ------KLLQGKSNKNRIDNRNSVAVDSIN--L---TMSSK---DQI--------ATWKKNRRLMAYSTVG 210 (377)
T ss_pred ------ccc------cccccccccccccccccccccccc--c---cccch---hhh--------hhhhhcccccccccCC
Confidence 000 000000000000000000000000 0 00000 000 0000000111234689
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh--ccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~--~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
|+.|+|||++.+..|+.++|||||||+||||++|..||.+....+.+..+.. ..+.+|....++.++++||.+||. +
T Consensus 211 t~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~ 289 (377)
T cd05629 211 TPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-N 289 (377)
T ss_pred CccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-C
Confidence 9999999999999999999999999999999999999988777777776664 334556555689999999999997 8
Q ss_pred cCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCCCc
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCD 828 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~~~ 828 (857)
|.+|++ +.++.++++||||.+++|+.++...+|++|....
T Consensus 290 ~~~r~~-r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~ 329 (377)
T cd05629 290 AENRLG-RGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKS 329 (377)
T ss_pred HhhcCC-CCCHHHHhcCCCcCCCCHHHHccCCCCcccCCCC
Confidence 888762 1239999999999999999998888888887544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=427.78 Aligned_cols=305 Identities=31% Similarity=0.560 Sum_probs=235.2
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+|+.++||||++++++|.++..+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997654444445567888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++||+|..++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999887653 48999999999999999999999999999999999999999999999999986432110000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.+.. ............... ... .. ..............+|
T Consensus 159 ----------------~~~~----~~~~~~~~~~~~~~~-----~~~-----~~----------~~~~~~~~~~~~~~~G 198 (363)
T cd05628 159 ----------------FYRN----LNHSLPSDFTFQNMN-----SKR-----KA----------ETWKRNRRQLAFSTVG 198 (363)
T ss_pred ----------------cccc----ccccccccccccccc-----ccc-----cc----------chhhhccccccccccC
Confidence 0000 000000000000000 000 00 0000001112245689
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh--ccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~--~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
|+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+.. ..+.+|....++.++++||.+|+. +
T Consensus 199 t~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~ 277 (363)
T cd05628 199 TPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-E 277 (363)
T ss_pred CccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-C
Confidence 9999999999999999999999999999999999999998888888877775 345566555689999999999886 6
Q ss_pred cCCcCCchhhHHHHHcCCCCCCCChhhhccC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGLNWALIRCA 818 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~ 818 (857)
|.+|++ +++++||++||||.+++|..++..
T Consensus 278 ~~~r~~-r~~~~ei~~hp~f~~~~~~~~~~~ 307 (363)
T cd05628 278 WEHRIG-APGVEEIKTNPFFEGVDWEHIRER 307 (363)
T ss_pred hhhcCC-CCCHHHHhCCCCCCCCCHHHHHhC
Confidence 666643 233999999999999999988643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=415.74 Aligned_cols=274 Identities=36% Similarity=0.689 Sum_probs=237.3
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||.|+||+||+|.+..+++.||||++.............+.+|+++|+.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36899999999999999999999999999999997654333344566889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----- 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----- 153 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----
Confidence 9999999999887653 489999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.....+|
T Consensus 154 -------------------------------------------------------------------------~~~~~~g 160 (291)
T cd05612 154 -------------------------------------------------------------------------RTWTLCG 160 (291)
T ss_pred -------------------------------------------------------------------------CcccccC
Confidence 0113468
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
|+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..+.+..+......++. .++..+++||++||..||.
T Consensus 161 t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dp~ 238 (291)
T cd05612 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR--HLDLYAKDLIKKLLVVDRT 238 (291)
T ss_pred ChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc--cCCHHHHHHHHHHcCCCHH
Confidence 99999999999999999999999999999999999999998888888888877766664 4799999999999999999
Q ss_pred CcCCch-hhHHHHHcCCCCCCCChhhhc--cCCCCCCCC
Q 035930 790 NRLGAV-KGAAEIKQHPFFEGLNWALIR--CAVPPELPR 825 (857)
Q Consensus 790 ~Rpt~~-~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~ 825 (857)
+|+++. ..++++++||||..++|..+. ...|+..|.
T Consensus 239 ~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~ 277 (291)
T cd05612 239 RRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPK 277 (291)
T ss_pred HccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCC
Confidence 999532 248999999999999998664 345666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=421.28 Aligned_cols=271 Identities=39% Similarity=0.725 Sum_probs=231.4
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGG 555 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gG 555 (857)
+.||+|+||+||+|.+..+++.||||+++............+.+|+++|+.++||||++++++|..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444455567788999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCC
Q 035930 556 DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPV 635 (857)
Q Consensus 556 sL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~ 635 (857)
+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~----------- 147 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS----------- 147 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-----------
Confidence 9988887653 489999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccC
Q 035930 636 EEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLA 715 (857)
Q Consensus 636 ~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmA 715 (857)
.......++||+.|||
T Consensus 148 ----------------------------------------------------------------~~~~~~~~~gt~~y~a 163 (323)
T cd05571 148 ----------------------------------------------------------------DGATMKTFCGTPEYLA 163 (323)
T ss_pred ----------------------------------------------------------------CCCcccceecCccccC
Confidence 0001124569999999
Q ss_pred hhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCch
Q 035930 716 PEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV 795 (857)
Q Consensus 716 PEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~ 795 (857)
||++.+..++.++|||||||++|||++|+.||...+....+..+......+|. .++.++.+||.+||..||++||+..
T Consensus 164 PE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~ 241 (323)
T cd05571 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGG 241 (323)
T ss_pred hhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCCHHHcCCCC
Confidence 99999999999999999999999999999999988777777777777666664 5899999999999999999999321
Q ss_pred h-hHHHHHcCCCCCCCChhhhc--cCCCCCCCC
Q 035930 796 K-GAAEIKQHPFFEGLNWALIR--CAVPPELPR 825 (857)
Q Consensus 796 ~-~a~ELL~HPfF~~l~w~li~--~~~pp~~P~ 825 (857)
. .+.+|++||||.+++|..+. ...||..|.
T Consensus 242 ~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~ 274 (323)
T cd05571 242 PEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQ 274 (323)
T ss_pred CCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 1 29999999999999998663 344555554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=432.57 Aligned_cols=262 Identities=35% Similarity=0.597 Sum_probs=233.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc--cchhHHHHHHHHHHHcC-CCCccccceeeeeCC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR--KKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~--~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~ 543 (857)
...+.|.+++.||+|.||+|++|.+..++..||+|++++...... ...+.+.+|+.+|+.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 445789999999999999999999999999999998877533211 34456778999999999 999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC-CcEEEecccchhhc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED-GHIMLSDFDLSLRC 622 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d-g~iKL~DFGLA~r~ 622 (857)
.+||||||+.||+|++++... ..+.|..++.++.||+.||+|||++||+||||||||||++.+ +++||+|||++..+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999999883 349999999999999999999999999999999999999999 99999999997431
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
. ..+.
T Consensus 172 ~---------------------------------------------------------------------------~~~~ 176 (370)
T KOG0583|consen 172 P---------------------------------------------------------------------------GEDG 176 (370)
T ss_pred C---------------------------------------------------------------------------CCCC
Confidence 0 0122
Q ss_pred ccccccCCCCccChhhhcCCC-C-CcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEG-H-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLI 780 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~-~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI 780 (857)
...++|||+.|+|||++.+.. | +.++||||+||+||.|++|+.||...+...++..+....+.+|.+-. +.++++||
T Consensus 177 ~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~-S~~~~~Li 255 (370)
T KOG0583|consen 177 LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL-SPEARSLI 255 (370)
T ss_pred cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC-CHHHHHHH
Confidence 345789999999999999988 8 68999999999999999999999998888889999999999987622 99999999
Q ss_pred HhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
++||..||.+|++ +.+|+.||||+.-
T Consensus 256 ~~mL~~~P~~R~t----~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 256 EKMLVPDPSTRIT----LLEILEHPWFQKE 281 (370)
T ss_pred HHHcCCCcccCCC----HHHHhhChhhccC
Confidence 9999999999999 9999999999963
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-48 Score=410.84 Aligned_cols=280 Identities=34% Similarity=0.543 Sum_probs=232.2
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|++.+.||+|+||+||+|.+..+++.||||++.............+.+|+.+|+.++|+||+.++++|.+++..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37899999999999999999999999999999976544433444567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++|+|..++.......+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE------ 154 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC------
Confidence 99999998777654444589999999999999999999999999999999999999999999999998743100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
.......+||
T Consensus 155 ----------------------------------------------------------------------~~~~~~~~g~ 164 (285)
T cd05631 155 ----------------------------------------------------------------------GETVRGRVGT 164 (285)
T ss_pred ----------------------------------------------------------------------CCeecCCCCC
Confidence 0001234689
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh--ccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~--~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
+.|||||++.+..++.++|||||||+||||++|+.||.+.........+.. ..........++.++.+||++||..||
T Consensus 165 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P 244 (285)
T cd05631 165 VGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNP 244 (285)
T ss_pred CCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCH
Confidence 999999999999999999999999999999999999987654332222221 111122234589999999999999999
Q ss_pred CCcCCch-hhHHHHHcCCCCCCCChhhhcc--CCCCCCCCC
Q 035930 789 DNRLGAV-KGAAEIKQHPFFEGLNWALIRC--AVPPELPRS 826 (857)
Q Consensus 789 e~Rpt~~-~~a~ELL~HPfF~~l~w~li~~--~~pp~~P~~ 826 (857)
.+||+.. .+++++++||||.+++|..+.. ..||+.|++
T Consensus 245 ~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05631 245 KERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPDP 285 (285)
T ss_pred HHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCCC
Confidence 9999743 3489999999999999998864 578999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=443.55 Aligned_cols=262 Identities=31% Similarity=0.533 Sum_probs=235.0
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
+-|++++.||.|+.|.|-+|++..||+.+|||+|.+..-........+.+|+-||+.+.|||+++||++|++..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45899999999999999999999999999999998764444455667889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++||.|++++.+... +++.++.++++||+.|+.|+|..+|+||||||+|+||+..++|||+|||+|..
T Consensus 92 Eyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsL-------- 161 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASL-------- 161 (786)
T ss_pred EecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeec--------
Confidence 99999999988877643 99999999999999999999999999999999999999999999999999821
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
+..+....+.||
T Consensus 162 --------------------------------------------------------------------e~~gklLeTSCG 173 (786)
T KOG0588|consen 162 --------------------------------------------------------------------EVPGKLLETSCG 173 (786)
T ss_pred --------------------------------------------------------------------ccCCccccccCC
Confidence 011122235579
Q ss_pred CCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 710 THEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 710 T~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
.|.|.|||++.|.+| +.++||||.|||||.||+|+.||++.+-..++.++..+.+..|. .++.++++||++||..||
T Consensus 174 SPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs--~Is~eaQdLLr~ml~VDp 251 (786)
T KOG0588|consen 174 SPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS--NISSEAQDLLRRMLDVDP 251 (786)
T ss_pred CcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC--cCCHHHHHHHHHHhccCc
Confidence 999999999999999 88999999999999999999999998888889999899888885 499999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCCCChhhh
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l~w~li 815 (857)
++|+| .+||++|||+.+..-...
T Consensus 252 ~~RiT----~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 252 STRIT----TEEILKHPFLSGYTSLPS 274 (786)
T ss_pred ccccc----HHHHhhCchhhcCCCCCh
Confidence 99999 999999999998765443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=423.48 Aligned_cols=316 Identities=33% Similarity=0.597 Sum_probs=242.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++++.||.|+||+||+|++..+++.||||++.............+.+|+++|+.++||||++++++|.+++++||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 37999999999999999999999999999999997654433445566788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..+.......
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999999887654 38999999999999999999999999999999999999999999999999985432110000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.. ........ .........+...... ...+...........+|
T Consensus 159 -------~~---~~~~~~~~----------~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~g 201 (364)
T cd05599 159 -------FY---RILSHALP----------SNFLDFISKPMSSKRK-----------------AETWKRNRRALAYSTVG 201 (364)
T ss_pred -------cc---cccccccc----------cccccccccccccccc-----------------ccchhhccccccccccc
Confidence 00 00000000 0000000000000000 00000001112234689
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc--ccCCCCCCCCHHHHHHHHhhccCC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS--LRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~--~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
|+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..++... +.++....+++++++||.+||. +
T Consensus 202 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~ 280 (364)
T cd05599 202 TPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-E 280 (364)
T ss_pred CccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-C
Confidence 999999999999999999999999999999999999999887777777666533 3445545689999999999996 9
Q ss_pred cCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRS 826 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~ 826 (857)
|.+|++. ..+.++++||||.+++|..++...++.+|..
T Consensus 281 p~~R~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 318 (364)
T cd05599 281 AERRLGN-NGVNEIKSHPFFKGVDWEHIRERPAPIIPEL 318 (364)
T ss_pred HhhcCCC-CCHHHHhcCCCcCCCCHHHHhhcCCCCCCCC
Confidence 9999973 4599999999999999998887777777764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=413.35 Aligned_cols=259 Identities=29% Similarity=0.492 Sum_probs=220.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
+.|+.+.++|+|+||+||+|+++.||+.||||.+-... .+..-.+..++|+++|++|.|+|+|.|+++|.....++||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 56888999999999999999999999999999985431 22233455789999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|||+..-|+.+- +.+ ..++.+.++.|++|++.|+.|+|+++|||||||||||||+.+|.+||||||+|+-+..
T Consensus 81 E~~dhTvL~eLe-~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~----- 153 (396)
T KOG0593|consen 81 EYCDHTVLHELE-RYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA----- 153 (396)
T ss_pred eecchHHHHHHH-hcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-----
Confidence 999877776654 444 3499999999999999999999999999999999999999999999999999964321
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.+...+.++-
T Consensus 154 ----------------------------------------------------------------------pgd~YTDYVA 163 (396)
T KOG0593|consen 154 ----------------------------------------------------------------------PGDNYTDYVA 163 (396)
T ss_pred ----------------------------------------------------------------------Ccchhhhhhh
Confidence 1223345678
Q ss_pred CCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhc-------------------cccCCC-
Q 035930 710 THEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ-------------------SLRFPG- 768 (857)
Q Consensus 710 T~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~-------------------~~~~p~- 768 (857)
|.+|+|||.+.| ..|+.++|||++||++.||++|.+.|.|.+.-+.+..|... ++++|.
T Consensus 164 TRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~ 243 (396)
T KOG0593|consen 164 TRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEP 243 (396)
T ss_pred hhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCC
Confidence 999999999998 67999999999999999999999999999887777666541 122332
Q ss_pred ---------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 769 ---------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 769 ---------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.+.++.-+.||+++||..||.+|++ .+++|.||||.++
T Consensus 244 ~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s----c~qll~H~yFd~~ 290 (396)
T KOG0593|consen 244 EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS----CEQLLHHPYFDGF 290 (396)
T ss_pred CCccchhhhcccchHHHHHHHHHHhcCCcccccc----HHHHhcChHHHHH
Confidence 3557778999999999999999999 8999999999654
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=416.42 Aligned_cols=274 Identities=38% Similarity=0.643 Sum_probs=237.6
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+++.||+|+||.||+|++..+++.||||++.............+.+|+++|+.++||||+++++++..++..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 37999999999999999999999999999999998764444445567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++||+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 9999999999987653 489999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.....+|
T Consensus 154 -------------------------------------------------------------------------~~~~~~g 160 (333)
T cd05600 154 -------------------------------------------------------------------------YANSVVG 160 (333)
T ss_pred -------------------------------------------------------------------------ccCCccc
Confidence 1123469
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc--ccCCCC----CCCCHHHHHHHHhh
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS--LRFPGY----PVVSFHARDLIRGL 783 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~--~~~p~~----~~is~~l~dLI~k~ 783 (857)
|+.|+|||++.+..++.++|||||||+||||++|..||.+.+..+.+..+.... +..+.. ..++.++.+||.+|
T Consensus 161 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 240 (333)
T cd05600 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKL 240 (333)
T ss_pred CccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHH
Confidence 999999999999999999999999999999999999999887777666655422 222222 24689999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCCC
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSC 827 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~~ 827 (857)
|..+|.+|++ +.++++||||..++|..++...|+++|...
T Consensus 241 l~~~~~rr~s----~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~ 280 (333)
T cd05600 241 INDPSRRFGS----LEDIKNHPFFKEVDWNELRELKPPFVPELE 280 (333)
T ss_pred hhChhhhcCC----HHHHHhCcccCCCCHHHHhhCCCCCCCCCC
Confidence 9999999999 999999999999999988888888888653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=417.06 Aligned_cols=307 Identities=38% Similarity=0.694 Sum_probs=246.8
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+.+.||+|+||+||+|++..+++.||||+++............+.+|+++|+.++||||++++++|.+++++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 37999999999999999999999999999999998765444455667889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|..++... ..+++..++.++.||+.||+|||.+||+||||||+|||++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999998776 348999999999999999999999999999999999999999999999999986532211000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
. .... .....+.. .... ...............+|
T Consensus 159 ~----------------~~~~-~~~~~~~~----------~~~~-------------------~~~~~~~~~~~~~~~~g 192 (350)
T cd05573 159 Y----------------YLND-SHNLLFRD----------NVLV-------------------RRRDHKQRRVRANSTVG 192 (350)
T ss_pred c----------------cccc-cccccccc----------cccc-------------------ccccccccccccccccc
Confidence 0 0000 00000000 0000 00000001112345679
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh--ccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~--~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
|+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+.. ..+.+|....+++++++||.+||. |
T Consensus 193 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-d 271 (350)
T cd05573 193 TPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-D 271 (350)
T ss_pred CccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-C
Confidence 9999999999999999999999999999999999999998887777777776 566677666689999999999997 9
Q ss_pred cCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCCCc
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCD 828 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~~~ 828 (857)
|.+|+++ ++++++||||.+++|..+....|+.+|....
T Consensus 272 p~~R~~s---~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~ 309 (350)
T cd05573 272 PEDRLGS---FEEIKSHPFFKGIDWENLRETKPPFVPELSS 309 (350)
T ss_pred hhhcCCC---HHHHhcCCCcCCCCHHHHhhCCCCcCCCCCC
Confidence 9999985 8999999999999999888777888776433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=414.74 Aligned_cols=277 Identities=36% Similarity=0.683 Sum_probs=238.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+.+.||+|+||+||+|.+..+++.||||+++............+.+|+.+++.++||||+++++++.+++.+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46999999999999999999999999999999998764434445567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++|+|..++..... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~--- 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYED-QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK--- 156 (330)
T ss_pred CCCCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC---
Confidence 99999999999877532 48999999999999999999999999999999999999999999999999974321000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.......+|
T Consensus 157 -----------------------------------------------------------------------~~~~~~~~g 165 (330)
T cd05601 157 -----------------------------------------------------------------------MVNSKLPVG 165 (330)
T ss_pred -----------------------------------------------------------------------ceeeecccC
Confidence 000122368
Q ss_pred CCCccChhhhc------CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhc--cccCCCCCCCCHHHHHHHH
Q 035930 710 THEYLAPEIIK------GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ--SLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 710 T~~YmAPEil~------g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~--~~~~p~~~~is~~l~dLI~ 781 (857)
|+.|+|||++. +..++.++|||||||++|||++|+.||........+.+++.. ...+|..+.++.++.+||+
T Consensus 166 t~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 245 (330)
T cd05601 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQ 245 (330)
T ss_pred CccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHH
Confidence 99999999997 456789999999999999999999999988777777776653 2455666678999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRS 826 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~ 826 (857)
+||. ||.+||+ ++++++||||..++|..++...|+.+|..
T Consensus 246 ~ll~-~p~~R~t----~~~l~~h~~~~~~~~~~~~~~~~~~~~~~ 285 (330)
T cd05601 246 SLLC-GQKERLG----YEGLCCHPFFSKIDWNNIRNSLPPFVPTL 285 (330)
T ss_pred HHcc-ChhhCCC----HHHHhCCCCcCCCCHHHHhhCCCCccCcC
Confidence 9998 9999999 99999999999999999988878877764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=419.52 Aligned_cols=258 Identities=27% Similarity=0.507 Sum_probs=226.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
..+|.+.+.||.|+||+||+|+++.++..||||.|.+..+ ..+..+.+..|+.||+.++|||||.|++++.+++++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999987754 345567788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC------CcEEEecccchhhc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED------GHIMLSDFDLSLRC 622 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d------g~iKL~DFGLA~r~ 622 (857)
||||+||+|.+|+++.. .++|..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+
T Consensus 88 MEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999998875 39999999999999999999999999999999999999764 35899999999764
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
... .
T Consensus 166 ~~~----------------------------------------------------------------------------~ 169 (429)
T KOG0595|consen 166 QPG----------------------------------------------------------------------------S 169 (429)
T ss_pred Cch----------------------------------------------------------------------------h
Confidence 311 1
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC-CCCCCHHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG-YPVVSFHARDLIR 781 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~-~~~is~~l~dLI~ 781 (857)
...+.||++.|||||++....|+.++|+||+|+|||+|++|+.||+..+..+.+..+-++....|. ...++..+.+|+.
T Consensus 170 ~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~ 249 (429)
T KOG0595|consen 170 MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLI 249 (429)
T ss_pred HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhh
Confidence 123678999999999999999999999999999999999999999999988888876665544433 2346777889999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
.+|.++|..|.+ ..+-+.|+|+..
T Consensus 250 ~ll~~~~~~~~~----~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 250 SLLQRNPKDRIS----FEDFFDHPFLAA 273 (429)
T ss_pred HHHhcCccccCc----hHHhhhhhhccc
Confidence 999999999998 788888888754
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=411.75 Aligned_cols=279 Identities=36% Similarity=0.713 Sum_probs=238.1
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~LVm 549 (857)
+|.+.+.||+|+||+||+|++..++..||||++.+...........+..|..++..+ +|++|+.++++|.+.+.+||||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999999999999999999876544444455667788888777 5899999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~----- 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW----- 153 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC-----
Confidence 9999999988887653 389999999999999999999999999999999999999999999999998732100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........+|
T Consensus 154 ----------------------------------------------------------------------~~~~~~~~~g 163 (323)
T cd05616 154 ----------------------------------------------------------------------DGVTTKTFCG 163 (323)
T ss_pred ----------------------------------------------------------------------CCCccccCCC
Confidence 0001124569
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||++||.
T Consensus 164 t~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~l~~~p~ 241 (323)
T cd05616 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLMTKHPG 241 (323)
T ss_pred ChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--cCCHHHHHHHHHHcccCHH
Confidence 99999999999999999999999999999999999999998888888888877766664 5899999999999999999
Q ss_pred CcCCchh-hHHHHHcCCCCCCCChhhhc--cCCCCCCCCCCc
Q 035930 790 NRLGAVK-GAAEIKQHPFFEGLNWALIR--CAVPPELPRSCD 828 (857)
Q Consensus 790 ~Rpt~~~-~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~~~ 828 (857)
+|++... ...++++||||..++|..+. ...||..|+.+.
T Consensus 242 ~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (323)
T cd05616 242 KRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACG 283 (323)
T ss_pred hcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCC
Confidence 9998532 46899999999999998774 455677776544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=422.01 Aligned_cols=324 Identities=33% Similarity=0.554 Sum_probs=239.1
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|.+++.||+|+||+||+|++..+++.||||++.+...........+.+|+++|+.++||||++++++|.+++++|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 68999999999999999999999999999999976544334455678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
||++|+|..++.+.. .+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||++..+........
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 999999998887653 489999999999999999999999999999999999999999999999999743211100000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
. ....... .... .|........ .....+...... ...............+||
T Consensus 160 ~----------~~~~~~~----------~~~~---~~~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~~~~~gt 211 (382)
T cd05625 160 Y----------QSGDHVR----------QDSM---DFSNEWGDPA---NCRCGDRLKPLE--RRAARQHQRCLAHSLVGT 211 (382)
T ss_pred c----------ccccccc----------cccc---cccccccccc---cccccccccchh--hhhccccccccccccccC
Confidence 0 0000000 0000 0000000000 000000000000 000000111223467899
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh--ccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~--~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+....+.. ....+|....+++++.+||.+|+ .+|
T Consensus 212 ~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p 290 (382)
T cd05625 212 PNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGP 290 (382)
T ss_pred cccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCH
Confidence 999999999999999999999999999999999999998877776666664 33455555678999999999986 599
Q ss_pred CCcCCchhhHHHHHcCCCCCCCChhh-hccCCCCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGLNWAL-IRCAVPPELPRS 826 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l~w~l-i~~~~pp~~P~~ 826 (857)
++|++ ..+++++++||||.+++|.. ++...+|.+|..
T Consensus 291 ~~R~~-~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~ 328 (382)
T cd05625 291 EDRLG-KNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKI 328 (382)
T ss_pred hHcCC-CCCHHHHhcCCCcCCcChHHHHhcCCCCccCcC
Confidence 99997 34589999999999999974 455555666653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=411.35 Aligned_cols=272 Identities=39% Similarity=0.754 Sum_probs=231.8
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||+|+||+||+|++..+++.||||++.+...........+..|.++|..+ +||||++++++|.+++.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544455556678899999866 799999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
|+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~---------- 148 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL---------- 148 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc----------
Confidence 99988887653 389999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
........+||+.|+
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 163 (321)
T cd05591 149 -----------------------------------------------------------------NGVTTTTFCGTPDYI 163 (321)
T ss_pred -----------------------------------------------------------------CCccccccccCcccc
Confidence 000112346899999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||..||++|+++
T Consensus 164 aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~ 241 (321)
T cd05591 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV--WLSKEAVSILKAFMTKNPNKRLGC 241 (321)
T ss_pred CHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCC
Confidence 999999999999999999999999999999999998888888888877766664 389999999999999999999954
Q ss_pred hh---hHHHHHcCCCCCCCChhhhc--cCCCCCCCCC
Q 035930 795 VK---GAAEIKQHPFFEGLNWALIR--CAVPPELPRS 826 (857)
Q Consensus 795 ~~---~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~ 826 (857)
.. .+.++++||||..++|..+. ...|++.|..
T Consensus 242 ~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~ 278 (321)
T cd05591 242 VASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKI 278 (321)
T ss_pred CCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCC
Confidence 32 49999999999999998774 3445555553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=421.46 Aligned_cols=320 Identities=33% Similarity=0.564 Sum_probs=237.5
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|++++.||+|+||+||+|.+..+++.||||++.............+.+|+++|+.++||||++++++|.+.+++|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58999999999999999999999999999999987654445556678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc--c
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM--V 628 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~--l 628 (857)
|++||+|..++.... .+++..++.++.||+.||+|||..||+||||||+|||++.+|+++|+|||++..+..... .
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 999999999887653 389999999999999999999999999999999999999999999999999754311100 0
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.......... ...+...........+..... ..... ...........+++
T Consensus 160 ~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~-------~~~~~----------~~~~~~~~~~~~~~ 209 (381)
T cd05626 160 YQKGSHIRQD-------------SMEPSDLWDDVSNCRCGDRLK-------TLEQR----------ATKQHQRCLAHSLV 209 (381)
T ss_pred cccccccccc-------------ccCcccccccccccccccccc-------hhhcc----------cccccccccccccc
Confidence 0000000000 000000000000000000000 00000 00001111234678
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh--ccccCCCCCCCCHHHHHHHHhhccC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~--~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+....++. ....++....+++++++||.+||..
T Consensus 210 gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~ 289 (381)
T cd05626 210 GTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCS 289 (381)
T ss_pred CCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccC
Confidence 99999999999999999999999999999999999999998776666666553 3345565556899999999997655
Q ss_pred --CcCCcCCchhhHHHHHcCCCCCCCChhh-hccCCCCCCCCC
Q 035930 787 --EPDNRLGAVKGAAEIKQHPFFEGLNWAL-IRCAVPPELPRS 826 (857)
Q Consensus 787 --DPe~Rpt~~~~a~ELL~HPfF~~l~w~l-i~~~~pp~~P~~ 826 (857)
+|..|++ +++|++||||.+++|.. ++...+|.+|..
T Consensus 290 ~~~~~~R~~----~~~~l~hp~f~~~~~~~~~~~~~~~~~p~~ 328 (381)
T cd05626 290 AEERLGRNG----ADDIKAHPFFSEVDFSSDIRTQPAPYVPKI 328 (381)
T ss_pred cccccCCCC----HHHHhcCcccCCCChhHHhhcCCCCccCcC
Confidence 4445998 99999999999999965 455556666654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=410.67 Aligned_cols=277 Identities=36% Similarity=0.706 Sum_probs=234.7
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCC-CccccceeeeeCCeEEEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP-FLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HP-nIV~L~~~f~~~~~l~LVm 549 (857)
+|++++.||+|+||.||+|.+..+++.||||++.+...........+..|+++++.+.|+ +|+.++++|.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544445566778899999999764 6888999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~----- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF----- 153 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC-----
Confidence 9999999998887653 389999999999999999999999999999999999999999999999998732100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........+|
T Consensus 154 ----------------------------------------------------------------------~~~~~~~~~g 163 (324)
T cd05587 154 ----------------------------------------------------------------------GGKTTRTFCG 163 (324)
T ss_pred ----------------------------------------------------------------------CCCceeeecC
Confidence 0001123469
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||.+||.
T Consensus 164 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~ 241 (324)
T cd05587 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLLTKHPA 241 (324)
T ss_pred CccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHH
Confidence 99999999999999999999999999999999999999988888888888776666554 5899999999999999999
Q ss_pred CcCCch-hhHHHHHcCCCCCCCChhhhc--cCCCCCCCCC
Q 035930 790 NRLGAV-KGAAEIKQHPFFEGLNWALIR--CAVPPELPRS 826 (857)
Q Consensus 790 ~Rpt~~-~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~ 826 (857)
+|++.. ...+++++||||..++|..+. ...++..|..
T Consensus 242 ~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~ 281 (324)
T cd05587 242 KRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKV 281 (324)
T ss_pred HcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcC
Confidence 999843 235899999999999998663 3445555543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=411.96 Aligned_cols=272 Identities=37% Similarity=0.724 Sum_probs=231.8
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||+|+||+||+|++..+++.||||++.+...........+..|..++..+ +||||++++++|...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544445566778888888876 699999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~---------- 148 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF---------- 148 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc----------
Confidence 99998887653 489999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
........+||+.|+
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 163 (320)
T cd05590 149 -----------------------------------------------------------------NGKTTSTFCGTPDYI 163 (320)
T ss_pred -----------------------------------------------------------------CCCcccccccCcccc
Confidence 000112346999999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++++||++||++||.+|+++
T Consensus 164 aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 164 APEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHcccCHHHCCCC
Confidence 999999999999999999999999999999999988888888888776666554 489999999999999999999994
Q ss_pred hh--hHHHHHcCCCCCCCChhhhc--cCCCCCCCCC
Q 035930 795 VK--GAAEIKQHPFFEGLNWALIR--CAVPPELPRS 826 (857)
Q Consensus 795 ~~--~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~ 826 (857)
.. +.+++++||||..++|..+. ...||+.|..
T Consensus 242 ~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~ 277 (320)
T cd05590 242 LTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRI 277 (320)
T ss_pred CCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 21 23899999999999998763 4556777765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=420.11 Aligned_cols=286 Identities=36% Similarity=0.696 Sum_probs=258.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l 545 (857)
+...+|.++.+||.|+||.|.+++.+++.+.||||+++++.+.....++..+.|.++|.... -|++++|+..|++-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 55678999999999999999999999999999999999999888888888889999998775 67999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+.||+|-..++.... +.|..+.+|+++|+.||-|||++|||+||||.+||||+.+|+|||+|||+++.-.
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-- 501 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-- 501 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc--
Confidence 999999999999888877643 8999999999999999999999999999999999999999999999999974310
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
-.+..+.
T Consensus 502 -------------------------------------------------------------------------~~~~TTk 508 (683)
T KOG0696|consen 502 -------------------------------------------------------------------------FDGVTTK 508 (683)
T ss_pred -------------------------------------------------------------------------cCCccee
Confidence 0123356
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
++||||.|+|||++...+|+.++|||++||+|||||.|++||+|.+.++.++.|......+|.. ++.++.+++..+|.
T Consensus 509 TFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKs--lSkEAv~ickg~lt 586 (683)
T KOG0696|consen 509 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKS--LSKEAVAICKGLLT 586 (683)
T ss_pred eecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccc--ccHHHHHHHHHHhh
Confidence 8999999999999999999999999999999999999999999999999999999999999864 99999999999999
Q ss_pred CCcCCcCCchh-hHHHHHcCCCCCCCChhhhc--cCCCCCCCCC-Ccccc
Q 035930 786 KEPDNRLGAVK-GAAEIKQHPFFEGLNWALIR--CAVPPELPRS-CDAVI 831 (857)
Q Consensus 786 ~DPe~Rpt~~~-~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~-~~~~~ 831 (857)
+.|.+|+++.+ +-.+|..||||+.|+|+.+. ...||+-|+. |+-..
T Consensus 587 K~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~ 636 (683)
T KOG0696|consen 587 KHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDA 636 (683)
T ss_pred cCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCch
Confidence 99999999865 45789999999999999884 5779999987 54443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=432.76 Aligned_cols=257 Identities=28% Similarity=0.524 Sum_probs=233.4
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
+++|.+.+.||+|.||+||+|+.+.+.+.||||.+.+.. ...+++..+.+|++|++.|+|||||.++++|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 367889999999999999999999999999999998764 3455677899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
+||+.| +|+.++..... ++|+.++.+++|++.||.|||+++|+|||+||.|||+..+|++|+||||+|+.+..+..
T Consensus 80 te~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~- 155 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS- 155 (808)
T ss_pred ehhhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCce-
Confidence 999965 99999987643 99999999999999999999999999999999999999999999999999965433221
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
..+++-
T Consensus 156 --------------------------------------------------------------------------vltsik 161 (808)
T KOG0597|consen 156 --------------------------------------------------------------------------VLTSIK 161 (808)
T ss_pred --------------------------------------------------------------------------eeeecc
Confidence 124566
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
|||.|||||++.+.+|+..+|+||||||||||+.|++||......+....|+....++|. ..+..+++|++++|.+||
T Consensus 162 GtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~--~~S~~f~nfl~gLL~kdP 239 (808)
T KOG0597|consen 162 GTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS--TASSSFVNFLQGLLIKDP 239 (808)
T ss_pred CcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc--cccHHHHHHHHHHhhcCh
Confidence 999999999999999999999999999999999999999998888888999999888886 699999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l 810 (857)
..|++ ..+++.|||+++-
T Consensus 240 ~~Rlt----W~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 240 AQRLT----WTDLLGHPFWKGK 257 (808)
T ss_pred hhccc----HHHHhcChHHhhh
Confidence 99999 9999999999863
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=416.99 Aligned_cols=305 Identities=31% Similarity=0.581 Sum_probs=236.5
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||+|+||+||++.+..+++.||||+++............+..|+.+|..++||||++++++|.+++++||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36899999999999999999999999999999997654444555667889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++||+|..++.+.. .+++..++.++.||+.||+|||++|||||||||+|||++.+|+++|+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999999887653 38999999999999999999999999999999999999999999999999985432110000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
. ....+..+. .......... . .................+|
T Consensus 159 ~-----------------~~~~~~~~~---~~~~~~~~~~-----~---------------~~~~~~~~~~~~~~~~~~g 198 (360)
T cd05627 159 F-----------------YRNLTHNPP---SDFSFQNMNS-----K---------------RKAETWKKNRRQLAYSTVG 198 (360)
T ss_pred c-----------------ccccccCCc---cccccccccc-----c---------------cccccccccccccccccCC
Confidence 0 000000000 0000000000 0 0000000111122345689
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhc--cccCCCCCCCCHHHHHHHHhhccCC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ--SLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~--~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
|+.|||||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++.. .+.+|....++.++++||.+|+ .|
T Consensus 199 t~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~ 277 (360)
T cd05627 199 TPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TD 277 (360)
T ss_pred CccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cC
Confidence 99999999999999999999999999999999999999988887777777653 3445554558999999999987 49
Q ss_pred cCCcCCchhhHHHHHcCCCCCCCChhhhccC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGLNWALIRCA 818 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~ 818 (857)
|.+|++. .++.++++||||.+++|+.++..
T Consensus 278 p~~R~~~-~~~~ei~~hp~f~~~~~~~~~~~ 307 (360)
T cd05627 278 SENRIGS-NGVEEIKSHPFFEGVDWGHIRER 307 (360)
T ss_pred hhhcCCC-CCHHHHhcCCCCCCCCHHHHhcC
Confidence 9999972 35899999999999999987543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=410.38 Aligned_cols=274 Identities=38% Similarity=0.731 Sum_probs=232.5
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHH---HcCCCCccccceeeeeCCeEEEE
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ---MLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr---~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
|++.+.||+|+||.||+|.+..+++.||||++++.........+.+.+|+.++. .++||||++++++|.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999998664444445566777776654 56799999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~---- 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG---- 153 (324)
T ss_pred EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC----
Confidence 9999999998877543 489999999999999999999999999999999999999999999999998632100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.......++
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (324)
T cd05589 154 -----------------------------------------------------------------------FGDRTSTFC 162 (324)
T ss_pred -----------------------------------------------------------------------CCCcccccc
Confidence 001112457
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
||+.|||||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......+|. .++..+.+||.+||..||
T Consensus 163 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP 240 (324)
T cd05589 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSREAISIMRRLLRRNP 240 (324)
T ss_pred cCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhhcCH
Confidence 999999999999999999999999999999999999999988877888887777666654 589999999999999999
Q ss_pred CCcCCchh-hHHHHHcCCCCCCCChhhhc--cCCCCCCCC
Q 035930 789 DNRLGAVK-GAAEIKQHPFFEGLNWALIR--CAVPPELPR 825 (857)
Q Consensus 789 e~Rpt~~~-~a~ELL~HPfF~~l~w~li~--~~~pp~~P~ 825 (857)
.+||++.. .+.++++||||..++|..+. ...|+++|.
T Consensus 241 ~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~ 280 (324)
T cd05589 241 ERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPT 280 (324)
T ss_pred hHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCC
Confidence 99996433 48999999999999998653 445666664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=408.31 Aligned_cols=268 Identities=40% Similarity=0.709 Sum_probs=229.5
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCCCh
Q 035930 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL 557 (857)
Q Consensus 478 LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL 557 (857)
||+|+||+||+|++..+++.||||++.............+.+|+.+|+.++||||++++++|..++..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999999765444445566778999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCC
Q 035930 558 HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEE 637 (857)
Q Consensus 558 ~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~ 637 (857)
..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~------------- 145 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK------------- 145 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc-------------
Confidence 98887643 489999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChh
Q 035930 638 PPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPE 717 (857)
Q Consensus 638 p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPE 717 (857)
........+||+.|+|||
T Consensus 146 --------------------------------------------------------------~~~~~~~~~gt~~y~aPE 163 (312)
T cd05585 146 --------------------------------------------------------------DDDKTNTFCGTPEYLAPE 163 (312)
T ss_pred --------------------------------------------------------------CCCccccccCCcccCCHH
Confidence 001122456999999999
Q ss_pred hhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhh
Q 035930 718 IIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKG 797 (857)
Q Consensus 718 il~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~ 797 (857)
++.+..++.++|||||||++|||++|+.||.+.+..+.+..++.....++. .++..+++||.+||..||.+||+. ..
T Consensus 164 ~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~~~-~~ 240 (312)
T cd05585 164 LLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGY-NG 240 (312)
T ss_pred HHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHcCCCHHHcCCC-CC
Confidence 999999999999999999999999999999988777778888777666664 589999999999999999999863 34
Q ss_pred HHHHHcCCCCCCCChhhhc--cCCCCCCCC
Q 035930 798 AAEIKQHPFFEGLNWALIR--CAVPPELPR 825 (857)
Q Consensus 798 a~ELL~HPfF~~l~w~li~--~~~pp~~P~ 825 (857)
+.++|+||||...+|..+. ...|+..|.
T Consensus 241 ~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 270 (312)
T cd05585 241 AQEIKNHPFFSQLSWKKLLMKGIQPPFKPA 270 (312)
T ss_pred HHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 8999999999999997553 334444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=412.91 Aligned_cols=271 Identities=37% Similarity=0.740 Sum_probs=230.4
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGG 555 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gG 555 (857)
+.||+|+||+||++++..++..||||++.+...........+.+|+++|+.++||||++++++|..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544555677889999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCC
Q 035930 556 DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPV 635 (857)
Q Consensus 556 sL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~ 635 (857)
+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---------- 148 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---------- 148 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc----------
Confidence 9988876653 4899999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccC
Q 035930 636 EEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLA 715 (857)
Q Consensus 636 ~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmA 715 (857)
......++||+.|+|
T Consensus 149 -----------------------------------------------------------------~~~~~~~~gt~~y~a 163 (328)
T cd05593 149 -----------------------------------------------------------------AATMKTFCGTPEYLA 163 (328)
T ss_pred -----------------------------------------------------------------ccccccccCCcCccC
Confidence 001123569999999
Q ss_pred hhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCch
Q 035930 716 PEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV 795 (857)
Q Consensus 716 PEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~ 795 (857)
||++.+..++.++|||||||+||+|++|+.||.+.+..+.+..+......+|. .++.++.+||++||.+||.+|++..
T Consensus 164 PE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~ 241 (328)
T cd05593 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGG 241 (328)
T ss_pred hhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC--CCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 99999999999999999999999999999999888777777777666666654 5899999999999999999998321
Q ss_pred -hhHHHHHcCCCCCCCChhhhc--cCCCCCCCC
Q 035930 796 -KGAAEIKQHPFFEGLNWALIR--CAVPPELPR 825 (857)
Q Consensus 796 -~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~ 825 (857)
+.+.+|++||||.+++|..+. ...|+..|.
T Consensus 242 ~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~ 274 (328)
T cd05593 242 PDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQ 274 (328)
T ss_pred CCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCc
Confidence 139999999999999998653 344555544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=419.88 Aligned_cols=318 Identities=32% Similarity=0.566 Sum_probs=236.9
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+++|+.++||||++++++|.+++.+|||||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 69999999999999999999999999999999976544444455678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc--c
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM--V 628 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~--l 628 (857)
|+++|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+|..+..... .
T Consensus 82 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 82 YIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 999999999987653 489999999999999999999999999999999999999999999999999743211100 0
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
....... . ............ ...+-...+ ..+ ............++
T Consensus 160 ~~~~~~~---~----~~~~~~~~~~~~-------~~~~~~~~~-----~~~---------------~~~~~~~~~~~~~~ 205 (376)
T cd05598 160 YQKGDHH---R----QDSMEPSEEWSE-------IDRCRLKPL-----ERR---------------RKRQHQRCLAHSLV 205 (376)
T ss_pred ccccccc---c----cccccccccccc-------cccccccch-----hhh---------------hhhhcccccccccC
Confidence 0000000 0 000000000000 000000000 000 00001112234678
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhc--cccCCCCCCCCHHHHHHHHhhccC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ--SLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~--~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
||+.|||||++.+..++.++|||||||+||||++|+.||.+....+.+..+... ...++....++.++.+||.+|+ .
T Consensus 206 gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~ 284 (376)
T cd05598 206 GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-C 284 (376)
T ss_pred CCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-c
Confidence 999999999999999999999999999999999999999988776666655543 3344555568999999999987 5
Q ss_pred CcCCcCCchhhHHHHHcCCCCCCCChhhh-ccCCCCCCCCC
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFEGLNWALI-RCAVPPELPRS 826 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~~l~w~li-~~~~pp~~P~~ 826 (857)
+|.+|++. ..+.++++||||.+++|..+ +...++.+|..
T Consensus 285 ~p~~R~~~-~t~~ell~h~~~~~~~~~~~~~~~~~~~~~~~ 324 (376)
T cd05598 285 GAEDRLGK-NGADEIKAHPFFKGIDFASLIRRQKAPYIPKI 324 (376)
T ss_pred CHhhcCCC-CCHHHHhCCCCcCCCCHHHHhhcCCCCCCCcC
Confidence 99999931 12999999999999999877 44445555543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=410.93 Aligned_cols=271 Identities=38% Similarity=0.727 Sum_probs=230.6
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGG 555 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gG 555 (857)
+.||+|+||+||++++..++..||+|++.............+.+|+++|+.++||||++++++|..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998764444455567788999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCC
Q 035930 556 DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPV 635 (857)
Q Consensus 556 sL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~ 635 (857)
+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~----------- 147 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS----------- 147 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC-----------
Confidence 9988877653 489999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccC
Q 035930 636 EEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLA 715 (857)
Q Consensus 636 ~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmA 715 (857)
........+||+.|+|
T Consensus 148 ----------------------------------------------------------------~~~~~~~~~gt~~y~a 163 (323)
T cd05595 148 ----------------------------------------------------------------DGATMKTFCGTPEYLA 163 (323)
T ss_pred ----------------------------------------------------------------CCCccccccCCcCcCC
Confidence 0001123469999999
Q ss_pred hhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCch
Q 035930 716 PEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV 795 (857)
Q Consensus 716 PEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~ 795 (857)
||++.+..++.++|||||||+||||++|+.||...+..+.+..+......+|. .+++++++||.+||..||.+|++..
T Consensus 164 PE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~ 241 (323)
T cd05595 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGG 241 (323)
T ss_pred cccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHccCCHHHhCCCC
Confidence 99999999999999999999999999999999988777777777777666664 5899999999999999999998321
Q ss_pred -hhHHHHHcCCCCCCCChhhhc--cCCCCCCCC
Q 035930 796 -KGAAEIKQHPFFEGLNWALIR--CAVPPELPR 825 (857)
Q Consensus 796 -~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~ 825 (857)
..+.++++||||.+++|..+. ...|+..|.
T Consensus 242 ~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~ 274 (323)
T cd05595 242 PSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQ 274 (323)
T ss_pred CCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 139999999999999998653 344555554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=421.35 Aligned_cols=271 Identities=32% Similarity=0.579 Sum_probs=229.9
Q ss_pred ccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc-----------cchhHHHHHHHHHHHcCCCC
Q 035930 463 QHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR-----------KKMPRAQTEREIMQMLDHPF 531 (857)
Q Consensus 463 ~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~-----------~~~~~~~~EieILr~L~HPn 531 (857)
..++..+++|++++.||.|.||.|-+|++..+++.||||++.+..+... ...+.+++|+.||++|+|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 3455778899999999999999999999999999999999976533221 22457899999999999999
Q ss_pred ccccceeeeeC--CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC
Q 035930 532 LPTLFAHFTTE--KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG 609 (857)
Q Consensus 532 IV~L~~~f~~~--~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg 609 (857)
||+|+++..+. +.+|||+|||..|.+...-...+ .+.+.++|.|+++++.||+|||.+|||||||||.|+||+.+|
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~--els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKP--ELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCCCcc--cccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 99999998764 68999999999988854332221 289999999999999999999999999999999999999999
Q ss_pred cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhccc
Q 035930 610 HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQV 689 (857)
Q Consensus 610 ~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~ 689 (857)
++||+|||.+..+... ..
T Consensus 248 ~VKIsDFGVs~~~~~~---------------------~~----------------------------------------- 265 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQG---------------------SD----------------------------------------- 265 (576)
T ss_pred cEEeeccceeeecccC---------------------Cc-----------------------------------------
Confidence 9999999987432110 00
Q ss_pred CCCCcccccCCCCccccccCCCCccChhhhcCC---CC-CcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc
Q 035930 690 SPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGE---GH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR 765 (857)
Q Consensus 690 ~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~---~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~ 765 (857)
+..+......+|||.|||||.+.+. .+ +.+.|||||||+||.|++|+.||.+....+++.+|+...+.
T Consensus 266 --------~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~ 337 (576)
T KOG0585|consen 266 --------EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLE 337 (576)
T ss_pred --------cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCccc
Confidence 0000111235799999999999873 23 77999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 766 FPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 766 ~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
||..+.+..+++|||.+||++||+.|++ +.+|..|||...
T Consensus 338 fP~~pe~~e~~kDli~~lL~KdP~~Ri~----l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 338 FPENPEINEDLKDLIKRLLEKDPEQRIT----LPDIKLHPWVTR 377 (576)
T ss_pred CCCcccccHHHHHHHHHHhhcChhheee----hhhheecceecc
Confidence 9999999999999999999999999999 999999999764
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=415.35 Aligned_cols=281 Identities=36% Similarity=0.632 Sum_probs=237.7
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
..+...+|++.+.||+|+||+||++++..++..||||++.+...........+.+|+.+|+.++||||++++++|.+++.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 34566789999999999999999999999999999999976543334445567889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+||||||++||+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999999888654 388999999999999999999999999999999999999999999999998743110
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
. .....
T Consensus 195 ~--------------------------------------------------------------------------~~~~~ 200 (370)
T cd05596 195 N--------------------------------------------------------------------------GMVRC 200 (370)
T ss_pred C--------------------------------------------------------------------------CcccC
Confidence 0 00011
Q ss_pred ccccCCCCccChhhhcCC----CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc--ccCCCCCCCCHHHHH
Q 035930 705 NSFVGTHEYLAPEIIKGE----GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS--LRFPGYPVVSFHARD 778 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~----~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~--~~~p~~~~is~~l~d 778 (857)
...+||+.|||||++.+. .++.++|||||||+||||++|+.||.+.+....+..++... +.+|....++.++++
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKD 280 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHH
Confidence 235699999999999764 37889999999999999999999999887777777777643 556666678999999
Q ss_pred HHHhhccCCcCC--cCCchhhHHHHHcCCCCCCCChhh--hccCCCCCCCCC
Q 035930 779 LIRGLLVKEPDN--RLGAVKGAAEIKQHPFFEGLNWAL--IRCAVPPELPRS 826 (857)
Q Consensus 779 LI~k~L~~DPe~--Rpt~~~~a~ELL~HPfF~~l~w~l--i~~~~pp~~P~~ 826 (857)
||.+||..+|.+ |++ +++|++||||...+|.. ++...+|++|..
T Consensus 281 li~~~L~~~p~r~~R~s----~~ell~h~~~~~~~~~~~~~~~~~~~~~p~~ 328 (370)
T cd05596 281 LICAFLTDREVRLGRNG----VDEIKSHPFFKNDQWTFDNIRETVAPVVPEL 328 (370)
T ss_pred HHHHHccChhhccCCCC----HHHHhcCcccCCCChhhHHhcCCCcCccCcC
Confidence 999999999987 988 99999999999988864 455566777753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=408.08 Aligned_cols=271 Identities=38% Similarity=0.753 Sum_probs=224.6
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||+|+||+||+|++..+++.||||++++...........+..|+.+++.+ +||||++++++|.+++.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544445566788999999888 699999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---------- 148 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR---------- 148 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc----------
Confidence 99988876553 499999999999999999999999999999999999999999999999998732000
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
.......++||+.|+
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 163 (329)
T cd05588 149 -----------------------------------------------------------------PGDTTSTFCGTPNYI 163 (329)
T ss_pred -----------------------------------------------------------------CCCccccccCCcccc
Confidence 000112457999999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC---------hhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN---------DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~---------~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
|||++.+..++.++|||||||++|||++|+.||..... ......+.....++| ..++..+.+||++||.
T Consensus 164 aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~~~L~ 241 (329)
T cd05588 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKASSVLKGFLN 241 (329)
T ss_pred CHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHhc
Confidence 99999999999999999999999999999999964221 123344445555555 3589999999999999
Q ss_pred CCcCCcCCch--hhHHHHHcCCCCCCCChhhhcc--CCCCCCCC
Q 035930 786 KEPDNRLGAV--KGAAEIKQHPFFEGLNWALIRC--AVPPELPR 825 (857)
Q Consensus 786 ~DPe~Rpt~~--~~a~ELL~HPfF~~l~w~li~~--~~pp~~P~ 825 (857)
.||.+|+++. .+++++++||||..++|..+.. ..|+..|.
T Consensus 242 ~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
T cd05588 242 KDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPN 285 (329)
T ss_pred cCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCcccc
Confidence 9999999843 3489999999999999987753 33444444
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=415.20 Aligned_cols=281 Identities=36% Similarity=0.655 Sum_probs=234.2
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
..+..++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++||||++++++|.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 34566789999999999999999999999999999999976443334445567889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|+||||+++|+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999999988654 389999999999999999999999999999999999999999999999999743210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
. .....
T Consensus 195 ~--------------------------------------------------------------------------~~~~~ 200 (370)
T cd05621 195 T--------------------------------------------------------------------------GMVRC 200 (370)
T ss_pred C--------------------------------------------------------------------------Cceec
Confidence 0 00011
Q ss_pred ccccCCCCccChhhhcCCC----CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc--ccCCCCCCCCHHHHH
Q 035930 705 NSFVGTHEYLAPEIIKGEG----HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS--LRFPGYPVVSFHARD 778 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~----~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~--~~~p~~~~is~~l~d 778 (857)
...+||+.|||||++.+.. ++.++|||||||+||||++|+.||.+.+....+..++... +.+|....++..+++
T Consensus 201 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~ 280 (370)
T cd05621 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKN 280 (370)
T ss_pred ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHH
Confidence 2457999999999997653 7889999999999999999999999888777777777643 455655568999999
Q ss_pred HHHhhccCCcCC--cCCchhhHHHHHcCCCCCCCCh--hhhccCCCCCCCCC
Q 035930 779 LIRGLLVKEPDN--RLGAVKGAAEIKQHPFFEGLNW--ALIRCAVPPELPRS 826 (857)
Q Consensus 779 LI~k~L~~DPe~--Rpt~~~~a~ELL~HPfF~~l~w--~li~~~~pp~~P~~ 826 (857)
||.+||..++.+ |++ +.++++||||+...| ..++...+|.+|..
T Consensus 281 li~~~L~~~~~r~~R~~----~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~ 328 (370)
T cd05621 281 LICAFLTDREVRLGRNG----VEEIKQHPFFKNDQWNWDNIRETAAPVVPEL 328 (370)
T ss_pred HHHHHccCchhccCCCC----HHHHhcCcccCCCCcChHhcCCCCCCcCCCC
Confidence 999999855543 777 999999999998665 44555566777754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=400.21 Aligned_cols=313 Identities=60% Similarity=1.018 Sum_probs=257.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||+|+||+||+|.+..+++.||||.+.............+..|+++|+.++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998764443345667889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+.+++|..++.......+++..++.++.||+.||+|||..||+||||||+|||++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999887655669999999999999999999999999999999999999999999999999985432111000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.. .. ....... . ...........+.......++|
T Consensus 161 ~~------~~--------~~~~~~~-------------~-------------------~~~~~~~~~~~~~~~~~~~~~g 194 (316)
T cd05574 161 SK------AL--------RKGSRRS-------------S-------------------VNSIPSETFSEEPSFRSNSFVG 194 (316)
T ss_pred cc------cc--------ccccccc-------------c-------------------ccccchhhhcccccCCCCCCcC
Confidence 00 00 0000000 0 0000011112233334456789
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
|..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++....++..+++||.+||..||+
T Consensus 195 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 274 (316)
T cd05574 195 TEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPS 274 (316)
T ss_pred ccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHh
Confidence 99999999999999999999999999999999999999988888888888877777776666899999999999999999
Q ss_pred CcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCCCc
Q 035930 790 NRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCD 828 (857)
Q Consensus 790 ~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~~~ 828 (857)
+||++..+++++|+||||++.+|..++-..||.+|...+
T Consensus 275 ~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (316)
T cd05574 275 KRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPDD 313 (316)
T ss_pred HCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCccc
Confidence 999988889999999999999999999999999886543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=425.41 Aligned_cols=261 Identities=32% Similarity=0.486 Sum_probs=224.5
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCC-e
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEK-F 544 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~-~ 544 (857)
+..++|.++++||.|.||.||+|+.+.++..||||.+++.+.. .++. .-.+|+.-|++|+ |||||+|.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 4467899999999999999999999999999999999877543 1111 2368999999999 999999999999887 9
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|+||||| ..+|+.++..+ .+.|++..++.|++||+.||+|+|++|++||||||||||+.....|||+|||||+....
T Consensus 85 L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999999 67999988877 56799999999999999999999999999999999999999888999999999975321
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
.+ -.
T Consensus 163 kp----------------------------------------------------------------------------PY 166 (538)
T KOG0661|consen 163 KP----------------------------------------------------------------------------PY 166 (538)
T ss_pred CC----------------------------------------------------------------------------Cc
Confidence 10 12
Q ss_pred ccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh-------------------ccc
Q 035930 705 NSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS-------------------QSL 764 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~-------------------~~~ 764 (857)
+.++-|.+|+|||+++.. .|+.++|||++|||++|+.+-++.|.|.+..+.+.+|.. -++
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 456789999999998765 479999999999999999999999999988888777764 123
Q ss_pred cCCC---------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 765 RFPG---------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 765 ~~p~---------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
+||. .+.++.++.+||.+||.+||.+||| |.++|+||||+.-.
T Consensus 247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT----A~~al~~pffq~~~ 298 (538)
T KOG0661|consen 247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT----ASQALQHPFFQVGR 298 (538)
T ss_pred CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc----HHHHhcCccccccc
Confidence 3443 2458889999999999999999999 99999999998643
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=405.20 Aligned_cols=280 Identities=36% Similarity=0.718 Sum_probs=238.2
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LVm 549 (857)
+|++.+.||+|+||+||+|++..+++.||||++.+...........+..|+.+++.+. |++|+.++++|.+++.+||||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4789999999999999999999999999999998764444445566788999998886 578888999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~----- 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV----- 153 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC-----
Confidence 9999999998887653 389999999999999999999999999999999999999999999999998732100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........+|
T Consensus 154 ----------------------------------------------------------------------~~~~~~~~~g 163 (323)
T cd05615 154 ----------------------------------------------------------------------DGVTTRTFCG 163 (323)
T ss_pred ----------------------------------------------------------------------CCccccCccC
Confidence 0001123468
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+......+|. .++.++.+||.+||.+||.
T Consensus 164 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~~p~ 241 (323)
T cd05615 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLMTKHPS 241 (323)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHcccCHh
Confidence 99999999999999999999999999999999999999988877888888777666654 4899999999999999999
Q ss_pred CcCCch-hhHHHHHcCCCCCCCChhhhc--cCCCCCCCCCCcc
Q 035930 790 NRLGAV-KGAAEIKQHPFFEGLNWALIR--CAVPPELPRSCDA 829 (857)
Q Consensus 790 ~Rpt~~-~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~~~~ 829 (857)
+|++.. ...+++++||||..++|..+. ...+|+.|..+..
T Consensus 242 ~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 284 (323)
T cd05615 242 KRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGK 284 (323)
T ss_pred hCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCCC
Confidence 999853 246899999999999998874 3457777765554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=406.70 Aligned_cols=272 Identities=39% Similarity=0.705 Sum_probs=229.1
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHH-HHHHcCCCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE-IMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~Eie-ILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||+|+||+||+|.+..+++.||||++.+...........+..|.. +++.++||||++++++|.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999997654433334445555555 56889999999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
|+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~---------- 148 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE---------- 148 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc----------
Confidence 99998887653 489999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
........+||+.|+
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 163 (323)
T cd05575 149 -----------------------------------------------------------------HSKTTSTFCGTPEYL 163 (323)
T ss_pred -----------------------------------------------------------------CCCccccccCChhhc
Confidence 000112346999999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++.....++ +.++..+.+||++||+.||.+||+.
T Consensus 164 aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~ 241 (323)
T cd05575 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK--PNISVSARHLLEGLLQKDRTKRLGA 241 (323)
T ss_pred ChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHhhcCHHhCCCC
Confidence 99999999999999999999999999999999998877777777777655544 4579999999999999999999997
Q ss_pred hhhHHHHHcCCCCCCCChhhhc--cCCCCCCCCC
Q 035930 795 VKGAAEIKQHPFFEGLNWALIR--CAVPPELPRS 826 (857)
Q Consensus 795 ~~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~ 826 (857)
...+.++++||||..++|..+. ...+|+.|..
T Consensus 242 ~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05575 242 KDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNV 275 (323)
T ss_pred CCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCC
Confidence 7778999999999999998764 3445655543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=407.82 Aligned_cols=271 Identities=40% Similarity=0.740 Sum_probs=229.6
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGG 555 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gG 555 (857)
+.||+|+||+||++.+..++..||+|++.+...........+.+|+++++.++||||++++++|..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444455567788999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 556 DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 556 sL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
+|..++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~---------- 148 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK---------- 148 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC----------
Confidence 9988877653 48999999999999999999997 7999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
........+||+.||
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 163 (325)
T cd05594 149 -----------------------------------------------------------------DGATMKTFCGTPEYL 163 (325)
T ss_pred -----------------------------------------------------------------CCcccccccCCcccC
Confidence 000112346999999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......+|. .+++++.+||.+||.+||.+|++.
T Consensus 164 aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~ 241 (325)
T cd05594 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGG 241 (325)
T ss_pred CHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhhcCHHHhCCC
Confidence 999999999999999999999999999999999988777777777776666664 489999999999999999999832
Q ss_pred h-hhHHHHHcCCCCCCCChhhhc--cCCCCCCCC
Q 035930 795 V-KGAAEIKQHPFFEGLNWALIR--CAVPPELPR 825 (857)
Q Consensus 795 ~-~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~ 825 (857)
. +.+.++++||||.++.|.... ...|++.|.
T Consensus 242 ~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T cd05594 242 GPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQ 275 (325)
T ss_pred CCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCc
Confidence 1 139999999999999998553 344555554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=405.05 Aligned_cols=272 Identities=39% Similarity=0.780 Sum_probs=229.5
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||+|+||+||+|++..++..||||++++...........+..|.++++.+ +||||++++++|.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544455566778899999888 699999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
|+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---------- 148 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL---------- 148 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc----------
Confidence 99988887653 389999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
........+||+.|+
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~g~~~y~ 163 (318)
T cd05570 149 -----------------------------------------------------------------GGVTTSTFCGTPDYI 163 (318)
T ss_pred -----------------------------------------------------------------CCCcccceecCcccc
Confidence 000112346899999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++. .++..+.+||++||..||.+||++
T Consensus 164 aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--WLSKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred CHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHccCCHHHcCCC
Confidence 999999999999999999999999999999999988777777777766666554 489999999999999999999992
Q ss_pred h-hhHHHHHcCCCCCCCChhhhc--cCCCCCCCCC
Q 035930 795 V-KGAAEIKQHPFFEGLNWALIR--CAVPPELPRS 826 (857)
Q Consensus 795 ~-~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~ 826 (857)
. ..+.+++.||||..++|..+. ...||..|..
T Consensus 242 ~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (318)
T cd05570 242 LPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKI 276 (318)
T ss_pred CCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 1 112999999999999997653 3445555543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=404.18 Aligned_cols=269 Identities=35% Similarity=0.725 Sum_probs=225.1
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||+|+||.||+|++..++..||||+++...............|..++..+ +||||++++++|.+++++||||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999875443334455667788888754 899999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~---------- 148 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---------- 148 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc----------
Confidence 99988887643 389999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
........+||+.|+
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 163 (316)
T cd05620 149 -----------------------------------------------------------------GDNRASTFCGTPDYI 163 (316)
T ss_pred -----------------------------------------------------------------CCCceeccCCCcCcc
Confidence 000112456999999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++++||.+||..||.+|++.
T Consensus 164 aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~ 241 (316)
T cd05620 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--WITKESKDILEKLFERDPTRRLGV 241 (316)
T ss_pred CHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHccCCHHHcCCC
Confidence 999999999999999999999999999999999988777777666655544544 489999999999999999999992
Q ss_pred hhhHHHHHcCCCCCCCChhhhc--cCCCCCCCCC
Q 035930 795 VKGAAEIKQHPFFEGLNWALIR--CAVPPELPRS 826 (857)
Q Consensus 795 ~~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~ 826 (857)
.+++++||||..++|..+. ...|++.|..
T Consensus 242 ---~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~ 272 (316)
T cd05620 242 ---VGNIRGHPFFKTINWTALEKRELDPPFKPKV 272 (316)
T ss_pred ---hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 3689999999999998653 3445555543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=394.65 Aligned_cols=279 Identities=34% Similarity=0.551 Sum_probs=229.0
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|++.+.||+|+||+||++.+..+++.||||++.............+.+|+.+|+.++||||++++++|.+++++|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999976544333334556789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++|+|..++.......+++..++.++.||+.||.|||+.||+||||||+|||+++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE------ 154 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC------
Confidence 99999998887655444589999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
.......+|+
T Consensus 155 ----------------------------------------------------------------------~~~~~~~~~~ 164 (285)
T cd05605 155 ----------------------------------------------------------------------GETIRGRVGT 164 (285)
T ss_pred ----------------------------------------------------------------------CCccccccCC
Confidence 0001234689
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhc--cccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ--SLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~--~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+... .........++..+.+||.+||..||
T Consensus 165 ~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 244 (285)
T cd05605 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDP 244 (285)
T ss_pred CCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999876554333332221 11122234589999999999999999
Q ss_pred CCcCCch-hhHHHHHcCCCCCCCChhhhc--cCCCCCCCC
Q 035930 789 DNRLGAV-KGAAEIKQHPFFEGLNWALIR--CAVPPELPR 825 (857)
Q Consensus 789 e~Rpt~~-~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~ 825 (857)
.+||++. ..+++|++||||...+|..+. ...||..|+
T Consensus 245 ~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05605 245 GFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284 (285)
T ss_pred HHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCC
Confidence 9999321 128999999999999999774 455677774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=392.05 Aligned_cols=261 Identities=34% Similarity=0.599 Sum_probs=242.2
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
...+++|++++.||.|.||.||+|+.+.++..||+||+.+..+........+.+|++|-..|+||||+++|+||.++..+
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 35678999999999999999999999999999999999888777677777889999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||++||.++|.|+..++.++...+++..+..|++|++.||.|+|..+||||||||+|+|++.+|.+||+|||.++.
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~---- 173 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH---- 173 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee----
Confidence 9999999999999999977777799999999999999999999999999999999999999999999999998732
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.+ ..+..
T Consensus 174 ------------------------------------------------------------------------~p-~~kR~ 180 (281)
T KOG0580|consen 174 ------------------------------------------------------------------------AP-SNKRK 180 (281)
T ss_pred ------------------------------------------------------------------------cC-CCCce
Confidence 01 22345
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
+.|||..|++||+..+..++..+|+|++|++.||++.|.+||......+++++|.+-.+.+| ..++.+++|||.+||.
T Consensus 181 tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p--~~is~~a~dlI~~ll~ 258 (281)
T KOG0580|consen 181 TLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP--STISGGAADLISRLLV 258 (281)
T ss_pred eeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC--cccChhHHHHHHHHhc
Confidence 78999999999999999999999999999999999999999999999999999999988888 5699999999999999
Q ss_pred CCcCCcCCchhhHHHHHcCCCCCC
Q 035930 786 KEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
++|.+|+. ..|++.|||...
T Consensus 259 ~~p~~r~~----l~~v~~hpwI~a 278 (281)
T KOG0580|consen 259 KNPIERLA----LTEVMDHPWIVA 278 (281)
T ss_pred cCcccccc----HHHHhhhHHHHh
Confidence 99999999 999999999864
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=402.52 Aligned_cols=269 Identities=38% Similarity=0.759 Sum_probs=226.1
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHH-cCCCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM-LDHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~-L~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||+|+||+||+|++..++..||||+++...............|..++.. ++||||+++++++.+++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999987644334445566778888876 4899999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
|+|..++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~---------- 148 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML---------- 148 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC----------
Confidence 99998887643 389999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
........+||+.|+
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 163 (316)
T cd05619 149 -----------------------------------------------------------------GDAKTCTFCGTPDYI 163 (316)
T ss_pred -----------------------------------------------------------------CCCceeeecCCcccc
Confidence 000112346899999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++++||.+||..||.+|++
T Consensus 164 aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~- 240 (316)
T cd05619 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--WLTREAKDILVKLFVREPERRLG- 240 (316)
T ss_pred CHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHhccCHhhcCC-
Confidence 999999999999999999999999999999999988777777766555444443 48899999999999999999999
Q ss_pred hhhH-HHHHcCCCCCCCChhhhc--cCCCCCCCCCC
Q 035930 795 VKGA-AEIKQHPFFEGLNWALIR--CAVPPELPRSC 827 (857)
Q Consensus 795 ~~~a-~ELL~HPfF~~l~w~li~--~~~pp~~P~~~ 827 (857)
+ +++++||||..++|..+. ...|+..|...
T Consensus 241 ---~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (316)
T cd05619 241 ---VKGDIRQHPFFREIDWSALEEREIEPPFKPKVK 273 (316)
T ss_pred ---ChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCC
Confidence 6 489999999999998774 34466666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=402.61 Aligned_cols=268 Identities=40% Similarity=0.798 Sum_probs=224.6
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||+|+||+||+|++..++..||||+++............+..|..++..+ +||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876443344455566777777654 799999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--------- 149 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--------- 149 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---------
Confidence 99998887653 4899999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
.......+||+.|+
T Consensus 150 ------------------------------------------------------------------~~~~~~~~gt~~y~ 163 (316)
T cd05592 150 ------------------------------------------------------------------EGKASTFCGTPDYI 163 (316)
T ss_pred ------------------------------------------------------------------CCccccccCCcccc
Confidence 00112456999999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+| ..++.++.+||.+||..||.+|++.
T Consensus 164 aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~ll~~~l~~~P~~R~~~ 241 (316)
T cd05592 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP--RWISKEAKDCLSKLFERDPTKRLGV 241 (316)
T ss_pred CHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHccCCHHHcCCC
Confidence 99999999999999999999999999999999998877777777665544444 4589999999999999999999983
Q ss_pred hhhHHHHHcCCCCCCCChhhhc--cCCCCCCCC
Q 035930 795 VKGAAEIKQHPFFEGLNWALIR--CAVPPELPR 825 (857)
Q Consensus 795 ~~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~ 825 (857)
..++++||||..++|..+. ...|++.|.
T Consensus 242 ---~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~ 271 (316)
T cd05592 242 ---DGDIRQHPFFRGIDWERLEKREIPPPFKPK 271 (316)
T ss_pred ---hHHHHcCcccCCCCHHHHHhCCCCCCcCCC
Confidence 4689999999999998764 334455543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=410.16 Aligned_cols=283 Identities=35% Similarity=0.652 Sum_probs=234.9
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
..+..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||++++++|.+++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 45667899999999999999999999999999999999976433333445567889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|+||||+++|+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 99999999999999888654 388999999999999999999999999999999999999999999999999743210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
. .....
T Consensus 195 ~--------------------------------------------------------------------------~~~~~ 200 (371)
T cd05622 195 E--------------------------------------------------------------------------GMVRC 200 (371)
T ss_pred C--------------------------------------------------------------------------Ccccc
Confidence 0 00011
Q ss_pred ccccCCCCccChhhhcCCC----CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc--ccCCCCCCCCHHHHH
Q 035930 705 NSFVGTHEYLAPEIIKGEG----HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS--LRFPGYPVVSFHARD 778 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~----~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~--~~~p~~~~is~~l~d 778 (857)
...+||+.|||||++.+.. ++.++|||||||+||||++|+.||.+.+....+..++... +.+|....++..+++
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 280 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHH
Confidence 2457999999999997653 7889999999999999999999999887777777777643 556666679999999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHHcCCCCCCCCh--hhhccCCCCCCCCC
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW--ALIRCAVPPELPRS 826 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w--~li~~~~pp~~P~~ 826 (857)
||..||. +|..|++ +.++++|++||||.+..| ..++...+|.+|..
T Consensus 281 li~~~L~-~~~~r~~-r~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~ 328 (371)
T cd05622 281 LICAFLT-DREVRLG-RNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDL 328 (371)
T ss_pred HHHHHcC-ChhhhcC-CCCHHHHhcCcccCCCChhHHhcCCCCCCCCCCC
Confidence 9999998 5555443 123999999999998665 45566666777753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=402.59 Aligned_cols=278 Identities=36% Similarity=0.664 Sum_probs=230.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||+|+||+||++++..+++.||||++.+...........+.+|+.+++.++|+||++++++|.+++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997644334445566788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++|+|..++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--- 156 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC---
Confidence 9999999999887643 348999999999999999999999999999999999999999999999999874321000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.......+|
T Consensus 157 -----------------------------------------------------------------------~~~~~~~~g 165 (331)
T cd05597 157 -----------------------------------------------------------------------TVQSNVAVG 165 (331)
T ss_pred -----------------------------------------------------------------------Cccccceec
Confidence 000112368
Q ss_pred CCCccChhhhcC-----CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc--cCC-CCCCCCHHHHHHHH
Q 035930 710 THEYLAPEIIKG-----EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL--RFP-GYPVVSFHARDLIR 781 (857)
Q Consensus 710 T~~YmAPEil~g-----~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~--~~p-~~~~is~~l~dLI~ 781 (857)
|+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..++.... .++ ....++..+++||+
T Consensus 166 t~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~ 245 (331)
T cd05597 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIR 245 (331)
T ss_pred cccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHH
Confidence 999999999974 4578899999999999999999999988777777777665432 222 22457999999999
Q ss_pred hhccCCcCC--cCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCC
Q 035930 782 GLLVKEPDN--RLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRS 826 (857)
Q Consensus 782 k~L~~DPe~--Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~ 826 (857)
+||..++.+ |++ +.++++||||.+++|..+....++.+|..
T Consensus 246 ~ll~~~~~r~~r~~----~~~~l~hp~~~~~~~~~~~~~~~~~~~~~ 288 (331)
T cd05597 246 RLICSPETRLGRNG----LQDFKDHPFFEGIDWDNIRNSTAPYVPEV 288 (331)
T ss_pred HHccCcccccCCCC----HHHHhcCCCCCCCCHHHHhhCCCCccCcC
Confidence 999764433 566 99999999999999999887777777754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=404.03 Aligned_cols=272 Identities=38% Similarity=0.743 Sum_probs=224.3
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||+|+||+||+|++..+++.||+|++++...........+.+|+.++..+ +||||++++++|..++.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544445556678899988776 799999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~---------- 148 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR---------- 148 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC----------
Confidence 99988876653 489999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
.......++||+.|+
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 163 (329)
T cd05618 149 -----------------------------------------------------------------PGDTTSTFCGTPNYI 163 (329)
T ss_pred -----------------------------------------------------------------CCCccccccCCcccc
Confidence 000112456999999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC--------C-hhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG--------N-DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~--------~-~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
|||++.+..++.++|||||||++|||++|+.||.... . ......+......+| ..++..+.+||.+||.
T Consensus 164 aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~ll~~~L~ 241 (329)
T cd05618 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKAASVLKSFLN 241 (329)
T ss_pred CHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHhc
Confidence 9999999999999999999999999999999996321 1 112333444455555 4588999999999999
Q ss_pred CCcCCcCCch--hhHHHHHcCCCCCCCChhhhc--cCCCCCCCCC
Q 035930 786 KEPDNRLGAV--KGAAEIKQHPFFEGLNWALIR--CAVPPELPRS 826 (857)
Q Consensus 786 ~DPe~Rpt~~--~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~ 826 (857)
.||.+|+++. .++.++++||||..++|..+. ...|+..|..
T Consensus 242 ~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~ 286 (329)
T cd05618 242 KDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNI 286 (329)
T ss_pred CCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCC
Confidence 9999999843 346899999999999998774 3455656543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=402.00 Aligned_cols=278 Identities=36% Similarity=0.646 Sum_probs=231.3
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+.+.||+|+||+||++++..+++.||+|++.+...........+.+|+.++..++|+||+.+++++.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997643333444456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++|+|..++.+... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~---- 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED---- 155 (332)
T ss_pred eccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC----
Confidence 99999999999876432 4899999999999999999999999999999999999999999999999987431100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........+|
T Consensus 156 ----------------------------------------------------------------------~~~~~~~~~g 165 (332)
T cd05623 156 ----------------------------------------------------------------------GTVQSSVAVG 165 (332)
T ss_pred ----------------------------------------------------------------------Ccceeccccc
Confidence 0001123469
Q ss_pred CCCccChhhhc-----CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC--CC-CCCCCHHHHHHHH
Q 035930 710 THEYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF--PG-YPVVSFHARDLIR 781 (857)
Q Consensus 710 T~~YmAPEil~-----g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~--p~-~~~is~~l~dLI~ 781 (857)
|+.|||||++. ...++.++|||||||+||||++|+.||.+.+..+.+..+.....++ |. ...++.++++||+
T Consensus 166 t~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~ 245 (332)
T cd05623 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIR 245 (332)
T ss_pred CccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHH
Confidence 99999999996 3457899999999999999999999999888778887777654333 32 2357999999999
Q ss_pred hhccCCcCC--cCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCC
Q 035930 782 GLLVKEPDN--RLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRS 826 (857)
Q Consensus 782 k~L~~DPe~--Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~ 826 (857)
+||..++.+ |++ ++++++||||.+++|..++...++.+|..
T Consensus 246 ~ll~~~~~r~~r~~----~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 288 (332)
T cd05623 246 RLICSREHRLGQNG----IEDFKQHPFFTGIDWDNIRNCEAPYIPEV 288 (332)
T ss_pred HHccChhhhcCCCC----HHHHhCCCCcCCCCHHHHhhCCCCccCCC
Confidence 999765544 455 99999999999999998876666666654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=403.46 Aligned_cols=281 Identities=35% Similarity=0.650 Sum_probs=233.5
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+.+.||+|+||+||++++..+++.||+|++.+...........+.+|+.+++.++|+||+.++++|.+++..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997643333444556788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++||+|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--- 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC---
Confidence 9999999999987643 248999999999999999999999999999999999999999999999999974321000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.......+|
T Consensus 157 -----------------------------------------------------------------------~~~~~~~~g 165 (331)
T cd05624 157 -----------------------------------------------------------------------TVQSSVAVG 165 (331)
T ss_pred -----------------------------------------------------------------------ceeeccccC
Confidence 000123469
Q ss_pred CCCccChhhhcC-----CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC--CC-CCCCCHHHHHHHH
Q 035930 710 THEYLAPEIIKG-----EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF--PG-YPVVSFHARDLIR 781 (857)
Q Consensus 710 T~~YmAPEil~g-----~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~--p~-~~~is~~l~dLI~ 781 (857)
|+.|||||++.+ ..++.++|||||||+||||++|+.||...+..+.+..++....++ |. ...++.++++||.
T Consensus 166 t~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~ 245 (331)
T cd05624 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQ 245 (331)
T ss_pred CcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHH
Confidence 999999999976 457889999999999999999999999887777777776654333 22 2347899999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSC 827 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~~ 827 (857)
+||..++. |+. +.+++++++||||++++|..++...+|.+|+..
T Consensus 246 ~ll~~~~~-~~~-~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p~~~ 289 (331)
T cd05624 246 RLICSRER-RLG-QNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVS 289 (331)
T ss_pred HHccCchh-hcC-CCCHHHHhcCCCcCCCCHHHHhhCCCCccCCCC
Confidence 99997554 432 133999999999999999999888888888643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=402.04 Aligned_cols=271 Identities=36% Similarity=0.721 Sum_probs=225.5
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+.++++|.+.+.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554455566788999999888 699999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~---------- 148 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG---------- 148 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC----------
Confidence 99988876553 399999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
........+||+.|+
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 163 (327)
T cd05617 149 -----------------------------------------------------------------PGDTTSTFCGTPNYI 163 (327)
T ss_pred -----------------------------------------------------------------CCCceecccCCcccC
Confidence 000112457999999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC------Ch-hhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG------ND-ETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~------~~-e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
|||++.+..++.++|||||||+||||++|+.||.... .. .....+.....++| ..++..+.+||.+||.+|
T Consensus 164 aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~~~L~~d 241 (327)
T cd05617 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP--RFLSVKASHVLKGFLNKD 241 (327)
T ss_pred CHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHHhccC
Confidence 9999999999999999999999999999999996432 11 23334444444444 458999999999999999
Q ss_pred cCCcCCch--hhHHHHHcCCCCCCCChhhhc--cCCCCCCCC
Q 035930 788 PDNRLGAV--KGAAEIKQHPFFEGLNWALIR--CAVPPELPR 825 (857)
Q Consensus 788 Pe~Rpt~~--~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~ 825 (857)
|.+|++.. .+++++++||||..++|.++. ...|++.|.
T Consensus 242 P~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~ 283 (327)
T cd05617 242 PKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQ 283 (327)
T ss_pred HHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCC
Confidence 99999853 357899999999999999875 344555665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=402.71 Aligned_cols=272 Identities=38% Similarity=0.682 Sum_probs=228.6
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHH-HHHHcCCCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE-IMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~Eie-ILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||+|+||+||+|.+..+|+.||||++.+...........+..|.. +++.++||||++++++|..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654333344445555655 46789999999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~---------- 148 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA---------- 148 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC----------
Confidence 99988876643 489999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
.......++||+.||
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 163 (325)
T cd05604 149 -----------------------------------------------------------------QSDTTTTFCGTPEYL 163 (325)
T ss_pred -----------------------------------------------------------------CCCCcccccCChhhC
Confidence 000112456999999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
|||++.+..++.++|||||||++|||++|..||...+..+.+..++.....++ +.++..+.+||++||..||.+||+.
T Consensus 164 aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~ll~~~p~~R~~~ 241 (325)
T cd05604 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR--PGASLTAWSILEELLEKDRQRRLGA 241 (325)
T ss_pred CHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC--CCCCHHHHHHHHHHhccCHHhcCCC
Confidence 99999999999999999999999999999999998877777777776655443 4588999999999999999999998
Q ss_pred hhhHHHHHcCCCCCCCChhhhcc--CCCCCCCCC
Q 035930 795 VKGAAEIKQHPFFEGLNWALIRC--AVPPELPRS 826 (857)
Q Consensus 795 ~~~a~ELL~HPfF~~l~w~li~~--~~pp~~P~~ 826 (857)
...+.+++.||||..+.|..+.. ..|+..|..
T Consensus 242 ~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T cd05604 242 KEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNV 275 (325)
T ss_pred CCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcC
Confidence 77789999999999999987653 344555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=404.21 Aligned_cols=270 Identities=40% Similarity=0.716 Sum_probs=226.9
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc---CCCCccccceeeeeCCeEEEEEeecCC
Q 035930 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML---DHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 478 LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L---~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
||+|+||+||+|++..++..||||++.+..............|..++..+ +||||+.++++|.+.+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765443334444556677777665 699999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~---------- 148 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT---------- 148 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC----------
Confidence 99988887653 489999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
........+||+.||
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 163 (330)
T cd05586 149 -----------------------------------------------------------------DNKTTNTFCGTTEYL 163 (330)
T ss_pred -----------------------------------------------------------------CCCCccCccCCcccc
Confidence 000112456999999
Q ss_pred ChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCC
Q 035930 715 APEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLG 793 (857)
Q Consensus 715 APEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt 793 (857)
|||++.+. .++.++|||||||+||+|++|+.||.+.+..+.+..+.....+++. ..++.++++||++||..||.+||+
T Consensus 164 aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~ 242 (330)
T cd05586 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK-NVLSDEGRQFVKGLLNRNPQHRLG 242 (330)
T ss_pred CHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC-ccCCHHHHHHHHHHcCCCHHHCCC
Confidence 99999765 4899999999999999999999999988777777777777776664 357999999999999999999998
Q ss_pred chhhHHHHHcCCCCCCCChhhhc--cCCCCCCCC
Q 035930 794 AVKGAAEIKQHPFFEGLNWALIR--CAVPPELPR 825 (857)
Q Consensus 794 ~~~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~ 825 (857)
+...+.++++||||..++|..+. ...|+..|.
T Consensus 243 ~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~ 276 (330)
T cd05586 243 AHRDAVELKEHPFFADIDWDLLSKKQITPPFKPI 276 (330)
T ss_pred CCCCHHHHhcCccccCCCHHHHHhCCCCCCccCC
Confidence 76779999999999999998774 233455443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=392.02 Aligned_cols=270 Identities=32% Similarity=0.596 Sum_probs=221.4
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCCCh
Q 035930 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL 557 (857)
Q Consensus 478 LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL 557 (857)
||+|+||+||++.+..+++.||+|++.............+..|+++|+.++||||++++++|..+...|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999765444444456678899999999999999999999999999999999999999
Q ss_pred HHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCC
Q 035930 558 HVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPV 635 (857)
Q Consensus 558 ~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~ 635 (857)
..++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~---------- 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG---------- 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC----------
Confidence 8776432 2235899999999999999999999999999999999999999999999999987431100
Q ss_pred CCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccC
Q 035930 636 EEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLA 715 (857)
Q Consensus 636 ~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmA 715 (857)
........||+.|+|
T Consensus 151 -----------------------------------------------------------------~~~~~~~~g~~~y~a 165 (280)
T cd05608 151 -----------------------------------------------------------------QSKTKGYAGTPGFMA 165 (280)
T ss_pred -----------------------------------------------------------------CccccccCCCcCccC
Confidence 000123468999999
Q ss_pred hhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChh----hhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCc
Q 035930 716 PEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE----TLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791 (857)
Q Consensus 716 PEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e----~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~R 791 (857)
||++.+..++.++|||||||++|||++|+.||....... ....+......++ ..++.++.+||.+||..||++|
T Consensus 166 PE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R 243 (280)
T cd05608 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYP--DKFSPASKSFCEALLAKDPEKR 243 (280)
T ss_pred HHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCc--ccCCHHHHHHHHHHhcCCHHHh
Confidence 999999999999999999999999999999998754322 2222222322222 4589999999999999999999
Q ss_pred CCchh-hHHHHHcCCCCCCCChhhhcc--CCCCCCC
Q 035930 792 LGAVK-GAAEIKQHPFFEGLNWALIRC--AVPPELP 824 (857)
Q Consensus 792 pt~~~-~a~ELL~HPfF~~l~w~li~~--~~pp~~P 824 (857)
++... .++++++||||++++|..+.. ..||+.|
T Consensus 244 ~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~ 279 (280)
T cd05608 244 LGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279 (280)
T ss_pred cCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence 95432 489999999999999997643 4456665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=398.37 Aligned_cols=270 Identities=39% Similarity=0.691 Sum_probs=226.1
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHH-HHHHcCCCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE-IMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~Eie-ILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||+|+||+||+|++..++..||||++.+...........+..|.. +++.++||||++++++|.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999997654433333444555554 67889999999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~---------- 148 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE---------- 148 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC----------
Confidence 99988776543 489999999999999999999999999999999999999999999999998632000
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
.......++||+.|+
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 163 (321)
T cd05603 149 -----------------------------------------------------------------PEETTSTFCGTPEYL 163 (321)
T ss_pred -----------------------------------------------------------------CCCccccccCCcccC
Confidence 000112456899999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
|||++.+..++.++|||||||++|||++|..||.+.+..+.+..++.....++ +..+..+.+||.+||+.||.+|++.
T Consensus 164 aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~ 241 (321)
T cd05603 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP--GGKTVAACDLLVGLLHKDQRRRLGA 241 (321)
T ss_pred CHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHccCCHhhcCCC
Confidence 99999999999999999999999999999999998877777777776655554 4588999999999999999999997
Q ss_pred hhhHHHHHcCCCCCCCChhhhc--cCCCCCCC
Q 035930 795 VKGAAEIKQHPFFEGLNWALIR--CAVPPELP 824 (857)
Q Consensus 795 ~~~a~ELL~HPfF~~l~w~li~--~~~pp~~P 824 (857)
...+.++++|+||..++|..+. ...|+..|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T cd05603 242 KADFLEIKNHVFFSPINWDDLYHKRITPPYNP 273 (321)
T ss_pred CCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCC
Confidence 7778899999999999998653 33444444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=399.67 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=217.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccce-eeeeCCe-
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFA-HFTTEKF- 544 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~-~f~~~~~- 544 (857)
..+.+|+++++||.|.||+||++.+..+|..+|.|.++-+. .+.+..+.+..|+.+|++|+|||||++|+ .|.++..
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 34567999999999999999999999999999999998543 34556677899999999999999999999 4555554
Q ss_pred EEEEEeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHH--cC--ceeccCCCCcEEEccCCcEEEecccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHM--LG--VVYRDLKPENILVREDGHIMLSDFDL 618 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs--~G--IIHRDLKPeNILL~~dg~iKL~DFGL 618 (857)
++||||||.+|+|..+++.. ..+.++|..+|.++.|++.||.++|. .. |+||||||.||+++.+|.+||+||||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 89999999999998877643 34569999999999999999999998 44 99999999999999999999999999
Q ss_pred hhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccccc
Q 035930 619 SLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVE 698 (857)
Q Consensus 619 A~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~ 698 (857)
++.+...
T Consensus 175 ~r~l~s~------------------------------------------------------------------------- 181 (375)
T KOG0591|consen 175 GRFLSSK------------------------------------------------------------------------- 181 (375)
T ss_pred HhHhcch-------------------------------------------------------------------------
Confidence 8654211
Q ss_pred CCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHH
Q 035930 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARD 778 (857)
Q Consensus 699 ~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~d 778 (857)
.....+++|||.||+||.+.+.+|+.++|||||||+||||+.-..||.|.+-.+...+|.++.+..-....+|.++..
T Consensus 182 --~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~ 259 (375)
T KOG0591|consen 182 --TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRE 259 (375)
T ss_pred --hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHH
Confidence 112347899999999999999999999999999999999999999999997777778887776553222568999999
Q ss_pred HHHhhccCCcCCcCCc
Q 035930 779 LIRGLLVKEPDNRLGA 794 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~ 794 (857)
||..|+..||+.||+.
T Consensus 260 li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 260 LINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHccCCcccCCCc
Confidence 9999999999999984
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=389.56 Aligned_cols=271 Identities=30% Similarity=0.539 Sum_probs=223.2
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCCCh
Q 035930 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL 557 (857)
Q Consensus 478 LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL 557 (857)
||+|+||+||++++..+|+.||+|++.............+..|+++|+.++||||++++++|.++.+.|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999999765443333344556799999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCC
Q 035930 558 HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEE 637 (857)
Q Consensus 558 ~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~ 637 (857)
..++.......+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~------------ 148 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG------------ 148 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC------------
Confidence 88876655445899999999999999999999999999999999999999999999999987432100
Q ss_pred CCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChh
Q 035930 638 PPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPE 717 (857)
Q Consensus 638 p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPE 717 (857)
.......||+.|+|||
T Consensus 149 ----------------------------------------------------------------~~~~~~~~~~~y~aPE 164 (277)
T cd05607 149 ----------------------------------------------------------------KTITQRAGTNGYMAPE 164 (277)
T ss_pred ----------------------------------------------------------------ceeeccCCCCCccCHH
Confidence 0001235889999999
Q ss_pred hhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC----hhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCC
Q 035930 718 IIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN----DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLG 793 (857)
Q Consensus 718 il~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~----~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt 793 (857)
++.+..++.++|||||||++|||++|+.||..... .+...........++ ...++.++++||.+||.+||++||+
T Consensus 165 ~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~ 243 (277)
T cd05607 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAKKPEDRLG 243 (277)
T ss_pred HHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhccCHhhCCC
Confidence 99999999999999999999999999999976533 223333333333332 2458999999999999999999999
Q ss_pred chhhHHHHHcCCCCCCCChhhhc--cCCCCCCCC
Q 035930 794 AVKGAAEIKQHPFFEGLNWALIR--CAVPPELPR 825 (857)
Q Consensus 794 ~~~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~ 825 (857)
+....++++.||||.+++|..++ ...||++|+
T Consensus 244 ~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~ 277 (277)
T cd05607 244 SREKNDDPRKHEFFKTINFPRLEAGLIPPPFVPD 277 (277)
T ss_pred CccchhhhhcChhhcCCCHHHHhcCcCCCCCCCC
Confidence 65555889999999999999886 345666663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=398.72 Aligned_cols=262 Identities=39% Similarity=0.700 Sum_probs=222.2
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHH-HHHHcCCCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE-IMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~Eie-ILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||+|+||+||+|++..+++.||+|++.+...........+..|.. +++.++||||++++++|..++.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999997654332333334444444 57889999999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~---------- 148 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE---------- 148 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc----------
Confidence 99998887653 388999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
.......++||+.||
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 163 (325)
T cd05602 149 -----------------------------------------------------------------HNGTTSTFCGTPEYL 163 (325)
T ss_pred -----------------------------------------------------------------CCCCcccccCCcccc
Confidence 000112456999999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++ +.++..+.+||.+||++||.+|++.
T Consensus 164 aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~ 241 (325)
T cd05602 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--PNITNSARHLLEGLLQKDRTKRLGA 241 (325)
T ss_pred CHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC--CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 99999999999999999999999999999999998877777777776655443 4689999999999999999999998
Q ss_pred hhhHHHHHcCCCCCCCChhhhc
Q 035930 795 VKGAAEIKQHPFFEGLNWALIR 816 (857)
Q Consensus 795 ~~~a~ELL~HPfF~~l~w~li~ 816 (857)
...+.++++|+||..++|..+.
T Consensus 242 ~~~~~~i~~~~~~~~~~~~~~~ 263 (325)
T cd05602 242 KDDFMEIKNHIFFSPINWDDLI 263 (325)
T ss_pred CCCHHHHhcCcccCCCCHHHHH
Confidence 7778899999999999997663
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=398.12 Aligned_cols=261 Identities=39% Similarity=0.775 Sum_probs=221.6
Q ss_pred eEEccCCceEEEEEEEc---CCCeEEEEEEecccccc-cccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEee
Q 035930 476 KKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLV-GRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEY 551 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~---~tg~~VAVKvi~k~~~~-~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy 551 (857)
+.||+|+||.||++++. .+++.||||++.+.... .......+.+|+++|+.++||||++++++|..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999874 46889999999765332 223345667899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccC
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKS 631 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ 631 (857)
+++++|..++.... .+.+..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~------- 152 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH------- 152 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc-------
Confidence 99999998887653 388999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCC
Q 035930 632 SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711 (857)
Q Consensus 632 ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~ 711 (857)
........+||+
T Consensus 153 --------------------------------------------------------------------~~~~~~~~~gt~ 164 (323)
T cd05584 153 --------------------------------------------------------------------EGTVTHTFCGTI 164 (323)
T ss_pred --------------------------------------------------------------------CCCcccccCCCc
Confidence 000112346999
Q ss_pred CccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCc
Q 035930 712 EYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791 (857)
Q Consensus 712 ~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~R 791 (857)
.|+|||++.+..++.++|||||||+||||++|+.||.+.+....+..+......++ +.+++++.+||.+||.+||++|
T Consensus 165 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R 242 (323)
T cd05584 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP--PYLTPEARDLLKKLLKRNPSSR 242 (323)
T ss_pred cccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHcccCHhHc
Confidence 99999999999999999999999999999999999998877777777777665555 4589999999999999999999
Q ss_pred CCch-hhHHHHHcCCCCCCCChhhh
Q 035930 792 LGAV-KGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 792 pt~~-~~a~ELL~HPfF~~l~w~li 815 (857)
++.. ..++++++||||...+|..+
T Consensus 243 ~~~~~~~~~~l~~h~~~~~~~~~~~ 267 (323)
T cd05584 243 LGAGPGDAAEVQSHPFFRHVNWDDL 267 (323)
T ss_pred CCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 9321 12899999999999999765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=403.83 Aligned_cols=261 Identities=29% Similarity=0.461 Sum_probs=216.8
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC--eEEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK--FSCLV 548 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~--~l~LV 548 (857)
+|..++.||+|+||+||++.+..+|..+|||.+..... ...+.+.+|+.+|++|+|||||++++...... .+++.
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 46778999999999999999999999999999876521 11667899999999999999999999754443 79999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc-CCcEEEecccchhhcccCcc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE-DGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~-dg~iKL~DFGLA~r~~~~~~ 627 (857)
|||+++|+|.+++.+..+ .|++..++.+++||+.||+|||++|||||||||+|||++. +|.+||+|||++.+....
T Consensus 95 mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~-- 171 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK-- 171 (313)
T ss_pred eeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc--
Confidence 999999999999998775 6999999999999999999999999999999999999999 799999999998542210
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.........+
T Consensus 172 ----------------------------------------------------------------------~~~~~~~~~~ 181 (313)
T KOG0198|consen 172 ----------------------------------------------------------------------GTKSDSELSV 181 (313)
T ss_pred ----------------------------------------------------------------------cccccccccc
Confidence 0001122356
Q ss_pred cCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCC-CCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 708 VGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKG-SGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 708 vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g-~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
.||+.|||||++.+ ...+.++|||||||++.||+||+.||.. ....+.+..+......+..+..++.++++||.+||.
T Consensus 182 ~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~ 261 (313)
T KOG0198|consen 182 QGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFK 261 (313)
T ss_pred cCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhh
Confidence 79999999999996 2334599999999999999999999987 344444444544443334445699999999999999
Q ss_pred CCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 786 KEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
+||++||| |+++|+|||.....
T Consensus 262 ~~p~~Rpt----a~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 262 RDPEKRPT----AEELLEHPFLKQNS 283 (313)
T ss_pred cCcccCcC----HHHHhhChhhhccc
Confidence 99999999 99999999997643
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=396.34 Aligned_cols=278 Identities=44% Similarity=0.778 Sum_probs=222.8
Q ss_pred CeEEEeEEccCCceEEEEEEEc---CCCeEEEEEEecccccc-cccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLV-GRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~---~tg~~VAVKvi~k~~~~-~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l 545 (857)
+|++++.||+|+||+||++++. .+++.||+|++.+.... .....+.+..|+.+|+.+ +||||+.++++|..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 47889999999764322 223345678899999999 599999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+++|+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++..+...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 99999999999998887653 3899999999999999999999999999999999999999999999999987431100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
......
T Consensus 159 --------------------------------------------------------------------------~~~~~~ 164 (332)
T cd05614 159 --------------------------------------------------------------------------EKERTY 164 (332)
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 001112
Q ss_pred cccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCCh----hhhHHHhhccccCCCCCCCCHHHHHHH
Q 035930 706 SFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGND----ETLSNVVSQSLRFPGYPVVSFHARDLI 780 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~----e~l~~Iv~~~~~~p~~~~is~~l~dLI 780 (857)
.++||+.|||||++.+. .++.++|||||||+||||++|+.||...... .....+..... +....++..+++||
T Consensus 165 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li 242 (332)
T cd05614 165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP--PFPSFIGPEAQDLL 242 (332)
T ss_pred cccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHHHH
Confidence 45699999999999875 4789999999999999999999999754332 22233333322 33346899999999
Q ss_pred HhhccCCcCCcCCch-hhHHHHHcCCCCCCCChhhhc--cCCCCCCCCC
Q 035930 781 RGLLVKEPDNRLGAV-KGAAEIKQHPFFEGLNWALIR--CAVPPELPRS 826 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~ 826 (857)
.+||..||.+||++. ..++++++||||.+++|..+. ...+++.|..
T Consensus 243 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~ 291 (332)
T cd05614 243 HKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSI 291 (332)
T ss_pred HHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 999999999999531 138999999999999997664 3445555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=392.06 Aligned_cols=260 Identities=30% Similarity=0.538 Sum_probs=230.8
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..+.|.+.++||+|.|+.||++.+..+|+.||+|+++-..+... ..+.+.+|+.|-++|+||||++|.+.+..+...||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 34578889999999999999999999999999999987655443 77889999999999999999999999999999999
Q ss_pred EEeecCCCChH-HHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc---CCcEEEecccchhhcc
Q 035930 548 VMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE---DGHIMLSDFDLSLRCA 623 (857)
Q Consensus 548 VmEy~~gGsL~-~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~---dg~iKL~DFGLA~r~~ 623 (857)
|+|+|.|++|. +..++ -.++|..+-.+++||+.+|.|+|.+||||||+||+|+|+.. ..-+||+|||+|..+.
T Consensus 88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999999995 44444 23899999999999999999999999999999999999953 3469999999986432
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.+..
T Consensus 165 ----------------------------------------------------------------------------~g~~ 168 (355)
T KOG0033|consen 165 ----------------------------------------------------------------------------DGEA 168 (355)
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0111
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--CCCCCCHHHHHHHH
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--GYPVVSFHARDLIR 781 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--~~~~is~~l~dLI~ 781 (857)
...++|||+|||||++...+|+..+|||+-|||||-||.|++||.+.+...++++|.++.+.++ .++.+++++++||+
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvr 248 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIR 248 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHH
Confidence 2357899999999999999999999999999999999999999999999999999999888775 58899999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
+||..||.+|+| +.|+|+|||+.+-+
T Consensus 249 rML~~dP~kRIt----a~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 249 RMLTVNPKKRIT----ADEALKHPWICNRE 274 (355)
T ss_pred HHhccChhhhcc----HHHHhCCchhcchH
Confidence 999999999999 99999999997643
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=391.15 Aligned_cols=264 Identities=27% Similarity=0.380 Sum_probs=211.3
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|.+.+.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++.++...|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 3679999999999999999999999999999999875421 22334567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+ .++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---- 155 (303)
T cd07869 82 FEYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV---- 155 (303)
T ss_pred EECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC----
Confidence 9999 467777666543 3488999999999999999999999999999999999999999999999998732100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........+
T Consensus 156 -----------------------------------------------------------------------~~~~~~~~~ 164 (303)
T cd07869 156 -----------------------------------------------------------------------PSHTYSNEV 164 (303)
T ss_pred -----------------------------------------------------------------------CCccCCCCc
Confidence 000012345
Q ss_pred CCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCCh-hhhHHHhhcccc-----C------C--------
Q 035930 709 GTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVSQSLR-----F------P-------- 767 (857)
Q Consensus 709 GT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~-e~l~~Iv~~~~~-----~------p-------- 767 (857)
||+.|+|||++.+. .++.++|||||||+||||++|..||.+..+. +.+..+...... + +
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (303)
T cd07869 165 VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFT 244 (303)
T ss_pred ccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccccc
Confidence 89999999998764 5789999999999999999999999875432 222222210000 0 0
Q ss_pred -----------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhh
Q 035930 768 -----------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 768 -----------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li 815 (857)
....++.++++||.+||+.||.+||+ +.++|+||||..+.+.++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s----~~~~l~h~~f~~~~~~~~ 299 (303)
T cd07869 245 LYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS----AQAALSHEYFSDLPPRLW 299 (303)
T ss_pred ccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC----HHHHhcCcccccCChhhh
Confidence 00124578999999999999999999 999999999999876554
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=409.80 Aligned_cols=262 Identities=37% Similarity=0.581 Sum_probs=237.6
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~ 546 (857)
....|.+.+.||.|.||.||+|+.+.+|..||+|++.+.........+.+.+|+.||+.+. |||||.++++|++...+|
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3467999999999999999999999999999999999887766667788999999999998 999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc----CCcEEEecccchhhc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE----DGHIMLSDFDLSLRC 622 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~----dg~iKL~DFGLA~r~ 622 (857)
+|||+|.||.|.+.+... . +++..+..++.||+.++.|||+.||+||||||+|||+.. ++.+|++|||++...
T Consensus 113 lvmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 999999999999988876 2 999999999999999999999999999999999999954 357999999998542
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
. .+.
T Consensus 190 ~----------------------------------------------------------------------------~~~ 193 (382)
T KOG0032|consen 190 K----------------------------------------------------------------------------PGE 193 (382)
T ss_pred c----------------------------------------------------------------------------CCc
Confidence 1 122
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--CCCCCCHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--GYPVVSFHARDLI 780 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--~~~~is~~l~dLI 780 (857)
.....+||+.|+|||++.+.+|+..+||||+||++|.|++|..||.+.+..+....+....+.|+ .++.++..+++||
T Consensus 194 ~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i 273 (382)
T KOG0032|consen 194 RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFI 273 (382)
T ss_pred eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHH
Confidence 34567899999999999999999999999999999999999999999999999999999887664 5788999999999
Q ss_pred HhhccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
++||..||.+|++ +.++|+|||+.+...
T Consensus 274 ~~ll~~dp~~R~t----a~~~L~HpWi~~~~~ 301 (382)
T KOG0032|consen 274 RKLLEFDPRKRLT----AAQALQHPWIKSIGE 301 (382)
T ss_pred HHhcccCcccCCC----HHHHhcCccccCCcc
Confidence 9999999999999 999999999887533
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=385.06 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=211.5
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+.+.||+|+||+||+|++..++..||||++..... .......+.+|+++++.++||||++++++|..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 369999999999999999999999999999999975422 2334456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++++.+..+.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---- 153 (287)
T cd07848 80 EYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG---- 153 (287)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc----
Confidence 999888776554432 34899999999999999999999999999999999999999999999999997432100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.........|
T Consensus 154 ----------------------------------------------------------------------~~~~~~~~~~ 163 (287)
T cd07848 154 ----------------------------------------------------------------------SNANYTEYVA 163 (287)
T ss_pred ----------------------------------------------------------------------cccccccccc
Confidence 0001123468
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-------------------ccCCC--
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-------------------LRFPG-- 768 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-------------------~~~p~-- 768 (857)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.... ..++.
T Consensus 164 ~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (287)
T cd07848 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVN 243 (287)
T ss_pred ccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCccc
Confidence 999999999999999999999999999999999999998876544443332211 11111
Q ss_pred ---------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 769 ---------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 769 ---------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
...++.++.+||++||++||++||+ ++++|+||||
T Consensus 244 ~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s----~~~~l~hp~f 287 (287)
T cd07848 244 HPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL----TEQCLNHPAF 287 (287)
T ss_pred CcccHHHhhhcccCHHHHHHHHHHccCCcccCCC----HHHHhcCCCC
Confidence 1236788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=393.45 Aligned_cols=281 Identities=36% Similarity=0.733 Sum_probs=248.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l 545 (857)
+++.+|.++++||.|+|.+|.+++++.+.+.||+|+++++.....+.++-++.|..+..+. +||++|-|..+|+++..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 6788999999999999999999999999999999999999888888888899999988766 699999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
++|.||++||+|-.+++++. .++++.+++|..+|+.||.|||+.|||+||||.+|+|++..|++||+|+|+++.-
T Consensus 327 ffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~--- 401 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--- 401 (593)
T ss_pred EEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC---
Confidence 99999999999977776654 3999999999999999999999999999999999999999999999999986420
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
-..+..+.
T Consensus 402 ------------------------------------------------------------------------l~~gd~ts 409 (593)
T KOG0695|consen 402 ------------------------------------------------------------------------LGPGDTTS 409 (593)
T ss_pred ------------------------------------------------------------------------CCCCcccc
Confidence 00123456
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCC-------CChh-hhHHHhhccccCCCCCCCCHHHH
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGS-------GNDE-TLSNVVSQSLRFPGYPVVSFHAR 777 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~-------~~~e-~l~~Iv~~~~~~p~~~~is~~l~ 777 (857)
+|||||.|+|||+++|..|++.+|||+|||++|||+.|+.||+-- +.++ .++-|+...+++|.. ++-.+.
T Consensus 410 tfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs--lsvkas 487 (593)
T KOG0695|consen 410 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS--LSVKAS 487 (593)
T ss_pred cccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce--eehhhH
Confidence 899999999999999999999999999999999999999999731 2222 345566777888754 777888
Q ss_pred HHHHhhccCCcCCcCCchh--hHHHHHcCCCCCCCChhhhc--cCCCCCCCCC
Q 035930 778 DLIRGLLVKEPDNRLGAVK--GAAEIKQHPFFEGLNWALIR--CAVPPELPRS 826 (857)
Q Consensus 778 dLI~k~L~~DPe~Rpt~~~--~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~ 826 (857)
.+++..|.+||.+|+++.+ ++.++..|+||+.++|+++. ...||+.|..
T Consensus 488 ~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i 540 (593)
T KOG0695|consen 488 HVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQI 540 (593)
T ss_pred HHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCcc
Confidence 9999999999999999865 68999999999999999985 5789999974
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=387.21 Aligned_cols=256 Identities=29% Similarity=0.422 Sum_probs=212.0
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
+++|.+.+.||.|+||+||+|.+..++..||+|+++... .......+.+|+.+|+.++||||+++++++.+++..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 568999999999999999999999999999999997542 122334678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||++ ++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--- 156 (288)
T cd07871 82 FEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--- 156 (288)
T ss_pred EeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC---
Confidence 99996 58988776543 34789999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 157 ------------------------------------------------------------------------~~~~~~~~ 164 (288)
T cd07871 157 ------------------------------------------------------------------------TKTYSNEV 164 (288)
T ss_pred ------------------------------------------------------------------------CccccCce
Confidence 00012235
Q ss_pred CCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-------------------cCCC
Q 035930 709 GTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-------------------RFPG 768 (857)
Q Consensus 709 GT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-------------------~~p~ 768 (857)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..... .++.
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
T cd07871 165 VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQ 244 (288)
T ss_pred ecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCc
Confidence 7899999999876 5689999999999999999999999998776666554433110 0111
Q ss_pred ---------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 769 ---------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 769 ---------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.+.++.+++|||++||++||.+|+| ++|+|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t----~~~~l~hp~f 288 (288)
T cd07871 245 YRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS----AEAALRHSYF 288 (288)
T ss_pred cCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC----HHHHhcCCCC
Confidence 1346789999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=385.77 Aligned_cols=279 Identities=34% Similarity=0.580 Sum_probs=229.2
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|++.+.||+|+||+||++.+..+++.||||.+.............+.+|+.+|++++|+||+.+++.+.++++.|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999876543333334556789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE------ 154 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC------
Confidence 99999999888655444589999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
........||
T Consensus 155 ----------------------------------------------------------------------~~~~~~~~g~ 164 (285)
T cd05630 155 ----------------------------------------------------------------------GQTIKGRVGT 164 (285)
T ss_pred ----------------------------------------------------------------------CccccCCCCC
Confidence 0001133689
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh---hhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND---ETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~---e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
+.|+|||++.+..++.++|||||||++|+|++|+.||...... +....+... ........+++++++||++||+.|
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~ 243 (285)
T cd05630 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARSLCKMLLCKD 243 (285)
T ss_pred ccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHHHHHHHhhcC
Confidence 9999999999999999999999999999999999999875432 222222221 111223458899999999999999
Q ss_pred cCCcCCch-hhHHHHHcCCCCCCCChhhhcc--CCCCCCCCC
Q 035930 788 PDNRLGAV-KGAAEIKQHPFFEGLNWALIRC--AVPPELPRS 826 (857)
Q Consensus 788 Pe~Rpt~~-~~a~ELL~HPfF~~l~w~li~~--~~pp~~P~~ 826 (857)
|++|+++. ..++++++||||.+++|..++. ..|++.|++
T Consensus 244 p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05630 244 PKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP 285 (285)
T ss_pred HHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCCC
Confidence 99999842 1378999999999999998764 557888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=399.79 Aligned_cols=270 Identities=29% Similarity=0.425 Sum_probs=235.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
...++|++..+||.|.-++||+|+...++..||||+++-+... ..++.+++|+..|+.++||||++++..|..+..+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 5668999999999999999999999999999999999877543 44788999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||.||.+|++.+++.......|.|..+..++++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+..+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999999988777779999999999999999999999999999999999999999999999999863321100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
...-.++++
T Consensus 181 -----------------------------------------------------------------------~R~~~rf~t 189 (516)
T KOG0582|consen 181 -----------------------------------------------------------------------DRQVTRFNT 189 (516)
T ss_pred -----------------------------------------------------------------------ceeeEeecc
Confidence 001122367
Q ss_pred ccCCCCccChhhhc--CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--------CCCCCHHH
Q 035930 707 FVGTHEYLAPEIIK--GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--------YPVVSFHA 776 (857)
Q Consensus 707 ~vGT~~YmAPEil~--g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--------~~~is~~l 776 (857)
++||+.|||||+++ ..+|++++||||||++..||.+|..||....+...+...++...+.+. ...++..+
T Consensus 190 fvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf 269 (516)
T KOG0582|consen 190 FVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSF 269 (516)
T ss_pred ccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHH
Confidence 89999999999975 457899999999999999999999999999888888777776654332 34466789
Q ss_pred HHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 777 RDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 777 ~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
+++|..||++||.+||+ ++++|+|+||+...-.
T Consensus 270 ~e~i~~CL~kDP~kRpt----AskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 270 REMIALCLVKDPSKRPT----ASKLLKHAFFKKAKSK 302 (516)
T ss_pred HHHHHHHhhcCcccCCC----HHHHhccHHHhhccch
Confidence 99999999999999999 9999999999976543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=394.58 Aligned_cols=270 Identities=42% Similarity=0.780 Sum_probs=227.0
Q ss_pred eEEccCCceEEEEEEEc---CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeec
Q 035930 476 KKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYC 552 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~---~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~ 552 (857)
+.||+|+||+||++++. .++..||+|++...... ......+.+|+++|+.++||||++++++|.+++.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 67999999999999863 57899999999765322 223445678999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCC
Q 035930 553 PGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSS 632 (857)
Q Consensus 553 ~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~s 632 (857)
++|+|..++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~-------- 150 (318)
T cd05582 81 RGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-------- 150 (318)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--------
Confidence 9999998886653 489999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCC
Q 035930 633 SPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHE 712 (857)
Q Consensus 633 s~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~ 712 (857)
........+||+.
T Consensus 151 -------------------------------------------------------------------~~~~~~~~~g~~~ 163 (318)
T cd05582 151 -------------------------------------------------------------------HEKKAYSFCGTVE 163 (318)
T ss_pred -------------------------------------------------------------------CCCceecccCChh
Confidence 0001124569999
Q ss_pred ccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcC
Q 035930 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRL 792 (857)
Q Consensus 713 YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rp 792 (857)
|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++.+||++||+.||++||
T Consensus 164 y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~~P~~R~ 241 (318)
T cd05582 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRALFKRNPANRL 241 (318)
T ss_pred hcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHhHcC
Confidence 99999999999999999999999999999999999988777777777776665553 4899999999999999999999
Q ss_pred Cchh-hHHHHHcCCCCCCCChhhhcc--CCCCCCCC
Q 035930 793 GAVK-GAAEIKQHPFFEGLNWALIRC--AVPPELPR 825 (857)
Q Consensus 793 t~~~-~a~ELL~HPfF~~l~w~li~~--~~pp~~P~ 825 (857)
++.. .+.++++||||..++|..+.. ..|++.|.
T Consensus 242 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (318)
T cd05582 242 GAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPA 277 (318)
T ss_pred CCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCC
Confidence 9543 378899999999999987642 33455443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=405.57 Aligned_cols=262 Identities=31% Similarity=0.419 Sum_probs=220.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC--Ce
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE--KF 544 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~--~~ 544 (857)
.....|+.+++||+|.||.||+|++..+|+.||+|.+..+.. .........+||.||++|+||||++|.+...+. ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 344578999999999999999999999999999999976632 233344568999999999999999999998877 68
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|||+|||++ ||..++... .-.|++.+++.|+.||+.||+|||.+||+|||||..|||||.+|.+||+|||||+.+..
T Consensus 193 iYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999999955 676666543 23499999999999999999999999999999999999999999999999999965321
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
+ .....
T Consensus 271 ~--------------------------------------------------------------------------~~~~~ 276 (560)
T KOG0600|consen 271 S--------------------------------------------------------------------------GSAPY 276 (560)
T ss_pred C--------------------------------------------------------------------------CCccc
Confidence 1 11123
Q ss_pred ccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc----------ccCCC-----
Q 035930 705 NSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS----------LRFPG----- 768 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~----------~~~p~----- 768 (857)
++.+-|++|+|||+|+|. .|+.++|+||.||||.||+.|++.|.|.+.-+.+..|..-- ..+|.
T Consensus 277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~k 356 (560)
T KOG0600|consen 277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFK 356 (560)
T ss_pred ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccC
Confidence 566789999999999986 48999999999999999999999999998888888877511 11111
Q ss_pred ------------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 769 ------------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 769 ------------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
...++..+.+|+..||..||.+|.| |.++|+|+||..
T Consensus 357 p~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t----A~~aL~seyF~t 405 (560)
T KOG0600|consen 357 PQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT----ASSALQSEYFTT 405 (560)
T ss_pred CCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc----HHHHhcCccccc
Confidence 2456778999999999999999999 999999999943
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=400.36 Aligned_cols=257 Identities=32% Similarity=0.550 Sum_probs=236.3
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
.+|++.+.||.|.||.|-+|.....|+.||||.|+++.+.+...+-.+.+|++||..|+||||+.+|++|++.+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 46999999999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||..+|.|++|+..... |++.+++.+++||..|+.|+|.++|+|||||.+|||+|.++++||+||||+-.+.
T Consensus 133 EYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~------ 204 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA------ 204 (668)
T ss_pred EecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc------
Confidence 99999999999988754 9999999999999999999999999999999999999999999999999973221
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
......+|||
T Consensus 205 ----------------------------------------------------------------------~~kfLqTFCG 214 (668)
T KOG0611|consen 205 ----------------------------------------------------------------------DKKFLQTFCG 214 (668)
T ss_pred ----------------------------------------------------------------------cccHHHHhcC
Confidence 1122357899
Q ss_pred CCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 710 THEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 710 T~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
+|-|.+||++.|.+| +..+|.|||||+||.|++|..||+|.+....+++|-.+.++-|. .+.++.-||+.||..+|
T Consensus 215 SPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~PSdA~gLIRwmLmVNP 291 (668)
T KOG0611|consen 215 SPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---TPSDASGLIRWMLMVNP 291 (668)
T ss_pred CcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---CCchHHHHHHHHHhcCc
Confidence 999999999999999 88999999999999999999999999988888888888887765 57789999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
++|.| +++|-.|=|. ||.-
T Consensus 292 ~RRAT----ieDiAsHWWv---Nwgy 310 (668)
T KOG0611|consen 292 ERRAT----IEDIASHWWV---NWGY 310 (668)
T ss_pred ccchh----HHHHhhhhee---eccc
Confidence 99999 9999999775 6763
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=411.94 Aligned_cols=256 Identities=28% Similarity=0.467 Sum_probs=225.8
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
..|....+||+|+.|.||.|....++..||||.++... ....+.+.+|+.+|+..+|+|||++++.|..++.+++||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 46889999999999999999999999999999997653 334455799999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|||+||+|.+.+.... ++|.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||++..+.
T Consensus 350 Eym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~------ 420 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS------ 420 (550)
T ss_pred eecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccc------
Confidence 9999999999887654 9999999999999999999999999999999999999999999999999963321
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
....+..+.+|
T Consensus 421 ---------------------------------------------------------------------~~~~KR~TmVG 431 (550)
T KOG0578|consen 421 ---------------------------------------------------------------------EEQSKRSTMVG 431 (550)
T ss_pred ---------------------------------------------------------------------cccCccccccC
Confidence 01113456789
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh-ccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS-QSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~-~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
||+|||||++....|+.++||||||++++||+-|++||...++...+..|.. +..++.....+++.++|||.+||+.|+
T Consensus 432 TPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv 511 (550)
T KOG0578|consen 432 TPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDV 511 (550)
T ss_pred CCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcch
Confidence 9999999999999999999999999999999999999997666555555544 445566677899999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l 810 (857)
++|++ |.|||+||||...
T Consensus 512 ~~Ras----A~eLL~HpFl~~a 529 (550)
T KOG0578|consen 512 EQRAS----AKELLEHPFLKMA 529 (550)
T ss_pred hcCCC----HHHHhcChhhhhc
Confidence 99999 9999999999543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=377.11 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=220.9
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
.+|..+++||+|.||+||+|++..+|+.||||.++..... ......+.+|+.+|+.++|+||+.|+++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 4688899999999999999999999999999999765322 122345789999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||| ..+|+..++... ..+....++.|+.+++.||+|||.++|+||||||.|+|++.+|.+||+|||||+.+..
T Consensus 81 Efm-~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~----- 153 (318)
T KOG0659|consen 81 EFM-PTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS----- 153 (318)
T ss_pred Eec-cccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC-----
Confidence 999 679988887654 4599999999999999999999999999999999999999999999999999964311
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.+......+-
T Consensus 154 ----------------------------------------------------------------------p~~~~~~~V~ 163 (318)
T KOG0659|consen 154 ----------------------------------------------------------------------PNRIQTHQVV 163 (318)
T ss_pred ----------------------------------------------------------------------CCccccccee
Confidence 1111223367
Q ss_pred CCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-----cCCC---------------
Q 035930 710 THEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-----RFPG--------------- 768 (857)
Q Consensus 710 T~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-----~~p~--------------- 768 (857)
|.+|+|||+++|.. |+..+||||.|||+.||+-|.+.|.|.++-+.+..|+.... .||+
T Consensus 164 TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~ 243 (318)
T KOG0659|consen 164 TRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPK 243 (318)
T ss_pred eeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCC
Confidence 99999999999865 89999999999999999999999999998888888775221 1111
Q ss_pred ------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 769 ------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 769 ------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.+..+.++.||+.+||.+||.+|++ +.|+|+|+||...
T Consensus 244 ~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit----a~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 244 PPLNNLFPAASSDALDLLSKMLTYNPKKRIT----ASQALKHPYFKSL 287 (318)
T ss_pred CccccccccccHHHHHHHHhhhccCchhccc----HHHHhcchhhhcC
Confidence 2456778999999999999999999 9999999999864
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=380.07 Aligned_cols=280 Identities=33% Similarity=0.562 Sum_probs=231.2
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|+..+.||.|+||+||++.+..+++.||+|++.............+.+|+++|++++|+||+.++++|..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999976544333444557889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|..++.......+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE------ 154 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC------
Confidence 99999998887655444599999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
........|+
T Consensus 155 ----------------------------------------------------------------------~~~~~~~~g~ 164 (285)
T cd05632 155 ----------------------------------------------------------------------GESIRGRVGT 164 (285)
T ss_pred ----------------------------------------------------------------------CCcccCCCCC
Confidence 0001133589
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc--cCCCCCCCCHHHHHHHHhhccCCc
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL--RFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~--~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
+.|+|||++.+..++.++|+|||||++|||++|..||.+.........+..... .......++..+.+||..||..||
T Consensus 165 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 244 (285)
T cd05632 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDP 244 (285)
T ss_pred cCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCH
Confidence 999999999999999999999999999999999999987655433333322111 112234588899999999999999
Q ss_pred CCcCCchh-hHHHHHcCCCCCCCChhhhc--cCCCCCCCCC
Q 035930 789 DNRLGAVK-GAAEIKQHPFFEGLNWALIR--CAVPPELPRS 826 (857)
Q Consensus 789 e~Rpt~~~-~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~ 826 (857)
++||++.. .+.++++|+||..++|..++ ...|+++|.+
T Consensus 245 ~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05632 245 KQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP 285 (285)
T ss_pred hHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCCC
Confidence 99999643 47899999999999998764 4567888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=412.72 Aligned_cols=285 Identities=36% Similarity=0.658 Sum_probs=259.4
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
..+.+.+++++..||-|+||.|-++........+|+|++++..+...+..+.+..|..||..++.|+||+||-.|.++.+
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 34667789999999999999999999887777799999999888888888999999999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+||+||-|-||.|+..+..+.. |++..+++|+..++.|++|||.+|||+|||||+|.|++.+|.+||.|||+|+...
T Consensus 495 vYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~- 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG- 571 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc-
Confidence 9999999999999998877644 9999999999999999999999999999999999999999999999999996531
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
.+.++
T Consensus 572 ---------------------------------------------------------------------------~g~KT 576 (732)
T KOG0614|consen 572 ---------------------------------------------------------------------------SGRKT 576 (732)
T ss_pred ---------------------------------------------------------------------------cCCce
Confidence 23456
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
.+|||||.|.|||++++.+|+.++|.|+||+++||||+|.+||.+.++..++..|+++.-.+..+..++..+.+||+++.
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LC 656 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLC 656 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHH
Confidence 78999999999999999999999999999999999999999999999999999999876655555679999999999999
Q ss_pred cCCcCCcCCch-hhHHHHHcCCCCCCCChhhhc--cCCCCCCCCCC
Q 035930 785 VKEPDNRLGAV-KGAAEIKQHPFFEGLNWALIR--CAVPPELPRSC 827 (857)
Q Consensus 785 ~~DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~~ 827 (857)
..+|.+|++.. .++.+|.+|-||.++||..++ ...||++|...
T Consensus 657 r~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va 702 (732)
T KOG0614|consen 657 RDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVA 702 (732)
T ss_pred hcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCC
Confidence 99999999975 479999999999999999885 57788888653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=384.59 Aligned_cols=266 Identities=25% Similarity=0.368 Sum_probs=222.1
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccch-hHHHHHHHHHHHcCCCCccccceeeee--
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKM-PRAQTEREIMQMLDHPFLPTLFAHFTT-- 541 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~-~~~~~EieILr~L~HPnIV~L~~~f~~-- 541 (857)
+|-..+.|+.+.+|++|.||.||+|+++.+++.||+|.++.+. ....+ -...+|+.+|..++|||||.+-++..-
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek--ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK--EKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc--ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 4556678999999999999999999999999999999998663 22222 245899999999999999999887753
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
-+.+||||||| .-+|..++.... ..|...+++.++.|++.||+|||.++|+||||||+|+|+.+.|.+||+|||||+.
T Consensus 149 ~d~iy~VMe~~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 149 MDKIYIVMEYV-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred cceeeeeHHHH-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence 45799999999 458888888765 4599999999999999999999999999999999999999999999999999965
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
+..- -
T Consensus 227 ygsp---------------------------------------------------------------------------~ 231 (419)
T KOG0663|consen 227 YGSP---------------------------------------------------------------------------L 231 (419)
T ss_pred hcCC---------------------------------------------------------------------------c
Confidence 3110 0
Q ss_pred CccccccCCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-----------------
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS----------------- 763 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~----------------- 763 (857)
...+..+-|.+|+|||+++|.+ |+.++||||+|||+.||+++++.|.|.+..+.+..|+...
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 0123456799999999999865 8999999999999999999999999999888888887521
Q ss_pred --ccCCC---------CC--CCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 764 --LRFPG---------YP--VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 764 --~~~p~---------~~--~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
..++. +. .++....+|++.+|.+||.+|.| |++.|+|+||.+....
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t----A~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT----AEDGLKHEYFRETPLP 370 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc----HHHhhcccccccCCCC
Confidence 11111 11 14578889999999999999999 9999999999986433
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=386.61 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=210.4
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-----CeE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE-----KFS 545 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~-----~~l 545 (857)
+|++.+.||+|+||.||+|.+..++..||||++.... ........+.+|+++|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987432 1223345678999999999999999999988643 358
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+ +++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999999 578988877653 3899999999999999999999999999999999999999999999999997431100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
. .......
T Consensus 157 ~------------------------------------------------------------------------~~~~~~~ 164 (338)
T cd07859 157 T------------------------------------------------------------------------PTAIFWT 164 (338)
T ss_pred c------------------------------------------------------------------------Ccccccc
Confidence 0 0000112
Q ss_pred cccCCCCccChhhhcC--CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh----------------------
Q 035930 706 SFVGTHEYLAPEIIKG--EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS---------------------- 761 (857)
Q Consensus 706 s~vGT~~YmAPEil~g--~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~---------------------- 761 (857)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 165 ~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 244 (338)
T cd07859 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYL 244 (338)
T ss_pred CCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHH
Confidence 4579999999999976 6789999999999999999999999987654332221110
Q ss_pred ----ccccC---CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 762 ----QSLRF---PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 762 ----~~~~~---p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
..... ...+.+++.+.+||.+||..||++||+ ++++|+||||.++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 245 SSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT----AEEALADPYFKGLAKV 299 (338)
T ss_pred HhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC----HHHHhcCchhhhcCcc
Confidence 00000 012457788999999999999999999 9999999999987664
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=401.16 Aligned_cols=262 Identities=32% Similarity=0.510 Sum_probs=235.8
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
.-|.+.+.||+|.|.+|-+|++..+|..|||||+++..+.. .....+..|+..|+.++|||||+||++..+...+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 35889999999999999999999999999999998875532 22345788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc-CCcEEEecccchhhcccCccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE-DGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~-dg~iKL~DFGLA~r~~~~~~l 628 (857)
|+-++|+|++|+.+... .+.|+.++.|++||+.|+.|+|+..||||||||+||++-+ -|-+||+|||++-.+.
T Consensus 97 ELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~----- 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ----- 170 (864)
T ss_pred EecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-----
Confidence 99999999999988764 4999999999999999999999999999999999998865 5899999999873211
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.+...+++|
T Consensus 171 -----------------------------------------------------------------------PG~kL~TsC 179 (864)
T KOG4717|consen 171 -----------------------------------------------------------------------PGKKLTTSC 179 (864)
T ss_pred -----------------------------------------------------------------------Ccchhhccc
Confidence 123456789
Q ss_pred CCCCccChhhhcCCCCCc-ccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGHGS-SVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~-ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
|...|-|||+++|..|+. ++||||||||||-|++|+.||...+..+++..|+...+..|.. ++.+++|||..||+.|
T Consensus 180 GSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPsh--vS~eCrdLI~sMLvRd 257 (864)
T KOG4717|consen 180 GSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSH--VSKECRDLIQSMLVRD 257 (864)
T ss_pred chhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchh--hhHHHHHHHHHHHhcC
Confidence 999999999999999965 8999999999999999999999999999999999998888764 9999999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCCCCChhhh
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l~w~li 815 (857)
|.+|.+ +++|..|+|++.++..+-
T Consensus 258 PkkRAs----lEeI~s~~Wlq~~D~~~s 281 (864)
T KOG4717|consen 258 PKKRAS----LEEIVSTSWLQAGDRGLS 281 (864)
T ss_pred chhhcc----HHHHhccccccCCCCCcc
Confidence 999999 999999999999987654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=403.58 Aligned_cols=255 Identities=27% Similarity=0.362 Sum_probs=204.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCC------CCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH------PFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~H------PnIV~L~~~f~ 540 (857)
...++|+++++||+|+||+||+|.+..+++.||||+++.. .........|+++++.+.| .+|+.++++|.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3457899999999999999999999999999999999643 1223345678888877754 45888888887
Q ss_pred eC-CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCC---------
Q 035930 541 TE-KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDG--------- 609 (857)
Q Consensus 541 ~~-~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg--------- 609 (857)
.+ .++|||||++ |++|.+++.+.. .+++..++.++.||+.||+|||. .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 65 5899999999 888888776653 48999999999999999999997 6999999999999998765
Q ss_pred -------cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhh
Q 035930 610 -------HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIK 682 (857)
Q Consensus 610 -------~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~ 682 (857)
.+||+|||++...
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~------------------------------------------------------------ 298 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDE------------------------------------------------------------ 298 (467)
T ss_pred ccCCCCceEEECCCCccccC------------------------------------------------------------
Confidence 4999999975210
Q ss_pred hhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhc
Q 035930 683 SDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762 (857)
Q Consensus 683 ~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~ 762 (857)
......++||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+...
T Consensus 299 ------------------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 299 ------------------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred ------------------ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 00112457999999999999999999999999999999999999999987765554443322
Q ss_pred cccCCC----------------------------------------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHH
Q 035930 763 SLRFPG----------------------------------------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 763 ~~~~p~----------------------------------------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL 802 (857)
...+|. .....+.+.|||.+||++||++||+ ++|+|
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----a~e~L 436 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN----ARQMT 436 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC----HHHHh
Confidence 111110 0012456789999999999999999 99999
Q ss_pred cCCCCCCC
Q 035930 803 QHPFFEGL 810 (857)
Q Consensus 803 ~HPfF~~l 810 (857)
+||||...
T Consensus 437 ~Hp~~~~~ 444 (467)
T PTZ00284 437 THPYVLKY 444 (467)
T ss_pred cCcccccc
Confidence 99999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=397.73 Aligned_cols=249 Identities=29% Similarity=0.478 Sum_probs=214.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC-eEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK-FSCLV 548 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~-~l~LV 548 (857)
..+.+.+.||.|+||+||+|.+.++. .||||++......... ...+.+|+.+|.+++|||||.|++++.+.. .++||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 34556667999999999999997653 3999999866443333 678999999999999999999999999988 79999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC-ceeccCCCCcEEEccCC-cEEEecccchhhcccCc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG-VVYRDLKPENILVREDG-HIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G-IIHRDLKPeNILL~~dg-~iKL~DFGLA~r~~~~~ 626 (857)
|||+++|+|..+++......+++..+..|+.||++||+|||+++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 99999999999998743456999999999999999999999999 99999999999999998 99999999985421100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
...+.
T Consensus 199 ---------------------------------------------------------------------------~~~~~ 203 (362)
T KOG0192|consen 199 ---------------------------------------------------------------------------TSMTS 203 (362)
T ss_pred ---------------------------------------------------------------------------ccccC
Confidence 01122
Q ss_pred ccCCCCccChhhhc--CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 707 FVGTHEYLAPEIIK--GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 707 ~vGT~~YmAPEil~--g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
..||+.|||||++. ...|+.++||||||++||||+||+.||.+....+....++....+.+.+..+++.+..||..||
T Consensus 204 ~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW 283 (362)
T KOG0192|consen 204 VAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCW 283 (362)
T ss_pred CCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhC
Confidence 56999999999999 5699999999999999999999999999998877777777777777766669999999999999
Q ss_pred cCCcCCcCCch
Q 035930 785 VKEPDNRLGAV 795 (857)
Q Consensus 785 ~~DPe~Rpt~~ 795 (857)
..||..||++.
T Consensus 284 ~~dp~~RP~f~ 294 (362)
T KOG0192|consen 284 LVDPSRRPSFL 294 (362)
T ss_pred CCCCCcCCCHH
Confidence 99999999953
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=404.06 Aligned_cols=320 Identities=33% Similarity=0.589 Sum_probs=252.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+....|..++.||-|+||.|.++.-..|..+||+|.+++..+..+.....+..|.+||..-+.+-||+||..|.+++.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 44456999999999999999999999999999999999887777777888899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc--cc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC--AV 624 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~--~~ 624 (857)
+||+|++||++-.++-+. ..|.|+.+++|+++|.+|+++.|..|+|||||||+|||||.+|||||+||||+.-+ ..
T Consensus 706 FVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999997776654 34999999999999999999999999999999999999999999999999998433 22
Q ss_pred CcccccCCC-CCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 625 NPMVVKSSS-PVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 625 ~~~l~~~ss-~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
+.-.+..+. .-.+. .-..+.|....-....+...+..+. ....
T Consensus 784 dskYYq~gdH~RqDS-----------------mep~~e~~d~~~~lkvL~~ra~~~h-------------------~r~~ 827 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDS-----------------MEPSPEWADISKCLKVLERRAMRQH-------------------QRIL 827 (1034)
T ss_pred ccccccCCCcccccc-----------------CCCchhhccccccchHHHHHHHhhh-------------------hhhh
Confidence 211111111 00000 0011112111111222221111100 1112
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh--ccccCCCCCCCCHHHHHHHH
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~--~~~~~p~~~~is~~l~dLI~ 781 (857)
..+.+||+.|+|||+|...+|+..+|||+.|||||||+.|+.||-.....++..+++. ..+.++....+++++.+||.
T Consensus 828 ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~ 907 (1034)
T KOG0608|consen 828 AHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQ 907 (1034)
T ss_pred hhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHH
Confidence 3467999999999999999999999999999999999999999998887777666543 45667777789999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRS 826 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~ 826 (857)
+|. .+++.|++ ..++++|+.||||++|+|.-||....|-+|+.
T Consensus 908 kLc-~sad~RLG-kng~d~vKaHpfFkgIDfsslRkq~ApYIP~I 950 (1034)
T KOG0608|consen 908 KLC-CSADSRLG-KNGADQVKAHPFFKGIDFSSLRKQRAPYIPRI 950 (1034)
T ss_pred HHh-cChhhhhc-ccchhhhhcCccccccchHhhhhccCCcCccc
Confidence 865 58999998 46788899999999999999987776777764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=385.69 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=215.4
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|++.+.||.|+||.||++++..++..||+|++.... .......+.+|+++|+.++||||+++++++..++.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999987542 22334568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML-GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~-GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
||||+++++|..++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 156 (331)
T ss_pred EeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc--
Confidence 999999999999987654 389999999999999999999985 699999999999999999999999998732100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.....
T Consensus 157 ---------------------------------------------------------------------------~~~~~ 161 (331)
T cd06649 157 ---------------------------------------------------------------------------SMANS 161 (331)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00123
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHH---------------------------
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV--------------------------- 759 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~I--------------------------- 759 (857)
..||+.|+|||++.+..++.++|||||||+||||++|+.||......+....+
T Consensus 162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVS 241 (331)
T ss_pred CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccccc
Confidence 46899999999999999999999999999999999999999765433221111
Q ss_pred -------------------hhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 760 -------------------VSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 760 -------------------v~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
............++.++++||.+||.+||++||+ +.+|++||||.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~~~ 309 (331)
T cd06649 242 GHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERAD----LKMLMNHTFIKRSEV 309 (331)
T ss_pred ccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCC----HHHHhcChHHhhccc
Confidence 0010111112347889999999999999999999 999999999986544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=373.83 Aligned_cols=256 Identities=27% Similarity=0.389 Sum_probs=208.9
Q ss_pred CCeEEEeEEccCCceEEEEEEEcC-CCeEEEEEEecccccccccchhHHHHHHHHHHHc---CCCCccccceeee-----
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIG-TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML---DHPFLPTLFAHFT----- 540 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~-tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L---~HPnIV~L~~~f~----- 540 (857)
++|++.+.||+|+||+||+|++.. ++..||||+++..... ......+.+|+.+++.+ +||||++++++|.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 379999999999999999999864 4688999998754321 22233456788877766 6999999999885
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
....+|+||||++ ++|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457899999995 689888876655568999999999999999999999999999999999999999999999999874
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
.....
T Consensus 159 ~~~~~--------------------------------------------------------------------------- 163 (290)
T cd07862 159 IYSFQ--------------------------------------------------------------------------- 163 (290)
T ss_pred eccCC---------------------------------------------------------------------------
Confidence 21100
Q ss_pred CCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-----CC--------
Q 035930 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-----FP-------- 767 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-----~p-------- 767 (857)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..++..... ++
T Consensus 164 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (290)
T cd07862 164 -MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 242 (290)
T ss_pred -cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccch
Confidence 0112346899999999999999999999999999999999999999988777777666542110 00
Q ss_pred ------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 768 ------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 768 ------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
..+.++..+++||.+||+.||++||+ +.++|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~hp~f 290 (290)
T cd07862 243 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYF 290 (290)
T ss_pred hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC----HHHHhcCCCC
Confidence 01346788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=374.02 Aligned_cols=275 Identities=41% Similarity=0.760 Sum_probs=234.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||.|+||.||++.+..+++.||+|++.............+.+|+++|++++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36999999999999999999999999999999997654444455677889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|..++.... .+++..++.++.||+.||.|||+.||+||||+|.|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~----- 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG----- 153 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC-----
Confidence 9999999999887663 489999999999999999999999999999999999999999999999998743100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
......|
T Consensus 154 -------------------------------------------------------------------------~~~~~~~ 160 (290)
T cd05580 154 -------------------------------------------------------------------------RTYTLCG 160 (290)
T ss_pred -------------------------------------------------------------------------CCCCCCC
Confidence 0112358
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+......++ ..++..+++||.+||..||.
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~ 238 (290)
T cd05580 161 TPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP--SFFSPDAKDLIRNLLQVDLT 238 (290)
T ss_pred CccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC--ccCCHHHHHHHHHHccCCHH
Confidence 8999999999988899999999999999999999999988776666666665555554 34799999999999999999
Q ss_pred CcCCch-hhHHHHHcCCCCCCCChhhhc--cCCCCCCCCC
Q 035930 790 NRLGAV-KGAAEIKQHPFFEGLNWALIR--CAVPPELPRS 826 (857)
Q Consensus 790 ~Rpt~~-~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~ 826 (857)
+|+++. ..++++++||||..+.|..+. ...+|+.|..
T Consensus 239 ~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (290)
T cd05580 239 KRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKV 278 (290)
T ss_pred HccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCC
Confidence 999432 348999999999999997664 2334555543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=407.82 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=218.3
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CC-----CccccceeeeeCCe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HP-----FLPTLFAHFTTEKF 544 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HP-----nIV~L~~~f~~~~~ 544 (857)
+|.+++.||+|+||+|.+|++.+|++.||||++++. .........|+.||..|+ |. |||+++++|...+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 899999999999999999999999999999999876 455667788999999997 43 89999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC--cEEEecccchhhc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG--HIMLSDFDLSLRC 622 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg--~iKL~DFGLA~r~ 622 (857)
+|||+|++ ..+|+++++.+.-.+|+...++.++.||+.||.+||++||||+|||||||||...+ .|||+|||.|...
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 88999999988888899999999999999999999999999999999999997544 6999999987220
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
+.
T Consensus 342 ------------------------------------------------------------------------------~q 343 (586)
T KOG0667|consen 342 ------------------------------------------------------------------------------SQ 343 (586)
T ss_pred ------------------------------------------------------------------------------CC
Confidence 01
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC---------------
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--------------- 767 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--------------- 767 (857)
..-+++.+..|+|||+|+|.+|+.+.||||||||++||++|.+.|.|.+..+.+..|++-...+|
T Consensus 344 ~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~ 423 (586)
T KOG0667|consen 344 RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFT 423 (586)
T ss_pred cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehh
Confidence 11266789999999999999999999999999999999999999999988888877764111000
Q ss_pred ------C----------------------------CC------------CCCHHHHHHHHhhccCCcCCcCCchhhHHHH
Q 035930 768 ------G----------------------------YP------------VVSFHARDLIRGLLVKEPDNRLGAVKGAAEI 801 (857)
Q Consensus 768 ------~----------------------------~~------------~is~~l~dLI~k~L~~DPe~Rpt~~~~a~EL 801 (857)
. .+ .....+.|||.+||.+||.+|+| ..++
T Consensus 424 ~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t----p~qa 499 (586)
T KOG0667|consen 424 SLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT----PAQA 499 (586)
T ss_pred ccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC----HHHH
Confidence 0 01 11234789999999999999999 9999
Q ss_pred HcCCCCCCC
Q 035930 802 KQHPFFEGL 810 (857)
Q Consensus 802 L~HPfF~~l 810 (857)
|+||||.+.
T Consensus 500 l~Hpfl~~~ 508 (586)
T KOG0667|consen 500 LNHPFLTGT 508 (586)
T ss_pred hcCcccccc
Confidence 999999964
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=386.50 Aligned_cols=260 Identities=27% Similarity=0.423 Sum_probs=220.8
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee-----CCe
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT-----EKF 544 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~-----~~~ 544 (857)
++|..++.||.|+||.|+.+.++.+|..||||.+...+ ......++..+|+.+|+.++|+||+.+++++.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 46777899999999999999999999999999987543 445667888999999999999999999999876 357
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|+|+|+| +.+|+..++.+.. ++++.++.+++||++||.|+|+.+|+||||||.|+|++.+..+||+|||||+....
T Consensus 101 vYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 89999999 8899999987654 99999999999999999999999999999999999999999999999999954211
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
. +.....
T Consensus 178 ~-------------------------------------------------------------------------~~~~~m 184 (359)
T KOG0660|consen 178 F-------------------------------------------------------------------------FEDGFM 184 (359)
T ss_pred c-------------------------------------------------------------------------Ccccch
Confidence 0 011223
Q ss_pred ccccCCCCccChhhhc-CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc--------------------
Q 035930 705 NSFVGTHEYLAPEIIK-GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-------------------- 763 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~-g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-------------------- 763 (857)
+.++-|.+|+|||++. ...|+.++||||+|||+.|||+|++.|.|.+.-+.+..|+.-.
T Consensus 185 TeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi 264 (359)
T KOG0660|consen 185 TEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYI 264 (359)
T ss_pred hcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHH
Confidence 5678899999999875 5679999999999999999999999999987666655554311
Q ss_pred ---ccCC------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 764 ---LRFP------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 764 ---~~~p------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
...| ..+..++.+.||+.+||..||.+|+| ++|+|.||||.++
T Consensus 265 ~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit----a~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 265 KSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT----AEEALAHPYLAPY 316 (359)
T ss_pred HhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC----HHHHhcChhhhhh
Confidence 1111 14678899999999999999999999 9999999999874
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=381.47 Aligned_cols=265 Identities=30% Similarity=0.484 Sum_probs=230.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccc-----ccchhHHHHHHHHHHHc-CCCCccccceeeeeCC
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG-----RKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEK 543 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~-----~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~ 543 (857)
..|...+.||.|..++|.+|.++.++..+|+|++....... ....+....|+.||+++ .||+|++|.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 56888899999999999999999999999999986432211 11233457799999998 5999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
.+++|+|.|+.|.|.+++...-. ++|...+.+++|++.|++|||.++||||||||+|||++++.+++|+|||+|..+.
T Consensus 97 F~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999999999987644 9999999999999999999999999999999999999999999999999984321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.+.+
T Consensus 175 ----------------------------------------------------------------------------~Gek 178 (411)
T KOG0599|consen 175 ----------------------------------------------------------------------------PGEK 178 (411)
T ss_pred ----------------------------------------------------------------------------Cchh
Confidence 2334
Q ss_pred cccccCCCCccChhhhcC------CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC--CCCCCCCHH
Q 035930 704 SNSFVGTHEYLAPEIIKG------EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF--PGYPVVSFH 775 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g------~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~--p~~~~is~~ 775 (857)
....||||+|+|||.+.. .+|+..+|+|++|||+|-||.|.+||......-.++.|+++.+.| |.|..++..
T Consensus 179 LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~ 258 (411)
T KOG0599|consen 179 LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISAT 258 (411)
T ss_pred HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhcccc
Confidence 557799999999999864 468889999999999999999999999887778889999998877 567889999
Q ss_pred HHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhc
Q 035930 776 ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIR 816 (857)
Q Consensus 776 l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~ 816 (857)
++|||.+||+.||++|+| ++|+|.||||.++-...-+
T Consensus 259 ~KdLIsrlLqVdp~~Rit----ake~LaHpff~q~~~~~~r 295 (411)
T KOG0599|consen 259 VKDLISRLLQVDPTKRIT----AKEALAHPFFIQIAQQQAR 295 (411)
T ss_pred HHHHHHHHHeeCchhccc----HHHHhcChHHHHHHHhccc
Confidence 999999999999999999 9999999999765443333
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=392.93 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=206.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+...+|.+++.||+|+||.||+|.+..+++.||||+... ..+.+|+++|+.|+||||++++++|..+...|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 455789999999999999999999999999999997542 23578999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+|||++ +++|..++.... .+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||+|.....
T Consensus 160 lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~-- 234 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD-- 234 (391)
T ss_pred EEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc--
Confidence 999999 578887776543 389999999999999999999999999999999999999999999999999732100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
........
T Consensus 235 ------------------------------------------------------------------------~~~~~~~~ 242 (391)
T PHA03212 235 ------------------------------------------------------------------------INANKYYG 242 (391)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00011124
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC-------hhhhHHHhhcc----------------
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-------DETLSNVVSQS---------------- 763 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~-------~e~l~~Iv~~~---------------- 763 (857)
++||+.|+|||++.+..|+.++|||||||+||||++|..||.+... ...+..++...
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 5799999999999999999999999999999999999988764321 11122121110
Q ss_pred ----------ccCCC-------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 764 ----------LRFPG-------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 764 ----------~~~p~-------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
...+. ...++.++.+||.+||++||++||+ +.|+|+||||..+
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt----a~elL~hp~f~~~ 382 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS----AEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC----HHHHhcChhhccC
Confidence 00000 1124668999999999999999999 9999999999874
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=400.49 Aligned_cols=258 Identities=29% Similarity=0.436 Sum_probs=208.5
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-----
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE----- 542 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~----- 542 (857)
..++|.+++.||+|+||+||+|.+..+++.||||++... .....+|+.+|+.++||||++++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-------cchHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 446899999999999999999999999999999988543 12345799999999999999999887532
Q ss_pred ---CeEEEEEeecCCCChHHHHhh--CCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC-cEEEecc
Q 035930 543 ---KFSCLVMEYCPGGDLHVLRQK--QPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG-HIMLSDF 616 (857)
Q Consensus 543 ---~~l~LVmEy~~gGsL~~ll~~--~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg-~iKL~DF 616 (857)
..+|+||||++ ++|..++.. .....+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 25789999996 467665542 1234589999999999999999999999999999999999998765 6999999
Q ss_pred cchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccc
Q 035930 617 DLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLV 696 (857)
Q Consensus 617 GLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~ 696 (857)
|+|+.+..
T Consensus 216 Gla~~~~~------------------------------------------------------------------------ 223 (440)
T PTZ00036 216 GSAKNLLA------------------------------------------------------------------------ 223 (440)
T ss_pred ccchhccC------------------------------------------------------------------------
Confidence 99853210
Q ss_pred ccCCCCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc------------
Q 035930 697 VEPTGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS------------ 763 (857)
Q Consensus 697 ~~~~~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~------------ 763 (857)
......++||+.|||||++.+. .|+.++|||||||+||||++|.+||.+....+.+..++...
T Consensus 224 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 224 ----GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred ----CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence 0011234689999999998764 68999999999999999999999999887766665554321
Q ss_pred -----ccCCC----------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 764 -----LRFPG----------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 764 -----~~~p~----------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
+.++. +...+.++++||.+||.+||.+||+ +.|+|+||||..+.+.
T Consensus 300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t----a~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN----PIEALADPFFDDLRDP 360 (440)
T ss_pred hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC----HHHHhCChhHHhhhcc
Confidence 11121 1236789999999999999999999 9999999999987654
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=375.07 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=212.9
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|.+.+.||+|+||+||+|++..++..||||+++.... ......+.+|+++++.++||||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4689999999999999999999999999999999875422 22334567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||++ ++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 83 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 157 (309)
T cd07872 83 FEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--- 157 (309)
T ss_pred EeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC---
Confidence 99996 57877766543 34889999999999999999999999999999999999999999999999987321000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 158 ------------------------------------------------------------------------~~~~~~~~ 165 (309)
T cd07872 158 ------------------------------------------------------------------------TKTYSNEV 165 (309)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00011235
Q ss_pred CCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-------------------ccCC-
Q 035930 709 GTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-------------------LRFP- 767 (857)
Q Consensus 709 GT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-------------------~~~p- 767 (857)
+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.... ..++
T Consensus 166 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (309)
T cd07872 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPK 245 (309)
T ss_pred ccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCc
Confidence 7899999999876 458999999999999999999999998876655544443210 1111
Q ss_pred --------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 768 --------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 768 --------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
..+.++.++++||.+||..||.+|++ +.|+|+||||+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~~ 293 (309)
T cd07872 246 YKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS----AEEAMKHAYFRSLG 293 (309)
T ss_pred cCCCchhhhccCCCHHHHHHHHHhccCChhhCCC----HHHHhcChhhhhcc
Confidence 12357889999999999999999999 99999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=387.43 Aligned_cols=255 Identities=28% Similarity=0.394 Sum_probs=206.4
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
..+|.+++.||.|+||+||+|.+..+++.||||++.... .......+.+|+++|+.++|+||++++++|..++.+|+|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 456788899999999999999999999999999986542 223345678999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+.+++|.... .+.+..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||++......
T Consensus 151 ~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--- 221 (353)
T PLN00034 151 LEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--- 221 (353)
T ss_pred EecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc---
Confidence 9999999985432 2567788899999999999999999999999999999999999999999987431100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.......+
T Consensus 222 ------------------------------------------------------------------------~~~~~~~~ 229 (353)
T PLN00034 222 ------------------------------------------------------------------------MDPCNSSV 229 (353)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00012346
Q ss_pred CCCCccChhhhcC-----CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHH--hhccccCCCCCCCCHHHHHHHH
Q 035930 709 GTHEYLAPEIIKG-----EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV--VSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 709 GT~~YmAPEil~g-----~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~I--v~~~~~~p~~~~is~~l~dLI~ 781 (857)
||..|+|||++.. ..++.++|||||||+||||++|+.||......+....+ ............++.++++||.
T Consensus 230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 309 (353)
T PLN00034 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFIS 309 (353)
T ss_pred cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHH
Confidence 8999999998843 33467899999999999999999999854333222111 1122222334568899999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+||..||++||+ +.|||+||||.+-
T Consensus 310 ~~l~~~P~~Rpt----~~ell~hp~~~~~ 334 (353)
T PLN00034 310 CCLQREPAKRWS----AMQLLQHPFILRA 334 (353)
T ss_pred HHccCChhhCcC----HHHHhcCcccccC
Confidence 999999999999 9999999999874
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=367.08 Aligned_cols=255 Identities=28% Similarity=0.406 Sum_probs=207.2
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc---CCCCccccceeeee-----C
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML---DHPFLPTLFAHFTT-----E 542 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L---~HPnIV~L~~~f~~-----~ 542 (857)
+|++.+.||+|+||+||+|++..+++.||+|+++..... ......+.+|+++++.+ +||||++++++|.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 589999999999999999999999999999998754221 22223456777777665 69999999998864 3
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
..+++||||++ ++|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 46899999996 58888887665556899999999999999999999999999999999999999999999999987321
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
... .
T Consensus 159 ~~~----------------------------------------------------------------------------~ 162 (288)
T cd07863 159 SCQ----------------------------------------------------------------------------M 162 (288)
T ss_pred cCc----------------------------------------------------------------------------c
Confidence 000 0
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-----cCC----------
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-----RFP---------- 767 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-----~~p---------- 767 (857)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+..... .++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07863 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAF 242 (288)
T ss_pred cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccccccc
Confidence 01123588999999999999999999999999999999999999988766665555443110 000
Q ss_pred ----------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 768 ----------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 768 ----------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
..+.++..+.+||.+||++||++||+ +.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~~~l~hp~f 288 (288)
T cd07863 243 SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS----AFRALQHPFF 288 (288)
T ss_pred CCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 01356788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=367.89 Aligned_cols=271 Identities=34% Similarity=0.586 Sum_probs=222.0
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCCCh
Q 035930 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL 557 (857)
Q Consensus 478 LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL 557 (857)
||+|+||+||+|.+..+++.||+|++.............+..|+++|+.++||||++++++|...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765443344455667899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCC
Q 035930 558 HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEE 637 (857)
Q Consensus 558 ~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~ 637 (857)
..++.......+++..++.++.||+.||.|||..||+||||+|+|||++.++.++|+|||++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------------- 147 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------------- 147 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-------------
Confidence 9888776544689999999999999999999999999999999999999999999999998743110
Q ss_pred CCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChh
Q 035930 638 PPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPE 717 (857)
Q Consensus 638 p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPE 717 (857)
........++..|+|||
T Consensus 148 ---------------------------------------------------------------~~~~~~~~~~~~y~~PE 164 (277)
T cd05577 148 ---------------------------------------------------------------GKKIKGRAGTPGYMAPE 164 (277)
T ss_pred ---------------------------------------------------------------CCccccccCCCCcCCHH
Confidence 00011234788999999
Q ss_pred hhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc--ccCCCCCCCCHHHHHHHHhhccCCcCCcCCch
Q 035930 718 IIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS--LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV 795 (857)
Q Consensus 718 il~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~--~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~ 795 (857)
++.+..++.++|||||||++|+|++|+.||...........+.... ........+++++.+||.+||..||.+||+..
T Consensus 165 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 244 (277)
T cd05577 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCR 244 (277)
T ss_pred HhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCC
Confidence 9998889999999999999999999999998764422222222111 12223345799999999999999999999655
Q ss_pred h-hHHHHHcCCCCCCCChhhhcc--CCCCCCC
Q 035930 796 K-GAAEIKQHPFFEGLNWALIRC--AVPPELP 824 (857)
Q Consensus 796 ~-~a~ELL~HPfF~~l~w~li~~--~~pp~~P 824 (857)
. .+.++++||||..++|..+.. ..||+.|
T Consensus 245 ~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 245 GGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred cccHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence 4 599999999999999987753 3466655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=382.36 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=208.4
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC------
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE------ 542 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~------ 542 (857)
.++|.+.+.||+|+||.||++.+..+++.||||++.... ........+.+|+.+++.++||||++++++|...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 468999999999999999999999999999999997543 2233445678899999999999999999988643
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
..+|+||||++ ++|..++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 36799999995 567666643 2788999999999999999999999999999999999999999999999997421
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.. ..
T Consensus 177 ~~----------------------------------------------------------------------------~~ 180 (364)
T cd07875 177 GT----------------------------------------------------------------------------SF 180 (364)
T ss_pred CC----------------------------------------------------------------------------CC
Confidence 00 00
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-----------------
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR----------------- 765 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~----------------- 765 (857)
.....+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..+.+..++.....
T Consensus 181 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (364)
T cd07875 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260 (364)
T ss_pred cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHH
Confidence 012346899999999999999999999999999999999999999887765555554431110
Q ss_pred -------------------CC----CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 766 -------------------FP----GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 766 -------------------~p----~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
++ .....+..+++||.+||..||.+||| +.++|+||||..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t----~~e~L~hp~~~~ 323 (364)
T cd07875 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINV 323 (364)
T ss_pred hhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCC----HHHHhcCccccc
Confidence 00 01123567899999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=382.44 Aligned_cols=255 Identities=28% Similarity=0.454 Sum_probs=206.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC-----
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK----- 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~----- 543 (857)
.++|++.+.||+|+||+||++.+..++..||||++.... ........+.+|+.+|+.++||||++++++|...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 478999999999999999999999999999999997542 22334556789999999999999999999986543
Q ss_pred -eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 544 -FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 544 -~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
.+|+||||+.+ +|..++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++...
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999954 56555532 2788999999999999999999999999999999999999999999999987321
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.. ..
T Consensus 174 ~~----------------------------------------------------------------------------~~ 177 (359)
T cd07876 174 CT----------------------------------------------------------------------------NF 177 (359)
T ss_pred cc----------------------------------------------------------------------------Cc
Confidence 00 00
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhc--------------------
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ-------------------- 762 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~-------------------- 762 (857)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..++..
T Consensus 178 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (359)
T cd07876 178 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV 257 (359)
T ss_pred cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence 012346899999999999999999999999999999999999999876544333222211
Q ss_pred --cccCC------------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 763 --SLRFP------------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 763 --~~~~p------------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
...++ .....+.++++||.+||..||++||+ +.|+|+||||..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~ 320 (359)
T cd07876 258 ENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS----VDEALRHPYITV 320 (359)
T ss_pred hhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCC----HHHHhcCchhhh
Confidence 11110 01124578999999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=370.65 Aligned_cols=294 Identities=37% Similarity=0.645 Sum_probs=237.9
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
.+|.+.+.||.|+||.||++.+..+++.||||.+.............+.+|+++++.++||||+++++.+..++++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999987654333445567789999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++|++|..++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|+|||+++........
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~- 157 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT- 157 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc-
Confidence 9999999999987653 4899999999999999999999999999999999999999999999999987421100000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
..+.. . ..............|
T Consensus 158 -----------------------------------~~~~~-~-----------------------~~~~~~~~~~~~~~~ 178 (305)
T cd05609 158 -----------------------------------NLYEG-H-----------------------IEKDTREFLDKQVCG 178 (305)
T ss_pred -----------------------------------ccccc-c-----------------------cccchhhccccCCcc
Confidence 00000 0 000000001123458
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCC-CCCCHHHHHHHHhhccCCc
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGY-PVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~-~~is~~l~dLI~k~L~~DP 788 (857)
+..|+|||++.+..++.++|+|||||++|||++|..||.+....+.+..+......++.. ..++.++++||.+||..||
T Consensus 179 ~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 258 (305)
T cd05609 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNP 258 (305)
T ss_pred CccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccCh
Confidence 899999999999899999999999999999999999999887777777777665555443 3578999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRS 826 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~ 826 (857)
++||++ ..+.++|+||||...+|+.+.......+|..
T Consensus 259 ~~R~~~-~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~ 295 (305)
T cd05609 259 LERLGT-GGAFEVKQHRFFLGLDWNGLLRQKAEFIPQL 295 (305)
T ss_pred hhccCc-cCHHHHHhCccccCCCHHHHhhcCCCCCCCC
Confidence 999984 3478999999999999987655555556654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=378.77 Aligned_cols=258 Identities=21% Similarity=0.320 Sum_probs=207.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc-----CCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI-----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~-----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~ 540 (857)
+..++|++.+.||.|+||+||+|.+. .++..||||++.... .......+.+|+.+|+.+ +||||++++++|.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 55678999999999999999999863 345689999987542 223345688999999999 8999999999887
Q ss_pred eC-CeEEEEEeecCCCChHHHHhhCC------------------------------------------------------
Q 035930 541 TE-KFSCLVMEYCPGGDLHVLRQKQP------------------------------------------------------ 565 (857)
Q Consensus 541 ~~-~~l~LVmEy~~gGsL~~ll~~~~------------------------------------------------------ 565 (857)
.. +.+|+||||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 46899999999999998886531
Q ss_pred ------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCC
Q 035930 566 ------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPP 639 (857)
Q Consensus 566 ------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~ 639 (857)
...+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++......+.
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~------------ 229 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------------ 229 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc------------
Confidence 12377888899999999999999999999999999999999999999999999743211000
Q ss_pred CCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhh
Q 035930 640 PKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEII 719 (857)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil 719 (857)
........+++.|||||++
T Consensus 230 -------------------------------------------------------------~~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 230 -------------------------------------------------------------YVRKGSARLPLKWMAPESI 248 (338)
T ss_pred -------------------------------------------------------------hhcccCCCCCccccCcHHh
Confidence 0001123467889999999
Q ss_pred cCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhH
Q 035930 720 KGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGA 798 (857)
Q Consensus 720 ~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a 798 (857)
.+..++.++|||||||+||||++ |..||.+....+.+...+...........+++.+.+||.+||..||.+||+ +
T Consensus 249 ~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~ 324 (338)
T cd05102 249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT----F 324 (338)
T ss_pred hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC----H
Confidence 99999999999999999999997 999998876555555555444444444568899999999999999999999 6
Q ss_pred HHHHc
Q 035930 799 AEIKQ 803 (857)
Q Consensus 799 ~ELL~ 803 (857)
.+|++
T Consensus 325 ~el~~ 329 (338)
T cd05102 325 SALVE 329 (338)
T ss_pred HHHHH
Confidence 77664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=379.01 Aligned_cols=258 Identities=25% Similarity=0.387 Sum_probs=212.4
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|++.+.||.|+||+||++.+..++..+|+|++.... .......+.+|+++|+.++||||++++++|.+++++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 4578999999999999999999999999999999987542 22334567899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML-GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~-GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
||||+++++|.+++.... .+++..++.++.||+.||.|||.. +|+||||||+|||++.+|.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-- 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 156 (333)
T ss_pred EEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh--
Confidence 999999999999887653 389999999999999999999974 799999999999999999999999998743100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.....
T Consensus 157 ---------------------------------------------------------------------------~~~~~ 161 (333)
T cd06650 157 ---------------------------------------------------------------------------SMANS 161 (333)
T ss_pred ---------------------------------------------------------------------------hcccc
Confidence 00113
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHH----------------------------
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN---------------------------- 758 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~---------------------------- 758 (857)
+.||..|+|||++.+..++.++|||||||++|||++|+.||......+....
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (333)
T cd06650 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSY 241 (333)
T ss_pred CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhh
Confidence 4589999999999999999999999999999999999999976543222110
Q ss_pred ----------------HhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 759 ----------------VVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 759 ----------------Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+............++.++++||.+||++||++||+ +.||+.||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~ 305 (333)
T cd06650 242 GPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRS 305 (333)
T ss_pred cccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcC----HHHHhhCHHHhcC
Confidence 00000000011236788999999999999999999 9999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=380.80 Aligned_cols=255 Identities=31% Similarity=0.516 Sum_probs=211.6
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-----CeE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE-----KFS 545 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~-----~~l 545 (857)
.|.-.+++|.|.||.||.|....++..||||.+-.+ .+. -.+|++||++++|||||+|..+|... -+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 588899999999999999999999999999987544 222 25799999999999999998888632 256
Q ss_pred EEEEeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC-CcEEEecccchhhc
Q 035930 546 CLVMEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED-GHIMLSDFDLSLRC 622 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d-g~iKL~DFGLA~r~ 622 (857)
.|||||| ..+|+.+++.. ....++.-.++.|++||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+
T Consensus 98 nlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 7899999 56887776632 12348888999999999999999999999999999999999987 89999999998653
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.. +.
T Consensus 177 ~~----------------------------------------------------------------------------~e 180 (364)
T KOG0658|consen 177 VK----------------------------------------------------------------------------GE 180 (364)
T ss_pred cc----------------------------------------------------------------------------CC
Confidence 21 11
Q ss_pred ccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhc-----------------cc
Q 035930 703 RSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ-----------------SL 764 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~-----------------~~ 764 (857)
...+++-|..|+|||.++|. .|+.+.||||.||++.||+-|++.|.|.+..+++..|++- ..
T Consensus 181 pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~ 260 (364)
T KOG0658|consen 181 PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEF 260 (364)
T ss_pred CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence 22466789999999999986 4899999999999999999999999998887777777641 11
Q ss_pred cCCC----------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 765 RFPG----------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 765 ~~p~----------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
++|. ...+++++.||+.++|.++|.+|.+ +.|+|.||||..+--.
T Consensus 261 ~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~----~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 261 KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS----ALEALAHPFFDELRDP 315 (364)
T ss_pred cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC----HHHHhcchhhHHhhCc
Confidence 2221 2457889999999999999999999 9999999999877433
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=381.99 Aligned_cols=262 Identities=22% Similarity=0.335 Sum_probs=212.2
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEc--CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELI--GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~--~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
...+|.+++.||.|+||.||+|... .++..||+|.+... ....+|+++|+.++||||++++++|..+...
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3468999999999999999999764 35678999988643 2346899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+ +++|..++... ..+++..++.++.||+.||.|||++|||||||||+|||++.++.++|+|||++......
T Consensus 162 ~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999 57888777543 34899999999999999999999999999999999999999999999999997432110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
. ......
T Consensus 239 ~-------------------------------------------------------------------------~~~~~~ 245 (392)
T PHA03207 239 P-------------------------------------------------------------------------DTPQCY 245 (392)
T ss_pred c-------------------------------------------------------------------------cccccc
Confidence 0 000112
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh---hhhHHHhhc----cccCC-----------
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND---ETLSNVVSQ----SLRFP----------- 767 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~---e~l~~Iv~~----~~~~p----------- 767 (857)
.++||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.... ..+..++.. ...++
T Consensus 246 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 325 (392)
T PHA03207 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHF 325 (392)
T ss_pred ccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHH
Confidence 457999999999999999999999999999999999999999876432 222222211 00000
Q ss_pred --------------C---CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhcc
Q 035930 768 --------------G---YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRC 817 (857)
Q Consensus 768 --------------~---~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~ 817 (857)
. ...++.++++||.+||..||++||+ +.|+|+||||....|..++.
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps----a~e~l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 326 KQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS----AQDILSLPLFTKEPINLLNI 388 (392)
T ss_pred HhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC----HHHHhhCchhhccchhhhcC
Confidence 0 0234678999999999999999999 99999999999999988753
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=382.95 Aligned_cols=261 Identities=25% Similarity=0.364 Sum_probs=212.1
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC-----eE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK-----FS 545 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~-----~l 545 (857)
+|++++.||+|+||+||++.+..+++.||||++.... ........+.+|+++|+.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4788999999999999999999999999999986532 12233456789999999999999999999998776 88
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+. ++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 99999995 67877775543 4899999999999999999999999999999999999999999999999987431100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (372)
T cd07853 157 --------------------------------------------------------------------------ESKHMT 162 (372)
T ss_pred --------------------------------------------------------------------------ccccCC
Confidence 000012
Q ss_pred cccCCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhc----------------------
Q 035930 706 SFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ---------------------- 762 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~---------------------- 762 (857)
..++|+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 242 (372)
T cd07853 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILR 242 (372)
T ss_pred CCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHh
Confidence 235789999999998754 799999999999999999999999887665554443321
Q ss_pred -cccCC-------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 763 -SLRFP-------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 763 -~~~~p-------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
....+ .....+.++.+||.+||..||++||+ +.++|+||||.+..+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~~ 297 (372)
T cd07853 243 GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS----AADALAHPYLDEGRLR 297 (372)
T ss_pred CCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC----HHHHhcCHhhCCCcch
Confidence 11111 12346789999999999999999999 9999999999986554
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=357.65 Aligned_cols=260 Identities=28% Similarity=0.417 Sum_probs=219.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc--cccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV--GRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~--~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
++|.+.+.||+|+||.||+|.+..++..||||++...... .......+.+|+++++.++||||+++++++.+++..|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999999999999999998654221 12234567889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999999998887653 388999999999999999999999999999999999999999999999998743210000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
........
T Consensus 160 ------------------------------------------------------------------------~~~~~~~~ 167 (263)
T cd06625 160 ------------------------------------------------------------------------SGTGMKSV 167 (263)
T ss_pred ------------------------------------------------------------------------ccccccCC
Confidence 00001234
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
.|+..|+|||++.+..++.++|||||||++|||++|+.||......+.+..+............++..+.+||++||..+
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 247 (263)
T cd06625 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVEN 247 (263)
T ss_pred CcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcC
Confidence 57889999999999999999999999999999999999998776666555555554444444568999999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF 807 (857)
|.+||+ +.++++||||
T Consensus 248 p~~Rpt----~~~ll~~~~~ 263 (263)
T cd06625 248 AKKRPS----AEELLRHFFV 263 (263)
T ss_pred cccCCC----HHHHhhCCCC
Confidence 999999 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=374.47 Aligned_cols=262 Identities=28% Similarity=0.430 Sum_probs=219.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCC-ccccceeeeeCC----
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF-LPTLFAHFTTEK---- 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn-IV~L~~~f~~~~---- 543 (857)
...|..+++||+|+||+||+|+.+.+|..||+|.++-+... +..-....+|+.+|+.|+|+| |+.|++++.+++
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 34577778899999999999999999999999999765321 223345689999999999999 999999999887
Q ss_pred --eEEEEEeecCCCChHHHHhhCCC--CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 544 --FSCLVMEYCPGGDLHVLRQKQPS--RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 544 --~l~LVmEy~~gGsL~~ll~~~~~--~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
.++|||||+ .-+|..++...+. ..++...++.+++||+.||+|||++||+||||||.||||+.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 7799988887653 35888999999999999999999999999999999999999999999999998
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
+..... .
T Consensus 168 ra~~ip-------------~------------------------------------------------------------ 174 (323)
T KOG0594|consen 168 RAFSIP-------------M------------------------------------------------------------ 174 (323)
T ss_pred HHhcCC-------------c------------------------------------------------------------
Confidence 532110 0
Q ss_pred CCCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc--------------
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-------------- 764 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-------------- 764 (857)
.....-++|.+|+|||++.|. .|+..+||||+|||++||++++..|.+....+.+..|..-..
T Consensus 175 --~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~ 252 (323)
T KOG0594|consen 175 --RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLP 252 (323)
T ss_pred --ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccc
Confidence 002344689999999999998 689999999999999999999999999988888877765211
Q ss_pred ----cCCCC----------CCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 765 ----RFPGY----------PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 765 ----~~p~~----------~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
.|+.+ +...++..||+.+||+++|.+|.+ ++.+|.||||..+.
T Consensus 253 ~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S----a~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 253 DYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS----AKGALTHPYFSELP 309 (323)
T ss_pred cccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC----HHHHhcChhhcccc
Confidence 11111 223358899999999999999999 99999999999873
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=391.79 Aligned_cols=259 Identities=29% Similarity=0.469 Sum_probs=232.4
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe-EEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF-SCL 547 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~-l~L 547 (857)
+++|..++.+|.|+||.+++++++..+..|++|.+.-.....+ .......|+.+++++.|||||.+++.|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 4689999999999999999999999999999999987654433 33467899999999999999999999999887 999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||+||+||+|.+.+.++.+..|+++.+..|+.||+.||.|||++.|+|||||+.||+++.++.|+|+|||+|+.+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-- 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-- 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--
Confidence 999999999999998887778999999999999999999999999999999999999999999999999999653211
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.....+.
T Consensus 160 -------------------------------------------------------------------------~~~a~tv 166 (426)
T KOG0589|consen 160 -------------------------------------------------------------------------DSLASTV 166 (426)
T ss_pred -------------------------------------------------------------------------hhhhhee
Confidence 1123467
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
+||+.||+||++.+.+|+.++|||||||++|||++-+++|.+.+-...+.+|+... -.|.+..++.+++.||..||..+
T Consensus 167 vGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~ 245 (426)
T KOG0589|consen 167 VGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSMLRKN 245 (426)
T ss_pred cCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHHhhcC
Confidence 89999999999999999999999999999999999999999998888888888776 34555679999999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~ 808 (857)
|+.||+ +.+||.+|.+.
T Consensus 246 P~~RPs----a~~LL~~P~l~ 262 (426)
T KOG0589|consen 246 PEHRPS----ALELLRRPHLL 262 (426)
T ss_pred CccCCC----HHHHhhChhhh
Confidence 999999 99999999876
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=377.82 Aligned_cols=256 Identities=28% Similarity=0.431 Sum_probs=206.4
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-----
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE----- 542 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~----- 542 (857)
..++|++.+.||+|+||.||++.+..+++.||||++..... .......+.+|+.+|+.++||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34789999999999999999999999999999999875422 223345678899999999999999999988654
Q ss_pred -CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 543 -KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 543 -~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
...|+||||+++ +|..++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357999999954 66655543 288999999999999999999999999999999999999999999999999743
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
... .
T Consensus 169 ~~~----------------------------------------------------------------------------~ 172 (355)
T cd07874 169 AGT----------------------------------------------------------------------------S 172 (355)
T ss_pred CCC----------------------------------------------------------------------------c
Confidence 100 0
Q ss_pred CccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc------------------
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS------------------ 763 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~------------------ 763 (857)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..++...
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_pred cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHH
Confidence 00123468999999999999999999999999999999999999998766444333322210
Q ss_pred ----cc-----CC-------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 764 ----LR-----FP-------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 764 ----~~-----~p-------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
.. ++ .....+.++++||.+||..||++||+ +.|+|+||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps----~~ell~hp~~~~ 316 (355)
T cd07874 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDEALQHPYINV 316 (355)
T ss_pred HhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCC----HHHHhcCcchhc
Confidence 00 00 01224567899999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=365.01 Aligned_cols=261 Identities=29% Similarity=0.416 Sum_probs=212.9
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|.+.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc--ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 3568999999999999999999999999999999986542 12233456789999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||++ ++|..++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 82 v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-- 157 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-- 157 (301)
T ss_pred EEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--
Confidence 999996 68887776543 34889999999999999999999999999999999999999999999999987321000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.......
T Consensus 158 -------------------------------------------------------------------------~~~~~~~ 164 (301)
T cd07873 158 -------------------------------------------------------------------------TKTYSNE 164 (301)
T ss_pred -------------------------------------------------------------------------CCccccc
Confidence 0001123
Q ss_pred cCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-------------------ccCC
Q 035930 708 VGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-------------------LRFP 767 (857)
Q Consensus 708 vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-------------------~~~p 767 (857)
.+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.... ..++
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (301)
T cd07873 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP 244 (301)
T ss_pred ceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccC
Confidence 468899999998764 47889999999999999999999998776554443332210 1111
Q ss_pred C---------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 768 G---------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 768 ~---------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
. .+.+++++++||.+||..||.+||+ ++|+|+||||..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~eil~h~~f~~~~ 293 (301)
T cd07873 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS----AEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCccccccc
Confidence 1 1357889999999999999999999 99999999998775
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=390.04 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=226.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
..|..+..||.|.||.||+|.+..+++.||||+++-+ ......+++++|+.+|..++++||.++|+.|..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le--~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE--EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechh--hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 3577889999999999999999999999999999876 34566788999999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|||.||++.+++.... .+.+..+..++++++.||.|||.++.||||||+.||||..+|.+||+|||.+..+.
T Consensus 91 ey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~------ 162 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT------ 162 (467)
T ss_pred HHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee------
Confidence 9999999999998754 35888999999999999999999999999999999999999999999999873211
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.+..+..+|+|
T Consensus 163 ---------------------------------------------------------------------~~~~rr~tfvG 173 (467)
T KOG0201|consen 163 ---------------------------------------------------------------------NTVKRRKTFVG 173 (467)
T ss_pred ---------------------------------------------------------------------chhhccccccc
Confidence 11223368899
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
||.|||||++.+..|+.++||||||++.|||++|.+||....+...+..|-+...+.-+ ..+++.+++||..||.+||+
T Consensus 174 TPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~-~~~S~~~kEFV~~CL~k~P~ 252 (467)
T KOG0201|consen 174 TPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD-GDFSPPFKEFVEACLDKNPE 252 (467)
T ss_pred cccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc-cccCHHHHHHHHHHhhcCcc
Confidence 99999999999999999999999999999999999999988776665555444332222 37899999999999999999
Q ss_pred CcCCchhhHHHHHcCCCCCCCC
Q 035930 790 NRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 790 ~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
.||+ |.+||+|+|++...
T Consensus 253 ~Rps----A~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 253 FRPS----AKELLKHKFIKRAK 270 (467)
T ss_pred cCcC----HHHHhhhHHHHhcC
Confidence 9999 99999999998744
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=407.19 Aligned_cols=152 Identities=36% Similarity=0.637 Sum_probs=138.3
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
+++|.++++||+|+||+||+|.+..+++.||||+++............+..|+.+++.++||||+++++++...+++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999765444444456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
|||+.|++|..++.... .+++..++.|+.||+.||+|||.+|||||||||+||||+.+++++|+|||+++..
T Consensus 83 mEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 99999999999887653 4889999999999999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=376.37 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=208.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC------
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE------ 542 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~------ 542 (857)
.++|.+++.||.|+||+||+|.+..++..||||++..... .......+.+|+++|+.++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3689999999999999999999999999999999875422 122345577899999999999999999988643
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
...|++||++ +++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999998 88998877543 3899999999999999999999999999999999999999999999999987431
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
. .
T Consensus 169 ~------------------------------------------------------------------------------~ 170 (343)
T cd07878 169 D------------------------------------------------------------------------------D 170 (343)
T ss_pred C------------------------------------------------------------------------------C
Confidence 0 0
Q ss_pred ccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-----------------
Q 035930 703 RSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL----------------- 764 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~----------------- 764 (857)
....++||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07878 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK 250 (343)
T ss_pred CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHH
Confidence 0123468999999999987 5689999999999999999999999987655444443322110
Q ss_pred ------cCCC------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 765 ------RFPG------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 765 ------~~p~------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
..+. ....++.+.+||.+||..||.+||+ +.++|+||||...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s----~~ell~hp~~~~~ 304 (343)
T cd07878 251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS----ASEALAHPYFSQY 304 (343)
T ss_pred HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhcc
Confidence 0000 1235677899999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=358.58 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=211.3
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeC------
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTE------ 542 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~------ 542 (857)
+.|.+.+.||.|+||.||+|.+..+++.||+|++... ......+..|+.+++++ +||||++++++|...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC----CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 5688899999999999999999999999999998654 23345678899999998 699999999998753
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
..+|+||||+++++|..++.......+++..+..++.||+.||+|||+.+|+||||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999999999999888755456899999999999999999999999999999999999999999999999997431
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
... ..
T Consensus 162 ~~~---------------------------------------------------------------------------~~ 166 (272)
T cd06637 162 DRT---------------------------------------------------------------------------VG 166 (272)
T ss_pred ccc---------------------------------------------------------------------------cc
Confidence 100 00
Q ss_pred ccccccCCCCccChhhhc-----CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHAR 777 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~-----g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~ 777 (857)
......|++.|+|||++. +..++.++|||||||++|||++|..||...........+.....+......++..++
T Consensus 167 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (272)
T cd06637 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQ 246 (272)
T ss_pred cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHH
Confidence 112346899999999986 345888999999999999999999999766544444333333333333346789999
Q ss_pred HHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 778 DLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 778 dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
+||.+||..||.+||+ +.+++.||||
T Consensus 247 ~li~~~l~~~p~~Rpt----~~~il~~~~~ 272 (272)
T cd06637 247 SFIESCLVKNHSQRPT----TEQLMKHPFI 272 (272)
T ss_pred HHHHHHcCCChhhCCC----HHHHhhCCCC
Confidence 9999999999999999 9999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=350.84 Aligned_cols=256 Identities=24% Similarity=0.406 Sum_probs=218.8
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|.+.+.||+|+||.||+|.+..++..|++|.+...... ......+.+|+++++.++||||+++++++.+++..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999998754322 3445678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|..++.......+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~----- 154 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN----- 154 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc-----
Confidence 999999999988764556899999999999999999999999999999999999999999999999987432100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
........|+
T Consensus 155 ----------------------------------------------------------------------~~~~~~~~~~ 164 (256)
T cd08529 155 ----------------------------------------------------------------------TNFANTIVGT 164 (256)
T ss_pred ----------------------------------------------------------------------cchhhccccC
Confidence 0001133578
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCC
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDN 790 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~ 790 (857)
+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+....... ....++..+.++|.+||+.+|++
T Consensus 165 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~ 243 (256)
T cd08529 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-VSQMYSQQLAQLIDQCLTKDYRQ 243 (256)
T ss_pred ccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHccCCccc
Confidence 89999999999999999999999999999999999998877666666655543322 22368899999999999999999
Q ss_pred cCCchhhHHHHHcCCCC
Q 035930 791 RLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 791 Rpt~~~~a~ELL~HPfF 807 (857)
||+ +.++++|||+
T Consensus 244 Rp~----~~~ll~~~~~ 256 (256)
T cd08529 244 RPD----TFQLLRNPSL 256 (256)
T ss_pred CcC----HHHHhhCCCC
Confidence 999 9999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.45 Aligned_cols=258 Identities=38% Similarity=0.727 Sum_probs=219.3
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCCCh
Q 035930 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL 557 (857)
Q Consensus 478 LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL 557 (857)
||.|+||.||+|.+..++..||+|++...........+.+.+|+++++.++||||+++++++.++...|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876544445557789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCC
Q 035930 558 HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEE 637 (857)
Q Consensus 558 ~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~ 637 (857)
..++.+.. .+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~------------ 146 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG------------ 146 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc------------
Confidence 99987653 3899999999999999999999999999999999999999999999999987431100
Q ss_pred CCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChh
Q 035930 638 PPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPE 717 (857)
Q Consensus 638 p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPE 717 (857)
.......|++.|++||
T Consensus 147 ----------------------------------------------------------------~~~~~~~~~~~~~~PE 162 (262)
T cd05572 147 ----------------------------------------------------------------QKTWTFCGTPEYVAPE 162 (262)
T ss_pred ----------------------------------------------------------------cccccccCCcCccChh
Confidence 0112335788999999
Q ss_pred hhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC--ChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc-
Q 035930 718 IIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG--NDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA- 794 (857)
Q Consensus 718 il~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~--~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~- 794 (857)
.+.+..++.++|+|+|||++|+|++|..||.... ..+.+..+.........+..++.++++||.+||..||.+|+++
T Consensus 163 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 242 (262)
T cd05572 163 IILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNL 242 (262)
T ss_pred HhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCc
Confidence 9998889999999999999999999999998776 4555666653333333334468999999999999999999984
Q ss_pred hhhHHHHHcCCCCCCCChh
Q 035930 795 VKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 795 ~~~a~ELL~HPfF~~l~w~ 813 (857)
...++|+++||||.+++|+
T Consensus 243 ~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 243 KGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred ccCHHHHhcChhhhCCCCC
Confidence 2347999999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=364.14 Aligned_cols=265 Identities=28% Similarity=0.460 Sum_probs=220.4
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.+.|++++.||.|+||.||+|++..++..||+|++... .......+.+|+.+++.++||||++++++|..++..|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 36799999999999999999999999999999998654 233456678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++++|..++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~---- 162 (292)
T cd06644 88 IEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK---- 162 (292)
T ss_pred EecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc----
Confidence 99999999987765443 3489999999999999999999999999999999999999999999999998632100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.........
T Consensus 163 -----------------------------------------------------------------------~~~~~~~~~ 171 (292)
T cd06644 163 -----------------------------------------------------------------------TLQRRDSFI 171 (292)
T ss_pred -----------------------------------------------------------------------cccccceec
Confidence 000012345
Q ss_pred CCCCccChhhhc-----CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-cCCCCCCCCHHHHHHHHh
Q 035930 709 GTHEYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-RFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 709 GT~~YmAPEil~-----g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-~~p~~~~is~~l~dLI~k 782 (857)
+++.|+|||++. ...++.++|||||||++|||++|..||...+....+..+..... .......++.++.+||.+
T Consensus 172 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (292)
T cd06644 172 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKT 251 (292)
T ss_pred CCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHH
Confidence 788999999985 34568899999999999999999999987665555555443322 223345678899999999
Q ss_pred hccCCcCCcCCchhhHHHHHcCCCCCCCChhhhc
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIR 816 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~ 816 (857)
||..||++||+ ++++++||||..++|....
T Consensus 252 ~l~~~p~~Rp~----~~~il~~~~~~~~~~~~~~ 281 (292)
T cd06644 252 ALDKHPETRPS----AAQLLEHPFVSSVTSNRPL 281 (292)
T ss_pred HhcCCcccCcC----HHHHhcCccccccccchhH
Confidence 99999999999 9999999999999997643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=355.87 Aligned_cols=254 Identities=37% Similarity=0.634 Sum_probs=209.8
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEee
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEY 551 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy 551 (857)
|++.+.||+|+||+||++.+..++..||+|++........ ......+|+.+++.++||||+++++++.++...|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 7899999999999999999999999999999987633221 122335599999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccC
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKS 631 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ 631 (857)
+++++|..++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~------- 150 (260)
T PF00069_consen 80 CPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE------- 150 (260)
T ss_dssp ETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-------
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 9999999988843 3389999999999999999999999999999999999999999999999998743100
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCC
Q 035930 632 SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711 (857)
Q Consensus 632 ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~ 711 (857)
.........+|.
T Consensus 151 --------------------------------------------------------------------~~~~~~~~~~~~ 162 (260)
T PF00069_consen 151 --------------------------------------------------------------------NNENFNPFVGTP 162 (260)
T ss_dssp --------------------------------------------------------------------TTSEBSSSSSSG
T ss_pred --------------------------------------------------------------------cccccccccccc
Confidence 011123456899
Q ss_pred CccChhhhc-CCCCCcccceehhhHHHHHHhhCCCCCCCCC---ChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhcc
Q 035930 712 EYLAPEIIK-GEGHGSSVDWWTFGIFLFELLYGRTPFKGSG---NDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLLV 785 (857)
Q Consensus 712 ~YmAPEil~-g~~~s~ksDVWSLGvILyELLtGk~PF~g~~---~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L~ 785 (857)
.|+|||++. +..++.++||||||+++|+|++|..||.... ....+............ .......+.+||.+||.
T Consensus 163 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 242 (260)
T PF00069_consen 163 EYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLS 242 (260)
T ss_dssp GGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHcc
Confidence 999999998 8889999999999999999999999999873 22333333332222221 11234899999999999
Q ss_pred CCcCCcCCchhhHHHHHcCCCC
Q 035930 786 KEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.||++||+ +.++++||||
T Consensus 243 ~~p~~R~~----~~~l~~~~~~ 260 (260)
T PF00069_consen 243 KDPEQRPS----AEELLKHPWF 260 (260)
T ss_dssp SSGGGSTT----HHHHHTSGGG
T ss_pred CChhHCcC----HHHHhcCCCC
Confidence 99999999 9999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.48 Aligned_cols=265 Identities=41% Similarity=0.757 Sum_probs=224.0
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCCCh
Q 035930 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL 557 (857)
Q Consensus 478 LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL 557 (857)
||.|+||.||++.+..++..||+|++.............+.+|+++++.++||||+++++.+..++..|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999776544445667789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCC
Q 035930 558 HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEE 637 (857)
Q Consensus 558 ~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~ 637 (857)
..++.... .+++..+..++.||+.||.|||.+||+||||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-------- 150 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN-------- 150 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc--------
Confidence 99887654 48999999999999999999999999999999999999999999999999874321110000
Q ss_pred CCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChh
Q 035930 638 PPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPE 717 (857)
Q Consensus 638 p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPE 717 (857)
............++..|+|||
T Consensus 151 -----------------------------------------------------------~~~~~~~~~~~~~~~~~~~Pe 171 (265)
T cd05579 151 -----------------------------------------------------------LNDDEKEDKRIVGTPDYIAPE 171 (265)
T ss_pred -----------------------------------------------------------cccccccccCcccCccccCHH
Confidence 000011123446788999999
Q ss_pred hhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhh
Q 035930 718 IIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKG 797 (857)
Q Consensus 718 il~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~ 797 (857)
.+.+..++.++||||||+++|+|++|..||......+.+..+..+...++....++..+.+||.+||+.+|.+||++ ..
T Consensus 172 ~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~-~~ 250 (265)
T cd05579 172 VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGA-KS 250 (265)
T ss_pred HhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCC-cc
Confidence 99988899999999999999999999999988877777777777666666554569999999999999999999992 22
Q ss_pred HHHHHcCCCCCCCCh
Q 035930 798 AAEIKQHPFFEGLNW 812 (857)
Q Consensus 798 a~ELL~HPfF~~l~w 812 (857)
+.++|+||||..++|
T Consensus 251 ~~~~l~~~~~~~~~~ 265 (265)
T cd05579 251 IEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHhcCccccCCCC
Confidence 399999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=359.61 Aligned_cols=254 Identities=30% Similarity=0.464 Sum_probs=209.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||+|+||.||+|.+..++..||+|++..+. .......+.+|+++|+.++||||++++++|..++..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999986542 1233456789999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|..+. .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----- 147 (279)
T cd06619 79 EFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----- 147 (279)
T ss_pred ecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc-----
Confidence 999999996542 278889999999999999999999999999999999999999999999998732100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
......+|
T Consensus 148 ------------------------------------------------------------------------~~~~~~~~ 155 (279)
T cd06619 148 ------------------------------------------------------------------------SIAKTYVG 155 (279)
T ss_pred ------------------------------------------------------------------------ccccCCCC
Confidence 00123468
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh-------hhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-------ETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~-------e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
|..|+|||++.+..++.++|||||||++|+|++|+.||...... +....+............++.++++||.+
T Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (279)
T cd06619 156 TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQ 235 (279)
T ss_pred ChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHH
Confidence 99999999999999999999999999999999999999754321 11122221211111124478899999999
Q ss_pred hccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
||..||++||+ ++++++||||...+-
T Consensus 236 ~l~~~P~~Rp~----~~eil~~~~~~~~~~ 261 (279)
T cd06619 236 CMRKQPKERPA----PENLMDHPFIVQYND 261 (279)
T ss_pred HhhCChhhCCC----HHHHhcCcccccccC
Confidence 99999999999 999999999987754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=386.15 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=215.6
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
.+..+.+.+++.||+|.||.||+|.+.++ ..||+|.++.. ....+.+.+|+++|+.|+|+|||+||++|..++.+
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 34556678899999999999999999765 36999998764 23345678999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|||||||+.|+|.++++...+..+...+...++.||+.||+||+++++|||||...||||+++..+||+|||||+....+
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999999999999866667999999999999999999999999999999999999999999999999999732111
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
....+ .
T Consensus 357 ~Y~~~---------------------------------------------------------------------~----- 362 (468)
T KOG0197|consen 357 EYTAS---------------------------------------------------------------------E----- 362 (468)
T ss_pred ceeec---------------------------------------------------------------------C-----
Confidence 11000 0
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
..--...|.|||.+....++.++|||||||+||||+| |+.||.+..+.+.+.. +..+.+.|.++.+|+.+.+||..||
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp~P~~CP~~vY~lM~~CW 441 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLPRPEGCPDEVYELMKSCW 441 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCCCCCCCCHHHHHHHHHHh
Confidence 0001356999999999999999999999999999997 9999999999888866 5677899999999999999999999
Q ss_pred cCCcCCcCCch
Q 035930 785 VKEPDNRLGAV 795 (857)
Q Consensus 785 ~~DPe~Rpt~~ 795 (857)
..+|++|||+.
T Consensus 442 ~~~P~~RPtF~ 452 (468)
T KOG0197|consen 442 HEDPEDRPTFE 452 (468)
T ss_pred hCCcccCCCHH
Confidence 99999999953
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=359.52 Aligned_cols=268 Identities=34% Similarity=0.648 Sum_probs=209.2
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHH---cCCCCccccceeeeeCCeEEEEEeecC
Q 035930 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM---LDHPFLPTLFAHFTTEKFSCLVMEYCP 553 (857)
Q Consensus 477 ~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~---L~HPnIV~L~~~f~~~~~l~LVmEy~~ 553 (857)
.||+|+||.||++.+..++..||+|++.+.............+|..+++. .+||||+.+++++..++..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999976543322222334455544444 479999999999999999999999999
Q ss_pred CCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCC
Q 035930 554 GGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSS 633 (857)
Q Consensus 554 gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss 633 (857)
+++|..++.... .+++..++.++.||+.||+|||..||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~--------- 149 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--------- 149 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc---------
Confidence 999988887653 389999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCc
Q 035930 634 PVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEY 713 (857)
Q Consensus 634 ~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Y 713 (857)
.......||+.|
T Consensus 150 --------------------------------------------------------------------~~~~~~~~~~~y 161 (279)
T cd05633 150 --------------------------------------------------------------------KKPHASVGTHGY 161 (279)
T ss_pred --------------------------------------------------------------------cCccCcCCCcCc
Confidence 000123589999
Q ss_pred cChhhhc-CCCCCcccceehhhHHHHHHhhCCCCCCCCCChh--hhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCC
Q 035930 714 LAPEIIK-GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE--TLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDN 790 (857)
Q Consensus 714 mAPEil~-g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e--~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~ 790 (857)
+|||++. +..++.++|||||||++|+|++|..||....... .+... ........++.++.++++||.+||..||.+
T Consensus 162 ~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 240 (279)
T cd05633 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKSLLEGLLQRDVSK 240 (279)
T ss_pred cCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHHHHHHHhcCCHHH
Confidence 9999986 4668999999999999999999999997653221 12111 111222233558999999999999999999
Q ss_pred cCCch-hhHHHHHcCCCCCCCChhhhc--cCCCCCCC
Q 035930 791 RLGAV-KGAAEIKQHPFFEGLNWALIR--CAVPPELP 824 (857)
Q Consensus 791 Rpt~~-~~a~ELL~HPfF~~l~w~li~--~~~pp~~P 824 (857)
|++.. ..+.++++||||++++|..+. ...+|.+|
T Consensus 241 R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~ 277 (279)
T cd05633 241 RLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP 277 (279)
T ss_pred hcCCCCCCHHHHHhCccccCCCHhHHhcCCCCCCCCC
Confidence 99421 238999999999999998653 22344444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=390.89 Aligned_cols=260 Identities=26% Similarity=0.377 Sum_probs=219.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCC-CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGT-SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~t-g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
..|.+.+.||.|+||.||+|....+ +..||+|.+... .......+.+|+.+|+.++||||++++++|..++++|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 3599999999999999999998777 788999977543 223344678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 549 MEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
|||+++|+|..++... ....+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||++.......
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999998876532 22358999999999999999999999999999999999999999999999999974321000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.......
T Consensus 224 -------------------------------------------------------------------------~~~~~~~ 230 (478)
T PTZ00267 224 -------------------------------------------------------------------------SLDVASS 230 (478)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001234
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
++||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..++..... +....++.++++||.+||..
T Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~ 309 (478)
T PTZ00267 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSK 309 (478)
T ss_pred cCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCccCCHHHHHHHHHHhcc
Confidence 57999999999999999999999999999999999999999988777777777665443 22345889999999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCCCCC
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
||++||+ +++++.|+|+..+
T Consensus 310 dP~~Rps----~~~~l~~~~~~~~ 329 (478)
T PTZ00267 310 NPALRPT----TQQLLHTEFLKYV 329 (478)
T ss_pred ChhhCcC----HHHHHhCHHHHHH
Confidence 9999999 9999999998654
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=349.18 Aligned_cols=256 Identities=21% Similarity=0.397 Sum_probs=215.3
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee-CCeEEEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT-EKFSCLVM 549 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~-~~~l~LVm 549 (857)
.|++++.||.|+||.||++.+..+++.||+|.+..... .....+.+.+|+++++.++|+||+++++.+.. +..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 48999999999999999999999999999999865432 22344567889999999999999999998864 45789999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|.+++.......+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~---- 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ---- 155 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc----
Confidence 9999999998887655556899999999999999999999999999999999999999999999999987321100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........|
T Consensus 156 -----------------------------------------------------------------------~~~~~~~~~ 164 (257)
T cd08223 156 -----------------------------------------------------------------------CDMASTLIG 164 (257)
T ss_pred -----------------------------------------------------------------------CCccccccC
Confidence 000123458
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..+... +....++..+.+||.+||..||+
T Consensus 165 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~ 243 (257)
T cd08223 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-PMPKDYSPELGELIATMLSKRPE 243 (257)
T ss_pred CcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCccccCHHHHHHHHHHhccCcc
Confidence 89999999999999999999999999999999999999877655555555444332 22346889999999999999999
Q ss_pred CcCCchhhHHHHHcCCCC
Q 035930 790 NRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 790 ~Rpt~~~~a~ELL~HPfF 807 (857)
+||+ +.++++||||
T Consensus 244 ~Rp~----~~~~l~~~~~ 257 (257)
T cd08223 244 KRPS----VKSILRQPYI 257 (257)
T ss_pred cCCC----HHHHhcCCCC
Confidence 9999 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=364.08 Aligned_cols=251 Identities=26% Similarity=0.363 Sum_probs=192.4
Q ss_pred EeEEccCCceEEEEEEEc--CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee--CCeEEEEEe
Q 035930 475 HKKLGCGDIGTVYLAELI--GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT--EKFSCLVME 550 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~--~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~--~~~l~LVmE 550 (857)
+++||+|+||+||+|.+. .+++.||+|++.... ....+.+|+++|+.++||||++++++|.. +..+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999975 467899999986542 23456789999999999999999999854 467899999
Q ss_pred ecCCCChHHHHhhCC-------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE----ccCCcEEEecccch
Q 035930 551 YCPGGDLHVLRQKQP-------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV----REDGHIMLSDFDLS 619 (857)
Q Consensus 551 y~~gGsL~~ll~~~~-------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL----~~dg~iKL~DFGLA 619 (857)
|+ +++|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 99 568877664321 1248999999999999999999999999999999999999 45678999999998
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
....... .
T Consensus 160 ~~~~~~~------------------------------------------------------------------------~ 167 (317)
T cd07868 160 RLFNSPL------------------------------------------------------------------------K 167 (317)
T ss_pred eccCCCC------------------------------------------------------------------------c
Confidence 4321000 0
Q ss_pred CCCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCCh---------hhhHHHhhccc-----
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGND---------ETLSNVVSQSL----- 764 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~---------e~l~~Iv~~~~----- 764 (857)
........+||+.|||||++.+. .++.++|||||||++|||++|+.||.+.... +.+..++....
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (317)
T cd07868 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK 247 (317)
T ss_pred cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChH
Confidence 00011235689999999999874 5899999999999999999999999754321 11222211000
Q ss_pred ------cCCC-------------------------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 765 ------RFPG-------------------------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 765 ------~~p~-------------------------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.++. ....+..+.+||.+||++||.+||| ++|+|+||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07868 248 DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPYF 317 (317)
T ss_pred HhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 0000 0123457899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=369.90 Aligned_cols=265 Identities=24% Similarity=0.344 Sum_probs=209.0
Q ss_pred EEeEEccC--CceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEee
Q 035930 474 LHKKLGCG--DIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEY 551 (857)
Q Consensus 474 i~~~LG~G--~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy 551 (857)
++.+||+| +|++||++.++.++..||||+++..... ......+.+|+++++.++||||++++++|..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 7899999999999999999999765321 22345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccC
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKS 631 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ 631 (857)
+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~---- 156 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ---- 156 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc----
Confidence 9999999998765444589999999999999999999999999999999999999999999999986532100000
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCC
Q 035930 632 SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711 (857)
Q Consensus 632 ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~ 711 (857)
.. .. .........++.
T Consensus 157 -----------------~~------------------------------------~~-----------~~~~~~~~~~~~ 172 (327)
T cd08227 157 -----------------RL------------------------------------RV-----------VHDFPKYSVKVL 172 (327)
T ss_pred -----------------cc------------------------------------cc-----------ccccccccccee
Confidence 00 00 000011234678
Q ss_pred CccChhhhcC--CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc------------------------
Q 035930 712 EYLAPEIIKG--EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR------------------------ 765 (857)
Q Consensus 712 ~YmAPEil~g--~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~------------------------ 765 (857)
.|+|||++.+ ..|+.++|||||||++|||++|+.||........+.........
T Consensus 173 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T cd08227 173 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANS 252 (327)
T ss_pred cccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcC
Confidence 8999999976 46899999999999999999999999865544333332221110
Q ss_pred --------------------CCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 766 --------------------FPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 766 --------------------~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
.+....+++++.+||.+||+.||++||+ +++|++||||..+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~ell~~p~f~~~~ 314 (327)
T cd08227 253 GLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIK 314 (327)
T ss_pred CCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC----HHHHhcChhhhhcc
Confidence 0111235678999999999999999999 99999999998864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=373.94 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=201.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
....+|.+++.||+|+||+||+|.+..++..||+|+.... ....|+.+|+.++||||++++++|...+..|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 3345799999999999999999999999999999985432 2356999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+ .++|..++.... ..+++..++.++.||+.||.|||++|||||||||+|||++.++.++|+|||++.....
T Consensus 134 lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 209 (357)
T PHA03209 134 MVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-- 209 (357)
T ss_pred EEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc--
Confidence 999999 568877776543 3489999999999999999999999999999999999999999999999998732100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 210 --------------------------------------------------------------------------~~~~~~ 215 (357)
T PHA03209 210 --------------------------------------------------------------------------APAFLG 215 (357)
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 000123
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCC-CCCCCh---------hhhHHHhhcc----ccCC-----
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPF-KGSGND---------ETLSNVVSQS----LRFP----- 767 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF-~g~~~~---------e~l~~Iv~~~----~~~p----- 767 (857)
..||+.|+|||++.+..++.++|||||||+||||+++..|+ ...... ..+..++... ..++
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 295 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295 (357)
T ss_pred ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence 45899999999999999999999999999999999855554 332111 1111111110 0011
Q ss_pred -----------------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 768 -----------------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 768 -----------------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
....++.++.+||.+||+.||.+||+ +.|||+||||+.+
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt----a~e~l~hp~f~~~ 357 (357)
T PHA03209 296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS----AEEILNYPMFAQL 357 (357)
T ss_pred HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC----HHHHhcCchhccC
Confidence 01245678889999999999999999 9999999999864
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=355.12 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=207.8
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|++.+.||+|+||+||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58899999999999999999999999999999865421 22334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 551 YCPGGDLHVLRQKQPS-RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~-~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|++ ++|..++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++..+...
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---- 154 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC----
Confidence 996 688777765432 45899999999999999999999999999999999999999999999999987321100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........+
T Consensus 155 -----------------------------------------------------------------------~~~~~~~~~ 163 (285)
T cd07861 155 -----------------------------------------------------------------------VRVYTHEVV 163 (285)
T ss_pred -----------------------------------------------------------------------cccccCCcc
Confidence 000112357
Q ss_pred CCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc------------------cC----
Q 035930 710 THEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL------------------RF---- 766 (857)
Q Consensus 710 T~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~------------------~~---- 766 (857)
++.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+.+..+..... .+
T Consensus 164 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
T cd07861 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWK 243 (285)
T ss_pred cccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccC
Confidence 8899999998764 478999999999999999999999987654433332221100 00
Q ss_pred -----CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 767 -----PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 767 -----p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.....++.++++||++||..||.+||+ +.+|+.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~ll~~~~~ 285 (285)
T cd07861 244 KGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS----AKKALNHPYF 285 (285)
T ss_pred cchhHHhcCCCCHHHHHHHHHHhcCChhhCCC----HHHHhcCCCC
Confidence 012347889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=392.78 Aligned_cols=265 Identities=27% Similarity=0.441 Sum_probs=222.1
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC----
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK---- 543 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~---- 543 (857)
..++|.+.+.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 44789999999999999999999999999999999976533 2334556788999999999999999988775432
Q ss_pred ----eEEEEEeecCCCChHHHHhhCC--CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEeccc
Q 035930 544 ----FSCLVMEYCPGGDLHVLRQKQP--SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFD 617 (857)
Q Consensus 544 ----~l~LVmEy~~gGsL~~ll~~~~--~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFG 617 (857)
.+++||||+++|+|..++.... ...+++..++.++.||+.||.|||+.|||||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 4789999999999998876432 2458999999999999999999999999999999999999999999999999
Q ss_pred chhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccc
Q 035930 618 LSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVV 697 (857)
Q Consensus 618 LA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~ 697 (857)
+++.+....
T Consensus 189 ls~~~~~~~----------------------------------------------------------------------- 197 (496)
T PTZ00283 189 FSKMYAATV----------------------------------------------------------------------- 197 (496)
T ss_pred cCeeccccc-----------------------------------------------------------------------
Confidence 974321000
Q ss_pred cCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHH
Q 035930 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHAR 777 (857)
Q Consensus 698 ~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~ 777 (857)
........+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..++..... +..+.+++++.
T Consensus 198 --~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 274 (496)
T PTZ00283 198 --SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-PLPPSISPEMQ 274 (496)
T ss_pred --cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCHHHH
Confidence 000112457999999999999999999999999999999999999999988777777766655433 33456899999
Q ss_pred HHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 778 DLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 778 dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
+||.+||..||.+||+ +.++++|||+...-
T Consensus 275 ~li~~~L~~dP~~RPs----~~ell~~p~~~~~~ 304 (496)
T PTZ00283 275 EIVTALLSSDPKRRPS----SSKLLNMPICKLFI 304 (496)
T ss_pred HHHHHHcccChhhCcC----HHHHHhCHHHHHhh
Confidence 9999999999999999 99999999987643
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=361.79 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=210.3
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||+|+||.||++.+..++..||+|.+.... .......+.+|+++|+.++||||++++++|.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36999999999999999999999999999999987542 1233456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
||+++++|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++.....
T Consensus 79 ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 152 (308)
T cd06615 79 EHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 152 (308)
T ss_pred eccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----
Confidence 9999999999987653 48999999999999999999997 6999999999999999999999999998632100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.....++
T Consensus 153 -------------------------------------------------------------------------~~~~~~~ 159 (308)
T cd06615 153 -------------------------------------------------------------------------SMANSFV 159 (308)
T ss_pred -------------------------------------------------------------------------cccccCC
Confidence 0012346
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-------------------------
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS------------------------- 763 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~------------------------- 763 (857)
|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..... .++...
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (308)
T cd06615 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238 (308)
T ss_pred CCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccccCCCCCccchhh
Confidence 889999999999888999999999999999999999999755422221 111100
Q ss_pred ------------ccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 764 ------------LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 764 ------------~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
........++.++++||.+||..||++||+ +.+|++||||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~ 292 (308)
T cd06615 239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD----LKELTKHPFIKR 292 (308)
T ss_pred HHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC----HHHHhcChhhhh
Confidence 000001236788999999999999999999 999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=355.50 Aligned_cols=259 Identities=35% Similarity=0.612 Sum_probs=205.8
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHH---HHHHcCCCCccccceeeeeCCeEEEEEeecC
Q 035930 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE---IMQMLDHPFLPTLFAHFTTEKFSCLVMEYCP 553 (857)
Q Consensus 477 ~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~Eie---ILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~ 553 (857)
.||+|+||+||++.+..+++.||+|++.+...........+..|.. +++..+||||+.++++|..++..|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999997654332222222334433 4455679999999999999999999999999
Q ss_pred CCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCC
Q 035930 554 GGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSS 633 (857)
Q Consensus 554 gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss 633 (857)
|++|..++.... .+++..++.++.|++.||+|||+.+|+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~--------- 149 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--------- 149 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc---------
Confidence 999998886543 489999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCc
Q 035930 634 PVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEY 713 (857)
Q Consensus 634 ~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Y 713 (857)
......+|+..|
T Consensus 150 --------------------------------------------------------------------~~~~~~~~~~~y 161 (278)
T cd05606 150 --------------------------------------------------------------------KKPHASVGTHGY 161 (278)
T ss_pred --------------------------------------------------------------------cCCcCcCCCcCC
Confidence 000123589999
Q ss_pred cChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCC---hhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 714 LAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGN---DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 714 mAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~---~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
+|||++.+ ..++.++|||||||++|||++|+.||..... ......+... .+.....++.++.+||.+||..||.
T Consensus 162 ~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~~~l~~~p~ 239 (278)
T cd05606 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVN 239 (278)
T ss_pred cCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--CCCCCCcCCHHHHHHHHHHhhcCHH
Confidence 99999975 4689999999999999999999999987632 2222222222 2223345789999999999999999
Q ss_pred CcCCch-hhHHHHHcCCCCCCCChhhhc
Q 035930 790 NRLGAV-KGAAEIKQHPFFEGLNWALIR 816 (857)
Q Consensus 790 ~Rpt~~-~~a~ELL~HPfF~~l~w~li~ 816 (857)
+|+... ..+.++++||||..++|..+.
T Consensus 240 ~R~~~~~~~~~~ll~~~~~~~~~~~~~~ 267 (278)
T cd05606 240 RRLGCLGRGAQEVKEHPFFRSLDWQMVF 267 (278)
T ss_pred hccCCCCCCHHHHHhCccccCCCchHhh
Confidence 999211 129999999999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=354.40 Aligned_cols=255 Identities=28% Similarity=0.421 Sum_probs=204.6
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|.+.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 58899999999999999999999999999999875422 22333557789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+. ++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~----- 152 (284)
T cd07839 80 YCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP----- 152 (284)
T ss_pred cCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC-----
Confidence 995 57877765543 34899999999999999999999999999999999999999999999999987431100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
........++
T Consensus 153 ----------------------------------------------------------------------~~~~~~~~~~ 162 (284)
T cd07839 153 ----------------------------------------------------------------------VRCYSAEVVT 162 (284)
T ss_pred ----------------------------------------------------------------------CCCcCCCccc
Confidence 0001123478
Q ss_pred CCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCC-CCChhhhHHHhhcc--------------cc---CC----
Q 035930 711 HEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKG-SGNDETLSNVVSQS--------------LR---FP---- 767 (857)
Q Consensus 711 ~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g-~~~~e~l~~Iv~~~--------------~~---~p---- 767 (857)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.. .+..+.+..+.... .. ++
T Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd07839 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPA 242 (284)
T ss_pred cCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCC
Confidence 8999999987754 78999999999999999999988643 33333333322110 00 00
Q ss_pred ------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 768 ------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 768 ------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
..+.++.++++||.+||..||.+||+ ++++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~il~h~~f 284 (284)
T cd07839 243 TTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS----AEEALQHPYF 284 (284)
T ss_pred cchhhhhcccCCHHHHHHHHHHhcCChhhcCC----HHHHhcCCCC
Confidence 12347889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.55 Aligned_cols=256 Identities=29% Similarity=0.460 Sum_probs=209.5
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++||||++++++|......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 469999999999999999999999999999999865421 1223345788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++++.|..++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 153 (286)
T cd07847 80 EYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP---- 153 (286)
T ss_pred eccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC----
Confidence 9999988887765433 3899999999999999999999999999999999999999999999999987431100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........+
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (286)
T cd07847 154 -----------------------------------------------------------------------GDDYTDYVA 162 (286)
T ss_pred -----------------------------------------------------------------------cccccCccc
Confidence 000112357
Q ss_pred CCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-------------------ccCCC-
Q 035930 710 THEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-------------------LRFPG- 768 (857)
Q Consensus 710 T~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-------------------~~~p~- 768 (857)
+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+.... ...+.
T Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd07847 163 TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEP 242 (286)
T ss_pred ccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCc
Confidence 889999999987 457899999999999999999999998876554443332210 01111
Q ss_pred ---------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 769 ---------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 769 ---------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.+.++..+.+||.+||..||++||+ +.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~eil~~~~f 286 (286)
T cd07847 243 ETREPLESKFPNISSPALSFLKGCLQMDPTERLS----CEELLEHPYF 286 (286)
T ss_pred ccccCHHHHhccCCHHHHHHHHHHhcCCccccCC----HHHHhcCCCC
Confidence 1346788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=349.48 Aligned_cols=256 Identities=34% Similarity=0.648 Sum_probs=216.2
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|++.+.||.|+||.||+|.+..++..||+|++.+...........+.+|++++++++||||+++++.+..+...|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987654444556788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+.|++|..++... ..+++..+..++.||+.||.|||.+||+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~----- 153 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD----- 153 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC-----
Confidence 99999999988765 24899999999999999999999999999999999999999999999999986321100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
.......|+
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (258)
T cd05578 154 -----------------------------------------------------------------------TLTTSTSGT 162 (258)
T ss_pred -----------------------------------------------------------------------ccccccCCC
Confidence 001123478
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC--hhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN--DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~--~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
..|+|||++.+..++.++|+|||||++|+|++|..||..... .+.+...... .....+..++.++.++|.+||..||
T Consensus 163 ~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p 241 (258)
T cd05578 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDAINKLLERDP 241 (258)
T ss_pred hhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHHHHHHccCCh
Confidence 899999999998899999999999999999999999987764 2222222221 2223335688999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF 807 (857)
.+|++.. +.|+++||||
T Consensus 242 ~~R~~~~--~~~l~~~~~~ 258 (258)
T cd05578 242 QKRLGDN--LKDLKNHPYF 258 (258)
T ss_pred hHcCCcc--HHHHhcCCCC
Confidence 9999922 3999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=354.76 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=210.3
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeee------
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTT------ 541 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~------ 541 (857)
.+.|++.+.||.|+||+||+|.+..++..||+|++... ......+..|+.+++.+ +||||++++++|..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 35789999999999999999999999999999998654 22345678899999888 69999999999853
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
...+|+||||+++|+|..++.......+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 46889999999999999988776555688999999999999999999999999999999999999999999999998743
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
.... .
T Consensus 171 ~~~~---------------------------------------------------------------------------~ 175 (282)
T cd06636 171 LDRT---------------------------------------------------------------------------V 175 (282)
T ss_pred hhcc---------------------------------------------------------------------------c
Confidence 1100 0
Q ss_pred CccccccCCCCccChhhhc-----CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHH
Q 035930 702 ARSNSFVGTHEYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHA 776 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~-----g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l 776 (857)
.......|++.|+|||++. +..++.++|||||||++|||++|..||......+.+..+............++..+
T Consensus 176 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (282)
T cd06636 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKF 255 (282)
T ss_pred cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHH
Confidence 0012345899999999986 35688899999999999999999999977654444433333222222234578999
Q ss_pred HHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 777 RDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 777 ~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.+||++||..||.+||+ +.||++||||
T Consensus 256 ~~li~~cl~~~p~~Rp~----~~ell~~~~~ 282 (282)
T cd06636 256 IDFIEGCLVKNYLSRPS----TEQLLKHPFI 282 (282)
T ss_pred HHHHHHHhCCChhhCcC----HHHHhcCCCC
Confidence 99999999999999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=351.10 Aligned_cols=256 Identities=39% Similarity=0.723 Sum_probs=213.8
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHH-HHcCCCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM-QMLDHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieIL-r~L~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||.|+||.||+|.+..+++.||||++.+...........+..|..++ ..++|+||++++++|..++.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999999999999999998765332223333445555544 455899999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
++|..++.... .+++..+..++.||+.||.|||..||+||||+|+|||++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------- 149 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------- 149 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------
Confidence 99999987653 389999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
.....|++.|+
T Consensus 150 ---------------------------------------------------------------------~~~~~~~~~y~ 160 (260)
T cd05611 150 ---------------------------------------------------------------------NKKFVGTPDYL 160 (260)
T ss_pred ---------------------------------------------------------------------cccCCCCcCcc
Confidence 11235788999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhccCCcCCcC
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLLVKEPDNRL 792 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L~~DPe~Rp 792 (857)
|||.+.+..++.++||||||+++|+|++|..||...+..+.+..+......++. ...++.++.+||.+||..||.+||
T Consensus 161 ~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 240 (260)
T cd05611 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRL 240 (260)
T ss_pred ChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHcc
Confidence 999999888999999999999999999999999888777766666655544432 235789999999999999999999
Q ss_pred CchhhHHHHHcCCCCCCCChh
Q 035930 793 GAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 793 t~~~~a~ELL~HPfF~~l~w~ 813 (857)
++ ..++|+|.||||..++|.
T Consensus 241 ~~-~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 241 GA-NGYQEIKSHPFFKSINWD 260 (260)
T ss_pred CC-CcHHHHHcChHhhcCCCC
Confidence 72 237899999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=346.06 Aligned_cols=261 Identities=29% Similarity=0.416 Sum_probs=218.2
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||.|+||+||+|.+..++..+|+|++...... .....+.+|+++|+.++|+||+++++.+..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 4799999999999999999999889999999998754322 25567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 550 EYCPGGDLHVLRQKQPS-RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~-~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
||+++++|..++..... ..+++..++.++.||+.||+|||++||+||||+|+||++++++.++|+|||++........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~- 157 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD- 157 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc-
Confidence 99999999998876432 4589999999999999999999999999999999999999999999999999744211000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.........+
T Consensus 158 ----------------------------------------------------------------------~~~~~~~~~~ 167 (267)
T cd06610 158 ----------------------------------------------------------------------RTRKVRKTFV 167 (267)
T ss_pred ----------------------------------------------------------------------cccccccccc
Confidence 0000112346
Q ss_pred CCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-CCC---CCCCCHHHHHHHHhh
Q 035930 709 GTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-FPG---YPVVSFHARDLIRGL 783 (857)
Q Consensus 709 GT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-~p~---~~~is~~l~dLI~k~ 783 (857)
|+..|+|||++... .++.++|+|||||++|+|++|+.||...+....+..++..... ++. ...++..+.+||.+|
T Consensus 168 ~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 247 (267)
T cd06610 168 GTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLC 247 (267)
T ss_pred CChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHH
Confidence 89999999999877 7899999999999999999999999877666666555544221 111 135788999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCC
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
|..||++||+ +.+|++||||
T Consensus 248 l~~~p~~Rp~----~~~ll~~p~~ 267 (267)
T cd06610 248 LQKDPSKRPT----AEELLKHKFF 267 (267)
T ss_pred cCCChhhCcC----HHHHhhCCCC
Confidence 9999999999 9999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=356.74 Aligned_cols=260 Identities=28% Similarity=0.455 Sum_probs=218.0
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||.|+||+||++.+..++..||+|++... .......+..|+++++.++||||+++++++..+...|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 5689999999999999999999889999999998643 2234456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|..++.... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~----- 155 (280)
T cd06611 82 EFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS----- 155 (280)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc-----
Confidence 9999999998887643 2489999999999999999999999999999999999999999999999998632100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.........|
T Consensus 156 ----------------------------------------------------------------------~~~~~~~~~~ 165 (280)
T cd06611 156 ----------------------------------------------------------------------TLQKRDTFIG 165 (280)
T ss_pred ----------------------------------------------------------------------cccccceeec
Confidence 0001123458
Q ss_pred CCCccChhhhc-----CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-cCCCCCCCCHHHHHHHHhh
Q 035930 710 THEYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-RFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 710 T~~YmAPEil~-----g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-~~p~~~~is~~l~dLI~k~ 783 (857)
|+.|+|||++. +..++.++|||||||++|||++|+.||........+..+..... .+.....++.++.+||.+|
T Consensus 166 ~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (280)
T cd06611 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSC 245 (280)
T ss_pred chhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHH
Confidence 89999999985 34568899999999999999999999988766666655544332 2223346889999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
|..||.+||+ +.++++||||....+
T Consensus 246 l~~~p~~Rps----~~~il~~~~~~~~~~ 270 (280)
T cd06611 246 LVKDPDDRPT----AAELLKHPFVSDQSD 270 (280)
T ss_pred hccChhhCcC----HHHHhcChhhcccch
Confidence 9999999999 999999999987644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.50 Aligned_cols=261 Identities=26% Similarity=0.425 Sum_probs=214.5
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc------cchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR------KKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~------~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
+|.+...||.|+||.||+|.+..++..||+|++........ ...+.+.+|+++++.++||||+++++++..++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 46788999999999999999988999999999875433211 223567889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
.++||||+++++|..++.... .+++..++.++.|++.||+|||++||+||||+|+|||++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999999987653 388999999999999999999999999999999999999999999999998754321
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
+... .......
T Consensus 159 ~~~~---------------------------------------------------------------------~~~~~~~ 169 (267)
T cd06628 159 NSLS---------------------------------------------------------------------TKTNGAR 169 (267)
T ss_pred cccc---------------------------------------------------------------------CCccccc
Confidence 0000 0000011
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
..+.|+..|+|||++.+..++.++|||+|||++|+|++|+.||........+..+... ........++..+.+||++||
T Consensus 170 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l 248 (267)
T cd06628 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-ASPEIPSNISSEAIDFLEKTF 248 (267)
T ss_pred cccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc-CCCcCCcccCHHHHHHHHHHc
Confidence 2345889999999999988999999999999999999999999876554444443332 222223458899999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCC
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
+.||.+||+ +.+|++||||
T Consensus 249 ~~~p~~Rp~----~~~il~~~~~ 267 (267)
T cd06628 249 EIDHNKRPT----AAELLKHPFL 267 (267)
T ss_pred cCCchhCcC----HHHHhhCCCC
Confidence 999999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=354.49 Aligned_cols=257 Identities=29% Similarity=0.435 Sum_probs=213.9
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEee
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEY 551 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy 551 (857)
|++.+.||.|+||.||++.+..++..+++|.+.... ......+.+|+++++.++||||++++++|..++..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 678899999999999999999999999999986542 23455678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccC
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKS 631 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ 631 (857)
+++++|..++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~------ 156 (282)
T cd06643 84 CAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT------ 156 (282)
T ss_pred cCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc------
Confidence 99999988765432 34899999999999999999999999999999999999999999999999987431100
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCC
Q 035930 632 SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711 (857)
Q Consensus 632 ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~ 711 (857)
........||+
T Consensus 157 ---------------------------------------------------------------------~~~~~~~~~~~ 167 (282)
T cd06643 157 ---------------------------------------------------------------------IQRRDSFIGTP 167 (282)
T ss_pred ---------------------------------------------------------------------ccccccccccc
Confidence 00112345889
Q ss_pred CccChhhhc-----CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-cCCCCCCCCHHHHHHHHhhcc
Q 035930 712 EYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-RFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 712 ~YmAPEil~-----g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-~~p~~~~is~~l~dLI~k~L~ 785 (857)
.|+|||++. +..++.++|||||||++|||++|+.||...+..+.+..+..... ..+....++..+++||.+||.
T Consensus 168 ~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 247 (282)
T cd06643 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLE 247 (282)
T ss_pred cccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHcc
Confidence 999999984 45578899999999999999999999987766555555543322 223344588999999999999
Q ss_pred CCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 786 KEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
.||.+||+ ++++++||||....
T Consensus 248 ~~p~~Rp~----~~~il~~~~~~~~~ 269 (282)
T cd06643 248 KNVDARWT----TTQLLQHPFVTVNS 269 (282)
T ss_pred CChhhCcC----HHHHhcCCCEeccC
Confidence 99999999 99999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=352.68 Aligned_cols=258 Identities=30% Similarity=0.456 Sum_probs=217.8
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+++++.++|+||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 36889999999999999999999999999999987542 2334456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|..++... .+++..++.++.||+.||.|||..||+||||+|+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---- 151 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST---- 151 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc----
Confidence 999999999888764 4899999999999999999999999999999999999999999999999987432100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........|
T Consensus 152 -----------------------------------------------------------------------~~~~~~~~~ 160 (274)
T cd06609 152 -----------------------------------------------------------------------MSKRNTFVG 160 (274)
T ss_pred -----------------------------------------------------------------------ccccccccC
Confidence 001123458
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
++.|+|||++.+..++.++|||+|||++|+|++|..||...+.......+............++.++.+||.+||..||+
T Consensus 161 ~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~ 240 (274)
T cd06609 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPK 240 (274)
T ss_pred CccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChh
Confidence 88999999999988999999999999999999999999876655555444433222211122788999999999999999
Q ss_pred CcCCchhhHHHHHcCCCCCCCC
Q 035930 790 NRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 790 ~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
+||+ ++++++||||....
T Consensus 241 ~Rpt----~~~il~~~~~~~~~ 258 (274)
T cd06609 241 ERPS----AKELLKHKFIKKAK 258 (274)
T ss_pred hCcC----HHHHhhChhhcCCC
Confidence 9999 99999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=352.05 Aligned_cols=254 Identities=29% Similarity=0.435 Sum_probs=211.4
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++..++..|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 357888999999999999999999999999999986542 23345678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++++|.+++.... .+++..++.++.||+.||.|||.+||+|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06645 85 MEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--- 159 (267)
T ss_pred EeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc---
Confidence 99999999999887653 4899999999999999999999999999999999999999999999999987432100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 160 ------------------------------------------------------------------------~~~~~~~~ 167 (267)
T cd06645 160 ------------------------------------------------------------------------IAKRKSFI 167 (267)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00012345
Q ss_pred CCCCccChhhhc---CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC---CCCCCHHHHHHHHh
Q 035930 709 GTHEYLAPEIIK---GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG---YPVVSFHARDLIRG 782 (857)
Q Consensus 709 GT~~YmAPEil~---g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~---~~~is~~l~dLI~k 782 (857)
|++.|+|||++. ...++.++|||||||++|+|++|..||........+..........+. ...++..+.+||.+
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (267)
T cd06645 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKM 247 (267)
T ss_pred CcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHH
Confidence 899999999985 455888999999999999999999999766554444433333333222 22477899999999
Q ss_pred hccCCcCCcCCchhhHHHHHcCCC
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQHPF 806 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~HPf 806 (857)
||..||++||+ +++|++|||
T Consensus 248 ~l~~~P~~R~~----~~~ll~~~~ 267 (267)
T cd06645 248 ALTKNPKKRPT----AEKLLQHPF 267 (267)
T ss_pred HccCCchhCcC----HHHHhcCCC
Confidence 99999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=389.11 Aligned_cols=260 Identities=29% Similarity=0.460 Sum_probs=225.3
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.|+..||.|+||.||+|..+.++...|.|+|.-. ....++++.-|++||..++||+||.||+.|..++.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 3577889999999999999999999999999998643 4567888999999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|||.||-+...+-.-. +.|.+.+++.+++|++.||.|||++.|||||||..|||++.+|.|+|+|||.+...
T Consensus 109 EFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn------- 180 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN------- 180 (1187)
T ss_pred eecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc-------
Confidence 9999999976665543 45999999999999999999999999999999999999999999999999986220
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
..+-.+..+|+|
T Consensus 181 --------------------------------------------------------------------~~t~qkRDsFIG 192 (1187)
T KOG0579|consen 181 --------------------------------------------------------------------KSTRQKRDSFIG 192 (1187)
T ss_pred --------------------------------------------------------------------hhHHhhhccccC
Confidence 001123457899
Q ss_pred CCCccChhhhc-----CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-cCCCCCCCCHHHHHHHHhh
Q 035930 710 THEYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-RFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 710 T~~YmAPEil~-----g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-~~p~~~~is~~l~dLI~k~ 783 (857)
||+|||||+.. ..+|++++||||||++|+||.-+.+|-...+...++-.|..... .+-.+..|+..+.||+.+|
T Consensus 193 TPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~c 272 (1187)
T KOG0579|consen 193 TPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRC 272 (1187)
T ss_pred CcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHH
Confidence 99999999875 56899999999999999999999999988888777777766433 2334567899999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
|.+||..||+ +++||+||||..+.-
T Consensus 273 L~Knp~~Rp~----aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 273 LVKNPRNRPP----AAQLLKHPFVQNAPS 297 (1187)
T ss_pred HhcCCccCCC----HHHHhhCcccccCCc
Confidence 9999999999 999999999996643
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=350.28 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=210.5
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
...+|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++..++.+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3467999999999999999999999999999999986432 2334567889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||+|+|||++.++.++|+|||++..+...
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT-- 159 (267)
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--
Confidence 999999999998886543 4899999999999999999999999999999999999999999999999997432100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.......
T Consensus 160 -------------------------------------------------------------------------~~~~~~~ 166 (267)
T cd06646 160 -------------------------------------------------------------------------IAKRKSF 166 (267)
T ss_pred -------------------------------------------------------------------------ccccCcc
Confidence 0001234
Q ss_pred cCCCCccChhhhc---CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC---CCCCCHHHHHHHH
Q 035930 708 VGTHEYLAPEIIK---GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG---YPVVSFHARDLIR 781 (857)
Q Consensus 708 vGT~~YmAPEil~---g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~---~~~is~~l~dLI~ 781 (857)
.|++.|+|||.+. ...++.++|||||||++|||++|+.||......+....+....+..+. ...++..+.+||+
T Consensus 167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (267)
T cd06646 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVK 246 (267)
T ss_pred ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHH
Confidence 5889999999985 344788999999999999999999999765544333333333333222 2357889999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPF 806 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPf 806 (857)
+||..||++||+ +++|++|+|
T Consensus 247 ~~l~~~P~~Rp~----~~~il~~l~ 267 (267)
T cd06646 247 ISLTKNPKKRPT----AERLLTHLF 267 (267)
T ss_pred HHhhCChhhCcC----HHHHhcCCC
Confidence 999999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.36 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=221.1
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|++++.||.|+||.||.+++..++..+++|.+...... ......+.+|+++|++++|+||++++++|.+.+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 699999999999999999999999999999998654322 2345567899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|..++.......+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~---- 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---- 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence 9999999999887644558999999999999999999999999999999999999999999999999874311000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
.......|+
T Consensus 156 -----------------------------------------------------------------------~~~~~~~~~ 164 (256)
T cd08221 156 -----------------------------------------------------------------------SMAETVVGT 164 (256)
T ss_pred -----------------------------------------------------------------------ccccccCCC
Confidence 001234588
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCC
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDN 790 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~ 790 (857)
+.|+|||++.+..++.++|||||||++|||++|..||......+....+....... ....++.++.+||.+||..+|.+
T Consensus 165 ~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~ 243 (256)
T cd08221 165 PYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSSELISLVHSLLQQDPEK 243 (256)
T ss_pred ccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHcccCccc
Confidence 99999999999889999999999999999999999999877777777776654443 23568899999999999999999
Q ss_pred cCCchhhHHHHHcCCCC
Q 035930 791 RLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 791 Rpt~~~~a~ELL~HPfF 807 (857)
||+ +.++++|||+
T Consensus 244 R~s----~~~ll~~~~l 256 (256)
T cd08221 244 RPT----ADEVLDQPLL 256 (256)
T ss_pred CCC----HHHHhhCcCC
Confidence 999 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=345.56 Aligned_cols=256 Identities=24% Similarity=0.415 Sum_probs=218.2
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|++.+.||.|+||+||++.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++...++.|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 589999999999999999999999999999998754322 2334578899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+.+++|..++.......+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~----- 154 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----- 154 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc-----
Confidence 999999998887654445899999999999999999999999999999999999999999999999987321100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
........|+
T Consensus 155 ----------------------------------------------------------------------~~~~~~~~~~ 164 (256)
T cd08218 155 ----------------------------------------------------------------------VELARTCIGT 164 (256)
T ss_pred ----------------------------------------------------------------------hhhhhhccCC
Confidence 0001123478
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCC
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDN 790 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~ 790 (857)
+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+.+..++.+... +....++.++.+||.+||..+|.+
T Consensus 165 ~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~ 243 (256)
T cd08218 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-PVSSHYSYDLRNLVSQLFKRNPRD 243 (256)
T ss_pred ccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-CCcccCCHHHHHHHHHHhhCChhh
Confidence 8999999999988999999999999999999999999877666666666554432 233568899999999999999999
Q ss_pred cCCchhhHHHHHcCCCC
Q 035930 791 RLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 791 Rpt~~~~a~ELL~HPfF 807 (857)
||+ +.++++||||
T Consensus 244 Rp~----~~~vl~~~~~ 256 (256)
T cd08218 244 RPS----VNSILEKNFI 256 (256)
T ss_pred CcC----HHHHhhCcCC
Confidence 999 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=356.07 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=215.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
.+|++.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||++++++|..+.+.|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 589999999999999999999999999999999876432 23456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|..++... .+++..+..++.|++.||+|||..||+||||||+|||++.++.++|+|||++......
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~---- 169 (296)
T cd06654 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169 (296)
T ss_pred cccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc----
Confidence 999999999988653 3789999999999999999999999999999999999999999999999987421100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........|
T Consensus 170 -----------------------------------------------------------------------~~~~~~~~~ 178 (296)
T cd06654 170 -----------------------------------------------------------------------QSKRSTMVG 178 (296)
T ss_pred -----------------------------------------------------------------------ccccCcccC
Confidence 000112358
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-cCCCCCCCCHHHHHHHHhhccCCc
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-RFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
++.|+|||++.+..++.++|||||||++|+|++|+.||........+..+..... ..+....++..+.+||.+||..||
T Consensus 179 ~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 258 (296)
T cd06654 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258 (296)
T ss_pred CccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCc
Confidence 8999999999998899999999999999999999999987665444433332221 222345688899999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l 810 (857)
++||+ +.+|++||||...
T Consensus 259 ~~Rpt----~~eil~~~~~~~~ 276 (296)
T cd06654 259 EKRGS----AKELLQHQFLKIA 276 (296)
T ss_pred ccCcC----HHHHhhChhhhcc
Confidence 99999 9999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.72 Aligned_cols=261 Identities=25% Similarity=0.362 Sum_probs=212.9
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc---cccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV---GRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~---~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
+|++.+.||.|+||+||+|.+ .++..+|||.+...... .......+.+|+++|+.++|+||++++++|.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478899999999999999987 47889999998654211 12234567889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||+++++|..++.+.. .+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999987653 388999999999999999999999999999999999999999999999998754210000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
. ..........
T Consensus 158 ----------------~-----------------------------------------------------~~~~~~~~~~ 168 (265)
T cd06631 158 ----------------H-----------------------------------------------------GTHSNMLKSM 168 (265)
T ss_pred ----------------c-----------------------------------------------------cccccccccc
Confidence 0 0000011234
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-CCCCCCCCHHHHHHHHhhccC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-FPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-~p~~~~is~~l~dLI~k~L~~ 786 (857)
.|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+...... .+....++.++.+||++||..
T Consensus 169 ~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 248 (265)
T cd06631 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTR 248 (265)
T ss_pred CCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcC
Confidence 5899999999999999999999999999999999999999876555444444333222 223455889999999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCC
Q 035930 787 EPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF 807 (857)
+|.+||+ +.++++||||
T Consensus 249 ~p~~Rp~----~~~~l~~~~~ 265 (265)
T cd06631 249 DQHERPS----ALQLLRHDFL 265 (265)
T ss_pred CcccCCC----HHHHhcCCCC
Confidence 9999999 9999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.74 Aligned_cols=242 Identities=14% Similarity=0.171 Sum_probs=205.8
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee----CCeEEEEEee
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT----EKFSCLVMEY 551 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~----~~~l~LVmEy 551 (857)
..||+|++|.||+|.+ +|+.||||+++..........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999998 678999999976533233335677899999999999999999999877 3578999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
+++|+|..++.... .+++.....++.|++.||.|||. .+++||||||+|||++.++.+||+|||++..+...
T Consensus 104 ~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----- 176 (283)
T PHA02988 104 CTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----- 176 (283)
T ss_pred CCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----
Confidence 99999999987653 48899999999999999999998 59999999999999999999999999997432100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
....+||
T Consensus 177 -------------------------------------------------------------------------~~~~~~~ 183 (283)
T PHA02988 177 -------------------------------------------------------------------------PFKNVNF 183 (283)
T ss_pred -------------------------------------------------------------------------cccccCc
Confidence 0123578
Q ss_pred CCccChhhhcC--CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 711 HEYLAPEIIKG--EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 711 ~~YmAPEil~g--~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..++....+++.+..++..+++||.+||+.||
T Consensus 184 ~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp 263 (283)
T PHA02988 184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDS 263 (283)
T ss_pred ccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCc
Confidence 99999999976 6789999999999999999999999998887788777776666666555689999999999999999
Q ss_pred CCcCCchhhHHHHHc
Q 035930 789 DNRLGAVKGAAEIKQ 803 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~ 803 (857)
++||+ +.+|++
T Consensus 264 ~~Rps----~~ell~ 274 (283)
T PHA02988 264 IKRPN----IKEILY 274 (283)
T ss_pred ccCcC----HHHHHH
Confidence 99999 666664
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=353.66 Aligned_cols=270 Identities=21% Similarity=0.287 Sum_probs=214.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
+..++|++.+.||.|+||.||+|.++. .+..||+|.++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999997652 356899999864421 1223456789999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCC--------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEE
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQP--------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML 613 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~--------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL 613 (857)
.+..|+||||+++|+|..++.... ...++...+..++.||+.||.|||++||+||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999999886532 123567788899999999999999999999999999999999999999
Q ss_pred ecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCC
Q 035930 614 SDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMP 693 (857)
Q Consensus 614 ~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p 693 (857)
+|||+++.......
T Consensus 161 ~Dfg~~~~~~~~~~------------------------------------------------------------------ 174 (288)
T cd05061 161 GDFGMTRDIYETDY------------------------------------------------------------------ 174 (288)
T ss_pred CcCCcccccccccc------------------------------------------------------------------
Confidence 99998743210000
Q ss_pred cccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCC
Q 035930 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVV 772 (857)
Q Consensus 694 ~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~i 772 (857)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+..... .+....+
T Consensus 175 -------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 246 (288)
T cd05061 175 -------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-LDQPDNC 246 (288)
T ss_pred -------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Confidence 000012235678999999999899999999999999999998 8999988777776666554432 2223457
Q ss_pred CHHHHHHHHhhccCCcCCcCCchhhHHHHHc--CCCCCCCCh
Q 035930 773 SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ--HPFFEGLNW 812 (857)
Q Consensus 773 s~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~--HPfF~~l~w 812 (857)
+..+++||.+||..||.+||+....++.+.+ ||||.+++|
T Consensus 247 ~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 247 PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 8999999999999999999994433333333 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.40 Aligned_cols=256 Identities=30% Similarity=0.429 Sum_probs=209.8
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|++.+.||.|+||.||+|.+..++..||||++..... .......+.+|+++|++++||||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48899999999999999999999999999999875432 22334567899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+. ++|..++.......+++..++.++.||+.||+|||..||+||||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~----- 153 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP----- 153 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC-----
Confidence 995 68888877655556899999999999999999999999999999999999999999999999987321100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
........++
T Consensus 154 ----------------------------------------------------------------------~~~~~~~~~~ 163 (284)
T cd07860 154 ----------------------------------------------------------------------VRTYTHEVVT 163 (284)
T ss_pred ----------------------------------------------------------------------cccccccccc
Confidence 0001122468
Q ss_pred CCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc------------------cCCC---
Q 035930 711 HEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL------------------RFPG--- 768 (857)
Q Consensus 711 ~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~------------------~~p~--- 768 (857)
+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+.++..... .++.
T Consensus 164 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd07860 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWAR 243 (284)
T ss_pred ccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccc
Confidence 8999999987754 58899999999999999999999987765444443332110 0111
Q ss_pred ------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 769 ------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 769 ------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.+.++.++++||.+||..||.+||+ ++++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~f 284 (284)
T cd07860 244 QDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS----AKAALAHPFF 284 (284)
T ss_pred cCHHHHcccCCHHHHHHHHHhcCCCcccCCC----HHHHhcCCCC
Confidence 2347889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=343.62 Aligned_cols=254 Identities=31% Similarity=0.474 Sum_probs=214.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+.+.||.|+||.||+|.+..++..+|+|++.... ......+.+|+++++.++||||+++++++..++.+|+||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 57999999999999999999999899999999997542 224567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|..++.... ..+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---- 154 (262)
T cd06613 80 EYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT---- 154 (262)
T ss_pred eCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh----
Confidence 9999999998887652 24899999999999999999999999999999999999999999999999987431100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........|
T Consensus 155 -----------------------------------------------------------------------~~~~~~~~~ 163 (262)
T cd06613 155 -----------------------------------------------------------------------IAKRKSFIG 163 (262)
T ss_pred -----------------------------------------------------------------------hhccccccC
Confidence 001123458
Q ss_pred CCCccChhhhcCC---CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC---CCCCCCHHHHHHHHhh
Q 035930 710 THEYLAPEIIKGE---GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP---GYPVVSFHARDLIRGL 783 (857)
Q Consensus 710 T~~YmAPEil~g~---~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p---~~~~is~~l~dLI~k~ 783 (857)
+..|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+....+..+ ....++.++.+||++|
T Consensus 164 ~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 243 (262)
T cd06613 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKC 243 (262)
T ss_pred CccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHH
Confidence 8899999999877 789999999999999999999999987765555544444433322 1234678899999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCC
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPF 806 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPf 806 (857)
|..||.+||+ +.+|+.|+|
T Consensus 244 l~~~p~~Rpt----~~~il~~~~ 262 (262)
T cd06613 244 LTKDPKKRPT----ATKLLQHPF 262 (262)
T ss_pred cCCChhhCCC----HHHHhcCCC
Confidence 9999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=341.29 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=217.2
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|++.+.||+|+||.||++.+..++..||||++..... .......+.+|+++|+.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999976533 23345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC-CcEEEecccchhhcccCcccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED-GHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d-g~iKL~DFGLA~r~~~~~~l~ 629 (857)
|+++++|.+++.......+++..+..++.|++.||.|||++||+||||+|+||+++.+ +.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----
Confidence 9999999999877555558999999999999999999999999999999999999865 46899999987431100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.......|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (256)
T cd08220 156 ------------------------------------------------------------------------SKAYTVVG 163 (256)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00112357
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......+...... +....++.++.+||.+||..||.
T Consensus 164 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~ 242 (256)
T cd08220 164 TPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-PISDRYSPDLRQLILSMLNLDPS 242 (256)
T ss_pred CCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC-CCCCCcCHHHHHHHHHHccCChh
Confidence 88999999999988999999999999999999999999887766666665544322 23345899999999999999999
Q ss_pred CcCCchhhHHHHHcCCCC
Q 035930 790 NRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 790 ~Rpt~~~~a~ELL~HPfF 807 (857)
+||+ +.+|++||||
T Consensus 243 ~Rpt----~~~ll~~p~~ 256 (256)
T cd08220 243 KRPQ----LSQIMAQPIC 256 (256)
T ss_pred hCCC----HHHHhhCCCC
Confidence 9999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=345.56 Aligned_cols=260 Identities=28% Similarity=0.420 Sum_probs=212.2
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc--cccchhHHHHHHHHHHHcCCCCccccceeeeeC--CeE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV--GRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE--KFS 545 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~--~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~--~~l 545 (857)
.+|.+.+.||+|+||.||++.+..++..||||++...... .......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4799999999999999999999999999999998643211 122345778899999999999999999998763 578
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+++++|.+++.... .+++..+..++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 89999999999999887653 3788999999999999999999999999999999999999999999999987432100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.. ......
T Consensus 160 ~~------------------------------------------------------------------------~~~~~~ 167 (265)
T cd06652 160 CL------------------------------------------------------------------------SGTGMK 167 (265)
T ss_pred cc------------------------------------------------------------------------cccccc
Confidence 00 000012
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
...|+..|+|||++.+..++.++|||||||++|||++|+.||........+..+.........+..++..+.++|++||.
T Consensus 168 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 247 (265)
T cd06652 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV 247 (265)
T ss_pred cCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc
Confidence 34588999999999998899999999999999999999999987655555554443333333334577889999999995
Q ss_pred CCcCCcCCchhhHHHHHcCCCCC
Q 035930 786 KEPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
+|.+||+ +++|++|||+.
T Consensus 248 -~p~~Rp~----~~~il~~~~~~ 265 (265)
T cd06652 248 -EAKLRPS----ADELLRHTFVH 265 (265)
T ss_pred -ChhhCCC----HHHHhcCcccC
Confidence 9999999 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=347.58 Aligned_cols=259 Identities=29% Similarity=0.443 Sum_probs=210.3
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc--cccchhHHHHHHHHHHHcCCCCccccceeeee--CCeEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV--GRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT--EKFSC 546 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~--~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~--~~~l~ 546 (857)
+|.+.+.||+|+||.||+|.+..++..||+|++...... ..+....+.+|+.+++.++||||+++++++.+ +..++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 688999999999999999999999999999998654221 12234567889999999999999999998875 36789
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++++|..++.... .+++..++.++.||+.||+|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 83 l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 9999999999998887653 38899999999999999999999999999999999999999999999999975321000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
. .......
T Consensus 161 ---------------------~---------------------------------------------------~~~~~~~ 168 (266)
T cd06651 161 ---------------------M---------------------------------------------------SGTGIRS 168 (266)
T ss_pred ---------------------c---------------------------------------------------cCCcccc
Confidence 0 0000112
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
..|+..|+|||++.+..++.++|||||||++|||++|+.||......+.+..+............++..+++|| .||..
T Consensus 169 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~ 247 (266)
T cd06651 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFV 247 (266)
T ss_pred CCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcC
Confidence 35789999999999999999999999999999999999999876555544444333222222345788899999 57778
Q ss_pred CcCCcCCchhhHHHHHcCCCCC
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
+|++||+ ++||++||||+
T Consensus 248 ~p~~Rp~----~~eil~hp~~~ 265 (266)
T cd06651 248 EARHRPS----AEELLRHPFAQ 265 (266)
T ss_pred ChhhCcC----HHHHhcCcccc
Confidence 9999999 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.43 Aligned_cols=256 Identities=28% Similarity=0.437 Sum_probs=209.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+++|+.++||||++++++|..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 3689999999999999999999989999999998654322 223456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++++.|..+..... .+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~---- 153 (286)
T cd07846 80 EFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP---- 153 (286)
T ss_pred ecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC----
Confidence 9999998887765432 3899999999999999999999999999999999999999999999999987431100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........+
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (286)
T cd07846 154 -----------------------------------------------------------------------GEVYTDYVA 162 (286)
T ss_pred -----------------------------------------------------------------------ccccCcccc
Confidence 001123457
Q ss_pred CCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-------------------ccCC--
Q 035930 710 THEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-------------------LRFP-- 767 (857)
Q Consensus 710 T~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-------------------~~~p-- 767 (857)
+..|+|||++.+. .++.++|||||||++|||++|+.||......+.+..+.... ...+
T Consensus 163 ~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd07846 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEV 242 (286)
T ss_pred eeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccc
Confidence 8999999999764 46889999999999999999999998665444333332110 1111
Q ss_pred --------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 768 --------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 768 --------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
..+.++..+.+||.+||..||++||+ +.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 286 (286)
T cd07846 243 KEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS----SSQLLHHEFF 286 (286)
T ss_pred cCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh----HHHHhcCCCC
Confidence 12457889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=345.39 Aligned_cols=256 Identities=29% Similarity=0.431 Sum_probs=210.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCC----
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEK---- 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~---- 543 (857)
.++|++.+.||.|+||+||+|.+..++..|++|++.... .....+.+|+++++++ +|+||++++++|....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 468999999999999999999999899999999987542 2345688999999999 6999999999997644
Q ss_pred --eEEEEEeecCCCChHHHHhhCC--CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 544 --FSCLVMEYCPGGDLHVLRQKQP--SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 544 --~l~LVmEy~~gGsL~~ll~~~~--~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
.+|+||||+++++|.+++.... ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 5899999999999988876533 345899999999999999999999999999999999999999999999999987
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
......
T Consensus 161 ~~~~~~-------------------------------------------------------------------------- 166 (275)
T cd06608 161 AQLDST-------------------------------------------------------------------------- 166 (275)
T ss_pred eecccc--------------------------------------------------------------------------
Confidence 431100
Q ss_pred CCCccccccCCCCccChhhhcC-----CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-cCCCCCCCC
Q 035930 700 TGARSNSFVGTHEYLAPEIIKG-----EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-RFPGYPVVS 773 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g-----~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-~~p~~~~is 773 (857)
........|+..|+|||++.+ ..++.++|||||||+||+|++|..||........+..+..... .......++
T Consensus 167 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (275)
T cd06608 167 -LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWS 245 (275)
T ss_pred -hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcC
Confidence 000123458899999999864 3467899999999999999999999987655555555444322 122223477
Q ss_pred HHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 774 FHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.++++||.+||..||++||+ +.+|++|||+
T Consensus 246 ~~~~~li~~~l~~dp~~Rpt----~~~ll~~~~~ 275 (275)
T cd06608 246 KKFNDFISECLIKNYEQRPF----MEELLEHPFI 275 (275)
T ss_pred HHHHHHHHHHhhcChhhCcC----HHHHhcCCCC
Confidence 89999999999999999999 9999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=379.70 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=203.6
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+++|+.|+||||+++++++..++..|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996422 2357899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
||++ .++|..++..... .+++..++.++.||+.||.|||++|||||||||+||||+.++.++|+|||++..+....
T Consensus 239 ~e~~-~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-- 314 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW-- 314 (461)
T ss_pred EEcc-CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc--
Confidence 9999 5788877765432 48999999999999999999999999999999999999999999999999974321000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........+
T Consensus 315 -----------------------------------------------------------------------~~~~~~~~~ 323 (461)
T PHA03211 315 -----------------------------------------------------------------------STPFHYGIA 323 (461)
T ss_pred -----------------------------------------------------------------------ccccccccC
Confidence 000012346
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC-------hhhhHHHhhc-ccc---CC----------
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-------DETLSNVVSQ-SLR---FP---------- 767 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~-------~e~l~~Iv~~-~~~---~p---------- 767 (857)
||+.|||||++.+..++.++|||||||+||||++|..|+..... ...+.+++.. ... ++
T Consensus 324 GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~ 403 (461)
T PHA03211 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQ 403 (461)
T ss_pred CCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHH
Confidence 99999999999999999999999999999999998876543221 1222222221 110 10
Q ss_pred -------------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 768 -------------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 768 -------------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
....++.++.+||.+||..||.+||+ +.|||+||||+.
T Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs----a~elL~hp~f~~ 460 (461)
T PHA03211 404 YRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS----AAELLRLPLFQS 460 (461)
T ss_pred HHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC----HHHHhhCcccCC
Confidence 01135568999999999999999999 999999999974
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=345.14 Aligned_cols=261 Identities=25% Similarity=0.415 Sum_probs=212.1
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccc---ccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG---RKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~---~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
+|+..+.||+|+||.||++.+..++..||+|++....... ......+.+|+.+|++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999987542111 1234678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC-cEEEecccchhhcccCc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG-HIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg-~iKL~DFGLA~r~~~~~ 626 (857)
||||+++++|..++.... .+++..++.++.||+.||.|||++||+||||+|+||+++.++ .++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 999999999999887643 489999999999999999999999999999999999998776 59999999874421100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
. ........
T Consensus 159 ~-----------------------------------------------------------------------~~~~~~~~ 167 (268)
T cd06630 159 T-----------------------------------------------------------------------GAGEFQGQ 167 (268)
T ss_pred c-----------------------------------------------------------------------cCCccccc
Confidence 0 00000123
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHH---hhccccCCCCCCCCHHHHHHHHhh
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV---VSQSLRFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~I---v~~~~~~p~~~~is~~l~dLI~k~ 783 (857)
..|+..|+|||++.+..++.++|||+|||++|+|++|..||...........+ ............++.++.++|.+|
T Consensus 168 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 247 (268)
T cd06630 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRC 247 (268)
T ss_pred cccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHH
Confidence 45899999999999999999999999999999999999999755433222222 222222223345788999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCC
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
|..+|.+||+ +.++++||||+
T Consensus 248 l~~~p~~R~~----~~~ll~~~~~~ 268 (268)
T cd06630 248 LELQPEDRPP----SRELLKHPVFR 268 (268)
T ss_pred cCCCcccCcC----HHHHhcCcccC
Confidence 9999999999 99999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=355.69 Aligned_cols=256 Identities=28% Similarity=0.423 Sum_probs=214.5
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
.+|.+.+.||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||++++++|..++..|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 68999999999999999999999999999999986542 223456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|..++... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~---- 168 (297)
T cd06656 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 168 (297)
T ss_pred cccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC----
Confidence 999999999988653 3789999999999999999999999999999999999999999999999987321000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........|
T Consensus 169 -----------------------------------------------------------------------~~~~~~~~~ 177 (297)
T cd06656 169 -----------------------------------------------------------------------QSKRSTMVG 177 (297)
T ss_pred -----------------------------------------------------------------------ccCcCcccC
Confidence 000112357
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-ccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-LRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+....+..+.... ........++..+++||.+||..||
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 257 (297)
T cd06656 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDV 257 (297)
T ss_pred CccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCCh
Confidence 889999999999999999999999999999999999998765443333222221 1222334578899999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.+||+ ++++++||||...
T Consensus 258 ~~Rps----~~~il~~~~~~~~ 275 (297)
T cd06656 258 DRRGS----AKELLQHPFLKLA 275 (297)
T ss_pred hhCcC----HHHHhcCchhccc
Confidence 99999 9999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=353.62 Aligned_cols=273 Identities=27% Similarity=0.398 Sum_probs=216.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC--Ce
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE--KF 544 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~--~~ 544 (857)
....+|++.+.||.|+||.||+|.+..++..||+|++...... ......+.+|+.+|+.++|+||+++++++... +.
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 3567899999999999999999999999999999998654221 22223456899999999999999999998765 57
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|+||||+. ++|..++.... ..+++..++.++.||+.||.|||..||+||||||+|||++.++.++|+|||++.....
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 899999995 58887776543 3489999999999999999999999999999999999999999999999998743210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
. ....
T Consensus 161 ~---------------------------------------------------------------------------~~~~ 165 (309)
T cd07845 161 P---------------------------------------------------------------------------AKPM 165 (309)
T ss_pred c---------------------------------------------------------------------------cCCC
Confidence 0 0000
Q ss_pred ccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-------------------c
Q 035930 705 NSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-------------------L 764 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-------------------~ 764 (857)
....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.... +
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (309)
T cd07845 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245 (309)
T ss_pred CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccc
Confidence 11235788999999876 557999999999999999999999999887766666554421 1
Q ss_pred cCCC---------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCC
Q 035930 765 RFPG---------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPR 825 (857)
Q Consensus 765 ~~p~---------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~ 825 (857)
..+. ...+++.+.+||.+||..||++||+ +.+++.||||.+. ++- ..|..+|.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~~il~h~~f~~~--~~~--~~~~~~~~ 307 (309)
T cd07845 246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT----AEEALESSYFKEK--PLP--CEPEMMPT 307 (309)
T ss_pred cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC----HHHHhcChhhccC--CCC--CCCCcCCC
Confidence 1110 1235788999999999999999999 9999999999853 332 22556654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=348.14 Aligned_cols=255 Identities=20% Similarity=0.264 Sum_probs=210.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc---CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~---~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
+...+|++.+.||+|+||.||+|.+. ..+..||+|+++... .......+.+|+.+|+.++||||+++++++..++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34567999999999999999999875 456789999987642 1233456789999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
+.||||||+++|+|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999887653 348999999999999999999999999999999999999999999999999752210
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
... ...
T Consensus 159 ~~~--------------------------------------------------------------------------~~~ 164 (266)
T cd05064 159 SEA--------------------------------------------------------------------------IYT 164 (266)
T ss_pred ccc--------------------------------------------------------------------------hhc
Confidence 000 000
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+ .....++....++..+.+|+..
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 243 (266)
T cd05064 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRNCPNLLHQLMLD 243 (266)
T ss_pred ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHH
Confidence 012235678999999999999999999999999999774 99999887766665554 3444556667789999999999
Q ss_pred hccCCcCCcCCchhhHHHHHc
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||..+|.+||+ +.+|++
T Consensus 244 c~~~~p~~RP~----~~~i~~ 260 (266)
T cd05064 244 CWQKERGERPR----FSQIHS 260 (266)
T ss_pred HcCCCchhCCC----HHHHHH
Confidence 99999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=354.06 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=217.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
.+|++.+.||.|+||+||+|.+..+++.||||.+.... ......+.+|+.+++.++||||++++++|..++.+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 57999999999999999999999999999999986542 233466789999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|..++... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~---- 168 (296)
T cd06655 96 EYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE---- 168 (296)
T ss_pred EecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc----
Confidence 999999999888653 3899999999999999999999999999999999999999999999999986321100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........|
T Consensus 169 -----------------------------------------------------------------------~~~~~~~~~ 177 (296)
T cd06655 169 -----------------------------------------------------------------------QSKRSTMVG 177 (296)
T ss_pred -----------------------------------------------------------------------cccCCCcCC
Confidence 000112358
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-cCCCCCCCCHHHHHHHHhhccCCc
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-RFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+....+..+..... .+.....+++.+.+||++||..||
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 257 (296)
T cd06655 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDV 257 (296)
T ss_pred CccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcCh
Confidence 8999999999998899999999999999999999999988766555444433222 222345688999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.+||+ +.+|++||||...
T Consensus 258 ~~Rpt----~~~il~~~~~~~~ 275 (296)
T cd06655 258 EKRGS----AKELLQHPFLKLA 275 (296)
T ss_pred hhCCC----HHHHhhChHhhhc
Confidence 99999 9999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=347.29 Aligned_cols=261 Identities=26% Similarity=0.363 Sum_probs=208.0
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHH-HHHcCCCCccccceeeeeCCeEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI-MQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieI-Lr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
++|++.+.||+|+||.||++.+..+|..||||+++..... .....+..|+.+ ++.++||||+++++++..++..|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 4799999999999999999999999999999998764221 122344556654 6777999999999999999999999
Q ss_pred EeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 549 MEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHML-GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~-GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|||++ |+|..++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99995 6887666542 224589999999999999999999997 999999999999999999999999998742100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.....
T Consensus 157 ---------------------------------------------------------------------------~~~~~ 161 (283)
T cd06617 157 ---------------------------------------------------------------------------SVAKT 161 (283)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00011
Q ss_pred cccCCCCccChhhhcC----CCCCcccceehhhHHHHHHhhCCCCCCCCC-ChhhhHHHhhccccCCCCCCCCHHHHHHH
Q 035930 706 SFVGTHEYLAPEIIKG----EGHGSSVDWWTFGIFLFELLYGRTPFKGSG-NDETLSNVVSQSLRFPGYPVVSFHARDLI 780 (857)
Q Consensus 706 s~vGT~~YmAPEil~g----~~~s~ksDVWSLGvILyELLtGk~PF~g~~-~~e~l~~Iv~~~~~~p~~~~is~~l~dLI 780 (857)
...|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||.... ..+.+..+.......-....++.++.+||
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (283)
T cd06617 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFV 241 (283)
T ss_pred cccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 2357889999999865 456889999999999999999999997532 23444444433222111235789999999
Q ss_pred HhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
.+||..+|.+||+ +.+++.||||....+.
T Consensus 242 ~~~l~~~p~~Rp~----~~~il~~~~~~~~~~~ 270 (283)
T cd06617 242 NKCLKKNYKERPN----YPELLQHPFFELHLSK 270 (283)
T ss_pred HHHccCChhhCcC----HHHHhcCchhhhcccc
Confidence 9999999999999 9999999999987665
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=342.04 Aligned_cols=252 Identities=25% Similarity=0.453 Sum_probs=213.7
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|++.+.||.|+||.||++.+..++..||+|.++... .....+.+.+|+.+++.++||||++++++|.+++.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5889999999999999999999999999999986542 22345677889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|..++.......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~----- 153 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----- 153 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-----
Confidence 999999988887655556899999999999999999999999999999999999999999999999987431100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
........|+
T Consensus 154 ----------------------------------------------------------------------~~~~~~~~~~ 163 (255)
T cd08219 154 ----------------------------------------------------------------------GAYACTYVGT 163 (255)
T ss_pred ----------------------------------------------------------------------ccccccccCC
Confidence 0001234588
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCC
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDN 790 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~ 790 (857)
+.|+|||++.+..++.++|+||||+++|+|++|..||...+....+..+...... +....++..+++||.+||..||++
T Consensus 164 ~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~ 242 (255)
T cd08219 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMFKRNPRS 242 (255)
T ss_pred ccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHHhCCccc
Confidence 9999999999999999999999999999999999999877666665555544333 233568899999999999999999
Q ss_pred cCCchhhHHHHHcC
Q 035930 791 RLGAVKGAAEIKQH 804 (857)
Q Consensus 791 Rpt~~~~a~ELL~H 804 (857)
||+ +.+|+.-
T Consensus 243 Rp~----~~~il~~ 252 (255)
T cd08219 243 RPS----ATTILSR 252 (255)
T ss_pred CCC----HHHHhhc
Confidence 999 8888763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=341.67 Aligned_cols=253 Identities=28% Similarity=0.458 Sum_probs=213.5
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+.+.||.|+||.||+|.+..++..||+|.+.... ..+.+.+|+++++.++||||+++++++.++...|++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 57899999999999999999999889999999986542 1567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|.+++.... ..+++..++.++.||+.||.|||..||+||||+|+||+++.++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~---- 152 (256)
T cd06612 78 EYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---- 152 (256)
T ss_pred ecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC----
Confidence 9999999999887543 34899999999999999999999999999999999999999999999999987431100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........|
T Consensus 153 -----------------------------------------------------------------------~~~~~~~~~ 161 (256)
T cd06612 153 -----------------------------------------------------------------------MAKRNTVIG 161 (256)
T ss_pred -----------------------------------------------------------------------ccccccccC
Confidence 000122347
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-ccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-LRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.... ..+.....++.++.+||.+||..||
T Consensus 162 ~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 241 (256)
T cd06612 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDP 241 (256)
T ss_pred CccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcCh
Confidence 889999999999999999999999999999999999998765544433332211 1122234578899999999999999
Q ss_pred CCcCCchhhHHHHHcCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF 807 (857)
.+||+ +.++|.||||
T Consensus 242 ~~Rps----~~~il~~~~~ 256 (256)
T cd06612 242 EERPS----AIQLLQHPFI 256 (256)
T ss_pred hhCcC----HHHHhcCCCC
Confidence 99999 9999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=348.28 Aligned_cols=256 Identities=31% Similarity=0.453 Sum_probs=204.9
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++.+.||.|+||+||+|.+..+++.||||.+..... ......+.+|+++|+.++||||+++++++.+++..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 4689999999999999999999998999999999875421 22233467899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+. ++|..++..... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 82 ~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 156 (291)
T cd07844 82 FEYLD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--- 156 (291)
T ss_pred EecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC---
Confidence 99996 589888876543 5899999999999999999999999999999999999999999999999987321000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 157 ------------------------------------------------------------------------~~~~~~~~ 164 (291)
T cd07844 157 ------------------------------------------------------------------------SKTYSNEV 164 (291)
T ss_pred ------------------------------------------------------------------------Cccccccc
Confidence 00001124
Q ss_pred CCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCC-ChhhhHHHhhc-------------------cccCC
Q 035930 709 GTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSG-NDETLSNVVSQ-------------------SLRFP 767 (857)
Q Consensus 709 GT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~-~~e~l~~Iv~~-------------------~~~~p 767 (857)
++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. ..+.+..+... ...++
T Consensus 165 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (291)
T cd07844 165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFP 244 (291)
T ss_pred cccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccccc
Confidence 6788999999876 458999999999999999999999997654 22222211110 00000
Q ss_pred ---------CCCCCC--HHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 768 ---------GYPVVS--FHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 768 ---------~~~~is--~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
..+.++ .++.+||.+||..||++||+ +.++++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps----~~e~l~~~~f 291 (291)
T cd07844 245 FYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS----AAEAMKHPYF 291 (291)
T ss_pred ccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 012344 78899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=346.28 Aligned_cols=257 Identities=33% Similarity=0.488 Sum_probs=211.6
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|++.+.||+|+||.||+|.+..++..||||++...... ......+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 589999999999999999999999999999998765321 2334678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+ +++|..++.... ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~---- 153 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE---- 153 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC----
Confidence 99 999998886544 448999999999999999999999999999999999999999999999999874321000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
........|+
T Consensus 154 ----------------------------------------------------------------------~~~~~~~~~~ 163 (286)
T cd07832 154 ----------------------------------------------------------------------PRLYSHQVAT 163 (286)
T ss_pred ----------------------------------------------------------------------CCccccccCc
Confidence 0001123588
Q ss_pred CCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-------------------cCCC--
Q 035930 711 HEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-------------------RFPG-- 768 (857)
Q Consensus 711 ~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-------------------~~p~-- 768 (857)
..|+|||++.+.. ++.++|||||||++|||++|.+||.+....+.+..++.... .++.
T Consensus 164 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (286)
T cd07832 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESK 243 (286)
T ss_pred ccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCC
Confidence 9999999987654 68999999999999999999988987665555544433110 1111
Q ss_pred -------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCC
Q 035930 769 -------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 769 -------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
.+..+..+.+||.+||..||++||+ ++++++||||.
T Consensus 244 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~----~~~~l~h~~~~ 286 (286)
T cd07832 244 PIPLEEIFPDASPEALDLLKGLLVYDPSKRLS----AAEALRHPYFT 286 (286)
T ss_pred cchHHHhCCCccHHHHHHHHHHhccChhhCCC----HHHHhhCcCcC
Confidence 1346788999999999999999999 99999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=370.05 Aligned_cols=258 Identities=20% Similarity=0.300 Sum_probs=210.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCC-----eEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTS-----CLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg-----~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~ 540 (857)
+..++|++.+.||+|+||.||+|.+...+ ..||||+++.... ......+.+|+++|+.+ +|+||++++++|.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 45568999999999999999999875443 5799999975422 23345678999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCC-------------------------------------------------------
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQP------------------------------------------------------- 565 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~------------------------------------------------------- 565 (857)
..+..||||||+++|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999988875421
Q ss_pred -------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCC
Q 035930 566 -------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSS 632 (857)
Q Consensus 566 -------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~s 632 (857)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~------ 266 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS------ 266 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc------
Confidence 1247888999999999999999999999999999999999999999999999974311000
Q ss_pred CCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCC
Q 035930 633 SPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHE 712 (857)
Q Consensus 633 s~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~ 712 (857)
.........++..
T Consensus 267 -------------------------------------------------------------------~~~~~~~~~~~~~ 279 (374)
T cd05106 267 -------------------------------------------------------------------NYVVKGNARLPVK 279 (374)
T ss_pred -------------------------------------------------------------------ceeeccCCCCccc
Confidence 0000112235678
Q ss_pred ccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCc
Q 035930 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791 (857)
Q Consensus 713 YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~R 791 (857)
|||||++.+..++.++|||||||+||||++ |+.||........+..++......+....+++++.+||.+||+.||.+|
T Consensus 280 y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 359 (374)
T cd05106 280 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTER 359 (374)
T ss_pred eeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhC
Confidence 999999999999999999999999999997 9999988766666666666655555555678999999999999999999
Q ss_pred CCchhhHHHHHc
Q 035930 792 LGAVKGAAEIKQ 803 (857)
Q Consensus 792 pt~~~~a~ELL~ 803 (857)
|+ +.+|++
T Consensus 360 Ps----~~~l~~ 367 (374)
T cd05106 360 PT----FSQISQ 367 (374)
T ss_pred cC----HHHHHH
Confidence 99 666654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=368.67 Aligned_cols=258 Identities=20% Similarity=0.289 Sum_probs=210.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEE-----cCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAEL-----IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~-----~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~ 540 (857)
+..++|++.+.||.|+||+||+|.+ ..++..||||+++... .....+.+.+|+.+|+.+ +||||++++++|.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 4456899999999999999999975 3456789999997542 123345678999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCC-------------------------------------------------------
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQP------------------------------------------------------- 565 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~------------------------------------------------------- 565 (857)
..+..|+|||||++|+|..++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999988876432
Q ss_pred ------------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 566 ------------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 566 ------------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 11377888999999999999999999999999999999999999999999999743211000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.......
T Consensus 270 -------------------------------------------------------------------------~~~~~~~ 276 (375)
T cd05104 270 -------------------------------------------------------------------------YVVKGNA 276 (375)
T ss_pred -------------------------------------------------------------------------ccccCCC
Confidence 0000122
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
.++..|+|||++.+..++.++|||||||+||||++ |..||........+...+....+...+...+.++++||.+||..
T Consensus 277 ~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 356 (375)
T cd05104 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDA 356 (375)
T ss_pred CCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccC
Confidence 35678999999999999999999999999999997 99999887666555666665555544456788999999999999
Q ss_pred CcCCcCCchhhHHHHHc
Q 035930 787 EPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~ 803 (857)
||++||+ +.+|++
T Consensus 357 dP~~RPs----~~eil~ 369 (375)
T cd05104 357 DPLKRPT----FKQIVQ 369 (375)
T ss_pred ChhHCcC----HHHHHH
Confidence 9999999 777765
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=345.24 Aligned_cols=279 Identities=38% Similarity=0.635 Sum_probs=224.9
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LV 548 (857)
++|.+.+.||.|+||.||++.+..++..||+|++.............+.+|+++++.++ ||||+++++++..++..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 37999999999999999999999999999999998754444445567889999999998 99999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+.+++|..++.... .+++..++.++.||+.||.|||+.|++|+||+|+||+++.+++++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999887764 4999999999999999999999999999999999999999999999999998543211000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
. ...+ ..+. ..............+.
T Consensus 159 ~--------------~~~~----------------~~~~-------------------------~~~~~~~~~~~~~~~~ 183 (280)
T cd05581 159 E--------------SNKG----------------DATN-------------------------IDSQIEKNRRRFASFV 183 (280)
T ss_pred c--------------cCCC----------------CCcc-------------------------cccccccccccccccc
Confidence 0 0000 0000 0000001112234567
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
|+..|+|||++.+..++.++|+|+|||++|+|++|+.||...+....+..+......++ ..++..+.+||.+||..||
T Consensus 184 ~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p 261 (280)
T cd05581 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFP--PNFPPDAKDLIEKLLVLDP 261 (280)
T ss_pred CCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCC--CccCHHHHHHHHHHhcCCH
Confidence 89999999999988899999999999999999999999998876666666665444444 4579999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF 807 (857)
.+||++....++||+||||
T Consensus 262 ~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 262 QDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred hhCCCcccCHHHHhcCCCC
Confidence 9999921122999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=349.77 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=211.3
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++++.||+|+||+||++.+..++..||+|++.... .......+.+|+++|++++||||+++++++..++.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 36889999999999999999999999999999986531 2233467889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 550 EYCPGGDLHVLRQKQP-SRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~-~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||+++++|..++.... ...+++..++.++.||+.||.|||. .||+||||||+|||++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 9999999988876531 2248999999999999999999996 5999999999999999999999999998732100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
......
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (286)
T cd06622 156 --------------------------------------------------------------------------SLAKTN 161 (286)
T ss_pred --------------------------------------------------------------------------CccccC
Confidence 001123
Q ss_pred cCCCCccChhhhcCC------CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh--ccccCCCCCCCCHHHHHH
Q 035930 708 VGTHEYLAPEIIKGE------GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QSLRFPGYPVVSFHARDL 779 (857)
Q Consensus 708 vGT~~YmAPEil~g~------~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~--~~~~~p~~~~is~~l~dL 779 (857)
.|++.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.. .......++.++.++.+|
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (286)
T cd06622 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDF 241 (286)
T ss_pred CCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHH
Confidence 478899999998654 358899999999999999999999976544443332211 112222334589999999
Q ss_pred HHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 780 IRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
|.+||..+|.+||+ +.++++||||...
T Consensus 242 i~~~l~~~p~~Rp~----~~~l~~~~~~~~~ 268 (286)
T cd06622 242 VAKCLNKIPNRRPT----YAQLLEHPWLVKY 268 (286)
T ss_pred HHHHcccCcccCCC----HHHHhcChhhhhc
Confidence 99999999999999 9999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=354.39 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=190.5
Q ss_pred EeEEccCCceEEEEEEEcC--CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeee--eCCeEEEEEe
Q 035930 475 HKKLGCGDIGTVYLAELIG--TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFT--TEKFSCLVME 550 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~--tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~--~~~~l~LVmE 550 (857)
+.+||+|+||+||+|.+.. ++..||+|.+... .....+.+|+++|+.++||||++++++|. .+..+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-----GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC-----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999999754 5688999998654 22345688999999999999999999885 3568899999
Q ss_pred ecCCCChHHHHhhC-------CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE----ccCCcEEEecccch
Q 035930 551 YCPGGDLHVLRQKQ-------PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV----REDGHIMLSDFDLS 619 (857)
Q Consensus 551 y~~gGsL~~ll~~~-------~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL----~~dg~iKL~DFGLA 619 (857)
|+. ++|..++... ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 995 5776665421 12248899999999999999999999999999999999999 45679999999998
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
+.......
T Consensus 160 ~~~~~~~~------------------------------------------------------------------------ 167 (317)
T cd07867 160 RLFNSPLK------------------------------------------------------------------------ 167 (317)
T ss_pred eccCCCcc------------------------------------------------------------------------
Confidence 53210000
Q ss_pred CCCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCCh---------hhhHHHhhc-------
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGND---------ETLSNVVSQ------- 762 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~---------e~l~~Iv~~------- 762 (857)
........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.....+ ..+..+...
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (317)
T cd07867 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADK 247 (317)
T ss_pred cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChh
Confidence 00011234689999999999874 5799999999999999999999999754321 011111100
Q ss_pred -------cccC----------------------CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 763 -------SLRF----------------------PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 763 -------~~~~----------------------p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
...+ ......+..+.+||.+||+.||.+||| ++|+|+||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07867 248 DWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRIT----SEQALQDPYF 317 (317)
T ss_pred hhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 0000 001124567889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=352.32 Aligned_cols=255 Identities=23% Similarity=0.329 Sum_probs=203.4
Q ss_pred CCCeEEEeEEccCCceEEEEEEEc----------------CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCc
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELI----------------GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~----------------~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnI 532 (857)
.++|.+.++||+|+||.||+|.+. +++..||||++.... .......+.+|+++|+.++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 468999999999999999999863 244579999987542 12234568899999999999999
Q ss_pred cccceeeeeCCeEEEEEeecCCCChHHHHhhCCC-----------------CCCcHHHHHHHHHHHHHHHHHHHHcCcee
Q 035930 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPS-----------------RFFSEQAARFYVAEVLLALEYLHMLGVVY 595 (857)
Q Consensus 533 V~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~-----------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIH 595 (857)
++++++|.+.+..||||||+++|+|.+++..... ..+++..+..++.||+.||.|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 9999999999999999999999999988764321 23677889999999999999999999999
Q ss_pred ccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHH
Q 035930 596 RDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVA 675 (857)
Q Consensus 596 RDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~ 675 (857)
|||||+|||++.++.+||+|||++........
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~------------------------------------------------ 193 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY------------------------------------------------ 193 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCce------------------------------------------------
Confidence 99999999999999999999998743210000
Q ss_pred HhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh--CCCCCCCCCCh
Q 035930 676 AKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY--GRTPFKGSGND 753 (857)
Q Consensus 676 ~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt--Gk~PF~g~~~~ 753 (857)
........++..|||||++.+..++.++|||||||++|||++ +..||.+....
T Consensus 194 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 248 (304)
T cd05096 194 -------------------------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248 (304)
T ss_pred -------------------------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHH
Confidence 000122346788999999999999999999999999999986 67888877665
Q ss_pred hhhHHHhh---c---cccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHH
Q 035930 754 ETLSNVVS---Q---SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 754 e~l~~Iv~---~---~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL 802 (857)
+.+..+.. . .......+.++..+.+||.+||..||.+||+ +.+|.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs----~~~i~ 299 (304)
T cd05096 249 QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS----FSDIH 299 (304)
T ss_pred HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC----HHHHH
Confidence 55544322 1 1112223467899999999999999999999 77774
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=346.24 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=207.4
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeee-----e
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFT-----T 541 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~-----~ 541 (857)
..++|++.+.||+|+||+||++.+..++..||+|++... ......+.+|+.+++.+ +||||++++++|. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI----HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc----cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 457899999999999999999999999999999988643 12234577899999999 6999999999884 4
Q ss_pred CCeEEEEEeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
++..|+||||+++++|..++... ....+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 46789999999999998876532 2235889999999999999999999999999999999999999999999999987
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
......
T Consensus 172 ~~~~~~-------------------------------------------------------------------------- 177 (286)
T cd06638 172 AQLTST-------------------------------------------------------------------------- 177 (286)
T ss_pred eecccC--------------------------------------------------------------------------
Confidence 432100
Q ss_pred CCCccccccCCCCccChhhhcC-----CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-ccCCCCCCCC
Q 035930 700 TGARSNSFVGTHEYLAPEIIKG-----EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-LRFPGYPVVS 773 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g-----~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-~~~p~~~~is 773 (857)
........|++.|+|||++.+ ..++.++|||||||++|||++|+.||........+..+.... ........++
T Consensus 178 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (286)
T cd06638 178 -RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWS 256 (286)
T ss_pred -CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcC
Confidence 000112358899999999853 457889999999999999999999998765544443332221 1222233467
Q ss_pred HHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 774 FHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
..+.+||.+||..||++||+ +.||++|+||
T Consensus 257 ~~~~~li~~~l~~~p~~Rps----~~ell~~~~~ 286 (286)
T cd06638 257 NEFNDFIRKCLTKDYEKRPT----VSDLLQHVFI 286 (286)
T ss_pred HHHHHHHHHHccCCcccCCC----HHHHhhcccC
Confidence 89999999999999999999 9999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=400.00 Aligned_cols=266 Identities=27% Similarity=0.382 Sum_probs=217.2
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee--C
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT--E 542 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~--~ 542 (857)
+.....+|.+++.||+|+||+||+|++..++..||+|++..... .......+..|+.+|+.|+|||||+++++|.. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 44566799999999999999999999999999999999975532 22345678899999999999999999999864 3
Q ss_pred CeEEEEEeecCCCChHHHHhhCC--CCCCcHHHHHHHHHHHHHHHHHHHHc-------CceeccCCCCcEEEcc------
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQP--SRFFSEQAARFYVAEVLLALEYLHML-------GVVYRDLKPENILVRE------ 607 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~--~~~l~e~~~r~i~~QIl~gL~yLHs~-------GIIHRDLKPeNILL~~------ 607 (857)
..+||||||+++|+|..++.... ...+++..++.|+.||+.||.|||.. +||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 57899999999999998886532 23589999999999999999999985 4999999999999964
Q ss_pred -----------CCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHH
Q 035930 608 -----------DGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAA 676 (857)
Q Consensus 608 -----------dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~ 676 (857)
.+.+||+|||++..+...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~--------------------------------------------------- 195 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIE--------------------------------------------------- 195 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccc---------------------------------------------------
Confidence 234899999987431100
Q ss_pred hhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcC--CCCCcccceehhhHHHHHHhhCCCCCCCCCChh
Q 035930 677 KSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKG--EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE 754 (857)
Q Consensus 677 ~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g--~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e 754 (857)
......+||+.|+|||++.+ ..++.++||||||||||||++|..||.......
T Consensus 196 -------------------------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 196 -------------------------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred -------------------------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 00123469999999999975 447899999999999999999999998766655
Q ss_pred hhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 755 TLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 755 ~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
.+...+.....++. ..++.++.+||..||..+|.+||+ +.++|.||||..+..
T Consensus 251 qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPS----a~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 251 QLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPS----ALQCLGYQIIKNVGP 303 (1021)
T ss_pred HHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcC----HHHHhccHHHhhcCC
Confidence 55555544433332 457899999999999999999999 999999999987654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=338.86 Aligned_cols=256 Identities=29% Similarity=0.473 Sum_probs=216.2
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|.+.+.||.|+||.||++.+..++..||+|.+..... .....+.+.+|+++++.++|+||+++++.+..+...|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58899999999999999999999999999999876432 22344567899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC-cEEEecccchhhcccCcccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG-HIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg-~iKL~DFGLA~r~~~~~~l~ 629 (857)
|+++++|.+++.......+++..++.++.||+.||.|||..+|+|+||||+||+++.++ .++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS---- 155 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC----
Confidence 99999999988776555589999999999999999999999999999999999999886 4699999987431100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........|
T Consensus 156 -----------------------------------------------------------------------~~~~~~~~~ 164 (257)
T cd08225 156 -----------------------------------------------------------------------MELAYTCVG 164 (257)
T ss_pred -----------------------------------------------------------------------cccccccCC
Confidence 000112347
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
++.|+|||++.+..++.++|+|||||++|||++|..||...+..+.+..+...... +..+.++.+++++|.+||..+|+
T Consensus 165 ~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~ 243 (257)
T cd08225 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLISQLFKVSPR 243 (257)
T ss_pred CccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC-CCCCCCCHHHHHHHHHHhccChh
Confidence 89999999999888999999999999999999999999877666655555443322 33456789999999999999999
Q ss_pred CcCCchhhHHHHHcCCCC
Q 035930 790 NRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 790 ~Rpt~~~~a~ELL~HPfF 807 (857)
+||+ +.+|++||||
T Consensus 244 ~Rpt----~~~ll~~~~~ 257 (257)
T cd08225 244 DRPS----ITSILKRPFL 257 (257)
T ss_pred hCcC----HHHHhhCCCC
Confidence 9999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=348.21 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=212.4
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCC-----eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTS-----CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg-----~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
...+|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 3467999999999999999999987655 789999986542 223345678999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCC--------------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPS--------------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED 608 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~--------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d 608 (857)
+..|++|||+++++|..++..... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 999999999999999988875421 347889999999999999999999999999999999999999
Q ss_pred CcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcc
Q 035930 609 GHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQ 688 (857)
Q Consensus 609 g~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~ 688 (857)
+.++|+|||++........
T Consensus 161 ~~~~L~dfg~~~~~~~~~~------------------------------------------------------------- 179 (283)
T cd05048 161 LTVKISDFGLSRDIYSADY------------------------------------------------------------- 179 (283)
T ss_pred CcEEECCCcceeecccccc-------------------------------------------------------------
Confidence 9999999999743210000
Q ss_pred cCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCC
Q 035930 689 VSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFP 767 (857)
Q Consensus 689 ~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p 767 (857)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.... ..+
T Consensus 180 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~ 246 (283)
T cd05048 180 ------------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ-LLP 246 (283)
T ss_pred ------------ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCC
Confidence 000112346788999999998899999999999999999997 999999887777666655443 333
Q ss_pred CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 768 GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 768 ~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
....++.++.+|+.+||..||.+||+ +.+|+++
T Consensus 247 ~~~~~~~~~~~l~~~c~~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05048 247 CPEDCPARVYALMIECWNEIPARRPR----FKDIHTR 279 (283)
T ss_pred CcccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 44568999999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.86 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=210.0
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeC----
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTE---- 542 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~---- 542 (857)
..++|.+.+.||.|+||.||++.+..+++.||+|++... ......+.+|+.+++.+ +||||++++++|...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc----ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 357899999999999999999999999999999998643 12234567899999998 799999999998754
Q ss_pred -CeEEEEEeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 543 -KFSCLVMEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 543 -~~l~LVmEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
+..|+||||+++++|..++... ....+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 3689999999999998887532 2235899999999999999999999999999999999999999999999999987
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
......
T Consensus 176 ~~~~~~-------------------------------------------------------------------------- 181 (291)
T cd06639 176 AQLTST-------------------------------------------------------------------------- 181 (291)
T ss_pred hhcccc--------------------------------------------------------------------------
Confidence 431100
Q ss_pred CCCccccccCCCCccChhhhcCC-----CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-cCCCCCCCC
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGE-----GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-RFPGYPVVS 773 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~-----~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-~~p~~~~is 773 (857)
........|+..|+|||++... .++.++|||||||++|||++|+.||......+.+..+..... .+.....++
T Consensus 182 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (291)
T cd06639 182 -RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWC 260 (291)
T ss_pred -cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccC
Confidence 0001123578899999998643 368899999999999999999999987765555554433322 222334577
Q ss_pred HHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCC
Q 035930 774 FHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
..+.+||.+||..||++||+ +.+|++||||.
T Consensus 261 ~~l~~li~~~l~~~p~~Rps----~~~il~~~~~~ 291 (291)
T cd06639 261 RSFNHFISQCLIKDFEARPS----VTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHHHHhhcChhhCcC----HHHHhcCcccC
Confidence 88999999999999999999 99999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.14 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=212.6
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccc--ccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFL--VGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~--~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
+|+..+.||+|+||+||+|.+..++..|++|++..... ........+.+|+++|+.++|+||+++++++..+..+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999988999999999865321 1123456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++++|..++.... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~--- 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF--- 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc---
Confidence 99999999999887653 3889999999999999999999999999999999999999999999999987431100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (258)
T cd06632 156 -------------------------------------------------------------------------SFAKSFK 162 (258)
T ss_pred -------------------------------------------------------------------------ccccccC
Confidence 0012345
Q ss_pred CCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
|++.|+|||.+.... ++.++|+|||||++|+|++|+.||......+....+............++.++.+||.+||..+
T Consensus 163 ~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 242 (258)
T cd06632 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRD 242 (258)
T ss_pred CCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcC
Confidence 889999999998776 8999999999999999999999998765444444443322222223457899999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF 807 (857)
|.+||+ +.+++.||||
T Consensus 243 p~~Rp~----~~~~l~~~~~ 258 (258)
T cd06632 243 PSLRPT----AAELLEHPFV 258 (258)
T ss_pred cccCcC----HHHHhcCCCC
Confidence 999999 9999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.65 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=212.5
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+...+|.+.+.||+|+||.||+|.+..++..||+|++..+ ......+.+|+++|+.++||||+++++++..++.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 4456799999999999999999999999999999998754 233456889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++++|.+++.......+++..++.++.|++.||+|||.+||+||||||+|||++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999998876554568999999999999999999999999999999999999999999999999874321000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 159 --------------------------------------------------------------------------~~~~~~ 164 (263)
T cd05052 159 --------------------------------------------------------------------------YTAHAG 164 (263)
T ss_pred --------------------------------------------------------------------------eeccCC
Confidence 000011
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
..++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+ ....+.+....++..+.+||.+||.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~ 243 (263)
T cd05052 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKGYRMERPEGCPPKVYELMRACWQ 243 (263)
T ss_pred CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHHHcc
Confidence 224678999999999999999999999999999998 99999887665555444 3344455556789999999999999
Q ss_pred CCcCCcCCchhhHHHHHc
Q 035930 786 KEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~ 803 (857)
.||.+||+ +.++++
T Consensus 244 ~~p~~Rp~----~~~l~~ 257 (263)
T cd05052 244 WNPSDRPS----FAEIHQ 257 (263)
T ss_pred CCcccCCC----HHHHHH
Confidence 99999999 666654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.55 Aligned_cols=257 Identities=29% Similarity=0.433 Sum_probs=210.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||+|+||.||+|.+..++..||||+++.... .......+.+|+++|+.++|+||++++++|..++..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 369999999999999999999999999999999865422 2334567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++++.+..+.... ..+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~---- 153 (288)
T cd07833 80 EYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR---- 153 (288)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC----
Confidence 999887776665543 23899999999999999999999999999999999999999999999999987431100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.......+++
T Consensus 154 ----------------------------------------------------------------------~~~~~~~~~~ 163 (288)
T cd07833 154 ----------------------------------------------------------------------PASPLTDYVA 163 (288)
T ss_pred ----------------------------------------------------------------------ccccccCccc
Confidence 0001123468
Q ss_pred CCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-------------------ccCC--
Q 035930 710 THEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-------------------LRFP-- 767 (857)
Q Consensus 710 T~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-------------------~~~p-- 767 (857)
+..|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+.+..+.... ..++
T Consensus 164 ~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd07833 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEP 243 (288)
T ss_pred ccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCC
Confidence 8999999999988 78999999999999999999999998765444333222100 0010
Q ss_pred ---------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 768 ---------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 768 ---------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
....++.++++||++||..||++||+ ++++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~f 288 (288)
T cd07833 244 SQPESLERRYPGKVSSPALDFLKACLRMDPKERLT----CDELLQHPYF 288 (288)
T ss_pred CCcHHHHHhcCCccchHHHHHHHHHhccCchhccc----HHHHhcCCCC
Confidence 01234888999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.80 Aligned_cols=258 Identities=27% Similarity=0.400 Sum_probs=207.0
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCe----
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKF---- 544 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~---- 544 (857)
++|++.+.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 36999999999999999999999999999999986542 12233456788999999995 6999999999987665
Q ss_pred -EEEEEeecCCCChHHHHhhCC---CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc-CCcEEEecccch
Q 035930 545 -SCLVMEYCPGGDLHVLRQKQP---SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE-DGHIMLSDFDLS 619 (857)
Q Consensus 545 -l~LVmEy~~gGsL~~ll~~~~---~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~-dg~iKL~DFGLA 619 (857)
.|+||||+++ +|..++.... ...+++..++.++.||+.||.|||..||+||||+|+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 7877765432 235899999999999999999999999999999999999998 889999999987
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
......
T Consensus 159 ~~~~~~-------------------------------------------------------------------------- 164 (295)
T cd07837 159 RAFSIP-------------------------------------------------------------------------- 164 (295)
T ss_pred eecCCC--------------------------------------------------------------------------
Confidence 432100
Q ss_pred CCCccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc--------------
Q 035930 700 TGARSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-------------- 764 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-------------- 764 (857)
........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 165 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T cd07837 165 -VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLR 243 (295)
T ss_pred -ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhcc
Confidence 000012246788999999875 4579999999999999999999999988766555544432110
Q ss_pred ---cCCC---------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCC
Q 035930 765 ---RFPG---------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 765 ---~~p~---------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
.++. .+.++..+.+||.+||..||.+||+ +.+++.||||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~----~~eil~~~~~~ 295 (295)
T cd07837 244 DWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS----AKAALTHPYFD 295 (295)
T ss_pred chhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC----HHHHhcCCCcC
Confidence 0010 1357889999999999999999999 99999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.88 Aligned_cols=268 Identities=39% Similarity=0.739 Sum_probs=216.1
Q ss_pred CeEEEeEEccCCceEEEEEEEc---CCCeEEEEEEeccccccc-ccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLVG-RKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~---~tg~~VAVKvi~k~~~~~-~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l 545 (857)
+|++.+.||.|+||.||++.+. .+|..||+|++....... ....+.+.+|+.+|+.+ +|+||+.++++|..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999885 478899999997643222 22345678899999999 599999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+++++|.+++.... .+++..+..++.||+.||.|||+.||+||||+|+|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999999887653 3889999999999999999999999999999999999999999999999987432100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
. .....
T Consensus 159 ~--------------------------------------------------------------------------~~~~~ 164 (290)
T cd05613 159 E--------------------------------------------------------------------------VERAY 164 (290)
T ss_pred c--------------------------------------------------------------------------ccccc
Confidence 0 00011
Q ss_pred cccCCCCccChhhhcCC--CCCcccceehhhHHHHHHhhCCCCCCCCCChh----hhHHHhhccccCCCCCCCCHHHHHH
Q 035930 706 SFVGTHEYLAPEIIKGE--GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE----TLSNVVSQSLRFPGYPVVSFHARDL 779 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~--~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e----~l~~Iv~~~~~~p~~~~is~~l~dL 779 (857)
...|+..|+|||++.+. .++.++|||||||++|+|++|..||...+... ....+......+ ...++..+.+|
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 242 (290)
T cd05613 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQEMSALAKDI 242 (290)
T ss_pred cccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC--CccCCHHHHHH
Confidence 34588999999998753 46889999999999999999999997543322 222222222223 34588999999
Q ss_pred HHhhccCCcCCcCCch-hhHHHHHcCCCCCCCChhhhc
Q 035930 780 IRGLLVKEPDNRLGAV-KGAAEIKQHPFFEGLNWALIR 816 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li~ 816 (857)
|.+||..||.+|+++. ..+++++.||||..++|..+.
T Consensus 243 l~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 280 (290)
T cd05613 243 IQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA 280 (290)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHh
Confidence 9999999999998532 348999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=349.18 Aligned_cols=257 Identities=27% Similarity=0.401 Sum_probs=213.1
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
...+|++.+.||+|+||+||++.+..++..||+|++.... .......+.+|+++++.++||||+++++++...+.+||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3467889999999999999999999999999999986542 23345678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
||||+++++|..++.... .+++..++.++.|++.||.|||+ .||+||||+|+||+++.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~-- 156 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN-- 156 (284)
T ss_pred EEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh--
Confidence 999999999998887643 48999999999999999999996 6999999999999999999999999998632100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.....
T Consensus 157 ---------------------------------------------------------------------------~~~~~ 161 (284)
T cd06620 157 ---------------------------------------------------------------------------SIADT 161 (284)
T ss_pred ---------------------------------------------------------------------------hccCc
Confidence 00012
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh-----------hhhHHHhhccccCCCCCCCCHH
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-----------ETLSNVVSQSLRFPGYPVVSFH 775 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~-----------e~l~~Iv~~~~~~p~~~~is~~ 775 (857)
.+|+..|+|||++.+..++.++|||||||++|+|++|+.||...... +.+..+............++.+
T Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd06620 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED 241 (284)
T ss_pred cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHH
Confidence 45899999999999888999999999999999999999999865432 2222332222111112237789
Q ss_pred HHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 776 ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 776 l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
+.+||.+||..||.+||+ +.|+++|+||..
T Consensus 242 ~~~li~~~l~~dp~~Rpt----~~e~~~~~~~~~ 271 (284)
T cd06620 242 LRDFVDACLLKDPTERPT----PQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHhcCCcccCcC----HHHHhcCccccc
Confidence 999999999999999999 999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=376.75 Aligned_cols=260 Identities=33% Similarity=0.516 Sum_probs=235.1
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
....|.+.+.||.|.|++|.++.+.-++..||||++++..+... ....+.+|+++|+.|+|||||++|.+......+|+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 44679999999999999999999999999999999998865433 33458999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||+.+|.+++++.+... +.+..++.++.|++.|++|||.++|||||||++||||+.+.++||+|||++..+..
T Consensus 133 V~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--- 207 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--- 207 (596)
T ss_pred EEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc---
Confidence 9999999999999988754 77899999999999999999999999999999999999999999999999754321
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
+....++
T Consensus 208 -------------------------------------------------------------------------~~~lqt~ 214 (596)
T KOG0586|consen 208 -------------------------------------------------------------------------GLMLQTF 214 (596)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 1223578
Q ss_pred cCCCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 708 VGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
||++.|.|||++.|..| +..+|+|+||++||-|+.|..||++.+-.+.-..++.+.+++|.. ++-++.+||+++|..
T Consensus 215 cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~--ms~dce~lLrk~lvl 292 (596)
T KOG0586|consen 215 CGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY--MSCDCEDLLRKFLVL 292 (596)
T ss_pred CCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce--eechhHHHHHHhhcc
Confidence 99999999999999998 779999999999999999999999998888889999999999876 899999999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
+|.+|++ +++++.|.|.....-
T Consensus 293 ~Pskr~~----~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 293 NPSKRGP----CDQIMKDRWRNDLLE 314 (596)
T ss_pred CccccCC----HHHhhhhcccchhhh
Confidence 9999999 999999999865433
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=377.79 Aligned_cols=254 Identities=28% Similarity=0.364 Sum_probs=226.8
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|.-++.||.|+||-||-|++..+...||||.+....-.....+.++..|+.+|+.|.|||++.+.++|..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 47788999999999999999999999999999988777777888999999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|| -|+-.+++.... +++.+-.+..|+.+.+.||+|||+++.||||||..|||+++.|.|||+|||.|-..
T Consensus 107 YC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~-------- 176 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM-------- 176 (948)
T ss_pred HH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc--------
Confidence 99 677777776554 34899999999999999999999999999999999999999999999999976210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
...++|+||
T Consensus 177 -----------------------------------------------------------------------~PAnsFvGT 185 (948)
T KOG0577|consen 177 -----------------------------------------------------------------------APANSFVGT 185 (948)
T ss_pred -----------------------------------------------------------------------CchhcccCC
Confidence 013578999
Q ss_pred CCccChhhhcC---CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 711 HEYLAPEIIKG---EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 711 ~~YmAPEil~g---~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
|.|||||+|+. ..|+-++||||||++.+||.-.++|+..++....+..|.+..-+--....|+..+++||..||.+-
T Consensus 186 PywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKi 265 (948)
T KOG0577|consen 186 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKI 265 (948)
T ss_pred ccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhC
Confidence 99999999964 458999999999999999999999999998888888877765554445679999999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
|.+||| .+++|.|+|...
T Consensus 266 pqeRpt----se~ll~H~fv~R 283 (948)
T KOG0577|consen 266 PQERPT----SEELLKHRFVLR 283 (948)
T ss_pred cccCCc----HHHHhhcchhcc
Confidence 999999 899999999753
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.48 Aligned_cols=259 Identities=29% Similarity=0.413 Sum_probs=211.0
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccc--ccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG--RKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~--~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
+|.+.+.||.|+||.||+|.+..++..||||.+....... ......+..|+++++.++|+||+++++++.+++..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4889999999999999999999999999999997653321 12234567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+ +++|..++.... ..+++..++.++.||+.||.|||.+||+|+||+|+|||++.+|.++|+|||++..+...
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--- 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--- 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC---
Confidence 9999 999999887654 35899999999999999999999999999999999999999999999999987432100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (298)
T cd07841 156 ------------------------------------------------------------------------NRKMTHQV 163 (298)
T ss_pred ------------------------------------------------------------------------Cccccccc
Confidence 00011224
Q ss_pred CCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-----C---------------C
Q 035930 709 GTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-----F---------------P 767 (857)
Q Consensus 709 GT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-----~---------------p 767 (857)
+++.|+|||++.+ ..++.++|||||||++|||++|..||.+....+.+..+...... + +
T Consensus 164 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T cd07841 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFP 243 (298)
T ss_pred cceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccC
Confidence 6788999999865 45789999999999999999998888877665555444321100 0 0
Q ss_pred ------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 768 ------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 768 ------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
....++..+.+||.+||..||.+||+ +.+++.||||++.
T Consensus 244 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~e~l~~~~~~~~ 288 (298)
T cd07841 244 PTPLKQIFPAASDDALDLLQRLLTLNPNKRIT----ARQALEHPYFSND 288 (298)
T ss_pred CcchhhhcccccHHHHHHHHHHhcCCcccCcC----HHHHhhCccccCC
Confidence 01345788999999999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.61 Aligned_cols=256 Identities=27% Similarity=0.377 Sum_probs=202.7
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
..+|.+.+.||+|+||.||+|.+..++..||||++..... ......+.+|+++|+.++|+||+++++++..++..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999865421 22234567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+. ++|..++.... ..+++..++.++.||+.||.|||..||+||||||+|||++.++.++|+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 156 (291)
T cd07870 82 FEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--- 156 (291)
T ss_pred Eeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC---
Confidence 99995 67766655443 24788889999999999999999999999999999999999999999999987321000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 157 ------------------------------------------------------------------------~~~~~~~~ 164 (291)
T cd07870 157 ------------------------------------------------------------------------SQTYSSEV 164 (291)
T ss_pred ------------------------------------------------------------------------CCCCCCcc
Confidence 00011234
Q ss_pred CCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCCh-hhhHHHhhccc-----------cC---------
Q 035930 709 GTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVSQSL-----------RF--------- 766 (857)
Q Consensus 709 GT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~-e~l~~Iv~~~~-----------~~--------- 766 (857)
+++.|+|||++.+. .++.++|||||||+||+|++|..||.+.... +.+..+..... ..
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (291)
T cd07870 165 VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFL 244 (291)
T ss_pred ccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhcc
Confidence 78899999998764 5788999999999999999999999765432 22222211000 00
Q ss_pred ---C-------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 767 ---P-------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 767 ---p-------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
+ ..-..+..+.+||.+||..||.+||+ +.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t----~~~~l~h~~~ 291 (291)
T cd07870 245 PCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS----AQDALLHPYF 291 (291)
T ss_pred ccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC----HHHHhcCCCC
Confidence 0 00123568999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=358.91 Aligned_cols=255 Identities=28% Similarity=0.456 Sum_probs=206.6
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC------
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE------ 542 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~------ 542 (857)
.++|++.+.||+|+||+||+|.+..+++.||||++.+... .......+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4689999999999999999999999999999999865421 223345677899999999999999999988644
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
.+.|+||||+. ++|..++... +++..+..++.||+.||+|||.+||+||||||+|||++.++.++|+|||++...
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 35799999994 5887776543 889999999999999999999999999999999999999999999999987431
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
... .
T Consensus 169 ~~~----------------------------------------------------------------------------~ 172 (353)
T cd07850 169 GTS----------------------------------------------------------------------------F 172 (353)
T ss_pred CCC----------------------------------------------------------------------------C
Confidence 100 0
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-----------------
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR----------------- 765 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~----------------- 765 (857)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....+..++.....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (353)
T cd07850 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYV 252 (353)
T ss_pred CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHh
Confidence 011235789999999999999999999999999999999999999876554444333221000
Q ss_pred -------------------CCC-----CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 766 -------------------FPG-----YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 766 -------------------~p~-----~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
++. ....+..+++||.+||..||.+||+ +.|+|+||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~eiL~~~~~~~ 316 (353)
T cd07850 253 ENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS----VDDALQHPYINV 316 (353)
T ss_pred hcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcC----HHHHhcChhHhh
Confidence 000 1134567899999999999999999 999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.79 Aligned_cols=258 Identities=29% Similarity=0.470 Sum_probs=209.9
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccccc-------chhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRK-------KMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~-------~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
+|.+.+.||.|+||.||+|.+..++..||||.++........ ..+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588999999999999999999989999999988643211111 2345678999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..++||||+++++|..++.... .+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 9999999999999999887653 48999999999999999999999999999999999999999999999999874310
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.. . ....
T Consensus 160 ~~------------------~-------------------------------------------------------~~~~ 166 (272)
T cd06629 160 DI------------------Y-------------------------------------------------------DNDQ 166 (272)
T ss_pred cc------------------c-------------------------------------------------------cccc
Confidence 00 0 0000
Q ss_pred cccccCCCCccChhhhcCCC--CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc--CCC--CCCCCHHHH
Q 035930 704 SNSFVGTHEYLAPEIIKGEG--HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR--FPG--YPVVSFHAR 777 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~--~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~--~p~--~~~is~~l~ 777 (857)
.....|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||......+.+..+...... ++. ...++..+.
T Consensus 167 ~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (272)
T cd06629 167 NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVAL 246 (272)
T ss_pred cccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHH
Confidence 12345889999999998755 789999999999999999999999765554444443322222 221 234688999
Q ss_pred HHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 778 DLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 778 dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
+||.+||..||.+||+ ++++++||||
T Consensus 247 ~li~~~l~~~p~~Rps----~~~il~~~~~ 272 (272)
T cd06629 247 DFLNACFTINPDNRPT----ARELLQHPFI 272 (272)
T ss_pred HHHHHHhcCChhhCCC----HHHHhhCCCC
Confidence 9999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.61 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=211.9
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ......+.+|+++++.++||||+++++++..++..|+|||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 57888999999999999999999999999999876532 2344567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|+++++|..++.... ..+++..+..++.||+.||+|||. .||+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~---- 154 (265)
T cd06605 80 YMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---- 154 (265)
T ss_pred ecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence 999999999987653 348999999999999999999999 99999999999999999999999999986321000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
......|
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (265)
T cd06605 155 -------------------------------------------------------------------------LAKTFVG 161 (265)
T ss_pred -------------------------------------------------------------------------HhhcccC
Confidence 0001457
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC-----ChhhhHHHhhccccCCCCC-CCCHHHHHHHHhh
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG-----NDETLSNVVSQSLRFPGYP-VVSFHARDLIRGL 783 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~-----~~e~l~~Iv~~~~~~p~~~-~is~~l~dLI~k~ 783 (857)
+..|+|||++.+..++.++|||||||++|+|++|..||.... ..+.+..+.... ...... .++.++++||.+|
T Consensus 162 ~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~ 240 (265)
T cd06605 162 TSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-PPRLPSGKFSPDFQDFVNLC 240 (265)
T ss_pred ChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-CCCCChhhcCHHHHHHHHHH
Confidence 889999999999999999999999999999999999997542 122233333222 111112 2788999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
|..||++||+ +.+++.||||+.
T Consensus 241 l~~~p~~Rpt----~~~ll~~~~~~~ 262 (265)
T cd06605 241 LIKDPRERPS----YKELLEHPFIKK 262 (265)
T ss_pred cCCCchhCcC----HHHHhhCchhhc
Confidence 9999999999 999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.28 Aligned_cols=261 Identities=26% Similarity=0.358 Sum_probs=211.0
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||.|+||+||+|.+..+++.||||.+..... .......+.+|+++++.++||||+++++++.++.+.|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999865422 2233456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc-CCcEEEecccchhhcccCccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE-DGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~-dg~iKL~DFGLA~r~~~~~~l 628 (857)
||++ ++|..++.......+++..++.++.||+.||+|||++||+||||+|+||+++. ++.+||+|||++......
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--- 156 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--- 156 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC---
Confidence 9995 57877776555444788999999999999999999999999999999999985 567999999987431100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 157 ------------------------------------------------------------------------~~~~~~~~ 164 (294)
T PLN00009 157 ------------------------------------------------------------------------VRTFTHEV 164 (294)
T ss_pred ------------------------------------------------------------------------ccccccCc
Confidence 00011235
Q ss_pred CCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc---------------------cC
Q 035930 709 GTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL---------------------RF 766 (857)
Q Consensus 709 GT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~---------------------~~ 766 (857)
|++.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+.+++.... .+
T Consensus 165 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (294)
T PLN00009 165 VTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKW 244 (294)
T ss_pred eeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccC
Confidence 78899999998764 578999999999999999999999987765555544332100 00
Q ss_pred C------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 767 P------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 767 p------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
+ ..+.++..+++||.+||..||++||+ +.++++||||.++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~~~l~~~~~~~~~ 291 (294)
T PLN00009 245 PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT----ARAALEHEYFKDLG 291 (294)
T ss_pred CCCCHHHhCcCCChHHHHHHHHHccCChhhCcC----HHHHhcCchHhHHh
Confidence 0 12457889999999999999999999 99999999998764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=353.66 Aligned_cols=261 Identities=31% Similarity=0.501 Sum_probs=218.6
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEEEeecCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
+.||+|+|+.|--|....+|..||||++.+.. .....++.+|++++..++ |+||++|+++|+++..+|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 57999999999999999999999999998762 334567899999999985 99999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC---cEEEecccchhhcccCcccccC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG---HIMLSDFDLSLRCAVNPMVVKS 631 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg---~iKL~DFGLA~r~~~~~~l~~~ 631 (857)
|.|..+++++.. |+|.++.+++.+|+.||.|||.+||.||||||+|||..... -+|||||+|+--...+
T Consensus 161 GplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~------ 232 (463)
T KOG0607|consen 161 GPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN------ 232 (463)
T ss_pred chHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC------
Confidence 999888887754 99999999999999999999999999999999999997654 4799999986211110
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCC
Q 035930 632 SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711 (857)
Q Consensus 632 ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~ 711 (857)
.+|+.. ..| ...+-+|+.
T Consensus 233 -------------~~~spa----------------------------------------stP---------~L~tPvGSA 250 (463)
T KOG0607|consen 233 -------------NDCSPA----------------------------------------STP---------ELLTPVGSA 250 (463)
T ss_pred -------------CCCCCC----------------------------------------CCc---------cccCcccch
Confidence 011100 001 123457999
Q ss_pred CccChhhhc-----CCCCCcccceehhhHHHHHHhhCCCCCCCCC---------------ChhhhHHHhhccccCCC--C
Q 035930 712 EYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYGRTPFKGSG---------------NDETLSNVVSQSLRFPG--Y 769 (857)
Q Consensus 712 ~YmAPEil~-----g~~~s~ksDVWSLGvILyELLtGk~PF~g~~---------------~~e~l~~Iv~~~~~~p~--~ 769 (857)
.|||||+.. ...|+.+.|.||||||||.||.|.+||.|+- ....+..|..+.+.||+ |
T Consensus 251 EfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW 330 (463)
T KOG0607|consen 251 EFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW 330 (463)
T ss_pred hhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhh
Confidence 999999863 3458999999999999999999999998752 23556777788888886 6
Q ss_pred CCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 770 PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 770 ~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
..++.+++|||..+|.+|+.+|+. +..+++|||+..+..+
T Consensus 331 ahIS~eakdlisnLlvrda~~rls----a~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 331 AHISSEAKDLISNLLVRDAKQRLS----AAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHhhHHHHHHHHHHHhccHHhhhh----hhhccCCccccccchh
Confidence 679999999999999999999999 9999999999987544
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.44 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=209.0
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|++.+.||.|+||+||+|.+..++..||||+++.... ......+.+|+++++.++||||++++++|.+.+..|||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999976532 2334567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 551 YCPGGDLHVLRQKQP-SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 551 y~~gGsL~~ll~~~~-~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|+++ +|..++.... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~---- 153 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---- 153 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC----
Confidence 9974 7877765433 235899999999999999999999999999999999999999999999999987431100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........+
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (284)
T cd07836 154 -----------------------------------------------------------------------VNTFSNEVV 162 (284)
T ss_pred -----------------------------------------------------------------------ccccccccc
Confidence 000112347
Q ss_pred CCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc------------------cCCC--
Q 035930 710 THEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL------------------RFPG-- 768 (857)
Q Consensus 710 T~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~------------------~~p~-- 768 (857)
++.|++||++.+. .++.++|||+|||++|+|++|+.||.+.+..+.+..+..... .++.
T Consensus 163 ~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd07836 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYP 242 (284)
T ss_pred cccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCC
Confidence 8899999998764 568899999999999999999999988776665554432110 0010
Q ss_pred -------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 769 -------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 769 -------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.+.++..++++|.+||+.||.+||+ +.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~~l~~~~f 284 (284)
T cd07836 243 PQDLQQLFPHADPLGIDLLHRLLQLNPELRIS----AHDALQHPWF 284 (284)
T ss_pred hHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC----HHHHhcCCCC
Confidence 1346788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.58 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=211.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++.++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 45678999999999999999999875 45679999886532 23467889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++++|..++.......+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999999876655568899999999999999999999999999999999999999999999999974321000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (261)
T cd05072 158 --------------------------------------------------------------------------YTAREG 163 (261)
T ss_pred --------------------------------------------------------------------------eeccCC
Confidence 000012
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
..++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+ .....++....++.++.+||.+||.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~ 242 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYRMPRMENCPDELYDIMKTCWK 242 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 235678999999998889999999999999999998 99999887666655554 3445566666789999999999999
Q ss_pred CCcCCcCCchhhHHHHHc
Q 035930 786 KEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~ 803 (857)
.+|++||+ ++++++
T Consensus 243 ~~p~~Rp~----~~~i~~ 256 (261)
T cd05072 243 EKAEERPT----FDYLQS 256 (261)
T ss_pred CCcccCcC----HHHHHH
Confidence 99999999 666653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=336.26 Aligned_cols=259 Identities=31% Similarity=0.540 Sum_probs=213.6
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|.+.+.||+|+||.||++.+..++..||+|+++..... ......+..|+++++.++|+||+++++++...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 588999999999999999999989999999999765332 3456778999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|.+++.... .+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~--- 154 (264)
T cd06626 80 YCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT--- 154 (264)
T ss_pred cCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC---
Confidence 999999999887653 378999999999999999999999999999999999999999999999998744211000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
. .........++
T Consensus 155 ---------------~-----------------------------------------------------~~~~~~~~~~~ 166 (264)
T cd06626 155 ---------------T-----------------------------------------------------MGEEVQSLAGT 166 (264)
T ss_pred ---------------c-----------------------------------------------------ccccccCCcCC
Confidence 0 00001124578
Q ss_pred CCccChhhhcCCC---CCcccceehhhHHHHHHhhCCCCCCCCCChhhhH-HHhh-ccccCCCCCCCCHHHHHHHHhhcc
Q 035930 711 HEYLAPEIIKGEG---HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS-NVVS-QSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 711 ~~YmAPEil~g~~---~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~-~Iv~-~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
+.|+|||++.+.. ++.++|||+|||++|+|++|+.||.......... .+.. ....+|....++..+.+||.+||.
T Consensus 167 ~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 246 (264)
T cd06626 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLE 246 (264)
T ss_pred cCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHcc
Confidence 8999999998776 8899999999999999999999997654332222 2222 122344444568999999999999
Q ss_pred CCcCCcCCchhhHHHHHcCCCC
Q 035930 786 KEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.||.+||+ +.+++.|||+
T Consensus 247 ~~p~~R~~----~~~i~~~~~~ 264 (264)
T cd06626 247 SDPKKRPT----ASELLQHPFV 264 (264)
T ss_pred CCcccCCC----HHHHhcCCCC
Confidence 99999999 9999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=336.03 Aligned_cols=256 Identities=26% Similarity=0.416 Sum_probs=213.1
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee--CCeEEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT--EKFSCLV 548 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~--~~~l~LV 548 (857)
+|++++.||.|+||.||++.+..++..||+|++..... .....+.+..|+++|+.++||||+++++++.. +...|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58899999999999999999999999999999875432 23344567889999999999999999998764 4578999
Q ss_pred EeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHH-----HcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 549 MEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLH-----MLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLH-----s~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
|||+++++|..++... ....+++..++.++.||+.||.||| ..+|+|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999998887653 2235899999999999999999999 89999999999999999999999999998743
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
.... .
T Consensus 160 ~~~~---------------------------------------------------------------------------~ 164 (265)
T cd08217 160 LGHD---------------------------------------------------------------------------S 164 (265)
T ss_pred ccCC---------------------------------------------------------------------------c
Confidence 1100 0
Q ss_pred CccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHH
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~ 781 (857)
.......|++.|+|||++.+..++.++|+|+||+++|+|++|+.||...+..+....+..... ......++.++.+|+.
T Consensus 165 ~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 243 (265)
T cd08217 165 SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF-RRIPYRYSSELNEVIK 243 (265)
T ss_pred ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-CCCccccCHHHHHHHH
Confidence 001234588999999999998899999999999999999999999998765555554444332 2223468899999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
+||..+|.+||+ +.+|++|||+
T Consensus 244 ~~l~~~p~~Rp~----~~~il~~~~~ 265 (265)
T cd08217 244 SMLNVDPDKRPS----TEELLQLPLI 265 (265)
T ss_pred HHccCCcccCCC----HHHHhhCCCC
Confidence 999999999999 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=337.49 Aligned_cols=257 Identities=30% Similarity=0.458 Sum_probs=216.5
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|++.+.||.|+||.||+|.+..++..||||++..... ......+.+|+.++..++|+||+++++++...+..|+|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 68999999999999999999999999999999876532 1345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|+++++|..++... ..+++..+..++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~---- 153 (264)
T cd06623 80 YMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT---- 153 (264)
T ss_pred ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC----
Confidence 99999999998765 348999999999999999999999 99999999999999999999999999986321100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........+
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (264)
T cd06623 154 -----------------------------------------------------------------------LDQCNTFVG 162 (264)
T ss_pred -----------------------------------------------------------------------CCcccceee
Confidence 000113357
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC---ChhhhHHHhhccccCCCCCC-CCHHHHHHHHhhcc
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG---NDETLSNVVSQSLRFPGYPV-VSFHARDLIRGLLV 785 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~---~~e~l~~Iv~~~~~~p~~~~-is~~l~dLI~k~L~ 785 (857)
+..|+|||.+.+..++.++|+|+||+++|+|++|..||...+ ..+....+. .......... ++..+.+||..||.
T Consensus 163 ~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~ 241 (264)
T cd06623 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDFISACLQ 241 (264)
T ss_pred cccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHHHHHHcc
Confidence 889999999999989999999999999999999999998774 223333333 2222333334 78899999999999
Q ss_pred CCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 786 KEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
.+|.+||+ +.++++||||+.++
T Consensus 242 ~~p~~R~~----~~~ll~~~~~~~~~ 263 (264)
T cd06623 242 KDPKKRPS----AAELLQHPFIKKAD 263 (264)
T ss_pred CChhhCCC----HHHHHhCHHHHhcc
Confidence 99999999 99999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.79 Aligned_cols=255 Identities=26% Similarity=0.471 Sum_probs=211.3
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC---CCCccccceeeeeCCeEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD---HPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~---HPnIV~L~~~f~~~~~l~L 547 (857)
.|++.+.||.|+||.||+|.+..++..||+|+++... .......+.+|+.+++.+. ||||++++++|..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4788899999999999999999999999999987542 2334566788999999996 9999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||+++++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-- 154 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN-- 154 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC--
Confidence 99999999999888654 4899999999999999999999999999999999999999999999999987432110
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (277)
T cd06917 155 -------------------------------------------------------------------------SSKRSTF 161 (277)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001233
Q ss_pred cCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhc
Q 035930 708 VGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLL 784 (857)
Q Consensus 708 vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L 784 (857)
.|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+... ..+. ...++.++.+||.+||
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l 239 (277)
T cd06917 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLREFVAACL 239 (277)
T ss_pred cCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHHHHHHHc
Confidence 58899999999875 45789999999999999999999999876544433322222 1222 1237889999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
..||.+||+ +.+++.|+||+...
T Consensus 240 ~~~p~~R~~----~~~il~~~~~~~~~ 262 (277)
T cd06917 240 DEEPKERLS----AEELLKSKWIKAHS 262 (277)
T ss_pred CCCcccCcC----HHHHhhChHhhccc
Confidence 999999999 99999999997653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=359.79 Aligned_cols=259 Identities=22% Similarity=0.336 Sum_probs=209.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~ 540 (857)
+..++|++.+.||.|+||.||+|.+.+ +++.||+|+++... .......+..|+++++++ +|+||++++++|.
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 445689999999999999999997544 35789999987542 223345678899999999 7999999999886
Q ss_pred e-CCeEEEEEeecCCCChHHHHhhCCC-----------------------------------------------------
Q 035930 541 T-EKFSCLVMEYCPGGDLHVLRQKQPS----------------------------------------------------- 566 (857)
Q Consensus 541 ~-~~~l~LVmEy~~gGsL~~ll~~~~~----------------------------------------------------- 566 (857)
. +..+++||||+++++|..++.....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 4678999999999999888754221
Q ss_pred ------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCC
Q 035930 567 ------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPP 640 (857)
Q Consensus 567 ------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~ 640 (857)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~------------- 228 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------------- 228 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-------------
Confidence 2478999999999999999999999999999999999999999999999999854211000
Q ss_pred CCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhc
Q 035930 641 KKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIK 720 (857)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~ 720 (857)
........++..|||||++.
T Consensus 229 ------------------------------------------------------------~~~~~~~~~~~~y~aPE~~~ 248 (337)
T cd05054 229 ------------------------------------------------------------YVRKGDARLPLKWMAPESIF 248 (337)
T ss_pred ------------------------------------------------------------hhhccCCCCCccccCcHHhc
Confidence 00012234677899999999
Q ss_pred CCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHH
Q 035930 721 GEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAA 799 (857)
Q Consensus 721 g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ 799 (857)
+..++.++|||||||+||||++ |..||.+....+.+...+...........+++++.+|+.+||+.+|++||+ +.
T Consensus 249 ~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs----~~ 324 (337)
T cd05054 249 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT----FS 324 (337)
T ss_pred CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC----HH
Confidence 9999999999999999999997 999998866656665665555554445568899999999999999999999 78
Q ss_pred HHHcC
Q 035930 800 EIKQH 804 (857)
Q Consensus 800 ELL~H 804 (857)
+|++|
T Consensus 325 ell~~ 329 (337)
T cd05054 325 ELVEI 329 (337)
T ss_pred HHHHH
Confidence 88764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=387.47 Aligned_cols=262 Identities=28% Similarity=0.439 Sum_probs=215.2
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceee-eeC
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHF-TTE 542 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f-~~~ 542 (857)
-.++..++++.+.|.+|||+.||+|++.+.|..||+|.+-.. +...+..+.+|+++|+.|. |+|||.+++.. ...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 346777899999999999999999999988899999987433 4567788899999999997 99999999932 211
Q ss_pred ------CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEccCCcEEEe
Q 035930 543 ------KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG--VVYRDLKPENILVREDGHIMLS 614 (857)
Q Consensus 543 ------~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G--IIHRDLKPeNILL~~dg~iKL~ 614 (857)
-.++|.||||.||.|-+++..+....|+|.++..|++|+++|+.+||.+. |||||||-|||||..+|+.|||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 25789999999999998888665566999999999999999999999998 9999999999999999999999
Q ss_pred cccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCc
Q 035930 615 DFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQ 694 (857)
Q Consensus 615 DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~ 694 (857)
|||.|.-....+. ++......++..
T Consensus 189 DFGSatt~~~~~~-----------------------------------------------~~~e~~~ve~eI-------- 213 (738)
T KOG1989|consen 189 DFGSATTKILSPT-----------------------------------------------SAQEVNYVEEEI-------- 213 (738)
T ss_pred cccccccccCCCc-----------------------------------------------cHHHHHHHHHHH--------
Confidence 9998632110000 011111111111
Q ss_pred ccccCCCCccccccCCCCccChhhh---cCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCC
Q 035930 695 LVVEPTGARSNSFVGTHEYLAPEII---KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPV 771 (857)
Q Consensus 695 l~~~~~~~~~~s~vGT~~YmAPEil---~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~ 771 (857)
....|+.|+|||+| .|.+.+.++|||+|||+||-|++...||.+.+. ..|+.+.+.||..+.
T Consensus 214 -----------~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~Y~~P~~p~ 278 (738)
T KOG1989|consen 214 -----------EKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGNYSFPPFPN 278 (738)
T ss_pred -----------HhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEeccccCCCCcc
Confidence 11368999999987 578899999999999999999999999987654 356788999999999
Q ss_pred CCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 772 VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 772 is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
++..+++||+.||+.||.+||+ +-+++.
T Consensus 279 ys~~l~~LI~~mL~~nP~~RPn----I~Qv~~ 306 (738)
T KOG1989|consen 279 YSDRLKDLIRTMLQPNPDERPN----IYQVLE 306 (738)
T ss_pred HHHHHHHHHHHHhccCcccCCC----HHHHHH
Confidence 9999999999999999999999 555554
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=346.24 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=215.1
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|+..+.||.|+||.||+|.+..++..||||++.... .......+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 5778899999999999999999999999999987542 12345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|.+++... .+++..+..++.|++.||+|||..+|+|+||+|+||+++.++.++|+|||++..+...
T Consensus 83 ~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~----- 154 (277)
T cd06640 83 YLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT----- 154 (277)
T ss_pred cCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC-----
Confidence 99999999888653 3889999999999999999999999999999999999999999999999987431100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
........++
T Consensus 155 ----------------------------------------------------------------------~~~~~~~~~~ 164 (277)
T cd06640 155 ----------------------------------------------------------------------QIKRNTFVGT 164 (277)
T ss_pred ----------------------------------------------------------------------ccccccccCc
Confidence 0001223578
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCC
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDN 790 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~ 790 (857)
..|+|||++.+..++.++|+|||||++|||++|..||...........+.. .........++..+.+||.+||..+|++
T Consensus 165 ~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~ 243 (277)
T cd06640 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK-NNPPTLTGEFSKPFKEFIDACLNKDPSF 243 (277)
T ss_pred ccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc-CCCCCCchhhhHHHHHHHHHHcccCccc
Confidence 899999999998899999999999999999999999987765544443322 2222223457788999999999999999
Q ss_pred cCCchhhHHHHHcCCCCCCCCh
Q 035930 791 RLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 791 Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
||+ +.++++||||.....
T Consensus 244 Rp~----~~~il~~~~~~~~~~ 261 (277)
T cd06640 244 RPT----AKELLKHKFIVKNAK 261 (277)
T ss_pred CcC----HHHHHhChHhhhcch
Confidence 999 999999999976544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.99 Aligned_cols=256 Identities=22% Similarity=0.318 Sum_probs=209.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCe----EEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSC----LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~----~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
+...+|++.+.||+|+||+||+|.+..++. .||||+++.. ........+.+|+.+++.++||||++++++|..+
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 445689999999999999999999866555 3899998643 1233445788899999999999999999999875
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
..++|+||+++|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 46799999999999998876543 4888999999999999999999999999999999999999999999999998542
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
..... ..
T Consensus 160 ~~~~~-------------------------------------------------------------------------~~ 166 (316)
T cd05108 160 GADEK-------------------------------------------------------------------------EY 166 (316)
T ss_pred cCCCc-------------------------------------------------------------------------ce
Confidence 11000 00
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~ 781 (857)
......++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+ +..++.....++..+.++.++.+||.
T Consensus 167 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (316)
T cd05108 167 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 245 (316)
T ss_pred eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 0011234678999999999999999999999999999997 999998765444 45566666677777778999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
+||..||.+||+ +.+++.+
T Consensus 246 ~cl~~~p~~Rps----~~~l~~~ 264 (316)
T cd05108 246 KCWMIDADSRPK----FRELIIE 264 (316)
T ss_pred HHccCChhhCcC----HHHHHHH
Confidence 999999999999 6666654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=346.15 Aligned_cols=260 Identities=26% Similarity=0.359 Sum_probs=204.5
Q ss_pred CeEEEeEEccCCceEEEEEEEcC--CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC--CeEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIG--TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE--KFSC 546 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~--tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~--~~l~ 546 (857)
+|.+.+.||+|+||.||+|.+.. ++..||||++.............+.+|+++++.++||||++++++|.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8899999999874322334456678899999999999999999999988 8899
Q ss_pred EEEeecCCCChHHHHhhCC---CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc----CCcEEEecccch
Q 035930 547 LVMEYCPGGDLHVLRQKQP---SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE----DGHIMLSDFDLS 619 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~---~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~----dg~iKL~DFGLA 619 (857)
|||||++ ++|..++.... ...+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 46665554321 125899999999999999999999999999999999999999 899999999987
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
..+.....
T Consensus 160 ~~~~~~~~------------------------------------------------------------------------ 167 (316)
T cd07842 160 RLFNAPLK------------------------------------------------------------------------ 167 (316)
T ss_pred cccCCCcc------------------------------------------------------------------------
Confidence 43211000
Q ss_pred CCCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChh---------hhHHHhh--------
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE---------TLSNVVS-------- 761 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e---------~l~~Iv~-------- 761 (857)
........++|+.|+|||++.+. .++.++|||||||+||+|++|+.||.+..... .+..++.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 247 (316)
T cd07842 168 PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEK 247 (316)
T ss_pred cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchh
Confidence 00011234688999999998774 57999999999999999999999998664332 1111110
Q ss_pred ------------------ccccCC---------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 762 ------------------QSLRFP---------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 762 ------------------~~~~~p---------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
....++ .....+.++.+||.+||..||++||+ +.++++||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~eil~~~~f 316 (316)
T cd07842 248 DWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT----AEEALEHPYF 316 (316)
T ss_pred HHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCCCC
Confidence 000111 00146778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.46 Aligned_cols=258 Identities=20% Similarity=0.274 Sum_probs=208.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
+..++|++.+.||+|+||+||+|.+.+ ++..||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 455789999999999999999998753 35689999986432 12233457889999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCC--------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEE
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQPS--------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML 613 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~~--------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL 613 (857)
+...|+||||+++++|.+++..... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999988865321 23577888999999999999999999999999999999999999999
Q ss_pred ecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCC
Q 035930 614 SDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMP 693 (857)
Q Consensus 614 ~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p 693 (857)
+|||++..+......
T Consensus 161 ~dfg~~~~~~~~~~~----------------------------------------------------------------- 175 (277)
T cd05062 161 GDFGMTRDIYETDYY----------------------------------------------------------------- 175 (277)
T ss_pred CCCCCccccCCccee-----------------------------------------------------------------
Confidence 999987432110000
Q ss_pred cccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCC
Q 035930 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVV 772 (857)
Q Consensus 694 ~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~i 772 (857)
.......+++.|||||++.+..++.++|||||||++|||++ |..||.+....+.+..+...... +....+
T Consensus 176 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 246 (277)
T cd05062 176 --------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL-DKPDNC 246 (277)
T ss_pred --------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-CCCCCC
Confidence 00011235788999999999999999999999999999998 79999888777666665554432 233567
Q ss_pred CHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 773 SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 773 s~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
+..+.+||.+||+.||++||+ +.|++++
T Consensus 247 ~~~~~~li~~~l~~~p~~Rps----~~e~l~~ 274 (277)
T cd05062 247 PDMLFELMRMCWQYNPKMRPS----FLEIISS 274 (277)
T ss_pred CHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 889999999999999999999 7887753
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.60 Aligned_cols=255 Identities=21% Similarity=0.329 Sum_probs=210.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
.++|.+.+.||+|+||.||+|.+.. ++..||||+++... .......+.+|+++|+.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4678999999999999999998753 36789999987542 1223467889999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCC------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcE
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQP------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHI 611 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~i 611 (857)
..|+||||+++++|..++.... ...+++..+..++.||+.||.|||.+||+||||||+|||++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999886542 1347889999999999999999999999999999999999999999
Q ss_pred EEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCC
Q 035930 612 MLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSP 691 (857)
Q Consensus 612 KL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~ 691 (857)
+|+|||++........
T Consensus 162 kl~d~g~~~~~~~~~~---------------------------------------------------------------- 177 (280)
T cd05049 162 KIGDFGMSRDVYTTDY---------------------------------------------------------------- 177 (280)
T ss_pred EECCcccceecccCcc----------------------------------------------------------------
Confidence 9999998742110000
Q ss_pred CCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCC
Q 035930 692 MPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYP 770 (857)
Q Consensus 692 ~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~ 770 (857)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+....... ...
T Consensus 178 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~ 247 (280)
T cd05049 178 ---------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ-RPR 247 (280)
T ss_pred ---------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC-CCC
Confidence 000012246788999999999999999999999999999998 999998887777776666444333 235
Q ss_pred CCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 771 VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 771 ~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.++..+.+||.+||..||.+||+ +.|+++
T Consensus 248 ~~~~~~~~li~~~l~~~p~~Rp~----~~eil~ 276 (280)
T cd05049 248 TCPSEVYDIMLGCWKRDPQQRIN----IKDIHE 276 (280)
T ss_pred CCCHHHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 68899999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=339.44 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=207.6
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+.+.||+|+||.||+|++..++..||||.+.............+.+|+++|+.++||||+++++++.+.+..|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999886543333444556788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCC--CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 550 EYCPGGDLHVLRQKQP--SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~--~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||+++++|..++.... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 9999999988775321 2348899999999999999999999999999999999999999999999999874311000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
......
T Consensus 161 --------------------------------------------------------------------------~~~~~~ 166 (267)
T cd08228 161 --------------------------------------------------------------------------TAAHSL 166 (267)
T ss_pred --------------------------------------------------------------------------HHHhcC
Confidence 000123
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC--hhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN--DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~--~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
.|++.|+|||.+.+..++.++|+|||||++|||++|+.||..... .+....+............++..+.+||.+||.
T Consensus 167 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 246 (267)
T cd08228 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIY 246 (267)
T ss_pred CCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCC
Confidence 578899999999998899999999999999999999999976532 233333222222111123577889999999999
Q ss_pred CCcCCcCCchhhHHHHHc
Q 035930 786 KEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~ 803 (857)
.+|.+||+ +.++++
T Consensus 247 ~~p~~Rp~----~~~vl~ 260 (267)
T cd08228 247 PDPDQRPD----IGYVHQ 260 (267)
T ss_pred CCcccCcC----HHHHHH
Confidence 99999999 888876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=342.84 Aligned_cols=267 Identities=41% Similarity=0.767 Sum_probs=215.6
Q ss_pred CeEEEeEEccCCceEEEEEEEc---CCCeEEEEEEeccccccc-ccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLVG-RKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~---~tg~~VAVKvi~k~~~~~-~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l 545 (857)
+|.+.+.||.|+||.||++.+. .++..||||++.+..... ......+.+|+++++.+ +||||+.+++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 457889999987543221 23345678899999999 599999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+++++|..++.... .+++..++.++.|++.||.|||..|++||||+|.|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999988876543 4889999999999999999999999999999999999999999999999987431100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
......
T Consensus 159 --------------------------------------------------------------------------~~~~~~ 164 (288)
T cd05583 159 --------------------------------------------------------------------------EEERAY 164 (288)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000011
Q ss_pred cccCCCCccChhhhcCCC--CCcccceehhhHHHHHHhhCCCCCCCCCCh----hhhHHHhhccccCCCCCCCCHHHHHH
Q 035930 706 SFVGTHEYLAPEIIKGEG--HGSSVDWWTFGIFLFELLYGRTPFKGSGND----ETLSNVVSQSLRFPGYPVVSFHARDL 779 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~--~s~ksDVWSLGvILyELLtGk~PF~g~~~~----e~l~~Iv~~~~~~p~~~~is~~l~dL 779 (857)
...|+..|+|||.+.+.. ++.++|||+||+++|||++|..||...+.. +....+.... .+....++..+.+|
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l 242 (288)
T cd05583 165 SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--PPFPKTMSAEARDF 242 (288)
T ss_pred cccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--CCCCcccCHHHHHH
Confidence 245889999999997765 788999999999999999999999654322 2222333332 23345588999999
Q ss_pred HHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhc
Q 035930 780 IRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIR 816 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~ 816 (857)
|.+||+.||++||++ ..+.++|+||||+.++|+.+.
T Consensus 243 i~~~l~~~p~~R~t~-~~~~~~l~~~~~~~~~~~~~~ 278 (288)
T cd05583 243 IQKLLEKDPKKRLGA-NGADEIKNHPFFQGIDWDDLA 278 (288)
T ss_pred HHHHhcCCHhhccCc-chHHHHhcCcccccCCHHHHh
Confidence 999999999999983 357889999999999998774
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=340.30 Aligned_cols=251 Identities=27% Similarity=0.441 Sum_probs=201.1
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeC--CeEEEE
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTE--KFSCLV 548 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~--~~l~LV 548 (857)
|++.+.||+|+||.||+|.+..++..||+|+++.... ........+|+.+++++. |+||+++++++.++ +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--CchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6789999999999999999999999999999875421 112223457888888885 99999999999987 899999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||++ ++|..++.... ..+++..++.++.||+.||+|||..||+||||+|+||+++. +.++|+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--- 152 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--- 152 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---
Confidence 99996 57776666543 34899999999999999999999999999999999999999 99999999987431100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.......
T Consensus 153 -------------------------------------------------------------------------~~~~~~~ 159 (282)
T cd07831 153 -------------------------------------------------------------------------PPYTEYI 159 (282)
T ss_pred -------------------------------------------------------------------------CCcCCCC
Confidence 0011235
Q ss_pred CCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhc------------------cccCCC-
Q 035930 709 GTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ------------------SLRFPG- 768 (857)
Q Consensus 709 GT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~------------------~~~~p~- 768 (857)
+++.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+... ...++.
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd07831 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSK 239 (282)
T ss_pred CCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCccc
Confidence 7889999998754 45688999999999999999999999877654444333221 011111
Q ss_pred --------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 769 --------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 769 --------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.+.++..+.+||.+||.+||++||+ +.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~----~~~~l~~~~~ 282 (282)
T cd07831 240 KGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT----AKQALRHPYF 282 (282)
T ss_pred ccccHHHHcccccHHHHHHHHHHhccCcccccC----HHHHhhCCCC
Confidence 1346889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=349.43 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=213.5
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|...+.||.|+||.||+|.+..++..||+|++.... .......+.+|+++++.++||||++++++|..++..|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4667788999999999999999999999999987542 12344678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|..++... .+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~----- 154 (277)
T cd06642 83 YLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT----- 154 (277)
T ss_pred ccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc-----
Confidence 99999998887643 3889999999999999999999999999999999999999999999999987431100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
........|+
T Consensus 155 ----------------------------------------------------------------------~~~~~~~~~~ 164 (277)
T cd06642 155 ----------------------------------------------------------------------QIKRNTFVGT 164 (277)
T ss_pred ----------------------------------------------------------------------chhhhcccCc
Confidence 0001123578
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCC
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDN 790 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~ 790 (857)
..|+|||++.+..++.++|+|||||++|||++|+.||...........+.... .......++..+.+||.+||..+|.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~ 243 (277)
T cd06642 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-PPTLEGQYSKPFKEFVEACLNKDPRF 243 (277)
T ss_pred ccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC-CCCCCcccCHHHHHHHHHHccCCccc
Confidence 89999999999999999999999999999999999997665554444332222 21222357889999999999999999
Q ss_pred cCCchhhHHHHHcCCCCCCCCh
Q 035930 791 RLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 791 Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
||+ +.++++||||....+
T Consensus 244 Rp~----~~~il~~~~~~~~~~ 261 (277)
T cd06642 244 RPT----AKELLKHKFITRYTK 261 (277)
T ss_pred CcC----HHHHHHhHHHHHHhh
Confidence 999 999999999976544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=353.08 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=205.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-----Ce
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE-----KF 544 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~-----~~ 544 (857)
++|.+.+.||+|+||+||+|.+..++..||||++... ........+.+|+.+|+.++||||+++++++... .+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 6899999999999999999999999999999998642 1233445678899999999999999999987654 35
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
.|+||||+. ++|..++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 899999995 5887766543 389999999999999999999999999999999999999999999999998743210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
... .....
T Consensus 159 ~~~------------------------------------------------------------------------~~~~~ 166 (336)
T cd07849 159 EHD------------------------------------------------------------------------HTGFL 166 (336)
T ss_pred ccc------------------------------------------------------------------------ccCCc
Confidence 000 00011
Q ss_pred ccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh---------------cc-----
Q 035930 705 NSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS---------------QS----- 763 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~---------------~~----- 763 (857)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.. ..
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (336)
T cd07849 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYI 246 (336)
T ss_pred CCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHH
Confidence 23468999999998765 5689999999999999999999999976543322222111 00
Q ss_pred --ccC----C---CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 764 --LRF----P---GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 764 --~~~----p---~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
... + ..+.++.++.+||.+||..||++||+ +.++++||||..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~e~l~hp~~~~~ 298 (336)
T cd07849 247 KSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT----VEEALAHPYLEQY 298 (336)
T ss_pred hhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC----HHHHhcCcccccc
Confidence 000 0 01346788999999999999999999 9999999999866
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=351.00 Aligned_cols=255 Identities=29% Similarity=0.431 Sum_probs=212.6
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.|...+..|+|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3555678999999999999999999999999986532 2334567899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|..++... .+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 100 ~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----- 171 (292)
T cd06658 100 FLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE----- 171 (292)
T ss_pred CCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc-----
Confidence 99999999887543 3889999999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
........|+
T Consensus 172 ----------------------------------------------------------------------~~~~~~~~~~ 181 (292)
T cd06658 172 ----------------------------------------------------------------------VPKRKSLVGT 181 (292)
T ss_pred ----------------------------------------------------------------------cccCceeecC
Confidence 0001234588
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-ccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-LRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
..|+|||++.+..++.++|||||||++|||++|+.||......+.+..+.... ..++....++..+.+||.+||..||.
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 261 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPS 261 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChh
Confidence 99999999999899999999999999999999999998776655554433221 12223345788999999999999999
Q ss_pred CcCCchhhHHHHHcCCCCCCC
Q 035930 790 NRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 790 ~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+||+ ++++++||||...
T Consensus 262 ~Rpt----~~~il~~~~~~~~ 278 (292)
T cd06658 262 QRAT----AQELLQHPFLKLA 278 (292)
T ss_pred HCcC----HHHHhhChhhhcc
Confidence 9999 9999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.78 Aligned_cols=156 Identities=28% Similarity=0.424 Sum_probs=136.5
Q ss_pred CCccccCCCCCCCCCCCCCccchhHHHHhhhccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc
Q 035930 432 EDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR 511 (857)
Q Consensus 432 ~~s~~s~ss~g~s~p~~~~d~~~~~~~~~~~~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~ 511 (857)
+++....+..||++|....|. |...+|.+.++||||.|+|||+|++..+.+.||+||++.. .
T Consensus 54 eqE~~~dY~kGGYHpV~IGD~--------------F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----q 115 (590)
T KOG1290|consen 54 EQEDPEDYRKGGYHPVRIGDV--------------FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----Q 115 (590)
T ss_pred cccChhhhhcCCCceeecccc--------------ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----h
Confidence 445566678899999877765 5668999999999999999999999999999999999865 3
Q ss_pred cchhHHHHHHHHHHHcC-----C---CCccccceeeee----CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHH
Q 035930 512 KKMPRAQTEREIMQMLD-----H---PFLPTLFAHFTT----EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVA 579 (857)
Q Consensus 512 ~~~~~~~~EieILr~L~-----H---PnIV~L~~~f~~----~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~ 579 (857)
...+....|+.+|+++. | .+||+|+++|.. +.|+|||+|++ |.+|..++.....+.++...++.|++
T Consensus 116 hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~ 194 (590)
T KOG1290|consen 116 HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICR 194 (590)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHH
Confidence 34556788999999983 3 379999999975 45999999999 89999999988888899999999999
Q ss_pred HHHHHHHHHH-HcCceeccCCCCcEEEc
Q 035930 580 EVLLALEYLH-MLGVVYRDLKPENILVR 606 (857)
Q Consensus 580 QIl~gL~yLH-s~GIIHRDLKPeNILL~ 606 (857)
|||.||.||| ++||||.||||+|||+.
T Consensus 195 qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 195 QVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred HHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9999999999 67999999999999994
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=343.41 Aligned_cols=261 Identities=28% Similarity=0.382 Sum_probs=203.7
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC-----
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK----- 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~----- 543 (857)
.++|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+++++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4579999999999999999999999999999999865422 1222334578999999999999999999887653
Q ss_pred ---eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 544 ---FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 544 ---~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
..|+||||+. ++|..++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4599999995 57877776543 248999999999999999999999999999999999999999999999999974
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
....... ..
T Consensus 168 ~~~~~~~-----------------------------------------------------------------------~~ 176 (310)
T cd07865 168 AFSLSKN-----------------------------------------------------------------------SK 176 (310)
T ss_pred cccCCcc-----------------------------------------------------------------------cC
Confidence 3211000 00
Q ss_pred CCccccccCCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc----------------
Q 035930 701 GARSNSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS---------------- 763 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~---------------- 763 (857)
........++..|+|||++.+.. ++.++|||||||++|||++|+.||.+.+....+..+..-.
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (310)
T cd07865 177 PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLEL 256 (310)
T ss_pred CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhh
Confidence 00012345788999999987654 6889999999999999999999998765443332222110
Q ss_pred ---ccCCC-----------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 764 ---LRFPG-----------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 764 ---~~~p~-----------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
..++. ....+..+.+||.+||..||.+||+ ++++|+||||
T Consensus 257 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t----~~e~l~h~~f 310 (310)
T cd07865 257 FKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID----ADTALNHDFF 310 (310)
T ss_pred hhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC----HHHHhcCCCC
Confidence 01111 1123567889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=336.30 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=207.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
..+|++.+.||+|+||.||++.+.. +..+|+|.+.... .....+.+|+++|+.++||||++++++|..++..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 3568999999999999999998854 4579999886442 2345678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++|+|.+++..... .+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05114 78 TEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY- 155 (256)
T ss_pred EEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence 999999999988875433 489999999999999999999999999999999999999999999999998743210000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (256)
T cd05114 156 -------------------------------------------------------------------------TSSSGAK 162 (256)
T ss_pred -------------------------------------------------------------------------eccCCCC
Confidence 0001123
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+.+..+.... +.......+..+.+||.+||..|
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~c~~~~ 241 (256)
T cd05114 163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPKLASMTVYEVMYSCWHEK 241 (256)
T ss_pred CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHccCC
Confidence 5678999999999999999999999999999999 999998887777776665543 33334557889999999999999
Q ss_pred cCCcCCchhhHHHHHc
Q 035930 788 PDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~ 803 (857)
|.+||+ +++|++
T Consensus 242 p~~Rps----~~~l~~ 253 (256)
T cd05114 242 PEGRPT----FAELLR 253 (256)
T ss_pred cccCcC----HHHHHH
Confidence 999999 788765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=377.59 Aligned_cols=269 Identities=22% Similarity=0.314 Sum_probs=198.6
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCC-eEEEEEE--------------ecccccccccchhHHHHHHHHHHHcCCCCc
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTS-CLFALKV--------------MDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg-~~VAVKv--------------i~k~~~~~~~~~~~~~~EieILr~L~HPnI 532 (857)
...+|++++.||+|+||+||+|.++... ..+++|. +.+...........+.+|+++|+.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999999765332 2222221 111111112233457889999999999999
Q ss_pred cccceeeeeCCeEEEEEeecCCCChHHHHhhCC---CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC
Q 035930 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQP---SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG 609 (857)
Q Consensus 533 V~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~---~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg 609 (857)
+++++++..++..|+|||++ +++|..++.... ........++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999999999999999999 566766554322 11234667888999999999999999999999999999999999
Q ss_pred cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhccc
Q 035930 610 HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQV 689 (857)
Q Consensus 610 ~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~ 689 (857)
.+||+|||++..+...
T Consensus 305 ~vkL~DFGla~~~~~~---------------------------------------------------------------- 320 (501)
T PHA03210 305 KIVLGDFGTAMPFEKE---------------------------------------------------------------- 320 (501)
T ss_pred CEEEEeCCCceecCcc----------------------------------------------------------------
Confidence 9999999997432100
Q ss_pred CCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC---hhhhHHHhhcc---
Q 035930 690 SPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN---DETLSNVVSQS--- 763 (857)
Q Consensus 690 ~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~---~e~l~~Iv~~~--- 763 (857)
.......++||+.|+|||++.+..|+.++|||||||+||||++|..++.+... ...+..++...
T Consensus 321 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 390 (501)
T PHA03210 321 ----------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVC 390 (501)
T ss_pred ----------cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccC
Confidence 00111245799999999999999999999999999999999998865443221 12222222100
Q ss_pred -ccCCC--------------------------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhh
Q 035930 764 -LRFPG--------------------------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 764 -~~~p~--------------------------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li 815 (857)
..++. ...++.++.++|.+||.+||.+||+ +.|+|.||||...++..+
T Consensus 391 ~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps----a~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 391 DEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG----AAELLALPLFSAEEEEEI 465 (501)
T ss_pred hhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC----HHHHhhChhhhcCCchHH
Confidence 00110 1235677889999999999999999 999999999998776543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=346.66 Aligned_cols=256 Identities=30% Similarity=0.482 Sum_probs=219.0
Q ss_pred ccCCCeEEE-eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeee---
Q 035930 467 MGMRHFKLH-KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTT--- 541 (857)
Q Consensus 467 ~~~~~Y~i~-~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~--- 541 (857)
-.+++|.+- ++||-|-.|.|..|.++.++..+|+|++... ...++|+++.-+. .|||||.++++|++
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 345678775 4799999999999999999999999998532 4568899875544 69999999999864
Q ss_pred -CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc---CCcEEEeccc
Q 035930 542 -EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE---DGHIMLSDFD 617 (857)
Q Consensus 542 -~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~---dg~iKL~DFG 617 (857)
...+.+|||+|+||.|...++.+....|+|.++-.|+.||..|+.|||..+|.||||||||+|+.. |..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 357889999999999999999888888999999999999999999999999999999999999964 4579999999
Q ss_pred chhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccc
Q 035930 618 LSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVV 697 (857)
Q Consensus 618 LA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~ 697 (857)
+|++...+
T Consensus 210 FAK~t~~~------------------------------------------------------------------------ 217 (400)
T KOG0604|consen 210 FAKETQEP------------------------------------------------------------------------ 217 (400)
T ss_pred cccccCCC------------------------------------------------------------------------
Confidence 99642110
Q ss_pred cCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC----hhhhHHHhhccccCCC--CCC
Q 035930 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN----DETLSNVVSQSLRFPG--YPV 771 (857)
Q Consensus 698 ~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~----~e~l~~Iv~~~~~~p~--~~~ 771 (857)
....+-|-||.|.|||++..+.|+...|+|||||++|-||+|.+||+.... .....+|..+.+.||. |..
T Consensus 218 ----~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~ 293 (400)
T KOG0604|consen 218 ----GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC 293 (400)
T ss_pred ----ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence 111234679999999999999999999999999999999999999987643 2345677778877765 678
Q ss_pred CCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 772 VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 772 is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+|.+++|+|++||..+|++|+| +++++.|||+.+-
T Consensus 294 VSe~aKdlIR~LLkt~PteRlT----I~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 294 VSEAAKDLIRKLLKTEPTERLT----IEEVMDHPWINQY 328 (400)
T ss_pred HHHHHHHHHHHHhcCCchhhee----HHHhhcCchhccc
Confidence 9999999999999999999999 9999999999864
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=360.34 Aligned_cols=262 Identities=29% Similarity=0.385 Sum_probs=216.1
Q ss_pred hccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC--CC----Ccccc
Q 035930 462 KQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD--HP----FLPTL 535 (857)
Q Consensus 462 ~~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~--HP----nIV~L 535 (857)
.+.+.....+|.+...||+|.||.|..+.+..++..||||+++.- .+..+..+.|+++|+++. -| -+|.+
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 444556678999999999999999999999999999999999754 344556688999999994 23 37899
Q ss_pred ceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc--------
Q 035930 536 FAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE-------- 607 (857)
Q Consensus 536 ~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~-------- 607 (857)
.+||...++.|||+|.+ |-++++++..+....++...++.+++||+.+++|||+++++|.||||||||+..
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 99999999999999999 889999999888788999999999999999999999999999999999999942
Q ss_pred ------------CCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHH
Q 035930 608 ------------DGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVA 675 (857)
Q Consensus 608 ------------dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~ 675 (857)
+..|+|+|||.|..-
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~----------------------------------------------------- 262 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFD----------------------------------------------------- 262 (415)
T ss_pred cCCccceeccCCCcceEEEecCCccee-----------------------------------------------------
Confidence 235788888876321
Q ss_pred HhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhh
Q 035930 676 AKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET 755 (857)
Q Consensus 676 ~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~ 755 (857)
.......+.|..|+|||+++|.+|+.++||||+||||+||.+|...|.+.++.|.
T Consensus 263 -------------------------~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 263 -------------------------HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred -------------------------ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 1112466889999999999999999999999999999999999999999987774
Q ss_pred h---HHHhh------------------ccccCCCC-----------------------CCCCHHHHHHHHhhccCCcCCc
Q 035930 756 L---SNVVS------------------QSLRFPGY-----------------------PVVSFHARDLIRGLLVKEPDNR 791 (857)
Q Consensus 756 l---~~Iv~------------------~~~~~p~~-----------------------~~is~~l~dLI~k~L~~DPe~R 791 (857)
+ +.|+. +.+.+++. ...--.+.|||++||.+||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 4 33332 01111110 0011247799999999999999
Q ss_pred CCchhhHHHHHcCCCCCCC
Q 035930 792 LGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 792 pt~~~~a~ELL~HPfF~~l 810 (857)
+| +.|+|.||||..+
T Consensus 398 iT----l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 398 IT----LREALSHPFFARL 412 (415)
T ss_pred cc----HHHHhcCHHhhcC
Confidence 99 9999999999875
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=337.17 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=205.0
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
+..+.....||+|+||+||+|.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++++..++..|+|
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 445555678999999999999999999999999886542 22345678999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCC--cHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc-CCcEEEecccchhhcccC
Q 035930 549 MEYCPGGDLHVLRQKQPSRFF--SEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE-DGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l--~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~-dg~iKL~DFGLA~r~~~~ 625 (857)
|||+++++|..++..... .+ ++..+..++.||+.||.|||..||+||||||+||+++. ++.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 84 MEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 999999999988875422 24 78888999999999999999999999999999999976 679999999987431100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.....
T Consensus 163 ---------------------------------------------------------------------------~~~~~ 167 (268)
T cd06624 163 ---------------------------------------------------------------------------NPCTE 167 (268)
T ss_pred ---------------------------------------------------------------------------CCccc
Confidence 00011
Q ss_pred cccCCCCccChhhhcCCC--CCcccceehhhHHHHHHhhCCCCCCCCCChhh-hHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 706 SFVGTHEYLAPEIIKGEG--HGSSVDWWTFGIFLFELLYGRTPFKGSGNDET-LSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~--~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~-l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
...|++.|+|||++.+.. ++.++|||||||++|+|++|+.||........ ...+.........+..++.++++||.+
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence 234789999999987654 78899999999999999999999976543222 111111111122234578899999999
Q ss_pred hccCCcCCcCCchhhHHHHHcCCCC
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
||..+|.+||+ +.+++.||||
T Consensus 248 ~l~~~p~~Rpt----~~~ll~~~~~ 268 (268)
T cd06624 248 CFEPDPDKRAS----AHDLLQDPFL 268 (268)
T ss_pred HcCCCchhCCC----HHHHHhCCCC
Confidence 99999999999 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=367.56 Aligned_cols=255 Identities=20% Similarity=0.298 Sum_probs=210.2
Q ss_pred ccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 463 QHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 463 ~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
+.|.+..+.+.++.+||+|.||+||+|+|.++ ||||+++.+.... ..++.|++|+.+|++-+|.||+-+.|||...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 44556677888999999999999999999876 9999998876544 4788999999999999999999999999998
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
.. .||+.+|.|.+|+.+++.... .|.....+.|+.||++||.|||.++|||||||..||+|.+++.|||+||||+..-
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred ce-eeeehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 88 899999999999999887654 4899999999999999999999999999999999999999999999999997210
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
. +..+ ..
T Consensus 539 ~----~w~g---------------------------------------------------------------------~~ 545 (678)
T KOG0193|consen 539 T----RWSG---------------------------------------------------------------------EQ 545 (678)
T ss_pred e----eecc---------------------------------------------------------------------cc
Confidence 0 0000 00
Q ss_pred ccccccCCCCccChhhhcC---CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC---CCCCCCHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKG---EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP---GYPVVSFHA 776 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g---~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p---~~~~is~~l 776 (857)
....-.|...|||||+++. .+|++.+|||||||++|||++|..||...+.++++..+-.+.+... .....+.++
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~m 625 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAM 625 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHH
Confidence 0111236788999999974 5689999999999999999999999996666666655544433221 134577899
Q ss_pred HHHHHhhccCCcCCcCCchh
Q 035930 777 RDLIRGLLVKEPDNRLGAVK 796 (857)
Q Consensus 777 ~dLI~k~L~~DPe~Rpt~~~ 796 (857)
++|+..||.+++++||.+..
T Consensus 626 k~Ll~~C~~~~~~eRP~F~~ 645 (678)
T KOG0193|consen 626 KRLLSDCWKFDREERPLFPQ 645 (678)
T ss_pred HHHHHHHHhcCcccCccHHH
Confidence 99999999999999999433
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=339.95 Aligned_cols=255 Identities=29% Similarity=0.417 Sum_probs=209.0
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEee
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEY 551 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy 551 (857)
|++.+.||.|++|+||+|.+..+|..||||++..... .......+.+|+++++.++||||+++++++.+++..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999875532 223345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccC
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKS 631 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ 631 (857)
+ +++|..++.......+++..+..++.||+.||+|||.++++||||+|+||+++.++.++|+|||++......
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~------ 152 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP------ 152 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC------
Confidence 9 568988887765445899999999999999999999999999999999999999999999999987431100
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCC
Q 035930 632 SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711 (857)
Q Consensus 632 ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~ 711 (857)
........+++
T Consensus 153 ---------------------------------------------------------------------~~~~~~~~~~~ 163 (283)
T cd07835 153 ---------------------------------------------------------------------VRTYTHEVVTL 163 (283)
T ss_pred ---------------------------------------------------------------------ccccCcccccc
Confidence 00001224688
Q ss_pred CccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc------------------CC-----
Q 035930 712 EYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR------------------FP----- 767 (857)
Q Consensus 712 ~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~------------------~p----- 767 (857)
.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..++..... ++
T Consensus 164 ~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T cd07835 164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQ 243 (283)
T ss_pred CCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccccccc
Confidence 99999988764 5788999999999999999999999877654444443321100 10
Q ss_pred ----CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 768 ----GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 768 ----~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
..+.++..+.+||.+||+.||.+||+ +++++.||||
T Consensus 244 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~il~~~~~ 283 (283)
T cd07835 244 DLSKVVPNLDEDGLDLLSKMLVYDPAKRIS----AKAALQHPYF 283 (283)
T ss_pred chhhhcCCCCHHHHHHHHHHhcCChhhCcC----HHHHhcCCCC
Confidence 12457789999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=335.36 Aligned_cols=259 Identities=27% Similarity=0.403 Sum_probs=213.0
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccc--cccccchhHHHHHHHHHHHcCCCCccccceeeeeC--CeE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDF--LVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE--KFS 545 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~--~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~--~~l 545 (857)
.+|.+.+.||+|+||.||+|.+..++..||+|++.... .........+.+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875431 11223445788999999999999999999998764 568
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999998887653 3889999999999999999999999999999999999999999999999987432100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
. .......
T Consensus 160 ~------------------------------------------------------------------------~~~~~~~ 167 (264)
T cd06653 160 C------------------------------------------------------------------------MSGTGIK 167 (264)
T ss_pred c------------------------------------------------------------------------ccCcccc
Confidence 0 0000012
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
.+.|+..|+|||++.+..++.++|||||||++|+|++|+.||......+.+.++.........+..++..+.++|.+||.
T Consensus 168 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~ 247 (264)
T cd06653 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV 247 (264)
T ss_pred ccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc
Confidence 34589999999999998899999999999999999999999987765555555544443333345688999999999999
Q ss_pred CCcCCcCCchhhHHHHHcCCCC
Q 035930 786 KEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
+|..||+ +.+++.|||.
T Consensus 248 -~~~~r~~----~~~~~~~~~~ 264 (264)
T cd06653 248 -EEKRRPT----AEFLLRHPFV 264 (264)
T ss_pred -CcccCcc----HHHHhcCCCC
Confidence 5799999 9999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=329.47 Aligned_cols=256 Identities=31% Similarity=0.521 Sum_probs=217.8
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|.+.+.||.|+||.||++.+..++..||+|++..... .......+.+|+++++.++|||++++++.+......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58899999999999999999998999999999876532 22445567899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCC--CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 551 YCPGGDLHVLRQKQP--SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 551 y~~gGsL~~ll~~~~--~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|+++++|..++.... ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~--- 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--- 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC---
Confidence 999999998887653 345899999999999999999999999999999999999999999999999987331100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 157 ------------------------------------------------------------------------~~~~~~~~ 164 (258)
T cd08215 157 ------------------------------------------------------------------------VDLAKTVV 164 (258)
T ss_pred ------------------------------------------------------------------------cceeccee
Confidence 00012235
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
|++.|+|||.+.+..++.++|+|+||+++|+|++|..||...+..+........... +....++..+.++|..||..+|
T Consensus 165 ~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p 243 (258)
T cd08215 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP-PIPSQYSSELRNLVSSLLQKDP 243 (258)
T ss_pred eeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCh
Confidence 888999999999999999999999999999999999999887666666555544322 2234688999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF 807 (857)
.+||+ +.++|+||||
T Consensus 244 ~~Rp~----~~~ll~~~~~ 258 (258)
T cd08215 244 EERPS----IAQILQSPFI 258 (258)
T ss_pred hhCcC----HHHHhcCCCC
Confidence 99999 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=341.47 Aligned_cols=271 Identities=26% Similarity=0.375 Sum_probs=208.4
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC---
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE--- 542 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~--- 542 (857)
+...++|.+.+.||.|+||.||+|.+..++..||||++...... ......+.+|+++|+.++||||+++++++...
T Consensus 4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 34568999999999999999999999999999999998654221 22234567899999999999999999987543
Q ss_pred -----CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEeccc
Q 035930 543 -----KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFD 617 (857)
Q Consensus 543 -----~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFG 617 (857)
..+|+||||+. ++|..++.... ..+++..++.++.||+.||.|||.+||+||||||+|||++.++.++|+|||
T Consensus 83 ~~~~~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 83 SKRKRGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ccccCceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 35799999995 56766655432 349999999999999999999999999999999999999999999999999
Q ss_pred chhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccc
Q 035930 618 LSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVV 697 (857)
Q Consensus 618 LA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~ 697 (857)
++.......... . . . .
T Consensus 161 ~~~~~~~~~~~~------------------~---~--------------------------------------~-----~ 176 (311)
T cd07866 161 LARPYDGPPPNP------------------K---G--------------------------------------G-----G 176 (311)
T ss_pred cchhccCCCccc------------------c---c--------------------------------------C-----C
Confidence 985422110000 0 0 0 0
Q ss_pred cCCCCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC----------
Q 035930 698 EPTGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF---------- 766 (857)
Q Consensus 698 ~~~~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~---------- 766 (857)
...........|++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+....+..+.......
T Consensus 177 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T cd07866 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRS 256 (311)
T ss_pred cccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhh
Confidence 0001122345789999999998764 57899999999999999999999998776655544433211100
Q ss_pred -------------C-----CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 767 -------------P-----GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 767 -------------p-----~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
+ ....+...+.+||.+||..||.+||+ +.+++.||||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~~ell~~~~f 311 (311)
T cd07866 257 LPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT----ASDALEHPYF 311 (311)
T ss_pred cccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC----HHHHhcCCCC
Confidence 0 01234568899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.73 Aligned_cols=261 Identities=23% Similarity=0.330 Sum_probs=206.8
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LV 548 (857)
.+|...+.||+|+||.||++.+..++..||||.+...... .....+.+|+.++.++. ||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4677788999999999999999999999999998754321 33456788999999996 99999999999999999999
Q ss_pred EeecCCCChHHHH---hhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 549 MEYCPGGDLHVLR---QKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 549 mEy~~gGsL~~ll---~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
|||+. ++|..+. .......+++..+..++.|++.||+|||+ .||+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99984 5654433 22222458999999999999999999997 5999999999999999999999999999743210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
. ...
T Consensus 161 ~----------------------------------------------------------------------------~~~ 164 (288)
T cd06616 161 S----------------------------------------------------------------------------IAK 164 (288)
T ss_pred C----------------------------------------------------------------------------Ccc
Confidence 0 000
Q ss_pred ccccCCCCccChhhhcCC---CCCcccceehhhHHHHHHhhCCCCCCCCCC-hhhhHHHhhccc-cCC--CCCCCCHHHH
Q 035930 705 NSFVGTHEYLAPEIIKGE---GHGSSVDWWTFGIFLFELLYGRTPFKGSGN-DETLSNVVSQSL-RFP--GYPVVSFHAR 777 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~---~~s~ksDVWSLGvILyELLtGk~PF~g~~~-~e~l~~Iv~~~~-~~p--~~~~is~~l~ 777 (857)
....|++.|+|||++.+. .++.++|||||||++|+|++|+.||..... .+.+..+..... .++ ....++.++.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 244 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFV 244 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHH
Confidence 123478899999999876 689999999999999999999999976542 122222222211 111 1234788999
Q ss_pred HHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 778 DLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 778 dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
+||.+||..||.+||+ +++|+.||||+...|.
T Consensus 245 ~li~~~l~~~p~~Rpt----~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 245 NFINLCLIKDESKRPK----YKELLEHPFIKDYEER 276 (288)
T ss_pred HHHHHHccCChhhCcC----HHHHhcChhhhchhhc
Confidence 9999999999999999 9999999999886553
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=332.48 Aligned_cols=250 Identities=48% Similarity=0.865 Sum_probs=214.3
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCCCh
Q 035930 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL 557 (857)
Q Consensus 478 LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL 557 (857)
||.|+||.||++.+..++..||+|++.............+..|+++++.++||||+++++.+..++..|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999988999999999876544444566789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCC
Q 035930 558 HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEE 637 (857)
Q Consensus 558 ~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~ 637 (857)
..++.... .+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----------- 147 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----------- 147 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-----------
Confidence 99887654 38999999999999999999999999999999999999999999999999874321000
Q ss_pred CCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChh
Q 035930 638 PPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPE 717 (857)
Q Consensus 638 p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPE 717 (857)
.......|+..|++||
T Consensus 148 ----------------------------------------------------------------~~~~~~~~~~~~~~Pe 163 (250)
T cd05123 148 ----------------------------------------------------------------SRTNTFCGTPEYLAPE 163 (250)
T ss_pred ----------------------------------------------------------------CcccCCcCCccccChH
Confidence 0112345788999999
Q ss_pred hhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhh
Q 035930 718 IIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKG 797 (857)
Q Consensus 718 il~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~ 797 (857)
.+.+..++.++|+|+||+++|+|++|..||...+..+.+..+......++ ..++..+.+||++||..||++||+...
T Consensus 164 ~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~~i~~~l~~~p~~R~~~~~- 240 (250)
T cd05123 164 VLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP--EFLSPEARDLISGLLQKDPTKRLGSGG- 240 (250)
T ss_pred HhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHhcCCHhhCCCccc-
Confidence 99998899999999999999999999999987766666666666444444 447999999999999999999999322
Q ss_pred HHHHHcCCCC
Q 035930 798 AAEIKQHPFF 807 (857)
Q Consensus 798 a~ELL~HPfF 807 (857)
++++++||||
T Consensus 241 ~~~l~~~~~f 250 (250)
T cd05123 241 AEEIKAHPFF 250 (250)
T ss_pred HHHHHhCCCC
Confidence 3999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=346.00 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=214.6
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
.+|.+.+.||+|+||+||++.+..++..||+|++.... ....+.+.+|+.+++.++||||++++++|...+..|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 57999999999999999999998889999999986432 233456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|..++... .+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~----- 167 (293)
T cd06647 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP----- 167 (293)
T ss_pred ecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc-----
Confidence 999999999988754 378999999999999999999999999999999999999999999999998632100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.........|
T Consensus 168 ----------------------------------------------------------------------~~~~~~~~~~ 177 (293)
T cd06647 168 ----------------------------------------------------------------------EQSKRSTMVG 177 (293)
T ss_pred ----------------------------------------------------------------------cccccccccC
Confidence 0000122358
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh-ccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS-QSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~-~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+.+..+.. ....++....++..+++||++||..+|
T Consensus 178 ~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 257 (293)
T cd06647 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 257 (293)
T ss_pred ChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCCh
Confidence 8999999999988899999999999999999999999987655444333222 222233344577889999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
++||+ +.+++.|+||...+
T Consensus 258 ~~Rp~----~~~il~h~~~~~~~ 276 (293)
T cd06647 258 EKRGS----AKELLQHPFLKIAK 276 (293)
T ss_pred hhCcC----HHHHhcCHHHhcCc
Confidence 99999 99999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=347.52 Aligned_cols=255 Identities=27% Similarity=0.371 Sum_probs=210.2
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
+.|.+.+.||+|+||+||+|.+..++..||+|++.............+.+|+++++.++||||++++++|..++..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56999999999999999999999899999999986543333344456889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+. |+|..++.... ..+++..+..++.||+.||.|||..||+||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----- 167 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----- 167 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-----
Confidence 9996 56766655432 2489999999999999999999999999999999999999999999999998632100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
...+.|
T Consensus 168 --------------------------------------------------------------------------~~~~~~ 173 (307)
T cd06607 168 --------------------------------------------------------------------------ANSFVG 173 (307)
T ss_pred --------------------------------------------------------------------------CCCccC
Confidence 012357
Q ss_pred CCCccChhhhc---CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 710 THEYLAPEIIK---GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 710 T~~YmAPEil~---g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
++.|+|||++. ...++.++|||||||++|||++|+.||.+.+.......+............++..+++||.+||..
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 253 (307)
T cd06607 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQK 253 (307)
T ss_pred CccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcC
Confidence 88999999985 355788999999999999999999999877655544443332222112234788999999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCCCC
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
||.+||+ +.+|+.||||..
T Consensus 254 ~p~~Rp~----~~~il~~~~~~~ 272 (307)
T cd06607 254 IPQDRPS----SEELLKHRFVLR 272 (307)
T ss_pred ChhhCcC----HHHHhcChhhcc
Confidence 9999999 999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=347.35 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=212.8
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|.....||.|+||.||++.+..++..||||++.... ......+.+|+.+++.++||||++++++|..++..|+|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 3555668999999999999999899999999986532 2334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 99 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~----- 170 (297)
T cd06659 99 FLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----- 170 (297)
T ss_pred cCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc-----
Confidence 99999998877553 3899999999999999999999999999999999999999999999999987321100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
.......+|+
T Consensus 171 ----------------------------------------------------------------------~~~~~~~~~~ 180 (297)
T cd06659 171 ----------------------------------------------------------------------VPKRKSLVGT 180 (297)
T ss_pred ----------------------------------------------------------------------cccccceecC
Confidence 0011234689
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-CCCCCCCCHHHHHHHHhhccCCcC
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-FPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
+.|+|||++.+..++.++|||||||++|||++|+.||......+.+..+...... +.....++..+.+||++||..||.
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~ 260 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQ 260 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcc
Confidence 9999999999989999999999999999999999999877655555544332211 222345788999999999999999
Q ss_pred CcCCchhhHHHHHcCCCCCCC
Q 035930 790 NRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 790 ~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+||+ +.+|++||||...
T Consensus 261 ~Rps----~~~ll~~~~~~~~ 277 (297)
T cd06659 261 ERAT----AQELLDHPFLLQT 277 (297)
T ss_pred cCcC----HHHHhhChhhccC
Confidence 9999 9999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=337.89 Aligned_cols=257 Identities=22% Similarity=0.281 Sum_probs=209.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCC-----CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGT-----SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~t-----g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
+..++|.+.+.||.|+||.||+|.+... +..||+|.+.... .......+.+|+.+|+.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4557899999999999999999988644 4789999986542 12223467889999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCC--------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEE
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQP--------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML 613 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~--------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL 613 (857)
....|+||||+++++|..++.... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 999999999999999998886532 123678899999999999999999999999999999999999999999
Q ss_pred ecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCC
Q 035930 614 SDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMP 693 (857)
Q Consensus 614 ~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p 693 (857)
+|||++........
T Consensus 161 ~dfg~~~~~~~~~~------------------------------------------------------------------ 174 (277)
T cd05032 161 GDFGMTRDIYETDY------------------------------------------------------------------ 174 (277)
T ss_pred CCcccchhhccCcc------------------------------------------------------------------
Confidence 99998743211000
Q ss_pred cccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCC
Q 035930 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVV 772 (857)
Q Consensus 694 ~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~i 772 (857)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+.+..+. ....++.+..+
T Consensus 175 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 246 (277)
T cd05032 175 -------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGGHLDLPENC 246 (277)
T ss_pred -------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCCCCCCCCCC
Confidence 000112346788999999998889999999999999999998 999998877666665555 33333444557
Q ss_pred CHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 773 SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 773 s~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+..+.+||.+||..+|.+||+ +.+|+.
T Consensus 247 ~~~~~~li~~~l~~~p~~Rpt----~~~l~~ 273 (277)
T cd05032 247 PDKLLELMRMCWQYNPKMRPT----FLEIVS 273 (277)
T ss_pred CHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 899999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=341.36 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=208.6
Q ss_pred CCCeEEEeEEccCCceEEEEEEEc----CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELI----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
+.+|++.+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+++|+.++||||+++++++..++.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 467999999999999999999863 456789999987532 22334567889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCC---------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC
Q 035930 545 SCLVMEYCPGGDLHVLRQKQP---------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG 609 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~---------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg 609 (857)
.|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 999999999999998875322 12378889999999999999999999999999999999999999
Q ss_pred cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhccc
Q 035930 610 HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQV 689 (857)
Q Consensus 610 ~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~ 689 (857)
.++|+|||++........
T Consensus 162 ~~kl~dfg~~~~~~~~~~-------------------------------------------------------------- 179 (283)
T cd05090 162 HVKISDLGLSREIYSADY-------------------------------------------------------------- 179 (283)
T ss_pred cEEeccccccccccCCcc--------------------------------------------------------------
Confidence 999999999754211000
Q ss_pred CCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCC
Q 035930 690 SPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPG 768 (857)
Q Consensus 690 ~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~ 768 (857)
........++..|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+.. ...++.
T Consensus 180 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 247 (283)
T cd05090 180 -----------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK-RQLLPC 247 (283)
T ss_pred -----------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCcCCC
Confidence 000122346778999999998889999999999999999998 9999988766555544433 333444
Q ss_pred CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 769 YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 769 ~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
...++..+.+||.+||..||++||+ +.+|+++
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05090 248 SEDCPPRMYSLMTECWQEGPSRRPR----FKDIHTR 279 (283)
T ss_pred CCCCCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 5668999999999999999999999 7777664
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=343.71 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=208.6
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC--CeEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE--KFSC 546 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~--~~l~ 546 (857)
.++|++.+.||.|+||.||+|.+..+++.||+|.++..... ......+.+|+++|+.++||||+++++++... +..|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999999999999999755322 22334567899999999999999999999877 8999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||++ ++|..++..... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..+....
T Consensus 83 lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999996 589888776443 48999999999999999999999999999999999999999999999999874321100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.....
T Consensus 161 ---------------------------------------------------------------------------~~~~~ 165 (293)
T cd07843 161 ---------------------------------------------------------------------------KPYTQ 165 (293)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00112
Q ss_pred ccCCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-------------------c-
Q 035930 707 FVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-------------------R- 765 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-------------------~- 765 (857)
..+++.|+|||++.+.. ++.++|||||||++|+|++|..||......+.+..+..... .
T Consensus 166 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (293)
T cd07843 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTF 245 (293)
T ss_pred ccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccccc
Confidence 34688999999997654 68899999999999999999999987765555444332100 0
Q ss_pred ----C----CCCCC--CCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 766 ----F----PGYPV--VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 766 ----~----p~~~~--is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
+ ...+. +++.+.+||++||..||++||+ +.|+|.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t----~~ell~~~~f 293 (293)
T cd07843 246 TKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS----AEDALKHPYF 293 (293)
T ss_pred ccccchhhhccccccCCChHHHHHHHHHhccCccccCC----HHHHhcCCCC
Confidence 0 00111 5888999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=334.22 Aligned_cols=252 Identities=26% Similarity=0.334 Sum_probs=209.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++.+.||+|+||.||+|.+.. +..||||.++... .....+.+|+.+|+.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 455789999999999999999998754 5689999987542 23456788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++..+....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999877654568999999999999999999999999999999999999999999999999975421000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
. .....
T Consensus 158 ~--------------------------------------------------------------------------~~~~~ 163 (261)
T cd05068 158 Y--------------------------------------------------------------------------EAREG 163 (261)
T ss_pred c--------------------------------------------------------------------------cccCC
Confidence 0 00001
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
..++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+. .....+....++..+.+||.+||.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 242 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELYDIMLDCWK 242 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHhh
Confidence 123468999999999999999999999999999999 999998877666665553 334445556688999999999999
Q ss_pred CCcCCcCCchhhHHHHH
Q 035930 786 KEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL 802 (857)
.||.+||+ +.+|+
T Consensus 243 ~~P~~Rp~----~~~l~ 255 (261)
T cd05068 243 EDPDDRPT----FETLQ 255 (261)
T ss_pred cCcccCCC----HHHHH
Confidence 99999999 66665
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=340.87 Aligned_cols=255 Identities=29% Similarity=0.444 Sum_probs=214.0
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|...+.||.|+||.||++.+..++..||+|+++... ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4566689999999999999999899999999986432 2334557889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|.+++... .+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~----- 168 (285)
T cd06648 97 FLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----- 168 (285)
T ss_pred ccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-----
Confidence 99999999888762 3889999999999999999999999999999999999999999999999986321000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
........|+
T Consensus 169 ----------------------------------------------------------------------~~~~~~~~~~ 178 (285)
T cd06648 169 ----------------------------------------------------------------------VPRRKSLVGT 178 (285)
T ss_pred ----------------------------------------------------------------------CcccccccCC
Confidence 0001234588
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC-CCCCCCCHHHHHHHHhhccCCcC
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF-PGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~-p~~~~is~~l~dLI~k~L~~DPe 789 (857)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+....... .....++..+.+||++||..||+
T Consensus 179 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 258 (285)
T cd06648 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPA 258 (285)
T ss_pred ccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChh
Confidence 99999999999899999999999999999999999998776666655554442222 22234788999999999999999
Q ss_pred CcCCchhhHHHHHcCCCCCCC
Q 035930 790 NRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 790 ~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+||+ +.++++||||...
T Consensus 259 ~Rpt----~~~il~~~~~~~~ 275 (285)
T cd06648 259 QRAT----AAELLNHPFLAKA 275 (285)
T ss_pred hCcC----HHHHccCcccccC
Confidence 9999 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.36 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=212.6
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
..+|.+++.||.|+||+||+|.+.. +..+|+|++.... ......+..|+.+|+.++||||+++++++...+..|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4578999999999999999999987 8899999987642 22345678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++++|.+++.......+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-- 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-- 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence 999999999999987655568999999999999999999999999999999999999999999999999874321000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.......
T Consensus 159 -------------------------------------------------------------------------~~~~~~~ 165 (261)
T cd05148 159 -------------------------------------------------------------------------YLSSDKK 165 (261)
T ss_pred -------------------------------------------------------------------------ccccCCC
Confidence 0001123
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
++..|+|||++.+..++.++|||+|||++|+|++ |+.||.+....+.+..+. ...+.+....++..+.++|.+||..|
T Consensus 166 ~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~ 244 (261)
T cd05148 166 IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIMLECWAAE 244 (261)
T ss_pred CceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHHHHHcCCC
Confidence 5678999999998899999999999999999998 899998877667766655 34555556678999999999999999
Q ss_pred cCCcCCchhhHHHHHc
Q 035930 788 PDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~ 803 (857)
|.+||+ +.+|++
T Consensus 245 p~~Rpt----~~~l~~ 256 (261)
T cd05148 245 PEDRPS----FKALRE 256 (261)
T ss_pred chhCcC----HHHHHH
Confidence 999999 666553
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.20 Aligned_cols=259 Identities=29% Similarity=0.445 Sum_probs=208.9
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC--CeEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE--KFSCL 547 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~--~~l~L 547 (857)
++|...++||.|+||.||+|.+..++..||+|++.... .......+.+|+++|+.++||||++++++|... +.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 36899999999999999999999999999999987542 123456788999999999999999999988654 47899
Q ss_pred EEeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 548 VMEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||||+++++|.+++... ....+++..+..++.||+.||.|||..||+|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 99999999998876532 2334889999999999999999999999999999999999999999999999986321000
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
...
T Consensus 159 -----------------------------------------------------------------------------~~~ 161 (287)
T cd06621 159 -----------------------------------------------------------------------------LAG 161 (287)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 001
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC-----hhhhHHHhhccc-cCCC----CCCCCHH
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-----DETLSNVVSQSL-RFPG----YPVVSFH 775 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~-----~e~l~~Iv~~~~-~~p~----~~~is~~ 775 (857)
...++..|+|||.+.+..++.++|||+|||++|+|++|..||..... .+....+..... .++. ...+++.
T Consensus 162 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (287)
T cd06621 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEE 241 (287)
T ss_pred cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHH
Confidence 23467889999999999999999999999999999999999986522 222222222111 1111 1235678
Q ss_pred HHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 776 ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 776 l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
+.+||.+||..||.+||+ +.|+++||||....
T Consensus 242 ~~~li~~~l~~~p~~Rpt----~~eil~~~~~~~~~ 273 (287)
T cd06621 242 FKDFIKQCLEKDPTRRPT----PWDMLEHPWIKAQM 273 (287)
T ss_pred HHHHHHHHcCCCcccCCC----HHHHHhCccccccc
Confidence 999999999999999999 99999999997653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=336.41 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=207.0
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
.+|.+.+.||.|+||.||++.+..++..||||.+.............+.+|+.+++.++||||++++++|..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 47889999999999999999999999999999886543333344567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 550 EYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||+++++|..++... ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC--
Confidence 999999999887642 2235899999999999999999999999999999999999999999999999987431100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.......
T Consensus 160 -------------------------------------------------------------------------~~~~~~~ 166 (267)
T cd08229 160 -------------------------------------------------------------------------TTAAHSL 166 (267)
T ss_pred -------------------------------------------------------------------------Ccccccc
Confidence 0001134
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh--hhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND--ETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~--e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
.|+..|+|||++.+..++.++||||||+++|+|++|..||.+.... +....+............++..+++||.+||.
T Consensus 167 ~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 246 (267)
T cd08229 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCIN 246 (267)
T ss_pred cCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcC
Confidence 5889999999999999999999999999999999999999765432 22333322222211223578899999999999
Q ss_pred CCcCCcCCchhhHHHHH
Q 035930 786 KEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL 802 (857)
.||.+||+ +.+|+
T Consensus 247 ~~p~~Rpt----~~~i~ 259 (267)
T cd08229 247 PDPEKRPD----ITYVY 259 (267)
T ss_pred CCcccCCC----HHHHH
Confidence 99999999 66654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=363.68 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=207.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCC-----CeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGT-----SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~t-----g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~ 540 (857)
+..++|+++++||.|+||+||+|.+... +..||||++.... .....+.+.+|+++|+.+. ||||++++++|.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 4567899999999999999999987543 3579999996542 2233457889999999996 999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCC-------------------------------------------------------
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQP------------------------------------------------------- 565 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~------------------------------------------------------- 565 (857)
+.+.+|||||||++|+|.+++....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 9999999999999999988775421
Q ss_pred ---------------------------------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc
Q 035930 566 ---------------------------------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR 606 (857)
Q Consensus 566 ---------------------------------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~ 606 (857)
...+++..+..++.||+.||+|||..||+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 12377888899999999999999999999999999999999
Q ss_pred cCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhh
Q 035930 607 EDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLA 686 (857)
Q Consensus 607 ~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~ 686 (857)
.++.++|+|||++..+.....
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~----------------------------------------------------------- 292 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSN----------------------------------------------------------- 292 (400)
T ss_pred CCCEEEEEeCCcceecccccc-----------------------------------------------------------
Confidence 999999999999743210000
Q ss_pred cccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhcccc
Q 035930 687 AQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLR 765 (857)
Q Consensus 687 ~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~ 765 (857)
........+++.|||||++.+..++.++|||||||+||||++ |..||........+...+....+
T Consensus 293 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~ 358 (400)
T cd05105 293 --------------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358 (400)
T ss_pred --------------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCC
Confidence 000122357788999999999999999999999999999997 99999877655555555666566
Q ss_pred CCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 766 FPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 766 ~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
++....++.++.+||.+||..||++||++
T Consensus 359 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 387 (400)
T cd05105 359 MAKPDHATQEVYDIMVKCWNSEPEKRPSF 387 (400)
T ss_pred CCCCccCCHHHHHHHHHHCccCHhHCcCH
Confidence 66666789999999999999999999993
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.75 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=207.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||+|+||.||+|.+..+++.||+|.++............+.+|+++++.++|+||++++++|..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999899999999987543333444667889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 550 EYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||+++++|..++... ....+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 999999998887642 22348999999999999999999999999999999999999999999999999874311000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
......
T Consensus 161 --------------------------------------------------------------------------~~~~~~ 166 (267)
T cd08224 161 --------------------------------------------------------------------------TAAHSL 166 (267)
T ss_pred --------------------------------------------------------------------------ccccee
Confidence 001123
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC--hhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN--DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~--~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||..... .+....+............++..+.++|.+||.
T Consensus 167 ~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~ 246 (267)
T cd08224 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCIN 246 (267)
T ss_pred cCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcC
Confidence 578899999999999999999999999999999999999975432 122223222222111122578899999999999
Q ss_pred CCcCCcCCchhhHHHHHc
Q 035930 786 KEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~ 803 (857)
.+|.+||+ +.+|++
T Consensus 247 ~~p~~Rp~----~~~il~ 260 (267)
T cd08224 247 PDPEKRPD----ISYVLQ 260 (267)
T ss_pred CCcccCCC----HHHHHH
Confidence 99999999 666653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.80 Aligned_cols=255 Identities=24% Similarity=0.293 Sum_probs=210.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCC---CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGT---SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~t---g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
.++|++.+.||+|+||+||+|.+... ...||||+++... .......+.+|+.+|+.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 35799999999999999999998643 4689999986542 223345678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+++++|..++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999999876543 4899999999999999999999999999999999999999999999999998543100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.. .....
T Consensus 160 ~~-------------------------------------------------------------------------~~~~~ 166 (266)
T cd05033 160 EA-------------------------------------------------------------------------TYTTK 166 (266)
T ss_pred cc-------------------------------------------------------------------------ceecc
Confidence 00 00001
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
...+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.. ....+....++..+.+|+.+||
T Consensus 167 ~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl 245 (266)
T cd05033 167 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-GYRLPPPMDCPSALYQLMLDCW 245 (266)
T ss_pred CCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHc
Confidence 1235678999999999999999999999999999997 9999987766666555543 3444555668999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcC
Q 035930 785 VKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~H 804 (857)
..+|++||+ +.+|+++
T Consensus 246 ~~~p~~Rp~----~~ei~~~ 261 (266)
T cd05033 246 QKDRNERPT----FSQIVST 261 (266)
T ss_pred CCCcccCcC----HHHHHHH
Confidence 999999999 7777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=339.80 Aligned_cols=258 Identities=23% Similarity=0.364 Sum_probs=210.2
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCC-----CeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGT-----SCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~t-----g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~ 540 (857)
+...+|++.+.||+|+||.||++.+... ...+|+|++.... .......+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 5567899999999999999999988644 3789999987542 223345678899999999 7999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhC--------------CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQ--------------PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR 606 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~--------------~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~ 606 (857)
.++.+|+||||+++|+|..++... ....+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 999999999999999999888642 234588999999999999999999999999999999999999
Q ss_pred cCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhh
Q 035930 607 EDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLA 686 (857)
Q Consensus 607 ~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~ 686 (857)
.++.++|+|||++........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~----------------------------------------------------------- 187 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDY----------------------------------------------------------- 187 (293)
T ss_pred CCCeEEeCccccccccccccc-----------------------------------------------------------
Confidence 999999999998743211000
Q ss_pred cccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhcccc
Q 035930 687 AQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLR 765 (857)
Q Consensus 687 ~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~ 765 (857)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+. ....
T Consensus 188 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~ 252 (293)
T cd05053 188 --------------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK-EGYR 252 (293)
T ss_pred --------------eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCc
Confidence 000011124678999999999999999999999999999997 999998776655555443 3344
Q ss_pred CCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 766 FPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 766 ~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
+.....++.++.+|+.+||..||.+||+ +.+++++
T Consensus 253 ~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~eil~~ 287 (293)
T cd05053 253 MEKPQNCTQELYHLMRDCWHEVPSQRPT----FKQLVED 287 (293)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 4444568899999999999999999999 7777764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=344.60 Aligned_cols=258 Identities=21% Similarity=0.301 Sum_probs=213.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc-----CCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI-----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~-----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~ 540 (857)
+..++|.+.+.||+|+||.||++.+. .++..||||+++... .....+.+.+|+++++++ +||||++++++|.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 55568999999999999999999863 345689999987542 123345678999999999 7999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
..+..|+||||+++|+|..++.......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999999999876544458999999999999999999999999999999999999999999999999874
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
.......
T Consensus 190 ~~~~~~~------------------------------------------------------------------------- 196 (302)
T cd05055 190 DIMNDSN------------------------------------------------------------------------- 196 (302)
T ss_pred cccCCCc-------------------------------------------------------------------------
Confidence 3210000
Q ss_pred CCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHH
Q 035930 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDL 779 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dL 779 (857)
........+++.|+|||++.+..++.++|||||||++|||++ |..||......+.+...+....+......++..+.+|
T Consensus 197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 276 (302)
T cd05055 197 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDI 276 (302)
T ss_pred eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 000012246788999999999999999999999999999998 9999988776666666666555555555688999999
Q ss_pred HHhhccCCcCCcCCchhhHHHHHc
Q 035930 780 IRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
|.+||..+|++||+ +.+|++
T Consensus 277 i~~cl~~~p~~Rpt----~~ell~ 296 (302)
T cd05055 277 MKTCWDADPLKRPT----FKQIVQ 296 (302)
T ss_pred HHHHcCCCchhCcC----HHHHHH
Confidence 99999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=353.54 Aligned_cols=263 Identities=24% Similarity=0.351 Sum_probs=206.0
Q ss_pred eEEccC--CceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecC
Q 035930 476 KKLGCG--DIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCP 553 (857)
Q Consensus 476 ~~LG~G--~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~ 553 (857)
..||.| +||+||++++..+++.||+|++...... ....+.+.+|+.+++.++||||++++++|..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 345666 9999999999999999999998754322 2334678889999999999999999999999999999999999
Q ss_pred CCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCC
Q 035930 554 GGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSS 633 (857)
Q Consensus 554 gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss 633 (857)
+++|..++.......+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+||+.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~------ 156 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ------ 156 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc------
Confidence 99999988876545589999999999999999999999999999999999999999999999986532110000
Q ss_pred CCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCc
Q 035930 634 PVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEY 713 (857)
Q Consensus 634 ~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Y 713 (857)
.. ... ........++..|
T Consensus 157 ~~----------------------------------------------------------~~~----~~~~~~~~~~~~y 174 (328)
T cd08226 157 KA----------------------------------------------------------KVV----YDFPQFSTSVLPW 174 (328)
T ss_pred cc----------------------------------------------------------ccc----ccccccccCccCc
Confidence 00 000 0000012356779
Q ss_pred cChhhhcCC--CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc---------------------------
Q 035930 714 LAPEIIKGE--GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL--------------------------- 764 (857)
Q Consensus 714 mAPEil~g~--~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~--------------------------- 764 (857)
||||++.+. .++.++|||||||++|||++|..||.+....+.+...+....
T Consensus 175 ~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (328)
T cd08226 175 LSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGI 254 (328)
T ss_pred cChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhccc
Confidence 999999874 478999999999999999999999987655444433332111
Q ss_pred ------------------cCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 765 ------------------RFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 765 ------------------~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
..+....+++.+.+||++||+.||++||+ +.++|+||||..+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----a~e~l~~~~~~~~~ 315 (328)
T cd08226 255 GESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS----ASSLLSHAFFKQVK 315 (328)
T ss_pred ccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC----HHHHhhCHHHHHHH
Confidence 11112336678999999999999999999 99999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=350.27 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=209.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-----Ce
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE-----KF 544 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~-----~~ 544 (857)
++|.+.+.||.|+||+||+|.+..++..||||.+..... .......+.+|+.+|+.++|+||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 579999999999999999999999999999999875432 233345677899999999999999999988654 35
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
.||||||+ +++|..++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 89999999 578888876543 489999999999999999999999999999999999999999999999998743110
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
. ....
T Consensus 161 ~---------------------------------------------------------------------------~~~~ 165 (337)
T cd07858 161 K---------------------------------------------------------------------------GDFM 165 (337)
T ss_pred C---------------------------------------------------------------------------cccc
Confidence 0 0011
Q ss_pred ccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh----------------------
Q 035930 705 NSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS---------------------- 761 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~---------------------- 761 (857)
....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (337)
T cd07858 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYI 245 (337)
T ss_pred cccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHH
Confidence 23457889999999875 4689999999999999999999999987643322222111
Q ss_pred -ccccC------CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 762 -QSLRF------PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 762 -~~~~~------p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
..... ...+.++..+++||++||..||++||+ ++++++||||..+.-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps----~~ell~h~~~~~~~~ 299 (337)
T cd07858 246 RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT----VEEALAHPYLASLHD 299 (337)
T ss_pred HhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC----HHHHHcCcchhhhcC
Confidence 00000 012457899999999999999999999 999999999987643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=339.69 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=213.3
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
-|++.+.||.|+||.||+|.+..++..||||++.... .......+.+|+.+++.++||||++++++|..++..|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 3778899999999999999998899999999986442 12344567899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|..++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~----- 154 (277)
T cd06641 83 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT----- 154 (277)
T ss_pred eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc-----
Confidence 99999999888643 3889999999999999999999999999999999999999999999999987321100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
........|+
T Consensus 155 ----------------------------------------------------------------------~~~~~~~~~~ 164 (277)
T cd06641 155 ----------------------------------------------------------------------QIKRNTFVGT 164 (277)
T ss_pred ----------------------------------------------------------------------hhhhccccCC
Confidence 0001223578
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCC
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDN 790 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~ 790 (857)
..|+|||++.+..++.++|+|||||++|+|++|..||...........+.... .......++.++.++|.+||..+|.+
T Consensus 165 ~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~ 243 (277)
T cd06641 165 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEPSF 243 (277)
T ss_pred ccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC-CCCCCcccCHHHHHHHHHHccCChhh
Confidence 89999999998888999999999999999999999998766555444443322 22223457889999999999999999
Q ss_pred cCCchhhHHHHHcCCCCCCC
Q 035930 791 RLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 791 Rpt~~~~a~ELL~HPfF~~l 810 (857)
||+ +.++++||||...
T Consensus 244 Rp~----~~~~l~~~~~~~~ 259 (277)
T cd06641 244 RPT----AKELLKHKFIVRF 259 (277)
T ss_pred CcC----HHHHHhCHHHhhh
Confidence 999 9999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=339.76 Aligned_cols=260 Identities=30% Similarity=0.432 Sum_probs=219.7
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
...|.+.+.||+|+||.||++.+..++..||+|++..... ....+.+|+++|+.++|+||++++++|..++..|+|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4568899999999999999999998899999999975421 456678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++++|.+++.... ..+++..+..++.||+.||.|||..||+|+||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--- 169 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--- 169 (286)
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc---
Confidence 99999999999988764 24899999999999999999999999999999999999999999999999986321100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 170 ------------------------------------------------------------------------~~~~~~~~ 177 (286)
T cd06614 170 ------------------------------------------------------------------------KSKRNSVV 177 (286)
T ss_pred ------------------------------------------------------------------------hhhhcccc
Confidence 00011234
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-cCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-RFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-~~p~~~~is~~l~dLI~k~L~~D 787 (857)
++..|++||++.+..++.++|+|||||++|+|++|+.||...........+..... ..+....++..+.+||.+||+.+
T Consensus 178 ~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (286)
T cd06614 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKD 257 (286)
T ss_pred CCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccC
Confidence 78899999999999999999999999999999999999987765555554443332 22333347899999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
|.+||+ +.+++.|+||....|
T Consensus 258 p~~Rpt----~~~il~~~~~~~~~~ 278 (286)
T cd06614 258 PEKRPS----AEELLQHPFLKKACP 278 (286)
T ss_pred hhhCcC----HHHHhhChHhhccCc
Confidence 999999 999999999998554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.42 Aligned_cols=257 Identities=32% Similarity=0.477 Sum_probs=213.9
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC--CeEEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE--KFSCLV 548 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~--~~l~LV 548 (857)
+|.+.+.||+|+||.||+|.+..++..|++|++...... ....+.+.+|++++++++||||+++++.+... ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 488899999999999999999989999999998765321 34467789999999999999999999999988 899999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET- 156 (260)
T ss_pred EEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc-
Confidence 99999999999988765 489999999999999999999999999999999999999999999999998743211000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 157 ------------------------------------------------------------------------~~~~~~~~ 164 (260)
T cd06606 157 ------------------------------------------------------------------------GEGTGSVR 164 (260)
T ss_pred ------------------------------------------------------------------------cccccCCC
Confidence 00012235
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh-hhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~-e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
++..|+|||.+.+..++.++|||+||+++|+|++|..||...... ..+..+............++..+++||.+||..|
T Consensus 165 ~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~ 244 (260)
T cd06606 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRD 244 (260)
T ss_pred CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCC
Confidence 788999999999888999999999999999999999999876522 2222222212222233457899999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF 807 (857)
|.+||+ +.++++||||
T Consensus 245 p~~Rp~----~~~ll~~~~~ 260 (260)
T cd06606 245 PKKRPT----ADELLQHPFL 260 (260)
T ss_pred hhhCCC----HHHHhhCCCC
Confidence 999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=349.80 Aligned_cols=262 Identities=26% Similarity=0.408 Sum_probs=209.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee----CCeE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT----EKFS 545 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~----~~~l 545 (857)
++|.+.+.||.|+||.||+|.+..++..||+|++..... .......+.+|+.+|+.++||||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999876432 23345667889999999999999999998863 3578
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+ +++|..++.... .+++..++.++.||+.||.|||..||+||||||+|||++.+|.++|+|||++......
T Consensus 84 ~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehh-hhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999999 568988876543 3899999999999999999999999999999999999999999999999987432100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.. .......
T Consensus 161 ~~-----------------------------------------------------------------------~~~~~~~ 169 (334)
T cd07855 161 PT-----------------------------------------------------------------------EHKYFMT 169 (334)
T ss_pred Cc-----------------------------------------------------------------------CCCcccc
Confidence 00 0000112
Q ss_pred cccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc--------------------
Q 035930 706 SFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-------------------- 764 (857)
Q Consensus 706 s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-------------------- 764 (857)
..+|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+.....
T Consensus 170 ~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~ 249 (334)
T cd07855 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQ 249 (334)
T ss_pred cccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHh
Confidence 3468999999999876 4589999999999999999999999987654333322221000
Q ss_pred cCCC---------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 765 RFPG---------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 765 ~~p~---------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.++. .+.++.++++||.+||+.||++||+ +++++.||||.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~~~~~ 300 (334)
T cd07855 250 NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT----VEQALQHPFLAQY 300 (334)
T ss_pred hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC----HHHHHhChhhhhc
Confidence 0110 1446889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.66 Aligned_cols=251 Identities=27% Similarity=0.353 Sum_probs=205.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+...+|++.++||+|+||+||+|.+..+. .||||++.... .....+.+|+++++.++||||+++++++. ++..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCc----cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 34568999999999999999999887664 59999987532 22356789999999999999999999875 45679
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++|+|.+++.......+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999876554558999999999999999999999999999999999999999999999999874321000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
. .....
T Consensus 157 ~--------------------------------------------------------------------------~~~~~ 162 (262)
T cd05071 157 Y--------------------------------------------------------------------------TARQG 162 (262)
T ss_pred c--------------------------------------------------------------------------ccccC
Confidence 0 00011
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
..++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.. ....+....++..+.+||.+||.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~ 241 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWR 241 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-CCCCCCccccCHHHHHHHHHHcc
Confidence 236778999999999999999999999999999999 8999988776666655543 33444456688999999999999
Q ss_pred CCcCCcCCchhhHHHHH
Q 035930 786 KEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL 802 (857)
.||++||+ +.+++
T Consensus 242 ~~p~~Rp~----~~~~~ 254 (262)
T cd05071 242 KEPEERPT----FEYLQ 254 (262)
T ss_pred CCcccCCC----HHHHH
Confidence 99999999 55554
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=333.20 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=201.2
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGG 555 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gG 555 (857)
+.||+|+||+||+|.+..++..||+|.+.... .......+.+|+++|+.++||||++++++|......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999999999999999886432 2233456889999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCC
Q 035930 556 DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPV 635 (857)
Q Consensus 556 sL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~ 635 (857)
+|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 79 ~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 149 (252)
T cd05084 79 DFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-------- 149 (252)
T ss_pred cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc--------
Confidence 9999886543 3489999999999999999999999999999999999999999999999998743110000
Q ss_pred CCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccC
Q 035930 636 EEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLA 715 (857)
Q Consensus 636 ~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmA 715 (857)
........++..|+|
T Consensus 150 -----------------------------------------------------------------~~~~~~~~~~~~y~a 164 (252)
T cd05084 150 -----------------------------------------------------------------ASTGGMKQIPVKWTA 164 (252)
T ss_pred -----------------------------------------------------------------cccCCCCCCceeecC
Confidence 000001123467999
Q ss_pred hhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 716 PEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 716 PEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
||++.+..++.++|||||||++|||++ |..||...........+. .....+....++..+.+||.+||..||++||+
T Consensus 165 PE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps- 242 (252)
T cd05084 165 PEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWEYDPGQRPS- 242 (252)
T ss_pred chhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcCCChhhCcC-
Confidence 999999899999999999999999997 999997765554444333 33444445568899999999999999999999
Q ss_pred hhhHHHHHc
Q 035930 795 VKGAAEIKQ 803 (857)
Q Consensus 795 ~~~a~ELL~ 803 (857)
+.++++
T Consensus 243 ---~~~~~~ 248 (252)
T cd05084 243 ---FSTVHQ 248 (252)
T ss_pred ---HHHHHH
Confidence 777653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.27 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=208.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++++.||+|+||+||++.+.+ +..||||.+.... .....+.+|+.++++++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS----MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc----ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 3579999999999999999998764 4469999886542 2235678999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+.+++|.+++..... .+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-- 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc--
Confidence 999999999998876543 48999999999999999999999999999999999999999999999999864311000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (256)
T cd05113 155 ------------------------------------------------------------------------YTSSVGSK 162 (256)
T ss_pred ------------------------------------------------------------------------eeecCCCc
Confidence 00001123
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+... .+.+.....+..+++|+.+||..|
T Consensus 163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05113 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-LRLYRPHLASEKVYAIMYSCWHEK 241 (256)
T ss_pred cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCC
Confidence 5678999999998889999999999999999998 99999887766666666544 333334557899999999999999
Q ss_pred cCCcCCchhhHHHHHcC
Q 035930 788 PDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~H 804 (857)
|.+||+ +.+|+.+
T Consensus 242 p~~Rp~----~~~ll~~ 254 (256)
T cd05113 242 AEERPT----FQQLLSS 254 (256)
T ss_pred cccCCC----HHHHHHh
Confidence 999999 8888754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=344.13 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=206.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeE--EEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCL--FALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~--VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~ 543 (857)
+...+|.+.+.||.|+||+||+|.+..++.. +|+|.+... ........+.+|+++|.++ +||||+++++++..++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 3456899999999999999999998877654 577766532 1223445678899999999 8999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQP--------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG 609 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~--------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg 609 (857)
.+|+||||+++++|..++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999886542 12478999999999999999999999999999999999999999
Q ss_pred cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhccc
Q 035930 610 HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQV 689 (857)
Q Consensus 610 ~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~ 689 (857)
.++|+|||++.....
T Consensus 162 ~~kl~dfg~~~~~~~----------------------------------------------------------------- 176 (303)
T cd05088 162 VAKIADFGLSRGQEV----------------------------------------------------------------- 176 (303)
T ss_pred cEEeCccccCcccch-----------------------------------------------------------------
Confidence 999999998631000
Q ss_pred CCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCC
Q 035930 690 SPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPG 768 (857)
Q Consensus 690 ~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~ 768 (857)
........++..|+|||++.+..++.++|||||||+||||++ |..||.+....+....+ .....+..
T Consensus 177 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~ 244 (303)
T cd05088 177 -----------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRLEK 244 (303)
T ss_pred -----------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH-hcCCcCCC
Confidence 000001124567999999998889999999999999999998 99999877666655544 33333334
Q ss_pred CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 769 YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 769 ~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
...++.++.+||.+||..+|++||+ +++++++
T Consensus 245 ~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~ 276 (303)
T cd05088 245 PLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 276 (303)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 4457899999999999999999999 7777765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.94 Aligned_cols=257 Identities=20% Similarity=0.287 Sum_probs=208.9
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34679999999999999999999987 77899999886432 122234678899999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCC-----CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC---cEEEe
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPS-----RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG---HIMLS 614 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~-----~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg---~iKL~ 614 (857)
+..|+||||+++++|..++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999998876432 2488999999999999999999999999999999999998765 59999
Q ss_pred cccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCc
Q 035930 615 DFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQ 694 (857)
Q Consensus 615 DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~ 694 (857)
|||++..+.....
T Consensus 162 dfg~~~~~~~~~~------------------------------------------------------------------- 174 (277)
T cd05036 162 DFGMARDIYRASY------------------------------------------------------------------- 174 (277)
T ss_pred cCccccccCCccc-------------------------------------------------------------------
Confidence 9999754210000
Q ss_pred ccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCC
Q 035930 695 LVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVS 773 (857)
Q Consensus 695 l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is 773 (857)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+. ...+......++
T Consensus 175 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~ 247 (277)
T cd05036 175 ------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GGGRLDPPKGCP 247 (277)
T ss_pred ------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCC
Confidence 000011224567999999999999999999999999999996 999998876666554443 333344445688
Q ss_pred HHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 774 FHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
..+.+||.+||..+|++||+ +.+|++|
T Consensus 248 ~~~~~~i~~cl~~~p~~Rps----~~~vl~~ 274 (277)
T cd05036 248 GPVYRIMTDCWQHTPEDRPN----FATILER 274 (277)
T ss_pred HHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 99999999999999999999 8888876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=343.27 Aligned_cols=256 Identities=28% Similarity=0.365 Sum_probs=212.7
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|...+.||+|+||+||+|.+..++..||+|++.............+.+|+++++.++||||+++++++.++...|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 37778899999999999999999999999999876543333445667889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+. |+|..++.... ..+++..+..++.||+.||.|||..||+||||+|+||+++.++.++|+|||++....
T Consensus 102 ~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------- 172 (313)
T cd06633 102 YCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------- 172 (313)
T ss_pred cCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-------
Confidence 995 57766665433 348999999999999999999999999999999999999999999999999862100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
......|+
T Consensus 173 ------------------------------------------------------------------------~~~~~~~~ 180 (313)
T cd06633 173 ------------------------------------------------------------------------PANSFVGT 180 (313)
T ss_pred ------------------------------------------------------------------------CCCCcccc
Confidence 01124588
Q ss_pred CCccChhhhc---CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 711 HEYLAPEIIK---GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 711 ~~YmAPEil~---g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
..|+|||++. +..++.++|||||||++|+|++|..||...+....+..+............++..+++||.+||+++
T Consensus 181 ~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 260 (313)
T cd06633 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKI 260 (313)
T ss_pred ccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCC
Confidence 8999999984 3567889999999999999999999998876655555554443333333457888999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
|.+||+ +.+++.||||....
T Consensus 261 P~~Rp~----~~~~l~~~~~~~~~ 280 (313)
T cd06633 261 PQERPA----SAELLRHDFVRRDR 280 (313)
T ss_pred hhhCcC----HHHHhcCcccCCCc
Confidence 999999 99999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=334.19 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=207.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
.+|++.+.||+|+||.||++.+. ++..+|+|++.... .....+.+|+++++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA----MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC----CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46889999999999999999886 46689999986532 22346788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|.+++..... .+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~--- 154 (256)
T cd05059 79 EYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--- 154 (256)
T ss_pred ecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc---
Confidence 99999999998876543 48999999999999999999999999999999999999999999999999874311000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........+
T Consensus 155 -----------------------------------------------------------------------~~~~~~~~~ 163 (256)
T cd05059 155 -----------------------------------------------------------------------YTSSQGTKF 163 (256)
T ss_pred -----------------------------------------------------------------------ccccCCCCC
Confidence 000001124
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
+..|+|||++.+..++.++|||||||++|||++ |+.||......+.+..+. .....+....++..+.+|+.+||..+|
T Consensus 164 ~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p 242 (256)
T cd05059 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMYSCWHEKP 242 (256)
T ss_pred CccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhcCCh
Confidence 567999999999999999999999999999998 899998776666655543 344445556689999999999999999
Q ss_pred CCcCCchhhHHHHHcC
Q 035930 789 DNRLGAVKGAAEIKQH 804 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~H 804 (857)
++||+ +.++++.
T Consensus 243 ~~Rpt----~~~~l~~ 254 (256)
T cd05059 243 EDRPA----FKKLLSQ 254 (256)
T ss_pred hhCcC----HHHHHHH
Confidence 99999 8888753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=323.44 Aligned_cols=252 Identities=30% Similarity=0.499 Sum_probs=213.2
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|.+.+.||.|+||.||++.+..++..|++|++..... .....+.+|+++++.++|+||+++++++..+...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999998999999999976532 345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|..++.... ..+++..+..++.|++.||.|||.+|++||||+|+||+++.++.++|+|||++......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~----- 151 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT----- 151 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc-----
Confidence 999999999887753 34899999999999999999999999999999999999999999999999987431100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
.......|+
T Consensus 152 -----------------------------------------------------------------------~~~~~~~~~ 160 (253)
T cd05122 152 -----------------------------------------------------------------------KARNTMVGT 160 (253)
T ss_pred -----------------------------------------------------------------------ccccceecC
Confidence 001234578
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhc-cccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ-SLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~-~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
..|+|||++.+..++.++|||+||+++|+|++|+.||...+..+.+..+... ....+....++..+.+||.+||..||.
T Consensus 161 ~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 240 (253)
T cd05122 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPE 240 (253)
T ss_pred CcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChh
Confidence 8999999999888999999999999999999999999876544444333332 122233333589999999999999999
Q ss_pred CcCCchhhHHHHHcCCC
Q 035930 790 NRLGAVKGAAEIKQHPF 806 (857)
Q Consensus 790 ~Rpt~~~~a~ELL~HPf 806 (857)
+||+ +.++++|||
T Consensus 241 ~R~t----~~~~l~~~~ 253 (253)
T cd05122 241 KRPT----AEQLLKHPF 253 (253)
T ss_pred hCCC----HHHHhcCCC
Confidence 9999 999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.39 Aligned_cols=256 Identities=30% Similarity=0.437 Sum_probs=209.6
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC-----
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK----- 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~----- 543 (857)
.++|++.+.||.|+||+||++.+..++..||||++.... ........+.+|+++|+.++||||++++++|..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467999999999999999999999999999999986542 22233456789999999999999999999987654
Q ss_pred -eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 544 -FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 544 -~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
.+|+||||+ +++|..++... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 469999999 88998877643 3899999999999999999999999999999999999999999999999987421
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
..
T Consensus 169 ~~------------------------------------------------------------------------------ 170 (343)
T cd07880 169 DS------------------------------------------------------------------------------ 170 (343)
T ss_pred cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred ccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--------------
Q 035930 703 RSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP-------------- 767 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p-------------- 767 (857)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+....+..++......+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07880 171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250 (343)
T ss_pred CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHH
Confidence 0012347889999999976 4578999999999999999999999987665444444332111100
Q ss_pred ---------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 768 ---------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 768 ---------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
..+.++..+.+||.+||..||.+||+ +.+++.||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t----~~~~l~~~~~~~~~ 305 (343)
T cd07880 251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT----AAEALAHPYFEEFH 305 (343)
T ss_pred HHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC----HHHHhcCccHhhhc
Confidence 12357888999999999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.21 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=206.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCe----EEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSC----LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~----~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
+...+|++.+.||.|+||+||+|.+..++. .||+|++.... .......+.+|+.+++.++||||+.+++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 456789999999999999999999877765 48999986542 223345678899999999999999999998754
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
..+++|||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 5689999999999998887643 34899999999999999999999999999999999999999999999999987532
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
..... ..
T Consensus 160 ~~~~~-------------------------------------------------------------------------~~ 166 (279)
T cd05109 160 DIDET-------------------------------------------------------------------------EY 166 (279)
T ss_pred ccccc-------------------------------------------------------------------------ee
Confidence 11000 00
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~ 781 (857)
......+++.|+|||.+.+..++.++|||||||++|||++ |..||......... ..+......+....++.++.+||.
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~ 245 (279)
T cd05109 167 HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLPQPPICTIDVYMIMV 245 (279)
T ss_pred ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCCCCccCCHHHHHHHH
Confidence 0011124678999999999999999999999999999998 99999876554444 344444455555678999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHc
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+||..||++||+ +.+++.
T Consensus 246 ~~l~~dp~~Rp~----~~~l~~ 263 (279)
T cd05109 246 KCWMIDSECRPR----FRELVD 263 (279)
T ss_pred HHcCCChhhCcC----HHHHHH
Confidence 999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.10 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=216.0
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|.+.+.||.|+||.||++.+..++..||+|.+...... ......+.+|+++++.++|||++++++++.+++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 588999999999999999999989999999999766432 2345678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---- 153 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS---- 153 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc----
Confidence 99999999988765 348999999999999999999999999999999999999999999999999875421100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
.......++
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (254)
T cd06627 154 -----------------------------------------------------------------------KDDASVVGT 162 (254)
T ss_pred -----------------------------------------------------------------------ccccccccc
Confidence 001223578
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCC
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDN 790 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~ 790 (857)
..|+|||.+.+..++.++|||+||+++|+|++|..||........+..+... ...+....++..++++|.+||..+|++
T Consensus 163 ~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~ 241 (254)
T cd06627 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-DHPPLPEGISPELKDFLMQCFQKDPNL 241 (254)
T ss_pred hhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-CCCCCCCCCCHHHHHHHHHHHhCChhh
Confidence 8999999998888999999999999999999999999876654444444322 222334568899999999999999999
Q ss_pred cCCchhhHHHHHcCCCC
Q 035930 791 RLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 791 Rpt~~~~a~ELL~HPfF 807 (857)
||+ +.+++.||||
T Consensus 242 R~~----~~~~l~~~~~ 254 (254)
T cd06627 242 RPT----AKQLLKHPWI 254 (254)
T ss_pred CcC----HHHHhcCCCC
Confidence 999 9999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.56 Aligned_cols=249 Identities=29% Similarity=0.401 Sum_probs=209.5
Q ss_pred eEEccCCceEEEEEEEcCC---CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeec
Q 035930 476 KKLGCGDIGTVYLAELIGT---SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYC 552 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~t---g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~ 552 (857)
+.||+|+||.||+|.+... +..||+|++...... .....+.+|+++++.++|+||+++++++.++..+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4689999999999999866 889999999765322 14567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCC-------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 553 PGGDLHVLRQKQP-------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 553 ~gGsL~~ll~~~~-------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
++++|..++.... ...+++..++.++.||+.||+|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999987752 245899999999999999999999999999999999999999999999999987542211
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.. .....
T Consensus 159 ~~-------------------------------------------------------------------------~~~~~ 165 (262)
T cd00192 159 DY-------------------------------------------------------------------------YRKKT 165 (262)
T ss_pred cc-------------------------------------------------------------------------ccccc
Confidence 00 00112
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
...+++.|+|||.+.+..++.++|||||||++|||++ |..||......+.+..+.. ....+....++.++.++|.+||
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l 244 (262)
T cd00192 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDELYELMLSCW 244 (262)
T ss_pred CCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHHHHHHHHHc
Confidence 3357889999999998889999999999999999998 6999998866666655554 3444555668999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcC
Q 035930 785 VKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~H 804 (857)
..||.+||+ +.++++|
T Consensus 245 ~~~p~~Rps----~~~l~~~ 260 (262)
T cd00192 245 QLDPEDRPT----FSELVER 260 (262)
T ss_pred cCCcccCcC----HHHHHHh
Confidence 999999999 8888865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.15 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=204.3
Q ss_pred eEEEeEEccCCceEEEEEEEcC---CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe----
Q 035930 472 FKLHKKLGCGDIGTVYLAELIG---TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF---- 544 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~---tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~---- 544 (857)
|.+++.||+|+||.||+|.+.. .+..||||.++.+.. .......+.+|+++|+.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5788999999999999998764 347899999875422 12335578899999999999999999998866543
Q ss_pred --EEEEEeecCCCChHHHHhhC----CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccc
Q 035930 545 --SCLVMEYCPGGDLHVLRQKQ----PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618 (857)
Q Consensus 545 --l~LVmEy~~gGsL~~ll~~~----~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGL 618 (857)
.++||||+++|+|..++... ....+++..++.++.|++.||+|||+.||+||||||+|||+++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999998877443 123589999999999999999999999999999999999999999999999999
Q ss_pred hhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccccc
Q 035930 619 SLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVE 698 (857)
Q Consensus 619 A~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~ 698 (857)
++........
T Consensus 160 ~~~~~~~~~~---------------------------------------------------------------------- 169 (273)
T cd05035 160 SKKIYSGDYY---------------------------------------------------------------------- 169 (273)
T ss_pred eeeccccccc----------------------------------------------------------------------
Confidence 7532110000
Q ss_pred CCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHH
Q 035930 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHAR 777 (857)
Q Consensus 699 ~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~ 777 (857)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+..+.+.+..+... ..+.....++..+.
T Consensus 170 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 245 (273)
T cd05035 170 ---RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NRLKQPEDCLDELY 245 (273)
T ss_pred ---cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcCCCHHHH
Confidence 00011224678999999998999999999999999999999 99999887776666555443 33344456899999
Q ss_pred HHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 778 DLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 778 dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
+||.+||..||.+||+ +.+++++
T Consensus 246 ~li~~~l~~~p~~Rp~----~~e~~~~ 268 (273)
T cd05035 246 DLMYSCWRADPKDRPT----FTKLREV 268 (273)
T ss_pred HHHHHHcCCChhhCcC----HHHHHHH
Confidence 9999999999999999 7777653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=338.70 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=208.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEEc-----CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELI-----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~-----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
..+|.+.+.||+|+||+||++.+. .++..||+|.+.... ......+.+|+++|+.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 357999999999999999999863 356679999886531 234556889999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCC-----------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEE
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQP-----------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIM 612 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~-----------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iK 612 (857)
..|+||||+++++|..++.... ...+++..++.++.||+.||+|||.+||+||||||+|||++.++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999998886542 12489999999999999999999999999999999999999999999
Q ss_pred EecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCC
Q 035930 613 LSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPM 692 (857)
Q Consensus 613 L~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~ 692 (857)
|+|||++........
T Consensus 161 l~dfg~~~~~~~~~~----------------------------------------------------------------- 175 (288)
T cd05093 161 IGDFGMSRDVYSTDY----------------------------------------------------------------- 175 (288)
T ss_pred eccCCccccccCCce-----------------------------------------------------------------
Confidence 999998743210000
Q ss_pred CcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCC
Q 035930 693 PQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPV 771 (857)
Q Consensus 693 p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~ 771 (857)
........++..|+|||++.+..++.++|||||||++|+|++ |..||......+.+..+..... ++....
T Consensus 176 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~ 246 (288)
T cd05093 176 --------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-LQRPRT 246 (288)
T ss_pred --------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc-CCCCCC
Confidence 000012236788999999999999999999999999999998 9999988877777666655443 233346
Q ss_pred CCHHHHHHHHhhccCCcCCcCCchhhHHHHH
Q 035930 772 VSFHARDLIRGLLVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 772 is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL 802 (857)
++..+.+|+.+||..||.+||+ +.+++
T Consensus 247 ~~~~l~~li~~~l~~~p~~Rpt----~~~v~ 273 (288)
T cd05093 247 CPKEVYDLMLGCWQREPHMRLN----IKEIH 273 (288)
T ss_pred CCHHHHHHHHHHccCChhhCCC----HHHHH
Confidence 8899999999999999999999 66654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=333.21 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=207.2
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc---CCCCccccceeeeeCCe----
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML---DHPFLPTLFAHFTTEKF---- 544 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L---~HPnIV~L~~~f~~~~~---- 544 (857)
|++.+.||.|+||.||+|++..++..||+|++..... .......+.+|+.+++++ .||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6789999999999999999998899999999975432 122233456788877766 59999999999988776
Q ss_pred -EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 545 -SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 545 -l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
+|++|||++ ++|..++.......+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 588888776554458999999999999999999999999999999999999999999999999874311
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.. ..
T Consensus 159 ~~----------------------------------------------------------------------------~~ 162 (287)
T cd07838 159 FE----------------------------------------------------------------------------MA 162 (287)
T ss_pred CC----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-----cCC-----------
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-----RFP----------- 767 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-----~~p----------- 767 (857)
.....++..|+|||++.+..++.++|||||||++|||++|..||.+....+.+.++..... .++
T Consensus 163 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T cd07838 163 LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFP 242 (287)
T ss_pred cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcc
Confidence 1122478899999999999999999999999999999999999998777666666554210 000
Q ss_pred C---------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 768 G---------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 768 ~---------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
. .+.++..+.+||.+||..||.+||+ +.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----~~~il~~~~~ 287 (287)
T cd07838 243 SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS----AFEALQHPYF 287 (287)
T ss_pred cccccchhhhhhhhhHHHHHHHHHHhccCCccCCC----HHHHhcCcCC
Confidence 0 1235678899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.06 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=206.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++.++||.|+||+||+|.+. .+..||+|.+..... ..+.+.+|+.+|++++|+||+++++++. +...|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 34567999999999999999999875 455799999875422 2356789999999999999999999885 45679
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++++|..++.......+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999999999876555568999999999999999999999999999999999999999999999999874321000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (260)
T cd05070 157 --------------------------------------------------------------------------YTARQG 162 (260)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 000011
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
..++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+.. ...++.....+..+.+||.+||.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~ 241 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRMPCPQDCPISLHELMLQCWK 241 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHHHHHHHHcc
Confidence 235678999999999899999999999999999999 9999988776666655543 34445556688999999999999
Q ss_pred CCcCCcCCchhhHHHHH
Q 035930 786 KEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL 802 (857)
+||.+||+ +.+++
T Consensus 242 ~~p~~Rpt----~~~l~ 254 (260)
T cd05070 242 KDPEERPT----FEYLQ 254 (260)
T ss_pred cCcccCcC----HHHHH
Confidence 99999999 66655
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.55 Aligned_cols=247 Identities=31% Similarity=0.491 Sum_probs=199.2
Q ss_pred CCeEEEeEE--ccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEE
Q 035930 470 RHFKLHKKL--GCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 470 ~~Y~i~~~L--G~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~ 546 (857)
++|.+.+.+ |.|+||+||++.+..++..||+|++...... ..|+.+...+ +||||++++++|..++..|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--------~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--------AIEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--------hhhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 355666655 9999999999999999999999998654211 1123333322 7999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC-cEEEecccchhhcccC
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG-HIMLSDFDLSLRCAVN 625 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg-~iKL~DFGLA~r~~~~ 625 (857)
+||||+++++|..++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 86 iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~-- 161 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG-- 161 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC--
Confidence 9999999999999887654 489999999999999999999999999999999999999998 99999999863210
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
...
T Consensus 162 -----------------------------------------------------------------------------~~~ 164 (267)
T PHA03390 162 -----------------------------------------------------------------------------TPS 164 (267)
T ss_pred -----------------------------------------------------------------------------CCc
Confidence 001
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhh-HHHhh-ccccCCCCCCCCHHHHHHHHhh
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL-SNVVS-QSLRFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l-~~Iv~-~~~~~p~~~~is~~l~dLI~k~ 783 (857)
...|+..|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+.. .....+..+.++..+.+||.+|
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 244 (267)
T PHA03390 165 CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSM 244 (267)
T ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHH
Confidence 124788999999999999999999999999999999999999865443321 11111 1122233346899999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCC
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
|+.||.+|+++ ++++|+||||.
T Consensus 245 l~~~p~~R~~~---~~~~l~h~~~~ 266 (267)
T PHA03390 245 LKYNINYRLTN---YNEIIKHPFLK 266 (267)
T ss_pred hccChhhCCch---HHHHhcCCccc
Confidence 99999999962 69999999996
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.93 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=204.5
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeee-eCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFT-TEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~-~~~~l 545 (857)
+...+|.+.+.||+|+||.||++... +..||+|.+..+ .....+.+|+.++++++|+||+++++++. .++..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 55678999999999999999999775 667999998643 23456789999999999999999999764 55678
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+++++|..++.......+++..+..++.||+.||+|||.+||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 154 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 154 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-
Confidence 9999999999999998776555589999999999999999999999999999999999999999999999998742100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
...
T Consensus 155 -----------------------------------------------------------------------------~~~ 157 (256)
T cd05082 155 -----------------------------------------------------------------------------TQD 157 (256)
T ss_pred -----------------------------------------------------------------------------cCC
Confidence 000
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
...++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+. ........+.++..+.+||.+||
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMKQCW 236 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHh
Confidence 1124567999999999999999999999999999997 999998765555554443 33344444668999999999999
Q ss_pred cCCcCCcCCchhhHHHHHc
Q 035930 785 VKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~ 803 (857)
..||++||+ +.++++
T Consensus 237 ~~~p~~Rpt----~~~l~~ 251 (256)
T cd05082 237 HLDAATRPS----FLQLRE 251 (256)
T ss_pred cCChhhCcC----HHHHHH
Confidence 999999999 666654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.24 Aligned_cols=257 Identities=24% Similarity=0.335 Sum_probs=208.8
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCC----------------eEEEEEEecccccccccchhHHHHHHHHHHHcCCCC
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTS----------------CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg----------------~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn 531 (857)
...+|++.+.||+|+||.||+|.+..++ ..||+|++..... ......+.+|+++|+.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3468999999999999999999876543 5689999875522 234566788999999999999
Q ss_pred ccccceeeeeCCeEEEEEeecCCCChHHHHhhCC---------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCc
Q 035930 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQP---------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPEN 602 (857)
Q Consensus 532 IV~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~---------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeN 602 (857)
|++++++|..++..++||||+++++|..++.... ...+++..++.++.|++.||+|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999998887653 1248999999999999999999999999999999999
Q ss_pred EEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhh
Q 035930 603 ILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIK 682 (857)
Q Consensus 603 ILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~ 682 (857)
||++.++.++|+|||++........
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~------------------------------------------------------- 185 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY------------------------------------------------------- 185 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-------------------------------------------------------
Confidence 9999999999999998743210000
Q ss_pred hhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh--CCCCCCCCCChhhhHHHh
Q 035930 683 SDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY--GRTPFKGSGNDETLSNVV 760 (857)
Q Consensus 683 ~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt--Gk~PF~g~~~~e~l~~Iv 760 (857)
........+++.|+|||++.+..++.++|||||||++|||++ |..||......+.+..+.
T Consensus 186 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~ 247 (296)
T cd05051 186 ------------------YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAG 247 (296)
T ss_pred ------------------eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHH
Confidence 000113346789999999998889999999999999999998 788998776666665554
Q ss_pred hc------cccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 761 SQ------SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 761 ~~------~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.. ....+....++.++.+||.+||+.||.+||+ +.+|++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt----~~el~~ 292 (296)
T cd05051 248 HFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT----FREIHL 292 (296)
T ss_pred hccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC----HHHHHH
Confidence 32 1122334457889999999999999999999 888764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.04 Aligned_cols=255 Identities=27% Similarity=0.376 Sum_probs=214.6
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
+.|...+.||+|+||.||++.+..++..||+|++.............+.+|+++|+.++|||++++++++..++..||||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34888999999999999999999999999999987653333344567888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++ |+|.+++.... ..+++..+..++.||+.||.|||..||+||||+|+||+++.++.++|+|||++....
T Consensus 105 e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------ 176 (317)
T cd06635 105 EYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------ 176 (317)
T ss_pred eCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC------
Confidence 9996 57766665433 348999999999999999999999999999999999999999999999999862100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
......|
T Consensus 177 -------------------------------------------------------------------------~~~~~~~ 183 (317)
T cd06635 177 -------------------------------------------------------------------------PANSFVG 183 (317)
T ss_pred -------------------------------------------------------------------------CcccccC
Confidence 0012347
Q ss_pred CCCccChhhhc---CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 710 THEYLAPEIIK---GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 710 T~~YmAPEil~---g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
++.|+|||++. +..++.++|||||||++|||++|+.||........+..+............++..+++||.+||..
T Consensus 184 ~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 263 (317)
T cd06635 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQK 263 (317)
T ss_pred CccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccC
Confidence 88999999984 356788999999999999999999999887666666666665544444456888999999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCCCC
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
+|.+||+ +.++++|+|+..
T Consensus 264 ~p~~Rpt----~~~il~~~~~~~ 282 (317)
T cd06635 264 IPQDRPT----SEELLKHMFVLR 282 (317)
T ss_pred CcccCcC----HHHHHhChhhhc
Confidence 9999999 999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=346.57 Aligned_cols=261 Identities=27% Similarity=0.387 Sum_probs=214.4
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC-----eE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK-----FS 545 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~-----~l 545 (857)
+|.+.+.||.|+||.||+|.+..++..||||++.... ........+.+|+++|+.++||||+++++++...+ .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999999889999999987642 12344567889999999999999999999998775 88
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||++ ++|..++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999996 58888776543 4999999999999999999999999999999999999999999999999987432100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.. ......
T Consensus 157 ~~------------------------------------------------------------------------~~~~~~ 164 (330)
T cd07834 157 ED------------------------------------------------------------------------EKGFLT 164 (330)
T ss_pred cc------------------------------------------------------------------------cccccc
Confidence 00 000112
Q ss_pred cccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC-----------------
Q 035930 706 SFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP----------------- 767 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p----------------- 767 (857)
...+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..++......+
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
T cd07834 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLK 244 (330)
T ss_pred ccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHh
Confidence 34578999999999888 789999999999999999999999988876665555443211100
Q ss_pred ------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 768 ------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 768 ------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
..+.++.++.+||.+||++||.+||+ ++++++||||+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~~~ 296 (330)
T cd07834 245 SLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT----ADEALAHPYLAQLH 296 (330)
T ss_pred hcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC----HHHHHhCccHHhhc
Confidence 02346889999999999999999999 99999999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.81 Aligned_cols=255 Identities=30% Similarity=0.433 Sum_probs=210.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe----
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF---- 544 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~---- 544 (857)
.++|.+.+.||.|+||+||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++..++.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4579999999999999999999999999999999865421 22334567789999999999999999998876654
Q ss_pred --EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 545 --SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 545 --l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
.|+||||+ +++|..++... .+++..++.++.||+.||.|||..||+||||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 77998888753 3899999999999999999999999999999999999999999999999987321
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
..
T Consensus 169 ~~------------------------------------------------------------------------------ 170 (343)
T cd07851 169 DD------------------------------------------------------------------------------ 170 (343)
T ss_pred cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred ccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--------------
Q 035930 703 RSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP-------------- 767 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p-------------- 767 (857)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+.+..+.......+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07851 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARN 250 (343)
T ss_pred cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHH
Confidence 0112357888999999875 4678999999999999999999999988766655555433211000
Q ss_pred ---------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 768 ---------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 768 ---------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
....++..+.+||.+||..||.+||+ +.+|++||||...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt----~~ell~h~~~~~~ 304 (343)
T cd07851 251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT----AAEALAHPYLAEY 304 (343)
T ss_pred HHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC----HHHHhcCCCcccc
Confidence 01246889999999999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=363.72 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=206.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l 545 (857)
+..+.|++++.||.||.+.||++...+.+ .||+|.+... ..+...+.-+.+|+.+|.+|+ |.+||+||+|-..++.+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 45577999999999999999999886555 4555544322 134556778899999999995 99999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||||||- ..+|..++.+.... ++...+++|..|+|+++.++|++||||-||||.|+|+- .|.+||+|||+|.....
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~- 511 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP- 511 (677)
T ss_pred EEEeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc-
Confidence 9999987 67998888876543 44448899999999999999999999999999999995 78999999999843221
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
+.+.....
T Consensus 512 ------------------------------------------------------------------------DTTsI~kd 519 (677)
T KOG0596|consen 512 ------------------------------------------------------------------------DTTSIVKD 519 (677)
T ss_pred ------------------------------------------------------------------------cccceeec
Confidence 12233345
Q ss_pred cccCCCCccChhhhcCCC-----------CCcccceehhhHHHHHHhhCCCCCCCCCC-hhhhHHHhhccc--cCCCCCC
Q 035930 706 SFVGTHEYLAPEIIKGEG-----------HGSSVDWWTFGIFLFELLYGRTPFKGSGN-DETLSNVVSQSL--RFPGYPV 771 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~-----------~s~ksDVWSLGvILyELLtGk~PF~g~~~-~e~l~~Iv~~~~--~~p~~~~ 771 (857)
+.+||+.||+||.+.... .+.++||||||||||+|++|++||....+ ..-+..|..-.. .||..+.
T Consensus 520 sQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~ 599 (677)
T KOG0596|consen 520 SQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE 599 (677)
T ss_pred cccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC
Confidence 678999999999996543 45789999999999999999999976432 223333443323 4554322
Q ss_pred CCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 772 VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 772 is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
..++.++++.||.+||.+||+ +.+||+|||++.+
T Consensus 600 -~~~li~~mK~CL~rdPkkR~s----i~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 600 -NDELIDVMKCCLARDPKKRWS----IPELLQHPFLQIQ 633 (677)
T ss_pred -chHHHHHHHHHHhcCcccCCC----cHHHhcCcccccc
Confidence 223999999999999999999 9999999999864
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=337.71 Aligned_cols=260 Identities=27% Similarity=0.352 Sum_probs=207.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC---
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK--- 543 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~--- 543 (857)
....+|++.+.||+|+||+||+|.+..++..||||+++.... .......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456789999999999999999999999999999999875421 1223345678999999999999999999987655
Q ss_pred -------eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecc
Q 035930 544 -------FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616 (857)
Q Consensus 544 -------~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DF 616 (857)
.+|+||||+++ +|..++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 89999999965 6766665542 34899999999999999999999999999999999999999999999999
Q ss_pred cchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccc
Q 035930 617 DLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLV 696 (857)
Q Consensus 617 GLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~ 696 (857)
|++.......
T Consensus 161 g~~~~~~~~~---------------------------------------------------------------------- 170 (302)
T cd07864 161 GLARLYNSEE---------------------------------------------------------------------- 170 (302)
T ss_pred cccccccCCc----------------------------------------------------------------------
Confidence 9874321000
Q ss_pred ccCCCCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-----C----
Q 035930 697 VEPTGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-----F---- 766 (857)
Q Consensus 697 ~~~~~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-----~---- 766 (857)
........++..|+|||++.+. .++.++|||||||++|||++|+.||...+..+.+..+...... +
T Consensus 171 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (302)
T cd07864 171 ----SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVI 246 (302)
T ss_pred ----ccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccc
Confidence 0000112357789999988754 5789999999999999999999999876555444443331100 0
Q ss_pred -------------------CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 767 -------------------PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 767 -------------------p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.....++..+.+||.+||..||.+||+ +.+++.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 302 (302)
T cd07864 247 KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT----AEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC----HHHHhcCCCC
Confidence 012346889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=349.11 Aligned_cols=255 Identities=31% Similarity=0.477 Sum_probs=207.2
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC------C
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE------K 543 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~------~ 543 (857)
.+|.+.+.||.|+||.||+|.+..++..||||++.+... .......+.+|+.+++.++||||++++++|... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 589999999999999999999999999999999876432 223345678899999999999999999998754 3
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
.+|+||||+. .+|..++. ..+++..++.++.||+.||+|||.+||+||||||+|||++.++.++|+|||++....
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 5699999995 57766542 238999999999999999999999999999999999999999999999999863210
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
..
T Consensus 169 ------------------------------------------------------------------------------~~ 170 (342)
T cd07879 169 ------------------------------------------------------------------------------AE 170 (342)
T ss_pred ------------------------------------------------------------------------------CC
Confidence 00
Q ss_pred cccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-------------------
Q 035930 704 SNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS------------------- 763 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~------------------- 763 (857)
.....||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..++...
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (342)
T cd07879 171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY 250 (342)
T ss_pred CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHH
Confidence 112357889999999876 468999999999999999999999998876544444333210
Q ss_pred ----ccCC------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 764 ----LRFP------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 764 ----~~~p------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
..++ ..+.++.++.+||.+||+.||.+||+ +.+++.||||.++.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~----~~e~l~h~~f~~~~~ 305 (342)
T cd07879 251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT----ATEALEHPYFDSFRD 305 (342)
T ss_pred HhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC----HHHHhcCcchhhccc
Confidence 0001 02357788999999999999999999 999999999998765
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=330.06 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=207.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|+++++||+|+||.||+|... ++..||+|.+.... .....+.+|+.+|+.++|+||+++++++. ++..|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS----MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 44568999999999999999999865 56789999987542 23456789999999999999999999874 45789
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+.+++|.+++.......+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999998876555568999999999999999999999999999999999999999999999999874311000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (260)
T cd05067 157 --------------------------------------------------------------------------YTAREG 162 (260)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 000012
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
..++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.+..+ ......+....++.++.+||.+||.
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~ 241 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-ERGYRMPRPDNCPEELYELMRLCWK 241 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 235778999999999999999999999999999998 99999887665555544 3344445556688999999999999
Q ss_pred CCcCCcCCchhhHHHHHc
Q 035930 786 KEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~ 803 (857)
.+|++||+ +++++.
T Consensus 242 ~~p~~Rp~----~~~l~~ 255 (260)
T cd05067 242 EKPEERPT----FEYLRS 255 (260)
T ss_pred CChhhCCC----HHHHHH
Confidence 99999999 676654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=339.50 Aligned_cols=256 Identities=20% Similarity=0.316 Sum_probs=208.9
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCC-----CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGT-----SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~t-----g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
...+|++.+.||.|+||+||+|.+..+ +..||||+++... .......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 345688899999999999999987643 5789999997542 122235678899999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQP--------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED 608 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~--------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d 608 (857)
+..++++||+.+++|..++.... ...+++..+..++.|++.||.|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 99999999999999998875321 1247888899999999999999999999999999999999999
Q ss_pred CcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcc
Q 035930 609 GHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQ 688 (857)
Q Consensus 609 g~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~ 688 (857)
+.+||+|||+++.......
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~------------------------------------------------------------- 179 (283)
T cd05091 161 LNVKISDLGLFREVYAADY------------------------------------------------------------- 179 (283)
T ss_pred CceEecccccccccccchh-------------------------------------------------------------
Confidence 9999999998743210000
Q ss_pred cCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCC
Q 035930 689 VSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFP 767 (857)
Q Consensus 689 ~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p 767 (857)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+...... +
T Consensus 180 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-~ 246 (283)
T cd05091 180 ------------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL-P 246 (283)
T ss_pred ------------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-C
Confidence 000112346788999999998889999999999999999998 88999888777777666655433 3
Q ss_pred CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 768 GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 768 ~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
....++..+.+|+.+||+.+|.+||+ +.+|+.
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~RP~----~~~i~~ 278 (283)
T cd05091 247 CPDDCPAWVYTLMLECWNEFPSRRPR----FKDIHS 278 (283)
T ss_pred CCCCCCHHHHHHHHHHhCCCcccCCC----HHHHHH
Confidence 33568999999999999999999999 788775
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=364.59 Aligned_cols=245 Identities=27% Similarity=0.429 Sum_probs=214.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+-.+...-++-||.|+.|-||+|+.. ++.||||.++.- -..+|+.|++|+||||+.|.++|.....+|
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 33344455678999999999999985 567999987531 145788899999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
||||||..|.|+..++... .+.......|..+|+.||.|||.+.|||||||.-||||..+..|||+|||-++.....
T Consensus 189 IiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~- 265 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK- 265 (904)
T ss_pred EeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence 9999999999999988754 4889999999999999999999999999999999999999999999999976432100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
....+
T Consensus 266 ---------------------------------------------------------------------------STkMS 270 (904)
T KOG4721|consen 266 ---------------------------------------------------------------------------STKMS 270 (904)
T ss_pred ---------------------------------------------------------------------------hhhhh
Confidence 01247
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
|+||..|||||+|+.++.+.++|||||||+|||||||..||..-+...++.-+-...+.+|.+..+++.++=||+.||.-
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence 88999999999999999999999999999999999999999988877777777777888888889999999999999999
Q ss_pred CcCCcCCchhhHHHHHcCC
Q 035930 787 EPDNRLGAVKGAAEIKQHP 805 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HP 805 (857)
.|.+||+ +.+||.|-
T Consensus 351 KpRNRPS----Frqil~Hl 365 (904)
T KOG4721|consen 351 KPRNRPS----FRQILLHL 365 (904)
T ss_pred CCCCCcc----HHHHHHHH
Confidence 9999999 88888883
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=332.53 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=208.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCC---CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGT---SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~t---g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
..+|++.+.||.|+||.||+|.+..+ +..||+|.++.... ......+.+|+.+|+.++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 35799999999999999999988644 34799999865421 22345678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+++++|..++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999999876543 4899999999999999999999999999999999999999999999999987432110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.. + .....
T Consensus 160 ~~------------------------~------------------------------------------------~~~~~ 167 (267)
T cd05066 160 PE------------------------A------------------------------------------------AYTTR 167 (267)
T ss_pred cc------------------------e------------------------------------------------eeecC
Confidence 00 0 00001
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
...++..|+|||++.+..++.++|+|+|||++|||++ |..||.+....+.+..+.. ..+++....++..+.+|+.+||
T Consensus 168 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l 246 (267)
T cd05066 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-GYRLPAPMDCPAALHQLMLDCW 246 (267)
T ss_pred CCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC-CCcCCCCCCCCHHHHHHHHHHc
Confidence 1224568999999999899999999999999999886 9999988766665555443 3455655678899999999999
Q ss_pred cCCcCCcCCchhhHHHHHc
Q 035930 785 VKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~ 803 (857)
+++|.+||+ +.++++
T Consensus 247 ~~~p~~Rp~----~~~i~~ 261 (267)
T cd05066 247 QKDRNERPK----FEQIVS 261 (267)
T ss_pred ccCchhCCC----HHHHHH
Confidence 999999999 666653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.74 Aligned_cols=259 Identities=22% Similarity=0.335 Sum_probs=206.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc-----CCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI-----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~-----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~ 540 (857)
+..++|++.+.||.|+||+||+|.+. .+++.||||+++... .......+.+|+.+|..+ +||||++++++|.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 45578999999999999999999853 457889999997542 223345678899999999 6899999999886
Q ss_pred eC-CeEEEEEeecCCCChHHHHhhCC------------------------------------------------------
Q 035930 541 TE-KFSCLVMEYCPGGDLHVLRQKQP------------------------------------------------------ 565 (857)
Q Consensus 541 ~~-~~l~LVmEy~~gGsL~~ll~~~~------------------------------------------------------ 565 (857)
.. ..+|+||||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 56899999999999998876431
Q ss_pred -----------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 566 -----------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 566 -----------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~------- 234 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------- 234 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-------
Confidence 12367788889999999999999999999999999999999999999999999743211000
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
........+++.|+
T Consensus 235 ------------------------------------------------------------------~~~~~~~~~~~~y~ 248 (343)
T cd05103 235 ------------------------------------------------------------------YVRKGDARLPLKWM 248 (343)
T ss_pred ------------------------------------------------------------------hhhcCCCCCCcceE
Confidence 00001123567899
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCC
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLG 793 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt 793 (857)
|||++.+..++.++|||||||++|+|++ |..||.+......+...+......+....+++++.+++..||..||.+||+
T Consensus 249 aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps 328 (343)
T cd05103 249 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 328 (343)
T ss_pred CcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence 9999999999999999999999999996 999998765544444445444444444457889999999999999999999
Q ss_pred chhhHHHHHcC
Q 035930 794 AVKGAAEIKQH 804 (857)
Q Consensus 794 ~~~~a~ELL~H 804 (857)
+.+|++|
T Consensus 329 ----~~eil~~ 335 (343)
T cd05103 329 ----FSELVEH 335 (343)
T ss_pred ----HHHHHHH
Confidence 8888875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=331.88 Aligned_cols=255 Identities=31% Similarity=0.458 Sum_probs=207.0
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC--CeEEEEE
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE--KFSCLVM 549 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~--~~l~LVm 549 (857)
|.+.+.||.|+||.||+|.+..++..||+|++.... ........+.+|+++++.++||||+++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678999999999999999999999999999998653 2233445678899999999999999999999988 8999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++ ++|..++.... ..+++..++.++.||+.||+|||..|++|+||+|+|||++.++.++|+|||++.......
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~--- 154 (287)
T cd07840 80 EYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN--- 154 (287)
T ss_pred cccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC---
Confidence 9996 58887776543 348999999999999999999999999999999999999999999999999874321000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........+
T Consensus 155 -----------------------------------------------------------------------~~~~~~~~~ 163 (287)
T cd07840 155 -----------------------------------------------------------------------SADYTNRVI 163 (287)
T ss_pred -----------------------------------------------------------------------ccccccccc
Confidence 000112246
Q ss_pred CCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-----cCCC---------------
Q 035930 710 THEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-----RFPG--------------- 768 (857)
Q Consensus 710 T~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-----~~p~--------------- 768 (857)
+..|+|||.+.+ ..++.++|||+|||++|||++|+.||...+....+..+..... .++.
T Consensus 164 ~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (287)
T cd07840 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKP 243 (287)
T ss_pred ccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcccccc
Confidence 788999998875 4578999999999999999999999988765555444433110 0000
Q ss_pred --------CCC-CCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 769 --------YPV-VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 769 --------~~~-is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
... ++..+.++|++||..||.+||+ +.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~~~~ 287 (287)
T cd07840 244 YKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS----ADQALQHEYF 287 (287)
T ss_pred chhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC----HHHHhhCcCC
Confidence 011 3788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.63 Aligned_cols=258 Identities=30% Similarity=0.503 Sum_probs=220.4
Q ss_pred EeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCC
Q 035930 475 HKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
.++||.|-||+||-|.++.+|+.||||+|++..+.... ...+++|+.||+.++||.||.|...|++.+.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 47899999999999999999999999999987765443 37789999999999999999999999999999999999955
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC---cEEEecccchhhcccCcccccC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG---HIMLSDFDLSLRCAVNPMVVKS 631 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg---~iKL~DFGLA~r~~~~~~l~~~ 631 (857)
.-|.-.+... ..++++...++++.||+.||.|||-++|+|.||||||||+.... .+||||||+|+....
T Consensus 648 DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE------- 719 (888)
T KOG4236|consen 648 DMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE------- 719 (888)
T ss_pred hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch-------
Confidence 5555545444 45599999999999999999999999999999999999996543 699999999854211
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCC
Q 035930 632 SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711 (857)
Q Consensus 632 ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~ 711 (857)
.....+.+|||
T Consensus 720 ---------------------------------------------------------------------ksFRrsVVGTP 730 (888)
T KOG4236|consen 720 ---------------------------------------------------------------------KSFRRSVVGTP 730 (888)
T ss_pred ---------------------------------------------------------------------hhhhhhhcCCc
Confidence 11234678999
Q ss_pred CccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhccCCcC
Q 035930 712 EYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 712 ~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L~~DPe 789 (857)
.|+|||+++..+|...-||||.|||+|--|.|..||.. .+++-.+|....+-||. |..++.++.|||..+|+..-+
T Consensus 731 AYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~ 808 (888)
T KOG4236|consen 731 AYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMR 808 (888)
T ss_pred cccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999965 35566666666666654 567999999999999999999
Q ss_pred CcCCchhhHHHHHcCCCCCCCC-hhhhc
Q 035930 790 NRLGAVKGAAEIKQHPFFEGLN-WALIR 816 (857)
Q Consensus 790 ~Rpt~~~~a~ELL~HPfF~~l~-w~li~ 816 (857)
+|.+ ++..|.|||+++.. |..||
T Consensus 809 kRys----vdk~lsh~Wlq~yq~w~DLR 832 (888)
T KOG4236|consen 809 KRYS----VDKSLSHPWLQDYQTWLDLR 832 (888)
T ss_pred Hhcc----hHhhccchhhhcchHHHHHH
Confidence 9999 99999999999753 44444
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.05 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=200.1
Q ss_pred CceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCCChHHHH
Q 035930 482 DIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLR 561 (857)
Q Consensus 482 ~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL~~ll 561 (857)
++|.||+++...+++.||||++.... ........+.+|+++|+.++||||++++++|.+++..|++|||+++++|..++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 45666777677789999999997652 22345677899999999999999999999999999999999999999999998
Q ss_pred hhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCC
Q 035930 562 QKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPK 641 (857)
Q Consensus 562 ~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~ 641 (857)
.......+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++..+.......
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~------------ 158 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ------------ 158 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc------------
Confidence 86544558999999999999999999999999999999999999999999999999874321100000
Q ss_pred CCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcC
Q 035930 642 KASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKG 721 (857)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g 721 (857)
...........++..|+|||++.+
T Consensus 159 --------------------------------------------------------~~~~~~~~~~~~~~~y~aPE~~~~ 182 (314)
T cd08216 159 --------------------------------------------------------RVVHDFPKSSVKNLPWLSPEVLQQ 182 (314)
T ss_pred --------------------------------------------------------cccccccccccccccccCHHHhcC
Confidence 000000123457889999999976
Q ss_pred --CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc--------------------------------CC
Q 035930 722 --EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR--------------------------------FP 767 (857)
Q Consensus 722 --~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~--------------------------------~p 767 (857)
..++.++|||||||++|||++|..||........+......... .+
T Consensus 183 ~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (314)
T cd08216 183 NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHP 262 (314)
T ss_pred CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcc
Confidence 35889999999999999999999999865443332222211100 01
Q ss_pred CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 768 GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 768 ~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
....++.++.+||..||..||.+||+ +.++|+||||.++
T Consensus 263 ~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~p~~~~~ 301 (314)
T cd08216 263 YTRTFSEHFHQFVELCLQRDPESRPS----ASQLLNHSFFKQC 301 (314)
T ss_pred hhhHHHHHHHHHHHHHhhcCCCcCcC----HHHHhcCchHhhh
Confidence 11234567899999999999999999 9999999999876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=327.75 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=211.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|.+.+.||.|+||+||+|.+. .+..||||.+.... .....+.+|+.+++.++||||+++++++..+...|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 56688999999999999999999975 45779999987542 23456889999999999999999999999989999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++++|..++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999999887655568999999999999999999999999999999999999999999999999874321000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
. .....
T Consensus 158 ~--------------------------------------------------------------------------~~~~~ 163 (261)
T cd05034 158 Y--------------------------------------------------------------------------TAREG 163 (261)
T ss_pred h--------------------------------------------------------------------------hhhhc
Confidence 0 00001
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
..++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+......+..+.. .+..+.....+..+.++|.+||.
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~ 242 (261)
T cd05034 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-GYRMPRPPNCPEELYDLMLQCWD 242 (261)
T ss_pred cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcc
Confidence 124568999999999999999999999999999998 9999988776666666543 34455556678999999999999
Q ss_pred CCcCCcCCchhhHHHHH
Q 035930 786 KEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL 802 (857)
.+|.+||+ +++++
T Consensus 243 ~~p~~Rp~----~~~l~ 255 (261)
T cd05034 243 KDPEERPT----FEYLQ 255 (261)
T ss_pred cCcccCCC----HHHHH
Confidence 99999999 77665
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.82 Aligned_cols=272 Identities=27% Similarity=0.347 Sum_probs=210.0
Q ss_pred CeE-EEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccccc-----------chhHHHHHHHHHHHcCCCCcccccee
Q 035930 471 HFK-LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRK-----------KMPRAQTEREIMQMLDHPFLPTLFAH 538 (857)
Q Consensus 471 ~Y~-i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~-----------~~~~~~~EieILr~L~HPnIV~L~~~ 538 (857)
+|. +.+.||.|+||+||+|.+..+++.||||++......... ....+.+|+++|+.++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 454 567899999999999999999999999998654322100 11246789999999999999999999
Q ss_pred eeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccc
Q 035930 539 FTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618 (857)
Q Consensus 539 f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGL 618 (857)
|..++..|+||||+. |+|..++.... .+++..+..++.||+.||.|||+.||+||||+|+|||++.++.++|+|||+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 999999999999995 68988876543 389999999999999999999999999999999999999999999999999
Q ss_pred hhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccccc
Q 035930 619 SLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVE 698 (857)
Q Consensus 619 A~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~ 698 (857)
+......... .... . +. ..
T Consensus 166 ~~~~~~~~~~-~~~~--------~-----------------------------------------~~-----------~~ 184 (335)
T PTZ00024 166 ARRYGYPPYS-DTLS--------K-----------------------------------------DE-----------TM 184 (335)
T ss_pred eeeccccccc-cccc--------c-----------------------------------------cc-----------cc
Confidence 7543211000 0000 0 00 00
Q ss_pred CCCCccccccCCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-----CC-----
Q 035930 699 PTGARSNSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-----FP----- 767 (857)
Q Consensus 699 ~~~~~~~s~vGT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-----~p----- 767 (857)
..........+++.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+.+..+...... ++
T Consensus 185 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 264 (335)
T PTZ00024 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKL 264 (335)
T ss_pred cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhc
Confidence 0001112335788999999998754 689999999999999999999999988776666554431110 00
Q ss_pred ----------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 768 ----------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 768 ----------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.....+.++.+||.+||..||++||+ ++++|.||||+.-
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~~~~~~~~ 319 (335)
T PTZ00024 265 PLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS----AKEALKHEYFKSD 319 (335)
T ss_pred ccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC----HHHHhcCcccCCC
Confidence 01345788999999999999999999 9999999999854
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=338.82 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=209.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc-------CCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCcccccee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI-------GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAH 538 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~-------~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~ 538 (857)
+...+|.+.+.||+|+||.||+|++. ..+..||+|++.... .......+.+|+.+++.+ +||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 45578999999999999999999763 234579999987542 233456788999999999 79999999999
Q ss_pred eeeCCeEEEEEeecCCCChHHHHhhCC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 035930 539 FTTEKFSCLVMEYCPGGDLHVLRQKQP--------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604 (857)
Q Consensus 539 f~~~~~l~LVmEy~~gGsL~~ll~~~~--------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNIL 604 (857)
+...+..|+||||+++|+|..++.... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 999999999999999999998887542 124788889999999999999999999999999999999
Q ss_pred EccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhh
Q 035930 605 VREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD 684 (857)
Q Consensus 605 L~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d 684 (857)
++.++.++|+|||++..+.....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~--------------------------------------------------------- 192 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDY--------------------------------------------------------- 192 (304)
T ss_pred EcCCCcEEECCCccceecccccc---------------------------------------------------------
Confidence 99999999999999754211000
Q ss_pred hhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhcc
Q 035930 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQS 763 (857)
Q Consensus 685 ~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~ 763 (857)
........+++.|+|||++.+..++.++|||||||+||+|++ |..||.+....+.+..+. ..
T Consensus 193 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~ 255 (304)
T cd05101 193 ----------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EG 255 (304)
T ss_pred ----------------cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cC
Confidence 000112235678999999999999999999999999999998 889998876666655543 33
Q ss_pred ccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 764 ~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
........++..+.+||.+||..+|.+||+ +.++++
T Consensus 256 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps----~~e~l~ 291 (304)
T cd05101 256 HRMDKPANCTNELYMMMRDCWHAIPSHRPT----FKQLVE 291 (304)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccChhhCCC----HHHHHH
Confidence 344444568899999999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=328.71 Aligned_cols=250 Identities=26% Similarity=0.342 Sum_probs=205.2
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|.+.+.||+|+||+||+|.+..+. .+|+|.+.... ...+.+.+|+++++.++||||+++++++. .+..|+|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 457999999999999999999886654 59999886542 23356788999999999999999998875 4567999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++++|.+++.......+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence 9999999999998766555589999999999999999999999999999999999999999999999998743210000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.......
T Consensus 158 -------------------------------------------------------------------------~~~~~~~ 164 (260)
T cd05069 158 -------------------------------------------------------------------------TARQGAK 164 (260)
T ss_pred -------------------------------------------------------------------------cccCCCc
Confidence 0001123
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.. ....+....++..+++||.+||.+|
T Consensus 165 ~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~ 243 (260)
T cd05069 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMPCPQGCPESLHELMKLCWKKD 243 (260)
T ss_pred cchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHHHHHHHccCC
Confidence 5678999999998889999999999999999999 9999988766666555443 3444445568899999999999999
Q ss_pred cCCcCCchhhHHHHHc
Q 035930 788 PDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~ 803 (857)
|.+||+ +++|++
T Consensus 244 p~~Rp~----~~~i~~ 255 (260)
T cd05069 244 PDERPT----FEYIQS 255 (260)
T ss_pred cccCcC----HHHHHH
Confidence 999999 666653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=332.52 Aligned_cols=256 Identities=21% Similarity=0.331 Sum_probs=213.2
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
.++|++.+.||.|+||+||+|+++. ....||+|++.... .......+.+|+++|++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4679999999999999999999753 35679999886531 1223567899999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCC-------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPS-------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~-------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DF 616 (857)
..|+||||+++|+|..++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999998876541 14899999999999999999999999999999999999999999999999
Q ss_pred cchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccc
Q 035930 617 DLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLV 696 (857)
Q Consensus 617 GLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~ 696 (857)
|++......
T Consensus 162 ~~~~~~~~~----------------------------------------------------------------------- 170 (275)
T cd05046 162 SLSKDVYNS----------------------------------------------------------------------- 170 (275)
T ss_pred ccccccCcc-----------------------------------------------------------------------
Confidence 986321000
Q ss_pred ccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHH
Q 035930 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFH 775 (857)
Q Consensus 697 ~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~ 775 (857)
.........++..|+|||.+.+..++.++|||||||++|+|++ |..||........+..+..+...++....++..
T Consensus 171 ---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (275)
T cd05046 171 ---EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSR 247 (275)
T ss_pred ---cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHH
Confidence 0000112346778999999998889999999999999999998 889998777677777666666666666678999
Q ss_pred HHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 776 ARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 776 l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
+.+||.+||..||.+||+ +.+++.+
T Consensus 248 l~~~i~~~l~~~p~~Rp~----~~~~l~~ 272 (275)
T cd05046 248 LYKLMTRCWAVNPKDRPS----FSELVSA 272 (275)
T ss_pred HHHHHHHHcCCCcccCCC----HHHHHHH
Confidence 999999999999999999 8887753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=330.68 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=209.0
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCe---EEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSC---LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~---~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
..+|++.+.||.|+||.||+|.+..++. .||||++.... .......+..|+.+++.++||||+++++++.++...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3568999999999999999999886654 69999987542 233446788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+++++|..++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999998887653 34899999999999999999999999999999999999999999999999986432100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.. . +......
T Consensus 160 ~~---------~-------------------------------------------------------------~~~~~~~ 169 (269)
T cd05065 160 TS---------D-------------------------------------------------------------PTYTSSL 169 (269)
T ss_pred cc---------c-------------------------------------------------------------ccccccc
Confidence 00 0 0000000
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
....+..|+|||++.+..++.++|||||||++|||++ |..||......+....+ ......+....++..+.+|+.+||
T Consensus 170 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~li~~~l 248 (269)
T cd05065 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMDCPTALHQLMLDCW 248 (269)
T ss_pred CCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCcccCCHHHHHHHHHHc
Confidence 1112467999999999999999999999999999886 99999887666655554 344555656678899999999999
Q ss_pred cCCcCCcCCchhhHHHHHc
Q 035930 785 VKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~ 803 (857)
..+|.+||+ +.+|+.
T Consensus 249 ~~~p~~Rp~----~~~i~~ 263 (269)
T cd05065 249 QKDRNARPK----FGQIVS 263 (269)
T ss_pred CCChhhCcC----HHHHHH
Confidence 999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=345.78 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=207.4
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-----
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE----- 542 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~----- 542 (857)
..++|.+.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+++++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 34789999999999999999999999999999999875421 222345677899999999999999999988643
Q ss_pred -CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 543 -KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 543 -~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
...|++++++ +++|..++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3578999988 88998877643 389999999999999999999999999999999999999999999999998732
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
..
T Consensus 170 ~~------------------------------------------------------------------------------ 171 (345)
T cd07877 170 TD------------------------------------------------------------------------------ 171 (345)
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred CccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc----------------
Q 035930 702 ARSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL---------------- 764 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~---------------- 764 (857)
.......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+....+..++....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T cd07877 172 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251 (345)
T ss_pred ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence 00112357889999999877 5688999999999999999999999987655444433322110
Q ss_pred -------cCCC------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 765 -------RFPG------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 765 -------~~p~------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
..+. ....++++.+||.+||..||.+|++ +.+++.||||.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~f~~~ 306 (345)
T cd07877 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQY 306 (345)
T ss_pred HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC----HHHHhcChhhhhc
Confidence 0010 1235788999999999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=324.92 Aligned_cols=254 Identities=29% Similarity=0.444 Sum_probs=214.4
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+|++.+.||+|+||.||++.+..++..||+|.+...... ......+.+|+++++.++|+||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 588999999999999999999999999999998764332 2334567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCC--CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 551 YCPGGDLHVLRQKQP--SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 551 y~~gGsL~~ll~~~~--~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|+++++|..++.... ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 999999988876521 234899999999999999999999999999999999999999999999999987431100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (256)
T cd08530 157 --------------------------------------------------------------------------MAKTQI 162 (256)
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 001224
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
|++.|++||.+.+..++.++|+||||+++|+|++|+.||...+..+....+...... +....++.+++++|.+||..+|
T Consensus 163 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p 241 (256)
T cd08530 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSMLQVKP 241 (256)
T ss_pred CCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCchhhCHHHHHHHHHHcCCCc
Confidence 788999999999999999999999999999999999999887665555554443322 2234688999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF 807 (857)
.+||+ +.++++||++
T Consensus 242 ~~Rp~----~~~~l~~p~~ 256 (256)
T cd08530 242 KLRPN----CDKILASPAV 256 (256)
T ss_pred ccCCC----HHHHhcCCCC
Confidence 99999 9999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=339.54 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=206.1
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcC-------CCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceee
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIG-------TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHF 539 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~-------tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f 539 (857)
..++|.+++.||+|+||.||++++.+ +...||+|+++... .......+.+|+++++.+ +||||++++++|
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 34679999999999999999998754 23579999987542 223445678899999999 799999999999
Q ss_pred eeCCeEEEEEeecCCCChHHHHhhCCC--------------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE
Q 035930 540 TTEKFSCLVMEYCPGGDLHVLRQKQPS--------------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV 605 (857)
Q Consensus 540 ~~~~~l~LVmEy~~gGsL~~ll~~~~~--------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL 605 (857)
..++..|+||||+++|+|..++..... ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 999999999999999999998876421 247889999999999999999999999999999999999
Q ss_pred ccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhh
Q 035930 606 REDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDL 685 (857)
Q Consensus 606 ~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~ 685 (857)
+.++.++|+|||++........
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~---------------------------------------------------------- 195 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDY---------------------------------------------------------- 195 (307)
T ss_pred cCCCcEEECCCcccccccccch----------------------------------------------------------
Confidence 9999999999998743210000
Q ss_pred hcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccc
Q 035930 686 AAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSL 764 (857)
Q Consensus 686 ~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~ 764 (857)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.... +....
T Consensus 196 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~ 259 (307)
T cd05098 196 ---------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL-LKEGH 259 (307)
T ss_pred ---------------hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-HHcCC
Confidence 000011124568999999999999999999999999999998 8999977655444443 44444
Q ss_pred cCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 765 RFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 765 ~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
..+....++.++.+||.+||..+|.+||+ +.++++
T Consensus 260 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~evl~ 294 (307)
T cd05098 260 RMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVE 294 (307)
T ss_pred CCCCCCcCCHHHHHHHHHHcccChhhCcC----HHHHHH
Confidence 44445568899999999999999999999 667664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=341.22 Aligned_cols=256 Identities=27% Similarity=0.357 Sum_probs=212.6
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
..|...+.||+|+||+||+|.+..++..||||.+.............+.+|+++++.++|+|++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34778899999999999999999999999999986543333344556788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+. |+|..++.... ..+++..++.++.|++.||.|||..||+||||+|+|||++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 9995 67766665433 3489999999999999999999999999999999999999999999999998632100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.....|
T Consensus 168 --------------------------------------------------------------------------~~~~~~ 173 (308)
T cd06634 168 --------------------------------------------------------------------------ANXFVG 173 (308)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 012357
Q ss_pred CCCccChhhhcC---CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 710 THEYLAPEIIKG---EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 710 T~~YmAPEil~g---~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
++.|+|||++.+ ..++.++|||||||++|+|++|..||......+.+..+............++..+.+||.+||..
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 253 (308)
T cd06634 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253 (308)
T ss_pred CccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhC
Confidence 889999999853 45788999999999999999999999877655555555544443333446888999999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCCCCC
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+|.+||+ +.++++||||...
T Consensus 254 ~P~~Rp~----~~~ll~~~~~~~~ 273 (308)
T cd06634 254 IPQDRPT----SEVLLKHRFVLRE 273 (308)
T ss_pred CcccCCC----HHHHhhCcccccc
Confidence 9999999 9999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=330.02 Aligned_cols=256 Identities=23% Similarity=0.295 Sum_probs=209.1
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCe---EEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSC---LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~---~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
...+|+..+.||+|+||.||+|.+..++. .+|+|.+.... .......+..|+++++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 44578999999999999999999875543 79999986542 12234567889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
.|+||||+++++|..++.... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++..+..
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999998887643 3489999999999999999999999999999999999999999999999998743211
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
.... ....
T Consensus 160 ~~~~------------------------------------------------------------------------~~~~ 167 (268)
T cd05063 160 DPEG------------------------------------------------------------------------TYTT 167 (268)
T ss_pred cccc------------------------------------------------------------------------ceec
Confidence 0000 0000
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhh
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~ 783 (857)
.....++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.. ....+....++..+.+|+.+|
T Consensus 168 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c 246 (268)
T cd05063 168 SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPSAVYQLMLQC 246 (268)
T ss_pred cCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHH
Confidence 01123567999999998889999999999999999997 9999987766666655543 455565566889999999999
Q ss_pred ccCCcCCcCCchhhHHHHHc
Q 035930 784 LVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~ 803 (857)
|..||.+||+ +.+|++
T Consensus 247 ~~~~p~~Rp~----~~~i~~ 262 (268)
T cd05063 247 WQQDRARRPR----FVDIVN 262 (268)
T ss_pred cCCCcccCcC----HHHHHH
Confidence 9999999999 667664
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=350.45 Aligned_cols=255 Identities=28% Similarity=0.432 Sum_probs=219.5
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEee
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEY 551 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy 551 (857)
|.++.+||+|+||.||+|.++.+|..+|||.+.-+ ..++.+..|+.||++++.|++|++|+.|.....+++||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 67889999999999999999999999999998654 5678889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccC
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKS 631 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ 631 (857)
|..|++.+.++.+. +.+.++++..+++..+.||+|||...-||||||..|||++-+|+.||+|||.|-.+
T Consensus 110 CGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQL--------- 179 (502)
T KOG0574|consen 110 CGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQL--------- 179 (502)
T ss_pred cCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchh---------
Confidence 99999998877554 45999999999999999999999999999999999999999999999999987211
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCC
Q 035930 632 SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711 (857)
Q Consensus 632 ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~ 711 (857)
..+-++.++.+|||
T Consensus 180 ------------------------------------------------------------------TDTMAKRNTVIGTP 193 (502)
T KOG0574|consen 180 ------------------------------------------------------------------TDTMAKRNTVIGTP 193 (502)
T ss_pred ------------------------------------------------------------------hhhHHhhCccccCc
Confidence 01123456789999
Q ss_pred CccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh-ccccCCCCCCCCHHHHHHHHhhccCCcCC
Q 035930 712 EYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS-QSLRFPGYPVVSFHARDLIRGLLVKEPDN 790 (857)
Q Consensus 712 ~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~-~~~~~p~~~~is~~l~dLI~k~L~~DPe~ 790 (857)
.|||||++..-+|+..+||||||++..||.-|++||....+...+..|-. -...|..+..++.++.|||+.||.+.|++
T Consensus 194 FWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~ 273 (502)
T KOG0574|consen 194 FWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEE 273 (502)
T ss_pred ccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHH
Confidence 99999999999999999999999999999999999987654333222211 12223345668999999999999999999
Q ss_pred cCCchhhHHHHHcCCCCCCCC
Q 035930 791 RLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 791 Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
|-| +.+|++|||.+.-.
T Consensus 274 R~T----A~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 274 RKT----ALRLCEHTFIKNAP 290 (502)
T ss_pred HHH----HHHHhhhhhhcCCC
Confidence 988 99999999998643
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=335.55 Aligned_cols=253 Identities=22% Similarity=0.347 Sum_probs=205.1
Q ss_pred CeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
+|++.+.||+|+||+||+|.+.. ....+|+|++..... ......+.+|+.+|+.++||||+++++.|..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998753 235799998865421 22345688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCC----------------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcE
Q 035930 546 CLVMEYCPGGDLHVLRQKQP----------------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENI 603 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~----------------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNI 603 (857)
|+||||+.+++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999999999998876421 12478899999999999999999999999999999999
Q ss_pred EEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhh
Q 035930 604 LVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKS 683 (857)
Q Consensus 604 LL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~ 683 (857)
|+++++.++|+|||++.........
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~------------------------------------------------------- 183 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSY------------------------------------------------------- 183 (290)
T ss_pred EEcCCCcEEeccccccccccCccch-------------------------------------------------------
Confidence 9999999999999987432110000
Q ss_pred hhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhc
Q 035930 684 DLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQ 762 (857)
Q Consensus 684 d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~ 762 (857)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+ ..+..
T Consensus 184 ------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~ 244 (290)
T cd05045 184 ------------------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF-NLLKT 244 (290)
T ss_pred ------------------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhC
Confidence 00011235678999999999999999999999999999998 99999877655544 44444
Q ss_pred cccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 763 ~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
...++....++.++.+||..||..||.+||+ +.+|++
T Consensus 245 ~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~----~~~i~~ 281 (290)
T cd05045 245 GYRMERPENCSEEMYNLMLTCWKQEPDKRPT----FADISK 281 (290)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCCC----HHHHHH
Confidence 4555555678899999999999999999999 666653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=377.57 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=217.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
+...+.++.+.||+|+||+||+|+..+ ....||||.++.. ...+...+|++|+++|..|+|||||+|+|+|.+
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 556678889999999999999998753 3468999999876 334466789999999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCC------------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQPS------------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG 609 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~~------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg 609 (857)
++.+|||+|||..|||+.|+..... ..|+..+...++.||+.||+||-++.+|||||..+|+||.++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 9999999999999999998865321 1378889999999999999999999999999999999999999
Q ss_pred cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhccc
Q 035930 610 HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQV 689 (857)
Q Consensus 610 ~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~ 689 (857)
.|||+||||++..+...+.. .
T Consensus 641 ~VKIsDfGLsRdiYssDYYk---------------------------------------------------------~-- 661 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYK---------------------------------------------------------V-- 661 (774)
T ss_pred EEEecccccchhhhhhhhhc---------------------------------------------------------c--
Confidence 99999999986543221110 0
Q ss_pred CCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCC
Q 035930 690 SPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPG 768 (857)
Q Consensus 690 ~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~ 768 (857)
.....-...|||||.|+..+|+..+|||||||+|||+++ |+.||.+..++|++..+.++.+ ++.
T Consensus 662 --------------~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~ 726 (774)
T KOG1026|consen 662 --------------RGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSC 726 (774)
T ss_pred --------------cCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccC
Confidence 001123578999999999999999999999999999995 9999999999999999988887 888
Q ss_pred CCCCCHHHHHHHHhhccCCcCCcCC
Q 035930 769 YPVVSFHARDLIRGLLVKEPDNRLG 793 (857)
Q Consensus 769 ~~~is~~l~dLI~k~L~~DPe~Rpt 793 (857)
+..+|.++.+||..||+.+|.+||+
T Consensus 727 Pe~CP~~vY~LM~~CW~~~P~~RPs 751 (774)
T KOG1026|consen 727 PENCPTEVYSLMLECWNENPKRRPS 751 (774)
T ss_pred CCCCCHHHHHHHHHHhhcCcccCCC
Confidence 8899999999999999999999999
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=344.59 Aligned_cols=258 Identities=25% Similarity=0.366 Sum_probs=204.5
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-------
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE------- 542 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~------- 542 (857)
.+|.+.+.||.|+||.||+|.+..++..||+|++.... ......+.+|+++|+.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 68999999999999999999999999999999986542 24456678899999999999999999876654
Q ss_pred -------CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc-CCcEEEe
Q 035930 543 -------KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE-DGHIMLS 614 (857)
Q Consensus 543 -------~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~-dg~iKL~ 614 (857)
...|+||||++ ++|..++... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35799999996 6888777543 3899999999999999999999999999999999999974 5678999
Q ss_pred cccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCc
Q 035930 615 DFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQ 694 (857)
Q Consensus 615 DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~ 694 (857)
|||++...... ..
T Consensus 158 dfg~~~~~~~~--~~----------------------------------------------------------------- 170 (342)
T cd07854 158 DFGLARIVDPH--YS----------------------------------------------------------------- 170 (342)
T ss_pred CcccceecCCc--cc-----------------------------------------------------------------
Confidence 99987432100 00
Q ss_pred ccccCCCCccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc----------
Q 035930 695 LVVEPTGARSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS---------- 763 (857)
Q Consensus 695 l~~~~~~~~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~---------- 763 (857)
.........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++...
T Consensus 171 -----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07854 171 -----HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNE 245 (342)
T ss_pred -----cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 0000012247889999998764 567889999999999999999999998765444433332210
Q ss_pred ------------ccCC------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 764 ------------LRFP------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 764 ------------~~~p------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
...+ ..+.++.++++||.+||..||++||+ +.+++.||||+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~ell~h~~~~~~ 306 (342)
T cd07854 246 LLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT----AEEALMHPYMSCY 306 (342)
T ss_pred hhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC----HHHHhCCCccccc
Confidence 0000 02357789999999999999999999 9999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=330.77 Aligned_cols=253 Identities=21% Similarity=0.325 Sum_probs=201.5
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCe--EEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC------C
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSC--LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE------K 543 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~--~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~------~ 543 (857)
|.+++.||+|+||.||+|.+..++. .||+|.++... ........+..|+++|+.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4577899999999999999877664 69999886542 2233456788899999999999999999987532 2
Q ss_pred eEEEEEeecCCCChHHHHhhC----CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQ----PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~----~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
..++||||+.+|+|..++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 568999999999998876422 1234889999999999999999999999999999999999999999999999997
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
........
T Consensus 160 ~~~~~~~~------------------------------------------------------------------------ 167 (272)
T cd05075 160 KKIYNGDY------------------------------------------------------------------------ 167 (272)
T ss_pred cccCcccc------------------------------------------------------------------------
Confidence 43210000
Q ss_pred CCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHH
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARD 778 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~d 778 (857)
........+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+... ..++..+.++..+.+
T Consensus 168 -~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 245 (272)
T cd05075 168 -YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-NRLKQPPDCLDGLYS 245 (272)
T ss_pred -eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHH
Confidence 000011235678999999999999999999999999999999 89999887666655554443 333444568899999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHHc
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||.+||..||++||+ +.+|++
T Consensus 246 li~~~l~~~p~~Rps----~~~l~~ 266 (272)
T cd05075 246 LMSSCWLLNPKDRPS----FETLRC 266 (272)
T ss_pred HHHHHcCCCcccCcC----HHHHHH
Confidence 999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=364.93 Aligned_cols=251 Identities=30% Similarity=0.487 Sum_probs=211.5
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCCC
Q 035930 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGD 556 (857)
Q Consensus 477 ~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGs 556 (857)
+||.|.||+||.|++..+...+|||.+... ..+..+.+..|+.+.+.|.|.|||++++.|.+++++-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 799999999999999999999999998653 24556778999999999999999999999999999999999999999
Q ss_pred hHHHHhhCCCCCC--cHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc-cCCcEEEecccchhhcccCcccccCCC
Q 035930 557 LHVLRQKQPSRFF--SEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR-EDGHIMLSDFDLSLRCAVNPMVVKSSS 633 (857)
Q Consensus 557 L~~ll~~~~~~~l--~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~-~dg~iKL~DFGLA~r~~~~~~l~~~ss 633 (857)
|..++...-++ + .|...-+|.+||++||.|||++.|||||||-+||||+ -.|.+||+|||-++|++.-
T Consensus 659 LSsLLrskWGP-lKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-------- 729 (1226)
T KOG4279|consen 659 LSSLLRSKWGP-LKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-------- 729 (1226)
T ss_pred HHHHHHhccCC-CccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC--------
Confidence 98887754332 5 8899999999999999999999999999999999996 4799999999998775310
Q ss_pred CCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCc
Q 035930 634 PVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEY 713 (857)
Q Consensus 634 ~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Y 713 (857)
-| -+.+|.||.+|
T Consensus 730 -----------nP--------------------------------------------------------~TETFTGTLQY 742 (1226)
T KOG4279|consen 730 -----------NP--------------------------------------------------------CTETFTGTLQY 742 (1226)
T ss_pred -----------Cc--------------------------------------------------------cccccccchhh
Confidence 01 12367799999
Q ss_pred cChhhhcCC--CCCcccceehhhHHHHHHhhCCCCCCCCCChhh-hHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCC
Q 035930 714 LAPEIIKGE--GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET-LSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDN 790 (857)
Q Consensus 714 mAPEil~g~--~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~-l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~ 790 (857)
||||+|... +|+.++|||||||++.||.||++||...+..+. +-++---...+|.+..++.++++||.+|+..||.+
T Consensus 743 MAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~ 822 (1226)
T KOG4279|consen 743 MAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCD 822 (1226)
T ss_pred hChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCccc
Confidence 999999754 589999999999999999999999987754332 22221122234445568889999999999999999
Q ss_pred cCCchhhHHHHHcCCCCCCC
Q 035930 791 RLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 791 Rpt~~~~a~ELL~HPfF~~l 810 (857)
||+ |.++|+.||++.-
T Consensus 823 R~s----A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 823 RPS----AKDLLQDPFLQHN 838 (1226)
T ss_pred Ccc----HHHhccCcccccC
Confidence 999 9999999999754
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=334.16 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=208.2
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEc-----CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELI-----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~-----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
..++|++.++||+|+||.||++... .++..+|+|.+... .......+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3467899999999999999999753 35678999987643 223455788999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCC-------------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPS-------------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG 609 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~-------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg 609 (857)
+..|+||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 999999999999999988875432 2478999999999999999999999999999999999999999
Q ss_pred cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhccc
Q 035930 610 HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQV 689 (857)
Q Consensus 610 ~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~ 689 (857)
.++|+|||++..+.....
T Consensus 160 ~~kL~dfg~~~~~~~~~~-------------------------------------------------------------- 177 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDY-------------------------------------------------------------- 177 (280)
T ss_pred CEEECCCCceeEcCCCce--------------------------------------------------------------
Confidence 999999998743210000
Q ss_pred CCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCC
Q 035930 690 SPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPG 768 (857)
Q Consensus 690 ~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~ 768 (857)
........+++.|+|||++.+..++.++|||||||++|||++ |..||......+.+..+... ..+..
T Consensus 178 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~ 245 (280)
T cd05092 178 -----------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG-RELER 245 (280)
T ss_pred -----------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC-ccCCC
Confidence 000112235788999999999999999999999999999998 99999877666666555443 23334
Q ss_pred CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 769 YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 769 ~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
...++..+.+||.+||+.||.+||+ +.+|+.
T Consensus 246 ~~~~~~~~~~li~~cl~~~P~~Rp~----~~~l~~ 276 (280)
T cd05092 246 PRTCPPEVYAIMQGCWQREPQQRMV----IKDIHS 276 (280)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 4568899999999999999999999 677653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=328.38 Aligned_cols=256 Identities=27% Similarity=0.456 Sum_probs=208.3
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccc--ccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG--RKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~--~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
+|.+.+.||.|+||+||++.+...+..+++|+++...... ......+..|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999998887778888776432211 12233566789999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 549 MEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
|||+++++|..++... ....+++..++.++.|++.||.|||+.||+|+||+|+||+++. +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 9999999998887642 2345899999999999999999999999999999999999974 67999999987432100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 159 --------------------------------------------------------------------------~~~~~~ 164 (260)
T cd08222 159 --------------------------------------------------------------------------CDLATT 164 (260)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 000112
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
..|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+..... ......++.++.+||.+||..
T Consensus 165 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~ 243 (260)
T cd08222 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT-PSLPETYSRQLNSIMQSMLNK 243 (260)
T ss_pred CCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC-CCCcchhcHHHHHHHHHHhcC
Confidence 3478899999999988899999999999999999999999987655555555443322 222345788999999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCC
Q 035930 787 EPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF 807 (857)
||++||+ +.++++||||
T Consensus 244 ~p~~Rp~----~~~il~~~~~ 260 (260)
T cd08222 244 DPSLRPS----AAEILRNPFI 260 (260)
T ss_pred ChhhCcC----HHHHhhCCCC
Confidence 9999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=329.74 Aligned_cols=253 Identities=34% Similarity=0.476 Sum_probs=205.2
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEEEe
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LVmE 550 (857)
|.+.+.||+|+||+||+|.+..+++.||||.+..... ........+|+..++.+. ||||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999998999999999875422 112223457899999999 9999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+ +|+|..++.......+++..+..++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~----- 152 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR----- 152 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-----
Confidence 99 889988777654445899999999999999999999999999999999999999999999999987321000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
.......|+
T Consensus 153 -----------------------------------------------------------------------~~~~~~~~~ 161 (283)
T cd07830 153 -----------------------------------------------------------------------PPYTDYVST 161 (283)
T ss_pred -----------------------------------------------------------------------CCcCCCCCc
Confidence 001123578
Q ss_pred CCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-------------------cCC---
Q 035930 711 HEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-------------------RFP--- 767 (857)
Q Consensus 711 ~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-------------------~~p--- 767 (857)
..|+|||++.+ ..++.++|+||||+++|||++|+.||......+.+..+..... .++
T Consensus 162 ~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd07830 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFA 241 (283)
T ss_pred ccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccc
Confidence 89999998854 4578999999999999999999999987765554443322100 000
Q ss_pred ------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 768 ------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 768 ------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
..+..+.++.+||++||..||++||+ +.|++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~~~~~ 283 (283)
T cd07830 242 PTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT----ASQALQHPYF 283 (283)
T ss_pred cccHHHHcccCCHHHHHHHHHhcccCcccCCC----HHHHhhCCCC
Confidence 01234678999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=333.67 Aligned_cols=251 Identities=30% Similarity=0.458 Sum_probs=202.4
Q ss_pred EEEeEEccCCceEEEEEEEc----CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 473 KLHKKLGCGDIGTVYLAELI----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 473 ~i~~~LG~G~fGtVyla~~~----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.+.+.||.|.||.||+|.+. ..+..|+||+++.. ......+.+.+|+++|+.++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999998 45678999999543 2233467889999999999999999999999988889999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++|+|.+++.......+++..+..|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~- 158 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK- 158 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 9999999999999887445599999999999999999999999999999999999999999999999999743200000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 159 ------------------------------------------------------------------------~~~~~~~~ 166 (259)
T PF07714_consen 159 ------------------------------------------------------------------------YKNDSSQQ 166 (259)
T ss_dssp ------------------------------------------------------------------------EEESTTSE
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00011223
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
+...|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ....+.+....++..+.+||..||..|
T Consensus 167 ~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~C~~~~ 245 (259)
T PF07714_consen 167 LPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLIQQCWSHD 245 (259)
T ss_dssp SGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHHHHHT-SS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHHHHHcCCC
Confidence 5678999999999989999999999999999999 78999888777766666 444555555678999999999999999
Q ss_pred cCCcCCchhhHHHHHc
Q 035930 788 PDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~ 803 (857)
|++||+ +.+|++
T Consensus 246 p~~RPs----~~~i~~ 257 (259)
T PF07714_consen 246 PEKRPS----FQEILQ 257 (259)
T ss_dssp GGGS------HHHHHH
T ss_pred hhhCcC----HHHHHh
Confidence 999999 777764
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=334.42 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=206.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
.++|.+.+.||+|+||.||+|.+.. ++..+++|.+.... ......+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4579999999999999999998643 45679999886542 223356789999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQP--------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG 609 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~--------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg 609 (857)
..++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999886542 12478999999999999999999999999999999999999999
Q ss_pred cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhccc
Q 035930 610 HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQV 689 (857)
Q Consensus 610 ~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~ 689 (857)
.++|+|||++........
T Consensus 161 ~~~l~dfg~a~~~~~~~~-------------------------------------------------------------- 178 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDY-------------------------------------------------------------- 178 (291)
T ss_pred cEEECCCCcccccCCCce--------------------------------------------------------------
Confidence 999999998743110000
Q ss_pred CCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCC
Q 035930 690 SPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPG 768 (857)
Q Consensus 690 ~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~ 768 (857)
........|++.|+|||++.+..++.++|||||||++|||++ |..||...+..+.+..+.... ....
T Consensus 179 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~ 246 (291)
T cd05094 179 -----------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR-VLER 246 (291)
T ss_pred -----------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC-CCCC
Confidence 000112346788999999999999999999999999999998 999998877666665554433 2233
Q ss_pred CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHH
Q 035930 769 YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 769 ~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL 802 (857)
...++..+.+||.+||..||.+||+ +.+++
T Consensus 247 ~~~~~~~~~~li~~~l~~~P~~Rpt----~~~v~ 276 (291)
T cd05094 247 PRVCPKEVYDIMLGCWQREPQQRLN----IKEIY 276 (291)
T ss_pred CccCCHHHHHHHHHHcccChhhCcC----HHHHH
Confidence 3557899999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=335.08 Aligned_cols=261 Identities=25% Similarity=0.365 Sum_probs=209.0
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCe
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKF 544 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~ 544 (857)
.+..++|.+.+.||.|+||+||+|.+..++..||||+++.... ......+..|+.++.++. ||||++++++|.++..
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 3566789999999999999999999998899999999975421 122344566777666664 9999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
.|+||||+ ++.|..++..... .+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.++|+|||++....
T Consensus 89 ~~~v~e~~-~~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 89 VFICMELM-STCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEEEeecc-CcCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99999999 5577777665432 58999999999999999999997 699999999999999999999999999874311
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.. ..
T Consensus 167 ~~----------------------------------------------------------------------------~~ 170 (296)
T cd06618 167 DS----------------------------------------------------------------------------KA 170 (296)
T ss_pred CC----------------------------------------------------------------------------Cc
Confidence 00 00
Q ss_pred cccccCCCCccChhhhcCCC----CCcccceehhhHHHHHHhhCCCCCCCCCC-hhhhHHHhhccc-cCCCCCCCCHHHH
Q 035930 704 SNSFVGTHEYLAPEIIKGEG----HGSSVDWWTFGIFLFELLYGRTPFKGSGN-DETLSNVVSQSL-RFPGYPVVSFHAR 777 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~----~s~ksDVWSLGvILyELLtGk~PF~g~~~-~e~l~~Iv~~~~-~~p~~~~is~~l~ 777 (857)
.....++..|+|||++.+.. ++.++|||||||++|+|++|+.||..... .+.+..++.... .++....++.++.
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFC 250 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHH
Confidence 01124778899999997654 78899999999999999999999976432 344555544432 2233334788999
Q ss_pred HHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 778 DLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 778 dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+||.+||..||.+||+ ++++++||||...
T Consensus 251 ~li~~~l~~~p~~Rp~----~~~il~~~~~~~~ 279 (296)
T cd06618 251 SFVDLCLTKDHRKRPK----YRELLQHPFIRRY 279 (296)
T ss_pred HHHHHHccCChhhCCC----HHHHhcChhhhcc
Confidence 9999999999999999 9999999999853
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=326.08 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=206.2
Q ss_pred eEEccCCceEEEEEEEcC-CC--eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeec
Q 035930 476 KKLGCGDIGTVYLAELIG-TS--CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYC 552 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~-tg--~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~ 552 (857)
+.||+|+||+||+|.+.. .+ ..||||++...... .....+.+|+.+|++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999998865 33 36999999776432 455678899999999999999999999988 8999999999
Q ss_pred CCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCC
Q 035930 553 PGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSS 632 (857)
Q Consensus 553 ~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~s 632 (857)
++++|..++.......+++..++.++.|++.||.|||.+||+||||||+|||++.++.++|+|||++..+.....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~----- 152 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED----- 152 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc-----
Confidence 999999988775434589999999999999999999999999999999999999999999999998754211000
Q ss_pred CCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCC
Q 035930 633 SPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHE 712 (857)
Q Consensus 633 s~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~ 712 (857)
.........++..
T Consensus 153 -------------------------------------------------------------------~~~~~~~~~~~~~ 165 (257)
T cd05040 153 -------------------------------------------------------------------HYVMEEHLKVPFA 165 (257)
T ss_pred -------------------------------------------------------------------ceecccCCCCCce
Confidence 0000012347788
Q ss_pred ccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCc
Q 035930 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791 (857)
Q Consensus 713 YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~R 791 (857)
|+|||++.+..++.++|||||||++|||++ |..||...+..+.+..+......++....++..+.+||.+||..+|.+|
T Consensus 166 y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 245 (257)
T cd05040 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADR 245 (257)
T ss_pred ecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccC
Confidence 999999999999999999999999999998 9999987777776666665444455555688999999999999999999
Q ss_pred CCchhhHHHHHc
Q 035930 792 LGAVKGAAEIKQ 803 (857)
Q Consensus 792 pt~~~~a~ELL~ 803 (857)
|+ +.++++
T Consensus 246 ps----~~~~~~ 253 (257)
T cd05040 246 PT----FAALRE 253 (257)
T ss_pred CC----HHHHHH
Confidence 99 777764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=325.42 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=207.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++.+.||.|+||.||+|... ++.||||.+..... ....+.+|+.+++.++|+||+++++++.+++..|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 34578999999999999999999874 67899999976521 4567889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++++|.+++.......+++..++.++.|++.||.|||..||+||||||+|||++.++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~- 155 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG- 155 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc-
Confidence 9999999999999988765446899999999999999999999999999999999999999999999999987431000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
...
T Consensus 156 -----------------------------------------------------------------------------~~~ 158 (256)
T cd05039 156 -----------------------------------------------------------------------------QDS 158 (256)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 001
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
..++..|+|||++.+..++.++|||||||++|||++ |..||......+....+ ...........++..+.+||.+||.
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~ 237 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-EKGYRMEAPEGCPPEVYKVMKDCWE 237 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hcCCCCCCccCCCHHHHHHHHHHhc
Confidence 124567999999998889999999999999999997 99999877555544433 3333444445688999999999999
Q ss_pred CCcCCcCCchhhHHHHHc
Q 035930 786 KEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~ 803 (857)
.+|++||+ +.++++
T Consensus 238 ~~p~~Rp~----~~~l~~ 251 (256)
T cd05039 238 LDPAKRPT----FKQLRE 251 (256)
T ss_pred cChhhCcC----HHHHHH
Confidence 99999999 666664
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=332.54 Aligned_cols=255 Identities=19% Similarity=0.264 Sum_probs=203.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCe----EEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSC----LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~----~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
+...+|++++.||.|+||+||+|.+..++. .|++|.+... ........+..|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~- 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG- 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence 445689999999999999999999977765 4677776432 122334567778888999999999999998764
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
...++||||+++|+|..++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 55789999999999999987654 34899999999999999999999999999999999999999999999999987432
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.... ...
T Consensus 160 ~~~~-------------------------------------------------------------------------~~~ 166 (279)
T cd05111 160 YPDD-------------------------------------------------------------------------KKY 166 (279)
T ss_pred cCCC-------------------------------------------------------------------------ccc
Confidence 1000 000
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~ 781 (857)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+...... ..++......+....++.++.+++.
T Consensus 167 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~ 245 (279)
T cd05111 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQPQICTIDVYMVMV 245 (279)
T ss_pred ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCCCCCHHHHHHHH
Confidence 0112346788999999999899999999999999999998 9999987654443 3444444444545567889999999
Q ss_pred hhccCCcCCcCCchhhHHHHHc
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+||..||.+||+ +.|+++
T Consensus 246 ~c~~~~p~~Rps----~~el~~ 263 (279)
T cd05111 246 KCWMIDENVRPT----FKELAN 263 (279)
T ss_pred HHcCCCcccCcC----HHHHHH
Confidence 999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=337.81 Aligned_cols=257 Identities=23% Similarity=0.320 Sum_probs=206.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC-------CCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCcccccee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG-------TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAH 538 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~-------tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~ 538 (857)
+...+|.+.+.||+|+||.||++++.+ ....||+|+++... .......+..|+++++.+ +||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 445689999999999999999998642 34579999987542 223355678899999999 59999999999
Q ss_pred eeeCCeEEEEEeecCCCChHHHHhhCC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 035930 539 FTTEKFSCLVMEYCPGGDLHVLRQKQP--------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604 (857)
Q Consensus 539 f~~~~~l~LVmEy~~gGsL~~ll~~~~--------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNIL 604 (857)
|..++.+|+||||+++|+|..++.... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 999999999999999999999886542 134788999999999999999999999999999999999
Q ss_pred EccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhh
Q 035930 605 VREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD 684 (857)
Q Consensus 605 L~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d 684 (857)
++.++.++|+|||+++.......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~--------------------------------------------------------- 189 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDY--------------------------------------------------------- 189 (314)
T ss_pred EcCCCcEEEcccccccccccccc---------------------------------------------------------
Confidence 99999999999999743210000
Q ss_pred hhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhcc
Q 035930 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQS 763 (857)
Q Consensus 685 ~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~ 763 (857)
........++..|||||++.+..++.++|||||||++|||++ |..||.+....+.+..+...
T Consensus 190 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~- 252 (314)
T cd05099 190 ----------------YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG- 252 (314)
T ss_pred ----------------ccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 000001124567999999999999999999999999999998 89999887666666555443
Q ss_pred ccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 764 ~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
........++.++++||.+||..||++||+ +.++++
T Consensus 253 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~~ll~ 288 (314)
T cd05099 253 HRMDKPSNCTHELYMLMRECWHAVPTQRPT----FKQLVE 288 (314)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 333334567889999999999999999999 666664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=335.79 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=205.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCe--EEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSC--LFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~--~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~ 546 (857)
++|++.+.||.|+||.||+|.+..++. .+++|.++.. ........+.+|++++.++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877664 4788887632 1223345678899999999 7999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEE
Q 035930 547 LVMEYCPGGDLHVLRQKQP--------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIM 612 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~--------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iK 612 (857)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999886542 12488999999999999999999999999999999999999999999
Q ss_pred EecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCC
Q 035930 613 LSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPM 692 (857)
Q Consensus 613 L~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~ 692 (857)
|+|||++......
T Consensus 160 l~dfg~~~~~~~~------------------------------------------------------------------- 172 (297)
T cd05089 160 IADFGLSRGEEVY------------------------------------------------------------------- 172 (297)
T ss_pred ECCcCCCccccce-------------------------------------------------------------------
Confidence 9999986310000
Q ss_pred CcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCC
Q 035930 693 PQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPV 771 (857)
Q Consensus 693 p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~ 771 (857)
........+..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.. ...++....
T Consensus 173 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 242 (297)
T cd05089 173 ---------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRMEKPRN 242 (297)
T ss_pred ---------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CCCCCCCCC
Confidence 00001123457999999999999999999999999999997 9999988776666655543 334444456
Q ss_pred CCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 772 VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 772 is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
++..+++||.+||..||.+||+ ++++++.
T Consensus 243 ~~~~~~~li~~~l~~~p~~Rp~----~~~i~~~ 271 (297)
T cd05089 243 CDDEVYELMRQCWRDRPYERPP----FAQISVQ 271 (297)
T ss_pred CCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 8999999999999999999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=332.76 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=202.7
Q ss_pred CCeEEEeEEccCCceEEEEEEE----cCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC--C
Q 035930 470 RHFKLHKKLGCGDIGTVYLAEL----IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE--K 543 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~----~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~--~ 543 (857)
+.|++++.||+|+||.||++.. ..++..||+|.++... .......+.+|+++|+.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 5689999999999999999975 4568899999986542 233446788999999999999999999998875 5
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..++||||++|++|..++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 78999999999999998876532 48999999999999999999999999999999999999999999999999874321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
..... ...
T Consensus 161 ~~~~~------------------------------------------------------------------------~~~ 168 (284)
T cd05079 161 TDKEY------------------------------------------------------------------------YTV 168 (284)
T ss_pred cCccc------------------------------------------------------------------------eee
Confidence 10000 000
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC--------------ChhhhHHHhhccccCCCC
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG--------------NDETLSNVVSQSLRFPGY 769 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~--------------~~e~l~~Iv~~~~~~p~~ 769 (857)
.....|+..|+|||++.+..++.++|||||||++|||++++.|+.... ........+.....++..
T Consensus 169 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (284)
T cd05079 169 KDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRP 248 (284)
T ss_pred cCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCC
Confidence 112346778999999999889999999999999999999877653210 111122223333445555
Q ss_pred CCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 770 PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 770 ~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
..++..+.+||.+||..||.+||+ +.++++
T Consensus 249 ~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~ 278 (284)
T cd05079 249 PNCPEEVYQLMRKCWEFQPSKRTT----FQNLIE 278 (284)
T ss_pred CCCCHHHHHHHHHHccCCcccCcC----HHHHHH
Confidence 678999999999999999999999 777775
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=378.29 Aligned_cols=269 Identities=23% Similarity=0.304 Sum_probs=207.2
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.++||+|+||+||+|.+..+++.||||++..+.........++.+|+++++.++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999997653333334457889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCC---------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 550 EYCPGGDLHVLRQKQP---------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~---------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
||++||+|..++.... ...++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 9999999988876421 1235567788899999999999999999999999999999999999999999986
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
.......... .... .... .+ ...
T Consensus 162 ~i~~~~~~~~------------~l~~-----~~~~---------s~-------------------------------~s~ 184 (932)
T PRK13184 162 FKKLEEEDLL------------DIDV-----DERN---------IC-------------------------------YSS 184 (932)
T ss_pred eccccccccc------------cccc-----cccc---------cc-------------------------------ccc
Confidence 4311100000 0000 0000 00 000
Q ss_pred CCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHH-HhhccccCCCCCCCCHHHHHH
Q 035930 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN-VVSQSLRFPGYPVVSFHARDL 779 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~-Iv~~~~~~p~~~~is~~l~dL 779 (857)
.......+||+.|||||++.+..++.++|||||||++|||++|+.||........... .+...........+++.+.++
T Consensus 185 ~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~L 264 (932)
T PRK13184 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQI 264 (932)
T ss_pred cccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHH
Confidence 0112346799999999999999999999999999999999999999987544333222 111222222234688999999
Q ss_pred HHhhccCCcCCcCCch
Q 035930 780 IRGLLVKEPDNRLGAV 795 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~~ 795 (857)
+.+||..||.+|+++.
T Consensus 265 I~rcL~~DP~kR~ss~ 280 (932)
T PRK13184 265 AMKALAVDPAERYSSV 280 (932)
T ss_pred HHHHccCChhhCcCHH
Confidence 9999999999999853
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=335.72 Aligned_cols=256 Identities=22% Similarity=0.327 Sum_probs=204.4
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCC--------------CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccc
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGT--------------SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPT 534 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~t--------------g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~ 534 (857)
.++|++.+.||+|+||.||+|++.++ ...||||+++... .......+.+|+++|+.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 35899999999999999999987543 3469999987542 2233456889999999999999999
Q ss_pred cceeeeeCCeEEEEEeecCCCChHHHHhhCCC----------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 035930 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPS----------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604 (857)
Q Consensus 535 L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~----------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNIL 604 (857)
+++++..++..|+||||+++++|..++..... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 99999999999999999999999988864321 13678889999999999999999999999999999999
Q ss_pred EccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhh
Q 035930 605 VREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD 684 (857)
Q Consensus 605 L~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d 684 (857)
++.++.++|+|||++.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~---------------------------------------------------------- 183 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD---------------------------------------------------------- 183 (295)
T ss_pred EcCCCcEEecccccccccccCc----------------------------------------------------------
Confidence 9999999999999874321000
Q ss_pred hhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh--CCCCCCCCCChhhhHHHhh-
Q 035930 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY--GRTPFKGSGNDETLSNVVS- 761 (857)
Q Consensus 685 ~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt--Gk~PF~g~~~~e~l~~Iv~- 761 (857)
.........++..|+|||++.+..++.++|||||||++|+|++ |..||......+.+..+..
T Consensus 184 ---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~ 248 (295)
T cd05097 184 ---------------YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEF 248 (295)
T ss_pred ---------------ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHh
Confidence 0000112345788999999999999999999999999999988 7789987766665554432
Q ss_pred -----ccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 762 -----QSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 762 -----~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
........+.++..+.+||.+||..||++||+ +.+|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs----~~~i~~ 291 (295)
T cd05097 249 FRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT----FNKIHH 291 (295)
T ss_pred hhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHH
Confidence 11122334567899999999999999999999 777654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=362.68 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=224.5
Q ss_pred HhhhccccccCCCeEEEeEEccCCceEEEEEEEcCCC---eE-EEEEEecccccccccchhHHHHHHHHHHHcCCCCccc
Q 035930 459 CVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTS---CL-FALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPT 534 (857)
Q Consensus 459 ~~~~~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg---~~-VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~ 534 (857)
.+.++.|.+...+-.+.++||+|+||.||+|..+..+ .. ||||..+............+.+|.++|+.++|||||+
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 3455667777788888999999999999999887542 23 8999988654455677788999999999999999999
Q ss_pred cceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEe
Q 035930 535 LFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLS 614 (857)
Q Consensus 535 L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~ 614 (857)
|||+...+..+|||||+|+||+|.+++++.+. .++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+||+
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeC
Confidence 99999999999999999999999999998765 48999999999999999999999999999999999999999999999
Q ss_pred cccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCc
Q 035930 615 DFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQ 694 (857)
Q Consensus 615 DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~ 694 (857)
||||++..... .. .
T Consensus 305 DFGLs~~~~~~--~~--------------~-------------------------------------------------- 318 (474)
T KOG0194|consen 305 DFGLSRAGSQY--VM--------------K-------------------------------------------------- 318 (474)
T ss_pred ccccccCCcce--ee--------------c--------------------------------------------------
Confidence 99997432100 00 0
Q ss_pred ccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCC
Q 035930 695 LVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVS 773 (857)
Q Consensus 695 l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is 773 (857)
. ..---...|+|||.+....|+.++|||||||++||+++ |..||.+....++...|+...++.+.+...+
T Consensus 319 ----~-----~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p 389 (474)
T KOG0194|consen 319 ----K-----FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTP 389 (474)
T ss_pred ----c-----ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCH
Confidence 0 00012467999999999999999999999999999998 8999999999999999988888888878889
Q ss_pred HHHHHHHHhhccCCcCCcCCc
Q 035930 774 FHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
.++..++..||..||++|+++
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm 410 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTM 410 (474)
T ss_pred HHHHHHHHHhccCChhhccCH
Confidence 999999999999999999994
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=326.93 Aligned_cols=241 Identities=25% Similarity=0.332 Sum_probs=195.5
Q ss_pred EEccCCceEEEEEEE--cCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCC
Q 035930 477 KLGCGDIGTVYLAEL--IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 477 ~LG~G~fGtVyla~~--~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
.||+|+||.||+|.+ ..++..||+|+++... ......+.+.+|+.+|+.++||||+++++++.. +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 689999999999965 4677899999986542 122344678899999999999999999998864 467899999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
++|..++.... .+++..+..++.||+.||+|||++||+||||||.|||++.++.++|+|||++.........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~------ 151 (257)
T cd05116 80 GPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY------ 151 (257)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe------
Confidence 99999887653 4899999999999999999999999999999999999999999999999987432110000
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
+ .......+++.|+
T Consensus 152 ----------------------~--------------------------------------------~~~~~~~~~~~y~ 165 (257)
T cd05116 152 ----------------------Y--------------------------------------------KAKTHGKWPVKWY 165 (257)
T ss_pred ----------------------e--------------------------------------------eecCCCCCCcccc
Confidence 0 0001123567899
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCC
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLG 793 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt 793 (857)
|||.+.+..++.++|||||||++|||++ |..||......+....+.. ...++.+..++.++.+||.+||+.||++||+
T Consensus 166 aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~ 244 (257)
T cd05116 166 APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-GERMECPQRCPPEMYDLMKLCWTYGVDERPG 244 (257)
T ss_pred CHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHhccCchhCcC
Confidence 9999988889999999999999999997 9999988766666555543 3344445568999999999999999999999
Q ss_pred c
Q 035930 794 A 794 (857)
Q Consensus 794 ~ 794 (857)
.
T Consensus 245 ~ 245 (257)
T cd05116 245 F 245 (257)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=329.62 Aligned_cols=254 Identities=30% Similarity=0.470 Sum_probs=207.8
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEee
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEY 551 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy 551 (857)
|.+.+.||.|++|.||+|.+..++..+|+|.+..... .......+.+|+++|+.++|+||+++++++..++..|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 5678899999999999999998999999999876532 223445778899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccC
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKS 631 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ 631 (857)
+++ +|..++.... ..+++..+..++.||+.||.|||..||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----- 152 (283)
T cd05118 80 MDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----- 152 (283)
T ss_pred cCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-----
Confidence 965 7777666543 348999999999999999999999999999999999999999999999999874321000
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCC
Q 035930 632 SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711 (857)
Q Consensus 632 ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~ 711 (857)
.......++.
T Consensus 153 ----------------------------------------------------------------------~~~~~~~~~~ 162 (283)
T cd05118 153 ----------------------------------------------------------------------RPYTHYVVTR 162 (283)
T ss_pred ----------------------------------------------------------------------ccccCccCcc
Confidence 0011234788
Q ss_pred CccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-------------------CC----
Q 035930 712 EYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-------------------FP---- 767 (857)
Q Consensus 712 ~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-------------------~p---- 767 (857)
.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+.+..+...... ++
T Consensus 163 ~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05118 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAG 242 (283)
T ss_pred cccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccc
Confidence 99999999877 7899999999999999999999999877665554444321110 11
Q ss_pred -----CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 768 -----GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 768 -----~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
..+.++.++++||.+||..||.+||+ +.+|++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~ll~~~~~ 283 (283)
T cd05118 243 MPLPKLFPNASPQALDLLSQMLHYDPHKRIT----AEQALAHPYF 283 (283)
T ss_pred cCHHHhhhhhCHHHHHHHHHHhccCcccCcC----HHHHhhCCCC
Confidence 01346788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=365.55 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=213.9
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecc-cccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe--EEEE
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDN-DFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF--SCLV 548 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k-~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~--l~LV 548 (857)
.++..+||+|+|-+||+|.|..+|..||--.++. +.......++++..|+.+|+.|+||||+++|++|.+... +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 4566799999999999999999998888654432 233445667899999999999999999999999987754 8899
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEccC-CcEEEecccchhhcccC
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG--VVYRDLKPENILVRED-GHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G--IIHRDLKPeNILL~~d-g~iKL~DFGLA~r~~~~ 625 (857)
+|++..|+|+.|+.+... ++...++.|++|||.||.|||.+. |||||||.+||+|+.+ |.|||+|+|||....
T Consensus 122 TEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r-- 197 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR-- 197 (632)
T ss_pred eecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh--
Confidence 999999999999988754 889999999999999999999986 9999999999999865 899999999984321
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.....
T Consensus 198 ---------------------------------------------------------------------------~s~ak 202 (632)
T KOG0584|consen 198 ---------------------------------------------------------------------------KSHAK 202 (632)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 01223
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC-hhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-DETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~-~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
+.+|||.|||||++. +.|+..+||||||+.++||+|+.+||..-.+ .++|.++..+..+-.....-.+++++||.+||
T Consensus 203 svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl 281 (632)
T KOG0584|consen 203 SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCL 281 (632)
T ss_pred eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHh
Confidence 578999999999998 7899999999999999999999999987655 45555555544333333445789999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.. ..+||+ +.|||+||||..-
T Consensus 282 ~~-~~~R~s----a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 282 AT-KSERLS----AKELLKDPFFDED 302 (632)
T ss_pred cC-chhccC----HHHHhhChhhccc
Confidence 99 999999 9999999999874
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.12 Aligned_cols=254 Identities=31% Similarity=0.460 Sum_probs=209.0
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEee
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEY 551 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy 551 (857)
|++.+.||+|+||.||+|.+..++..||+|++.... ........+..|+++++.++|+||+++++++...+..|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999997653 2233445678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccC
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKS 631 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ 631 (857)
++ ++|..++.... ..+++..++.++.|++.||.|||.+||+||||+|+||+++.++.++|+|||++......
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~------ 151 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP------ 151 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC------
Confidence 96 58998887753 24899999999999999999999999999999999999999999999999987431100
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCC
Q 035930 632 SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711 (857)
Q Consensus 632 ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~ 711 (857)
........++.
T Consensus 152 ---------------------------------------------------------------------~~~~~~~~~~~ 162 (282)
T cd07829 152 ---------------------------------------------------------------------LRTYTHEVVTL 162 (282)
T ss_pred ---------------------------------------------------------------------ccccCccccCc
Confidence 00011224577
Q ss_pred CccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc------------------ccCCC----
Q 035930 712 EYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS------------------LRFPG---- 768 (857)
Q Consensus 712 ~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~------------------~~~p~---- 768 (857)
.|+|||++.+. .++.++|||+|||++|||++|+.||.+....+.+..+.... ..++.
T Consensus 163 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (282)
T cd07829 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPK 242 (282)
T ss_pred CcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCcc
Confidence 89999999876 78999999999999999999999998876555544433210 01111
Q ss_pred -----CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 769 -----YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 769 -----~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.+.++..+.+||++||..||++||+ +.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~p~~ 282 (282)
T cd07829 243 DLEKVLPRLDPEGIDLLSKMLQYNPAKRIS----AKEALKHPYF 282 (282)
T ss_pred chHHhcccccHHHHHHHHHhhccCcccCCC----HHHHhhCcCC
Confidence 2345788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=336.73 Aligned_cols=252 Identities=29% Similarity=0.447 Sum_probs=209.7
Q ss_pred EEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecC
Q 035930 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCP 553 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~ 553 (857)
...+||+|+||.||++.+..++..||||++... .......+.+|+.+++.++|+||++++++|...++.|+||||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 346899999999999999999999999988543 12344567889999999999999999999999999999999999
Q ss_pred CCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCC
Q 035930 554 GGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSS 633 (857)
Q Consensus 554 gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss 633 (857)
+++|..++... .+++..++.++.|++.||+|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 101 ~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~-------- 169 (292)
T cd06657 101 GGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-------- 169 (292)
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--------
Confidence 99999887543 3889999999999999999999999999999999999999999999999986321000
Q ss_pred CCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCc
Q 035930 634 PVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEY 713 (857)
Q Consensus 634 ~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Y 713 (857)
........|++.|
T Consensus 170 -------------------------------------------------------------------~~~~~~~~~~~~y 182 (292)
T cd06657 170 -------------------------------------------------------------------VPRRKSLVGTPYW 182 (292)
T ss_pred -------------------------------------------------------------------cccccccccCccc
Confidence 0001234588999
Q ss_pred cChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-ccCCCCCCCCHHHHHHHHhhccCCcCCcC
Q 035930 714 LAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-LRFPGYPVVSFHARDLIRGLLVKEPDNRL 792 (857)
Q Consensus 714 mAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-~~~p~~~~is~~l~dLI~k~L~~DPe~Rp 792 (857)
+|||++.+..++.++|+|||||++|+|++|..||.+....+.+..+.... ..+.....++..+.+||.+||..||.+||
T Consensus 183 ~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~ 262 (292)
T cd06657 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRA 262 (292)
T ss_pred cCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCc
Confidence 99999988889999999999999999999999998765554444332221 12223345789999999999999999999
Q ss_pred CchhhHHHHHcCCCCCCC
Q 035930 793 GAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 793 t~~~~a~ELL~HPfF~~l 810 (857)
+ +.+++.||||...
T Consensus 263 ~----~~~ll~~~~~~~~ 276 (292)
T cd06657 263 T----AAELLKHPFLAKA 276 (292)
T ss_pred C----HHHHhcChHHhcc
Confidence 9 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=341.21 Aligned_cols=258 Identities=22% Similarity=0.339 Sum_probs=207.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCC-------CeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCcccccee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGT-------SCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAH 538 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~t-------g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~ 538 (857)
+...+|++++.||+|+||.||+|++.+. +..||+|+++... .......+.+|+++++++ +||||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 4556899999999999999999987532 3479999887541 223456788999999999 79999999999
Q ss_pred eeeCCeEEEEEeecCCCChHHHHhhCC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 035930 539 FTTEKFSCLVMEYCPGGDLHVLRQKQP--------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604 (857)
Q Consensus 539 f~~~~~l~LVmEy~~gGsL~~ll~~~~--------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNIL 604 (857)
|..++..|+||||+++|+|..++.... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 999999999999999999998887532 124778888999999999999999999999999999999
Q ss_pred EccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhh
Q 035930 605 VREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD 684 (857)
Q Consensus 605 L~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d 684 (857)
++.++.++|+|||+++.......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~--------------------------------------------------------- 189 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDY--------------------------------------------------------- 189 (334)
T ss_pred EcCCCcEEECCcccceecccccc---------------------------------------------------------
Confidence 99999999999998743210000
Q ss_pred hhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhcc
Q 035930 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQS 763 (857)
Q Consensus 685 ~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~ 763 (857)
........++..|||||++.+..++.++|||||||+||||++ |..||.+....+.+..+.. .
T Consensus 190 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~ 252 (334)
T cd05100 190 ----------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE-G 252 (334)
T ss_pred ----------------cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-C
Confidence 000011224567999999999999999999999999999998 8999988766666555443 3
Q ss_pred ccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 764 ~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
..++....++..+.+||.+||..+|.+||+ +.+|+++
T Consensus 253 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~ell~~ 289 (334)
T cd05100 253 HRMDKPANCTHELYMIMRECWHAVPSQRPT----FKQLVED 289 (334)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCcC----HHHHHHH
Confidence 344444567889999999999999999999 6776664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=354.13 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=211.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~ 540 (857)
+..++|.+++.||+|+||.||+|.+.+ .+..||||+++... .......+.+|+++|..+. ||||++++++|.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 455678999999999999999998653 45689999997542 2223456789999999997 999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCC------------------------------------------------------
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQPS------------------------------------------------------ 566 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~~------------------------------------------------------ 566 (857)
..+..||||||+++|+|.+++.....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999988865321
Q ss_pred ------------------------------------------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 035930 567 ------------------------------------------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604 (857)
Q Consensus 567 ------------------------------------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNIL 604 (857)
..+++..++.++.||+.||+|||..||+||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 23677788889999999999999999999999999999
Q ss_pred EccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhh
Q 035930 605 VREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD 684 (857)
Q Consensus 605 L~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d 684 (857)
++.++.++|+|||++........
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~--------------------------------------------------------- 294 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSN--------------------------------------------------------- 294 (401)
T ss_pred EeCCCEEEEEecCcceecccccc---------------------------------------------------------
Confidence 99999999999999743210000
Q ss_pred hhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhcc
Q 035930 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQS 763 (857)
Q Consensus 685 ~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~ 763 (857)
........+++.|||||++.+..++.++|||||||+||||++ |..||......+.+...+...
T Consensus 295 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~ 358 (401)
T cd05107 295 ----------------YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG 358 (401)
T ss_pred ----------------cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcC
Confidence 000112357889999999999999999999999999999998 899998876666666666666
Q ss_pred ccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 764 ~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.+++.+..++.++.+||.+||..||.+||+ +.+|++
T Consensus 359 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs----~~ell~ 394 (401)
T cd05107 359 YRMAKPAHASDEIYEIMQKCWEEKFEIRPD----FSQLVH 394 (401)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 666555678999999999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.20 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=204.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++.+.||.|+||.||++.. +++.||+|++..+ .....+.+|+.+|+.++||||+++++++..+. .|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~ 74 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-----VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LY 74 (254)
T ss_pred ccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cE
Confidence 4557899999999999999999874 6778999998653 22356789999999999999999999987654 69
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++++|..++.......+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 9999999999999987665555899999999999999999999999999999999999999999999999987321000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
...
T Consensus 154 -----------------------------------------------------------------------------~~~ 156 (254)
T cd05083 154 -----------------------------------------------------------------------------VDN 156 (254)
T ss_pred -----------------------------------------------------------------------------CCC
Confidence 001
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
...+..|+|||++.+..++.++|||||||++|||++ |+.||......+....+. ...+++....++..+.+||.+||.
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 235 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSCWE 235 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHHcC
Confidence 123467999999998899999999999999999997 999998876665555443 334444456688999999999999
Q ss_pred CCcCCcCCchhhHHHHHc
Q 035930 786 KEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~ 803 (857)
.+|++||+ +.+|+.
T Consensus 236 ~~p~~Rp~----~~~l~~ 249 (254)
T cd05083 236 TEPKKRPS----FHKLRE 249 (254)
T ss_pred CChhhCcC----HHHHHH
Confidence 99999999 666654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.56 Aligned_cols=251 Identities=23% Similarity=0.355 Sum_probs=206.2
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
..+|++.+.||.|+||.||++.+. .+..+|+|++.... .....+.+|+++++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA----MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC----CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 347899999999999999999885 46689999986542 2235678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++++|.+++..... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc--
Confidence 999999999988875443 48899999999999999999999999999999999999999999999999874311000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (256)
T cd05112 155 ------------------------------------------------------------------------YTSSTGTK 162 (256)
T ss_pred ------------------------------------------------------------------------ccccCCCc
Confidence 00001123
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
++..|+|||++.+..++.++|||||||++|||++ |..||......+.+..+... .+.......+..+.+|+.+||..+
T Consensus 163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~ 241 (256)
T cd05112 163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPRLASQSVYELMQHCWKER 241 (256)
T ss_pred cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHHcccC
Confidence 5678999999998889999999999999999998 99999877666655554433 333333457899999999999999
Q ss_pred cCCcCCchhhHHHHHcC
Q 035930 788 PDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~H 804 (857)
|++||+ +.+++++
T Consensus 242 p~~Rp~----~~~~l~~ 254 (256)
T cd05112 242 PEDRPS----FSLLLHQ 254 (256)
T ss_pred hhhCCC----HHHHHHh
Confidence 999999 8888753
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=329.13 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=197.2
Q ss_pred CeEEEeEEccCCceEEEEEEE----cCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC--Ce
Q 035930 471 HFKLHKKLGCGDIGTVYLAEL----IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE--KF 544 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~----~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~--~~ 544 (857)
.|++.+.||+|+||+||++.. ..++..||+|+++... .......+.+|+++|+.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 349999999999999988753 3567899999987542 122345678899999999999999999988653 46
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|+||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 89999999999999988764 389999999999999999999999999999999999999999999999998743211
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
.... ....
T Consensus 160 ~~~~------------------------------------------------------------------------~~~~ 167 (283)
T cd05080 160 GHEY------------------------------------------------------------------------YRVR 167 (283)
T ss_pred cchh------------------------------------------------------------------------hccC
Confidence 0000 0000
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh--------------hhhHHHhhccccCCCCC
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND--------------ETLSNVVSQSLRFPGYP 770 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~--------------e~l~~Iv~~~~~~p~~~ 770 (857)
....++..|+|||++.+..++.++|||||||++|||++|..||...... ..+...+......+...
T Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (283)
T cd05080 168 EDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPK 247 (283)
T ss_pred CCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCC
Confidence 1123566799999999888999999999999999999999998643211 11111122223333345
Q ss_pred CCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 771 VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 771 ~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.++..+.+|+..||..||.+||+ +.+|+.
T Consensus 248 ~~~~~~~~li~~cl~~~p~~Rps----~~~i~~ 276 (283)
T cd05080 248 NCPQEVYILMKNCWETEAKFRPT----FRSLIP 276 (283)
T ss_pred CCCHHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 67899999999999999999999 677664
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.34 Aligned_cols=260 Identities=28% Similarity=0.410 Sum_probs=204.6
Q ss_pred CeEEEeEEccCCceEEEEEEEcCC--CeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeC----C
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGT--SCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTE----K 543 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~t--g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~----~ 543 (857)
+|.+.+.||.|+||.||++.+..+ +..||||++.... ........+.+|+++++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999888 8999999986532 1222345678899999999 599999999875432 4
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
.+|++|||+ +++|..++.... .+++..++.++.||+.||+|||.+||+||||||+|||++.++.++|+|||++....
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 678999999 578988876543 48999999999999999999999999999999999999999999999999985421
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.... .....
T Consensus 157 ~~~~-----------------------------------------------------------------------~~~~~ 165 (332)
T cd07857 157 ENPG-----------------------------------------------------------------------ENAGF 165 (332)
T ss_pred cccc-----------------------------------------------------------------------ccccc
Confidence 1000 00001
Q ss_pred cccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-------------------
Q 035930 704 SNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS------------------- 763 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~------------------- 763 (857)
...++||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..++...
T Consensus 166 ~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (332)
T cd07857 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNY 245 (332)
T ss_pred ccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHH
Confidence 124578999999998876 568999999999999999999999998765433333222110
Q ss_pred ---------ccCC-CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 764 ---------LRFP-GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 764 ---------~~~p-~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
..++ ..+.++..+.+||.+||..||.+||+ +.+++.||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~ll~~~~~~~ 297 (332)
T cd07857 246 IRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS----VEEALEHPYLAI 297 (332)
T ss_pred HHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcChhhhh
Confidence 0010 12346789999999999999999999 999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.45 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=203.8
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcC----------------CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCc
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIG----------------TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~----------------tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnI 532 (857)
.++|++.+.||+|+||+||++.+.. ++..||+|++.... .......+.+|+++|+.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4579999999999999999986532 34579999987542 22334567899999999999999
Q ss_pred cccceeeeeCCeEEEEEeecCCCChHHHHhhCCC---------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcE
Q 035930 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPS---------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENI 603 (857)
Q Consensus 533 V~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~---------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNI 603 (857)
+++++++..++..|+||||+++++|..++..... ..+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999999999999999999999999988875431 2367788999999999999999999999999999999
Q ss_pred EEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhh
Q 035930 604 LVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKS 683 (857)
Q Consensus 604 LL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~ 683 (857)
|++.++.++|+|||++..+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-------------------------------------------------------- 185 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY-------------------------------------------------------- 185 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc--------------------------------------------------------
Confidence 999999999999998743211000
Q ss_pred hhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh--CCCCCCCCCChhhhHHHhh
Q 035930 684 DLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY--GRTPFKGSGNDETLSNVVS 761 (857)
Q Consensus 684 d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt--Gk~PF~g~~~~e~l~~Iv~ 761 (857)
........+++.|+|||.+.+..++.++|||||||++|||++ |..||......+.+.....
T Consensus 186 -----------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~ 248 (296)
T cd05095 186 -----------------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248 (296)
T ss_pred -----------------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHH
Confidence 000112235678999999988899999999999999999998 7899987666555443321
Q ss_pred ------ccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 762 ------QSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 762 ------~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
....++....++..+.+||..||..||.+||+ +.+|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~ 292 (296)
T cd05095 249 FFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS----FQEIHA 292 (296)
T ss_pred HHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 11223444568899999999999999999999 666643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=322.80 Aligned_cols=251 Identities=23% Similarity=0.328 Sum_probs=206.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|.+.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|+++|+.++|+||+++++++.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 45678999999999999999999865 4456999988653 2234567889999999999999999999887 7789
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++++|.+++.......+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999999887655568889999999999999999999999999999999999999999999999874321000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
. .....
T Consensus 157 ~--------------------------------------------------------------------------~~~~~ 162 (260)
T cd05073 157 Y--------------------------------------------------------------------------TAREG 162 (260)
T ss_pred c--------------------------------------------------------------------------ccccC
Confidence 0 00011
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
..++..|+|||++.+..++.++|+|||||++|+|++ |+.||.+.+..+....+ ......+....++.++.+++.+||.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~ 241 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEELYNIMMRCWK 241 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hCCCCCCCcccCCHHHHHHHHHHcc
Confidence 235677999999998889999999999999999998 99999887655555443 3444555556788999999999999
Q ss_pred CCcCCcCCchhhHHHHH
Q 035930 786 KEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL 802 (857)
.+|++||+ +.+++
T Consensus 242 ~~p~~Rp~----~~~l~ 254 (260)
T cd05073 242 NRPEERPT----FEYIQ 254 (260)
T ss_pred cCcccCcC----HHHHH
Confidence 99999999 55554
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.35 Aligned_cols=246 Identities=22% Similarity=0.316 Sum_probs=199.3
Q ss_pred eEEccCCceEEEEEEEcCCC---eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeec
Q 035930 476 KKLGCGDIGTVYLAELIGTS---CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYC 552 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg---~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~ 552 (857)
++||+|+||.||+|.+...+ ..||+|.+...... .....+.+|+++|+.++||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876554 78999998765332 34456788999999999999999999876 45679999999
Q ss_pred CCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCC
Q 035930 553 PGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSS 632 (857)
Q Consensus 553 ~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~s 632 (857)
++++|.+++.... .+++..+..++.|++.||+|||..||+||||||+|||++.++.++|+|||++..+.......
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~--- 152 (257)
T cd05060 78 PLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY--- 152 (257)
T ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc---
Confidence 9999999988765 48999999999999999999999999999999999999999999999999875321100000
Q ss_pred CCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCC
Q 035930 633 SPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHE 712 (857)
Q Consensus 633 s~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~ 712 (857)
.......++..
T Consensus 153 ---------------------------------------------------------------------~~~~~~~~~~~ 163 (257)
T cd05060 153 ---------------------------------------------------------------------RATTAGRWPLK 163 (257)
T ss_pred ---------------------------------------------------------------------ccccCcccccc
Confidence 00001124568
Q ss_pred ccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCc
Q 035930 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791 (857)
Q Consensus 713 YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~R 791 (857)
|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+ ......+....++..+++||.+||..||.+|
T Consensus 164 y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 242 (257)
T cd05060 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-ESGERLPRPEECPQEIYSIMLSCWKYRPEDR 242 (257)
T ss_pred ccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHhcCChhhC
Confidence 999999999999999999999999999997 99999877655554444 3444445556788999999999999999999
Q ss_pred CCchhhHHHHHc
Q 035930 792 LGAVKGAAEIKQ 803 (857)
Q Consensus 792 pt~~~~a~ELL~ 803 (857)
|+ +.+|++
T Consensus 243 p~----~~~l~~ 250 (257)
T cd05060 243 PT----FSELES 250 (257)
T ss_pred cC----HHHHHH
Confidence 99 666553
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.17 Aligned_cols=241 Identities=23% Similarity=0.317 Sum_probs=194.3
Q ss_pred EEccCCceEEEEEEEc--CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCC
Q 035930 477 KLGCGDIGTVYLAELI--GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 477 ~LG~G~fGtVyla~~~--~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.+|++++||||+++++++.. +..|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999775 456679999986542 23334568899999999999999999998864 578999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
++|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..........
T Consensus 79 ~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~----- 152 (257)
T cd05115 79 GPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY----- 152 (257)
T ss_pred CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce-----
Confidence 99998886543 348999999999999999999999999999999999999999999999999874321100000
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
.......+++.|+
T Consensus 153 -------------------------------------------------------------------~~~~~~~~~~~y~ 165 (257)
T cd05115 153 -------------------------------------------------------------------KARSAGKWPLKWY 165 (257)
T ss_pred -------------------------------------------------------------------eccCCCCCCcccC
Confidence 0000112467899
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCC
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLG 793 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt 793 (857)
|||++.+..++.++|||||||++|||++ |..||......+.+..+ ....+.+.....+.++.+||.+||..||++||+
T Consensus 166 aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~ 244 (257)
T cd05115 166 APECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-EQGKRLDCPAECPPEMYALMKDCWIYKWEDRPN 244 (257)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 9999998889999999999999999996 99999887666655444 333444445668999999999999999999999
Q ss_pred c
Q 035930 794 A 794 (857)
Q Consensus 794 ~ 794 (857)
.
T Consensus 245 ~ 245 (257)
T cd05115 245 F 245 (257)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.47 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=207.1
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
...+|++.+.||.|+||.||+|.+.+ ++..||+|++.... .......+.+|+.+++.++||||+++++++.++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 34679999999999999999998753 67899999987542 122345678899999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCC--------------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQP--------------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPEN 602 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~--------------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeN 602 (857)
+..|+||||+++++|..++.... ...+++..+..++.||+.||+|||..||+||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999998886432 1237888899999999999999999999999999999
Q ss_pred EEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhh
Q 035930 603 ILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIK 682 (857)
Q Consensus 603 ILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~ 682 (857)
||++.++.++|+|||++..+..... +
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~-------------------~----------------------------------- 186 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY-------------------Y----------------------------------- 186 (288)
T ss_pred eEecCCCceEECccccceecccCcc-------------------c-----------------------------------
Confidence 9999999999999998642110000 0
Q ss_pred hhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhh
Q 035930 683 SDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVS 761 (857)
Q Consensus 683 ~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~ 761 (857)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+..
T Consensus 187 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~ 247 (288)
T cd05050 187 -------------------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD 247 (288)
T ss_pred -------------------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 00011124567999999999999999999999999999997 8899988777776666554
Q ss_pred ccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 762 QSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 762 ~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
... ++....++..+.+||.+||..||.+||+ +.||++
T Consensus 248 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~el~~ 284 (288)
T cd05050 248 GNV-LSCPDNCPLELYNLMRLCWSKLPSDRPS----FASINR 284 (288)
T ss_pred CCC-CCCCCCCCHHHHHHHHHHcccCcccCCC----HHHHHH
Confidence 433 2333467899999999999999999999 666653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=342.22 Aligned_cols=263 Identities=32% Similarity=0.471 Sum_probs=209.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeC--CeE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTE--KFS 545 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~--~~l 545 (857)
.++|.+.+.||+|+||.||+|.+..++..||||.+..... .......+.+|+.+++.+ +||||++++++|... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4679999999999999999999998999999998865322 223345567899999999 999999999998654 468
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||++ ++|..++... .+++..++.++.||+.||+|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99999996 6998887654 4888999999999999999999999999999999999999999999999997542110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
... .......
T Consensus 161 ~~~----------------------------------------------------------------------~~~~~~~ 170 (337)
T cd07852 161 EEN----------------------------------------------------------------------PENPVLT 170 (337)
T ss_pred ccc----------------------------------------------------------------------ccCcchh
Confidence 000 0000112
Q ss_pred cccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-------------------
Q 035930 706 SFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR------------------- 765 (857)
Q Consensus 706 s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~------------------- 765 (857)
.++||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+......
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (337)
T cd07852 171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLD 250 (337)
T ss_pred cccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhh
Confidence 3468999999998865 45789999999999999999999999876555444333222110
Q ss_pred ------C----CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 766 ------F----PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 766 ------~----p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
. ...+.++.++.+||.+||+.||.+||+ +.++++||||.++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps----~~~il~~~~~~~~ 301 (337)
T cd07852 251 SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT----AEEALEHPYVAQF 301 (337)
T ss_pred hcccccccchhhhccCCCHHHHHHHHHhccCCcccccC----HHHHhhChhhhhh
Confidence 0 012346889999999999999999999 9999999999876
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=390.31 Aligned_cols=261 Identities=29% Similarity=0.477 Sum_probs=220.8
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
++.-...||.|.||.||-|....+|...|+|-++..... .+....+.+|+.+|..|.|||+|++|++-.+.+..+|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 466778999999999999999999999999988755433 6667788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
||.+|+|.++++... ..+|...+.|..|++.||.|||++|||||||||+||||+.+|.+|++|||.|+....+-.
T Consensus 1315 yC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~--- 1389 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ--- 1389 (1509)
T ss_pred HhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh---
Confidence 999999999988754 378889999999999999999999999999999999999999999999999865322100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
+ + .......+||
T Consensus 1390 -------------------------------------------------~-----------~--------~~el~~~~GT 1401 (1509)
T KOG4645|consen 1390 -------------------------------------------------T-----------M--------PGELQSMMGT 1401 (1509)
T ss_pred -------------------------------------------------c-----------C--------CHHHHhhcCC
Confidence 0 0 0012356899
Q ss_pred CCccChhhhcC---CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 711 HEYLAPEIIKG---EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 711 ~~YmAPEil~g---~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
+.|||||+|.| .+++.+.|||||||++.||+||+.||...+++=.+.-.+..+..++.+..++.+.+|||..||+.|
T Consensus 1402 ~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~d 1481 (1509)
T KOG4645|consen 1402 PMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQD 1481 (1509)
T ss_pred chhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcC
Confidence 99999999976 457889999999999999999999998876654444444444444444559999999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
|+.|++ +.|||.|-|-..
T Consensus 1482 P~~Rw~----~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1482 PKMRWT----ASQLLEHAFGKS 1499 (1509)
T ss_pred chhhhH----HHHHHHhhcccc
Confidence 999999 889999998653
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.12 Aligned_cols=255 Identities=23% Similarity=0.327 Sum_probs=201.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEE----cCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee--C
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAEL----IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT--E 542 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~----~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~--~ 542 (857)
..+|++.+.||+|+||+||++.. ..++..||||.+.... ......+.+|+++|+.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 35799999999999999999974 4578899999986542 2334567899999999999999999998753 3
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
..+|+||||+++++|..++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 578999999999999998876432 3899999999999999999999999999999999999999999999999997542
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
...... ..
T Consensus 159 ~~~~~~------------------------------------------------------------------------~~ 166 (284)
T cd05081 159 PQDKEY------------------------------------------------------------------------YK 166 (284)
T ss_pred cCCCcc------------------------------------------------------------------------ee
Confidence 110000 00
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh---------------hhhHHHhhccccCC
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND---------------ETLSNVVSQSLRFP 767 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~---------------e~l~~Iv~~~~~~p 767 (857)
......++..|+|||++.+..++.++|||||||++|||++|..|+...... ..+..++.....++
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (284)
T cd05081 167 VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP 246 (284)
T ss_pred ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCC
Confidence 000112345699999999989999999999999999999988776433111 01223344444555
Q ss_pred CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 768 GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 768 ~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
....++.++.+||.+||..+|++||+ +.+|++
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05081 247 APPGCPAEIYAIMKECWNNDPSQRPS----FSELAL 278 (284)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 56678899999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.14 Aligned_cols=257 Identities=18% Similarity=0.250 Sum_probs=208.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee-
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT- 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~- 541 (857)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345789999999999999999999875 3578999988643 223345667899999999999999999998776
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCC------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEec
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQPS------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSD 615 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~~------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~D 615 (857)
+...++++||+++++|..++..... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 4678999999999999988865422 3489999999999999999999999999999999999999999999999
Q ss_pred ccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcc
Q 035930 616 FDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQL 695 (857)
Q Consensus 616 FGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l 695 (857)
||+++.+......
T Consensus 161 ~g~~~~~~~~~~~------------------------------------------------------------------- 173 (280)
T cd05043 161 NALSRDLFPMDYH------------------------------------------------------------------- 173 (280)
T ss_pred CCCcccccCCceE-------------------------------------------------------------------
Confidence 9997532110000
Q ss_pred cccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCH
Q 035930 696 VVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSF 774 (857)
Q Consensus 696 ~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~ 774 (857)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+.. ..+.....++....++.
T Consensus 174 ------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 246 (280)
T cd05043 174 ------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQPINCPD 246 (280)
T ss_pred ------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH-HHHHcCCCCCCCCcCCH
Confidence 00011235678999999999999999999999999999998 99999877555544 44444555555556789
Q ss_pred HHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 775 HARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 775 ~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
++.++|.+||..||++||+ +.++++
T Consensus 247 ~~~~li~~~l~~~p~~Rps----~~~~~~ 271 (280)
T cd05043 247 ELFAVMACCWALDPEERPS----FSQLVQ 271 (280)
T ss_pred HHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 9999999999999999999 666663
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=327.12 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=204.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCe----EEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSC----LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~----~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
+...+|++.+.||+|+||+||+|.+..++. .||+|++..... ......+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345689999999999999999999876654 689998865521 2344567889999999999999999999987
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
...|+||||+++|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 788999999999999998876543 3899999999999999999999999999999999999999999999999988542
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
...... .
T Consensus 160 ~~~~~~-------------------------------------------------------------------------~ 166 (279)
T cd05057 160 DVDEKE-------------------------------------------------------------------------Y 166 (279)
T ss_pred cCcccc-------------------------------------------------------------------------e
Confidence 110000 0
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~ 781 (857)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+....+....+. ....++.+...+.++.+++.
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 245 (279)
T cd05057 167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDVYMVLV 245 (279)
T ss_pred ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHH
Confidence 0001124568999999998889999999999999999998 999998876665554443 44445555668899999999
Q ss_pred hhccCCcCCcCCc
Q 035930 782 GLLVKEPDNRLGA 794 (857)
Q Consensus 782 k~L~~DPe~Rpt~ 794 (857)
+||..||..||+.
T Consensus 246 ~~l~~~p~~Rp~~ 258 (279)
T cd05057 246 KCWMIDAESRPTF 258 (279)
T ss_pred HHcCCChhhCCCH
Confidence 9999999999993
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=338.44 Aligned_cols=256 Identities=28% Similarity=0.411 Sum_probs=206.5
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee-CCeEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT-EKFSC 546 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~-~~~l~ 546 (857)
..++|.+.+.||.|+||.||+|.+..+++.||||++..... .......+..|+++++.++||||++++++|.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35689999999999999999999999999999999865432 23344567889999999999999999999875 56789
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+ +++|..++... .+++..+..++.||+.||.|||+.||+||||+|.|||++.++.++|+|||++....
T Consensus 87 lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~--- 159 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD--- 159 (328)
T ss_pred EEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC---
Confidence 999999 67898877643 37888999999999999999999999999999999999999999999999863210
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.....
T Consensus 160 ---------------------------------------------------------------------------~~~~~ 164 (328)
T cd07856 160 ---------------------------------------------------------------------------PQMTG 164 (328)
T ss_pred ---------------------------------------------------------------------------CCcCC
Confidence 00112
Q ss_pred ccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh---------------c--------
Q 035930 707 FVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS---------------Q-------- 762 (857)
Q Consensus 707 ~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~---------------~-------- 762 (857)
..+++.|+|||++.+ ..++.++|||+|||++|+|++|+.||.+......+..+.. .
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (328)
T cd07856 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244 (328)
T ss_pred CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence 357888999999866 5689999999999999999999999977643222111110 0
Q ss_pred ---cccCC---CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 763 ---SLRFP---GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 763 ---~~~~p---~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
....+ ..+.++..+.+||.+||+.+|++||+ +++++.||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~ell~~~~~~~~ 294 (328)
T cd07856 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS----AAEALAHPYLAPY 294 (328)
T ss_pred ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCCccccc
Confidence 00011 12346789999999999999999999 9999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=319.73 Aligned_cols=251 Identities=29% Similarity=0.423 Sum_probs=208.9
Q ss_pred eEEEeEEccCCceEEEEEEEcCCC----eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTS----CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg----~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
|++.+.||.|+||.||++.+...+ ..||+|++..... ......+..|+++|+.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 457789999999999999998766 8999999965521 2245678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||+++++|..++.......+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999988765443389999999999999999999999999999999999999999999999998743211000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
......
T Consensus 159 --------------------------------------------------------------------------~~~~~~ 164 (258)
T smart00219 159 --------------------------------------------------------------------------YKKKGG 164 (258)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 000011
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
.+++.|+|||.+.+..++.++|||+|||++|+|++ |..||......+.+..+.... ..+....++.++.+++.+||..
T Consensus 165 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~ 243 (258)
T smart00219 165 KLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPKPENCPPEIYKLMLQCWAE 243 (258)
T ss_pred CCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCHHHHHHHHHHCcC
Confidence 26788999999988889999999999999999998 899998876666666655443 3344455899999999999999
Q ss_pred CcCCcCCchhhHHHHHc
Q 035930 787 EPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~ 803 (857)
||++||+ +.++++
T Consensus 244 ~p~~Rpt----~~~ll~ 256 (258)
T smart00219 244 DPEDRPT----FSELVE 256 (258)
T ss_pred ChhhCcC----HHHHHh
Confidence 9999999 888875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=319.35 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=199.4
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGG 555 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gG 555 (857)
++||+|+||.||+|.+. ++..||+|+++... .......+.+|+++++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999864 67899999987542 1222346788999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCC
Q 035930 556 DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPV 635 (857)
Q Consensus 556 sL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~ 635 (857)
+|..++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--------- 147 (250)
T cd05085 78 DFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI--------- 147 (250)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc---------
Confidence 9998886543 347899999999999999999999999999999999999999999999999874211000
Q ss_pred CCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccC
Q 035930 636 EEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLA 715 (857)
Q Consensus 636 ~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmA 715 (857)
........+++.|+|
T Consensus 148 -----------------------------------------------------------------~~~~~~~~~~~~y~a 162 (250)
T cd05085 148 -----------------------------------------------------------------YSSSGLKQIPIKWTA 162 (250)
T ss_pred -----------------------------------------------------------------cccCCCCCCcccccC
Confidence 000001124578999
Q ss_pred hhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 716 PEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 716 PEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
||++.+..++.++|||||||++|+|++ |..||.+.........+. ...+......++.++.+|+.+||..+|++||+
T Consensus 163 PE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~- 240 (250)
T cd05085 163 PEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPK- 240 (250)
T ss_pred HHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCC-
Confidence 999998889999999999999999998 999998876655554443 33333444568899999999999999999999
Q ss_pred hhhHHHHHc
Q 035930 795 VKGAAEIKQ 803 (857)
Q Consensus 795 ~~~a~ELL~ 803 (857)
+.++++
T Consensus 241 ---~~~l~~ 246 (250)
T cd05085 241 ---FSELQK 246 (250)
T ss_pred ---HHHHHH
Confidence 677654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=323.33 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=205.0
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCC---CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGT---SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~t---g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
...+|.+.+.||+|+||.||+|.+... ...||||.+.... .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 345799999999999999999987543 4569999886542 12344578899999999999999999998875 45
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
.|+||||+++++|..++..... .+++..++.++.||+.||+|||+.|++||||||+|||++.++.++|+|||++..+..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 7899999999999999876543 489999999999999999999999999999999999999999999999998743211
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
... ...
T Consensus 160 ~~~--------------------------------------------------------------------------~~~ 165 (270)
T cd05056 160 ESY--------------------------------------------------------------------------YKA 165 (270)
T ss_pred ccc--------------------------------------------------------------------------eec
Confidence 000 000
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhh
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~ 783 (857)
....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+.. ...++....++..+.+||.+|
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 244 (270)
T cd05056 166 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-GERLPMPPNCPPTLYSLMTKC 244 (270)
T ss_pred CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHH
Confidence 11124568999999998899999999999999999996 9999988776666554433 334455567899999999999
Q ss_pred ccCCcCCcCCchhhHHHHHc
Q 035930 784 LVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~ 803 (857)
|..+|.+||+ +.+++.
T Consensus 245 l~~~P~~Rpt----~~~~~~ 260 (270)
T cd05056 245 WAYDPSKRPR----FTELKA 260 (270)
T ss_pred cCCChhhCcC----HHHHHH
Confidence 9999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=323.43 Aligned_cols=248 Identities=20% Similarity=0.317 Sum_probs=192.1
Q ss_pred eEEccCCceEEEEEEEcC--CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecC
Q 035930 476 KKLGCGDIGTVYLAELIG--TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCP 553 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~--tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~ 553 (857)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+++++.++||||++++++|......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997543 34578888775431 22334567889999999999999999999999999999999999
Q ss_pred CCChHHHHhhCCC---CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 554 GGDLHVLRQKQPS---RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 554 gGsL~~ll~~~~~---~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
+|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 156 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-- 156 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence 9999998876432 23567888999999999999999999999999999999999999999999987321100000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
.......++
T Consensus 157 -----------------------------------------------------------------------~~~~~~~~~ 165 (269)
T cd05042 157 -----------------------------------------------------------------------ITKDCHAVP 165 (269)
T ss_pred -----------------------------------------------------------------------eccCCCCCc
Confidence 000122357
Q ss_pred CCccChhhhcC-------CCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhcc-ccCCC---CCCCCHHHHH
Q 035930 711 HEYLAPEIIKG-------EGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQS-LRFPG---YPVVSFHARD 778 (857)
Q Consensus 711 ~~YmAPEil~g-------~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~-~~~p~---~~~is~~l~d 778 (857)
+.|+|||++.. ..++.++|||||||++|||++ |..||....+.+.+..++... ..++. ...++..+.+
T Consensus 166 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (269)
T cd05042 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE 245 (269)
T ss_pred ccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHH
Confidence 78999999753 456889999999999999998 888998776666666555433 22222 2357788999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHHc
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
++..|| .||++||+ +++|++
T Consensus 246 ~~~~~~-~dp~~Rpt----~~~v~~ 265 (269)
T cd05042 246 VMQFCW-LDPETRPT----AEEVHE 265 (269)
T ss_pred HHHHHh-cCcccccC----HHHHHH
Confidence 999999 59999999 666654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=319.21 Aligned_cols=246 Identities=26% Similarity=0.374 Sum_probs=202.0
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGG 555 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gG 555 (857)
++||.|+||.||++.+.. ++.||+|.+...... .....+.+|+++++.++||||+++++++.+....|+||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999977 899999998765321 34456889999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCC
Q 035930 556 DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPV 635 (857)
Q Consensus 556 sL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~ 635 (857)
+|..++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 78 ~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-------- 148 (251)
T cd05041 78 SLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-------- 148 (251)
T ss_pred cHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc--------
Confidence 99988866433 478999999999999999999999999999999999999999999999998743210000
Q ss_pred CCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccC
Q 035930 636 EEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLA 715 (857)
Q Consensus 636 ~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmA 715 (857)
........++..|+|
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~~~~y~~ 163 (251)
T cd05041 149 -----------------------------------------------------------------TVSDGLKQIPIKWTA 163 (251)
T ss_pred -----------------------------------------------------------------eeccccCcceeccCC
Confidence 000001124567999
Q ss_pred hhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 716 PEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 716 PEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
||++.+..++.++|||||||++|||++ |..||...........+ .....++....++..+.+||.+||..+|.+||+
T Consensus 164 PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~- 241 (251)
T cd05041 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPS- 241 (251)
T ss_pred hHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-hcCCCCCCCccCCHHHHHHHHHHhccChhhCcC-
Confidence 999999899999999999999999998 89999877655544443 333444445568899999999999999999999
Q ss_pred hhhHHHHHc
Q 035930 795 VKGAAEIKQ 803 (857)
Q Consensus 795 ~~~a~ELL~ 803 (857)
+.++++
T Consensus 242 ---~~ell~ 247 (251)
T cd05041 242 ---FSEIYN 247 (251)
T ss_pred ---HHHHHH
Confidence 888875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=311.27 Aligned_cols=258 Identities=29% Similarity=0.458 Sum_probs=216.7
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|.-.++||+|.||+||+|+...+++.||+|.++-+.. ++..-....+|+-+|+.|.|.|||+++++...+..+-||+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 45566899999999999999999999999999876521 22233567899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|| ..+|..+.....+ .++.+.++.++.|+++||.|+|+++++||||||.|+|++.+|.+||+||||++.+.
T Consensus 82 ~c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafg------- 152 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFG------- 152 (292)
T ss_pred Hh-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcC-------
Confidence 99 6788877776554 48999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
.++.||+. -+-|
T Consensus 153 -------------------------------ipvrcysa-------------------------------------evvt 164 (292)
T KOG0662|consen 153 -------------------------------IPVRCYSA-------------------------------------EVVT 164 (292)
T ss_pred -------------------------------CceEeeec-------------------------------------eeee
Confidence 13344442 1358
Q ss_pred CCccChhhhcCCC-CCcccceehhhHHHHHHh-hCCCCCCCCCChhhhHHHhhcccc-----CCC---------------
Q 035930 711 HEYLAPEIIKGEG-HGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETLSNVVSQSLR-----FPG--------------- 768 (857)
Q Consensus 711 ~~YmAPEil~g~~-~s~ksDVWSLGvILyELL-tGk~PF~g~~~~e~l~~Iv~~~~~-----~p~--------------- 768 (857)
.+|++|.+++|.. |+...|+||.|||+.||. .|++.|.|.+.++.+.+|+..... +|.
T Consensus 165 lwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypa 244 (292)
T KOG0662|consen 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPA 244 (292)
T ss_pred eeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccc
Confidence 9999999999876 689999999999999999 599999999999998888753211 111
Q ss_pred -------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 769 -------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 769 -------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.+.++..-+||++++|..+|..|++ ++++|+||||...
T Consensus 245 ttswsqivp~lns~grdllqkll~cnp~qris----aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 245 TTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS----AEAALQHPYFSDF 289 (292)
T ss_pred cchHHHHhhhhcchhHHHHHHHhccCcccccC----HHHHhcCcccccc
Confidence 1223345679999999999999999 9999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=346.00 Aligned_cols=248 Identities=26% Similarity=0.321 Sum_probs=194.4
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC-eEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK-FSC 546 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~-~l~ 546 (857)
.+++|...+.||+|+||+||+|..... ..||||.+...... . ..+|.+|+++|.+++|||+|+|+|||.+.+ +.+
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~--~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQ--G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCc--c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 457899999999999999999998644 88999987654221 1 455999999999999999999999999998 599
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG---VVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G---IIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
||+|||++|+|.+++.......++|..+..|+.+++.||+|||+.. |||||||+.|||||++...||+|||||+...
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 9999999999999988765425899999999999999999999754 9999999999999999999999999984311
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.. ...
T Consensus 229 ~~---------------------------------------------------------------------------~~~ 233 (361)
T KOG1187|consen 229 EG---------------------------------------------------------------------------DTS 233 (361)
T ss_pred cc---------------------------------------------------------------------------ccc
Confidence 00 000
Q ss_pred cccc-cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC--ChhhhHH----Hhhcc-c-cCCCC----C
Q 035930 704 SNSF-VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG--NDETLSN----VVSQS-L-RFPGY----P 770 (857)
Q Consensus 704 ~~s~-vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~--~~e~l~~----Iv~~~-~-~~p~~----~ 770 (857)
.... .||.+|+|||++.....+.++|||||||+|.||++|+.+.+... .+..+.. .+... + .+.++ .
T Consensus 234 ~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~ 313 (361)
T KOG1187|consen 234 VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEG 313 (361)
T ss_pred eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCC
Confidence 0111 69999999999998889999999999999999999998887542 1111111 11111 1 11110 1
Q ss_pred CCC--H---HHHHHHHhhccCCcCCcCCc
Q 035930 771 VVS--F---HARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 771 ~is--~---~l~dLI~k~L~~DPe~Rpt~ 794 (857)
... . .+..+...|+..+|.+||++
T Consensus 314 ~~~~~~~~~~~~~~a~~C~~~~~~~RP~m 342 (361)
T KOG1187|consen 314 EYPDEKEVKKLAELALRCLRPDPKERPTM 342 (361)
T ss_pred CCChHHHHHHHHHHHHHHcCcCCCcCcCH
Confidence 222 2 25568889999999999994
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=323.49 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=205.6
Q ss_pred CCCeEEEeEEccCCceEEEEEEEc----CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee--C
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELI----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT--E 542 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~--~ 542 (857)
.++|++.+.||+|+||.||++.+. .++..||||++...... .....+.+|+++++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 357889999999999999999865 34789999999765321 245678999999999999999999999887 5
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
...|+||||+++++|..++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 689999999999999999876543 4899999999999999999999999999999999999999999999999987432
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
...... ..
T Consensus 160 ~~~~~~------------------------------------------------------------------------~~ 167 (284)
T cd05038 160 PEDKDY------------------------------------------------------------------------YY 167 (284)
T ss_pred ccCCcc------------------------------------------------------------------------ee
Confidence 100000 00
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh--------------hhhHHHhhccccCCC
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND--------------ETLSNVVSQSLRFPG 768 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~--------------e~l~~Iv~~~~~~p~ 768 (857)
......++..|+|||.+.+..++.++|||||||++|||++|..||...... ..+...+.....++.
T Consensus 168 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (284)
T cd05038 168 VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR 247 (284)
T ss_pred ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCC
Confidence 000123456799999999889999999999999999999999998754221 112333444455555
Q ss_pred CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 769 YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 769 ~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
...++..+.+|+.+||..+|.+||+ +.+|++
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05038 248 PPSCPDEVYDLMKLCWEAEPQDRPS----FADLIL 278 (284)
T ss_pred CccCCHHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 5667889999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=323.84 Aligned_cols=245 Identities=24% Similarity=0.331 Sum_probs=197.8
Q ss_pred eEEccCCceEEEEEEEcCCCe--EEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEEEEeec
Q 035930 476 KKLGCGDIGTVYLAELIGTSC--LFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCLVMEYC 552 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~--~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~LVmEy~ 552 (857)
+.||+|+||.||+|.+..++. .+|+|.++.. ........+.+|+++++++ +||||++++++|...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999987765 4688887643 1223345678899999999 7999999999999999999999999
Q ss_pred CCCChHHHHhhCC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccc
Q 035930 553 PGGDLHVLRQKQP--------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618 (857)
Q Consensus 553 ~gGsL~~ll~~~~--------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGL 618 (857)
++|+|.+++.... ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.++|+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999886542 12478999999999999999999999999999999999999999999999998
Q ss_pred hhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccccc
Q 035930 619 SLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVE 698 (857)
Q Consensus 619 A~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~ 698 (857)
+......
T Consensus 159 ~~~~~~~------------------------------------------------------------------------- 165 (270)
T cd05047 159 SRGQEVY------------------------------------------------------------------------- 165 (270)
T ss_pred ccccchh-------------------------------------------------------------------------
Confidence 6310000
Q ss_pred CCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHH
Q 035930 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHAR 777 (857)
Q Consensus 699 ~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~ 777 (857)
........+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+.. ....+....++.++.
T Consensus 166 ---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 241 (270)
T cd05047 166 ---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDDEVY 241 (270)
T ss_pred ---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CCCCCCCCcCCHHHH
Confidence 00001123567999999999999999999999999999996 9999988766665555433 233334445788999
Q ss_pred HHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 778 DLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 778 dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+|+.+||..||.+||+ +.++++
T Consensus 242 ~li~~~l~~~p~~Rps----~~~il~ 263 (270)
T cd05047 242 DLMRQCWREKPYERPS----FAQILV 263 (270)
T ss_pred HHHHHHcccChhhCCC----HHHHHH
Confidence 9999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=319.73 Aligned_cols=249 Identities=20% Similarity=0.264 Sum_probs=193.6
Q ss_pred eEEccCCceEEEEEEEcC---CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeee-eCCeEEEEEee
Q 035930 476 KKLGCGDIGTVYLAELIG---TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFT-TEKFSCLVMEY 551 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~---tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~-~~~~l~LVmEy 551 (857)
+.||+|+||+||+|.+.. ....||||.+... ........+.+|+.+++.++||||+++++++. .++..|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998753 3467999987542 12233457788999999999999999999775 45678999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccC
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKS 631 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ 631 (857)
+.+++|..++..... .+.+..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++.........
T Consensus 79 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~--- 154 (262)
T cd05058 79 MKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY--- 154 (262)
T ss_pred CCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce---
Confidence 999999999876543 3677788889999999999999999999999999999999999999999987432100000
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCC
Q 035930 632 SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711 (857)
Q Consensus 632 ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~ 711 (857)
.........++.
T Consensus 155 --------------------------------------------------------------------~~~~~~~~~~~~ 166 (262)
T cd05058 155 --------------------------------------------------------------------SVHNHTGAKLPV 166 (262)
T ss_pred --------------------------------------------------------------------eecccccCcCCc
Confidence 000001223577
Q ss_pred CccChhhhcCCCCCcccceehhhHHHHHHhhC-CCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCC
Q 035930 712 EYLAPEIIKGEGHGSSVDWWTFGIFLFELLYG-RTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDN 790 (857)
Q Consensus 712 ~YmAPEil~g~~~s~ksDVWSLGvILyELLtG-k~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~ 790 (857)
.|+|||++.+..++.++|||||||++|||++| ..||...+..+....+. ....++....++..+.+|+.+||..+|++
T Consensus 167 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 245 (262)
T cd05058 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEVMLSCWHPKPEM 245 (262)
T ss_pred cccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHHHHcCCChhh
Confidence 89999999989999999999999999999994 66676655555444433 33334434557899999999999999999
Q ss_pred cCCchhhHHHHHc
Q 035930 791 RLGAVKGAAEIKQ 803 (857)
Q Consensus 791 Rpt~~~~a~ELL~ 803 (857)
||+ +.+|++
T Consensus 246 Rp~----~~~il~ 254 (262)
T cd05058 246 RPT----FSELVS 254 (262)
T ss_pred CCC----HHHHHH
Confidence 999 777764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.13 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=199.9
Q ss_pred eEEccCCceEEEEEEEcCCC------eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 476 KKLGCGDIGTVYLAELIGTS------CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg------~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
+.||.|+||.||+|++.... ..||||.+.... .......+.+|+++|+.++||||++++++|...+..|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999886543 789999886542 1234557889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhC-----CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC-----cEEEecccch
Q 035930 550 EYCPGGDLHVLRQKQ-----PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG-----HIMLSDFDLS 619 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~-----~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg-----~iKL~DFGLA 619 (857)
||+++++|..++... ....+++..+..++.||+.||+|||+.+|+|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999888653 223478899999999999999999999999999999999999887 8999999987
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
..+.....
T Consensus 159 ~~~~~~~~------------------------------------------------------------------------ 166 (269)
T cd05044 159 RDIYKSDY------------------------------------------------------------------------ 166 (269)
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 43210000
Q ss_pred CCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHH
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARD 778 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~d 778 (857)
........++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+ .....+.....++..+.+
T Consensus 167 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 244 (269)
T cd05044 167 -YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-TAGGRLQKPENCPDKIYQ 244 (269)
T ss_pred -cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH-hcCCccCCcccchHHHHH
Confidence 000012235678999999999999999999999999999998 99999877665555444 333344444568899999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHHc
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||.+||..+|.+||+ +.++++
T Consensus 245 li~~~l~~~p~~Rp~----~~~i~~ 265 (269)
T cd05044 245 LMTNCWAQDPSERPT----FDRIQE 265 (269)
T ss_pred HHHHHcCCCcccCCC----HHHHHH
Confidence 999999999999999 666653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=320.57 Aligned_cols=233 Identities=32% Similarity=0.428 Sum_probs=190.3
Q ss_pred CCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCCChHHH
Q 035930 481 GDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVL 560 (857)
Q Consensus 481 G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL~~l 560 (857)
|.||.||++++..+++.||+|++.... ...+|...+....||||+++++++...+..|+||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999987542 123455555566799999999999999999999999999999988
Q ss_pred HhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCC
Q 035930 561 RQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPP 640 (857)
Q Consensus 561 l~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~ 640 (857)
+.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..+..
T Consensus 76 l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~---------------- 137 (237)
T cd05576 76 ISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED---------------- 137 (237)
T ss_pred HHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc----------------
Confidence 87653 389999999999999999999999999999999999999999999999997632100
Q ss_pred CCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhc
Q 035930 641 KKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIK 720 (857)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~ 720 (857)
......++..|+|||++.
T Consensus 138 --------------------------------------------------------------~~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 138 --------------------------------------------------------------SCDGEAVENMYCAPEVGG 155 (237)
T ss_pred --------------------------------------------------------------ccccCCcCccccCCcccC
Confidence 001123567799999998
Q ss_pred CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCch-hhHH
Q 035930 721 GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV-KGAA 799 (857)
Q Consensus 721 g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~-~~a~ 799 (857)
+..++.++|||||||++|||++|+.||...... ......+..+..++..+++||.+||+.||.+|+++. .+++
T Consensus 156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~ 229 (237)
T cd05576 156 ISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVE 229 (237)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchH
Confidence 888999999999999999999999988643211 011111222245889999999999999999999842 2369
Q ss_pred HHHcCCCC
Q 035930 800 EIKQHPFF 807 (857)
Q Consensus 800 ELL~HPfF 807 (857)
++++||||
T Consensus 230 ~~~~h~~~ 237 (237)
T cd05576 230 DIKSHPFF 237 (237)
T ss_pred HHHcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=329.37 Aligned_cols=255 Identities=23% Similarity=0.344 Sum_probs=205.5
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCe----EEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSC----LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~----~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
+...+|+..+.||+|+||.||+|.+..++. .||+|++.... .......+.+|+.+++.++||||++++++|...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 445689999999999999999999877765 47888876542 122234578899999999999999999998754
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
..++||||+++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 46799999999999988876532 4889999999999999999999999999999999999999999999999997432
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
..... ..
T Consensus 160 ~~~~~-------------------------------------------------------------------------~~ 166 (303)
T cd05110 160 EGDEK-------------------------------------------------------------------------EY 166 (303)
T ss_pred cCccc-------------------------------------------------------------------------cc
Confidence 10000 00
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~ 781 (857)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+ +..++.....++..+.++.++.+||.
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQPPICTIDVYMVMV 245 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 0112235678999999999999999999999999999997 999998764333 44555555566666678899999999
Q ss_pred hhccCCcCCcCCchhhHHHHHc
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.||..||++||+ +.++++
T Consensus 246 ~c~~~~p~~Rp~----~~~l~~ 263 (303)
T cd05110 246 KCWMIDADSRPK----FKELAA 263 (303)
T ss_pred HHcCCChhhCcC----HHHHHH
Confidence 999999999999 666655
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=327.50 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=213.3
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~L 547 (857)
.++.+++..||.|..|+||+++.+.+|..+|||.+.+. ...+...+++..++++.+.+ .|+||+.++||..+...++
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 34566778999999999999999999999999999876 34556677788888776664 8999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH-MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLH-s~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
.||.| ..-+..++.+-. ..++|..+-.+..-++.||.||. .+||||||+||+|||+|+.|++||||||++-++...
T Consensus 169 cMelM-s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS- 245 (391)
T KOG0983|consen 169 CMELM-STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS- 245 (391)
T ss_pred HHHHH-HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc-
Confidence 99998 444555555443 34999999999999999999998 579999999999999999999999999997543110
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
. ....
T Consensus 246 ------------------------------------------------k---------------------------Ahtr 250 (391)
T KOG0983|consen 246 ------------------------------------------------K---------------------------AHTR 250 (391)
T ss_pred ------------------------------------------------c---------------------------cccc
Confidence 0 0112
Q ss_pred ccCCCCccChhhhcC---CCCCcccceehhhHHHHHHhhCCCCCCCCC-ChhhhHHHhhcccc-CCCCCCCCHHHHHHHH
Q 035930 707 FVGTHEYLAPEIIKG---EGHGSSVDWWTFGIFLFELLYGRTPFKGSG-NDETLSNVVSQSLR-FPGYPVVSFHARDLIR 781 (857)
Q Consensus 707 ~vGT~~YmAPEil~g---~~~s~ksDVWSLGvILyELLtGk~PF~g~~-~~e~l~~Iv~~~~~-~p~~~~is~~l~dLI~ 781 (857)
-.|.+.|||||.+.- ..|+.++||||||++|+||.||+.||.+.+ ..+++..+++...+ ++....+++++++|+.
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~ 330 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVK 330 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHH
Confidence 358999999999863 468999999999999999999999999854 56778888774432 2334459999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.||.+|+.+||. -.+||+|||+...
T Consensus 331 ~CL~kd~r~RP~----Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 331 DCLTKDHRKRPK----YNKLLEHPFIKRY 355 (391)
T ss_pred HHhhcCcccCcc----hHHHhcCcceeec
Confidence 999999999999 8999999998754
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.36 Aligned_cols=238 Identities=21% Similarity=0.282 Sum_probs=190.5
Q ss_pred eEEccCCceEEEEEEEcCCCe-------EEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 476 KKLGCGDIGTVYLAELIGTSC-------LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~-------~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
+.||.|+||+||+|.+...+. .||+|++.... ....+.+..|+.+|+.++||||+++++++..++..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999998865543 38888875432 23445678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc--------EEEecccchh
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH--------IMLSDFDLSL 620 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~--------iKL~DFGLA~ 620 (857)
|||+++|+|..++..... .+++..+..++.||+.||+|||+.||+||||||+|||++.++. ++|+|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999998876543 4899999999999999999999999999999999999987765 6889998762
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
...
T Consensus 157 ~~~----------------------------------------------------------------------------- 159 (258)
T cd05078 157 TVL----------------------------------------------------------------------------- 159 (258)
T ss_pred ccC-----------------------------------------------------------------------------
Confidence 210
Q ss_pred CCccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCC-CCCCCCCChhhhHHHhhccccCCCCCCCCHHHHH
Q 035930 701 GARSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGR-TPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARD 778 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk-~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~d 778 (857)
......+++.|+|||++.+ ..++.++|||||||++|||++|. .||........ ..+......+|. ..+.++.+
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~ 234 (258)
T cd05078 160 --PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPA--PKWTELAN 234 (258)
T ss_pred --CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCC--CCcHHHHH
Confidence 0012347888999999987 45799999999999999999984 66655443333 233333334443 46788999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHHc
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||.+||+.||++||+ +++|++
T Consensus 235 li~~~l~~~p~~Rps----~~~il~ 255 (258)
T cd05078 235 LINQCMDYEPDFRPS----FRAIIR 255 (258)
T ss_pred HHHHHhccChhhCCC----HHHHHH
Confidence 999999999999999 888876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.01 Aligned_cols=266 Identities=22% Similarity=0.337 Sum_probs=214.1
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC--
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK-- 543 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~-- 543 (857)
.+..++|++.+.||+|||+-||+++...++..||+|.+.... .+..+..++|++..++++|||+++++++...+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 367789999999999999999999999999999999986542 456778899999999999999999999886443
Q ss_pred ---eEEEEEeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEccCCcEEEecc
Q 035930 544 ---FSCLVMEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLG--VVYRDLKPENILVREDGHIMLSDF 616 (857)
Q Consensus 544 ---~l~LVmEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~G--IIHRDLKPeNILL~~dg~iKL~DF 616 (857)
..||++.|...|+|.+.++.. .+..++|.++.+|+.+|++||++||+.. ++||||||.|||+.+.+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 589999999999998887654 3346999999999999999999999999 999999999999999999999999
Q ss_pred cchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccc
Q 035930 617 DLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLV 696 (857)
Q Consensus 617 GLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~ 696 (857)
|.+...... ...........++ +
T Consensus 174 GS~~~a~i~----------------------------------------------i~~~~~a~~lQe~-a---------- 196 (302)
T KOG2345|consen 174 GSATQAPIQ----------------------------------------------IEGSRQALRLQEW-A---------- 196 (302)
T ss_pred cCccccceE----------------------------------------------eechHHHHHHHHH-H----------
Confidence 976321100 0000111111111 1
Q ss_pred ccCCCCccccccCCCCccChhhhcC---CCCCcccceehhhHHHHHHhhCCCCCCCCC--ChhhhHHHhhccccCCCCCC
Q 035930 697 VEPTGARSNSFVGTHEYLAPEIIKG---EGHGSSVDWWTFGIFLFELLYGRTPFKGSG--NDETLSNVVSQSLRFPGYPV 771 (857)
Q Consensus 697 ~~~~~~~~~s~vGT~~YmAPEil~g---~~~s~ksDVWSLGvILyELLtGk~PF~g~~--~~e~l~~Iv~~~~~~p~~~~ 771 (857)
.-..|..|+|||.+.- ...+.++|||||||+||+|++|..||...- ...+.-.+....+.+|....
T Consensus 197 ---------~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~ 267 (302)
T KOG2345|consen 197 ---------EERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSR 267 (302)
T ss_pred ---------HHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCC
Confidence 1125788999999964 446889999999999999999999996431 12223345566788898888
Q ss_pred CCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 772 VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 772 is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
++..+.+||+.||+.||.+||+ +.+|+.+
T Consensus 268 yse~l~~lik~mlqvdP~qRP~----i~~ll~~ 296 (302)
T KOG2345|consen 268 YSEALHQLIKSMLQVDPNQRPT----IPELLSK 296 (302)
T ss_pred ccHHHHHHHHHHhcCCcccCCC----HHHHHHH
Confidence 9999999999999999999999 7777753
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.62 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=192.1
Q ss_pred eEEccCCceEEEEEEEc--CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecC
Q 035930 476 KKLGCGDIGTVYLAELI--GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCP 553 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~--~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~ 553 (857)
+.||+|+||.||+|.+. .++..+|+|.++.... ......+.+|+.++++++||||+++++++.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999865 3456799998865421 2233467889999999999999999999999999999999999
Q ss_pred CCChHHHHhhCCC---CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 554 GGDLHVLRQKQPS---RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 554 gGsL~~ll~~~~~---~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
+|+|.+++..... ..+++..++.++.|++.||+|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~---- 154 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED---- 154 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc----
Confidence 9999988865321 235677888899999999999999999999999999999999999999999873210000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
.........|+
T Consensus 155 ---------------------------------------------------------------------~~~~~~~~~~~ 165 (269)
T cd05087 155 ---------------------------------------------------------------------YYVTPDQLWVP 165 (269)
T ss_pred ---------------------------------------------------------------------eeecCCCcCCc
Confidence 00001123578
Q ss_pred CCccChhhhcCC-------CCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhh-ccccCCCC---CCCCHHHHH
Q 035930 711 HEYLAPEIIKGE-------GHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVS-QSLRFPGY---PVVSFHARD 778 (857)
Q Consensus 711 ~~YmAPEil~g~-------~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~-~~~~~p~~---~~is~~l~d 778 (857)
..|+|||++.+. .++.++|||||||++|||++ |+.||......+.+...+. ...+++.. ...+..+.+
T Consensus 166 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (269)
T cd05087 166 LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYE 245 (269)
T ss_pred ccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHH
Confidence 899999998643 35789999999999999996 9999987766555443332 22222221 246788999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHHc
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||..|| .+|++||+ +++|+.
T Consensus 246 l~~~c~-~~P~~Rpt----~~~l~~ 265 (269)
T cd05087 246 VMQFCW-LQPEQRPS----AEEVHL 265 (269)
T ss_pred HHHHHh-cCcccCCC----HHHHHH
Confidence 999999 68999999 777763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=352.86 Aligned_cols=244 Identities=33% Similarity=0.503 Sum_probs=205.3
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~ 546 (857)
....|.+...||.|+|+.|-.+.+..++..+++|++.+. .....+|+.++.+. +||||+++++.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc-------ccccccccchhhhhcCCCcceeecceecCCceee
Confidence 356788999999999999999999999999999999765 12235677666555 6999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE-ccCCcEEEecccchhhcccC
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV-REDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL-~~dg~iKL~DFGLA~r~~~~ 625 (857)
+|||++.|+-|.+.+...+. +. ..+..|++||+.|+.|||++|||||||||+|||+ +..|+++|+|||.+......
T Consensus 393 ~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999999988766665432 33 7888899999999999999999999999999999 68999999999987431100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
..
T Consensus 470 ------------------------------------------------------------------------------~~ 471 (612)
T KOG0603|consen 470 ------------------------------------------------------------------------------CD 471 (612)
T ss_pred ------------------------------------------------------------------------------hc
Confidence 01
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh-hhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~-e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
+-+-|..|.|||++...+|+.++||||||++||+||+|+.||.....+ +++..+.... ....+|+.++|||++||
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~----~s~~vS~~AKdLl~~LL 547 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK----FSECVSDEAKDLLQQLL 547 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc----cccccCHHHHHHHHHhc
Confidence 224578999999999999999999999999999999999999988766 3443333222 22569999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCC
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
+.||.+||+ +.+++.||||
T Consensus 548 ~~dP~~Rl~----~~~i~~h~w~ 566 (612)
T KOG0603|consen 548 QVDPALRLG----ADEIGAHPWF 566 (612)
T ss_pred cCChhhCcC----hhhhccCcch
Confidence 999999999 9999999999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=349.34 Aligned_cols=271 Identities=28% Similarity=0.427 Sum_probs=223.5
Q ss_pred chhHHH-HhhhccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC---
Q 035930 453 RWDAIR-CVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD--- 528 (857)
Q Consensus 453 ~~~~~~-~~~~~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~--- 528 (857)
.|+... ++..+.|.+...+|.+....|.|-|++|.+|.+..-|..||||+|..+.+.. ..=+.|++||++|+
T Consensus 414 NWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD 489 (752)
T KOG0670|consen 414 NWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDAD 489 (752)
T ss_pred CcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccC
Confidence 476654 4455667788899999999999999999999999989999999998764332 23368999999995
Q ss_pred ---CCCccccceeeeeCCeEEEEEeecCCCChHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 035930 529 ---HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPS-RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604 (857)
Q Consensus 529 ---HPnIV~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~-~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNIL 604 (857)
--|+++|+-.|...+|+|||||.+ ..+|..++.+... -.|....++.|+.||+.||..|-.+||+|.||||+|||
T Consensus 490 ~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiL 568 (752)
T KOG0670|consen 490 PEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNIL 568 (752)
T ss_pred chhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceE
Confidence 348999999999999999999999 7899998887643 35889999999999999999999999999999999999
Q ss_pred EccCC-cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhh
Q 035930 605 VREDG-HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKS 683 (857)
Q Consensus 605 L~~dg-~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~ 683 (857)
|++.. .+||||||.|.....+..
T Consensus 569 VNE~k~iLKLCDfGSA~~~~enei-------------------------------------------------------- 592 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASENEI-------------------------------------------------------- 592 (752)
T ss_pred eccCcceeeeccCccccccccccc--------------------------------------------------------
Confidence 99864 689999998744222110
Q ss_pred hhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc
Q 035930 684 DLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS 763 (857)
Q Consensus 684 d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~ 763 (857)
+-+.-+..|+|||+|+|.+|++..|+||.||+||||.||+..|.|..+.+++.-.+.-.
T Consensus 593 ---------------------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 593 ---------------------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred ---------------------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 11123467999999999999999999999999999999999999999888877666544
Q ss_pred ccCCC---------------------------------------------------CCCCC-------HHHHHHHHhhcc
Q 035930 764 LRFPG---------------------------------------------------YPVVS-------FHARDLIRGLLV 785 (857)
Q Consensus 764 ~~~p~---------------------------------------------------~~~is-------~~l~dLI~k~L~ 785 (857)
.+||. .+.++ .++++||.+||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 33331 00111 258899999999
Q ss_pred CCcCCcCCchhhHHHHHcCCCCCC
Q 035930 786 KEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
.||++|++ +.++|+||||.+
T Consensus 732 LdP~KRit----~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 732 LDPEKRIT----VNQALKHPFITE 751 (752)
T ss_pred cChhhcCC----HHHHhcCCcccC
Confidence 99999999 999999999975
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=369.20 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=220.3
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCC-----CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGT-----SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~t-----g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
......+++.||.|+||.||.|...+. ...||||.+.+. .+.....+|.+|..+|+.++|||||++++++.+.
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 356788999999999999999988643 235899988765 4456677899999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCC-----CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEeccc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQP-----SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFD 617 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~-----~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFG 617 (857)
...+|++|||.||+|..|+++.. ...+....+..++.||+.|+.||+++++|||||..+|+||+....+||+|||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999999998762 2348899999999999999999999999999999999999999999999999
Q ss_pred chhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccc
Q 035930 618 LSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVV 697 (857)
Q Consensus 618 LA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~ 697 (857)
||+......+.....
T Consensus 848 lArDiy~~~yyr~~~----------------------------------------------------------------- 862 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHG----------------------------------------------------------------- 862 (1025)
T ss_pred hhHhhhhchheeccC-----------------------------------------------------------------
Confidence 997543322221100
Q ss_pred cCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHH
Q 035930 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHA 776 (857)
Q Consensus 698 ~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l 776 (857)
.-.-...|||||.+....++.++|||||||+|||+++ |..||.+.++.+++..++.+. +++.+..++..+
T Consensus 863 --------~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~l 933 (1025)
T KOG1095|consen 863 --------EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPPSYCPEKL 933 (1025)
T ss_pred --------ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCCCCCChHH
Confidence 0012357999999999999999999999999999997 999999999999999888877 888888899999
Q ss_pred HHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 777 RDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 777 ~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.+||..||..+|++||+ +..|++
T Consensus 934 y~lM~~CW~~~pe~RP~----F~~i~~ 956 (1025)
T KOG1095|consen 934 YQLMLQCWKHDPEDRPS----FRTIVE 956 (1025)
T ss_pred HHHHHHHccCChhhCcc----HHHHHh
Confidence 99999999999999999 555554
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.33 Aligned_cols=239 Identities=21% Similarity=0.283 Sum_probs=189.6
Q ss_pred eEEccCCceEEEEEEEcC------------CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 476 KKLGCGDIGTVYLAELIG------------TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~------------tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
+.||+|+||+||+|.... ....+|+|++.... ......+.+|+.+|+.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999998542 23458999876532 233456788899999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc-------EEEecc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH-------IMLSDF 616 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~-------iKL~DF 616 (857)
..++||||+++++|..++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++. ++|+||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999988876543 34899999999999999999999999999999999999987664 899999
Q ss_pred cchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccc
Q 035930 617 DLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLV 696 (857)
Q Consensus 617 GLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~ 696 (857)
|++....
T Consensus 157 g~~~~~~------------------------------------------------------------------------- 163 (262)
T cd05077 157 GIPITVL------------------------------------------------------------------------- 163 (262)
T ss_pred CCCcccc-------------------------------------------------------------------------
Confidence 9863210
Q ss_pred ccCCCCccccccCCCCccChhhhc-CCCCCcccceehhhHHHHHHh-hCCCCCCCCCChhhhHHHhhccccCCCCCCCCH
Q 035930 697 VEPTGARSNSFVGTHEYLAPEIIK-GEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSF 774 (857)
Q Consensus 697 ~~~~~~~~~s~vGT~~YmAPEil~-g~~~s~ksDVWSLGvILyELL-tGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~ 774 (857)
......|+..|||||++. +..++.++|||||||++|||+ .|..||......+. .......... ....+.
T Consensus 164 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~~~--~~~~~~ 234 (262)
T cd05077 164 ------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQCML--VTPSCK 234 (262)
T ss_pred ------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcCccC--CCCChH
Confidence 001234778899999987 567899999999999999998 58888876543332 2222222222 233567
Q ss_pred HHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 775 HARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 775 ~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
++.+||.+||..||.+||+ +.+|+++
T Consensus 235 ~~~~li~~cl~~dp~~Rp~----~~~il~~ 260 (262)
T cd05077 235 ELADLMTHCMNYDPNQRPF----FRAIMRD 260 (262)
T ss_pred HHHHHHHHHcCCChhhCcC----HHHHHHh
Confidence 8999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=324.13 Aligned_cols=238 Identities=24% Similarity=0.289 Sum_probs=189.7
Q ss_pred EEccCCceEEEEEEEcC------------------------CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCc
Q 035930 477 KLGCGDIGTVYLAELIG------------------------TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532 (857)
Q Consensus 477 ~LG~G~fGtVyla~~~~------------------------tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnI 532 (857)
.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 68999999999997532 12458999886432 2233467788999999999999
Q ss_pred cccceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC---
Q 035930 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG--- 609 (857)
Q Consensus 533 V~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg--- 609 (857)
+++++++..+...||||||+++|+|..++.... ..+++..+..++.||+.||+|||+.||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999988886543 3488999999999999999999999999999999999997654
Q ss_pred ----cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhh
Q 035930 610 ----HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDL 685 (857)
Q Consensus 610 ----~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~ 685 (857)
.++|+|||++.....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~------------------------------------------------------------- 176 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS------------------------------------------------------------- 176 (274)
T ss_pred CccceeeecCCcccccccc-------------------------------------------------------------
Confidence 389999998632100
Q ss_pred hcccCCCCcccccCCCCccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHh-hCCCCCCCCCChhhhHHHhhcc
Q 035930 686 AAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETLSNVVSQS 763 (857)
Q Consensus 686 ~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELL-tGk~PF~g~~~~e~l~~Iv~~~ 763 (857)
.....++..|+|||++.+ ..++.++|||||||++|||+ +|..||......+.. .+....
T Consensus 177 ------------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~ 237 (274)
T cd05076 177 ------------------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-RFYEKK 237 (274)
T ss_pred ------------------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-HHHHhc
Confidence 001246778999999876 56899999999999999995 799999876554432 333333
Q ss_pred ccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 764 ~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
..++. ....++.+||.+||..+|++||+ +.+|+++
T Consensus 238 ~~~~~--~~~~~~~~li~~cl~~~p~~Rps----~~~il~~ 272 (274)
T cd05076 238 HRLPE--PSCKELATLISQCLTYEPTQRPS----FRTILRD 272 (274)
T ss_pred cCCCC--CCChHHHHHHHHHcccChhhCcC----HHHHHHh
Confidence 34443 35678999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.26 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=204.8
Q ss_pred CeEEEeEEccCCceEEEEEEEcC-CCeEEEEEEecccccc-------cccchhHHHHHHHHHHH-cCCCCccccceeeee
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIG-TSCLFALKVMDNDFLV-------GRKKMPRAQTEREIMQM-LDHPFLPTLFAHFTT 541 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~-tg~~VAVKvi~k~~~~-------~~~~~~~~~~EieILr~-L~HPnIV~L~~~f~~ 541 (857)
+|++.+.||+|+||.||++.+.. .+..+|+|.+...... .......+.+|+.++.. ++||||++++++|..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999987 6789999988643211 12233456778887764 799999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCcEEEecccc
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDL 618 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~iKL~DFGL 618 (857)
++..|+||||+++++|.+++... ....+++..++.++.|++.||.|||. .||+|+||+|+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999998877432 22358999999999999999999995 7899999999999999999999999998
Q ss_pred hhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccccc
Q 035930 619 SLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVE 698 (857)
Q Consensus 619 A~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~ 698 (857)
+......
T Consensus 161 ~~~~~~~------------------------------------------------------------------------- 167 (269)
T cd08528 161 AKQKQPE------------------------------------------------------------------------- 167 (269)
T ss_pred eeecccc-------------------------------------------------------------------------
Confidence 7331100
Q ss_pred CCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHH
Q 035930 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARD 778 (857)
Q Consensus 699 ~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~d 778 (857)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||...........+............++..+.+
T Consensus 168 ---~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 244 (269)
T cd08528 168 ---SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTD 244 (269)
T ss_pred ---cccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHH
Confidence 00123357889999999999889999999999999999999999998776655555555544443333367899999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHHc
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||.+||..||.+||+ +.|+..
T Consensus 245 li~~cl~~~p~~Rp~----~~e~~~ 265 (269)
T cd08528 245 VITSCLTPDAEARPD----IIQVSA 265 (269)
T ss_pred HHHHHCCCCCccCCC----HHHHHH
Confidence 999999999999999 666543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.89 Aligned_cols=236 Identities=24% Similarity=0.295 Sum_probs=190.6
Q ss_pred eEEccCCceEEEEEEEcCCC----------eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 476 KKLGCGDIGTVYLAELIGTS----------CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg----------~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
+.||+|+||.||+|.+..++ ..+++|++.... .....+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998776 457888776442 125678899999999999999999999988 778
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC-------cEEEecccc
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG-------HIMLSDFDL 618 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg-------~iKL~DFGL 618 (857)
|+||||+++|+|..++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999998876543 489999999999999999999999999999999999999888 799999998
Q ss_pred hhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccccc
Q 035930 619 SLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVE 698 (857)
Q Consensus 619 A~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~ 698 (857)
+.....
T Consensus 155 a~~~~~-------------------------------------------------------------------------- 160 (259)
T cd05037 155 PITVLS-------------------------------------------------------------------------- 160 (259)
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 742100
Q ss_pred CCCCccccccCCCCccChhhhcCC--CCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHH
Q 035930 699 PTGARSNSFVGTHEYLAPEIIKGE--GHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFH 775 (857)
Q Consensus 699 ~~~~~~~s~vGT~~YmAPEil~g~--~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~ 775 (857)
.....++..|+|||++.+. .++.++|||||||++|||++ |..||......+..... ......+.. ....
T Consensus 161 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~--~~~~ 232 (259)
T cd05037 161 -----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-QDQHRLPMP--DCAE 232 (259)
T ss_pred -----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-hcCCCCCCC--CchH
Confidence 0112356779999999877 78999999999999999999 68888766543333322 222222221 3378
Q ss_pred HHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 776 ARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 776 l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+.+||.+||..+|.+||+ +.++++
T Consensus 233 ~~~li~~~l~~~p~~Rpt----~~~il~ 256 (259)
T cd05037 233 LANLINQCWTYDPTKRPS----FRAILR 256 (259)
T ss_pred HHHHHHHHhccChhhCCC----HHHHHH
Confidence 999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=321.80 Aligned_cols=259 Identities=16% Similarity=0.240 Sum_probs=189.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCC---CeEEEEEEecccccccccc--------hhHHHHHHHHHHHcCCCCcccc
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGT---SCLFALKVMDNDFLVGRKK--------MPRAQTEREIMQMLDHPFLPTL 535 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~t---g~~VAVKvi~k~~~~~~~~--------~~~~~~EieILr~L~HPnIV~L 535 (857)
+..++|.+.+.||+|+||+||+|.+..+ +..+|+|+........... ......+...+..++|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4457899999999999999999999877 6678888654321100000 0011122334556689999999
Q ss_pred ceeeeeCC----eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcE
Q 035930 536 FAHFTTEK----FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHI 611 (857)
Q Consensus 536 ~~~f~~~~----~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~i 611 (857)
++++.... ..+++||++ ..++..++.... .+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 98766543 457889988 557766665542 26788899999999999999999999999999999999999999
Q ss_pred EEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCC
Q 035930 612 MLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSP 691 (857)
Q Consensus 612 KL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~ 691 (857)
+|+|||+|..+..+....
T Consensus 166 ~l~DFGla~~~~~~~~~~-------------------------------------------------------------- 183 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHI-------------------------------------------------------------- 183 (294)
T ss_pred EEEEcCCceeeccCCccc--------------------------------------------------------------
Confidence 999999985532110000
Q ss_pred CCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhh---------HHHhhc
Q 035930 692 MPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL---------SNVVSQ 762 (857)
Q Consensus 692 ~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l---------~~Iv~~ 762 (857)
...........||+.|+|||++.+..++.++|||||||+||||++|..||.+.+....+ ..+...
T Consensus 184 ------~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (294)
T PHA02882 184 ------EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEG 257 (294)
T ss_pred ------ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhh
Confidence 00000112346999999999999999999999999999999999999999887432221 222222
Q ss_pred cccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 763 ~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
... .+..++.+.++++.||..+|++||+ ..+|++
T Consensus 258 ~~~---~~~~~~~~~~~~~~~~~~~~~~rp~----~~~l~~ 291 (294)
T PHA02882 258 KIK---IKNANKFIYDFIECVTKLSYEEKPD----YDALIK 291 (294)
T ss_pred hhc---cCCCCHHHHHHHHHHHhCCCCCCCC----HHHHHH
Confidence 222 2346889999999999999999999 777764
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.35 Aligned_cols=264 Identities=28% Similarity=0.420 Sum_probs=204.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCC----eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee-CC
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTS----CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT-EK 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg----~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~-~~ 543 (857)
+..|++...||+|.||.||+|....++ +.||||.++.... .........+|+.+++.|+||||+.|..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 346999999999999999999665443 3799999875421 12233467899999999999999999999987 88
Q ss_pred eEEEEEeecCCCChHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC----CcEEEecc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQ---PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED----GHIMLSDF 616 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~---~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d----g~iKL~DF 616 (857)
.++|++||++. +|...++.. ..+.++...++.+++||+.|+.|||++.|+||||||.||||..+ |.+||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999965 555554432 22468999999999999999999999999999999999999877 89999999
Q ss_pred cchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccc
Q 035930 617 DLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLV 696 (857)
Q Consensus 617 GLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~ 696 (857)
|||+.+. ++. .++
T Consensus 181 GlaR~~~-~pl--------------------------------------------------------------kpl---- 193 (438)
T KOG0666|consen 181 GLARLFN-NPL--------------------------------------------------------------KPL---- 193 (438)
T ss_pred cHHHHhh-ccc--------------------------------------------------------------ccc----
Confidence 9996532 110 000
Q ss_pred ccCCCCccccccCCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCC---------ChhhhHHHhhcc---
Q 035930 697 VEPTGARSNSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSG---------NDETLSNVVSQS--- 763 (857)
Q Consensus 697 ~~~~~~~~~s~vGT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~---------~~e~l~~Iv~~~--- 763 (857)
......+-|.+|+|||+++|.. |+.++|||+.|||+.|||+-.+.|.+.. ..+.+.+|+.-.
T Consensus 194 -----~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~P 268 (438)
T KOG0666|consen 194 -----ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTP 268 (438)
T ss_pred -----ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCC
Confidence 0112456799999999999876 6999999999999999999999998742 123344443310
Q ss_pred --ccCC------C------------------------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 764 --LRFP------G------------------------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 764 --~~~p------~------------------------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
-.+| + ...-++.+.+|+.+||.+||.+|+| ++++|+|+||..-
T Consensus 269 t~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIt----a~qAleh~yF~~d 343 (438)
T KOG0666|consen 269 TDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRIT----AEQALEHPYFTED 343 (438)
T ss_pred ccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhcc----HHHHhcccccccC
Confidence 0111 1 1123445789999999999999999 9999999999864
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=316.79 Aligned_cols=253 Identities=22% Similarity=0.351 Sum_probs=200.4
Q ss_pred eEEEeEEccCCceEEEEEEEc---CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC-----
Q 035930 472 FKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK----- 543 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~---~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~----- 543 (857)
|.+.+.||+|+||+||+|.+. +++..||||++..+.. .....+.+.+|+++|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 677889999999999999865 4578999999875432 2334566889999999999999999999886542
Q ss_pred -eEEEEEeecCCCChHHHHhhCC----CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccc
Q 035930 544 -FSCLVMEYCPGGDLHVLRQKQP----SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618 (857)
Q Consensus 544 -~l~LVmEy~~gGsL~~ll~~~~----~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGL 618 (857)
..++++||+.+|+|..++.... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 3478999999999987764321 12478999999999999999999999999999999999999999999999998
Q ss_pred hhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccccc
Q 035930 619 SLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVE 698 (857)
Q Consensus 619 A~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~ 698 (857)
+........
T Consensus 160 ~~~~~~~~~----------------------------------------------------------------------- 168 (273)
T cd05074 160 SKKIYSGDY----------------------------------------------------------------------- 168 (273)
T ss_pred cccccCCcc-----------------------------------------------------------------------
Confidence 754211000
Q ss_pred CCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHH
Q 035930 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHAR 777 (857)
Q Consensus 699 ~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~ 777 (857)
........+++.|++||.+.+..++.++|||||||++|||++ |+.||.+.+..+.+..+... ..+...+.++..+.
T Consensus 169 --~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 245 (273)
T cd05074 169 --YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NRLKQPPDCLEDVY 245 (273)
T ss_pred --eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHH
Confidence 000012235678999999999999999999999999999999 89999877665555544433 23333356789999
Q ss_pred HHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 778 DLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 778 dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+|+.+||..+|.+||+ +.++++
T Consensus 246 ~l~~~~l~~~p~~Rps----~~~~~~ 267 (273)
T cd05074 246 ELMCQCWSPEPKCRPS----FQHLRD 267 (273)
T ss_pred HHHHHHcCCChhhCcC----HHHHHH
Confidence 9999999999999999 666664
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=316.41 Aligned_cols=248 Identities=18% Similarity=0.274 Sum_probs=191.9
Q ss_pred eEEccCCceEEEEEEEcCC--CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecC
Q 035930 476 KKLGCGDIGTVYLAELIGT--SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCP 553 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~t--g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~ 553 (857)
+.||+|+||+||+++.... ...+++|.+.... .......+.+|+.+++.++||||++++++|......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3689999999999976433 3456677765432 12334678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhCC--CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccC
Q 035930 554 GGDLHVLRQKQP--SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKS 631 (857)
Q Consensus 554 gGsL~~ll~~~~--~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ 631 (857)
+|+|..++.... ...+++..++.++.||+.||+|||+.+|+||||||+|||++.++.++|+|||++........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 999998887542 23467778889999999999999999999999999999999999999999998632100000
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCC
Q 035930 632 SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711 (857)
Q Consensus 632 ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~ 711 (857)
........|+.
T Consensus 155 ---------------------------------------------------------------------~~~~~~~~~~~ 165 (268)
T cd05086 155 ---------------------------------------------------------------------IETEDDKCVPL 165 (268)
T ss_pred ---------------------------------------------------------------------hhcccCCcCcc
Confidence 00012345788
Q ss_pred CccChhhhcC-------CCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccc-cC---CCCCCCCHHHHHH
Q 035930 712 EYLAPEIIKG-------EGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSL-RF---PGYPVVSFHARDL 779 (857)
Q Consensus 712 ~YmAPEil~g-------~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~-~~---p~~~~is~~l~dL 779 (857)
.|+|||++.+ ..++.++|||||||++|||++ |..||......+.+..++.... .. .....+++.+.+|
T Consensus 166 ~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 245 (268)
T cd05086 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEV 245 (268)
T ss_pred cccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHH
Confidence 9999999853 245779999999999999996 6778887766666666554432 21 1123478899999
Q ss_pred HHhhccCCcCCcCCchhhHHHHHc
Q 035930 780 IRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
|..|| .+|++||+ +.+|++
T Consensus 246 ~~~c~-~~P~~Rp~----~~~i~~ 264 (268)
T cd05086 246 LQFCW-LSPEKRAT----AEEVHR 264 (268)
T ss_pred HHHHh-hCcccCCC----HHHHHH
Confidence 99999 68999999 777764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=360.99 Aligned_cols=273 Identities=26% Similarity=0.391 Sum_probs=208.9
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC------
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE------ 542 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~------ 542 (857)
..+|+.+..||+||||.||+++.+-+|+.||||.|.... .......+.+|+.+|.+|+|||||++|..|.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 357899999999999999999999999999999998764 456667889999999999999999998776110
Q ss_pred --------------------------------------------------------------------------------
Q 035930 543 -------------------------------------------------------------------------------- 542 (857)
Q Consensus 543 -------------------------------------------------------------------------------- 542 (857)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHH
Q 035930 543 ---------------------------------KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589 (857)
Q Consensus 543 ---------------------------------~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLH 589 (857)
..+||-||||+...|.+++.++... -....+|++++||+.||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHH
Confidence 1258999999888888888776431 147789999999999999999
Q ss_pred HcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCccccccc
Q 035930 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTP 669 (857)
Q Consensus 590 s~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~ 669 (857)
++|||||||||.||+++.++.|||+|||+|.....+...+.
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d--------------------------------------- 755 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESID--------------------------------------- 755 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHh---------------------------------------
Confidence 99999999999999999999999999999854221110000
Q ss_pred chhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCC---CCcccceehhhHHHHHHhhCCCC
Q 035930 670 RLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEG---HGSSVDWWTFGIFLFELLYGRTP 746 (857)
Q Consensus 670 ~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~---~s~ksDVWSLGvILyELLtGk~P 746 (857)
+....-...........++.+||.-|+|||++.+.. |+.++||||||+|||||++ |
T Consensus 756 ------------------~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---P 814 (1351)
T KOG1035|consen 756 ------------------QDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---P 814 (1351)
T ss_pred ------------------hccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---c
Confidence 000000011112223457889999999999998765 9999999999999999995 5
Q ss_pred CCCC-CChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCC
Q 035930 747 FKGS-GNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 747 F~g~-~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
|... ....++.++....++++. +..--+.-..+|++||.+||.+||| |.|||++.||-
T Consensus 815 F~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt----A~eLL~s~llp 875 (1351)
T KOG1035|consen 815 FGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT----ATELLNSELLP 875 (1351)
T ss_pred CCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCC----HHHHhhccCCC
Confidence 6432 233445555445555441 0112234567999999999999999 99999999996
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=344.59 Aligned_cols=263 Identities=21% Similarity=0.249 Sum_probs=182.7
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCC----CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCcccccee---
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGT----SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAH--- 538 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~t----g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~--- 538 (857)
.+..++|.+.+.||+|+||+||+|.+..+ +..||||.+.... ..+....+ .++...+.++..++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 35678999999999999999999999988 8999999875421 11111111 1222233333333322
Q ss_pred ---eeeCCeEEEEEeecCCCChHHHHhhCCCC------------------CCcHHHHHHHHHHHHHHHHHHHHcCceecc
Q 035930 539 ---FTTEKFSCLVMEYCPGGDLHVLRQKQPSR------------------FFSEQAARFYVAEVLLALEYLHMLGVVYRD 597 (857)
Q Consensus 539 ---f~~~~~l~LVmEy~~gGsL~~ll~~~~~~------------------~l~e~~~r~i~~QIl~gL~yLHs~GIIHRD 597 (857)
...+..++|||||+.+++|.+++...... ...+..++.++.||+.||+|||++||||||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 24566899999999999998887654211 112345678999999999999999999999
Q ss_pred CCCCcEEEcc-CCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHH
Q 035930 598 LKPENILVRE-DGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAA 676 (857)
Q Consensus 598 LKPeNILL~~-dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~ 676 (857)
|||+|||++. ++.+||+|||+|..+...
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~--------------------------------------------------- 309 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVG--------------------------------------------------- 309 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccc---------------------------------------------------
Confidence 9999999986 589999999998432100
Q ss_pred hhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCC----------------------CCcccceehhh
Q 035930 677 KSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEG----------------------HGSSVDWWTFG 734 (857)
Q Consensus 677 ~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~----------------------~s~ksDVWSLG 734 (857)
.......++||+.|||||++.... ++.++||||||
T Consensus 310 -----------------------~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 310 -----------------------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred -----------------------cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 001112457899999999764332 34567999999
Q ss_pred HHHHHHhhCCCCCCCCCChhhhHHHhhc-ccc-------------------CCCCCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 735 IFLFELLYGRTPFKGSGNDETLSNVVSQ-SLR-------------------FPGYPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 735 vILyELLtGk~PF~g~~~~e~l~~Iv~~-~~~-------------------~p~~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
|+||||+++..++.. ....+..++.. ... +.........++|||.+||++||++||+
T Consensus 367 viL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t- 443 (566)
T PLN03225 367 LIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS- 443 (566)
T ss_pred HHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC-
Confidence 999999997766542 11112111111 000 0001112334669999999999999999
Q ss_pred hhhHHHHHcCCCCCCCChhhh
Q 035930 795 VKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 795 ~~~a~ELL~HPfF~~l~w~li 815 (857)
+.++|+||||.+..+..+
T Consensus 444 ---a~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 444 ---AKAALAHPYFDREGLLGL 461 (566)
T ss_pred ---HHHHhCCcCcCCCCcccc
Confidence 999999999999888644
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=328.56 Aligned_cols=268 Identities=28% Similarity=0.450 Sum_probs=215.4
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccc----ccchhHHHHHHHHHHHcCCCCccccceeeee-C
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG----RKKMPRAQTEREIMQMLDHPFLPTLFAHFTT-E 542 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~----~~~~~~~~~EieILr~L~HPnIV~L~~~f~~-~ 542 (857)
..++|.++..||.|||+.||+|.+....+.||||+-..+..+. ....+...+|..|.+.|+||.||++|+||.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3457999999999999999999999999999999864332121 1223456789999999999999999999974 4
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEcc---CCcEEEeccc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG--VVYRDLKPENILVRE---DGHIMLSDFD 617 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G--IIHRDLKPeNILL~~---dg~iKL~DFG 617 (857)
+.+|-|+|||+|.+|..|+.... .+++.+++.|+.||+.||.||.+.. |||-||||.||||-. -|.|||+|||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 67899999999999998888764 4999999999999999999999765 999999999999954 4689999999
Q ss_pred chhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccc
Q 035930 618 LSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVV 697 (857)
Q Consensus 618 LA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~ 697 (857)
|++.+..+..- .
T Consensus 619 LSKIMdddSy~--------------------------------------------------------------------~ 630 (775)
T KOG1151|consen 619 LSKIMDDDSYN--------------------------------------------------------------------S 630 (775)
T ss_pred hhhhccCCccC--------------------------------------------------------------------c
Confidence 98654322110 0
Q ss_pred cCCCCccccccCCCCccChhhhcCC----CCCcccceehhhHHHHHHhhCCCCCCCCCC-hhhhHH--Hh-hccccCCCC
Q 035930 698 EPTGARSNSFVGTHEYLAPEIIKGE----GHGSSVDWWTFGIFLFELLYGRTPFKGSGN-DETLSN--VV-SQSLRFPGY 769 (857)
Q Consensus 698 ~~~~~~~~s~vGT~~YmAPEil~g~----~~s~ksDVWSLGvILyELLtGk~PF~g~~~-~e~l~~--Iv-~~~~~~p~~ 769 (857)
...-..+..+.||.+|++||.+.-. ..+.++||||+|||+|..++|+.||..... .++++. |+ .....||.-
T Consensus 631 vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K 710 (775)
T KOG1151|consen 631 VDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPK 710 (775)
T ss_pred ccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCC
Confidence 0001123456799999999988532 368899999999999999999999975432 223221 12 356788888
Q ss_pred CCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 770 PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 770 ~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
|.++.++++||++||++.-++|.. +.+|-.||||..
T Consensus 711 PvVsseAkaFIRRCLaYRKeDR~D----V~qLA~dpyllP 746 (775)
T KOG1151|consen 711 PVVSSEAKAFIRRCLAYRKEDRID----VQQLACDPYLLP 746 (775)
T ss_pred CccCHHHHHHHHHHHHhhhhhhhh----HHHHccCccccc
Confidence 999999999999999999999988 899999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=292.25 Aligned_cols=242 Identities=45% Similarity=0.737 Sum_probs=202.2
Q ss_pred CceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCCChHHHH
Q 035930 482 DIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLR 561 (857)
Q Consensus 482 ~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL~~ll 561 (857)
+||.||+|.+.+++..+|+|++........ ...+.+|+++++.++|+||+++++++......++||||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999999999999999976532211 577899999999999999999999999999999999999999999988
Q ss_pred hhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCC
Q 035930 562 QKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPK 641 (857)
Q Consensus 562 ~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~ 641 (857)
..... +++..+..++.+++.+|.|||..||+|+||+|.||+++.++.++|+|||++......
T Consensus 79 ~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---------------- 140 (244)
T smart00220 79 KKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---------------- 140 (244)
T ss_pred HhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc----------------
Confidence 76543 889999999999999999999999999999999999999999999999987432110
Q ss_pred CCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcC
Q 035930 642 KASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKG 721 (857)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g 721 (857)
.......++..|++||.+.+
T Consensus 141 ------------------------------------------------------------~~~~~~~~~~~~~~pE~~~~ 160 (244)
T smart00220 141 ------------------------------------------------------------GLLTTFVGTPEYMAPEVLLG 160 (244)
T ss_pred ------------------------------------------------------------cccccccCCcCCCCHHHHcc
Confidence 01123457889999999998
Q ss_pred CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhc-cccCCCCCC-CCHHHHHHHHhhccCCcCCcCCchhhHH
Q 035930 722 EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ-SLRFPGYPV-VSFHARDLIRGLLVKEPDNRLGAVKGAA 799 (857)
Q Consensus 722 ~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~-~~~~p~~~~-is~~l~dLI~k~L~~DPe~Rpt~~~~a~ 799 (857)
..++.++|||+||+++|+|++|..||......+.+...+.. ...+..... ++.++.+++.+||..+|.+||+ +.
T Consensus 161 ~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~ 236 (244)
T smart00220 161 KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT----AE 236 (244)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC----HH
Confidence 88999999999999999999999999874344433333333 222222211 8899999999999999999999 99
Q ss_pred HHHcCCCC
Q 035930 800 EIKQHPFF 807 (857)
Q Consensus 800 ELL~HPfF 807 (857)
++++||||
T Consensus 237 ~~~~~~~~ 244 (244)
T smart00220 237 EALQHPFF 244 (244)
T ss_pred HHhhCCCC
Confidence 99999998
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=339.47 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=221.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeee-----C
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTT-----E 542 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~-----~ 542 (857)
..-|.+...||.|.+|.||+++.+.+++..|+|++..+ ...-+.+..|.+||+.+ +|||++.+|++|.. +
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 35689999999999999999999999999999998765 33445667888999887 59999999999863 4
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
+.++||||||.||+.-+++....+..+.|..+..|++.+++||.+||.+.+||||||-.|||++.+|.+||+|||++..
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ- 172 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ- 172 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee-
Confidence 6899999999999999999887777899999999999999999999999999999999999999999999999998632
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.+.+-.
T Consensus 173 --------------------------------------------------------------------------ldsT~g 178 (953)
T KOG0587|consen 173 --------------------------------------------------------------------------LDSTVG 178 (953)
T ss_pred --------------------------------------------------------------------------eecccc
Confidence 122445
Q ss_pred ccccccCCCCccChhhhcCC-----CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-ccCCCCCCCCHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGE-----GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-LRFPGYPVVSFHA 776 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~-----~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-~~~p~~~~is~~l 776 (857)
+.++++|||.|||||++-.. .|+.++|+||||++..||.-|.+|+-++.+...+..|-... .+...+..++..+
T Consensus 179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~F 258 (953)
T KOG0587|consen 179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKF 258 (953)
T ss_pred cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHH
Confidence 67889999999999999643 47889999999999999999999998876655544433221 1222356789999
Q ss_pred HHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 777 RDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 777 ~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.|||..||.+|-++||+ ..++|+|||....
T Consensus 259 ndFIs~cL~Kd~e~RP~----~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 259 NDFISTCLVKDYEQRPS----TEELLKHPFITEQ 288 (953)
T ss_pred HHHHHHHHhhccccCcc----hhhhccCCccccc
Confidence 99999999999999999 9999999999843
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=338.06 Aligned_cols=243 Identities=30% Similarity=0.484 Sum_probs=195.0
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC------eE
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK------FS 545 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~------~l 545 (857)
+...+.||+|+||.||+++++.+|+.||||+++... .....+...+|+++|++|+|+|||+++++-++.. ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 456689999999999999999999999999998764 3455667789999999999999999999876554 56
Q ss_pred EEEEeecCCCChHHHHhhC-CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc--cCCc--EEEecccchh
Q 035930 546 CLVMEYCPGGDLHVLRQKQ-PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR--EDGH--IMLSDFDLSL 620 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~-~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~--~dg~--iKL~DFGLA~ 620 (857)
.+|||||.||+|+..+.+- ...+|++.+...++.++..||.|||++|||||||||+||++- .+|. -||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 8999999999998887643 334699999999999999999999999999999999999994 3343 5999999986
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
.+..
T Consensus 173 el~d---------------------------------------------------------------------------- 176 (732)
T KOG4250|consen 173 ELDD---------------------------------------------------------------------------- 176 (732)
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 5321
Q ss_pred CCccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCCh----hhhHHHhhcc------------
Q 035930 701 GARSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGND----ETLSNVVSQS------------ 763 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~----e~l~~Iv~~~------------ 763 (857)
+....+++||..|++||++.. ..|+..+|.|||||++|+.+||..||...... +++..+..+.
T Consensus 177 ~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~e 256 (732)
T KOG4250|consen 177 NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEE 256 (732)
T ss_pred CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeeccc
Confidence 223568899999999999984 78999999999999999999999999765433 3443333211
Q ss_pred ---cc----CCCCCCCCH----HHHHHHHhhccCCcCCcC
Q 035930 764 ---LR----FPGYPVVSF----HARDLIRGLLVKEPDNRL 792 (857)
Q Consensus 764 ---~~----~p~~~~is~----~l~dLI~k~L~~DPe~Rp 792 (857)
++ +|.+-..+. .+...+..||..+|++|.
T Consensus 257 Ngpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 257 NGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11 222222333 355688899999999998
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=336.49 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=216.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC---CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG---TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~---tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
+..++..+.++||+|.||.||+|.|.. +-..||||+++.+.+. ..+.+|++|+.+|.+|+|||+++||++..+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 344566778999999999999998863 3357999999877543 277899999999999999999999999988 6
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
.+.||||++++|+|.+.+++.....|....+..|+.||+.||.||..+++|||||...||||-....|||+||||.+.+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 78999999999999999888666678899999999999999999999999999999999999988899999999986543
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.+...+ .+
T Consensus 264 ~ned~Y---------------------------vm--------------------------------------------- 271 (1039)
T KOG0199|consen 264 ENEDMY---------------------------VM--------------------------------------------- 271 (1039)
T ss_pred CCCcce---------------------------Ee---------------------------------------------
Confidence 332111 00
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
....--.+.|+|||.|....++.++|||+|||+||||++ |.-||.|....+++++|- ..-+++.++.++.++.+++..
T Consensus 272 ~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk~ 350 (1039)
T KOG0199|consen 272 APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDIYQIMKN 350 (1039)
T ss_pred cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHHH
Confidence 001112467999999999999999999999999999995 999999999989988876 667788888899999999999
Q ss_pred hccCCcCCcCCc
Q 035930 783 LLVKEPDNRLGA 794 (857)
Q Consensus 783 ~L~~DPe~Rpt~ 794 (857)
||..+|++||++
T Consensus 351 cWah~paDRptF 362 (1039)
T KOG0199|consen 351 CWAHNPADRPTF 362 (1039)
T ss_pred hccCCccccccH
Confidence 999999999994
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=308.79 Aligned_cols=266 Identities=26% Similarity=0.369 Sum_probs=211.2
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC---
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE--- 542 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~--- 542 (857)
+.....|.-..+||+|.||.||+|+.+.+++.||+|++--+. .....-....+|+.+|..|.|+|++.+++.|...
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 344556778889999999999999999999999998764321 1122334578999999999999999999988543
Q ss_pred -----CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEeccc
Q 035930 543 -----KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFD 617 (857)
Q Consensus 543 -----~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFG 617 (857)
..+||||.+|. -+|..++.... ..|+...++.++.+++.||.|+|...|+|||+|++|+||+.+|.++|+|||
T Consensus 92 ~~r~r~t~ylVf~~ce-hDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCE-HDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cccccceeeeeHHHhh-hhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 35899999994 57877776543 348999999999999999999999999999999999999999999999999
Q ss_pred chhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccc
Q 035930 618 LSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVV 697 (857)
Q Consensus 618 LA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~ 697 (857)
+++.+......
T Consensus 170 lar~fs~~~n~--------------------------------------------------------------------- 180 (376)
T KOG0669|consen 170 LARAFSTSKNV--------------------------------------------------------------------- 180 (376)
T ss_pred cccceeccccc---------------------------------------------------------------------
Confidence 98654322110
Q ss_pred cCCCCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh--cccc---CCC---
Q 035930 698 EPTGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS--QSLR---FPG--- 768 (857)
Q Consensus 698 ~~~~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~--~~~~---~p~--- 768 (857)
...+.+..+-|..|++||.++|. .|+.+.|||..|||+.||+++.+.|.+..+...+..|-. +.+. ||.
T Consensus 181 --~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~ 258 (376)
T KOG0669|consen 181 --VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDN 258 (376)
T ss_pred --CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCccc
Confidence 11123456779999999999886 489999999999999999999999999887777665532 1111 110
Q ss_pred -------------------------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 769 -------------------------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 769 -------------------------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
+-.-.+++.||+.+||..||.+|+. +.++|+|.||..
T Consensus 259 lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~----ad~alnh~~F~k 320 (376)
T KOG0669|consen 259 LPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID----ADQALNHDFFWK 320 (376)
T ss_pred chHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc----hHhhhchhhhhc
Confidence 0012347889999999999999999 999999999953
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=310.49 Aligned_cols=255 Identities=27% Similarity=0.450 Sum_probs=213.3
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC-----
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK----- 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~----- 543 (857)
..+|.-++.+|.|.- .|..+-+.-.++.||+|.+... ........+..+|..+|..+.|+||+.++.+|+-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 457888999999998 8889999889999999998777 445667788999999999999999999999997553
Q ss_pred -eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 544 -FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 544 -~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
..|+||||| ..+|...+.-. ++-..++.+++|++.|+.|||+.||+||||||+||++..++.+||.|||+|+..
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 679999999 77898877732 778899999999999999999999999999999999999999999999998541
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
. +.-
T Consensus 169 ~----------------------------------------------------------------------------~~~ 172 (369)
T KOG0665|consen 169 D----------------------------------------------------------------------------TDF 172 (369)
T ss_pred C----------------------------------------------------------------------------ccc
Confidence 1 011
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-------------------
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS------------------- 763 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~------------------- 763 (857)
+.+-++.|..|+|||++.|..|...+||||+||++.||++|...|.|.+.-+.+.++....
T Consensus 173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv 252 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYV 252 (369)
T ss_pred ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHh
Confidence 2345678999999999999999999999999999999999999999876555555544311
Q ss_pred --------c----cCCC---------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 764 --------L----RFPG---------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 764 --------~----~~p~---------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
+ .||+ .+.-...++||+.+||..||++|.+ +.++|+||||+ + |
T Consensus 253 ~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris----v~daL~HPY~~-v-w 316 (369)
T KOG0665|consen 253 ENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS----VDDALRHPYIK-V-W 316 (369)
T ss_pred hcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc----HHHHhcCCeee-e-e
Confidence 0 0111 1223456899999999999999999 99999999998 3 7
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=324.76 Aligned_cols=264 Identities=21% Similarity=0.245 Sum_probs=191.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc----------------CCCeEEEEEEecccccccc-----------cchhHHHH
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI----------------GTSCLFALKVMDNDFLVGR-----------KKMPRAQT 519 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~----------------~tg~~VAVKvi~k~~~~~~-----------~~~~~~~~ 519 (857)
+..++|.+.++||+|+||+||+|.+. ..++.||||.++....... ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45678999999999999999999752 2346799999864321100 11122345
Q ss_pred HHHHHHHcCCCCc-----cccceeeee--------CCeEEEEEeecCCCChHHHHhhCCC--------------------
Q 035930 520 EREIMQMLDHPFL-----PTLFAHFTT--------EKFSCLVMEYCPGGDLHVLRQKQPS-------------------- 566 (857)
Q Consensus 520 EieILr~L~HPnI-----V~L~~~f~~--------~~~l~LVmEy~~gGsL~~ll~~~~~-------------------- 566 (857)
|+.++.+++|.++ +.++++|.. ++..||||||+++++|.+++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777766544 677777753 3568999999999999888764211
Q ss_pred --CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCC
Q 035930 567 --RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKAS 644 (857)
Q Consensus 567 --~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~ 644 (857)
..+++..++.++.||+.||.|||..+|+||||||+|||++.++.++|+|||++.......
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~------------------ 363 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI------------------ 363 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC------------------
Confidence 124567888999999999999999999999999999999999999999999874311000
Q ss_pred CCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCC-
Q 035930 645 SPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEG- 723 (857)
Q Consensus 645 ~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~- 723 (857)
........+|+.|+|||++....
T Consensus 364 --------------------------------------------------------~~~~~~g~~tp~Y~aPE~l~~~~~ 387 (507)
T PLN03224 364 --------------------------------------------------------NFNPLYGMLDPRYSPPEELVMPQS 387 (507)
T ss_pred --------------------------------------------------------ccCccccCCCcceeChhhhcCCCC
Confidence 00001123578999999986432
Q ss_pred -------------------CC--cccceehhhHHHHHHhhCCC-CCCCCC-----------ChhhhHHHhhccccCCCCC
Q 035930 724 -------------------HG--SSVDWWTFGIFLFELLYGRT-PFKGSG-----------NDETLSNVVSQSLRFPGYP 770 (857)
Q Consensus 724 -------------------~s--~ksDVWSLGvILyELLtGk~-PF~g~~-----------~~e~l~~Iv~~~~~~p~~~ 770 (857)
|+ ...||||+||+||+|++|.. ||.+.. ....+..+....+.++..+
T Consensus 388 ~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d 467 (507)
T PLN03224 388 CPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLD 467 (507)
T ss_pred CCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCccccc
Confidence 22 24799999999999999886 775421 1111222233455566667
Q ss_pred CCCHHHHHHHHhhccCCc---CCcCCchhhHHHHHcCCCCC
Q 035930 771 VVSFHARDLIRGLLVKEP---DNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 771 ~is~~l~dLI~k~L~~DP---e~Rpt~~~~a~ELL~HPfF~ 808 (857)
.++..++|||.+||.++| .+|++ ++|+|+||||.
T Consensus 468 ~~s~~~~dLi~~LL~~~~~~~~~RlS----a~eaL~Hp~f~ 504 (507)
T PLN03224 468 RNKEAGWDLACKLITKRDQANRGRLS----VGQALSHRFFL 504 (507)
T ss_pred ccChHHHHHHHHHhccCCCCcccCCC----HHHHhCCCCcC
Confidence 789999999999999876 68999 99999999995
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=320.10 Aligned_cols=256 Identities=21% Similarity=0.315 Sum_probs=211.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+......+.++||+|-||.|.+|+..+ +..||+|.++.+. .......|..|+++|.+|+||||++|+++|..++.+|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 455678899999999999999998854 7899999998763 3344578899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
||||||++|+|..++.......+.......++.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++-++..+
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999999988754434455566699999999999999999999999999999999999999999986433211
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.. .....
T Consensus 692 yy-------------------------------------------------------------------------~vqgr 698 (807)
T KOG1094|consen 692 YY-------------------------------------------------------------------------RVQGR 698 (807)
T ss_pred ce-------------------------------------------------------------------------eeecc
Confidence 10 11123
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHh--hCCCCCCCCCChhhhHHHhh---cc---ccCCCCCCCCHHHHH
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL--YGRTPFKGSGNDETLSNVVS---QS---LRFPGYPVVSFHARD 778 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELL--tGk~PF~g~~~~e~l~~Iv~---~~---~~~p~~~~is~~l~d 778 (857)
++-...|||||.|.-.+++.++|+|+||++|||++ +...||....+++...+.-. .. .-++.++.++..+.+
T Consensus 699 ~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lye 778 (807)
T KOG1094|consen 699 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYE 778 (807)
T ss_pred eeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHH
Confidence 45678999999999999999999999999999988 48889988877766655422 11 112445678999999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHH
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL 802 (857)
||-+||.+|-++||+ +++|-
T Consensus 779 lml~Cw~~es~~RPs----Fe~lh 798 (807)
T KOG1094|consen 779 LMLRCWRRESEQRPS----FEQLH 798 (807)
T ss_pred HHHHHhchhhhcCCC----HHHHH
Confidence 999999999999999 66654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=321.64 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=217.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+...+..+.++||-|-||.||.|.|+.....||||.++.+ ...++.|+.|..+|+.++|||+|+|+++|+.+..+|
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 5556778899999999999999999999999999999865 456788999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
||+|||..|+|.+|+++.....++.-.+.+++.||..||+||...++|||||...|+||.++..+|++||||++.+..+.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 99999999999999998877778888888999999999999999999999999999999999999999999997643221
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
. +.+. .
T Consensus 420 Y----------------------------------------TAHA----------------------------------G 425 (1157)
T KOG4278|consen 420 Y----------------------------------------TAHA----------------------------------G 425 (1157)
T ss_pred e----------------------------------------eccc----------------------------------C
Confidence 1 0000 0
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
.--...|.|||-+-...++.++|||+|||+|||+.| |-.||.|.+-.++ ..++...++...+..+++.+.+||+.||.
T Consensus 426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-Y~LLEkgyRM~~PeGCPpkVYeLMraCW~ 504 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YGLLEKGYRMDGPEGCPPKVYELMRACWN 504 (1157)
T ss_pred ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-HHHHhccccccCCCCCCHHHHHHHHHHhc
Confidence 011356999999999999999999999999999996 9999999855444 45677888888888999999999999999
Q ss_pred CCcCCcCCc
Q 035930 786 KEPDNRLGA 794 (857)
Q Consensus 786 ~DPe~Rpt~ 794 (857)
+.|.+||++
T Consensus 505 WsPsDRPsF 513 (1157)
T KOG4278|consen 505 WSPSDRPSF 513 (1157)
T ss_pred CCcccCccH
Confidence 999999994
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=309.43 Aligned_cols=262 Identities=24% Similarity=0.351 Sum_probs=211.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHH-HHcCCCCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM-QMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieIL-r~L~HPnIV~L~~~f~~~~~l 545 (857)
+...+.+-+..||.|.||+|++..++.+|+..|||.++.... .+...+++.|.+.. +.-+.||||++|+++..++..
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 444566677899999999999999999999999999986633 45667788888864 555799999999999999999
Q ss_pred EEEEeecCCCChHHHHh---hCCCCCCcHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 546 CLVMEYCPGGDLHVLRQ---KQPSRFFSEQAARFYVAEVLLALEYLH-MLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~---~~~~~~l~e~~~r~i~~QIl~gL~yLH-s~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
+|.||+| ..+|..+.. .-....++|..+-.++...+.||.||- ++.|||||+||+|||++..|.+||||||++-.
T Consensus 139 WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 139 WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 9999999 567644322 112234999999999999999999998 57899999999999999999999999998622
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
+. ..-+
T Consensus 218 Lv-------------------------------------------------~SiA------------------------- 223 (361)
T KOG1006|consen 218 LV-------------------------------------------------DSIA------------------------- 223 (361)
T ss_pred HH-------------------------------------------------HHHH-------------------------
Confidence 10 0000
Q ss_pred CccccccCCCCccChhhhc--CCCCCcccceehhhHHHHHHhhCCCCCCCCCC-hhhhHHHhhccccCCC----CCCCCH
Q 035930 702 ARSNSFVGTHEYLAPEIIK--GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-DETLSNVVSQSLRFPG----YPVVSF 774 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~--g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~-~e~l~~Iv~~~~~~p~----~~~is~ 774 (857)
.+...|...|||||.+. +.+|+.++||||||++|||+.||+.||.+.+. .+.+..++.+..+.-. .-.++.
T Consensus 224 --kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 224 --KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred --hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 12335899999999995 45699999999999999999999999988653 4666666666544322 134788
Q ss_pred HHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 775 HARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 775 ~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
.++.+|..||.+|-..||. ..+|+++||++...
T Consensus 302 ~~~~fintCl~Kd~~~Rpk----y~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPK----YDDLKKFPFYRMYA 334 (361)
T ss_pred HHHHHHHHHhhcccccCcc----hhhhhcCchhhhhh
Confidence 9999999999999999999 89999999997643
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=332.29 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=219.7
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCC---eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTS---CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg---~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
.+......|.++||.|.||.||+|+.+..+ ..||||.++... .++...+|+.|..||-+++||||++|.++.+..
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 356667899999999999999999998665 579999998763 355667899999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
..++||+|||++|+|..|++.+.++ |..-++.-+++.|+.||.||-+.++|||||...||||+.+-.+|++||||++.+
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 9999999999999999999988765 899999999999999999999999999999999999999999999999998654
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
..++.-
T Consensus 782 edd~~~-------------------------------------------------------------------------- 787 (996)
T KOG0196|consen 782 EDDPEA-------------------------------------------------------------------------- 787 (996)
T ss_pred ccCCCc--------------------------------------------------------------------------
Confidence 322100
Q ss_pred ccccccC--CCCccChhhhcCCCCCcccceehhhHHHHHHh-hCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHH
Q 035930 703 RSNSFVG--THEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDL 779 (857)
Q Consensus 703 ~~~s~vG--T~~YmAPEil~g~~~s~ksDVWSLGvILyELL-tGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dL 779 (857)
..++.-| ...|.|||.|...+++.++||||||++|||.+ +|..||..+.+++.+..| .+++++|.+..++..|..|
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-e~gyRLPpPmDCP~aL~qL 866 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EQGYRLPPPMDCPAALYQL 866 (996)
T ss_pred cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-HhccCCCCCCCCcHHHHHH
Confidence 0001112 36799999999999999999999999999988 699999999999998776 5678888888999999999
Q ss_pred HHhhccCCcCCcCCc
Q 035930 780 IRGLLVKEPDNRLGA 794 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~ 794 (857)
|..||++|-.+||.+
T Consensus 867 MldCWqkdR~~RP~F 881 (996)
T KOG0196|consen 867 MLDCWQKDRNRRPKF 881 (996)
T ss_pred HHHHHHHHhhcCCCH
Confidence 999999999999994
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=316.82 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=212.2
Q ss_pred CCCeEEEeEEccCCceEEEEEEEc----CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELI----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
.+...+.+.||.|-||.||.|... +....||||..+.+. .....+.|..|.-+|+.++||||++|+|+|.+. .
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 344556789999999999999764 334569999998763 234467899999999999999999999999765 5
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
.+||||+++-|.|+.|++.+.. .++......|++||+.||.|||+..+|||||..+|||+....-+||+||||++.+..
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred eeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 7899999999999999988764 499999999999999999999999999999999999999999999999999865322
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
.... + .
T Consensus 544 ~~yY-k-------------------------------------------------------------------------a 549 (974)
T KOG4257|consen 544 DAYY-K-------------------------------------------------------------------------A 549 (974)
T ss_pred cchh-h-------------------------------------------------------------------------c
Confidence 1110 0 0
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhh
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~ 783 (857)
....-..-|||||-+.-..++.++|||.|||.+||++. |..||.+-.+.+.+-.+ ..+-++|.++.+++.+..|+.+|
T Consensus 550 S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-EnGeRlP~P~nCPp~LYslmskc 628 (974)
T KOG4257|consen 550 SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-ENGERLPCPPNCPPALYSLMSKC 628 (974)
T ss_pred cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-cCCCCCCCCCCCChHHHHHHHHH
Confidence 01112467999999999999999999999999999995 99999999888877654 45567888899999999999999
Q ss_pred ccCCcCCcCCchh---hHHHHHc
Q 035930 784 LVKEPDNRLGAVK---GAAEIKQ 803 (857)
Q Consensus 784 L~~DPe~Rpt~~~---~a~ELL~ 803 (857)
|.+||.+||.+.. .+.++++
T Consensus 629 WayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 629 WAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred hccCcccCCcHHHHHHHHHHHHH
Confidence 9999999999632 2345554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=338.90 Aligned_cols=237 Identities=22% Similarity=0.290 Sum_probs=184.3
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|...+.||+|+||.||+|.+..++..||||.+.... .....|+++|++++|||||+++++|.+++..|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-------SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc-------cccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 4667789999999999999999999999999986431 112356889999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH---MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLH---s~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
|+++|+|.++++. +++..+..++.||+.||+||| ..+|+||||||+|||++.++..++. ||+.....
T Consensus 764 y~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~---- 833 (968)
T PLN00113 764 YIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC---- 833 (968)
T ss_pred CCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc----
Confidence 9999999999853 788999999999999999999 6699999999999999988887765 55431000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.....
T Consensus 834 ---------------------------------------------------------------------------~~~~~ 838 (968)
T PLN00113 834 ---------------------------------------------------------------------------TDTKC 838 (968)
T ss_pred ---------------------------------------------------------------------------cCCCc
Confidence 00112
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC-hhhhHHHhhc-------------cccC--CCCCC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-DETLSNVVSQ-------------SLRF--PGYPV 771 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~-~e~l~~Iv~~-------------~~~~--p~~~~ 771 (857)
.||+.|||||++.+..++.++|||||||++|||++|+.||..... ...+...... .... +....
T Consensus 839 ~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (968)
T PLN00113 839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918 (968)
T ss_pred cccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHH
Confidence 578999999999999999999999999999999999999964321 1111111110 0000 00011
Q ss_pred CCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 772 VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 772 is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
...++.+|+.+||..||++||+ +.|+++
T Consensus 919 ~~~~~~~l~~~Cl~~~P~~RPt----~~evl~ 946 (968)
T PLN00113 919 EIVEVMNLALHCTATDPTARPC----ANDVLK 946 (968)
T ss_pred HHHHHHHHHHhhCcCCchhCcC----HHHHHH
Confidence 1235678999999999999999 677665
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=301.24 Aligned_cols=299 Identities=25% Similarity=0.367 Sum_probs=212.5
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcC---CCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeee
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIG---TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTT 541 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~---tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~ 541 (857)
......|.+..+||+|.|++||++.+.. ..+.||+|.+... ....++.+|+++|..+. +.||+.+.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3455779999999999999999999887 7889999998654 34567899999999885 9999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc-CCcEEEecccchh
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE-DGHIMLSDFDLSL 620 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~-dg~iKL~DFGLA~ 620 (857)
++..++||||+++....++... ++...++.|++.++.||.|+|.+|||||||||.|+|++. -++-.|+|||||.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999999999888764 678899999999999999999999999999999999975 4789999999996
Q ss_pred hcccCcccccCCC-CCCCCCC-CCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccccc
Q 035930 621 RCAVNPMVVKSSS-PVEEPPP-KKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVE 698 (857)
Q Consensus 621 r~~~~~~l~~~ss-~~~~p~~-~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~ 698 (857)
+......-....+ -....++ .....+|... .. .....+...-..+
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~---------------------~~------------~~~p~g~~~~~~~ 228 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSV---------------------AT------------ASKPAGYYRRCND 228 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCccccccc---------------------cc------------ccCCCCceeccCC
Confidence 4211110000000 0000000 0000000000 00 0000000000012
Q ss_pred CCCCccccccCCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCCh-hhhHHHhh--------------c
Q 035930 699 PTGARSNSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVS--------------Q 762 (857)
Q Consensus 699 ~~~~~~~s~vGT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~-e~l~~Iv~--------------~ 762 (857)
..........||++|+|||+++..+ .+.++||||.|||+.-+++++.||.....+ +.+..++. +
T Consensus 229 ~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g 308 (418)
T KOG1167|consen 229 GRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPG 308 (418)
T ss_pred CccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCC
Confidence 2333345678999999999998765 588999999999999999999998643211 11111110 0
Q ss_pred c---------------------c--------------cCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 763 S---------------------L--------------RFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 763 ~---------------------~--------------~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
. + .......++..+.||+.+||..||.+|.+ ++++|+||||
T Consensus 309 ~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRit----AEeALkHpFF 384 (418)
T KOG1167|consen 309 RILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRIT----AEDALKHPFF 384 (418)
T ss_pred ceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhccc----HHHHhcCcCC
Confidence 0 0 00112334557899999999999999999 9999999999
Q ss_pred CCCC
Q 035930 808 EGLN 811 (857)
Q Consensus 808 ~~l~ 811 (857)
...+
T Consensus 385 ~~~~ 388 (418)
T KOG1167|consen 385 DEAD 388 (418)
T ss_pred cchh
Confidence 9654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-34 Score=295.90 Aligned_cols=262 Identities=25% Similarity=0.380 Sum_probs=208.0
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC-----eE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK-----FS 545 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~-----~l 545 (857)
+.+..+.||.|+||.||.+.+..+|+.||+|.+..- ...-....++.+|+.+|..++|.|++..++...... .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 344568999999999999999999999999988543 222334467889999999999999999988776543 46
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+|+|+| ..+|+..+-.- ..++.+.++-+++||++||.|||+.+|+||||||.|+|++.+..+||||||||+....+
T Consensus 133 YV~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 8899999 67888777543 34899999999999999999999999999999999999999999999999998542111
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
. .+ ..+
T Consensus 210 ~---------------------------------------------------~~-----------------------hMT 215 (449)
T KOG0664|consen 210 D---------------------------------------------------RL-----------------------NMT 215 (449)
T ss_pred h---------------------------------------------------hh-----------------------hhH
Confidence 0 00 112
Q ss_pred cccCCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh-----------------------
Q 035930 706 SFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS----------------------- 761 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~----------------------- 761 (857)
.-+-|..|+|||+++|.. |+.++||||.|||+.||+..+..|...++-+.+..|..
T Consensus 216 qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR 295 (449)
T KOG0664|consen 216 HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLR 295 (449)
T ss_pred HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhc
Confidence 224578899999999875 79999999999999999999999988776666554432
Q ss_pred ccccCCCC---------CCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 762 QSLRFPGY---------PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 762 ~~~~~p~~---------~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
...+.|.. ..-..+..+++..||..||.+|.+ .++.+.|+|+.+.....
T Consensus 296 ~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris----~~~A~~~~~~~e~R~r~ 353 (449)
T KOG0664|consen 296 AGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS----VEEALQHRYLEEGRLRF 353 (449)
T ss_pred cCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc----Hhhhcccccccccceee
Confidence 22233321 122346778999999999999999 89999999998776653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=317.36 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=210.2
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcC-------CCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccce
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIG-------TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFA 537 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~-------tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~ 537 (857)
.+..++..+.+.||+|.||.||+|...+ ....||||.++.... ....+.+..|+++|+.+. |+||+.+++
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 3455666778899999999999997542 146799999876633 356678899999999995 999999999
Q ss_pred eeeeCCeEEEEEeecCCCChHHHHhhCC------C--------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcE
Q 035930 538 HFTTEKFSCLVMEYCPGGDLHVLRQKQP------S--------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENI 603 (857)
Q Consensus 538 ~f~~~~~l~LVmEy~~gGsL~~ll~~~~------~--------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNI 603 (857)
+|...+.+++|+||+..|+|..++.... . ..++......+++||+.|++||++..+|||||..+||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999988887654 0 1288899999999999999999999999999999999
Q ss_pred EEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhh
Q 035930 604 LVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKS 683 (857)
Q Consensus 604 LL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~ 683 (857)
|+.++..+||+|||||+.........
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~------------------------------------------------------ 475 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYR------------------------------------------------------ 475 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceE------------------------------------------------------
Confidence 99999999999999996532211110
Q ss_pred hhhcccCCCCcccccCCCCccccccC--CCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCC-ChhhhHHH
Q 035930 684 DLAAQVSPMPQLVVEPTGARSNSFVG--THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSG-NDETLSNV 759 (857)
Q Consensus 684 d~~~~~~~~p~l~~~~~~~~~~s~vG--T~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~-~~e~l~~I 759 (857)
...-.| ...|||||.+....|+.++|||||||+||||++ |..||.+.. ..+. .+.
T Consensus 476 --------------------~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l-~~~ 534 (609)
T KOG0200|consen 476 --------------------TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL-LEF 534 (609)
T ss_pred --------------------ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH-HHH
Confidence 000011 245999999999999999999999999999997 999999866 4444 557
Q ss_pred hhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchh
Q 035930 760 VSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVK 796 (857)
Q Consensus 760 v~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~ 796 (857)
+..+.+...+..++.++.+||+.||..+|++||++..
T Consensus 535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~ 571 (609)
T KOG0200|consen 535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSE 571 (609)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence 7888888777789999999999999999999999543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-33 Score=322.38 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=198.1
Q ss_pred eEEEeEEccCCceE-EEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEEE
Q 035930 472 FKLHKKLGCGDIGT-VYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 472 Y~i~~~LG~G~fGt-Vyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LVm 549 (857)
|.-.+.+|.|+-|+ ||+|.. .|+.||||.+-.+ ....+++|+.+|+..+ |||||++|+.-.+++++||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 55567899999986 889987 5678999987433 3456799999999885 999999999999999999999
Q ss_pred eecCCCChHHHHhhC-CCCCC-cHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc---CC--cEEEecccchhhc
Q 035930 550 EYCPGGDLHVLRQKQ-PSRFF-SEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE---DG--HIMLSDFDLSLRC 622 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~-~~~~l-~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~---dg--~iKL~DFGLA~r~ 622 (857)
|+| ..+|.+++... ....+ ..-..+..+.|++.||++||+.+||||||||.||||+. ++ .++|+|||+++++
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 77999998874 11111 11345778899999999999999999999999999976 34 6899999999876
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
..+..-.+
T Consensus 662 ~~~~sS~~------------------------------------------------------------------------ 669 (903)
T KOG1027|consen 662 AGGKSSFS------------------------------------------------------------------------ 669 (903)
T ss_pred CCCcchhh------------------------------------------------------------------------
Confidence 54322110
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhC-CCCCCCCCChhhhHHHhhccccCCCC-CCCCHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYG-RTPFKGSGNDETLSNVVSQSLRFPGY-PVVSFHARDLI 780 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtG-k~PF~g~~~~e~l~~Iv~~~~~~p~~-~~is~~l~dLI 780 (857)
+.....||-+|+|||++....-..++|||||||++|+.++| ..||... .+.-.+|+.+....-.. +....+++|||
T Consensus 670 r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~L~~~~d~eA~dLI 747 (903)
T KOG1027|consen 670 RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVHLEPLPDCEAKDLI 747 (903)
T ss_pred cccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceeeeccCchHHHHHHH
Confidence 12244599999999999999889999999999999999985 9999754 33445666655443221 11112899999
Q ss_pred HhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
.+||.+||..||+ |.++|.||||-.
T Consensus 748 ~~ml~~dP~~RPs----a~~VL~HPlFW~ 772 (903)
T KOG1027|consen 748 SRMLNPDPQLRPS----ATDVLNHPLFWD 772 (903)
T ss_pred HHhcCCCcccCCC----HHHHhCCCccCC
Confidence 9999999999999 999999999953
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=280.94 Aligned_cols=253 Identities=26% Similarity=0.455 Sum_probs=205.6
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeC--Ce
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTE--KF 544 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~--~~ 544 (857)
..++|++.+++|+|.|+.|+.|....++..++||+++.- ....+.+|+.||+.|. ||||++|++...+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 457899999999999999999999989999999998743 3456899999999996 99999999998765 46
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC-CcEEEecccchhhcc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED-GHIMLSDFDLSLRCA 623 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d-g~iKL~DFGLA~r~~ 623 (857)
.-||+||+++.+...+... ++.-.++.++.|++.||.|+|+.||+|||+||.|++++.. -.++|+|+|||-...
T Consensus 110 paLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 7899999999888766543 7788899999999999999999999999999999999875 479999999985432
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
... .
T Consensus 185 p~~----------------------------------------------------------------------------e 188 (338)
T KOG0668|consen 185 PGK----------------------------------------------------------------------------E 188 (338)
T ss_pred CCc----------------------------------------------------------------------------e
Confidence 110 1
Q ss_pred cccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCC-CCCCChhhhHHHhh--------------------
Q 035930 704 SNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPF-KGSGNDETLSNVVS-------------------- 761 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF-~g~~~~e~l~~Iv~-------------------- 761 (857)
.+-.+-+..|--||++..- .|+..-|+|||||+|..|++.+-|| .|.++.+.+.+|..
T Consensus 189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 1223456778899998764 5799999999999999999988886 46666666655542
Q ss_pred -------ccccCC--------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 762 -------QSLRFP--------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 762 -------~~~~~p--------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
...+.+ ..-.+++++.||+.++|.+|-.+||| |.|++.||||..+-
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT----akEam~HpyF~~~~ 329 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT----AKEAMAHPYFAPVR 329 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc----hHHHhcCchHHHHH
Confidence 000000 11235789999999999999999999 99999999998653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=308.23 Aligned_cols=250 Identities=24% Similarity=0.310 Sum_probs=209.3
Q ss_pred eEEEeEEccCCceEEEEEEEcCCC----eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTS----CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg----~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
++..++||.|+||+||+|.+...| ..||||++... ...+....+..|+-+|..|+|||+++|+++|.... +.|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 455689999999999999987655 36899988655 34555678899999999999999999999998776 789
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
|++||++|.|.++++.... .+-.+....|..||+.||.|||++++|||||-.+||||....++||+|||+|+-+..+..
T Consensus 775 vtq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999999887654 388888999999999999999999999999999999999999999999999865432211
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
-+ . ....
T Consensus 854 ey--------------------------------------------------------~-----------------~~~g 860 (1177)
T KOG1025|consen 854 EY--------------------------------------------------------S-----------------APGG 860 (1177)
T ss_pred cc--------------------------------------------------------c-----------------cccc
Confidence 00 0 0011
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
--.+-|||-|.+....|+.++|||||||++|||+| |..|+.+...+++ .+.++.+.+++.++.++.++.-+|.+||..
T Consensus 861 K~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-~dlle~geRLsqPpiCtiDVy~~mvkCwmi 939 (1177)
T KOG1025|consen 861 KVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-PDLLEKGERLSQPPICTIDVYMVMVKCWMI 939 (1177)
T ss_pred ccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-hHHHhccccCCCCCCccHHHHHHHHHHhcc
Confidence 12466999999999999999999999999999997 9999999865554 566777778999999999999999999999
Q ss_pred CcCCcCCchhhHH
Q 035930 787 EPDNRLGAVKGAA 799 (857)
Q Consensus 787 DPe~Rpt~~~~a~ 799 (857)
|+..||++...++
T Consensus 940 d~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 940 DADSRPTFKELAE 952 (1177)
T ss_pred CcccCccHHHHHH
Confidence 9999999654433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=301.79 Aligned_cols=202 Identities=28% Similarity=0.496 Sum_probs=177.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc-----cchhHHHHHHHHHHHcC---CCCccccceeee
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR-----KKMPRAQTEREIMQMLD---HPFLPTLFAHFT 540 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~-----~~~~~~~~EieILr~L~---HPnIV~L~~~f~ 540 (857)
..+|..++.||+|+||.||+|.++.....|+||.|.++++.-. ..+-.+-.|++||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3469999999999999999999999999999999988765433 23334567999999997 999999999999
Q ss_pred eCCeEEEEEeec-CCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 541 TEKFSCLVMEYC-PGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 541 ~~~~l~LVmEy~-~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
+++++||+||.- +|.+|.+++...+. ++|.+++.+++||+.|+++||.+||||||||-+||.++.+|-+||+|||.|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 999999999985 45688999988765 999999999999999999999999999999999999999999999999976
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
...
T Consensus 718 a~~----------------------------------------------------------------------------- 720 (772)
T KOG1152|consen 718 AYT----------------------------------------------------------------------------- 720 (772)
T ss_pred hhh-----------------------------------------------------------------------------
Confidence 321
Q ss_pred CCCccccccCCCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCC
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKG 749 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g 749 (857)
.+.....|+||.+|.|||++.|.+| +..-|||+||++||-+++...||+.
T Consensus 721 ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 721 KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 0112346889999999999999998 8889999999999999999999974
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=305.07 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=221.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
.+|.++.++|.|.||.||+++++.++...|+|+++-.. ...+.-++.|+-+++.++|||||.+++.+...+.+++.|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 57999999999999999999999999999999998653 345666788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|||.||+|.+..+-.. .+++.++.+..++.+.||+|||..|-+|||||-.|||+++.|.+||+|||.+...
T Consensus 92 EycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqi------- 162 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQI------- 162 (829)
T ss_pred EecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhh-------
Confidence 9999999988766543 4999999999999999999999999999999999999999999999999976211
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
..+-.+..+|+|
T Consensus 163 --------------------------------------------------------------------tati~KrksfiG 174 (829)
T KOG0576|consen 163 --------------------------------------------------------------------TATIAKRKSFIG 174 (829)
T ss_pred --------------------------------------------------------------------hhhhhhhhcccC
Confidence 012234568899
Q ss_pred CCCccChhhh---cCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC---CCCCCCHHHHHHHHhh
Q 035930 710 THEYLAPEII---KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP---GYPVVSFHARDLIRGL 783 (857)
Q Consensus 710 T~~YmAPEil---~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p---~~~~is~~l~dLI~k~ 783 (857)
|+.|||||+. +..+|...+|||++|++..||---..|.....+...+...-+..++.| +...++..+.+|++.+
T Consensus 175 tpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~a 254 (829)
T KOG0576|consen 175 TPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGA 254 (829)
T ss_pred CccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHH
Confidence 9999999986 467799999999999999999998888766656666655555555544 4466899999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
|.++|.+||+ ++.+|+|||..+-
T Consensus 255 ltknpKkRpt----aeklL~h~fvs~~ 277 (829)
T KOG0576|consen 255 LTKNPKKRPT----AEKLLQHPFVSQT 277 (829)
T ss_pred hcCCCccCCC----hhhheeceeeccc
Confidence 9999999999 9999999998753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=244.59 Aligned_cols=213 Identities=38% Similarity=0.611 Sum_probs=183.4
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCCCh
Q 035930 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL 557 (857)
Q Consensus 478 LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL 557 (857)
||.|.+|.||++.+..++..+++|++....... ....+.+|+++++.+.|++|+++++++......++||||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997653211 346789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc-CCcEEEecccchhhcccCcccccCCCCCC
Q 035930 558 HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE-DGHIMLSDFDLSLRCAVNPMVVKSSSPVE 636 (857)
Q Consensus 558 ~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~-dg~iKL~DFGLA~r~~~~~~l~~~ss~~~ 636 (857)
..++.... ..+++..++.++.+++.+|.|||..|++|+||+|.||+++. ++.++|+|||++.......
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~---------- 147 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK---------- 147 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc----------
Confidence 99887653 23889999999999999999999999999999999999999 8999999999874311000
Q ss_pred CCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccCh
Q 035930 637 EPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAP 716 (857)
Q Consensus 637 ~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAP 716 (857)
.......+...|++|
T Consensus 148 -----------------------------------------------------------------~~~~~~~~~~~~~~p 162 (215)
T cd00180 148 -----------------------------------------------------------------SLLKTIVGTPAYMAP 162 (215)
T ss_pred -----------------------------------------------------------------chhhcccCCCCccCh
Confidence 001123467889999
Q ss_pred hhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCch
Q 035930 717 EIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV 795 (857)
Q Consensus 717 Eil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~ 795 (857)
|.+... .++.+.|+|+||+++|+| ..+.+++.+||..||.+||+
T Consensus 163 e~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~~-- 207 (215)
T cd00180 163 EVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRPS-- 207 (215)
T ss_pred hHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCcC--
Confidence 999887 789999999999999999 67889999999999999999
Q ss_pred hhHHHHHcCC
Q 035930 796 KGAAEIKQHP 805 (857)
Q Consensus 796 ~~a~ELL~HP 805 (857)
+.++++|+
T Consensus 208 --~~~l~~~~ 215 (215)
T cd00180 208 --AKEILEHL 215 (215)
T ss_pred --HHHHhhCC
Confidence 89999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=284.70 Aligned_cols=247 Identities=25% Similarity=0.322 Sum_probs=187.9
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc--CCCCccccceeeeeCC----
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML--DHPFLPTLFAHFTTEK---- 543 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L--~HPnIV~L~~~f~~~~---- 543 (857)
....++..||+|.||+||+|... ++.||||++... ..+.+++|.+|.... .|+||++++++-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 44567789999999999999985 478999998643 345678898887765 6999999999876554
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHc---------CceeccCCCCcEEEccCCcEEEe
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML---------GVVYRDLKPENILVREDGHIMLS 614 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~---------GIIHRDLKPeNILL~~dg~iKL~ 614 (857)
.++||+||.+.|+|.+|+..+- +++....+++.-+++||+|||+. .|+|||||..||||..|+..-|+
T Consensus 282 eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 7899999999999999998764 89999999999999999999963 49999999999999999999999
Q ss_pred cccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCc
Q 035930 615 DFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQ 694 (857)
Q Consensus 615 DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~ 694 (857)
|||||.++....
T Consensus 359 DFGLAl~~~p~~-------------------------------------------------------------------- 370 (534)
T KOG3653|consen 359 DFGLALRLEPGK-------------------------------------------------------------------- 370 (534)
T ss_pred ccceeEEecCCC--------------------------------------------------------------------
Confidence 999997753110
Q ss_pred ccccCCCCccccccCCCCccChhhhcCCCC------CcccceehhhHHHHHHhhCCC------------CCCC-----CC
Q 035930 695 LVVEPTGARSNSFVGTHEYLAPEIIKGEGH------GSSVDWWTFGIFLFELLYGRT------------PFKG-----SG 751 (857)
Q Consensus 695 l~~~~~~~~~~s~vGT~~YmAPEil~g~~~------s~ksDVWSLGvILyELLtGk~------------PF~g-----~~ 751 (857)
+.+ ....-+||..|||||++.|.-. -.+.||||+|.+||||++... ||.. ..
T Consensus 371 ----~~~-d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 371 ----PQG-DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ----CCc-chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 000 1123589999999999976532 237899999999999997433 2320 11
Q ss_pred ChhhhHHHhhccccCCCCCC-----CCHHHHHHHHhhccCCcCCcCCchhhHHH
Q 035930 752 NDETLSNVVSQSLRFPGYPV-----VSFHARDLIRGLLVKEPDNRLGAVKGAAE 800 (857)
Q Consensus 752 ~~e~l~~Iv~~~~~~p~~~~-----is~~l~dLI~k~L~~DPe~Rpt~~~~a~E 800 (857)
-++....++....++..+.. --..+++.|..||..||+.|+|+.-..+.
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR 499 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEER 499 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHH
Confidence 22333444444433322111 22458899999999999999996544443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=277.92 Aligned_cols=243 Identities=26% Similarity=0.337 Sum_probs=186.6
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHH--HHcCCCCccccceeeeeCC----
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM--QMLDHPFLPTLFAHFTTEK---- 543 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieIL--r~L~HPnIV~L~~~f~~~~---- 543 (857)
++..+.+.||+|.||.||+|.+++. .||||++... +.....+|.+|. .+|+|+||+.+++.-..++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe--~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGE--DVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccccCC--ceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 5678999999999999999999755 5999999643 233456677765 4679999999998765443
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHc--------CceeccCCCCcEEEccCCcEEEec
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML--------GVVYRDLKPENILVREDGHIMLSD 615 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~--------GIIHRDLKPeNILL~~dg~iKL~D 615 (857)
.++||++|-+.|+|++|+.+.. ++.+....++..++.||+|||.. .|.|||||..||||..+|..-|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRNT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhhcc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 6899999999999999999853 88999999999999999999964 399999999999999999999999
Q ss_pred ccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcc
Q 035930 616 FDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQL 695 (857)
Q Consensus 616 FGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l 695 (857)
||||.+......
T Consensus 360 LGLAv~h~~~t~-------------------------------------------------------------------- 371 (513)
T KOG2052|consen 360 LGLAVRHDSDTD-------------------------------------------------------------------- 371 (513)
T ss_pred ceeeEEecccCC--------------------------------------------------------------------
Confidence 999976432211
Q ss_pred cccCCCCccccccCCCCccChhhhcCCC----C--CcccceehhhHHHHHHhh----------CCCCCCCCC----Chhh
Q 035930 696 VVEPTGARSNSFVGTHEYLAPEIIKGEG----H--GSSVDWWTFGIFLFELLY----------GRTPFKGSG----NDET 755 (857)
Q Consensus 696 ~~~~~~~~~~s~vGT~~YmAPEil~g~~----~--s~ksDVWSLGvILyELLt----------Gk~PF~g~~----~~e~ 755 (857)
..+...+..+||..|||||+|...- + -..+||||||.++||++. -..||++.- ..+.
T Consensus 372 ---~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ee 448 (513)
T KOG2052|consen 372 ---TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEE 448 (513)
T ss_pred ---cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHH
Confidence 1122335678999999999996532 1 236899999999999985 256887542 3344
Q ss_pred hHHHh-hccccCCCCCCCC--H---HHHHHHHhhccCCcCCcCCc
Q 035930 756 LSNVV-SQSLRFPGYPVVS--F---HARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 756 l~~Iv-~~~~~~p~~~~is--~---~l~dLI~k~L~~DPe~Rpt~ 794 (857)
+.+++ .+.+++..+..+. + .+-.||+.||..+|.-|+|+
T Consensus 449 MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 449 MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 44443 3445544333333 2 35579999999999999995
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=261.74 Aligned_cols=217 Identities=27% Similarity=0.396 Sum_probs=173.8
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHH-HcCCCCccccceeeeeCCeEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ-MLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr-~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
++..-+..||.|+||.|-+.++..+|...|+|.+... ...+...+..+|+++.. ....|++|++|+.+..+..+++.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t--vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT--VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh--cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 3455667999999999999999999999999998654 23455567788888754 44799999999999999999999
Q ss_pred EeecCCCChHHHHhh--CCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 549 MEYCPGGDLHVLRQK--QPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 549 mEy~~gGsL~~ll~~--~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||.| ..+|..+..+ ..+..++|..+-.++..++.||.|||+ ..|||||+||.|||++.+|++||||||++-.+.
T Consensus 124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~-- 200 (282)
T KOG0984|consen 124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV-- 200 (282)
T ss_pred HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh--
Confidence 9999 6677555432 123458999999999999999999995 589999999999999999999999999862210
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
..-+ .+
T Consensus 201 -----------------------------------------------dSiA---------------------------kt 206 (282)
T KOG0984|consen 201 -----------------------------------------------DSIA---------------------------KT 206 (282)
T ss_pred -----------------------------------------------hhhH---------------------------HH
Confidence 0000 01
Q ss_pred cccCCCCccChhhhcC----CCCCcccceehhhHHHHHHhhCCCCCCCC-CChhhhHHHhhcccc
Q 035930 706 SFVGTHEYLAPEIIKG----EGHGSSVDWWTFGIFLFELLYGRTPFKGS-GNDETLSNVVSQSLR 765 (857)
Q Consensus 706 s~vGT~~YmAPEil~g----~~~s~ksDVWSLGvILyELLtGk~PF~g~-~~~e~l~~Iv~~~~~ 765 (857)
-..|...|||||.+.. ..|+.++||||||++++||.+++.||... .+.+.+.+++...-+
T Consensus 207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 1348889999999853 36899999999999999999999999865 456777888776443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=248.19 Aligned_cols=214 Identities=44% Similarity=0.697 Sum_probs=178.0
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEee
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEY 551 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy 551 (857)
|.+.+.||.|+||+||++.+..++..+|+|.+...... .....+.+|++.++.++|+|++++++++......+++|||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56889999999999999999988999999999765322 2456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccC
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKS 631 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ 631 (857)
+++++|..++...... +++..+..++.+++.+|.|||..+++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~----- 152 (225)
T smart00221 79 CEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL----- 152 (225)
T ss_pred cCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-----
Confidence 9999999998765432 7899999999999999999999999999999999999999999999999874321000
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCC
Q 035930 632 SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711 (857)
Q Consensus 632 ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~ 711 (857)
........++.
T Consensus 153 ---------------------------------------------------------------------~~~~~~~~~~~ 163 (225)
T smart00221 153 ---------------------------------------------------------------------AALLKTVKGTP 163 (225)
T ss_pred ---------------------------------------------------------------------cccccceeccC
Confidence 00112345788
Q ss_pred CccChhhh-cCCCCCcccceehhhHHHHHHhhCCCCCCC-CCChhhhHHHhhc
Q 035930 712 EYLAPEII-KGEGHGSSVDWWTFGIFLFELLYGRTPFKG-SGNDETLSNVVSQ 762 (857)
Q Consensus 712 ~YmAPEil-~g~~~s~ksDVWSLGvILyELLtGk~PF~g-~~~~e~l~~Iv~~ 762 (857)
.|++||.+ ....++.++|||+||+++|+|++|+.||.. .++...+.+.+..
T Consensus 164 ~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 164 FYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred CcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 89999999 677788899999999999999999999987 4455344444333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=293.93 Aligned_cols=260 Identities=42% Similarity=0.733 Sum_probs=221.8
Q ss_pred EEccCCceEEEEEEEc---CCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEEEeec
Q 035930 477 KLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLVMEYC 552 (857)
Q Consensus 477 ~LG~G~fGtVyla~~~---~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LVmEy~ 552 (857)
.+|+|.||.|++++-. ..+..||+|++++......... ....|..++..++ ||+++++...|+.+...+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 3799999999987542 4577899999987765544443 5677889999997 999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCC
Q 035930 553 PGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSS 632 (857)
Q Consensus 553 ~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~s 632 (857)
.||+|...+.... .+.+...+.+.++++.+++++|+.||+|||+|++||+++.+|++++.|||+++....
T Consensus 80 rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~-------- 149 (612)
T KOG0603|consen 80 RGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK-------- 149 (612)
T ss_pred ccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh--------
Confidence 9999977666554 388999999999999999999999999999999999999999999999999743110
Q ss_pred CCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCC
Q 035930 633 SPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHE 712 (857)
Q Consensus 633 s~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~ 712 (857)
....|||..
T Consensus 150 -----------------------------------------------------------------------~~~~cgt~e 158 (612)
T KOG0603|consen 150 -----------------------------------------------------------------------EKIACGTYE 158 (612)
T ss_pred -----------------------------------------------------------------------hhhcccchh
Confidence 001179999
Q ss_pred ccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcC
Q 035930 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRL 792 (857)
Q Consensus 713 YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rp 792 (857)
|||||++. ++..++||||||+++|||++|..||.+ ++...|+...+.+|. ..+..+++++..|+..+|.+|+
T Consensus 159 ymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~~r~p~nrL 230 (612)
T KOG0603|consen 159 YRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR--ELSAEARSLFRQLFKRNPENRL 230 (612)
T ss_pred hhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch--hhhHHHHHHHHHHHhhCHHHHh
Confidence 99999998 789999999999999999999999987 788888887777765 4899999999999999999999
Q ss_pred Cch-hhHHHHHcCCCCCCCChhhh--ccCCCCCCCCC
Q 035930 793 GAV-KGAAEIKQHPFFEGLNWALI--RCAVPPELPRS 826 (857)
Q Consensus 793 t~~-~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~ 826 (857)
... .++.|+++|+||..++|..+ +...||+.|..
T Consensus 231 g~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~ 267 (612)
T KOG0603|consen 231 GAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGS 267 (612)
T ss_pred ccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcc
Confidence 964 46899999999999999965 45666777754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=306.60 Aligned_cols=237 Identities=16% Similarity=0.199 Sum_probs=158.9
Q ss_pred HHcCC-CCccccceee-------eeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceec
Q 035930 525 QMLDH-PFLPTLFAHF-------TTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYR 596 (857)
Q Consensus 525 r~L~H-PnIV~L~~~f-------~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHR 596 (857)
+.+.| +||++++++| .....++++|||+ +++|+.++.... ..+++..++.+++||+.||+|||++|||||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 34556 6888888888 3334678889988 779999997542 449999999999999999999999999999
Q ss_pred cCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHH
Q 035930 597 DLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAA 676 (857)
Q Consensus 597 DLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~ 676 (857)
||||+||||+..|.+|++|||++.....+.. ... +.. ..+... ......
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~----------~~~-ki~---DfG~a~----------------~~~~~~- 153 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDED----------ATT-KSR---EIGSSR----------------REEILS- 153 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCccccccc----------Ccc-ccc---cccccc----------------cccccc-
Confidence 9999999999989999999998743211000 000 000 000000 000000
Q ss_pred hhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhh
Q 035930 677 KSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756 (857)
Q Consensus 677 ~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l 756 (857)
.+.......... .+........+||+.|||||++.+..|+.++|||||||+||||++|..||... ...+
T Consensus 154 -~~~~~~~~~~~~--------~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~--~~~~ 222 (793)
T PLN00181 154 -ERRIEKLEEVKK--------QPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK--SRTM 222 (793)
T ss_pred -ccchhhhhcccc--------CCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH--HHHH
Confidence 000000000000 00011122357999999999999999999999999999999999999887642 1222
Q ss_pred HHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 757 ~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
..+....+ .+......+.+.+++.+||.+||.+||+ +.|||+||||...
T Consensus 223 ~~~~~~~~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps----~~eil~h~~~~~~ 271 (793)
T PLN00181 223 SSLRHRVL-PPQILLNWPKEASFCLWLLHPEPSCRPS----MSELLQSEFINEP 271 (793)
T ss_pred HHHHHhhc-ChhhhhcCHHHHHHHHHhCCCChhhCcC----hHHHhhchhhhhh
Confidence 22222211 1211123456789999999999999999 9999999999764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=261.03 Aligned_cols=258 Identities=16% Similarity=0.207 Sum_probs=210.7
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCC-----eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceee
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTS-----CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHF 539 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg-----~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f 539 (857)
..+...++++.-.+-+|.||.||+|.++... +.|-+|.++.. ..+.....+..|--+|..+.|||+..+.+++
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3456677999999999999999999776432 34566766544 3445566788888888889999999999988
Q ss_pred eeC-CeEEEEEeecCCCChHHHHhhC------CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEE
Q 035930 540 TTE-KFSCLVMEYCPGGDLHVLRQKQ------PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIM 612 (857)
Q Consensus 540 ~~~-~~l~LVmEy~~gGsL~~ll~~~------~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iK 612 (857)
.++ ...++++.++..|+|..++... ..+.++..+...++.|++.|++|||.+||||.||..+|+++++.-++|
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence 755 5678899999999999988722 123477788889999999999999999999999999999999999999
Q ss_pred EecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCC
Q 035930 613 LSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPM 692 (857)
Q Consensus 613 L~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~ 692 (857)
|+|=.|++.+.. +..+|.+.+..
T Consensus 437 ltDsaLSRDLFP------------------~DYhcLGDnEn--------------------------------------- 459 (563)
T KOG1024|consen 437 LTDSALSRDLFP------------------GDYHCLGDNEN--------------------------------------- 459 (563)
T ss_pred eccchhccccCc------------------ccccccCCCCC---------------------------------------
Confidence 999999866431 22333332221
Q ss_pred CcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCC
Q 035930 693 PQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPV 771 (857)
Q Consensus 693 p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~ 771 (857)
....||+||.+....|+.++|+|||||+||||+| |+.||..-++.|.. .+++.++++.++-+
T Consensus 460 ----------------RPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-~ylkdGyRlaQP~N 522 (563)
T KOG1024|consen 460 ----------------RPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-HYLKDGYRLAQPFN 522 (563)
T ss_pred ----------------CcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-HHHhccceecCCCC
Confidence 2456999999999999999999999999999997 99999988776654 56677888888888
Q ss_pred CCHHHHHHHHhhccCCcCCcCCchhhHHHHH
Q 035930 772 VSFHARDLIRGLLVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 772 is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL 802 (857)
+++++..+|.-||..+|++||+ .+++.
T Consensus 523 CPDeLf~vMacCWallpeeRPs----f~Qlv 549 (563)
T KOG1024|consen 523 CPDELFTVMACCWALLPEERPS----FSQLV 549 (563)
T ss_pred CcHHHHHHHHHHHhcCcccCCC----HHHHH
Confidence 9999999999999999999999 55554
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=254.66 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=190.2
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccce-eeeeCCeEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFA-HFTTEKFSCL 547 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~-~f~~~~~l~L 547 (857)
+.|.+.+.||+|.||.+.+|+++++...+++|.+.+.. ....+|.+|...--.| .|.||+.-|+ .|++.+.+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 46999999999999999999999999999999998763 3456677777654444 4899998887 5778889999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc--cCCcEEEecccchhhcccC
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR--EDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~--~dg~iKL~DFGLA~r~~~~ 625 (857)
+|||++.|+|..-+.. ..+-|...+.++.|++.||+|||+.++||||||.+||||- +..++||||||+.+...
T Consensus 100 ~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-- 174 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-- 174 (378)
T ss_pred eeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--
Confidence 9999999999766554 3488999999999999999999999999999999999994 23589999999864310
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
....
T Consensus 175 ----------------------------------------------------------------------------~tV~ 178 (378)
T KOG1345|consen 175 ----------------------------------------------------------------------------TTVK 178 (378)
T ss_pred ----------------------------------------------------------------------------ceeh
Confidence 0000
Q ss_pred cccCCCCccChhhhcC---CC--CCcccceehhhHHHHHHhhCCCCCCCCCC-hhhhHHHhh----ccccCC-CCCCCCH
Q 035930 706 SFVGTHEYLAPEIIKG---EG--HGSSVDWWTFGIFLFELLYGRTPFKGSGN-DETLSNVVS----QSLRFP-GYPVVSF 774 (857)
Q Consensus 706 s~vGT~~YmAPEil~g---~~--~s~ksDVWSLGvILyELLtGk~PF~g~~~-~e~l~~Iv~----~~~~~p-~~~~is~ 774 (857)
..--+..|.+||.... +. .....|+|.||+++|.+|+|+.||..... +.-+.+.++ .....| ....+++
T Consensus 179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~ 258 (378)
T KOG1345|consen 179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSE 258 (378)
T ss_pred hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCH
Confidence 1113566899998753 33 36789999999999999999999974321 222222222 112222 2455889
Q ss_pred HHHHHHHhhccCCcCCc---CCchhhHHHHHcCCCC
Q 035930 775 HARDLIRGLLVKEPDNR---LGAVKGAAEIKQHPFF 807 (857)
Q Consensus 775 ~l~dLI~k~L~~DPe~R---pt~~~~a~ELL~HPfF 807 (857)
.+..+.++-|..+|++| .+ ++......|.
T Consensus 259 ~a~r~Fkk~lt~~~~drcki~~----~kk~rk~~w~ 290 (378)
T KOG1345|consen 259 KALRLFKKSLTPRFKDRCKIWT----AKKMRKCLWK 290 (378)
T ss_pred HHHHHHHHhcCCcccccchhHH----HHHHHHHHHH
Confidence 99999999999999999 44 5666655554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=229.91 Aligned_cols=262 Identities=38% Similarity=0.571 Sum_probs=204.0
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCC-CccccceeeeeCCeEEEEEe
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP-FLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HP-nIV~L~~~f~~~~~l~LVmE 550 (857)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 67999999876443333467789999999999988 79999999988888899999
Q ss_pred ecCCCChHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC-cEEEecccchhhcccCccc
Q 035930 551 YCPGGDLHVLRQKQPS-RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG-HIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~-~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg-~iKL~DFGLA~r~~~~~~l 628 (857)
|+.+++|..++..... ..+.+..+..++.|++.+|.|+|..|++||||||+|||++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999966665432 1489999999999999999999999999999999999999988 7999999987421100000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
. .........+
T Consensus 159 -------------------------~--------------------------------------------~~~~~~~~~~ 169 (384)
T COG0515 159 -------------------------S--------------------------------------------SIPALPSTSV 169 (384)
T ss_pred -------------------------c--------------------------------------------cccccccccc
Confidence 0 0001234567
Q ss_pred CCCCccChhhhcC---CCCCcccceehhhHHHHHHhhCCCCCCCCCC----hhhhHHHhhcccc-CCC--CCCC----CH
Q 035930 709 GTHEYLAPEIIKG---EGHGSSVDWWTFGIFLFELLYGRTPFKGSGN----DETLSNVVSQSLR-FPG--YPVV----SF 774 (857)
Q Consensus 709 GT~~YmAPEil~g---~~~s~ksDVWSLGvILyELLtGk~PF~g~~~----~e~l~~Iv~~~~~-~p~--~~~i----s~ 774 (857)
||..|+|||.+.+ ..+....|+|++|+++|++++|..||..... ......+...... ... .... ..
T Consensus 170 ~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (384)
T COG0515 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISK 249 (384)
T ss_pred cccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhH
Confidence 9999999999998 5789999999999999999999999887764 3333333333322 221 1111 15
Q ss_pred HHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 775 HARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 775 ~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
.+.+++..++..+|..|.+ ..+...++|+..
T Consensus 250 ~~~~~~~~~~~~~~~~r~~----~~~~~~~~~~~~ 280 (384)
T COG0515 250 AASDLLKKLLAKDPKNRLS----SSSDLSHDLLAH 280 (384)
T ss_pred HHHHHHHHHHhcCchhcCC----HHHHhhchHhhC
Confidence 7899999999999999999 666666655443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=282.36 Aligned_cols=253 Identities=37% Similarity=0.631 Sum_probs=191.6
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
.+|..++.|-.|+||-||+++++.+.+.+|+| ++++.+. +++ ||.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lRn---ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LRN---ILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hhc---cccccCCccee----------------
Confidence 57889999999999999999999999999995 4433211 111 45555666665
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|+-..++..-.. ++.+ ++.+++|||..||+|||+||+|.||+.-|++|++||||++..-
T Consensus 136 -----gDc~tllk~~g~--lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL------ 194 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGP--LPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL------ 194 (1205)
T ss_pred -----chhhhhcccCCC--Ccch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhh------
Confidence 444444443222 3332 3789999999999999999999999999999999999974310
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
+... -|+. .-.+.. .. ..-.....||
T Consensus 195 -------------ms~a---------tnl~--------eg~I~k-------~t-----------------~Ef~dKqvcg 220 (1205)
T KOG0606|consen 195 -------------MSLA---------TNLK--------EGHIEK-------DT-----------------HEFQDKQVCG 220 (1205)
T ss_pred -------------hhcc---------chhh--------hcchHH-------HH-----------------HHhhhccccC
Confidence 0000 0000 000000 00 0111245689
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC-CCCCCHHHHHHHHhhccCCc
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG-YPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~-~~~is~~l~dLI~k~L~~DP 788 (857)
|+.|+|||++...+|+..+|||+||+|+||.+-|..||.+...++.+..++.....||+ ....++++++||..||+.+|
T Consensus 221 TPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp 300 (1205)
T KOG0606|consen 221 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNP 300 (1205)
T ss_pred CccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhCh
Confidence 99999999999999999999999999999999999999999999999999998888876 35578999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCCCChh-hhccCCCCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGLNWA-LIRCAVPPELPRS 826 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l~w~-li~~~~pp~~P~~ 826 (857)
..|+... ++-++.+|+||+.++|. |||+. .+|+|..
T Consensus 301 ~~Rlgt~-ga~evk~h~ff~~LDw~~llRqk-aefvpql 337 (1205)
T KOG0606|consen 301 LCRLGTG-GALEVKQHGFFQLLDWKSLLRQK-AEFVPQL 337 (1205)
T ss_pred Hhhcccc-hhhhhhhccceeecccchhhhhh-ccccccc
Confidence 9999865 78999999999999997 66643 3455543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=226.43 Aligned_cols=161 Identities=22% Similarity=0.195 Sum_probs=127.5
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
|+|.+++.... ..+++..++.++.||+.||.|||+++ ||+|||++.++.+++ ||++.....
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 68888887643 34999999999999999999999998 999999999999999 998632100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
....||+.||
T Consensus 62 ----------------------------------------------------------------------~~~~g~~~y~ 71 (176)
T smart00750 62 ----------------------------------------------------------------------EQSRVDPYFM 71 (176)
T ss_pred ----------------------------------------------------------------------ccCCCccccc
Confidence 0114889999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh-hhhHHHhhccccC-----CCCCCCCH--HHHHHHHhhccC
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVSQSLRF-----PGYPVVSF--HARDLIRGLLVK 786 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~-e~l~~Iv~~~~~~-----p~~~~is~--~l~dLI~k~L~~ 786 (857)
|||++.+..|+.++|||||||++|||++|+.||...... ..+..+....... +....++. .+++||.+||..
T Consensus 72 aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~ 151 (176)
T smart00750 72 APEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASR 151 (176)
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhc
Confidence 999999999999999999999999999999999765432 3333333322221 11122333 699999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCCC
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
||.+||+ +.++++|+|+.
T Consensus 152 ~p~~Rp~----~~~ll~~~~~~ 169 (176)
T smart00750 152 LPQRREA----ANHYLAHCRAL 169 (176)
T ss_pred ccccccC----HHHHHHHHHHH
Confidence 9999999 99999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-24 Score=233.53 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=195.2
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCC-eEEEEEEecccccccccchhHHHHHHHHHHHcCC----CCccccceee-eeCCe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTS-CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH----PFLPTLFAHF-TTEKF 544 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg-~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~H----PnIV~L~~~f-~~~~~ 544 (857)
+|.+.+.||+|+||.||++.+..++ ..+|+|+....... .. ..+..|+.+|..+.. ++++.+++.+ ..+.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~--~~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS--KP-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC--CC-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987764 68999987654211 11 156789999988873 5899999999 58889
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC-----CcEEEecccch
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED-----GHIMLSDFDLS 619 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d-----g~iKL~DFGLA 619 (857)
.||||+.+ |.+|.+++...+.+.|+...+..++.|++.+|++||+.|+|||||||.|+++... -.+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 9999999977776679999999999999999999999999999999999999765 35899999999
Q ss_pred hhcc--cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccc
Q 035930 620 LRCA--VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVV 697 (857)
Q Consensus 620 ~r~~--~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~ 697 (857)
++.. ...... .
T Consensus 175 r~~~~~~~~~~~-------------------------------------------------------------------~ 187 (322)
T KOG1164|consen 175 RRFKYVGDSGGN-------------------------------------------------------------------L 187 (322)
T ss_pred ccccccCCCCcc-------------------------------------------------------------------c
Confidence 7321 110000 0
Q ss_pred cCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC---CCCCCCH
Q 035930 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP---GYPVVSF 774 (857)
Q Consensus 698 ~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p---~~~~is~ 774 (857)
.+.......+.||..|.++....+...+.+.|+||++.++.||+.|..||.+.........+........ .....+.
T Consensus 188 ~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (322)
T KOG1164|consen 188 RPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPE 267 (322)
T ss_pred ccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChH
Confidence 0000001346799999999999999999999999999999999999999987654333333322222111 1233556
Q ss_pred HHHHHHHhhccCCcCCcCCc
Q 035930 775 HARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 775 ~l~dLI~k~L~~DPe~Rpt~ 794 (857)
.+.+++..+-..+...+|..
T Consensus 268 ~~~~~~~~~~~~~~~~~Pdy 287 (322)
T KOG1164|consen 268 EFAKILEYIDSLDYEDKPDY 287 (322)
T ss_pred HHHHHHHHhhccCCcCCCCH
Confidence 77788777777888889884
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-26 Score=268.45 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=198.8
Q ss_pred EEEeEEccCCceEEEEEEEcCCCeEEEEEEecc---cccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDN---DFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 473 ~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k---~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
....++|.|++|.|+.+........++.|.+.. .....+.....+..|+.+-..|.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 567899999999888888776666666665432 11111222222556777777889999998888877776666669
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|||++ +|..++... ..+....+..++.||+.||.|||..||.||||||+|+|+..+|.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~----- 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY----- 472 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeecc-----
Confidence 99999 999888775 2388899999999999999999999999999999999999999999999998622100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
..+..-.....++|
T Consensus 473 ------------------------------------------------------------------~~e~~~~~~~g~~g 486 (601)
T KOG0590|consen 473 ------------------------------------------------------------------PWEKNIHESSGIVG 486 (601)
T ss_pred ------------------------------------------------------------------CcchhhhhhcCccc
Confidence 00111123456789
Q ss_pred CCCccChhhhcCCCCCc-ccceehhhHHHHHHhhCCCCCCCCCChhhh--HHHhhcccc-----CCCCCCCCHHHHHHHH
Q 035930 710 THEYLAPEIIKGEGHGS-SVDWWTFGIFLFELLYGRTPFKGSGNDETL--SNVVSQSLR-----FPGYPVVSFHARDLIR 781 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~-ksDVWSLGvILyELLtGk~PF~g~~~~e~l--~~Iv~~~~~-----~p~~~~is~~l~dLI~ 781 (857)
+-.|+|||++.+..|+. .+||||.|++++.|++|+.||......+.. ......... ......++.+.+.+|.
T Consensus 487 S~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~ 566 (601)
T KOG0590|consen 487 SDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIY 566 (601)
T ss_pred CCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHH
Confidence 99999999999999955 789999999999999999999866544332 111111111 1112446778899999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
+||+.||.+|.+ +++|++.+||+.++
T Consensus 567 ~~l~~~P~~R~t----i~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 567 RMLQLDPTKRIT----IEQILNDEWIRSIE 592 (601)
T ss_pred HHccCChhheec----HHHHhhChHhhhcc
Confidence 999999999999 99999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=236.96 Aligned_cols=142 Identities=23% Similarity=0.200 Sum_probs=114.0
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcC-CCeEEEEEEeccccc--ccccchhHHHHHHHHHHHcCCCCccc-cceeeeeCC
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIG-TSCLFALKVMDNDFL--VGRKKMPRAQTEREIMQMLDHPFLPT-LFAHFTTEK 543 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~-tg~~VAVKvi~k~~~--~~~~~~~~~~~EieILr~L~HPnIV~-L~~~f~~~~ 543 (857)
...+|.+.+.||+|+||+||+|.+.. ++..||||++..... ........+.+|+++|+.++|+||+. ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 34679999999999999999999876 677889998753211 11223456899999999999999985 4432 4
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccC-CCCcEEEccCCcEEEecccchhhc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDL-KPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDL-KPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
..||||||++|++|... . . .. ...++.|++.+|.|||++||+|||| ||+|||++.++.++|+|||+|..+
T Consensus 92 ~~~LVmE~~~G~~L~~~-~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred CcEEEEEccCCCCHHHh-C--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 57999999999999632 1 1 11 1457889999999999999999999 999999999999999999998653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=209.41 Aligned_cols=252 Identities=19% Similarity=0.271 Sum_probs=195.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCC-CCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH-PFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~H-PnIV~L~~~f~~~~~l 545 (857)
+....|.++++||.|+||.+|+|.....|..||||+-... ..-..+..|..+.+.|++ ..|+.+..++.+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-----CCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 5567899999999999999999999999999999987554 223346779999999974 6888999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC---CcEEEecccchhhc
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED---GHIMLSDFDLSLRC 622 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d---g~iKL~DFGLA~r~ 622 (857)
.|||+++ |.+|.++..-... .|+...+..++.|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||||+++
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeeecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9999999 9999988876543 48999999999999999999999999999999999999643 46899999999764
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.....- . .-.-.
T Consensus 165 ~d~~t~-------------------------~-------------------------------------------HIpyr 176 (341)
T KOG1163|consen 165 RDIRTR-------------------------Q-------------------------------------------HIPYR 176 (341)
T ss_pred cccccc-------------------------c-------------------------------------------cCccc
Confidence 321100 0 00001
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC---ChhhhHHHhhccccCCC---CCCCCHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG---NDETLSNVVSQSLRFPG---YPVVSFHA 776 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~---~~e~l~~Iv~~~~~~p~---~~~is~~l 776 (857)
......||..|.+--...|...+.+.|+-|+|.+|.++.-|..||.+.. ..+-+..|.......+. -..+|.++
T Consensus 177 e~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF 256 (341)
T KOG1163|consen 177 EDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEF 256 (341)
T ss_pred cCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHH
Confidence 1245679999999888888888999999999999999999999999864 33445555554444332 23466677
Q ss_pred HHHHHhhccCCcCCcCC
Q 035930 777 RDLIRGLLVKEPDNRLG 793 (857)
Q Consensus 777 ~dLI~k~L~~DPe~Rpt 793 (857)
.-.+.-|=..--++-|.
T Consensus 257 ~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 257 AMYLNYCRGLGFEEKPD 273 (341)
T ss_pred HHHHHHHhhcCCCCCCc
Confidence 77776665544444444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-22 Score=211.50 Aligned_cols=208 Identities=23% Similarity=0.409 Sum_probs=173.0
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~L 547 (857)
.-+|+++++||+|.||.+++|...-++..||||.-... .....+..|....+.|. .+.|+..|.+...+.+-.|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 34899999999999999999999999999999975432 34556788888888885 7899999988888888999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC-----cEEEecccchhhc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG-----HIMLSDFDLSLRC 622 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg-----~iKL~DFGLA~r~ 622 (857)
|||++ |.+|.++..-... .|+...+..++.|++.-++|+|++.+|+|||||+|+||...+ .|.|+|||+|+..
T Consensus 102 VidLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 99999 9999988876653 499999999999999999999999999999999999996543 5899999999653
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.. |..+. .+ .-.
T Consensus 180 rD-------------p~Tkq-----------------------------------------HI--------------PYr 191 (449)
T KOG1165|consen 180 RD-------------PKTKQ-----------------------------------------HI--------------PYR 191 (449)
T ss_pred cC-------------ccccc-----------------------------------------cC--------------ccc
Confidence 21 11000 00 001
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG 751 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~ 751 (857)
...+..||-.||+--..+|...+.+.|+-|||-++++.|-|..||.|..
T Consensus 192 E~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 192 EHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 1245679999999999999999999999999999999999999998863
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-22 Score=212.76 Aligned_cols=237 Identities=24% Similarity=0.316 Sum_probs=152.8
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCC----------CCccccceee
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH----------PFLPTLFAHF 539 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~H----------PnIV~L~~~f 539 (857)
+.+...+.||.|+|+.||.+++.++++.+|||++..........++.+.+|.-....+.+ -.++--++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 357788999999999999999999999999999866554455566666666654444322 1122222221
Q ss_pred ---------eeC---C-----eEEEEEeecCCCChHHHHhh---CCCC--CCcHHHHHHHHHHHHHHHHHHHHcCceecc
Q 035930 540 ---------TTE---K-----FSCLVMEYCPGGDLHVLRQK---QPSR--FFSEQAARFYVAEVLLALEYLHMLGVVYRD 597 (857)
Q Consensus 540 ---------~~~---~-----~l~LVmEy~~gGsL~~ll~~---~~~~--~l~e~~~r~i~~QIl~gL~yLHs~GIIHRD 597 (857)
... . ..+++|+-+ -++|..++.. .... .+.......+..|++..+++||..||||+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 111 1 337788888 6788766432 2111 122233344558999999999999999999
Q ss_pred CCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHh
Q 035930 598 LKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAK 677 (857)
Q Consensus 598 LKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~ 677 (857)
|+|+|+|++.+|.++|+||+...+...
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~----------------------------------------------------- 197 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT----------------------------------------------------- 197 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE-----------------------------------------------------
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc-----------------------------------------------------
Confidence 999999999999999999997644110
Q ss_pred hhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcC--------CCCCcccceehhhHHHHHHhhCCCCCCC
Q 035930 678 SRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKG--------EGHGSSVDWWTFGIFLFELLYGRTPFKG 749 (857)
Q Consensus 678 ~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g--------~~~s~ksDVWSLGvILyELLtGk~PF~g 749 (857)
.......+..|.+||.... ..++.+.|.|+||++||.|++|+.||..
T Consensus 198 -------------------------~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 198 -------------------------RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp -------------------------EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred -------------------------eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 0000123467899997743 2468899999999999999999999987
Q ss_pred CCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCc
Q 035930 750 SGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791 (857)
Q Consensus 750 ~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~R 791 (857)
......... .|..-..++..+++||++||++||++|
T Consensus 253 ~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 253 SSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 643322221 233333688999999999999999998
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-22 Score=216.63 Aligned_cols=211 Identities=25% Similarity=0.290 Sum_probs=154.9
Q ss_pred CCCCccccceeeeeC---------------------------CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHH
Q 035930 528 DHPFLPTLFAHFTTE---------------------------KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAE 580 (857)
Q Consensus 528 ~HPnIV~L~~~f~~~---------------------------~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~Q 580 (857)
.|||||+++.+|.+. ..+|+||..+ .-+|+.++-.+. .+....+.++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 499999999988653 3579999998 568888887654 567788889999
Q ss_pred HHHHHHHHHHcCceeccCCCCcEEE--ccCC--cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCc
Q 035930 581 VLLALEYLHMLGVVYRDLKPENILV--REDG--HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPF 656 (857)
Q Consensus 581 Il~gL~yLHs~GIIHRDLKPeNILL--~~dg--~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~ 656 (857)
+++|+.|||++||.|||||.+|||+ ++|+ .+.|+|||.+..+....
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hG------------------------------ 399 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHG------------------------------ 399 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccc------------------------------
Confidence 9999999999999999999999999 4444 57899999874432211
Q ss_pred cCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCC-----C-Ccccce
Q 035930 657 CLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEG-----H-GSSVDW 730 (857)
Q Consensus 657 ~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~-----~-s~ksDV 730 (857)
|+.... . .....-|.-..||||+....+ . -.++|.
T Consensus 400 -----lqlpy~--------------------------S--------~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~ 440 (598)
T KOG4158|consen 400 -----LQLPYE--------------------------S--------DEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADT 440 (598)
T ss_pred -----cccccc--------------------------c--------ccccCCCcceecchhhhhcCCCCceeeccchhhh
Confidence 111100 0 011223677789999987543 1 337899
Q ss_pred ehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 731 WTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 731 WSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
|+.|.+.||++....||++.+....-..-.++..-++.+..+++.+++||..+|+.||.+|++. ..++.+|+.-.|..-
T Consensus 441 WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp-~iAANvl~LsLw~~~ 519 (598)
T KOG4158|consen 441 WAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP-NIAANVLNLSLWRMG 519 (598)
T ss_pred hhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc-cHHHhHHHHHHhcCc
Confidence 9999999999999999998543222112222223334456799999999999999999999984 346778877767666
Q ss_pred Ch
Q 035930 811 NW 812 (857)
Q Consensus 811 ~w 812 (857)
+|
T Consensus 520 ~~ 521 (598)
T KOG4158|consen 520 ED 521 (598)
T ss_pred hH
Confidence 66
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.1e-22 Score=201.63 Aligned_cols=141 Identities=23% Similarity=0.250 Sum_probs=109.4
Q ss_pred EeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccc-----------------------hhHHHHHHHHHHHcCCCC
Q 035930 475 HKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKK-----------------------MPRAQTEREIMQMLDHPF 531 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~-----------------------~~~~~~EieILr~L~HPn 531 (857)
...||+|+||+||+|.+. +|+.||||+++......... ......|+++|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999996 89999999997653211110 012245999999998888
Q ss_pred ccccceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHH-HHcCceeccCCCCcEEEccCCc
Q 035930 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL-HMLGVVYRDLKPENILVREDGH 610 (857)
Q Consensus 532 IV~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yL-Hs~GIIHRDLKPeNILL~~dg~ 610 (857)
+...+.+... . .+|||||++|+++....... ..+++..+..++.||+.+|.|| |..|||||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 7554433322 2 38999999888776543322 2488999999999999999999 799999999999999998 588
Q ss_pred EEEecccchhh
Q 035930 611 IMLSDFDLSLR 621 (857)
Q Consensus 611 iKL~DFGLA~r 621 (857)
++|+|||+|..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=203.61 Aligned_cols=140 Identities=19% Similarity=0.192 Sum_probs=114.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhH------HHHHHHHHHHcCCCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPR------AQTEREIMQMLDHPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~------~~~EieILr~L~HPnIV~L~~~f~ 540 (857)
+...+|++.++||.|+||.||++.+ ++..+|||+++......+..... +.+|+..+.++.|++|+.+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4467999999999999999999766 35579999997654433333333 578888999999999999999876
Q ss_pred eC--------CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEE
Q 035930 541 TE--------KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIM 612 (857)
Q Consensus 541 ~~--------~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iK 612 (857)
.. +..+|||||++|.+|.++.. +++. ...+|+.+|..||..||+|||+||+||+++.+| ++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence 43 35799999999999977632 3332 355999999999999999999999999999988 99
Q ss_pred Eecccch
Q 035930 613 LSDFDLS 619 (857)
Q Consensus 613 L~DFGLA 619 (857)
|+|||..
T Consensus 175 liDfg~~ 181 (232)
T PRK10359 175 IIDLSGK 181 (232)
T ss_pred EEECCCc
Confidence 9999975
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-22 Score=236.65 Aligned_cols=244 Identities=24% Similarity=0.337 Sum_probs=180.6
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccc-cccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDF-LVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~-~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
+|...+.||.+.|=+|.+|++.+ | .|+|||+-+.. ...-....+...|++ ...++|||++.+.-+-..+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 68888999999999999999864 4 38999985542 112222233334444 55668999999998888888999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
+|+ .-+|++.+..++ ++..-+.++|+.||+.||.-+|..||+|+|||.|||||+.-..+.|+||.-- +|..+
T Consensus 101 qyv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsF-----KPtYL 172 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASF-----KPTYL 172 (1431)
T ss_pred HHH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhccccc-----CCccC
Confidence 999 678998887765 4888899999999999999999999999999999999999999999999743 23322
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
+.- .....+-|..
T Consensus 173 PeD-------------------------------------------------------------------NPadf~fFFD 185 (1431)
T KOG1240|consen 173 PED-------------------------------------------------------------------NPADFTFFFD 185 (1431)
T ss_pred CCC-------------------------------------------------------------------CcccceEEEe
Confidence 111 1111111222
Q ss_pred C----CCccChhhhcCC----------C-CCcccceehhhHHHHHHhh-CCCCCCCC-------CChhhhHHHhhccccC
Q 035930 710 T----HEYLAPEIIKGE----------G-HGSSVDWWTFGIFLFELLY-GRTPFKGS-------GNDETLSNVVSQSLRF 766 (857)
Q Consensus 710 T----~~YmAPEil~g~----------~-~s~ksDVWSLGvILyELLt-Gk~PF~g~-------~~~e~l~~Iv~~~~~~ 766 (857)
| ..|+|||.+... + .+.+.||||+||+++||++ |++||.-. ++......++.+
T Consensus 186 TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~---- 261 (1431)
T KOG1240|consen 186 TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEK---- 261 (1431)
T ss_pred cCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHh----
Confidence 2 359999988542 2 5678999999999999997 78888521 111111222221
Q ss_pred CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 767 PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 767 p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
.-+..+++||..|++.||.+|++ |+++|+.
T Consensus 262 ----Ied~~~Rnlil~Mi~rdPs~RlS----AedyL~~ 291 (1431)
T KOG1240|consen 262 ----IEDVSLRNLILSMIQRDPSKRLS----AEDYLQK 291 (1431)
T ss_pred ----CcCccHHHHHHHHHccCchhccC----HHHHHHh
Confidence 13447899999999999999999 9999986
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.5e-21 Score=193.64 Aligned_cols=140 Identities=21% Similarity=0.204 Sum_probs=110.8
Q ss_pred EeEEccCCceEEEEEEEcCCCeEEEEEEeccccccccc------------------c-----hhHHHHHHHHHHHcCCCC
Q 035930 475 HKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRK------------------K-----MPRAQTEREIMQMLDHPF 531 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~------------------~-----~~~~~~EieILr~L~HPn 531 (857)
...||+|+||+||+|.+. +|+.||||+++........ . ...+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 8999999999865211000 0 112357889999999998
Q ss_pred ccccceeeeeCCeEEEEEeecCCCChHHH-HhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCC
Q 035930 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVL-RQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDG 609 (857)
Q Consensus 532 IV~L~~~f~~~~~l~LVmEy~~gGsL~~l-l~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg 609 (857)
|.....+.... .||||||++|+++... +.. ..+++..+..++.|++.+|.|||. .||+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 86555444333 4899999988865433 332 237888999999999999999999 9999999999999998 89
Q ss_pred cEEEecccchhh
Q 035930 610 HIMLSDFDLSLR 621 (857)
Q Consensus 610 ~iKL~DFGLA~r 621 (857)
.++|+|||++..
T Consensus 155 ~~~liDFG~a~~ 166 (190)
T cd05145 155 KPYIIDVSQAVE 166 (190)
T ss_pred CEEEEEccccee
Confidence 999999999865
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-21 Score=201.86 Aligned_cols=242 Identities=18% Similarity=0.306 Sum_probs=200.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+......++.+|.+...|..|+|+++++. ++.|+++-.... .....+|..|.-.|+.+.||||+.+++.|....++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 34455677889999999999999998776 667887654333 233456788888899999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEccCCcEEE--ecccchhhc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG--VVYRDLKPENILVREDGHIML--SDFDLSLRC 622 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G--IIHRDLKPeNILL~~dg~iKL--~DFGLA~r~ 622 (857)
++..||+.|+|+.+++.+..-..+..++..++.+|++|++|||+.. |.---|....+++|++-..+| +|--++..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq- 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ- 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence 9999999999999999887666788899999999999999999875 444467888899988766554 33222110
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
T Consensus 343 -------------------------------------------------------------------------------- 342 (448)
T KOG0195|consen 343 -------------------------------------------------------------------------------- 342 (448)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCCCccChhhhcCCCCC---cccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHG---SSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDL 779 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s---~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dL 779 (857)
.....-.|.||+||.+...+.+ .++|+|||+++||||.|...||....+.+.-.++..++++...++.++.....|
T Consensus 343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHH
Confidence 0112346889999999877653 478999999999999999999999999999889999999988889999999999
Q ss_pred HHhhccCCcCCcCC
Q 035930 780 IRGLLVKEPDNRLG 793 (857)
Q Consensus 780 I~k~L~~DPe~Rpt 793 (857)
|.-|+..||.+||.
T Consensus 422 m~icmnedpgkrpk 435 (448)
T KOG0195|consen 422 MNICMNEDPGKRPK 435 (448)
T ss_pred HHHHhcCCCCcCCC
Confidence 99999999999998
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-20 Score=191.85 Aligned_cols=202 Identities=22% Similarity=0.233 Sum_probs=141.1
Q ss_pred EEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccccc-chhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEEEe
Q 035930 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRK-KMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 473 ~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~-~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.+...|+.|+||+||++.. .+..++.+.+......... ....+.+|+++|++|+ |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4568999999999998765 5666777766544221111 1225789999999995 5889999886 34699999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccC-CCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDL-KPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDL-KPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|+.|.+|...... . ...++.|++.+|++||.+||||||| ||+|||++.+|.++|+|||+|........
T Consensus 79 yI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~-- 147 (218)
T PRK12274 79 YLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR-- 147 (218)
T ss_pred eecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch--
Confidence 9999998643321 1 1346789999999999999999999 79999999999999999999853211000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
+. +++. .+|+..... .....
T Consensus 148 -------------------------------------~~-r~L~--------~rDl~~llk--------------~~~~y 167 (218)
T PRK12274 148 -------------------------------------WM-RLLA--------REDLRHLLK--------------HKRMY 167 (218)
T ss_pred -------------------------------------HH-HHHH--------HHHHHHHHH--------------HHHhc
Confidence 00 0000 011111000 01126
Q ss_pred CCCccChhhhcCC-CCC-cccceehhhHHHHHHhhCCCCCCCCC
Q 035930 710 THEYLAPEIIKGE-GHG-SSVDWWTFGIFLFELLYGRTPFKGSG 751 (857)
Q Consensus 710 T~~YmAPEil~g~-~~s-~ksDVWSLGvILyELLtGk~PF~g~~ 751 (857)
++.|+.|+...-. ..+ .+.+|++.|+-+|.++|++.++.+.+
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 168 CPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 8899999975433 223 56799999999999999999987654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.9e-20 Score=221.02 Aligned_cols=198 Identities=26% Similarity=0.397 Sum_probs=161.1
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC---CCCccccceeeeeC
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD---HPFLPTLFAHFTTE 542 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~---HPnIV~L~~~f~~~ 542 (857)
.++...|.|.+.||+|+||+||+|.... |+.||||+-+..... ++.--.+++.+|. -+.|+.+..++.-.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W------EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW------EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce------eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4567789999999999999999999876 999999987654321 1222334444554 34566777777777
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc-------CCcEEEec
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE-------DGHIMLSD 615 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~-------dg~iKL~D 615 (857)
+..+||+||.+.|+|.+++.. .+.+++..+.+++.|++..|++||..+|||+||||+|+||.. ..-++|+|
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 778999999999999999984 355999999999999999999999999999999999999953 23589999
Q ss_pred ccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcc
Q 035930 616 FDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQL 695 (857)
Q Consensus 616 FGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l 695 (857)
||.+..+.
T Consensus 845 fG~siDm~------------------------------------------------------------------------ 852 (974)
T KOG1166|consen 845 FGRSIDMK------------------------------------------------------------------------ 852 (974)
T ss_pred cccceeee------------------------------------------------------------------------
Confidence 99875432
Q ss_pred cccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCC
Q 035930 696 VVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRT 745 (857)
Q Consensus 696 ~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~ 745 (857)
.-+.+.++..+++|-.+-.+|+..|.+|++.+|.|.|+.++|-||+|++
T Consensus 853 -lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 853 -LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred -EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 1223345667789999999999999999999999999999999999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=224.21 Aligned_cols=312 Identities=32% Similarity=0.495 Sum_probs=234.8
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
...|.+.+.+-.|.|+.++.+.-..+|...++|+............+....+-.++-...||.+++...-|......+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 45678888999999999999988888888888877655444344444445555555555678888877777778899999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|+|+.+++|...++..+ ..+++.++.++..+.++++|||...++|||++|.|+|...+|+.+++|||+......-+.+
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999988887765 3788889999999999999999999999999999999999999999999954322111111
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
...+ ++...+ .+.-...+. ..+++..+ ...+....+
T Consensus 961 ~~~s------------g~~~~~---~~~~~~~~~----------------------------~~~~l~~~-~~~~~~~~~ 996 (1205)
T KOG0606|consen 961 TDLS------------GPSSSG---TPRRLSRSE----------------------------RRPQLSAD-EARRKHAVV 996 (1205)
T ss_pred CCcc------------cccccC---ccccccccc----------------------------cccccccc-hhhcccccc
Confidence 1000 000000 000000000 00011111 112345678
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCC-CCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGY-PVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~-~~is~~l~dLI~k~L~~D 787 (857)
||+.|.+||.+.+..++.++|||++|++++|.++|.+||.....+.++.++......+|.. ...+..+++++..+|..+
T Consensus 997 ~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~ 1076 (1205)
T KOG0606|consen 997 GTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEE 1076 (1205)
T ss_pred CCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccC
Confidence 9999999999999999999999999999999999999999999999999999998888874 457889999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSC 827 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~~ 827 (857)
|.+|.++ .++.++..|+||+.++|+-+.-..-+++|...
T Consensus 1077 ~~qr~~a-~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~ 1115 (1205)
T KOG0606|consen 1077 PTQRLGA-KGAAEVKGHPFFQDVDWENLALQKAEFVPQPE 1115 (1205)
T ss_pred chhccCc-ccccccccCCccCCCCccccccccCccCCCCC
Confidence 9999993 44569999999999999977544444555443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-19 Score=184.74 Aligned_cols=135 Identities=19% Similarity=0.210 Sum_probs=106.9
Q ss_pred EEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-----CCCCccccceeeeeCC---eE
Q 035930 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-----DHPFLPTLFAHFTTEK---FS 545 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-----~HPnIV~L~~~f~~~~---~l 545 (857)
-.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.+|+.+ +||||+++|+++.++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 357899999999996 6666655 699886532 22346689999999999 5799999999999874 43
Q ss_pred E-EEEee--cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHH-HHHHHcCceeccCCCCcEEEccC----CcEEEeccc
Q 035930 546 C-LVMEY--CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLAL-EYLHMLGVVYRDLKPENILVRED----GHIMLSDFD 617 (857)
Q Consensus 546 ~-LVmEy--~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL-~yLHs~GIIHRDLKPeNILL~~d----g~iKL~DFG 617 (857)
+ +|||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3 78999 5579999999763 26665 35678888888 99999999999999999999743 379999955
Q ss_pred ch
Q 035930 618 LS 619 (857)
Q Consensus 618 LA 619 (857)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 43
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=183.24 Aligned_cols=145 Identities=26% Similarity=0.235 Sum_probs=112.1
Q ss_pred CCeEEEeEEccCCceEEEEEE-EcCCCeEEEEEEeccccccccc---------------------chhHHHHHHHHHHHc
Q 035930 470 RHFKLHKKLGCGDIGTVYLAE-LIGTSCLFALKVMDNDFLVGRK---------------------KMPRAQTEREIMQML 527 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~-~~~tg~~VAVKvi~k~~~~~~~---------------------~~~~~~~EieILr~L 527 (857)
..|.+.+.||.|+||.||+|. +..+|+.||||+++........ ....+.+|+++++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999998 6678999999998754211000 012356899999999
Q ss_pred CCC--CccccceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC-ceeccCCCCcEE
Q 035930 528 DHP--FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG-VVYRDLKPENIL 604 (857)
Q Consensus 528 ~HP--nIV~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G-IIHRDLKPeNIL 604 (857)
.+. .++.++++ . ..||||||++|++|..+..... .+....+..++.||+.+|.|||..| |+||||||+|||
T Consensus 108 ~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 108 YEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred HhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 753 23344432 2 3489999999988865543222 2566677889999999999999999 999999999999
Q ss_pred EccCCcEEEecccchhh
Q 035930 605 VREDGHIMLSDFDLSLR 621 (857)
Q Consensus 605 L~~dg~iKL~DFGLA~r 621 (857)
++ ++.++|+|||++..
T Consensus 182 i~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 182 VH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EE-CCCEEEEEChhhhc
Confidence 99 88999999999853
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.3e-18 Score=171.63 Aligned_cols=136 Identities=22% Similarity=0.231 Sum_probs=112.9
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccc-----cchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR-----KKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~-----~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
+.||+|++|.||+|.+ .+..+++|+......... .....+.+|++++..+.|++|+....++...+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 556799998654322111 112356789999999999999888888877888899999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
|++|++|.+++.... . ....++.+++.+|.+||..||+||||+|.|||++ ++.++|+|||++.
T Consensus 80 ~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 999999998886532 2 7788899999999999999999999999999999 8899999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=167.37 Aligned_cols=132 Identities=23% Similarity=0.251 Sum_probs=106.5
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEeccccccc-----ccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEee
Q 035930 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG-----RKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEY 551 (857)
Q Consensus 477 ~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~-----~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy 551 (857)
.||+|+||+||++.+ ++..+++|+........ .....++.+|+++++.+.|+++.....++...+..+|||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999985 45679999865432111 11235567899999999988776666666677778999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
++|++|.+++.... . .++.|++.+|.+||..||+|+|++|.|||++ ++.++|+|||++.
T Consensus 79 ~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 79 IEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred ECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 99999988765421 1 7788999999999999999999999999999 8999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-17 Score=169.57 Aligned_cols=139 Identities=25% Similarity=0.216 Sum_probs=108.0
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc-------------------cchhHHHHHHHHHHHcCCCC
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR-------------------KKMPRAQTEREIMQMLDHPF 531 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~-------------------~~~~~~~~EieILr~L~HPn 531 (857)
.|.+.+.||.|+||.||++.+. +|+.||||+++....... .....+..|..++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888999999999999999874 789999999765320000 00113567888999998774
Q ss_pred --ccccceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC
Q 035930 532 --LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG 609 (857)
Q Consensus 532 --IV~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg 609 (857)
++.+++ ....|+||||++|++|..+... .....++.+++.+|.++|..||+||||||+|||++.++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 444443 2345899999999998665321 23567888999999999999999999999999999999
Q ss_pred cEEEecccchhhc
Q 035930 610 HIMLSDFDLSLRC 622 (857)
Q Consensus 610 ~iKL~DFGLA~r~ 622 (857)
.++|+|||++..+
T Consensus 163 ~~~liDfg~~~~~ 175 (198)
T cd05144 163 KIYIIDWPQMVST 175 (198)
T ss_pred cEEEEECCccccC
Confidence 9999999998554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.6e-19 Score=207.07 Aligned_cols=262 Identities=26% Similarity=0.377 Sum_probs=204.1
Q ss_pred CeEEEeEEccCCceEEEEEEEcC-CCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIG-TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~-tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LV 548 (857)
.|.+.+.||+|+|+.|-+..... ....+|+|.+.... ...........|..+-+.+. |+|++.+++...+.+..+++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 46777889999999999987754 34567777665543 22333445556777777787 99999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEEccCC-cEEEecccchhhcccCc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH-MLGVVYRDLKPENILVREDG-HIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLH-s~GIIHRDLKPeNILL~~dg-~iKL~DFGLA~r~~~~~ 626 (857)
++|..|+++...+.......++...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .+++.|||+|......
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~- 178 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK- 178 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc-
Confidence 99999999988773222224778888999999999999999 99999999999999999999 9999999998432110
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.........
T Consensus 179 -----------------------------------------------------------------------~g~~~~~~~ 187 (601)
T KOG0590|consen 179 -----------------------------------------------------------------------NGAERSLKD 187 (601)
T ss_pred -----------------------------------------------------------------------CCcceeeec
Confidence 001111234
Q ss_pred ccC-CCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCChhhh-HHHhhc--cccCCCCCCCCHHHHHHHH
Q 035930 707 FVG-THEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETL-SNVVSQ--SLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 707 ~vG-T~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l-~~Iv~~--~~~~p~~~~is~~l~dLI~ 781 (857)
.+| ++.|+|||.+.+..| ....|+||.|+++.-+++|..|+......... ...... .+....+..++..+.+++.
T Consensus 188 ~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (601)
T KOG0590|consen 188 RCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLH 267 (601)
T ss_pred ccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhccc
Confidence 467 999999999998544 78999999999999999999999765433321 222222 1224445678899999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
++|..+|..|.+ .+++..+||+..
T Consensus 268 k~l~~~~~~r~s----~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 268 KILKENPSNRLS----IEELKLDNWLSS 291 (601)
T ss_pred ccccCCchhccc----cccccccccccc
Confidence 999999999999 999999999998
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.7e-17 Score=191.84 Aligned_cols=139 Identities=24% Similarity=0.260 Sum_probs=111.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc-----cccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV-----GRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~-----~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
..|...+.||+|+||+||++.+.+.. +++|+....... ......++.+|+++|+.++|++|+..+.++.+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 45577899999999999999886554 444432211111 11123567889999999999999988888877778
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
.++||||++|++|.+++. ....++.|++.+|.|||+.||+||||||+|||+ .++.++|+|||++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999988775 346788999999999999999999999999999 678999999999854
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.9e-18 Score=193.77 Aligned_cols=185 Identities=28% Similarity=0.427 Sum_probs=137.2
Q ss_pred CeEEEEEeecCCCChHHHHhhC-CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQ-PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~-~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
.++||.|++|...+|.+|+.+. .....+......++.|+..|++| +|.+|||+||.||++..+..+||.||||...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 3689999999999999999743 33346778889999999999999 9999999999999999999999999999743
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
....+ + .-+..
T Consensus 406 ~~~~~------------~---------------------------------------------------------~~~~~ 416 (516)
T KOG1033|consen 406 QDKDE------------T---------------------------------------------------------VAPAA 416 (516)
T ss_pred cccCC------------c---------------------------------------------------------ccchh
Confidence 22110 0 00011
Q ss_pred CccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHH
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLI 780 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI 780 (857)
+..+..+||+.||+||+|.|..|+.++|||+||+|||||+. =...|... ..+..+..+.++ |....--+.-.+|+
T Consensus 417 a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~ip-~~~~~d~p~e~~ll 492 (516)
T KOG1033|consen 417 ASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGIIP-PEFLQDYPEEYTLL 492 (516)
T ss_pred hhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCCCC-hHHhhcCcHHHHHH
Confidence 22345679999999999999999999999999999999997 44444322 122222222222 11111224456899
Q ss_pred HhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
..||...|.+||+ +.+.-.|+|.
T Consensus 493 ~~lls~~p~~RP~----~~~~~~~~~~ 515 (516)
T KOG1033|consen 493 QQLLSPSPEERPS----AIEVALHEFL 515 (516)
T ss_pred HHhcCCCcccCch----HHHHhhhhhc
Confidence 9999999999997 7777777764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-16 Score=159.50 Aligned_cols=137 Identities=23% Similarity=0.232 Sum_probs=98.0
Q ss_pred EeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchh---------------------HHHHHHHHHHHcCCCC--
Q 035930 475 HKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP---------------------RAQTEREIMQMLDHPF-- 531 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~---------------------~~~~EieILr~L~HPn-- 531 (857)
.+.||+|+||+||+|.+. ++..||||++............ ....|.+.+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999886 7889999998754221111111 1135666666665433
Q ss_pred ccccceeeeeCCeEEEEEeecCCCChHH-HHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCC
Q 035930 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDG 609 (857)
Q Consensus 532 IV~L~~~f~~~~~l~LVmEy~~gGsL~~-ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg 609 (857)
++.++++ ...||||||++++.+.. .+.... . ...++.++.+++.++.+||. +||+||||||+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 3444432 23589999999865421 111110 1 15678899999999999999 9999999999999999 99
Q ss_pred cEEEecccchhh
Q 035930 610 HIMLSDFDLSLR 621 (857)
Q Consensus 610 ~iKL~DFGLA~r 621 (857)
.++|+|||.+..
T Consensus 152 ~~~liDfg~a~~ 163 (187)
T cd05119 152 KVYIIDVPQAVE 163 (187)
T ss_pred cEEEEECccccc
Confidence 999999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-15 Score=161.18 Aligned_cols=136 Identities=25% Similarity=0.282 Sum_probs=104.1
Q ss_pred eEEc-cCCceEEEEEEEcCCCeEEEEEEeccccc----------ccccchhHHHHHHHHHHHcCCCCc--cccceeeeeC
Q 035930 476 KKLG-CGDIGTVYLAELIGTSCLFALKVMDNDFL----------VGRKKMPRAQTEREIMQMLDHPFL--PTLFAHFTTE 542 (857)
Q Consensus 476 ~~LG-~G~fGtVyla~~~~tg~~VAVKvi~k~~~----------~~~~~~~~~~~EieILr~L~HPnI--V~L~~~f~~~ 542 (857)
..|| .|+.|+||.+... +..++||.+....+ .......++.+|++++..|.|++| +..+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 5677 7888899998774 56799998854321 011223567889999999998875 6667665433
Q ss_pred C----eEEEEEeecCC-CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEeccc
Q 035930 543 K----FSCLVMEYCPG-GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFD 617 (857)
Q Consensus 543 ~----~l~LVmEy~~g-GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFG 617 (857)
. ..+|||||++| .+|..++... .+++.. +.||+.+|.+||.+||+||||||+|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 23599999997 6898887653 255543 5689999999999999999999999999999999999999
Q ss_pred chh
Q 035930 618 LSL 620 (857)
Q Consensus 618 LA~ 620 (857)
.+.
T Consensus 188 ~~~ 190 (239)
T PRK01723 188 RGE 190 (239)
T ss_pred Ccc
Confidence 874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-15 Score=143.68 Aligned_cols=131 Identities=26% Similarity=0.291 Sum_probs=110.8
Q ss_pred EEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCC--CCccccceeeeeCCeEEEEEee
Q 035930 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH--PFLPTLFAHFTTEKFSCLVMEY 551 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~H--PnIV~L~~~f~~~~~l~LVmEy 551 (857)
+.+.||.|.++.||++...+ ..+++|++..... ...+..|+.+++.+.| .++++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999999854 6799999865421 4567899999999976 5899999998888899999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEccCCcEEEecccchh
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML---GVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~---GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
++|+.+..+ +......++.+++.+|++||.. +++|+||+|+|||++.++.++|+|||++.
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 988877543 3455667788999999999984 79999999999999998999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.4e-15 Score=172.43 Aligned_cols=197 Identities=21% Similarity=0.278 Sum_probs=147.7
Q ss_pred HHHcCCCCccccceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCc-eeccCCCCc
Q 035930 524 MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV-VYRDLKPEN 602 (857)
Q Consensus 524 Lr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GI-IHRDLKPeN 602 (857)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.... ..+++--...++++|+.||.|||.--| .|+.|+..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 467889999999999999999999999999999999998744 337777778888999999999997655 999999999
Q ss_pred EEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhh
Q 035930 603 ILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIK 682 (857)
Q Consensus 603 ILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~ 682 (857)
++++....+||+|||+....... +..
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~-------------------------------~~~----------------------- 105 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEET-------------------------------AEP----------------------- 105 (484)
T ss_pred ceeeeeEEEEechhhhccccccc-------------------------------ccc-----------------------
Confidence 99999999999999985221000 000
Q ss_pred hhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCC-------CCcccceehhhHHHHHHhhCCCCCCCCCC---
Q 035930 683 SDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEG-------HGSSVDWWTFGIFLFELLYGRTPFKGSGN--- 752 (857)
Q Consensus 683 ~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~-------~s~ksDVWSLGvILyELLtGk~PF~g~~~--- 752 (857)
.. .....-..-|.|||.+.+.. .+.+.||||||+++||+++...||.....
T Consensus 106 -----------------~~--~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~ 166 (484)
T KOG1023|consen 106 -----------------EA--HHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVED 166 (484)
T ss_pred -----------------cc--cchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCC
Confidence 00 00000224589999998742 35679999999999999999999986432
Q ss_pred -hhhhHHHhhccccC--CC---CCCCCHHHHHHHHhhccCCcCCcCCc
Q 035930 753 -DETLSNVVSQSLRF--PG---YPVVSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 753 -~e~l~~Iv~~~~~~--p~---~~~is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
.+++..+....... |. ...+.+++..+++.||..+|+.||+.
T Consensus 167 ~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 167 PDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred hHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 23444433312221 11 11345579999999999999999994
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2e-13 Score=157.18 Aligned_cols=262 Identities=21% Similarity=0.242 Sum_probs=192.6
Q ss_pred CCeEEEeEEcc--CCceEEEEEEE--cCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCe
Q 035930 470 RHFKLHKKLGC--GDIGTVYLAEL--IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKF 544 (857)
Q Consensus 470 ~~Y~i~~~LG~--G~fGtVyla~~--~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~ 544 (857)
..|.+...+|. |.+|.||.+.. ..++..+|+|.-+...- ....-.+-.+|..-.+.++ |+|.++.+..|...+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccCCc
Confidence 45778899999 99999999988 88899999997433221 1122223356666666665 9999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHH----HHHHHHHcCceeccCCCCcEEEccC-CcEEEecccch
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLL----ALEYLHMLGVVYRDLKPENILVRED-GHIMLSDFDLS 619 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~----gL~yLHs~GIIHRDLKPeNILL~~d-g~iKL~DFGLA 619 (857)
.|+-+|++ +.+|..+.... ...+++..++..+.+... ||.++|..+|+|-|+||.||++..+ ...+++|||+.
T Consensus 193 lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred ceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 99999999 68887776643 344888999999999999 9999999999999999999999999 88999999986
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
........ .. .|
T Consensus 271 ~~i~~~~~----------------~~--------------------~~-------------------------------- 282 (524)
T KOG0601|consen 271 SKISDGNF----------------SS--------------------VF-------------------------------- 282 (524)
T ss_pred EEccCCcc----------------cc--------------------ce--------------------------------
Confidence 43211100 00 00
Q ss_pred CCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHH
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDL 779 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dL 779 (857)
.......|...|++||.+.+. ++...|+|+||.++.+..+|-.++....+..+. .+-...++.......+..+...
T Consensus 283 --~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-~~r~~~ip~e~~~~~s~~l~~~ 358 (524)
T KOG0601|consen 283 --KVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-QLRQGYIPLEFCEGGSSSLRSV 358 (524)
T ss_pred --eeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcc-ccccccCchhhhcCcchhhhhH
Confidence 000112366779999999765 888999999999999999987776544222111 1111111111223356667779
Q ss_pred HHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 780 IRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+..|+..+|..|++ +..+++|+|....
T Consensus 359 ~~~~~d~~~~~~~~----~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 359 TSQMLDEDPRLRLT----AQILTALNVIHSK 385 (524)
T ss_pred HHHhcCcchhhhhH----HHHHhccccccch
Confidence 99999999999999 8999999998744
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.8e-13 Score=151.15 Aligned_cols=141 Identities=23% Similarity=0.283 Sum_probs=95.1
Q ss_pred EeEEccCCceEEEEEEEcCCCeEEEEEEeccccccc---------------------cc--ch--------------hHH
Q 035930 475 HKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG---------------------RK--KM--------------PRA 517 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~---------------------~~--~~--------------~~~ 517 (857)
.+.||.|++|+||+|+.. +|+.||||+.+...... .. .. -++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 368999999999999885 78899999986431000 00 00 023
Q ss_pred HHHHHHHHHcC-----CCCc--cccceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHH-HHHHHH
Q 035930 518 QTEREIMQMLD-----HPFL--PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLL-ALEYLH 589 (857)
Q Consensus 518 ~~EieILr~L~-----HPnI--V~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~-gL~yLH 589 (857)
.+|...+.++. +++| +.+| +......+|||||++|++|.++....... +. ...++.+++. .+..+|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~--~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVY--WDRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEe--hhhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHHHH
Confidence 34555555542 3332 2333 22234468999999999998765432211 22 2344555555 467899
Q ss_pred HcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 590 s~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
..|++|+|+||.||+++.+|.++|+|||++..+
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999998553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.7e-13 Score=157.49 Aligned_cols=145 Identities=19% Similarity=0.241 Sum_probs=92.5
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc---------------------cc----------cchhHHH
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV---------------------GR----------KKMPRAQ 518 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~---------------------~~----------~~~~~~~ 518 (857)
..|.. +.||.|++|+||+|+++.+|+.||||+++..... .. +....+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 7999999999999999888999999999754210 00 0111222
Q ss_pred HHHHH------HHHcC----CCCccccceeee-eCCeEEEEEeecCCCChHHHH--hhCCC--CCCcHHHHHHHHHHHHH
Q 035930 519 TEREI------MQMLD----HPFLPTLFAHFT-TEKFSCLVMEYCPGGDLHVLR--QKQPS--RFFSEQAARFYVAEVLL 583 (857)
Q Consensus 519 ~EieI------Lr~L~----HPnIV~L~~~f~-~~~~l~LVmEy~~gGsL~~ll--~~~~~--~~l~e~~~r~i~~QIl~ 583 (857)
+|+++ +.++. +...+.+-.++. .....+|||||+.|+.+.++. ..... ..+.+..+..++.||+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 33333 33331 222222222221 133457999999999997642 22110 1244444445555554
Q ss_pred HHHHHHHcCceeccCCCCcEEEccCC----cEEEecccchhhc
Q 035930 584 ALEYLHMLGVVYRDLKPENILVREDG----HIMLSDFDLSLRC 622 (857)
Q Consensus 584 gL~yLHs~GIIHRDLKPeNILL~~dg----~iKL~DFGLA~r~ 622 (857)
..|++|+|+||+||+++.+| .++++|||+..++
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 58999999999999999988 9999999997543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.6e-13 Score=153.45 Aligned_cols=251 Identities=21% Similarity=0.280 Sum_probs=186.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc-CCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCe
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI-GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKF 544 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~-~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~ 544 (857)
..+.+|.++..||.|.|+.|+.+... .++..|++|.+.+.......++ .-..|+-+...+. |.+++.++..|...++
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 45678999999999999999998766 7889999998876543222221 2245666666664 9999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC-CcEEEecccchhhcc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED-GHIMLSDFDLSLRCA 623 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d-g~iKL~DFGLA~r~~ 623 (857)
.|+-.|||.++++...+.- ...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.+.++.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 9999999999998655422 1237888899999999999999999999999999999999876 778999999864422
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
+...
T Consensus 419 ~~~~---------------------------------------------------------------------------- 422 (524)
T KOG0601|consen 419 FSSG---------------------------------------------------------------------------- 422 (524)
T ss_pred eecc----------------------------------------------------------------------------
Confidence 1110
Q ss_pred cccccCCCCcc--ChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHH
Q 035930 704 SNSFVGTHEYL--APEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 704 ~~s~vGT~~Ym--APEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~ 781 (857)
.+.+.-+|+ +++......+..+.|+|+||..+++.++|...-... .....+..+ ..+..+....++..+.+
T Consensus 423 --~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~~~--~~p~~~~~~~~~q~~~k 495 (524)
T KOG0601|consen 423 --VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIRSG--DTPNLPGLKLQLQVLLK 495 (524)
T ss_pred --cccccccccccchhhccccccccccccccccccccccccCcccCccc---ccceeeecc--cccCCCchHHhhhhhhh
Confidence 111223334 455555667899999999999999999987653322 112222222 33444556688899999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.++..|+..|+. +.++..|.=|
T Consensus 496 v~~~~~~~~~~l----~~~l~~~~~~ 517 (524)
T KOG0601|consen 496 VMINPDRKRRPS----AVELSLHSEF 517 (524)
T ss_pred hhcCCccccchh----hhhhcccchh
Confidence 999999999988 7777777644
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.6e-12 Score=126.50 Aligned_cols=127 Identities=20% Similarity=0.297 Sum_probs=95.4
Q ss_pred EeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCc-cccceeeeeCCeEEEEEeecC
Q 035930 475 HKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL-PTLFAHFTTEKFSCLVMEYCP 553 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnI-V~L~~~f~~~~~l~LVmEy~~ 553 (857)
.+.|+.|.++.||+++.. +..|+||+..... .....+..|+.+++.+.+.++ ++++.++. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGT----ELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCc----ccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999874 6689999875442 112345789999998865544 45554433 33579999999
Q ss_pred CCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCc-----eeccCCCCcEEEccCCcEEEecccchh
Q 035930 554 GGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV-----VYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 554 gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GI-----IHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
|..+... . . ....++.+++.+|+.||..++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 75 G~~l~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887542 0 1 113456789999999999885 9999999999998 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.3e-11 Score=143.73 Aligned_cols=122 Identities=16% Similarity=0.189 Sum_probs=101.6
Q ss_pred EEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEeecCCCChHHHHhhCCCC
Q 035930 488 LAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSR 567 (857)
Q Consensus 488 la~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~ 567 (857)
.|..+.++..|.|.+.+.... .....+.+-++-|+.|+||||+++++.++.++.+|||+|-+. -|..++.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----
Confidence 456667788888888765421 334556778888999999999999999999999999999983 45555554
Q ss_pred CCcHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 568 FFSEQAARFYVAEVLLALEYLH-MLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 568 ~l~e~~~r~i~~QIl~gL~yLH-s~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
+....+...++||+.||-||| +.+++|++|.-.-|+|+..|..||++|.++
T Consensus 101 -l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v 152 (690)
T KOG1243|consen 101 -LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELV 152 (690)
T ss_pred -hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEE
Confidence 346677888899999999998 778999999999999999999999999986
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.4e-11 Score=127.28 Aligned_cols=139 Identities=18% Similarity=0.179 Sum_probs=99.0
Q ss_pred eEEccCCceEEEEEEEcC------CCeEEEEEEeccccc---------ccc----------cchhHH----HHHHHHHHH
Q 035930 476 KKLGCGDIGTVYLAELIG------TSCLFALKVMDNDFL---------VGR----------KKMPRA----QTEREIMQM 526 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~------tg~~VAVKvi~k~~~---------~~~----------~~~~~~----~~EieILr~ 526 (857)
..||.|--+.||.|.... .+..+|||+.+-... .++ .....+ .+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999997643 357899999742111 001 111223 378999998
Q ss_pred cCC--CCccccceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHH-HHcCceeccCCCCcE
Q 035930 527 LDH--PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL-HMLGVVYRDLKPENI 603 (857)
Q Consensus 527 L~H--PnIV~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yL-Hs~GIIHRDLKPeNI 603 (857)
+.. -+++.++++ ...+|||||+.++.+....-+. ..+++..+..+..|++.+|.+| |..||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 853 466677654 3457999999665442211111 1255666777889999999999 899999999999999
Q ss_pred EEccCCcEEEecccchhh
Q 035930 604 LVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 604 LL~~dg~iKL~DFGLA~r 621 (857)
|++ ++.+.|+|||.+..
T Consensus 157 L~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EEE-CCcEEEEECCCcee
Confidence 996 57899999998854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=8.7e-12 Score=134.65 Aligned_cols=245 Identities=20% Similarity=0.253 Sum_probs=161.8
Q ss_pred ceEEEEEEEcCCCeEEEEEEecccccccccchh-HHHHHHHHHHHcCCCCccccceeeeeCC-----eEEEEEeecCCCC
Q 035930 483 IGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP-RAQTEREIMQMLDHPFLPTLFAHFTTEK-----FSCLVMEYCPGGD 556 (857)
Q Consensus 483 fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~-~~~~EieILr~L~HPnIV~L~~~f~~~~-----~l~LVmEy~~gGs 556 (857)
.-.||++.+...|..|.--.+........+..+ ....-...|-++.|-|||+++.||.+.. ...++.|||..|+
T Consensus 79 id~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs 158 (458)
T KOG1266|consen 79 IDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGS 158 (458)
T ss_pred hHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchh
Confidence 345788888777755532222111111111111 1112223455567999999999997654 5789999999999
Q ss_pred hHHHHhhCC--CCCCcHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCC
Q 035930 557 LHVLRQKQP--SRFFSEQAARFYVAEVLLALEYLHMLG--VVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSS 632 (857)
Q Consensus 557 L~~ll~~~~--~~~l~e~~~r~i~~QIl~gL~yLHs~G--IIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~s 632 (857)
|..++++.. ...+.....++|+.||+.||.|||+.. |||++|..+-|++..+|-|||.--.-. .
T Consensus 159 ~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~---s--------- 226 (458)
T KOG1266|consen 159 LKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPD---S--------- 226 (458)
T ss_pred HHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCcc---c---------
Confidence 988887543 235788899999999999999999886 999999999999999999987421100 0
Q ss_pred CCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCC
Q 035930 633 SPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHE 712 (857)
Q Consensus 633 s~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~ 712 (857)
+-+.... ..... ...-.+-++
T Consensus 227 ----------------------------------~h~s~~~-~~~~E------------------------k~~~~~~~g 247 (458)
T KOG1266|consen 227 ----------------------------------THPSVNS-TREAE------------------------KSVNTSLPG 247 (458)
T ss_pred ----------------------------------cchhhhh-hhHhh------------------------hhccccCCc
Confidence 0000000 00000 001125688
Q ss_pred ccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCC-C---ChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGS-G---NDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 713 YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~-~---~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
|.+||.-.....+.++|||+||....||..|..--... . .++.+.+++... -...-+++|.+||+-+|
T Consensus 248 ~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l--------en~lqr~~i~kcl~~eP 319 (458)
T KOG1266|consen 248 FSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL--------ENGLQRGSITKCLEGEP 319 (458)
T ss_pred cccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec--------cCccccCcCcccccCCC
Confidence 99999887777888999999999999999887643221 1 223333332211 11223579999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l 810 (857)
..||+ +.++|-||.+-++
T Consensus 320 ~~rp~----ar~llfHpllfeV 337 (458)
T KOG1266|consen 320 NGRPD----ARLLLFHPLLFEV 337 (458)
T ss_pred CCCcc----hhhhhcCceeeec
Confidence 99999 9999999976544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.3e-10 Score=116.84 Aligned_cols=138 Identities=20% Similarity=0.224 Sum_probs=103.6
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCC--CCccccceeeeeC---CeEEEEEe
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH--PFLPTLFAHFTTE---KFSCLVME 550 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~H--PnIV~L~~~f~~~---~~l~LVmE 550 (857)
+.|+.|.++.||++.... |..|++|+....... .....+..|.++++.+.+ .++++++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 678999999999998743 578999997654211 234567899999999975 3467777776654 36789999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM---------------------------------------- 590 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs---------------------------------------- 590 (857)
|++|.++...+.. ..+++.....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9999888654421 125666666677777777777773
Q ss_pred ----------------cCceeccCCCCcEEEcc--CCcEEEecccch
Q 035930 591 ----------------LGVVYRDLKPENILVRE--DGHIMLSDFDLS 619 (857)
Q Consensus 591 ----------------~GIIHRDLKPeNILL~~--dg~iKL~DFGLA 619 (857)
..+||+|++|.|||++. ++.+.|+||+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~ 204 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELA 204 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccc
Confidence 23699999999999998 667899999986
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.4e-10 Score=113.40 Aligned_cols=144 Identities=18% Similarity=0.142 Sum_probs=106.1
Q ss_pred EEeEEccCCceEEEEEEEcCCCeEEEEEEe-----cccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVM-----DNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~tg~~VAVKvi-----~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.+..|-+|+-+.|+++.+. |+.+.||.= +...+...-...+..+|..+|.++.--.|.-..-+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678899999999999884 556677642 223233333445678899999888654554444466666667899
Q ss_pred EeecCC-CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC---cEEEecccch
Q 035930 549 MEYCPG-GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG---HIMLSDFDLS 619 (857)
Q Consensus 549 mEy~~g-GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg---~iKL~DFGLA 619 (857)
|||++| .++.+++...-...........++.+|-..|.-||.++|||+||..+||++..+| .+.|+||||+
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 999976 3677777665443333444477888999999999999999999999999997765 3589999997
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.5e-10 Score=113.62 Aligned_cols=133 Identities=23% Similarity=0.244 Sum_probs=97.9
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecc-----cccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDN-----DFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k-----~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
..+++|+-+.+|.+.+.+ ..+++|.=.. ..+..+-...+..+|..+|..+.--.|...+-++.+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 357889999999997743 3366665322 222222233456789999988865555555556667777789999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
|++|..|.+++.... -.++..|-.-+.-||..||||+||.+.||++..+ .+.++||||+.
T Consensus 80 ~I~G~~lkd~l~~~~---------~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEAR---------PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhcc---------hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccc
Confidence 999999998887641 3355667777888999999999999999999754 49999999984
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-10 Score=133.68 Aligned_cols=168 Identities=21% Similarity=0.353 Sum_probs=122.2
Q ss_pred HHHHHHHHHHH-HcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCcc
Q 035930 579 AEVLLALEYLH-MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFC 657 (857)
Q Consensus 579 ~QIl~gL~yLH-s~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~ 657 (857)
.+++.||.|+| +.++||++|.|++|.++.+|..||+.|+++..... + ..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~-------------~----~~------------- 155 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANG-------------P----TE------------- 155 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCC-------------C----Cc-------------
Confidence 34558999999 56899999999999999999999999998632100 0 00
Q ss_pred CCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHH
Q 035930 658 LHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFL 737 (857)
Q Consensus 658 ~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvIL 737 (857)
+....|++++.. ...-...|.|||++.+...+.++|+|||||++
T Consensus 156 ----~p~~~yd~~lp~--------------------------------~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li 199 (700)
T KOG2137|consen 156 ----YPFSEYDPPLPL--------------------------------LLQPHLNFLAPEYLLGTTNTPASDVFSLGVLI 199 (700)
T ss_pred ----cccccCCCCCCh--------------------------------hhccCcccccchhhccccccccccceeeeeEE
Confidence 122222222111 01234679999999998889999999999999
Q ss_pred HHHh-hCCCCCCCCCChhhhHHHhh--ccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 738 FELL-YGRTPFKGSGNDETLSNVVS--QSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 738 yELL-tGk~PF~g~~~~e~l~~Iv~--~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
|.+. .|+..|...+....+..... +...+-....++.++++=|.++|..++..||+ +.+++..|||.+..-.-
T Consensus 200 ~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~----~~~l~~~~ff~D~~~~a 275 (700)
T KOG2137|consen 200 YTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT----LDLLLSIPFFSDPGLKA 275 (700)
T ss_pred EEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc----hhhhhcccccCCchhhh
Confidence 9999 67777776654444332221 11122233569999999999999999999998 99999999999876655
Q ss_pred hc
Q 035930 815 IR 816 (857)
Q Consensus 815 i~ 816 (857)
|+
T Consensus 276 Lr 277 (700)
T KOG2137|consen 276 LR 277 (700)
T ss_pred hh
Confidence 54
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.1e-08 Score=116.47 Aligned_cols=134 Identities=22% Similarity=0.194 Sum_probs=106.5
Q ss_pred ceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee----CCeEEEEEeecCC-CCh
Q 035930 483 IGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT----EKFSCLVMEYCPG-GDL 557 (857)
Q Consensus 483 fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~----~~~l~LVmEy~~g-GsL 557 (857)
-.+.|++...-+|..|++|.++.+....... ...-+++++++.|+|||.|.++|.. +..++||++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3588999999999999999996554333322 2446788999999999999999873 4578999999976 466
Q ss_pred HHHHhhC-------------CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 558 HVLRQKQ-------------PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 558 ~~ll~~~-------------~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
.++.-.. .+...+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+-+++|...|..
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence 5442211 1224789999999999999999999999999999999999998888888766653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.4e-08 Score=109.99 Aligned_cols=134 Identities=16% Similarity=0.073 Sum_probs=95.0
Q ss_pred eEEEEEEEcCCCeEEEEEEecccccc----c----ccchhHHHHHHHHHHHcCCCCcc--ccceeeee-----CCeEEEE
Q 035930 484 GTVYLAELIGTSCLFALKVMDNDFLV----G----RKKMPRAQTEREIMQMLDHPFLP--TLFAHFTT-----EKFSCLV 548 (857)
Q Consensus 484 GtVyla~~~~tg~~VAVKvi~k~~~~----~----~~~~~~~~~EieILr~L~HPnIV--~L~~~f~~-----~~~l~LV 548 (857)
..|++... .|+.|.||........ . ......+.+|...+.+|..-+|. .+++++.. ....+||
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 34556554 4567899976433210 0 01111467899988888544443 34555543 2357899
Q ss_pred EeecCCC-ChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc-------CCcEEEecccch
Q 035930 549 MEYCPGG-DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE-------DGHIMLSDFDLS 619 (857)
Q Consensus 549 mEy~~gG-sL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~-------dg~iKL~DFGLA 619 (857)
||++++. +|.+++........++.....++.+|+..+.-||..||+|+||++.|||++. ++.+.|+||+.+
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 9999876 7888876432233567778889999999999999999999999999999975 467999999976
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=6.8e-09 Score=106.77 Aligned_cols=127 Identities=24% Similarity=0.283 Sum_probs=81.8
Q ss_pred EEEEEEEcCCCeEEEEEEeccccc---------c------------ccc--chhHHHHHHHHHHHcCCC--Cccccceee
Q 035930 485 TVYLAELIGTSCLFALKVMDNDFL---------V------------GRK--KMPRAQTEREIMQMLDHP--FLPTLFAHF 539 (857)
Q Consensus 485 tVyla~~~~tg~~VAVKvi~k~~~---------~------------~~~--~~~~~~~EieILr~L~HP--nIV~L~~~f 539 (857)
.||.|.. ..|..+|||+.+.... . .+. ......+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899987 5677999998743110 0 000 112457799999999754 567776543
Q ss_pred eeCCeEEEEEeecC--CCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHH-HHHcCceeccCCCCcEEEccCCcEEEecc
Q 035930 540 TTEKFSCLVMEYCP--GGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEY-LHMLGVVYRDLKPENILVREDGHIMLSDF 616 (857)
Q Consensus 540 ~~~~~l~LVmEy~~--gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~y-LHs~GIIHRDLKPeNILL~~dg~iKL~DF 616 (857)
+ .+|||||++ |..+..+.... +.......++.+++..+.. +|..||||+||.+.|||++++ .+.|+||
T Consensus 80 --~--~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp --T--TEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred --C--CEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 2 369999998 65565544322 2234566677788886655 579999999999999999876 9999999
Q ss_pred cchhh
Q 035930 617 DLSLR 621 (857)
Q Consensus 617 GLA~r 621 (857)
|.+..
T Consensus 151 ~qav~ 155 (188)
T PF01163_consen 151 GQAVD 155 (188)
T ss_dssp TTEEE
T ss_pred Cccee
Confidence 98854
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.4e-07 Score=97.93 Aligned_cols=106 Identities=29% Similarity=0.305 Sum_probs=84.0
Q ss_pred chhHHHHHHHHHHHcCCCC--ccccceeeeeC----CeEEEEEeecCCC-ChHHHHhhCCCCCCcHHHHHHHHHHHHHHH
Q 035930 513 KMPRAQTEREIMQMLDHPF--LPTLFAHFTTE----KFSCLVMEYCPGG-DLHVLRQKQPSRFFSEQAARFYVAEVLLAL 585 (857)
Q Consensus 513 ~~~~~~~EieILr~L~HPn--IV~L~~~f~~~----~~l~LVmEy~~gG-sL~~ll~~~~~~~l~e~~~r~i~~QIl~gL 585 (857)
...+..+|...+..|..-. .+..+++.... ...+||||++++. +|.+++..... ++......++.+++..+
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLI 131 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHH
Confidence 3456788988888875433 44556665543 2458999999874 79888876433 56667888999999999
Q ss_pred HHHHHcCceeccCCCCcEEEccCC---cEEEecccchh
Q 035930 586 EYLHMLGVVYRDLKPENILVREDG---HIMLSDFDLSL 620 (857)
Q Consensus 586 ~yLHs~GIIHRDLKPeNILL~~dg---~iKL~DFGLA~ 620 (857)
.-||.+||+|+||++.|||++.++ .+.|+||+.+.
T Consensus 132 ~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 132 AKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 999999999999999999999887 89999999764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=7.1e-07 Score=100.03 Aligned_cols=235 Identities=21% Similarity=0.282 Sum_probs=151.6
Q ss_pred EEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccce------eeeeC-Ce
Q 035930 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFA------HFTTE-KF 544 (857)
Q Consensus 473 ~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~------~f~~~-~~ 544 (857)
.+++.||+|+-+.+|-.-...+ .+-|+....-.. .....++.|... .||-+-.=+. |.-++ ..
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa------~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPA------AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchhhc---hhheeecCCCch------HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 3568999999999997644333 245777654211 112223333333 4664332111 11122 23
Q ss_pred EEEEEeecCCCC-hHHHHh----hCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 545 SCLVMEYCPGGD-LHVLRQ----KQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 545 l~LVmEy~~gGs-L~~ll~----~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
+-+.|..+.|.. ++.++. ++....+.++-+.+.++.|+.+.+-||+.|.+-+|+.++|||+.+++.+.|.|=+--
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 778888887653 233321 122234778888899999999999999999999999999999999999999885421
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
-.+ .
T Consensus 165 qi~----------------------------------------------------------------------------~ 168 (637)
T COG4248 165 QIN----------------------------------------------------------------------------A 168 (637)
T ss_pred eec----------------------------------------------------------------------------c
Confidence 000 0
Q ss_pred CCCccccccCCCCccChhhhc-----CCCCCcccceehhhHHHHHHhhC-CCCCCCCC-------ChhhhHHHhhc----
Q 035930 700 TGARSNSFVGTHEYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYG-RTPFKGSG-------NDETLSNVVSQ---- 762 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~-----g~~~s~ksDVWSLGvILyELLtG-k~PF~g~~-------~~e~l~~Iv~~---- 762 (857)
.+.....-+|...|.+||.-. |..-+...|.|.|||+||+||.| +.||.|.. ..|. .|..+
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~--~Ia~g~f~y 246 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET--DIAHGRFAY 246 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--hhhcceeee
Confidence 111223447889999999754 44557789999999999999986 99998642 1221 22211
Q ss_pred ------cccCC----CCCCCCHHHHHHHHhhccC--CcCCcCCc
Q 035930 763 ------SLRFP----GYPVVSFHARDLIRGLLVK--EPDNRLGA 794 (857)
Q Consensus 763 ------~~~~p----~~~~is~~l~dLI~k~L~~--DPe~Rpt~ 794 (857)
.++.+ .+..+++++..|..+|+.. ++.-||+.
T Consensus 247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a 290 (637)
T COG4248 247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA 290 (637)
T ss_pred chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence 11111 1245778999999999975 46789996
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.9e-07 Score=100.27 Aligned_cols=136 Identities=29% Similarity=0.304 Sum_probs=99.1
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecc------------cccc-----cccc--hhHHHHHHHHHHHcCCC--
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDN------------DFLV-----GRKK--MPRAQTEREIMQMLDHP-- 530 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k------------~~~~-----~~~~--~~~~~~EieILr~L~HP-- 530 (857)
+.++..||-|.-+.||.|.+. .|..+|||.-+. +.+. .+.. ...+++|.++|.+|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567899999999999999885 678999996421 1100 1111 12357899999999644
Q ss_pred CccccceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc
Q 035930 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH 610 (857)
Q Consensus 531 nIV~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~ 610 (857)
.++..+++ +..++||||+.|-.|....- .......++..|+.-+.-+-..||||+|+.+=|||+++||.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 56666554 34579999998877754431 23334455566666666666999999999999999999999
Q ss_pred EEEecccch
Q 035930 611 IMLSDFDLS 619 (857)
Q Consensus 611 iKL~DFGLA 619 (857)
+.++||-.+
T Consensus 241 ~~vIDwPQ~ 249 (304)
T COG0478 241 IVVIDWPQA 249 (304)
T ss_pred EEEEeCccc
Confidence 999999765
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.2e-06 Score=91.61 Aligned_cols=140 Identities=18% Similarity=0.175 Sum_probs=101.7
Q ss_pred ccCCceEEEEEEEcCCCeEEEEEEeccccccc---ccchhHHHHHHHHHHHcCCCC--ccccceeee-e----CCeEEEE
Q 035930 479 GCGDIGTVYLAELIGTSCLFALKVMDNDFLVG---RKKMPRAQTEREIMQMLDHPF--LPTLFAHFT-T----EKFSCLV 548 (857)
Q Consensus 479 G~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~---~~~~~~~~~EieILr~L~HPn--IV~L~~~f~-~----~~~l~LV 548 (857)
|.||.+-|+.....+. .|-||.-....... .-....+.+|...|+.|..-+ ++.+. ++. . .-..+||
T Consensus 27 ~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5688899999876444 57778653211111 335567899999998885332 44444 332 1 1246899
Q ss_pred EeecCC-CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc--EEEecccchhh
Q 035930 549 MEYCPG-GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH--IMLSDFDLSLR 621 (857)
Q Consensus 549 mEy~~g-GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~--iKL~DFGLA~r 621 (857)
+|-++| .+|.+++....-...++.....++.+|+..|.-||..|+.|+|+-+.|||++.+|. +.++||.-+++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997743 58888876654444677888899999999999999999999999999999987777 99999987643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.3e-08 Score=116.27 Aligned_cols=263 Identities=17% Similarity=0.150 Sum_probs=174.4
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCC-ccccceeeeeCCeEEEEEe
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF-LPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn-IV~L~~~f~~~~~l~LVmE 550 (857)
|...+.++.|+++.+|+.+...+...+ .+++... ....-++++|.+++||| .+..++-++.+++..++|+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 444566789999999999887665444 5655432 33456899999999999 6777777778889999999
Q ss_pred ecCCC-ChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 551 YCPGG-DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 551 y~~gG-sL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
++.++ +......... -.+.+-+...+.+.-+++|+|||+.-=+||| |||..+ +..++.||+....+.
T Consensus 315 i~s~~rs~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~------ 382 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSE-IALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLT------ 382 (829)
T ss_pred hhcCCccccccCChhh-HhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccC------
Confidence 99877 2221111110 0122223334455677899999988778999 888764 678888888641100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.....+++.+
T Consensus 383 ----------------------------------------------------------------------~~~~~~t~~~ 392 (829)
T KOG0576|consen 383 ----------------------------------------------------------------------RTMKPRTAIG 392 (829)
T ss_pred ----------------------------------------------------------------------cccccccCCC
Confidence 0002356779
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--CCCCCCHHHH-HHHHhhccC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--GYPVVSFHAR-DLIRGLLVK 786 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--~~~~is~~l~-dLI~k~L~~ 786 (857)
|+.++|||++.+..+....|.|++|+-..+|.-|-.|-... ......+-.+.-.+. ....+++... ++...||..
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g 470 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNG 470 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcCcccccCCcccccCC
Confidence 99999999999999999999999999877777777664321 111000000000000 0011222222 478889999
Q ss_pred CcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCCCccccc
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCDAVIG 832 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~~~~~~~ 832 (857)
.|..|+. ...++-|.+|.+.. =.|.|+.++..|.-.+..+.
T Consensus 471 ~P~~pkv----~mgacfsKvfngCp-l~i~~aaswIhp~t~dq~ll 511 (829)
T KOG0576|consen 471 LPPTPKV----HMGACFSKVFNGCP-LRIHCAASWIHPSTRDQALL 511 (829)
T ss_pred CCCCCcc----hhhHHHHHHhccCc-ccceecccccCcchhhhHhh
Confidence 9999988 89999999999874 34568888888876554443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.6e-06 Score=89.70 Aligned_cols=140 Identities=18% Similarity=0.187 Sum_probs=93.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhH------HHHHHHHHHHc---CCCCccccce
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPR------AQTEREIMQML---DHPFLPTLFA 537 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~------~~~EieILr~L---~HPnIV~L~~ 537 (857)
+...+|.+.+++-.....-|.+-.. +|..|++|+.+......++.+.. ..+++..+..+ .-..+..++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 4557899999999988888888776 45679999876543222222221 12333333333 2233333333
Q ss_pred eeee-----CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEE
Q 035930 538 HFTT-----EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIM 612 (857)
Q Consensus 538 ~f~~-----~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iK 612 (857)
+.+- -...+|||||++|..|.++.. +++. +...|..+|.-||..|++|+|.+|.|++++.+ .++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEE
Confidence 3322 234568999999988866532 3332 33467778999999999999999999999855 499
Q ss_pred Eecccch
Q 035930 613 LSDFDLS 619 (857)
Q Consensus 613 L~DFGLA 619 (857)
++||+..
T Consensus 175 iID~~~k 181 (229)
T PF06176_consen 175 IIDTQGK 181 (229)
T ss_pred EEECccc
Confidence 9999853
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.5e-07 Score=105.55 Aligned_cols=143 Identities=22% Similarity=0.227 Sum_probs=87.6
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEeccccc---------------------cc-c-cch--------h------HHH
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFL---------------------VG-R-KKM--------P------RAQ 518 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~---------------------~~-~-~~~--------~------~~~ 518 (857)
..|+.++.|+||+|+.. +|+.|||||.+..-. .. + -.. + ++.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 68999999999999996 489999999754311 00 0 000 0 122
Q ss_pred HHHHHHHHcC-----CCCccccceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCc
Q 035930 519 TEREIMQMLD-----HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593 (857)
Q Consensus 519 ~EieILr~L~-----HPnIV~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GI 593 (857)
+|...+.++. .++|.--.=|++....-.|+|||++|.-+.+...-.. ..++...+.....++. +..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 3333344332 3332222223333445579999999988876632221 1244322222222211 223335899
Q ss_pred eeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 594 VYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 594 IHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
+|.|.+|.||+++.+|++.+.|||+..+.
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecC
Confidence 99999999999999999999999997543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.7e-06 Score=86.42 Aligned_cols=134 Identities=13% Similarity=0.085 Sum_probs=84.0
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCC--ccccceeeeeCCeEEEEEeecC
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF--LPTLFAHFTTEKFSCLVMEYCP 553 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn--IV~L~~~f~~~~~l~LVmEy~~ 553 (857)
..||.|..+.||+. .+..+++|+.... .....+.+|.++|+.+..-. +++.+++....+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~-----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG-----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC-----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999984 2335778987542 12345688999999986433 4677888878888899999998
Q ss_pred CCC-hH--------------HH-------HhhCCCCCCcHHHH-HHHHH----------HHHH-HHHHHHH----cCcee
Q 035930 554 GGD-LH--------------VL-------RQKQPSRFFSEQAA-RFYVA----------EVLL-ALEYLHM----LGVVY 595 (857)
Q Consensus 554 gGs-L~--------------~l-------l~~~~~~~l~e~~~-r~i~~----------QIl~-gL~yLHs----~GIIH 595 (857)
|.. +. .. ++..+......... ..+.. .+.. ...+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 11 00 11111111111110 01100 1111 1223321 24789
Q ss_pred ccCCCCcEEEccCCcEEEecccch
Q 035930 596 RDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 596 RDLKPeNILL~~dg~iKL~DFGLA 619 (857)
+|+.|.||++++++ +.|+||+.+
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a 180 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDF 180 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhc
Confidence 99999999999888 999999976
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.2e-05 Score=85.89 Aligned_cols=138 Identities=23% Similarity=0.231 Sum_probs=92.7
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEeccccccccc----------------c-----hhHHHHHHHHHHHcC--CCCc
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRK----------------K-----MPRAQTEREIMQMLD--HPFL 532 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~----------------~-----~~~~~~EieILr~L~--HPnI 532 (857)
..|..|.-+.||+|.. +++..+|+|+++........ . ..-...|...|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3677888889999976 56789999998543221111 0 011234666666663 4445
Q ss_pred cccceeeeeCCeEEEEEeecCCCChH-HHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCc
Q 035930 533 PTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGH 610 (857)
Q Consensus 533 V~L~~~f~~~~~l~LVmEy~~gGsL~-~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~ 610 (857)
++.+.++. -.|||||+....+. -.+.. -.+....+..+..+++..+.-|-. .|+||+||..=|||+. ++.
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 55554442 36999999543211 01111 113344688888899999988876 9999999999999998 889
Q ss_pred EEEecccchhhc
Q 035930 611 IMLSDFDLSLRC 622 (857)
Q Consensus 611 iKL~DFGLA~r~ 622 (857)
+.|+|||.|...
T Consensus 205 p~iID~~QaV~~ 216 (268)
T COG1718 205 PYIIDVSQAVTI 216 (268)
T ss_pred EEEEECcccccc
Confidence 999999998653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.4e-05 Score=81.72 Aligned_cols=139 Identities=27% Similarity=0.352 Sum_probs=83.1
Q ss_pred EeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCC--Cccccceeeee---CCeEEEEE
Q 035930 475 HKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP--FLPTLFAHFTT---EKFSCLVM 549 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HP--nIV~L~~~f~~---~~~l~LVm 549 (857)
++.|+.|..+.||+..... + .+++|+.... .....+..|..+++.|... -+++++.+... ....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-EEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4789999999999998865 3 7899986543 2345677899998888533 35677764432 34679999
Q ss_pred eecCCCChHH----------------H---HhhC--CCCCCcHHH---H---HHH---------------HHHHHH-HHH
Q 035930 550 EYCPGGDLHV----------------L---RQKQ--PSRFFSEQA---A---RFY---------------VAEVLL-ALE 586 (857)
Q Consensus 550 Ey~~gGsL~~----------------l---l~~~--~~~~l~e~~---~---r~i---------------~~QIl~-gL~ 586 (857)
++++|..+.. + ++.. ....+.... . ... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987765 1 1111 101011000 0 000 111222 334
Q ss_pred HHHH-------cCceeccCCCCcEEEc-cCCcEEEecccchh
Q 035930 587 YLHM-------LGVVYRDLKPENILVR-EDGHIMLSDFDLSL 620 (857)
Q Consensus 587 yLHs-------~GIIHRDLKPeNILL~-~dg~iKL~DFGLA~ 620 (857)
.++. ..+||+|+.|.|||++ .++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 4442 4599999999999999 66777899999863
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.6e-05 Score=96.98 Aligned_cols=81 Identities=19% Similarity=0.287 Sum_probs=58.1
Q ss_pred EEeEEccCCceEEEEEEEcCCC--eEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCc--cccceeeeeC---CeE
Q 035930 474 LHKKLGCGDIGTVYLAELIGTS--CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFL--PTLFAHFTTE---KFS 545 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~tg--~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnI--V~L~~~f~~~---~~l 545 (857)
..+.|+.|.+..+|+......+ ..+++|+...... ......+.+|.++|+.|. |.++ ++++.+|.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~--~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL--LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc--CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 4678899999999998775433 4677777543211 112345789999999996 6765 7777777664 467
Q ss_pred EEEEeecCCCC
Q 035930 546 CLVMEYCPGGD 556 (857)
Q Consensus 546 ~LVmEy~~gGs 556 (857)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999998764
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.7e-05 Score=82.13 Aligned_cols=135 Identities=20% Similarity=0.127 Sum_probs=83.0
Q ss_pred EEccCCc-eEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEEEeecCC
Q 035930 477 KLGCGDI-GTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 477 ~LG~G~f-GtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
.|-.|.. ..||+....+ ..+.||+..... ...+.+|+++++.+. +--++++++++...+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~~--~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGKN--PGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCCC--CcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3445555 7899997643 568888875431 234678999998884 44466778877776778999999998
Q ss_pred CChHHHH-------------------hhCCCC--CCcHH------HHHHHHH----------------HHHHHHHHHH--
Q 035930 555 GDLHVLR-------------------QKQPSR--FFSEQ------AARFYVA----------------EVLLALEYLH-- 589 (857)
Q Consensus 555 GsL~~ll-------------------~~~~~~--~l~e~------~~r~i~~----------------QIl~gL~yLH-- 589 (857)
..|.... +..+.. .+... .....+. .+...+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 8764321 111110 11100 0000000 0111122221
Q ss_pred -----HcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 590 -----MLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 590 -----s~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
...++|+|+.|.|||+++++.+.|+||+.+
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a 191 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRL 191 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccc
Confidence 234899999999999998877889999976
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.91 E-value=3.8e-05 Score=90.32 Aligned_cols=139 Identities=23% Similarity=0.236 Sum_probs=84.9
Q ss_pred EeEEccCCceEEEEEEEcCCCeEEEEEEeccccccc--------------------c--------cchh------HHHHH
Q 035930 475 HKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG--------------------R--------KKMP------RAQTE 520 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~--------------------~--------~~~~------~~~~E 520 (857)
.+.||.-+.|+||+|+.+. |..|||||-+...-.. . +..+ ++.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3689999999999999976 9999999864321000 0 0000 11223
Q ss_pred HHHH----HHcCCCC------ccccceeeeeCCeEEEEEeecCCCChHHH--HhhCCCCCCcHHHHHHHHHHHHHHHHHH
Q 035930 521 REIM----QMLDHPF------LPTLFAHFTTEKFSCLVMEYCPGGDLHVL--RQKQPSRFFSEQAARFYVAEVLLALEYL 588 (857)
Q Consensus 521 ieIL----r~L~HPn------IV~L~~~f~~~~~l~LVmEy~~gGsL~~l--l~~~~~~~l~e~~~r~i~~QIl~gL~yL 588 (857)
.+.. +.+.|-+ |+++|-.+. ....|+||||+|.-+.++ +.+.. ++...+...+.++.. +-+
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~--~qI 317 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYL--EQI 317 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHH--HHH
Confidence 2222 2223444 455543332 346799999999877544 33322 555533332222221 222
Q ss_pred HHcCceeccCCCCcEEEcc----CCcEEEecccchhh
Q 035930 589 HMLGVVYRDLKPENILVRE----DGHIMLSDFDLSLR 621 (857)
Q Consensus 589 Hs~GIIHRDLKPeNILL~~----dg~iKL~DFGLA~r 621 (857)
-..|++|.|=+|.|||++. ++.+.|-|||+...
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 3578999999999999984 56899999999743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00014 Score=75.86 Aligned_cols=128 Identities=23% Similarity=0.292 Sum_probs=89.5
Q ss_pred CCeEEEeEEccCCc-eEEEEEEEcCCCeEEEEEEecccccccc------------------cchhHHHHHHHHHHHc---
Q 035930 470 RHFKLHKKLGCGDI-GTVYLAELIGTSCLFALKVMDNDFLVGR------------------KKMPRAQTEREIMQML--- 527 (857)
Q Consensus 470 ~~Y~i~~~LG~G~f-GtVyla~~~~tg~~VAVKvi~k~~~~~~------------------~~~~~~~~EieILr~L--- 527 (857)
.+++.++.||.|.- |.||+++. .|..||||++..-..... .....+..|-+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999998 456899999432100000 1234566677765555
Q ss_pred CCCCc--cccceeeeeC------------------CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHH
Q 035930 528 DHPFL--PTLFAHFTTE------------------KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEY 587 (857)
Q Consensus 528 ~HPnI--V~L~~~f~~~------------------~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~y 587 (857)
++.++ |+.++|..-. ...-||.||++... .+.... +.+|++-|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHH
Confidence 45566 8888887322 12367888775543 122223 4478888899
Q ss_pred HHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 588 LHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 588 LHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
||..||+-+|+++.|.. .-+|+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999999987 3589999853
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.82 E-value=7.8e-05 Score=92.51 Aligned_cols=201 Identities=23% Similarity=0.271 Sum_probs=134.1
Q ss_pred HHHHHHHHHHcCCCCccccceeeeeCCeE----EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC
Q 035930 517 AQTEREIMQMLDHPFLPTLFAHFTTEKFS----CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592 (857)
Q Consensus 517 ~~~EieILr~L~HPnIV~L~~~f~~~~~l----~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G 592 (857)
...|++.+..+.|+|++.++.|...+... .+..|+|..-++...++.-. ..+...++.+..+++.||+|+|++.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 34466667888999999999887665432 34457888888877776553 3889999999999999999999985
Q ss_pred ceeccCCCC---cEEEccCCcEEEe--cccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCccccc
Q 035930 593 VVYRDLKPE---NILVREDGHIMLS--DFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCF 667 (857)
Q Consensus 593 IIHRDLKPe---NILL~~dg~iKL~--DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~ 667 (857)
..|.-|... +..++..+.+.++ ||+...+...
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d------------------------------------------- 343 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD------------------------------------------- 343 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCC-------------------------------------------
Confidence 555444333 3333344455554 6665422110
Q ss_pred ccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcc--cceehhhHHHHHHhhCCC
Q 035930 668 TPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSS--VDWWTFGIFLFELLYGRT 745 (857)
Q Consensus 668 s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~k--sDVWSLGvILyELLtGk~ 745 (857)
........-+..|.++|......+..+ .|+|.+|..+..+..|..
T Consensus 344 ---------------------------------~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~ 390 (1351)
T KOG1035|consen 344 ---------------------------------NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGED 390 (1351)
T ss_pred ---------------------------------cccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCc
Confidence 001112234556788888877766554 699999999999998765
Q ss_pred CCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 746 PFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 746 PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+-.. ......++.. .......+++.+|+.-++++|+. +.+++.|+|...-
T Consensus 391 i~~~---~~~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~----~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 391 ISEK---SAVPVSLLDV--------LSTSELLDALPKCLDEDSEERLS----ALELLTHPFLRFP 440 (1351)
T ss_pred cccc---ccchhhhhcc--------ccchhhhhhhhhhcchhhhhccc----hhhhhhchhcccc
Confidence 4221 1111111111 11126778999999999999999 9999999998643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00029 Score=73.42 Aligned_cols=133 Identities=22% Similarity=0.268 Sum_probs=93.5
Q ss_pred EeEEccCCceEEEEEEEcCCCeEEEEEEecccccc-------------cccchhHHHHHHHHHHHcC------CCCcccc
Q 035930 475 HKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV-------------GRKKMPRAQTEREIMQMLD------HPFLPTL 535 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~-------------~~~~~~~~~~EieILr~L~------HPnIV~L 535 (857)
...||.|+.-.||.-- .+....|||+...... .........+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3578999999999753 3334688998766410 1122345566777665555 7899999
Q ss_pred ceeeeeCCeEEEEEeecCC------CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC-
Q 035930 536 FAHFTTEKFSCLVMEYCPG------GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED- 608 (857)
Q Consensus 536 ~~~f~~~~~l~LVmEy~~g------GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d- 608 (857)
||+.+++.-.-+|+|.+.. .+|.+++.... +++ ..+. .+-.-..||-+++|+.+||+|.||++...
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 9999999999999998743 25677775432 555 3332 33344568899999999999999999643
Q ss_pred -C--cEEEec-cc
Q 035930 609 -G--HIMLSD-FD 617 (857)
Q Consensus 609 -g--~iKL~D-FG 617 (857)
| .+.|+| ||
T Consensus 156 ~~~~~lvlIDG~G 168 (199)
T PF10707_consen 156 SGEFRLVLIDGLG 168 (199)
T ss_pred CCceEEEEEeCCC
Confidence 2 577888 55
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00011 Score=75.06 Aligned_cols=129 Identities=27% Similarity=0.344 Sum_probs=91.7
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCc-cccceeeeeCCeEEEEEe
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL-PTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnI-V~L~~~f~~~~~l~LVmE 550 (857)
....+.||.|.+|.||+|.+.+ ..+|+|+-+.+ .....+..|.++|..+.--++ +++|.|..+ ++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRG--GEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeeccC--ceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence 3456789999999999999854 47999986554 344567889999999975544 456555443 35599
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCC-CCcEEEccCCcEEEecccchh
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLK-PENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLK-PeNILL~~dg~iKL~DFGLA~ 620 (857)
|+.|-.|..+-... + +.-+..++..-.-|-..||-|..|. |..++|..++.+.|+||+-|.
T Consensus 93 ~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 93 YIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 99988886654321 1 2223355666555678899999885 555666667799999999874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00022 Score=74.62 Aligned_cols=75 Identities=23% Similarity=0.366 Sum_probs=49.3
Q ss_pred EeEEccCCceEEEEEEEcC-CCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEEEeec
Q 035930 475 HKKLGCGDIGTVYLAELIG-TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLVMEYC 552 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~-tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LVmEy~ 552 (857)
++.|..|-...+|++.... .+..|++|+.... ....-...+|+.+++.+. +...+++++.+. + .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~----~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK----TELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCC----ccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4677888888999997643 3567889976542 111223357898998885 333455554432 2 3799999
Q ss_pred CCCCh
Q 035930 553 PGGDL 557 (857)
Q Consensus 553 ~gGsL 557 (857)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 88765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00012 Score=77.12 Aligned_cols=72 Identities=8% Similarity=0.115 Sum_probs=46.0
Q ss_pred eEEccCCce-EEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCC---CccccceeeeeC---CeEEEE
Q 035930 476 KKLGCGDIG-TVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP---FLPTLFAHFTTE---KFSCLV 548 (857)
Q Consensus 476 ~~LG~G~fG-tVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HP---nIV~L~~~f~~~---~~l~LV 548 (857)
+.|+.|+.. .||+.. ..+++|+.... .....+.+|.++|+.|... -++.+++..... ...|+|
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 567777776 489762 24777875432 1234678899999888632 344555444332 245899
Q ss_pred EeecCCCCh
Q 035930 549 MEYCPGGDL 557 (857)
Q Consensus 549 mEy~~gGsL 557 (857)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999998766
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00017 Score=74.30 Aligned_cols=97 Identities=24% Similarity=0.260 Sum_probs=78.1
Q ss_pred HHHHHHHHHcCC-CCccccceeeeeCCeEEEEEeecCCCChHHH---HhhCCCCCCcHHHHHHHHHHHHHHHHHHHH---
Q 035930 518 QTEREIMQMLDH-PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVL---RQKQPSRFFSEQAARFYVAEVLLALEYLHM--- 590 (857)
Q Consensus 518 ~~EieILr~L~H-PnIV~L~~~f~~~~~l~LVmEy~~gGsL~~l---l~~~~~~~l~e~~~r~i~~QIl~gL~yLHs--- 590 (857)
..|.-+|+.+++ +++++++|+|-. ++|.||+..+.+... +... ...+|..+..++.+++..+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 458888999976 699999999942 678999987766421 1111 125788999999999999999987
Q ss_pred cCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 591 LGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 591 ~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
..+.-.|++|+|+.++++|++|++|.+.+.
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 458889999999999999999999999763
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0018 Score=74.21 Aligned_cols=81 Identities=19% Similarity=0.243 Sum_probs=56.6
Q ss_pred EEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccc-cc---ccchhHHHHHHHHHHHcC---CCCccccceeeeeCCeE
Q 035930 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFL-VG---RKKMPRAQTEREIMQMLD---HPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 473 ~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~-~~---~~~~~~~~~EieILr~L~---HPnIV~L~~~f~~~~~l 545 (857)
.-.+.||.|.+..||++.+...++.|+||.-..... .. ....++...|.+.|+.+. -.+++++|.+ ++...
T Consensus 29 ~~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~ 106 (401)
T PRK09550 29 LTAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELA 106 (401)
T ss_pred ceeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCC
Confidence 345789999999999999865446899998531100 01 224567788888888863 3467777766 44567
Q ss_pred EEEEeecCCC
Q 035930 546 CLVMEYCPGG 555 (857)
Q Consensus 546 ~LVmEy~~gG 555 (857)
++||||+++.
T Consensus 107 ~lVME~L~~~ 116 (401)
T PRK09550 107 VTVMEDLSDH 116 (401)
T ss_pred EEEEecCCCc
Confidence 8999999764
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0012 Score=72.77 Aligned_cols=79 Identities=15% Similarity=0.059 Sum_probs=57.3
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCC---CCccccceeeeeC---CeE
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH---PFLPTLFAHFTTE---KFS 545 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~H---PnIV~L~~~f~~~---~~l 545 (857)
-.-.+.||.|..+.||+....+ + .+.+|+.+. ......+..|.+.|+.|.- -.++++++++..+ +..
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMARS-----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred hheeeecCCccceeEEEEEcCC-C-CEEEEEecc-----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 3456789999999999996533 3 466777432 1123567899999999853 3678888877543 668
Q ss_pred EEEEeecCCCCh
Q 035930 546 CLVMEYCPGGDL 557 (857)
Q Consensus 546 ~LVmEy~~gGsL 557 (857)
+||||+++|+++
T Consensus 89 ~LVmE~i~G~~~ 100 (297)
T PRK10593 89 VLLLERLRGVSV 100 (297)
T ss_pred EEEEeccCCEec
Confidence 999999988754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0017 Score=71.24 Aligned_cols=143 Identities=18% Similarity=0.167 Sum_probs=84.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCC--ccccceee------ee
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF--LPTLFAHF------TT 541 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn--IV~L~~~f------~~ 541 (857)
.....++.|+.|....+|+.... ++ .+++|+.... .....+..|.++++.|.... +++++... ..
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~-----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKR-----VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred CCceeccccCCccccceEEEEeC-CC-cEEEEEecCC-----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 34555778888888899998653 33 5778986542 12334566778877774222 34443321 22
Q ss_pred CCeEEEEEeecCCCChH-----H------H---HhhCCCC---------CCc-HHH--HH----------HHHHHHHHHH
Q 035930 542 EKFSCLVMEYCPGGDLH-----V------L---RQKQPSR---------FFS-EQA--AR----------FYVAEVLLAL 585 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~-----~------l---l~~~~~~---------~l~-e~~--~r----------~i~~QIl~gL 585 (857)
.+..++||||++|..+. . . ++..... .+. +.. .. .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 45678999999885431 0 0 1110000 000 000 00 0011233445
Q ss_pred HHHHH-------cCceeccCCCCcEEEccCCcEEEecccch
Q 035930 586 EYLHM-------LGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 586 ~yLHs-------~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
++|.. .++||+|+.+.||+++.++...|+||+.+
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 55542 58999999999999998887789999986
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0011 Score=72.37 Aligned_cols=75 Identities=20% Similarity=0.290 Sum_probs=48.7
Q ss_pred EeEEccCCceEEEEEEEcC------CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCC-CccccceeeeeCCeEEE
Q 035930 475 HKKLGCGDIGTVYLAELIG------TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP-FLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~------tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HP-nIV~L~~~f~~~~~l~L 547 (857)
++.|..|-...||+..... .+..|++|+..... .......+|.++++.+... -.++++.++. + .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence 3556667777899887643 25789999865431 2233457888888888532 3445555553 2 36
Q ss_pred EEeecCCCCh
Q 035930 548 VMEYCPGGDL 557 (857)
Q Consensus 548 VmEy~~gGsL 557 (857)
||||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999988765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00021 Score=78.92 Aligned_cols=136 Identities=22% Similarity=0.339 Sum_probs=94.4
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEec------------ccccc-----cccchh--HHHHHHHHHHHcC-CC
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMD------------NDFLV-----GRKKMP--RAQTEREIMQMLD-HP 530 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~------------k~~~~-----~~~~~~--~~~~EieILr~L~-HP 530 (857)
-+.+++.||-|.-+.||.+-+ +.|..+++|.-+ ++++. .+..+. .+.+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 377899999999999999987 456788888632 11111 111222 2356888888885 43
Q ss_pred C-ccccceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC
Q 035930 531 F-LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG 609 (857)
Q Consensus 531 n-IV~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg 609 (857)
+ ++..++ .+..|+|||++.|-.|....+-. + +..+...+..-+--|..+|+||+|..-=||++++++
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~-----d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHVE-----D---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeeecC-----C---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 3 233333 34568999999888886554322 1 223344455556678899999999999999999999
Q ss_pred cEEEecccch
Q 035930 610 HIMLSDFDLS 619 (857)
Q Consensus 610 ~iKL~DFGLA 619 (857)
.++++||-..
T Consensus 240 ~i~vIDFPQm 249 (465)
T KOG2268|consen 240 KIVVIDFPQM 249 (465)
T ss_pred CEEEeechHh
Confidence 9999999764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0024 Score=68.14 Aligned_cols=132 Identities=20% Similarity=0.218 Sum_probs=75.9
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCC-ccccceeeeeCCeEEEEEeecCCCC
Q 035930 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF-LPTLFAHFTTEKFSCLVMEYCPGGD 556 (857)
Q Consensus 478 LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn-IV~L~~~f~~~~~l~LVmEy~~gGs 556 (857)
+..|-...+|+... ++..|++|+..... ....-...+|.++|+.+..-. .++++..+. -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 45677788998873 45678888754321 111013477999999886433 344544432 268999998866
Q ss_pred hHH--------------H---HhhCC--CCCCcH-HHHHHHHHHH---------HHHHHHHHH--------cCceeccCC
Q 035930 557 LHV--------------L---RQKQP--SRFFSE-QAARFYVAEV---------LLALEYLHM--------LGVVYRDLK 599 (857)
Q Consensus 557 L~~--------------l---l~~~~--~~~l~e-~~~r~i~~QI---------l~gL~yLHs--------~GIIHRDLK 599 (857)
+.. . ++..+ ...++. ..+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 521 1 11111 111121 1122222111 111222222 248999999
Q ss_pred CCcEEEccCCcEEEecccch
Q 035930 600 PENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 600 PeNILL~~dg~iKL~DFGLA 619 (857)
|.|||++.++ +.|+||+.|
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a 173 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYA 173 (256)
T ss_pred cCcEEEeCCC-CEEEecccc
Confidence 9999999877 789999987
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0035 Score=67.99 Aligned_cols=140 Identities=16% Similarity=0.122 Sum_probs=83.7
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCC--cccccee------eeeCC
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF--LPTLFAH------FTTEK 543 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn--IV~L~~~------f~~~~ 543 (857)
..-.+.|..|....+|+....+ ..+++|+... .....+..|+++++.|.+-. +++++.. ...++
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~~~--~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTTDS--GRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred hhheecccCccccceEEEEeCC--CcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 3346678888888999986533 3688898753 12344567888888774322 4444432 23345
Q ss_pred eEEEEEeecCCCChHH-----H---------HhhC----CCC-----CCcHHHH--H--------HHHHHHHHHHHHHHH
Q 035930 544 FSCLVMEYCPGGDLHV-----L---------RQKQ----PSR-----FFSEQAA--R--------FYVAEVLLALEYLHM 590 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~-----l---------l~~~----~~~-----~l~e~~~--r--------~i~~QIl~gL~yLHs 590 (857)
..++||+|++|..+.. + ++.. ... ...+... . .....+..++.++..
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 6789999998876421 0 1110 000 0010000 0 011112334444443
Q ss_pred -------cCceeccCCCCcEEEccCCcEEEecccch
Q 035930 591 -------LGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 591 -------~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
.++||+|+.|.|||++.++.+.|+||+.+
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 47999999999999998877899999986
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.17 E-value=3.5e-05 Score=96.97 Aligned_cols=209 Identities=14% Similarity=0.002 Sum_probs=137.5
Q ss_pred HHHHHHHHHHHcCCCCccccceeee--eCCeEEEEEeecCCCChHHHHhhCCCC--CCcHHHHHHHHHHHHHHHHHHHHc
Q 035930 516 RAQTEREIMQMLDHPFLPTLFAHFT--TEKFSCLVMEYCPGGDLHVLRQKQPSR--FFSEQAARFYVAEVLLALEYLHML 591 (857)
Q Consensus 516 ~~~~EieILr~L~HPnIV~L~~~f~--~~~~l~LVmEy~~gGsL~~ll~~~~~~--~l~e~~~r~i~~QIl~gL~yLHs~ 591 (857)
+...|++.++...|+++...+.-.. +....|.+++|+.+|.+...+-+.-.. .+.+..+.....+.+.+..-+|..
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 3455666666778998877655443 234568999999999998887665332 233333333333447777777743
Q ss_pred -----CceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccc
Q 035930 592 -----GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSC 666 (857)
Q Consensus 592 -----GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 666 (857)
-.+|++||+-|.++.-+.++++.++|+.+.. +
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--n----------------------------------------- 1391 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--N----------------------------------------- 1391 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCccccccccccccc--C-----------------------------------------
Confidence 2899999999999999999999999997410 0
Q ss_pred cccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCC
Q 035930 667 FTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTP 746 (857)
Q Consensus 667 ~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~P 746 (857)
+.....+..++++.|+.|++...-.++.++|+|..|+-+|++-.|..+
T Consensus 1392 --------------------------------p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~ 1439 (2724)
T KOG1826|consen 1392 --------------------------------PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAY 1439 (2724)
T ss_pred --------------------------------chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHH
Confidence 001122345688899999999999999999999999999999999888
Q ss_pred CCCCCChhhhHHHhhcccc----CCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCC
Q 035930 747 FKGSGNDETLSNVVSQSLR----FPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 747 F~g~~~~e~l~~Iv~~~~~----~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
|.. .++.++++... +...-..+.++-.+...+|-..-..||. -...+.-+.|.
T Consensus 1440 fi~-----flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~----q~isls~d~~a 1496 (2724)
T KOG1826|consen 1440 FIF-----FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPG----QYISLSRDHFA 1496 (2724)
T ss_pred HHH-----HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcch----hhhhccccccc
Confidence 743 23333332221 1111122334444444455555567877 56666666554
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0035 Score=68.90 Aligned_cols=138 Identities=16% Similarity=0.111 Sum_probs=76.1
Q ss_pred EEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCC--ccccce------eeeeCCeE
Q 035930 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF--LPTLFA------HFTTEKFS 545 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn--IV~L~~------~f~~~~~l 545 (857)
-.+.|+.|...++|+.... +| .+++|++.. .....+..|..+++.|.... ++.++. +....+..
T Consensus 26 ~~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~------~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~ 97 (319)
T PRK05231 26 SLKGIAEGIENSNFFLTTT-QG-EYVLTLFER------LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKP 97 (319)
T ss_pred ccchhccccccceEEEEeC-CC-cEEEEEecc------CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEE
Confidence 3456777888899998764 33 588998751 11233445666666663211 333332 12335667
Q ss_pred EEEEeecCCCChH-----HH------H---hhCCC---------CCCcH--HHHH-----------HHHHH-HHHHHHHH
Q 035930 546 CLVMEYCPGGDLH-----VL------R---QKQPS---------RFFSE--QAAR-----------FYVAE-VLLALEYL 588 (857)
Q Consensus 546 ~LVmEy~~gGsL~-----~l------l---~~~~~---------~~l~e--~~~r-----------~i~~Q-Il~gL~yL 588 (857)
+++|||++|..+. .+ + +.... ..+.+ .... ..+.+ +...++.+
T Consensus 98 ~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 177 (319)
T PRK05231 98 AAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFL 177 (319)
T ss_pred EEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhh
Confidence 9999999887431 11 1 11000 00101 0000 01111 11122333
Q ss_pred H-------HcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 589 H-------MLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 589 H-------s~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
. ..|+||+|+.|.|||++.+...-|+||+.+
T Consensus 178 ~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~ 215 (319)
T PRK05231 178 ASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFA 215 (319)
T ss_pred hccccccCCcccCCCCCCCCcEEEECCceEEEEecccc
Confidence 2 238999999999999986655689999986
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0033 Score=71.14 Aligned_cols=76 Identities=16% Similarity=0.131 Sum_probs=51.1
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEeccc-cc---ccccchhHHHHHHHHHHHcC--CC-CccccceeeeeCCeEEEEE
Q 035930 477 KLGCGDIGTVYLAELIGTSCLFALKVMDND-FL---VGRKKMPRAQTEREIMQMLD--HP-FLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 477 ~LG~G~fGtVyla~~~~tg~~VAVKvi~k~-~~---~~~~~~~~~~~EieILr~L~--HP-nIV~L~~~f~~~~~l~LVm 549 (857)
.||.|....||++.+.+.++.|+||.-..- .. ...-..++...|.+.|+... -| +++++ |+.++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~v--y~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRI--FHFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeE--EEEccccceehH
Confidence 579999999999998644467999974311 10 11344567778888887764 34 45555 344555667999
Q ss_pred eecCC
Q 035930 550 EYCPG 554 (857)
Q Consensus 550 Ey~~g 554 (857)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0071 Score=68.17 Aligned_cols=142 Identities=23% Similarity=0.278 Sum_probs=93.6
Q ss_pred EEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc---------------------cccchh--HHHHHHHHHHHcCC
Q 035930 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV---------------------GRKKMP--RAQTEREIMQMLDH 529 (857)
Q Consensus 473 ~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~---------------------~~~~~~--~~~~EieILr~L~H 529 (857)
.+...|..|.-+.||.|.. .+|..+|||+++-.-+. ....+- .+..|+.-|++|+.
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3555777888899999876 46777999997522110 001111 13456777887764
Q ss_pred CCccccceeeeeCCeEEEEEeecCCCChH-HHHhhCCCCCCcHHHHHHHHHHHHHHHHHH-HHcCceeccCCCCcEEEcc
Q 035930 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYL-HMLGVVYRDLKPENILVRE 607 (857)
Q Consensus 530 PnIV~L~~~f~~~~~l~LVmEy~~gGsL~-~ll~~~~~~~l~e~~~r~i~~QIl~gL~yL-Hs~GIIHRDLKPeNILL~~ 607 (857)
-.|+-.--... ....|||+|+.+.... -.+.. -.++...++.+..|++.-|.-| |.+++||.||.-=|+|+.
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH- 299 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-
Confidence 44432211111 1236999999433221 11221 2377888999999999988877 578999999999999995
Q ss_pred CCcEEEecccchhh
Q 035930 608 DGHIMLSDFDLSLR 621 (857)
Q Consensus 608 dg~iKL~DFGLA~r 621 (857)
+|.+.|+|.+.++.
T Consensus 300 dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVE 313 (520)
T ss_pred CCEEEEEEcccccc
Confidence 78999999987643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.018 Score=64.88 Aligned_cols=138 Identities=14% Similarity=0.160 Sum_probs=81.5
Q ss_pred EEeEEccCCceEEEEEEEcC----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCC-ccccceeeeeCCeEEEE
Q 035930 474 LHKKLGCGDIGTVYLAELIG----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF-LPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn-IV~L~~~f~~~~~l~LV 548 (857)
-+..|-.|-.-.+|++.... .++.|++|+..... ..... ..+|..+++.+..-+ -+++++.+.. + .|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v 111 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RV 111 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eE
Confidence 34455558888999987532 24679999875431 22223 377999999886433 3456665533 2 58
Q ss_pred EeecCCCChHHH-----------------HhhCC--CC--CCcHHHHHHHHHHH-----------------HHHHHHH--
Q 035930 549 MEYCPGGDLHVL-----------------RQKQP--SR--FFSEQAARFYVAEV-----------------LLALEYL-- 588 (857)
Q Consensus 549 mEy~~gGsL~~l-----------------l~~~~--~~--~l~e~~~r~i~~QI-----------------l~gL~yL-- 588 (857)
+||+++.+|... ++... .. ......+..+..++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999987766311 11111 00 11223333333221 1111122
Q ss_pred --H----HcCceeccCCCCcEEEcc-CCcEEEecccch
Q 035930 589 --H----MLGVVYRDLKPENILVRE-DGHIMLSDFDLS 619 (857)
Q Consensus 589 --H----s~GIIHRDLKPeNILL~~-dg~iKL~DFGLA 619 (857)
. ...++|+||++.|||+++ ++.+.|+||+.+
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya 229 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYA 229 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhc
Confidence 1 235899999999999986 478999999987
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.021 Score=65.45 Aligned_cols=79 Identities=18% Similarity=0.280 Sum_probs=53.7
Q ss_pred EEeEEccCCceEEEEEEEcCCCeEEEEEEecccc---cccccchhHHHHHHHHHHHcC--CC-CccccceeeeeCCeEEE
Q 035930 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDF---LVGRKKMPRAQTEREIMQMLD--HP-FLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~---~~~~~~~~~~~~EieILr~L~--HP-nIV~L~~~f~~~~~l~L 547 (857)
..+.||.|.-.-||++.+...+..|+||.-..-. -.-.-..++...|.++|+.+. -| +++++| +.++....+
T Consensus 33 ~~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~ 110 (409)
T PRK12396 33 QCKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCC 110 (409)
T ss_pred eeeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhH
Confidence 3789999999999999984334578998642111 111344567788999998774 34 455564 345556679
Q ss_pred EEeecCC
Q 035930 548 VMEYCPG 554 (857)
Q Consensus 548 VmEy~~g 554 (857)
|||+++.
T Consensus 111 vMEdL~~ 117 (409)
T PRK12396 111 VMEDLSD 117 (409)
T ss_pred HHHhCcc
Confidence 9999954
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.017 Score=64.63 Aligned_cols=140 Identities=11% Similarity=0.189 Sum_probs=80.1
Q ss_pred CeEEEeEEccCCceEEEEEEEcCC---CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCc-cccceeeeeCCeEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGT---SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL-PTLFAHFTTEKFSC 546 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~t---g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnI-V~L~~~f~~~~~l~ 546 (857)
.+.+. .|..|=.-.+|+....+. +..|++|+.... ....-...+|..+++.+..-++ +++++++. .+
T Consensus 16 ~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~----t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 16 DFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPN----TDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred ceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCC----cCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 34444 444477778998876542 347889987543 1122233679999998864444 56666653 22
Q ss_pred EEEeecCCCChHH--H---------------HhhCCC---CCC-cHHHHHHHHHHH----------------------HH
Q 035930 547 LVMEYCPGGDLHV--L---------------RQKQPS---RFF-SEQAARFYVAEV----------------------LL 583 (857)
Q Consensus 547 LVmEy~~gGsL~~--l---------------l~~~~~---~~l-~e~~~r~i~~QI----------------------l~ 583 (857)
+|.+|++|..|.. + ++..+. ..+ .+..+..+..++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5899998776521 0 111110 001 122233332221 11
Q ss_pred HHHHHH----HcC----ceeccCCCCcEEEcc-CCcEEEecccch
Q 035930 584 ALEYLH----MLG----VVYRDLKPENILVRE-DGHIMLSDFDLS 619 (857)
Q Consensus 584 gL~yLH----s~G----IIHRDLKPeNILL~~-dg~iKL~DFGLA 619 (857)
-+..+. ..+ ++|.||.+.|||+++ ++.++|+||+.|
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 122221 112 799999999999975 578999999987
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.042 Score=59.87 Aligned_cols=28 Identities=29% Similarity=0.532 Sum_probs=25.0
Q ss_pred cCceeccCCCCcEEEccCCcEEEecccch
Q 035930 591 LGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 591 ~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
.++||+|+.+.|||++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47999999999999987 67899999965
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.022 Score=62.18 Aligned_cols=28 Identities=36% Similarity=0.488 Sum_probs=24.2
Q ss_pred CceeccCCCCcEEEccCCc-EEEecccch
Q 035930 592 GVVYRDLKPENILVREDGH-IMLSDFDLS 619 (857)
Q Consensus 592 GIIHRDLKPeNILL~~dg~-iKL~DFGLA 619 (857)
.+||+|++|.|||++.++. .-|+||+.+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a 214 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEA 214 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhc
Confidence 4899999999999997565 569999986
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.075 Score=61.32 Aligned_cols=77 Identities=19% Similarity=0.232 Sum_probs=53.6
Q ss_pred EEeEEccCCceEEEEEEEcCCCeEEEEEEeccccc-cc---ccchhHHHHHHHHHHHcC---CCCccccceeeeeCCeEE
Q 035930 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFL-VG---RKKMPRAQTEREIMQMLD---HPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~-~~---~~~~~~~~~EieILr~L~---HPnIV~L~~~f~~~~~l~ 546 (857)
..+.||.|....||+..+. +..|+||.-..-.. .+ .....+...|.+.|+.+. ..+++++|.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4678999999999999873 34688997542111 11 124566677788887764 247888888777 4467
Q ss_pred EEEeecCC
Q 035930 547 LVMEYCPG 554 (857)
Q Consensus 547 LVmEy~~g 554 (857)
+||||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999976
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.021 Score=59.23 Aligned_cols=29 Identities=41% Similarity=0.721 Sum_probs=21.0
Q ss_pred cCceeccCCCCcEEE-ccCCcEEEecccch
Q 035930 591 LGVVYRDLKPENILV-REDGHIMLSDFDLS 619 (857)
Q Consensus 591 ~GIIHRDLKPeNILL-~~dg~iKL~DFGLA 619 (857)
..++|.||.|.|||+ +.++.++|+||..|
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya 172 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYA 172 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHH
Confidence 358999999999999 88899999999987
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.036 Score=63.45 Aligned_cols=78 Identities=19% Similarity=0.321 Sum_probs=47.6
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCC-eE-----EEEEEecccccccccchhHHHHHHHHHHHcCCC-CccccceeeeeCC
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTS-CL-----FALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP-FLPTLFAHFTTEK 543 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg-~~-----VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HP-nIV~L~~~f~~~~ 543 (857)
.+.+ +.|..|-...+|++...... .. |.+++.. ......-.-.+|+++++.+... .-+++++.|..
T Consensus 52 ~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g----~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~-- 124 (383)
T PTZ00384 52 FIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS----TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD-- 124 (383)
T ss_pred cEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEecc----CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC--
Confidence 3444 45555888999999764331 22 3444321 1122222336789999999744 44666776643
Q ss_pred eEEEEEeecCCCCh
Q 035930 544 FSCLVMEYCPGGDL 557 (857)
Q Consensus 544 ~l~LVmEy~~gGsL 557 (857)
++|+||++|..|
T Consensus 125 --g~l~efIeGr~l 136 (383)
T PTZ00384 125 --FTIQEWVEGNTM 136 (383)
T ss_pred --EEEEEEeccccC
Confidence 599999998876
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.12 Score=56.98 Aligned_cols=76 Identities=18% Similarity=0.203 Sum_probs=49.8
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC---CCCccccceeeeeCCeEEEE
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD---HPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~---HPnIV~L~~~f~~~~~l~LV 548 (857)
.+-.+.|+-|....+|+.. .++..|.||+-.. .....+..|.+-|+.|. --.+++++++...++..|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 4456789999999999987 5677899998652 23456788888888884 44678899998888778999
Q ss_pred EeecCCC
Q 035930 549 MEYCPGG 555 (857)
Q Consensus 549 mEy~~gG 555 (857)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.11 Score=57.22 Aligned_cols=28 Identities=18% Similarity=0.164 Sum_probs=26.6
Q ss_pred CceeccCCCCcEEEccCCcEEEecccch
Q 035930 592 GVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 592 GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
++||+|+.+.|||++.++.+.|+||..+
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~ 224 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKA 224 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhc
Confidence 7999999999999999999999999986
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.16 Score=56.96 Aligned_cols=146 Identities=12% Similarity=0.102 Sum_probs=83.0
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCC--ccccceeeeeCC--eE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF--LPTLFAHFTTEK--FS 545 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn--IV~L~~~f~~~~--~l 545 (857)
....+.+.+-.|---.+|..... ++.++|+ ... ............+|..+|+.+.--. +...+++|.++. ..
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 34445555533333344444443 6678888 332 1222334456678888888875322 344566666665 67
Q ss_pred EEEEeecCCCCh---------H-HHHh-----------hCC-------C--CCCcHHHHHHHHH--------------HH
Q 035930 546 CLVMEYCPGGDL---------H-VLRQ-----------KQP-------S--RFFSEQAARFYVA--------------EV 581 (857)
Q Consensus 546 ~LVmEy~~gGsL---------~-~ll~-----------~~~-------~--~~l~e~~~r~i~~--------------QI 581 (857)
|.||+|+.|..+ . .+.. .-+ . ..+...++..+.. .+
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 999999988432 1 1111 000 0 0011111111211 12
Q ss_pred HHHHHHHHHc--------CceeccCCCCcEEEccCCcEEEecccch
Q 035930 582 LLALEYLHML--------GVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 582 l~gL~yLHs~--------GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
..-..||+.+ .++|+|+.+.||+++.++-+-+.||+++
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~ 226 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELA 226 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccc
Confidence 3345566644 3899999999999999988999999987
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.031 Score=65.40 Aligned_cols=80 Identities=19% Similarity=0.184 Sum_probs=57.9
Q ss_pred ccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC----------CCCCCHHHHHHHHhhccCCcCCcCCchh
Q 035930 727 SVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG----------YPVVSFHARDLIRGLLVKEPDNRLGAVK 796 (857)
Q Consensus 727 ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~----------~~~is~~l~dLI~k~L~~DPe~Rpt~~~ 796 (857)
++|||++|.++.|+.-|...|......+.+..+..-...... .-..+..+.++..+|+-..|..||.
T Consensus 111 KsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l--- 187 (725)
T KOG1093|consen 111 KSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL--- 187 (725)
T ss_pred chhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc---
Confidence 899999999999999998888765544444333321111000 0124566778999999999999997
Q ss_pred hHHHHHcCCCCCCC
Q 035930 797 GAAEIKQHPFFEGL 810 (857)
Q Consensus 797 ~a~ELL~HPfF~~l 810 (857)
..++++|+-|.++
T Consensus 188 -~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 188 -PMELSKRCSFTEV 200 (725)
T ss_pred -hhHHhcCccHHHH
Confidence 8899999998876
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.068 Score=60.51 Aligned_cols=85 Identities=22% Similarity=0.317 Sum_probs=60.8
Q ss_pred CCCCccccceee-eeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEE
Q 035930 528 DHPFLPTLFAHF-TTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH-MLGVVYRDLKPENILV 605 (857)
Q Consensus 528 ~HPnIV~L~~~f-~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLH-s~GIIHRDLKPeNILL 605 (857)
..++..+++-+- .+..+.|++|++- |+.|...-. ....++..++++.+..|+-|. ....=||||...||||
T Consensus 283 g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~ik~------~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI 355 (488)
T COG5072 283 GSVFLETLKVVSLDETLYLYLHFKDH-GTPISIIKA------DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI 355 (488)
T ss_pred cchhhhcceEEecCCceEEEEEEecC-Cceeeeeec------ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee
Confidence 345555554444 2334678899987 777643211 345667777888877777666 3468999999999999
Q ss_pred ccCCcEEEecccchh
Q 035930 606 REDGHIMLSDFDLSL 620 (857)
Q Consensus 606 ~~dg~iKL~DFGLA~ 620 (857)
+ +|+|.|+||-+++
T Consensus 356 d-~GnvtLIDfklsR 369 (488)
T COG5072 356 D-EGNVTLIDFKLSR 369 (488)
T ss_pred e-cCceEEEEeeeee
Confidence 9 9999999999985
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.6 Score=52.09 Aligned_cols=71 Identities=11% Similarity=0.007 Sum_probs=43.0
Q ss_pred CCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCC--ccc---cce--eeeeCCeEEEEEeecC
Q 035930 481 GDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF--LPT---LFA--HFTTEKFSCLVMEYCP 553 (857)
Q Consensus 481 G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn--IV~---L~~--~f~~~~~l~LVmEy~~ 553 (857)
+.-..||+... .++..|++|+.+.. ......+..|++++..|.... ++. .-+ +...++..+.|+++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~----~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPE----RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcc----cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 34467898875 34557999987533 123445677888887773211 222 112 2334567889999998
Q ss_pred CCC
Q 035930 554 GGD 556 (857)
Q Consensus 554 gGs 556 (857)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.22 Score=58.18 Aligned_cols=76 Identities=14% Similarity=0.228 Sum_probs=48.7
Q ss_pred EEeEEccCCceEEEEEEEcCC--------CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCc-cccceeeeeCCe
Q 035930 474 LHKKLGCGDIGTVYLAELIGT--------SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL-PTLFAHFTTEKF 544 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~t--------g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnI-V~L~~~f~~~~~ 544 (857)
-++.|..|=.-.+|++..... ++.|.+|+.-.. ...+-....|..+++.+..-.| +++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~----te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKD----VDELYNPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCC----ccceeCHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 556777777788999876422 467889987443 1222234678888888864444 45665553
Q ss_pred EEEEEeecCCCCh
Q 035930 545 SCLVMEYCPGGDL 557 (857)
Q Consensus 545 l~LVmEy~~gGsL 557 (857)
-+.|.||++|..|
T Consensus 181 gg~I~efi~g~~l 193 (442)
T PTZ00296 181 GGRIEEWLYGDPL 193 (442)
T ss_pred CCEEEEeeCCccC
Confidence 2467999988744
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.43 Score=61.32 Aligned_cols=139 Identities=20% Similarity=0.194 Sum_probs=76.4
Q ss_pred EeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-------CCCccccc-e----eeee-
Q 035930 475 HKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-------HPFLPTLF-A----HFTT- 541 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-------HPnIV~L~-~----~f~~- 541 (857)
.+.|+ |..-.+|+... .++..|++|+.+... ....+..|.++|..|. -|.++... + ....
T Consensus 30 ~~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-----~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~ 102 (1013)
T PRK06148 30 ATPLD-GERDLNFRLTT-DDGADYILKIVNPSE-----PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDP 102 (1013)
T ss_pred EeecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-----chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecC
Confidence 46775 45678898875 356679999987541 2223344555665552 22222221 1 1111
Q ss_pred CC--eEEEEEeecCCCChHHH---------------------HhhCCC----CCCcHH-----------------HHHHH
Q 035930 542 EK--FSCLVMEYCPGGDLHVL---------------------RQKQPS----RFFSEQ-----------------AARFY 577 (857)
Q Consensus 542 ~~--~l~LVmEy~~gGsL~~l---------------------l~~~~~----~~l~e~-----------------~~r~i 577 (857)
++ +.+-+|+|++|..|... ++.... +.+.|. ..+.+
T Consensus 103 ~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~ 182 (1013)
T PRK06148 103 DGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRAL 182 (1013)
T ss_pred CCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHH
Confidence 22 56788999998766431 110000 111111 11222
Q ss_pred HHHHHHHHH-----HHH--HcCceeccCCCCcEEEccCC--cEE-Eecccchh
Q 035930 578 VAEVLLALE-----YLH--MLGVVYRDLKPENILVREDG--HIM-LSDFDLSL 620 (857)
Q Consensus 578 ~~QIl~gL~-----yLH--s~GIIHRDLKPeNILL~~dg--~iK-L~DFGLA~ 620 (857)
+.+++..++ .|. ..++||.|+.+.|||++.++ ++. |+|||-+.
T Consensus 183 l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 183 VERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 333333322 122 25799999999999999875 555 99999863
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.42 Score=53.81 Aligned_cols=136 Identities=24% Similarity=0.298 Sum_probs=79.6
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCC------cccccee--eeeCC--eE
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF------LPTLFAH--FTTEK--FS 545 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn------IV~L~~~--f~~~~--~l 545 (857)
..|.+ .-..||+....... +++|+.+.. .....+..|.++|+.|.-.. +..+-+- ..-.. +.
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~--~iLki~~~~-----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~ 103 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGR--YILKIYRPG-----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP 103 (331)
T ss_pred ccccc-ccCceEEEEecCCC--eEEEEecCC-----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence 34444 45678888775443 489988654 23345677888887774211 2222221 11223 77
Q ss_pred EEEEeecCCCChHH-H------------------HhhCC----C--CCCcHH----HH---------HHHHHHHHHHHHH
Q 035930 546 CLVMEYCPGGDLHV-L------------------RQKQP----S--RFFSEQ----AA---------RFYVAEVLLALEY 587 (857)
Q Consensus 546 ~LVmEy~~gGsL~~-l------------------l~~~~----~--~~l~e~----~~---------r~i~~QIl~gL~y 587 (857)
+-|++|++|..+.. . .+..+ . ....+. .. .....++...++.
T Consensus 104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~ 183 (331)
T COG2334 104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR 183 (331)
T ss_pred EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence 88999999887751 0 01111 0 011121 00 0123455555555
Q ss_pred HHH--------cC--ceeccCCCCcEEEccCCc-EEEecccch
Q 035930 588 LHM--------LG--VVYRDLKPENILVREDGH-IMLSDFDLS 619 (857)
Q Consensus 588 LHs--------~G--IIHRDLKPeNILL~~dg~-iKL~DFGLA 619 (857)
+.+ .+ |||+|+.|.|||++.+.. +.++|||-+
T Consensus 184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa 226 (331)
T COG2334 184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDA 226 (331)
T ss_pred HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccc
Confidence 554 24 999999999999998874 899999976
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.15 Score=58.59 Aligned_cols=61 Identities=23% Similarity=0.144 Sum_probs=43.4
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEEcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH-MLGVVYRDLKPENILVRE 607 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLH-s~GIIHRDLKPeNILL~~ 607 (857)
...||-+|..|..+..++.... .++...+.++.-...||--|- -.+++|.|+.|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 3467788998888887776543 456566666655555554443 457999999999999964
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.55 E-value=0.2 Score=53.68 Aligned_cols=82 Identities=24% Similarity=0.344 Sum_probs=57.8
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC---CCCccccceeeeeCCe
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD---HPFLPTLFAHFTTEKF 544 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~---HPnIV~L~~~f~~~~~ 544 (857)
+..+.+..+.+.-|..-..|...+- ...|-||+=. ......+..|+.-|+.|. --.+++++.+....++
T Consensus 14 g~~~i~er~~v~gG~inea~~v~dg--~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~ 85 (286)
T COG3001 14 GEGEIKEREEVSGGDINEAWRLRDG--TDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDH 85 (286)
T ss_pred CchhhhcccccCCccccceeEeecC--CcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCe
Confidence 3334555566777777777777652 2357778632 344567788888777764 4567888889999999
Q ss_pred EEEEEeecCCCCh
Q 035930 545 SCLVMEYCPGGDL 557 (857)
Q Consensus 545 l~LVmEy~~gGsL 557 (857)
.||||||++-+.+
T Consensus 86 sylVle~L~~~~~ 98 (286)
T COG3001 86 SYLVLEYLPTGPL 98 (286)
T ss_pred eEEEEeeccCCCC
Confidence 9999999987655
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 857 | ||||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-34 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-34 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-34 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-32 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-26 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-22 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-26 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-22 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-26 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-21 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-26 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-25 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-25 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-25 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-25 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-25 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-25 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-25 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-25 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-25 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-25 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-25 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-25 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-25 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-25 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-25 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-21 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-25 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-25 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-25 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-25 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-19 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-25 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-19 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-25 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-25 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-25 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-19 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-25 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-25 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-19 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-25 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-25 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-19 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-25 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-25 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-25 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-25 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-25 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-25 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-25 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-25 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-25 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-25 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-21 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-25 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-25 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-25 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-24 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-24 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-24 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-24 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-24 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-24 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-20 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-24 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-24 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-24 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-19 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-24 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-24 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-19 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-24 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-24 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-24 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-24 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-24 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-24 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-24 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-24 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-24 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-24 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-24 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-24 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-19 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-24 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-24 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-17 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-23 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-19 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-23 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-23 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-23 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-19 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-23 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-23 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-23 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-23 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-23 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-23 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-23 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-23 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-23 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-23 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-23 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-23 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-23 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-23 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-22 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-22 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-18 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-22 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-22 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-22 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-22 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-22 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-22 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-21 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-21 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-21 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-21 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-21 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-21 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-21 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-16 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-21 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-21 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-21 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-20 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-19 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-16 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-19 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-19 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-19 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-19 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-19 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-16 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-17 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 8e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 4e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 4e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-04 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 7e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 8e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 5e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 7e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-04 |
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-55
Identities = 59/154 (38%), Positives = 86/154 (55%), Gaps = 4/154 (2%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
FK K LG G TV LA + TS +A+K+++ ++ K+P ER++M
Sbjct: 27 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 527 LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLAL 585
LDHPF L+ F ++ + Y G+L +R+ F E RFY AE++ AL
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSAL 143
Query: 586 EYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
EYLH G+++RDLKPENIL+ ED HI ++DF +
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 177
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 8e-46
Identities = 44/133 (33%), Positives = 66/133 (49%), Gaps = 4/133 (3%)
Query: 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND 753
L E AR+NSFVGT +Y++PE++ + S D W G +++L+ G PF+
Sbjct: 179 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 238
Query: 754 ETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA--VKGAAEIKQHPFFEGLN 811
++ FP ARDL+ LLV + RLG ++G +K HPFFE +
Sbjct: 239 LIFQKIIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 296
Query: 812 WALIRCAVPPELP 824
W + PP+L
Sbjct: 297 WENLHQQTPPKLT 309
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-55
Identities = 59/189 (31%), Positives = 105/189 (55%), Gaps = 2/189 (1%)
Query: 447 HMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDND 506
++++ L+W V+ + + F++ K +G G V + ++ T ++A+K+M+
Sbjct: 38 YVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW 97
Query: 507 FLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPS 566
++ R ++ + ER+++ D ++ L F E + LVMEY GGDL L K
Sbjct: 98 DMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE 157
Query: 567 RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626
R + ARFY+AE+++A++ +H LG V+RD+KP+NIL+ GHI L+DF L+ +
Sbjct: 158 R-IPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216
Query: 627 MVVKSSSPV 635
V+S V
Sbjct: 217 T-VRSLVAV 224
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-41
Identities = 53/133 (39%), Positives = 71/133 (53%), Gaps = 12/133 (9%)
Query: 703 RSNSFVGTHEYLAPEIIKGEG-------HGSSVDWWTFGIFLFELLYGRTPFKGSGNDET 755
RS VGT +YL+PEI++ G +G DWW G+F +E+ YG+TPF ET
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278
Query: 756 LSNVVS--QSLRFPGYPV-VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812
+V + L P V ARD I+ LL P+ RLG GA + + HPFF GL+W
Sbjct: 279 YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGR-GGAGDFRTHPFFFGLDW 336
Query: 813 ALIRCAVPPELPR 825
+R +VPP P
Sbjct: 337 DGLRDSVPPFTPD 349
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-53
Identities = 58/189 (30%), Positives = 99/189 (52%), Gaps = 4/189 (2%)
Query: 447 HMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDND 506
++ N L + + M +++ K +G G G V L T ++A+K++
Sbjct: 46 NIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 105
Query: 507 FLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPS 566
++ R ER+IM + P++ LF F +++ +VMEY PGGDL L
Sbjct: 106 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD- 164
Query: 567 RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626
E+ ARFY AEV+LAL+ +H +G ++RD+KP+N+L+ + GH+ L+DF ++
Sbjct: 165 --VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222
Query: 627 MVVKSSSPV 635
M V+ + V
Sbjct: 223 M-VRCDTAV 230
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-41
Identities = 49/131 (37%), Positives = 74/131 (56%), Gaps = 10/131 (7%)
Query: 703 RSNSFVGTHEYLAPEIIKGEG----HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN 758
R ++ VGT +Y++PE++K +G +G DWW+ G+FL+E+L G TPF T S
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 284
Query: 759 VVS--QSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA--L 814
+++ SL FP +S A++LI L + + RLG G EIK+H FF+ WA
Sbjct: 285 IMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGR-NGVEEIKRHLFFKNDQWAWET 342
Query: 815 IRCAVPPELPR 825
+R V P +P
Sbjct: 343 LRDTVAPVVPD 353
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-52
Identities = 62/155 (40%), Positives = 89/155 (57%), Gaps = 6/155 (3%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
+ M F K LG G G V L T +A+K++ + ++ + ++ TE ++Q
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 527 LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLA 584
HPFL L F T C VMEY GG+L H+ R+ R F+E+ ARFY AE++ A
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSA 117
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
LEYLH VVYRD+K EN+++ +DGHI ++DF L
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-43
Identities = 44/123 (35%), Positives = 72/123 (58%), Gaps = 4/123 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
GA +F GT EYLAPE+++ +G +VDWW G+ ++E++ GR PF ++ ++
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA-VKGAAEIKQHPFFEGLNW-ALIRCA 818
+ +RFP +S A+ L+ GLL K+P RLG A E+ +H FF +NW +++
Sbjct: 219 MEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 276
Query: 819 VPP 821
+ P
Sbjct: 277 LLP 279
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 181 bits (463), Expect = 2e-51
Identities = 55/154 (35%), Positives = 92/154 (59%), Gaps = 4/154 (2%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
++ F++ + LG G G V+L +A+KV+ + +V K++ ER ++ +
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 527 LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLAL 585
+ HPF+ ++ F + ++M+Y GG+L +LR+ S+ F A+FY AEV LAL
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLAL 119
Query: 586 EYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
EYLH ++YRDLKPENIL+ ++GHI ++DF +
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 38/123 (30%), Positives = 71/123 (57%), Gaps = 4/123 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
+ + GT +Y+APE++ + + S+DWW+FGI ++E+L G TPF S +T ++
Sbjct: 157 PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLNW-ALIRCA 818
+ LRFP + + +DL+ L+ ++ RLG ++ G ++K HP+F+ + W L+
Sbjct: 217 NAELRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRN 274
Query: 819 VPP 821
+
Sbjct: 275 IET 277
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-51
Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 2/160 (1%)
Query: 460 VQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQT 519
V ++ + HF++ + +G G G V + + T ++A+K M+ V R ++
Sbjct: 5 VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVA 579
E +IMQ L+HPFL L+ F E+ +V++ GGDL Q+ F E+ + ++
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFIC 122
Query: 580 EVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
E+++AL+YL +++RD+KP+NIL+ E GH+ ++DF+++
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-38
Identities = 35/130 (26%), Positives = 61/130 (46%), Gaps = 12/130 (9%)
Query: 699 PTGARSNSFVGTHEYLAPEII---KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-- 753
P + + GT Y+APE+ KG G+ +VDWW+ G+ +ELL GR P+ +
Sbjct: 166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225
Query: 754 -ETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812
E + + + +P S L++ LL PD R ++++ P+ +NW
Sbjct: 226 KEIVHTFETTVVTYP--SAWSQEMVSLLKKLLEPNPDQRFS---QLSDVQNFPYMNDINW 280
Query: 813 -ALIRCAVPP 821
A+ + + P
Sbjct: 281 DAVFQKRLIP 290
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-50
Identities = 56/160 (35%), Positives = 86/160 (53%), Gaps = 4/160 (2%)
Query: 461 QKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTE 520
+ F K LG G G V L + + +A+K++D +V K++ E
Sbjct: 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 521 REIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVA 579
+ I+Q ++ PFL L F +VMEY GG++ LR+ FSE ARFY A
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAA 148
Query: 580 EVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+++L EYLH L ++YRDLKPEN+L+ + G+I ++DF +
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-41
Identities = 42/123 (34%), Positives = 64/123 (52%), Gaps = 4/123 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
R+ + GT E LAPEII +G+ +VDWW G+ ++E+ G PF + +V
Sbjct: 192 KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLNW-ALIRCA 818
S +RFP + S +DL+R LL + R G +K G +IK H +F +W A+ +
Sbjct: 252 SGKVRFPSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRK 309
Query: 819 VPP 821
V
Sbjct: 310 VEA 312
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-50
Identities = 59/189 (31%), Positives = 102/189 (53%), Gaps = 2/189 (1%)
Query: 447 HMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDND 506
++ L W + + + F++ K +G G G V + +L +FA+K+++
Sbjct: 51 NILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW 110
Query: 507 FLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPS 566
++ R + + ER+++ D ++ TL F + LVM+Y GGDL L K
Sbjct: 111 EMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED 170
Query: 567 RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626
R E+ ARFY+AE+++A++ +H L V+RD+KP+NIL+ +GHI L+DF L+ +
Sbjct: 171 RL-PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229
Query: 627 MVVKSSSPV 635
V+SS V
Sbjct: 230 T-VQSSVAV 237
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-39
Identities = 48/138 (34%), Positives = 78/138 (56%), Gaps = 10/138 (7%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEIIKGE-----GHGSSVDWWTFGIFLFELLYGRTPFKGS 750
++E +S+ VGT +Y++PEI++ +G DWW+ G+ ++E+LYG TPF
Sbjct: 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284
Query: 751 GNDETLSNVVS--QSLRFPGY-PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
ET +++ + +FP VS +A+DLIR L+ ++RLG G + K+HPFF
Sbjct: 285 SLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICS-REHRLGQ-NGIEDFKKHPFF 342
Query: 808 EGLNWALIRCAVPPELPR 825
G++W IR P +P
Sbjct: 343 SGIDWDNIRNCEAPYIPE 360
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-50
Identities = 56/169 (33%), Positives = 91/169 (53%), Gaps = 4/169 (2%)
Query: 453 RWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRK 512
R+ + ++ Q MG F + LG G G V+ ++ T L+A K ++ L RK
Sbjct: 170 RFLQWKWLEAQP--MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227
Query: 513 KMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFS 570
A E++I+ + F+ +L F T+ CLVM GGD+ H+ + + F
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 571 EQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
E A FY A+++ LE+LH ++YRDLKPEN+L+ +DG++ +SD L+
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA 336
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-39
Identities = 37/127 (29%), Positives = 65/127 (51%), Gaps = 8/127 (6%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG----NDETL 756
++ + GT ++APE++ GE + SVD++ G+ L+E++ R PF+ G N E
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA-VKGAAEIKQHPFFEGLNW-AL 814
V+ Q++ +P S ++D LL K+P+ RLG ++ HP F ++W L
Sbjct: 403 QRVLEQAVTYPDK--FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL 460
Query: 815 IRCAVPP 821
+ P
Sbjct: 461 EAGMLTP 467
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-50
Identities = 66/165 (40%), Positives = 101/165 (61%), Gaps = 10/165 (6%)
Query: 460 VQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLVGRKKMPR 516
V++ H F+L K LG G G V+L + I L+A+KV+ L R ++ R
Sbjct: 14 VKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-R 72
Query: 517 AQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAA 574
+ ER+I+ ++HPF+ L F TE L++++ GGDL + ++ F+E+
Sbjct: 73 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE----VMFTEEDV 128
Query: 575 RFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+FY+AE+ LAL++LH LG++YRDLKPENIL+ E+GHI L+DF LS
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-45
Identities = 50/123 (40%), Positives = 73/123 (59%), Gaps = 4/123 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
++ SF GT EY+APE++ GH S DWW+FG+ +FE+L G PF+G ET++ ++
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA-VKGAAEIKQHPFFEGLNW-ALIRCA 818
L P + +S A+ L+R L + P NRLGA G EIK+H FF ++W L R
Sbjct: 240 KAKLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRRE 297
Query: 819 VPP 821
+ P
Sbjct: 298 IHP 300
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-50
Identities = 60/156 (38%), Positives = 91/156 (58%), Gaps = 7/156 (4%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
+G++ F L + +G G V L L T ++A+KV+ + + + + QTE+ + +
Sbjct: 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 527 -LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLL 583
+HPFL L + F TE V+EY GGDL H+ RQ R E+ ARFY AE+ L
Sbjct: 66 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISL 121
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
AL YLH G++YRDLK +N+L+ +GHI L+D+ +
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-40
Identities = 46/133 (34%), Positives = 74/133 (55%), Gaps = 14/133 (10%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-------- 752
G +++F GT Y+APEI++GE +G SVDWW G+ +FE++ GR+PF G+
Sbjct: 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 223
Query: 753 -DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA--VKGAAEIKQHPFFEG 809
D ++ + +R P +S A +++ L K+P RLG G A+I+ HPFF
Sbjct: 224 EDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
Query: 810 LNW-ALIRCAVPP 821
++W + + V P
Sbjct: 282 VDWDMMEQKQVVP 294
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-50
Identities = 57/159 (35%), Positives = 86/159 (54%), Gaps = 10/159 (6%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLVGRKK-MPRAQTERE 522
+ F+L + LG G G V+ + T +FA+KV+ +V K + ER
Sbjct: 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 523 IMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAE 580
I++ + HPF+ L F T L++EY GG+L + R+ F E A FY+AE
Sbjct: 74 ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAE 129
Query: 581 VLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ +AL +LH G++YRDLKPENI++ GH+ L+DF L
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 7e-45
Identities = 47/123 (38%), Positives = 72/123 (58%), Gaps = 4/123 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
G +++F GT EY+APEI+ GH +VDWW+ G ++++L G PF G +T+ ++
Sbjct: 175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV-KGAAEIKQHPFFEGLNW-ALIRCA 818
L P Y ++ ARDL++ LL + +RLGA A E++ HPFF +NW L+
Sbjct: 235 KCKLNLPPY--LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARK 292
Query: 819 VPP 821
V P
Sbjct: 293 VEP 295
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 8e-50
Identities = 61/156 (39%), Positives = 83/156 (53%), Gaps = 7/156 (4%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM-Q 525
F K +G G G V LA +A+KV+ ++ +K+ +ER ++ +
Sbjct: 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 526 MLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLL 583
+ HPFL L F T V++Y GG+L H+ Q R F E ARFY AE+
Sbjct: 95 NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIAS 150
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
AL YLH L +VYRDLKPENIL+ GHI+L+DF L
Sbjct: 151 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-44
Identities = 46/122 (37%), Positives = 68/122 (55%), Gaps = 3/122 (2%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
+ +++F GT EYLAPE++ + + +VDWW G L+E+LYG PF E N++
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW-ALIRCAV 819
++ L+ ++ AR L+ GLL K+ RLGA EIK H FF +NW LI +
Sbjct: 253 NKPLQLKPN--ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKI 310
Query: 820 PP 821
P
Sbjct: 311 TP 312
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-49
Identities = 61/156 (39%), Positives = 90/156 (57%), Gaps = 7/156 (4%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
+ + F LHK LG G G V+LAE T+ FA+K + D ++ + E+ ++ +
Sbjct: 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 527 -LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLL 583
+HPFL +F F T++ VMEY GGDL H+ Q F A FY AE++L
Sbjct: 74 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIIL 129
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L++LH G+VYRDLK +NIL+ +DGHI ++DF +
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-40
Identities = 47/122 (38%), Positives = 76/122 (62%), Gaps = 6/122 (4%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
A++N+F GT +Y+APEI+ G+ + SVDWW+FG+ L+E+L G++PF G +E ++
Sbjct: 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW-ALIRCAV 819
+ +P + + A+DL+ L V+EP+ RLG +I+QHP F +NW L R +
Sbjct: 232 MDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEELERKEI 286
Query: 820 PP 821
P
Sbjct: 287 DP 288
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 2e-49
Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 14/240 (5%)
Query: 380 SSSKPGFSLNCGNRNKAIVTKVDERSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGS 439
+ + +VT +R + Q EY S ++
Sbjct: 108 NFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYL----- 162
Query: 440 SRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFA 499
+ + L+W + +++Q + F+ ++ LG G G V ++ T ++A
Sbjct: 163 ----DSIYFNRFLQW---KWLERQP--VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 213
Query: 500 LKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV 559
K ++ + RK A E++I++ ++ F+ +L + T+ CLV+ GGDL
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 273
Query: 560 LRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
F E A FY AE+ LE LH +VYRDLKPENIL+ + GHI +SD L+
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-38
Identities = 44/129 (34%), Positives = 62/129 (48%), Gaps = 8/129 (6%)
Query: 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG----NDE 754
P G VGT Y+APE++K E + S DWW G L+E++ G++PF+ +E
Sbjct: 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 396
Query: 755 TLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV-KGAAEIKQHPFFEGLNW- 812
V + S AR L LL K+P RLG A E+K+HP F+ LN+
Sbjct: 397 VERLVKEVPEEYSER--FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454
Query: 813 ALIRCAVPP 821
L + P
Sbjct: 455 RLGAGMLEP 463
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-49
Identities = 62/156 (39%), Positives = 91/156 (58%), Gaps = 7/156 (4%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
+G+ +F+ + LG G G V LA + T L+A+KV+ D ++ + TE+ I+ +
Sbjct: 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 527 -LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLL 583
+HPFL LF F T VME+ GGDL H+ Q SR F E ARFY AE++
Sbjct: 80 ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEIIS 135
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
AL +LH G++YRDLK +N+L+ +GH L+DF +
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-42
Identities = 38/124 (30%), Positives = 69/124 (55%), Gaps = 5/124 (4%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
G + +F GT +Y+APEI++ +G +VDWW G+ L+E+L G PF+ D+ ++
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVK--GAAEIKQHPFFEGLNW-ALIRC 817
+ + +P + + A +++ + K P RLG++ G I +HPFF+ ++W L
Sbjct: 238 NDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHR 295
Query: 818 AVPP 821
+ P
Sbjct: 296 QIEP 299
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-49
Identities = 73/224 (32%), Positives = 111/224 (49%), Gaps = 11/224 (4%)
Query: 399 TKVDERSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIR 458
T V ER+ E E + ++I + + + S S + ++ +
Sbjct: 81 TTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAK 140
Query: 459 CVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQ 518
+ + M F+ K LG G G V L + T +A+K++ + +V + ++
Sbjct: 141 PKHR----VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL 196
Query: 519 TEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARF 576
TE ++Q HPFL L F T C VMEY GG+L H+ R+ R FSE ARF
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARF 252
Query: 577 YVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLS 619
Y AE++ AL+YLH VVYRDLK EN+++ +DGHI ++DF L
Sbjct: 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-40
Identities = 45/123 (36%), Positives = 71/123 (57%), Gaps = 4/123 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
GA +F GT EYLAPE+++ +G +VDWW G+ ++E++ GR PF +++ ++
Sbjct: 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 362
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA-VKGAAEIKQHPFFEGLNW-ALIRCA 818
+ +RFP + A+ L+ GLL K+P RLG + A EI QH FF G+ W +
Sbjct: 363 MEEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKK 420
Query: 819 VPP 821
+ P
Sbjct: 421 LSP 423
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-49
Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 7/156 (4%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
M + F LG G G V L+E GT L+A+K++ D ++ + E+ ++ +
Sbjct: 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 527 LD-HPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLL 583
PFL L + F T VMEY GGDL H+ + F E A FY AE+ +
Sbjct: 77 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAI 132
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L +L G++YRDLK +N+++ +GHI ++DF +
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-42
Identities = 47/123 (38%), Positives = 74/123 (60%), Gaps = 4/123 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
G + +F GT +Y+APEII + +G SVDWW FG+ L+E+L G+ PF+G DE +++
Sbjct: 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA-VKGAAEIKQHPFFEGLNW-ALIRCA 818
++ +P +S A + +GL+ K P RLG +G +IK+H FF ++W L R
Sbjct: 235 EHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 292
Query: 819 VPP 821
+ P
Sbjct: 293 IQP 295
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-49
Identities = 59/156 (37%), Positives = 91/156 (58%), Gaps = 7/156 (4%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
+G++ F L + +G G V L L T ++A++V+ + + + + QTE+ + +
Sbjct: 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 527 -LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLL 583
+HPFL L + F TE V+EY GGDL H+ RQ R E+ ARFY AE+ L
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISL 164
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
AL YLH G++YRDLK +N+L+ +GHI L+D+ +
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-39
Identities = 46/133 (34%), Positives = 74/133 (55%), Gaps = 14/133 (10%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-------- 752
G +++F GT Y+APEI++GE +G SVDWW G+ +FE++ GR+PF G+
Sbjct: 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266
Query: 753 -DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA--VKGAAEIKQHPFFEG 809
D ++ + +R P +S A +++ L K+P RLG G A+I+ HPFF
Sbjct: 267 EDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
Query: 810 LNW-ALIRCAVPP 821
++W + + V P
Sbjct: 325 VDWDMMEQKQVVP 337
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-48
Identities = 69/205 (33%), Positives = 116/205 (56%), Gaps = 14/205 (6%)
Query: 422 GEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCG 481
E S+ + + G G + ++LR + ++ +G+ +F+L K LG G
Sbjct: 9 EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEK---VGIENFELLKVLGTG 65
Query: 482 DIGTVYLAELI---GTSCLFALKVMDNDFLVGRKKM-PRAQTEREIMQMLDH-PFLPTLF 536
G V+L I T L+A+KV+ +V + K +TER++++ + PFL TL
Sbjct: 66 AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 125
Query: 537 AHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVV 594
F TE L+++Y GG+L H+ ++++ F+E + YV E++LALE+LH LG++
Sbjct: 126 YAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKLGII 181
Query: 595 YRDLKPENILVREDGHIMLSDFDLS 619
YRD+K ENIL+ +GH++L+DF LS
Sbjct: 182 YRDIKLENILLDSNGHVVLTDFGLS 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-41
Identities = 50/133 (37%), Positives = 74/133 (55%), Gaps = 10/133 (7%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGE--GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE 754
V R+ F GT EY+AP+I++G GH +VDWW+ G+ ++ELL G +PF G
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269
Query: 755 TLS----NVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEG 809
+ + ++ +P +S A+DLI+ LL+K+P RLG A EIK+H FF+
Sbjct: 270 SQAEISRRILKSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
Query: 810 LNW-ALIRCAVPP 821
+NW L VP
Sbjct: 328 INWDDLAAKKVPA 340
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-46
Identities = 62/310 (20%), Positives = 112/310 (36%), Gaps = 9/310 (2%)
Query: 313 QDSTSASSSCTPCDVSASNDPGPSTSYLDVHMHNCTVNNERKENMKTTPAPSGTNMSTDV 372
+ S + S + + + +S ++
Sbjct: 186 PMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEI 245
Query: 373 NSSVGDSSSSKPGFSLNCGNRNKAIVTKVDERSRSREKGEFSQSSKSSIGEYSSSTSISE 432
S + G + + + S+E+GE+ G + +
Sbjct: 246 WDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQK 305
Query: 433 DSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELI 492
+ + + + M + F LG G G V L+E
Sbjct: 306 FERAKIGQGTKAPEEKTANTISKFDNNGNRDR--MKLTDFNFLMVLGKGSFGKVMLSERK 363
Query: 493 GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM-LDHPFLPTLFAHFTTEKFSCLVMEY 551
GT L+A+K++ D ++ + E+ ++ + PFL L + F T VMEY
Sbjct: 364 GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 423
Query: 552 CPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG 609
GGDL H+ + F E A FY AE+ + L +L G++YRDLK +N+++ +G
Sbjct: 424 VNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG 479
Query: 610 HIMLSDFDLS 619
HI ++DF +
Sbjct: 480 HIKIADFGMC 489
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 154 bits (389), Expect = 4e-39
Identities = 47/123 (38%), Positives = 74/123 (60%), Gaps = 4/123 (3%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
G + +F GT +Y+APEII + +G SVDWW FG+ L+E+L G+ PF+G DE +++
Sbjct: 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA-VKGAAEIKQHPFFEGLNW-ALIRCA 818
++ +P +S A + +GL+ K P RLG +G +IK+H FF ++W L R
Sbjct: 556 EHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 613
Query: 819 VPP 821
+ P
Sbjct: 614 IQP 616
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 65/358 (18%), Positives = 118/358 (32%), Gaps = 89/358 (24%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE--IMQM 526
+ F+ + LG G G V+ A+ C +A+K + + +++ R + RE +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR----LPNRELAREKVMREVKALAK 59
Query: 527 LDHPFLPTLFAHFTTE------------KFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQA 573
L+HP + F + + + + M+ C +L + +
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 574 ARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSS 633
++ A+E+LH G+++RDLKP NI D + + DF L
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV-------------- 165
Query: 634 PVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMP 693
E + + P + T
Sbjct: 166 -------TAMDQDEEEQTVLTPMPAYARHTGQVGTKL----------------------- 195
Query: 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND 753
Y++PE I G + VD ++ G+ LFELLY
Sbjct: 196 -------------------YMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERV 234
Query: 754 ETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811
TL++V + P + +++ +L P R A I ++ FE L+
Sbjct: 235 RTLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERP----EAINIIENAVFEDLD 287
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-45
Identities = 54/161 (33%), Positives = 85/161 (52%), Gaps = 5/161 (3%)
Query: 462 KQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTER 521
+ + + M F +H+ +G G G VY T ++A+K +D + ++ A ER
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 522 EIMQML---DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYV 578
++ ++ D PF+ + F T +++ GGDLH + FSE RFY
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYA 298
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
AE++L LE++H VVYRDLKP NIL+ E GH+ +SD L+
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-38
Identities = 45/133 (33%), Positives = 73/133 (54%), Gaps = 8/133 (6%)
Query: 695 LVVEPTGARSNSFVGTHEYLAPEII-KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN- 752
L + + + ++ VGTH Y+APE++ KG + SS DW++ G LF+LL G +PF+
Sbjct: 338 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397
Query: 753 --DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAV-KGAAEIKQHPFFEG 809
E ++ ++ P S R L+ GLL ++ + RLG + +GA E+K+ PFF
Sbjct: 398 DKHEIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
Query: 810 LNW-ALIRCAVPP 821
L+W + PP
Sbjct: 456 LDWQMVFLQKYPP 468
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 1e-44
Identities = 48/152 (31%), Positives = 77/152 (50%), Gaps = 4/152 (2%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
+ F + + LG G G VYLA + ALKV+ L + + E EI L
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
HP + ++ +F K L++E+ P G+L L++ F EQ + ++ E+ AL Y
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHY 129
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
H V++RD+KPEN+L+ G + ++DF S
Sbjct: 130 CHERKVIHRDIKPENLLMGYKGELKIADFGWS 161
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 37/111 (33%), Positives = 55/111 (49%), Gaps = 6/111 (5%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
V R + GT +YL PE+I+G+ H VD W G+ +E L G PF + ET
Sbjct: 162 VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+V+ L+FP + +S ++DLI LL P RL + +HP+
Sbjct: 222 RRIVNVDLKFPPF--LSDGSKDLISKLLRYHPPQRL----PLKGVMEHPWV 266
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 2/151 (1%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
+ F++ + LG G G VYLA + + ALKV+ L + + E EI L
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
HP + L+ +F L++EY P G ++ QK F EQ Y+ E+ AL Y
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYC 125
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
H V++RD+KPEN+L+ G + ++DF S
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 37/113 (32%), Positives = 53/113 (46%), Gaps = 6/113 (5%)
Query: 695 LVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE 754
V +R GT +YL PE+I+G H VD W+ G+ +E L G+ PF+ + E
Sbjct: 155 WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
Query: 755 TLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
T + FP + V+ ARDLI LL P R E+ +HP+
Sbjct: 215 TYKRISRVEFTFPDF--VTEGARDLISRLLKHNPSQRP----MLREVLEHPWI 261
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-39
Identities = 35/181 (19%), Positives = 71/181 (39%), Gaps = 25/181 (13%)
Query: 460 VQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQT 519
V+++ + +++ + L G + L E +ALK + L ++ ++
Sbjct: 23 VKEKDKYIN--DYRIIRTLNQGKFNKIILCEKDNK--FYALKKYEKSLLEKKRDFTKSNN 78
Query: 520 --------------EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL------HV 559
E +I+ + + + T T ++ EY +
Sbjct: 79 DKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF 138
Query: 560 LRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDL 618
+ K + F Q + + VL + Y+H + +RD+KP NIL+ ++G + LSDF
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 619 S 619
S
Sbjct: 199 S 199
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 28/140 (20%), Positives = 54/140 (38%), Gaps = 24/140 (17%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEG--HGSSVDWWTFGIFLFELLYGRTPFKGSGN-D 753
+ GT+E++ PE E +G+ VD W+ GI L+ + Y PF +
Sbjct: 200 EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259
Query: 754 ETLSNVVSQSLRFP-----------------GYPVVSFHARDLIRGLLVKEPDNRLGAVK 796
E +N+ ++++ +P +S D ++ L K P R+
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI---- 315
Query: 797 GAAEIKQHPFFEGLNWALIR 816
+ + +H + N +R
Sbjct: 316 TSEDALKHEWLADTNIEDLR 335
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 42/189 (22%), Positives = 76/189 (40%), Gaps = 18/189 (9%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F+ LG G G V A S +A+K + + +K+ +E ++ L+H +
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQY 63
Query: 532 LPTLFAHF-------------TTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYV 578
+ +A + + + MEYC G L+ L +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLF 122
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEP 638
++L AL Y+H G+++RDLKP NI + E ++ + DF L+ + ++K S
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 639 PPKKASSPC 647
+S
Sbjct: 183 SSDNLTSAI 191
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 30/133 (22%), Positives = 51/133 (38%), Gaps = 11/133 (8%)
Query: 678 SRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGH-GSSVDWWTFGIF 736
++ + L L S +GT Y+A E++ G GH +D ++ GI
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNL--TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220
Query: 737 LFELLYGRTPFKGSGNDETLSNVVSQSLRFPGY--PVVSFHARDLIRGLLVKEPDNRLGA 794
FE++Y G L + S S+ FP + +IR L+ +P+ R
Sbjct: 221 FFEMIYP--FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP-- 276
Query: 795 VKGAAEIKQHPFF 807
GA + +
Sbjct: 277 --GARTLLNSGWL 287
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 38/156 (24%), Positives = 71/156 (45%), Gaps = 7/156 (4%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE--IMQMLD 528
++L + +G G V T FA+K++D + +RE I ML
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALE 586
HP + L ++++ +V E+ G DL ++++ +SE A Y+ ++L AL
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 587 YLHMLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
Y H +++RD+KP +L+ + L F ++
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 7/113 (6%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
+ +G + VGT ++APE++K E +G VD W G+ LF LL G PF G+ +
Sbjct: 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLF 241
Query: 757 SNVVSQSLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
++ + + +S A+DL+R +L+ +P R+ E HP+
Sbjct: 242 EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI----TVYEALNHPWL 290
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+ L LG G V+ T LFA+KV +N + + E E+++ L+H
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKN 68
Query: 532 LPTLFAHF--TTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
+ LFA TT + L+ME+CP G L VL + + E + +V+ + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 589 HMLGVVYRDLKPENILVR----EDGHIMLSDFDLS 619
G+V+R++KP NI+ L+DF +
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 21/138 (15%), Positives = 42/138 (30%), Gaps = 39/138 (28%)
Query: 705 NSFVGTHEYLAPEIIKG--------EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
S GT EYL P++ + + +G++VD W+ G+ + G PF+
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 757 SNVVSQ-----------------------SLRFPGYPVVSFHARD----LIRGLLVKEPD 789
V+ + S P +S + ++ +L + +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 790 NRLGAVKGAAEIKQHPFF 807
G +
Sbjct: 293 KCW----GFDQFFAETSD 306
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 47/152 (30%), Positives = 81/152 (53%), Gaps = 3/152 (1%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
+ FK+ LG G VY AE I T A+K++D + + R Q E +I L
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
HP + L+ +F + LV+E C G++ L+ + + FSE AR ++ +++ + Y
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLY 127
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
LH G+++RDL N+L+ + +I ++DF L+
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 35/99 (35%), Positives = 47/99 (47%), Gaps = 6/99 (6%)
Query: 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG 768
GT Y++PEI HG D W+ G + LL GR PF TL+ VV P
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS 233
Query: 769 YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+ +S A+DLI LL + P +RL + + HPF
Sbjct: 234 F--LSIEAKDLIHQLLRRNPADRL----SLSSVLDHPFM 266
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 42/150 (28%), Positives = 60/150 (40%), Gaps = 4/150 (2%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM-QMLDH 529
F+ +LG G G V+ L+A+K + F G K R E ++ H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQH 116
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
P L + L E C G L + + E Y+ + LLAL +LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASL-PEAQVWGYLRDTLLALAHLH 174
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
G+V+ D+KP NI + G L DF L
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLL 204
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 20/108 (18%), Positives = 39/108 (36%), Gaps = 8/108 (7%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
T G Y+APE+++G +G++ D ++ G+ + E+ E +
Sbjct: 209 TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH---GGEGWQQL 264
Query: 760 VSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
L +S R ++ +L +P R A + P
Sbjct: 265 RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRA----TAEALLALPVL 308
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-35
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+ L LG G V+ T LFA+KV +N + + E E+++ L+H
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKN 68
Query: 532 LPTLFAHF--TTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
+ LFA TT + L+ME+CP G L VL + + E + +V+ + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 589 HMLGVVYRDLKPENILVR----EDGHIMLSDFDLS 619
G+V+R++KP NI+ L+DF +
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 21/125 (16%), Positives = 41/125 (32%), Gaps = 35/125 (28%)
Query: 705 NSFVGTHEYLAPEIIKG--------EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
S GT EYL P++ + + +G++VD W+ G+ + G PF+
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 757 SNVVSQ-----------------------SLRFPGYPVVSFHARD----LIRGLLVKEPD 789
V+ + S P +S + ++ +L + +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 790 NRLGA 794
G
Sbjct: 293 KCWGF 297
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 4/152 (2%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
R + + LG G + T +FA K++ L+ + + E I + L
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
H + F F +V+E C L + ++++ +E AR+Y+ +++L +Y
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQY 130
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
LH V++RDLK N+ + ED + + DF L+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 38/131 (29%), Positives = 57/131 (43%), Gaps = 13/131 (9%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
VE G R GT Y+APE++ +GH VD W+ G ++ LL G+ PF+ S ET
Sbjct: 165 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY 224
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIR 816
+ P + ++ A LI+ +L +P R E+ FF
Sbjct: 225 LRIKKNEYSIPKH--INPVAASLIQKMLQTDPTARP----TINELLNDEFFT-------S 271
Query: 817 CAVPPELPRSC 827
+P LP +C
Sbjct: 272 GYIPARLPITC 282
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 37/151 (24%), Positives = 71/151 (47%), Gaps = 1/151 (0%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
M + +K+G G G L + + +K ++ + K+ ++ E ++ +
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK 81
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
HP + F +VM+YC GGDL Q F E + ++ LAL+++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
H +++RD+K +NI + +DG + L DF ++
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 27/114 (23%), Positives = 47/114 (41%), Gaps = 7/114 (6%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET 755
V+ T + + +GT YL+PEI + + + + D W G L+EL + F+
Sbjct: 174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233
Query: 756 LSNVVSQSLRFPGYP-VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808
+ ++S FP S+ R L+ L + P +R I + F
Sbjct: 234 VLKIISG--SFPPVSLHYSYDLRSLVSQLFKRNPRDRP----SVNSILEKGFIA 281
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 4/152 (2%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
R + + LG G + T +FA K++ L+ + + E I + L
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
H + F F +V+E C L + ++++ +E AR+Y+ +++L +Y
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQY 156
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
LH V++RDLK N+ + ED + + DF L+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 38/131 (29%), Positives = 57/131 (43%), Gaps = 13/131 (9%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
VE G R GT Y+APE++ +GH VD W+ G ++ LL G+ PF+ S ET
Sbjct: 191 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY 250
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIR 816
+ P + ++ A LI+ +L +P R E+ FF
Sbjct: 251 LRIKKNEYSIPKH--INPVAASLIQKMLQTDPTARP----TINELLNDEFF-------TS 297
Query: 817 CAVPPELPRSC 827
+P LP +C
Sbjct: 298 GYIPARLPITC 308
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
F + LG G V+L + T LFALK + + + E +++ + H
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSL---ENEIAVLKKIKHE 66
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
+ TL + + LVM+ GG+L +L + ++E+ A + +VL A++YL
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYL 122
Query: 589 HMLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
H G+V+RDLKPEN+L E+ IM++DF LS
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 28/106 (26%), Positives = 48/106 (45%), Gaps = 6/106 (5%)
Query: 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR 765
+ GT Y+APE++ + + +VD W+ G+ + LL G PF + +
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE 225
Query: 766 FPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
F + +S A+D I LL K+P+ R + HP+ +G
Sbjct: 226 FESPFWDDISESAKDFICHLLEKDPNERY----TCEKALSHPWIDG 267
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 2/153 (1%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
+ +F++ KK+G G VY A + ALK + L+ K E ++++ L+
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVL--RQKQPSRFFSEQAARFYVAEVLLALE 586
HP + +A F + +V+E GDL + K+ R E+ Y ++ ALE
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++H V++RD+KP N+ + G + L D L
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 27/114 (23%), Positives = 45/114 (39%), Gaps = 8/114 (7%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKG-SGNDE 754
++S VGT Y++PE I G+ D W+ G L+E+ ++PF G N
Sbjct: 185 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 244
Query: 755 TLSNVVSQSLRFPGYP--VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
+L + Q +P P S R L+ + +P+ R +
Sbjct: 245 SLCKKIEQC-DYPPLPSDHYSEELRQLVNMCINPDPEKRP----DVTYVYDVAK 293
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 7/154 (4%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
F +KLG G G V+L E + +K ++ D + E E+++ LDHP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE--AEIEVLKSLDHP 80
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
+ +F F +VME C GG+L ++ + + SE + +++ AL Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 589 HMLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
H VV++DLKPENIL + I + DF L+
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 29/108 (26%), Positives = 51/108 (47%), Gaps = 6/108 (5%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
S + GT Y+APE+ K + D W+ G+ ++ LL G PF G+ +E
Sbjct: 180 DEHSTNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT 238
Query: 761 SQSLRFPGYP-VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+ + ++ A DL++ +L K+P+ R AA++ H +F
Sbjct: 239 YKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP----SAAQVLHHEWF 282
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 53/153 (34%), Positives = 73/153 (47%), Gaps = 10/153 (6%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
++ L +G G G V +A GT A K + F+ + + E EIM+ LDHP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDHP 66
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ L+ F LVME C GG+L + K+ F E A + +VL A+ Y H
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCH 123
Query: 590 MLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
L V +RDLKPEN L D + L DF L+
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 8e-19
Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 7/107 (6%)
Query: 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL 764
+ VGT Y++P++++G +G D W+ G+ ++ LL G PF + E + + +
Sbjct: 166 RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF 224
Query: 765 RFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
FP + VS A LIR LL K P R+ + + +H +FE
Sbjct: 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRI----TSLQALEHEWFEK 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMD----NDFLVGRKKMPRAQTERE--IM 524
+++ + LG G V T +A+K++D F + R T +E I+
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 525 QMLD-HPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVL 582
+ + HP + L + T F LV + G+L L +K SE+ R + +L
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALL 134
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ LH L +V+RDLKPENIL+ +D +I L+DF S
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 12/120 (10%)
Query: 705 NSFVGTHEYLAPEIIKG------EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN 758
GT YLAPEII+ G+G VD W+ G+ ++ LL G PF L
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240
Query: 759 VVSQSLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIR 816
++S + +F + S +DL+ LV +P R A E HPFF+ +R
Sbjct: 241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY----TAEEALAHPFFQQYVVEEVR 296
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-34
Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+K + LG G G V L + T A+KV+ + + E ++++ LDHP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
+ L+ F + + LV E GG+L ++ +K FSE A + +VL + Y+
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYM 142
Query: 589 HMLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
H +V+RDLKPEN+L+ +D +I + DF LS
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-19
Identities = 32/113 (28%), Positives = 49/113 (43%), Gaps = 7/113 (6%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
+ +GT Y+APE++ G + D W+ G+ L+ LL G PF G+ + L V
Sbjct: 182 SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240
Query: 761 SQSLRFPGYP--VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811
F VS A+DLIR +L P R+ A + H + +
Sbjct: 241 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI----SARDALDHEWIQTYT 289
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-34
Identities = 31/172 (18%), Positives = 55/172 (31%), Gaps = 22/172 (12%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTER 521
+G + +H LG G VY A F LKV +
Sbjct: 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLM 118
Query: 522 EIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH---VLRQKQPSRFFSEQAARFYV 578
E ++ ++ + S LV E G L L + P + + +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVR-----------EDGHIMLSDFDLS 619
+L +E +H +++ D+KP+N ++ + L D S
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 15/133 (11%), Positives = 36/133 (27%), Gaps = 19/133 (14%)
Query: 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND 753
+ + P G + T + E++ + +D++ ++ +L+G +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291
Query: 754 --------------ETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAA 799
+ + L P + DL+R L K
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIP--DCHHLPSLDLLRQKLKKVFQQHYTN---KI 346
Query: 800 EIKQHPFFEGLNW 812
++ L
Sbjct: 347 RALRNRLIVLLLE 359
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 1e-33
Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG-RKKMPRAQTERE--IMQML 527
H+++ ++LG G V GT +A K + L R+ + R + ERE I++ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALE 586
HP + TL F + L++E GG+L L +K+ +E A ++ ++L +
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVH 122
Query: 587 YLHMLGVVYRDLKPENILV----REDGHIMLSDFDLS 619
YLH + + DLKPENI++ + I L DF ++
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 18/144 (12%)
Query: 671 LLSVAAKSRKIK-SD--LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSS 727
LL + +IK D +A ++ G + GT E++APEI+ E G
Sbjct: 141 LLDKNVPNPRIKLIDFGIAHKIEA---------GNEFKNIFGTPEFVAPEIVNYEPLGLE 191
Query: 728 VDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLLV 785
D W+ G+ + LL G +PF G ETL+N+ + + F + S A+D IR LLV
Sbjct: 192 ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLV 251
Query: 786 KEPDNRLGAVKGAAEIKQHPFFEG 809
K+P R+ A+ +H + +
Sbjct: 252 KDPKRRM----TIAQSLEHSWIKA 271
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 1e-33
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 8/153 (5%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
++ + ++LG G V T FA K+++ L + + + E I + L HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHP 65
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ L E F LV + GG+L + ++ F+SE A + ++L ++ Y H
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCH 122
Query: 590 MLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
G+V+R+LKPEN+L+ + + L+DF L+
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 28/107 (26%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL 764
+ F GT YL+PE++K + + VD W G+ L+ LL G PF + + + +
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 224
Query: 765 RFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
+P + V+ A+ LI +L P R+ A + + P+
Sbjct: 225 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRI----TADQALKVPWICN 267
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 41/176 (23%), Positives = 80/176 (45%), Gaps = 9/176 (5%)
Query: 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML 527
+H+ +KLG G V L E + +ALK + ++ AQ E ++ ++
Sbjct: 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL---CHEQQDREEAQREADMHRLF 83
Query: 528 DHPFLPTLFAHFTTEKFS----CLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEV 581
+HP + L A+ E+ + L++ + G L + R K F +E + + +
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 582 LLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEE 637
LE +H G +RDLKP NIL+ ++G +L D + ++ + + +++
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 21/121 (17%), Positives = 42/121 (34%), Gaps = 15/121 (12%)
Query: 706 SFVGTHEYLAPEIIKGEGH---GSSVDWWTFGIFLFELLYGRTPFKGSG-NDETLSNVVS 761
+ T Y APE+ + H D W+ G L+ +++G P+ ++++ V
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261
Query: 762 QSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPP 821
L P P S L+ ++ +P R + ++ P
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRP----HIPLLLSQLEA-------LQPPAPG 310
Query: 822 E 822
+
Sbjct: 311 Q 311
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 14/228 (6%)
Query: 403 ERSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQK 462
R + ++ I S S + + ++P + +L + ++ +
Sbjct: 23 RREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDE 82
Query: 463 QHGCMGMRHF----KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKM---P 515
+ F +G G V T FA+K+M+ +
Sbjct: 83 LPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEV 142
Query: 516 RAQTERE--IMQML-DHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSE 571
R T RE I++ + HP + TL + + F LV + G+L L +K SE
Sbjct: 143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSE 199
Query: 572 QAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ R + +L A+ +LH +V+RDLKPENIL+ ++ I LSDF S
Sbjct: 200 KETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 40/112 (35%), Positives = 51/112 (45%), Gaps = 12/112 (10%)
Query: 705 NSFVGTHEYLAPEIIKG------EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN 758
GT YLAPEI+K G+G VD W G+ LF LL G PF L
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316
Query: 759 VVSQSLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808
++ +F + S +DLI LL +P+ RL A + QHPFFE
Sbjct: 317 IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL----TAEQALQHPFFE 364
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 8/153 (5%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+ + LG G G V + T +A+KV++ K E E+++ LDHP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ LF +V E GG+L + +++ FSE A + +V + Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH 138
Query: 590 MLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
+V+RDLKPENIL+ +D I + DF LS
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 7/105 (6%)
Query: 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL 764
+GT Y+APE+++G + D W+ G+ L+ LL G PF G + L V +
Sbjct: 181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
Query: 765 RFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
F + +S A+DLIR +L P R+ A + +HP+
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRI----TATQCLEHPWI 280
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG-----RKKMPRAQTEREIMQ 525
+ + K LG G G V LA T A+K++ +TE EI++
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 526 MLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH---VLRQKQPSRFFSEQAARFYVAEVL 582
L+HP + + F E + +V+E GG+L V ++ E + Y ++L
Sbjct: 71 KLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQML 124
Query: 583 LALEYLHMLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
LA++YLH G+++RDLKPEN+L+ ED I ++DF S
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 34/109 (31%), Positives = 49/109 (44%), Gaps = 10/109 (9%)
Query: 707 FVGTHEYLAPEIIKG---EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL-SNVVSQ 762
GT YLAPE++ G+ +VD W+ G+ LF L G PF +L + S
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 763 SLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
F + VS A DL++ LLV +P R E +HP+ +
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARF----TTEEALRHPWLQD 280
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 36/160 (22%), Positives = 68/160 (42%), Gaps = 10/160 (6%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
+++ +G G G + K +D + +K +E +++ L
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ-MLVSEVNLLRELK 63
Query: 529 HPFLPTLFAHF--TTEKFSCLVMEYCPGGDLHVL--RQKQPSRFFSEQAARFYVAEVLLA 584
HP + + T +VMEYC GGDL + + + ++ E+ + ++ LA
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 585 LEYLH-----MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L+ H V++RDLKP N+ + ++ L DF L+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 25/113 (22%), Positives = 45/113 (39%), Gaps = 7/113 (6%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET 755
++ + + +FVGT Y++PE + + D W+ G L+EL PF E
Sbjct: 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224
Query: 756 LSNVVSQSLRFPGYP-VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+ +F P S ++I +L + +R EI ++P
Sbjct: 225 AGKIREG--KFRRIPYRYSDELNEIITRMLNLKDYHRP----SVEEILENPLI 271
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 11/160 (6%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP-RAQTERE--IMQML 527
+ + ++LG G V T +A K + ++ R + ERE I++ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALE 586
H + TL + L++E GG+L L QK+ SE+ A ++ ++L +
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVN 129
Query: 587 YLHMLGVVYRDLKPENILVR----EDGHIMLSDFDLSLRC 622
YLH + + DLKPENI++ HI L DF L+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 40/105 (38%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF 766
GT E++APEI+ E G D W+ G+ + LL G +PF G ETL+N+ S S F
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 767 PG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
+ S A+D IR LLVKE RL E +HP+
Sbjct: 238 DEEFFSHTSELAKDFIRKLLVKETRKRL----TIQEALRHPWITP 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 31/156 (19%), Positives = 65/156 (41%), Gaps = 17/156 (10%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE--IMQMLD 528
+ + + LG G+ G V+ + + K + K + ++E I+ +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK------VKGTDQVLVKKEISILNIAR 59
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLH---VLRQKQPSRFFSEQAARFYVAEVLLAL 585
H + L F + + ++ E+ G D+ + +E+ YV +V AL
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE----LNEREIVSYVHQVCEAL 115
Query: 586 EYLHMLGVVYRDLKPENILV--REDGHIMLSDFDLS 619
++LH + + D++PENI+ R I + +F +
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 6/100 (6%)
Query: 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF- 766
EY APE+ + + ++ D W+ G ++ LL G PF N + + N+++ F
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223
Query: 767 -PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHP 805
+ +S A D + LLVKE +R+ A+E QHP
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHP 259
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-32
Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 15/159 (9%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR-----KKMPRAQTEREIMQ 525
+ + K LG G G V LA T A++++ +TE EI++
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 526 MLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLL 583
L+HP + + F E + +V+E GG+L V+ K E + Y ++LL
Sbjct: 196 KLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLL 250
Query: 584 ALEYLHMLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
A++YLH G+++RDLKPEN+L+ ED I ++DF S
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 34/109 (31%), Positives = 49/109 (44%), Gaps = 10/109 (9%)
Query: 707 FVGTHEYLAPEIIKG---EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL-SNVVSQ 762
GT YLAPE++ G+ +VD W+ G+ LF L G PF +L + S
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360
Query: 763 SLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
F + VS A DL++ LLV +P R E +HP+ +
Sbjct: 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARF----TTEEALRHPWLQD 405
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 49/191 (25%), Positives = 77/191 (40%), Gaps = 42/191 (21%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR--KKMPRAQTEREIMQMLD 528
+ L +G G G V +A T + A+K+M+ + + K + R +TE +M+ L
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDL------------------------------- 557
HP + L+ + E++ CLVME C GG L
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 558 -------HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV--RED 608
++ E+ + ++ AL YLH G+ +RD+KPEN L +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 609 GHIMLSDFDLS 619
I L DF LS
Sbjct: 207 FEIKLVDFGLS 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 7e-21
Identities = 36/107 (33%), Positives = 53/107 (49%), Gaps = 8/107 (7%)
Query: 705 NSFVGTHEYLAPEIIKGEGH--GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
+ GT ++APE++ G D W+ G+ L LL G PF G + +T+S V+++
Sbjct: 232 TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK 291
Query: 763 SLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
L F Y V+S ARDL+ LL + D R A QHP+
Sbjct: 292 KLCFENPNYNVLSPLARDLLSNLLNRNVDERF----DAMRALQHPWI 334
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-32
Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 10/154 (6%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+ + LG G G V + T +A+KV++ K E E+++ LDHP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
+ LF +V E GG+L ++++K FSE A + +V + Y+
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYM 137
Query: 589 HMLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
H +V+RDLKPENIL+ +D I + DF LS
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-19
Identities = 32/111 (28%), Positives = 52/111 (46%), Gaps = 7/111 (6%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
+ +GT Y+APE+++G + D W+ G+ L+ LL G PF G + L V
Sbjct: 177 NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235
Query: 761 SQSLRFPGYP--VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
+ F +S A+DLIR +L P R+ A + +HP+ +
Sbjct: 236 TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI----TATQCLEHPWIQK 282
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-32
Identities = 39/153 (25%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
++L ++LG G V + +A +++ L R + + E I ++L HP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-KLEREARICRLLKHP 70
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ L + E L+ + GG+L + ++ ++SE A + ++L A+ + H
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCH 127
Query: 590 MLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
+GVV+R+LKPEN+L+ + + L+DF L+
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 35/115 (30%), Positives = 53/115 (46%), Gaps = 6/115 (5%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
VE F GT YL+PE+++ + +G VD W G+ L+ LL G PF
Sbjct: 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY 222
Query: 757 SNVVSQSLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
+ + + FP + V+ A+DLI +L P R+ AAE +HP+
Sbjct: 223 QQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI----TAAEALKHPWISH 273
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 11/157 (7%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP-RAQTERE--IMQML 527
+ + ++LG G V T +A K + ++ R + ERE I++ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALE 586
HP + TL + L++E GG+L L QK+ SE+ A ++ ++L +
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVN 129
Query: 587 YLHMLGVVYRDLKPENILVR----EDGHIMLSDFDLS 619
YLH + + DLKPENI++ HI L DF L+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 39/105 (37%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF 766
GT E++APEI+ E G D W+ G+ + LL G +PF G ETL+N+ + S F
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 767 PG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
+ S A+D IR LLVKE RL E +HP+
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRL----TIQEALRHPWITP 278
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 13/158 (8%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP-RAQTERE--IMQML 527
++ ++LG G V T +A K + ++ R ERE I++ +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLAL 585
HP + TL + + L++E GG+L + ++ +E+ A ++ ++L +
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGV 127
Query: 586 EYLHMLGVVYRDLKPENILVR----EDGHIMLSDFDLS 619
YLH L + + DLKPENI++ I + DF L+
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF 766
GT E++APEI+ E G D W+ G+ + LL G +PF G ETL+NV + + F
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 767 PG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811
+ S A+D IR LLVK+P R+ + QHP+ + +
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKPKD 279
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 37/155 (23%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
++ + ++LG G G V+ T +F K ++ + + + + E IM L HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHP 108
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
L L F + L++E+ GG+L + + SE Y+ + L+++
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHM 165
Query: 589 HMLGVVYRDLKPENILV--REDGHIMLSDFDLSLR 621
H +V+ D+KPENI+ ++ + + DF L+ +
Sbjct: 166 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 38/104 (36%), Positives = 51/104 (49%), Gaps = 6/104 (5%)
Query: 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF- 766
T E+ APEI+ E G D W G+ + LL G +PF G + ETL NV F
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270
Query: 767 -PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
+ VS A+D I+ LL KEP RL + +HP+ +G
Sbjct: 271 EDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHPWLKG 310
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 8/153 (5%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
++ + ++LG G V T FA K+++ L R + + E I + L HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHP 88
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ L E F LV + GG+L + ++ F+SE A + ++L ++ Y H
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCH 145
Query: 590 MLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
G+V+R+LKPEN+L+ + + L+DF L+
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 28/107 (26%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL 764
+ F GT YL+PE++K + + VD W G+ L+ LL G PF + + + +
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 247
Query: 765 RFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
+P + V+ A+ LI +L P R+ A + + P+
Sbjct: 248 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRI----TADQALKVPWICN 290
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-32
Identities = 48/154 (31%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
++ KKLG G G V L T A+K++ + + E ++++LDHP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHP 96
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
+ L+ F ++ LVME GG+L ++ + F+E A + +VL + YL
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYL 152
Query: 589 HMLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
H +V+RDLKPEN+L+ +D I + DF LS
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 7e-19
Identities = 34/127 (26%), Positives = 55/127 (43%), Gaps = 7/127 (5%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
+ +GT Y+APE+++ + + D W+ G+ LF LL G PF G + E L V
Sbjct: 192 QKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250
Query: 761 SQSLRFPGYP--VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCA 818
F VS A+DLI+ +L + R+ A + +HP+ + +
Sbjct: 251 KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI----SAQQALEHPWIKEMCSKKESGI 306
Query: 819 VPPELPR 825
P L
Sbjct: 307 ELPSLAN 313
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 41/150 (27%), Positives = 74/150 (49%), Gaps = 16/150 (10%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPT 534
K LG G ++ FA+K++ ++ Q E +++ + HP +
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIIS------KRMEANTQKEITALKLCEGHPNIVK 70
Query: 535 LFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592
L F + + LVME GG+L + ++K FSE A + + +++ A+ ++H +G
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDVG 126
Query: 593 VVYRDLKPENILVR---EDGHIMLSDFDLS 619
VV+RDLKPEN+L ++ I + DF +
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFA 156
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 35/151 (23%), Positives = 65/151 (43%), Gaps = 13/151 (8%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-- 753
+ P + T Y APE++ G+ S D W+ G+ L+ +L G+ PF+
Sbjct: 158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT 217
Query: 754 -----ETLSNVVSQSLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
E + + F G + VS A+DLI+GLL +P+ RL + ++ + +
Sbjct: 218 CTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL----KMSGLRYNEW 273
Query: 807 FEGLNWALIRCAVPPELPRSCDAVIGSQKKE 837
+ + + P++ S A + + K
Sbjct: 274 LQDGSQLSSNPLMTPDILGSSGAAVHTCVKA 304
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 51/240 (21%), Positives = 98/240 (40%), Gaps = 13/240 (5%)
Query: 389 NCGNRNKAIVTKVDERSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHM 448
+ + + +S + S+S + E S+ ++E + +
Sbjct: 7 HHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDI 66
Query: 449 SNDLRWDAIRCVQKQHGCMGMRHFKLHKK--LGCGDIGTVYLAELIGTSCLFALKVMDND 506
R V + G + + + K LG G G V+ E T A K++
Sbjct: 67 PAPPAPFDHRIVTAKQGAVN-SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR 125
Query: 507 FLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQ 564
+ ++++ E +M LDH L L+ F ++ LVMEY GG+L ++ +
Sbjct: 126 GMKDKEEVKN---EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY 182
Query: 565 PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV--REDGHIMLSDFDLSLRC 622
+E ++ ++ + ++H + +++ DLKPENIL R+ I + DF L+ R
Sbjct: 183 N---LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 6/106 (5%)
Query: 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF- 766
GT E+LAPE++ + D W+ G+ + LL G +PF G + ETL+N+++
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308
Query: 767 -PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811
+ +S A++ I LL+KE R+ A+E +HP+
Sbjct: 309 DEEFQDISEEAKEFISKLLIKEKSWRI----SASEALKHPWLSDHK 350
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 14/156 (8%)
Query: 471 HFKLHKK-LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-D 528
++L + LG G V + TS +A+K+++ R ++ R E E++
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQG 69
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALE 586
H + L F E LV E GG + H+ +++ F+E A V +V AL+
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALD 125
Query: 587 YLHMLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
+LH G+ +RDLKPENIL + + + DFDL
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 36/148 (24%), Positives = 60/148 (40%), Gaps = 27/148 (18%)
Query: 684 DLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKG-----EGHGSSVDWWTFGIFLF 738
DL + + + + G+ EY+APE+++ + D W+ G+ L+
Sbjct: 159 DLGSGIKL-NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 739 ELLYGRTPFKGSGNDETLSNVVSQS---------------LRFPG--YPVVSFHARDLIR 781
LL G PF G + + FP + +S A+DLI
Sbjct: 218 ILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS 277
Query: 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
LLV++ RL AA++ QHP+ +G
Sbjct: 278 KLLVRDAKQRL----SAAQVLQHPWVQG 301
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 51/155 (32%), Positives = 75/155 (48%), Gaps = 16/155 (10%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
F++ +LG G VY + GT +ALKV+ +TE ++ L HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSHP 108
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLH---VLRQKQPSRFFSEQAARFYVAEVLLALEY 587
+ L F T LV+E GG+L V + +SE+ A V ++L A+ Y
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY-----YSERDAADAVKQILEAVAY 163
Query: 588 LHMLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
LH G+V+RDLKPEN+L D + ++DF LS
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 7/108 (6%)
Query: 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL-SNVVSQS 763
+ GT Y APEI++G +G VD W+ GI + LL G PF D+ + +++
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE 267
Query: 764 LRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
F + VS +A+DL+R L+V +P RL + QHP+ G
Sbjct: 268 YYFISPWWDEVSLNAKDLVRKLIVLDPKKRL----TTFQALQHPWVTG 311
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-31
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 19/164 (11%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRA----------QTE 520
+ +KLG G G V L + A+KV+ + E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 521 REIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYV 578
+++ LDHP + LF F +K+ LV E+ GG+L ++ + + F E A +
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANIM 152
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
++L + YLH +V+RD+KPENIL+ +I + DF LS
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-18
Identities = 26/111 (23%), Positives = 49/111 (44%), Gaps = 7/111 (6%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
+ +GT Y+APE++K + + D W+ G+ ++ LL G PF G + + + V
Sbjct: 202 DYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260
Query: 761 SQSLRFPGYP--VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
F +S A++LI+ +L + + R A E + +
Sbjct: 261 KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC----TAEEALNSRWIKK 307
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 18/156 (11%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DH 529
+++ + +G G T+ FA+K++D K E EI+ H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-------KSKRDPTEEIEILLRYGQH 75
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
P + TL + K+ +V E GG+L +LRQK FFSE+ A + + +EY
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEY 131
Query: 588 LHMLGVVYRDLKPENILVREDGH----IMLSDFDLS 619
LH GVV+RDLKP NIL ++ I + DF +
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 32/119 (26%), Positives = 58/119 (48%), Gaps = 9/119 (7%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-- 753
+ + T ++APE+++ +G+ ++ D W+ G+ L+ +L G TPF +D
Sbjct: 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP 228
Query: 754 -ETLSNVVSQSLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
E L+ + S G + VS A+DL+ +L +P RL AA + +HP+
Sbjct: 229 EEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL----TAALVLRHPWIVH 283
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 32/167 (19%), Positives = 62/167 (37%), Gaps = 23/167 (13%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
FK + +G G G V+ A+ + +K + +A+ E + + LD
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-------YNNEKAEREVKALAKLD 62
Query: 529 HPFLPTLFAHFTTEKFS----------------CLVMEYCPGGDLHVLRQKQPSRFFSEQ 572
H + + + + ME+C G L +K+ +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 573 AARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
A ++ ++Y+H ++ RDLKP NI + + + + DF L
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 26/104 (25%), Positives = 45/104 (43%), Gaps = 12/104 (11%)
Query: 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQS 763
GT Y++PE I + +G VD + G+ L ELL+ T F+ S L + +
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI--- 235
Query: 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+ + L++ LL K+P++R +EI +
Sbjct: 236 --IS--DIFDKKEKTLLQKLLSKKPEDRP----NTSEILRTLTV 271
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 461 QKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTE 520
K G + + H+ L LG G G V + E T A+K+++ + + + + E
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 521 REIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH---VLRQKQPSRFFSEQAARFY 577
+ +++ HP + L+ +T +VMEY GG+L + E AR
Sbjct: 62 IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR-----VEEMEARRL 116
Query: 578 VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++L A++Y H VV+RDLKPEN+L+ + ++DF LS
Sbjct: 117 FQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 27/100 (27%), Positives = 42/100 (42%), Gaps = 7/100 (7%)
Query: 709 GTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP 767
G+ Y APE+I G G VD W+ G+ L+ LL G PF + P
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP 231
Query: 768 GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
Y ++ L+ +L +P R +I++H +F
Sbjct: 232 EY--LNRSVATLLMHMLQVDPLKRA----TIKDIREHEWF 265
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 467 MGMRH---FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRA--QTER 521
M + + L + LG G G V LA T A+K++D K+ ++
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD------MKRAVDCPENIKK 54
Query: 522 EI--MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH---VLRQKQPSRFFSEQAARF 576
EI +ML+H + + H L +EYC GG+L E A+
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQR 109
Query: 577 YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ +++ + YLH +G+ +RD+KPEN+L+ E ++ +SDF L+
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 152
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 28/115 (24%), Positives = 49/115 (42%), Gaps = 7/115 (6%)
Query: 705 NSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVSQ 762
N GT Y+APE++K H VD W+ GI L +L G P+ + + S+ +
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF-EGLNWALIR 816
+ + L+ +LV+ P R+ +IK+ ++ + L R
Sbjct: 225 KTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYNKPLKKGAKR 275
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-30
Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 10/156 (6%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
H+ +H++LG G G V+ T FA K + ++ + + E + M +L HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLRHP 214
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
L L F + ++ E+ GG+L V + SE A Y+ +V L ++
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHM 271
Query: 589 HMLGVVYRDLKPENILV--REDGHIMLSDFDLSLRC 622
H V+ DLKPENI+ + + L DF L+
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 1e-17
Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 6/107 (5%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
GT E+ APE+ +G+ G D W+ G+ + LL G +PF G +DETL NV
Sbjct: 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369
Query: 761 SQSLRF--PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHP 805
S + +S +D IR LL+ +P+ R+ + +HP
Sbjct: 370 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM----TIHQALEHP 412
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 52/184 (28%), Positives = 83/184 (45%), Gaps = 28/184 (15%)
Query: 461 QKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPR---- 516
C+ + + L ++G G G V LA + +A+KV+ L+ + PR
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 517 -----------------AQTEREI--MQMLDHPFLPTLF--AHFTTEKFSCLVMEYCPGG 555
Q +EI ++ LDHP + L E +V E G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 556 DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSD 615
+ + +P SE ARFY +++ +EYLH +++RD+KP N+LV EDGHI ++D
Sbjct: 124 PVMEVPTLKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 616 FDLS 619
F +S
Sbjct: 181 FGVS 184
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 7/104 (6%)
Query: 707 FVGTHEYLAPEIIKGEG---HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS 763
VGT ++APE + G ++D W G+ L+ ++G+ PF S + SQ+
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQA 256
Query: 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
L FP P ++ +DLI +L K P++R+ EIK HP+
Sbjct: 257 LEFPDQPDIAEDLKDLITRMLDKNPESRI----VVPEIKLHPWV 296
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 14/156 (8%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQM 526
R + + K++G G V+ L ++A+K ++ L EI +
Sbjct: 27 GRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVN---LEEADNQTLDSYRNEIAYLNK 82
Query: 527 LDHPFLP--TLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLL 583
L L+ + T+++ +VME DL+ L++K+ + Y +L
Sbjct: 83 LQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLE 138
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
A+ +H G+V+ DLKP N L+ DG + L DF ++
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 173
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 27/120 (22%), Positives = 47/120 (39%), Gaps = 16/120 (13%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEG-----------HGSSVDWWTFGIFLFELLYGRTPFK 748
T +S VGT Y+ PE IK D W+ G L+ + YG+TPF+
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240
Query: 749 G-SGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
L ++ + + +D+++ L ++P R+ E+ HP+
Sbjct: 241 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI----SIPELLAHPYV 296
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 6/153 (3%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQMLD 528
+ + LG G G V T C A+K++ L R A ++EI ++ L
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLR 64
Query: 529 HPFLPTLF--AHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
H + L + ++ +VMEYC G +L P + F A Y +++ LE
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEML-DSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
YLH G+V++D+KP N+L+ G + +S ++
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 33/117 (28%), Positives = 50/117 (42%), Gaps = 9/117 (7%)
Query: 709 GTHEYLAPEIIKGEG--HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF 766
G+ + PEI G G VD W+ G+ L+ + G PF+G + N+ S
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI 232
Query: 767 PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF-EGLNWALIRCAVPPE 822
PG DL++G+L EP R +I+QH +F + A +PP
Sbjct: 233 PGD--CGPPLSDLLKGMLEYEPAKRF----SIRQIRQHSWFRKKHPPAEAPVPIPPS 283
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 50/150 (33%), Positives = 80/150 (53%), Gaps = 5/150 (3%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+++L K +G G+ V LA I T A+K++D L + + E IM++L+HP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHP 74
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ LF TEK L+MEY GG++ L E+ AR +++ A++Y H
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCH 131
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+V+RDLK EN+L+ D +I ++DF S
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 37/129 (28%), Positives = 56/129 (43%), Gaps = 8/129 (6%)
Query: 705 NSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS 763
++F G Y APE+ +G+ G VD W+ G+ L+ L+ G PF G E V+
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
Query: 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF-EGLNWALIRCAVPPE 822
R P Y +S +L++ LV P R +I + + G ++ V PE
Sbjct: 231 YRIPFY--MSTDCENLLKRFLVLNPIKRG----TLEQIMKDRWINAGHEEDELKPFVEPE 284
Query: 823 LPRSCDAVI 831
L S I
Sbjct: 285 LDISDQKRI 293
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 467 MGMRH---FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRA--QTER 521
M + + L + LG G G V LA T A+K++D K+ ++
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD------MKRAVDCPENIKK 54
Query: 522 EI--MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH---VLRQKQPSRFFSEQAARF 576
EI +ML+H + + H L +EYC GG+L E A+
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQR 109
Query: 577 YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ +++ + YLH +G+ +RD+KPEN+L+ E ++ +SDF L+
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 152
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 30/147 (20%), Positives = 55/147 (37%), Gaps = 7/147 (4%)
Query: 705 NSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVSQ 762
N GT Y+APE++K H VD W+ GI L +L G P+ + + S+ +
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF-EGLNWALIRCAVPP 821
+ + L+ +LV+ P R+ +IK+ ++ + L R V
Sbjct: 225 KTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYNKPLKKGAKRPRVTS 280
Query: 822 ELPRSCDAVIGSQKKESTKCEESKGAA 848
+ + + A+
Sbjct: 281 GGVSESPSGFSKHIQSNLDFSPVNSAS 307
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 9e-30
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 12/159 (7%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+++ ++LG G G V T A+K + K R E +IM+ L+HP
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS--PKNRERWCLEIQIMKKLNHP 72
Query: 531 FLPTLFA------HFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLL 583
+ + L MEYC GGDL L Q + E R ++++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGH---IMLSDFDLS 619
AL YLH +++RDLKPENI+++ + D +
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 6e-14
Identities = 26/129 (20%), Positives = 48/129 (37%), Gaps = 26/129 (20%)
Query: 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV---- 760
FVGT +YLAPE+++ + + +VD+W+FG FE + G PF + V
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS 240
Query: 761 ----------SQSLRFPGYPVVSFH--------ARDLIRGLLVKEPDNRLGAVKGAAEIK 802
+ +++F H ++ +L+ R +
Sbjct: 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG----TDPQNP 296
Query: 803 QHPFFEGLN 811
F+ L+
Sbjct: 297 NVGCFQALD 305
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 5/150 (3%)
Query: 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH-PFL 532
K+LG G V T +A K + G+ E ++++ P +
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRV 91
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592
L + L++EY GG++ L + + SE + ++L + YLH
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 593 VVYRDLKPENILV---REDGHIMLSDFDLS 619
+V+ DLKP+NIL+ G I + DF +S
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 40/143 (27%), Positives = 59/143 (41%), Gaps = 13/143 (9%)
Query: 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF 766
+GT EYLAPEI+ + ++ D W GI + LL +PF G N ET N+ ++ +
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY 252
Query: 767 PG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELP 824
+ VS A D I+ LLVK P+ R A H W L +
Sbjct: 253 SEETFSSVSQLATDFIQSLLVKNPEKRP----TAEICLSHS------W-LQQWDFENLFH 301
Query: 825 RSCDAVIGSQKKESTKCEESKGA 847
+ + S + E K +
Sbjct: 302 PEETSSSSQTQDHSVRSSEDKTS 324
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 38/155 (24%), Positives = 69/155 (44%), Gaps = 14/155 (9%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQML 527
R + + K++G G V+ L ++A+K ++ L EI + L
Sbjct: 9 RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVN---LEEADNQTLDSYRNEIAYLNKL 64
Query: 528 DHPFLP--TLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLA 584
L+ + T+++ +VME DL+ L++K+ + Y +L A
Sbjct: 65 QQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEA 120
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ +H G+V+ DLKP N L+ DG + L DF ++
Sbjct: 121 VHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 154
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 27/120 (22%), Positives = 47/120 (39%), Gaps = 16/120 (13%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEG-----------HGSSVDWWTFGIFLFELLYGRTPFK 748
T +S VGT Y+ PE IK D W+ G L+ + YG+TPF+
Sbjct: 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221
Query: 749 G-SGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
L ++ + + +D+++ L ++P R+ E+ HP+
Sbjct: 222 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI----SIPELLAHPYV 277
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 38/160 (23%), Positives = 68/160 (42%), Gaps = 14/160 (8%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMD-----NDFLVGRKKMPRAQTEREI 523
+ + LG G G V+ A + +K + D + K+ + E I
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 524 MQMLDHPFLPTLFAHFTTEKFSCLVME-YCPGGDLH---VLRQKQPSRFFSEQAARFYVA 579
+ ++H + + F + F LVME + G DL + E A +
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-----LDEPLASYIFR 137
Query: 580 EVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+++ A+ YL + +++RD+K ENI++ ED I L DF +
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 28/102 (27%), Positives = 44/102 (43%), Gaps = 13/102 (12%)
Query: 707 FVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR 765
F GT EY APE++ G G ++ W+ G+ L+ L++ PF L V ++
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVEAAIH 242
Query: 766 FPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
P VS L+ GLL P+ R ++ P+
Sbjct: 243 PPYL--VSKELMSLVSGLLQPVPERRT----TLEKLVTDPWV 278
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 17/166 (10%)
Query: 471 HFKLHKK-LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-D 528
++L K+ LG G G V T ALK++ P+A+ E +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDHHWQASG 80
Query: 529 HPFLPTLFAHF----TTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLA 584
P + + + ++ ++ME GG+L Q++ + F+E+ A + ++ A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 585 LEYLHMLGVVYRDLKPENILV---REDGHIMLSDFDLSLRCAVNPM 627
+++LH + +RD+KPEN+L +D + L+DF + N +
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 30/110 (27%), Positives = 46/110 (41%), Gaps = 10/110 (9%)
Query: 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET----LSNVVS 761
+ T Y+APE++ E + S D W+ G+ ++ LL G PF + +
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247
Query: 762 QSLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
FP + VS A+ LIR LL +P RL + HP+
Sbjct: 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL----TITQFMNHPWINQ 293
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-29
Identities = 46/218 (21%), Positives = 84/218 (38%), Gaps = 19/218 (8%)
Query: 413 FSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLR---WDAIRCVQKQHGCMGM 469
S S S + + ++P + + +Q + +
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-D 528
+ + LG G G V T FALK++ P+A+ E E+
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQ 113
Query: 529 HPFLPTLFAHF----TTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLA 584
P + + + K +VME GG+L Q + + F+E+ A + + A
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 585 LEYLHMLGVVYRDLKPENILV---REDGHIMLSDFDLS 619
++YLH + + +RD+KPEN+L R + + L+DF +
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 30/107 (28%), Positives = 45/107 (42%), Gaps = 10/107 (9%)
Query: 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET----LSNVV 760
+ T Y+APE++ E + S D W+ G+ ++ LL G PF + + +
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 761 SQSLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHP 805
FP + VS + LIR LL EP R+ E HP
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNHP 323
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 8/162 (4%)
Query: 461 QKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTE 520
QK G + + H+ L LG G G V + + T A+K+++ + + + + E
Sbjct: 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66
Query: 521 REIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH---VLRQKQPSRFFSEQAARFY 577
+ +++ HP + L+ +T +VMEY GG+L + E+ +R
Sbjct: 67 IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR-----LDEKESRRL 121
Query: 578 VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++L ++Y H VV+RDLKPEN+L+ + ++DF LS
Sbjct: 122 FQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 27/102 (26%), Positives = 43/102 (42%), Gaps = 7/102 (6%)
Query: 707 FVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR 765
G+ Y APE+I G G VD W+ G+ L+ LL G PF +
Sbjct: 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY 234
Query: 766 FPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
P Y ++ L++ +L +P R +I++H +F
Sbjct: 235 TPQY--LNPSVISLLKHMLQVDPMKRA----TIKDIREHEWF 270
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 44/206 (21%), Positives = 82/206 (39%), Gaps = 15/206 (7%)
Query: 419 SSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKL 478
S G + + E + + P + D D + + R + + K++
Sbjct: 6 HSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDD-DKASSSANECISVKGRIYSILKQI 64
Query: 479 GCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQMLDHPFLP--T 534
G G V+ L ++A+K ++ L EI + L
Sbjct: 65 GSGGSSKVFQV-LNEKKQIYAIKYVN---LEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 535 LFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
L+ + T+++ +VME DL+ L++K+ + Y +L A+ +H G+
Sbjct: 121 LYDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 594 VYRDLKPENILVREDGHIMLSDFDLS 619
V+ DLKP N L+ DG + L DF ++
Sbjct: 177 VHSDLKPANFLI-VDGMLKLIDFGIA 201
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 2e-18
Identities = 26/120 (21%), Positives = 46/120 (38%), Gaps = 16/120 (13%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEG-----------HGSSVDWWTFGIFLFELLYGRTPFK 748
T +S VG Y+ PE IK D W+ G L+ + YG+TPF+
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268
Query: 749 G-SGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
L ++ + + +D+++ L ++P R+ E+ HP+
Sbjct: 269 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI----SIPELLAHPYV 324
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 65/398 (16%), Positives = 118/398 (29%), Gaps = 101/398 (25%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML--- 527
+ + +KLG G TV+L+ I A+KV+ + A E +++ +
Sbjct: 38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNS 93
Query: 528 --DHP---FLPTLFAHFTTE----KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYV 578
+ P + L F C+V E G L K + + +
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 579 AEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEE 637
+VL L+YLH +++ D+KPENIL+ + + E
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA------------------EA 194
Query: 638 PPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVV 697
+++ +P S + + + K + A
Sbjct: 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC---------- 244
Query: 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE--- 754
+ T +Y + E++ G G+ + D W+ FEL G F+ +E
Sbjct: 245 -WVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR 303
Query: 755 ---------------------------------------------TLSNVVSQSLRFPGY 769
L V+ + +
Sbjct: 304 DEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQE 363
Query: 770 PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
F D + +L P+ R AAE +HP+
Sbjct: 364 EAAGFT--DFLLPMLELIPEKRA----TAAECLRHPWL 395
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 16/157 (10%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ-MLD 528
+ + LG G G V T FALK++ P+A+ E E+
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQ 69
Query: 529 HPFLPTLFAHF----TTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLA 584
P + + + K +VME GG+L Q + + F+E+ A + + A
Sbjct: 70 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 585 LEYLHMLGVVYRDLKPENILVR---EDGHIMLSDFDL 618
++YLH + + +RD+KPEN+L + + L+DF
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 27/102 (26%), Positives = 39/102 (38%), Gaps = 11/102 (10%)
Query: 714 LAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET----LSNVVSQSLRFPG- 768
A E E + S D W+ G+ ++ LL G PF + + + FP
Sbjct: 166 FAKETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 769 -YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
+ VS + LIR LL EP R+ E HP+
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNHPWIMQ 262
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 36/174 (20%), Positives = 68/174 (39%), Gaps = 8/174 (4%)
Query: 465 GCMGMR-----HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQT 519
G MGM+ F +K+G G+ G+V+ C++A+K + +
Sbjct: 1 GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVL--RQKQPSRFFSEQAARFY 577
+ H + F+ + + + EYC GG L + +F E +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 578 VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR-CAVNPMVVK 630
+ +V L Y+H + +V+ D+KP NI + + + A N ++ K
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 17/104 (16%), Positives = 37/104 (35%), Gaps = 11/104 (10%)
Query: 705 NSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS 763
G +LA E+++ H D + + + + N + +
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR---NGDQWHEIRQGR 244
Query: 764 L-RFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
L R P V+S +L++ ++ +P+ R A + +H
Sbjct: 245 LPRIPQ--VLSQEFTELLKVMIHPDPERR----PSAMALVKHSV 282
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 9/152 (5%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+ + + LG G G V LA T ALK + L R + E +++L HP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLH---VLRQKQPSRFFSEQAARFYVAEVLLALEY 587
+ L+ TT +V+EY GG+L V +++ +E R + +++ A+EY
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR-----MTEDEGRRFFQQIICAIEY 123
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
H +V+RDLKPEN+L+ ++ ++ ++DF LS
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNLNVKIADFGLS 155
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 7/100 (7%)
Query: 709 GTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP 767
G+ Y APE+I G+ G VD W+ GI L+ +L GR PF V S P
Sbjct: 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP 228
Query: 768 GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+ +S A+ LIR ++V +P R+ EI++ P+F
Sbjct: 229 DF--LSPGAQSLIRRMIVADPMQRI----TIQEIRRDPWF 262
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 34/258 (13%), Positives = 68/258 (26%), Gaps = 54/258 (20%)
Query: 395 KAIVTKVDERSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRW 454
++ ++ R S+ +S+ S++ + S G RP
Sbjct: 21 DVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERP-------- 72
Query: 455 DAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKM 514
R LG D A T F + V +
Sbjct: 73 ---------------RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI 117
Query: 515 PRAQTEREIMQML-------------------------DHPFLPTLFAHFTTEKFSCLVM 549
+ + E +++L + +
Sbjct: 118 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 177
Query: 550 EY-CPGGDLHVL-----RQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENI 603
Y +L + A +V+ L LH G+V+ L+P +I
Sbjct: 178 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 237
Query: 604 LVREDGHIMLSDFDLSLR 621
++ + G + L+ F+ +R
Sbjct: 238 VLDQRGGVFLTGFEHLVR 255
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 1e-21
Identities = 20/133 (15%), Positives = 35/133 (26%), Gaps = 26/133 (19%)
Query: 703 RSNSFVGTHEYLAPEIIKGEG-----------HGSSVDWWTFGIFLFELLYGRTPFKGSG 751
+ + PE+ S D W G+ ++ + P
Sbjct: 258 ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDA 317
Query: 752 NDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811
+ P R L+ G L ++RL + + P +E L
Sbjct: 318 ALGGSEWIFRSCKNIPQP------VRALLEGFLRYPKEDRL----LPLQAMETPEYEQL- 366
Query: 812 WALIRCAVPPELP 824
R + LP
Sbjct: 367 ----RTELSAALP 375
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 42/158 (26%), Positives = 66/158 (41%), Gaps = 18/158 (11%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQM 526
+ K +G G+ G L T L A+K ++ R +REI +
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE------RGAAIDENVQREIINHRS 72
Query: 527 LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH---VLRQKQPSRFFSEQAARFYVAEVLL 583
L HP + T ++MEY GG+L+ + FSE ARF+ ++L
Sbjct: 73 LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR-----FSEDEARFFFQQLLS 127
Query: 584 ALEYLHMLGVVYRDLKPENILVRED--GHIMLSDFDLS 619
+ Y H + + +RDLK EN L+ + + DF S
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 30/108 (27%), Positives = 47/108 (43%), Gaps = 11/108 (10%)
Query: 706 SFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL-----SNV 759
S VGT Y+APE++ + G D W+ G+ L+ +L G PF+ + +
Sbjct: 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPRDYRKTIQRI 234
Query: 760 VSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+S P +S LI + V +P R+ EIK H +F
Sbjct: 235 LSVKYSIPDDIRISPECCHLISRIFVADPATRI----SIPEIKTHSWF 278
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 42/211 (19%), Positives = 77/211 (36%), Gaps = 17/211 (8%)
Query: 416 SSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMG--MRHFK 473
S S G+ S S+++ + P ++ ++ +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRA-QTEREIMQMLDHPFL 532
++G G G V+ + T A+K + + E L P +
Sbjct: 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRI 112
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
L+ + + ME GG L +++Q E A +Y+ + L LEYLH
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---LPEDRALYYLGQALEGLEYLHTR 169
Query: 592 GVVYRDLKPENILVREDG-HIMLSDFDLSLR 621
+++ D+K +N+L+ DG L DF +L
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALC 200
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 22/108 (20%), Positives = 42/108 (38%), Gaps = 5/108 (4%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
+ + GT ++APE++ G+ + VD W+ + +L G P+ +
Sbjct: 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 268
Query: 760 VSQS-LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
S+ P + I+ L KEP +R A E+++
Sbjct: 269 ASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHR----ASAMELRRKVG 312
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 35/185 (18%), Positives = 52/185 (28%), Gaps = 32/185 (17%)
Query: 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML 527
G R KL + L GD V+L + FALKV R ++ R L
Sbjct: 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARL 119
Query: 528 DHPFLPTLFAHFTTEKFS--------------------------CLVMEYCPGGDLHVL- 560
S L+M DL +L
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLF 178
Query: 561 ----RQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616
A A+++ L G+V+ P+N+ + DG +ML D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 617 DLSLR 621
+
Sbjct: 239 SALWK 243
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 3e-21
Identities = 20/118 (16%), Positives = 35/118 (29%), Gaps = 13/118 (11%)
Query: 699 PTGARSNSFVGTHEYLAPEIIKGEG--HGSSVDWWTFGIFLFELLYGRTPFKGSGND--- 753
G R + Y E + +++ W G+ ++ + PF
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 754 ----ETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+L + SL F + + LI L + RL E + P F
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL----LPLEAMETPEF 356
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 47/202 (23%), Positives = 84/202 (41%), Gaps = 15/202 (7%)
Query: 427 STSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTV 486
+S SG GS NDL + +++ +++ LG G G+V
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES--QYQVGPLLGSGGFGSV 59
Query: 487 YLAELIGTSCLFALKVMDNDFLVGRKKMPR-AQTEREI--MQMLDHPFLP---TLFAHFT 540
Y + + A+K ++ D + ++P + E+ ++ + F L F
Sbjct: 60 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF-SGVIRLLDWFE 118
Query: 541 TEKFSCLVMEYC-PGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDL 598
L++E P DL + ++ E+ AR + +VL A+ + H GV++RD+
Sbjct: 119 RPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHNCGVLHRDI 175
Query: 599 KPENILV-REDGHIMLSDFDLS 619
K ENIL+ G + L DF
Sbjct: 176 KDENILIDLNRGELKLIDFGSG 197
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 30/102 (29%), Positives = 44/102 (43%), Gaps = 13/102 (12%)
Query: 707 FVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR 765
F GT Y PE I+ HG S W+ GI L++++ G PF+ ++ +
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 261
Query: 766 FPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
F VS + LIR L P +R EI+ HP+
Sbjct: 262 FRQR--VSSECQHLIRWCLALRPSDRP----TFEEIQNHPWM 297
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 44/205 (21%), Positives = 78/205 (38%), Gaps = 22/205 (10%)
Query: 439 SSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLF 498
S GG+ +D Q +G ++ + L G VY A+ +G+ +
Sbjct: 5 GSLGGASGRDQSDFV--------GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREY 56
Query: 499 ALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFS--------CLVM 549
ALK + +K E M+ L HP + + + K L+
Sbjct: 57 ALKRLL---SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLT 113
Query: 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG--VVYRDLKPENILVRE 607
E C G + L++ + S + A++++H +++RDLK EN+L+
Sbjct: 114 ELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN 173
Query: 608 DGHIMLSDFDLSLRCAVNPMVVKSS 632
G I L DF + + P S+
Sbjct: 174 QGTIKLCDFGSATTISHYPDYSWSA 198
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 26/103 (25%), Positives = 35/103 (33%), Gaps = 11/103 (10%)
Query: 707 FVGTHEYLAPEII---KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS 763
T Y PEII G D W G L+ L + + PF D +V+
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKLRIVNGK 265
Query: 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
P + LIR +L P+ RL AE+
Sbjct: 266 YSIPPHDTQYTVFHSLIRAMLQVNPEERL----SIAEVVHQLQ 304
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 43/183 (23%), Positives = 69/183 (37%), Gaps = 20/183 (10%)
Query: 443 GSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKV 502
GS P + D + V +G F LG G GT+ + + A+K
Sbjct: 2 GSSPSLEQDDGDEETSVVI-----VGKISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKR 55
Query: 503 MDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLR 561
+ + A E ++++ D HP + F +F + +E C +
Sbjct: 56 IL------PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVE 109
Query: 562 QKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH-----IMLSDF 616
QK + + + L +LH L +V+RDLKP NIL+ M+SDF
Sbjct: 110 QKDFA--HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167
Query: 617 DLS 619
L
Sbjct: 168 GLC 170
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 33/149 (22%), Positives = 63/149 (42%), Gaps = 23/149 (15%)
Query: 671 LLSVAAKSRKIK---SD--LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKG---E 722
L+S+ KIK SD L +++ + +R + GT ++APE++ E
Sbjct: 150 LISMPNAHGKIKAMISDFGLCKKLAVG-----RHSFSRRSGVPGTEGWIAPEMLSEDCKE 204
Query: 723 GHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETLSNVVSQSLRFPG---YPVVSFHARD 778
+VD ++ G + ++ G PF + + +N++ + AR+
Sbjct: 205 NPTYTVDIFSAGCVFYYVISEGSHPF--GKSLQRQANILLGACSLDCLHPEKHEDVIARE 262
Query: 779 LIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
LI ++ +P R A + +HPFF
Sbjct: 263 LIEKMIAMDPQKRP----SAKHVLKHPFF 287
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 4e-26
Identities = 41/168 (24%), Positives = 66/168 (39%), Gaps = 25/168 (14%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD- 528
K LG G GTV A+K M A E +++ D
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRML------IDFCDIALMEIKLLTESDD 67
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGG--DLHVLRQK--QPSRFFSEQAARFYVAEVLLA 584
HP + + TT++F + +E C DL + + + E + ++
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 585 LEYLHMLGVVYRDLKPENILV-------------REDGHIMLSDFDLS 619
+ +LH L +++RDLKP+NILV E+ I++SDF L
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 4e-16
Identities = 25/120 (20%), Positives = 46/120 (38%), Gaps = 19/120 (15%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGH-------GSSVDWWTFGIFLFELL-YGRTPFKGSGN 752
N+ GT + APE+++ + S+D ++ G + +L G+ PF
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDK 243
Query: 753 DETLSNVVSQSLRFPGYPV-----VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
SN++ + A DLI ++ +P R A ++ +HP F
Sbjct: 244 YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP----TAMKVLRHPLF 299
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 13/161 (8%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQT-EREI--MQ 525
++L LG G GTV+ + A+KV+ + ++G + + T E+ +
Sbjct: 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 526 MLD----HPFLPTLFAHFTTEKFSCLVMEY-CPGGDL-HVLRQKQPSRFFSEQAARFYVA 579
+ HP + L F T++ LV+E P DL + +K P E +R +
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFG 146
Query: 580 EVLLALEYLHMLGVVYRDLKPENILV-REDGHIMLSDFDLS 619
+V+ A+++ H GVV+RD+K ENIL+ G L DF
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 31/126 (24%), Positives = 46/126 (36%), Gaps = 14/126 (11%)
Query: 707 FVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR 765
F GT Y PE I H W+ GI L++++ G PF E ++ L
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF------ERDQEILEAELH 251
Query: 766 FPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF-EGLNWALIRCAVPPELP 824
FP + VS LIR L +P +R EI P+ + + P
Sbjct: 252 FPAH--VSPDCCALIRRCLAPKPSSRP----SLEEILLDPWMQTPAEDVPLNPSKGGPAP 305
Query: 825 RSCDAV 830
+ +
Sbjct: 306 LAWSLL 311
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 41/148 (27%), Positives = 64/148 (43%), Gaps = 5/148 (3%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTL 535
LG G G VY + A+K + + E + + L H +
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 536 FAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRF-FSEQAARFYVAEVLLALEYLHMLGVV 594
F+ F + ME PGG L L + + +EQ FY ++L L+YLH +V
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 595 YRDLKPENILV-REDGHIMLSDFDLSLR 621
+RD+K +N+L+ G + +SDF S R
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKR 172
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 30/110 (27%), Positives = 46/110 (41%), Gaps = 7/110 (6%)
Query: 700 TGARSNSFVGTHEYLAPEIIKG--EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS 757
+ +F GT +Y+APEII G+G + D W+ G + E+ G+ PF G +
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235
Query: 758 NVVSQSLRFPGYP-VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
V P P +S A+ I +PD R A ++ F
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRA----CANDLLVDEF 281
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 36/148 (24%), Positives = 66/148 (44%), Gaps = 3/148 (2%)
Query: 471 HFKLHKKLGCG--DIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
++L +G G D+ TV LA T ++ ++ + + + Q E + ++ +
Sbjct: 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE-ACSNEMVTFLQGELHVSKLFN 84
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
HP + A F + +V + G L +E A + + VL AL+Y+
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDF 616
H +G V+R +K +IL+ DG + LS
Sbjct: 145 HHMGYVHRSVKASHILISVDGKVYLSGL 172
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 29/161 (18%), Positives = 44/161 (27%), Gaps = 57/161 (35%)
Query: 700 TGARSNS-------FVGTHEYLAPEIIK--GEGHGSSVDWWTFGIFLFELLYGRTPF--- 747
G R V +L+PE+++ +G+ + D ++ GI EL G PF
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
Query: 748 -----------------------------------------KGSGNDETLSNVVSQSLRF 766
S T S
Sbjct: 241 PATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSH 300
Query: 767 PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
P + S H + L + PD R A+ + H FF
Sbjct: 301 PYHRTFSPHFHHFVEQCLQRNPDARP----SASTLLNHSFF 337
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 39/152 (25%), Positives = 66/152 (43%), Gaps = 8/152 (5%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
++L + +G G V A A+K ++ + + M E + M HP
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE--KCQTSMDELLKEIQAMSQCHHP 73
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRF-----FSEQAARFYVAEVLLA 584
+ + + F + LVM+ GG + +++ E + EVL
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616
LEYLH G ++RD+K NIL+ EDG + ++DF
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 35/134 (26%), Positives = 52/134 (38%), Gaps = 22/134 (16%)
Query: 686 AAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIK-GEGHGSSVDWWTFGIFLFELLYGR 744
+A ++ +FVGT ++APE+++ G+ D W+FGI EL G
Sbjct: 168 SAFLA---TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
Query: 745 TP----------FKGSGNDE-TLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLG 793
P ND +L V Y R +I L K+P+ R
Sbjct: 225 APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKY---GKSFRKMISLCLQKDPEKRP- 280
Query: 794 AVKGAAEIKQHPFF 807
AAE+ +H FF
Sbjct: 281 ---TAAELLRHKFF 291
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 38/146 (26%), Positives = 68/146 (46%), Gaps = 5/146 (3%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
F +K+G G G V+ T + A+K++D + ++ Q E ++ D P
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSP 80
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
++ + + + ++MEY GG L + P E + E+L L+YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHS 137
Query: 591 LGVVYRDLKPENILVREDGHIMLSDF 616
++RD+K N+L+ E G + L+DF
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADF 163
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 35/119 (29%), Positives = 49/119 (41%), Gaps = 27/119 (22%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTP----------FKG 749
T + N+FVGT ++APE+IK + S D W+ GI EL G P F
Sbjct: 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231
Query: 750 SGNDE-TLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
N+ TL S+ L ++ + L KEP R A E+ +H F
Sbjct: 232 PKNNPPTLEGNYSKPL------------KEFVEACLNKEPSFRP----TAKELLKHKFI 274
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-24
Identities = 34/258 (13%), Positives = 72/258 (27%), Gaps = 54/258 (20%)
Query: 395 KAIVTKVDERSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRW 454
++ ++ R S+ +S+ S++ + S G RP
Sbjct: 26 DVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERP-------- 77
Query: 455 DAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKM 514
R LG D A T F + V +
Sbjct: 78 ---------------RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI 122
Query: 515 PRAQTEREIMQ----------------------MLDHPFLPTLFAHFTTEKFSCLVMEY- 551
+ + E ++ ++ P + E+ ++ +
Sbjct: 123 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 182
Query: 552 ---CPGGDLHVL-----RQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENI 603
+L + A +V+ L LH G+V+ L+P +I
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 242
Query: 604 LVREDGHIMLSDFDLSLR 621
++ + G + L+ F+ +R
Sbjct: 243 VLDQRGGVFLTGFEHLVR 260
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 94.4 bits (234), Expect = 1e-20
Identities = 19/133 (14%), Positives = 35/133 (26%), Gaps = 15/133 (11%)
Query: 698 EPTGARSNSFVGTHEYLAPEIIKGEGHG-----SSVDWWTFGIFLFELLYGRTPFKGSGN 752
+ E A ++ H + D WT G+ ++ + P
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322
Query: 753 DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812
+ P R L+ G L ++RL + + P +E L
Sbjct: 323 LGGSEWIFRSCKNIPQP------VRALLEGFLRYPKEDRL----LPLQAMETPEYEQLRT 372
Query: 813 ALIRCAVPPELPR 825
L +
Sbjct: 373 ELSAALPLYQTDG 385
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 41/146 (28%), Positives = 75/146 (51%), Gaps = 4/146 (2%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+++ +LG G G VY A+ T L A KV++ +++ E EI+ DHP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDHP 76
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
++ L + + +++E+CPGG + + + +E + ++L AL +LH
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL-TEPQIQVVCRQMLEALNFLHS 135
Query: 591 LGVVYRDLKPENILVREDGHIMLSDF 616
+++RDLK N+L+ +G I L+DF
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADF 161
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 33/124 (26%), Positives = 52/124 (41%), Gaps = 30/124 (24%)
Query: 700 TGARSNSFVGTHEYLAPEII-----KGEGHGSSVDWWTFGIFLFELLYGRTP-------- 746
T + +SF+GT ++APE++ K + D W+ GI L E+ P
Sbjct: 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229
Query: 747 --FKGSGNDE-TLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803
K + +D TL S+ F RD ++ L K P+ R AA++ +
Sbjct: 230 VLLKIAKSDPPTLLTPSKWSVEF----------RDFLKIALDKNPETR----PSAAQLLE 275
Query: 804 HPFF 807
HPF
Sbjct: 276 HPFV 279
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 36/157 (22%), Positives = 67/157 (42%), Gaps = 10/157 (6%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH 529
R K ++G G TVY T+ A + + + + + R + E E+++ L H
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR-KLTKSERQRFKEEAEMLKGLQH 84
Query: 530 P----FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLAL 585
P F + + +K LV E G L ++ + R + ++L L
Sbjct: 85 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGL 142
Query: 586 EYLH--MLGVVYRDLKPENILV-REDGHIMLSDFDLS 619
++LH +++RDLK +NI + G + + D L+
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 24/109 (22%), Positives = 50/109 (45%), Gaps = 6/109 (5%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
+ + + +GT E++APE+ + E + SVD + FG+ + E+ P+ N +
Sbjct: 183 RASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 241
Query: 760 VSQSLRFPGYP-VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
V+ ++ + V +++I G + + D R ++ H FF
Sbjct: 242 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY----SIKDLLNHAFF 286
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 43/146 (29%), Positives = 62/146 (42%), Gaps = 2/146 (1%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
F +++G G G VY A + S + A+K M +K E +Q L HP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
+ E + LVMEYC G +L + + E L L YLH
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 591 LGVVYRDLKPENILVREDGHIMLSDF 616
+++RD+K NIL+ E G + L DF
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDF 198
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 30/119 (25%), Positives = 50/119 (42%), Gaps = 27/119 (22%)
Query: 702 ARSNSFVGTHEYLAPEII---KGEGHGSSVDWWTFGIFLFELLYGRTP----------FK 748
A +NSFVGT ++APE+I + VD W+ GI EL + P +
Sbjct: 205 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 264
Query: 749 GSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+ N+ S +L+ + S + R+ + L K P +R + + +H F
Sbjct: 265 IAQNE-------SPALQSGHW---SEYFRNFVDSCLQKIPQDR----PTSEVLLKHRFV 309
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 43/145 (29%), Positives = 67/145 (46%), Gaps = 6/145 (4%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+ +K+G G GTVY A + T A++ M+ L + K E +M+ +P
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPN 78
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ + +VMEY GG L + + E E L ALE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN 135
Query: 592 GVVYRDLKPENILVREDGHIMLSDF 616
V++RD+K +NIL+ DG + L+DF
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDF 160
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 37/157 (23%), Positives = 59/157 (37%), Gaps = 49/157 (31%)
Query: 679 RKIKSD----------------LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGE 722
R IKSD AQ++P ++ ++ VGT ++APE++ +
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITP--------EQSKRSTMVGTPYWMAPEVVTRK 191
Query: 723 GHGSSVDWWTFGIFLFELLYGRTP----------FKGSGNDE-TLSNVVSQSLRFPGYPV 771
+G VD W+ GI E++ G P + + N L N S F
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF----- 246
Query: 772 VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808
RD + L + + R A E+ QH F +
Sbjct: 247 -----RDFLNRCLEMDVEKR----GSAKELLQHQFLK 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 6/145 (4%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
F + +KLG G G+VY A T + A+K + + + E IMQ D P
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCDSPH 85
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ + + +VMEYC G + + + + ++ A + L LEYLH +
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA-TILQSTLKGLEYLHFM 144
Query: 592 GVVYRDLKPENILVREDGHIMLSDF 616
++RD+K NIL+ +GH L+DF
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADF 169
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 33/120 (27%), Positives = 49/120 (40%), Gaps = 25/120 (20%)
Query: 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTP----------FK 748
T A+ N+ +GT ++APE+I+ G+ D W+ GI E+ G+ P F
Sbjct: 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM 236
Query: 749 GSGNDE-TLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
N T S F D ++ LVK P+ R A ++ QHPF
Sbjct: 237 IPTNPPPTFRKPELWSDNF----------TDFVKQCLVKSPEQR----ATATQLLQHPFV 282
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 6/145 (4%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+ K+G G G V LA + A+K+MD L +++ E IM+ H
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFN 103
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ ++ + + ++ME+ GG L + + +E+ VL AL YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQ 160
Query: 592 GVVYRDLKPENILVREDGHIMLSDF 616
GV++RD+K ++IL+ DG + LSDF
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDF 185
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 33/133 (24%), Positives = 51/133 (38%), Gaps = 33/133 (24%)
Query: 686 AAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRT 745
AQ+S + S VGT ++APE+I + + VD W+ GI + E++ G
Sbjct: 188 CAQISK--------DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239
Query: 746 P----------FKGSGNDE-TLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA 794
P + + L N S RD + +LV++P R
Sbjct: 240 PYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVL----------RDFLERMLVRDPQER--- 286
Query: 795 VKGAAEIKQHPFF 807
A E+ HPF
Sbjct: 287 -ATAQELLDHPFL 298
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI---MQML 527
F+L + +G G G VY + T L A+KVMD + ++EI +
Sbjct: 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------GDEEEEIKQEINMLKKYS 78
Query: 528 DHPFLPTLFAHFTTEKFSC------LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEV 581
H + T + F + LVME+C G + L + E+ + E+
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 582 LLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L L +LH V++RD+K +N+L+ E+ + L DF +S
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 29/123 (23%), Positives = 45/123 (36%), Gaps = 29/123 (23%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGE-----GHGSSVDWWTFGIFLFELLYGRTP-------- 746
T R N+F+GT ++APE+I + + D W+ GI E+ G P
Sbjct: 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241
Query: 747 --FKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804
F N + L+ + S + I LVK R ++ +H
Sbjct: 242 ALFLIPRNP-------APRLKSKKW---SKKFQSFIESCLVKNHSQR----PATEQLMKH 287
Query: 805 PFF 807
PF
Sbjct: 288 PFI 290
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
++ + +G G G V A+ A+K ++++ + E + ++HP
Sbjct: 10 IEVEEVVGRGAFGVVCKAKWRAKDV--AIKQIESE-----SERKAFIVELRQLSRVNHPN 62
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
+ CLVMEY GG L+ VL +P +++ A + + + YLH
Sbjct: 63 I-VKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 591 L---GVVYRDLKPENILVREDGHIM-LSDFDLS 619
+ +++RDLKP N+L+ G ++ + DF +
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 17/63 (26%), Positives = 31/63 (49%), Gaps = 1/63 (1%)
Query: 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKG-SGNDETLSNVVSQSL 764
+ G+ ++APE+ +G + D +++GI L+E++ R PF G + V
Sbjct: 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT 221
Query: 765 RFP 767
R P
Sbjct: 222 RPP 224
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 6e-21
Identities = 40/167 (23%), Positives = 74/167 (44%), Gaps = 7/167 (4%)
Query: 452 LRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR 511
R +A +++ G + F+ +LG G+ G V+ + + A K++ + +
Sbjct: 15 KRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKP 72
Query: 512 KKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFS 570
+ E +++ + P++ + F ++ + ME+ GG L VL++
Sbjct: 73 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IP 129
Query: 571 EQAARFYVAEVLLALEYLH-MLGVVYRDLKPENILVREDGHIMLSDF 616
EQ V+ L YL +++RD+KP NILV G I L DF
Sbjct: 130 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 176
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 20/64 (31%), Positives = 29/64 (45%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS 763
+NSFVGT Y++PE ++G + D W+ G+ L E+ GR P E Q
Sbjct: 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 246
Query: 764 LRFP 767
Sbjct: 247 EGDA 250
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 39/159 (24%), Positives = 63/159 (39%), Gaps = 12/159 (7%)
Query: 463 QHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE 522
Q + + ++G G G V+ T + A+K M K + +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS----GNKEENKRILMD 73
Query: 523 I---MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGG-DLHVLRQKQPSRFFSEQAARFYV 578
+ ++ D P++ F F T + ME + R + P E+
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP---IPERILGKMT 130
Query: 579 AEVLLALEYLH-MLGVVYRDLKPENILVREDGHIMLSDF 616
++ AL YL GV++RD+KP NIL+ E G I L DF
Sbjct: 131 VAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF 169
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 28/110 (25%), Positives = 45/110 (40%), Gaps = 11/110 (10%)
Query: 705 NSFVGTHEYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSN 758
+ G Y+APE I + D W+ GI L EL G+ P+K D E L+
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK 241
Query: 759 VV-SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
V+ + PG+ S + ++ L K+ R ++ +H F
Sbjct: 242 VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKR----PKYNKLLEHSFI 287
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 9e-21
Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 25/157 (15%)
Query: 472 FKLHKKLGCGDIGTVYLAE---LIGTSCLFALKVM----DNDFLVGRKKMPRAQTEREIM 524
+++ + G +G +YLA + G LK + D + A ER+ +
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGR--PVVLKGLVHSGDAEAQA------MAMAERQFL 133
Query: 525 QMLDHPFLPTLFAHFTTEKFSC-----LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVA 579
+ HP + +F +VMEY G L + ++ +A Y+
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLP---VAEAIA-YLL 189
Query: 580 EVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616
E+L AL YLH +G+VY DLKPENI++ E+ + L D
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDL 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 17/89 (19%), Positives = 28/89 (31%), Gaps = 9/89 (10%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
GT + APEI++ ++ D +T G L L G + +
Sbjct: 233 SFGYLYGTPGFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLPTRNG----RYVDGLPED 287
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNR 791
Y L+R + +P R
Sbjct: 288 DPVLKTYDSY----GRLLRRAIDPDPRQR 312
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-21
Identities = 31/152 (20%), Positives = 58/152 (38%), Gaps = 10/152 (6%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI---MQML 527
K ++G G G+V + + A+K + + + + Q ++ M+
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST----VDEKEQKQLLMDLDVVMRSS 78
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQ--KQPSRFFSEQAARFYVAEVLLAL 585
D P++ + E + ME + E+ + AL
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 586 EYLH-MLGVVYRDLKPENILVREDGHIMLSDF 616
+L L +++RD+KP NIL+ G+I L DF
Sbjct: 139 NHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 29/116 (25%), Positives = 44/116 (37%), Gaps = 13/116 (11%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSS----VDWWTFGIFLFELLYGRTPFKGSGND-E 754
+ A++ G Y+APE I D W+ GI L+EL GR P+ + +
Sbjct: 179 SIAKTR-DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237
Query: 755 TLSNVVSQ---SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
L+ VV L S + + L K+ R E+ +HPF
Sbjct: 238 QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKR----PKYKELLKHPFI 289
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 6/153 (3%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH 529
+ +K+G G GTV+ AE G+ A+K++ +++ E IM+ L H
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWHGSDV--AVKILMEQDFHA-ERVNEFLREVAIMKRLRH 93
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
P + T +V EY G L+ +L + E+ +V + YL
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 589 HMLG--VVYRDLKPENILVREDGHIMLSDFDLS 619
H +V+R+LK N+LV + + + DF LS
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 24/96 (25%), Positives = 43/96 (44%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET 755
+ T S S GT E++APE+++ E D ++FG+ L+EL + P+ +
Sbjct: 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV 247
Query: 756 LSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791
++ V + R ++ +I G EP R
Sbjct: 248 VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 14/164 (8%)
Query: 465 GCMGMR---HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTER 521
G M +R ++L +K+G G G +YL I A+K+ K P+ E
Sbjct: 1 GSMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIES 55
Query: 522 EIMQMLDH-PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAE 580
+I +M+ +PT+ ++ +VME G L L SR FS + +
Sbjct: 56 KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQ 113
Query: 581 VLLALEYLHMLGVVYRDLKPENILVREDGH---IMLSDFDLSLR 621
++ +EY+H ++RD+KP+N L+ + + DF L+ +
Sbjct: 114 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 33/151 (21%), Positives = 60/151 (39%), Gaps = 9/151 (5%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI---MQML 527
+ +LG G G V + + + A+K + + + ++ M+ +
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV----NSQEQKRLLMDLDISMRTV 63
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQ-KQPSRFFSEQAARFYVAEVLLALE 586
D PF T + E + ME +Q + E ++ ALE
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 587 YLHM-LGVVYRDLKPENILVREDGHIMLSDF 616
+LH L V++RD+KP N+L+ G + + DF
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDF 154
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 31/111 (27%), Positives = 41/111 (36%), Gaps = 15/111 (13%)
Query: 705 NSFVGTHEYLAPEIIKGEGHGSS----VDWWTFGIFLFELLYGRTPFKGSGND-ETLSNV 759
+ G Y+APE I E + D W+ GI + EL R P+ G + L V
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
Query: 760 VSQ---SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
V + L + S D L K R E+ QHPFF
Sbjct: 227 VEEPSPQLPADKF---SAEFVDFTSQCLKKNSKER----PTYPELMQHPFF 270
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 27/145 (18%), Positives = 49/145 (33%), Gaps = 4/145 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
++L G + A AL +D ++ + + + +D P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML 591
+ + T +V E+ GG L + PS A R + + A + H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPS---PVGAIR-AMQSLAAAADAAHRA 148
Query: 592 GVVYRDLKPENILVREDGHIMLSDF 616
GV P + V DG ++L+
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYP 173
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 13/89 (14%), Positives = 23/89 (25%), Gaps = 12/89 (13%)
Query: 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP 767
+ + D G L+ LL R P +G L+ + P
Sbjct: 170 LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
Query: 768 GYP-----VVSFHARDLIRGLLVKEPDNR 791
P + F + + + R
Sbjct: 223 IEPADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 37/183 (20%), Positives = 73/183 (39%), Gaps = 18/183 (9%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+ LG G G T + +K + ++ E ++M+ L+HP
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF---LKEVKVMRCLEHPN 68
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRF-------FSEQAARFYVAEVLLA 584
+ +K + EY GG L + + S++ F++ A
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS--------G 120
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKAS 644
+ YLH + +++RDL N LVRE+ +++++DF L+ + +++P KK
Sbjct: 121 MAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 645 SPC 647
+
Sbjct: 181 TVV 183
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 16/72 (22%), Positives = 32/72 (44%), Gaps = 2/72 (2%)
Query: 678 SRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFL 737
+R + + + + +P + + VG ++APE+I G + VD ++FGI L
Sbjct: 155 ARLMVDEKTQ--PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVL 212
Query: 738 FELLYGRTPFKG 749
E++
Sbjct: 213 CEIIGRVNADPD 224
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 7e-20
Identities = 71/410 (17%), Positives = 126/410 (30%), Gaps = 128/410 (31%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQML 527
+++ +G G G V A + A+K + F + + REI + L
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRL 109
Query: 528 DHPFLPTLFAHFTTEKFSC-----LVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEV 581
+H + + + +V+E D + R +E + + +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVY---LTELHIKTLLYNL 165
Query: 582 LLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPK 641
L+ ++Y+H G+++RDLKP N LV +D + + DF L+ R P S P+
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA-RTVDYPENGNSQLPISPREDD 224
Query: 642 KASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701
++ + VV
Sbjct: 225 MNLVTFPHTKNLKRQ-----------------------------------LTGHVV---- 245
Query: 702 ARSNSFVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELL----------YGRTP-FKG 749
T Y APE+I + + ++D W+ G ELL R P F G
Sbjct: 246 --------TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPG 297
Query: 750 SG-----------------------------------NDETLSNVVSQSLR-----FPGY 769
S ++E + + + + FP
Sbjct: 298 SSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357
Query: 770 PVVSFH---------ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810
A L++ +LV P+ R+ E HPFF+ +
Sbjct: 358 EGTDLAERFPASSADAIHLLKRMLVFNPNKRI----TINECLAHPFFKEV 403
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 37/166 (22%), Positives = 61/166 (36%), Gaps = 28/166 (16%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRA----QTEREIMQML 527
+ K++G G G V+ L+ + A+K + G +M Q E IM L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRF-------FSEQAARFYVAE 580
+HP + +VME+ P GDL+ + A
Sbjct: 81 NHPNI-VKLYGLMHNPP-RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL----- 133
Query: 581 VLLALEYLHMLG--VVYRDLKPENILVREDG-----HIMLSDFDLS 619
+EY+ +V+RDL+ NI ++ ++DF LS
Sbjct: 134 ---GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 20/96 (20%), Positives = 40/96 (41%), Gaps = 12/96 (12%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSS--VDWWTFGIFLFELLYGRTPFKGSGNDE--TLSNV 759
+ +G +++APE I E + D ++F + L+ +L G PF + ++ +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 760 VSQSLRFPGYPVVSFHA----RDLIRGLLVKEPDNR 791
+ LR P + R++I +P R
Sbjct: 243 REEGLR----PTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 24/152 (15%), Positives = 48/152 (31%), Gaps = 2/152 (1%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
+ H + + + + D L M + M
Sbjct: 61 LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP-LSSPSPMDAPSVKIRRMDPFS 119
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEY 587
+ + + + M+ C +L + ++ ++ A+E+
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
LH G+++RDLKP NI D + + DF L
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 211
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 7e-16
Identities = 32/115 (27%), Positives = 52/115 (45%), Gaps = 11/115 (9%)
Query: 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFK-GSGNDETL 756
P A VGT Y++PE I G + VD ++ G+ LFELLY F +
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRII 283
Query: 757 SNVVSQSLRFPGYPVVSFH-ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810
++V ++L+FP + +++ +L P R A +I ++ FE L
Sbjct: 284 TDV--RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP----EATDIIENAIFENL 332
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 10/155 (6%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKV--MDNDFLVGRKKMPRAQTEREI--M 524
M +F+ +K+G G G VY A T + ALK +D + + +P REI +
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPS-TAIREISLL 56
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLA 584
+ L+HP + L TE LV E+ DL + Y+ ++L
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L + H V++RDLKP+N+L+ +G I L+DF L+
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 4/146 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+K+ KLG G + TVYLAE + A+K + + + R + E L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
+ ++ + LVMEY G L + P S A + ++L +++ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHD 129
Query: 591 LGVVYRDLKPENILVREDGHIMLSDF 616
+ +V+RD+KP+NIL+ + + + DF
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDF 155
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 28/103 (27%), Positives = 48/103 (46%), Gaps = 11/103 (10%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET 755
+ E + ++N +GT +Y +PE KGE D ++ GI L+E+L G PF G ET
Sbjct: 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG----ET 216
Query: 756 LSNVVSQSLRFPGYPVVSFHARD-------LIRGLLVKEPDNR 791
++ + ++ V + +D +I K+ NR
Sbjct: 217 AVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRA-QTEREIMQMLDHPF 531
L + +G G G VY A IG A+K +D + + E ++ ML HP
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDEV--AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 532 LPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPS----RFFSEQAARFYVAEVLLALE 586
+ L E CLVME+ GG L+ VL K+ ++ Q AR +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIAR--------GMN 119
Query: 587 YLHMLG---VVYRDLKPENILVREDGHIM--------LSDFDLS 619
YLH +++RDLK NIL+ + ++DF L+
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 23/86 (26%), Positives = 36/86 (41%)
Query: 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR 765
S G + ++APE+I+ D W++G+ L+ELL G PF+G V L
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 766 FPGYPVVSFHARDLIRGLLVKEPDNR 791
P L+ +P +R
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 47/232 (20%), Positives = 81/232 (34%), Gaps = 44/232 (18%)
Query: 417 SKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHK 476
S + I S + E S SGS G L I + ++ K
Sbjct: 1 SMTYIPPGESLRDLIEQSQSSGSGSG------LPLLVQRTI-----------AKQIQMVK 43
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM--LDHPFLPT 534
++G G G V++ + G A+KV + E EI Q + H +
Sbjct: 44 QIGKGRYGEVWMGKWRGEK--VAVKVFFTT------EEASWFRETEIYQTVLMRHENILG 95
Query: 535 LFAHFTTEKFS----CLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
A S L+ +Y G L+ L+ + + + L +LH
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDA---KSMLKL-AYSSVSGLCHLH 151
Query: 590 ML--------GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSS 633
+ +RDLK +NILV+++G ++D L+++ + V
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 43/147 (29%), Positives = 63/147 (42%), Gaps = 4/147 (2%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
++L + +G G +G VY AE + ALK+M R Q E L P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ + + + M G DL +LR++ P + A V ++ AL+ H
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH 151
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDF 616
G +RD+KPENILV D L DF
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDF 178
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 22/96 (22%), Positives = 36/96 (37%), Gaps = 13/96 (13%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
+ + VGT Y+APE D + L+E L G P++G + LS V+
Sbjct: 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG----DQLS-VMGA 245
Query: 763 SLRFPGYPVVSFHARDLIRGL-------LVKEPDNR 791
+ P S + + K P++R
Sbjct: 246 HINQA-IPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 32/157 (20%), Positives = 64/157 (40%), Gaps = 13/157 (8%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH- 529
H+K+ +++G G G ++ + + A+K P+ + E ++L
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGC 65
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+P ++ + LV++ G L L R FS + ++L ++ +H
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH 123
Query: 590 MLGVVYRDLKPENILVREDGH-----IMLSDFDLSLR 621
+VYRD+KP+N L+ I + DF +
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 28/157 (17%), Positives = 55/157 (35%), Gaps = 9/157 (5%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
+ KL G ++ G +KV+ RK E +++
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRWQGNDI--VVKVLKVRDWSTRK-SRDFNEECPRLRIFS 65
Query: 529 HPFLPTLFAHFTTEKFS--CLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLAL 585
HP + + + L+ + P G L +VL + QA +F ++ +
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF-ALDMARGM 124
Query: 586 EYLHMLG--VVYRDLKPENILVREDGHIMLSDFDLSL 620
+LH L + L ++++ ED +S D+
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 24/91 (26%), Positives = 42/91 (46%), Gaps = 3/91 (3%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGS---SVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
S + ++APE ++ + + S D W+F + L+EL+ PF N E V
Sbjct: 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791
+ LR P +S H L++ + ++P R
Sbjct: 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 49/166 (29%), Positives = 73/166 (43%), Gaps = 15/166 (9%)
Query: 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKV--MDNDFLVGRKKMPRAQTERE 522
G M ++ ++G G GTVY A + ALK + N G +P T RE
Sbjct: 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG-GGGGGGLPI-STVRE 61
Query: 523 I-----MQMLDHPFLPTLFAHFTTEKFSC-----LVMEYCPGGDLHVLRQKQPSRFFSEQ 572
+ ++ +HP + L T + LV E+ DL K P +
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAE 120
Query: 573 AARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618
+ + + L L++LH +V+RDLKPENILV G + L+DF L
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 8e-06
Identities = 23/128 (17%), Positives = 37/128 (28%), Gaps = 34/128 (26%)
Query: 710 THE-----YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG------------- 751
T Y APE++ + + VD W+ G E+ + F G+
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 752 --NDETLSNVVS-QSLRFPGYPVVSF---------HARDLIRGLLVKEPDNRLGAVKGAA 799
++ VS FP L+ +L P R+ A
Sbjct: 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI----SAF 292
Query: 800 EIKQHPFF 807
QH +
Sbjct: 293 RALQHSYL 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 36/183 (19%), Positives = 65/183 (35%), Gaps = 35/183 (19%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM--L 527
R L + +G G G V+ G + A+K+ + E E+ L
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSR------DEKSWFRETELYNTVML 59
Query: 528 DHPFLPTLFAHFTTEKFS----CLVMEYCPGGDLH-VLRQKQPSRF----FSEQAARFYV 578
H + A T + S L+ Y G L+ L+ A
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIAS--- 116
Query: 579 AEVLLALEYLHML--------GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630
L +LH+ + +RDLK +NILV+++G ++D L++ + + +
Sbjct: 117 -----GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 631 SSS 633
+
Sbjct: 172 VGN 174
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 34/154 (22%), Positives = 69/154 (44%), Gaps = 20/154 (12%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532
+ +++G G GTVY + G A+K+++ ++ + + E +++ H +
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNI 82
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRF-------FSEQAARFYVAEVLLAL 585
+ T + +V ++C G L+ ++F + Q AR +
Sbjct: 83 LLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR--------GM 133
Query: 586 EYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+YLH +++RDLK NI + ED + + DF L+
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 21/96 (21%), Positives = 43/96 (44%), Gaps = 7/96 (7%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHG---SSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
+ G+ ++APE+I+ + D + FGI L+EL+ G+ P+ N + + +
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237
Query: 760 VSQSLRFPGYPVVSFHARDLIRGLLVK----EPDNR 791
V + P V + ++ L+ + + D R
Sbjct: 238 VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 49/235 (20%), Positives = 81/235 (34%), Gaps = 52/235 (22%)
Query: 418 KSSIGEYSSSTSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKK 477
+ I E ++ + D SGS G L I R L +
Sbjct: 7 RPFISEGTTLKDLIYDMTTSGSGSG------LPLLVQRTI-----------ARTIVLQES 49
Query: 478 LGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM--LDHPFLPTL 535
+G G G V+ + G A+K+ F ++ E EI Q L H +
Sbjct: 50 IGKGRFGEVWRGKWRGEE--VAVKI----FSSREERS--WFREAEIYQTVMLRHENILGF 101
Query: 536 FAHFTTEKFS----CLVMEYCPGGDLH-VLRQKQPSRF----FSEQAARFYVAEVLLALE 586
A + + LV +Y G L L + + + A L
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTAS--------GLA 153
Query: 587 YLHM--------LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSS 633
+LHM + +RDLK +NILV+++G ++D L++R + +
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 38/150 (25%), Positives = 69/150 (46%), Gaps = 8/150 (5%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
++L + LG G + V+LA + A+KV+ D R + E + L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 532 LPTLF----AHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALE 586
+ ++ A +VMEY G L ++ + P + + A +A+ AL
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALN 130
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDF 616
+ H G+++RD+KP NI++ + + DF
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDF 160
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 26/100 (26%), Positives = 46/100 (46%), Gaps = 14/100 (14%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS-- 757
+ ++ + +GT +YL+PE +G+ + D ++ G L+E+L G PF G D +S
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG---DSPVSVA 228
Query: 758 ------NVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791
+ + S R G ++ L K P+NR
Sbjct: 229 YQHVREDPIPPSARHEGLSA---DLDAVVLKALAKNPENR 265
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 48/161 (29%), Positives = 70/161 (43%), Gaps = 24/161 (14%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTE-------- 520
M + KLG G TVY + T L ALK + R + E
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI------------RLEHEEGAPCTAI 48
Query: 521 REI--MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYV 578
RE+ ++ L H + TL TEK LV EY DL + + ++
Sbjct: 49 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQY-LDDCGNIINMHNVKLFL 106
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++L L Y H V++RDLKP+N+L+ E G + L+DF L+
Sbjct: 107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA 147
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 34/150 (22%), Positives = 53/150 (35%), Gaps = 44/150 (29%)
Query: 710 THE-----YLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSG------------ 751
+E Y P+I+ G + +D W G +E+ GR F GS
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217
Query: 752 ---NDETLSNVVS----QSLRFPGYPVVSF---------HARDLIRGLLVKEPDNRLGAV 795
+ET ++S ++ +P Y + DL+ LL E NR+
Sbjct: 218 GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI--- 274
Query: 796 KGAAEIKQHPFFEGLNWALIRCAVPPELPR 825
A + +HPFF L +LP
Sbjct: 275 -SAEDAMKHPFFLSLG------ERIHKLPD 297
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 36/170 (21%), Positives = 61/170 (35%), Gaps = 19/170 (11%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCL--------FALKV--MDNDFLVGRKKMPRAQT 519
R +KL + G +Y A T F+LK+ D + RA
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 520 EREI-----MQMLDHPFLPTLFAHFTTE-KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQA 573
++ + +PT + K+ LV+ G L P SE++
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERS 160
Query: 574 ARFYVAEVLLALEYLHMLGVVYRDLKPENILV--REDGHIMLSDFDLSLR 621
+L ALE+LH V+ ++ ENI V + + L+ + + R
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 42/182 (23%), Positives = 74/182 (40%), Gaps = 16/182 (8%)
Query: 442 GGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALK 501
G H S+ + + M ++ +G G G V T + A+K
Sbjct: 2 GHHHHHHSSGVDLGT-----ENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK 56
Query: 502 --VMDNDFLVGRKKMPRAQTEREI--MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL 557
+ +D KM + REI ++ L H L L +K LV E+ +
Sbjct: 57 KFLESDD-----DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TI 110
Query: 558 HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFD 617
+ P+ Q + Y+ +++ + + H +++RD+KPENILV + G + L DF
Sbjct: 111 LDDLELFPNGL-DYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFG 169
Query: 618 LS 619
+
Sbjct: 170 FA 171
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 36/152 (23%), Positives = 50/152 (32%), Gaps = 44/152 (28%)
Query: 710 THE-----YLAPEIIKGEGH-GSSVDWWTFG-IFLFELLYGRTPFKGSGNDETL------ 756
E Y APE++ G+ G +VD W G + E+ G F G + + L
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLV-TEMFMGEPLFPGDSDIDQLYHIMMC 240
Query: 757 -------------SNVVSQSLRFPG----------YPVVSFHARDLIRGLLVKEPDNRLG 793
N V +R P YP +S DL + L +PD R
Sbjct: 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP- 299
Query: 794 AVKGAAEIKQHPFFEGLNWALIRCAVPPELPR 825
AE+ H FF+ EL
Sbjct: 300 ---FCAELLHHDFFQMDG---FAERFSQELQL 325
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH- 529
+F++ KK+GCG+ G + L + + T+ A+K+ + P+ E + L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-----SRAPQLHLEYRFYKQLGSG 64
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+P ++ K++ +V+E G L L R FS + +++ +EY+H
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH 122
Query: 590 MLGVVYRDLKPENILVREDGH-----IMLSDFDLS 619
++YRD+KPEN L+ G+ I + DF L+
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 25/154 (16%), Positives = 62/154 (40%), Gaps = 20/154 (12%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL 532
++ + +G G G VY G A++++D + ++ + E + H +
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENV 91
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRF-------FSEQAARFYVAEVLLAL 585
+ ++ C G L+ + + +++ + +
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVK--------GM 143
Query: 586 EYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
YLH G++++DLK +N+ ++G ++++DF L
Sbjct: 144 GYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLF 176
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 19/95 (20%), Positives = 32/95 (33%), Gaps = 13/95 (13%)
Query: 708 VGTHEYLAPEIIKGEGHGSS---------VDWWTFGIFLFELLYGRTPFKGSGNDETLSN 758
G +LAPEII+ + D + G +EL PFK E +
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-PAEAIIW 253
Query: 759 VVSQSLRFPGYPVVSFHA--RDLIRGLLVKEPDNR 791
+ ++ P + D++ E + R
Sbjct: 254 QMGTGMK-PNLSQIGMGKEISDILLFCWAFEQEER 287
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 19/156 (12%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM---Q 525
++L +KLG G V+ A I + +K++ V +KK +REI
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKK-----IKREIKILEN 86
Query: 526 MLDHPFLPTLFA--HFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLL 583
+ P + TL + LV E+ D L Q ++ RFY+ E+L
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILK 141
Query: 584 ALEYLHMLGVVYRDLKPENILV-REDGHIMLSDFDL 618
AL+Y H +G+++RD+KP N+++ E + L D+ L
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 24/143 (16%), Positives = 45/143 (31%), Gaps = 41/143 (28%)
Query: 705 NSFVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTP-FKGSGN---------- 752
N V + + PE++ S+D W+ G L +++ + P F G N
Sbjct: 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247
Query: 753 ------DETLSNVVSQSLR-----FPGYPVVSFH--------------ARDLIRGLLVKE 787
+ + + + + A D + LL +
Sbjct: 248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 307
Query: 788 PDNRLGAVKGAAEIKQHPFFEGL 810
+RL A E +HP+F +
Sbjct: 308 HQSRL----TAREAMEHPYFYTV 326
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKV--MDNDFLVGRKKMPRAQTEREI--M 524
FK +KLG G TVY T ALK +D++ + P REI M
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-----EGTPS-TAIREISLM 57
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVL----RQKQPSRFFSEQAARFYVAE 580
+ L H + L+ TE LV E+ DL R +++ +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 581 VLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+L L + H +++RDLKP+N+L+ + G + L DF L+
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 30/139 (21%), Positives = 50/139 (35%), Gaps = 42/139 (30%)
Query: 710 THE-----YLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS------ 757
+ E Y AP+++ G +S+D W+ G L E++ G+ F G+ ++E L
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225
Query: 758 --------------------------NVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791
+ Q L+ + + D + GLL PD R
Sbjct: 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMR 285
Query: 792 LGAVKGAAEIKQHPFFEGL 810
L A + HP+F
Sbjct: 286 L----SAKQALHHPWFAEY 300
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 47/157 (29%), Positives = 64/157 (40%), Gaps = 20/157 (12%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKV-----MDNDFLVGRKKMPRAQTEREIM 524
+ KL + +G G+ G V L + G A+K FL E +M
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQAFL----------AEASVM 68
Query: 525 QMLDHPFLPTLFAHFTTEKFS-CLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYVAEVL 582
L H L L EK +V EY G L LR + S + +F +V
Sbjct: 69 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVC 127
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
A+EYL V+RDL N+LV ED +SDF L+
Sbjct: 128 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 7e-17
Identities = 43/155 (27%), Positives = 79/155 (50%), Gaps = 11/155 (7%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKV--MDNDFLVGRKKMPRAQTEREI--M 524
M+ ++ +K+G G GTV+ A+ T + ALK +D+D + +P REI +
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD----DEGVPS-SALREICLL 55
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLA 584
+ L H + L ++K LV E+C DL + + + ++ ++L
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKY-FDSCNGDLDPEIVKSFLFQLLKG 113
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L + H V++RDLKP+N+L+ +G + L++F L+
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 31/139 (22%), Positives = 50/139 (35%), Gaps = 44/139 (31%)
Query: 710 THE-----YLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTP-FKGSGNDETLSNV--- 759
+ E Y P+++ G +S+D W+ G EL P F G+ D+ L +
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
Query: 760 -----------VSQSLRFPGY----------------PVVSFHARDLIRGLLVKEPDNRL 792
+++ P Y P ++ RDL++ LL P R+
Sbjct: 219 LGTPTEEQWPSMTK---LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275
Query: 793 GAVKGAAEIKQHPFFEGLN 811
A E QHP+F
Sbjct: 276 ----SAEEALQHPYFSDFC 290
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 40/156 (25%), Positives = 62/156 (39%), Gaps = 18/156 (11%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM------DNDFLVGRKKMPRAQTEREIM 524
+ KLG G G VY S A+K + +FL E +M
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL----------KEAAVM 63
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYVAEVLL 583
+ + HP L L T E ++ E+ G+L LR+ + ++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISS 122
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
A+EYL ++RDL N LV E+ + ++DF LS
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 46/186 (24%), Positives = 69/186 (37%), Gaps = 37/186 (19%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMD----NDFLVGRKKMPRAQTEREIM 524
+ + KL + +G G G VY L A+KV +F E+ I
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANRQNF----------INEKNIY 59
Query: 525 QM--LDHPFLPTLFA-----HFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFY 577
++ ++H + LVMEY P G L S + +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDW----VSSCR 115
Query: 578 VA-EVLLALEYLHM---------LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627
+A V L YLH + +RDL N+LV+ DG ++SDF LS+R N +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 628 VVKSSS 633
V
Sbjct: 176 VRPGEE 181
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 16/77 (20%), Positives = 31/77 (40%), Gaps = 7/77 (9%)
Query: 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKG-------EGHGSSVDWWTFGIFL 737
L+ +++ + + S VGT Y+APE+++G E VD + G+
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
Query: 738 FELLYGRTPFKGSGNDE 754
+E+ T +
Sbjct: 226 WEIFMRCTDLFPGESVP 242
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 11/154 (7%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALK--VMDNDFLVGRKKMPRAQTEREI--M 524
M ++ K+G G G V+ T + A+K + D + + REI +
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-----DPVIKKIALREIRML 56
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLA 584
+ L HP L L F ++ LV EYC + + R E + + L A
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ-RGVPEHLVKSITWQTLQA 114
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618
+ + H ++RD+KPENIL+ + I L DF
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 4e-06
Identities = 29/137 (21%), Positives = 46/137 (33%), Gaps = 39/137 (28%)
Query: 710 THE-----YLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSG------------ 751
E Y +PE++ G+ G VD W G ELL G + G
Sbjct: 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219
Query: 752 ---NDETLSNVVS----QSLRFPGY----------PVVSFHARDLIRGLLVKEPDNRLGA 794
+ ++ P P +S+ A L++G L +P RL
Sbjct: 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL-- 277
Query: 795 VKGAAEIKQHPFFEGLN 811
++ HP+FE +
Sbjct: 278 --TCEQLLHHPYFENIR 292
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 25/205 (12%)
Query: 427 STSISEDSILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRH----FKLHKKLGCGD 482
+TS +E +S D + V G R + K +G G
Sbjct: 7 TTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGS 66
Query: 483 IGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE--IMQMLDHPFLPTLFAHFT 540
G VY A+L + L A+K + D K+ RE IM+ LDH + L F
Sbjct: 67 FGVVYQAKLCDSGELVAIKKVLQD-----KRF----KNRELQIMRKLDHCNIVRLRYFFY 117
Query: 541 T------EKFSCLVMEYCPGGDLH-VLRQKQPSR-FFSEQAARFYVAEVLLALEYLHMLG 592
+ E + LV++Y P ++ V R ++ + Y+ ++ +L Y+H G
Sbjct: 118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 593 VVYRDLKPENILVREDGHIM-LSDF 616
+ +RD+KP+N+L+ D ++ L DF
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDF 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 35/126 (27%), Positives = 44/126 (34%), Gaps = 32/126 (25%)
Query: 713 YLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKG-SG--------------NDETL 756
Y APE+I G SS+D W+ G L ELL G+ F G SG E +
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 757 SNVVSQ--SLRFPGYPVVSFH----------ARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804
+ +FP + A L LL P RL E H
Sbjct: 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAH 337
Query: 805 PFFEGL 810
FF+ L
Sbjct: 338 SFFDEL 343
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKV--MDNDFLVGRKKMPRAQTEREI--M 524
+ ++ LG G TVY A T+ + A+K + + + + R REI +
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-EAKDGINR-TALREIKLL 66
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLA 584
Q L HP + L F + LV ++ DL V+ K S + + Y+ L
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVI-IKDNSLVLTPSHIKAYMLMTLQG 124
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618
LEYLH +++RDLKP N+L+ E+G + L+DF L
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 34/173 (19%), Positives = 58/173 (33%), Gaps = 40/173 (23%)
Query: 710 THE-----YLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV---- 759
TH+ Y APE++ G G VD W G L ELL G + + L+ +
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229
Query: 760 ----------VSQ---SLRFPGYPVVSFH---------ARDLIRGLLVKEPDNRLGAVKG 797
+ + F +P + H DLI+GL + P R+
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI----T 285
Query: 798 AAEIKQHPFFEGLNWALIRCAVPPELPRSCDAVIGSQKKESTKCEESKGAADE 850
A + + +F +LPR V +++ + + +
Sbjct: 286 ATQALKMKYF----SNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEA 334
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 40/170 (23%), Positives = 66/170 (38%), Gaps = 38/170 (22%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIG----TSCLFALKVM-------DNDFLVGRKKMPRAQ 518
RH K ++LG G+ G+V + T + A+K + DF
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE---------- 90
Query: 519 TEREIMQMLDHPFLPTLFAHFTTEKFS--CLVMEYCPGGDLHV-LRQKQPS------RFF 569
E EI++ L H + + L+MEY P G L L++ + +
Sbjct: 91 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 150
Query: 570 SEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ Q + +EYL ++RDL NILV + + + DF L+
Sbjct: 151 TSQICK--------GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 4e-16
Identities = 38/155 (24%), Positives = 71/155 (45%), Gaps = 11/155 (7%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DH 529
F+L +K+G G G +YL I T+ A+K+ + K P+ E +I ++L
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKIYRILQGG 62
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+P + ++ LVM+ G L L SR S + +++ +E++H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVH 120
Query: 590 MLGVVYRDLKPENILVREDGH---IMLSDFDLSLR 621
++RD+KP+N L+ + + DF L+ +
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 45/170 (26%), Positives = 68/170 (40%), Gaps = 38/170 (22%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIG----TSCLFALKVM-------DNDFLVGRKKMPRAQ 518
RH K +LG G+ G+V L T L A+K + DF
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ---------- 72
Query: 519 TEREIMQMLDHPFLPTLFA--HFTTEKFSCLVMEYCPGGDLHV-LRQKQPS------RFF 569
E +I++ L F+ + + LVMEY P G L L++ + +
Sbjct: 73 REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 132
Query: 570 SEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
S Q + +EYL V+RDL NILV + H+ ++DF L+
Sbjct: 133 SSQICK--------GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-16
Identities = 38/153 (24%), Positives = 66/153 (43%), Gaps = 11/153 (7%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTE--RE--IMQM 526
L +++G G+ G V+ L + L A+K P + + +E I++
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET------LPPDLKAKFLQEARILKQ 168
Query: 527 LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
HP + L T ++ +VME GGD + + +R + + V + +E
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQM-VGDAAAGME 227
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
YL ++RDL N LV E + +SDF +S
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 5e-16
Identities = 39/156 (25%), Positives = 62/156 (39%), Gaps = 18/156 (11%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM------DNDFLVGRKKMPRAQTEREIM 524
+ KLG G G VY S A+K + +FL E +M
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL----------KEAAVM 270
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYVAEVLL 583
+ + HP L L T E ++ E+ G+L LR+ + ++
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISS 329
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
A+EYL ++R+L N LV E+ + ++DF LS
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS 365
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 40/170 (23%), Positives = 66/170 (38%), Gaps = 38/170 (22%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIG----TSCLFALKVM-------DNDFLVGRKKMPRAQ 518
RH K ++LG G+ G+V + T + A+K + DF
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE---------- 59
Query: 519 TEREIMQMLDHPFLPTLFAHFTTEKFS--CLVMEYCPGGDLHV-LRQKQPS------RFF 569
E EI++ L H + + L+MEY P G L L++ + +
Sbjct: 60 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 570 SEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ Q + +EYL ++RDL NILV + + + DF L+
Sbjct: 120 TSQICK--------GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-16
Identities = 47/156 (30%), Positives = 63/156 (40%), Gaps = 20/156 (12%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKV-----MDNDFLVGRKKMPRAQTEREIMQ 525
KL + +G G+ G V L + G A+K FL E +M
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQAFL----------AEASVMT 241
Query: 526 MLDHPFLPTLFAHFTTEK-FSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYVAEVLL 583
L H L L EK +V EY G L LR + S + +F +V
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCE 300
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
A+EYL V+RDL N+LV ED +SDF L+
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 38/171 (22%), Positives = 61/171 (35%), Gaps = 39/171 (22%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELI----GTSCLFALKVM--------DNDFLVGRKKMPRA 517
R K + LG G G V L T A+K + D
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK--------- 71
Query: 518 QTEREIMQMLDHPFLPTLFAHFTTEKFS--CLVMEYCPGGDLHV-LRQKQPS------RF 568
E EI++ L H + T + + L+ME+ P G L L + +
Sbjct: 72 -KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130
Query: 569 FSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++ Q + ++YL V+RDL N+LV + + + DF L+
Sbjct: 131 YAVQICK--------GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 41/161 (25%), Positives = 64/161 (39%), Gaps = 21/161 (13%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELI----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ 525
R+ K + LG G G V L GT + A+K + D G + + E +I++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILR 88
Query: 526 MLDHPFLPTLFAHFTTEKFS--CLVMEYCPGGDLHV-LRQKQPSR----FFSEQAARFYV 578
L H + + LVMEY P G L L + F++Q
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICE--- 145
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ YLH ++RDL N+L+ D + + DF L+
Sbjct: 146 -----GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKV--MDNDFLVGRKKMPRAQTEREI--M 524
M + +K+G G G VY A+ FALK ++ + + +P T REI +
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKE----DEGIPS-TTIREISIL 54
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLA 584
+ L H + L+ T+K LV E+ DL L A+ ++ ++L
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGL-ESVTAKSFLLQLLNG 112
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ Y H V++RDLKP+N+L+ +G + ++DF L+
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 7e-07
Identities = 27/135 (20%), Positives = 51/135 (37%), Gaps = 37/135 (27%)
Query: 710 THE-----YLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV---- 759
THE Y AP+++ G +++D W+ G E++ G F G + L +
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217
Query: 760 ----------VSQ----SLRFPGYPVVSF---------HARDLIRGLLVKEPDNRLGAVK 796
V++ F Y + + DL+ +L +P+ R+
Sbjct: 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---- 273
Query: 797 GAAEIKQHPFFEGLN 811
A + +H +F+ N
Sbjct: 274 TAKQALEHAYFKENN 288
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 45/194 (23%), Positives = 85/194 (43%), Gaps = 22/194 (11%)
Query: 434 SILSGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIG 493
++ + G + + + + + G + K +G G G V+ A+L+
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE 63
Query: 494 TSCLFALKVMDNDFLVGRKKMPRAQTERE--IMQMLDHPFLPTLFAHFTT------EKFS 545
+ A+K + D + RE IM+++ HP + L A F + E F
Sbjct: 64 SD-EVAIKKVLQD---------KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113
Query: 546 CLVMEYCPGGDLH-VLRQKQPSR-FFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENI 603
LV+EY P ++ R + + Y+ ++L +L Y+H +G+ +RD+KP+N+
Sbjct: 114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNL 172
Query: 604 LV-REDGHIMLSDF 616
L+ G + L DF
Sbjct: 173 LLDPPSGVLKLIDF 186
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 36/126 (28%), Positives = 50/126 (39%), Gaps = 32/126 (25%)
Query: 713 YLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKG-SG--------------NDETL 756
Y APE+I G + +++D W+ G + EL+ G+ F G SG + E +
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 757 SNVVSQSLR--FPGYPVVSFH----------ARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804
+ + FP F A DLI LL P RL A E H
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL----TAIEALCH 322
Query: 805 PFFEGL 810
PFF+ L
Sbjct: 323 PFFDEL 328
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 37/163 (22%), Positives = 70/163 (42%), Gaps = 17/163 (10%)
Query: 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKV--MDNDFLVGRKKMPRAQTERE 522
+ ++ KLG G G VY A T+ A+K ++++ + +P RE
Sbjct: 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE----EEGVPG-TAIRE 83
Query: 523 I--MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAE 580
+ ++ L H + L + L+ EY DL K P S + + ++ +
Sbjct: 84 VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQ 140
Query: 581 VLLALEYLHMLGVVYRDLKPENILV-----REDGHIMLSDFDL 618
++ + + H ++RDLKP+N+L+ E + + DF L
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 30/135 (22%), Positives = 45/135 (33%), Gaps = 38/135 (28%)
Query: 710 THE-----YLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV---- 759
THE Y PEI+ G H +SVD W+ E+L F G + L +
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254
Query: 760 ----------VSQ----SLRFPGYPVVSF----------HARDLIRGLLVKEPDNRLGAV 795
V+ FP + + DL+ +L +P R+
Sbjct: 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI--- 311
Query: 796 KGAAEIKQHPFFEGL 810
A +HP+F
Sbjct: 312 -SAKNALEHPYFSHN 325
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 43/153 (28%), Positives = 59/153 (38%), Gaps = 7/153 (4%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLF---ALKVMDNDFLVGRKKMPRAQTEREIMQML 527
+L +KLG G G V E S A+K + D L + M E M L
Sbjct: 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYVAEVLLALE 586
DH L L+ T +V E P G L LR+ Q F Y +V +
Sbjct: 79 DHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMG 135
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
YL ++RDL N+L+ + + DF L
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 19/167 (11%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQML 527
+ + +G G G+V A + A+K + F + ++ + RE+ ++ +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHM 80
Query: 528 DHPFLPTLFAHFT----TEKFSC--LVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAE 580
H + L FT F LVM + DL ++ K FSE+ ++ V +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK-----FSEEKIQYLVYQ 134
Query: 581 VLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627
+L L+Y+H GVV+RDLKP N+ V ED + + DF L+ R A M
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA-RHADAEM 180
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 39/144 (27%), Positives = 55/144 (38%), Gaps = 39/144 (27%)
Query: 702 ARSNS-----FVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSG---- 751
AR +V T Y APE+I H +VD W+ G + E+L G+T FKG
Sbjct: 173 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232
Query: 752 -----------NDETLSNVVSQSLR-----FPGYPVVSFH---------ARDLIRGLLVK 786
E + + ++ + P P F A DL+ +L
Sbjct: 233 LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL 292
Query: 787 EPDNRLGAVKGAAEIKQHPFFEGL 810
+ D RL AA+ HPFFE
Sbjct: 293 DVDKRL----TAAQALTHPFFEPF 312
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 33/185 (17%), Positives = 64/185 (34%), Gaps = 33/185 (17%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH 529
+L + G G V+ A+L+ A+K+ F + K+ + + E + + H
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLLNEY--VAVKI----FPIQDKQSWQNEYEVYSLPGMKH 77
Query: 530 PFLPTLFAHFTTEKFS----CLVMEYCPGGDLH-VLRQKQ---PSRF-FSEQAARFYVAE 580
+ L+ + G L L+ +E AR
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMAR----- 132
Query: 581 VLLALEYLHM----------LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630
L YLH + +RD+K +N+L++ + ++DF L+L+
Sbjct: 133 ---GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 631 SSSPV 635
+ V
Sbjct: 190 THGQV 194
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 42/170 (24%), Positives = 77/170 (45%), Gaps = 24/170 (14%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQML 527
++ +G G G+V A T A+K + F + + +T RE+ ++ +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHM 85
Query: 528 DHP--------FLPTLFAHFTTEKFSC--LVMEYCPGGDLHVLRQKQPSRFFSEQAARFY 577
H F P + E+F+ LV G DL+ + + Q ++ +F
Sbjct: 86 KHENVIGLLDVFTPAR----SLEEFNDVYLVTHLM-GADLNNIVKCQK---LTDDHVQFL 137
Query: 578 VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627
+ ++L L+Y+H +++RDLKP N+ V ED + + DF L+ R + M
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-RHTADEM 186
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 40/144 (27%), Positives = 57/144 (39%), Gaps = 39/144 (27%)
Query: 702 ARSNS-----FVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSG---- 751
AR + +V T Y APEI+ H +VD W+ G + ELL GRT F G+
Sbjct: 179 ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238
Query: 752 -----------NDETLSNVVSQSLR-----FPGYPVVSFH---------ARDLIRGLLVK 786
E L + S+S R P ++F A DL+ +LV
Sbjct: 239 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL 298
Query: 787 EPDNRLGAVKGAAEIKQHPFFEGL 810
+ D R+ AA+ H +F
Sbjct: 299 DSDKRI----TAAQALAHAYFAQY 318
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 42/163 (25%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 461 QKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKV--MDNDFLVGRKKMPRAQ 518
+ + M ++ +K+G G G VY A+ + ALK +D + + +P
Sbjct: 12 ENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE----DEGIPS-T 65
Query: 519 TEREI--MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARF 576
REI ++ L HP + +L +E+ LV E+ DL + + + + +
Sbjct: 66 AIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGL-QDSQIKI 123
Query: 577 YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
Y+ ++L + + H +++RDLKP+N+L+ DG + L+DF L+
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 29/136 (21%), Positives = 49/136 (36%), Gaps = 38/136 (27%)
Query: 710 THE-----YLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSG------------ 751
THE Y AP+++ G +SVD W+ G E++ G+ F G
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236
Query: 752 ---NDETLSNVVS----QSLRFPGYPVVSF---------HARDLIRGLLVKEPDNRLGAV 795
N V + F + + DL+ +L +P+ R+
Sbjct: 237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI--- 293
Query: 796 KGAAEIKQHPFFEGLN 811
A + HP+F+ L+
Sbjct: 294 -SARDAMNHPYFKDLD 308
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 38/162 (23%), Positives = 62/162 (38%), Gaps = 26/162 (16%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKV---------MDN---DFLVGRKKMPRAQ 518
FK K LG G GTVY I + V + L
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL---------- 65
Query: 519 TEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFY 577
E +M +D+P + L T L+ + P G L +R+ + + Q +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDN--IGSQYLLNW 122
Query: 578 VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++ + YL +V+RDL N+LV+ H+ ++DF L+
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 19/172 (11%)
Query: 460 VQKQHGCMGMRHFKLHKKLGCGDIGTVYLA-ELIGTSCLFALKV--MDNDFLVGRKKMPR 516
++K C + ++ ++G G G V+ A +L ALK + + MP
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG----EEGMP- 55
Query: 517 AQTEREI-----MQMLDHPFLPTLFAHFTTEKFSC-----LVMEYCPGGDLHVLRQKQPS 566
T RE+ ++ +HP + LF T + LV E+ DL K P
Sbjct: 56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPE 114
Query: 567 RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618
+ + + ++L L++LH VV+RDLKP+NILV G I L+DF L
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 5e-06
Identities = 29/147 (19%), Positives = 46/147 (31%), Gaps = 36/147 (24%)
Query: 710 THE-----YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG------------- 751
T Y APE++ + + VD W+ G E+ + F+GS
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 752 --NDETLSNVVS-QSLRFPGYPVVSF---------HARDLIRGLLVKEPDNRLGAVKGAA 799
+E V+ F +DL+ L P R+ A
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI----SAY 292
Query: 800 EIKQHPFFEGLNWALIRCAVPPELPRS 826
HP+F+ L + + LP S
Sbjct: 293 SALSHPYFQDLE--RCKENLDSHLPPS 317
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 4e-15
Identities = 41/188 (21%), Positives = 76/188 (40%), Gaps = 22/188 (11%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQML 527
++ + +G G G VYLA T A+K ++ F + + REI + L
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILREITILNRL 82
Query: 528 DHP--------FLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYV 578
+P F E + +V+E DL + + +E+ + +
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFD-ELY--IVLEIA-DSDLKKLFKTPIF---LTEEHIKTIL 135
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEP 638
+LL ++H G+++RDLKP N L+ +D + + DF L+ R + + +EE
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA-RTINSEKDTNIVNDLEEN 194
Query: 639 PPKKASSP 646
+
Sbjct: 195 EEPGPHNK 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 40/173 (23%), Positives = 68/173 (39%), Gaps = 28/173 (16%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-- 527
+ L KK+G G G +YLA A V+ V ++ +E + Q +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK----VEYQENGPLFSELKFYQRVAK 92
Query: 528 -------------DHPFLPTLFAHFTTE----KFSCLVMEYCPGGDLHVLRQKQPSRFFS 570
D+ +P + TE + +VME G DL + + + F
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFK 149
Query: 571 EQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV--REDGHIMLSDFDLSLR 621
+ +L LEY+H V+ D+K N+L+ + + L+D+ LS R
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 39/161 (24%), Positives = 59/161 (36%), Gaps = 23/161 (14%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKV---------MDN---DFLVGRKKMPRAQ 518
K +G G+ G VY L +S + V + DFL
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL---------- 94
Query: 519 TEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYV 578
E IM H + L + K ++ EY G L +++ F Q +
Sbjct: 95 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM-L 153
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ ++YL + V+RDL NILV + +SDF LS
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 37/156 (23%), Positives = 66/156 (42%), Gaps = 20/156 (12%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM------DNDFLVGRKKMPRAQTEREIM 524
KL ++LG G G V++ G + + A+K + + FL E +M
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFL----------AEANLM 62
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLL 583
+ L H L L+A T E ++ EY G L L+ + + A++
Sbjct: 63 KQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDM-AAQIAE 120
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ ++ ++RDL+ NILV + ++DF L+
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 39/159 (24%), Positives = 75/159 (47%), Gaps = 18/159 (11%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQML 527
+ ++ K +G G G V A A+K + F + + + RE+ M+ +
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCV 118
Query: 528 DHPFLPTLF----AHFTTEKFSC--LVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAE 580
+H + +L T E+F LVME +L V++ + + + + +
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME-----LDHERMSYLLYQ 172
Query: 581 VLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+L +++LH G+++RDLKP NI+V+ D + + DF L+
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 31/144 (21%), Positives = 51/144 (35%), Gaps = 44/144 (30%)
Query: 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG--------------- 751
+V T Y APE+I G G+ +VD W+ G + E++ + F G
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282
Query: 752 NDETLSNVVSQSLRF----PGYPVVSFH---------------------ARDLIRGLLVK 786
E + + + P Y ++F ARDL+ +LV
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342
Query: 787 EPDNRLGAVKGAAEIKQHPFFEGL 810
+P R+ + QHP+
Sbjct: 343 DPAKRI----SVDDALQHPYINVW 362
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 29/166 (17%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALK-VMDNDFLVGRKKMPR-AQTEREIMQM 526
M F++ + G G GTV L + T A+K V+ + PR E +IMQ
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD---------PRFRNRELQIMQD 72
Query: 527 L---DHP--------FLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSR-FFSEQA 573
L HP F + + +VMEY P LH R +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRR-DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 574 ARFYVAEVLLALEYLHM--LGVVYRDLKPENILV-REDGHIMLSDF 616
+ ++ +++ ++ LH+ + V +RD+KP N+LV DG + L DF
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 29/129 (22%), Positives = 47/129 (36%), Gaps = 35/129 (27%)
Query: 713 YLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKG-SG--------------NDETL 756
Y APE+I G H ++VD W+ G E++ G F+G + + E L
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256
Query: 757 SNVVSQ--SLRFPGYPVVSFH-------------ARDLIRGLLVKEPDNRLGAVKGAAEI 801
+ + + + A DL+ LL P+ R+ E
Sbjct: 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM----KPYEA 312
Query: 802 KQHPFFEGL 810
HP+F+ L
Sbjct: 313 LCHPYFDEL 321
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 16/166 (9%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQML 527
++ + +G G G V A T A+K + F + ++ + RE+ ++ +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHM 81
Query: 528 DHPFLPTLFAHFT----TEKFSC--LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEV 581
H + L FT + F+ LVM + G DL L + + E +F V ++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQM 137
Query: 582 LLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627
L L Y+H G+++RDLKP N+ V ED + + DF L+ R A + M
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-RQADSEM 182
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 36/144 (25%), Positives = 54/144 (37%), Gaps = 39/144 (27%)
Query: 702 ARSNS-----FVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSG---- 751
AR +V T Y APE+I +VD W+ G + E++ G+T FKGS
Sbjct: 175 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234
Query: 752 -----------NDETLSNVVSQSLR-----FPGYPVVSFH---------ARDLIRGLLVK 786
E + + S + P F A +L+ +LV
Sbjct: 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 294
Query: 787 EPDNRLGAVKGAAEIKQHPFFEGL 810
+ + R+ A E HP+FE L
Sbjct: 295 DAEQRV----TAGEALAHPYFESL 314
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 37/160 (23%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQM 526
++ ++ K +G G G V A A+K + F + + + RE+ M+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKC 80
Query: 527 LDHPFLPTLF----AHFTTEKFSC--LVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVA 579
++H + L + E+F +VME +L V++ + + + +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME-----LDHERMSYLLY 134
Query: 580 EVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++L +++LH G+++RDLKP NI+V+ D + + DF L+
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 33/144 (22%), Positives = 50/144 (34%), Gaps = 44/144 (30%)
Query: 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG--------------- 751
+V T Y APE+I G G+ +VD W+ G + E++ G F G+
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245
Query: 752 NDETLSNVVSQSLRF----PGYPVVSFH---------------------ARDLIRGLLVK 786
E + + + P Y SF ARDL+ +LV
Sbjct: 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 787 EPDNRLGAVKGAAEIKQHPFFEGL 810
+ R+ E QHP+
Sbjct: 306 DASKRI----SVDEALQHPYINVW 325
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 41/156 (26%), Positives = 65/156 (41%), Gaps = 18/156 (11%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM------DNDFLVGRKKMPRAQTEREI 523
+++G G G V+L + + A+K + + DF+ E E+
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFI----------EEAEV 56
Query: 524 MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLL 583
M L HP L L+ + CLV E+ G L + Q F +E +V
Sbjct: 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM-CLDVCE 115
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ YL V++RDL N LV E+ I +SDF ++
Sbjct: 116 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 34/179 (18%), Positives = 69/179 (38%), Gaps = 37/179 (20%)
Query: 470 RHFKLHKKLGCGDIGTVYLAEL-----IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM 524
+K+ +G G G +YLA++ +G+ +KV TE +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE-------PSDNGPLFTELKFY 87
Query: 525 QML---------------DHPFLPTLFAH----FTTEKFSCLVMEYCPGGDLHVLRQKQP 565
Q + +P + + + ++M+ G DL + +
Sbjct: 88 QRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN- 145
Query: 566 SRFFSEQAARFYVAEVLL-ALEYLHMLGVVYRDLKPENILV--REDGHIMLSDFDLSLR 621
++ FS + ++ +L LEY+H V+ D+K N+L+ + + L D+ L+ R
Sbjct: 146 AKRFSRKTV-LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 32/162 (19%), Positives = 56/162 (34%), Gaps = 26/162 (16%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKV-----------MDN-DFLVGRKKMPRAQ 518
+ K LG G GTV+ I + V
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT---------- 63
Query: 519 TEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFY 577
+ LDH + L LV +Y P G L +RQ + + Q +
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNW 120
Query: 578 VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++ + YL G+V+R+L N+L++ + ++DF ++
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 38/157 (24%), Positives = 61/157 (38%), Gaps = 20/157 (12%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM------DNDFLVGRKKMPRAQTEREI 523
L K+LG G G V L + G + A+K++ +++F E +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEFF----------QEAQT 56
Query: 524 MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVL 582
M L HP L + + E +V EY G L + LR +V
Sbjct: 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVC 114
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ +L ++RDL N LV D + +SDF ++
Sbjct: 115 EGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 13/182 (7%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM---QM 526
R ++L KKLG G G V+ + T + A+K + + F + +T REIM ++
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF---QNSTDAQRTFREIMILTEL 65
Query: 527 LDHPFLPTLFAHFTTEKFSC--LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLA 584
H + L + LV +Y DLH + + ++ V +++
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANI---LEPVHKQYVVYQLIKV 121
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKAS 644
++YLH G+++RD+KP NIL+ + H+ ++DF LS R VN V ++ P+ +
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLS-RSFVNIRRVTNNIPLSINENTENF 180
Query: 645 SP 646
Sbjct: 181 DD 182
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 31/149 (20%), Positives = 49/149 (32%), Gaps = 50/149 (33%)
Query: 708 VGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSG--------------- 751
V T Y APEI+ G + +D W+ G L E+L G+ F GS
Sbjct: 191 VATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFP 250
Query: 752 NDETLSNVVSQSLR-----FPGYPVVSFH-------------------------ARDLIR 781
++E + ++ S + + A DL+
Sbjct: 251 SNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD 310
Query: 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810
LL P+ R+ A + +HPF
Sbjct: 311 KLLQFNPNKRI----SANDALKHPFVSIF 335
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 20/156 (12%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM------DNDFLVGRKKMPRAQTEREIM 524
KL KKLG G G V++A + + A+K M FL E +M
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFL----------AEANVM 237
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLL 583
+ L H L L A T E ++ E+ G L L+ + S+ + F A++
Sbjct: 238 KTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-SAQIAE 295
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ ++ ++RDL+ NILV ++DF L+
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 44/161 (27%), Positives = 61/161 (37%), Gaps = 22/161 (13%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLF---ALKVM--------DNDFLVGRKKMPRAQ 518
+ K +G GD G V L A+K + DFL
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL---------- 98
Query: 519 TEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYV 578
+E IM DHP + L T + + +V EY G L + +F Q +
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM-L 157
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
V + YL LG V+RDL N+LV + +SDF LS
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 39/161 (24%), Positives = 62/161 (38%), Gaps = 25/161 (15%)
Query: 471 HFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVM--------DNDFLVGRKKMPRAQT 519
+L + +G G G V+ + + A+K FL
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----------Q 65
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYV 578
E M+ DHP + L T ++ME C G+L L+ ++ S + Y
Sbjct: 66 EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS--LDLASLILYA 122
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++ AL YL V+RD+ N+LV + + L DF LS
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-14
Identities = 42/156 (26%), Positives = 66/156 (42%), Gaps = 20/156 (12%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM------DNDFLVGRKKMPRAQTEREIM 524
+L KLG G G V++ GT A+K + FL E ++M
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----------QEAQVM 233
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLL 583
+ L H L L+A + E +V EY G L L+ + Q A++
Sbjct: 234 KKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIAS 291
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ Y+ + V+RDL+ NILV E+ ++DF L+
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 38/162 (23%), Positives = 62/162 (38%), Gaps = 26/162 (16%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKV---------MDN---DFLVGRKKMPRAQ 518
FK K LG G GTVY I + V + L
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL---------- 65
Query: 519 TEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFY 577
E +M +D+P + L T L+ + P G L +R+ + + Q +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDN--IGSQYLLNW 122
Query: 578 VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++ + YL +V+RDL N+LV+ H+ ++DF L+
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 35/168 (20%), Positives = 66/168 (39%), Gaps = 31/168 (18%)
Query: 473 KLHKKLGCGDIGTVYLAELIGT-----SCLFALKVM--------DNDFLVGRKKMPRAQT 519
+ ++LG G G VY G A+K + +FL
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL----------N 77
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYV 578
E +M+ + + L + + + ++ME GDL LR +P+ + A +
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 579 AEVLL-------ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++++ + YL+ V+RDL N +V ED + + DF ++
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 26/158 (16%)
Query: 474 LHKKLGCGDIGTVYLAELIGTSCLF--ALKVM---------DNDFLVGRKKMPRAQTERE 522
K+LG G+ GTV + A+K++ ++ L E
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL----------AEAN 70
Query: 523 IMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYVAEV 581
+MQ LD+P++ + E + LVME G L+ L+Q +R ++ V +V
Sbjct: 71 VMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQV 126
Query: 582 LLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ ++YL V+RDL N+L+ + +SDF LS
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 8e-14
Identities = 39/161 (24%), Positives = 62/161 (38%), Gaps = 25/161 (15%)
Query: 471 HFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVM--------DNDFLVGRKKMPRAQT 519
+L + +G G G V+ + + A+K FL
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----------Q 440
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYV 578
E M+ DHP + L T ++ME C G+L L+ ++ S + Y
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFS--LDLASLILYA 497
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++ AL YL V+RD+ N+LV + + L DF LS
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 44/164 (26%), Positives = 69/164 (42%), Gaps = 18/164 (10%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP-----RAQ-TEREI 523
+ + + + G G V + A+K + N GR + REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 524 --MQMLDHP---FLPTLFAHFTTEKFSC--LVMEYCPGGDLH-VLRQKQPSRFFSEQAAR 575
+ HP L +F HF LV E DL V+ ++ S Q +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIV--ISPQHIQ 137
Query: 576 FYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+++ +LL L LH GVV+RDL P NIL+ ++ I + DF+L+
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 32/147 (21%), Positives = 50/147 (34%), Gaps = 42/147 (28%)
Query: 702 ARSNS-------FVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSG-- 751
AR ++ +V Y APE++ VD W+ G + E+ + F+GS
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240
Query: 752 -------------NDETLSNVVSQSLR------FPGYPVVSFH---------ARDLIRGL 783
E + S S R P ++ A DLI +
Sbjct: 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKM 300
Query: 784 LVKEPDNRLGAVKGAAEIKQHPFFEGL 810
L P R+ + +HP+FE L
Sbjct: 301 LEFNPQRRI----STEQALRHPYFESL 323
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 48/189 (25%), Positives = 74/189 (39%), Gaps = 49/189 (25%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
+ + L K LG G G V I + FALK + D E +IM++LD
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-------RYKNRELDIMKVLD 58
Query: 529 HPFLPTLFAHFTT--------------------------------------EKFSCLVME 550
H + L +F T K+ ++ME
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 551 YCPGGDLH-VLRQKQPSR-FFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV-RE 607
Y P LH VL+ S Y+ ++ A+ ++H LG+ +RD+KP+N+LV +
Sbjct: 119 YVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177
Query: 608 DGHIMLSDF 616
D + L DF
Sbjct: 178 DNTLKLCDF 186
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 32/133 (24%), Positives = 50/133 (37%), Gaps = 32/133 (24%)
Query: 706 SFVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSG------------- 751
+++ + Y APE++ G S+D W+ G EL+ G+ F G
Sbjct: 200 AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMG 259
Query: 752 --NDETLSNVVSQ--SLRFPGYPVVSFH----------ARDLIRGLLVKEPDNRLGAVKG 797
E + + +RFP + A DL+ +L EPD R+
Sbjct: 260 TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI----N 315
Query: 798 AAEIKQHPFFEGL 810
E HPFF+ L
Sbjct: 316 PYEAMAHPFFDHL 328
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 37/174 (21%), Positives = 62/174 (35%), Gaps = 37/174 (21%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSC-----LFALKV-----MD---NDFLVGRKKMPRAQT 519
+ ++LG G VY L G + A+K +F
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR----------H 61
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYV 578
E + L HP + L T ++ ++ YC GDLH L + P V
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 579 AEVLLALEYLHML-----GVVY--------RDLKPENILVREDGHIMLSDFDLS 619
L +++H++ G+ Y +DL N+LV + ++ +SD L
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 43/160 (26%), Positives = 63/160 (39%), Gaps = 22/160 (13%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLF---ALKVM--------DNDFLVGRKKMPRAQT 519
+ + K +G G+ G V L S A+K + DFL
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL----------G 95
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVA 579
E IM DHP + L T K +V EY G L +K ++F Q +
Sbjct: 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM-LR 154
Query: 580 EVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ ++YL +G V+RDL NIL+ + +SDF L
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM------DNDFLVGRKKMPRAQTEREI 523
+ K+LG G G V + G + A+K++ +++F+ E ++
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFI----------EEAKV 72
Query: 524 MQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVL 582
M L H L L+ T ++ ++ EY G L + LR+ + RF ++Q +V
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEM-CKDVC 130
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
A+EYL ++RDL N LV + G + +SDF LS
Sbjct: 131 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 19/166 (11%)
Query: 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALK--VMDNDFLVGRKKMPRAQTERE 522
C + ++ K+G G G V+ A T ALK +M+N+ ++ P RE
Sbjct: 12 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE----KEGFP-ITALRE 66
Query: 523 I--MQMLDHPFLPTLFAHFTTEKFSC--------LVMEYCPGGDLHVLRQKQPSRFFSEQ 572
I +Q+L H + L T+ LV ++C DL L F+
Sbjct: 67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGL-LSNVLVKFTLS 124
Query: 573 AARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618
+ + +L L Y+H +++RD+K N+L+ DG + L+DF L
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 29/134 (21%), Positives = 44/134 (32%), Gaps = 40/134 (29%)
Query: 710 THE-----YLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSG------------ 751
T+ Y PE++ GE G +D W G + E+ +G+
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245
Query: 752 ---NDETLSNVVS----QSLRFPGYP-----------VVSFHARDLIRGLLVKEPDNRLG 793
E NV + + L V +A DLI LLV +P R+
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI- 304
Query: 794 AVKGAAEIKQHPFF 807
+ + H FF
Sbjct: 305 ---DSDDALNHDFF 315
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 43/161 (26%), Positives = 62/161 (38%), Gaps = 25/161 (15%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLF---ALKVM--------DNDFLVGRKKMPRAQT 519
L++ LG G G VY A+K F+ +
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM----------S 62
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYV 578
E IM+ LDHP + L E ++ME P G+L H L + + S Y
Sbjct: 63 EAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNS--LKVLTLVLYS 119
Query: 579 AEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++ A+ YL + V+RD+ NILV + L DF LS
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 36/157 (22%), Positives = 64/157 (40%), Gaps = 15/157 (9%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQML 527
+ +G G G V A A+K + F + +T REI +
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-F---EHQTYCQRTLREIKILLRF 82
Query: 528 DHP---FLPTLFAHFTTEKFSC--LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVL 582
H + + T E+ +V + DL+ L + Q S +++ ++L
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQIL 138
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L+Y+H V++RDLKP N+L+ + + DF L+
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 31/133 (23%), Positives = 47/133 (35%), Gaps = 34/133 (25%)
Query: 708 VGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSG--------------- 751
V T Y APEI+ S+D W+ G L E+L R F G
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 752 NDETLSNVVSQSLR-----FPGYPVVSFH---------ARDLIRGLLVKEPDNRLGAVKG 797
+ E L+ +++ R P V ++ A DL+ +L P R+
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI----E 307
Query: 798 AAEIKQHPFFEGL 810
+ HP+ E
Sbjct: 308 VEQALAHPYLEQY 320
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 40/153 (26%), Positives = 62/153 (40%), Gaps = 22/153 (14%)
Query: 477 KLGCGDIGTVYLAELIGTSCLF--ALKVM--------DNDFLVGRKKMPRAQTEREIMQM 526
+LGCG+ G+V A+KV+ + + E +IM
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM----------REAQIMHQ 66
Query: 527 LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
LD+P++ L E LVME GG LH + A + +V + ++
Sbjct: 67 LDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAEL-LHQVSMGMK 124
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
YL V+RDL N+L+ + +SDF LS
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 42/173 (24%), Positives = 60/173 (34%), Gaps = 36/173 (20%)
Query: 473 KLHKKLGCGDIGTVYLAELIGT-----SCLFALKVM-------DNDFLVGRKKMPRAQTE 520
L ++LG G G V+LAE L A+K + DF E
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ----------RE 67
Query: 521 REIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVA 579
E++ L H + + +V EY GDL+ LR P
Sbjct: 68 AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 580 EVLLALEYLHML-----GVVY--------RDLKPENILVREDGHIMLSDFDLS 619
L + LH+ G+VY RDL N LV + + + DF +S
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 4e-13
Identities = 40/147 (27%), Positives = 61/147 (41%), Gaps = 8/147 (5%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLF--ALKVMDNDFLVGRKKMPRA-QTEREIMQMLDHPFL 532
+LGCG+ G+V A+KV+ K E +IM LD+P++
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYI 398
Query: 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG 592
L E LVME GG LH + A + +V + ++YL
Sbjct: 399 VRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAEL-LHQVSMGMKYLEEKN 456
Query: 593 VVYRDLKPENILVREDGHIMLSDFDLS 619
V+R+L N+L+ + +SDF LS
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 42/156 (26%), Positives = 68/156 (43%), Gaps = 20/156 (12%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM------DNDFLVGRKKMPRAQTEREIM 524
+L KLG G G V++ GT+ + A+K + FL E ++M
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFL----------QEAQVM 316
Query: 525 QMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLL 583
+ L H L L+A + E +V EY G L L+ + Q A++
Sbjct: 317 KKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIAS 374
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ Y+ + V+RDL+ NILV E+ ++DF L+
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 45/182 (24%), Positives = 73/182 (40%), Gaps = 28/182 (15%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALK---VMDNDFLVGRKKMPRAQTEREI--M 524
F+L LG G G V A T + A+K D R T REI +
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR-------TLREIKIL 63
Query: 525 QMLDHP--------FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARF 576
+ H P F +F E + ++ E DLH + Q S+ ++
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFN-EVY--IIQELM-QTDLHRVISTQM---LSDDHIQY 116
Query: 577 YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVE 636
++ + L A++ LH V++RDLKP N+L+ + + + DF L+ R S +
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA-RIIDESAADNSEPTGQ 175
Query: 637 EP 638
+
Sbjct: 176 QS 177
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 40/159 (25%), Positives = 57/159 (35%), Gaps = 37/159 (23%)
Query: 685 LAAQVSPMPQLVVEPTGARSN--SFVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELL 741
LA + EPTG +S FV T Y APE++ ++D W+ G L EL
Sbjct: 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217
Query: 742 YGRTPFKGS----------------GNDETLSNVVSQSLR-----FPGYPVVSFH----- 775
R F G +D L + S R P YP
Sbjct: 218 LRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR 277
Query: 776 ----ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810
DL++ +LV +P R+ A E +HP+ +
Sbjct: 278 VNPKGIDLLQRMLVFDPAKRI----TAKEALEHPYLQTY 312
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 17/155 (10%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPR-AQTEREIMQML--- 527
+++ K +G G G V A ALK++ N K+ R A E I++ L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQ 153
Query: 528 ----DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLL 583
+ + +FT C+ E +L+ L +K + FS R + +L
Sbjct: 154 DKDNTMNVI-HMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGH--IMLSDF 616
L+ LH +++ DLKPENIL+++ G I + DF
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 17/45 (37%), Positives = 23/45 (51%)
Query: 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS 757
Y APE+I G +G +D W+ G L ELL G G + L+
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA 309
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 41/168 (24%), Positives = 73/168 (43%), Gaps = 29/168 (17%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPR-AQTEREIMQML--- 527
+ L +KLG G TV+LA+ + + A+K++ D K A+ E +++Q +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDA 75
Query: 528 -----DHPFLP---TLFAHFTTEKFS----CLVMEYCPGGDLHVLRQKQPSRFFSEQAAR 575
D L HF + + +V E G +L L +K R +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134
Query: 576 FYVAEVLLALEYLH-MLGVVYRDLKPENILVRE------DGHIMLSDF 616
++LL L+Y+H G+++ D+KPEN+L+ I ++D
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 25/152 (16%), Positives = 48/152 (31%), Gaps = 54/152 (35%)
Query: 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKG------SGNDE----- 754
+ + T EY +PE++ G G D W+ +FEL+ G F+ + +D+
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 755 -------------------------------------TLSNVVSQSLRFPGYPVVSFHAR 777
L +V+++ +F
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS-- 311
Query: 778 DLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809
D + +L +P R A + HP+ +
Sbjct: 312 DFLSPMLQLDPRKRA----DAGGLVNHPWLKD 339
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 43/172 (25%), Positives = 62/172 (36%), Gaps = 35/172 (20%)
Query: 473 KLHKKLGCGDIGTVYLAELI--GTSCLFALKVM--------DNDFLVGRKKMPRAQTERE 522
K +G G+ G V A + G A+K M DF E E
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA----------GELE 77
Query: 523 IMQML-DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAE 580
++ L HP + L + L +EY P G+L LR+ + A A
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 581 VLLALEYLHML-------------GVVYRDLKPENILVREDGHIMLSDFDLS 619
L + + LH ++RDL NILV E+ ++DF LS
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 44/172 (25%), Positives = 62/172 (36%), Gaps = 35/172 (20%)
Query: 473 KLHKKLGCGDIGTVYLAELIGT-----SCLFALKVM-------DNDFLVGRKKMPRAQTE 520
L +LG G G V+LAE L A+K + DF E
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ----------RE 93
Query: 521 REIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARF--- 576
E++ ML H + F T + +V EY GDL+ LR P
Sbjct: 94 AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153
Query: 577 ---------YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
++V + YL L V+RDL N LV + + + DF +S
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 37/160 (23%), Positives = 67/160 (41%), Gaps = 25/160 (15%)
Query: 473 KLHKKLGCGDIGTVYLAELI---GTSCLFALKVMD--------NDFLVGRKKMPRAQTER 521
++ +G G G VY L+ G A+K ++ + FL TE
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL----------TEG 77
Query: 522 EIMQMLDHPFLPTLFAHFTTEKFS-CLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVA 579
IM+ HP + +L + S +V+ Y GDL +R + + + + +
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGL 135
Query: 580 EVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+V ++YL V+RDL N ++ E + ++DF L+
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 26/166 (15%), Positives = 53/166 (31%), Gaps = 21/166 (12%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLF-------ALKVMDNDFLVGRKKMPRAQTERE 522
++ LG G ++ LKV+D +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF---FEAAS 64
Query: 523 IMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYVAEV 581
+M L H L + + LV E+ G L L++ + + ++
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAKQL 122
Query: 582 LLALEYLHMLGVVYRDLKPENILVREDGHIM--------LSDFDLS 619
A+ +L +++ ++ +NIL+ + LSD +S
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 39/182 (21%), Positives = 68/182 (37%), Gaps = 45/182 (24%)
Query: 473 KLHKKLGCGDIGTVYLAELIG-----TSCLFALKVM--------DNDFLVGRKKMPRAQT 519
L K LG G+ G V A A+K++ D L +
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL----------S 75
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARF-- 576
E +++ ++HP + L+ + + L++EY G L LR+ + +
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 577 -------------------YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFD 617
+ ++ ++YL + +V+RDL NILV E + +SDF
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 618 LS 619
LS
Sbjct: 196 LS 197
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 39/173 (22%), Positives = 61/173 (35%), Gaps = 32/173 (18%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE---------I 523
K LG G G V A G L D V K + + E +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYG------LIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 524 MQML-DHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYV--- 578
+ L +H + L T + ++ EYC GDL + LR+K+ S S+ +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 579 ------------AEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+V + +L ++RDL NIL+ + DF L+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 55/261 (21%), Positives = 99/261 (37%), Gaps = 54/261 (20%)
Query: 392 NRNKAIVTKVDERSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGSSR---GGSRPHM 448
+++ V K+ +R R + S S SS+ + I+ + + G S +
Sbjct: 11 SQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYEL 70
Query: 449 SNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIG-------TSCLFALK 501
D +W+ R L K LG G G V +AE +G + A+K
Sbjct: 71 PEDPKWEFPR-----------DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK 119
Query: 502 VM--------DNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCLVMEYC 552
++ +D + +E E+M+M+ H + L T + +++EY
Sbjct: 120 MLKDDATEKDLSDLV----------SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 169
Query: 553 PGGDLH-VLRQKQPSRFFSEQAARFYVAEVLL-------------ALEYLHMLGVVYRDL 598
G+L LR ++P E + +EYL ++RDL
Sbjct: 170 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 229
Query: 599 KPENILVREDGHIMLSDFDLS 619
N+LV E+ + ++DF L+
Sbjct: 230 AARNVLVTENNVMKIADFGLA 250
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 47/242 (19%), Positives = 87/242 (35%), Gaps = 30/242 (12%)
Query: 391 GNRNKAIVTKVDERSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHMSN 450
G R ++ + S + S Y + S E+ G++ N
Sbjct: 15 GRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGS--ENLYFQGANTVHIDLSALN 72
Query: 451 DLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVM---- 503
A++ V ++ +G G G VY L+ G A+K +
Sbjct: 73 PELVQAVQHVVIGPS---SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 129
Query: 504 ----DNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS-CLVMEYCPGGDLH 558
+ FL TE IM+ HP + +L + S +V+ Y GDL
Sbjct: 130 DIGEVSQFL----------TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 559 -VLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFD 617
+R + + + + + +V +++L V+RDL N ++ E + ++DF
Sbjct: 180 NFIRNETHN--PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 237
Query: 618 LS 619
L+
Sbjct: 238 LA 239
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 39/177 (22%), Positives = 62/177 (35%), Gaps = 48/177 (27%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLF---ALKVM---------DNDFLVGRKKMPRAQTE 520
L + LG G+ G+V A+L F A+K++ +FL E
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL----------RE 75
Query: 521 REIMQMLDHPFLPTLFA------HFTTEKFSCLVMEYCPGGDLH-VLRQKQPSR------ 567
M+ DHP + L +++ + GDLH L +
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 568 -----FFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
F A +EYL ++RDL N ++ ED + ++DF LS
Sbjct: 136 LQTLVRFMVDIAC--------GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 17/157 (10%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPR-AQTEREIMQML-- 527
+++ +G G G V A A+K++ N +K AQ E +++++
Sbjct: 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQAQIEVRLLELMNK 109
Query: 528 ----DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLL 583
++ L HF CLV E +L+ L + R S R + ++
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 584 ALEYLHM--LGVVYRDLKPENILVREDGH--IMLSDF 616
AL +L L +++ DLKPENIL+ I + DF
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 12/45 (26%), Positives = 24/45 (53%)
Query: 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS 757
Y +PE++ G + ++D W+ G L E+ G F G+ + ++
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 268
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 41/177 (23%), Positives = 71/177 (40%), Gaps = 40/177 (22%)
Query: 473 KLHKKLGCGDIGTVYLAELIG-------TSCLFALKVM--------DNDFLVGRKKMPRA 517
L K LG G G V +AE +G + A+K++ +D +
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV--------- 88
Query: 518 QTEREIMQML-DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAAR 575
+E E+M+M+ H + L T + +++EY G+L LR ++P
Sbjct: 89 -SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 576 FYVAEVLL-------------ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
E + +EYL ++RDL N+LV E+ + ++DF L+
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 44/169 (26%), Positives = 72/169 (42%), Gaps = 30/169 (17%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALK--VMDNDFLVGRKKMPRAQTEREI--MQ 525
+ K LGCG G V+ A A+K V+ + V REI ++
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH-------ALREIKIIR 63
Query: 526 MLDHP--------FLP----TLFAHFTTEKFS--CLVMEYCPGGDLHVLRQKQPSRFFSE 571
LDH P + + + +V EY DL + ++ P E
Sbjct: 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGP---LLE 119
Query: 572 QAARFYVAEVLLALEYLHMLGVVYRDLKPENILV-REDGHIMLSDFDLS 619
+ AR ++ ++L L+Y+H V++RDLKP N+ + ED + + DF L+
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 25/132 (18%), Positives = 44/132 (33%), Gaps = 33/132 (25%)
Query: 708 VGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSG--------------- 751
+ T Y +P ++ + ++D W G E+L G+T F G+
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 752 NDETLSNVVSQSLRF----PGYPVVSFH---------ARDLIRGLLVKEPDNRLGAVKGA 798
++E ++S + P A D + +L P +RL A
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL----TA 300
Query: 799 AEIKQHPFFEGL 810
E HP+
Sbjct: 301 EEALSHPYMSIY 312
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 40/162 (24%), Positives = 66/162 (40%), Gaps = 23/162 (14%)
Query: 473 KLHKKLGCGDIGTVYLA--ELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
K+G G G VY A + +ALK ++ G A E +++ L HP
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GIS--MSACREIALLRELKHP 78
Query: 531 FLPTL---FAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEV------ 581
+ +L F K L+ +Y DL + + + +++ + V
Sbjct: 79 NVISLQKVFLSHADRKVW-LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 582 -LLALEYLHMLGVVYRDLKPENILVRED----GHIMLSDFDL 618
L + YLH V++RDLKP NILV + G + ++D
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 41/182 (22%), Positives = 62/182 (34%), Gaps = 45/182 (24%)
Query: 473 KLHKKLGCGDIGTVYLAELIG-----TSCLFALKVM--------DNDFLVGRKKMPRAQT 519
+ + +G G G V+ A G + A+K++ DF
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ----------R 99
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYV 578
E +M D+P + L K CL+ EY GDL+ LR P S +
Sbjct: 100 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 579 AEVLLAL---------------------EYLHMLGVVYRDLKPENILVREDGHIMLSDFD 617
+ + YL V+RDL N LV E+ + ++DF
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 618 LS 619
LS
Sbjct: 220 LS 221
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 39/176 (22%), Positives = 65/176 (36%), Gaps = 39/176 (22%)
Query: 473 KLHKKLGCGDIGTVYLAELIG-----TSCLFALKVM--------DNDFLVGRKKMPRAQT 519
KL K LG G G V A+ G T A+K++ + +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM----------S 79
Query: 520 EREIMQMLD-HPFLPTLFAHFTTEKFS-CLVMEYCPGGDLH-VLRQKQPSRFFSEQAARF 576
E +I+ + H + L T +++E+C G+L LR K+ + A
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 577 YVAEVL-------------LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ L +E+L ++RDL NIL+ E + + DF L+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 38/168 (22%), Positives = 64/168 (38%), Gaps = 31/168 (18%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLF---ALKVM---------DNDFLVGRKKMPRAQTE 520
L K LG G+ G+V L A+K M +FL +E
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL----------SE 86
Query: 521 REIMQMLDHPFLPTLFA-----HFTTEKFSCLVMEYCPGGDLH-VLRQKQP---SRFFSE 571
M+ HP + L +++ + GDLH L + +
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 572 QAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
Q ++ ++ L +EYL ++RDL N ++R+D + ++DF LS
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 40/168 (23%), Positives = 61/168 (36%), Gaps = 41/168 (24%)
Query: 473 KLHKKLGCGDIGTVYLAELIG-----TSCLFALKVM--------DNDFLVGRKKMPRAQT 519
+ +G G G VY E I C A+K + FL
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQC--AIKSLSRITEMQQVEAFL----------R 71
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCL-VMEYCPGGDLH-VLRQKQPSR------FFSE 571
E +M+ L+HP + L + ++ Y GDL +R Q + F
Sbjct: 72 EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 572 QAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
Q AR +EYL V+RDL N ++ E + ++DF L+
Sbjct: 132 QVAR--------GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 42/171 (24%), Positives = 67/171 (39%), Gaps = 28/171 (16%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE---------I 523
L K LG G G V LAE IG + V K + TE++ +
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIG----LDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 127
Query: 524 MQML-DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHV-LRQKQPSRFFSEQAARF----- 576
M+M+ H + L T + +++EY G+L L+ ++P
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 577 --------YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+V +EYL ++RDL N+LV ED + ++DF L+
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 41/170 (24%), Positives = 72/170 (42%), Gaps = 14/170 (8%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPR-AQTEREIMQML--- 527
F + +K+G G G V L + I +A+KV+ N KK R A+ E +I++ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQND 91
Query: 528 ---DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLA 584
++ + F CL+ E G L+ + + F + + Y E+L A
Sbjct: 92 DINNNNIV-KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634
L YL + + + DLKPENIL+ + + + ++ S
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 36/173 (20%), Positives = 60/173 (34%), Gaps = 36/173 (20%)
Query: 473 KLHKKLGCGDIGTVYLAELIG-----TSCLFALKVM--------DNDFLVGRKKMPRAQT 519
+ K LG G G V A G A+K++ + +
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM----------S 98
Query: 520 EREIMQMLD-HPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARF- 576
E +IM L H + L T ++ EYC GDL + LR+K A
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 577 ----------YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ ++V + +L ++RD+ N+L+ + DF L+
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 39/178 (21%), Positives = 53/178 (29%), Gaps = 37/178 (20%)
Query: 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE---------I 523
+ K LG G G V A G + V K + E +
Sbjct: 48 EFGKVLGSGAFGKVMNATAYG------ISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 524 MQML-DHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEV 581
M L H + L T L+ EYC GDL + LR K+ E
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 582 LLAL--------------------EYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
E+L V+RDL N+LV + + DF L+
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 33/168 (19%), Positives = 59/168 (35%), Gaps = 31/168 (18%)
Query: 473 KLHKKLGCGDIGTVYLAELIG-----TSCLFALKVM--------DNDFLVGRKKMPRAQT 519
L + LG G G VY ++ G + A+K + + DFL
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----------M 123
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQP----SRFFSEQAA 574
E I+ +H + +++E GGDL LR+ +P +
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 575 RFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML---SDFDLS 619
++ +YL ++RD+ N L+ G + DF ++
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 34/168 (20%), Positives = 59/168 (35%), Gaps = 31/168 (18%)
Query: 473 KLHKKLGCGDIGTVYLAELIG-----TSCLFALKVM--------DNDFLVGRKKMPRAQT 519
L + LG G G VY ++ G + A+K + + DFL
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----------M 82
Query: 520 EREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPS----RFFSEQAA 574
E I+ +H + ++ME GGDL LR+ +P +
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 575 RFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML---SDFDLS 619
++ +YL ++RD+ N L+ G + DF ++
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 45/159 (28%), Positives = 66/159 (41%), Gaps = 24/159 (15%)
Query: 472 FKLHKKLGCGDIGTVYLAELI-GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
F +G G G VY L G ALK + G ++ +TE E + HP
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLRDGA--KVALKRRTPESSQGIEEF---ETEIETLSFCRHP 95
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL--HVLRQKQPSRFFS-EQ-------AARFYVAE 580
L +L L+ +Y G+L H+ P+ S EQ AAR
Sbjct: 96 HLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR----- 150
Query: 581 VLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L YLH +++RD+K NIL+ E+ ++DF +S
Sbjct: 151 ---GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 30/153 (19%), Positives = 55/153 (35%), Gaps = 16/153 (10%)
Query: 472 FKLHKKLGCGDIGTVYLA-ELIGTSCLFALKVMDNDFLVGRKKMPR-AQTEREIMQML-- 527
+++ LG G G V + ALK++ N K A+ E +++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKE 75
Query: 528 -----DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVL 582
+ + F C+ E G + ++ + + R ++
Sbjct: 76 KDKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSD 615
AL +LH + + DLKPENIL L +
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYN 166
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 35/164 (21%), Positives = 47/164 (28%), Gaps = 55/164 (33%)
Query: 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL---------------- 756
Y PE+I G D W+ G LFE G T F+ N E L
Sbjct: 205 YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIH 264
Query: 757 ------------------------SNVVSQSLR--FPGYPVVSFHARDLIRGLLVKEPDN 790
+ L+ + DL+R +L +P
Sbjct: 265 RTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324
Query: 791 RLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCDAVIGSQ 834
R+ AE HPFF GL PE + S+
Sbjct: 325 RI----TLAEALLHPFFAGL---------TPEERSFHTSRNPSR 355
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.4 bits (140), Expect = 3e-09
Identities = 38/212 (17%), Positives = 68/212 (32%), Gaps = 56/212 (26%)
Query: 458 RCVQKQ----HGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKV--MDNDFLVGR 511
C QK C+ + +K+G G G V+ T A+K+ ++ LV
Sbjct: 4 ECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNG 61
Query: 512 KKMPRAQT---EREIMQMLDH--------------------------PFLPTLFAHFTTE 542
+ E I + L P L + H+ +
Sbjct: 62 SHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121
Query: 543 KFSC-------------LVMEYCPGG-DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
K S +V+E+ GG DL + ++ S A+ + ++ +L
Sbjct: 122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLE----QMRTKLSSLATAKSILHQLTASLAVA 177
Query: 589 H-MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L +RDL N+L+++ L
Sbjct: 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNG 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 61/321 (19%), Positives = 104/321 (32%), Gaps = 57/321 (17%)
Query: 472 FKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
KL K LG G G V A+ G T A+K++ + +E +I+
Sbjct: 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIH 81
Query: 527 LD-HPFLPTLFAHFTTEKFS-CLVMEYCPGGDLHV-LRQKQPSRFFSEQAARFYVAEVLL 583
+ H + L T +++E+C G+L LR K+ Y +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE-------FVPYKTKGAR 134
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKA 643
+ +G + DLK + S F + ++ +
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194
Query: 644 SSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703
+ S+QV+ L A + I DLAA+ L+ E +
Sbjct: 195 -------------LICYSFQVAKGMEFL----ASRKCIHRDLAAR----NILLSEKNVVK 233
Query: 704 SNSF-----VGTHEY-------------LAPEIIKGEGHGSSVDWWTFGIFLFELL-YGR 744
F + +APE I + D W+FG+ L+E+ G
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293
Query: 745 TPFKGSGNDETLSNVVSQSLR 765
+P+ G DE + + R
Sbjct: 294 SPYPGVKIDEEFCRRLKEGTR 314
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 8e-09
Identities = 47/154 (30%), Positives = 68/154 (44%), Gaps = 12/154 (7%)
Query: 472 FKLHKKLGCGDIGTVYLAELI-GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
F LG G G VY L GT L A+K + + G + QTE E++ M H
Sbjct: 32 FSNKNILGRGGFGKVYKGRLADGT--LVAVKRLKEERTQGGELQ--FQTEVEMISMAVHR 87
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLA--LEY 587
L L T LV Y G + LR++ S+ + R +A + A L Y
Sbjct: 88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA-LGSARGLAY 146
Query: 588 LH---MLGVVYRDLKPENILVREDGHIMLSDFDL 618
LH +++RD+K NIL+ E+ ++ DF L
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 28/153 (18%), Positives = 58/153 (37%), Gaps = 16/153 (10%)
Query: 472 FKLHKKLGCGDIGTVYLA-ELIGTSCLFALKVMDNDFLVGRKKMPR-AQTEREIMQML-- 527
+++ LG G G V + A+K++ N + A++E ++++ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEAARSEIQVLEHLNT 70
Query: 528 -----DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVL 582
+ + F C+V E G + ++ F R ++
Sbjct: 71 TDPNSTFRCV-QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSD 615
++ +LH + + DLKPENIL + + +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 6e-05
Identities = 29/140 (20%), Positives = 42/140 (30%), Gaps = 46/140 (32%)
Query: 713 YLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS--------------- 757
Y APE+I G D W+ G L E G T F + E L+
Sbjct: 200 YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259
Query: 758 ------NVVSQSLRFPGYPVVSFHAR---------------------DLIRGLLVKEPDN 790
L + + + DLI+ +L +P
Sbjct: 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319
Query: 791 RLGAVKGAAEIKQHPFFEGL 810
R+ E +HPFF+ L
Sbjct: 320 RI----TLREALKHPFFDLL 335
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 2e-08
Identities = 49/374 (13%), Positives = 102/374 (27%), Gaps = 107/374 (28%)
Query: 2 DGPSSTCEIVESIEELEFASKRNEKAKKHSLPKSGNKYSIEDDIN--RLFEAIDVK---- 55
+ I I ++ +R K+K + + ++ + + A ++
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPY--ENC---LLVLLNVQNAKAWNAFNLSCKIL 269
Query: 56 --TSAKNL-DALRKSALKRPIRVSS-------------SQALGIGISE-PVNLKQALRG- 97
T K + D L + + L + P ++ L
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP---REVLTTN 326
Query: 98 -LCISQAAEM-------------AAMKRLSKPSGSSRSS-EAGTIKRLYRAVVVEANESG 142
+S AE +L+ SS + E ++++ + V +
Sbjct: 327 PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH 386
Query: 143 IPL-------NEGKGNLVEI--------SLVPENITSNSSEKVHESQQVPRAESSRHAAH 187
IP + + V + SLV + ++ + + + A
Sbjct: 387 IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS-IPSIYLELKVKLENEYAL 445
Query: 188 HSPPLDIVTKPKAIPSK---LPSLD--------------QVVPLVTEFEE--------KP 222
H +D PK S P LD + +T F +
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQ 505
Query: 223 KAEHHNLNSPESSSVP-------------------FTREVEEVEIIAPSSVEVLVNSPVS 263
K H + S S+ + R V + P E L+ S +
Sbjct: 506 KIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYT 565
Query: 264 DKGQKSKLHPGSSL 277
D + + + ++
Sbjct: 566 DLLRIALMAEDEAI 579
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 3e-05
Identities = 88/624 (14%), Positives = 169/624 (27%), Gaps = 207/624 (33%)
Query: 25 EKAKKHSLPKSGNKYSIEDDINRLFEAIDVKTSAKNLDALRKSALKRPIRVSSSQALGIG 84
K S + +RL+ V K + R
Sbjct: 96 SPIKTEQRQPSMMTRMYIEQRDRLYNDNQV---------FAKYNVSRL------------ 134
Query: 85 ISEPV-NLKQALRGLCISQAAEMAAMKRLSKPSGSSRSSEAGTIKRLYRAVVVEANESGI 143
+P L+QAL L ++ + + GS ++ A + Y+ V + I
Sbjct: 135 --QPYLKLRQALLELRPAKNVLIDGVL------GSGKTWVALDVCLSYK--VQCKMDFKI 184
Query: 144 P-LNEGKGNLVEISLVPEN-----ITSNSSEKVHESQQVP------RAESSRHAAHHSPP 191
LN N E L I N + + S + +AE R
Sbjct: 185 FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 192 -----LDIVTKPKAIPSKLPSLD---QVVPLVT-------EFEEKPKAEHHNLNSPESSS 236
L V KA + + ++ L+T +F H +L + S
Sbjct: 245 NCLLVLLNVQNAKAWNA----FNLSCKI--LLTTRFKQVTDFLSAATTTHISL---DHHS 295
Query: 237 VPFTREVEEVEIIAPSSVEVLVNSPVSD-KGQKSKLHPGSSLSSSSNGSRLTKCGSNSQR 295
+ T + E ++ + L + D + +P S + + G
Sbjct: 296 MTLTPD-EVKSLLL----KYL-DCRPQDLPREVLTTNP---RRLSIIAESI-RDGLA--- 342
Query: 296 LVKPVFRSKGFVRRKVKQDS-TSASSSC----TPCDVSASNDPGPSTSYLDVHMHNCTVN 350
+ + V D T+ S P + + +V
Sbjct: 343 ------TWDNW--KHVNCDKLTTIIESSLNVLEPAEYRKM--------FDR-----LSVF 381
Query: 351 NERKENMKTTPAPSGT------NMSTDVNSSVGDSSSSKPGFSLNCGNRNKAIVT----K 400
+ P+ ++ V + SL ++ ++
Sbjct: 382 PP------SAHIPTILLSLIWFDVIKSDVMVVVNKLHKY---SLVEKQPKESTISIPSIY 432
Query: 401 VDERSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGSSRG------GSRPHMSN---- 450
++ + + + +S + Y+ + D ++ G H+ N
Sbjct: 433 LELKVKLENEYALH---RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH--HLKNIEHP 487
Query: 451 -----------DLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFA 499
D R+ + QK +RH T + A + L
Sbjct: 488 ERMTLFRMVFLDFRF--LE--QK------IRH-----------DSTAWNASGSILNTLQQ 526
Query: 500 LK-----VMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPG 554
LK + DND + ER + +LD FLP + + K++ L+
Sbjct: 527 LKFYKPYICDND----------PKYERLVNAILD--FLPKIEENLICSKYTDLL------ 568
Query: 555 GDLHVLRQ---KQPSRFFSEQAAR 575
+ E+A +
Sbjct: 569 -------RIALMAEDEAIFEEAHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 3e-04
Identities = 67/506 (13%), Positives = 135/506 (26%), Gaps = 160/506 (31%)
Query: 184 HAAHHSPPLDIVTKPKAIPSK--LPSLDQVVPLVTEFEEKPKAEHHNLNSPESSSVPFTR 241
H HH +D T K L + V F+ K + P+S +
Sbjct: 2 HHHHH---MDFETGEHQYQYKDILSVFED--AFVDNFDCK-----DVQDMPKS--ILSKE 49
Query: 242 EVEEVEIIAPSSVE-------VLVNSP-------VSDKGQK------SKLHP---GSSLS 278
E++ + I++ +V L++ V + + S + S+
Sbjct: 50 EIDHI-IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMM 108
Query: 279 SSSNGSRLTKCGSNSQRLVK-PVFRSKGF--VRRKVKQDSTSASSSCTPCDVSASNDPGP 335
+ + + +++Q K V R + + +R+ + + P
Sbjct: 109 TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLEL-----------------RPAK 151
Query: 336 STSYLDVH-MHNCTVNNERKENMKTTPAPSGTNMSTDVNSSVGDSSSSKPGFS-----LN 389
+ + + KT A V S + LN
Sbjct: 152 ---NVLIDGVLGSG---------KTWVA-----------LDVCLSYKVQCKMDFKIFWLN 188
Query: 390 CGNRNKA-IVTKVDERSRSREKGEFSQSSKSSIGEYSSSTSISEDSILSGSSRGGSRPHM 448
N N V ++ ++ + ++ S ++SS+ + SI + R
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRS-----DHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 449 SNDLR-----WDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVM 503
N L +A + F L C + L+ T +V
Sbjct: 244 ENCLLVLLNVQNA-KAW---------NAFNL----SC----KI----LLTTR---FKQVT 278
Query: 504 DNDFLVGRKKMPRAQTEREIMQMLDHPFLP----TLFAHFTTEKFSCLVMEYCPGGDLHV 559
D FL A T + P +L + + L E +
Sbjct: 279 D--FLSA------ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL 330
Query: 560 -----LRQKQPSRF-FSEQAARFYVAEVL-LALEYL---------HMLGVVYRDLK-PEN 602
+ + + + + ++ +L L L V P
Sbjct: 331 SIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTI 390
Query: 603 ILVR--------EDGHIMLSDFDLSL 620
+L + ++ SL
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSL 416
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 8e-08
Identities = 39/152 (25%), Positives = 61/152 (40%), Gaps = 20/152 (13%)
Query: 477 KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRA-QTEREIMQMLDHPFLPTL 535
K+G G G VY + T+ A+K + + +++ + E ++M H L L
Sbjct: 38 KMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 536 FAHFTTEKFSCLVMEYCPGGD----LHVLRQKQP----SRF-FSEQAARFYVAEVLLALE 586
+ CLV Y P G L L P R ++ AA +
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------GIN 147
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618
+LH ++RD+K NIL+ E +SDF L
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGL 179
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 857 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.9 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.73 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.56 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.56 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.36 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.12 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.73 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.65 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.63 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.55 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.35 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.21 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.2 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.2 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.19 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.12 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.08 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.76 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.11 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.11 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.92 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.1 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-63 Score=544.13 Aligned_cols=278 Identities=36% Similarity=0.659 Sum_probs=250.4
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++++.||+|+||+||+|+++.+++.||||++++.........+.+.+|+++|+.|+|||||+++++|.+++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999999999999999999887666667778899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
||||+||+|.+++.+.. .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 111 mEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~--- 185 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE--- 185 (311)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT---
T ss_pred EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC---
Confidence 99999999999987653 4999999999999999999999999999999999999999999999999998543110
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.......+++
T Consensus 186 ----------------------------------------------------------------------~~~~~~~~~~ 195 (311)
T 4aw0_A 186 ----------------------------------------------------------------------SKQARANSFV 195 (311)
T ss_dssp ----------------------------------------------------------------------TTCCCBCCCC
T ss_pred ----------------------------------------------------------------------CCcccccCcc
Confidence 0112345679
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++.+++...+.+|. .+++++++||.+||++||
T Consensus 196 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~lL~~dp 273 (311)
T 4aw0_A 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE--KFFPKARDLVEKLLVLDA 273 (311)
T ss_dssp SCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--TCCHHHHHHHHHHSCSSG
T ss_pred cCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--ccCHHHHHHHHHHccCCH
Confidence 999999999999999999999999999999999999999999888999999998888775 599999999999999999
Q ss_pred CCcCCchh--hHHHHHcCCCCCCCChhhhccCCCCCC
Q 035930 789 DNRLGAVK--GAAEIKQHPFFEGLNWALIRCAVPPEL 823 (857)
Q Consensus 789 e~Rpt~~~--~a~ELL~HPfF~~l~w~li~~~~pp~~ 823 (857)
.+|||+.. ...+|++||||++++|+.|+...||.+
T Consensus 274 ~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 274 TKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp GGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred hHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 99999543 345689999999999999988888765
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-62 Score=530.07 Aligned_cols=277 Identities=42% Similarity=0.764 Sum_probs=238.6
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEc---CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~---~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
..++|++++.||+|+||+||+|++. .+++.||||++++..... .....+.+|+++|+.|+|||||+++++|.+++.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 3468999999999999999999884 468899999998765432 334467889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|||||||+||+|.+++.+.. .+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999999988754 399999999999999999999999999999999999999999999999999853210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
.....
T Consensus 179 ---------------------------------------------------------------------------~~~~~ 183 (304)
T 3ubd_A 179 ---------------------------------------------------------------------------HEKKA 183 (304)
T ss_dssp -----------------------------------------------------------------------------CCC
T ss_pred ---------------------------------------------------------------------------CCccc
Confidence 01123
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
.+++||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++..++.....+|. .+++++++||.+||
T Consensus 184 ~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L 261 (304)
T 3ubd_A 184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRMLF 261 (304)
T ss_dssp CSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHT
T ss_pred cccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHc
Confidence 4578999999999999999999999999999999999999999999889999999988777764 59999999999999
Q ss_pred cCCcCCcCCch-hhHHHHHcCCCCCCCChhhh--ccCCCCCCC
Q 035930 785 VKEPDNRLGAV-KGAAEIKQHPFFEGLNWALI--RCAVPPELP 824 (857)
Q Consensus 785 ~~DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li--~~~~pp~~P 824 (857)
++||++||++. .+++||++||||++++|..+ +...||++|
T Consensus 262 ~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 262 KRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp CSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred ccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 99999999964 35789999999999999876 456788887
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-60 Score=521.43 Aligned_cols=262 Identities=24% Similarity=0.414 Sum_probs=227.3
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.... ....+.+.+|+++|+.|+|||||+++++|.+++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 357899999999999999999999999999999999876432 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
|||||+||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--- 177 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--- 177 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH---
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC---
Confidence 99999999999999876656689999999999999999999999999999999999999999999999999853210
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
......++
T Consensus 178 ------------------------------------------------------------------------~~~~~~~~ 185 (350)
T 4b9d_A 178 ------------------------------------------------------------------------TVELARAC 185 (350)
T ss_dssp ------------------------------------------------------------------------HHHHHHHH
T ss_pred ------------------------------------------------------------------------Cccccccc
Confidence 00012346
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++.+++...+. +.+..+++++++||.+||++|
T Consensus 186 ~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~L~~d 264 (350)
T 4b9d_A 186 IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRN 264 (350)
T ss_dssp HSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHccCC
Confidence 7999999999999999999999999999999999999999999888888888887654 334579999999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
|.+||+ ++|||+||||+.-
T Consensus 265 P~~R~s----~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 265 PRDRPS----VNSILEKGFIAKR 283 (350)
T ss_dssp GGGSCC----HHHHHTSHHHHTT
T ss_pred hhHCcC----HHHHhcCHHhhcC
Confidence 999999 9999999999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-59 Score=515.10 Aligned_cols=256 Identities=29% Similarity=0.439 Sum_probs=228.0
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
.+|+++++||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+++|+.|+|||||+++++|.+++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG---CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997542 344566789999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|||+||+|.+++.+. .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 151 Ey~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~----- 222 (346)
T 4fih_A 151 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK----- 222 (346)
T ss_dssp CCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-----
T ss_pred eCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC-----
Confidence 999999999998764 399999999999999999999999999999999999999999999999999854210
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
......+++|
T Consensus 223 ----------------------------------------------------------------------~~~~~~~~~G 232 (346)
T 4fih_A 223 ----------------------------------------------------------------------EVPRRKSLVG 232 (346)
T ss_dssp ----------------------------------------------------------------------SSCCBCCCCS
T ss_pred ----------------------------------------------------------------------CCCccccccc
Confidence 1112346789
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-cCCCCCCCCHHHHHHHHhhccCCc
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-RFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
|+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+..... .++.+..+++++++||.+||++||
T Consensus 233 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP 312 (346)
T 4fih_A 233 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDP 312 (346)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSST
T ss_pred CcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999999999999999888888877765432 334456789999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l 810 (857)
++||| ++|||+||||+..
T Consensus 313 ~~R~t----a~e~l~Hp~~~~~ 330 (346)
T 4fih_A 313 AQRAT----AAELLKHPFLAKA 330 (346)
T ss_dssp TTSCC----HHHHTTCGGGGGC
T ss_pred hHCcC----HHHHhcCHhhcCC
Confidence 99999 9999999999854
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=496.75 Aligned_cols=255 Identities=31% Similarity=0.503 Sum_probs=215.9
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++++.||+|+||+||+|++..+|+.||||++++...........+.+|+++|+.++|||||+++++|.+++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999999999999999999999887666566677899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||| +|+|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---- 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---- 164 (275)
T ss_dssp EECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC----
Confidence 9999 789988887754 499999999999999999999999999999999999999999999999999843210
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.....+.+
T Consensus 165 ------------------------------------------------------------------------~~~~~~~~ 172 (275)
T 3hyh_A 165 ------------------------------------------------------------------------GNFLKTSC 172 (275)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ------------------------------------------------------------------------CCccCCee
Confidence 01123468
Q ss_pred CCCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
||+.|||||++.+..| +.++|||||||+||||++|+.||.+.+..+.+..+......+|. .+++++++||.+||++|
T Consensus 173 GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~d 250 (275)
T 3hyh_A 173 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK--FLSPGAAGLIKRMLIVN 250 (275)
T ss_dssp --CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHSCSS
T ss_pred ECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCC
Confidence 9999999999999887 57999999999999999999999998888888888888777664 59999999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~ 808 (857)
|++||| ++|+|+||||+
T Consensus 251 P~~R~s----~~eil~hpw~k 267 (275)
T 3hyh_A 251 PLNRIS----IHEIMQDDWFK 267 (275)
T ss_dssp GGGSCC----HHHHHHCHHHH
T ss_pred hhHCcC----HHHHHcCcccc
Confidence 999999 99999999996
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-58 Score=517.82 Aligned_cols=256 Identities=29% Similarity=0.439 Sum_probs=228.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|+++++||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+.+|+.|+|||||++|++|.+++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT---CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997642 344567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|||+||+|.+++... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 228 Ey~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~----- 299 (423)
T 4fie_A 228 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK----- 299 (423)
T ss_dssp ECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS-----
T ss_pred eCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC-----
Confidence 999999999998764 399999999999999999999999999999999999999999999999999854210
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
......+++|
T Consensus 300 ----------------------------------------------------------------------~~~~~~~~~G 309 (423)
T 4fie_A 300 ----------------------------------------------------------------------EVPRRKSLVG 309 (423)
T ss_dssp ----------------------------------------------------------------------SCCCBCCCEE
T ss_pred ----------------------------------------------------------------------CCcccccccc
Confidence 1112346789
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-cCCCCCCCCHHHHHHHHhhccCCc
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-RFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
|+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+..... .++.+..+++++++||.+||++||
T Consensus 310 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP 389 (423)
T 4fie_A 310 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDP 389 (423)
T ss_dssp CTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSST
T ss_pred CcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999999999999999888888877766432 344556799999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l 810 (857)
++||+ ++|||+||||+..
T Consensus 390 ~~R~t----a~ell~Hp~~~~~ 407 (423)
T 4fie_A 390 AQRAT----AAELLKHPFLAKA 407 (423)
T ss_dssp TTSCC----HHHHTTCGGGGGC
T ss_pred hHCcC----HHHHhcCHHhcCC
Confidence 99999 9999999999853
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=538.99 Aligned_cols=281 Identities=35% Similarity=0.644 Sum_probs=241.3
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHH---HHHHHcCCCCccccceeeeeC
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTER---EIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~Ei---eILr~L~HPnIV~L~~~f~~~ 542 (857)
.+.+++|+++++||+|+||+||+|+++.+|+.||||++++..+........+.+|. .+++.++|||||+++++|.++
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 46788999999999999999999999999999999999877655555555555554 455566899999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
+.+|||||||+||+|..++.+.. .|++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999999988754 3999999999999999999999999999999999999999999999999998532
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
. ..
T Consensus 343 ~-----------------------------------------------------------------------------~~ 345 (689)
T 3v5w_A 343 S-----------------------------------------------------------------------------KK 345 (689)
T ss_dssp S-----------------------------------------------------------------------------SC
T ss_pred C-----------------------------------------------------------------------------CC
Confidence 1 01
Q ss_pred ccccccCCCCccChhhhc-CCCCCcccceehhhHHHHHHhhCCCCCCCCCCh---hhhHHHhhccccCCCCCCCCHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIK-GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND---ETLSNVVSQSLRFPGYPVVSFHARD 778 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~-g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~---e~l~~Iv~~~~~~p~~~~is~~l~d 778 (857)
...+++||+.|||||++. +..|+.++|||||||+||||++|+.||.+.+.. +++..+......+|. .+++++++
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~--~~S~~a~d 423 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELRS 423 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc--cCCHHHHH
Confidence 123568999999999996 568999999999999999999999999875432 345556666666654 59999999
Q ss_pred HHHhhccCCcCCcCCch-hhHHHHHcCCCCCCCChhhh--ccCCCCCCCCCC
Q 035930 779 LIRGLLVKEPDNRLGAV-KGAAEIKQHPFFEGLNWALI--RCAVPPELPRSC 827 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~ 827 (857)
||.+||++||.+|+++. .+++||++||||++++|..+ +...||++|...
T Consensus 424 LI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~ 475 (689)
T 3v5w_A 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRG 475 (689)
T ss_dssp HHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTT
T ss_pred HHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCC
Confidence 99999999999999863 46899999999999999977 467799999653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=484.18 Aligned_cols=253 Identities=23% Similarity=0.411 Sum_probs=215.0
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee----CCeEEE
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT----EKFSCL 547 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~----~~~l~L 547 (857)
|++.++||+|+||+||+|.+..++..||||++...... ....+.+.+|+++|+.|+|||||+++++|.+ ++.+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 47888999999999999999999999999999765332 3345678999999999999999999999975 457899
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEc-cCCcEEEecccchhhccc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG--VVYRDLKPENILVR-EDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G--IIHRDLKPeNILL~-~dg~iKL~DFGLA~r~~~ 624 (857)
|||||+||+|.+++.+.. .+++..++.|+.||+.||+|||++| ||||||||+||||+ .+|.+||+|||+|+...
T Consensus 107 vmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~- 183 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-
Confidence 999999999999998753 4999999999999999999999998 99999999999997 47999999999984210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
....
T Consensus 184 ----------------------------------------------------------------------------~~~~ 187 (290)
T 3fpq_A 184 ----------------------------------------------------------------------------ASFA 187 (290)
T ss_dssp ----------------------------------------------------------------------------TTSB
T ss_pred ----------------------------------------------------------------------------CCcc
Confidence 0112
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-CCCCCCCCHHHHHHHHhh
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-FPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-~p~~~~is~~l~dLI~k~ 783 (857)
.+++||+.|||||++.+ .|+.++|||||||+||||+||+.||.+......+...+..... ......+++++++||.+|
T Consensus 188 ~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~ 266 (290)
T 3fpq_A 188 KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 266 (290)
T ss_dssp EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHH
T ss_pred CCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHH
Confidence 35689999999999875 6999999999999999999999999877665555444444333 223345789999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
|.+||.+||+ ++|||+||||++
T Consensus 267 L~~dP~~R~s----~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 267 IRQNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp SCSSGGGSCC----HHHHHTSGGGC-
T ss_pred ccCChhHCcC----HHHHhcCccccC
Confidence 9999999999 999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=494.65 Aligned_cols=258 Identities=23% Similarity=0.328 Sum_probs=222.4
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
..+|.+.++||+|+||+||+|+++.+|+.||||+++.+.. ..+|+.+|+.|+|||||++|++|.+++.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999976422 24699999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC-cEEEecccchhhcccCcc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG-HIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg-~iKL~DFGLA~r~~~~~~ 627 (857)
||||+||+|.+++.... .+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+..+..
T Consensus 129 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp ECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999999997653 499999999999999999999999999999999999999988 699999999864321100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.........+
T Consensus 207 ----------------------------------------------------------------------~~~~~~~~~~ 216 (336)
T 4g3f_A 207 ----------------------------------------------------------------------GKSLLTGDYI 216 (336)
T ss_dssp -----------------------------------------------------------------------------CCC
T ss_pred ----------------------------------------------------------------------ccceecCCcc
Confidence 0000112356
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC-CCCCCCHHHHHHHHhhccC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP-GYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p-~~~~is~~l~dLI~k~L~~ 786 (857)
+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++..+......+. .++.+++++++||.+||++
T Consensus 217 ~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~ 296 (336)
T 4g3f_A 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRK 296 (336)
T ss_dssp CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCS
T ss_pred ccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccC
Confidence 899999999999999999999999999999999999999999888888888888765543 3467999999999999999
Q ss_pred CcCCcCCchhhHHHH-------------HcCCCCCCC
Q 035930 787 EPDNRLGAVKGAAEI-------------KQHPFFEGL 810 (857)
Q Consensus 787 DPe~Rpt~~~~a~EL-------------L~HPfF~~l 810 (857)
||.+||+ +.|| |+|||+.+.
T Consensus 297 dP~~R~s----a~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 297 EPVHRAS----AMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp SGGGSCC----HHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred CHhHCcC----HHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 9999999 7776 578998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=478.74 Aligned_cols=270 Identities=26% Similarity=0.415 Sum_probs=203.6
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC------
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK------ 543 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~------ 543 (857)
.+|++++.||+|+||+||+|+++.+++.||||+++... .....+.+.+|+++|+.|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 47999999999999999999999999999999997542 2233467889999999999999999999997644
Q ss_pred ------eEEEEEeecCCCChHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecc
Q 035930 544 ------FSCLVMEYCPGGDLHVLRQKQPS-RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616 (857)
Q Consensus 544 ------~l~LVmEy~~gGsL~~ll~~~~~-~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DF 616 (857)
++|||||||+||+|.+++..... ....+..++.|+.||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 47999999999999999876532 23456778999999999999999999999999999999999999999999
Q ss_pred cchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccc
Q 035930 617 DLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLV 696 (857)
Q Consensus 617 GLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~ 696 (857)
|+|+.+......... ..
T Consensus 163 Gla~~~~~~~~~~~~---------------------------------------------------------------~~ 179 (299)
T 4g31_A 163 GLVTAMDQDEEEQTV---------------------------------------------------------------LT 179 (299)
T ss_dssp CCC-----------------------------------------------------------------------------
T ss_pred ccceecCCCcccccc---------------------------------------------------------------cc
Confidence 998654321110000 00
Q ss_pred ccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh-hhhHHHhhccccCC-CCCCCCH
Q 035930 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVSQSLRFP-GYPVVSF 774 (857)
Q Consensus 697 ~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~-e~l~~Iv~~~~~~p-~~~~is~ 774 (857)
..+......+.+||+.|||||++.+..|+.++|||||||+||||++ ||.+.... ..+..+.. ..+| .....++
T Consensus 180 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~--~~~p~~~~~~~~ 254 (299)
T 4g31_A 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRN--LKFPPLFTQKYP 254 (299)
T ss_dssp ------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHT--TCCCHHHHHHCH
T ss_pred ccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhc--CCCCCCCcccCH
Confidence 0011123356789999999999999999999999999999999996 88643211 22222222 2222 2234567
Q ss_pred HHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 775 HARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 775 ~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
.+.+||.+||++||.+||+ +.|||+||||++++|.
T Consensus 255 ~~~~li~~~L~~dP~~Rps----~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 255 CEYVMVQDMLSPSPMERPE----AINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHHHHHHHTCSSGGGSCC----HHHHHTSGGGCCC---
T ss_pred HHHHHHHHHcCCChhHCcC----HHHHhcCHhhCCCCCC
Confidence 7899999999999999999 9999999999999984
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=488.83 Aligned_cols=265 Identities=25% Similarity=0.361 Sum_probs=222.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee------CC
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT------EK 543 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~------~~ 543 (857)
++|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|+++|+.|+|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 579999999999999999999999999999999976532 22334567899999999999999999998764 36
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
++|||||||+ |+|..++.... .+++..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 8999999995 77988887653 49999999999999999999999999999999999999999999999999985421
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.... .....
T Consensus 210 ~~~~-----------------------------------------------------------------------~~~~~ 218 (398)
T 4b99_A 210 TSPA-----------------------------------------------------------------------EHQYF 218 (398)
T ss_dssp -----------------------------------------------------------------------------CCC
T ss_pred cCcc-----------------------------------------------------------------------ccccc
Confidence 1000 01122
Q ss_pred cccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--------------
Q 035930 704 SNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG-------------- 768 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~-------------- 768 (857)
..+++||+.|||||++.+. .|+.++|||||||+||||++|+.||.+.+..+.+..|+.....++.
T Consensus 219 ~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~ 298 (398)
T 4b99_A 219 MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAY 298 (398)
T ss_dssp CCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHH
T ss_pred cccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhh
Confidence 3467899999999999886 4699999999999999999999999999888888777653322210
Q ss_pred ---------------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 769 ---------------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 769 ---------------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
.+.++++++|||.+||++||.+||| ++|+|+||||+...+.
T Consensus 299 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 299 IQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS----AAAALRHPFLAKYHDP 354 (398)
T ss_dssp HHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC----HHHHTTSGGGTTTCCG
T ss_pred hhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC----HHHHhcCHhhCcCCCC
Confidence 2357899999999999999999999 9999999999987543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=476.43 Aligned_cols=281 Identities=25% Similarity=0.384 Sum_probs=211.6
Q ss_pred CCCeEEEeEEccCCceEEEEEEEc---CCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCe
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~---~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~ 544 (857)
.++|++++.||+|+||+||+|+++ .+++.||||++... ....++.+|+++|+.+ +||||++++++|.++++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 367999999999999999999875 46789999998654 2345678999999998 69999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC-CcEEEecccchhhcc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED-GHIMLSDFDLSLRCA 623 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d-g~iKL~DFGLA~r~~ 623 (857)
+|||||||+||+|.+++. .+++..++.|++||+.||+|||++|||||||||+|||++.+ +++||+|||+|+...
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 999999999999999884 28999999999999999999999999999999999999877 899999999996532
Q ss_pred cCcccc-cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 624 VNPMVV-KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 624 ~~~~l~-~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
...... +..... . ....+... ..........
T Consensus 170 ~~~~~~~~~~~~~------~-----~~~~~~~~-------------------------------------~~~~~~~~~~ 201 (361)
T 4f9c_A 170 DTKIELLKFVQSE------A-----QQERCSQN-------------------------------------KCSICLSRRQ 201 (361)
T ss_dssp TCSCGGGGGC----------------------------------------------------------------------
T ss_pred Ccccccccccccc------c-----cccccccc-------------------------------------cccccccccc
Confidence 211100 000000 0 00000000 0000001122
Q ss_pred ccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCC-hhhhHHHhhc------------------
Q 035930 703 RSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGN-DETLSNVVSQ------------------ 762 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~-~e~l~~Iv~~------------------ 762 (857)
...+.+||+.|||||++.+. .|+.++|||||||++|||++|+.||....+ .+.+..+...
T Consensus 202 ~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~ 281 (361)
T 4f9c_A 202 QVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSIL 281 (361)
T ss_dssp ----CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEE
T ss_pred cccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhcccccc
Confidence 34567999999999999886 489999999999999999999999965443 3333333210
Q ss_pred ----------------------------------cccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCC
Q 035930 763 ----------------------------------SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 763 ----------------------------------~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
......+..++++++|||++||++||.+|+| ++|+|+||||+
T Consensus 282 ~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~t----a~eaL~Hp~f~ 357 (361)
T 4f9c_A 282 CSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRIT----AEEALLHPFFK 357 (361)
T ss_dssp ESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCC----HHHHHTSGGGT
T ss_pred ccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccC
Confidence 0011224568899999999999999999999 99999999999
Q ss_pred CCC
Q 035930 809 GLN 811 (857)
Q Consensus 809 ~l~ 811 (857)
+++
T Consensus 358 ~i~ 360 (361)
T 4f9c_A 358 DMS 360 (361)
T ss_dssp TC-
T ss_pred CCC
Confidence 885
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=471.19 Aligned_cols=282 Identities=36% Similarity=0.723 Sum_probs=244.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l 545 (857)
+..++|++++.||+|+||+||+|++..+++.||||++++...........+.+|+.+|+.+ +||||++++++|.+.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 5568999999999999999999999999999999999876555556677788999999988 699999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||||||++||+|..++.... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence 99999999999998887653 399999999999999999999999999999999999999999999999999742100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
......
T Consensus 177 --------------------------------------------------------------------------~~~~~~ 182 (353)
T 3txo_A 177 --------------------------------------------------------------------------NGVTTA 182 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 011123
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
.++||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..++.....+|.. ++.++++||++||.
T Consensus 183 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~lL~ 260 (353)
T 3txo_A 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW--LHEDATGILKSFMT 260 (353)
T ss_dssp ---CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHTC
T ss_pred ccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHHhh
Confidence 5679999999999999999999999999999999999999999998899999999988887754 89999999999999
Q ss_pred CCcCCcCCc--hhhHHHHHcCCCCCCCChhhh--ccCCCCCCCCCC
Q 035930 786 KEPDNRLGA--VKGAAEIKQHPFFEGLNWALI--RCAVPPELPRSC 827 (857)
Q Consensus 786 ~DPe~Rpt~--~~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~ 827 (857)
+||.+||++ ..++++|++||||++++|..+ +...||+.|...
T Consensus 261 ~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~ 306 (353)
T 3txo_A 261 KNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIK 306 (353)
T ss_dssp SSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred hCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCC
Confidence 999999995 234599999999999999876 467789998743
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-54 Score=501.48 Aligned_cols=262 Identities=29% Similarity=0.456 Sum_probs=233.6
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
+++|++++.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+++|+.|+|||||+|+++|.+++.+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999976532 2345678999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC--CcEEEecccchhhcccCc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED--GHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d--g~iKL~DFGLA~r~~~~~ 626 (857)
||||+||+|.+++.... ..+++..++.|++||+.||+|||++|||||||||+||||+.+ |++||+|||+|+.+..
T Consensus 233 ~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-- 309 (573)
T 3uto_A 233 YEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 309 (573)
T ss_dssp EECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--
T ss_pred EeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC--
Confidence 99999999999886543 349999999999999999999999999999999999999854 8999999999854211
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 310 --------------------------------------------------------------------------~~~~~~ 315 (573)
T 3uto_A 310 --------------------------------------------------------------------------KQSVKV 315 (573)
T ss_dssp --------------------------------------------------------------------------TSEEEE
T ss_pred --------------------------------------------------------------------------CCceee
Confidence 011235
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLL 784 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L 784 (857)
.+||+.|||||++.+.+|+.++|||||||+||||++|+.||.+.+..+++..+....+.++. +..+++++++||.+||
T Consensus 316 ~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L 395 (573)
T 3uto_A 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 395 (573)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTS
T ss_pred eEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHc
Confidence 68999999999999999999999999999999999999999999999999999887766653 4678999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
++||.+||+ +.|+|+||||+..+|..
T Consensus 396 ~~dp~~R~t----~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 396 LADPNTRMT----IHQALEHPWLTPGNAPG 421 (573)
T ss_dssp CSSGGGSCC----HHHHHHSTTTSCCCCTT
T ss_pred cCChhHCcC----HHHHhcCcCcCCCCCCC
Confidence 999999999 99999999999988853
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=471.72 Aligned_cols=283 Identities=37% Similarity=0.743 Sum_probs=242.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l 545 (857)
+..++|+++++||+|+||+||+|+++.+++.||||++++...........+.+|+.+|+.+ +||||++++++|.+++.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 5567899999999999999999999999999999999887666666677789999999877 899999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||||||++||+|..++.... .+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+++....
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 99999999999998887653 399999999999999999999999999999999999999999999999999742100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
......
T Consensus 206 --------------------------------------------------------------------------~~~~~~ 211 (396)
T 4dc2_A 206 --------------------------------------------------------------------------PGDTTS 211 (396)
T ss_dssp --------------------------------------------------------------------------TTCCBC
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 011234
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC---------ChhhhHHHhhccccCCCCCCCCHHH
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG---------NDETLSNVVSQSLRFPGYPVVSFHA 776 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~---------~~e~l~~Iv~~~~~~p~~~~is~~l 776 (857)
.++||+.|+|||++.+..|+.++|||||||+||||++|+.||.... ....+..+......+|. .++.++
T Consensus 212 ~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~ 289 (396)
T 4dc2_A 212 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKA 289 (396)
T ss_dssp CCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred cccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cCCHHH
Confidence 5689999999999999999999999999999999999999997532 12345566666666664 499999
Q ss_pred HHHHHhhccCCcCCcCCch--hhHHHHHcCCCCCCCChhhh--ccCCCCCCCCCCc
Q 035930 777 RDLIRGLLVKEPDNRLGAV--KGAAEIKQHPFFEGLNWALI--RCAVPPELPRSCD 828 (857)
Q Consensus 777 ~dLI~k~L~~DPe~Rpt~~--~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~~ 828 (857)
++||++||++||.+||++. .+++||++||||++++|..+ +...||++|...+
T Consensus 290 ~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~ 345 (396)
T 4dc2_A 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISG 345 (396)
T ss_dssp HHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred HHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCC
Confidence 9999999999999999963 35799999999999999977 4577999997543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=460.30 Aligned_cols=282 Identities=37% Similarity=0.715 Sum_probs=248.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++++.||+|+||+||+|++..+++.||||++++...........+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 34678999999999999999999999999999999998765555566778899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
|||||++||+|..++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+++....
T Consensus 82 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 157 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp EEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--
Confidence 9999999999998887653 389999999999999999999999999999999999999999999999999742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.......
T Consensus 158 -------------------------------------------------------------------------~~~~~~~ 164 (337)
T 1o6l_A 158 -------------------------------------------------------------------------DGATMKT 164 (337)
T ss_dssp -------------------------------------------------------------------------TTCCBCC
T ss_pred -------------------------------------------------------------------------CCCcccc
Confidence 0111235
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
++||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+......+|. .+++++++||.+||..
T Consensus 165 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~ 242 (337)
T 1o6l_A 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKK 242 (337)
T ss_dssp CEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCS
T ss_pred cccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhc
Confidence 67999999999999999999999999999999999999999998888888888888777764 5899999999999999
Q ss_pred CcCCcCCch-hhHHHHHcCCCCCCCChhhh--ccCCCCCCCCCC
Q 035930 787 EPDNRLGAV-KGAAEIKQHPFFEGLNWALI--RCAVPPELPRSC 827 (857)
Q Consensus 787 DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~ 827 (857)
||.+||+.. .++++|++||||.+++|..+ +...||+.|...
T Consensus 243 dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~ 286 (337)
T 1o6l_A 243 DPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVT 286 (337)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCS
T ss_pred CHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCC
Confidence 999999432 13999999999999999866 457788888753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=462.44 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=214.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
+..++|.+.++||+|+||+||+|++.+ ++..||||+++.. .....+.+.+|+++|++|+|||||+++++|.+
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 455789999999999999999998753 6889999999754 23345678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCC-------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQP-------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED 608 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~-------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d 608 (857)
++.+|||||||++|+|.+++.... ...+++..+..|+.||+.||+|||+++||||||||+||||+.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 999999999999999999987642 1358999999999999999999999999999999999999999
Q ss_pred CcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcc
Q 035930 609 GHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQ 688 (857)
Q Consensus 609 g~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~ 688 (857)
+++||+|||+|+......
T Consensus 195 ~~~Ki~DFGla~~~~~~~-------------------------------------------------------------- 212 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTD-------------------------------------------------------------- 212 (329)
T ss_dssp TEEEECCCC-----------------------------------------------------------------------
T ss_pred CcEEEcccccceeccCCC--------------------------------------------------------------
Confidence 999999999985421100
Q ss_pred cCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCC
Q 035930 689 VSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFP 767 (857)
Q Consensus 689 ~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p 767 (857)
........+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+ .+++
T Consensus 213 -----------~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g-~~~~ 280 (329)
T 4aoj_A 213 -----------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-RELE 280 (329)
T ss_dssp ------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT-CCCC
T ss_pred -----------cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCC
Confidence 0011234579999999999999999999999999999999998 99999998888877776654 3455
Q ss_pred CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 768 GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 768 ~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.+..+++++.+||.+||+.||++||+ +.||++
T Consensus 281 ~p~~~~~~~~~li~~cl~~dP~~RPs----~~ei~~ 312 (329)
T 4aoj_A 281 RPRACPPEVYAIMRGCWQREPQQRHS----IKDVHA 312 (329)
T ss_dssp CCTTCCHHHHHHHHHHCCSSTTTSCC----HHHHHH
T ss_pred CcccccHHHHHHHHHHcCcChhHCcC----HHHHHH
Confidence 55679999999999999999999999 777765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=458.42 Aligned_cols=259 Identities=20% Similarity=0.329 Sum_probs=218.5
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc-----CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI-----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~-----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
+..++|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.+.+|+++|++|+|||||+++++|.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 55678999999999999999999875 35789999999754 23345678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCC-----------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQP-----------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH 610 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~-----------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~ 610 (857)
++.+|||||||++|+|.+++.... ...+++..+..|+.||+.||+|||+++||||||||+||||+.+++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 999999999999999999987542 345999999999999999999999999999999999999999999
Q ss_pred EEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccC
Q 035930 611 IMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVS 690 (857)
Q Consensus 611 iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~ 690 (857)
+||+|||+|+.......
T Consensus 167 ~Ki~DFGla~~~~~~~~--------------------------------------------------------------- 183 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDY--------------------------------------------------------------- 183 (299)
T ss_dssp EEECCCSCHHHHTGGGC---------------------------------------------------------------
T ss_pred EEECCcccceecCCCCc---------------------------------------------------------------
Confidence 99999999864321100
Q ss_pred CCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCC
Q 035930 691 PMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGY 769 (857)
Q Consensus 691 ~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~ 769 (857)
.......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+++..+..+. .++.+
T Consensus 184 ----------~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p 252 (299)
T 4asz_A 184 ----------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRP 252 (299)
T ss_dssp ----------EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC-CCCCC
T ss_pred ----------eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCC
Confidence 001123469999999999999999999999999999999998 999999998888887776654 34445
Q ss_pred CCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCC
Q 035930 770 PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 770 ~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
..+++++.+||.+||+.||++||+ +.+|+ +||+
T Consensus 253 ~~~~~~~~~li~~cl~~dP~~RPs----~~~i~--~~L~ 285 (299)
T 4asz_A 253 RTCPQEVYELMLGCWQREPHMRKN----IKGIH--TLLQ 285 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCC----HHHHH--HHHH
T ss_pred ccchHHHHHHHHHHcCCChhHCcC----HHHHH--HHHH
Confidence 679999999999999999999999 77774 4544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=471.87 Aligned_cols=283 Identities=35% Similarity=0.637 Sum_probs=248.6
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
..+..++|.+++.||+|+||+||+|++..+++.||||++++...........+.+|+.+|+.++||||++++++|.+++.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 34677899999999999999999999999999999999987655555566678899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+||||||++||+|..++... .+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+++....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 99999999999999988764 389999999999999999999999999999999999999999999999999853211
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
. .....
T Consensus 221 ~--------------------------------------------------------------------------~~~~~ 226 (410)
T 3v8s_A 221 E--------------------------------------------------------------------------GMVRC 226 (410)
T ss_dssp T--------------------------------------------------------------------------SEEEC
T ss_pred C--------------------------------------------------------------------------Ccccc
Confidence 0 00112
Q ss_pred ccccCCCCccChhhhcCCC----CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc--ccCCCCCCCCHHHHH
Q 035930 705 NSFVGTHEYLAPEIIKGEG----HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS--LRFPGYPVVSFHARD 778 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~----~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~--~~~p~~~~is~~l~d 778 (857)
...+||+.|+|||++.+.. |+.++|||||||+||||++|+.||.+.+..+.+..++... +.+|....++.++++
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~ 306 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHH
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHH
Confidence 3568999999999998776 7899999999999999999999999988888888888754 567776789999999
Q ss_pred HHHhhccCCcCC--cCCchhhHHHHHcCCCCCCCChhh--hccCCCCCCCCCCc
Q 035930 779 LIRGLLVKEPDN--RLGAVKGAAEIKQHPFFEGLNWAL--IRCAVPPELPRSCD 828 (857)
Q Consensus 779 LI~k~L~~DPe~--Rpt~~~~a~ELL~HPfF~~l~w~l--i~~~~pp~~P~~~~ 828 (857)
||.+||..+|.+ |++ ++||++||||++++|.. ++...||++|...+
T Consensus 307 li~~lL~~~~~rlgR~~----~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~ 356 (410)
T 3v8s_A 307 LICAFLTDREVRLGRNG----VEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSS 356 (410)
T ss_dssp HHHHHSSCGGGCTTSSC----HHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSS
T ss_pred HHHHHccChhhhCCCCC----HHHHhcCccccCCCHHHHhhcccCCCCCCcCCC
Confidence 999999988888 888 99999999999999964 46788999998543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-53 Score=457.97 Aligned_cols=263 Identities=21% Similarity=0.311 Sum_probs=213.4
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
|.+..++|.+.++||+|+||+||+|++.+ .||||+++... ......+.+.+|+++|++++|||||++++++.+ +.
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 34677899999999999999999998754 49999987542 223445778999999999999999999998865 56
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|||||||+||+|.+++..... .+++..+..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEEEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 8999999999999999876543 499999999999999999999999999999999999999999999999999853210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
. ......
T Consensus 185 ~-------------------------------------------------------------------------~~~~~~ 191 (307)
T 3omv_A 185 W-------------------------------------------------------------------------SGSQQV 191 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------Ccceee
Confidence 0 001112
Q ss_pred ccccCCCCccChhhhcCC---CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC----CCCCCHHHH
Q 035930 705 NSFVGTHEYLAPEIIKGE---GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG----YPVVSFHAR 777 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~---~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~----~~~is~~l~ 777 (857)
...+||+.|||||++.+. +|+.++|||||||+||||+||+.||.+.++.+.+..++......|. +..+++++.
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~ 271 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMK 271 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHH
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHH
Confidence 356799999999999753 5899999999999999999999999988877777777766555443 356889999
Q ss_pred HHHHhhccCCcCCcCCchhhH--HHHHcCCC
Q 035930 778 DLIRGLLVKEPDNRLGAVKGA--AEIKQHPF 806 (857)
Q Consensus 778 dLI~k~L~~DPe~Rpt~~~~a--~ELL~HPf 806 (857)
+||.+||+.||++||++...+ -++|+|+|
T Consensus 272 ~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 272 RLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp HHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 999999999999999943221 23456664
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=456.21 Aligned_cols=258 Identities=21% Similarity=0.313 Sum_probs=218.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc-----CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI-----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~-----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
+...+++++++||+|+||+||+|.+. .+++.||||+++... .....+.+.+|+.+|++|+|||||+++++|.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 55678999999999999999999874 367899999997542 33445678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQP--------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE 607 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~--------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~ 607 (857)
++.+|||||||++|+|.+++.... ...+++..+..|+.||+.||+|||+++||||||||+||||+.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 999999999999999999986532 124899999999999999999999999999999999999999
Q ss_pred CCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhc
Q 035930 608 DGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAA 687 (857)
Q Consensus 608 dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~ 687 (857)
++++||+|||+|+.+....
T Consensus 181 ~~~~Ki~DFGlar~~~~~~------------------------------------------------------------- 199 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAAD------------------------------------------------------------- 199 (308)
T ss_dssp GGCEEECCSCCBCGGGGGG-------------------------------------------------------------
T ss_pred CCCEEECCcccceeccCCC-------------------------------------------------------------
Confidence 9999999999985422100
Q ss_pred ccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccC
Q 035930 688 QVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRF 766 (857)
Q Consensus 688 ~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~ 766 (857)
........+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+++..+..+ ...
T Consensus 200 ------------~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~-~~~ 266 (308)
T 4gt4_A 200 ------------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-QVL 266 (308)
T ss_dssp ------------CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT-CCC
T ss_pred ------------ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC
Confidence 0111234579999999999999999999999999999999998 89999999888877776554 445
Q ss_pred CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 767 PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 767 p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
+.++.++.++.+||.+||+.||.+||+ +.||+++
T Consensus 267 ~~p~~~~~~~~~li~~C~~~dP~~RPs----~~ei~~~ 300 (308)
T 4gt4_A 267 PCPDDCPAWVYALMIECWNEFPSRRPR----FKDIHSR 300 (308)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCcccchHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 556779999999999999999999999 6776653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=454.82 Aligned_cols=283 Identities=37% Similarity=0.735 Sum_probs=242.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l 545 (857)
+..++|++++.||+|+||+||+|++..+++.||||++++...........+.+|+.+|+.+ +||||++++++|.+++.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 5567899999999999999999999999999999999876554455566788999999988 899999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||||||++||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~- 162 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 162 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC-
Confidence 99999999999998887653 399999999999999999999999999999999999999999999999999742100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
......
T Consensus 163 --------------------------------------------------------------------------~~~~~~ 168 (345)
T 3a8x_A 163 --------------------------------------------------------------------------PGDTTS 168 (345)
T ss_dssp --------------------------------------------------------------------------TTCCBC
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 011123
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCC---------CChhhhHHHhhccccCCCCCCCCHHH
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGS---------GNDETLSNVVSQSLRFPGYPVVSFHA 776 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~---------~~~e~l~~Iv~~~~~~p~~~~is~~l 776 (857)
.++||+.|+|||++.+..|+.++|||||||+||||++|+.||... .....+..+......+|. .++.++
T Consensus 169 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~ 246 (345)
T 3a8x_A 169 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKA 246 (345)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred ccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CCCHHH
Confidence 567999999999999999999999999999999999999999753 223344556666666654 589999
Q ss_pred HHHHHhhccCCcCCcCCch--hhHHHHHcCCCCCCCChhhh--ccCCCCCCCCCCc
Q 035930 777 RDLIRGLLVKEPDNRLGAV--KGAAEIKQHPFFEGLNWALI--RCAVPPELPRSCD 828 (857)
Q Consensus 777 ~dLI~k~L~~DPe~Rpt~~--~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~~ 828 (857)
++||.+||.+||.+||++. .++++|++||||.+++|..+ +...||+.|...+
T Consensus 247 ~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~ 302 (345)
T 3a8x_A 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISG 302 (345)
T ss_dssp HHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCT
T ss_pred HHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCC
Confidence 9999999999999999963 35799999999999999877 4577888887543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=450.37 Aligned_cols=279 Identities=34% Similarity=0.696 Sum_probs=247.2
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++++.||+|+||+||+|++..+++.||||++++.........+.+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 34678999999999999999999999999999999998765555566677889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
|||||++||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++....
T Consensus 83 lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~--- 157 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--- 157 (318)
T ss_dssp EEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS---
T ss_pred EEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC---
Confidence 9999999999999988754 49999999999999999999999999999999999999999999999999974310
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.....
T Consensus 158 ---------------------------------------------------------------------------~~~~~ 162 (318)
T 1fot_A 158 ---------------------------------------------------------------------------DVTYT 162 (318)
T ss_dssp ---------------------------------------------------------------------------SCBCC
T ss_pred ---------------------------------------------------------------------------Ccccc
Confidence 01124
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
.+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..++.....+|. .++.++++||.+||..
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~lL~~ 240 (318)
T 1fot_A 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLITR 240 (318)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCS
T ss_pred ccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhcc
Confidence 57999999999999999999999999999999999999999998888888888888777764 5899999999999999
Q ss_pred CcCCcCCchh-hHHHHHcCCCCCCCChhhh--ccCCCCCCCCCC
Q 035930 787 EPDNRLGAVK-GAAEIKQHPFFEGLNWALI--RCAVPPELPRSC 827 (857)
Q Consensus 787 DPe~Rpt~~~-~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~ 827 (857)
||.+||+... ++++|++||||++++|..+ +...||+.|...
T Consensus 241 dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~ 284 (318)
T 1fot_A 241 DLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQ 284 (318)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-
T ss_pred CHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcC
Confidence 9999995332 4899999999999999866 456788888654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=459.88 Aligned_cols=283 Identities=35% Similarity=0.704 Sum_probs=250.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l 545 (857)
+...+|++++.||+|+||+||+|++..+++.||||++++...........+..|..+|..+ +||||++++++|.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 5678999999999999999999999999999999999876555556677788999999887 799999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||||||++||+|..++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||++.....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 99999999999999887653 399999999999999999999999999999999999999999999999999742100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
......
T Consensus 174 --------------------------------------------------------------------------~~~~~~ 179 (353)
T 2i0e_A 174 --------------------------------------------------------------------------DGVTTK 179 (353)
T ss_dssp --------------------------------------------------------------------------TTCCBC
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 001123
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
.++||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+++..++.....+|. .++.++++||.+||.
T Consensus 180 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~ 257 (353)
T 2i0e_A 180 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLMT 257 (353)
T ss_dssp CCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTC
T ss_pred cccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhh
Confidence 567999999999999999999999999999999999999999998888889999988877774 599999999999999
Q ss_pred CCcCCcCCch-hhHHHHHcCCCCCCCChhhh--ccCCCCCCCCCCc
Q 035930 786 KEPDNRLGAV-KGAAEIKQHPFFEGLNWALI--RCAVPPELPRSCD 828 (857)
Q Consensus 786 ~DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~~ 828 (857)
+||.+||++. .++++|++||||++++|..+ +...||+.|..++
T Consensus 258 ~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~ 303 (353)
T 2i0e_A 258 KHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACG 303 (353)
T ss_dssp SCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC
T ss_pred cCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCC
Confidence 9999999753 35899999999999999877 4678999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=472.28 Aligned_cols=287 Identities=33% Similarity=0.619 Sum_probs=248.8
Q ss_pred ccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 463 QHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 463 ~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
....+..++|+++++||+|+||+||+|++..+++.||||++++...........+.+|+.+|+.++||||++++++|.++
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 33456778999999999999999999999999999999999875544455556689999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
+.+|||||||+||+|..++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++..
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 99999999999999999997643 34999999999999999999999999999999999999999999999999998542
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
... ...
T Consensus 226 ~~~--------------------------------------------------------------------------~~~ 231 (437)
T 4aw2_A 226 MED--------------------------------------------------------------------------GTV 231 (437)
T ss_dssp CTT--------------------------------------------------------------------------SCE
T ss_pred ccC--------------------------------------------------------------------------CCc
Confidence 110 001
Q ss_pred ccccccCCCCccChhhhc-----CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc--ccCCCC-CCCCH
Q 035930 703 RSNSFVGTHEYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS--LRFPGY-PVVSF 774 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~-----g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~--~~~p~~-~~is~ 774 (857)
.....+||+.|||||++. +..|+.++|||||||+||||++|+.||.+.+..+.+..++... +.+|.. ..+++
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 311 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCH
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCH
Confidence 123457999999999997 5568999999999999999999999999998888888887643 444443 45899
Q ss_pred HHHHHHHhhccCCcCC--cCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCCCc
Q 035930 775 HARDLIRGLLVKEPDN--RLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCD 828 (857)
Q Consensus 775 ~l~dLI~k~L~~DPe~--Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~~~ 828 (857)
++++||++||+.+|++ |++ ++||++||||++++|..++...||++|...+
T Consensus 312 ~~~dLi~~lL~~~~~r~~r~~----~~eil~Hpff~~i~w~~l~~~~~p~~P~~~~ 363 (437)
T 4aw2_A 312 NAKDLIRRLICSREHRLGQNG----IEDFKKHPFFSGIDWDNIRNCEAPYIPEVSS 363 (437)
T ss_dssp HHHHHHHTTSSCGGGCTTTTT----THHHHTSGGGTTCCTTTGGGSCCSCCCCCSS
T ss_pred HHHHHHHHHhcccccccCCCC----HHHHhCCCccCCCCHHHHhhCCCCCCCcCCC
Confidence 9999999999998887 887 9999999999999999999889999997543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=458.97 Aligned_cols=277 Identities=39% Similarity=0.756 Sum_probs=239.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l 545 (857)
+..++|.+.+.||+|+||+||+|+++.+++.||||++++...........+..|..+|+.+ +||||++++++|.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 5678999999999999999999999999999999999876554455667788999999877 899999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||||||++||+|..++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence 99999999999999887653 399999999999999999999999999999999999999999999999999742100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
......
T Consensus 171 --------------------------------------------------------------------------~~~~~~ 176 (345)
T 1xjd_A 171 --------------------------------------------------------------------------GDAKTN 176 (345)
T ss_dssp --------------------------------------------------------------------------TTCCBC
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 011124
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
.++||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++++||.+||.
T Consensus 177 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~ 254 (345)
T 1xjd_A 177 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAKDLLVKLFV 254 (345)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHSC
T ss_pred CCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc--ccCHHHHHHHHHHhc
Confidence 568999999999999999999999999999999999999999998888888888887776664 489999999999999
Q ss_pred CCcCCcCCchhhHH-HHHcCCCCCCCChhhh--ccCCCCCCCCC
Q 035930 786 KEPDNRLGAVKGAA-EIKQHPFFEGLNWALI--RCAVPPELPRS 826 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~-ELL~HPfF~~l~w~li--~~~~pp~~P~~ 826 (857)
.||.+||+ +. +|++||||++++|..+ +...||+.|..
T Consensus 255 ~dp~~R~~----~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~ 294 (345)
T 1xjd_A 255 REPEKRLG----VRGDIRQHPLFREINWEELERKEIDPPFRPKV 294 (345)
T ss_dssp SSGGGSBT----TBSCGGGSGGGTTCCHHHHHTTCSCC------
T ss_pred CCHhHcCC----ChHHHHcCccccCCCHHHHhhCCCCCCcCCCC
Confidence 99999999 65 9999999999999877 35678888865
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=462.65 Aligned_cols=282 Identities=38% Similarity=0.676 Sum_probs=239.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHH-HHHcCCCCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI-MQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieI-Lr~L~HPnIV~L~~~f~~~~~l 545 (857)
+..++|++++.||+|+||+||+|+++.+++.||||++++...........+.+|..+ ++.++||||++++++|.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 445789999999999999999999999999999999987765555555566777776 5778999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||||||++||+|..++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~- 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE- 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC-
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc-
Confidence 99999999999998887653 389999999999999999999999999999999999999999999999999753110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
......
T Consensus 192 --------------------------------------------------------------------------~~~~~~ 197 (373)
T 2r5t_A 192 --------------------------------------------------------------------------HNSTTS 197 (373)
T ss_dssp --------------------------------------------------------------------------CCCCCC
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 011224
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
.++||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+..++.....++ +.++.++++||.+||+
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~lL~ 275 (373)
T 2r5t_A 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--PNITNSARHLLEGLLQ 275 (373)
T ss_dssp SBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC--SSSCHHHHHHHHHHTC
T ss_pred cccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC--CCCCHHHHHHHHHHcc
Confidence 56899999999999999999999999999999999999999999888888889888877766 4599999999999999
Q ss_pred CCcCCcCCchhhHHHHHcCCCCCCCChhhh--ccCCCCCCCCCC
Q 035930 786 KEPDNRLGAVKGAAEIKQHPFFEGLNWALI--RCAVPPELPRSC 827 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~ 827 (857)
+||.+||++..++.+|++||||++++|..+ +...||+.|...
T Consensus 276 ~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~ 319 (373)
T 2r5t_A 276 KDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVS 319 (373)
T ss_dssp SSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCC
T ss_pred cCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCC
Confidence 999999998777899999999999999876 457789998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=454.08 Aligned_cols=280 Identities=35% Similarity=0.647 Sum_probs=249.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
...++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|+.++||||++++++|.+++.+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 55678999999999999999999999999999999998765555566778899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
|||||++||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++....
T Consensus 118 lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~--- 192 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--- 192 (350)
T ss_dssp EEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS---
T ss_pred EEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc---
Confidence 9999999999999887653 39999999999999999999999999999999999999999999999999974311
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.....
T Consensus 193 ---------------------------------------------------------------------------~~~~~ 197 (350)
T 1rdq_E 193 ---------------------------------------------------------------------------GRTWT 197 (350)
T ss_dssp ---------------------------------------------------------------------------SCBCC
T ss_pred ---------------------------------------------------------------------------CCccc
Confidence 01124
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
.+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+......+|. .++.++++||.+||..
T Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~lL~~ 275 (350)
T 1rdq_E 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHHSCS
T ss_pred ccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhc
Confidence 57999999999999999999999999999999999999999998888888888888777764 5899999999999999
Q ss_pred CcCCcCCch-hhHHHHHcCCCCCCCChhhh--ccCCCCCCCCCCc
Q 035930 787 EPDNRLGAV-KGAAEIKQHPFFEGLNWALI--RCAVPPELPRSCD 828 (857)
Q Consensus 787 DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~~ 828 (857)
||.+||++. .++++|++||||.+++|..+ +...||++|...+
T Consensus 276 dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~ 320 (350)
T 1rdq_E 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKG 320 (350)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred CHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCC
Confidence 999999853 35899999999999999866 4677899987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=469.12 Aligned_cols=290 Identities=36% Similarity=0.632 Sum_probs=247.0
Q ss_pred hhccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeee
Q 035930 461 QKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFT 540 (857)
Q Consensus 461 ~~~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~ 540 (857)
......+..++|++++.||+|+||+||+|+++.+++.||||++++...........+.+|+.+|..++||||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 33444577889999999999999999999999999999999998654444455667889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
+++.+||||||++||+|..++.+.. ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+++
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 9999999999999999999987643 249999999999999999999999999999999999999999999999999985
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
..... .
T Consensus 211 ~~~~~--------------------------------------------------------------------------~ 216 (412)
T 2vd5_A 211 KLRAD--------------------------------------------------------------------------G 216 (412)
T ss_dssp ECCTT--------------------------------------------------------------------------S
T ss_pred eccCC--------------------------------------------------------------------------C
Confidence 42110 0
Q ss_pred CCccccccCCCCccChhhhc-------CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc--ccCCC-CC
Q 035930 701 GARSNSFVGTHEYLAPEIIK-------GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS--LRFPG-YP 770 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~-------g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~--~~~p~-~~ 770 (857)
.......+||+.|+|||++. +..|+.++|||||||+||||++|+.||.+.+..+.+..++... +.+|. ..
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 296 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence 00123467999999999997 3568999999999999999999999999988888888887643 44443 24
Q ss_pred CCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCCC
Q 035930 771 VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSC 827 (857)
Q Consensus 771 ~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~~ 827 (857)
.++.++++||++||. +|.+|++ +.+++||++||||++++|..++...||++|...
T Consensus 297 ~~s~~~~dli~~lL~-~p~~Rlg-r~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~~ 351 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC-PPETRLG-RGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFE 351 (412)
T ss_dssp CCCHHHHHHHHTTSS-CGGGCTT-TTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC--
T ss_pred CCCHHHHHHHHHHcC-ChhhcCC-CCCHHHHhcCCCcCCCCHHHHhhcCCCCCCcCC
Confidence 699999999999999 9999974 235999999999999999999888999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=460.07 Aligned_cols=260 Identities=23% Similarity=0.342 Sum_probs=222.1
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCC-----eEEEEEEecccccccccchhHHHHHHHHHHHcCC-CCccccceee
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTS-----CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH-PFLPTLFAHF 539 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg-----~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~H-PnIV~L~~~f 539 (857)
.+..++|++++.||+|+||+||+|.+.+++ +.||||+++.... ......+.+|+++|+.+.| ||||+++++|
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 466789999999999999999999987643 6899999976532 2345678999999999965 9999999999
Q ss_pred eeC-CeEEEEEeecCCCChHHHHhhCC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 035930 540 TTE-KFSCLVMEYCPGGDLHVLRQKQP--------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604 (857)
Q Consensus 540 ~~~-~~l~LVmEy~~gGsL~~ll~~~~--------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNIL 604 (857)
.++ +.+|||||||++|+|.++++... ...+++..+..|+.||+.||+|||+++||||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 764 57899999999999999987532 234899999999999999999999999999999999999
Q ss_pred EccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhh
Q 035930 605 VREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD 684 (857)
Q Consensus 605 L~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d 684 (857)
++.++.+||+|||+|+.+..+.
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~---------------------------------------------------------- 239 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDP---------------------------------------------------------- 239 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCT----------------------------------------------------------
T ss_pred eCCCCCEEECcchhhhhcccCC----------------------------------------------------------
Confidence 9999999999999985422110
Q ss_pred hhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhcc
Q 035930 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQS 763 (857)
Q Consensus 685 ~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~ 763 (857)
........+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....+.+..++...
T Consensus 240 ---------------~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g 304 (353)
T 4ase_A 240 ---------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 304 (353)
T ss_dssp ---------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred ---------------CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcC
Confidence 0112235679999999999999999999999999999999998 999999987777777777777
Q ss_pred ccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 764 ~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
.+++.+..+++++.+||.+||+.||.+||+ +.+|++|
T Consensus 305 ~~~~~p~~~~~~~~~li~~c~~~dP~~RPt----~~eil~~ 341 (353)
T 4ase_A 305 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 341 (353)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCcChhHCcC----HHHHHHH
Confidence 777777789999999999999999999999 8888876
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=484.89 Aligned_cols=283 Identities=35% Similarity=0.693 Sum_probs=251.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l 545 (857)
+...+|.+++.||+|+||+||+|++..+++.||||++++...........+..|..+|..+ +||||+.++++|.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 5678999999999999999999999999999999999876555566777889999999887 699999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||||||++||+|..++.... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++....
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 494 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 494 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC-
T ss_pred EEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc-
Confidence 99999999999999888753 399999999999999999999999999999999999999999999999999843110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
......
T Consensus 495 --------------------------------------------------------------------------~~~~~~ 500 (674)
T 3pfq_A 495 --------------------------------------------------------------------------DGVTTK 500 (674)
T ss_dssp --------------------------------------------------------------------------TTCCBC
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 011234
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
.++||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++..++.....+|. .++.++++||++||.
T Consensus 501 ~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~ 578 (674)
T 3pfq_A 501 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLMT 578 (674)
T ss_dssp CCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT--TSCHHHHHHHHHHSC
T ss_pred cccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHcc
Confidence 568999999999999999999999999999999999999999999889999999998888775 599999999999999
Q ss_pred CCcCCcCCc-hhhHHHHHcCCCCCCCChhhh--ccCCCCCCCCCCc
Q 035930 786 KEPDNRLGA-VKGAAEIKQHPFFEGLNWALI--RCAVPPELPRSCD 828 (857)
Q Consensus 786 ~DPe~Rpt~-~~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~~ 828 (857)
+||.+||++ ..+++||++||||++++|..+ +...||+.|...+
T Consensus 579 ~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~ 624 (674)
T 3pfq_A 579 KHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG 624 (674)
T ss_dssp SSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG
T ss_pred CCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC
Confidence 999999995 245699999999999999877 4578999997654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=451.03 Aligned_cols=279 Identities=29% Similarity=0.612 Sum_probs=241.2
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
+.+..++|.+++.||+|+||+||+|++..+++.||||++.+...........+.+|+++|+.++||||++++++|.+.+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 44667899999999999999999999999999999999987765566677788999999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|+||||+.||+|..++.... .+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++..+..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999999988653 499999999999999999999999999999999999999999999999999743210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
....
T Consensus 168 ----------------------------------------------------------------------------~~~~ 171 (384)
T 4fr4_A 168 ----------------------------------------------------------------------------ETQI 171 (384)
T ss_dssp ----------------------------------------------------------------------------TCCB
T ss_pred ----------------------------------------------------------------------------CCce
Confidence 0112
Q ss_pred ccccCCCCccChhhhcC---CCCCcccceehhhHHHHHHhhCCCCCCCCCC---hhhhHHHhhccccCCCCCCCCHHHHH
Q 035930 705 NSFVGTHEYLAPEIIKG---EGHGSSVDWWTFGIFLFELLYGRTPFKGSGN---DETLSNVVSQSLRFPGYPVVSFHARD 778 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g---~~~s~ksDVWSLGvILyELLtGk~PF~g~~~---~e~l~~Iv~~~~~~p~~~~is~~l~d 778 (857)
..++||+.|+|||++.+ ..|+.++|||||||+||||++|+.||..... .+.+..+......+| ..++.++.+
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p--~~~s~~~~~ 249 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP--SAWSQEMVS 249 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC--TTSCHHHHH
T ss_pred eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC--CcCCHHHHH
Confidence 35679999999999974 5689999999999999999999999986543 333444444445555 458999999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhh--ccCCCCCCCCC
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI--RCAVPPELPRS 826 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~ 826 (857)
||.+||..||.+||++ +++|++||||.+++|..+ +...||++|..
T Consensus 250 li~~lL~~dP~~R~s~---~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~ 296 (384)
T 4fr4_A 250 LLKKLLEPNPDQRFSQ---LSDVQNFPYMNDINWDAVFQKRLIPGFIPNK 296 (384)
T ss_dssp HHHHHSCSSGGGSCCS---HHHHHTSGGGTTCCHHHHHTTCSCCCCCCSC
T ss_pred HHHHHhcCCHhHhccc---HHHHHcChhhhcCCHHHHHhCCCCCCCCCCC
Confidence 9999999999999984 789999999999999866 45778999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=459.53 Aligned_cols=283 Identities=38% Similarity=0.722 Sum_probs=236.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++++.||+|+||+||+|.+..+++.||||++.............+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 55678999999999999999999999999999999998765555556667789999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|||||+++|+|..++.... .+++..++.++.||+.||+|||+ .|||||||||+||||+.+|++||+|||++.....
T Consensus 225 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 301 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK- 301 (446)
T ss_dssp EEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC-
Confidence 9999999999998887653 48999999999999999999998 9999999999999999999999999999742100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
......
T Consensus 302 --------------------------------------------------------------------------~~~~~~ 307 (446)
T 4ejn_A 302 --------------------------------------------------------------------------DGATMK 307 (446)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 001123
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
..+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+......+|. .+++++.+||.+||.
T Consensus 308 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~ 385 (446)
T 4ejn_A 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLGPEAKSLLSGLLK 385 (446)
T ss_dssp CSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTC
T ss_pred cccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHcc
Confidence 467999999999999999999999999999999999999999998888888888888777764 489999999999999
Q ss_pred CCcCCcCCch-hhHHHHHcCCCCCCCChhhh--ccCCCCCCCCCCc
Q 035930 786 KEPDNRLGAV-KGAAEIKQHPFFEGLNWALI--RCAVPPELPRSCD 828 (857)
Q Consensus 786 ~DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~~ 828 (857)
+||.+||+.. ..++|||+||||.+++|..+ +...||+.|....
T Consensus 386 ~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~ 431 (446)
T 4ejn_A 386 KDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTS 431 (446)
T ss_dssp SSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSS
T ss_pred cCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCC
Confidence 9999999211 12999999999999999866 4566888886543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=434.92 Aligned_cols=282 Identities=37% Similarity=0.725 Sum_probs=233.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc---CCCeEEEEEEecccccc-cccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLV-GRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~---~tg~~VAVKvi~k~~~~-~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
+..++|++.+.||+|+||+||+|++. .+++.||||++++.... .......+.+|+++|+.++||||++++++|.++
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 45678999999999999999999985 68899999999865432 223445678899999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
+.+||||||++|++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++...
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred CEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999998887653 3899999999999999999999999999999999999999999999999987421
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.. ...
T Consensus 172 ~~---------------------------------------------------------------------------~~~ 176 (327)
T 3a62_A 172 IH---------------------------------------------------------------------------DGT 176 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc---------------------------------------------------------------------------CCc
Confidence 10 001
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++.....+| +.++.++++||.+
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~ 254 (327)
T 3a62_A 177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--PYLTQEARDLLKK 254 (327)
T ss_dssp --CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC--TTSCHHHHHHHHH
T ss_pred cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCHHHHHHHHH
Confidence 12345799999999999999999999999999999999999999999888888888888776666 4589999999999
Q ss_pred hccCCcCCcCCch-hhHHHHHcCCCCCCCChhhh--ccCCCCCCCCCC
Q 035930 783 LLVKEPDNRLGAV-KGAAEIKQHPFFEGLNWALI--RCAVPPELPRSC 827 (857)
Q Consensus 783 ~L~~DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~ 827 (857)
||..||.+||++. .++.++++||||.+++|..+ +...||+.|...
T Consensus 255 ~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~ 302 (327)
T 3a62_A 255 LLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQ 302 (327)
T ss_dssp HSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC--
T ss_pred HHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcC
Confidence 9999999999543 24899999999999999865 456678888643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=464.96 Aligned_cols=285 Identities=32% Similarity=0.587 Sum_probs=247.6
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
.+..++|.+++.||+|+||+||+|++..+|+.||||++.+...........+.+|+++|+.++||||++++++|.+.+.+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 46778999999999999999999999999999999999877665566677889999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCC--CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 546 CLVMEYCPGGDLHVLRQKQP--SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~--~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
||||||++||+|..++.... ...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999998887643 3359999999999999999999999999999999999999999999999999985321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.. ...
T Consensus 341 ~~---------------------------------------------------------------------------~~~ 345 (543)
T 3c4z_A 341 AG---------------------------------------------------------------------------QTK 345 (543)
T ss_dssp TT---------------------------------------------------------------------------CCC
T ss_pred CC---------------------------------------------------------------------------Ccc
Confidence 00 011
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC----hhhhHHHhhccccCCCCCCCCHHHHHH
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN----DETLSNVVSQSLRFPGYPVVSFHARDL 779 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~----~e~l~~Iv~~~~~~p~~~~is~~l~dL 779 (857)
...++||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+. .++...++.....+| ..++.++++|
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~l 423 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFSPASKDF 423 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--TTSCHHHHHH
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--cccCHHHHHH
Confidence 2345799999999999999999999999999999999999999987642 455566666666665 4599999999
Q ss_pred HHhhccCCcCCcCCchh-hHHHHHcCCCCCCCChhhhc--cCCCCCCCCCC
Q 035930 780 IRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLNWALIR--CAVPPELPRSC 827 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~~~-~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~~ 827 (857)
|.+||.+||.+||++.. ++++|++||||++++|..+. ...||++|...
T Consensus 424 i~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~ 474 (543)
T 3c4z_A 424 CEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSR 474 (543)
T ss_dssp HHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCSS
T ss_pred HHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCcc
Confidence 99999999999998643 57999999999999998774 56799999753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=430.68 Aligned_cols=261 Identities=30% Similarity=0.496 Sum_probs=231.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
...++|++++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+++|+.++||||+++++++.+++.+|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 345789999999999999999999999999999999976533 2334567889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++..+..
T Consensus 91 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 166 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-- 166 (328)
T ss_dssp EEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS--
T ss_pred EEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC--
Confidence 9999999999999887653 399999999999999999999999999999999999999999999999999743210
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 167 --------------------------------------------------------------------------~~~~~~ 172 (328)
T 3fe3_A 167 --------------------------------------------------------------------------GGKLDA 172 (328)
T ss_dssp --------------------------------------------------------------------------SCGGGT
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 011234
Q ss_pred ccCCCCccChhhhcCCCCC-cccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHG-SSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s-~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
.+||+.|+|||++.+..+. .++|||||||+||+|++|+.||.+.+..+....+......+|. .+++++.+||++||.
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~ 250 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDCENLLKRFLV 250 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHCC
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHCC
Confidence 5799999999999998875 7999999999999999999999999888888888888777765 489999999999999
Q ss_pred CCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 786 KEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
.||.+||+ ++++++||||....+
T Consensus 251 ~dP~~R~t----~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 251 LNPIKRGT----LEQIMKDRWINAGHE 273 (328)
T ss_dssp SSTTTSCC----HHHHTTCTTTTTTCT
T ss_pred CChhHCcC----HHHHhcCHhhcCCCc
Confidence 99999999 999999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=464.50 Aligned_cols=284 Identities=34% Similarity=0.552 Sum_probs=244.7
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
..+..++|.+++.||+|+||+||+|++..+|+.||||++.+...........+.+|+++|+.++||||++++++|.+++.
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 34677899999999999999999999999999999999987655555666778999999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+||||||++||+|..++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.....
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999999988876555699999999999999999999999999999999999999999999999999843210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
....
T Consensus 339 ----------------------------------------------------------------------------~~~~ 342 (576)
T 2acx_A 339 ----------------------------------------------------------------------------GQTI 342 (576)
T ss_dssp ----------------------------------------------------------------------------TCCE
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0011
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC----hhhhHHHhhccccCCCCCCCCHHHHHHH
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN----DETLSNVVSQSLRFPGYPVVSFHARDLI 780 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~----~e~l~~Iv~~~~~~p~~~~is~~l~dLI 780 (857)
...+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+... .++...+......++ ..+++++++||
T Consensus 343 ~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~~dLI 420 (576)
T 2acx_A 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQARSLC 420 (576)
T ss_dssp ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHH
T ss_pred cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHHHHHH
Confidence 245799999999999999999999999999999999999999987643 233444444444444 46999999999
Q ss_pred HhhccCCcCCcCCchh-hHHHHHcCCCCCCCChhhhc--cCCCCCCCCC
Q 035930 781 RGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLNWALIR--CAVPPELPRS 826 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~-~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~ 826 (857)
.+||.+||.+||++.. +++||++||||++++|..+. ...||++|..
T Consensus 421 ~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~ 469 (576)
T 2acx_A 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP 469 (576)
T ss_dssp HHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred HHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCc
Confidence 9999999999996432 48999999999999998774 5678999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=435.86 Aligned_cols=264 Identities=30% Similarity=0.469 Sum_probs=232.7
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc---cchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR---KKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~---~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
.++|.+++.||+|+||+||+|.+..+|..||||++++...... ...+.+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 3579999999999999999999999999999999986543221 1346789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC----cEEEecccchhh
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG----HIMLSDFDLSLR 621 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg----~iKL~DFGLA~r 621 (857)
||||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||++..
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999999987643 499999999999999999999999999999999999998877 799999999743
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
... .
T Consensus 169 ~~~----------------------------------------------------------------------------~ 172 (361)
T 2yab_A 169 IED----------------------------------------------------------------------------G 172 (361)
T ss_dssp CCT----------------------------------------------------------------------------T
T ss_pred cCC----------------------------------------------------------------------------C
Confidence 210 0
Q ss_pred CccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHH
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDL 779 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dL 779 (857)
......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.+..+....+.++. +..++..+++|
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 252 (361)
T 2yab_A 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDF 252 (361)
T ss_dssp CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHH
Confidence 0123457999999999999999999999999999999999999999998888888888887766653 35689999999
Q ss_pred HHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 780 IRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
|.+||..||.+||+ +.|+|+||||..++|..
T Consensus 253 i~~~L~~dP~~R~t----~~e~l~hp~~~~~~~~~ 283 (361)
T 2yab_A 253 IRKLLVKETRKRLT----IQEALRHPWITPVDTQQ 283 (361)
T ss_dssp HHHHSCSSTTTSCC----HHHHHTSTTTSCSSHHH
T ss_pred HHHHCCCChhHCcC----HHHHhcCcCcCCCchhh
Confidence 99999999999999 99999999999999853
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=432.03 Aligned_cols=274 Identities=23% Similarity=0.325 Sum_probs=223.2
Q ss_pred cCCCeEEEeEEccC--CceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 468 GMRHFKLHKKLGCG--DIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G--~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
..++|++++.||+| +||+||+|++..+++.||||+++.... .......+.+|+.+|+.++||||++++++|.+++.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 34689999999999 999999999999999999999976532 233456778899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||||||+++|+|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 99999999999999998765556999999999999999999999999999999999999999999999999987542211
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.... ........
T Consensus 182 ~~~~--------------------------------------------------------------------~~~~~~~~ 193 (389)
T 3gni_B 182 GQRQ--------------------------------------------------------------------RVVHDFPK 193 (389)
T ss_dssp TEEC--------------------------------------------------------------------SCBCCCCT
T ss_pred cccc--------------------------------------------------------------------cccccccc
Confidence 0000 00001112
Q ss_pred cccCCCCccChhhhcC--CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc------------------
Q 035930 706 SFVGTHEYLAPEIIKG--EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR------------------ 765 (857)
Q Consensus 706 s~vGT~~YmAPEil~g--~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~------------------ 765 (857)
..+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+.+..+.+..++.....
T Consensus 194 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (389)
T 3gni_B 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPS 273 (389)
T ss_dssp TCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------------------
T ss_pred cccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccc
Confidence 3479999999999988 67999999999999999999999999987766666554432221
Q ss_pred --------------------------CCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 766 --------------------------FPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 766 --------------------------~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
.+....+++++++||.+||+.||.+||+ +.|+|+||||+++.|..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----a~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 274 RSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp --------------------------------CCHHHHHHHHHHTCSCTTTSCC----HHHHTTSGGGGGC---C
T ss_pred ccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC----HHHHhcCHHHHHHhhcc
Confidence 1123457889999999999999999999 99999999999998854
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=415.97 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=223.9
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.+|+.++||||++++++|..++.+|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 468999999999999999999999999999999987542 33456688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 168 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---- 168 (297)
T ss_dssp EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS----
T ss_pred EECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC----
Confidence 9999999999998875 389999999999999999999999999999999999999999999999998743210
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........+
T Consensus 169 -----------------------------------------------------------------------~~~~~~~~~ 177 (297)
T 3fxz_A 169 -----------------------------------------------------------------------EQSKRSTMV 177 (297)
T ss_dssp -----------------------------------------------------------------------TTCCBCCCC
T ss_pred -----------------------------------------------------------------------cccccCCcc
Confidence 001123457
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-cCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-RFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-~~p~~~~is~~l~dLI~k~L~~D 787 (857)
||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+..... .+.....++..+++||.+||..|
T Consensus 178 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 257 (297)
T 3fxz_A 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 257 (297)
T ss_dssp SCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSS
T ss_pred CCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCC
Confidence 99999999999999999999999999999999999999998876666655554432 33444568999999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
|++||+ +.|+++||||+..
T Consensus 258 p~~Rps----~~ell~h~~~~~~ 276 (297)
T 3fxz_A 258 VEKRGS----AKELLQHQFLKIA 276 (297)
T ss_dssp TTTSCC----HHHHTTCGGGGGC
T ss_pred hhHCcC----HHHHhhChhhccc
Confidence 999999 9999999999854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=426.41 Aligned_cols=248 Identities=23% Similarity=0.256 Sum_probs=189.8
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHH--HHHHHHHHcCCCCccccceeeeeCC----
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQ--TEREIMQMLDHPFLPTLFAHFTTEK---- 543 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~--~EieILr~L~HPnIV~L~~~f~~~~---- 543 (857)
++|.+.++||+|+||+||+|++ +|+.||||+++... ...+. .|+.++..++|||||+++++|.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~------~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 5799999999999999999988 57899999996542 22333 4555556789999999999998764
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHc--------CceeccCCCCcEEEccCCcEEEec
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML--------GVVYRDLKPENILVREDGHIMLSD 615 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~--------GIIHRDLKPeNILL~~dg~iKL~D 615 (857)
.+|||||||++|+|.+++.... +++..+..++.|++.||+|||++ +||||||||+||||+.++++||+|
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCCcHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 6899999999999999998753 89999999999999999999987 999999999999999999999999
Q ss_pred ccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcc
Q 035930 616 FDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQL 695 (857)
Q Consensus 616 FGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l 695 (857)
||+|+.......
T Consensus 152 FGla~~~~~~~~-------------------------------------------------------------------- 163 (303)
T 3hmm_A 152 LGLAVRHDSATD-------------------------------------------------------------------- 163 (303)
T ss_dssp CTTCEEEETTTT--------------------------------------------------------------------
T ss_pred CCCCccccCCCC--------------------------------------------------------------------
Confidence 999865321100
Q ss_pred cccCCCCccccccCCCCccChhhhcCC------CCCcccceehhhHHHHHHhhCCCCCCCCCC---------------hh
Q 035930 696 VVEPTGARSNSFVGTHEYLAPEIIKGE------GHGSSVDWWTFGIFLFELLYGRTPFKGSGN---------------DE 754 (857)
Q Consensus 696 ~~~~~~~~~~s~vGT~~YmAPEil~g~------~~s~ksDVWSLGvILyELLtGk~PF~g~~~---------------~e 754 (857)
.........+||+.|||||++.+. .|+.++|||||||+||||+||..||..... .+
T Consensus 164 ---~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 164 ---TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp ---EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred ---ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 001112346799999999999865 367799999999999999999877643221 12
Q ss_pred hhHHHhhccccCCCCC-----CCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 755 TLSNVVSQSLRFPGYP-----VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 755 ~l~~Iv~~~~~~p~~~-----~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
....+..+.++++.+. ..+..+.+||.+||..||.+||| +.||++
T Consensus 241 ~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~ 290 (303)
T 3hmm_A 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKK 290 (303)
T ss_dssp HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC----HHHHHH
T ss_pred HHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcC----HHHHHH
Confidence 2223333443332211 12346889999999999999999 677664
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=414.29 Aligned_cols=260 Identities=32% Similarity=0.551 Sum_probs=219.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccc-----------------------ccchhHHHHHHHH
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG-----------------------RKKMPRAQTEREI 523 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~-----------------------~~~~~~~~~EieI 523 (857)
+..++|++.+.||+|+||+||+|.+..+++.||||++....... ....+.+.+|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 44678999999999999999999999999999999997653221 1224668899999
Q ss_pred HHHcCCCCccccceeeee--CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCC
Q 035930 524 MQMLDHPFLPTLFAHFTT--EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPE 601 (857)
Q Consensus 524 Lr~L~HPnIV~L~~~f~~--~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPe 601 (857)
|+.++||||+++++++.+ ++.+||||||+++++|..++.. ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999999999999999986 6789999999999999776543 34999999999999999999999999999999999
Q ss_pred cEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhh
Q 035930 602 NILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKI 681 (857)
Q Consensus 602 NILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~ 681 (857)
|||++.++.+||+|||++......
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~-------------------------------------------------------- 190 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGS-------------------------------------------------------- 190 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSS--------------------------------------------------------
T ss_pred HEEECCCCCEEEecCCCccccccc--------------------------------------------------------
Confidence 999999999999999997432100
Q ss_pred hhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCC---CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHH
Q 035930 682 KSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEG---HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN 758 (857)
Q Consensus 682 ~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~---~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~ 758 (857)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........
T Consensus 191 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 251 (298)
T 2zv2_A 191 -------------------DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK 251 (298)
T ss_dssp -------------------SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred -------------------cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHH
Confidence 00112346999999999998765 37889999999999999999999998877777777
Q ss_pred HhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCC
Q 035930 759 VVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 759 Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
+......++..+.++.++.+||.+||..||.+||+ +.|||+||||.
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s----~~e~l~hp~~~ 297 (298)
T 2zv2_A 252 IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIV----VPEIKLHPWVT 297 (298)
T ss_dssp HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC----HHHHTTCHHHH
T ss_pred HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCC----HHHHhcCcccc
Confidence 77777777777789999999999999999999999 99999999995
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=416.96 Aligned_cols=263 Identities=28% Similarity=0.469 Sum_probs=229.6
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc---cchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR---KKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~---~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
++|.+.+.||+|+||+||+|.+..++..||||++........ ...+.+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 469999999999999999999999999999999976543221 13567889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC----cEEEecccchhhc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG----HIMLSDFDLSLRC 622 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg----~iKL~DFGLA~r~ 622 (857)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 9999999999999987643 499999999999999999999999999999999999999887 8999999997432
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
... .
T Consensus 169 ~~~----------------------------------------------------------------------------~ 172 (326)
T 2y0a_A 169 DFG----------------------------------------------------------------------------N 172 (326)
T ss_dssp CTT----------------------------------------------------------------------------S
T ss_pred CCC----------------------------------------------------------------------------C
Confidence 100 0
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLI 780 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI 780 (857)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+......++. ...++..+++||
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (326)
T 2y0a_A 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252 (326)
T ss_dssp CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHH
Confidence 112346999999999999999999999999999999999999999988877887777766555543 256899999999
Q ss_pred HhhccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
.+||..||.+||+ +.++|+||||...+|..
T Consensus 253 ~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~~ 282 (326)
T 2y0a_A 253 RRLLVKDPKKRMT----IQDSLQHPWIKPKDTQQ 282 (326)
T ss_dssp HHHSCSSGGGSCC----HHHHHHSTTTSCCSHHH
T ss_pred HHHccCChhhCCC----HHHHhcCCCccCCcchh
Confidence 9999999999999 99999999999998853
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=413.60 Aligned_cols=263 Identities=26% Similarity=0.414 Sum_probs=217.3
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|++++.||+|+||+||+|++. +++.||||++..... .......+.+|+++|+.++||||++++++|.+++.+||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 4578999999999999999999985 588999999975532 23334678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||++ ++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 97 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-- 172 (311)
T 3niz_A 97 VFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-- 172 (311)
T ss_dssp EEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC--
T ss_pred EEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC--
Confidence 999996 57877776544 34899999999999999999999999999999999999999999999999997432100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.......
T Consensus 173 -------------------------------------------------------------------------~~~~~~~ 179 (311)
T 3niz_A 173 -------------------------------------------------------------------------VRSYTHE 179 (311)
T ss_dssp -------------------------------------------------------------------------CC---CC
T ss_pred -------------------------------------------------------------------------cccccCC
Confidence 0011234
Q ss_pred cCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC-------------------
Q 035930 708 VGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP------------------- 767 (857)
Q Consensus 708 vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p------------------- 767 (857)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+........
T Consensus 180 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (311)
T 3niz_A 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQ 259 (311)
T ss_dssp CCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCC
T ss_pred cccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccc
Confidence 68999999999987 5689999999999999999999999998887777766654211110
Q ss_pred ---------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 768 ---------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 768 ---------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
..+.++.++.+||.+||+.||.+||+ ++|+|+||||+++++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 260 VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS----ARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTSCTT
T ss_pred cccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC----HHHHhcCcccccCCcc
Confidence 02346789999999999999999999 9999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=407.12 Aligned_cols=259 Identities=26% Similarity=0.389 Sum_probs=212.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+|+.++||||++++++|.+++.+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 689999999999999999999999999999999976532 2334467789999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++ +|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 154 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP---- 154 (292)
T ss_dssp ECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC----
T ss_pred ecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc----
Confidence 99965 5554444432 34999999999999999999999999999999999999999999999999997432100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.......+|
T Consensus 155 -----------------------------------------------------------------------~~~~~~~~~ 163 (292)
T 3o0g_A 155 -----------------------------------------------------------------------VRCYSAEVV 163 (292)
T ss_dssp -----------------------------------------------------------------------CSCCCSCCS
T ss_pred -----------------------------------------------------------------------cccccCCcc
Confidence 001123468
Q ss_pred CCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCC-CCCCChhhhHHHhhccccC---------------------
Q 035930 710 THEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPF-KGSGNDETLSNVVSQSLRF--------------------- 766 (857)
Q Consensus 710 T~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF-~g~~~~e~l~~Iv~~~~~~--------------------- 766 (857)
|+.|+|||++.+.. ++.++|||||||++|||++|..|| .+.+..+.+..+......+
T Consensus 164 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T 3o0g_A 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243 (292)
T ss_dssp CGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCC
T ss_pred ccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccccccc
Confidence 99999999998876 799999999999999999888875 4444455555554321111
Q ss_pred ------CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 767 ------PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 767 ------p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
...+.++.++++||.+||+.||++||+ ++|+|+||||+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSDF 289 (292)
T ss_dssp TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTC
T ss_pred CCcchhhcccccChHHHHHHHHHhccChhhCCC----HHHHhcCcccccC
Confidence 012357889999999999999999999 9999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=419.12 Aligned_cols=257 Identities=23% Similarity=0.398 Sum_probs=227.2
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|.+.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 46899999999999999999999999999999998754 23345678999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc--CCcEEEecccchhhcccCc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE--DGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~--dg~iKL~DFGLA~r~~~~~ 626 (857)
|||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 80 FEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp ECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 99999999999887643 24899999999999999999999999999999999999987 78999999999743210
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (321)
T 1tki_A 157 --------------------------------------------------------------------------GDNFRL 162 (321)
T ss_dssp --------------------------------------------------------------------------TCEEEE
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 001123
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLL 784 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L 784 (857)
.+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++. ++.++.++++||.+||
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 242 (321)
T 1tki_A 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL 242 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTS
T ss_pred ccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHc
Confidence 46899999999999998999999999999999999999999998888888888887766653 3568999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
..||.+||+ +.|+|+||||.+.
T Consensus 243 ~~dp~~Rpt----~~e~l~hp~~~~~ 264 (321)
T 1tki_A 243 VKERKSRMT----ASEALQHPWLKQK 264 (321)
T ss_dssp CSSGGGSCC----HHHHHHSHHHHSC
T ss_pred CCChhHCcC----HHHHhcChhhccC
Confidence 999999999 9999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=405.78 Aligned_cols=263 Identities=26% Similarity=0.355 Sum_probs=216.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc--cccchhHHHHHHHHHHHcC---CCCccccceeeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV--GRKKMPRAQTEREIMQMLD---HPFLPTLFAHFTT 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~--~~~~~~~~~~EieILr~L~---HPnIV~L~~~f~~ 541 (857)
+..++|++.+.||+|+||+||+|++..+++.||||++...... .......+.+|+++++.+. ||||++++++|..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567999999999999999999999999999999999754221 1222345678888877764 9999999999987
Q ss_pred CC-----eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecc
Q 035930 542 EK-----FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616 (857)
Q Consensus 542 ~~-----~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DF 616 (857)
.. .+|+||||+. ++|..++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 6899999995 69999988776666999999999999999999999999999999999999999999999999
Q ss_pred cchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccc
Q 035930 617 DLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLV 696 (857)
Q Consensus 617 GLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~ 696 (857)
|++.....
T Consensus 165 g~a~~~~~------------------------------------------------------------------------ 172 (308)
T 3g33_A 165 GLARIYSY------------------------------------------------------------------------ 172 (308)
T ss_dssp SCTTTSTT------------------------------------------------------------------------
T ss_pred ccccccCC------------------------------------------------------------------------
Confidence 99743110
Q ss_pred ccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--------
Q 035930 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG-------- 768 (857)
Q Consensus 697 ~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~-------- 768 (857)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..++......+.
T Consensus 173 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (308)
T 3g33_A 173 ----QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS 248 (308)
T ss_dssp ----CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCS
T ss_pred ----CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhh
Confidence 00112356899999999999999999999999999999999999999998877777776653211110
Q ss_pred -----------------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 769 -----------------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 769 -----------------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.+.++..+.+||.+||+.||.+||+ +.|+|+||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~h~~~~~~ 303 (308)
T 3g33_A 249 LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS----AFRALQHSYLHKD 303 (308)
T ss_dssp SCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSTTC---
T ss_pred ccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC----HHHHhcCccccCC
Confidence 1357889999999999999999999 9999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=403.85 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=213.9
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++++.||+|+||+||+|++ .+++.||||++..... .......+.+|+++|+.++||||+++++++.+++..|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 6788999999976532 2334467889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++ ++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 153 (288)
T 1ob3_A 80 EHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---- 153 (288)
T ss_dssp ECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc----
Confidence 9996 58988887653 34899999999999999999999999999999999999999999999999998542100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.......+|
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (288)
T 1ob3_A 154 -----------------------------------------------------------------------VRKYTHEIV 162 (288)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred -----------------------------------------------------------------------ccccccccc
Confidence 001123468
Q ss_pred CCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC-----C----------------
Q 035930 710 THEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF-----P---------------- 767 (857)
Q Consensus 710 T~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~-----p---------------- 767 (857)
|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+....... +
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T 1ob3_A 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242 (288)
T ss_dssp CCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCC
T ss_pred cccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccccc
Confidence 9999999999875 58999999999999999999999999887766666654321100 0
Q ss_pred ------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 768 ------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 768 ------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
....++.++.+||.+||..||.+||+ ++|+|+||||++.|
T Consensus 243 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKENN 288 (288)
T ss_dssp CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC--
T ss_pred CccHHHHhhhcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhcC
Confidence 01347889999999999999999999 99999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=423.56 Aligned_cols=258 Identities=31% Similarity=0.503 Sum_probs=224.5
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|.+.+.||+|+||+||+|.+..+++.||||++.............+.+|+.+|+.++||||++++++|.+.+.+||
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 35789999999999999999999999999999999987655555556778999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 v~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~--- 160 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--- 160 (336)
T ss_dssp EECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---
T ss_pred EEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---
Confidence 99999 788888776553 399999999999999999999999999999999999999999999999999743110
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.......
T Consensus 161 -------------------------------------------------------------------------~~~~~~~ 167 (336)
T 3h4j_B 161 -------------------------------------------------------------------------GNFLKTS 167 (336)
T ss_dssp -------------------------------------------------------------------------SBTTCCC
T ss_pred -------------------------------------------------------------------------Ccccccc
Confidence 0112345
Q ss_pred cCCCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 708 VGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+....+.+..+......+| ..+++++++||++||..
T Consensus 168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~ 245 (336)
T 3h4j_B 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP--DFLSPGAQSLIRRMIVA 245 (336)
T ss_dssp TTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC--TTSCHHHHHHHHTTSCS
T ss_pred cCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc--ccCCHHHHHHHHHHcCC
Confidence 79999999999998887 7899999999999999999999998776666665555544444 45899999999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCCCCC
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
||.+||+ ++||++||||..-
T Consensus 246 dP~~Rpt----~~eil~hp~~~~~ 265 (336)
T 3h4j_B 246 DPMQRIT----IQEIRRDPWFNVN 265 (336)
T ss_dssp SGGGSCC----HHHHTTCHHHHTT
T ss_pred ChhHCcC----HHHHHhChhhccC
Confidence 9999999 9999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=421.53 Aligned_cols=264 Identities=27% Similarity=0.485 Sum_probs=223.0
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc--cchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR--KKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~--~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
.++|++.+.||+|+||+||+|.+..+++.||||++........ ...+.+.+|+.+|+.++||||++++++|.+++.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3579999999999999999999999999999999975432221 23567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc---EEEecccchhh
Q 035930 547 LVMEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH---IMLSDFDLSLR 621 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~---iKL~DFGLA~r 621 (857)
|||||++|++|..++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999997766542 2234899999999999999999999999999999999999987654 99999999854
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
.... .
T Consensus 183 ~~~~---------------------------------------------------------------------------~ 187 (351)
T 3c0i_A 183 LGES---------------------------------------------------------------------------G 187 (351)
T ss_dssp CCTT---------------------------------------------------------------------------S
T ss_pred ecCC---------------------------------------------------------------------------C
Confidence 2110 0
Q ss_pred CccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHH
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDL 779 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dL 779 (857)
......+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+. ..+.+..+......++. +..++.++++|
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 266 (351)
T 3c0i_A 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDL 266 (351)
T ss_dssp CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 0112457999999999999999999999999999999999999999875 45566666666554432 35689999999
Q ss_pred HHhhccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 780 IRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
|.+||..||.+||+ +.++|+||||.+.++
T Consensus 267 i~~~L~~dP~~R~s----~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 267 VRRMLMLDPAERIT----VYEALNHPWLKERDR 295 (351)
T ss_dssp HHHHTCSSTTTSCC----HHHHHTSHHHHTHHH
T ss_pred HHHHCCCChhHCcC----HHHHhcChhhcCCcc
Confidence 99999999999999 999999999988665
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=404.37 Aligned_cols=259 Identities=33% Similarity=0.562 Sum_probs=227.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++.+.||+|+||+||+|.+..++..||||++.............+.+|+.+++.++||||++++++|.+.+..|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 56689999999999999999999999999999999997665444455667889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-- 161 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 161 (279)
T ss_dssp EEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence 9999999999998887653 389999999999999999999999999999999999999999999999998732100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.....
T Consensus 162 ---------------------------------------------------------------------------~~~~~ 166 (279)
T 3fdn_A 162 ---------------------------------------------------------------------------SRRTD 166 (279)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00123
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
..||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++. .++.++++||.+||..
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~ 244 (279)
T 3fdn_A 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISRLLKH 244 (279)
T ss_dssp -CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHCCS
T ss_pred cCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC--cCCHHHHHHHHHHhcc
Confidence 46899999999999999999999999999999999999999988877777777766666554 5899999999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCCCCC
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
||.+||+ +.||++||||...
T Consensus 245 ~p~~Rps----~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 245 NPSQRPM----LREVLEHPWITAN 264 (279)
T ss_dssp SGGGSCC----HHHHHHCHHHHHH
T ss_pred ChhhCCC----HHHHhhCccccCC
Confidence 9999999 9999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=423.14 Aligned_cols=258 Identities=27% Similarity=0.503 Sum_probs=226.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|.+.+.||+|+||+||+|.+..++..||||++..... .....+.+.+|+.+|+.++||||++++++|.+++..|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3579999999999999999999999999999999976533 223456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC---CcEEEecccchhhcccC
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED---GHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d---g~iKL~DFGLA~r~~~~ 625 (857)
|||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~- 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND- 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT-
T ss_pred EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC-
Confidence 99999999988887653 48999999999999999999999999999999999999765 4599999999743210
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.....
T Consensus 184 ---------------------------------------------------------------------------~~~~~ 188 (362)
T 2bdw_A 184 ---------------------------------------------------------------------------SEAWH 188 (362)
T ss_dssp ---------------------------------------------------------------------------CCSCC
T ss_pred ---------------------------------------------------------------------------Ccccc
Confidence 00112
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhh
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGL 783 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~ 783 (857)
..+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.+..+......++. +..+++++++||.+|
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 268 (362)
T 2bdw_A 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 268 (362)
T ss_dssp CSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHH
T ss_pred cCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 456999999999999999999999999999999999999999998888888888887776654 356899999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
|..||.+||+ +.++|+||||..
T Consensus 269 L~~dP~~R~t----~~e~l~hp~~~~ 290 (362)
T 2bdw_A 269 LTVNPKKRIT----ADQALKVPWICN 290 (362)
T ss_dssp SCSSGGGSCC----HHHHTTSHHHHT
T ss_pred cCCChhhCcC----HHHHhcCcccCC
Confidence 9999999999 999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=418.53 Aligned_cols=284 Identities=39% Similarity=0.724 Sum_probs=229.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc---CCCeEEEEEEecccccc-cccchhHHHHHHHHHHHc-CCCCccccceeeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLV-GRKKMPRAQTEREIMQML-DHPFLPTLFAHFTT 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~---~tg~~VAVKvi~k~~~~-~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~ 541 (857)
+..++|++++.||+|+||+||+|++. .+++.||||+++..... .......+.+|+++|+.+ +||||++++++|..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 45578999999999999999999984 58899999999765332 223445667899999999 69999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
++.+||||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999999887653 389999999999999999999999999999999999999999999999999853
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
+... ..
T Consensus 209 ~~~~--------------------------------------------------------------------------~~ 214 (355)
T 1vzo_A 209 FVAD--------------------------------------------------------------------------ET 214 (355)
T ss_dssp CCGG--------------------------------------------------------------------------GG
T ss_pred cccC--------------------------------------------------------------------------CC
Confidence 2100 00
Q ss_pred CccccccCCCCccChhhhcCC--CCCcccceehhhHHHHHHhhCCCCCCCCCChhh----hHHHhhccccCCCCCCCCHH
Q 035930 702 ARSNSFVGTHEYLAPEIIKGE--GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET----LSNVVSQSLRFPGYPVVSFH 775 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~--~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~----l~~Iv~~~~~~p~~~~is~~ 775 (857)
.....++||+.|+|||++.+. .++.++|||||||+||||++|+.||...+.... ...+......+ ...++..
T Consensus 215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 292 (355)
T 1vzo_A 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQEMSAL 292 (355)
T ss_dssp GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC--CTTSCHH
T ss_pred CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC--CcccCHH
Confidence 112245799999999999863 478999999999999999999999986543332 23333333333 3568999
Q ss_pred HHHHHHhhccCCcCCcCCch-hhHHHHHcCCCCCCCChhhhc--cCCCCCCCCCCc
Q 035930 776 ARDLIRGLLVKEPDNRLGAV-KGAAEIKQHPFFEGLNWALIR--CAVPPELPRSCD 828 (857)
Q Consensus 776 l~dLI~k~L~~DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~~~ 828 (857)
+++||.+||..||.+||++. ..++++++||||..++|..+. ...||+.|...+
T Consensus 293 ~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~ 348 (355)
T 1vzo_A 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRD 348 (355)
T ss_dssp HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC
T ss_pred HHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCcccc
Confidence 99999999999999999321 129999999999999998764 344677775433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=414.30 Aligned_cols=263 Identities=23% Similarity=0.322 Sum_probs=214.4
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|++++.||+|+||+||+|.+..+++.||||+++.... .......+.+|+++|+.++||||+++++++.+++.+||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 45689999999999999999999999999999999976532 22334556789999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc-----cCCcEEEecccchhhc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR-----EDGHIMLSDFDLSLRC 622 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~-----~dg~iKL~DFGLA~r~ 622 (857)
||||++ |+|..++..... +++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..+
T Consensus 111 v~e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999996 599988887643 99999999999999999999999999999999999994 4556999999998543
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
... ..
T Consensus 188 ~~~---------------------------------------------------------------------------~~ 192 (329)
T 3gbz_A 188 GIP---------------------------------------------------------------------------IR 192 (329)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred CCc---------------------------------------------------------------------------cc
Confidence 110 00
Q ss_pred ccccccCCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC-------------
Q 035930 703 RSNSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG------------- 768 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~------------- 768 (857)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+....+.+..++......+.
T Consensus 193 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (329)
T 3gbz_A 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWK 272 (329)
T ss_dssp -------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhh
Confidence 112346899999999998754 899999999999999999999999988777777666543211110
Q ss_pred ---------------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 769 ---------------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 769 ---------------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
...++.++++||.+||..||.+||+ ++|+|+||||++.+|+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 273 QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS----AKNALEHPYFSHNDFD 328 (329)
T ss_dssp TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSSSCSC
T ss_pred hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC----HHHHhCCcccCCCCCC
Confidence 0116789999999999999999999 9999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=414.19 Aligned_cols=262 Identities=26% Similarity=0.431 Sum_probs=219.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++++.||+|+||+||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+++..|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999975432 22335678999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 159 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 159 (323)
T ss_dssp EECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC--
Confidence 99999999998886543 49999999999999999999999999999999999999999999999999974321100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........+
T Consensus 160 -----------------------------------------------------------------------~~~~~~~~~ 168 (323)
T 3tki_A 160 -----------------------------------------------------------------------RERLLNKMC 168 (323)
T ss_dssp -----------------------------------------------------------------------EECCBCSCC
T ss_pred -----------------------------------------------------------------------cccccCCCc
Confidence 001123457
Q ss_pred CCCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCCh-hhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 709 GTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 709 GT~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~-e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+.... ..+.........++....++..+.+||.+||..
T Consensus 169 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 248 (323)
T 3tki_A 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE 248 (323)
T ss_dssp SCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCS
T ss_pred cCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccC
Confidence 9999999999988876 77999999999999999999999876554 333333444444444567899999999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
||.+||+ +.||++||||...-
T Consensus 249 dP~~R~t----~~eil~h~~~~~~~ 269 (323)
T 3tki_A 249 NPSARIT----IPDIKKDRWYNKPL 269 (323)
T ss_dssp STTTSCC----HHHHTTCTTTTCCC
T ss_pred ChhhCcC----HHHHhhChhhcccc
Confidence 9999999 99999999998653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=432.29 Aligned_cols=259 Identities=27% Similarity=0.502 Sum_probs=226.2
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+++|+.++||||++++++|.+++..|||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 35799999999999999999999999999999999765432 23345688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc---cCCcEEEecccchhhcccC
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR---EDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~---~dg~iKL~DFGLA~r~~~~ 625 (857)
|||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999999998887754 399999999999999999999999999999999999998 4678999999997432100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.....
T Consensus 167 ---------------------------------------------------------------------------~~~~~ 171 (444)
T 3soa_A 167 ---------------------------------------------------------------------------QQAWF 171 (444)
T ss_dssp ---------------------------------------------------------------------------CCBCC
T ss_pred ---------------------------------------------------------------------------Cceee
Confidence 01123
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhh
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGL 783 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~ 783 (857)
..+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+.+..+.+..+..+...++. ++.+++++++||.+|
T Consensus 172 ~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 251 (444)
T 3soa_A 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKM 251 (444)
T ss_dssp CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred cccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHH
Confidence 457999999999999999999999999999999999999999998888888888887766654 457899999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
|..||.+||+ +.|+|+||||..
T Consensus 252 L~~dP~~Rpt----a~e~L~hp~~~~ 273 (444)
T 3soa_A 252 LTINPSKRIT----AAEALKHPWISH 273 (444)
T ss_dssp SCSSTTTSCC----HHHHHHSCTTHH
T ss_pred cCCChhHCCC----HHHHhcCccccC
Confidence 9999999999 999999999964
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=416.17 Aligned_cols=260 Identities=28% Similarity=0.415 Sum_probs=220.2
Q ss_pred hccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-----CCCccccc
Q 035930 462 KQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-----HPFLPTLF 536 (857)
Q Consensus 462 ~~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-----HPnIV~L~ 536 (857)
...+.+..++|.++++||+|+||+||+|++..+++.||||++... ......+..|+++|+.+. ||||++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 345556778999999999999999999999999999999999743 233456678999999996 99999999
Q ss_pred eeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc---------
Q 035930 537 AHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE--------- 607 (857)
Q Consensus 537 ~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~--------- 607 (857)
++|...+..||||||+ +++|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence 9999999999999999 999999998776566999999999999999999999999999999999999975
Q ss_pred ----------------CCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccch
Q 035930 608 ----------------DGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRL 671 (857)
Q Consensus 608 ----------------dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~ 671 (857)
++.+||+|||++....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~------------------------------------------------ 213 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS------------------------------------------------ 213 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETT------------------------------------------------
T ss_pred hhcccccccccccccCCCCEEEEeccCceecC------------------------------------------------
Confidence 7899999999874210
Q ss_pred hhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC
Q 035930 672 LSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG 751 (857)
Q Consensus 672 ~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~ 751 (857)
......+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.+
T Consensus 214 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 214 ------------------------------DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp ------------------------------SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ------------------------------CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 00123468999999999999999999999999999999999999999877
Q ss_pred ChhhhHHHhhccccCC--------------------------CC------------------CCCCHHHHHHHHhhccCC
Q 035930 752 NDETLSNVVSQSLRFP--------------------------GY------------------PVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 752 ~~e~l~~Iv~~~~~~p--------------------------~~------------------~~is~~l~dLI~k~L~~D 787 (857)
..+.+..+......+| .. ...+..+.+||.+||+.|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 6666655543222221 00 012367889999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~ 808 (857)
|.+||+ +.|+|+||||+
T Consensus 344 P~~Rpt----a~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPS----PAELLKHKFLE 360 (360)
T ss_dssp GGGSCC----HHHHTTSGGGC
T ss_pred hhhCCC----HHHHhcCcccC
Confidence 999999 99999999995
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=402.35 Aligned_cols=260 Identities=33% Similarity=0.558 Sum_probs=229.2
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
.+..++|.+.+.||+|+||+||+|.+..++..||||++.............+.+|+++++.++||||+++++++.+++..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 35567899999999999999999999999999999999765544445556789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+++++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 99999999999998887653 389999999999999999999999999999999999999999999999998732100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
....
T Consensus 167 ----------------------------------------------------------------------------~~~~ 170 (284)
T 2vgo_A 167 ----------------------------------------------------------------------------LRRR 170 (284)
T ss_dssp ----------------------------------------------------------------------------SCBC
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0112
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
...||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+......++ ..++.++++||.+||.
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~ 248 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP--PFLSDGSKDLISKLLR 248 (284)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--TTSCHHHHHHHHHHSC
T ss_pred cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC--CcCCHHHHHHHHHHhh
Confidence 34689999999999999999999999999999999999999998877777777777666555 4589999999999999
Q ss_pred CCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 786 KEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.||.+||+ +.++++||||...
T Consensus 249 ~~p~~Rps----~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 249 YHPPQRLP----LKGVMEHPWVKAN 269 (284)
T ss_dssp SSGGGSCC----HHHHHTCHHHHHH
T ss_pred cCHhhCCC----HHHHhhCHHHHhh
Confidence 99999999 9999999999754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=411.70 Aligned_cols=264 Identities=28% Similarity=0.394 Sum_probs=206.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++++.||+|+||+||+|.+..+++.||||+++... .......+.+|+++|+.++||||++++++|.+++.+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 367999999999999999999999999999999997653 234456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCC----CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 549 MEYCPGGDLHVLRQKQP----SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~----~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
|||++ |+|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99996 68988776432 23489999999999999999999999999999999999999999999999999743210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
. ....
T Consensus 161 ~---------------------------------------------------------------------------~~~~ 165 (317)
T 2pmi_A 161 P---------------------------------------------------------------------------VNTF 165 (317)
T ss_dssp C---------------------------------------------------------------------------CCCC
T ss_pred C---------------------------------------------------------------------------cccC
Confidence 0 0011
Q ss_pred ccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC-----------------
Q 035930 705 NSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF----------------- 766 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~----------------- 766 (857)
...+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.......
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 245 (317)
T 2pmi_A 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPN 245 (317)
T ss_dssp CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTT
T ss_pred CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccc
Confidence 234689999999999874 68999999999999999999999999887777666664421110
Q ss_pred ---------------CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 767 ---------------PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 767 ---------------p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
.....++.++++||.+||+.||.+||+ +.|+|+||||.+..|..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 246 IQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS----AKQALHHPWFAEYYHHA 304 (317)
T ss_dssp CCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCC--
T ss_pred cccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC----HHHHhCChhhhcccchh
Confidence 011247889999999999999999999 99999999999876653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=420.84 Aligned_cols=280 Identities=27% Similarity=0.430 Sum_probs=210.9
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCC--e
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEK--F 544 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~--~ 544 (857)
..++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+|+.+. ||||++++++|..++ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3478999999999999999999999999999999986542 22344566789999999997 999999999997554 7
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|||||||. ++|..++... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+..
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 999999996 6898888764 389999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
...... . .+.... .............
T Consensus 162 ~~~~~~-----------~-----------~~~~~~--------------------------------~~~~~~~~~~~~~ 187 (388)
T 3oz6_A 162 IRRVTN-----------N-----------IPLSIN--------------------------------ENTENFDDDQPIL 187 (388)
T ss_dssp CCCCCC-----------C-----------GGGCCC---------------------------------------------
T ss_pred cccccc-----------c-----------cccccc--------------------------------ccccccccccccc
Confidence 100000 0 000000 0000000111223
Q ss_pred ccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC----------------
Q 035930 705 NSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP---------------- 767 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p---------------- 767 (857)
..++||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+.+..+.+..++... .+|
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~p~~~~~~~~~~~~~~~~ 266 (388)
T 3oz6_A 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI-DFPSNEDVESIQSPFAKTM 266 (388)
T ss_dssp --CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCHHHHHTSCCSSHHHH
T ss_pred cCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-CCCCHHHHHhccCHHHHHH
Confidence 46789999999999987 678999999999999999999999999988777776665321 111
Q ss_pred ------------------------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 768 ------------------------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 768 ------------------------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
....+++++.+||.+||..||.+||| ++|+|+||||+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t----~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 267 IESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS----ANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC----HHHHTTSTTTTTTC
T ss_pred HHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC----HHHHhCCHHHHHhc
Confidence 11257899999999999999999999 99999999987654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=406.39 Aligned_cols=264 Identities=30% Similarity=0.463 Sum_probs=229.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc---cchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR---KKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~---~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
++|++.+.||+|+||+||+|.+..+++.||||++........ ...+.+.+|+.+|+.++||||++++++|.+++..|
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 579999999999999999999999999999999976533221 13567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC----cEEEecccchhhc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG----HIMLSDFDLSLRC 622 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg----~iKL~DFGLA~r~ 622 (857)
+||||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 9999999999999987653 489999999999999999999999999999999999999888 7999999987432
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.. ..
T Consensus 170 ~~----------------------------------------------------------------------------~~ 173 (321)
T 2a2a_A 170 ED----------------------------------------------------------------------------GV 173 (321)
T ss_dssp CT----------------------------------------------------------------------------TC
T ss_pred Cc----------------------------------------------------------------------------cc
Confidence 10 00
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLI 780 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI 780 (857)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+......++. ...++..+++||
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 253 (321)
T 2a2a_A 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFI 253 (321)
T ss_dssp CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHH
T ss_pred cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHH
Confidence 112346899999999999999999999999999999999999999988878887777766555442 246889999999
Q ss_pred HhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhh
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li 815 (857)
.+||..||.+||+ +.++++||||..++|...
T Consensus 254 ~~~l~~dp~~Rps----~~e~l~hp~~~~~~~~~~ 284 (321)
T 2a2a_A 254 RKLLVKETRKRLT----IQEALRHPWITPVDNQQA 284 (321)
T ss_dssp HTTSCSSTTTSCC----HHHHHHSTTTSCSSHHHH
T ss_pred HHHcCCChhhCcC----HHHHhcCccccCCCcccc
Confidence 9999999999999 999999999999988643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=398.01 Aligned_cols=260 Identities=31% Similarity=0.573 Sum_probs=202.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++.+.||+|+||+||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999999999999999999766544445567889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~--- 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--- 165 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC---
Confidence 99999999999887653 34899999999999999999999999999999999999999999999999987432100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 166 ------------------------------------------------------------------------~~~~~~~~ 173 (278)
T 3cok_A 166 ------------------------------------------------------------------------HEKHYTLC 173 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ------------------------------------------------------------------------CCcceecc
Confidence 00012346
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+......++ ..++.++.+||.+||..||
T Consensus 174 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp 251 (278)
T 3cok_A 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP--SFLSIEAKDLIHQLLRRNP 251 (278)
T ss_dssp ------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC--TTSCHHHHHHHHHHSCSSG
T ss_pred CCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc--cccCHHHHHHHHHHcccCH
Confidence 89999999999999999999999999999999999999998776666665555444444 4589999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.+||+ ++++++||||...
T Consensus 252 ~~Rps----~~~~l~h~~~~~~ 269 (278)
T 3cok_A 252 ADRLS----LSSVLDHPFMSRN 269 (278)
T ss_dssp GGSCC----HHHHTTSTTTC--
T ss_pred hhCCC----HHHHhcCccccCC
Confidence 99999 9999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=430.45 Aligned_cols=293 Identities=25% Similarity=0.373 Sum_probs=204.3
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-----C
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE-----K 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~-----~ 543 (857)
.++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+++|+.++||||++++++|... .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 368999999999999999999999999999999996542 2233456788999999999999999999999543 5
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
.+||||||+ +++|..++.... .+++..++.+++||+.||+|||++|||||||||+||||+.++++||+|||+|+...
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eEEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 799999998 689988887653 49999999999999999999999999999999999999999999999999986532
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
...... ... +. .+... +. ....++. .......
T Consensus 208 ~~~~~~-------------~~~---------~~-----------~~~~~-----------~~--~~~~~~~--~~~~~~~ 239 (458)
T 3rp9_A 208 YPENGN-------------SQL---------PI-----------SPRED-----------DM--NLVTFPH--TKNLKRQ 239 (458)
T ss_dssp SCTTCC-------------CCC---------C------------------------------------------------
T ss_pred Cccccc-------------ccc---------cc-----------Ccccc-----------cc--ccccccc--ccccccc
Confidence 111000 000 00 00000 00 0000000 0001122
Q ss_pred cccccCCCCccChhhh-cCCCCCcccceehhhHHHHHHhh-----------CCCCCCCCCC-------------------
Q 035930 704 SNSFVGTHEYLAPEII-KGEGHGSSVDWWTFGIFLFELLY-----------GRTPFKGSGN------------------- 752 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil-~g~~~s~ksDVWSLGvILyELLt-----------Gk~PF~g~~~------------------- 752 (857)
...++||+.|||||++ .+..|+.++|||||||+||||++ |+++|.+.+.
T Consensus 240 ~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ 319 (458)
T 3rp9_A 240 LTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRG 319 (458)
T ss_dssp -----CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHH
T ss_pred ccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccC
Confidence 3567899999999987 46679999999999999999998 7777876531
Q ss_pred -hhhhHHHhhccc--------------------cC---------CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHH
Q 035930 753 -DETLSNVVSQSL--------------------RF---------PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 753 -~e~l~~Iv~~~~--------------------~~---------p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL 802 (857)
.+.+..++.... .+ ...+.++.++.+||++||.+||.+||| ++|+|
T Consensus 320 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----~~e~L 395 (458)
T 3rp9_A 320 NRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT----INECL 395 (458)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCC----HHHHH
T ss_pred CHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCC----HHHHh
Confidence 122222211000 00 113457899999999999999999999 99999
Q ss_pred cCCCCCCCChhhhcc
Q 035930 803 QHPFFEGLNWALIRC 817 (857)
Q Consensus 803 ~HPfF~~l~w~li~~ 817 (857)
+||||+++.|.....
T Consensus 396 ~Hp~f~~~~~~~~e~ 410 (458)
T 3rp9_A 396 AHPFFKEVRIAEVET 410 (458)
T ss_dssp HSGGGTTTCCGGGCC
T ss_pred cCHhhhhcCCCccCC
Confidence 999999999987653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=394.19 Aligned_cols=264 Identities=27% Similarity=0.486 Sum_probs=229.2
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++.+.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4689999999999999999999999999999999976532 233456778999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc---EEEecccchhhcccC
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH---IMLSDFDLSLRCAVN 625 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~---iKL~DFGLA~r~~~~ 625 (857)
|||+++++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~- 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND- 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS-
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc-
Confidence 99999999988776653 3899999999999999999999999999999999999987655 99999998743210
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.....
T Consensus 161 ---------------------------------------------------------------------------~~~~~ 165 (284)
T 3kk8_A 161 ---------------------------------------------------------------------------SEAWH 165 (284)
T ss_dssp ---------------------------------------------------------------------------SCBCC
T ss_pred ---------------------------------------------------------------------------Ccccc
Confidence 00112
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhh
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGL 783 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~ 783 (857)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+......++. ...+++++.+||.+|
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (284)
T 3kk8_A 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 245 (284)
T ss_dssp CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred CCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHH
Confidence 346899999999999999999999999999999999999999998888888877777665543 357899999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCCCChhhh
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li 815 (857)
|..||.+||+ +.++|+||||....+...
T Consensus 246 l~~dp~~Rps----~~~~l~h~~~~~~~~~~~ 273 (284)
T 3kk8_A 246 LTVNPKKRIT----ADQALKVPWICNRERVAS 273 (284)
T ss_dssp SCSSTTTSCC----HHHHTTSHHHHSCCCGGG
T ss_pred cccChhhCCC----HHHHhcCccccCChhHHh
Confidence 9999999999 999999999998766543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=417.07 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=212.6
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++||||++++++|.+.+.+||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA----AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST----TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc----cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 4568999999999999999999999999999999997542 234567899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc--EEEecccchhhcccC
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH--IMLSDFDLSLRCAVN 625 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~--iKL~DFGLA~r~~~~ 625 (857)
||||+++|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 94 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~- 170 (361)
T 3uc3_A 94 IMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 170 (361)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc-
Confidence 999999999998887643 3999999999999999999999999999999999999987765 99999998742100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.....
T Consensus 171 ---------------------------------------------------------------------------~~~~~ 175 (361)
T 3uc3_A 171 ---------------------------------------------------------------------------HSQPK 175 (361)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------cCCCC
Confidence 00112
Q ss_pred cccCCCCccChhhhcCCCCCcc-cceehhhHHHHHHhhCCCCCCCCCCh----hhhHHHhhccccCCCCCCCCHHHHHHH
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSS-VDWWTFGIFLFELLYGRTPFKGSGND----ETLSNVVSQSLRFPGYPVVSFHARDLI 780 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~k-sDVWSLGvILyELLtGk~PF~g~~~~----e~l~~Iv~~~~~~p~~~~is~~l~dLI 780 (857)
..+||+.|+|||++.+..++.+ +|||||||+||+|++|+.||.+.... ..+..+......++....+++++++||
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 255 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHH
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHH
Confidence 3469999999999998888655 89999999999999999999876543 334445556666777667899999999
Q ss_pred HhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
.+||..||.+||+ +.||++||||..
T Consensus 256 ~~~L~~dP~~Rps----~~ell~hp~f~~ 280 (361)
T 3uc3_A 256 SRIFVADPATRIS----IPEIKTHSWFLK 280 (361)
T ss_dssp HHHSCSCTTTSCC----HHHHHTSHHHHT
T ss_pred HHHccCChhHCcC----HHHHHhCcchhc
Confidence 9999999999999 999999999943
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=402.90 Aligned_cols=263 Identities=28% Similarity=0.430 Sum_probs=215.4
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+++|+.++||||++++++|.+.+..|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 368999999999999999999999999999999986542 1222345678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 155 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--- 155 (311)
T ss_dssp EECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc---
Confidence 99999999988877653 3899999999999999999999999999999999999999999999999997432100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.......+
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (311)
T 4agu_A 156 ------------------------------------------------------------------------SDYYDDEV 163 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ------------------------------------------------------------------------ccccCCCc
Confidence 00112346
Q ss_pred CCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-------------------ccCCC
Q 035930 709 GTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-------------------LRFPG 768 (857)
Q Consensus 709 GT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-------------------~~~p~ 768 (857)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+.... ...+.
T Consensus 164 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 4agu_A 164 ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPD 243 (311)
T ss_dssp --GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCC
T ss_pred CCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCC
Confidence 8999999999987 568999999999999999999999999887666554443211 11111
Q ss_pred ----------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 769 ----------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 769 ----------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
.+.++.++.+||.+||..||.+||+ +++||+||||+++.|-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 244 PEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT----CEQLLHHPYFENIREI 294 (311)
T ss_dssp CSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC----HHHHHTSGGGTTCC--
T ss_pred ccccchhhhhcccccHHHHHHHHHHccCChhhcCC----HHHHhcChHHHhccCH
Confidence 1457889999999999999999999 9999999999998764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=411.56 Aligned_cols=263 Identities=29% Similarity=0.400 Sum_probs=214.6
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+++.||+|+||+||+|.+..+++.||||++..... ......+.+|+++|+.++||||+++++++.+++..||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 689999999999999999999999999999999975432 122223457999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||++ |+|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~---- 153 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---- 153 (324)
T ss_dssp ECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC----
Confidence 9996 68888877654 34899999999999999999999999999999999999999999999999997431100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.......+|
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (324)
T 3mtl_A 154 -----------------------------------------------------------------------TKTYDNEVV 162 (324)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -----------------------------------------------------------------------ccccccccC
Confidence 001123468
Q ss_pred CCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC-------------------C--
Q 035930 710 THEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF-------------------P-- 767 (857)
Q Consensus 710 T~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~-------------------p-- 767 (857)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....... +
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (324)
T 3mtl_A 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKY 242 (324)
T ss_dssp CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCC
T ss_pred cccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccc
Confidence 999999999987 568999999999999999999999999987777666655421111 1
Q ss_pred -------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhh
Q 035930 768 -------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 768 -------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li 815 (857)
..+.++.++.+||.+||+.||.+||+ ++|+|+||||.++.+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~ 293 (324)
T 3mtl_A 243 RAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS----AEDAMKHPFFLSLGERIH 293 (324)
T ss_dssp CCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCSTTS
T ss_pred cchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC----HHHHhcChhhhhcccccc
Confidence 12357889999999999999999999 999999999998876554
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=418.73 Aligned_cols=258 Identities=29% Similarity=0.502 Sum_probs=218.6
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~L 547 (857)
.++|++.+.||+|+||+||+|.+..+++.||||++.+.. ....+|+++|.++ +||||++++++|.+++.+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 357999999999999999999999999999999997642 1235788888887 79999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC----CcEEEecccchhhcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED----GHIMLSDFDLSLRCA 623 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d----g~iKL~DFGLA~r~~ 623 (857)
||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+..+ +.+||+|||++....
T Consensus 94 v~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 999999999999887653 49999999999999999999999999999999999998543 359999999975321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.. ...
T Consensus 172 ~~---------------------------------------------------------------------------~~~ 176 (342)
T 2qr7_A 172 AE---------------------------------------------------------------------------NGL 176 (342)
T ss_dssp CT---------------------------------------------------------------------------TCC
T ss_pred CC---------------------------------------------------------------------------CCc
Confidence 00 011
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCC---CChhhhHHHhhccccCCC--CCCCCHHHHH
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGS---GNDETLSNVVSQSLRFPG--YPVVSFHARD 778 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~---~~~e~l~~Iv~~~~~~p~--~~~is~~l~d 778 (857)
....+||+.|+|||++.+..|+.++|||||||+||||++|..||.+. ...+++..+....+.++. +..++.++++
T Consensus 177 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 256 (342)
T 2qr7_A 177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKD 256 (342)
T ss_dssp BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHH
T ss_pred eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHH
Confidence 23457899999999999888999999999999999999999999863 334556666666665543 4578999999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhc
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIR 816 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~ 816 (857)
||++||..||.+||+ +.++++||||. +|..+.
T Consensus 257 li~~~L~~dP~~R~t----~~~il~hp~~~--~~~~~~ 288 (342)
T 2qr7_A 257 LVSKMLHVDPHQRLT----AALVLRHPWIV--HWDQLP 288 (342)
T ss_dssp HHHHHTCSSTTTSCC----HHHHTTSHHHH--TGGGSC
T ss_pred HHHHHCCCChhHCcC----HHHHhcCCeec--Cccccc
Confidence 999999999999999 99999999995 576553
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=412.37 Aligned_cols=271 Identities=32% Similarity=0.505 Sum_probs=226.0
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc--cccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV--GRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~--~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
++|++.+.||+|+||+||+|.+..++..||||++...... .......+.+|+++|+.++||||++++++|.+++..||
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5799999999999999999999999999999999765332 23455778999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhC--------------------------------------CCCCCcHHHHHHHHHHHHHHHHHHH
Q 035930 548 VMEYCPGGDLHVLRQKQ--------------------------------------PSRFFSEQAARFYVAEVLLALEYLH 589 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~--------------------------------------~~~~l~e~~~r~i~~QIl~gL~yLH 589 (857)
||||++||+|.+++... ....+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999887521 0112478889999999999999999
Q ss_pred HcCceeccCCCCcEEEccCC--cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCccccc
Q 035930 590 MLGVVYRDLKPENILVREDG--HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCF 667 (857)
Q Consensus 590 s~GIIHRDLKPeNILL~~dg--~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~ 667 (857)
++||+||||||+|||++.++ .+||+|||++..+.....
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~---------------------------------------- 225 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN---------------------------------------- 225 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC----------------------------------------
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCc----------------------------------------
Confidence 99999999999999998776 899999999854211000
Q ss_pred ccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcC--CCCCcccceehhhHHHHHHhhCCC
Q 035930 668 TPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKG--EGHGSSVDWWTFGIFLFELLYGRT 745 (857)
Q Consensus 668 s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g--~~~s~ksDVWSLGvILyELLtGk~ 745 (857)
..........||+.|+|||++.+ ..++.++|||||||+||||++|+.
T Consensus 226 -------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~ 274 (345)
T 3hko_A 226 -------------------------------GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274 (345)
T ss_dssp -------------------------------C--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------cccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 00001224569999999999976 678999999999999999999999
Q ss_pred CCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhh
Q 035930 746 PFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 746 PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li 815 (857)
||.+....+.+..++.....++. ...+++++++||.+||..||.+||+ +.++|+||||.++.|.+.
T Consensus 275 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~hp~~~~~~~~~~ 342 (345)
T 3hko_A 275 PFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD----AMRALQHPWISQFSDKIY 342 (345)
T ss_dssp SSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC----HHHHHHSHHHHTTSSCSS
T ss_pred CCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCC----HHHHhcChhhccChHhhE
Confidence 99999888888888877766544 3348999999999999999999999 999999999999876553
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=411.96 Aligned_cols=257 Identities=33% Similarity=0.517 Sum_probs=210.7
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|.+.+.||+|+||+||+|++..+++.||||+++... ..+.+.+|+++|+.++||||++++++|.+.+..|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 467999999999999999999999999999999997542 234578899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc---CCcEEEecccchhhcccC
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE---DGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~---dg~iKL~DFGLA~r~~~~ 625 (857)
|||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 127 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~- 203 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH- 203 (349)
T ss_dssp ECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc-
Confidence 99999999999887653 4899999999999999999999999999999999999975 88999999999743110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.....
T Consensus 204 ---------------------------------------------------------------------------~~~~~ 208 (349)
T 2w4o_A 204 ---------------------------------------------------------------------------QVLMK 208 (349)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00112
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChh-hhHHHhhccccCC--CCCCCCHHHHHHHHh
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE-TLSNVVSQSLRFP--GYPVVSFHARDLIRG 782 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e-~l~~Iv~~~~~~p--~~~~is~~l~dLI~k 782 (857)
..+||+.|+|||++.+..++.++|||||||+||||++|..||.+....+ .+..+......++ .+..++.++++||.+
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 288 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK 288 (349)
T ss_dssp ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHT
T ss_pred cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHH
Confidence 3468999999999999999999999999999999999999998776655 5556665554443 346789999999999
Q ss_pred hccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
||..||++||+ +.++|+||||.+..+
T Consensus 289 ~L~~dP~~Rpt----~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 289 LIVLDPKKRLT----TFQALQHPWVTGKAA 314 (349)
T ss_dssp TSCSSGGGSCC----HHHHHHSTTTTSTTC
T ss_pred HccCChhhCcC----HHHHhcCcccCCCcc
Confidence 99999999999 999999999987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=433.92 Aligned_cols=263 Identities=27% Similarity=0.452 Sum_probs=232.5
Q ss_pred ccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 463 QHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 463 ~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
..+.+..++|.+++.||+|+||+||+|.+..+|+.||||+++............+.+|+.+|+.++||||+++++++.+.
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 34556778999999999999999999999999999999999876544445567889999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
+.+||||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 99999999999999999987643 4999999999999999999999999999999999999999999999999997431
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.. ..
T Consensus 167 ~~----------------------------------------------------------------------------~~ 170 (476)
T 2y94_A 167 SD----------------------------------------------------------------------------GE 170 (476)
T ss_dssp CT----------------------------------------------------------------------------TC
T ss_pred cc----------------------------------------------------------------------------cc
Confidence 10 01
Q ss_pred ccccccCCCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~ 781 (857)
.....+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+.+..+.+..+....+..| ..+++++.+||.
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~Li~ 248 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP--QYLNPSVISLLK 248 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC--TTCCHHHHHHHH
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC--ccCCHHHHHHHH
Confidence 1234579999999999998876 7899999999999999999999999888888888877766555 358999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
+||..||.+||+ +.+|++||||..
T Consensus 249 ~~L~~dP~~Rpt----~~eil~hp~~~~ 272 (476)
T 2y94_A 249 HMLQVDPMKRAT----IKDIREHEWFKQ 272 (476)
T ss_dssp HHTCSSTTTSCC----HHHHHTCHHHHT
T ss_pred HHcCCCchhCcC----HHHHHhCHHhhh
Confidence 999999999999 999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=432.33 Aligned_cols=263 Identities=30% Similarity=0.466 Sum_probs=231.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++.+.||+|+||+||+|.+..+++.||||++.............+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 45799999999999999999999999999999999876555556677889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE---ccCCcEEEecccchhhcccC
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV---REDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL---~~dg~iKL~DFGLA~r~~~~ 625 (857)
|||+.+|+|.+++.... .+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||++..+...
T Consensus 105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 99999999998887653 49999999999999999999999999999999999999 56789999999998543110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
....
T Consensus 183 ----------------------------------------------------------------------------~~~~ 186 (484)
T 3nyv_A 183 ----------------------------------------------------------------------------KKMK 186 (484)
T ss_dssp ----------------------------------------------------------------------------CSHH
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0112
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--CCCCCCHHHHHHHHhh
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--GYPVVSFHARDLIRGL 783 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--~~~~is~~l~dLI~k~ 783 (857)
..+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+....+.++ .+..+++++++||++|
T Consensus 187 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 265 (484)
T 3nyv_A 187 DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKM 265 (484)
T ss_dssp HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHH
T ss_pred cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHH
Confidence 3469999999999987 699999999999999999999999999988888888888766554 3467899999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
|.+||.+||+ +.++|+||||+...+..
T Consensus 266 L~~dp~~R~s----~~e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 266 LTYVPSMRIS----ARDALDHEWIQTYTKEQ 292 (484)
T ss_dssp TCSSGGGSCC----HHHHHTSHHHHHHTC--
T ss_pred CCCChhHCcC----HHHHhhChhhccccccc
Confidence 9999999999 99999999998765543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=418.65 Aligned_cols=261 Identities=29% Similarity=0.444 Sum_probs=226.3
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++++.||+|+||+||+|.+..+++.||+|++..... .....+.+|+++|+.++||||++++++|.+++.+|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 3689999999999999999999999999999999976421 2234678999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc--CCcEEEecccchhhcccCc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE--DGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~--dg~iKL~DFGLA~r~~~~~ 626 (857)
|||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 127 ~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 99999999999887543 24899999999999999999999999999999999999974 478999999997432100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.....
T Consensus 205 ---------------------------------------------------------------------------~~~~~ 209 (387)
T 1kob_A 205 ---------------------------------------------------------------------------EIVKV 209 (387)
T ss_dssp ---------------------------------------------------------------------------SCEEE
T ss_pred ---------------------------------------------------------------------------cceee
Confidence 01123
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLL 784 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L 784 (857)
.+||+.|+|||++.+..++.++|||||||+||||++|..||.+.+..+.+..+......++. ...++.++++||.+||
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 289 (387)
T 1kob_A 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 289 (387)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTS
T ss_pred eccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHc
Confidence 46899999999999999999999999999999999999999998877788777776555443 4568999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
..||.+||+ +.++|+||||.+..+.
T Consensus 290 ~~dP~~Rpt----~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 290 QKEPRKRLT----VHDALEHPWLKGDHSN 314 (387)
T ss_dssp CSSGGGSCC----HHHHHTSTTTSSCCTT
T ss_pred CCChhHCcC----HHHHhhCccccCCccc
Confidence 999999999 9999999999986554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=401.67 Aligned_cols=267 Identities=30% Similarity=0.463 Sum_probs=213.4
Q ss_pred CCeEEE-eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEE
Q 035930 470 RHFKLH-KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 470 ~~Y~i~-~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~L 547 (857)
++|.+. +.||+|+||+||+|.+..+++.||||++.... ......+.+|+++|+++ +||||++++++|.+++.+|+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 578885 78999999999999999999999999997642 34456789999999885 79999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc---EEEecccchhhccc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH---IMLSDFDLSLRCAV 624 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~---iKL~DFGLA~r~~~ 624 (857)
||||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999887653 3899999999999999999999999999999999999998776 99999999743211
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
.... . .......
T Consensus 167 ~~~~-------------------~-------------------------------------------------~~~~~~~ 178 (316)
T 2ac3_A 167 NGDC-------------------S-------------------------------------------------PISTPEL 178 (316)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCcc-------------------c-------------------------------------------------ccccccc
Confidence 1000 0 0000112
Q ss_pred ccccCCCCccChhhhcC-----CCCCcccceehhhHHHHHHhhCCCCCCCCCCh---------------hhhHHHhhccc
Q 035930 705 NSFVGTHEYLAPEIIKG-----EGHGSSVDWWTFGIFLFELLYGRTPFKGSGND---------------ETLSNVVSQSL 764 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g-----~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~---------------e~l~~Iv~~~~ 764 (857)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..+..+.....
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 258 (316)
T 2ac3_A 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY 258 (316)
T ss_dssp ---CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC
T ss_pred ccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc
Confidence 24569999999999976 45899999999999999999999999876432 23455555555
Q ss_pred cCCC--CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 765 RFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 765 ~~p~--~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
.++. ...++..+++||.+||..||.+||+ +.|+|+||||++..|.
T Consensus 259 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 259 EFPDKDWAHISCAAKDLISKLLVRDAKQRLS----AAQVLQHPWVQGCAPE 305 (316)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSTTCC-----
T ss_pred ccCchhcccCCHHHHHHHHHHhhCChhhCCC----HHHHhcChhhcCCCCc
Confidence 5543 2458999999999999999999999 9999999999987664
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=404.93 Aligned_cols=265 Identities=28% Similarity=0.444 Sum_probs=227.8
Q ss_pred CCeEEE-eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEE
Q 035930 470 RHFKLH-KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 470 ~~Y~i~-~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~L 547 (857)
++|.+. +.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+|+.+. ||||++++++|.+.+..|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 467777 899999999999999999999999999976532 2334567889999999995 7999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc---CCcEEEecccchhhccc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE---DGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~---dg~iKL~DFGLA~r~~~ 624 (857)
||||+.+|+|..++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 999999999999887655556999999999999999999999999999999999999987 78999999999743210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
. ...
T Consensus 187 ~----------------------------------------------------------------------------~~~ 190 (327)
T 3lm5_A 187 A----------------------------------------------------------------------------CEL 190 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c----------------------------------------------------------------------------ccc
Confidence 0 001
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--CCCCCCHHHHHHHHh
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--GYPVVSFHARDLIRG 782 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--~~~~is~~l~dLI~k 782 (857)
...+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..+.+..+......++ ....++..+++||.+
T Consensus 191 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 270 (327)
T 3lm5_A 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQS 270 (327)
T ss_dssp ---CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHH
Confidence 234699999999999999999999999999999999999999999888777777766555443 345789999999999
Q ss_pred hccCCcCCcCCchhhHHHHHcCCCCCCCChhhh
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li 815 (857)
||..||.+||+ +++||+||||++++|..+
T Consensus 271 ~L~~dP~~Rpt----~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 271 LLVKNPEKRPT----AEICLSHSWLQQWDFENL 299 (327)
T ss_dssp HSCSSGGGSCC----HHHHTTCGGGCCCCTTCC
T ss_pred HcCCChhhCcC----HHHHhCCHhhcccccccc
Confidence 99999999999 999999999999999765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=419.89 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=209.4
Q ss_pred CCCeEEE-eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHH-HHcCCCCccccceeeee----C
Q 035930 469 MRHFKLH-KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM-QMLDHPFLPTLFAHFTT----E 542 (857)
Q Consensus 469 ~~~Y~i~-~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieIL-r~L~HPnIV~L~~~f~~----~ 542 (857)
.++|.+. +.||.|+||+||+|.+..+++.||||+++.. ..+.+|++++ +.++||||++++++|.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 3567776 7999999999999999999999999998632 3567888887 55689999999999876 6
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc---CCcEEEecccch
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE---DGHIMLSDFDLS 619 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~---dg~iKL~DFGLA 619 (857)
+++|||||||+||+|.+++.......+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 68999999999999999998765556999999999999999999999999999999999999987 789999999997
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
.....
T Consensus 212 ~~~~~--------------------------------------------------------------------------- 216 (400)
T 1nxk_A 212 KETTS--------------------------------------------------------------------------- 216 (400)
T ss_dssp EECC----------------------------------------------------------------------------
T ss_pred cccCC---------------------------------------------------------------------------
Confidence 43110
Q ss_pred CCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChh----hhHHHhhccccCCC--CCCCC
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE----TLSNVVSQSLRFPG--YPVVS 773 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e----~l~~Iv~~~~~~p~--~~~is 773 (857)
.......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+..... ....+....+.++. +..++
T Consensus 217 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 295 (400)
T 1nxk_A 217 -HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSC
T ss_pred -CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCC
Confidence 001124578999999999999999999999999999999999999998765432 34555555555543 45789
Q ss_pred HHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 774 FHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
.++++||++||..||.+||+ +.+||+||||.+
T Consensus 296 ~~~~~li~~~L~~dP~~Rpt----~~eil~hp~~~~ 327 (400)
T 1nxk_A 296 EEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 327 (400)
T ss_dssp HHHHHHHHTTSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcC----HHHHhcCccccC
Confidence 99999999999999999999 999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=429.19 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=210.2
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-----
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE----- 542 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~----- 542 (857)
..++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+|+.++||||++++++|...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 3578999999999999999999999999999999997653 2334456788999999999999999999999654
Q ss_pred -CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 543 -KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 543 -~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
..+||||||+++ +|..++.. .+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 467999999965 46555543 289999999999999999999999999999999999999999999999999843
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
... .
T Consensus 214 ~~~----------------------------------------------------------------------------~ 217 (464)
T 3ttj_A 214 AGT----------------------------------------------------------------------------S 217 (464)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred cCC----------------------------------------------------------------------------C
Confidence 110 0
Q ss_pred CccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC---------------
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF--------------- 766 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~--------------- 766 (857)
......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..++......
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~ 297 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297 (464)
T ss_dssp CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHH
T ss_pred cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhH
Confidence 11234579999999999999999999999999999999999999999988777776665421110
Q ss_pred ----CCCCC---------------------CCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 767 ----PGYPV---------------------VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 767 ----p~~~~---------------------is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
+.... .++++++||.+||.+||.+||| ++|+|+||||..
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~~~~ 361 (464)
T 3ttj_A 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINV 361 (464)
T ss_dssp HTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGG
T ss_pred hhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC----HHHHhcChhhhh
Confidence 00000 1467999999999999999999 999999999984
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=413.62 Aligned_cols=259 Identities=29% Similarity=0.426 Sum_probs=213.0
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC-----
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK----- 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~----- 543 (857)
.++|++++.||+|+||+||+|.+..+|+.||||++.... ........+.+|+++|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 468999999999999999999999999999999996543 22334567889999999999999999999998763
Q ss_pred -eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 544 -FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 544 -~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
.+|+||||+ +++|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 89999988764 3899999999999999999999999999999999999999999999999997431
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
. .
T Consensus 179 ~------------------------------------------------------------------------------~ 180 (367)
T 1cm8_A 179 D------------------------------------------------------------------------------S 180 (367)
T ss_dssp C------------------------------------------------------------------------------S
T ss_pred c------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred ccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--------------
Q 035930 703 RSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP-------------- 767 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p-------------- 767 (857)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..++.....++
T Consensus 181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~ 260 (367)
T 1cm8_A 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 260 (367)
T ss_dssp SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence 0123568999999999988 6799999999999999999999999998877766666554211110
Q ss_pred ---------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 768 ---------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 768 ---------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
..+.+++++.+||.+||..||.+||+ ++++|+||||..+.+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t----~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHDTE 318 (367)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC---
T ss_pred HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC----HHHHhcChHHHhhcCCc
Confidence 12457899999999999999999999 99999999999886654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=396.18 Aligned_cols=260 Identities=27% Similarity=0.493 Sum_probs=227.8
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|.+.+.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 44689999999999999999999999999999999977654444556678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 93 v~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 168 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-- 168 (294)
T ss_dssp EEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--
Confidence 999999999998887653 3899999999999999999999999999999999999999999999999987432100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.......
T Consensus 169 -------------------------------------------------------------------------~~~~~~~ 175 (294)
T 2rku_A 169 -------------------------------------------------------------------------GERKKVL 175 (294)
T ss_dssp -------------------------------------------------------------------------TCCBCCC
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011234
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+......++ ..++..+.+||.+||..|
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~ 253 (294)
T 2rku_A 176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--KHINPVAASLIQKMLQTD 253 (294)
T ss_dssp CSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--TTSCHHHHHHHHHHTCSS
T ss_pred cCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc--cccCHHHHHHHHHHcccC
Confidence 689999999999999999999999999999999999999998877777777766655555 458999999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
|.+||+ ++++++||||...
T Consensus 254 p~~Rps----~~~ll~~~~~~~~ 272 (294)
T 2rku_A 254 PTARPT----INELLNDEFFTSG 272 (294)
T ss_dssp GGGSCC----GGGGGGSHHHHTS
T ss_pred hhhCcC----HHHHhhChheecC
Confidence 999999 9999999999764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=401.72 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=220.6
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|...+.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+.+|+.++||||++++++|...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4888999999999999999999999999999997542 3445678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
|+++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 123 ~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----- 194 (321)
T 2c30_A 123 FLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----- 194 (321)
T ss_dssp CCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-----
T ss_pred cCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC-----
Confidence 99999999988653 3899999999999999999999999999999999999999999999999987432100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
.......+||
T Consensus 195 ----------------------------------------------------------------------~~~~~~~~gt 204 (321)
T 2c30_A 195 ----------------------------------------------------------------------VPKRKSLVGT 204 (321)
T ss_dssp ----------------------------------------------------------------------SCCBCCCCSC
T ss_pred ----------------------------------------------------------------------ccccccccCC
Confidence 0011245699
Q ss_pred CCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-CCCCCCCCHHHHHHHHhhccCCcC
Q 035930 711 HEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-FPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 711 ~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..+...... +.....++..+++||.+||..||+
T Consensus 205 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 284 (321)
T 2c30_A 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQ 284 (321)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred ccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999999999999999999987776666665544322 223345889999999999999999
Q ss_pred CcCCchhhHHHHHcCCCCCCC
Q 035930 790 NRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 790 ~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+||+ +.++++||||.+.
T Consensus 285 ~Rps----~~ell~hp~~~~~ 301 (321)
T 2c30_A 285 ERAT----AQELLDHPFLLQT 301 (321)
T ss_dssp TSCC----HHHHHTSGGGGGC
T ss_pred hCcC----HHHHhcChhhccC
Confidence 9999 9999999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=391.72 Aligned_cols=254 Identities=34% Similarity=0.544 Sum_probs=223.2
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||+|+||+||+|.+..++..||+|++.... ....+.+.+|+++|+.++||||++++++|.+.+..|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999997643 234567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE---ccCCcEEEecccchhhcccCc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV---REDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL---~~dg~iKL~DFGLA~r~~~~~ 626 (857)
||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp ECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred eccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 9999999988887653 38999999999999999999999999999999999999 77899999999987432100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.....
T Consensus 163 ---------------------------------------------------------------------------~~~~~ 167 (277)
T 3f3z_A 163 ---------------------------------------------------------------------------KMMRT 167 (277)
T ss_dssp ---------------------------------------------------------------------------SCBCC
T ss_pred ---------------------------------------------------------------------------cchhc
Confidence 01123
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLL 784 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L 784 (857)
..||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+.+..+......++. ...+++.+.+||.+||
T Consensus 168 ~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 246 (277)
T 3f3z_A 168 KVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLL 246 (277)
T ss_dssp CCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHT
T ss_pred cCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHc
Confidence 4689999999998765 999999999999999999999999998888888888777666654 2368999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
..||.+||+ +.++|+||||+.
T Consensus 247 ~~dp~~R~s----~~~~l~h~~~~~ 267 (277)
T 3f3z_A 247 TKSPKQRIT----SLQALEHEWFEK 267 (277)
T ss_dssp CSSTTTSCC----HHHHTTSHHHHH
T ss_pred cCChhhCcC----HHHHhcCHHHhc
Confidence 999999999 999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=392.00 Aligned_cols=267 Identities=30% Similarity=0.426 Sum_probs=225.0
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc------cccchhHHHHHHHHHHHcC-CCCccccceeeee
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV------GRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTT 541 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~------~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~ 541 (857)
.++|++.+.||+|+||+||+|.+..+++.||||+++..... .....+.+.+|+++|+.+. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46899999999999999999999999999999999754211 1122356788999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
++..|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 999999999999999999987653 489999999999999999999999999999999999999999999999998743
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
....
T Consensus 174 ~~~~---------------------------------------------------------------------------- 177 (298)
T 1phk_A 174 LDPG---------------------------------------------------------------------------- 177 (298)
T ss_dssp CCTT----------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 2100
Q ss_pred CccccccCCCCccChhhhc------CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCC
Q 035930 702 ARSNSFVGTHEYLAPEIIK------GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVS 773 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~------g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is 773 (857)
.......||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.+..+.+..+......++. ...++
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (298)
T 1phk_A 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 257 (298)
T ss_dssp CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSC
T ss_pred cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccC
Confidence 0112346899999999985 456899999999999999999999999988777777777776665543 34689
Q ss_pred HHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhcc
Q 035930 774 FHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRC 817 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~ 817 (857)
..+.+||.+||..||.+||+ +.++++||||++..|+.++.
T Consensus 258 ~~l~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~~~~ 297 (298)
T 1phk_A 258 DTVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQYVVEEVRH 297 (298)
T ss_dssp HHHHHHHHHHCCSSGGGSCC----HHHHTTSGGGCTTC------
T ss_pred HHHHHHHHHHccCCcccCCC----HHHHHhChHhhhccchhhcc
Confidence 99999999999999999999 99999999999998876653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=401.74 Aligned_cols=268 Identities=24% Similarity=0.382 Sum_probs=209.0
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC------
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK------ 543 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~------ 543 (857)
++|++++.||+|+||+||+|++..+++.||||++.... .....+.+.+|+++|+.++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 57999999999999999999999999999999997542 2344567899999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEeecCCCChHHHHhhCCC-CCCcH
Q 035930 544 ---------------------------------------------------FSCLVMEYCPGGDLHVLRQKQPS-RFFSE 571 (857)
Q Consensus 544 ---------------------------------------------------~l~LVmEy~~gGsL~~ll~~~~~-~~l~e 571 (857)
+.|+||||+++++|.+++..... ....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999999999999886543 23566
Q ss_pred HHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCC
Q 035930 572 QAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEAS 651 (857)
Q Consensus 572 ~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~ 651 (857)
..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~-------------------- 223 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV-------------------- 223 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc--------------------
Confidence 678999999999999999999999999999999999999999999998653211100000
Q ss_pred cCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCccccee
Q 035930 652 CIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWW 731 (857)
Q Consensus 652 ~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVW 731 (857)
....+........+||+.|+|||++.+..++.++|||
T Consensus 224 -------------------------------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 260 (332)
T 3qd2_B 224 -------------------------------------------LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260 (332)
T ss_dssp ---------------------------------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHH
T ss_pred -------------------------------------------cccccccccccccCCCcCccChHHhcCCCCcchhhHH
Confidence 0000001122456799999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC-CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 732 TFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP-GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 732 SLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p-~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
||||++|||++|..|+.. ....+..+... .++ .....++++.+||.+||..||.+||+ +.++|+||||+++
T Consensus 261 slG~il~el~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 261 SLGLILFELLYSFSTQME--RVRIITDVRNL--KFPLLFTQKYPQEHMMVQDMLSPSPTERPE----ATDIIENAIFENL 332 (332)
T ss_dssp HHHHHHHHHHSCCCCHHH--HHHHHHHHHTT--CCCHHHHHHCHHHHHHHHHHHCSSGGGSCC----HHHHHHSTTCCCC
T ss_pred HHHHHHHHHHHcCCChhH--HHHHHHHhhcc--CCCcccccCChhHHHHHHHHccCCCCcCCC----HHHHhhchhhhcC
Confidence 999999999998777532 11222222222 222 12345778999999999999999999 9999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=419.36 Aligned_cols=288 Identities=25% Similarity=0.355 Sum_probs=214.2
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-----C
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE-----K 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~-----~ 543 (857)
.++|.+++.||+|+||+||+|.+..+++.||||++.... .......++.+|+.+|+.++||||+++++++... +
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 468999999999999999999999999999999997542 2233456788999999999999999999999876 5
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
.+||||||+ +++|..++.... .+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIA-DSDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecC-CcCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 799999999 569998887653 49999999999999999999999999999999999999999999999999986532
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
....... ....... . .+..........
T Consensus 181 ~~~~~~~-------------~~~~~~~------------------------~----------------~~~~~~~~~~~~ 207 (432)
T 3n9x_A 181 SEKDTNI-------------VNDLEEN------------------------E----------------EPGPHNKNLKKQ 207 (432)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccccc-------------ccccccc------------------------c----------------cccccccchhcc
Confidence 1110000 0000000 0 000000001122
Q ss_pred cccccCCCCccChhhh-cCCCCCcccceehhhHHHHHHhhC-----------CCCCCCCCC-----------------hh
Q 035930 704 SNSFVGTHEYLAPEII-KGEGHGSSVDWWTFGIFLFELLYG-----------RTPFKGSGN-----------------DE 754 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil-~g~~~s~ksDVWSLGvILyELLtG-----------k~PF~g~~~-----------------~e 754 (857)
...++||+.|+|||++ .+..|+.++|||||||+||||++| .++|.+.+. .+
T Consensus 208 ~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ 287 (432)
T 3n9x_A 208 LTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287 (432)
T ss_dssp ---CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHH
T ss_pred ccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHH
Confidence 3567899999999986 556699999999999999999984 444444321 11
Q ss_pred hhHHHhhc------------------------cccCC-----CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCC
Q 035930 755 TLSNVVSQ------------------------SLRFP-----GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHP 805 (857)
Q Consensus 755 ~l~~Iv~~------------------------~~~~p-----~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HP 805 (857)
.+..++.. ....+ ..+.+++++.+||.+||..||.+||+ ++|+|+||
T Consensus 288 ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp 363 (432)
T 3n9x_A 288 QLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRIT----IDQALDHP 363 (432)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTCG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCC----HHHHhcCh
Confidence 12111110 00011 12458999999999999999999999 99999999
Q ss_pred CCCCCChhhhcc
Q 035930 806 FFEGLNWALIRC 817 (857)
Q Consensus 806 fF~~l~w~li~~ 817 (857)
||+++.|.....
T Consensus 364 ~f~~~~~~~~e~ 375 (432)
T 3n9x_A 364 YLKDVRKKKLEN 375 (432)
T ss_dssp GGTTTCCTTTC-
T ss_pred hhhhccCcccCc
Confidence 999999986653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=406.74 Aligned_cols=271 Identities=27% Similarity=0.392 Sum_probs=217.9
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccc--ccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG--RKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~--~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
.++|.+++.||+|+||+||+|.+..+++.||||++....... ......+.+|+++|+.++||||++++++|.+.+..|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 468999999999999999999999999999999997543221 122356789999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+.+ +|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-- 164 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-- 164 (346)
T ss_dssp EEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--
T ss_pred EEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC--
Confidence 99999965 8887776543 3488999999999999999999999999999999999999999999999999843210
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.......
T Consensus 165 -------------------------------------------------------------------------~~~~~~~ 171 (346)
T 1ua2_A 165 -------------------------------------------------------------------------PNRAYTH 171 (346)
T ss_dssp -------------------------------------------------------------------------CCCCCCC
T ss_pred -------------------------------------------------------------------------CcccCCc
Confidence 0011224
Q ss_pred ccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC-----CC------------
Q 035930 707 FVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF-----PG------------ 768 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~-----p~------------ 768 (857)
.+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..++...... +.
T Consensus 172 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
T 1ua2_A 172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 251 (346)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred ccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccc
Confidence 4689999999999765 48999999999999999999999999988777777776532111 10
Q ss_pred ---------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCC
Q 035930 769 ---------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVP 820 (857)
Q Consensus 769 ---------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~p 820 (857)
...++.++++||.+||..||.+||+ +.|+|+||||....|....+..|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~h~~f~~~~~~~~~~~~~ 308 (346)
T 1ua2_A 252 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRPGPTPGCQLP 308 (346)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSSCCCCSSSSC
T ss_pred cCCCChHHhhccCCHHHHHHHHHHhccChhhCCC----HHHHhcChhhhcCCCCCCcccCC
Confidence 1346789999999999999999999 99999999999887665444333
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=390.64 Aligned_cols=262 Identities=27% Similarity=0.447 Sum_probs=220.1
Q ss_pred cccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 464 HGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 464 ~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
.+.+..++|.+++.||+|+||+||+|.+..+++.||||++.............+.+|+.+|+.++||||+++++++.+.+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34466789999999999999999999999999999999997665444556678899999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred eEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999999999887653 38999999999999999999999999999999999999999999999999974311
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.. ..
T Consensus 163 ~~----------------------------------------------------------------------------~~ 166 (276)
T 2h6d_A 163 DG----------------------------------------------------------------------------EF 166 (276)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred CC----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred cccccCCCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......+.+..+......++ ..++..+.+||.+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~ 244 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP--EYLNRSVATLLMH 244 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHHH
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc--hhcCHHHHHHHHH
Confidence 113358999999999998776 6899999999999999999999998777676666665554444 4589999999999
Q ss_pred hccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
||..||.+||+ +.+|++||||+.
T Consensus 245 ~l~~~p~~Rps----~~~~l~h~~~~~ 267 (276)
T 2h6d_A 245 MLQVDPLKRAT----IKDIREHEWFKQ 267 (276)
T ss_dssp HTCSSGGGSCC----HHHHHHSHHHHT
T ss_pred HccCChhhCCC----HHHHHhChhhcc
Confidence 99999999999 999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=406.04 Aligned_cols=260 Identities=27% Similarity=0.493 Sum_probs=228.5
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|.+.+.||+|+||+||++.+..+++.||+|++...........+.+.+|+.+|+.++||||++++++|.+.+.+|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34689999999999999999999999999999999987654444556678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||+.+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 119 v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 194 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-- 194 (335)
T ss_dssp EECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--
Confidence 999999999998887653 3899999999999999999999999999999999999999999999999997432100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.......
T Consensus 195 -------------------------------------------------------------------------~~~~~~~ 201 (335)
T 2owb_A 195 -------------------------------------------------------------------------GERKKVL 201 (335)
T ss_dssp -------------------------------------------------------------------------TCCBCCC
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011234
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
+||+.|+|||++.+..++.++|||||||+||+|++|+.||......+.+..+......++ ..++..+.+||.+||..|
T Consensus 202 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~d 279 (335)
T 2owb_A 202 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--KHINPVAASLIQKMLQTD 279 (335)
T ss_dssp CSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--TTSCHHHHHHHHHHTCSS
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC--ccCCHHHHHHHHHHccCC
Confidence 699999999999999999999999999999999999999998877777777776666555 458999999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
|.+||+ +.+|++||||...
T Consensus 280 p~~Rps----~~ell~~~~~~~~ 298 (335)
T 2owb_A 280 PTARPT----INELLNDEFFTSG 298 (335)
T ss_dssp GGGSCC----GGGGGGSHHHHTS
T ss_pred hhHCcC----HHHHhcCccccCC
Confidence 999999 9999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=416.97 Aligned_cols=258 Identities=29% Similarity=0.460 Sum_probs=219.1
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEee
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEY 551 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy 551 (857)
|...+.||+|+||+||+|.+..++..||||+++.... ...+.+.+|+++|+.++||||++++++|.+.+.+||||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 4447789999999999999999999999999976432 3345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE--ccCCcEEEecccchhhcccCcccc
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV--REDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL--~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 168 ~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~---- 242 (373)
T 2x4f_A 168 VDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---- 242 (373)
T ss_dssp CTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT----
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc----
Confidence 99999988876543 248999999999999999999999999999999999999 56689999999998532100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
......+|
T Consensus 243 ------------------------------------------------------------------------~~~~~~~g 250 (373)
T 2x4f_A 243 ------------------------------------------------------------------------EKLKVNFG 250 (373)
T ss_dssp ------------------------------------------------------------------------CBCCCCCS
T ss_pred ------------------------------------------------------------------------cccccccC
Confidence 01123469
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhccCC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L~~D 787 (857)
|+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++.....++. ...++.++++||.+||..|
T Consensus 251 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 330 (373)
T 2x4f_A 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKE 330 (373)
T ss_dssp SCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSS
T ss_pred CCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCC
Confidence 99999999999999999999999999999999999999998888888888877665543 3568999999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
|.+||+ +.|+|+||||.+..|.
T Consensus 331 p~~Rps----~~e~l~hp~~~~~~~~ 352 (373)
T 2x4f_A 331 KSWRIS----ASEALKHPWLSDHKLH 352 (373)
T ss_dssp GGGSCC----HHHHHHSHHHHCHHHH
T ss_pred hhhCCC----HHHHhcCcCcCCCchh
Confidence 999999 9999999999987764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=392.52 Aligned_cols=264 Identities=28% Similarity=0.495 Sum_probs=226.0
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc---cchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR---KKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~---~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
++|++.+.||+|+||+||+|.+..+++.||||+++....... ...+.+.+|+.+|+.++||||+++++++.+.+..|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999976543222 23567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC----cEEEecccchhhc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG----HIMLSDFDLSLRC 622 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg----~iKL~DFGLA~r~ 622 (857)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999887643 389999999999999999999999999999999999998877 8999999987432
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
... .
T Consensus 163 ~~~----------------------------------------------------------------------------~ 166 (283)
T 3bhy_A 163 EAG----------------------------------------------------------------------------N 166 (283)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred cCC----------------------------------------------------------------------------C
Confidence 100 0
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLI 780 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI 780 (857)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+......++. ...++..+.+||
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 246 (283)
T 3bhy_A 167 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 246 (283)
T ss_dssp -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHH
T ss_pred cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHH
Confidence 012345899999999999999999999999999999999999999988777777776655544432 246889999999
Q ss_pred HhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhh
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li 815 (857)
.+||..||.+||+ +.++++||||+.+.|...
T Consensus 247 ~~~l~~dp~~Rps----~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 247 RRLLVKDPKRRMT----IAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp HTTSCSSGGGSCC----HHHHHHCHHHHHHHHCCC
T ss_pred HHHccCCHhHCcC----HHHHHhCHHHHHHHHHhh
Confidence 9999999999999 999999999998876654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=419.13 Aligned_cols=259 Identities=29% Similarity=0.470 Sum_probs=210.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC------C
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE------K 543 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~------~ 543 (857)
.+|.+++.||+|+||+||+|++..+++.||||++..+. ....+|+++|+.++||||++++++|... .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 47999999999999999999999999999999986541 1224799999999999999999998542 2
Q ss_pred eEEEEEeecCCCChHHHHhh--CCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC-CcEEEecccchh
Q 035930 544 FSCLVMEYCPGGDLHVLRQK--QPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED-GHIMLSDFDLSL 620 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~--~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d-g~iKL~DFGLA~ 620 (857)
+++|||||+++ +|..++.. .....+++..++.++.||+.||+|||++|||||||||+||||+.+ +.+||+|||+++
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 57899999965 55544432 122459999999999999999999999999999999999999965 578999999985
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
.+..
T Consensus 206 ~~~~---------------------------------------------------------------------------- 209 (420)
T 1j1b_A 206 QLVR---------------------------------------------------------------------------- 209 (420)
T ss_dssp ECCT----------------------------------------------------------------------------
T ss_pred hccc----------------------------------------------------------------------------
Confidence 3210
Q ss_pred CCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhc-----------------
Q 035930 701 GARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ----------------- 762 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~----------------- 762 (857)
......++||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.+..+.+..++..
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~ 289 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 289 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 0011245789999999999875 7899999999999999999999999998777766666542
Q ss_pred cccCCC----------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhc
Q 035930 763 SLRFPG----------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIR 816 (857)
Q Consensus 763 ~~~~p~----------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~ 816 (857)
.+.++. .+.++.++++||.+||.+||.+||+ +.|+|+||||.++.|...+
T Consensus 290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~ 349 (420)
T 1j1b_A 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELRDPNVK 349 (420)
T ss_dssp CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGGCTTCC
T ss_pred hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC----HHHHhCCHhhccccccccc
Confidence 112221 1346889999999999999999999 9999999999988776543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=397.79 Aligned_cols=264 Identities=26% Similarity=0.380 Sum_probs=220.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeee----
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTT---- 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~---- 541 (857)
...++|++.+.||+|+||+||+|.+..+++.||||++... ......+.+|+.+|+.+ +||||++++++|..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC----cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 4457899999999999999999999999999999998754 23456788999999999 79999999999987
Q ss_pred --CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 542 --EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 542 --~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
.+.+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 568999999999999999998765456999999999999999999999999999999999999999999999999987
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
......
T Consensus 177 ~~~~~~-------------------------------------------------------------------------- 182 (326)
T 2x7f_A 177 AQLDRT-------------------------------------------------------------------------- 182 (326)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred eecCcC--------------------------------------------------------------------------
Confidence 431100
Q ss_pred CCCccccccCCCCccChhhhc-----CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCH
Q 035930 700 TGARSNSFVGTHEYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSF 774 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~-----g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~ 774 (857)
.......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+......+..+............++.
T Consensus 183 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 2x7f_A 183 -VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 261 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCH
T ss_pred -ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCH
Confidence 00112346899999999997 566899999999999999999999999887766666655554444344466899
Q ss_pred HHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 775 HARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 775 ~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
.+.+||.+||..||.+||+ +.++++||||....+.
T Consensus 262 ~l~~li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 262 KFQSFIESCLVKNHSQRPA----TEQLMKHPFIRDQPNE 296 (326)
T ss_dssp HHHHHHHHHCCSSGGGSCC----HHHHHTSHHHHCCTTH
T ss_pred HHHHHHHHHhccChhhCCC----HHHHhhChHHhhCccc
Confidence 9999999999999999999 9999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=392.14 Aligned_cols=257 Identities=30% Similarity=0.474 Sum_probs=216.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+.+.||+|+||+||+|.+..++..||+|++.... .....+.+.+|+++|+.++||||++++++|.+.+..|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 57999999999999999999999999999999997653 2345677899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE---ccCCcEEEecccchhhccc
Q 035930 550 EYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV---REDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL---~~dg~iKL~DFGLA~r~~~ 624 (857)
||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999998877532 12349999999999999999999999999999999999999 4567899999998743110
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
. ...
T Consensus 180 ~----------------------------------------------------------------------------~~~ 183 (285)
T 3is5_A 180 D----------------------------------------------------------------------------EHS 183 (285)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c----------------------------------------------------------------------------ccC
Confidence 0 011
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC-CCCCCHHHHHHHHhh
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG-YPVVSFHARDLIRGL 783 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~-~~~is~~l~dLI~k~ 783 (857)
....||+.|+|||++. ..++.++|||||||++|||++|+.||.+....+....+......++. ...+++++.+||.+|
T Consensus 184 ~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 262 (285)
T 3is5_A 184 TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQM 262 (285)
T ss_dssp ---CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHH
T ss_pred cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHH
Confidence 2346899999999986 46899999999999999999999999988777666665554444332 244789999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
|..||.+||+ +.|||+||||++
T Consensus 263 L~~dP~~Rps----~~e~l~hp~f~~ 284 (285)
T 3is5_A 263 LTKDPERRPS----AAQVLHHEWFKQ 284 (285)
T ss_dssp TCSCTTTSCC----HHHHHTSGGGGC
T ss_pred ccCChhhCcC----HHHHhcCHHhhc
Confidence 9999999999 999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=403.41 Aligned_cols=267 Identities=23% Similarity=0.403 Sum_probs=229.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccch--------------hHHHHHHHHHHHcCCCCc
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKM--------------PRAQTEREIMQMLDHPFL 532 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~--------------~~~~~EieILr~L~HPnI 532 (857)
...++|.+.+.||+|+||+||+|.+ +++.||||++........... ..+.+|+++|+.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 4567999999999999999999999 899999999976543322222 778999999999999999
Q ss_pred cccceeeeeCCeEEEEEeecCCCChHHH------HhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEE
Q 035930 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVL------RQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILV 605 (857)
Q Consensus 533 V~L~~~f~~~~~l~LVmEy~~gGsL~~l------l~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL 605 (857)
+++++++.+.+..|+||||+++++|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999887 555434569999999999999999999999 999999999999999
Q ss_pred ccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhh
Q 035930 606 REDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDL 685 (857)
Q Consensus 606 ~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~ 685 (857)
+.++.++|+|||++......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~------------------------------------------------------------ 205 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK------------------------------------------------------------ 205 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT------------------------------------------------------------
T ss_pred cCCCcEEEeccccccccccc------------------------------------------------------------
Confidence 99999999999987431100
Q ss_pred hcccCCCCcccccCCCCccccccCCCCccChhhhcCC-CCCc-ccceehhhHHHHHHhhCCCCCCCCCC-hhhhHHHhhc
Q 035930 686 AAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGE-GHGS-SVDWWTFGIFLFELLYGRTPFKGSGN-DETLSNVVSQ 762 (857)
Q Consensus 686 ~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~-~~s~-ksDVWSLGvILyELLtGk~PF~g~~~-~e~l~~Iv~~ 762 (857)
......||+.|+|||++.+. .++. ++|||||||++|||++|..||..... .+.+..+...
T Consensus 206 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~ 268 (348)
T 2pml_X 206 -----------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268 (348)
T ss_dssp -----------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC
T ss_pred -----------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence 11234689999999999987 6766 99999999999999999999998776 6666777666
Q ss_pred cccCCCC-----------------CCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhc
Q 035930 763 SLRFPGY-----------------PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIR 816 (857)
Q Consensus 763 ~~~~p~~-----------------~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~ 816 (857)
...++.. ..++.++.+||.+||..||.+||+ +.++++||||.+.+|..+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps----~~e~l~hp~f~~~~~~~~~ 335 (348)
T 2pml_X 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT----SEDALKHEWLADTNIEDLR 335 (348)
T ss_dssp CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGTTCCHHHHH
T ss_pred CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCC----HHHHhcCccccCCCHHHHH
Confidence 6665532 568999999999999999999999 9999999999999997654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=408.36 Aligned_cols=268 Identities=25% Similarity=0.389 Sum_probs=223.8
Q ss_pred ccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 463 QHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 463 ~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
..+.+..++|++.+.||+|+||+||+|.+..++..||+|++.... .......+.+|+.+|+.++||||++++++|.++
T Consensus 26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 345677789999999999999999999999999999999997652 233446788999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML-GVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~-GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
+..||||||+++++|.+++.... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++..
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred CEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999999999987653 389999999999999999999985 999999999999999999999999998743
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
...
T Consensus 182 ~~~----------------------------------------------------------------------------- 184 (360)
T 3eqc_A 182 LID----------------------------------------------------------------------------- 184 (360)
T ss_dssp HHH-----------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 210
Q ss_pred CccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhh-------------------------
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL------------------------- 756 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l------------------------- 756 (857)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 0012346899999999999999999999999999999999999999876543321
Q ss_pred -----------------HHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhh
Q 035930 757 -----------------SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 757 -----------------~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li 815 (857)
..+............++.++++||.+||..||.+||+ ++++|+||||++.+|..+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCC----HHHHHTSHHHHHHHHSCC
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCC----HHHHhhChHhhcchHhhh
Confidence 1111221111222357889999999999999999999 999999999998877644
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=386.16 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=219.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG--CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc--chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 57999999999999999999999999999999997542 2234567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--- 159 (276)
T 2yex_A 85 EYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN--- 159 (276)
T ss_dssp ECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT---
T ss_pred EecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc---
Confidence 999999999888654 348999999999999999999999999999999999999999999999999874321100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........+|
T Consensus 160 ----------------------------------------------------------------------~~~~~~~~~~ 169 (276)
T 2yex_A 160 ----------------------------------------------------------------------RERLLNKMCG 169 (276)
T ss_dssp ----------------------------------------------------------------------EECCBCCCCS
T ss_pred ----------------------------------------------------------------------chhcccCCcc
Confidence 0001124568
Q ss_pred CCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCCh-hhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 710 THEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 710 T~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~-e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
|+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.... ..+..+.......+....++..+.+||.+||..|
T Consensus 170 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 249 (276)
T 2yex_A 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVEN 249 (276)
T ss_dssp CGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSS
T ss_pred ccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCC
Confidence 999999999988776 77999999999999999999999876543 2334444433344444578999999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
|.+||+ +++|++||||...
T Consensus 250 p~~Rps----~~~il~~~~~~~~ 268 (276)
T 2yex_A 250 PSARIT----IPDIKKDRWYNKP 268 (276)
T ss_dssp TTTSCC----HHHHTTCTTTTCC
T ss_pred chhCCC----HHHHhcCccccCh
Confidence 999999 9999999999865
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=399.06 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=205.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHH-HcCCCCccccceeeeeCCeEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ-MLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr-~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
++|++.++||+|+||+||+|.+..+++.||||++....... ........|+..+. .++||||++++++|.+++.+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh-HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 57999999999999999999999999999999986543222 22233444555554 44899999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+ +++|..++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--- 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--- 210 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC---
Confidence 9999 778887776553 34999999999999999999999999999999999999999999999999997432100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.......
T Consensus 211 -------------------------------------------------------------------------~~~~~~~ 217 (311)
T 3p1a_A 211 -------------------------------------------------------------------------GAGEVQE 217 (311)
T ss_dssp -----------------------------------------------------------------------------CCC
T ss_pred -------------------------------------------------------------------------CCCcccC
Confidence 0012345
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
||+.|+|||++.+ .++.++|||||||+||||++|..||.+. +.+..+............++.++.+||.+||..||
T Consensus 218 gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 293 (311)
T 3p1a_A 218 GDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDP 293 (311)
T ss_dssp CCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSST
T ss_pred CCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHhccCCCcccccCCCHHHHHHHHHHcCCCh
Confidence 8999999999987 6999999999999999999998777543 23333333333222235689999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~ 809 (857)
++||+ +++||+||||++
T Consensus 294 ~~Rpt----~~ell~hp~~~~ 310 (311)
T 3p1a_A 294 KLRAT----AEALLALPVLRQ 310 (311)
T ss_dssp TTSCC----HHHHHTSGGGSC
T ss_pred hhCcC----HHHHHhCccccC
Confidence 99999 999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=391.91 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=210.6
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeee--CCe
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTT--EKF 544 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~--~~~ 544 (857)
..++|++++.||+|+||+||+|.+..+++.||||+++.. ....+.+|+++|+.+. ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 457899999999999999999999999999999998643 3466889999999997 9999999999987 678
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC-cEEEecccchhhcc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG-HIMLSDFDLSLRCA 623 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg-~iKL~DFGLA~r~~ 623 (857)
.|+||||+++++|..++.. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 108 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999999988753 88999999999999999999999999999999999999777 89999999974321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.. ..
T Consensus 183 ~~----------------------------------------------------------------------------~~ 186 (330)
T 3nsz_A 183 PG----------------------------------------------------------------------------QE 186 (330)
T ss_dssp TT----------------------------------------------------------------------------CC
T ss_pred CC----------------------------------------------------------------------------Cc
Confidence 00 01
Q ss_pred cccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCC-hhhhHHHhh-------------cccc---
Q 035930 704 SNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-DETLSNVVS-------------QSLR--- 765 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~-~e~l~~Iv~-------------~~~~--- 765 (857)
....+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||..... .+.+..+.. ....
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence 123468999999999987 6689999999999999999999999964432 222222211 0000
Q ss_pred -------------------CCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 766 -------------------FPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 766 -------------------~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
......++.++++||.+||..||.+||+ ++|+|+||||.++.|.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVKD 329 (330)
T ss_dssp HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSGGGTTCC--
T ss_pred chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC----HHHHhcCccHhhhccC
Confidence 1112237899999999999999999999 9999999999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=405.99 Aligned_cols=254 Identities=29% Similarity=0.509 Sum_probs=198.1
Q ss_pred CCeEEE---eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeE
Q 035930 470 RHFKLH---KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 470 ~~Y~i~---~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l 545 (857)
.+|.+. +.||+|+||+||+|.+..+++.||||++... ....+.+|+.+|+.+. ||||++++++|.++...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 356665 7899999999999999999999999999653 3456788999999997 99999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC---cEEEecccchhhc
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG---HIMLSDFDLSLRC 622 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg---~iKL~DFGLA~r~ 622 (857)
||||||+++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999988763 499999999999999999999999999999999999998766 8999999997431
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
... ..
T Consensus 160 ~~~---------------------------------------------------------------------------~~ 164 (325)
T 3kn6_A 160 PPD---------------------------------------------------------------------------NQ 164 (325)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred CCC---------------------------------------------------------------------------CC
Confidence 100 01
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC-------hhhhHHHhhccccCCC--CCCCC
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-------DETLSNVVSQSLRFPG--YPVVS 773 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~-------~e~l~~Iv~~~~~~p~--~~~is 773 (857)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+. .+.+..+....+.++. +..++
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 11234689999999999999999999999999999999999999987543 3445555555554443 23589
Q ss_pred HHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 774 FHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+++++||.+||..||.+||+ +.++++||||++.
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt----~~ell~h~w~~~~ 277 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLK----MSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCC----TTTSTTCGGGCTT
T ss_pred HHHHHHHHHHCCCChhHCCC----HHHHhcChhhccC
Confidence 99999999999999999999 9999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=425.13 Aligned_cols=258 Identities=31% Similarity=0.488 Sum_probs=224.3
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 579999999999999999999999999999999975432 2344567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc---cCCcEEEecccchhhcccCc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR---EDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~---~dg~iKL~DFGLA~r~~~~~ 626 (857)
||+.+|+|.+++.... .+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||++..+...
T Consensus 101 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 9999999988876653 399999999999999999999999999999999999995 4568999999997432100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.....
T Consensus 178 ---------------------------------------------------------------------------~~~~~ 182 (486)
T 3mwu_A 178 ---------------------------------------------------------------------------TKMKD 182 (486)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred ---------------------------------------------------------------------------CccCC
Confidence 01123
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--CCCCCCHHHHHHHHhhc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--GYPVVSFHARDLIRGLL 784 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--~~~~is~~l~dLI~k~L 784 (857)
.+||+.|+|||++.+. |+.++|||||||++|+|++|..||.+.+..+.+..+......++ .+..+++++++||.+||
T Consensus 183 ~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 261 (486)
T 3mwu_A 183 RIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261 (486)
T ss_dssp CTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHT
T ss_pred CcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHc
Confidence 4699999999999874 99999999999999999999999999888888888887766543 44678999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
..||.+||+ +.++|+||||+...
T Consensus 262 ~~dp~~R~t----~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 262 TFHPSLRIT----ATQCLEHPWIQKYS 284 (486)
T ss_dssp CSSTTTSCC----HHHHHHCHHHHHTC
T ss_pred CCChhhCcC----HHHHhcCHhhccCc
Confidence 999999999 99999999998653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=411.76 Aligned_cols=273 Identities=30% Similarity=0.473 Sum_probs=216.1
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC----
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK---- 543 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~---- 543 (857)
...+|.+.+.||+|+||+||+|++..++. ||+|.+.... . ...+|+++|+.++||||++++++|...+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~----~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK----R---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT----T---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc----c---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 34579999999999999999999987776 7888775431 1 1247999999999999999999996543
Q ss_pred --eEEEEEeecCCCChHHHHhh-CCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc-cCCcEEEecccch
Q 035930 544 --FSCLVMEYCPGGDLHVLRQK-QPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR-EDGHIMLSDFDLS 619 (857)
Q Consensus 544 --~l~LVmEy~~gGsL~~ll~~-~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~-~dg~iKL~DFGLA 619 (857)
++||||||++++.+..+... .....+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||++
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 48999999976555443321 1223599999999999999999999999999999999999999 7999999999998
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
+.+..
T Consensus 190 ~~~~~--------------------------------------------------------------------------- 194 (394)
T 4e7w_A 190 KILIA--------------------------------------------------------------------------- 194 (394)
T ss_dssp EECCT---------------------------------------------------------------------------
T ss_pred ccccC---------------------------------------------------------------------------
Confidence 53210
Q ss_pred CCCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc---------------
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS--------------- 763 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~--------------- 763 (857)
......++||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.+..+.+..++...
T Consensus 195 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 195 -GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp -TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred -CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 0011245689999999999875 48999999999999999999999999988777766665421
Q ss_pred --ccCCC----------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCCCCCc
Q 035930 764 --LRFPG----------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELPRSCD 828 (857)
Q Consensus 764 --~~~p~----------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P~~~~ 828 (857)
..++. .+.+++++++||.+||++||.+||+ +.|+|+||||+++.|...+......+|...+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~ 346 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT----AIEALCHPFFDELRTGEARMPNGRELPPLFN 346 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGSTTTSSCCCCTTSSCCCCSCC
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC----HHHHhcChhhhhhccccccCCCCCCCCCcCC
Confidence 11111 2347889999999999999999999 9999999999999987665433344554433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=424.84 Aligned_cols=260 Identities=31% Similarity=0.485 Sum_probs=221.2
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++++.||+|+||+||+|++..++..||||++.+.... ......+.+|+.+|+.++||||++++++|.+.+.+||||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4799999999999999999999999999999999865432 233567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc---CCcEEEecccchhhcccCc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE---DGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~---dg~iKL~DFGLA~r~~~~~ 626 (857)
|||++|+|.+++.... .+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||++..+..
T Consensus 116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~-- 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN-- 191 (494)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT--
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC--
Confidence 9999999988776653 3899999999999999999999999999999999999976 45599999999743210
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 192 --------------------------------------------------------------------------~~~~~~ 197 (494)
T 3lij_A 192 --------------------------------------------------------------------------QKKMKE 197 (494)
T ss_dssp --------------------------------------------------------------------------TBCBCC
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 001224
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLL 784 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L 784 (857)
.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+....+.+..+......++. +..++..+++||++||
T Consensus 198 ~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 276 (494)
T 3lij_A 198 RLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQML 276 (494)
T ss_dssp CCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHT
T ss_pred cCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHC
Confidence 569999999999874 6999999999999999999999999999888888888887766543 4678999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
..||.+||+ +.++|+||||....+.
T Consensus 277 ~~dp~~R~s----~~e~l~hp~~~~~~~~ 301 (494)
T 3lij_A 277 QFDSQRRIS----AQQALEHPWIKEMCSK 301 (494)
T ss_dssp CSSTTTSCC----HHHHHTCHHHHHHHHH
T ss_pred CCChhhCcc----HHHHhcCcccccCccc
Confidence 999999999 9999999999875443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=396.93 Aligned_cols=261 Identities=25% Similarity=0.342 Sum_probs=216.5
Q ss_pred cccccCCCeEEEeEEccCCceEEEEEEE-cCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCC------Cccccc
Q 035930 464 HGCMGMRHFKLHKKLGCGDIGTVYLAEL-IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP------FLPTLF 536 (857)
Q Consensus 464 ~~~~~~~~Y~i~~~LG~G~fGtVyla~~-~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HP------nIV~L~ 536 (857)
.+....++|++.+.||+|+||+||+|.+ ..+++.||||+++.. ......+.+|+++|+.++|+ +|++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 3445668999999999999999999998 568899999999753 23346678899999988655 599999
Q ss_pred eeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc---------
Q 035930 537 AHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE--------- 607 (857)
Q Consensus 537 ~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~--------- 607 (857)
++|.+.++.||||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 899999888776556899999999999999999999999999999999999987
Q ss_pred ----------CCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHh
Q 035930 608 ----------DGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAK 677 (857)
Q Consensus 608 ----------dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~ 677 (857)
++.++|+|||++....
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~------------------------------------------------------ 188 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDD------------------------------------------------------ 188 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETT------------------------------------------------------
T ss_pred ccccccccccCCCceEeeCcccccCc------------------------------------------------------
Confidence 6689999999874210
Q ss_pred hhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhH
Q 035930 678 SRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS 757 (857)
Q Consensus 678 ~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~ 757 (857)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+.
T Consensus 189 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 189 ------------------------EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp ------------------------SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred ------------------------cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 00123468999999999999999999999999999999999999999877655544
Q ss_pred HHhhccccCC------------------------------------------CCCCCCHHHHHHHHhhccCCcCCcCCch
Q 035930 758 NVVSQSLRFP------------------------------------------GYPVVSFHARDLIRGLLVKEPDNRLGAV 795 (857)
Q Consensus 758 ~Iv~~~~~~p------------------------------------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~ 795 (857)
.+......+| .....+.++.+||.+||..||.+||+
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-- 322 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT-- 322 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC--
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC--
Confidence 4332111111 01223567899999999999999999
Q ss_pred hhHHHHHcCCCCCCCC
Q 035930 796 KGAAEIKQHPFFEGLN 811 (857)
Q Consensus 796 ~~a~ELL~HPfF~~l~ 811 (857)
+.|+++||||+.+.
T Consensus 323 --~~ell~hp~f~~~~ 336 (339)
T 1z57_A 323 --LREALKHPFFDLLK 336 (339)
T ss_dssp --HHHHTTSGGGGGGG
T ss_pred --HHHHhcCHHHHHHh
Confidence 99999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=404.47 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=213.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc-----cchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR-----KKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~-----~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
++|++.+.||+|+||+||+|.+..+++.||||+++....... .....+.+|+++|+.++||||++++++|.+++.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 579999999999999999999999999999999987543222 234456789999999999999999999999999
Q ss_pred EEEEEeecCCC-ChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 545 SCLVMEYCPGG-DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 545 l~LVmEy~~gG-sL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
+|+||||+.+| +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999999777 9998887654 39999999999999999999999999999999999999999999999999874321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
. ...
T Consensus 182 ~----------------------------------------------------------------------------~~~ 185 (335)
T 3dls_A 182 R----------------------------------------------------------------------------GKL 185 (335)
T ss_dssp T----------------------------------------------------------------------------TCC
T ss_pred C----------------------------------------------------------------------------CCc
Confidence 0 011
Q ss_pred cccccCCCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||... ..........+ ..++.++.+||.+
T Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~~~~--~~~~~~l~~li~~ 257 (335)
T 3dls_A 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL------EETVEAAIHPP--YLVSKELMSLVSG 257 (335)
T ss_dssp BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG------GGGTTTCCCCS--SCCCHHHHHHHHH
T ss_pred eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH------HHHHhhccCCC--cccCHHHHHHHHH
Confidence 124569999999999998887 88999999999999999999999753 12222223333 4489999999999
Q ss_pred hccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
||..||.+||+ +.+|++||||.+
T Consensus 258 ~L~~dP~~Rps----~~ell~hp~~~~ 280 (335)
T 3dls_A 258 LLQPVPERRTT----LEKLVTDPWVTQ 280 (335)
T ss_dssp HTCSSGGGSCC----HHHHHHCTTTTC
T ss_pred HccCChhhCcC----HHHHhcCccccC
Confidence 99999999999 999999999965
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=413.83 Aligned_cols=256 Identities=25% Similarity=0.358 Sum_probs=215.5
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc------CCCCccccceeeee
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML------DHPFLPTLFAHFTT 541 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L------~HPnIV~L~~~f~~ 541 (857)
...+|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+|+.+ +|+||++++++|..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 456899999999999999999999999999999999754 22335567888888887 57899999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc--EEEecccch
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH--IMLSDFDLS 619 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~--iKL~DFGLA 619 (857)
.+++||||||+ +++|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.++. +||+|||++
T Consensus 171 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999999999 468988888776566999999999999999999999999999999999999999987 999999987
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
....
T Consensus 250 ~~~~---------------------------------------------------------------------------- 253 (429)
T 3kvw_A 250 CYEH---------------------------------------------------------------------------- 253 (429)
T ss_dssp EETT----------------------------------------------------------------------------
T ss_pred eecC----------------------------------------------------------------------------
Confidence 3210
Q ss_pred CCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC------------
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP------------ 767 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p------------ 767 (857)
......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..++......+
T Consensus 254 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~ 331 (429)
T 3kvw_A 254 --QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331 (429)
T ss_dssp --CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHH
T ss_pred --CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhh
Confidence 011245789999999999999999999999999999999999999998877776665553210000
Q ss_pred -------------------------------------C--------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHH
Q 035930 768 -------------------------------------G--------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 768 -------------------------------------~--------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL 802 (857)
. ....++++.+||.+||+.||.+||| ++|+|
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt----a~e~L 407 (429)
T 3kvw_A 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT----PGQAL 407 (429)
T ss_dssp HBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC----HHHHH
T ss_pred ccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC----HHHHh
Confidence 0 0123778999999999999999999 99999
Q ss_pred cCCCCCCC
Q 035930 803 QHPFFEGL 810 (857)
Q Consensus 803 ~HPfF~~l 810 (857)
+||||+..
T Consensus 408 ~Hpw~~~~ 415 (429)
T 3kvw_A 408 RHPWLRRR 415 (429)
T ss_dssp TSTTTC--
T ss_pred CChhhccC
Confidence 99999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=406.58 Aligned_cols=273 Identities=27% Similarity=0.412 Sum_probs=216.5
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC----
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK---- 543 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~---- 543 (857)
..++|.+++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+|+.++||||++++++|...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 3578999999999999999999999999999999997642 22334466789999999999999999999997665
Q ss_pred --eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 544 --FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 544 --~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
.+|+||||++ ++|..++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999995 578777753 389999999999999999999999999999999999999999999999999743
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
... .
T Consensus 177 ~~~----------------------------------------------------------------------------~ 180 (371)
T 2xrw_A 177 AGT----------------------------------------------------------------------------S 180 (371)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc----------------------------------------------------------------------------c
Confidence 110 0
Q ss_pred CccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC---------------
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF--------------- 766 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~--------------- 766 (857)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..++......
T Consensus 181 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 260 (371)
T 2xrw_A 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260 (371)
T ss_dssp ---------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHH
T ss_pred cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 01123468999999999999999999999999999999999999999887766666655421110
Q ss_pred ----CCCC---------------------CCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCC
Q 035930 767 ----PGYP---------------------VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPP 821 (857)
Q Consensus 767 ----p~~~---------------------~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp 821 (857)
+... ..+.++++||.+||..||.+||| ++|+|+||||.......-....||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~~~~~~~~~~ 336 (371)
T 2xrw_A 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINVWYDPSEAEAPPP 336 (371)
T ss_dssp HHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHSHHHHTTCCHHHHTCCCC
T ss_pred HhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC----HHHHhCCcchhhhcCccccCCCCC
Confidence 0000 01467899999999999999999 999999999986544444455666
Q ss_pred CCCCC
Q 035930 822 ELPRS 826 (857)
Q Consensus 822 ~~P~~ 826 (857)
.+|..
T Consensus 337 ~~~~~ 341 (371)
T 2xrw_A 337 KIPDK 341 (371)
T ss_dssp CCCTT
T ss_pred CCCCh
Confidence 77654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=399.82 Aligned_cols=266 Identities=26% Similarity=0.334 Sum_probs=216.7
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee-------
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT------- 541 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~------- 541 (857)
..+|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+++|+.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4689999999999999999999999999999999876532 23334567899999999999999999999987
Q ss_pred -CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 542 -EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 542 -~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
.+.+||||||+. ++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 95 CKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp --CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 457899999996 57766665543 349999999999999999999999999999999999999999999999999985
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
.+..... ..
T Consensus 173 ~~~~~~~-----------------------------------------------------------------------~~ 181 (351)
T 3mi9_A 173 AFSLAKN-----------------------------------------------------------------------SQ 181 (351)
T ss_dssp ECCCCSS-----------------------------------------------------------------------SS
T ss_pred ccccccc-----------------------------------------------------------------------cc
Confidence 4211000 00
Q ss_pred CCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCC------
Q 035930 701 GARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPV------ 771 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~------ 771 (857)
.......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+.+..+......++. ++.
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 261 (351)
T 3mi9_A 182 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 261 (351)
T ss_dssp CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGG
T ss_pred ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchh
Confidence 1122345789999999999874 5799999999999999999999999998777766666543222221 111
Q ss_pred ----------------------CCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 772 ----------------------VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 772 ----------------------is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
.++.+.+||.+||..||.+||+ ++|+|+||||....+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 262 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWSDPM 320 (351)
T ss_dssp GTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGSSSC
T ss_pred hcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC----HHHHhCCCCcCCCCC
Confidence 2677999999999999999999 999999999986543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=406.54 Aligned_cols=256 Identities=22% Similarity=0.344 Sum_probs=206.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC--------CCCcccccee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD--------HPFLPTLFAH 538 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~--------HPnIV~L~~~ 538 (857)
+..++|++.+.||+|+||+||+|++..+++.||||++... ......+.+|+.+|+.+. |+||++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 3457899999999999999999999999999999999754 233466789999999985 7889999999
Q ss_pred ee----eCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEccCC----
Q 035930 539 FT----TEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML-GVVYRDLKPENILVREDG---- 609 (857)
Q Consensus 539 f~----~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~-GIIHRDLKPeNILL~~dg---- 609 (857)
|. ...++||||||+ +++|..++.......+++..++.++.||+.||.|||++ |||||||||+||||+.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence 98 556899999999 66666665555445599999999999999999999998 999999999999999776
Q ss_pred ---------------------------------------------cEEEecccchhhcccCcccccCCCCCCCCCCCCCC
Q 035930 610 ---------------------------------------------HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKAS 644 (857)
Q Consensus 610 ---------------------------------------------~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~ 644 (857)
.+||+|||++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~--------------------- 247 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--------------------- 247 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT---------------------
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc---------------------
Confidence 78999999874311
Q ss_pred CCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCC
Q 035930 645 SPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGH 724 (857)
Q Consensus 645 ~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~ 724 (857)
......+||+.|+|||++.+..|
T Consensus 248 ---------------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 248 ---------------------------------------------------------KHFTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp ---------------------------------------------------------BCSCSCCSCGGGCCHHHHHTSCC
T ss_pred ---------------------------------------------------------ccCccCCCCCcccCChhhcCCCC
Confidence 00123468999999999999999
Q ss_pred CcccceehhhHHHHHHhhCCCCCCCCCChh------hhHHHhhccccC--------------------------------
Q 035930 725 GSSVDWWTFGIFLFELLYGRTPFKGSGNDE------TLSNVVSQSLRF-------------------------------- 766 (857)
Q Consensus 725 s~ksDVWSLGvILyELLtGk~PF~g~~~~e------~l~~Iv~~~~~~-------------------------------- 766 (857)
+.++|||||||+||||++|+.||.+.+..+ .+..+......+
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 999999999999999999999998765332 122221110000
Q ss_pred --------CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 767 --------PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 767 --------p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
.....++..+++||.+||..||.+||+ ++|||+||||.+
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~ 397 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT----AAECLRHPWLNS 397 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC----HHHHHTSGGGGC
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC----HHHHhhCccccC
Confidence 011223457889999999999999999 999999999963
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=393.60 Aligned_cols=255 Identities=29% Similarity=0.488 Sum_probs=220.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+.+.||+|+||+||+|++..+++.||||++..... .....+.+|+.+|+.++||||++++++|.+.+..|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 579999999999999999999999999999999975421 23356789999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE---ccCCcEEEecccchhhcccCc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV---REDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL---~~dg~iKL~DFGLA~r~~~~~ 626 (857)
||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++....
T Consensus 86 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~--- 160 (304)
T 2jam_A 86 QLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--- 160 (304)
T ss_dssp CCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC---
T ss_pred EcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC---
Confidence 9999999988886643 38999999999999999999999999999999999999 778999999999863200
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 161 --------------------------------------------------------------------------~~~~~~ 166 (304)
T 2jam_A 161 --------------------------------------------------------------------------NGIMST 166 (304)
T ss_dssp --------------------------------------------------------------------------CBTTHH
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 000112
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--CCCCCCHHHHHHHHhhc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--GYPVVSFHARDLIRGLL 784 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--~~~~is~~l~dLI~k~L 784 (857)
.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+......++ ....++.++.+||.+||
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l 246 (304)
T 2jam_A 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLL 246 (304)
T ss_dssp HHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHH
T ss_pred ccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHc
Confidence 3589999999999999999999999999999999999999998877777777777665543 34578999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
..||.+||+ ++++++||||.+.
T Consensus 247 ~~dp~~Rps----~~~~l~h~~~~~~ 268 (304)
T 2jam_A 247 EKDPNERYT----CEKALSHPWIDGN 268 (304)
T ss_dssp CSSTTTSCC----HHHHHTSHHHHSS
T ss_pred CCChhHCcC----HHHHhcCccccCC
Confidence 999999999 9999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=403.95 Aligned_cols=256 Identities=28% Similarity=0.359 Sum_probs=221.2
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|.+++.||+|+||+||+|++..+++.||||++.............+.+|+++|+.++||||++++++|.+++..||||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999997654333445567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~------ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 205 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS------
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC------
Confidence 9996 67777665433 348999999999999999999999999999999999999999999999999873210
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.....+|
T Consensus 206 -------------------------------------------------------------------------~~~~~~g 212 (348)
T 1u5q_A 206 -------------------------------------------------------------------------PANSFVG 212 (348)
T ss_dssp -------------------------------------------------------------------------SBCCCCS
T ss_pred -------------------------------------------------------------------------CCCcccC
Confidence 0123469
Q ss_pred CCCccChhhhc---CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 710 THEYLAPEIIK---GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 710 T~~YmAPEil~---g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
|+.|+|||++. +..++.++|||||||+||||++|+.||.+.+..+.+..+............++..+++||.+||..
T Consensus 213 t~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 292 (348)
T 1u5q_A 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 292 (348)
T ss_dssp CGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccc
Confidence 99999999995 567899999999999999999999999988777777777666555444567899999999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCCCCC
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
||.+||+ +++|++||||...
T Consensus 293 dP~~Rps----~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 293 IPQDRPT----SEVLLKHRFVLRE 312 (348)
T ss_dssp SGGGSCC----HHHHTTCHHHHSC
T ss_pred ChhhCcC----HHHHhhChhhhcc
Confidence 9999999 9999999999653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=401.95 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=216.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-----Ce
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE-----KF 544 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~-----~~ 544 (857)
.+|++++.||+|+||+||+|.+..++..||||++.... .......+.+|+++|+.++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 58999999999999999999999999999999997532 233446788999999999999999999999765 47
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
.|+||||+. ++|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 899999995 6898888764 389999999999999999999999999999999999999999999999999843211
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
.. ......
T Consensus 181 ~~------------------------------------------------------------------------~~~~~~ 188 (364)
T 3qyz_A 181 DH------------------------------------------------------------------------DHTGFL 188 (364)
T ss_dssp GG------------------------------------------------------------------------CBCCTT
T ss_pred CC------------------------------------------------------------------------Cccccc
Confidence 00 000112
Q ss_pred ccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC-----------------
Q 035930 705 NSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF----------------- 766 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~----------------- 766 (857)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++......
T Consensus 189 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 268 (364)
T 3qyz_A 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268 (364)
T ss_dssp CCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHH
T ss_pred cccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHH
Confidence 34579999999998765 458999999999999999999999999988777776665321111
Q ss_pred ---C---------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 767 ---P---------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 767 ---p---------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+ ..+.++.++.+||.+||..||.+||+ +.++|+||||+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 269 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQY 320 (364)
T ss_dssp HTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTT
T ss_pred HhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhhc
Confidence 0 02457899999999999999999999 9999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=402.94 Aligned_cols=264 Identities=24% Similarity=0.358 Sum_probs=218.6
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC----
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK---- 543 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~---- 543 (857)
..++|++.+.||+|+||+||+|++..+++.||||++.............+.+|+++++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3468999999999999999999999999999999998765444445567889999999999999999999987654
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..||||||++|++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred ccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 4599999999999999987653 38999999999999999999999999999999999999999999999999974321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.... ....
T Consensus 168 ~~~~------------------------------------------------------------------------~~~~ 175 (311)
T 3ork_A 168 DSGN------------------------------------------------------------------------SVTQ 175 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc------------------------------------------------------------------------cccc
Confidence 1000 0011
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHH
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIR 781 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~ 781 (857)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.......+. ...++.++.+||.
T Consensus 176 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 255 (311)
T 3ork_A 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL 255 (311)
T ss_dssp ------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHH
T ss_pred ccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHH
Confidence 22456999999999999999999999999999999999999999988777776666655443321 3458999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
+||..||++||+ +.+++.|+|++.
T Consensus 256 ~~l~~dP~~R~~----~~~~l~~~l~~~ 279 (311)
T 3ork_A 256 KALAKNPENRYQ----TAAEMRADLVRV 279 (311)
T ss_dssp HHTCSSGGGSCS----SHHHHHHHHHHH
T ss_pred HHHhcCHhhChh----hHHHHHHHHHHH
Confidence 999999999999 789999998764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=392.37 Aligned_cols=265 Identities=25% Similarity=0.419 Sum_probs=220.8
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccc-ccchhHHHHHHHHHHHcCCCCccccceeee--eCCeE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG-RKKMPRAQTEREIMQMLDHPFLPTLFAHFT--TEKFS 545 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~-~~~~~~~~~EieILr~L~HPnIV~L~~~f~--~~~~l 545 (857)
.++|++++.||+|+||.||+|.+..+++.||||+++...... ......+.+|+++|+.++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999999999999999997653322 234567899999999999999999999984 45689
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+.++ |..++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999776 777776655566999999999999999999999999999999999999999999999999987432100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
. ......
T Consensus 163 ~-------------------------------------------------------------------------~~~~~~ 169 (305)
T 2wtk_C 163 A-------------------------------------------------------------------------ADDTCR 169 (305)
T ss_dssp C-------------------------------------------------------------------------SSCEEC
T ss_pred c-------------------------------------------------------------------------cccccc
Confidence 0 001112
Q ss_pred cccCCCCccChhhhcCCCC--CcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhh
Q 035930 706 SFVGTHEYLAPEIIKGEGH--GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~--s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~ 783 (857)
...||+.|+|||++.+... +.++|||||||++|||++|+.||.+.+..+.+..+......++ ..++..+.+||.+|
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--~~~~~~l~~li~~~ 247 (305)
T 2wtk_C 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP--GDCGPPLSDLLKGM 247 (305)
T ss_dssp CCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC--SSSCHHHHHHHHHH
T ss_pred cCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC--CccCHHHHHHHHHH
Confidence 3468999999999987543 7899999999999999999999998877777777766655554 45899999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
|..||.+||+ +.++++||||....+.
T Consensus 248 l~~dp~~Rps----~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 248 LEYEPAKRFS----IRQIRQHSWFRKKHPP 273 (305)
T ss_dssp TCSSTTTSCC----HHHHHHSHHHHSCCCC
T ss_pred ccCChhhCCC----HHHHhcCcccccCCCC
Confidence 9999999999 9999999999876543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=422.09 Aligned_cols=259 Identities=28% Similarity=0.439 Sum_probs=222.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc----------cchhHHHHHHHHHHHcCCCCcccccee
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR----------KKMPRAQTEREIMQMLDHPFLPTLFAH 538 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~----------~~~~~~~~EieILr~L~HPnIV~L~~~ 538 (857)
.++|.++++||+|+||+||+|.+..++..||||++........ ...+.+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4689999999999999999999999999999999976543221 345678899999999999999999999
Q ss_pred eeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC---cEEEec
Q 035930 539 FTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG---HIMLSD 615 (857)
Q Consensus 539 f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg---~iKL~D 615 (857)
|.+...+|||||||+||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999988877653 399999999999999999999999999999999999998776 699999
Q ss_pred ccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcc
Q 035930 616 FDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQL 695 (857)
Q Consensus 616 FGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l 695 (857)
||++.....
T Consensus 193 fg~a~~~~~----------------------------------------------------------------------- 201 (504)
T 3q5i_A 193 FGLSSFFSK----------------------------------------------------------------------- 201 (504)
T ss_dssp CTTCEECCT-----------------------------------------------------------------------
T ss_pred CCCCEEcCC-----------------------------------------------------------------------
Confidence 999743210
Q ss_pred cccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--CCCCCC
Q 035930 696 VVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--GYPVVS 773 (857)
Q Consensus 696 ~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--~~~~is 773 (857)
.......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+....+.++ .+..++
T Consensus 202 -----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (504)
T 3q5i_A 202 -----DYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNIS 275 (504)
T ss_dssp -----TSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred -----CCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCC
Confidence 011224469999999999875 599999999999999999999999999988888888888766554 235789
Q ss_pred HHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 774 FHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+++++||++||.+||.+||+ ++++|+||||+..
T Consensus 276 ~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 276 DEAKELIKLMLTYDYNKRCT----AEEALNSRWIKKY 308 (504)
T ss_dssp HHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHT
T ss_pred HHHHHHHHHHcCCChhHCCC----HHHHhcCHhhhhc
Confidence 99999999999999999999 9999999999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=390.37 Aligned_cols=263 Identities=27% Similarity=0.445 Sum_probs=220.5
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|++.+.||+|+||+||+|.+..++..||+|++... .......+.+|+++|+.++||||+++++++..++..|+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 346899999999999999999999999999999998754 23456778999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||+++++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 94 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 170 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-- 170 (302)
T ss_dssp EEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred EEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999998876543 34899999999999999999999999999999999999999999999999987431000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.......
T Consensus 171 -------------------------------------------------------------------------~~~~~~~ 177 (302)
T 2j7t_A 171 -------------------------------------------------------------------------LQKRDSF 177 (302)
T ss_dssp -------------------------------------------------------------------------HHC----
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001234
Q ss_pred cCCCCccChhhhc-----CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-CCCCCCCCHHHHHHHH
Q 035930 708 VGTHEYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-FPGYPVVSFHARDLIR 781 (857)
Q Consensus 708 vGT~~YmAPEil~-----g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-~p~~~~is~~l~dLI~ 781 (857)
.||+.|+|||++. +..++.++|||||||++|+|++|..||...+..+.+..+...... ......++..+.+||.
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (302)
T 2j7t_A 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLK 257 (302)
T ss_dssp -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHH
Confidence 6899999999984 677899999999999999999999999988776666666554332 2233568899999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
+||..||.+||+ +.+|++||||..+.|.
T Consensus 258 ~~l~~dp~~Rps----~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 258 IALDKNPETRPS----AAQLLEHPFVSSITSN 285 (302)
T ss_dssp HHSCSCTTTSCC----HHHHTTSTTTTTCCCC
T ss_pred HHcccChhhCCC----HHHHhcChHHhhhccc
Confidence 999999999999 9999999999998774
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=408.61 Aligned_cols=258 Identities=31% Similarity=0.507 Sum_probs=211.3
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee------
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT------ 541 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~------ 541 (857)
..++|.+++.||+|+||+||+|.+..+++.||||++..+. . ...+|+++|+.++||||++++++|..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----R---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----T---SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----c---hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 4578999999999999999999999999999999986542 1 12479999999999999999999844
Q ss_pred --------------------------------CCeEEEEEeecCCCChHHHHhh--CCCCCCcHHHHHHHHHHHHHHHHH
Q 035930 542 --------------------------------EKFSCLVMEYCPGGDLHVLRQK--QPSRFFSEQAARFYVAEVLLALEY 587 (857)
Q Consensus 542 --------------------------------~~~l~LVmEy~~gGsL~~ll~~--~~~~~l~e~~~r~i~~QIl~gL~y 587 (857)
+.++|+||||++ |+|..++.. .....+++..++.++.||+.||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 345899999996 577665543 123459999999999999999999
Q ss_pred HHHcCceeccCCCCcEEEc-cCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccc
Q 035930 588 LHMLGVVYRDLKPENILVR-EDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSC 666 (857)
Q Consensus 588 LHs~GIIHRDLKPeNILL~-~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 666 (857)
||++||+||||||+|||++ .++.+||+|||++..+...
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~----------------------------------------- 195 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS----------------------------------------- 195 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-----------------------------------------
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-----------------------------------------
Confidence 9999999999999999997 6899999999998532100
Q ss_pred cccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCC
Q 035930 667 FTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRT 745 (857)
Q Consensus 667 ~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~ 745 (857)
......+||+.|+|||++.+.. |+.++|||||||++|||++|+.
T Consensus 196 -----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 196 -----------------------------------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp -----------------------------------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -----------------------------------CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 0112446899999999998755 8999999999999999999999
Q ss_pred CCCCCCChhhhHHHhhcc-----------------ccCCC----------CCCCCHHHHHHHHhhccCCcCCcCCchhhH
Q 035930 746 PFKGSGNDETLSNVVSQS-----------------LRFPG----------YPVVSFHARDLIRGLLVKEPDNRLGAVKGA 798 (857)
Q Consensus 746 PF~g~~~~e~l~~Iv~~~-----------------~~~p~----------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a 798 (857)
||.+.+..+.+..++... ..++. ...++.++.+||.+||..||.+||+ +
T Consensus 241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~ 316 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN----P 316 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----H
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC----H
Confidence 999988777777665421 11111 2347889999999999999999999 9
Q ss_pred HHHHcCCCCCCCChh
Q 035930 799 AEIKQHPFFEGLNWA 813 (857)
Q Consensus 799 ~ELL~HPfF~~l~w~ 813 (857)
.|+|+||||..+.+.
T Consensus 317 ~e~l~hp~f~~~~~~ 331 (383)
T 3eb0_A 317 YEAMAHPFFDHLRNS 331 (383)
T ss_dssp HHHHTSGGGHHHHHC
T ss_pred HHHhcCHHHHHHHhh
Confidence 999999999987553
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=396.40 Aligned_cols=273 Identities=25% Similarity=0.359 Sum_probs=217.9
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-----C
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE-----K 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~-----~ 543 (857)
.++|.+.+.||+|+||+||+|.+..+++.||||++... ........+.+|+++|+.++||||+++++++..+ .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 46899999999999999999999999999999999643 1223345678999999999999999999988764 6
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..|+||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 8899999995 6898888764 38999999999999999999999999999999999999999999999999985432
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
...... .. .......
T Consensus 164 ~~~~~~--------------~~---------------------------------------------------~~~~~~~ 178 (353)
T 2b9h_A 164 ESAADN--------------SE---------------------------------------------------PTGQQSG 178 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccc--------------cC---------------------------------------------------ccccccc
Confidence 110000 00 0000011
Q ss_pred cccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc------------------
Q 035930 704 SNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL------------------ 764 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~------------------ 764 (857)
...++||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T 2b9h_A 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRARE 258 (353)
T ss_dssp -CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHH
T ss_pred hhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhH
Confidence 234679999999998865 6789999999999999999999999998765555444332110
Q ss_pred ------cCCC------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhc
Q 035930 765 ------RFPG------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIR 816 (857)
Q Consensus 765 ------~~p~------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~ 816 (857)
.++. .+.++.++.+||.+||..||.+||+ +.+||+||||+.+.|....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~~~~ 318 (353)
T 2b9h_A 259 YIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT----AKEALEHPYLQTYHDPNDE 318 (353)
T ss_dssp HHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCCTTSS
T ss_pred HhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC----HHHHhcCccccccCCcccc
Confidence 0110 2468899999999999999999999 9999999999998776543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=414.77 Aligned_cols=262 Identities=30% Similarity=0.484 Sum_probs=210.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc-----cccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV-----GRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~-----~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
.++|.+.+.||+|+||+||+|.+..+++.||||++...... .......+.+|+++|+.++||||++++++|.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 36899999999999999999999999999999999765322 12223457899999999999999999999854 4
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC---cEEEecccchh
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG---HIMLSDFDLSL 620 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg---~iKL~DFGLA~ 620 (857)
..||||||+++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 5799999999999988876543 499999999999999999999999999999999999997544 59999999984
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
....
T Consensus 291 ~~~~---------------------------------------------------------------------------- 294 (419)
T 3i6u_A 291 ILGE---------------------------------------------------------------------------- 294 (419)
T ss_dssp SCC-----------------------------------------------------------------------------
T ss_pred ecCC----------------------------------------------------------------------------
Confidence 3110
Q ss_pred CCccccccCCCCccChhhhcC---CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhH-HHhhccccCC--CCCCCCH
Q 035930 701 GARSNSFVGTHEYLAPEIIKG---EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS-NVVSQSLRFP--GYPVVSF 774 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g---~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~-~Iv~~~~~~p--~~~~is~ 774 (857)
.......+||+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+......+. .+......+. .+..++.
T Consensus 295 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 374 (419)
T 3i6u_A 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374 (419)
T ss_dssp ----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCH
T ss_pred CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCH
Confidence 001124579999999999864 567889999999999999999999998765544443 3333333332 1246899
Q ss_pred HHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 775 HARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 775 ~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
.+.+||.+||..||.+||+ ++++|+||||++.+|.
T Consensus 375 ~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~ 409 (419)
T 3i6u_A 375 KALDLVKKLLVVDPKARFT----TEEALRHPWLQDEDMK 409 (419)
T ss_dssp HHHHHHHHHSCSSTTTSCC----HHHHHHSGGGCCHHHH
T ss_pred HHHHHHHHHccCChhHCcC----HHHHhCCcccCChhHH
Confidence 9999999999999999999 9999999999988775
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=391.65 Aligned_cols=272 Identities=26% Similarity=0.381 Sum_probs=200.6
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
.+..++|.+.+.||+|+||+||+|.+..++..||||++..... ......+.+|+.+|+.++||||+++++++..++..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 3567899999999999999999999988999999999875422 23455678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhh------CCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 546 CLVMEYCPGGDLHVLRQK------QPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~------~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
|+||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999988764 12345899999999999999999999999999999999999999999999999998
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
......... .
T Consensus 169 ~~~~~~~~~----------------------------------------------------------------------~ 178 (303)
T 2vwi_A 169 AFLATGGDI----------------------------------------------------------------------T 178 (303)
T ss_dssp HHCC----------------------------------------------------------------------------
T ss_pred heeccCCCc----------------------------------------------------------------------c
Confidence 543211000 0
Q ss_pred CCCccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC--------CCCC
Q 035930 700 TGARSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF--------PGYP 770 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~--------p~~~ 770 (857)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........+.......... ....
T Consensus 179 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (303)
T 2vwi_A 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLK 258 (303)
T ss_dssp ---------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCC
T ss_pred chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhh
Confidence 0011124569999999999976 568999999999999999999999999877666655544432211 1124
Q ss_pred CCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 771 VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 771 ~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
.++.++.+||.+||..||.+||+ +.++++||||....+.
T Consensus 259 ~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 259 KYGKSFRKMISLCLQKDPEKRPT----AAELLRHKFFQKAKNK 297 (303)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSTTC------
T ss_pred hhhHHHHHHHHHHccCChhhCcC----HHHHhhChhhhcCCCC
Confidence 57889999999999999999999 9999999999987654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=387.06 Aligned_cols=257 Identities=23% Similarity=0.404 Sum_probs=214.9
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee----CC
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT----EK 543 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~----~~ 543 (857)
..+.|++.+.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+|+.++||||++++++|.. ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 34569999999999999999999999999999999976533 23345678899999999999999999999875 46
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEc-cCCcEEEecccchh
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG--VVYRDLKPENILVR-EDGHIMLSDFDLSL 620 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G--IIHRDLKPeNILL~-~dg~iKL~DFGLA~ 620 (857)
.+|+||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.++|+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 7899999999999999987653 3899999999999999999999999 99999999999997 78999999999973
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
...
T Consensus 181 ~~~----------------------------------------------------------------------------- 183 (290)
T 1t4h_A 181 LKR----------------------------------------------------------------------------- 183 (290)
T ss_dssp GCC-----------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 210
Q ss_pred CCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-CCCCCCCCHHHHHH
Q 035930 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-FPGYPVVSFHARDL 779 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-~p~~~~is~~l~dL 779 (857)
........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+..... .......++++.+|
T Consensus 184 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 262 (290)
T 1t4h_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHH
Confidence 001123468999999998875 4899999999999999999999999886665554444443322 22234577899999
Q ss_pred HHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 780 IRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
|.+||..||.+||+ +.+|++||||++
T Consensus 263 i~~~l~~dp~~Rps----~~ell~h~~f~~ 288 (290)
T 1t4h_A 263 IEGCIRQNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp HHHHSCSSGGGSCC----HHHHHTSGGGC-
T ss_pred HHHHccCChhhCCC----HHHHhhCccccc
Confidence 99999999999999 999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=405.28 Aligned_cols=258 Identities=32% Similarity=0.495 Sum_probs=221.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc-----cccchhHHHHHHHHHHHc-CCCCccccceeeeeCC
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV-----GRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEK 543 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~-----~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~ 543 (857)
++|.+.+.||.|+||+||+|.+..+|+.||||++...... .......+.+|+.+|+.+ +||||++++++|....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999999999999999754211 011235678899999999 7999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..||||||++|++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999999887643 38999999999999999999999999999999999999999999999999874321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
. ...
T Consensus 252 ~----------------------------------------------------------------------------~~~ 255 (365)
T 2y7j_A 252 P----------------------------------------------------------------------------GEK 255 (365)
T ss_dssp T----------------------------------------------------------------------------TCC
T ss_pred C----------------------------------------------------------------------------Ccc
Confidence 0 001
Q ss_pred cccccCCCCccChhhhcC------CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHH
Q 035930 704 SNSFVGTHEYLAPEIIKG------EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFH 775 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g------~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~ 775 (857)
....+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+......+..+......++. +..++..
T Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 335 (365)
T 2y7j_A 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSST 335 (365)
T ss_dssp BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHH
T ss_pred cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHH
Confidence 124579999999999974 35889999999999999999999999988777777777776655432 3568899
Q ss_pred HHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 776 ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 776 l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
+.+||.+||..||.+||+ +.++|+||||+.
T Consensus 336 ~~~li~~~L~~dP~~Rps----~~ell~hp~f~r 365 (365)
T 2y7j_A 336 VKDLISRLLQVDPEARLT----AEQALQHPFFER 365 (365)
T ss_dssp HHHHHHHHSCSSTTTSCC----HHHHHHSGGGCC
T ss_pred HHHHHHHHcCCChhHCcC----HHHHhcCcccCC
Confidence 999999999999999999 999999999973
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=414.89 Aligned_cols=262 Identities=20% Similarity=0.234 Sum_probs=201.5
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc--CCCCccccc-------eeee
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML--DHPFLPTLF-------AHFT 540 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L--~HPnIV~L~-------~~f~ 540 (857)
.+|.+++.||+|+||+||+|.+..+++.||||++.............+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4699999999999999999999999999999999876544445556778886655555 699988755 4443
Q ss_pred eC-----------------CeEEEEEeecCCCChHHHHhhCCCCCCcHHHH------HHHHHHHHHHHHHHHHcCceecc
Q 035930 541 TE-----------------KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAA------RFYVAEVLLALEYLHMLGVVYRD 597 (857)
Q Consensus 541 ~~-----------------~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~------r~i~~QIl~gL~yLHs~GIIHRD 597 (857)
.. ..+||||||++ |+|.+++..... .+.+..+ ..++.||+.||+|||++||||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 33 34899999997 899998876422 2344444 56669999999999999999999
Q ss_pred CCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHh
Q 035930 598 LKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAK 677 (857)
Q Consensus 598 LKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~ 677 (857)
|||+||||+.+|.+||+|||++.....
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~----------------------------------------------------- 246 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT----------------------------------------------------- 246 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC-----------------------------------------------------
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC-----------------------------------------------------
Confidence 999999999999999999999843110
Q ss_pred hhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcC--CCCCcccceehhhHHHHHHhhCCCCCCCCCChhh
Q 035930 678 SRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKG--EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET 755 (857)
Q Consensus 678 ~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g--~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~ 755 (857)
......||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+......
T Consensus 247 -------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 301 (371)
T 3q60_A 247 -------------------------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301 (371)
T ss_dssp -------------------------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT
T ss_pred -------------------------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc
Confidence 0012346799999999988 7799999999999999999999999987643211
Q ss_pred --h-----HHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhh
Q 035930 756 --L-----SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 756 --l-----~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li 815 (857)
+ .........++..+.++..+.+||.+||..||++||+ +.++|+||||+++.|.+.
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~~ 364 (371)
T 3q60_A 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL----PLEAMETPEFLQLQNEIS 364 (371)
T ss_dssp TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC----HHHHTTSHHHHHHHHHHH
T ss_pred cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCHHHHHHHHHHh
Confidence 1 1111234445555678999999999999999999999 999999999999988754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=402.07 Aligned_cols=264 Identities=27% Similarity=0.387 Sum_probs=219.0
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++||||++++++|.+.+..|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 45789999999999999999999999999999999865421 22234457789999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||+++++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 102 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 177 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 177 (331)
T ss_dssp EEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence 999999999988766543 3999999999999999999999999999999999999999999999999987432100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.......
T Consensus 178 -------------------------------------------------------------------------~~~~~~~ 184 (331)
T 4aaa_A 178 -------------------------------------------------------------------------GEVYDDE 184 (331)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred -------------------------------------------------------------------------ccccCCC
Confidence 0011234
Q ss_pred cCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-------------------ccCC
Q 035930 708 VGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-------------------LRFP 767 (857)
Q Consensus 708 vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-------------------~~~p 767 (857)
+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+.+..++... ..++
T Consensus 185 ~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
T 4aaa_A 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP 264 (331)
T ss_dssp CCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCC
T ss_pred cCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCc
Confidence 689999999999876 68999999999999999999999999887666665554321 1111
Q ss_pred C----------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 768 G----------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 768 ~----------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
. .+.++..+.+||.+||..||.+||+ +.|||+||||+..+|.
T Consensus 265 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 316 (331)
T 4aaa_A 265 EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF----CAELLHHDFFQMDGFA 316 (331)
T ss_dssp CCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----GGGGGGSHHHHGGGHH
T ss_pred cccccchhhhcccchhHHHHHHHHHHhccCcccCCC----HHHHhcCchhccCChh
Confidence 1 2357899999999999999999999 9999999999987764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=408.91 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=203.6
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC------
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE------ 542 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~------ 542 (857)
.++|++++.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||++++++|...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 368999999999999999999999999999999997542 2233456778999999999999999999998754
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
..+|+||||+ +++|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred CeEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 5689999999 88998887653 4999999999999999999999999999999999999999999999999997431
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
. .
T Consensus 183 ~------------------------------------------------------------------------------~ 184 (367)
T 2fst_X 183 A------------------------------------------------------------------------------D 184 (367)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred ccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc----------------
Q 035930 703 RSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR---------------- 765 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~---------------- 765 (857)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..++.....
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 264 (367)
T 2fst_X 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264 (367)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 0123568999999999987 67899999999999999999999999988776666655432111
Q ss_pred -------CCC------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 766 -------FPG------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 766 -------~p~------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
.+. .+.+++++.+||.+||..||.+||+ ++++|+||||..+....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t----~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQYHDPD 322 (367)
T ss_dssp HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCCGG
T ss_pred HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC----HHHHhcChhhhhccCCC
Confidence 010 2346889999999999999999999 99999999999875543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=389.38 Aligned_cols=253 Identities=25% Similarity=0.335 Sum_probs=212.4
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
.+..++|++++.||+|+||+||+|++..++..||||++.............+.+|+.+++.++||||+++++++.+++.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 34567899999999999999999999999999999999765444444556789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||++|++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999999987654 3899999999999999999999999999999999999999999999999997432100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
......
T Consensus 165 --------------------------------------------------------------------------~~~~~~ 170 (294)
T 4eqm_A 165 --------------------------------------------------------------------------SLTQTN 170 (294)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 000112
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC---CCCCCCCHHHHHHHHh
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF---PGYPVVSFHARDLIRG 782 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~---p~~~~is~~l~dLI~k 782 (857)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.....+...... ...+.++..+.+||.+
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 250 (294)
T 4eqm_A 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILR 250 (294)
T ss_dssp ----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHH
Confidence 4569999999999999999999999999999999999999999887666655555543322 1235689999999999
Q ss_pred hccCCcCCcCCc
Q 035930 783 LLVKEPDNRLGA 794 (857)
Q Consensus 783 ~L~~DPe~Rpt~ 794 (857)
||..||.+||++
T Consensus 251 ~l~~dp~~R~~~ 262 (294)
T 4eqm_A 251 ATEKDKANRYKT 262 (294)
T ss_dssp HSCSSGGGSCSS
T ss_pred HhcCCHhHcccc
Confidence 999999999963
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=388.93 Aligned_cols=265 Identities=27% Similarity=0.381 Sum_probs=220.6
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEc-CCCeEEEEEEecccccccccchhHHHHHHHHHHHc---CCCCccccceeee---
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELI-GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML---DHPFLPTLFAHFT--- 540 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~-~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L---~HPnIV~L~~~f~--- 540 (857)
..++|++.+.||+|+||+||+|++. .+++.||||++..... .......+.+|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc-cccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3478999999999999999999995 6789999999975432 122334567788887776 8999999999987
Q ss_pred --eCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccc
Q 035930 541 --TEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618 (857)
Q Consensus 541 --~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGL 618 (857)
.....|+||||+. |+|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5678999999996 6999998877655699999999999999999999999999999999999999999999999998
Q ss_pred hhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccccc
Q 035930 619 SLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVE 698 (857)
Q Consensus 619 A~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~ 698 (857)
+.....
T Consensus 167 ~~~~~~-------------------------------------------------------------------------- 172 (326)
T 1blx_A 167 ARIYSF-------------------------------------------------------------------------- 172 (326)
T ss_dssp CCCCCG--------------------------------------------------------------------------
T ss_pred cccccC--------------------------------------------------------------------------
Confidence 732100
Q ss_pred CCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-----cCC------
Q 035930 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-----RFP------ 767 (857)
Q Consensus 699 ~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-----~~p------ 767 (857)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..++.... .++
T Consensus 173 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (326)
T 1blx_A 173 --QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 250 (326)
T ss_dssp --GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred --CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccc
Confidence 0011234689999999999999999999999999999999999999998877777666654211 000
Q ss_pred --------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 768 --------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 768 --------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
....++..+++||.+||..||.+||+ +.++++||||.+++|..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 251 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLERCK 307 (326)
T ss_dssp GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCCCC
T ss_pred hhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC----HHHHhcCccccccchhh
Confidence 12457889999999999999999999 99999999999988753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=396.19 Aligned_cols=262 Identities=25% Similarity=0.334 Sum_probs=215.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCC-eEEEEEEecccccccccchhHHHHHHHHHHHcCCCC------ccccceee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTS-CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF------LPTLFAHF 539 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg-~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn------IV~L~~~f 539 (857)
...++|++.+.||+|+||+||+|.+..++ ..||||+++.. ......+.+|+.+|+.+.|++ ++.+++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 44579999999999999999999998776 79999999753 233456788999999997655 89999999
Q ss_pred eeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE--------------
Q 035930 540 TTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV-------------- 605 (857)
Q Consensus 540 ~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL-------------- 605 (857)
...++.||||||+ +++|..++.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 9999999999999 6677666665544459999999999999999999999999999999999999
Q ss_pred -----ccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhh
Q 035930 606 -----REDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRK 680 (857)
Q Consensus 606 -----~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~ 680 (857)
+.++.+||+|||++....
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~--------------------------------------------------------- 193 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDH--------------------------------------------------------- 193 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETT---------------------------------------------------------
T ss_pred ccccccCCCcEEEeecCcccccc---------------------------------------------------------
Confidence 567899999999874210
Q ss_pred hhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHh
Q 035930 681 IKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760 (857)
Q Consensus 681 ~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv 760 (857)
......+||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+.+..+.
T Consensus 194 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (355)
T 2eu9_A 194 ---------------------EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252 (355)
T ss_dssp ---------------------SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ---------------------ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 00123468999999999999999999999999999999999999999877665554443
Q ss_pred hccccCC------------------------------------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhH
Q 035930 761 SQSLRFP------------------------------------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGA 798 (857)
Q Consensus 761 ~~~~~~p------------------------------------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a 798 (857)
.....+| .....+.++.+||.+||..||.+||+ +
T Consensus 253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~ 328 (355)
T 2eu9_A 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT----L 328 (355)
T ss_dssp HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC----H
T ss_pred HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC----H
Confidence 3211111 01122457889999999999999999 9
Q ss_pred HHHHcCCCCCCCChhhh
Q 035930 799 AEIKQHPFFEGLNWALI 815 (857)
Q Consensus 799 ~ELL~HPfF~~l~w~li 815 (857)
.++|+||||.+++|...
T Consensus 329 ~e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 329 AEALLHPFFAGLTPEER 345 (355)
T ss_dssp HHHTTSGGGGGCCHHHH
T ss_pred HHHhcChhhcCCChhhc
Confidence 99999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=401.39 Aligned_cols=259 Identities=31% Similarity=0.430 Sum_probs=216.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE---
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS--- 545 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l--- 545 (857)
.++|.+.+.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+|+.++||||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 368999999999999999999999999999999997643 2233356778999999999999999999999877654
Q ss_pred ---EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 546 ---CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 546 ---~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
|+||||+. ++|..++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999995 688777643 3899999999999999999999999999999999999999999999999987421
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
. .
T Consensus 195 ~------------------------------------------------------------------------------~ 196 (371)
T 4exu_A 195 D------------------------------------------------------------------------------A 196 (371)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred ccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC---------------
Q 035930 703 RSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF--------------- 766 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~--------------- 766 (857)
.....+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+.+..++......
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 276 (371)
T 4exu_A 197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 276 (371)
T ss_dssp ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHH
T ss_pred CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhh
Confidence 0123468999999999987 678999999999999999999999999887766666654421110
Q ss_pred --------C------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhh
Q 035930 767 --------P------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 767 --------p------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li 815 (857)
+ ..+.+++++++||.+||+.||.+||+ ++++|+||||+.+.+...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~~ 335 (371)
T 4exu_A 277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDPEE 335 (371)
T ss_dssp HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCGGG
T ss_pred hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC----HHHHhcCcccccCCCccc
Confidence 0 02457899999999999999999999 999999999998766544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=416.52 Aligned_cols=253 Identities=18% Similarity=0.194 Sum_probs=204.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHH---HHHcCCCCccccc-------ee
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI---MQMLDHPFLPTLF-------AH 538 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieI---Lr~L~HPnIV~L~-------~~ 538 (857)
.++|.+.+.||+|+||+||+|++..+++.||||++...........+.+.+|+++ |+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4689999999999999999999999999999999986544445566788899954 5555799999998 55
Q ss_pred eeeCC-----------------eEEEEEeecCCCChHHHHhhCCC-----CCCcHHHHHHHHHHHHHHHHHHHHcCceec
Q 035930 539 FTTEK-----------------FSCLVMEYCPGGDLHVLRQKQPS-----RFFSEQAARFYVAEVLLALEYLHMLGVVYR 596 (857)
Q Consensus 539 f~~~~-----------------~l~LVmEy~~gGsL~~ll~~~~~-----~~l~e~~~r~i~~QIl~gL~yLHs~GIIHR 596 (857)
+.+.+ ..||||||+ +|+|.+++..... ..+++..++.++.||+.||+|||++|||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 55443 389999999 7899988875321 123458888899999999999999999999
Q ss_pred cCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHH
Q 035930 597 DLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAA 676 (857)
Q Consensus 597 DLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~ 676 (857)
||||+||||+.+|.+||+|||+++...
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~----------------------------------------------------- 257 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG----------------------------------------------------- 257 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT-----------------------------------------------------
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC-----------------------------------------------------
Confidence 999999999999999999999974210
Q ss_pred hhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCC-----------CCCcccceehhhHHHHHHhhCCC
Q 035930 677 KSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGE-----------GHGSSVDWWTFGIFLFELLYGRT 745 (857)
Q Consensus 677 ~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~-----------~~s~ksDVWSLGvILyELLtGk~ 745 (857)
......+| +.|+|||++.+. .|+.++|||||||+||||++|+.
T Consensus 258 -------------------------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~ 311 (377)
T 3byv_A 258 -------------------------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311 (377)
T ss_dssp -------------------------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCC
Confidence 01124468 999999999988 89999999999999999999999
Q ss_pred CCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 746 PFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 746 PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
||.+....+.+..+... ...+++++.+||.+||..||.+||+ +.++++||||.++.
T Consensus 312 Pf~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 312 PITKDAALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLR 367 (377)
T ss_dssp CC------CCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCC----HHHHHTSHHHHHHH
T ss_pred CCcccccccchhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCC----HHHHhhChHHHHHH
Confidence 99887665555444322 2568999999999999999999999 99999999998763
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=400.20 Aligned_cols=273 Identities=26% Similarity=0.386 Sum_probs=206.4
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC----
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK---- 543 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~---- 543 (857)
..++|++.+.||+|+||+||+|.+..++..||||++..+ ........++++.|+.++||||++++++|...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD----PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECC----TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC----ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 347899999999999999999999999999999998654 233456678888899999999999999997543
Q ss_pred ---eEEEEEeecCCCChHHHHh-hCCCCCCcHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEcc-CCcEEEecc
Q 035930 544 ---FSCLVMEYCPGGDLHVLRQ-KQPSRFFSEQAARFYVAEVLLALEYLH--MLGVVYRDLKPENILVRE-DGHIMLSDF 616 (857)
Q Consensus 544 ---~l~LVmEy~~gGsL~~ll~-~~~~~~l~e~~~r~i~~QIl~gL~yLH--s~GIIHRDLKPeNILL~~-dg~iKL~DF 616 (857)
.+|+||||++++.+..+.. ......+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 3899999997643333222 122345899999999999999999999 999999999999999997 899999999
Q ss_pred cchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccc
Q 035930 617 DLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLV 696 (857)
Q Consensus 617 GLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~ 696 (857)
|++.....
T Consensus 177 g~a~~~~~------------------------------------------------------------------------ 184 (360)
T 3e3p_A 177 GSAKKLSP------------------------------------------------------------------------ 184 (360)
T ss_dssp TTCBCCCT------------------------------------------------------------------------
T ss_pred CCceecCC------------------------------------------------------------------------
Confidence 99743210
Q ss_pred ccCCCCccccccCCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC---------
Q 035930 697 VEPTGARSNSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF--------- 766 (857)
Q Consensus 697 ~~~~~~~~~s~vGT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~--------- 766 (857)
.......+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+..+.+..++......
T Consensus 185 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3e3p_A 185 ----SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260 (360)
T ss_dssp ----TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ----CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence 00112346899999999997655 8999999999999999999999999987777776665421110
Q ss_pred ---------------------CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCCCC
Q 035930 767 ---------------------PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPELP 824 (857)
Q Consensus 767 ---------------------p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~~P 824 (857)
......+.++.+||.+||+.||.+||+ +.|+|+||||+++.+.......++.+|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~~~~~~~~~~~ 335 (360)
T 3e3p_A 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK----PYEALCHPYFDELHDPATKLPNNKDLP 335 (360)
T ss_dssp TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCC----HHHHTTSGGGGGGGCTTCCCTTSCCCC
T ss_pred cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCC----HHHHhcCccccccCCccccCCCCCCCC
Confidence 011225678999999999999999999 999999999999866554433344444
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=398.26 Aligned_cols=260 Identities=24% Similarity=0.403 Sum_probs=212.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCC--CCccccceeeeeCCe
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH--PFLPTLFAHFTTEKF 544 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~H--PnIV~L~~~f~~~~~ 544 (857)
+..++|++++.||+|+||+||+|.+. ++..||||++..... .......+.+|+++|+.++| |||+++++++.+++.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 45578999999999999999999884 688999999975532 23344678899999999986 999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|||||| .+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9999995 4889999988764 489999999999999999999999999999999999997 68999999999743210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
.. .....
T Consensus 160 ~~-------------------------------------------------------------------------~~~~~ 166 (343)
T 3dbq_A 160 DT-------------------------------------------------------------------------TSVVK 166 (343)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc-------------------------------------------------------------------------ccccC
Confidence 00 00112
Q ss_pred ccccCCCCccChhhhcC-----------CCCCcccceehhhHHHHHHhhCCCCCCCCCCh-hhhHHHhhccccCCCCCCC
Q 035930 705 NSFVGTHEYLAPEIIKG-----------EGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVSQSLRFPGYPVV 772 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g-----------~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~-e~l~~Iv~~~~~~p~~~~i 772 (857)
...+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.... ..+..++............
T Consensus 167 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T 3dbq_A 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246 (343)
T ss_dssp ---CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCS
T ss_pred CCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccC
Confidence 34579999999999975 67899999999999999999999999875443 3444555444454455567
Q ss_pred CHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 773 SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 773 s~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
+.++.+||.+||..||.+||+ +.++|+||||+.
T Consensus 247 ~~~l~~li~~~L~~dp~~Rpt----~~e~l~hp~~~~ 279 (343)
T 3dbq_A 247 EKDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQI 279 (343)
T ss_dssp CHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHS
T ss_pred CHHHHHHHHHHcCCChhHCCC----HHHHHhCccccc
Confidence 889999999999999999999 999999999974
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=401.51 Aligned_cols=257 Identities=21% Similarity=0.327 Sum_probs=215.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC-------CCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCcccccee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG-------TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAH 538 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~-------tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~ 538 (857)
+..++|.+++.||+|+||+||+|++.+ ++..||||+++... .......+.+|+++|+.+ +||||++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 556789999999999999999999753 45689999997652 234456789999999999 89999999999
Q ss_pred eeeCCeEEEEEeecCCCChHHHHhhCCC--------------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 035930 539 FTTEKFSCLVMEYCPGGDLHVLRQKQPS--------------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604 (857)
Q Consensus 539 f~~~~~l~LVmEy~~gGsL~~ll~~~~~--------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNIL 604 (857)
|.+++.+||||||+++|+|.+++..... ..+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 9999999999999999999999876532 24889999999999999999999999999999999999
Q ss_pred EccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhh
Q 035930 605 VREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD 684 (857)
Q Consensus 605 L~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d 684 (857)
|+.+|.+||+|||++........
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~--------------------------------------------------------- 258 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDY--------------------------------------------------------- 258 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCT---------------------------------------------------------
T ss_pred ECCCCCEEEccccCCcccCcccc---------------------------------------------------------
Confidence 99999999999999854211000
Q ss_pred hhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhcc
Q 035930 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQS 763 (857)
Q Consensus 685 ~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~ 763 (857)
........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+....+.+..+.. .
T Consensus 259 ----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~-~ 321 (370)
T 2psq_A 259 ----------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE-G 321 (370)
T ss_dssp ----------------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-T
T ss_pred ----------------eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-C
Confidence 001122357889999999999999999999999999999999 9999998877666655443 3
Q ss_pred ccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 764 ~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
...+.+..++.++.+||.+||..||.+||+ +.||++
T Consensus 322 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~ell~ 357 (370)
T 2psq_A 322 HRMDKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVE 357 (370)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 444445678999999999999999999999 777765
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=379.31 Aligned_cols=253 Identities=19% Similarity=0.323 Sum_probs=208.2
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~LV 548 (857)
++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.++..+ +||||++++++|.+++..|+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 579999999999999999999999999999999976432 223345678899999999 899999999999999999999
Q ss_pred EeecCCCChHHHHhhCCC--CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC------------------
Q 035930 549 MEYCPGGDLHVLRQKQPS--RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED------------------ 608 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~--~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d------------------ 608 (857)
|||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 999999999988875421 348999999999999999999999999999999999999854
Q ss_pred -CcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhc
Q 035930 609 -GHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAA 687 (857)
Q Consensus 609 -g~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~ 687 (857)
+.++|+|||++.....
T Consensus 170 ~~~~kl~Dfg~~~~~~~--------------------------------------------------------------- 186 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISS--------------------------------------------------------------- 186 (289)
T ss_dssp CCCEEECCCTTCEETTC---------------------------------------------------------------
T ss_pred ceEEEEcccccccccCC---------------------------------------------------------------
Confidence 4799999998743110
Q ss_pred ccCCCCcccccCCCCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC
Q 035930 688 QVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF 766 (857)
Q Consensus 688 ~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~ 766 (857)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||... +.+..+..... .
T Consensus 187 ----------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~~~-~ 246 (289)
T 1x8b_A 187 ----------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWHEIRQGRL-P 246 (289)
T ss_dssp ----------------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHHHHHTTCC-C
T ss_pred ----------------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHHHHHcCCC-C
Confidence 0122489999999999876 5678999999999999999999887543 33344443332 2
Q ss_pred CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 767 PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 767 p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.....++.++.+||.+||..||.+||+ +.++++||||.+.
T Consensus 247 ~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 247 RIPQVLSQEFTELLKVMIHPDPERRPS----AMALVKHSVLLSA 286 (289)
T ss_dssp CCSSCCCHHHHHHHHHHTCSSGGGSCC----HHHHHTCTTC---
T ss_pred CCCcccCHHHHHHHHHHhCCCcccCCC----HHHHhhChHhhhh
Confidence 233568999999999999999999999 9999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=387.95 Aligned_cols=261 Identities=27% Similarity=0.443 Sum_probs=217.1
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|.+.+.||+|+||+||+|.+..+++.||||++... .....+.+|+.+|+.++||||+++++++..++..|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 456899999999999999999999999999999999754 345678999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 102 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-- 178 (314)
T ss_dssp EEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred EeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence 999999999999886432 34899999999999999999999999999999999999999999999999987432100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.......
T Consensus 179 -------------------------------------------------------------------------~~~~~~~ 185 (314)
T 3com_A 179 -------------------------------------------------------------------------MAKRNTV 185 (314)
T ss_dssp -------------------------------------------------------------------------BSCBCCC
T ss_pred -------------------------------------------------------------------------ccccCcc
Confidence 0011234
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-ccCCCCCCCCHHHHHHHHhhccC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-LRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||........+..+.... ..+.....++..+.+||.+||..
T Consensus 186 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 265 (314)
T 3com_A 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVK 265 (314)
T ss_dssp CSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCS
T ss_pred CCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccC
Confidence 68999999999999999999999999999999999999998776555444433322 22333445789999999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
||.+||+ +.++++||||.+..+.
T Consensus 266 dp~~Rpt----~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 266 SPEQRAT----ATQLLQHPFVRSAKGV 288 (314)
T ss_dssp CTTTSCC----HHHHTTSHHHHTCCCG
T ss_pred ChhhCcC----HHHHHhCHHHhcCCcc
Confidence 9999999 9999999999987654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=384.75 Aligned_cols=255 Identities=26% Similarity=0.394 Sum_probs=220.6
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
+.|.+++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+|+.++||||++++++|.+++..|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT--CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999997653 2345677899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 100 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---- 172 (303)
T 3a7i_A 100 EYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---- 172 (303)
T ss_dssp ECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT----
T ss_pred EeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc----
Confidence 999999999988753 4899999999999999999999999999999999999999999999999987432100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........|
T Consensus 173 -----------------------------------------------------------------------~~~~~~~~~ 181 (303)
T 3a7i_A 173 -----------------------------------------------------------------------QIKRNTFVG 181 (303)
T ss_dssp -----------------------------------------------------------------------BCCBCCCCS
T ss_pred -----------------------------------------------------------------------ccccCccCC
Confidence 001124568
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcC
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPD 789 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe 789 (857)
|+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+.... .......++..+.+||.+||..||.
T Consensus 182 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~ 260 (303)
T 3a7i_A 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEPS 260 (303)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCCSSCCHHHHHHHHHHCCSSGG
T ss_pred CcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-CCCCccccCHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999999999998876665555444332 2233456899999999999999999
Q ss_pred CcCCchhhHHHHHcCCCCCC
Q 035930 790 NRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 790 ~Rpt~~~~a~ELL~HPfF~~ 809 (857)
+||+ +.+|++||||..
T Consensus 261 ~Rps----~~~ll~~~~~~~ 276 (303)
T 3a7i_A 261 FRPT----AKELLKHKFILR 276 (303)
T ss_dssp GSCC----HHHHTTCHHHHH
T ss_pred hCcC----HHHHhhChhhhc
Confidence 9999 999999999954
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=384.39 Aligned_cols=261 Identities=24% Similarity=0.321 Sum_probs=204.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++.+.||+|+||+||+|.+..+++.||||++..... .......+.++..+++.++||||+++++++.+++..|
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 456789999999999999999999999999999999975422 1122233444555578889999999999999999999
Q ss_pred EEEeecCCCChHHHHhh--CCCCCCcHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 547 LVMEYCPGGDLHVLRQK--QPSRFFSEQAARFYVAEVLLALEYLHML-GVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~--~~~~~l~e~~~r~i~~QIl~gL~yLHs~-GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
+||||++ |+|..++.. .....+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999996 587666543 1223599999999999999999999998 99999999999999999999999999974321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.. ..
T Consensus 162 ~~----------------------------------------------------------------------------~~ 165 (290)
T 3fme_A 162 DD----------------------------------------------------------------------------VA 165 (290)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred cccccCCCCccChhhh----cCCCCCcccceehhhHHHHHHhhCCCCCCCCC-ChhhhHHHhhccccCCCCCCCCHHHHH
Q 035930 704 SNSFVGTHEYLAPEII----KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG-NDETLSNVVSQSLRFPGYPVVSFHARD 778 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil----~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~-~~e~l~~Iv~~~~~~p~~~~is~~l~d 778 (857)
.....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.... ....+...+...........++.++.+
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 245 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHH
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHH
Confidence 1123589999999996 56678999999999999999999999998643 334444544444443334568999999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
||.+||..||.+||+ +.++++||||+.
T Consensus 246 li~~~l~~~p~~Rpt----~~e~l~hp~f~~ 272 (290)
T 3fme_A 246 FTSQCLKKNSKERPT----YPELMQHPFFTL 272 (290)
T ss_dssp HHHHHTCSSGGGSCC----HHHHTTSHHHHH
T ss_pred HHHHHhhcChhhCcC----HHHHHhCccccc
Confidence 999999999999999 999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=390.39 Aligned_cols=277 Identities=21% Similarity=0.304 Sum_probs=206.0
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCe---EEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSC---LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~---~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
..+..++|.+++.||+|+||+||+|.+..++. .||||++..... .....+.+.+|+++|+.++||||+++++++..
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 44667899999999999999999999887765 899999976532 23446778999999999999999999999987
Q ss_pred CCeE------EEEEeecCCCChHHHHhhCC----CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcE
Q 035930 542 EKFS------CLVMEYCPGGDLHVLRQKQP----SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHI 611 (857)
Q Consensus 542 ~~~l------~LVmEy~~gGsL~~ll~~~~----~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~i 611 (857)
.... |+||||+.+|+|..++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 7655 99999999999988875432 1148999999999999999999999999999999999999999999
Q ss_pred EEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCC
Q 035930 612 MLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSP 691 (857)
Q Consensus 612 KL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~ 691 (857)
||+|||++........
T Consensus 177 kl~Dfg~a~~~~~~~~---------------------------------------------------------------- 192 (323)
T 3qup_A 177 CVADFGLSRKIYSGDY---------------------------------------------------------------- 192 (323)
T ss_dssp EECCCCC-------------------------------------------------------------------------
T ss_pred EEeecccccccccccc----------------------------------------------------------------
Confidence 9999999854211000
Q ss_pred CCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCC
Q 035930 692 MPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYP 770 (857)
Q Consensus 692 ~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~ 770 (857)
........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.... .++..+
T Consensus 193 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 262 (323)
T 3qup_A 193 ---------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RLKQPP 262 (323)
T ss_dssp -----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCT
T ss_pred ---------ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CCCCCC
Confidence 000112346889999999999999999999999999999999 999999888777776665543 444456
Q ss_pred CCCHHHHHHHHhhccCCcCCcCCchh---hHHHHHcCCCCCCCChhhhc
Q 035930 771 VVSFHARDLIRGLLVKEPDNRLGAVK---GAAEIKQHPFFEGLNWALIR 816 (857)
Q Consensus 771 ~is~~l~dLI~k~L~~DPe~Rpt~~~---~a~ELL~HPfF~~l~w~li~ 816 (857)
.++.++.+||.+||..||.+||++.. .+++++.|||+....+..+.
T Consensus 263 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~ 311 (323)
T 3qup_A 263 ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY 311 (323)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence 79999999999999999999999643 46889999999987776654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=391.64 Aligned_cols=261 Identities=31% Similarity=0.502 Sum_probs=212.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc-----cccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV-----GRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~-----~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
++|.+.+.||+|+||+||+|.+..+++.||||++...... .......+.+|+++|+.++||||+++++++..++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999999999999999999764321 1222345789999999999999999999997665
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc---EEEecccchhh
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH---IMLSDFDLSLR 621 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~---iKL~DFGLA~r 621 (857)
.|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 899999999999998887543 4999999999999999999999999999999999999987664 99999998743
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
....
T Consensus 167 ~~~~---------------------------------------------------------------------------- 170 (322)
T 2ycf_A 167 LGET---------------------------------------------------------------------------- 170 (322)
T ss_dssp CCCC----------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 1100
Q ss_pred CccccccCCCCccChhhhc---CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhh-HHHhhccccCC--CCCCCCHH
Q 035930 702 ARSNSFVGTHEYLAPEIIK---GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL-SNVVSQSLRFP--GYPVVSFH 775 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~---g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l-~~Iv~~~~~~p--~~~~is~~ 775 (857)
......+||+.|+|||++. +..++.++|||||||++|+|++|..||........+ ..+......+. .+..++..
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (322)
T 2ycf_A 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 250 (322)
T ss_dssp HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHH
Confidence 0011345899999999984 466899999999999999999999999876554333 33333333322 12458999
Q ss_pred HHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 776 ARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 776 l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
+.+||.+||..||.+||+ ++++|+||||.+.+|.
T Consensus 251 ~~~li~~~l~~dP~~Rps----~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 251 ALDLVKKLLVVDPKARFT----TEEALRHPWLQDEDMK 284 (322)
T ss_dssp HHHHHHHHSCSSTTTSCC----HHHHHTSGGGCCHHHH
T ss_pred HHHHHHHHcccCHhhCCC----HHHHhhCcCcCCHHHH
Confidence 999999999999999999 9999999999998875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=396.30 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=219.0
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEE-----cCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceee
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAEL-----IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHF 539 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~-----~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f 539 (857)
.+..++|++++.||+|+||+||+|++ ..+++.||||+++... .......+.+|+++|+.+ +||||++++++|
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 46678999999999999999999994 4567899999997642 223345689999999999 799999999999
Q ss_pred eeCC-eEEEEEeecCCCChHHHHhhCCC----------------------------------------------------
Q 035930 540 TTEK-FSCLVMEYCPGGDLHVLRQKQPS---------------------------------------------------- 566 (857)
Q Consensus 540 ~~~~-~l~LVmEy~~gGsL~~ll~~~~~---------------------------------------------------- 566 (857)
.+.+ .+|+||||+++|+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8755 58999999999999999876532
Q ss_pred ------------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCC
Q 035930 567 ------------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSP 634 (857)
Q Consensus 567 ------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~ 634 (857)
..+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||++.......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~-------- 247 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-------- 247 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT--------
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc--------
Confidence 128999999999999999999999999999999999999999999999999984321100
Q ss_pred CCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCcc
Q 035930 635 VEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYL 714 (857)
Q Consensus 635 ~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~Ym 714 (857)
.........||+.|+
T Consensus 248 -----------------------------------------------------------------~~~~~~~~~~t~~y~ 262 (359)
T 3vhe_A 248 -----------------------------------------------------------------DYVRKGDARLPLKWM 262 (359)
T ss_dssp -----------------------------------------------------------------TCEEC--CEECGGGC
T ss_pred -----------------------------------------------------------------cchhccccCCCceeE
Confidence 001112346899999
Q ss_pred ChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCC
Q 035930 715 APEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLG 793 (857)
Q Consensus 715 APEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt 793 (857)
|||++.+..++.++|||||||++|||++ |..||.+....+.+...+......+....+++++.+||.+||..||.+||+
T Consensus 263 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 342 (359)
T 3vhe_A 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 342 (359)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 9999999999999999999999999998 999999887777777777766666666779999999999999999999999
Q ss_pred chhhHHHHHcC
Q 035930 794 AVKGAAEIKQH 804 (857)
Q Consensus 794 ~~~~a~ELL~H 804 (857)
+.+|++|
T Consensus 343 ----~~ell~~ 349 (359)
T 3vhe_A 343 ----FSELVEH 349 (359)
T ss_dssp ----HHHHHHH
T ss_pred ----HHHHHHH
Confidence 8888765
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=405.25 Aligned_cols=261 Identities=23% Similarity=0.392 Sum_probs=215.0
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC--CCCccccceeeeeCCeE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD--HPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~--HPnIV~L~~~f~~~~~l 545 (857)
..++|.+++.||+|+||+||+|.+.. +..||||++..... .......+.+|+++|+.+. ||||+++++++..++.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34579999999999999999999865 88999999976532 2334567899999999996 59999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|||||+ .+++|..++.... .+++..++.++.||+.||.|||++|||||||||+||||+ ++.+||+|||++..+...
T Consensus 132 ~lv~E~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 132 YMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEEEC-CSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEEec-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 999994 5899999988764 489999999999999999999999999999999999995 689999999998432100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
. ......
T Consensus 208 ~-------------------------------------------------------------------------~~~~~~ 214 (390)
T 2zmd_A 208 T-------------------------------------------------------------------------TSVVKD 214 (390)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred C-------------------------------------------------------------------------ccccCC
Confidence 0 000123
Q ss_pred cccCCCCccChhhhcC-----------CCCCcccceehhhHHHHHHhhCCCCCCCCCCh-hhhHHHhhccccCCCCCCCC
Q 035930 706 SFVGTHEYLAPEIIKG-----------EGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVSQSLRFPGYPVVS 773 (857)
Q Consensus 706 s~vGT~~YmAPEil~g-----------~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~-e~l~~Iv~~~~~~p~~~~is 773 (857)
..+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+.... ..+..++.....++.....+
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (390)
T 2zmd_A 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 294 (390)
T ss_dssp CSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSC
T ss_pred CCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccch
Confidence 4579999999999976 36899999999999999999999999876433 45566666555555555678
Q ss_pred HHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 774 FHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
.++.+||.+||..||.+||+ +.+||+||||....
T Consensus 295 ~~~~~li~~~L~~dP~~Rps----~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 295 KDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHSCC
T ss_pred HHHHHHHHHHcccChhhCCC----HHHHhhCcCccccC
Confidence 99999999999999999999 99999999997543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=386.95 Aligned_cols=265 Identities=25% Similarity=0.359 Sum_probs=211.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeee------
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFT------ 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~------ 540 (857)
...++|++++.||+|+||+||+|.+..+++.||||++... .......+.+|+++|+.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 3457899999999999999999999999999999998654 2344567889999999999999999999873
Q ss_pred --------eCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc-cCCcE
Q 035930 541 --------TEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR-EDGHI 611 (857)
Q Consensus 541 --------~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~-~dg~i 611 (857)
+....|+||||+. |+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence 4478899999996 6999888653 389999999999999999999999999999999999997 56799
Q ss_pred EEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCC
Q 035930 612 MLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSP 691 (857)
Q Consensus 612 KL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~ 691 (857)
||+|||++.......
T Consensus 161 kl~Dfg~~~~~~~~~----------------------------------------------------------------- 175 (320)
T 2i6l_A 161 KIGDFGLARIMDPHY----------------------------------------------------------------- 175 (320)
T ss_dssp EECCCTTCBCC---------------------------------------------------------------------
T ss_pred EEccCccccccCCCc-----------------------------------------------------------------
Confidence 999999974321000
Q ss_pred CCcccccCCCCccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-----
Q 035930 692 MPQLVVEPTGARSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR----- 765 (857)
Q Consensus 692 ~p~l~~~~~~~~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~----- 765 (857)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..++.....
T Consensus 176 -------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (320)
T 2i6l_A 176 -------SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248 (320)
T ss_dssp -----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHH
T ss_pred -------ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence 00001123458999999999876 67899999999999999999999999988766666655443211
Q ss_pred -----------------CC------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 766 -----------------FP------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 766 -----------------~p------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
.+ ..+.++.++++||.+||..||.+||+ ++++|+||||+...|..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT----AEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSHHHHTTCC--
T ss_pred hhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC----HHHHhCCcccccccCcc
Confidence 01 12458999999999999999999999 99999999999887654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=401.51 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=213.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CC-----Cccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HP-----FLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HP-----nIV~L~~~f~ 540 (857)
...++|++.+.||+|+||+||+|.+..+++.||||+++.. ......+.+|+.+++.+. |+ +|+.++++|.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 4467999999999999999999999999999999999754 223456778999998885 55 4999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEc--cCCcEEEecc
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH--MLGVVYRDLKPENILVR--EDGHIMLSDF 616 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLH--s~GIIHRDLKPeNILL~--~dg~iKL~DF 616 (857)
..+++||||||+. ++|.+++.......+++..++.++.||+.||.||| +.|||||||||+||||+ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999999995 59999888766556999999999999999999999 57999999999999995 4778999999
Q ss_pred cchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccc
Q 035930 617 DLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLV 696 (857)
Q Consensus 617 GLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~ 696 (857)
|++....
T Consensus 206 G~a~~~~------------------------------------------------------------------------- 212 (382)
T 2vx3_A 206 GSSCQLG------------------------------------------------------------------------- 212 (382)
T ss_dssp TTCEETT-------------------------------------------------------------------------
T ss_pred cCceecc-------------------------------------------------------------------------
Confidence 9974310
Q ss_pred ccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC---------
Q 035930 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--------- 767 (857)
Q Consensus 697 ~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--------- 767 (857)
......+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++......+
T Consensus 213 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (382)
T 2vx3_A 213 -----QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK 287 (382)
T ss_dssp -----CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT
T ss_pred -----cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH
Confidence 011235689999999999999999999999999999999999999998877777766654211110
Q ss_pred ---------C-------------------CCC-------------------------CCHHHHHHHHhhccCCcCCcCCc
Q 035930 768 ---------G-------------------YPV-------------------------VSFHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 768 ---------~-------------------~~~-------------------------is~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
. ... ...++++||.+||+.||++|||
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt- 366 (382)
T 2vx3_A 288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ- 366 (382)
T ss_dssp HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC-
T ss_pred HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC-
Confidence 0 000 0137899999999999999999
Q ss_pred hhhHHHHHcCCCCCCCCh
Q 035930 795 VKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 795 ~~~a~ELL~HPfF~~l~w 812 (857)
++|+|+||||++..|
T Consensus 367 ---a~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 367 ---PYYALQHSFFKKTAD 381 (382)
T ss_dssp ---HHHHTTSGGGCC---
T ss_pred ---HHHHhcCcccccCCC
Confidence 999999999997654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=391.81 Aligned_cols=259 Identities=31% Similarity=0.435 Sum_probs=214.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe----
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF---- 544 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~---- 544 (857)
.++|.+.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 368999999999999999999999999999999997643 223334667899999999999999999999987654
Q ss_pred --EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 545 --SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 545 --l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
+|+||||+. ++|..++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999995 688776642 3899999999999999999999999999999999999999999999999987321
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
. .
T Consensus 177 ~------------------------------------------------------------------------------~ 178 (353)
T 3coi_A 177 D------------------------------------------------------------------------------A 178 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C------------------------------------------------------------------------------C
Confidence 0 0
Q ss_pred ccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-----------------
Q 035930 703 RSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL----------------- 764 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~----------------- 764 (857)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++....
T Consensus 179 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T 3coi_A 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258 (353)
T ss_dssp -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence 0123468999999999987 6789999999999999999999999998876666555543110
Q ss_pred -----------cC-CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhh
Q 035930 765 -----------RF-PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI 815 (857)
Q Consensus 765 -----------~~-p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li 815 (857)
.+ ...+.++.++.+||.+||..||.+||+ ++++|+||||..+.+..-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~~~~~ 317 (353)
T 3coi_A 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDPEE 317 (353)
T ss_dssp HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCGGG
T ss_pred HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhccCccc
Confidence 01 112457899999999999999999999 999999999998765543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=388.43 Aligned_cols=256 Identities=26% Similarity=0.340 Sum_probs=213.0
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
.+...+|++.+.||+|+||+||+|++ ++..||||++..... .......+.+|+++|+.++||||++++++|.+.+..
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 35667899999999999999999987 577899999976532 233446788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 546 CLVMEYCPGGDLHVLRQKQPS-RFFSEQAARFYVAEVLLALEYLHMLG--VVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~-~~l~e~~~r~i~~QIl~gL~yLHs~G--IIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
|+||||+++|+|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999999876432 23899999999999999999999999 999999999999999999999999997421
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.. ...
T Consensus 190 ~~---------------------------------------------------------------------------~~~ 194 (309)
T 3p86_A 190 AS---------------------------------------------------------------------------TFL 194 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc---------------------------------------------------------------------------ccc
Confidence 00 000
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+.....+++.+.+||.+
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 274 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274 (309)
T ss_dssp -------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHH
Confidence 11234699999999999999999999999999999999999999998877777776655555555566799999999999
Q ss_pred hccCCcCCcCCchhhHHHHHc
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||..||.+||+ +.+|++
T Consensus 275 ~l~~dP~~Rps----~~~ll~ 291 (309)
T 3p86_A 275 CWTNEPWKRPS----FATIMD 291 (309)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HccCChhhCcC----HHHHHH
Confidence 99999999999 777775
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=383.63 Aligned_cols=260 Identities=30% Similarity=0.473 Sum_probs=223.3
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+++|+.++||||+++++++.+.+..|+|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3689999999999999999999999999999999976532 234566789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC---CcEEEecccchhhcccC
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED---GHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d---g~iKL~DFGLA~r~~~~ 625 (857)
|||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999988776543 38999999999999999999999999999999999999754 47999999997432100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
....
T Consensus 178 ----------------------------------------------------------------------------~~~~ 181 (287)
T 2wei_A 178 ----------------------------------------------------------------------------TKMK 181 (287)
T ss_dssp ----------------------------------------------------------------------------SSCS
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0012
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--CCCCCCHHHHHHHHhh
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--GYPVVSFHARDLIRGL 783 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--~~~~is~~l~dLI~k~ 783 (857)
...||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+......++ ....++.++.+||.+|
T Consensus 182 ~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 260 (287)
T 2wei_A 182 DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM 260 (287)
T ss_dssp CHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHH
T ss_pred cccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHH
Confidence 23588999999999865 89999999999999999999999999887777777776655443 3356899999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
|..||.+||+ +.++|+||||++..|
T Consensus 261 l~~dp~~Rps----~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 261 LTFHPSLRIT----ATQCLEHPWIQKYSS 285 (287)
T ss_dssp TCSSGGGSCC----HHHHHHSHHHHHHCC
T ss_pred cccChhhCcC----HHHHhcCHHHhcccc
Confidence 9999999999 999999999987655
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=396.97 Aligned_cols=257 Identities=24% Similarity=0.384 Sum_probs=208.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-----------CCCcccc
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-----------HPFLPTL 535 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-----------HPnIV~L 535 (857)
+..++|.+.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+|+.+. ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 45578999999999999999999999999999999997542 23456788999998886 8999999
Q ss_pred ceeeeeCC----eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEcc---
Q 035930 536 FAHFTTEK----FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML-GVVYRDLKPENILVRE--- 607 (857)
Q Consensus 536 ~~~f~~~~----~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~-GIIHRDLKPeNILL~~--- 607 (857)
++++...+ .+|+||||+ +++|..++.......+++..++.++.||+.||+|||++ ||+||||||+||||+.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99998654 889999999 99999998876656699999999999999999999998 9999999999999953
Q ss_pred ---CCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhh
Q 035930 608 ---DGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD 684 (857)
Q Consensus 608 ---dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d 684 (857)
.+.+||+|||++.....
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~------------------------------------------------------------ 190 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE------------------------------------------------------------ 190 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB------------------------------------------------------------
T ss_pred CcCcceEEEcccccccccCC------------------------------------------------------------
Confidence 34799999998743110
Q ss_pred hhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC------hhhhHH
Q 035930 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN------DETLSN 758 (857)
Q Consensus 685 ~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~------~e~l~~ 758 (857)
.....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+... .+.+..
T Consensus 191 ------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 191 ------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp ------------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred ------------------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 01233689999999999999999999999999999999999999986542 222222
Q ss_pred HhhccccC----------------------------------------CCCCCCCHHHHHHHHhhccCCcCCcCCchhhH
Q 035930 759 VVSQSLRF----------------------------------------PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGA 798 (857)
Q Consensus 759 Iv~~~~~~----------------------------------------p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a 798 (857)
++.....+ .....++.++.+||.+||..||.+||+ +
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~ 328 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD----A 328 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----H
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC----H
Confidence 22111000 111234678899999999999999999 9
Q ss_pred HHHHcCCCCCCC
Q 035930 799 AEIKQHPFFEGL 810 (857)
Q Consensus 799 ~ELL~HPfF~~l 810 (857)
+|||+||||.+.
T Consensus 329 ~ell~hp~f~~~ 340 (373)
T 1q8y_A 329 GGLVNHPWLKDT 340 (373)
T ss_dssp HHHHTCGGGTTC
T ss_pred HHHhhChhhhcc
Confidence 999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=387.65 Aligned_cols=257 Identities=23% Similarity=0.371 Sum_probs=210.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC--e
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK--F 544 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~--~ 544 (857)
...++|.+.+.||+|+||+||+|.+..+++.||||++..... ....+.+.+|+++|+.++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 345789999999999999999999999999999999976432 334567789999999999999999999998765 8
Q ss_pred EEEEEeecCCCChHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE----ccCCcEEEecccch
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPS-RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV----REDGHIMLSDFDLS 619 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~-~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL----~~dg~iKL~DFGLA 619 (857)
.||||||+++++|..++..... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999998876432 238999999999999999999999999999999999999 77788999999997
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
......
T Consensus 164 ~~~~~~-------------------------------------------------------------------------- 169 (319)
T 4euu_A 164 RELEDD-------------------------------------------------------------------------- 169 (319)
T ss_dssp EECCTT--------------------------------------------------------------------------
T ss_pred eecCCC--------------------------------------------------------------------------
Confidence 432100
Q ss_pred CCCccccccCCCCccChhhhc--------CCCCCcccceehhhHHHHHHhhCCCCCCCCCC----hhhhHHHhhccc---
Q 035930 700 TGARSNSFVGTHEYLAPEIIK--------GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN----DETLSNVVSQSL--- 764 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~--------g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~----~e~l~~Iv~~~~--- 764 (857)
......+||+.|+|||++. +..++.++|||||||+||||++|+.||..... .+.+..++....
T Consensus 170 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 170 --EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (319)
T ss_dssp --CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred --CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence 0112346999999999987 57789999999999999999999999976543 334444443321
Q ss_pred ----------------cCCCC----CCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCC
Q 035930 765 ----------------RFPGY----PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHP 805 (857)
Q Consensus 765 ----------------~~p~~----~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HP 805 (857)
.++.. ..++..+.+||++||+.||++||+ ++|+|+||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s----~~ell~h~ 304 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG----FDQFFAET 304 (319)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC----HHHHHHHH
T ss_pred chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc----HHHhhhcc
Confidence 11111 123457889999999999999999 99999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=403.01 Aligned_cols=264 Identities=25% Similarity=0.319 Sum_probs=196.4
Q ss_pred CCeEE-EeEEccCCceEEEEEEEc--CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee--CCe
Q 035930 470 RHFKL-HKKLGCGDIGTVYLAELI--GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT--EKF 544 (857)
Q Consensus 470 ~~Y~i-~~~LG~G~fGtVyla~~~--~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~--~~~ 544 (857)
+.|.+ +++||+|+||+||+|++. .+++.||||++... .....+.+|+++|+.++||||++++++|.. +..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-----GISMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-----SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-----CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 45776 568999999999999976 56889999999754 233467899999999999999999999954 679
Q ss_pred EEEEEeecCCCChHHHHhhC-------CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE----ccCCcEEE
Q 035930 545 SCLVMEYCPGGDLHVLRQKQ-------PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV----REDGHIML 613 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~-------~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL----~~dg~iKL 613 (857)
+||||||+. ++|..++... ....+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999995 5776665421 11248999999999999999999999999999999999999 67789999
Q ss_pred ecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCC
Q 035930 614 SDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMP 693 (857)
Q Consensus 614 ~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p 693 (857)
+|||++..+....
T Consensus 174 ~Dfg~a~~~~~~~------------------------------------------------------------------- 186 (405)
T 3rgf_A 174 ADMGFARLFNSPL------------------------------------------------------------------- 186 (405)
T ss_dssp CCTTCCC-------------------------------------------------------------------------
T ss_pred EECCCceecCCCC-------------------------------------------------------------------
Confidence 9999985421000
Q ss_pred cccccCCCCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCCh---------hhhHHHhhcc
Q 035930 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGND---------ETLSNVVSQS 763 (857)
Q Consensus 694 ~l~~~~~~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~---------e~l~~Iv~~~ 763 (857)
.........+||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.... +.+..++...
T Consensus 187 -----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~ 261 (405)
T 3rgf_A 187 -----KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261 (405)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHH
T ss_pred -----cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhh
Confidence 000112345799999999999885 4899999999999999999999999765432 3333333211
Q ss_pred ccCC------------------------------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 764 LRFP------------------------------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 764 ~~~p------------------------------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
..++ .....+..+.+||.+||..||.+||| ++|+|+||||
T Consensus 262 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t----a~e~L~hp~f 337 (405)
T 3rgf_A 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPYF 337 (405)
T ss_dssp CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC----HHHHHTSGGG
T ss_pred CCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcChhh
Confidence 1000 01123778999999999999999999 9999999999
Q ss_pred CCCChhhh
Q 035930 808 EGLNWALI 815 (857)
Q Consensus 808 ~~l~w~li 815 (857)
.+..|...
T Consensus 338 ~~~~~~~~ 345 (405)
T 3rgf_A 338 LEDPLPTS 345 (405)
T ss_dssp TSSSCCCS
T ss_pred ccCCCCcc
Confidence 98766543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=375.07 Aligned_cols=254 Identities=22% Similarity=0.352 Sum_probs=216.3
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
.+..++|++.+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+++|+.++||||+++++++.+++..
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc----cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 356678999999999999999999986 56789999997652 2345688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEEeCCCCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999999999999876543 4899999999999999999999999999999999999999999999999998532100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
. .....
T Consensus 160 ~--------------------------------------------------------------------------~~~~~ 165 (269)
T 4hcu_A 160 Q--------------------------------------------------------------------------YTSST 165 (269)
T ss_dssp H--------------------------------------------------------------------------HHSTT
T ss_pred c--------------------------------------------------------------------------ccccc
Confidence 0 00011
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
...||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....+.+..+... ........++.++.+||.+||
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l 244 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCW 244 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHHT
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-ccCCCCCcCCHHHHHHHHHHc
Confidence 2346889999999999999999999999999999999 99999988777776666554 344445668999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcC
Q 035930 785 VKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~H 804 (857)
..||++||+ +.++++|
T Consensus 245 ~~~p~~Rps----~~~ll~~ 260 (269)
T 4hcu_A 245 RERPEDRPA----FSRLLRQ 260 (269)
T ss_dssp CSSGGGSCC----HHHHHHH
T ss_pred cCCcccCcC----HHHHHHH
Confidence 999999999 7888764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=378.94 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=218.6
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee--CCeEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT--EKFSC 546 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~--~~~l~ 546 (857)
.++|++++.||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4689999999999999999999999999999999976532 22345678899999999999999999998854 57899
Q ss_pred EEEeecCCCChHHHHhhCC--CCCCcHHHHHHHHHHHHHHHHHHHHcC-----ceeccCCCCcEEEccCCcEEEecccch
Q 035930 547 LVMEYCPGGDLHVLRQKQP--SRFFSEQAARFYVAEVLLALEYLHMLG-----VVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~--~~~l~e~~~r~i~~QIl~gL~yLHs~G-----IIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||+.| |+||||||+|||++.++.++|+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999999999998886532 234899999999999999999999999 999999999999999999999999998
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
.......
T Consensus 164 ~~~~~~~------------------------------------------------------------------------- 170 (279)
T 2w5a_A 164 RILNHDT------------------------------------------------------------------------- 170 (279)
T ss_dssp HHC---C-------------------------------------------------------------------------
T ss_pred eeecccc-------------------------------------------------------------------------
Confidence 5421000
Q ss_pred CCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHH
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDL 779 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dL 779 (857)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...... +....++.++.+|
T Consensus 171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~l 247 (279)
T 2w5a_A 171 --SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDELNEI 247 (279)
T ss_dssp --HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHH
T ss_pred --ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc-cCCcccCHHHHHH
Confidence 0011235899999999999999999999999999999999999999988766666666555432 2334689999999
Q ss_pred HHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 780 IRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
|.+||..||.+||+ +.+|++|+||.+
T Consensus 248 i~~~l~~~p~~Rps----~~~ll~~~~~~~ 273 (279)
T 2w5a_A 248 ITRMLNLKDYHRPS----VEEILENPLILE 273 (279)
T ss_dssp HHHHTCSSGGGSCC----HHHHHTSTTCCG
T ss_pred HHHHcCCCcccCCC----HHHHHhChhhhh
Confidence 99999999999999 999999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=388.24 Aligned_cols=261 Identities=20% Similarity=0.291 Sum_probs=220.6
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEc-----CCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceee
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELI-----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHF 539 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~-----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f 539 (857)
.+..++|.+.+.||+|+||+||+|.+. +++..||||++.... .......+.+|+.+|+.+ +||||++++++|
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 356689999999999999999999983 467789999997542 234557789999999999 899999999999
Q ss_pred eeCCeEEEEEeecCCCChHHHHhhCCC---------------------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccC
Q 035930 540 TTEKFSCLVMEYCPGGDLHVLRQKQPS---------------------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDL 598 (857)
Q Consensus 540 ~~~~~l~LVmEy~~gGsL~~ll~~~~~---------------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDL 598 (857)
...+..||||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 999999999999999999999876532 23789999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhh
Q 035930 599 KPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKS 678 (857)
Q Consensus 599 KPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~ 678 (857)
||+|||++.++.++|+|||++.......
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~---------------------------------------------------- 226 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDS---------------------------------------------------- 226 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCT----------------------------------------------------
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCc----------------------------------------------------
Confidence 9999999999999999999985321100
Q ss_pred hhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhH
Q 035930 679 RKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLS 757 (857)
Q Consensus 679 ~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~ 757 (857)
.........||+.|+|||++.+..++.++|||||||+||+|++ |..||.+....+.+.
T Consensus 227 ---------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 285 (344)
T 1rjb_A 227 ---------------------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 285 (344)
T ss_dssp ---------------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred ---------------------cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHH
Confidence 0001123457899999999999999999999999999999998 999999988777777
Q ss_pred HHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCC
Q 035930 758 NVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHP 805 (857)
Q Consensus 758 ~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HP 805 (857)
.++.....++....++.++.+||.+||..||.+||+ +.+|++|.
T Consensus 286 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~l 329 (344)
T 1rjb_A 286 KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSFL 329 (344)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHHHH
Confidence 777777777766779999999999999999999999 88888754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=392.78 Aligned_cols=262 Identities=27% Similarity=0.392 Sum_probs=209.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc--------cchhHHHHHHHHHHHcCCCCcccccee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR--------KKMPRAQTEREIMQMLDHPFLPTLFAH 538 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~--------~~~~~~~~EieILr~L~HPnIV~L~~~ 538 (857)
...++|.+.+.||+|+||+||+|.+.. +..||||++........ .....+.+|+++|+.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 345789999999999999999999864 88999999965432211 123678899999999999999999999
Q ss_pred eee-----CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEE
Q 035930 539 FTT-----EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML 613 (857)
Q Consensus 539 f~~-----~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL 613 (857)
|.. ...+|+||||+. |+|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 854 347899999996 68877776543 34899999999999999999999999999999999999999999999
Q ss_pred ecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCC
Q 035930 614 SDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMP 693 (857)
Q Consensus 614 ~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p 693 (857)
+|||++.....
T Consensus 176 ~Dfg~~~~~~~--------------------------------------------------------------------- 186 (362)
T 3pg1_A 176 CDFNLAREDTA--------------------------------------------------------------------- 186 (362)
T ss_dssp CCTTC---------------------------------------------------------------------------
T ss_pred EecCccccccc---------------------------------------------------------------------
Confidence 99999742110
Q ss_pred cccccCCCCccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC------
Q 035930 694 QLVVEPTGARSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF------ 766 (857)
Q Consensus 694 ~l~~~~~~~~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~------ 766 (857)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..++......
T Consensus 187 -------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (362)
T 3pg1_A 187 -------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV 259 (362)
T ss_dssp ----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred -------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhh
Confidence 001123468999999999987 678999999999999999999999999887666666654321110
Q ss_pred ------------------C------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 767 ------------------P------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 767 ------------------p------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
+ ..+.+++.+.+||.+||..||.+||+ +.++|+||||+.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS----TEQALRHPYFESLF 324 (362)
T ss_dssp HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGTTTC
T ss_pred hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC----HHHHHcCchhhhcc
Confidence 0 12456889999999999999999999 99999999999873
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=390.54 Aligned_cols=257 Identities=25% Similarity=0.337 Sum_probs=214.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCC---eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTS---CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg---~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
+...+|++.+.||+|+||+||+|.+..++ ..||||+++... .......+.+|+.+|+.++||||++++++|.+++
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 55678999999999999999999997544 469999997542 2334467889999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..||||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred ccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999987553 349999999999999999999999999999999999999999999999999985422
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.... ....
T Consensus 203 ~~~~------------------------------------------------------------------------~~~~ 210 (325)
T 3kul_A 203 DDPD------------------------------------------------------------------------AAYT 210 (325)
T ss_dssp ----------------------------------------------------------------------------CCEE
T ss_pred cCcc------------------------------------------------------------------------ceee
Confidence 1100 0000
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....+|+.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+... ..++....++..+.+||.+
T Consensus 211 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~ 289 (325)
T 3kul_A 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMGCPHALHQLMLD 289 (325)
T ss_dssp CC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCCcCHHHHHHHHH
Confidence 112346889999999999999999999999999999998 99999988777766665543 5556667799999999999
Q ss_pred hccCCcCCcCCchhhHHHHHc
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||..||.+||+ +.+|++
T Consensus 290 ~l~~dp~~Rps----~~eil~ 306 (325)
T 3kul_A 290 CWHKDRAQRPR----FSQIVS 306 (325)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HccCChhhCcC----HHHHHH
Confidence 99999999999 666664
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=400.70 Aligned_cols=274 Identities=18% Similarity=0.248 Sum_probs=224.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEE-----cCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAEL-----IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~-----~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
+..++|.+++.||+|+||+||+|.+ ..++..||||+++... .......+.+|+.+|+.++||||++++++|.+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 4557899999999999999999994 4577899999996532 23344567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCC-----CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC---cEEE
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQPS-----RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG---HIML 613 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~~-----~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg---~iKL 613 (857)
....||||||+++|+|..++..... ..+++..++.++.||+.||+|||++|||||||||+||||+.+| .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999998876432 3489999999999999999999999999999999999999655 5999
Q ss_pred ecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCC
Q 035930 614 SDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMP 693 (857)
Q Consensus 614 ~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p 693 (857)
+|||+++......
T Consensus 226 ~DFG~a~~~~~~~------------------------------------------------------------------- 238 (367)
T 3l9p_A 226 GDFGMARDIYRAG------------------------------------------------------------------- 238 (367)
T ss_dssp CCCHHHHHHHHHS-------------------------------------------------------------------
T ss_pred CCCcccccccccc-------------------------------------------------------------------
Confidence 9999985421100
Q ss_pred cccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCC
Q 035930 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVV 772 (857)
Q Consensus 694 ~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~i 772 (857)
.........||+.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+.... ..+....+
T Consensus 239 ------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~ 311 (367)
T 3l9p_A 239 ------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPPKNC 311 (367)
T ss_dssp ------SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCCTTC
T ss_pred ------ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCccC
Confidence 0011223468999999999999999999999999999999998 999999887777766665543 33444678
Q ss_pred CHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCC
Q 035930 773 SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVP 820 (857)
Q Consensus 773 s~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~p 820 (857)
+..+.+||.+||..||.+||+ +.+|++|.|+-.-+...+....|
T Consensus 312 ~~~l~~li~~~l~~dP~~Rps----~~eil~~l~~~~~~~~~~~~~~p 355 (367)
T 3l9p_A 312 PGPVYRIMTQCWQHQPEDRPN----FAIILERIEYCTQDPDVINTALP 355 (367)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHHHHCHHHHTCCCC
T ss_pred CHHHHHHHHHHcCCCHhHCcC----HHHHHHHHHHHhhChhhccCCCc
Confidence 999999999999999999999 99999998775555555544443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=383.17 Aligned_cols=268 Identities=19% Similarity=0.250 Sum_probs=212.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|.+++.||+|+||+||+|.+..++..||+|++... .......+.+|+++|+.++||||++++++|.+++..|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 5567899999999999999999999999999999998543 2344567889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++++|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999987543 48999999999999999999999999999999999999999999999999985432111
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
..... ......+.......
T Consensus 163 ~~~~~-------------------------------------------------------------~~~~~~~~~~~~~~ 181 (310)
T 3s95_A 163 TQPEG-------------------------------------------------------------LRSLKKPDRKKRYT 181 (310)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred ccccc-------------------------------------------------------------cccccccccccccc
Confidence 00000 00000011122335
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhh-HHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL-SNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l-~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
.+||+.|+|||++.+..++.++|||||||+||||++|..||......... .............+.+++.+.+||.+||.
T Consensus 182 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 261 (310)
T 3s95_A 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCD 261 (310)
T ss_dssp CCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTC
T ss_pred cCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHcc
Confidence 68999999999999999999999999999999999999999765332211 11111111112235688999999999999
Q ss_pred CCcCCcCCchhhHHHHHc
Q 035930 786 KEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~ 803 (857)
.||++||+ +.+|++
T Consensus 262 ~dP~~Rps----~~~l~~ 275 (310)
T 3s95_A 262 LDPEKRPS----FVKLEH 275 (310)
T ss_dssp SSGGGSCC----HHHHHH
T ss_pred CChhhCcC----HHHHHH
Confidence 99999999 788876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=386.98 Aligned_cols=257 Identities=19% Similarity=0.253 Sum_probs=210.2
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeE----EEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCL----FALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~----VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
.+...+|++++.||+|+||+||+|.+..++.. ||+|++... ........+.+|+.+++.++||||++++++|.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCT--TSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccc--ccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 35667899999999999999999999888765 677776543 22344456788999999999999999999886
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
++..|+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++..
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 456899999999999999887653 3489999999999999999999999999999999999999999999999999854
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
..... ..
T Consensus 165 ~~~~~-------------------------------------------------------------------------~~ 171 (325)
T 3kex_A 165 LPPDD-------------------------------------------------------------------------KQ 171 (325)
T ss_dssp SCCCT-------------------------------------------------------------------------TC
T ss_pred cCccc-------------------------------------------------------------------------cc
Confidence 32110 00
Q ss_pred CccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHH
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLI 780 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI 780 (857)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+.. ....+....++.++.+||
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 250 (325)
T 3kex_A 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK-GERLAQPQICTIDVYMVM 250 (325)
T ss_dssp CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT-TCBCCCCTTBCTTTTHHH
T ss_pred ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCCCcCcHHHHHHH
Confidence 01123458889999999999999999999999999999999 9999998776666555444 334444556899999999
Q ss_pred HhhccCCcCCcCCchhhHHHHHcC
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
.+||..||.+||+ +.++++|
T Consensus 251 ~~~l~~dp~~Rps----~~el~~~ 270 (325)
T 3kex_A 251 VKCWMIDENIRPT----FKELANE 270 (325)
T ss_dssp HHHTCSCTTTSCC----HHHHHHH
T ss_pred HHHcCCChhhCcC----HHHHHHH
Confidence 9999999999999 6666654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=381.24 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=217.2
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEc-----CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceee
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELI-----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHF 539 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~-----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f 539 (857)
+.+..++|.+.+.||+|+||+||+|.+. .++..||||++.... .......+.+|+++|+.++||||++++++|
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 3466789999999999999999999984 455899999997542 234456788999999999999999999999
Q ss_pred eeCCeEEEEEeecCCCChHHHHhhCCC----------------------CCCcHHHHHHHHHHHHHHHHHHHHcCceecc
Q 035930 540 TTEKFSCLVMEYCPGGDLHVLRQKQPS----------------------RFFSEQAARFYVAEVLLALEYLHMLGVVYRD 597 (857)
Q Consensus 540 ~~~~~l~LVmEy~~gGsL~~ll~~~~~----------------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRD 597 (857)
.+++..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999876532 2489999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHh
Q 035930 598 LKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAK 677 (857)
Q Consensus 598 LKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~ 677 (857)
|||+|||++.++.++|+|||++........
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-------------------------------------------------- 205 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDS-------------------------------------------------- 205 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSC--------------------------------------------------
T ss_pred cchheEEEcCCCCEEEcccccccccccccc--------------------------------------------------
Confidence 999999999999999999999754211000
Q ss_pred hhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhh
Q 035930 678 SRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETL 756 (857)
Q Consensus 678 ~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l 756 (857)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+..
T Consensus 206 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 262 (314)
T 2ivs_A 206 -----------------------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262 (314)
T ss_dssp -----------------------EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred -----------------------ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 000122347889999999999999999999999999999999 99999988766665
Q ss_pred HHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 757 ~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
..+. .....+....++.++.+||.+||..||.+||+ +.+|+++
T Consensus 263 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~l~~~ 305 (314)
T 2ivs_A 263 NLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV----FADISKD 305 (314)
T ss_dssp HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 5443 34444455679999999999999999999999 7777754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=384.63 Aligned_cols=267 Identities=21% Similarity=0.312 Sum_probs=214.5
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~ 546 (857)
..++|++.+.||+|+||+||+|.+..+++.||||++... .....+.+|+++|+.+ +||||+++++++..++..|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-----SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT-----CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccc-----cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 447899999999999999999999999999999998654 2234578999999999 8999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc-----EEEecccchhh
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH-----IMLSDFDLSLR 621 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~-----iKL~DFGLA~r 621 (857)
|||||+ +++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||++..
T Consensus 82 lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 999999 999999988653 35999999999999999999999999999999999999998887 99999999854
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
+...... .....
T Consensus 160 ~~~~~~~--------------------------------------------------------------------~~~~~ 171 (330)
T 2izr_A 160 YIDPETK--------------------------------------------------------------------KHIPY 171 (330)
T ss_dssp SBCTTTC--------------------------------------------------------------------CBCCC
T ss_pred eecCCCC--------------------------------------------------------------------ccccc
Confidence 3211000 00000
Q ss_pred CccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhh---hHHHhhccccCCC---CCCCCHH
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET---LSNVVSQSLRFPG---YPVVSFH 775 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~---l~~Iv~~~~~~p~---~~~is~~ 775 (857)
......+||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+. +..+.......+. ...++ +
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~ 250 (330)
T 2izr_A 172 REHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-E 250 (330)
T ss_dssp CCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-H
T ss_pred cccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-H
Confidence 112356799999999999999999999999999999999999999998654433 3444333333321 12244 9
Q ss_pred HHHHHHhhccCCcCCcCCchhhHHHHHc----------CCCCCCCChhh
Q 035930 776 ARDLIRGLLVKEPDNRLGAVKGAAEIKQ----------HPFFEGLNWAL 814 (857)
Q Consensus 776 l~dLI~k~L~~DPe~Rpt~~~~a~ELL~----------HPfF~~l~w~l 814 (857)
+.+||..||..||.+||++ .+|++ ..+...++|..
T Consensus 251 ~~~li~~~l~~~p~~RP~~----~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 251 MATYLRYVRRLDFFEKPDY----DYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp HHHHHHHHHHCCTTCCCCH----HHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred HHHHHHHHHhCCCCCCCCH----HHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 9999999999999999994 33333 45666788873
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=376.90 Aligned_cols=271 Identities=25% Similarity=0.400 Sum_probs=208.5
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee--------
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT-------- 541 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~-------- 541 (857)
++|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+|+.++||||++++++|.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 4799999999999999999999999999999999643 2345678899999999999999999998865
Q ss_pred -----CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecc
Q 035930 542 -----EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616 (857)
Q Consensus 542 -----~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DF 616 (857)
.+..|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 457899999999999999998654 34788999999999999999999999999999999999999999999999
Q ss_pred cchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccc
Q 035930 617 DLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLV 696 (857)
Q Consensus 617 GLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~ 696 (857)
|++............ . ...
T Consensus 161 g~~~~~~~~~~~~~~-------------------------------------------~------------------~~~ 179 (303)
T 1zy4_A 161 GLAKNVHRSLDILKL-------------------------------------------D------------------SQN 179 (303)
T ss_dssp CCCSCTTC------------------------------------------------------------------------
T ss_pred cchhhcccccchhcc-------------------------------------------c------------------ccc
Confidence 998542111000000 0 000
Q ss_pred ccCCCCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCC-CChhhhHHHhhccccCCC--CCCC
Q 035930 697 VEPTGARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGS-GNDETLSNVVSQSLRFPG--YPVV 772 (857)
Q Consensus 697 ~~~~~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~-~~~e~l~~Iv~~~~~~p~--~~~i 772 (857)
...........+||+.|+|||++.+. .++.++|||||||++|+|++ ||... ...+.+..+......++. ....
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (303)
T 1zy4_A 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNK 256 (303)
T ss_dssp --------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTT
T ss_pred ccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccc
Confidence 00001122355799999999999875 68999999999999999998 66432 223344444443333332 3456
Q ss_pred CHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 773 SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 773 s~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
+..+++||.+||..||.+||+ +.++++||||....+.
T Consensus 257 ~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 257 MKVEKKIIRLLIDHDPNKRPG----ARTLLNSGWLPVKHQD 293 (303)
T ss_dssp SHHHHHHHHHHTCSSGGGSCC----HHHHHHSSCSCCCCHH
T ss_pred hHHHHHHHHHHHhcCcccCcC----HHHHhCCCCcCCCChH
Confidence 778999999999999999999 9999999999887665
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=371.60 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=208.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccc-ccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG-RKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~-~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
+...+|++.+.||+|+||+||+|.+. +..||||++....... ....+.+.+|+++++.++||||++++++|.+++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 45678999999999999999999984 7889999987653322 33456788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEcc--------CCcEEEe
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG---VVYRDLKPENILVRE--------DGHIMLS 614 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G---IIHRDLKPeNILL~~--------dg~iKL~ 614 (857)
|+||||+++++|..++... .+++..++.++.||+.||.|||++| |+||||||+|||++. ++.++|+
T Consensus 82 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999999988643 4899999999999999999999999 999999999999986 7789999
Q ss_pred cccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCc
Q 035930 615 DFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQ 694 (857)
Q Consensus 615 DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~ 694 (857)
|||++......
T Consensus 159 Dfg~~~~~~~~--------------------------------------------------------------------- 169 (271)
T 3dtc_A 159 DFGLAREWHRT--------------------------------------------------------------------- 169 (271)
T ss_dssp CCCC----------------------------------------------------------------------------
T ss_pred cCCcccccccc---------------------------------------------------------------------
Confidence 99987431100
Q ss_pred ccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCH
Q 035930 695 LVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSF 774 (857)
Q Consensus 695 l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~ 774 (857)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......++....++.
T Consensus 170 --------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (271)
T 3dtc_A 170 --------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE 241 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred --------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCH
Confidence 011235899999999999999999999999999999999999999988777777777777777766678999
Q ss_pred HHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 775 HARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 775 ~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
.+.+||.+||..||.+||+ +.++++|
T Consensus 242 ~~~~li~~~l~~~p~~Rps----~~e~l~~ 267 (271)
T 3dtc_A 242 PFAKLMEDCWNPDPHSRPS----FTNILDQ 267 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHhcCCcccCcC----HHHHHHH
Confidence 9999999999999999999 7777764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=379.51 Aligned_cols=259 Identities=20% Similarity=0.294 Sum_probs=220.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEE-----cCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAEL-----IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~-----~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~ 540 (857)
+..++|.+.+.||+|+||+||+|.+ ..++..||||+++.... ....+.+.+|+.+|+.+ +||||++++++|.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 5567899999999999999999986 35678999999976522 23346788999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCCC----------------CCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQPSR----------------FFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~~~----------------~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNIL 604 (857)
+++..|+||||+++|+|.+++...... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 999999999999999999998765422 4899999999999999999999999999999999999
Q ss_pred EccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhh
Q 035930 605 VREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD 684 (857)
Q Consensus 605 L~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d 684 (857)
++.++.+||+|||++.......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~---------------------------------------------------------- 199 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDS---------------------------------------------------------- 199 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCT----------------------------------------------------------
T ss_pred EcCCCCEEEccccccccccccc----------------------------------------------------------
Confidence 9999999999999984321100
Q ss_pred hhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhcc
Q 035930 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQS 763 (857)
Q Consensus 685 ~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~ 763 (857)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||.+......+...+...
T Consensus 200 ---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 264 (313)
T 1t46_A 200 ---------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264 (313)
T ss_dssp ---------------TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT
T ss_pred ---------------cceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccC
Confidence 0001123457889999999999999999999999999999998 999999888777777777777
Q ss_pred ccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 764 ~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
........++..+.+||.+||..||.+||+ +.+++++
T Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 301 (313)
T 1t46_A 265 FRMLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQL 301 (313)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCcccCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 776666779999999999999999999999 7777753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=374.71 Aligned_cols=256 Identities=23% Similarity=0.309 Sum_probs=220.2
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
+.+...+|++.+.||+|+||+||+|.+..++..||||++... ....+.+.+|+++|+.++||||+++++++.+++.
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 346678899999999999999999999999999999999754 3345678899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
.|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999999886666799999999999999999999999999999999999999999999999999853211
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
.. ....
T Consensus 164 ~~--------------------------------------------------------------------------~~~~ 169 (288)
T 3kfa_A 164 DT--------------------------------------------------------------------------YTAH 169 (288)
T ss_dssp SS--------------------------------------------------------------------------SEEE
T ss_pred Cc--------------------------------------------------------------------------cccc
Confidence 00 0011
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhh
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~ 783 (857)
....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.... +......+....++..+.+||.+|
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~ 248 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMERPEGCPEKVYELMRAC 248 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhccCCCCCCCCCCHHHHHHHHHH
Confidence 22347889999999999999999999999999999999 9999988766655544 444455555677999999999999
Q ss_pred ccCCcCCcCCchhhHHHHHc
Q 035930 784 LVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~ 803 (857)
|..||.+||+ +.++++
T Consensus 249 l~~dp~~Rps----~~~~~~ 264 (288)
T 3kfa_A 249 WQWNPSDRPS----FAEIHQ 264 (288)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred hCCChhhCcC----HHHHHH
Confidence 9999999999 677664
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=376.41 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=212.0
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
..+|.....||+|+||+||+|.+..++..||||++... .......+.+|+.+++.++||||++++++|...+..|+|
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC---CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC---chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 34555566999999999999999999999999999754 234456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc-CCcEEEecccchhhcccCc
Q 035930 549 MEYCPGGDLHVLRQKQPS-RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE-DGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~-~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~-dg~iKL~DFGLA~r~~~~~ 626 (857)
|||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|||++......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~- 176 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI- 176 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC-
Confidence 999999999998876532 24678999999999999999999999999999999999987 899999999987432100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 177 --------------------------------------------------------------------------~~~~~~ 182 (295)
T 2clq_A 177 --------------------------------------------------------------------------NPCTET 182 (295)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 000123
Q ss_pred ccCCCCccChhhhcCCC--CCcccceehhhHHHHHHhhCCCCCCCCCChhh-hHHHhhccccCCCCCCCCHHHHHHHHhh
Q 035930 707 FVGTHEYLAPEIIKGEG--HGSSVDWWTFGIFLFELLYGRTPFKGSGNDET-LSNVVSQSLRFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~--~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~-l~~Iv~~~~~~p~~~~is~~l~dLI~k~ 783 (857)
..||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........ +...............++.++.+||.+|
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 262 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKC 262 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHT
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHH
Confidence 46899999999998754 78999999999999999999999976544322 2222222223333456899999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
|..||++||+ +.++++||||....
T Consensus 263 l~~dp~~Rps----~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 263 FEPDPDKRAC----ANDLLVDEFLKVSS 286 (295)
T ss_dssp TCSSTTTSCC----HHHHHTSGGGCC--
T ss_pred ccCChhhCCC----HHHHhcChhhhhcc
Confidence 9999999999 99999999998654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=384.53 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=216.9
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeee
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFT 540 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~ 540 (857)
.+..++|++++.||+|+||+||+|++.+ ++..||||+++... .......+.+|+.+|+.++||||++++++|.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4567899999999999999999999973 45899999997652 2334567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCC----------------------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccC
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQPS----------------------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDL 598 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~~----------------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDL 598 (857)
+++..||||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 99999999999999999999876421 35899999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhh
Q 035930 599 KPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKS 678 (857)
Q Consensus 599 KPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~ 678 (857)
||+|||++.++.+||+|||++........
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--------------------------------------------------- 229 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADY--------------------------------------------------- 229 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGC---------------------------------------------------
T ss_pred CcceEEECCCCeEEEeecCCCcccccCcc---------------------------------------------------
Confidence 99999999999999999999854311000
Q ss_pred hhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhH
Q 035930 679 RKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLS 757 (857)
Q Consensus 679 ~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~ 757 (857)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+.
T Consensus 230 ----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 287 (343)
T 1luf_A 230 ----------------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY 287 (343)
T ss_dssp ----------------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred ----------------------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHH
Confidence 001123458899999999999999999999999999999998 999999887777776
Q ss_pred HHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 758 NVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 758 ~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.+..... .+....++.++.+||.+||..||.+||+ +.++++
T Consensus 288 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~~~~ 328 (343)
T 1luf_A 288 YVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPS----FCSIHR 328 (343)
T ss_dssp HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCC----HHHHHH
Confidence 6655443 2334568999999999999999999999 677664
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=370.67 Aligned_cols=251 Identities=19% Similarity=0.295 Sum_probs=217.4
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC--C
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE--K 543 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~--~ 543 (857)
.+..++|.+.+.||+|+||+||+|.+. +..||||++..... .......+.+|+.+|+.++||||++++++|.+. +
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 356678999999999999999999985 77899999976532 223345688999999999999999999999887 7
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG--VVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G--IIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
..|+||||+++|+|.+++.......+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 8899999999999999998766556899999999999999999999999 99999999999999999999999997521
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
.
T Consensus 163 ~------------------------------------------------------------------------------- 163 (271)
T 3kmu_A 163 F------------------------------------------------------------------------------- 163 (271)
T ss_dssp T-------------------------------------------------------------------------------
T ss_pred e-------------------------------------------------------------------------------
Confidence 0
Q ss_pred CccccccCCCCccChhhhcCCCCCc---ccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHH
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGHGS---SVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARD 778 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~s~---ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~d 778 (857)
......||+.|+|||++.+..++. ++|||||||++|||++|+.||.+....+....+.........+..++.++.+
T Consensus 164 -~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (271)
T 3kmu_A 164 -QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSK 242 (271)
T ss_dssp -SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHH
T ss_pred -cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 011235899999999999876655 7999999999999999999999988888878887777777666789999999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHHc
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||.+||..||.+||+ +.++++
T Consensus 243 li~~~l~~~p~~Rps----~~~il~ 263 (271)
T 3kmu_A 243 LMKICMNEDPAKRPK----FDMIVP 263 (271)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHcCCChhhCcC----HHHHHH
Confidence 999999999999999 777764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=370.03 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=214.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++.+.||+|+||+||+|.+. ++..||||++.... .....+.+|+++|+.++||||+++++++.+++..|
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS----MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT----BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC----CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 55678999999999999999999886 56789999997642 23456889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 80 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999999887653 348999999999999999999999999999999999999999999999999974321100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
. .....
T Consensus 159 ~--------------------------------------------------------------------------~~~~~ 164 (268)
T 3sxs_A 159 Y--------------------------------------------------------------------------VSSVG 164 (268)
T ss_dssp E--------------------------------------------------------------------------EECCS
T ss_pred h--------------------------------------------------------------------------hcccC
Confidence 0 00112
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
..||+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+.... .......+++.+.+||.+||.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~ 243 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-RLYRPHLASDTIYQIMYSCWH 243 (268)
T ss_dssp CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTSCHHHHHHHHHTTC
T ss_pred CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-CCCCCCcChHHHHHHHHHHcC
Confidence 346788999999999999999999999999999998 999999887777666655443 333345689999999999999
Q ss_pred CCcCCcCCchhhHHHHHcC
Q 035930 786 KEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~H 804 (857)
.||.+||+ +.++++|
T Consensus 244 ~~p~~Rps----~~~ll~~ 258 (268)
T 3sxs_A 244 ELPEKRPT----FQQLLSS 258 (268)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred CChhhCcC----HHHHHHH
Confidence 99999999 8888764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=373.26 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=212.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++++.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+++|+.++||||++++++|.+++..|
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC----CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 56678999999999999999999886 67789999997652 23456889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 96 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999999987643 249999999999999999999999999999999999999999999999999985421000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
. .....
T Consensus 175 ~--------------------------------------------------------------------------~~~~~ 180 (283)
T 3gen_A 175 Y--------------------------------------------------------------------------TSSVG 180 (283)
T ss_dssp H--------------------------------------------------------------------------HSTTS
T ss_pred c--------------------------------------------------------------------------ccccC
Confidence 0 00112
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
..||+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+... ........+++.+.+||.+||.
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~ 259 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMYSCWH 259 (283)
T ss_dssp TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTC
T ss_pred CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-cCCCCCCcCCHHHHHHHHHHcc
Confidence 346889999999999999999999999999999998 99999988777666665544 3444446689999999999999
Q ss_pred CCcCCcCCchhhHHHHHcC
Q 035930 786 KEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~H 804 (857)
.||.+||+ +.++++|
T Consensus 260 ~~p~~Rps----~~~ll~~ 274 (283)
T 3gen_A 260 EKADERPT----FKILLSN 274 (283)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred CChhHCcC----HHHHHHH
Confidence 99999999 7787765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=370.67 Aligned_cols=254 Identities=17% Similarity=0.230 Sum_probs=208.4
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCe
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~ 544 (857)
.+..++|++.+.||+|+||+||+|.+..+++.||||++... .....+.+|+.+++.+ +|+||+++++++.++..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-----CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 35567899999999999999999999999999999998654 2334578899999999 79999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc-----EEEecccch
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH-----IMLSDFDLS 619 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~-----iKL~DFGLA 619 (857)
.|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||++
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 99999999 999999998654 34999999999999999999999999999999999999987776 999999998
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
.......... ..
T Consensus 159 ~~~~~~~~~~--------------------------------------------------------------------~~ 170 (298)
T 1csn_A 159 KFYRDPVTKQ--------------------------------------------------------------------HI 170 (298)
T ss_dssp EESBCTTTCC--------------------------------------------------------------------BC
T ss_pred cccccccccc--------------------------------------------------------------------cc
Confidence 5432110000 00
Q ss_pred CCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC---hhhhHHHhhccccCC---CCCCCC
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN---DETLSNVVSQSLRFP---GYPVVS 773 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~---~e~l~~Iv~~~~~~p---~~~~is 773 (857)
.........||+.|+|||++.+..++.++|||||||+||||++|+.||.+... .+.+..+.......+ ....++
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1csn_A 171 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 250 (298)
T ss_dssp CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSC
T ss_pred cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCc
Confidence 00112356799999999999999999999999999999999999999988543 333344433332222 124689
Q ss_pred HHHHHHHHhhccCCcCCcCCc
Q 035930 774 FHARDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~ 794 (857)
.++.+||.+||..||.+||++
T Consensus 251 ~~l~~li~~~l~~dp~~RP~~ 271 (298)
T 1csn_A 251 EEFYKYMHYARNLAFDATPDY 271 (298)
T ss_dssp HHHHHHHHHHHHCCTTCCCCH
T ss_pred HHHHHHHHHHhcCCcccCCCH
Confidence 999999999999999999994
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=382.00 Aligned_cols=256 Identities=22% Similarity=0.308 Sum_probs=207.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEE----EEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLF----ALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~V----AVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
+..++|++.+.||+|+||+||+|.+..++..+ |+|.+... ........+.+|+.+|+.++||||++++++|.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 45678999999999999999999998777654 77776543 2234556789999999999999999999999876
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
. .++||||+.+|+|.+++..... .+++..++.++.||+.||+|||++|||||||||+|||++.++++||+|||+++..
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred C-eEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 5 7899999999999998887543 4899999999999999999999999999999999999999999999999998653
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
..... ..
T Consensus 168 ~~~~~-------------------------------------------------------------------------~~ 174 (327)
T 3poz_A 168 GAEEK-------------------------------------------------------------------------EY 174 (327)
T ss_dssp TTTCC---------------------------------------------------------------------------
T ss_pred cCCcc-------------------------------------------------------------------------cc
Confidence 21100 00
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~ 781 (857)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.. .++.....++....++.++.+||.
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~ 253 (327)
T 3poz_A 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTIDVYMIMV 253 (327)
T ss_dssp -----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTTBCHHHHHHHH
T ss_pred cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHHHcCCCCCCCccCCHHHHHHHH
Confidence 1122347889999999999999999999999999999999 99999987665544 445555566666779999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
+||..||.+||+ +.+++++
T Consensus 254 ~~l~~~p~~Rps----~~ell~~ 272 (327)
T 3poz_A 254 KCWMIDADSRPK----FRELIIE 272 (327)
T ss_dssp HHTCSCGGGSCC----HHHHHHH
T ss_pred HHcCCChhhCCC----HHHHHHH
Confidence 999999999999 7777654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=383.81 Aligned_cols=270 Identities=20% Similarity=0.260 Sum_probs=223.0
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEc-----CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeee
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELI-----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFT 540 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~-----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~ 540 (857)
.+..++|.+.+.||+|+||+||+|.+. .++..||||++.... .......+.+|+.+|+.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 355678999999999999999999887 357889999997542 2233456789999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCC--------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEE
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQP--------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIM 612 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~--------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iK 612 (857)
+.+..|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 9999999999999999998876531 12478999999999999999999999999999999999999999999
Q ss_pred EecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCC
Q 035930 613 LSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPM 692 (857)
Q Consensus 613 L~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~ 692 (857)
|+|||++........
T Consensus 179 l~Dfg~~~~~~~~~~----------------------------------------------------------------- 193 (322)
T 1p4o_A 179 IGDFGMTRDIYETDY----------------------------------------------------------------- 193 (322)
T ss_dssp ECCTTCCCGGGGGGC-----------------------------------------------------------------
T ss_pred ECcCccccccccccc-----------------------------------------------------------------
Confidence 999998743211000
Q ss_pred CcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCC
Q 035930 693 PQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPV 771 (857)
Q Consensus 693 p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~ 771 (857)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+..+..... .+....
T Consensus 194 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 264 (322)
T 1p4o_A 194 --------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-LDKPDN 264 (322)
T ss_dssp --------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-CCCCTT
T ss_pred --------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc-CCCCCC
Confidence 001123357899999999999999999999999999999999 8999998877777666655443 333456
Q ss_pred CCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC------CCCCCCChhhh
Q 035930 772 VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH------PFFEGLNWALI 815 (857)
Q Consensus 772 is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H------PfF~~l~w~li 815 (857)
++..+.+||.+||..||.+||+ +.++++| +||..++|...
T Consensus 265 ~~~~l~~li~~~l~~dp~~Rps----~~e~l~~L~~~~~~~~~~~~~~~~ 310 (322)
T 1p4o_A 265 CPDMLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFREVSFYYS 310 (322)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHHHCSTTS
T ss_pred CCHHHHHHHHHHcCCCcccCcC----HHHHHHHHHHhhccCCcccccccc
Confidence 8999999999999999999999 6666665 78887777654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=370.52 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=210.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc----cchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR----KKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~----~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
+..++|++.+.||+|+||+||+|++..+++.||||++........ .....+.+|+++|+.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 556789999999999999999999999999999999865432221 2236788999999999999999999999776
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEccCCc-----EEEec
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG--VVYRDLKPENILVREDGH-----IMLSD 615 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G--IIHRDLKPeNILL~~dg~-----iKL~D 615 (857)
. ++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred C--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6 69999999999988776543 34999999999999999999999999 999999999999988776 99999
Q ss_pred ccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcc
Q 035930 616 FDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQL 695 (857)
Q Consensus 616 FGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l 695 (857)
||++....
T Consensus 173 fg~~~~~~------------------------------------------------------------------------ 180 (287)
T 4f0f_A 173 FGLSQQSV------------------------------------------------------------------------ 180 (287)
T ss_dssp CTTCBCCS------------------------------------------------------------------------
T ss_pred CCcccccc------------------------------------------------------------------------
Confidence 99873210
Q ss_pred cccCCCCccccccCCCCccChhhhc--CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhh--hHHHhhccccCCCCCC
Q 035930 696 VVEPTGARSNSFVGTHEYLAPEIIK--GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET--LSNVVSQSLRFPGYPV 771 (857)
Q Consensus 696 ~~~~~~~~~~s~vGT~~YmAPEil~--g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~--l~~Iv~~~~~~p~~~~ 771 (857)
.......||+.|+|||++. +..++.++|||||||++|||++|+.||........ ...+............
T Consensus 181 ------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 4f0f_A 181 ------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254 (287)
T ss_dssp ------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTT
T ss_pred ------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcc
Confidence 0112346899999999994 45578999999999999999999999987765444 4444455555555667
Q ss_pred CCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 772 VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 772 is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+++.+.+||.+||..||.+||+ +.+|++
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 282 (287)
T 4f0f_A 255 CPPRLRNVIELCWSGDPKKRPH----FSYIVK 282 (287)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred cCHHHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 9999999999999999999999 777764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=383.09 Aligned_cols=257 Identities=26% Similarity=0.382 Sum_probs=215.6
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc---cchhHHHHHHHHHHHcC--CCCccccceeee
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR---KKMPRAQTEREIMQMLD--HPFLPTLFAHFT 540 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~---~~~~~~~~EieILr~L~--HPnIV~L~~~f~ 540 (857)
....++|++.+.||+|+||+||+|.+..+++.||||++........ .....+.+|+.+|+.+. ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3556789999999999999999999999999999999976543221 12345678999999996 599999999999
Q ss_pred eCCeEEEEEeecCC-CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc-cCCcEEEecccc
Q 035930 541 TEKFSCLVMEYCPG-GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR-EDGHIMLSDFDL 618 (857)
Q Consensus 541 ~~~~l~LVmEy~~g-GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~-~dg~iKL~DFGL 618 (857)
.++..|+||||+.+ ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 99999999999976 89998887643 389999999999999999999999999999999999999 789999999998
Q ss_pred hhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccccc
Q 035930 619 SLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVE 698 (857)
Q Consensus 619 A~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~ 698 (857)
+.....
T Consensus 197 ~~~~~~-------------------------------------------------------------------------- 202 (320)
T 3a99_A 197 GALLKD-------------------------------------------------------------------------- 202 (320)
T ss_dssp CEECCS--------------------------------------------------------------------------
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 743110
Q ss_pred CCCCccccccCCCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHH
Q 035930 699 PTGARSNSFVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHAR 777 (857)
Q Consensus 699 ~~~~~~~s~vGT~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~ 777 (857)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||... ..+......++ ..++.++.
T Consensus 203 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------~~~~~~~~~~~--~~~~~~~~ 271 (320)
T 3a99_A 203 ---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR--QRVSSECQ 271 (320)
T ss_dssp ---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS--SCCCHHHH
T ss_pred ---ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh------hhhhccccccc--ccCCHHHH
Confidence 01123458999999999988776 68899999999999999999999753 12333333333 45899999
Q ss_pred HHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 778 DLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 778 dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
+||.+||..||.+||+ +++|++||||.++.+.
T Consensus 272 ~li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 272 HLIRWCLALRPSDRPT----FEEIQNHPWMQDVLLP 303 (320)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHHTSGGGSSCCCH
T ss_pred HHHHHHccCChhhCcC----HHHHhcCHhhcCccCc
Confidence 9999999999999999 9999999999988654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=381.75 Aligned_cols=258 Identities=20% Similarity=0.295 Sum_probs=219.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCe-----EEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSC-----LFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~-----~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~ 540 (857)
+..++|.+.+.||+|+||+||+|.+..++. .||+|++.... .......+.+|+.+|+.+ +||||++++++|.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 566899999999999999999999987654 79999997642 223456788999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCC------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQP------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED 608 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d 608 (857)
+++..|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 9999999999999999998876531 2347999999999999999999999999999999999999999
Q ss_pred CcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcc
Q 035930 609 GHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQ 688 (857)
Q Consensus 609 g~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~ 688 (857)
+.++|+|||++.......
T Consensus 201 ~~~kl~Dfg~~~~~~~~~-------------------------------------------------------------- 218 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDS-------------------------------------------------------------- 218 (333)
T ss_dssp GEEEBCCCGGGCCGGGCT--------------------------------------------------------------
T ss_pred CeEEECcccccccccccc--------------------------------------------------------------
Confidence 999999999984321100
Q ss_pred cCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCC
Q 035930 689 VSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFP 767 (857)
Q Consensus 689 ~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p 767 (857)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||.+......+..++......+
T Consensus 219 -----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 287 (333)
T 2i1m_A 219 -----------NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA 287 (333)
T ss_dssp -----------TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC
T ss_pred -----------ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC
Confidence 0001123457889999999999999999999999999999998 9999998877777777777777776
Q ss_pred CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 768 GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 768 ~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
....++..+.+||.+||..||.+||+ +.+|++
T Consensus 288 ~~~~~~~~l~~li~~~l~~~p~~Rps----~~~l~~ 319 (333)
T 2i1m_A 288 QPAFAPKNIYSIMQACWALEPTHRPT----FQQICS 319 (333)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCCCHHHHHHHHHHhccChhhCcC----HHHHHH
Confidence 66778999999999999999999999 777775
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=371.57 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=205.2
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC---CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG---TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~---tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
+..++|++.+.||+|+||+||+|.+.. .+..||||++.... .....+.+.+|+.+|+.++||||+++++++. ++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 556789999999999999999999865 35679999987542 2334567889999999999999999999985 56
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred ccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 7899999999999999987654 248999999999999999999999999999999999999999999999999984321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
... ...
T Consensus 168 ~~~--------------------------------------------------------------------------~~~ 173 (281)
T 1mp8_A 168 DST--------------------------------------------------------------------------YYK 173 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc--------------------------------------------------------------------------ccc
Confidence 000 000
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+... ...+..+.+++.+.+||.+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~ 252 (281)
T 1mp8_A 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMPPNCPPTLYSLMTK 252 (281)
T ss_dssp -----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHH
T ss_pred cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHH
Confidence 112346789999999999999999999999999999996 99999988777777666544 3344556799999999999
Q ss_pred hccCCcCCcCCchhhHHHHHc
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||..||.+||+ +.+|++
T Consensus 253 ~l~~~p~~Rps----~~~l~~ 269 (281)
T 1mp8_A 253 CWAYDPSRRPR----FTELKA 269 (281)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HccCChhhCcC----HHHHHH
Confidence 99999999999 777765
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=394.46 Aligned_cols=257 Identities=24% Similarity=0.334 Sum_probs=215.2
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
.+..++|.+.+.||+|+||+||+|.+..++..||||+++... .......+.+|+++|+.++||||++++++|..++.+
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 466789999999999999999999999999999999987542 223344678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||||||+++|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.....
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999999887543 24899999999999999999999999999999999999999999999999997431100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.. .....
T Consensus 267 ~~-------------------------------------------------------------------------~~~~~ 273 (377)
T 3cbl_A 267 VY-------------------------------------------------------------------------AASGG 273 (377)
T ss_dssp EE-------------------------------------------------------------------------ECCSS
T ss_pred ce-------------------------------------------------------------------------eecCC
Confidence 00 00001
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
...+++.|+|||++.+..++.++|||||||+||||++ |..||.+....+....+ ....+++.+..++..+.+||.+||
T Consensus 274 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl 352 (377)
T 3cbl_A 274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRLPCPELCPDAVFRLMEQCW 352 (377)
T ss_dssp CCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHc
Confidence 1235778999999999999999999999999999998 99999988766655444 444556666679999999999999
Q ss_pred cCCcCCcCCchhhHHHHHc
Q 035930 785 VKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~ 803 (857)
..||++||+ +.+|++
T Consensus 353 ~~dP~~Rps----~~~i~~ 367 (377)
T 3cbl_A 353 AYEPGQRPS----FSTIYQ 367 (377)
T ss_dssp CSSGGGSCC----HHHHHH
T ss_pred CCCchhCcC----HHHHHH
Confidence 999999999 666654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=377.44 Aligned_cols=259 Identities=23% Similarity=0.346 Sum_probs=217.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc-----CCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI-----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~-----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~ 540 (857)
+..++|++.+.||+|+||+||+|.+. .+++.||||++.... .......+.+|+.+|+.+ +||||++++++|.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 56689999999999999999999864 467899999997652 223345688999999999 6999999999988
Q ss_pred eCC-eEEEEEeecCCCChHHHHhhCCCC--------------CCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE
Q 035930 541 TEK-FSCLVMEYCPGGDLHVLRQKQPSR--------------FFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV 605 (857)
Q Consensus 541 ~~~-~l~LVmEy~~gGsL~~ll~~~~~~--------------~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL 605 (857)
..+ .+|+||||+++++|.+++...... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 754 589999999999999998865431 28999999999999999999999999999999999999
Q ss_pred ccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhh
Q 035930 606 REDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDL 685 (857)
Q Consensus 606 ~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~ 685 (857)
+.++.+||+|||++.......
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~----------------------------------------------------------- 202 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDP----------------------------------------------------------- 202 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCT-----------------------------------------------------------
T ss_pred CCCCCEEECCCccccccccCc-----------------------------------------------------------
Confidence 999999999999984321100
Q ss_pred hcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccc
Q 035930 686 AAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSL 764 (857)
Q Consensus 686 ~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~ 764 (857)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+...+....
T Consensus 203 --------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~ 268 (316)
T 2xir_A 203 --------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268 (316)
T ss_dssp --------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTC
T ss_pred --------------cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCc
Confidence 0011123457899999999999999999999999999999998 9999998876666666666655
Q ss_pred cCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 765 RFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 765 ~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
.++....+++.+.+||.+||..||.+||+ +.+|++|
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 304 (316)
T 2xir_A 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 304 (316)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 55555678999999999999999999999 8888875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=387.14 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=185.9
Q ss_pred CCCeEEEe-EEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee----CC
Q 035930 469 MRHFKLHK-KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT----EK 543 (857)
Q Consensus 469 ~~~Y~i~~-~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~----~~ 543 (857)
.++|.+.+ .||+|+||+||+|.+..+++.||||++... ..........++.+.||||++++++|.. +.
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 46899965 699999999999999999999999998643 1122233344677899999999999976 45
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc---CCcEEEecccchh
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE---DGHIMLSDFDLSL 620 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~---dg~iKL~DFGLA~ 620 (857)
.+||||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 6899999999999999998776556999999999999999999999999999999999999976 4559999999874
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
....
T Consensus 180 ~~~~---------------------------------------------------------------------------- 183 (336)
T 3fhr_A 180 ETTQ---------------------------------------------------------------------------- 183 (336)
T ss_dssp EC------------------------------------------------------------------------------
T ss_pred eccc----------------------------------------------------------------------------
Confidence 3110
Q ss_pred CCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhh----hHHHhhccc--cCCCCCCCCH
Q 035930 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET----LSNVVSQSL--RFPGYPVVSF 774 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~----l~~Iv~~~~--~~p~~~~is~ 774 (857)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...... ...+..... ..+.+..++.
T Consensus 184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (336)
T 3fhr_A 184 -NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCH
T ss_pred -cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCH
Confidence 001234589999999999999999999999999999999999999987654433 222222222 2333457899
Q ss_pred HHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 775 HARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 775 ~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
++++||.+||..||.+||+ +.++|+||||.+
T Consensus 263 ~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~ 293 (336)
T 3fhr_A 263 DAKQLIRLLLKTDPTERLT----ITQFMNHPWINQ 293 (336)
T ss_dssp HHHHHHHHHSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred HHHHHHHHHCCCChhHCcC----HHHHhcCccccc
Confidence 9999999999999999999 999999999976
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=372.81 Aligned_cols=249 Identities=18% Similarity=0.238 Sum_probs=207.6
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCC-------eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTS-------CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHF 539 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg-------~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f 539 (857)
+..++|.+.+.||+|+||+||+|.+..++ ..||+|++.... ....+.+.+|+++|+.++||||++++++|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 55678999999999999999999998776 579999996542 34456789999999999999999999999
Q ss_pred eeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc--------E
Q 035930 540 TTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH--------I 611 (857)
Q Consensus 540 ~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~--------i 611 (857)
.+++..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999988754 33899999999999999999999999999999999999998887 9
Q ss_pred EEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCC
Q 035930 612 MLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSP 691 (857)
Q Consensus 612 KL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~ 691 (857)
+|+|||++.....
T Consensus 161 kl~Dfg~~~~~~~------------------------------------------------------------------- 173 (289)
T 4fvq_A 161 KLSDPGISITVLP------------------------------------------------------------------- 173 (289)
T ss_dssp EECCCCSCTTTSC-------------------------------------------------------------------
T ss_pred eeccCcccccccC-------------------------------------------------------------------
Confidence 9999998732100
Q ss_pred CCcccccCCCCccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCC
Q 035930 692 MPQLVVEPTGARSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYP 770 (857)
Q Consensus 692 ~p~l~~~~~~~~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~ 770 (857)
.....||+.|+|||++.+ ..++.++|||||||++|||++|..|+..................++ .
T Consensus 174 ------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--~ 239 (289)
T 4fvq_A 174 ------------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP--A 239 (289)
T ss_dssp ------------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC--C
T ss_pred ------------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCC--C
Confidence 012247889999999988 6789999999999999999996555544444444444444444444 3
Q ss_pred CCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 771 VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 771 ~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
.++.++.+||.+||..||.+||+ +.++++|
T Consensus 240 ~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~ 269 (289)
T 4fvq_A 240 PKAAELANLINNCMDYEPDHRPS----FRAIIRD 269 (289)
T ss_dssp CSSCTTHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 47889999999999999999999 7887763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=387.18 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=216.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCC-------CeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCcccccee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGT-------SCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAH 538 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~t-------g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~ 538 (857)
+..++|.+++.||+|+||+||+|++.++ +..||||++.... .......+.+|+++|+.+ +||||++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 4557899999999999999999998643 3679999997652 234456788999999999 89999999999
Q ss_pred eeeCCeEEEEEeecCCCChHHHHhhCCC--------------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 035930 539 FTTEKFSCLVMEYCPGGDLHVLRQKQPS--------------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604 (857)
Q Consensus 539 f~~~~~l~LVmEy~~gGsL~~ll~~~~~--------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNIL 604 (857)
|.+++..||||||+++|+|.+++..... ..+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 9999999999999999999999886542 34899999999999999999999999999999999999
Q ss_pred EccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhh
Q 035930 605 VREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD 684 (857)
Q Consensus 605 L~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d 684 (857)
|+.++.+||+|||++.......
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~---------------------------------------------------------- 245 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHID---------------------------------------------------------- 245 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCC----------------------------------------------------------
T ss_pred EcCCCcEEEcccCccccccccc----------------------------------------------------------
Confidence 9999999999999974321000
Q ss_pred hhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhcc
Q 035930 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQS 763 (857)
Q Consensus 685 ~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~ 763 (857)
.........||+.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+. ..
T Consensus 246 ---------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~-~~ 309 (382)
T 3tt0_A 246 ---------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-EG 309 (382)
T ss_dssp ---------------TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred ---------------ccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 0001123357889999999999999999999999999999999 999999887666655544 44
Q ss_pred ccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 764 ~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
........++.++.+||.+||..||.+||+ +.+|+++
T Consensus 310 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 346 (382)
T 3tt0_A 310 HRMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVED 346 (382)
T ss_dssp CCCCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 444555679999999999999999999999 7777764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=374.35 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=208.5
Q ss_pred cccCCCeEEEeEEccCCceEEEEEE----EcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAE----LIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~----~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
.+..++|++++.||+|+||+||+|+ +..+++.||||++... .......+.+|+++|+.++||||++++++|..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3566899999999999999999998 5678999999999754 23345678899999999999999999999865
Q ss_pred C--CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 542 E--KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 542 ~--~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
. ..+|+||||+++|+|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 3 568999999999999999887643 4899999999999999999999999999999999999999999999999998
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
.........
T Consensus 162 ~~~~~~~~~----------------------------------------------------------------------- 170 (295)
T 3ugc_A 162 KVLPQDKEF----------------------------------------------------------------------- 170 (295)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ccccCCcce-----------------------------------------------------------------------
Confidence 542111000
Q ss_pred CCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh---------------hhhHHHhhccc
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND---------------ETLSNVVSQSL 764 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~---------------e~l~~Iv~~~~ 764 (857)
........||..|+|||++.+..++.++|||||||++|||++|..||...... ..+...+....
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (295)
T 3ugc_A 171 -FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249 (295)
T ss_dssp ------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC
T ss_pred -eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccC
Confidence 00011234778899999999999999999999999999999999998653211 01222334445
Q ss_pred cCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 765 RFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 765 ~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+++....++.++.+||.+||..||.+||+ +.+|++
T Consensus 250 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~el~~ 284 (295)
T 3ugc_A 250 RLPRPDGCPDEIYMIMTECWNNNVNQRPS----FRDLAL 284 (295)
T ss_dssp CCCCCTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHH
T ss_pred cCCCCcCcCHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 56666779999999999999999999999 666654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=363.77 Aligned_cols=253 Identities=22% Similarity=0.348 Sum_probs=214.7
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
.+..++|++.+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+++++.++||||+++++++.+++..
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 356678999999999999999999986 67789999997653 2335788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999987654 34899999999999999999999999999999999999999999999999997432100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
. .....
T Consensus 158 ~--------------------------------------------------------------------------~~~~~ 163 (267)
T 3t9t_A 158 Q--------------------------------------------------------------------------YTSST 163 (267)
T ss_dssp H--------------------------------------------------------------------------HHSTT
T ss_pred c--------------------------------------------------------------------------ccccc
Confidence 0 00011
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
...||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....+.+..+... ........++..+.+||.+||
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l 242 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCW 242 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-CcCCCCccCcHHHHHHHHHHc
Confidence 2347889999999999999999999999999999999 99999988777666665544 333444568999999999999
Q ss_pred cCCcCCcCCchhhHHHHHc
Q 035930 785 VKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~ 803 (857)
..||.+||+ +.++++
T Consensus 243 ~~~p~~Rps----~~~ll~ 257 (267)
T 3t9t_A 243 RERPEDRPA----FSRLLR 257 (267)
T ss_dssp CSSGGGSCC----HHHHHH
T ss_pred cCChhhCcC----HHHHHH
Confidence 999999999 777775
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=372.20 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=204.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
....+|++.+.||+|+||+||+|.+..++..||||++.............+.+|+.+|+.++||||++++++|..++..|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 45578999999999999999999999999999999997644334445567889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 547 LVMEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999999887642 234589999999999999999999999999999999999999999999999998743210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
. ....
T Consensus 189 ~---------------------------------------------------------------------------~~~~ 193 (310)
T 2wqm_A 189 K---------------------------------------------------------------------------TTAA 193 (310)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C---------------------------------------------------------------------------Cccc
Confidence 0 0001
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh--hhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND--ETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~--e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... .....+............++.++.+||.+
T Consensus 194 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 273 (310)
T 2wqm_A 194 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 273 (310)
T ss_dssp -----CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHH
T ss_pred cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHH
Confidence 2346899999999999999999999999999999999999999865432 33333333333332335689999999999
Q ss_pred hccCCcCCcCCchhhHHHHHc
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||..||.+||+ +.+|++
T Consensus 274 ~l~~dp~~Rps----~~~il~ 290 (310)
T 2wqm_A 274 CINPDPEKRPD----VTYVYD 290 (310)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HcCCChhhCCC----HHHHHH
Confidence 99999999999 777775
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=392.66 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=216.0
Q ss_pred hhccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeee
Q 035930 461 QKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFT 540 (857)
Q Consensus 461 ~~~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~ 540 (857)
....+.+..++|++.+.||+|+||+||+|.+. +..||||+++.. ...+.+.+|+.+|+.++||||+++++++.
T Consensus 184 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 256 (450)
T 1k9a_A 184 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIV 256 (450)
T ss_dssp HHTTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC-----TTSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cccccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc-----hHHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence 34556788899999999999999999999885 678999999764 24567899999999999999999999987
Q ss_pred eCC-eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 541 TEK-FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 541 ~~~-~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
... .+||||||+++|+|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 665 7999999999999999998765555799999999999999999999999999999999999999999999999997
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
+....
T Consensus 337 ~~~~~--------------------------------------------------------------------------- 341 (450)
T 1k9a_A 337 KEASS--------------------------------------------------------------------------- 341 (450)
T ss_dssp EECC----------------------------------------------------------------------------
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 42100
Q ss_pred CCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHH
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARD 778 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~d 778 (857)
......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+.. ..+++.+..+++.+.+
T Consensus 342 ---~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~ 417 (450)
T 1k9a_A 342 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYD 417 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT-TCCCCCCTTCCHHHHH
T ss_pred ---cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHHH
Confidence 0011246789999999999999999999999999999998 9999998877777766544 4555566779999999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHH
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL 802 (857)
||.+||..||.+||+ +.+|+
T Consensus 418 li~~cl~~dp~~Rpt----~~~l~ 437 (450)
T 1k9a_A 418 VMKNCWHLDAATRPT----FLQLR 437 (450)
T ss_dssp HHHHHTCSSGGGSCC----HHHHH
T ss_pred HHHHHcCCChhHCcC----HHHHH
Confidence 999999999999999 55554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=369.45 Aligned_cols=258 Identities=23% Similarity=0.281 Sum_probs=209.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEE----EcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAE----LIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~----~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
+..++|++++.||+|+||+||+|+ +..+++.||||++.... .......+.+|+++|+.++||||++++++|.++
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 455679999999999999999999 46789999999997653 344557789999999999999999999999877
Q ss_pred --CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 543 --KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 543 --~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
..+|+||||+++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 678999999999999999865443 38999999999999999999999999999999999999999999999999985
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
........
T Consensus 175 ~~~~~~~~------------------------------------------------------------------------ 182 (302)
T 4e5w_A 175 AIETDKEY------------------------------------------------------------------------ 182 (302)
T ss_dssp ECCTTCCE------------------------------------------------------------------------
T ss_pred cccCCCcc------------------------------------------------------------------------
Confidence 42111000
Q ss_pred CCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCC--------------CChhhhHHHhhccccC
Q 035930 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGS--------------GNDETLSNVVSQSLRF 766 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~--------------~~~e~l~~Iv~~~~~~ 766 (857)
........||..|+|||++.+..++.++|||||||++|+|++|..||... .....+...+.....+
T Consensus 183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (302)
T 4e5w_A 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL 262 (302)
T ss_dssp EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCC
T ss_pred eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCC
Confidence 00112345888999999999999999999999999999999999986422 1122233334445556
Q ss_pred CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 767 PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 767 p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+....+++.+.+||.+||..||.+||+ +.++++
T Consensus 263 ~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 295 (302)
T 4e5w_A 263 PCPPNCPDEVYQLMRKCWEFQPSNRTS----FQNLIE 295 (302)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCC----HHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCCCCCCC----HHHHHH
Confidence 666779999999999999999999999 666664
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=363.36 Aligned_cols=268 Identities=18% Similarity=0.282 Sum_probs=210.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceee-eeCCeEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHF-TTEKFSCL 547 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f-~~~~~l~L 547 (857)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+++++.+.|++++..+.++ ...+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 368999999999999999999999999999999876542 234578899999999988877666655 67788999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE---ccCCcEEEecccchhhccc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV---REDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL---~~dg~iKL~DFGLA~r~~~ 624 (857)
||||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEcc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 99999 9999999875433 49999999999999999999999999999999999999 7889999999999854321
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
..... .......
T Consensus 161 ~~~~~--------------------------------------------------------------------~~~~~~~ 172 (296)
T 4hgt_A 161 ARTHQ--------------------------------------------------------------------HIPYREN 172 (296)
T ss_dssp TTTCC--------------------------------------------------------------------BCCCCCS
T ss_pred cccCc--------------------------------------------------------------------cCCCCcc
Confidence 10000 0000112
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh---hhhHHHhhccccCCC---CCCCCHHHHH
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND---ETLSNVVSQSLRFPG---YPVVSFHARD 778 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~---e~l~~Iv~~~~~~p~---~~~is~~l~d 778 (857)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... +.+..+.......+. ...++.++.+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (296)
T 4hgt_A 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFAT 252 (296)
T ss_dssp CCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHH
T ss_pred cccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHH
Confidence 3457999999999999999999999999999999999999999875433 334444444444331 2457999999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHHc----------CCCCCCCChhhh
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIKQ----------HPFFEGLNWALI 815 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL~----------HPfF~~l~w~li 815 (857)
||..||..||++||+ +.+|++ ..|...++|..+
T Consensus 253 li~~~l~~~p~~Rpt----~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 253 YLNFCRSLRFDDKPD----YSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp HHHHHHTSCTTCCCC----HHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred HHHHHHhcCCCCCCC----HHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 999999999999999 555444 456666777655
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=374.96 Aligned_cols=266 Identities=24% Similarity=0.385 Sum_probs=214.5
Q ss_pred hccccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC--CCCccccceee
Q 035930 462 KQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD--HPFLPTLFAHF 539 (857)
Q Consensus 462 ~~~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~--HPnIV~L~~~f 539 (857)
.+...+..++|++++.||+|+||+||+|.+. +++.||||++..... .......+.+|+++|+.+. ||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3444566778999999999999999999985 588999999975432 2334567889999999997 59999999999
Q ss_pred eeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 540 TTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 540 ~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
.+++..|||||+ .+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++
T Consensus 98 ~~~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~ 173 (313)
T 3cek_A 98 ITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 173 (313)
T ss_dssp ECSSEEEEEECC-CSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred ecCCEEEEEEec-CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccc
Confidence 999999999995 5899999988754 489999999999999999999999999999999999996 589999999997
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
.......
T Consensus 174 ~~~~~~~------------------------------------------------------------------------- 180 (313)
T 3cek_A 174 NQMQPDT------------------------------------------------------------------------- 180 (313)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred ccccCcc-------------------------------------------------------------------------
Confidence 4321000
Q ss_pred CCCccccccCCCCccChhhhcC-----------CCCCcccceehhhHHHHHHhhCCCCCCCCCCh-hhhHHHhhccccCC
Q 035930 700 TGARSNSFVGTHEYLAPEIIKG-----------EGHGSSVDWWTFGIFLFELLYGRTPFKGSGND-ETLSNVVSQSLRFP 767 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g-----------~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~-e~l~~Iv~~~~~~p 767 (857)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..++.......
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 260 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccC
Confidence 0001123468999999999976 46888999999999999999999999876433 34444555444444
Q ss_pred CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 768 GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 768 ~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.....+.++.+||.+||..||.+||+ +.++++||||+..
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~h~~~~~~ 299 (313)
T 3cek_A 261 FPDIPEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQ 299 (313)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHCC
T ss_pred CcccchHHHHHHHHHHccCCcccCcC----HHHHhcCccccCC
Confidence 44567899999999999999999999 9999999999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=374.91 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=204.2
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc---cchhHHHHHHHHHHHc----CCCCccccceee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR---KKMPRAQTEREIMQML----DHPFLPTLFAHF 539 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~---~~~~~~~~EieILr~L----~HPnIV~L~~~f 539 (857)
...++|++.+.||+|+||+||+|.+..+++.||||++........ .....+.+|+.+++.+ +||||++++++|
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 345789999999999999999999999999999999976533221 1223456799999998 899999999999
Q ss_pred eeCCeEEEEEee-cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc-cCCcEEEeccc
Q 035930 540 TTEKFSCLVMEY-CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR-EDGHIMLSDFD 617 (857)
Q Consensus 540 ~~~~~l~LVmEy-~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~-~dg~iKL~DFG 617 (857)
...+..|+|||| +.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.++|+|||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 999999999999 78999999887653 389999999999999999999999999999999999999 78999999999
Q ss_pred chhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccc
Q 035930 618 LSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVV 697 (857)
Q Consensus 618 LA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~ 697 (857)
++.....
T Consensus 186 ~~~~~~~------------------------------------------------------------------------- 192 (312)
T 2iwi_A 186 SGALLHD------------------------------------------------------------------------- 192 (312)
T ss_dssp SCEECCS-------------------------------------------------------------------------
T ss_pred hhhhccc-------------------------------------------------------------------------
Confidence 8743210
Q ss_pred cCCCCccccccCCCCccChhhhcCCCCC-cccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHH
Q 035930 698 EPTGARSNSFVGTHEYLAPEIIKGEGHG-SSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHA 776 (857)
Q Consensus 698 ~~~~~~~~s~vGT~~YmAPEil~g~~~s-~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l 776 (857)
.......||+.|+|||++.+..+. .++|||||||++|+|++|+.||... ..+......++ ..++.++
T Consensus 193 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~--~~~~~~~ 260 (312)
T 2iwi_A 193 ----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFP--AHVSPDC 260 (312)
T ss_dssp ----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCC--TTSCHHH
T ss_pred ----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCc--ccCCHHH
Confidence 001234589999999999887774 5899999999999999999999753 23334444444 4589999
Q ss_pred HHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 777 RDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 777 ~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
++||.+||..||++||+ ++++++||||.....
T Consensus 261 ~~li~~~l~~~p~~Rps----~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 261 CALIRRCLAPKPSSRPS----LEEILLDPWMQTPAE 292 (312)
T ss_dssp HHHHHHHTCSSTTTSCC----HHHHHHSTTTCC---
T ss_pred HHHHHHHccCChhhCcC----HHHHhcChhhcCchh
Confidence 99999999999999999 999999999997643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=376.33 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=212.2
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEE--EEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLF--ALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~V--AVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~ 543 (857)
+..++|++.+.||+|+||+||+|++..++..+ |||++... ........+.+|+++|+.+ +||||+++++++.+++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 45578999999999999999999999888865 99998753 2334556789999999999 8999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQP--------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG 609 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~--------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg 609 (857)
..||||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999987653 23589999999999999999999999999999999999999999
Q ss_pred cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhccc
Q 035930 610 HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQV 689 (857)
Q Consensus 610 ~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~ 689 (857)
.+||+|||++......
T Consensus 180 ~~kL~Dfg~~~~~~~~---------------------------------------------------------------- 195 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---------------------------------------------------------------- 195 (327)
T ss_dssp CEEECCTTCEESSCEE----------------------------------------------------------------
T ss_pred eEEEcccCcCcccccc----------------------------------------------------------------
Confidence 9999999987421000
Q ss_pred CCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCC
Q 035930 690 SPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPG 768 (857)
Q Consensus 690 ~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~ 768 (857)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+.. ...++.
T Consensus 196 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-~~~~~~ 262 (327)
T 1fvr_A 196 ------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEK 262 (327)
T ss_dssp ------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-TCCCCC
T ss_pred ------------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc-CCCCCC
Confidence 00112346889999999999999999999999999999998 9999998876666555443 344455
Q ss_pred CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 769 YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 769 ~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
...++..+.+||.+||..||.+||+ +.++++|
T Consensus 263 ~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 294 (327)
T 1fvr_A 263 PLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 294 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 5678999999999999999999999 7777764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=401.54 Aligned_cols=255 Identities=23% Similarity=0.317 Sum_probs=219.5
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l 545 (857)
.+...+|.+.+.||+|+||+||+|.+..++..||||+++.. ....+.+.+|+.+|+.++||||++++++|.+++.+
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc----ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 35567899999999999999999999999999999999754 23467789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||||||+++|+|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999999998765566999999999999999999999999999999999999999999999999998532110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
.. ....
T Consensus 372 ~~--------------------------------------------------------------------------~~~~ 377 (495)
T 1opk_A 372 TY--------------------------------------------------------------------------TAHA 377 (495)
T ss_dssp CE--------------------------------------------------------------------------ECCT
T ss_pred ce--------------------------------------------------------------------------eecC
Confidence 00 0011
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
...+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.+..+.+.. +....+.+.+..++..+.+||.+||
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl 456 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMERPEGCPEKVYELMRACW 456 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 2346788999999999999999999999999999998 9999998876665544 4455566666779999999999999
Q ss_pred cCCcCCcCCchhhHHHHHc
Q 035930 785 VKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~ 803 (857)
..||.+||+ +.+|++
T Consensus 457 ~~dP~~RPs----~~el~~ 471 (495)
T 1opk_A 457 QWNPSDRPS----FAEIHQ 471 (495)
T ss_dssp CSSGGGSCC----HHHHHH
T ss_pred CcChhHCcC----HHHHHH
Confidence 999999999 666654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=373.29 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=204.1
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|++.+.||+|+||+||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++..++..|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 35789999999999999999999999999999999976644434445678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||+++++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 112 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 187 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE-- 187 (309)
T ss_dssp EEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc--
Confidence 999999999999887653 3899999999999999999999999999999999999999999999999987431100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
........
T Consensus 188 ------------------------------------------------------------------------~~~~~~~~ 195 (309)
T 2h34_A 188 ------------------------------------------------------------------------KLTQLGNT 195 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00011234
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC--CCCCCCCHHHHHHHHhhcc
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF--PGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~--p~~~~is~~l~dLI~k~L~ 785 (857)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .+...+...... ...+.++..+.+||.+||.
T Consensus 196 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 274 (309)
T 2h34_A 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMA 274 (309)
T ss_dssp -CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTC
T ss_pred CCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCCHHHHHHHHHhcc
Confidence 6899999999999999999999999999999999999999876544 333333333322 2245689999999999999
Q ss_pred CCcCCcCCchhhHHHHH
Q 035930 786 KEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL 802 (857)
.||++||++ +++++
T Consensus 275 ~dP~~Rp~s---~~~l~ 288 (309)
T 2h34_A 275 KNPEDRYVT---CGDLS 288 (309)
T ss_dssp SSGGGSCSS---HHHHH
T ss_pred CCHHHHHHh---HHHHH
Confidence 999999943 44444
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=379.73 Aligned_cols=274 Identities=18% Similarity=0.239 Sum_probs=218.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEE-----EcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAE-----LIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~-----~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
+..++|++++.||+|+||+||+|. +..++..||||++.... .......+.+|+.+|+.++||||+++++++.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 445789999999999999999998 45678899999996442 23344567899999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCC-----CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC---CcEEE
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQPS-----RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED---GHIML 613 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~~-----~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d---g~iKL 613 (857)
.+..||||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.++|
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999999886532 348999999999999999999999999999999999999844 46999
Q ss_pred ecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCC
Q 035930 614 SDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMP 693 (857)
Q Consensus 614 ~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p 693 (857)
+|||++........
T Consensus 185 ~Dfg~~~~~~~~~~------------------------------------------------------------------ 198 (327)
T 2yfx_A 185 GDFGMARDIYRASY------------------------------------------------------------------ 198 (327)
T ss_dssp CCCHHHHHHHC---------------------------------------------------------------------
T ss_pred Cccccccccccccc------------------------------------------------------------------
Confidence 99999854321100
Q ss_pred cccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCC
Q 035930 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVV 772 (857)
Q Consensus 694 ~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~i 772 (857)
........||+.|+|||++.+..++.++|||||||+||+|++ |..||.+....+.+..+.... .......+
T Consensus 199 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 270 (327)
T 2yfx_A 199 -------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPPKNC 270 (327)
T ss_dssp ----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCCTTC
T ss_pred -------cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-CCCCCCCC
Confidence 001123458899999999999999999999999999999998 999999887666666555443 33344678
Q ss_pred CHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCC
Q 035930 773 SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVP 820 (857)
Q Consensus 773 s~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~p 820 (857)
+..+.+||.+||..||.+||+ +.+|++|.|+-.-+........|
T Consensus 271 ~~~l~~li~~~l~~dp~~Rps----~~~ll~~l~~~~~~~~~~~~~~~ 314 (327)
T 2yfx_A 271 PGPVYRIMTQCWQHQPEDRPN----FAIILERIEYCTQDPDVINTALP 314 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHHHHCHHHHTCCCC
T ss_pred CHHHHHHHHHHhcCChhhCcC----HHHHHHHHHHHhcCHHHhccccc
Confidence 999999999999999999999 99999998765444444443333
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=372.78 Aligned_cols=261 Identities=25% Similarity=0.372 Sum_probs=200.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
...++|++++.||+|+||+||+|.+..+++.||||++...... ......+..+..+++.++||||+++++++.+++..|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 4567899999999999999999999999999999999765321 122233444555788889999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML-GVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~-GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
+||||+ ++.+..+..... ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 101 lv~e~~-~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEECCC-SEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEecc-CCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999999 666666555432 3489999999999999999999985 9999999999999999999999999987431100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
....
T Consensus 179 ----------------------------------------------------------------------------~~~~ 182 (318)
T 2dyl_A 179 ----------------------------------------------------------------------------KAKD 182 (318)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0011
Q ss_pred cccCCCCccChhhhc-----CCCCCcccceehhhHHHHHHhhCCCCCCCCC-ChhhhHHHhhccc-cCCCCCCCCHHHHH
Q 035930 706 SFVGTHEYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYGRTPFKGSG-NDETLSNVVSQSL-RFPGYPVVSFHARD 778 (857)
Q Consensus 706 s~vGT~~YmAPEil~-----g~~~s~ksDVWSLGvILyELLtGk~PF~g~~-~~e~l~~Iv~~~~-~~p~~~~is~~l~d 778 (857)
...||+.|+|||++. +..++.++|||||||+||||++|+.||.... ..+.+..++.... .++....++.++.+
T Consensus 183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 262 (318)
T 2dyl_A 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQS 262 (318)
T ss_dssp ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHH
T ss_pred ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHH
Confidence 235899999999994 5568899999999999999999999998744 3444555554432 23444568999999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
||.+||..||.+||+ +++|++||||...
T Consensus 263 li~~~l~~dp~~Rps----~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 263 FVKDCLTKDHRKRPK----YNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHTCSCTTTSCC----HHHHTTSHHHHHH
T ss_pred HHHHHccCChhHCcC----HHHHhhCHHHHhc
Confidence 999999999999999 9999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=362.17 Aligned_cols=255 Identities=20% Similarity=0.223 Sum_probs=206.7
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCe---EEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeE-E
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSC---LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFS-C 546 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~---~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l-~ 546 (857)
.|.+.+.||+|+||+||+|.+..++. .||+|++... ......+.+.+|+.+|+.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57788999999999999999765544 7999998753 2233456788999999999999999999999876655 9
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+.+|+|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999987643 348999999999999999999999999999999999999999999999999974321100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
. ........
T Consensus 179 ~-----------------------------------------------------------------------~~~~~~~~ 187 (298)
T 3pls_A 179 Y-----------------------------------------------------------------------YSVQQHRH 187 (298)
T ss_dssp G-----------------------------------------------------------------------GCSCCSSC
T ss_pred c-----------------------------------------------------------------------cccccCcC
Confidence 0 00011223
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
..||+.|+|||++.+..++.++|||||||++|+|++|..||........+...+......+....++..+.+||.+||..
T Consensus 188 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 267 (298)
T 3pls_A 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEA 267 (298)
T ss_dssp TTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccC
Confidence 46889999999999999999999999999999999965555444444444445555555666677999999999999999
Q ss_pred CcCCcCCchhhHHHHHc
Q 035930 787 EPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~ 803 (857)
||.+||+ +.++++
T Consensus 268 ~p~~Rps----~~~ll~ 280 (298)
T 3pls_A 268 DPAVRPT----FRVLVG 280 (298)
T ss_dssp SGGGSCC----HHHHHH
T ss_pred ChhhCcC----HHHHHH
Confidence 9999999 666664
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=379.45 Aligned_cols=265 Identities=22% Similarity=0.304 Sum_probs=194.3
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHH-HHHHcCCCCccccceeeeeCCe
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE-IMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~Eie-ILr~L~HPnIV~L~~~f~~~~~ 544 (857)
.+..++|++++.||+|+||+||+|.+..+++.||||++..... ......+..|+. +++.++||||+++++++.+++.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 4667899999999999999999999999999999999976421 222334455555 6777899999999999999999
Q ss_pred EEEEEeecCCCChHHHHhh---CCCCCCcHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEccCCcEEEecccchh
Q 035930 545 SCLVMEYCPGGDLHVLRQK---QPSRFFSEQAARFYVAEVLLALEYLHML-GVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~---~~~~~l~e~~~r~i~~QIl~gL~yLHs~-GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
.|+||||+.+ +|..++.. .....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999964 77666542 2234589999999999999999999998 99999999999999999999999999874
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
.....
T Consensus 175 ~~~~~--------------------------------------------------------------------------- 179 (327)
T 3aln_A 175 QLVDS--------------------------------------------------------------------------- 179 (327)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ecccc---------------------------------------------------------------------------
Confidence 31100
Q ss_pred CCccccccCCCCccChhhh----cCCCCCcccceehhhHHHHHHhhCCCCCCCCCC-hhhhHHHhhccc-cCC--CCCCC
Q 035930 701 GARSNSFVGTHEYLAPEII----KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-DETLSNVVSQSL-RFP--GYPVV 772 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil----~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~-~e~l~~Iv~~~~-~~p--~~~~i 772 (857)
.......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+... .+.+..+..... .++ ....+
T Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3aln_A 180 -IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREF 258 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCC
T ss_pred -cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccC
Confidence 001123589999999999 566789999999999999999999999987542 223333322211 111 12458
Q ss_pred CHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 773 SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 773 s~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
+..+.+||.+||..||.+||+ +.+|++||||...++.
T Consensus 259 ~~~l~~li~~~l~~dp~~Rps----~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 259 SPSFINFVNLCLTKDESKRPK----YKELLKHPFILMYEER 295 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHHHS
T ss_pred CHHHHHHHHHHhhCChhhCcC----HHHHHhChHHHHhHhh
Confidence 999999999999999999999 9999999999877664
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=375.23 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=208.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEE----EEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLF----ALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~V----AVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
+..++|++++.||+|+||+||+|.+..++..| |+|.+... ........+.+|+.+|+.++||||++++++|..+
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 55688999999999999999999998887665 55655433 2344567789999999999999999999999876
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
. .++||||+.+|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 5 7899999999999998877543 4899999999999999999999999999999999999999999999999998542
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.... ...
T Consensus 168 ~~~~-------------------------------------------------------------------------~~~ 174 (327)
T 3lzb_A 168 GAEE-------------------------------------------------------------------------KEY 174 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCcc-------------------------------------------------------------------------ccc
Confidence 1100 000
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~ 781 (857)
......||+.|+|||++.+..++.++|||||||+||||++ |..||.+....+... .+.....++....++.++.+||.
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~ 253 (327)
T 3lzb_A 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTIDVYMIMR 253 (327)
T ss_dssp -----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-HHHTTCCCCCCTTBCHHHHHHHH
T ss_pred cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCCCCCccCCHHHHHHHH
Confidence 0112347889999999999999999999999999999999 999999876665544 44455566666779999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHc
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+||..||.+||+ +.+|++
T Consensus 254 ~~l~~dp~~Rps----~~ell~ 271 (327)
T 3lzb_A 254 KCWMIDADSRPK----FRELII 271 (327)
T ss_dssp HHTCSSGGGSCC----HHHHHH
T ss_pred HHcCCChhHCcC----HHHHHH
Confidence 999999999999 677765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=375.66 Aligned_cols=258 Identities=21% Similarity=0.320 Sum_probs=213.5
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc-------CCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCcccccee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI-------GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAH 538 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~-------~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~ 538 (857)
+..++|.+.+.||+|+||+||+|.+. .++..||||+++... .......+.+|+++|+.+ +||||++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 55678999999999999999999986 356789999997652 234456788999999999 89999999999
Q ss_pred eeeCCeEEEEEeecCCCChHHHHhhCCC--------------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 035930 539 FTTEKFSCLVMEYCPGGDLHVLRQKQPS--------------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604 (857)
Q Consensus 539 f~~~~~l~LVmEy~~gGsL~~ll~~~~~--------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNIL 604 (857)
|.+++.+|+||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence 9999999999999999999999876532 24899999999999999999999999999999999999
Q ss_pred EccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhh
Q 035930 605 VREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD 684 (857)
Q Consensus 605 L~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d 684 (857)
++.++.+||+|||++........
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~--------------------------------------------------------- 212 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDY--------------------------------------------------------- 212 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSS---------------------------------------------------------
T ss_pred EcCCCCEEEcccccccccccccc---------------------------------------------------------
Confidence 99999999999999753211000
Q ss_pred hhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhcc
Q 035930 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQS 763 (857)
Q Consensus 685 ~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~ 763 (857)
........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.. .
T Consensus 213 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~ 275 (334)
T 2pvf_A 213 ----------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE-G 275 (334)
T ss_dssp ----------------EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-T
T ss_pred ----------------ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhc-C
Confidence 000122347889999999999999999999999999999999 9999998876666555444 3
Q ss_pred ccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 764 ~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
...+....++..+.+||.+||..||.+||+ +.+|+++
T Consensus 276 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 312 (334)
T 2pvf_A 276 HRMDKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVED 312 (334)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 344445678999999999999999999999 7777753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=370.25 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=209.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC-CC--eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG-TS--CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~-tg--~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
+..++|++.+.||+|+||+||+|.+.. ++ ..||||+++..........+.+.+|+++|+.++||||+++++++.++.
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 456789999999999999999998753 33 469999998765444556678899999999999999999999998765
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
.++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred -ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 789999999999998887643 348999999999999999999999999999999999999999999999999975421
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.... ....
T Consensus 173 ~~~~------------------------------------------------------------------------~~~~ 180 (291)
T 1u46_A 173 QNDD------------------------------------------------------------------------HYVM 180 (291)
T ss_dssp C-CC------------------------------------------------------------------------EEEC
T ss_pred cccc------------------------------------------------------------------------chhh
Confidence 1000 0000
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+.+..+......++....++.++.+||.+
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 260 (291)
T 1u46_A 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ 260 (291)
T ss_dssp -----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHH
T ss_pred hccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHH
Confidence 123357889999999999999999999999999999999 9999999888888888877777777777899999999999
Q ss_pred hccCCcCCcCCchhhHHHHHc
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||..||.+||+ +.++++
T Consensus 261 ~l~~~p~~Rps----~~~l~~ 277 (291)
T 1u46_A 261 CWAHKPEDRPT----FVALRD 277 (291)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HccCCcccCcC----HHHHHH
Confidence 99999999999 777775
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=363.81 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=213.7
Q ss_pred ccCCCeEEEe-EEccCCceEEEEEEEc--CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHK-KLGCGDIGTVYLAELI--GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~-~LG~G~fGtVyla~~~--~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
+..++|.+.. .||+|+||+||+|.+. .++..||||+++... .....+.+.+|+++|+.++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 4556788887 9999999999999864 568899999997642 234456788999999999999999999999 556
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..|+||||+++++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 7899999999999999886543 348999999999999999999999999999999999999999999999999985421
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
..... ...
T Consensus 162 ~~~~~------------------------------------------------------------------------~~~ 169 (287)
T 1u59_A 162 ADDSY------------------------------------------------------------------------YTA 169 (287)
T ss_dssp TCSCE------------------------------------------------------------------------ECC
T ss_pred cCcce------------------------------------------------------------------------eec
Confidence 11000 000
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+... ...+....+++++.+||.+
T Consensus 170 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~ 248 (287)
T 1u59_A 170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPELYALMSD 248 (287)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCCTTCCHHHHHHHHH
T ss_pred cccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-CcCCCCCCcCHHHHHHHHH
Confidence 122347899999999999999999999999999999998 99999988777766655443 3334446799999999999
Q ss_pred hccCCcCCcCCchhhHHHHHcCC
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQHP 805 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~HP 805 (857)
||..||.+||+ +.++++|.
T Consensus 249 ~l~~~p~~Rps----~~~l~~~l 267 (287)
T 1u59_A 249 CWIYKWEDRPD----FLTVEQRM 267 (287)
T ss_dssp TTCSSGGGSCC----HHHHHHHH
T ss_pred HcCCChhhCcC----HHHHHHHH
Confidence 99999999999 88888765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=388.08 Aligned_cols=257 Identities=24% Similarity=0.326 Sum_probs=205.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc---CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~---~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
+...+|.+.+.||+|+||+||+|++. .++..||||+++... .......+.+|+.+|+.++||||++++++|.+.+
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 55678999999999999999999887 567789999997542 2334567899999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..||||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred ceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999999987654 348999999999999999999999999999999999999999999999999985421
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
..... ...
T Consensus 199 ~~~~~------------------------------------------------------------------------~~~ 206 (373)
T 2qol_A 199 DDPEA------------------------------------------------------------------------AYT 206 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCCcc------------------------------------------------------------------------cee
Confidence 11000 000
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+. ...+.+....++..+.+||.+
T Consensus 207 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~ 285 (373)
T 2qol_A 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLD 285 (373)
T ss_dssp -------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTTCBHHHHHHHHH
T ss_pred ccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccccHHHHHHHHH
Confidence 112236788999999999999999999999999999997 999999887666665544 445555566789999999999
Q ss_pred hccCCcCCcCCchhhHHHHHc
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||..||.+||+ +.+|++
T Consensus 286 cl~~dp~~RPs----~~~i~~ 302 (373)
T 2qol_A 286 CWQKDRNNRPK----FEQIVS 302 (373)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HhCcChhhCcC----HHHHHH
Confidence 99999999999 555543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=363.96 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=210.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC---CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG---TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~---tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
+..++|.+.+.||+|+||+||+|.+.. ++..||||++.... .....+.+.+|+.+|+.++||||+++++++.++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 85 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE- 85 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence 456789999999999999999998754 34579999997652 223456788999999999999999999998754
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..|+||||+++++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 5689999999999999887653 348999999999999999999999999999999999999999999999999984321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
... ...
T Consensus 165 ~~~--------------------------------------------------------------------------~~~ 170 (281)
T 3cc6_A 165 DED--------------------------------------------------------------------------YYK 170 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc--------------------------------------------------------------------------ccc
Confidence 000 000
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.. ....+....+++.+.+||.+
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~ 249 (281)
T 3cc6_A 171 ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK-GDRLPKPDLCPPVLYTLMTR 249 (281)
T ss_dssp --CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH-TCCCCCCTTCCHHHHHHHHH
T ss_pred cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc-CCCCCCCCCCCHHHHHHHHH
Confidence 112347889999999999999999999999999999998 9999988776666555443 34455556789999999999
Q ss_pred hccCCcCCcCCchhhHHHHHcC
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
||..||.+||+ +.+++++
T Consensus 250 ~l~~~p~~Rps----~~ell~~ 267 (281)
T 3cc6_A 250 CWDYDPSDRPR----FTELVCS 267 (281)
T ss_dssp HTCSSGGGSCC----HHHHHHH
T ss_pred HccCCchhCcC----HHHHHHH
Confidence 99999999999 7777754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=378.25 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=198.3
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC--
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK-- 543 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~-- 543 (857)
.+...+|++++.||+|+||+||+|++. ++.||||++.... .......+|+.+|+.++||||++++++|....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 466789999999999999999999885 7899999996542 22334566888899999999999999998744
Q ss_pred --eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHc----------CceeccCCCCcEEEccCCcE
Q 035930 544 --FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML----------GVVYRDLKPENILVREDGHI 611 (857)
Q Consensus 544 --~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~----------GIIHRDLKPeNILL~~dg~i 611 (857)
.+|+||||+++|+|.+++.... +++..++.++.||+.||.|||+. ||+||||||+|||++.++.+
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred CceEEEEEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 5799999999999999997753 89999999999999999999999 99999999999999999999
Q ss_pred EEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCC
Q 035930 612 MLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSP 691 (857)
Q Consensus 612 KL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~ 691 (857)
||+|||++.......
T Consensus 171 kL~DFg~a~~~~~~~----------------------------------------------------------------- 185 (322)
T 3soc_A 171 CIADFGLALKFEAGK----------------------------------------------------------------- 185 (322)
T ss_dssp EECCCTTCEEECTTS-----------------------------------------------------------------
T ss_pred EEccCCccccccccc-----------------------------------------------------------------
Confidence 999999985432110
Q ss_pred CCcccccCCCCccccccCCCCccChhhhcCC-----CCCcccceehhhHHHHHHhhCCCCCCCCCChh------------
Q 035930 692 MPQLVVEPTGARSNSFVGTHEYLAPEIIKGE-----GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE------------ 754 (857)
Q Consensus 692 ~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~-----~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e------------ 754 (857)
........+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.....
T Consensus 186 --------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 186 --------SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp --------CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred --------CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 00011235699999999999873 45678899999999999999999998654321
Q ss_pred ---hhHHHhhccccCCCCC------CCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 755 ---TLSNVVSQSLRFPGYP------VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 755 ---~l~~Iv~~~~~~p~~~------~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.+...+......+..+ ..+..+.+||.+||..||++||+ +.+|++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~ 311 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS----AGCVGE 311 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcC----HHHHHH
Confidence 1111111111112111 12345999999999999999999 666664
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=394.41 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=214.0
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
+.+..++|.+.+.||+|+||+||+|.+. .+..||||+++.. ....+.+.+|+.+|+.++||||+++++++. ++.
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTT----SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred eeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCC----CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 3466789999999999999999999986 4678999999764 234677899999999999999999999987 567
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+||||||+++|+|.+++.......+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 89999999999999998754333488999999999999999999999999999999999999999999999999854210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
... ...
T Consensus 337 ~~~--------------------------------------------------------------------------~~~ 342 (454)
T 1qcf_A 337 NEY--------------------------------------------------------------------------TAR 342 (454)
T ss_dssp HHH--------------------------------------------------------------------------HTT
T ss_pred Cce--------------------------------------------------------------------------ecc
Confidence 000 000
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhh
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~ 783 (857)
....+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+. ...+++.+..++.++.+||.+|
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~c 421 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNIMMRC 421 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHHHHH
T ss_pred CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHH
Confidence 12246788999999999999999999999999999999 999999887777766654 4456666678999999999999
Q ss_pred ccCCcCCcCCchhhHHHHH
Q 035930 784 LVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL 802 (857)
|..||++||+ +++|+
T Consensus 422 l~~dp~~RPt----~~~i~ 436 (454)
T 1qcf_A 422 WKNRPEERPT----FEYIQ 436 (454)
T ss_dssp TCSSGGGSCC----HHHHH
T ss_pred ccCChhHCcC----HHHHH
Confidence 9999999999 66554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=362.11 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=211.6
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
+.+..++|++.+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+++|+.++||||+++++++.. +.
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence 4466689999999999999999999975 56789999997542 345678999999999999999999999874 45
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
.|+||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 79999999999999988754323489999999999999999999999999999999999999999999999999743211
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
... ...
T Consensus 162 ~~~--------------------------------------------------------------------------~~~ 167 (279)
T 1qpc_A 162 NEY--------------------------------------------------------------------------TAR 167 (279)
T ss_dssp SCE--------------------------------------------------------------------------ECC
T ss_pred ccc--------------------------------------------------------------------------ccc
Confidence 000 001
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhh
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~ 783 (857)
....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+.. .........++..+.+||.+|
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~ 246 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPDNCPEELYQLMRLC 246 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc-ccCCCCcccccHHHHHHHHHH
Confidence 12347889999999999899999999999999999999 9999998877666665544 344444567899999999999
Q ss_pred ccCCcCCcCCchhhHHHHHc
Q 035930 784 LVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~ 803 (857)
|..||++||+ +.+|++
T Consensus 247 l~~~p~~Rps----~~~l~~ 262 (279)
T 1qpc_A 247 WKERPEDRPT----FDYLRS 262 (279)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred hccChhhCCC----HHHHHH
Confidence 9999999999 666654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=365.61 Aligned_cols=257 Identities=21% Similarity=0.338 Sum_probs=202.5
Q ss_pred cccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 464 HGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 464 ~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
.+.+..++|++.+.||+|+||+||+|.+.. .||||+++.... .....+.+.+|+++|+.++||||+++++++ ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 345777899999999999999999998654 499999975432 233456788999999999999999999965 455
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..++||||+++++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred ccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 6899999999999999886554 348999999999999999999999999999999999999999999999999974321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
... ....
T Consensus 172 ~~~-------------------------------------------------------------------------~~~~ 178 (289)
T 3og7_A 172 RWS-------------------------------------------------------------------------GSHQ 178 (289)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-------------------------------------------------------------------------cccc
Confidence 000 0001
Q ss_pred cccccCCCCccChhhhc---CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC----CCCCCHHH
Q 035930 704 SNSFVGTHEYLAPEIIK---GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG----YPVVSFHA 776 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~---g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~----~~~is~~l 776 (857)
.....||+.|+|||++. +..++.++|||||||++|+|++|+.||.+....+.+...+......+. ...+++.+
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHH
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHH
Confidence 12346899999999997 667889999999999999999999999987776666665554433222 24678999
Q ss_pred HHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 777 RDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 777 ~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.+||.+||..||.+||+ +.+|++
T Consensus 259 ~~li~~~l~~~p~~Rps----~~ell~ 281 (289)
T 3og7_A 259 KRLMAECLKKKRDERPS----FPRILA 281 (289)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHccCChhhCCC----HHHHHH
Confidence 99999999999999999 666664
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=373.29 Aligned_cols=258 Identities=24% Similarity=0.290 Sum_probs=210.5
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCC----eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTS----CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg----~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
.+...+|.+.+.||+|+||+||+|.+..++ ..||||++.... .......+.+|+.+|+.++||||+++++++.+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 356678999999999999999999987553 469999997542 22334567899999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
.+..||||||+++++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999987653 3489999999999999999999999999999999999999999999999999854
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
...... ..
T Consensus 197 ~~~~~~------------------------------------------------------------------------~~ 204 (333)
T 1mqb_A 197 LEDDPE------------------------------------------------------------------------AT 204 (333)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred hccccc------------------------------------------------------------------------cc
Confidence 211000 00
Q ss_pred CccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHH
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLI 780 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI 780 (857)
.......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+.. ..+++....++..+.+||
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 283 (333)
T 1mqb_A 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-GFRLPTPMDCPSAIYQLM 283 (333)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTCBHHHHHHH
T ss_pred cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC-CCcCCCcccCCHHHHHHH
Confidence 00112346889999999999999999999999999999998 9999998877666665544 445555667899999999
Q ss_pred HhhccCCcCCcCCchhhHHHHHc
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.+||..||.+||+ +.++++
T Consensus 284 ~~~l~~~p~~Rps----~~~l~~ 302 (333)
T 1mqb_A 284 MQCWQQERARRPK----FADIVS 302 (333)
T ss_dssp HHHTCSSTTTSCC----HHHHHH
T ss_pred HHHcCCChhhCcC----HHHHHH
Confidence 9999999999999 666654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=374.18 Aligned_cols=268 Identities=22% Similarity=0.313 Sum_probs=212.8
Q ss_pred cccCCCeEEEeEEccCCceEEEEEE----EcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeee-
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAE----LIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFT- 540 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~----~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~- 540 (857)
.+..++|++++.||+|+||+||+|+ +..++..||||++.... ....+.+.+|+++|+.++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 3566899999999999999999999 46788999999997642 234456889999999999999999999886
Q ss_pred -eCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 541 -TEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 541 -~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
+....||||||+++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred CCCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 45679999999999999999876432 3899999999999999999999999999999999999999999999999998
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
........
T Consensus 175 ~~~~~~~~------------------------------------------------------------------------ 182 (327)
T 3lxl_A 175 KLLPLDKD------------------------------------------------------------------------ 182 (327)
T ss_dssp EECCTTCS------------------------------------------------------------------------
T ss_pred eecccCCc------------------------------------------------------------------------
Confidence 54211100
Q ss_pred CCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh--------------hhhHHHhhcccc
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND--------------ETLSNVVSQSLR 765 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~--------------e~l~~Iv~~~~~ 765 (857)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+...+.....
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (327)
T 3lxl_A 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR 262 (327)
T ss_dssp EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCC
T ss_pred cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccC
Confidence 000112345889999999999999999999999999999999999999654221 223333445555
Q ss_pred CCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHH---HcCCCCCCCChh
Q 035930 766 FPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEI---KQHPFFEGLNWA 813 (857)
Q Consensus 766 ~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~EL---L~HPfF~~l~w~ 813 (857)
.+....+++++.+||.+||..||.+||+ +.+| |+..|...-.|.
T Consensus 263 ~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 263 LPAPPACPAEVHELMKLCWAPSPQDRPS----FSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHC--------
T ss_pred CCCCCcccHHHHHHHHHHcCCChhhCcC----HHHHHHHHHHHHhhhcCcc
Confidence 6666789999999999999999999999 6666 444555444443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=361.36 Aligned_cols=257 Identities=18% Similarity=0.249 Sum_probs=206.7
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcC---CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceee-eeCC
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIG---TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHF-TTEK 543 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~---tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f-~~~~ 543 (857)
...+|++.+.||+|+||+||+|.+.. ....||+|++... ........+.+|+.+|+.++||||+++++++ ..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 34579999999999999999998754 3456999998753 2234456788999999999999999999985 4566
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred ceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 8899999999999999987643 348999999999999999999999999999999999999999999999999985321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.... .....
T Consensus 180 ~~~~-----------------------------------------------------------------------~~~~~ 188 (298)
T 3f66_A 180 DKEY-----------------------------------------------------------------------YSVHN 188 (298)
T ss_dssp CGGG-----------------------------------------------------------------------CBC--
T ss_pred ccch-----------------------------------------------------------------------hcccc
Confidence 1000 00001
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+.... .......++..+.+||.+
T Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 267 (298)
T 3f66_A 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLK 267 (298)
T ss_dssp ---CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-CCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-CCCCCccCCHHHHHHHHH
Confidence 123458899999999999999999999999999999999 667777766666665555443 333345689999999999
Q ss_pred hccCCcCCcCCchhhHHHHHc
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||..||.+||+ +.++++
T Consensus 268 ~l~~~p~~Rps----~~ell~ 284 (298)
T 3f66_A 268 CWHPKAEMRPS----FSELVS 284 (298)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HcCCChhhCcC----HHHHHH
Confidence 99999999999 666664
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.26 Aligned_cols=256 Identities=19% Similarity=0.282 Sum_probs=206.6
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceee-eeCCeEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHF-TTEKFSCL 547 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f-~~~~~l~L 547 (857)
.++|++.+.||+|+||+||+|++..+++.||||++... .....+.+|+.+++.+.|++++..+.++ ...+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESC-----SSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCC-----cchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 46899999999999999999999999999999998654 2334688999999999988876665555 66778899
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE---ccCCcEEEecccchhhccc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV---REDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL---~~dg~iKL~DFGLA~r~~~ 624 (857)
||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99999 999999987543 349999999999999999999999999999999999999 4889999999999854321
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
..... .......
T Consensus 161 ~~~~~--------------------------------------------------------------------~~~~~~~ 172 (296)
T 3uzp_A 161 ARTHQ--------------------------------------------------------------------HIPYREN 172 (296)
T ss_dssp TTTCC--------------------------------------------------------------------BCCCCCS
T ss_pred ccccc--------------------------------------------------------------------ccccccc
Confidence 10000 0000112
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC---ChhhhHHHhhccccCCC---CCCCCHHHHH
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG---NDETLSNVVSQSLRFPG---YPVVSFHARD 778 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~---~~e~l~~Iv~~~~~~p~---~~~is~~l~d 778 (857)
....||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ..+.+..+.......+. ...+++++.+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (296)
T 3uzp_A 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFAT 252 (296)
T ss_dssp CCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHH
T ss_pred cccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHH
Confidence 34579999999999999999999999999999999999999998743 33445555554444431 2458999999
Q ss_pred HHHhhccCCcCCcCCchhhHHHHHc
Q 035930 779 LIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 779 LI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||.+||..||.+||+ +.+|++
T Consensus 253 li~~~l~~dp~~Rps----~~~l~~ 273 (296)
T 3uzp_A 253 YLNFCRSLRFDDKPD----YSYLRQ 273 (296)
T ss_dssp HHHHHHTSCTTCCCC----HHHHHH
T ss_pred HHHHHHhcCcCcCCC----HHHHHH
Confidence 999999999999999 555543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=363.21 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=205.8
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-C
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE-K 543 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~-~ 543 (857)
+.+..++|++.+.||+|+||+||++.+. +..||||+++.. ...+.+.+|+++|+.++||||+++++++.+. +
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 3466789999999999999999999874 789999998754 2456788999999999999999999987554 5
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 78999999999999998876543347899999999999999999999999999999999999999999999999874210
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
. .
T Consensus 169 ~------------------------------------------------------------------------------~ 170 (278)
T 1byg_A 169 S------------------------------------------------------------------------------T 170 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....+++.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+.. ...+.....+++.+.+||.+
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~ 249 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEVMKN 249 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCcccCCHHHHHHHHH
Confidence 011246889999999999999999999999999999998 9999998776666655543 34445556789999999999
Q ss_pred hccCCcCCcCCchhhHHHHHc
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||..||.+||+ +.++++
T Consensus 250 ~l~~~p~~Rps----~~~l~~ 266 (278)
T 1byg_A 250 CWHLDAAMRPS----FLQLRE 266 (278)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HhcCChhhCCC----HHHHHH
Confidence 99999999999 666654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=361.28 Aligned_cols=245 Identities=22% Similarity=0.359 Sum_probs=206.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee--------
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT-------- 541 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~-------- 541 (857)
.+|++.+.||+|+||+||+|.+..+++.||||++.... ..+.+|+++|+.++||||++++++|..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 57999999999999999999999999999999997541 346789999999999999999998864
Q ss_pred --------CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEE
Q 035930 542 --------EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML 613 (857)
Q Consensus 542 --------~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL 613 (857)
...+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 456899999999999999997654456999999999999999999999999999999999999999999999
Q ss_pred ecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCC
Q 035930 614 SDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMP 693 (857)
Q Consensus 614 ~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p 693 (857)
+|||++......
T Consensus 164 ~Dfg~~~~~~~~-------------------------------------------------------------------- 175 (284)
T 2a19_B 164 GDFGLVTSLKND-------------------------------------------------------------------- 175 (284)
T ss_dssp CCCTTCEESSCC--------------------------------------------------------------------
T ss_pred Ccchhheecccc--------------------------------------------------------------------
Confidence 999987432100
Q ss_pred cccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCC
Q 035930 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVS 773 (857)
Q Consensus 694 ~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is 773 (857)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||... ......+... .+ ...++
T Consensus 176 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~~--~~~~~ 241 (284)
T 2a19_B 176 --------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--II--SDIFD 241 (284)
T ss_dssp --------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--CC--CTTSC
T ss_pred --------ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--cc--cccCC
Confidence 0012335899999999999999999999999999999999999988532 2222222222 12 24589
Q ss_pred HHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 774 FHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
..+++||.+||..||.+||+ +.++++|.|+
T Consensus 242 ~~~~~li~~~l~~dp~~Rps----~~e~l~~l~~ 271 (284)
T 2a19_B 242 KKEKTLLQKLLSKKPEDRPN----TSEILRTLTV 271 (284)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcC----HHHHHHHHHH
Confidence 99999999999999999999 9999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=363.53 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=209.1
Q ss_pred cccCCCeEEEe-EEccCCceEEEEEEE--cCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 466 CMGMRHFKLHK-KLGCGDIGTVYLAEL--IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 466 ~~~~~~Y~i~~-~LG~G~fGtVyla~~--~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
.+..++|.+.+ .||+|+||+||+|.+ ..++..||||+++... ......+.+.+|+++|+.++||||+++++++ ..
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 35567899998 999999999999955 5667899999997652 2233356789999999999999999999999 56
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
+..|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 77899999999999999998754 3899999999999999999999999999999999999999999999999997542
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
...... ..
T Consensus 168 ~~~~~~------------------------------------------------------------------------~~ 175 (291)
T 1xbb_A 168 RADENY------------------------------------------------------------------------YK 175 (291)
T ss_dssp CTTCSE------------------------------------------------------------------------EE
T ss_pred ccCCCc------------------------------------------------------------------------cc
Confidence 111000 00
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~ 781 (857)
......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....+....+.. ....+....++..+.+||.
T Consensus 176 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 254 (291)
T 1xbb_A 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDLMN 254 (291)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHH
T ss_pred ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHH
Confidence 0112246789999999999999999999999999999999 9999998776665555444 3334445678999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHc
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+||..||.+||+ +.++++
T Consensus 255 ~~l~~dp~~Rps----~~~l~~ 272 (291)
T 1xbb_A 255 LCWTYDVENRPG----FAAVEL 272 (291)
T ss_dssp HHTCSSTTTSCC----HHHHHH
T ss_pred HHcCCChhhCcC----HHHHHH
Confidence 999999999999 666654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=380.26 Aligned_cols=280 Identities=16% Similarity=0.184 Sum_probs=205.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCC-----CeEEEEEEeccccccccc--------chhHHHHHHHHHHHcCCCCcc
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGT-----SCLFALKVMDNDFLVGRK--------KMPRAQTEREIMQMLDHPFLP 533 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~t-----g~~VAVKvi~k~~~~~~~--------~~~~~~~EieILr~L~HPnIV 533 (857)
+..++|++++.||+|+||+||+|.+..+ ++.||||++......... ....+..|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456899999999999999999998764 578999998754211000 111233455566677899999
Q ss_pred ccceeeeeC----CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc--c
Q 035930 534 TLFAHFTTE----KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR--E 607 (857)
Q Consensus 534 ~L~~~f~~~----~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~--~ 607 (857)
++++++... .+.||||||+ |++|..++.... ..+++..++.++.||+.||+|||++|||||||||+||||+ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 999999765 5689999999 999999987753 3499999999999999999999999999999999999999 8
Q ss_pred CCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhc
Q 035930 608 DGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAA 687 (857)
Q Consensus 608 dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~ 687 (857)
++.+||+|||+++.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~----------------------------------------------------------- 210 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVH----------------------------------------------------------- 210 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCC-----------------------------------------------------------
T ss_pred CCeEEEEECCcceecccCCcc-----------------------------------------------------------
Confidence 899999999998543211000
Q ss_pred ccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC-
Q 035930 688 QVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF- 766 (857)
Q Consensus 688 ~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~- 766 (857)
...........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+......+..........
T Consensus 211 ---------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~ 281 (364)
T 3op5_A 211 ---------KAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYREN 281 (364)
T ss_dssp ---------CCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHC
T ss_pred ---------cccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhh
Confidence 0000111235579999999999999999999999999999999999999998654433332222211110
Q ss_pred --------CCCCCCCHHHHHHHHhhccCCcCCcCCchhhH---HHH---HcCCCCCCCChhhhc
Q 035930 767 --------PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGA---AEI---KQHPFFEGLNWALIR 816 (857)
Q Consensus 767 --------p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a---~EL---L~HPfF~~l~w~li~ 816 (857)
.....++.++.+||..||..||.+||++.... .++ +..++...++|....
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 282 IASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp HHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred HHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 01245799999999999999999999953211 111 124566777777654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=366.10 Aligned_cols=260 Identities=21% Similarity=0.295 Sum_probs=207.0
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcC---CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIG---TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~---tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
.+..++|.+.+.||+|+||+||+|.+.. ++..||||+++.... .......+.+|+.+|+.++||||+++++++.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3566789999999999999999998865 566899999975432 223456788999999999999999999999876
Q ss_pred C-----eEEEEEeecCCCChHHHHhhC----CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEE
Q 035930 543 K-----FSCLVMEYCPGGDLHVLRQKQ----PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML 613 (857)
Q Consensus 543 ~-----~l~LVmEy~~gGsL~~ll~~~----~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL 613 (857)
+ ..|+||||+++++|..++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 5 459999999999999887532 2245999999999999999999999999999999999999999999999
Q ss_pred ecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCC
Q 035930 614 SDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMP 693 (857)
Q Consensus 614 ~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p 693 (857)
+|||++........
T Consensus 189 ~Dfg~~~~~~~~~~------------------------------------------------------------------ 202 (313)
T 3brb_A 189 ADFGLSKKIYSGDY------------------------------------------------------------------ 202 (313)
T ss_dssp CSCSCC--------------------------------------------------------------------------
T ss_pred eecCcceecccccc------------------------------------------------------------------
Confidence 99999743211000
Q ss_pred cccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCC
Q 035930 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVV 772 (857)
Q Consensus 694 ~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~i 772 (857)
........+++.|+|||++.+..++.++|||||||+||+|++ |..||.+....+.+..+.... ..+....+
T Consensus 203 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 274 (313)
T 3brb_A 203 -------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLKQPEDC 274 (313)
T ss_dssp ---------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCBTTC
T ss_pred -------cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-CCCCCccc
Confidence 000112347889999999999999999999999999999999 999999887777766655543 34445678
Q ss_pred CHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 773 SFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 773 s~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
+..+.+||.+||..||.+||+ +.+|+++
T Consensus 275 ~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 302 (313)
T 3brb_A 275 LDELYEIMYSCWRTDPLDRPT----FSVLRLQ 302 (313)
T ss_dssp CHHHHHHHHHTTCSSGGGSCC----HHHHHHH
T ss_pred cHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 999999999999999999999 7777753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=377.22 Aligned_cols=258 Identities=22% Similarity=0.238 Sum_probs=208.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
...++|.+.+.||+|+||+||+|.+. ++..||||++... .....+.+.+|+++|+.++||||++++++|.+++..|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34578999999999999999999964 6889999998654 2344567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCC--CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 547 LVMEYCPGGDLHVLRQKQPS--RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~--~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999988865432 2489999999999999999999999999999999999999999999999999743110
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
.. .....
T Consensus 192 ~~-------------------------------------------------------------------------~~~~~ 198 (321)
T 2qkw_B 192 LD-------------------------------------------------------------------------QTHLS 198 (321)
T ss_dssp SS-------------------------------------------------------------------------CCCCB
T ss_pred cc-------------------------------------------------------------------------ccccc
Confidence 00 00111
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHh-------hccc--------cCCCC
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV-------SQSL--------RFPGY 769 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv-------~~~~--------~~p~~ 769 (857)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+...... ...+ .....
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIR 278 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSC
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccC
Confidence 23468999999999999999999999999999999999999998765443321110 1100 01111
Q ss_pred CCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCC
Q 035930 770 PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHP 805 (857)
Q Consensus 770 ~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HP 805 (857)
+.++..+.+||.+||..||++||+ +.++++|.
T Consensus 279 ~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~L 310 (321)
T 2qkw_B 279 PESLRKFGDTAVKCLALSSEDRPS----MGDVLWKL 310 (321)
T ss_dssp HHHHHHHHHHHHHHTCSSGGGSCC----HHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCcccCcC----HHHHHHHH
Confidence 234567899999999999999999 88888653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=376.12 Aligned_cols=261 Identities=22% Similarity=0.245 Sum_probs=207.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
...++|.+.+.||+|+||+||+|.+. ++..||||++..... ......+.+|+++|+.++||||++++++|.+.+..|
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccC--chHHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 56688999999999999999999854 688999999976532 223346889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCC--CCCcHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 547 LVMEYCPGGDLHVLRQKQPS--RFFSEQAARFYVAEVLLALEYLHML---GVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~--~~l~e~~~r~i~~QIl~gL~yLHs~---GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
+||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 99999999999999876542 2489999999999999999999999 999999999999999999999999999743
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
.... ..
T Consensus 184 ~~~~--------------------------------------------------------------------------~~ 189 (326)
T 3uim_A 184 MDYK--------------------------------------------------------------------------DT 189 (326)
T ss_dssp CCSS--------------------------------------------------------------------------SS
T ss_pred cCcc--------------------------------------------------------------------------cc
Confidence 2100 00
Q ss_pred CccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCC----CCChhhhHHHhhccccC-----------
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKG----SGNDETLSNVVSQSLRF----------- 766 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g----~~~~e~l~~Iv~~~~~~----------- 766 (857)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.. ......+...+......
T Consensus 190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 3uim_A 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL 269 (326)
T ss_dssp CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTC
T ss_pred cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhh
Confidence 112234699999999999999999999999999999999999999962 11222222222211111
Q ss_pred --CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCC
Q 035930 767 --PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 767 --p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
......+..+.+||.+||..||.+||+ +.+|++|-+-.
T Consensus 270 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~~L~~~ 309 (326)
T 3uim_A 270 QGNYKDEEVEQLIQVALLCTQSSPMERPK----MSEVVRMLEGD 309 (326)
T ss_dssp TTSCCHHHHHHHHHHHHHHTCSCGGGSCC----HHHHHHHHHTS
T ss_pred ccccCHHHHHHHHHHHHHHhCcCCccCCC----HHHHHHHhcCc
Confidence 111223367999999999999999999 88888776433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=387.51 Aligned_cols=254 Identities=23% Similarity=0.376 Sum_probs=204.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC--e
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK--F 544 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~--~ 544 (857)
...++|.+.+.||+|+||+||+|++..+++.||||++..... ....+.+.+|+++|+.++||||+++++++...+ .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 345789999999999999999999999999999999976432 334567789999999999999999999998765 7
Q ss_pred EEEEEeecCCCChHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE----ccCCcEEEecccch
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPS-RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV----REDGHIMLSDFDLS 619 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~-~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL----~~dg~iKL~DFGLA 619 (857)
.||||||+++|+|..++..... ..+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 8999999999999998875432 238999999999999999999999999999999999999 77778999999998
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
.....
T Consensus 164 ~~~~~--------------------------------------------------------------------------- 168 (396)
T 4eut_A 164 RELED--------------------------------------------------------------------------- 168 (396)
T ss_dssp EECCC---------------------------------------------------------------------------
T ss_pred eEccC---------------------------------------------------------------------------
Confidence 43210
Q ss_pred CCCccccccCCCCccChhhhcC--------CCCCcccceehhhHHHHHHhhCCCCCCCCC----ChhhhHHHhhcccc--
Q 035930 700 TGARSNSFVGTHEYLAPEIIKG--------EGHGSSVDWWTFGIFLFELLYGRTPFKGSG----NDETLSNVVSQSLR-- 765 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g--------~~~s~ksDVWSLGvILyELLtGk~PF~g~~----~~e~l~~Iv~~~~~-- 765 (857)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+.+..++.+...
T Consensus 169 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 169 -DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp -GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred -CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 001123569999999999875 567889999999999999999999997543 33444444443211
Q ss_pred -----------------CCCC----CCCCHHHHHHHHhhccCCcCCcCCchhhHHHHH
Q 035930 766 -----------------FPGY----PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 766 -----------------~p~~----~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL 802 (857)
++.. ..++..+.+||++||..||++||+ +.+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s----~~e~l 301 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG----FDQFF 301 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC----HHHHH
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc----HHHHH
Confidence 1111 123457889999999999999999 55553
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=362.27 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=197.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHH--cCCCCccccceeeee---
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM--LDHPFLPTLFAHFTT--- 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~--L~HPnIV~L~~~f~~--- 541 (857)
...++|++++.||+|+||+||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 3457899999999999999999988 6889999998643 23456678888877 789999999998754
Q ss_pred -CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHH--------HcCceeccCCCCcEEEccCCcEE
Q 035930 542 -EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH--------MLGVVYRDLKPENILVREDGHIM 612 (857)
Q Consensus 542 -~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLH--------s~GIIHRDLKPeNILL~~dg~iK 612 (857)
...+|+||||+++|+|.+++... .+++..++.++.||+.||+||| +.||+||||||+|||++.++.+|
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred CCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 35689999999999999999653 4899999999999999999999 99999999999999999999999
Q ss_pred EecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCC
Q 035930 613 LSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPM 692 (857)
Q Consensus 613 L~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~ 692 (857)
|+|||++.........
T Consensus 154 l~Dfg~a~~~~~~~~~---------------------------------------------------------------- 169 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQ---------------------------------------------------------------- 169 (301)
T ss_dssp ECCCTTCEEEETTTTE----------------------------------------------------------------
T ss_pred EeeCCCeeeccccccc----------------------------------------------------------------
Confidence 9999998542211000
Q ss_pred CcccccCCCCccccccCCCCccChhhhcCC------CCCcccceehhhHHHHHHhhC----------CCCCCCCCCh---
Q 035930 693 PQLVVEPTGARSNSFVGTHEYLAPEIIKGE------GHGSSVDWWTFGIFLFELLYG----------RTPFKGSGND--- 753 (857)
Q Consensus 693 p~l~~~~~~~~~~s~vGT~~YmAPEil~g~------~~s~ksDVWSLGvILyELLtG----------k~PF~g~~~~--- 753 (857)
........+||+.|+|||++.+. .++.++|||||||++|||++| ..||......
T Consensus 170 -------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~ 242 (301)
T 3q4u_A 170 -------LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242 (301)
T ss_dssp -------EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred -------ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence 00011234799999999999887 455799999999999999999 8898764322
Q ss_pred -hhhHHHhhccccCCCCC------CCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 754 -ETLSNVVSQSLRFPGYP------VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 754 -e~l~~Iv~~~~~~p~~~------~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+.+...+......+..+ .++..+.+||.+||..||.+||+ +.+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~~i~~ 295 (301)
T 3q4u_A 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT----ALRIKK 295 (301)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHH
T ss_pred hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC----HHHHHH
Confidence 22333332222222211 24467999999999999999999 777764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=391.55 Aligned_cols=261 Identities=25% Similarity=0.366 Sum_probs=200.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l 545 (857)
++..+|.+.+.||+|+||+||.. ...+++.||||++.... ...+.+|+++|+.+ +||||+++++++.+++..
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC------FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTT------EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 45567999999999999997643 44578899999996542 23357899999999 799999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc---C--CcEEEecccchh
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE---D--GHIMLSDFDLSL 620 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~---d--g~iKL~DFGLA~ 620 (857)
|||||||. |+|.+++...... +.+..++.++.||+.||.|||++|||||||||+||||+. + ..+||+|||++.
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFA-HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCC-CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEECCC-CCHHHHHHhcCCC-ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 99999995 6999888765432 555567789999999999999999999999999999953 2 357899999985
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
....... .
T Consensus 172 ~~~~~~~------------------------------------------------------------------------~ 179 (432)
T 3p23_A 172 KLAVGRH------------------------------------------------------------------------S 179 (432)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred eccCCCc------------------------------------------------------------------------c
Confidence 4211000 0
Q ss_pred CCccccccCCCCccChhhhc---CCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCC---CCCCCC
Q 035930 701 GARSNSFVGTHEYLAPEIIK---GEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFP---GYPVVS 773 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~---g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p---~~~~is 773 (857)
.......+||+.|+|||++. +..++.++|||||||+||||++ |..||......... +........ .....+
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 257 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--ILLGACSLDCLHPEKHED 257 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH--HHTTCCCCTTSCTTCHHH
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH--HHhccCCccccCcccccc
Confidence 01123457999999999998 4567889999999999999999 99999655433322 222222211 112245
Q ss_pred HHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 774 FHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
..+++||.+||..||.+||+ +.+|++||||..++|.+
T Consensus 258 ~~~~~li~~~L~~dP~~Rps----~~evl~hp~f~~~~~~~ 294 (432)
T 3p23_A 258 VIARELIEKMIAMDPQKRPS----AKHVLKHPFFWSLEKQL 294 (432)
T ss_dssp HHHHHHHHHHSCSSGGGSCC----HHHHHTSTTTCCHHHHH
T ss_pred HHHHHHHHHHHhCCHhhCCC----HHHHHhCccccChHHHH
Confidence 56899999999999999999 99999999999999853
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=389.77 Aligned_cols=254 Identities=26% Similarity=0.332 Sum_probs=211.5
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
+.+..++|++.+.||+|+||+||+|.+.. +..||||+++... ...+.+.+|+++|+.++||||+++++++.+ +.
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 34566789999999999999999999975 4579999997642 234678999999999999999999999876 67
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
.||||||+++|+|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 89999999999999998754334589999999999999999999999999999999999999999999999999843210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
.. ....
T Consensus 333 ~~--------------------------------------------------------------------------~~~~ 338 (452)
T 1fmk_A 333 NE--------------------------------------------------------------------------YTAR 338 (452)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Cc--------------------------------------------------------------------------eecc
Confidence 00 0001
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhh
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~ 783 (857)
....+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+. ...+.+.+..++..+.+||.+|
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~c 417 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQC 417 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHH
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHH
Confidence 12346789999999999999999999999999999999 999999887777766654 4455566677999999999999
Q ss_pred ccCCcCCcCCchhhHHHHHc
Q 035930 784 LVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~ 803 (857)
|..||++||+ +++|++
T Consensus 418 l~~dP~~Rpt----~~~l~~ 433 (452)
T 1fmk_A 418 WRKEPEERPT----FEYLQA 433 (452)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred ccCChhhCcC----HHHHHH
Confidence 9999999999 666664
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=376.74 Aligned_cols=244 Identities=17% Similarity=0.222 Sum_probs=198.5
Q ss_pred ccCCCeEEEeEEccCCceEEEEE-----EEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC---CCCcccccee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLA-----ELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD---HPFLPTLFAH 538 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla-----~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~---HPnIV~L~~~ 538 (857)
+..++|.+.+.||+|+||+||+| .+..+++.||||+++.. ....+..|+++++.++ |+||+.++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 56688999999999999999999 46678899999998654 3456788899998887 9999999999
Q ss_pred eeeCCeEEEEEeecCCCChHHHHhhC---CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc--------
Q 035930 539 FTTEKFSCLVMEYCPGGDLHVLRQKQ---PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE-------- 607 (857)
Q Consensus 539 f~~~~~l~LVmEy~~gGsL~~ll~~~---~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~-------- 607 (857)
+..++..||||||+++|+|.+++... ....+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999988642 2345999999999999999999999999999999999999998
Q ss_pred ---CCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhh
Q 035930 608 ---DGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD 684 (857)
Q Consensus 608 ---dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d 684 (857)
++.+||+|||+|+.+...
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~----------------------------------------------------------- 236 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLF----------------------------------------------------------- 236 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGS-----------------------------------------------------------
T ss_pred ccccCCEEEeeCchhhhhhcc-----------------------------------------------------------
Confidence 899999999998532110
Q ss_pred hhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc
Q 035930 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL 764 (857)
Q Consensus 685 ~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~ 764 (857)
.........+||+.|||||++.+..|+.++|||||||+||||++|+.||......... +..
T Consensus 237 --------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~-- 297 (365)
T 3e7e_A 237 --------------PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---PEG-- 297 (365)
T ss_dssp --------------CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---ECS--
T ss_pred --------------CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---ech--
Confidence 0111224567999999999999999999999999999999999999999754332211 111
Q ss_pred cCCCCCCCCHHHHHHHHhhccCCcCCcCCch
Q 035930 765 RFPGYPVVSFHARDLIRGLLVKEPDNRLGAV 795 (857)
Q Consensus 765 ~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~ 795 (857)
.+... ..+..+.+|+..||..+|.+|+...
T Consensus 298 ~~~~~-~~~~~~~~~~~~~l~~~p~~r~~~~ 327 (365)
T 3e7e_A 298 LFRRL-PHLDMWNEFFHVMLNIPDCHHLPSL 327 (365)
T ss_dssp CCTTC-SSHHHHHHHHHHHHCCCCTTCCCCH
T ss_pred hcccc-CcHHHHHHHHHHHcCCCCCCcchHH
Confidence 11111 2467788999999999999998753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=362.42 Aligned_cols=246 Identities=23% Similarity=0.408 Sum_probs=200.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++.+.||+|+||+||+|.+. ++.||||++... ...+.+.+|+++|+.++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45578999999999999999999884 678999998643 345678899999999999999999998874 478
Q ss_pred EEEeecCCCChHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEccCCc-EEEecccchhh
Q 035930 547 LVMEYCPGGDLHVLRQKQPS-RFFSEQAARFYVAEVLLALEYLHM---LGVVYRDLKPENILVREDGH-IMLSDFDLSLR 621 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~-~~l~e~~~r~i~~QIl~gL~yLHs---~GIIHRDLKPeNILL~~dg~-iKL~DFGLA~r 621 (857)
+||||+++|+|.+++..... ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999999876532 247889999999999999999999 89999999999999998886 79999998732
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
...
T Consensus 156 ~~~----------------------------------------------------------------------------- 158 (307)
T 2eva_A 156 IQT----------------------------------------------------------------------------- 158 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred CccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhh-hHHHhhccccCCCCCCCCHHHHHHH
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET-LSNVVSQSLRFPGYPVVSFHARDLI 780 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~-l~~Iv~~~~~~p~~~~is~~l~dLI 780 (857)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +..........+....++..+.+||
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (307)
T 2eva_A 159 -HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 237 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHH
T ss_pred -ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHH
Confidence 00123589999999999999999999999999999999999999986543322 2222233334444567899999999
Q ss_pred HhhccCCcCCcCCchhhHHHHHc
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.+||..||.+||+ +.++++
T Consensus 238 ~~~l~~dp~~Rps----~~ell~ 256 (307)
T 2eva_A 238 TRCWSKDPSQRPS----MEEIVK 256 (307)
T ss_dssp HHHTCSSGGGSCC----HHHHHH
T ss_pred HHHhcCChhhCcC----HHHHHH
Confidence 9999999999999 677765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=365.27 Aligned_cols=265 Identities=22% Similarity=0.359 Sum_probs=208.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee----C
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT----E 542 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~----~ 542 (857)
+..++|++.+.||+|+||+||+|.+..+++.||||++... .......+.+|+++++.++||||+++++++.. .
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 5567899999999999999999999999999999998653 23345678899999999999999999999973 3
Q ss_pred CeEEEEEeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
...|+||||+.+|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 5789999999999998887752 23458999999999999999999999999999999999999999999999999874
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
....... . ..... . .
T Consensus 183 ~~~~~~~------------------------------------------~--~~~~~--~-~------------------ 197 (317)
T 2buj_A 183 QACIHVE------------------------------------------G--SRQAL--T-L------------------ 197 (317)
T ss_dssp ESCEEEE------------------------------------------S--HHHHH--H-H------------------
T ss_pred hcccccc------------------------------------------c--ccccc--c-c------------------
Confidence 3210000 0 00000 0 0
Q ss_pred CCccccccCCCCccChhhhcCCC---CCcccceehhhHHHHHHhhCCCCCCCCC-ChhhhHHHhhccccCCCCCCCCHHH
Q 035930 701 GARSNSFVGTHEYLAPEIIKGEG---HGSSVDWWTFGIFLFELLYGRTPFKGSG-NDETLSNVVSQSLRFPGYPVVSFHA 776 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g~~---~s~ksDVWSLGvILyELLtGk~PF~g~~-~~e~l~~Iv~~~~~~p~~~~is~~l 776 (857)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.... ..+.+...+.....++..+.++..+
T Consensus 198 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 276 (317)
T 2buj_A 198 -QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSAL 276 (317)
T ss_dssp -HHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHH
T ss_pred -cccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHH
Confidence 0011235899999999998665 6889999999999999999999996421 1122333344456667667899999
Q ss_pred HHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 777 RDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 777 ~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
.+||.+||..||.+||+ +.+|++|
T Consensus 277 ~~li~~~l~~dp~~Rps----~~~ll~~ 300 (317)
T 2buj_A 277 WQLLNSMMTVDPHQRPH----IPLLLSQ 300 (317)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHhhcChhhCCC----HHHHHHH
Confidence 99999999999999999 8888864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=373.72 Aligned_cols=262 Identities=21% Similarity=0.233 Sum_probs=199.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC---CCeEEEEEEeccccccc--------ccchhHHHHHHHHHHHcCCCCcccc
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG---TSCLFALKVMDNDFLVG--------RKKMPRAQTEREIMQMLDHPFLPTL 535 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~---tg~~VAVKvi~k~~~~~--------~~~~~~~~~EieILr~L~HPnIV~L 535 (857)
+..++|.+.+.||+|+||+||+|.+.. ++..||||++....... ......+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345789999999999999999999987 78899999987542110 1122345678888999999999999
Q ss_pred ceeeee----CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC--
Q 035930 536 FAHFTT----EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG-- 609 (857)
Q Consensus 536 ~~~f~~----~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg-- 609 (857)
++++.. ....||||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 999988 78999999999 999999987654 499999999999999999999999999999999999999887
Q ss_pred cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhccc
Q 035930 610 HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQV 689 (857)
Q Consensus 610 ~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~ 689 (857)
.+||+|||+++........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~------------------------------------------------------------- 209 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNH------------------------------------------------------------- 209 (345)
T ss_dssp SEEECCCTTCEESSGGGCC-------------------------------------------------------------
T ss_pred cEEEEeCCCceeccccccc-------------------------------------------------------------
Confidence 9999999998543211000
Q ss_pred CCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhh-hHHHhhc-cccCC
Q 035930 690 SPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET-LSNVVSQ-SLRFP 767 (857)
Q Consensus 690 ~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~-l~~Iv~~-~~~~p 767 (857)
............||+.|+|||++.+..++.++|||||||+||||++|+.||.+...... +...... ...++
T Consensus 210 -------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 282 (345)
T 2v62_A 210 -------KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELP 282 (345)
T ss_dssp -------CCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTT
T ss_pred -------ccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhccccc
Confidence 00001112345799999999999999999999999999999999999999965332222 2111111 11111
Q ss_pred C-------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 768 G-------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 768 ~-------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
. ...++.++.+||..||..||.+||+ +.+|++
T Consensus 283 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~ 321 (345)
T 2v62_A 283 QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPN----YQALKK 321 (345)
T ss_dssp HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCC----HHHHHH
T ss_pred HHHHhhccccccHHHHHHHHHHHhhcCcccCCC----HHHHHH
Confidence 1 1268999999999999999999999 666654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=387.88 Aligned_cols=275 Identities=19% Similarity=0.260 Sum_probs=217.8
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCC-CCccccceeeeeCCeEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH-PFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~H-PnIV~L~~~f~~~~~l~ 546 (857)
..++|+++++||+|+||+||+|.+..+++.||||++.... ....+.+|+++++.|.| ++|+.+..++...+..|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-----SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 3478999999999999999999999999999999986542 23457899999999986 56666677777888999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE---ccCCcEEEecccchhhcc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV---REDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL---~~dg~iKL~DFGLA~r~~ 623 (857)
|||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.+.
T Consensus 80 lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 999999 999999987643 349999999999999999999999999999999999999 688999999999986432
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
...... ......
T Consensus 158 ~~~~~~--------------------------------------------------------------------~~~~~~ 169 (483)
T 3sv0_A 158 DTSTHQ--------------------------------------------------------------------HIPYRE 169 (483)
T ss_dssp CTTTCC--------------------------------------------------------------------BCCCCC
T ss_pred CCcccc--------------------------------------------------------------------cccccc
Confidence 110000 000011
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh---hhhHHHhhccccCC---CCCCCCHHHH
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND---ETLSNVVSQSLRFP---GYPVVSFHAR 777 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~---e~l~~Iv~~~~~~p---~~~~is~~l~ 777 (857)
....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.... +.+..+........ ....++.++.
T Consensus 170 ~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~ 249 (483)
T 3sv0_A 170 NKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFA 249 (483)
T ss_dssp CCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHH
T ss_pred ccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHH
Confidence 23567999999999999999999999999999999999999999886543 23333333222211 1145789999
Q ss_pred HHHHhhccCCcCCcCCchhh------HHHHHcCCCCCCCChhhhcc
Q 035930 778 DLIRGLLVKEPDNRLGAVKG------AAEIKQHPFFEGLNWALIRC 817 (857)
Q Consensus 778 dLI~k~L~~DPe~Rpt~~~~------a~ELL~HPfF~~l~w~li~~ 817 (857)
+||..||..||++||++... +.+.+.++|+..++|..++.
T Consensus 250 ~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~ 295 (483)
T 3sv0_A 250 SYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (483)
T ss_dssp HHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhcc
Confidence 99999999999999995321 22224589999999998853
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=367.37 Aligned_cols=256 Identities=22% Similarity=0.279 Sum_probs=208.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEE----cCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAEL----IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~----~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
+..+.|++++.||+|+||+||++.+ ..+++.||||+++... .......+.+|+++|+.++||||+++++++.+.
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 3444569999999999999988865 3578999999997652 234456789999999999999999999999874
Q ss_pred --CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 543 --KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 543 --~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
..+|+||||+++++|.+++.... +++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred CCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 68899999999999999987653 8999999999999999999999999999999999999999999999999985
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
........
T Consensus 183 ~~~~~~~~------------------------------------------------------------------------ 190 (318)
T 3lxp_A 183 AVPEGHEY------------------------------------------------------------------------ 190 (318)
T ss_dssp ECCTTCSE------------------------------------------------------------------------
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 42110000
Q ss_pred CCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh--------------hhhHHHhhccccC
Q 035930 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND--------------ETLSNVVSQSLRF 766 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~--------------e~l~~Iv~~~~~~ 766 (857)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+...+......
T Consensus 191 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (318)
T 3lxp_A 191 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL 270 (318)
T ss_dssp EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCC
T ss_pred cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCC
Confidence 00112345888999999999999999999999999999999999999753211 1123334455566
Q ss_pred CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 767 PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 767 p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+....++.++.+||.+||..||.+||+ +.+|++
T Consensus 271 ~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~ 303 (318)
T 3lxp_A 271 PRPDKCPAEVYHLMKNCWETEASFRPT----FENLIP 303 (318)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 666779999999999999999999999 777764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=365.80 Aligned_cols=264 Identities=24% Similarity=0.338 Sum_probs=190.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeee-----
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFT----- 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~----- 540 (857)
+...+|++.+.||+|+||+||+|++..+++.||||++.... ......+.+|+.+|+.+. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 55568999999999999999999999999999999985442 233456789999999996 999999999983
Q ss_pred ---eCCeEEEEEeecCCCChHHHHhh-CCCCCCcHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEccCCcEEEe
Q 035930 541 ---TEKFSCLVMEYCPGGDLHVLRQK-QPSRFFSEQAARFYVAEVLLALEYLHMLG--VVYRDLKPENILVREDGHIMLS 614 (857)
Q Consensus 541 ---~~~~l~LVmEy~~gGsL~~ll~~-~~~~~l~e~~~r~i~~QIl~gL~yLHs~G--IIHRDLKPeNILL~~dg~iKL~ 614 (857)
....+|+||||+ +|+|.+++.. .....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 102 SDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp STTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 445689999999 5788777654 22235999999999999999999999999 9999999999999999999999
Q ss_pred cccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCc
Q 035930 615 DFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQ 694 (857)
Q Consensus 615 DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~ 694 (857)
|||++.......... +. ...
T Consensus 181 Dfg~~~~~~~~~~~~-------------------------------------~~-------~~~---------------- 200 (337)
T 3ll6_A 181 DFGSATTISHYPDYS-------------------------------------WS-------AQR---------------- 200 (337)
T ss_dssp CCTTCBCCSSCC--------------------------------------------------------------------
T ss_pred cCccceeccccCccc-------------------------------------cc-------ccc----------------
Confidence 999985432111000 00 000
Q ss_pred ccccCCCCccccccCCCCccChhhh---cCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCC
Q 035930 695 LVVEPTGARSNSFVGTHEYLAPEII---KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPV 771 (857)
Q Consensus 695 l~~~~~~~~~~s~vGT~~YmAPEil---~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~ 771 (857)
..........+||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+..... ++.....++....
T Consensus 201 ---~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~ 273 (337)
T 3ll6_A 201 ---RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----IVNGKYSIPPHDT 273 (337)
T ss_dssp --------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------CCCCTTCC
T ss_pred ---cccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----hhcCcccCCcccc
Confidence 0000112245699999999999 56778999999999999999999999997654433 3344455555667
Q ss_pred CCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCC
Q 035930 772 VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHP 805 (857)
Q Consensus 772 is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HP 805 (857)
.+..+.+||.+||..||.+||+ +.++++|-
T Consensus 274 ~~~~~~~li~~~l~~~p~~Rps----~~e~l~~l 303 (337)
T 3ll6_A 274 QYTVFHSLIRAMLQVNPEERLS----IAEVVHQL 303 (337)
T ss_dssp SSGGGHHHHHHHSCSSGGGSCC----HHHHHHHH
T ss_pred cchHHHHHHHHHccCChhhCcC----HHHHHHHH
Confidence 8899999999999999999999 88888763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=395.22 Aligned_cols=254 Identities=26% Similarity=0.337 Sum_probs=213.8
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
+.+..++|++.+.||+|+||+||+|.+.. +..||||+++... ...+.+.+|+++|+.|+||||+++++++.+ +.
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 34667889999999999999999999975 4679999997642 234678999999999999999999999876 67
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+||||||+.+|+|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 89999999999999998754334589999999999999999999999999999999999999999999999999843210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
... ...
T Consensus 416 ~~~--------------------------------------------------------------------------~~~ 421 (535)
T 2h8h_A 416 NEY--------------------------------------------------------------------------TAR 421 (535)
T ss_dssp HHH--------------------------------------------------------------------------HTT
T ss_pred Cce--------------------------------------------------------------------------ecc
Confidence 000 001
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhh
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~ 783 (857)
....+|..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+. ...+.+....++..+.+||.+|
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~c 500 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQC 500 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHH
Confidence 12346788999999999999999999999999999999 999999887777766654 4455565677999999999999
Q ss_pred ccCCcCCcCCchhhHHHHHc
Q 035930 784 LVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~ 803 (857)
|..||++||+ +++|++
T Consensus 501 l~~dP~~RPt----~~~l~~ 516 (535)
T 2h8h_A 501 WRKEPEERPT----FEYLQA 516 (535)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred cCCChhHCcC----HHHHHH
Confidence 9999999999 666664
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=370.50 Aligned_cols=254 Identities=21% Similarity=0.302 Sum_probs=201.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCC--------CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccc------
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGT--------SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPT------ 534 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~t--------g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~------ 534 (857)
.++|.+.+.||+|+||+||+|++..+ ++.||||++... ..+.+|+++|+.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 36899999999999999999999874 789999998653 35789999999999999887
Q ss_pred ---------cceeeee-CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 035930 535 ---------LFAHFTT-EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604 (857)
Q Consensus 535 ---------L~~~f~~-~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNIL 604 (857)
+++++.. ++..||||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5666665 67899999999 999999998764455999999999999999999999999999999999999
Q ss_pred EccCC--cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhh
Q 035930 605 VREDG--HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIK 682 (857)
Q Consensus 605 L~~dg--~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~ 682 (857)
++.++ .+||+|||++..+......
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~------------------------------------------------------ 217 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKH------------------------------------------------------ 217 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCC------------------------------------------------------
T ss_pred EcCCCCceEEEecCcceeeccCCCcc------------------------------------------------------
Confidence 99998 8999999998543211000
Q ss_pred hhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC-ChhhhHHHhh
Q 035930 683 SDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG-NDETLSNVVS 761 (857)
Q Consensus 683 ~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~-~~e~l~~Iv~ 761 (857)
............||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ..+.+.....
T Consensus 218 --------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 283 (352)
T 2jii_A 218 --------------VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQ 283 (352)
T ss_dssp --------------CCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHH
T ss_pred --------------ccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHH
Confidence 0000111234579999999999999999999999999999999999999998764 3333322222
Q ss_pred ----ccccCCC----CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 762 ----QSLRFPG----YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 762 ----~~~~~p~----~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
....++. +..++..+.+||.+||..||.+||+ +.+|++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~ 329 (352)
T 2jii_A 284 KFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPP----YAMLRN 329 (352)
T ss_dssp HHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCC----HHHHHH
T ss_pred hccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCC----HHHHHH
Confidence 1111111 1246899999999999999999999 555543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=376.39 Aligned_cols=255 Identities=18% Similarity=0.250 Sum_probs=202.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCC---CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeee-eCCeE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGT---SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFT-TEKFS 545 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~t---g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~-~~~~l 545 (857)
..|.+.+.||+|+||+||+|.+..+ +..||||+++.. ........+.+|+.+|+.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 3588999999999999999988643 356899998653 23345567899999999999999999999865 45688
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999987653 34899999999999999999999999999999999999999999999999998542110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
... ......
T Consensus 246 ~~~-----------------------------------------------------------------------~~~~~~ 254 (373)
T 3c1x_A 246 EFD-----------------------------------------------------------------------SVHNKT 254 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------cccccC
Confidence 000 000112
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhc
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLL 784 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L 784 (857)
...||+.|+|||++.+..++.++|||||||+||||++ |..||.+.+..+....+.... +...+..++..+.+||.+||
T Consensus 255 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~~~~p~~~~~~l~~li~~cl 333 (373)
T 3c1x_A 255 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCW 333 (373)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-CCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHc
Confidence 3357889999999999999999999999999999999 788888877766666555443 34444668999999999999
Q ss_pred cCCcCCcCCchhhHHHHHc
Q 035930 785 VKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~ 803 (857)
..||++||+ +.++++
T Consensus 334 ~~dp~~RPs----~~ell~ 348 (373)
T 3c1x_A 334 HPKAEMRPS----FSELVS 348 (373)
T ss_dssp CSSGGGSCC----HHHHHH
T ss_pred CCChhhCcC----HHHHHH
Confidence 999999999 666665
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=382.31 Aligned_cols=256 Identities=26% Similarity=0.351 Sum_probs=196.2
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~LV 548 (857)
+.|.+.+.||+|+||+||.+. ..+|+.||||++..+ ..+.+.+|+++|+.+ +||||+++++++.+++.+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 457778999999999998764 457899999998654 234578899999876 899999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCC-----CcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC-------------Cc
Q 035930 549 MEYCPGGDLHVLRQKQPSRF-----FSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED-------------GH 610 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~-----l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d-------------g~ 610 (857)
||||. |+|.+++....... .++..++.++.||+.||+|||++|||||||||+|||++.+ ++
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 69999987653211 1333457799999999999999999999999999999754 48
Q ss_pred EEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccC
Q 035930 611 IMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVS 690 (857)
Q Consensus 611 iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~ 690 (857)
+||+|||++........
T Consensus 167 ~kL~DFG~a~~~~~~~~--------------------------------------------------------------- 183 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQS--------------------------------------------------------------- 183 (434)
T ss_dssp EEECCCTTCEECCC------------------------------------------------------------------
T ss_pred EEEcccccceecCCCCc---------------------------------------------------------------
Confidence 99999999854211000
Q ss_pred CCCcccccCCCCccccccCCCCccChhhhcC-------CCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhc
Q 035930 691 PMPQLVVEPTGARSNSFVGTHEYLAPEIIKG-------EGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQ 762 (857)
Q Consensus 691 ~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g-------~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~ 762 (857)
.........+||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+ ..++..
T Consensus 184 --------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~ 253 (434)
T 2rio_A 184 --------SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRG 253 (434)
T ss_dssp -------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHT
T ss_pred --------cceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcC
Confidence 00001124569999999999976 568999999999999999998 999997654333 344444
Q ss_pred cccCCCCC-----CCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 763 SLRFPGYP-----VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 763 ~~~~p~~~-----~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
...++... .++.++++||.+||..||.+||+ +.+|++||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~eil~hp~f~~~ 302 (434)
T 2rio_A 254 IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT----AMKVLRHPLFWPK 302 (434)
T ss_dssp CCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSCH
T ss_pred CCCcccccccccccchHHHHHHHHHHhhCChhhCCC----HHHHHhCCccCCc
Confidence 44443322 24578999999999999999999 9999999999764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=360.21 Aligned_cols=233 Identities=29% Similarity=0.472 Sum_probs=192.1
Q ss_pred CCCeEEE-eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHH-HHcCCCCccccceeeee----C
Q 035930 469 MRHFKLH-KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM-QMLDHPFLPTLFAHFTT----E 542 (857)
Q Consensus 469 ~~~Y~i~-~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieIL-r~L~HPnIV~L~~~f~~----~ 542 (857)
..+|.+. +.||+|+||+||+|.+..+++.||||++... ..+.+|++++ +.++||||++++++|.. +
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 3567777 7899999999999999999999999998542 3567888888 66789999999999987 6
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc---CCcEEEecccch
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE---DGHIMLSDFDLS 619 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~---dg~iKL~DFGLA 619 (857)
..+||||||+++|+|..++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 78999999999999999998876556999999999999999999999999999999999999998 789999999986
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
...
T Consensus 168 ~~~----------------------------------------------------------------------------- 170 (299)
T 3m2w_A 168 KET----------------------------------------------------------------------------- 170 (299)
T ss_dssp EEC-----------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 320
Q ss_pred CCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHH----HhhccccCCC--CCCCC
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN----VVSQSLRFPG--YPVVS 773 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~----Iv~~~~~~p~--~~~is 773 (857)
.+..++.++|||||||+||||++|+.||.+......... +......++. ...++
T Consensus 171 --------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (299)
T 3m2w_A 171 --------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 230 (299)
T ss_dssp --------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSC
T ss_pred --------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCC
Confidence 013367789999999999999999999987654333211 1112222221 14689
Q ss_pred HHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 774 FHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.++++||.+||..||.+||+ +.|+++||||.+.
T Consensus 231 ~~~~~li~~~l~~dP~~Rps----~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 231 EEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQS 263 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHTG
T ss_pred HHHHHHHHHHcccChhhCCC----HHHHhcChhhccc
Confidence 99999999999999999999 9999999999764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=394.21 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=208.8
Q ss_pred ccCCCeEEEe-EEccCCceEEEEEEEc--CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHK-KLGCGDIGTVYLAELI--GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~-~LG~G~fGtVyla~~~--~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
+...+|.+.. .||+|+||+||+|.+. .++..||||+++.. ......+.+.+|+++|+.++||||++++++|.. +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC--CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC--CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 4445677776 8999999999999876 45678999999765 233456788999999999999999999999976 5
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
.+||||||+++|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 6899999999999999887543 349999999999999999999999999999999999999999999999999985421
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
..... ...
T Consensus 488 ~~~~~------------------------------------------------------------------------~~~ 495 (613)
T 2ozo_A 488 ADDSY------------------------------------------------------------------------YTA 495 (613)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCCce------------------------------------------------------------------------eee
Confidence 10000 000
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+..+ .+.+.+..+++++.+||..
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~ 574 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPELYALMSD 574 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-CCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHH
Confidence 012236789999999999999999999999999999998 99999998888777666543 3445556799999999999
Q ss_pred hccCCcCCcCCchhhHHHHH
Q 035930 783 LLVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL 802 (857)
||..||++||+ +.+|+
T Consensus 575 cl~~dP~~RPs----~~~l~ 590 (613)
T 2ozo_A 575 CWIYKWEDRPD----FLTVE 590 (613)
T ss_dssp TTCSSTTTSCC----HHHHH
T ss_pred HcCCChhHCcC----HHHHH
Confidence 99999999999 55553
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=384.67 Aligned_cols=256 Identities=17% Similarity=0.170 Sum_probs=202.3
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCC-CCccccc----------
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH-PFLPTLF---------- 536 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~H-PnIV~L~---------- 536 (857)
..+.|.+.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+.| +|+..++
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34569999999999999999999999999999999985544445567788999999999987 3222111
Q ss_pred -----------eeeee-----CCeEEEEEeecCCCChHHHHh-----hCCCCCCcHHHHHHHHHHHHHHHHHHHHcCcee
Q 035930 537 -----------AHFTT-----EKFSCLVMEYCPGGDLHVLRQ-----KQPSRFFSEQAARFYVAEVLLALEYLHMLGVVY 595 (857)
Q Consensus 537 -----------~~f~~-----~~~l~LVmEy~~gGsL~~ll~-----~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIH 595 (857)
.++.. ...+|++|+++ +++|.+++. ......+++..+..++.||+.||+|||++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 11111 12467888877 789988874 222345788899999999999999999999999
Q ss_pred ccCCCCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHH
Q 035930 596 RDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVA 675 (857)
Q Consensus 596 RDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~ 675 (857)
|||||+||||+.+|.+||+|||+++...
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~---------------------------------------------------- 262 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDG---------------------------------------------------- 262 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETT----------------------------------------------------
T ss_pred CCcccceEEEecCCeEEEEeccceeecC----------------------------------------------------
Confidence 9999999999999999999999974310
Q ss_pred HhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhh----------cCCCCCcccceehhhHHHHHHhhCCC
Q 035930 676 AKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEII----------KGEGHGSSVDWWTFGIFLFELLYGRT 745 (857)
Q Consensus 676 ~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil----------~g~~~s~ksDVWSLGvILyELLtGk~ 745 (857)
......+| +.|||||++ .+..|+.++|||||||+||||++|+.
T Consensus 263 --------------------------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~ 315 (413)
T 3dzo_A 263 --------------------------ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315 (413)
T ss_dssp --------------------------EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSC
T ss_pred --------------------------CccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCC
Confidence 00224468 999999999 55568889999999999999999999
Q ss_pred CCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 746 PFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 746 PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
||.+.+..+.+..++. ....++.++.+||.+||..||++||+ +.++++||||+.+...
T Consensus 316 Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~~l~~~~~~~~~~~ 373 (413)
T 3dzo_A 316 PNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLRTE 373 (413)
T ss_dssp CCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHHHH
T ss_pred CCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcC----HHHHHhCHHHHHHHHH
Confidence 9988766555544433 23458899999999999999999999 9999999999987554
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.44 Aligned_cols=260 Identities=17% Similarity=0.244 Sum_probs=210.3
Q ss_pred cccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 464 HGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 464 ~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
.+.+..++|++.+.||+|+||+||+|.+.+. ||+|+++.... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~---~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESSS---EEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcCe---EEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 3446778999999999999999999998653 99999876432 2334456778999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
.+|+||||+++++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.++|+|||++....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999999999987654 3489999999999999999999999999999999999998 7899999999874321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.... ......
T Consensus 181 ~~~~----------------------------------------------------------------------~~~~~~ 190 (319)
T 2y4i_B 181 VLQA----------------------------------------------------------------------GRREDK 190 (319)
T ss_dssp -----------------------------------------------------------------------------CCS
T ss_pred cccc----------------------------------------------------------------------cccccc
Confidence 0000 000111
Q ss_pred cccccCCCCccChhhhcC---------CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCH
Q 035930 704 SNSFVGTHEYLAPEIIKG---------EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSF 774 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g---------~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~ 774 (857)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..+............++.
T Consensus 191 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (319)
T 2y4i_B 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270 (319)
T ss_dssp CBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCT
T ss_pred cccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCH
Confidence 223468999999999975 45788999999999999999999999988777776666555444444446889
Q ss_pred HHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 775 HARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 775 ~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
++.+||.+||..||.+||+ +.++++
T Consensus 271 ~l~~li~~~l~~~p~~Rpt----~~~l~~ 295 (319)
T 2y4i_B 271 EISDILLFCWAFEQEERPT----FTKLMD 295 (319)
T ss_dssp THHHHHHHHHCSSTTTSCC----HHHHHH
T ss_pred HHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 9999999999999999999 777765
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=359.41 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=195.2
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHc--CCCCccccceeeeeC----
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML--DHPFLPTLFAHFTTE---- 542 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L--~HPnIV~L~~~f~~~---- 542 (857)
.++|++.+.||+|+||+||+|++. ++.||||++... ......+|.+++..+ +||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 368999999999999999999885 889999998543 223445666666554 899999999999887
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHc--------CceeccCCCCcEEEccCCcEEEe
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML--------GVVYRDLKPENILVREDGHIMLS 614 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~--------GIIHRDLKPeNILL~~dg~iKL~ 614 (857)
..+||||||+++|+|.+++... .+++..++.++.||+.||+|||++ |||||||||+|||++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999765 389999999999999999999998 99999999999999999999999
Q ss_pred cccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCc
Q 035930 615 DFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQ 694 (857)
Q Consensus 615 DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~ 694 (857)
|||++..+......
T Consensus 185 Dfg~a~~~~~~~~~------------------------------------------------------------------ 198 (337)
T 3mdy_A 185 DLGLAVKFISDTNE------------------------------------------------------------------ 198 (337)
T ss_dssp CCTTCEECC-----------------------------------------------------------------------
T ss_pred eCCCceeecccccc------------------------------------------------------------------
Confidence 99998542111000
Q ss_pred ccccCCCCccccccCCCCccChhhhcCCCCCcc------cceehhhHHHHHHhhC----------CCCCCCCCCh----h
Q 035930 695 LVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSS------VDWWTFGIFLFELLYG----------RTPFKGSGND----E 754 (857)
Q Consensus 695 l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~k------sDVWSLGvILyELLtG----------k~PF~g~~~~----e 754 (857)
........+||+.|+|||++.+..++.. +|||||||++|||++| ..||...... .
T Consensus 199 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 273 (337)
T 3mdy_A 199 -----VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273 (337)
T ss_dssp ---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred -----ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchh
Confidence 0001124579999999999998877665 9999999999999999 7777654322 1
Q ss_pred hhHHHhh-ccccCCCC-----CCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 755 TLSNVVS-QSLRFPGY-----PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 755 ~l~~Iv~-~~~~~p~~-----~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
.+...+. ...+.... ..++.++.+||.+||..||.+||+ +.+|++|
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 325 (337)
T 3mdy_A 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT----ALRVKKT 325 (337)
T ss_dssp HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred hhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC----HHHHHHH
Confidence 2222222 22222111 235567999999999999999999 7777764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=363.02 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=189.2
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHH--HHcCCCCccccceeee----
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM--QMLDHPFLPTLFAHFT---- 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieIL--r~L~HPnIV~L~~~f~---- 540 (857)
+..++|++++.||+|+||+||+|++ +++.||||++... ....+..|.+++ ..++||||+++++++.
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA------NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc------chhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 5678999999999999999999977 6789999998643 223344555554 4589999999998553
Q ss_pred -eCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHc---------CceeccCCCCcEEEccCCc
Q 035930 541 -TEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML---------GVVYRDLKPENILVREDGH 610 (857)
Q Consensus 541 -~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~---------GIIHRDLKPeNILL~~dg~ 610 (857)
....+||||||+++|+|.+++.... +++..++.++.||+.||.|||+. |||||||||+||||+.++.
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred CCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 2347799999999999999997654 68899999999999999999999 9999999999999999999
Q ss_pred EEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccC
Q 035930 611 IMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVS 690 (857)
Q Consensus 611 iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~ 690 (857)
+||+|||++..+........
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~------------------------------------------------------------ 178 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRP------------------------------------------------------------ 178 (336)
T ss_dssp EEECCCTTCEECSSSSCC--------------------------------------------------------------
T ss_pred EEEeeccceeecccccccCc------------------------------------------------------------
Confidence 99999999865321110000
Q ss_pred CCCcccccCCCCccccccCCCCccChhhhcC-------CCCCcccceehhhHHHHHHhhCCCCCCCCCChh---------
Q 035930 691 PMPQLVVEPTGARSNSFVGTHEYLAPEIIKG-------EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE--------- 754 (857)
Q Consensus 691 ~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g-------~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e--------- 754 (857)
..........+||+.|+|||++.+ ..++.++|||||||+||||++|..||.......
T Consensus 179 -------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 251 (336)
T 3g2f_A 179 -------GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTE 251 (336)
T ss_dssp --------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHH
T ss_pred -------cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcc
Confidence 000111234579999999999987 456779999999999999999977765432211
Q ss_pred --------hhHHHhhccccCCC-C------CCCCHHHHHHHHhhccCCcCCcCCchhhHHHHH
Q 035930 755 --------TLSNVVSQSLRFPG-Y------PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 755 --------~l~~Iv~~~~~~p~-~------~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL 802 (857)
.+...+......+. . ..++..+.+||.+||..||++||+ +.|++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~e~l 310 (336)
T 3g2f_A 252 VGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT----AQXAE 310 (336)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCC----HHHHH
T ss_pred cCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcc----hHHHH
Confidence 11111111111111 1 123447999999999999999999 66663
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=361.70 Aligned_cols=258 Identities=21% Similarity=0.282 Sum_probs=208.8
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEE----cCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAEL----IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~----~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
.+..++|++++.||+|+||+||+|++ ..+++.||||++... .......+.+|+++|+.++||||+++++++..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 35567899999999999999999984 568999999999754 23445678899999999999999999999876
Q ss_pred CC--eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 542 EK--FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 542 ~~--~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
.+ .+|+||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 54 78999999999999999987643 4899999999999999999999999999999999999999999999999998
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
..........
T Consensus 193 ~~~~~~~~~~---------------------------------------------------------------------- 202 (326)
T 2w1i_A 193 KVLPQDKEYY---------------------------------------------------------------------- 202 (326)
T ss_dssp EECCSSCSEE----------------------------------------------------------------------
T ss_pred hhcccccccc----------------------------------------------------------------------
Confidence 5421110000
Q ss_pred CCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCC----------Ch-h----hhHHHhhccc
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG----------ND-E----TLSNVVSQSL 764 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~----------~~-e----~l~~Iv~~~~ 764 (857)
.......+|..|+|||++.+..++.++|||||||++|||++|..||.... .. . .+...+....
T Consensus 203 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (326)
T 2w1i_A 203 --KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280 (326)
T ss_dssp --ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC
T ss_pred --ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCC
Confidence 00112347888999999999999999999999999999999999986421 00 1 1223333444
Q ss_pred cCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 765 RFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 765 ~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+++....++.++.+||.+||..||.+||+ +.+|++
T Consensus 281 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~el~~ 315 (326)
T 2w1i_A 281 RLPRPDGCPDEIYMIMTECWNNNVNQRPS----FRDLAL 315 (326)
T ss_dssp CCCCCTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHH
T ss_pred CCCCCCcccHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 55556779999999999999999999999 667664
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=394.52 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=205.8
Q ss_pred CCeEEE-eEEccCCceEEEEEEE--cCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 470 RHFKLH-KKLGCGDIGTVYLAEL--IGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 470 ~~Y~i~-~~LG~G~fGtVyla~~--~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
..+.+. +.||+|+||+||+|.+ ..+++.||||+++... ......+.+.+|+++|+.++||||++++++|.. +..|
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence 344443 4899999999999965 4567899999997653 223445678999999999999999999999965 4578
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
|||||+++|+|.+++.... .+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+....
T Consensus 446 lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred EEEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 9999999999999997653 48999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.. ......
T Consensus 524 ~~------------------------------------------------------------------------~~~~~~ 531 (635)
T 4fl3_A 524 NY------------------------------------------------------------------------YKAQTH 531 (635)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------cccccC
Confidence 00 000112
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhcc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLV 785 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~ 785 (857)
..||+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+.. ..+.+....++.++.+||..||.
T Consensus 532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~ 610 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDLMNLCWT 610 (635)
T ss_dssp ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcC
Confidence 347889999999999999999999999999999998 9999999877776665544 34445556799999999999999
Q ss_pred CCcCCcCCchhhHHHHHc
Q 035930 786 KEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~ 803 (857)
.||++||+ +++|++
T Consensus 611 ~dP~~RPs----~~~l~~ 624 (635)
T 4fl3_A 611 YDVENRPG----FAAVEL 624 (635)
T ss_dssp SSTTTSCC----HHHHHH
T ss_pred CCHhHCcC----HHHHHH
Confidence 99999999 666553
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=356.95 Aligned_cols=252 Identities=21% Similarity=0.253 Sum_probs=200.8
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccc-ccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFL-VGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~-~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
|..++.||+|+||+||+|.+ ++..||||++..... ........+.+|+.+|+.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 45568999999999999986 577899999875432 223345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCC-CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 551 YCPGGDLHVLRQKQP-SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 551 y~~gGsL~~ll~~~~-~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--- 187 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--- 187 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS---
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc---
Confidence 999999998886432 2358999999999999999999999999999999999999999999999999874321000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.........|
T Consensus 188 ----------------------------------------------------------------------~~~~~~~~~g 197 (307)
T 2nru_A 188 ----------------------------------------------------------------------QTVMTSRIVG 197 (307)
T ss_dssp ----------------------------------------------------------------------SCEECSSCCS
T ss_pred ----------------------------------------------------------------------ccccccccCC
Confidence 0001123469
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc------------C-CCCCCCCHHH
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR------------F-PGYPVVSFHA 776 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~------------~-p~~~~is~~l 776 (857)
|+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+...... + ......+..+
T Consensus 198 ~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 276 (307)
T 2nru_A 198 TTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM 276 (307)
T ss_dssp CGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHH
T ss_pred CcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHH
Confidence 999999999876 4889999999999999999999999877655444333221100 0 1112345678
Q ss_pred HHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 777 RDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 777 ~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.+||.+||..||.+||+ +.+|++
T Consensus 277 ~~li~~cl~~~p~~Rps----~~~l~~ 299 (307)
T 2nru_A 277 YSVASQCLHEKKNKRPD----IKKVQQ 299 (307)
T ss_dssp HHHHHHHTCSSTTTSCC----HHHHHH
T ss_pred HHHHHHHcCCCcccCcC----HHHHHH
Confidence 99999999999999999 777765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=374.67 Aligned_cols=246 Identities=17% Similarity=0.220 Sum_probs=192.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc-----cccchhHHHHHHHHHHHcC-------------
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV-----GRKKMPRAQTEREIMQMLD------------- 528 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~-----~~~~~~~~~~EieILr~L~------------- 528 (857)
+..++|++++.||+|+||+||+|++ +++.||||++...... .......+.+|+.+|+.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3456799999999999999999998 6799999999865321 2334477899999999886
Q ss_pred -------------CCCccccceeeee-------------CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHH
Q 035930 529 -------------HPFLPTLFAHFTT-------------EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVL 582 (857)
Q Consensus 529 -------------HPnIV~L~~~f~~-------------~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl 582 (857)
||||++++++|.+ ++.+||||||+++|++...+.+ ..+++..++.++.||+
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLT 171 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHH
Confidence 5555566666554 7899999999999976555433 3489999999999999
Q ss_pred HHHHHHH-HcCceeccCCCCcEEEccCC--------------------cEEEecccchhhcccCcccccCCCCCCCCCCC
Q 035930 583 LALEYLH-MLGVVYRDLKPENILVREDG--------------------HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPK 641 (857)
Q Consensus 583 ~gL~yLH-s~GIIHRDLKPeNILL~~dg--------------------~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~ 641 (857)
.||+||| ++|||||||||+||||+.++ .+||+|||+|+...
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~------------------ 233 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER------------------ 233 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE------------------
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC------------------
Confidence 9999999 99999999999999999887 89999999984311
Q ss_pred CCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcC
Q 035930 642 KASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKG 721 (857)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g 721 (857)
....+||+.|||||++.+
T Consensus 234 --------------------------------------------------------------~~~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 234 --------------------------------------------------------------DGIVVFCDVSMDEDLFTG 251 (336)
T ss_dssp --------------------------------------------------------------TTEEECCCCTTCSGGGCC
T ss_pred --------------------------------------------------------------CCcEEEeecccChhhhcC
Confidence 012369999999999998
Q ss_pred CCCCcccceehhhHH-HHHHhhCCCCCCCCCC-hhhhHHHhhccccCCC------CCCCCHHHHHHHHhhccCCcCCcCC
Q 035930 722 EGHGSSVDWWTFGIF-LFELLYGRTPFKGSGN-DETLSNVVSQSLRFPG------YPVVSFHARDLIRGLLVKEPDNRLG 793 (857)
Q Consensus 722 ~~~s~ksDVWSLGvI-LyELLtGk~PF~g~~~-~e~l~~Iv~~~~~~p~------~~~is~~l~dLI~k~L~~DPe~Rpt 793 (857)
.. +.++||||||++ .++++.|..||.+... ......++.. ..+.. .+.+++++++||++||++| +
T Consensus 252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s 324 (336)
T 2vuw_A 252 DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQ-MTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S 324 (336)
T ss_dssp CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHT-CCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhh-hccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence 77 899999998777 7888899999954211 1122222211 11111 2246789999999999987 6
Q ss_pred chhhHHHHH-cCCCCC
Q 035930 794 AVKGAAEIK-QHPFFE 808 (857)
Q Consensus 794 ~~~~a~ELL-~HPfF~ 808 (857)
++|+| +||||+
T Consensus 325 ----a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 325 ----ATDLLCQHSLFK 336 (336)
T ss_dssp ----HHHHHHHCGGGC
T ss_pred ----HHHHHhcCCCcC
Confidence 99999 999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.93 Aligned_cols=250 Identities=23% Similarity=0.282 Sum_probs=198.8
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHH--cCCCCccccceeeeeCC---
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM--LDHPFLPTLFAHFTTEK--- 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~--L~HPnIV~L~~~f~~~~--- 543 (857)
.++|.+.+.||+|+||+||+|.+ +++.||||++... ....+.+|+++++. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 35799999999999999999998 5889999998643 23567889999988 78999999999998876
Q ss_pred -eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHH--------HcCceeccCCCCcEEEccCCcEEEe
Q 035930 544 -FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH--------MLGVVYRDLKPENILVREDGHIMLS 614 (857)
Q Consensus 544 -~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLH--------s~GIIHRDLKPeNILL~~dg~iKL~ 614 (857)
..|+||||+++|+|.+++... .+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred ceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 899999999999999999764 3899999999999999999999 8999999999999999999999999
Q ss_pred cccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCc
Q 035930 615 DFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQ 694 (857)
Q Consensus 615 DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~ 694 (857)
|||++.........
T Consensus 190 Dfg~~~~~~~~~~~------------------------------------------------------------------ 203 (342)
T 1b6c_B 190 DLGLAVRHDSATDT------------------------------------------------------------------ 203 (342)
T ss_dssp CCTTCEEEETTTTE------------------------------------------------------------------
T ss_pred ECCCceeccccccc------------------------------------------------------------------
Confidence 99998542211000
Q ss_pred ccccCCCCccccccCCCCccChhhhcCCC------CCcccceehhhHHHHHHhhC----------CCCCCCCCC-----h
Q 035930 695 LVVEPTGARSNSFVGTHEYLAPEIIKGEG------HGSSVDWWTFGIFLFELLYG----------RTPFKGSGN-----D 753 (857)
Q Consensus 695 l~~~~~~~~~~s~vGT~~YmAPEil~g~~------~s~ksDVWSLGvILyELLtG----------k~PF~g~~~-----~ 753 (857)
.........||+.|+|||++.+.. ++.++|||||||+||||++| ..||..... .
T Consensus 204 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 278 (342)
T 1b6c_B 204 -----IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278 (342)
T ss_dssp -----EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred -----cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHH
Confidence 000123456999999999998763 34689999999999999999 789876532 2
Q ss_pred hhhHHHhhccccCCCC-----CCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 754 ETLSNVVSQSLRFPGY-----PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 754 e~l~~Iv~~~~~~p~~-----~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
.....+.....+.... ..++..+.+||.+||..||.+||+ +.+|++|
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~i~~~ 330 (342)
T 1b6c_B 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKKT 330 (342)
T ss_dssp HHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC----HHHHHHH
Confidence 2222233333322211 123457899999999999999999 7777764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=386.76 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=209.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC---CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG---TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~---tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
+..++|.+.+.||+|+||+||+|.+.. .+..||||++.... .....+.+.+|+.+|+.++||||+++++++. ++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 455789999999999999999999864 35689999986542 2334467889999999999999999999985 45
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..||||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred ceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 6899999999999999987654 248999999999999999999999999999999999999999999999999974321
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
... ...
T Consensus 543 ~~~--------------------------------------------------------------------------~~~ 548 (656)
T 2j0j_A 543 DST--------------------------------------------------------------------------YYK 548 (656)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred CCc--------------------------------------------------------------------------cee
Confidence 000 000
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....||+.|||||++.+..++.++|||||||+||||++ |..||.+....+.+..+... ...+.++.+++.+.+||.+
T Consensus 549 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~ 627 (656)
T 2j0j_A 549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMPPNCPPTLYSLMTK 627 (656)
T ss_dssp -----CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-CCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CCCCCCccccHHHHHHHHH
Confidence 112347889999999999999999999999999999997 99999988777777666554 3344456799999999999
Q ss_pred hccCCcCCcCCchhhHHHHHc
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||..||.+||+ +.+|++
T Consensus 628 ~l~~dP~~RPs----~~el~~ 644 (656)
T 2j0j_A 628 CWAYDPSRRPR----FTELKA 644 (656)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HcCCChhHCcC----HHHHHH
Confidence 99999999999 666664
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=346.27 Aligned_cols=226 Identities=17% Similarity=0.149 Sum_probs=188.7
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++.+.||+|+||+||+|++..+++.||||++.............+.+|+.+++.++||||+++++++.+++..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44578999999999999999999999999999999998765444445577899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
|||||++|++|.+++... .....+..++.||+.||+|||++||+||||||+|||++.+|.++|++++
T Consensus 108 lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999998643 3455678899999999999999999999999999999999999987554
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
T Consensus 175 -------------------------------------------------------------------------------- 174 (286)
T 3uqc_A 175 -------------------------------------------------------------------------------- 174 (286)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhH---HHhhccccCC--CCCCCCHHHHHHHH
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS---NVVSQSLRFP--GYPVVSFHARDLIR 781 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~---~Iv~~~~~~p--~~~~is~~l~dLI~ 781 (857)
|++ +++.++|||||||+||||++|+.||.+.+..+.+. ..+......+ ..+.++.++.+||.
T Consensus 175 ------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 241 (286)
T 3uqc_A 175 ------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241 (286)
T ss_dssp ------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHH
T ss_pred ------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHH
Confidence 222 26889999999999999999999999876544332 1122221111 13568999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHc
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+||..||.+| + +.++++
T Consensus 242 ~~l~~dP~~R-s----~~el~~ 258 (286)
T 3uqc_A 242 RSVQGDGGIR-S----ASTLLN 258 (286)
T ss_dssp HHHCTTSSCC-C----HHHHHH
T ss_pred HHcccCCccC-C----HHHHHH
Confidence 9999999999 8 666664
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=397.73 Aligned_cols=263 Identities=25% Similarity=0.385 Sum_probs=208.1
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee------C
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT------E 542 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~------~ 542 (857)
.++|++.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+++|+.++||||+++++++.. +
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 368999999999999999999999999999999987642 23345678899999999999999999998765 6
Q ss_pred CeEEEEEeecCCCChHHHHhhCCC-CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCc---EEEecccc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPS-RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGH---IMLSDFDL 618 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~-~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~---iKL~DFGL 618 (857)
+..|+||||++||+|..++..... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++. ++|+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 788999999999999999876432 25899999999999999999999999999999999999997765 99999998
Q ss_pred hhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCccccc
Q 035930 619 SLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVE 698 (857)
Q Consensus 619 A~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~ 698 (857)
+.....
T Consensus 171 a~~~~~-------------------------------------------------------------------------- 176 (676)
T 3qa8_A 171 AKELDQ-------------------------------------------------------------------------- 176 (676)
T ss_dssp CCBTTS--------------------------------------------------------------------------
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 743110
Q ss_pred CCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhh--------------HHHhhccc
Q 035930 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL--------------SNVVSQSL 764 (857)
Q Consensus 699 ~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l--------------~~Iv~~~~ 764 (857)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+......+ .....+..
T Consensus 177 --~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~ 254 (676)
T 3qa8_A 177 --GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254 (676)
T ss_dssp --CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSC
T ss_pred --ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcccc
Confidence 00112456999999999999999999999999999999999999999764222111 01111111
Q ss_pred cCCC--------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 765 RFPG--------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 765 ~~p~--------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
.+.. ...++..+.+||.+||..||++||+ +.++++||||..++--
T Consensus 255 ~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT----a~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 255 KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT----DPQNPNVGCFQALDSI 307 (676)
T ss_dssp CCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C----CTTCCCCTTHHHHHHH
T ss_pred ccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC----HHHHhcCHHHHHHHHH
Confidence 1211 1235678999999999999999999 8999999999986443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=383.55 Aligned_cols=244 Identities=25% Similarity=0.316 Sum_probs=197.5
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC-CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe-
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG-TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF- 544 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~-tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~- 544 (857)
+..++|++.+.||+|+||+||+|.+.. +++.||||++.... .......+.+|+++|+.++||||++++++|...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 445799999999999999999999976 78999999986532 22344567899999999999999999999987665
Q ss_pred ----EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 545 ----SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 545 ----l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
.||||||++|++|..++.. .+++..++.++.||+.||.|||++|||||||||+|||++.+ .+||+|||++.
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999887654 38999999999999999999999999999999999999875 99999999874
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
....
T Consensus 230 ~~~~---------------------------------------------------------------------------- 233 (681)
T 2pzi_A 230 RINS---------------------------------------------------------------------------- 233 (681)
T ss_dssp ETTC----------------------------------------------------------------------------
T ss_pred hccc----------------------------------------------------------------------------
Confidence 3100
Q ss_pred CCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHH
Q 035930 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLI 780 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI 780 (857)
....+||+.|+|||++.+. ++.++|||||||+||+|++|..||.+....... .......+++.+.+||
T Consensus 234 ---~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li 301 (681)
T 2pzi_A 234 ---FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP--------EDDPVLKTYDSYGRLL 301 (681)
T ss_dssp ---CSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC--------TTCHHHHHCHHHHHHH
T ss_pred ---CCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc--------ccccccccCHHHHHHH
Confidence 0234699999999999875 488999999999999999999998753211110 0000012467899999
Q ss_pred HhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
.+||..||.+||+ ..+.+.|+|+.-
T Consensus 302 ~~~l~~dP~~R~~----~~~~l~~~l~~~ 326 (681)
T 2pzi_A 302 RRAIDPDPRQRFT----TAEEMSAQLTGV 326 (681)
T ss_dssp HHHTCSSGGGSCS----SHHHHHHHHHHH
T ss_pred hhhccCChhhCCC----HHHHHHHHHHHH
Confidence 9999999999999 677777887753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=313.74 Aligned_cols=191 Identities=17% Similarity=0.137 Sum_probs=134.6
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEeccccccc-------ccchhHHHHHHHHHHHc-CCCCccccceeeeeCCeEEE
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG-------RKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~-------~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~~l~L 547 (857)
..++.|++|.+..++..-.|..||+|++.+..... ....+.+.+|+++|+++ .|+||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 46778888888888777788889999997653221 23345689999999999 69999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||++|++|.+++.... .+++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 320 VMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--- 391 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--- 391 (569)
T ss_dssp EEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC---
Confidence 999999999999998754 36654 4789999999999999999999999999999999999999999853210
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
......+.
T Consensus 392 ------------------------------------------------------------------------~~~~~~t~ 399 (569)
T 4azs_A 392 ------------------------------------------------------------------------DCSWPTNL 399 (569)
T ss_dssp --------------------------------------------------------------------------CCSHHH
T ss_pred ------------------------------------------------------------------------CCccccCc
Confidence 01112356
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPF 747 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF 747 (857)
+||+.|||||++.+. +..++|+|++|+++|+|+++..+|
T Consensus 400 vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 400 VQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred eechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 899999999999875 677899999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-27 Score=273.02 Aligned_cols=194 Identities=16% Similarity=0.161 Sum_probs=144.7
Q ss_pred EEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccc-----cccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLV-----GRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 473 ~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~-----~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
...+.||+|+||+||+|.. .+..+++|++...... .....+++.+|+++|+.++||||+.+..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 4567999999999999944 5677899986543221 11123457899999999999999977777777778899
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
||||++|++|.+++.. +..++.||+.||+|||++|||||||||+|||++. ++||+|||+++.....
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~-- 482 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD-- 482 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH--
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCc--
Confidence 9999999999998865 4678999999999999999999999999999998 9999999998542100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.... .+.. .....+
T Consensus 483 -----------------------------------------------~~~~----~~~~---------------~~~~~~ 496 (540)
T 3en9_A 483 -----------------------------------------------EDKA----VDLI---------------VFKKAV 496 (540)
T ss_dssp -----------------------------------------------HHHH----HHHH---------------HHHHHH
T ss_pred -----------------------------------------------cccc----cchh---------------hhhhhh
Confidence 0000 0000 011356
Q ss_pred cCCCCccChhhhcC--CCCCcccceehhhHHHHHHhhCCCCCC
Q 035930 708 VGTHEYLAPEIIKG--EGHGSSVDWWTFGIFLFELLYGRTPFK 748 (857)
Q Consensus 708 vGT~~YmAPEil~g--~~~s~ksDVWSLGvILyELLtGk~PF~ 748 (857)
+||+.|||||++.+ ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 497 ~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 497 LSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 79999999999987 678888999999999998888777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=232.13 Aligned_cols=137 Identities=18% Similarity=0.121 Sum_probs=111.7
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc---------------cchhHHHHHHHHHHHcCCCCc
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR---------------KKMPRAQTEREIMQMLDHPFL 532 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~---------------~~~~~~~~EieILr~L~HPnI 532 (857)
....|.+++.||+|+||.||+|.+ .+|+.||||+++....... .....+.+|+++|+.++ |
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~- 163 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G- 163 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred CCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence 345688999999999999999999 8899999999965322111 12345789999999999 5
Q ss_pred cccceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEE
Q 035930 533 PTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIM 612 (857)
Q Consensus 533 V~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iK 612 (857)
+++++++.. +..|+||||++|++|.. +.. .....++.||+.||.|||++|||||||||+|||++ +|.++
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence 777776654 45699999999999987 321 13457899999999999999999999999999999 99999
Q ss_pred Eecccch
Q 035930 613 LSDFDLS 619 (857)
Q Consensus 613 L~DFGLA 619 (857)
|+|||+|
T Consensus 233 l~DFG~a 239 (282)
T 1zar_A 233 IIDFPQS 239 (282)
T ss_dssp ECCCTTC
T ss_pred EEECCCC
Confidence 9999987
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=198.06 Aligned_cols=140 Identities=16% Similarity=0.143 Sum_probs=108.1
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeE--EEEEEecccccccc---------------------cchhHHHHHHHHHHHc
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCL--FALKVMDNDFLVGR---------------------KKMPRAQTEREIMQML 527 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~--VAVKvi~k~~~~~~---------------------~~~~~~~~EieILr~L 527 (857)
-|.+.+.||.|+||+||+|.+..+|.. ||||+++....... .....+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999999778888 99999764321100 0012578899999999
Q ss_pred CCCCc--cccceeeeeCCeEEEEEeecCC-C----ChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHH-HcCceeccCC
Q 035930 528 DHPFL--PTLFAHFTTEKFSCLVMEYCPG-G----DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH-MLGVVYRDLK 599 (857)
Q Consensus 528 ~HPnI--V~L~~~f~~~~~l~LVmEy~~g-G----sL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLH-s~GIIHRDLK 599 (857)
.|++| +.++++ +..||||||+.+ | .|..+... +++..+..++.||+.||.||| ++||||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 98865 333332 346899999932 3 66665432 235567889999999999999 9999999999
Q ss_pred CCcEEEccCCcEEEecccchhh
Q 035930 600 PENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 600 PeNILL~~dg~iKL~DFGLA~r 621 (857)
|+|||++. .++|+|||+|..
T Consensus 199 p~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEE
T ss_pred HHHEEEcC--cEEEEECccccc
Confidence 99999987 999999999853
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-17 Score=185.85 Aligned_cols=140 Identities=16% Similarity=0.171 Sum_probs=100.1
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc-----------cchh--------HHHHHHHHHHHcCCCC
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR-----------KKMP--------RAQTEREIMQMLDHPF 531 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~-----------~~~~--------~~~~EieILr~L~HPn 531 (857)
-|.++..||.|+||.||+|.+. +|+.||||+++......+ .... ....|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3999999999999999999884 689999999864321100 0000 1234666666665444
Q ss_pred ccccceeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC--
Q 035930 532 LPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG-- 609 (857)
Q Consensus 532 IV~L~~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg-- 609 (857)
+.-..-+.. .. .+|||||++|+.|..+.. ...+..++.||+.+|.|||++|||||||||.||||+++|
T Consensus 175 v~vp~p~~~-~~-~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQ-SR-HTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEE-ET-TEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeec-cC-ceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 332221212 22 279999999988865432 123456788999999999999999999999999998877
Q ss_pred --------cEEEecccchhh
Q 035930 610 --------HIMLSDFDLSLR 621 (857)
Q Consensus 610 --------~iKL~DFGLA~r 621 (857)
.+.|+||+.+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 389999998743
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=3.4e-12 Score=132.75 Aligned_cols=138 Identities=18% Similarity=0.161 Sum_probs=111.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LV 548 (857)
..|.+...++.|+++.||++... +..|+||+...... .....+.+|+++|+.|. +..++++++++.+.+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 46899999999999999999753 56899999865321 22345789999999995 67788999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-------------------------------------- 590 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-------------------------------------- 590 (857)
|||++|.+|..... +......++.++..+|..||.
T Consensus 89 ~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999999976521 112234677899999999998
Q ss_pred ---------------------cCceeccCCCCcEEEccCCcEEEecccch
Q 035930 591 ---------------------LGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 591 ---------------------~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
..++|+|++|.|||++.++.+.|+||+.+
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 45999999999999986555679999976
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=2.7e-11 Score=124.26 Aligned_cols=134 Identities=16% Similarity=0.085 Sum_probs=98.9
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCC--ccccceeeeeCCeEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF--LPTLFAHFTTEKFSCL 547 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn--IV~L~~~f~~~~~l~L 547 (857)
..|.+....+.|.++.||++.. .+|..|+||+.... ....+.+|+++|+.+.+.+ ++++++++..++..|+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 4566654444666799999965 45677999997543 2345788999999986444 5678888888888999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC-----------------------------------
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG----------------------------------- 592 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G----------------------------------- 592 (857)
||||++|.+|. ... .. ...++.+++..|..||...
T Consensus 93 v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99999998884 111 11 1245667777777777643
Q ss_pred -----------------------ceeccCCCCcEEEccCCcEEEecccchh
Q 035930 593 -----------------------VVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 593 -----------------------IIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876666799999863
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.5e-10 Score=126.36 Aligned_cols=141 Identities=14% Similarity=0.159 Sum_probs=105.6
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEec--ccccccccchhHHHHHHHHHHHcC--CCCccccceeeeeC---Ce
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMD--NDFLVGRKKMPRAQTEREIMQMLD--HPFLPTLFAHFTTE---KF 544 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~--k~~~~~~~~~~~~~~EieILr~L~--HPnIV~L~~~f~~~---~~ 544 (857)
....+.|+.|.++.||++... +..+++|+.. .... ......+.+|..+|+.|. +..+++++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 345678999999999999764 3578888775 3211 112345788999999997 45678899888776 45
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM---------------------------------- 590 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs---------------------------------- 590 (857)
.|+||||++|..+.+.. ...+++.....++.+++..|..||.
T Consensus 116 ~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp CEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred eEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 89999999998874311 1226788888899999999999997
Q ss_pred ------------------------cCceeccCCCCcEEEccCCc--EEEecccchh
Q 035930 591 ------------------------LGVVYRDLKPENILVREDGH--IMLSDFDLSL 620 (857)
Q Consensus 591 ------------------------~GIIHRDLKPeNILL~~dg~--iKL~DFGLA~ 620 (857)
.++||+|++|.|||++.++. +.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 36999999999999997753 6899999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.90 E-value=8e-10 Score=118.04 Aligned_cols=132 Identities=16% Similarity=0.131 Sum_probs=96.7
Q ss_pred EeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCC--ccccceeeeeCC---eEEEE
Q 035930 475 HKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPF--LPTLFAHFTTEK---FSCLV 548 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPn--IV~L~~~f~~~~---~l~LV 548 (857)
.+.|+.|.+..||++. ..+++|+.... .....+.+|.++|+.+. +.. ++.++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3568999999999974 34889986432 23456789999999884 333 345554443333 34899
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-------------------------------------- 590 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-------------------------------------- 590 (857)
||+++|..|...... .++......++.|++..|..||.
T Consensus 95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999988643322 26777778888888888888885
Q ss_pred --------------------cCceeccCCCCcEEEcc--CCcEEEecccchh
Q 035930 591 --------------------LGVVYRDLKPENILVRE--DGHIMLSDFDLSL 620 (857)
Q Consensus 591 --------------------~GIIHRDLKPeNILL~~--dg~iKL~DFGLA~ 620 (857)
..++|+|++|.|||++. ++.+.|+||+.+.
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~ 222 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAA 222 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCc
Confidence 13799999999999998 4567899999863
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=3.7e-07 Score=94.96 Aligned_cols=132 Identities=20% Similarity=0.157 Sum_probs=92.7
Q ss_pred EEccCCce-EEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEEEeecCC
Q 035930 477 KLGCGDIG-TVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLVMEYCPG 554 (857)
Q Consensus 477 ~LG~G~fG-tVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LVmEy~~g 554 (857)
.+..|..+ .||+......+..++||+-... ....+.+|..+|+.|. +--++++++++.+++..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445554 7999887777778999986532 2456788999999885 33367889999999999999999999
Q ss_pred CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 035930 555 GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-------------------------------------------- 590 (857)
Q Consensus 555 GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-------------------------------------------- 590 (857)
.++........ .....+..++...|.-||.
T Consensus 105 ~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 105 KTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 88765443221 1112233344444444442
Q ss_pred -------c-------CceeccCCCCcEEEccCCcEEEecccchh
Q 035930 591 -------L-------GVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 591 -------~-------GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
. .++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1 27999999999999987777899999863
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=4.4e-07 Score=97.52 Aligned_cols=132 Identities=13% Similarity=0.109 Sum_probs=90.9
Q ss_pred EeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCC---Cccccceeee-eCCeEEEEEe
Q 035930 475 HKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP---FLPTLFAHFT-TEKFSCLVME 550 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HP---nIV~L~~~f~-~~~~l~LVmE 550 (857)
.+.++.|....||+. +..+++|+.... .....+.+|.++|+.|.+. .++.++.++. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456889999999998 345888985321 2345678999999999753 3566666664 4566789999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHc---------------------------------------
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHML--------------------------------------- 591 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~--------------------------------------- 591 (857)
|++|..|....-. .++......++.++...|..||..
T Consensus 94 ~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9999888653211 134444444445555555555432
Q ss_pred ---------------------CceeccCCCCcEEEcc---CCc-EEEecccchh
Q 035930 592 ---------------------GVVYRDLKPENILVRE---DGH-IMLSDFDLSL 620 (857)
Q Consensus 592 ---------------------GIIHRDLKPeNILL~~---dg~-iKL~DFGLA~ 620 (857)
.++|+|++|.|||++. ++. +.|+||+.+.
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 3599999999999987 455 4899999763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=3.4e-06 Score=93.26 Aligned_cols=81 Identities=19% Similarity=0.202 Sum_probs=52.5
Q ss_pred EEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccc-cc---ccchhHHHHHHHHHHHcCC--C-CccccceeeeeCCeE
Q 035930 473 KLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFL-VG---RKKMPRAQTEREIMQMLDH--P-FLPTLFAHFTTEKFS 545 (857)
Q Consensus 473 ~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~-~~---~~~~~~~~~EieILr~L~H--P-nIV~L~~~f~~~~~l 545 (857)
...+.||.|.++.||++.+...+..|+||....... .. .....++..|.++|+.+.. + .++.++.+ +.+..
T Consensus 33 ~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 33 LTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp CEEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred eEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 346789999999999997765677899998653211 11 1234567889999988742 3 34556543 34456
Q ss_pred EEEEeecCCC
Q 035930 546 CLVMEYCPGG 555 (857)
Q Consensus 546 ~LVmEy~~gG 555 (857)
++||||+++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=2.8e-06 Score=92.17 Aligned_cols=86 Identities=13% Similarity=0.045 Sum_probs=58.0
Q ss_pred eEEEeEE-ccCCceEEEEEEEc--C----CCeEEEEEEecccccccccchhHHHHHHHHHHHcC-C--CCccccceeeee
Q 035930 472 FKLHKKL-GCGDIGTVYLAELI--G----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-H--PFLPTLFAHFTT 541 (857)
Q Consensus 472 Y~i~~~L-G~G~fGtVyla~~~--~----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-H--PnIV~L~~~f~~ 541 (857)
....+.| +.|....+|+.... . ++..+++|+..............+.+|..+|+.|. + -.+++++.++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3456788 88999999998753 1 15678899865432000001245688999998885 3 357778887765
Q ss_pred C---CeEEEEEeecCCCCh
Q 035930 542 E---KFSCLVMEYCPGGDL 557 (857)
Q Consensus 542 ~---~~l~LVmEy~~gGsL 557 (857)
. +..|+||||++|..+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 5 356899999988665
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.12 E-value=2.5e-05 Score=83.29 Aligned_cols=137 Identities=14% Similarity=0.121 Sum_probs=79.5
Q ss_pred EEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC--CCCccccce------eeeeCCeE
Q 035930 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD--HPFLPTLFA------HFTTEKFS 545 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~--HPnIV~L~~------~f~~~~~l 545 (857)
-.+.|+.|..+.||++... ++ .+++|+.... ...+..|..+++.|. .-.++.++. +....+..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD-SG-AVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEET-TE-EEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeC-CC-CEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 3456677788999999763 33 4899998652 133445666666553 113444443 22356788
Q ss_pred EEEEeecCCCChH------------------HHHhhC--CCC------CCcHHH--------------------------
Q 035930 546 CLVMEYCPGGDLH------------------VLRQKQ--PSR------FFSEQA-------------------------- 573 (857)
Q Consensus 546 ~LVmEy~~gGsL~------------------~ll~~~--~~~------~l~e~~-------------------------- 573 (857)
++||||++|..+. ...... +.. ...+..
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986531 111111 100 001110
Q ss_pred -----HHHHHHHHHHHHHHHHH-------------cCceeccCCCCcEEEccCCcEEEecccch
Q 035930 574 -----ARFYVAEVLLALEYLHM-------------LGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 574 -----~r~i~~QIl~gL~yLHs-------------~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
+..+..++..++.+|+. .++||+|+++.|||++.++.+.|+||+.+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 11111223445666653 57999999999999988889999999976
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.73 E-value=9.7e-05 Score=82.56 Aligned_cols=77 Identities=18% Similarity=0.269 Sum_probs=47.8
Q ss_pred EEeEEccCCceEEEEEEEcCCCeEEEEEEeccccc-ccc---cchhHHHHHHHHHHHc---CCCCccccceeeeeCCeEE
Q 035930 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFL-VGR---KKMPRAQTEREIMQML---DHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~-~~~---~~~~~~~~EieILr~L---~HPnIV~L~~~f~~~~~l~ 546 (857)
-.+.||.|..+.||++.. ++..|+||....... ... ....+...|.+++..+ ....+++++.+. .+..+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 467899999999999964 456799995322110 011 1113334455554443 234677777665 45678
Q ss_pred EEEeec-CC
Q 035930 547 LVMEYC-PG 554 (857)
Q Consensus 547 LVmEy~-~g 554 (857)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00029 Score=76.51 Aligned_cols=78 Identities=15% Similarity=0.204 Sum_probs=61.7
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC---CCCccccceeeeeCCeEEEE
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD---HPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~---HPnIV~L~~~f~~~~~l~LV 548 (857)
..-.+.|+.|.+..+|+... .+..|+||+.... ....+..|.+.|+.|. ...+++++.++...+..|+|
T Consensus 38 i~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv 109 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL 109 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred eeeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence 34567899999999999975 3567889986532 2456788999998884 35688899988888899999
Q ss_pred EeecCCCCh
Q 035930 549 MEYCPGGDL 557 (857)
Q Consensus 549 mEy~~gGsL 557 (857)
|||++|..+
T Consensus 110 me~l~G~~~ 118 (312)
T 3jr1_A 110 LEALNKSKN 118 (312)
T ss_dssp EECCCCCCC
T ss_pred EEeccCCCC
Confidence 999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00035 Score=74.38 Aligned_cols=143 Identities=16% Similarity=0.109 Sum_probs=82.4
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCC--cccccee------eee
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF--LPTLFAH------FTT 541 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPn--IV~L~~~------f~~ 541 (857)
....-.+.|+.|....+|+....+ + .|++|+.... .....+..|+.+++.|.... +++++.. ...
T Consensus 22 ~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~-----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 22 GSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp CCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred CcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC-----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 344566788889999999997643 3 5889988652 12345567888887774211 3444421 223
Q ss_pred CCeEEEEEeecCCCChH-----HH---------HhhC----CCCC---Cc---HHHHH-H-----------HHHHHHHHH
Q 035930 542 EKFSCLVMEYCPGGDLH-----VL---------RQKQ----PSRF---FS---EQAAR-F-----------YVAEVLLAL 585 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~-----~l---------l~~~----~~~~---l~---e~~~r-~-----------i~~QIl~gL 585 (857)
.+..++||+|++|..+. .+ ++.. .... .. +.... . +...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 46779999999886531 00 1110 1000 11 11100 0 001234455
Q ss_pred HHHHH-------cCceeccCCCCcEEEccCCcEEEecccch
Q 035930 586 EYLHM-------LGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 586 ~yLHs-------~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
++|+. .++||+|+.+.|||++.++.+.|+||+.+
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a 215 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 215 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence 66653 36999999999999987766689999976
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00018 Score=76.42 Aligned_cols=132 Identities=14% Similarity=0.073 Sum_probs=75.5
Q ss_pred EeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEEEeec-
Q 035930 475 HKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLVMEYC- 552 (857)
Q Consensus 475 ~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LVmEy~- 552 (857)
.+.|+.|....+|++ ..|++|+..... .......+|..+++.+. +...++++.++ .+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT----EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc----cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 678999999999999 348889875431 11223356888888775 22225666544 33346899999
Q ss_pred CCCChHH--H----------------HhhCCCC---CC-cHHHHHHHHHH--------------HHHHHHHHH----H--
Q 035930 553 PGGDLHV--L----------------RQKQPSR---FF-SEQAARFYVAE--------------VLLALEYLH----M-- 590 (857)
Q Consensus 553 ~gGsL~~--l----------------l~~~~~~---~l-~e~~~r~i~~Q--------------Il~gL~yLH----s-- 590 (857)
+|..|.. + ++..... .+ ....+..+..+ +...+..|. .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 6655521 0 1111110 01 11122222111 112222221 1
Q ss_pred --cCceeccCCCCcEEEccCCcEEEecccch
Q 035930 591 --LGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 591 --~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
..++|+|+.+.||| ..++.+.|+||+.+
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a 200 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYS 200 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTC
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccc
Confidence 23899999999999 56778899999976
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0014 Score=69.05 Aligned_cols=80 Identities=16% Similarity=0.128 Sum_probs=57.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCC---CccccceeeeeCCeEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP---FLPTLFAHFTTEKFSC 546 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HP---nIV~L~~~f~~~~~l~ 546 (857)
....-...+|.|..+.||+.+. .+|+.|.+|+..... ......+..|...|+.|.-- -+++++++. + .+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ce
Confidence 4567788999999999999987 467889999865432 22335678899999988521 344555432 2 37
Q ss_pred EEEeecCCCCh
Q 035930 547 LVMEYCPGGDL 557 (857)
Q Consensus 547 LVmEy~~gGsL 557 (857)
+||||+.++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0016 Score=69.35 Aligned_cols=75 Identities=15% Similarity=0.086 Sum_probs=48.4
Q ss_pred eEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCC--Ccccccee-----eeeCCeEEEE
Q 035930 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP--FLPTLFAH-----FTTEKFSCLV 548 (857)
Q Consensus 476 ~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HP--nIV~L~~~-----f~~~~~l~LV 548 (857)
..|+ |....||++... +|..|++|+..... .....+..|..+++.|... .+++++.. ...++..++|
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 888899988653 45578999986331 1234567788888877421 24444432 2335677899
Q ss_pred EeecCCCC
Q 035930 549 MEYCPGGD 556 (857)
Q Consensus 549 mEy~~gGs 556 (857)
|||++|..
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00088 Score=75.55 Aligned_cols=75 Identities=21% Similarity=0.291 Sum_probs=51.4
Q ss_pred EEeEEccCCceEEEEEEEcC-------CCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeE
Q 035930 474 LHKKLGCGDIGTVYLAELIG-------TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~-------tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l 545 (857)
-.+.|+.|....||++.... .+..|++|+.... .....+.+|..+++.|. +...+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 45678889999999998753 2568999987431 11145567999998885 3334677766542
Q ss_pred EEEEeecCCCCh
Q 035930 546 CLVMEYCPGGDL 557 (857)
Q Consensus 546 ~LVmEy~~gGsL 557 (857)
.+||||++|..|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 289999987443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0011 Score=71.30 Aligned_cols=137 Identities=13% Similarity=0.074 Sum_probs=71.5
Q ss_pred EeEEccCCceE-EEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-C-CCccccceeeeeCCeEEEEEee
Q 035930 475 HKKLGCGDIGT-VYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-H-PFLPTLFAHFTTEKFSCLVMEY 551 (857)
Q Consensus 475 ~~~LG~G~fGt-Vyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-H-PnIV~L~~~f~~~~~l~LVmEy 551 (857)
.+.|+.|.... +|+... .++..|++|..... . ...+..|+.+++.|. + -.+++++.+....+ ++|||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~----~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPE----E--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTT----T--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCC----C--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 34565554444 667653 22556777764332 1 123456778777774 2 23566776644333 689999
Q ss_pred cCCCChHHHHhhC---------------------CC---CCCcHHHHH--------HHH------------HHHHHHHHH
Q 035930 552 CPGGDLHVLRQKQ---------------------PS---RFFSEQAAR--------FYV------------AEVLLALEY 587 (857)
Q Consensus 552 ~~gGsL~~ll~~~---------------------~~---~~l~e~~~r--------~i~------------~QIl~gL~y 587 (857)
+.+..+..++... .. ..+...... .+. ..+...++.
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9766554332211 00 112221110 000 011222333
Q ss_pred HH------HcCceeccCCCCcEEEccC----CcEEEecccchh
Q 035930 588 LH------MLGVVYRDLKPENILVRED----GHIMLSDFDLSL 620 (857)
Q Consensus 588 LH------s~GIIHRDLKPeNILL~~d----g~iKL~DFGLA~ 620 (857)
|. ...+||+|+.+.|||++.+ +.+.|+||+.+.
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 31 2469999999999999874 689999999874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00092 Score=73.02 Aligned_cols=75 Identities=13% Similarity=0.207 Sum_probs=46.0
Q ss_pred EEeEEccCCceEEEEEEEcC--------CCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCe
Q 035930 474 LHKKLGCGDIGTVYLAELIG--------TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKF 544 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~--------tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~ 544 (857)
-.+.|+.|....+|++...+ .+..|++|+..... ........|.++|+.|. +...+++++.+ .+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence 35678888889999998753 13578899875421 11223467888888885 32355676554 22
Q ss_pred EEEEEeecCCCC
Q 035930 545 SCLVMEYCPGGD 556 (857)
Q Consensus 545 l~LVmEy~~gGs 556 (857)
++||||++|..
T Consensus 110 -~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 -GRIEEWLYGDP 120 (369)
T ss_dssp -EEEEECCCSEE
T ss_pred -cEEEEEecCCc
Confidence 68999998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00086 Score=74.72 Aligned_cols=142 Identities=15% Similarity=0.207 Sum_probs=85.6
Q ss_pred CCeEEEeEEccCCceEEEEEEEcC-------CCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeee
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIG-------TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTT 541 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~-------tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~ 541 (857)
..+.+ +.|..|-...+|++.... .+..|+||+.-.. ........+|..+|+.|. +...+++++++.+
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~ 125 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE 125 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence 34443 567678888899998642 3568999985321 123455678999998885 4444677766653
Q ss_pred CCeEEEEEeecCCCChHH--------------H---HhhCC---CCCC--cHHHHHHHHHHHHH----------------
Q 035930 542 EKFSCLVMEYCPGGDLHV--------------L---RQKQP---SRFF--SEQAARFYVAEVLL---------------- 583 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~--------------l---l~~~~---~~~l--~e~~~r~i~~QIl~---------------- 583 (857)
.+||||++|..|.. . ++... .+.. -+.++..|..++..
T Consensus 126 ----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
T 3feg_A 126 ----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS 201 (379)
T ss_dssp ----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred ----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence 29999998865521 0 11111 1111 24555656544422
Q ss_pred ---HHHHHHH--------cCceeccCCCCcEEEccC----CcEEEecccchh
Q 035930 584 ---ALEYLHM--------LGVVYRDLKPENILVRED----GHIMLSDFDLSL 620 (857)
Q Consensus 584 ---gL~yLHs--------~GIIHRDLKPeNILL~~d----g~iKL~DFGLA~ 620 (857)
.++.|.+ ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2344432 259999999999999876 789999999873
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0037 Score=71.32 Aligned_cols=76 Identities=12% Similarity=0.224 Sum_probs=50.4
Q ss_pred EEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCc-cccceeeeeCCeEEEEEeec
Q 035930 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL-PTLFAHFTTEKFSCLVMEYC 552 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnI-V~L~~~f~~~~~l~LVmEy~ 552 (857)
-.+.|+.|-...+|++.....+..|++|+.... ....-...+|..+|+.|...++ +++++.+. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~----~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPK----TDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-----CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCC----hhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 456788899999999987654578999987432 1112123689999999974444 67777663 2 2599999
Q ss_pred CCCCh
Q 035930 553 PGGDL 557 (857)
Q Consensus 553 ~gGsL 557 (857)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.011 Score=64.09 Aligned_cols=72 Identities=10% Similarity=0.093 Sum_probs=45.7
Q ss_pred EeEE--ccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC---CCCcccccee------eeeCC
Q 035930 475 HKKL--GCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD---HPFLPTLFAH------FTTEK 543 (857)
Q Consensus 475 ~~~L--G~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~---HPnIV~L~~~------f~~~~ 543 (857)
.+.| |.|....||+.... +| .|++|+..... . ..|+.+|+.|. -|++++++.. ....+
T Consensus 26 ~~~l~~G~g~~N~vy~v~~~-~g-~~vLK~~~~~~------~---~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g 94 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADSE-SK-SYFIKLKYGYH------D---EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKH 94 (339)
T ss_dssp EEEETTTSCSSCEEEEEECS-SC-EEEEEEEECSS------C---CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSS
T ss_pred eEEeeccCccccceEEEEeC-CC-CEEEEEecCcc------c---hHHHHHHHHHHhcCCcccccceecCCCCEEEEECC
Confidence 3445 34447899999753 44 79999876532 1 35666666663 3335555432 23457
Q ss_pred eEEEEEeecCCCCh
Q 035930 544 FSCLVMEYCPGGDL 557 (857)
Q Consensus 544 ~l~LVmEy~~gGsL 557 (857)
..++||+|++|..+
T Consensus 95 ~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 95 FKIIAYPFIHAPNG 108 (339)
T ss_dssp EEEEEEECCCCCBT
T ss_pred EEEEEEeccCCCcC
Confidence 88999999988755
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.11 E-value=0.036 Score=62.58 Aligned_cols=76 Identities=14% Similarity=0.293 Sum_probs=50.2
Q ss_pred EEeEEccCCceEEEEEEEcCC-------CeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeE
Q 035930 474 LHKKLGCGDIGTVYLAELIGT-------SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFS 545 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~t-------g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l 545 (857)
-.+.|..|-...+|++..... +..|++|+.... ....-...+|..+++.|. +.-.+++++.+. +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~----t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH----VGKFYDSKVELDVFRYLSNINIAPNIIADFP--E-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC----C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC----cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--
Confidence 445677788889999987521 567999986432 122223467888888885 444566765442 2
Q ss_pred EEEEeecCCCCh
Q 035930 546 CLVMEYCPGGDL 557 (857)
Q Consensus 546 ~LVmEy~~gGsL 557 (857)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999998654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.92 E-value=0.026 Score=58.47 Aligned_cols=58 Identities=17% Similarity=0.056 Sum_probs=42.6
Q ss_pred ChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEEccCCcEEEe
Q 035930 556 DLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH-MLGVVYRDLKPENILVREDGHIMLS 614 (857)
Q Consensus 556 sL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLH-s~GIIHRDLKPeNILL~~dg~iKL~ 614 (857)
+|.+.+.... .+++|+++|.++.|.+.+|.-+- ...-..+=+-|..|+|..+|.|-+.
T Consensus 34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~ 92 (229)
T 2yle_A 34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLA 92 (229)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEEC
T ss_pred cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceecc
Confidence 6788777654 35999999999999999887662 1122234445788999999988765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.10 E-value=0.29 Score=54.29 Aligned_cols=28 Identities=36% Similarity=0.507 Sum_probs=24.2
Q ss_pred ceeccCCCCcEEE------ccCCcEEEecccchh
Q 035930 593 VVYRDLKPENILV------REDGHIMLSDFDLSL 620 (857)
Q Consensus 593 IIHRDLKPeNILL------~~dg~iKL~DFGLA~ 620 (857)
++|+|+.+.|||+ ++++.+.|+||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 345779999999873
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 857 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-21 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-34 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-39 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-21 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-24 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-25 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-38 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-23 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-24 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-23 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-31 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-36 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-21 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-24 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-36 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-16 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-10 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-24 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-20 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-34 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-34 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-24 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-13 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-34 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-34 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-15 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-15 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-33 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-13 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-24 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-33 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-15 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-19 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-16 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-22 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-18 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-14 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-31 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-15 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-31 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-15 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-10 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-18 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-21 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-30 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-30 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-30 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-13 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-15 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-11 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-29 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-13 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-13 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-12 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-13 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-12 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-26 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-07 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-25 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-25 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-13 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-12 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-16 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-48
Identities = 60/343 (17%), Positives = 109/343 (31%), Gaps = 44/343 (12%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
F+ +LG G+ G V+ + + A K++ + + + E +++ + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSP 64
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH- 589
++ + F ++ + ME+ GG L + +K EQ V+ L YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE 122
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSE 649
+++RD+KP NILV G I L DF +S + + + P + + S
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 650 ASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709
S I W + + G
Sbjct: 183 QSDI--------WSMGLSLVEMA---------------------------VGRYPIPPPD 207
Query: 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGY 769
E + EG + YG E L +V++
Sbjct: 208 AKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267
Query: 770 PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812
V S +D + L+K P R ++ H F + +
Sbjct: 268 GVFSLEFQDFVNKCLIKNPAERA----DLKQLMVHAFIKRSDA 306
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 48/149 (32%), Positives = 75/149 (50%), Gaps = 4/149 (2%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+++ +LG G G VY A+ TS L A KV+D +++ E +I+ DHP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHP 69
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
+ L F E +++E+C GG + + + R +E + + L AL YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLS 619
+++RDLK NIL DG I L+DF +S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVS 157
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.4 bits (229), Expect = 4e-21
Identities = 29/118 (24%), Positives = 47/118 (39%), Gaps = 10/118 (8%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEII-----KGEGHGSSVDWWTFGIFLFELLYGRTPFKGS 750
T R +SF+GT ++APE++ K + D W+ GI L E+ P
Sbjct: 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218
Query: 751 GNDETLSNVV-SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
L + S+ S + +D ++ L K D R +++ QHPF
Sbjct: 219 NPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW----TTSQLLQHPFV 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 9e-42
Identities = 62/169 (36%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
FK K LG G TV LA + TS +A+K+++ ++ K+P ER++M LDHP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
F L+ F ++ + Y G+L +K S F E RFY AE++ ALEYLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 126
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPP 639
G+++RDLKPENIL+ ED HI ++DF + + +++S V
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 2e-34
Identities = 43/129 (33%), Positives = 65/129 (50%), Gaps = 4/129 (3%)
Query: 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS 757
E AR+NSFVGT +Y++PE++ + S D W G +++L+ G PF+
Sbjct: 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 220
Query: 758 NVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA--VKGAAEIKQHPFFEGLNWALI 815
++ FP ARDL+ LLV + RLG ++G +K HPFFE + W +
Sbjct: 221 KIIKLEYDFP--EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278
Query: 816 RCAVPPELP 824
PP+L
Sbjct: 279 HQQTPPKLT 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 9e-41
Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 2/171 (1%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
+ F++ + LG G G VYLA + + ALKV+ L + + E EI L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
HP + L+ +F L++EY P G ++ QK F EQ Y+ E+ AL Y
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYC 122
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPP 639
H V++RD+KPEN+L+ G + ++DF S+ + + PP
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 173
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-26
Identities = 37/113 (32%), Positives = 53/113 (46%), Gaps = 6/113 (5%)
Query: 695 LVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE 754
V +R + GT +YL PE+I+G H VD W+ G+ +E L G+ PF+ + E
Sbjct: 152 WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211
Query: 755 TLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
T + FP V+ ARDLI LL P R E+ +HP+
Sbjct: 212 TYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRP----MLREVLEHPWI 258
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 149 bits (378), Expect = 2e-40
Identities = 65/347 (18%), Positives = 119/347 (34%), Gaps = 60/347 (17%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DH 529
++L +KLG G V+ A I + +K++ K + + E +I++ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRGG 89
Query: 530 PFLPTLFAHFT--TEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
P + TL + LV E+ D L Q ++ RFY+ E+L AL+Y
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDY 144
Query: 588 LHMLGVVYRDLKPENILV-REDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSP 646
H +G+++RD+KP N+++ E + L D+ L+
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--------------------------- 177
Query: 647 CSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706
E + + V + D + + + ++ +
Sbjct: 178 -------EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
Query: 707 FVGTHEYLAPE-IIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR 765
F G Y I K G D+ + + + S + +
Sbjct: 231 FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW------ERFVH 284
Query: 766 FPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812
+VS A D + LL + +RL A E +HP+F +
Sbjct: 285 SENQHLVSPEALDFLDKLLRYDHQSRL----TAREAMEHPYFYTVVK 327
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 2e-39
Identities = 43/150 (28%), Positives = 64/150 (42%), Gaps = 2/150 (1%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH 529
+ F +++G G G VY A + S + A+K M +K E +Q L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
P + E + LVMEYC G +L + + E L L YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+++RD+K NIL+ E G + L DF +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 93.1 bits (231), Expect = 3e-21
Identities = 28/108 (25%), Positives = 43/108 (39%), Gaps = 7/108 (6%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHG---SSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
+NSFVGT ++APE+I G VD W+ GI EL + P L ++
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
Query: 760 VSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
S + R+ + L K P +R + + +H F
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP----TSEVLLKHRFV 270
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 147 bits (371), Expect = 2e-39
Identities = 40/172 (23%), Positives = 79/172 (45%), Gaps = 6/172 (3%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
++ + ++LG G G V+ T +F K ++ + + + + E IM L HP
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISIMNQLHHP 86
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
L L F + L++E+ GG+L + + SE Y+ + L+++H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE 145
Query: 591 LGVVYRDLKPENILVR--EDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPP 640
+V+ D+KPENI+ + + + DF L+ + + +V +++ E P
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 197
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 102 bits (256), Expect = 4e-24
Identities = 39/125 (31%), Positives = 56/125 (44%), Gaps = 7/125 (5%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
T E+ APEI+ E G D W G+ + LL G +PF G + ETL NV
Sbjct: 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 240
Query: 760 VSQSLRFP--GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRC 817
F + VS A+D I+ LL KEP RL + +HP+ +G + + +
Sbjct: 241 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHPWLKG-DHSNLTS 295
Query: 818 AVPPE 822
+P
Sbjct: 296 RIPSS 300
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 146 bits (369), Expect = 5e-39
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 6/153 (3%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
+ H+ +H++LG G G V+ T FA K + ++ + E + M +L
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE---TVRKEIQTMSVLR 81
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
HP L L F + ++ E+ GG+L + ++ SE A Y+ +V L ++
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHM 140
Query: 589 HMLGVVYRDLKPENILV--REDGHIMLSDFDLS 619
H V+ DLKPENI+ + + L DF L+
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 107 bits (267), Expect = 1e-25
Identities = 37/140 (26%), Positives = 60/140 (42%), Gaps = 6/140 (4%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
GT E+ APE+ +G+ G D W+ G+ + LL G +PF G +DETL NV S
Sbjct: 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 240
Query: 763 SLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVP 820
+ +S +D IR LL+ +P+ R+ + +HP+ N +P
Sbjct: 241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRM----TIHQALEHPWLTPGNAPGRDSQIP 296
Query: 821 PELPRSCDAVIGSQKKESTK 840
I ++ +
Sbjct: 297 SSRYTKIRDSIKTKYDAWPE 316
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-38
Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 6/166 (3%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+ L + LG G G V LA T A+K++D V + + E I +ML+H
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE 63
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGD-LHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ + H L +EYC GG+ + E A+ + +++ + YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLH 120
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPV 635
+G+ +RD+KPEN+L+ E ++ +SDF L+ N +
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.4 bits (242), Expect = 5e-23
Identities = 27/116 (23%), Positives = 47/116 (40%), Gaps = 6/116 (5%)
Query: 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKG-SG 751
N GT Y+APE++K H VD W+ GI L +L G P+ S
Sbjct: 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211
Query: 752 NDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+ + S+ + + + L+ +LV+ P R+ +IK+ ++
Sbjct: 212 SCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWY 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (363), Expect = 4e-38
Identities = 54/156 (34%), Positives = 83/156 (53%), Gaps = 5/156 (3%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
+ M F +H+ +G G G VY T ++A+K +D + ++ A ER ++ +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 527 L---DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLL 583
+ D PF+ + F T +++ GGDLH + FSE RFY AE++L
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIIL 118
Query: 584 ALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
LE++H VVYRDLKP NIL+ E GH+ +SD L+
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 154
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 101 bits (253), Expect = 8e-24
Identities = 45/135 (33%), Positives = 72/135 (53%), Gaps = 5/135 (3%)
Query: 695 LVVEPTGARSNSFVGTHEYLAPEII-KGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND 753
L + + + ++ VGTH Y+APE++ KG + SS DW++ G LF+LL G +PF+
Sbjct: 153 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212
Query: 754 ETLSNVVSQSLRFPGYP-VVSFHARDLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLN 811
+ P S R L+ GLL ++ + RLG + GA E+K+ PFF L+
Sbjct: 213 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
Query: 812 WALI--RCAVPPELP 824
W ++ + PP +P
Sbjct: 273 WQMVFLQKYPPPLIP 287
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 140 bits (355), Expect = 6e-38
Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKK------MPRAQTEREIM 524
+++ + LG G V T +A+K++D E +I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 525 QML-DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVL 582
+ + HP + L + T F LV + G+L L +K SE+ R + +L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALL 120
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ LH L +V+RDLKPENIL+ +D +I L+DF S
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 99.4 bits (247), Expect = 1e-23
Identities = 38/117 (32%), Positives = 54/117 (46%), Gaps = 12/117 (10%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGE------GHGSSVDWWTFGIFLFELLYGRTPFKGSGND 753
G + GT YLAPEII+ G+G VD W+ G+ ++ LL G PF
Sbjct: 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221
Query: 754 ETLSNVVSQSLRF--PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808
L ++S + +F P + S +DL+ LV +P R A E HPFF+
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY----TAEEALAHPFFQ 274
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-37
Identities = 65/361 (18%), Positives = 114/361 (31%), Gaps = 67/361 (18%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+ K +G G G VY A+L + L A+K + + E +IM+ LDH
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHCN 74
Query: 532 LPTLFAHFTT------EKFSCLVMEYCPGGDLHVLRQ-KQPSRFFSEQAARFYVAEVLLA 584
+ L F + E + LV++Y P V R + + + Y+ ++ +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIM-LSDFDLSLRCAVNPMVVKSSSPVEEPPPKKA 643
L Y+H G+ +RD+KP+N+L+ D ++ L DF + + +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV---------------RGEPN 179
Query: 644 SSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703
S P + + + D V ++ E +
Sbjct: 180 VSYICSRYYRAPELIFGATDYTS---------------SID----VWSAGCVLAELLLGQ 220
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS 763
+ EIIK G + + + + +
Sbjct: 221 PIFPGDSGVDQLVEIIKVLGTPTREQIRE--------------MNPNYTEFKFPQIKAHP 266
Query: 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPEL 823
P A L LL P RL E H FF+ L ++ +
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAHSFFDELRDPNVKLPNGRDT 322
Query: 824 P 824
P
Sbjct: 323 P 323
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 140 bits (353), Expect = 3e-37
Identities = 53/151 (35%), Positives = 89/151 (58%), Gaps = 2/151 (1%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
++ F++ + LG G G V+L +A+KV+ + +V K++ ER ++ ++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
HPF+ ++ F + ++M+Y GG+L + S+ F A+FY AEV LALEYL
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELF--SLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
H ++YRDLKPENIL+ ++GHI ++DF +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFA 151
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (286), Expect = 2e-28
Identities = 47/159 (29%), Positives = 83/159 (52%), Gaps = 6/159 (3%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
+ + GT +Y+APE++ + + S+DWW+FGI ++E+L G TPF S +T +++
Sbjct: 157 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 216
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLNWA--LIRCAV 819
LRFP P + +DL+ L+ ++ RLG ++ G ++K HP+F+ + W L R
Sbjct: 217 ELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIE 274
Query: 820 PPELPR-SCDAVIGSQKKESTKCEESKGAADEHVEFEMF 857
P P SQ + + + + G E ++F
Sbjct: 275 TPYEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADLF 313
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 6e-37
Identities = 64/364 (17%), Positives = 120/364 (32%), Gaps = 56/364 (15%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
++ ++ K +G G G V A A+K + F + RA E +M+ ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN 74
Query: 529 HPFLPTLFAHFTTEKFS------CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVL 582
H + +L FT +K LVME V++ + + + + ++L
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQML 129
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN-PMVVKSSSPVEEPPPK 641
+++LH G+++RDLKP NI+V+ D + + DF L+ + M + P
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 642 KASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701
E I V
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKIL-------------------------------- 217
Query: 702 ARSNSFVGTHEY-LAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
F G ++I+ G + + R + G + + +
Sbjct: 218 -----FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 272
Query: 761 SQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVP 820
+ + + ARDL+ +LV +P R+ + QHP+ A P
Sbjct: 273 FPADS-EHNKLKASQARDLLSKMLVIDPAKRI----SVDDALQHPYINVWYDPAEVEAPP 327
Query: 821 PELP 824
P++
Sbjct: 328 PQIY 331
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-36
Identities = 66/339 (19%), Positives = 117/339 (34%), Gaps = 53/339 (15%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
M+ ++ +K+G G GTV+ A+ T + ALK + D A E +++ L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK 59
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
H + L ++K LV E+C + + + ++ ++L L +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKK--YFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCS 648
H V++RDLKP+N+L+ +G + L++F L+ P + S+
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAF--------------GIPVRCYSAEVV 163
Query: 649 EASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708
P L + S D+ + +L R
Sbjct: 164 TLWYRPPDVLFGAKLYST---------------SIDMWSAGCIFAELA---NAGRPLFPG 205
Query: 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG 768
+ I + G + W + Y P S +
Sbjct: 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV-------------- 251
Query: 769 YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
P ++ RDL++ LL P R+ A E QHP+F
Sbjct: 252 VPKLNATGRDLLQNLLKCNPVQRI----SAEEALQHPYF 286
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 59/153 (38%), Positives = 89/153 (58%), Gaps = 5/153 (3%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM-L 527
+ F LHK LG G G V+LAE T+ FA+K + D ++ + E+ ++ +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALE 586
+HPFL +F F T++ VMEY GGDL + ++ F A FY AE++L L+
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQ 117
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+LH G+VYRDLK +NIL+ +DGHI ++DF +
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 150
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-31
Identities = 47/131 (35%), Positives = 77/131 (58%), Gaps = 7/131 (5%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
A++N+F GT +Y+APEI+ G+ + SVDWW+FG+ L+E+L G++PF G +E
Sbjct: 153 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 212
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALI- 815
++ + +P + A+DL+ L V+EP+ RLG +I+QHP F +NW +
Sbjct: 213 HSIRMDNPFYP--RWLEKEAKDLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEELE 267
Query: 816 -RCAVPPELPR 825
+ PP P+
Sbjct: 268 RKEIDPPFRPK 278
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 36/157 (22%), Positives = 68/157 (43%), Gaps = 10/157 (6%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+++ +G G G + K +D + +K +E +++ L HP
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ-MLVSEVNLLRELKHPN 64
Query: 532 LPTLFAHFT--TEKFSCLVMEYCPGGDL--HVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
+ + T +VMEYC GGDL + + + ++ E+ + ++ LAL+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 588 LHMLG-----VVYRDLKPENILVREDGHIMLSDFDLS 619
H V++RDLKP N+ + ++ L DF L+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.7 bits (230), Expect = 2e-21
Identities = 24/111 (21%), Positives = 43/111 (38%), Gaps = 5/111 (4%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET 755
++ + + +FVGT Y++PE + + D W+ G L+EL PF E
Sbjct: 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 222
Query: 756 LSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPF 806
+ R S ++I +L + +R EI ++P
Sbjct: 223 AGKIREGKFRRIP-YRYSDELNEIITRMLNLKDYHRP----SVEEILENPL 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 5e-36
Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 6/150 (4%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH 529
+ + +K+G G GTVY A + T A++ M+ ++ E +M+ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---LIINEILVMRENKN 76
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
P + + +VMEY GG L + + E E L ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH 133
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLS 619
V++RD+K +NIL+ DG + L+DF
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 5e-24
Identities = 27/112 (24%), Positives = 50/112 (44%), Gaps = 5/112 (4%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
+ P ++ ++ VGT ++APE++ + +G VD W+ GI E++ G P+ L
Sbjct: 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
Query: 757 SNVVSQ-SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+ + + +S RD + L + + R A E+ QH F
Sbjct: 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG----SAKELLQHQFL 273
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 8e-36
Identities = 31/149 (20%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+ +++G G GTVY + G A+K+++ +++ + E +++ H
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHV 64
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
+ ++T +V ++C G L+ ++F + ++YLH
Sbjct: 65 NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHA 122
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLS 619
+++RDLK NI + ED + + DF L+
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLA 151
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.9 bits (189), Expect = 5e-16
Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 11/109 (10%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHG---SSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
+ G+ ++APE+I+ + D + FGI L+EL+ G+ P+ N + + +
Sbjct: 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 221
Query: 760 VSQSLRFPGYPVVSFH----ARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804
V + P V + + L+ L K+ D R +I
Sbjct: 222 VGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP----LFPQILAS 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (336), Expect = 3e-35
Identities = 43/190 (22%), Positives = 73/190 (38%), Gaps = 7/190 (3%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+ KLG G G VY S A+K + D ++ E +M+ + HP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHP 73
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
L L T E ++ E+ G+L ++ + S + ++ A+EYL
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVE---EPPPKKASSPC 647
++RDL N LV E+ + ++DF LS + + + P A +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 648 SEASCIEPFC 657
S S + F
Sbjct: 194 SIKSDVWAFG 203
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 60.9 bits (147), Expect = 1e-10
Identities = 16/100 (16%), Positives = 33/100 (33%)
Query: 692 MPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG 751
+ +L+ T ++ APE + D W FG+ L+E+
Sbjct: 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220
Query: 752 NDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791
+ + ++ + R +L+R P +R
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 260
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-35
Identities = 68/350 (19%), Positives = 115/350 (32%), Gaps = 55/350 (15%)
Query: 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ 525
C + ++ K+G G G V+ A T ALK + + A E +I+Q
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQ 64
Query: 526 MLDHPFLPTLFAHFTTEKFS--------CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFY 577
+L H + L T+ LV ++C +L SE +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRV 122
Query: 578 VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEE 637
+ +L L Y+H +++RD+K N+L+ DG + L+DF L+ ++ S +
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA----------RAFSLAKN 172
Query: 638 PPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVV 697
P + ++ P L DL M ++
Sbjct: 173 SQPNRYTNRVVTLWYRPPELLLGERDYGP---------------PIDLWGAGCIMAEMWT 217
Query: 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLS 757
RS G E +I G E+ ++ E +
Sbjct: 218 -----RSPIMQGNTEQHQLALIS----------QLCGSITPEVWPNVDNYELYEKLELVK 262
Query: 758 NVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+ V +A DLI LLV +P R+ + + H FF
Sbjct: 263 GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI----DSDDALNHDFF 308
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (335), Expect = 6e-35
Identities = 51/153 (33%), Positives = 79/153 (51%), Gaps = 9/153 (5%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+ LG G V LAE T L A+K + L G++ + E ++ + HP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAVLHKIKHP 67
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+ L + + L+M+ GG+L + +K ++E+ A + +VL A++YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124
Query: 590 MLGVVYRDLKPENILVR---EDGHIMLSDFDLS 619
LG+V+RDLKPEN+L ED IM+SDF LS
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (267), Expect = 6e-26
Identities = 32/118 (27%), Positives = 57/118 (48%), Gaps = 6/118 (5%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
+E G+ ++ GT Y+APE++ + + +VD W+ G+ + LL G PF + +
Sbjct: 159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218
Query: 757 SNVVSQSLRF--PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812
++ F P + +S A+D IR L+ K+P+ R + QHP+ G
Sbjct: 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF----TCEQALQHPWIAGDTA 272
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (337), Expect = 8e-35
Identities = 57/193 (29%), Positives = 94/193 (48%), Gaps = 2/193 (1%)
Query: 437 SGSSRGGSRPHMSNDLRWDAIRCVQKQHGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSC 496
GS + + ++ + + F K LG G G V L + +
Sbjct: 8 KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGN 67
Query: 497 LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGD 556
+A+K++D +V K++ E+ I+Q ++ PFL L F +VMEY GG+
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 557 LHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616
+ ++ FSE ARFY A+++L EYLH L ++YRDLKPEN+L+ + G+I ++DF
Sbjct: 128 MFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 617 DLSLRCAVNPMVV 629
+ R +
Sbjct: 186 GFAKRVKGRTWTL 198
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (254), Expect = 5e-24
Identities = 51/160 (31%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
R+ + GT E LAPEII +G+ +VDWW G+ ++E+ G PF + +VS
Sbjct: 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLNWALI--RCAV 819
+RFP S +DL+R LL + R G +K G +IK H +F +W I R
Sbjct: 254 KVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVE 311
Query: 820 PPELPRSCDAVIGSQKKESTKCEESKGAADEHV--EFEMF 857
P +P+ S + + EE + + +E EF F
Sbjct: 312 APFIPKFKGPGDTSNFDDYEE-EEIRVSINEKCGKEFTEF 350
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 131 bits (331), Expect = 8e-35
Identities = 40/174 (22%), Positives = 75/174 (43%), Gaps = 6/174 (3%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
++L + LG G + V+LA + A+KV+ D R + E + L+HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 531 FLPTLFAHFTTE----KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
+ ++ E +VMEY G L + + + + A +A+ AL
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALN 125
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPP 640
+ H G+++RD+KP NI++ + + DF ++ A + V ++ V
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 89.4 bits (221), Expect = 3e-20
Identities = 27/106 (25%), Positives = 49/106 (46%), Gaps = 5/106 (4%)
Query: 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV 759
+ ++ + +GT +YL+PE +G+ + D ++ G L+E+L G PF G
Sbjct: 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 226
Query: 760 VSQSLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803
V + P + +S ++ L K P+NR AAE++
Sbjct: 227 VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT---AAEMRA 269
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-34
Identities = 54/344 (15%), Positives = 101/344 (29%), Gaps = 59/344 (17%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+ +G G G V A A+K + + R E +I+ H
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRFRHE 66
Query: 531 FLPTLFAHFTTEKFS-----CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLAL 585
+ + LV +L+ + S +++ ++L L
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILRGL 122
Query: 586 EYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASS 645
+Y+H V++RDLKP N+L+ + + DF L+ + A
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA---------------------RVADP 161
Query: 646 PCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705
+ + + P ++ + K D+ + + +++ +
Sbjct: 162 DHDHTGFLTEYVATRWY----RAPEIMLNSKGYTK-SIDIWSVGCILAEML-----SNRP 211
Query: 706 SFVGTHEY-LAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL 764
F G H I+ G S D P K L
Sbjct: 212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL-------- 263
Query: 765 RFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808
+P A DL+ +L P R+ + HP+ E
Sbjct: 264 ----FPNADSKALDLLDKMLTFNPHKRI----EVEQALAHPYLE 299
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 2e-34
Identities = 36/157 (22%), Positives = 69/157 (43%), Gaps = 10/157 (6%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH 529
R K ++G G TVY T+ A + + L ++ R + E E+++ L H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ-RFKEEAEMLKGLQH 67
Query: 530 PFLPTLFAHFTT----EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLAL 585
P + + + + +K LV E G L ++ + + R + ++L L
Sbjct: 68 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGL 125
Query: 586 EYLHMLG--VVYRDLKPENILVR-EDGHIMLSDFDLS 619
++LH +++RDLK +NI + G + + D L+
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 24/115 (20%), Positives = 51/115 (44%), Gaps = 6/115 (5%)
Query: 695 LVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE 754
L + + + +GT E++APE+ + + SVD + FG+ + E+ P+ N
Sbjct: 161 LATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA 219
Query: 755 TLSNVVSQSLRFPGYP-VVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808
+ V+ ++ + V +++I G + + D R ++ H FF+
Sbjct: 220 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY----SIKDLLNHAFFQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-34
Identities = 59/151 (39%), Positives = 85/151 (56%), Gaps = 2/151 (1%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
M F K LG G G V L T +A+K++ + ++ + ++ TE ++Q
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
HPFL L F T C VMEY GG+L ++ F+E+ ARFY AE++ ALEYL
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYL 121
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
H VVYRD+K EN+++ +DGHI ++DF L
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-29
Identities = 47/137 (34%), Positives = 75/137 (54%), Gaps = 5/137 (3%)
Query: 697 VEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETL 756
GA +F GT EYLAPE+++ +G +VDWW G+ ++E++ GR PF ++
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLNWALI 815
++ + +RFP +S A+ L+ GLL K+P RLG A E+ +H FF +NW +
Sbjct: 215 ELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272
Query: 816 --RCAVPPELPRSCDAV 830
+ +PP P+ V
Sbjct: 273 VQKKLLPPFKPQVTSEV 289
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-34
Identities = 69/344 (20%), Positives = 113/344 (32%), Gaps = 55/344 (15%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
M +F+ +K+G G G VY A T + ALK + D A E +++ L+
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN 59
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
HP + L TE LV E+ + + + Y+ ++L L +
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLI-KSYLFQLLQGLAFC 118
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCS 648
H V++RDLKP+N+L+ +G I L+DF L A +
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGL------------------------ARAFGV 154
Query: 649 EASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708
+ + P +L K D+ + ++V T F
Sbjct: 155 PVRTYTHEVVTLWY----RAPEILL-GCKYYSTAVDIWSLGCIFAEMV---TRRA--LFP 204
Query: 709 GTHEY-LAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP 767
G E I + G V W + Q
Sbjct: 205 GDSEIDQLFRIFRTLGTPDEVVW-------------PGVTSMPDYKPSFPKWARQDFS-K 250
Query: 768 GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811
P + R L+ +L +P+ R+ A HPFF+ +
Sbjct: 251 VVPPLDEDGRSLLSQMLHYDPNKRI----SAKAALAHPFFQDVT 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 130 bits (327), Expect = 4e-34
Identities = 66/342 (19%), Positives = 120/342 (35%), Gaps = 59/342 (17%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
M + +K+G G G VY A+ FALK + + E I++ L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK 58
Query: 529 HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
H + L+ T+K LV E+ +L + A+ ++ ++L + Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYC 116
Query: 589 HMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCS 648
H V++RDLKP+N+L+ +G + ++DF L+ P +K +
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAF--------------GIPVRKYTHEIV 162
Query: 649 EASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708
P L S + S D+ + ++V G F
Sbjct: 163 TLWYRAPDVLMGSKKYST---------------TIDIWSVGCIFAEMV---NGTP--LFP 202
Query: 709 GTHEY-LAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP 767
G E I + G +S +W P + V + L +
Sbjct: 203 GVSEADQLMRIFRILGTPNSKNW---------------PNVTELPKYDPNFTVYEPLPWE 247
Query: 768 GY-PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808
+ + DL+ +L +P+ R+ A + +H +F+
Sbjct: 248 SFLKGLDESGIDLLSKMLKLDPNQRI----TAKQALEHAYFK 285
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (327), Expect = 6e-34
Identities = 38/182 (20%), Positives = 73/182 (40%), Gaps = 6/182 (3%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTS---CLFALKVMDNDFLVGRKKMPRAQTEREIMQ 525
+ K+ + +G G+ G V L A+K + + + +++ +E IM
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMG 82
Query: 526 MLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLAL 585
DHP + L T ++ E+ G L ++ +F + + + +
Sbjct: 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVGMLRGIAAGM 141
Query: 586 EYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASS 645
+YL + V+RDL NILV + +SDF LS + +S + P + ++
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 646 PC 647
P
Sbjct: 202 PE 203
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 69.8 bits (170), Expect = 2e-13
Identities = 24/112 (21%), Positives = 48/112 (42%), Gaps = 5/112 (4%)
Query: 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETL 756
+PT + + APE I+ S+ D W++GI ++E++ YG P+ N + +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA---VKGAAEIKQHP 805
+ + Q R P L+ K+ ++R V ++ ++P
Sbjct: 244 NAIE-QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 7e-34
Identities = 65/351 (18%), Positives = 117/351 (33%), Gaps = 67/351 (19%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
++ + +G G G V A T A+K + F RA E +++ + H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHE 77
Query: 531 FLPTLFAHFTTEKFS------CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLA 584
+ L FT ++ LVM + +++ ++ E +F V ++L
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LGEDRIQFLVYQMLKG 133
Query: 585 LEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPK-KA 643
L Y+H G+++RDLKP N+ V ED + + DF L+ R A + M + P
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-RQADSEMTGYVVTRWYRAPEVILN 192
Query: 644 SSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703
++ I + ++ T
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTL---------------------------------- 218
Query: 704 SNSFVGTHEY-LAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
F G+ EI+K G + + P + ++ S
Sbjct: 219 ---FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 275
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813
A +L+ +LV + + R+ A E HP+FE L+
Sbjct: 276 L------------AVNLLEKMLVLDAEQRV----TAGEALAHPYFESLHDT 310
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 7e-34
Identities = 43/149 (28%), Positives = 60/149 (40%), Gaps = 8/149 (5%)
Query: 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD 528
M+ KL + +G G+ G V L + G A+K + ND E +M L
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKND-----ATAQAFLAEASVMTQLR 58
Query: 529 HPFLPTLFAHFTTEKFS-CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
H L L EK +V EY G L + + + +V A+EY
Sbjct: 59 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDF 616
L V+RDL N+LV ED +SDF
Sbjct: 119 LEGNNFVHRDLAARNVLVSEDNVAKVSDF 147
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.3 bits (182), Expect = 3e-15
Identities = 18/106 (16%), Positives = 41/106 (38%), Gaps = 5/106 (4%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETLSNVVS 761
++ ++ APE ++ + + D W+FGI L+E+ +GR P+ + + V
Sbjct: 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE- 214
Query: 762 QSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGA---VKGAAEIKQH 804
+ + ++++ + R + IK H
Sbjct: 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-33
Identities = 46/187 (24%), Positives = 70/187 (37%), Gaps = 9/187 (4%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH 529
+ K+LG G G V + G A+K++ + E ++M L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQY-DVAIKMIKEGSMSED----EFIEEAKVMMNLSH 58
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
L L+ T ++ ++ EY G L ++ RF Q +V A+EYL
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF-QTQQLLEMCKDVCEAMEYLE 117
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSS---SPVEEPPPKKASSP 646
++RDL N LV + G + +SDF LS + PP S
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 647 CSEASCI 653
S S I
Sbjct: 178 FSSKSDI 184
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.2 bits (179), Expect = 6e-15
Identities = 21/114 (18%), Positives = 44/114 (38%), Gaps = 6/114 (5%)
Query: 692 MPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGS 750
+ + V++ S + PE++ S D W FG+ ++E+ G+ P++
Sbjct: 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205
Query: 751 GNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804
N ET ++ Q LR + S ++ ++ D R + +
Sbjct: 206 TNSETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERP----TFKILLSN 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-33
Identities = 37/184 (20%), Positives = 65/184 (35%), Gaps = 9/184 (4%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
KL ++LG G G V++ G + A+K + E +M+ L H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLKQG----SMSPDAFLAEANLMKQLQHQ 68
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
L L+A T E ++ EY G L + + A++ + ++
Sbjct: 69 RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSS---SPVEEPPPKKASSPC 647
++RDL+ NILV + ++DF L+ N + P
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 648 SEAS 651
+ S
Sbjct: 188 TIKS 191
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.1 bits (166), Expect = 4e-13
Identities = 26/120 (21%), Positives = 46/120 (38%), Gaps = 8/120 (6%)
Query: 691 PMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKG 749
+ +L+ + ++ APE I D W+FGI L E++ +GR P+ G
Sbjct: 154 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
Query: 750 SGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ--HPFF 807
N E + N+ + R L+R + P++R ++ FF
Sbjct: 214 MTNPEVIQNLE-RGYRMVRPDNCPEELYQLMRLCWKERPEDRP----TFDYLRSVLEDFF 268
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-33
Identities = 62/166 (37%), Positives = 98/166 (59%), Gaps = 7/166 (4%)
Query: 467 MGMRHFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLVGRKKMP-RAQTERE 522
+G+ +F+L K LG G G V+L I T L+A+KV+ +V + K +TER+
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 523 IMQMLDH-PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEV 581
+++ + PFL TL F TE L+++Y GG+L ++ F+E + YV E+
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEI 138
Query: 582 LLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627
+LALE+LH LG++YRD+K ENIL+ +GH++L+DF LS +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-24
Identities = 50/137 (36%), Positives = 76/137 (55%), Gaps = 7/137 (5%)
Query: 696 VVEPTGARSNSFVGTHEYLAPEIIKG--EGHGSSVDWWTFGIFLFELLYGRTPFKGSGND 753
V R+ F GT EY+AP+I++G GH +VDWW+ G+ ++ELL G +PF G
Sbjct: 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238
Query: 754 ETLSNVVSQSLRF--PGYPVVSFHARDLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGL 810
+ + + + L+ P +S A+DLI+ LL+K+P RLG A EIK+H FF+ +
Sbjct: 239 NSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298
Query: 811 NWALI--RCAVPPELPR 825
NW + + P P
Sbjct: 299 NWDDLAAKKVPAPFKPV 315
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 3e-33
Identities = 41/166 (24%), Positives = 65/166 (39%), Gaps = 6/166 (3%)
Query: 476 KKLGCGDIGTVYLAELI--GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLP 533
+LGCG+ G+V A+KV+ + E +IM LD+P++
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIV 72
Query: 534 TLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
L E LVME GG LH + + +V + ++YL
Sbjct: 73 RLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVSMGMKYLEEKNF 130
Query: 594 VYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPP 639
V+RDL N+L+ + +SDF LS + + S + P
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.6 bits (180), Expect = 8e-15
Identities = 20/112 (17%), Positives = 44/112 (39%), Gaps = 3/112 (2%)
Query: 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETL 756
+ ++ ++ APE I S D W++G+ ++E L YG+ P+K E +
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 222
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFE 808
+ + Q R P L+ + + ++R + + ++
Sbjct: 223 AFIE-QGKRMECPPECPPELYALMSDCWIYKWEDRPDF-LTVEQRMRACYYS 272
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 5e-33
Identities = 66/358 (18%), Positives = 114/358 (31%), Gaps = 70/358 (19%)
Query: 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSC-LFALKVMDNDFLVGRKKMPRAQTEREIM 524
C + ++ ++G G G V+ A + ALK + + E ++
Sbjct: 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-STIREVAVL 61
Query: 525 QML---DHPFLPTLFAHFTTEKFS-----CLVMEYCPGGDLHVLRQKQPSRFFSEQAARF 576
+ L +HP + LF T + LV E+ K P + +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKD 120
Query: 577 YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKS-SSPV 635
+ ++L L++LH VV+RDLKP+NILV G I L+DF L+ + + +
Sbjct: 121 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 180
Query: 636 EEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQL 695
P S + + W V C +
Sbjct: 181 YRAPEVLLQSSYATPVDL--------WSVGCIFAEMFR---------------------- 210
Query: 696 VVEPTGARSNSFVGTHEY-LAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDE 754
R F G+ + +I+ G DW P + +
Sbjct: 211 -------RKPLFRGSSDVDQLGKILDVIGLPGEEDW---------------PRDVALPRQ 248
Query: 755 TLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812
+ +Q + + +DL+ L P R+ A HP+F+ L
Sbjct: 249 AFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRI----SAYSALSHPYFQDLER 301
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 6e-33
Identities = 42/175 (24%), Positives = 74/175 (42%), Gaps = 16/175 (9%)
Query: 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIM-QMLDHPFL 532
+ LG G G V T FALK++ + P+A+ E E+ + P +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHI 67
Query: 533 PTLFAHFTT----EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYL 588
+ + K +VME GG+L Q + + F+E+ A + + A++YL
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 589 HMLGVVYRDLKPENILV---REDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPP 640
H + + +RD+KPEN+L R + + L+DF + + + P
Sbjct: 128 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.0 bits (220), Expect = 1e-19
Identities = 39/165 (23%), Positives = 65/165 (39%), Gaps = 19/165 (11%)
Query: 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN 758
+ + T Y+APE++ E + S D W+ G+ ++ LL G PF +
Sbjct: 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 224
Query: 759 VVSQ------SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812
+ ++ P + VS + LIR LL EP R+ E HP+
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNHPWI----- 275
Query: 813 ALIRCAVPPELPRSCDAVIGSQKK--ESTKCEESKGAADEHVEFE 855
++ P+ P V+ K+ E K E + A V++E
Sbjct: 276 --MQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYE 318
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 6e-33
Identities = 43/158 (27%), Positives = 62/158 (39%), Gaps = 6/158 (3%)
Query: 466 CM-GMRHFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLVGRKKMPRAQTER 521
C+ G + +L +KLG G G V E G + A+K + D L + M E
Sbjct: 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62
Query: 522 EIMQMLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEV 581
M LDH L L+ T +V E P G L +K F Y +V
Sbjct: 63 NAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHF-LLGTLSRYAVQV 120
Query: 582 LLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ YL ++RDL N+L+ + + DF L
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 158
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.0 bits (194), Expect = 1e-16
Identities = 19/95 (20%), Positives = 37/95 (38%), Gaps = 1/95 (1%)
Query: 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETL 756
+ + APE +K + D W FG+ L+E+ YG+ P+ G + L
Sbjct: 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791
+ + R P +++ +P++R
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 9e-33
Identities = 34/186 (18%), Positives = 71/186 (38%), Gaps = 8/186 (4%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+ + + LG G+ G V+ + + K + + E I+ + H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHR 61
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
+ L F + + ++ E+ G D+ +E+ YV +V AL++LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS 120
Query: 591 LGVVYRDLKPENILV--REDGHIMLSDFDLSLRCAVN-PMVVKSSSPVEEPPPKKASSPC 647
+ + D++PENI+ R I + +F + + + ++P P
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 648 SEASCI 653
S A+ +
Sbjct: 181 STATDM 186
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.4 bits (242), Expect = 1e-22
Identities = 34/122 (27%), Positives = 57/122 (46%), Gaps = 10/122 (8%)
Query: 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV 760
G EY APE+ + + ++ D W+ G ++ LL G PF N + + N++
Sbjct: 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216
Query: 761 SQSLRFP--GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF----EGLNWAL 814
+ F + +S A D + LLVKE +R+ A+E QHP+ E ++ +
Sbjct: 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHPWLKQKIERVSTKV 272
Query: 815 IR 816
IR
Sbjct: 273 IR 274
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 1e-32
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 6/167 (3%)
Query: 476 KKLGCGDIGTVYLAELI--GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLP 533
K+LG G+ GTV A+K++ N+ K E +MQ LD+P++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD-ELLAEANVMQQLDNPYIV 71
Query: 534 TLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
+ E + LVME G L+ Q+ R ++ V +V + ++YL
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 594 VYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPP 640
V+RDL N+L+ + +SDF LS + K+ + + P
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.4 bits (208), Expect = 2e-18
Identities = 22/110 (20%), Positives = 43/110 (39%), Gaps = 3/110 (2%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETLSNVVSQ 762
++ APE I S D W+FG+ ++E YG+ P++G E + + +
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-K 225
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812
R DL+ + +NR G ++ +++ +N
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGF-AAVELRLRNYYYDVVNE 274
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-32
Identities = 42/230 (18%), Positives = 74/230 (32%), Gaps = 33/230 (14%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTS-----CLFALKVMDNDFLVGRKKMPRAQTEREIMQ 525
+ + K LG G G V A G S A+K++ ++ +E ++M
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE--ALMSELKMMT 95
Query: 526 ML-DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRF---------------- 568
L H + L T L+ EYC GDL + + +F
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 569 -----FSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623
+ + + +V +E+L V+RDL N+LV + + DF L+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 624 VNPMVVKSSSPV----EEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTP 669
+ V + P + S + + + S
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.3 bits (174), Expect = 7e-14
Identities = 14/101 (13%), Positives = 34/101 (33%), Gaps = 5/101 (4%)
Query: 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETLSNVVSQS 763
+ +++APE + + D W++GI L+E+ G P+ G D ++
Sbjct: 224 GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG 283
Query: 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804
+ + +++ + R +
Sbjct: 284 FKMDQPFYATEEIYIIMQSCWAFDSRKRP----SFPNLTSF 320
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 1e-31
Identities = 38/149 (25%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+L KLG G G V++ GT+ A+K + + E ++M+ L H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPE----AFLQEAQVMKKLRHE 72
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
L L+A + E +V EY G L + + ++ A++ + Y+
Sbjct: 73 KLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ V+RDL+ NILV E+ ++DF L+
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLA 160
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.5 bits (185), Expect = 2e-15
Identities = 23/121 (19%), Positives = 39/121 (32%), Gaps = 6/121 (4%)
Query: 692 MPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG 751
+ +L+ + ++ APE D W+FGI L EL
Sbjct: 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218
Query: 752 NDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ--HPFFEG 809
+ + + V + R P P DL+ KEP+ R ++ +F
Sbjct: 219 VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP----TFEYLQAFLEDYFTS 274
Query: 810 L 810
Sbjct: 275 T 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 38/148 (25%), Positives = 60/148 (40%), Gaps = 6/148 (4%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
+++G G G V+L + A+K + + E E+M L HP
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEE----DFIEEAEVMMKLSHP 60
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM 590
L L+ + CLV E+ G L + Q F + + +V + YL
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYLEE 119
Query: 591 LGVVYRDLKPENILVREDGHIMLSDFDL 618
V++RDL N LV E+ I +SDF +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGM 147
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.3 bits (182), Expect = 3e-15
Identities = 17/113 (15%), Positives = 44/113 (38%), Gaps = 4/113 (3%)
Query: 692 MPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSG 751
M + V++ S ++ +PE+ + S D W+FG+ ++E+ +
Sbjct: 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206
Query: 752 NDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804
++ + +S R + S H ++ + P++R + + +
Sbjct: 207 SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRP----AFSRLLRQ 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-31
Identities = 36/212 (16%), Positives = 70/212 (33%), Gaps = 28/212 (13%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ 525
K LG G G V A G + A+K++ + ++ +E +++
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE--ALMSELKVLS 81
Query: 526 ML-DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRF---------------- 568
L +H + L T + ++ EYC GDL +++ F
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 569 FSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628
+ + +V + +L ++RDL NIL+ + DF L+ +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 629 VKSS----SPVEEPPPKKASSPCSEASCIEPF 656
V P + + S + +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.4 bits (148), Expect = 1e-10
Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 1/90 (1%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETLSNVVS 761
+ +++APE I + D W++GIFL+EL G +P+ G D ++
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262
Query: 762 QSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791
+ R D+++ +P R
Sbjct: 263 EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 7e-31
Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 4/146 (2%)
Query: 476 KKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTERE--IMQMLDHPFLP 533
LG G TVY A T+ + A+K + K RE ++Q L HP +
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 534 TLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGV 593
L F + LV ++ +++ S + + Y+ L LEYLH +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 594 VYRDLKPENILVREDGHIMLSDFDLS 619
++RDLKP N+L+ E+G + L+DF L+
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLA 147
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 3e-18
Identities = 30/146 (20%), Positives = 45/146 (30%), Gaps = 35/146 (23%)
Query: 707 FVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR 765
V T Y APE++ G +G VD W G L ELL G + + L+ +
Sbjct: 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 219
Query: 766 FPG--------------------------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAA 799
+ DLI+GL + P R+ A
Sbjct: 220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI----TAT 275
Query: 800 EIKQHPFFEGLNWALIRCAVPPELPR 825
+ + +F +LPR
Sbjct: 276 QALKMKYFSNRPGP----TPGCQLPR 297
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-30
Identities = 39/175 (22%), Positives = 71/175 (40%), Gaps = 7/175 (4%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMP---RAQTEREIMQML 527
+++ LG G G+VY + + A+K ++ D + ++P R E +++ +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 528 D--HPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLAL 585
+ L F L++E + E+ AR + +VL A+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL-QEELARSFFWQVLEAV 123
Query: 586 EYLHMLGVVYRDLKPENILVRED-GHIMLSDFDLSLRCAVNPMVVKSSSPVEEPP 639
+ H GV++RD+K ENIL+ + G + L DF + V PP
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPP 178
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 4e-21
Identities = 30/107 (28%), Positives = 46/107 (42%), Gaps = 13/107 (12%)
Query: 705 NSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS 763
F GT Y PE I+ HG S W+ GI L++++ G PF+ ++
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQ 220
Query: 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810
+ F VS + LIR L P +R EI+ HP+ + +
Sbjct: 221 VFFR--QRVSSECQHLIRWCLALRPSDRP----TFEEIQNHPWMQDV 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-30
Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 9/159 (5%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG-RKKMPRAQTERE--IMQML 527
++ ++LG G V T +A K + R+ + R ERE I++ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
HP + TL + + L++E GG+L ++ +E+ A ++ ++L + Y
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYY 128
Query: 588 LHMLGVVYRDLKPENILVREDG----HIMLSDFDLSLRC 622
LH L + + DLKPENI++ + I + DF L+ +
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 3e-28
Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 8/129 (6%)
Query: 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN 758
G + GT E++APEI+ E G D W+ G+ + LL G +PF G ETL+N
Sbjct: 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 227
Query: 759 VVSQSLRFPG--YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW--AL 814
V + + F + S A+D IR LLVK+P R+ + QHP+ + + AL
Sbjct: 228 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKPKDTQQAL 283
Query: 815 IRCAVPPEL 823
P+
Sbjct: 284 SSAWSHPQF 292
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-30
Identities = 61/343 (17%), Positives = 110/343 (32%), Gaps = 63/343 (18%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHP 530
++ +G G G+V A T A+K + F R E +++ + H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHE 77
Query: 531 FLPTLFAHFTT-----EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLAL 585
+ L FT E ++ + G DL+ + + Q ++ +F + ++L L
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 134
Query: 586 EYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASS 645
+Y+H +++RDLKP N+ V ED + + DF L+ ++ P
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 646 PCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705
++ I W V C LL+
Sbjct: 195 HYNQTVDI--------WSVGCIMAELLT-----------------------------GRT 217
Query: 706 SFVGTHEY-LAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL 764
F GT I++ G + N +
Sbjct: 218 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-------- 269
Query: 765 RFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF 807
+ + A DL+ +LV + D R+ AA+ H +F
Sbjct: 270 ----FIGANPLAVDLLEKMLVLDSDKRI----TAAQALAHAYF 304
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 5e-30
Identities = 38/152 (25%), Positives = 61/152 (40%), Gaps = 7/152 (4%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTS---CLFALKVMDNDFLVGRKKMPRAQTEREIMQML 527
+L + +G G G V+ + A+K N ++ + E M+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEALTMRQF 65
Query: 528 DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEY 587
DHP + L T E ++ME C G+L Q + + Y ++ AL Y
Sbjct: 66 DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSL-DLASLILYAYQLSTALAY 123
Query: 588 LHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
L V+RD+ N+LV + + L DF LS
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.0 bits (168), Expect = 2e-13
Identities = 25/112 (22%), Positives = 48/112 (42%), Gaps = 6/112 (5%)
Query: 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGN 752
+ + + T +++ +++APE I S+ D W FG+ ++E+L +G PF+G N
Sbjct: 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215
Query: 753 DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804
++ + + R P P L+ +P R E+K
Sbjct: 216 NDVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRP----RFTELKAQ 262
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (296), Expect = 7e-30
Identities = 38/160 (23%), Positives = 70/160 (43%), Gaps = 14/160 (8%)
Query: 467 MGMR---HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI 523
M +R ++L +K+G G G +YL I A+K+ + K P+ E +I
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKI 55
Query: 524 MQMLDHP-FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVL 582
+M+ +PT+ ++ +VME SR FS + +++
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQMI 113
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGH---IMLSDFDLS 619
+EY+H ++RD+KP+N L+ + + DF L+
Sbjct: 114 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 74.5 bits (182), Expect = 4e-15
Identities = 15/117 (12%), Positives = 33/117 (28%), Gaps = 8/117 (6%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
+ + GT Y + G D + G L G P++G
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228
Query: 763 SLRFPGYPV------VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF-EGLNW 812
S + P+ + D++ ++ ++ F +G ++
Sbjct: 229 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY-SYLRQLFRNLFHRQGFSY 284
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (295), Expect = 1e-29
Identities = 44/212 (20%), Positives = 70/212 (33%), Gaps = 33/212 (15%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ 525
+ + + +G G G V+ A G + A+K++ + + Q E +M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALMA 71
Query: 526 MLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRF---------------- 568
D+P + L K CL+ EY GDL+ LR P
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 569 -----FSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623
S +V + YL V+RDL N LV E+ + ++DF LS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 624 VNPMVVKSSSPV----EEPPPKKASSPCSEAS 651
+ PP + + S
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTES 223
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 116 bits (291), Expect = 3e-29
Identities = 31/155 (20%), Positives = 64/155 (41%), Gaps = 13/155 (8%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH- 529
H+K+ +++G G G ++ + + A+K R P+ + E ++L
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 60
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
+P ++ + LV++ +L R FS + ++L ++ +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIH 118
Query: 590 MLGVVYRDLKPENILVRE-----DGHIMLSDFDLS 619
+VYRD+KP+N L+ I + DF +
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 64.1 bits (155), Expect = 1e-11
Identities = 13/95 (13%), Positives = 21/95 (22%), Gaps = 6/95 (6%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
+ GT Y++ G D G L G P++G
Sbjct: 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
Query: 763 SLRFPGYPVVSFHA------RDLIRGLLVKEPDNR 791
+ P+ A + D
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-29
Identities = 42/201 (20%), Positives = 68/201 (33%), Gaps = 16/201 (7%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHP 530
K +G G+ G V A + + + E E++ L HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 531 FLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQK--------------QPSRFFSEQAARF 576
+ L + L +EY P G+L +K + S Q
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 577 YVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVE 636
+ A+V ++YL ++RDL NILV E+ ++DF LS V PV
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 191
Query: 637 EPPPKKA-SSPCSEASCIEPF 656
+ S + S + +
Sbjct: 192 WMAIESLNYSVYTTNSDVWSY 212
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (168), Expect = 4e-13
Identities = 21/107 (19%), Positives = 40/107 (37%), Gaps = 6/107 (5%)
Query: 699 PTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETLS 757
+ ++A E + + ++ D W++G+ L+E++ G TP+ G E
Sbjct: 178 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 758 NVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804
+ Q R DL+R ++P R A+I
Sbjct: 238 KLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERP----SFAQILVS 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 6e-28
Identities = 37/171 (21%), Positives = 60/171 (35%), Gaps = 4/171 (2%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDF--LVGRKKMPRAQTEREIMQMLDH 529
FK K LG G GTVY I + V + K E +M +D+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 530 PFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLH 589
P + L T L+ + P G L ++ Q + ++ + YL
Sbjct: 71 PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE 128
Query: 590 MLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPP 640
+V+RDL N+LV+ H+ ++DF L+ +
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.9 bits (165), Expect = 9e-13
Identities = 19/95 (20%), Positives = 44/95 (46%), Gaps = 2/95 (2%)
Query: 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETL 756
E + +++A E I + D W++G+ ++EL+ +G P+ G E +
Sbjct: 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-I 222
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791
S+++ + R P P+ + ++ + + D+R
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSR 257
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-27
Identities = 44/171 (25%), Positives = 69/171 (40%), Gaps = 24/171 (14%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTS-------CLFALKVMDNDFLVGRKKMPRAQTEREI 523
L K LG G G V LAE IG A+K++ +D K + +E E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71
Query: 524 MQML-DHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVL--------------RQKQPSRF 568
M+M+ H + L T + +++EY G+L P
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 569 FSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
S + +V +EYL ++RDL N+LV ED + ++DF L+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.2 bits (163), Expect = 1e-12
Identities = 17/95 (17%), Positives = 38/95 (40%), Gaps = 2/95 (2%)
Query: 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGSGNDETL 756
++ + +++APE + + D W+FG+ L+E+ G +P+ G +E
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNR 791
++ + R + ++R P R
Sbjct: 248 -KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 3e-27
Identities = 41/177 (23%), Positives = 68/177 (38%), Gaps = 7/177 (3%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIGTS----CLFALKVMDNDFLVGRKKMPRAQTEREIMQM 526
K +G G+ G VY L +S A+K + + ++ E IM
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQ 65
Query: 527 LDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
H + L + K ++ EY G L +++ FS + + ++
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMK 124
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKA 643
YL + V+RDL NILV + +SDF LS +P ++S + P A
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 5e-13
Identities = 16/88 (18%), Positives = 32/88 (36%)
Query: 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS 763
++ + APE I S+ D W+FGI ++E++ ++ + ++
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229
Query: 764 LRFPGYPVVSFHARDLIRGLLVKEPDNR 791
R P L+ +E R
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARR 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 1e-26
Identities = 37/185 (20%), Positives = 67/185 (36%), Gaps = 21/185 (11%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ 525
KL K LG G G V A+ G T A+K++ + + ++
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILIH 72
Query: 526 MLDHPFLPTLF-AHFTTEKFSCLVMEYCPGGDLHVLRQKQ--------------PSRFFS 570
+ H + L A +++E+C G+L + + F +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 571 EQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630
+ Y +V +E+L ++RDL NIL+ E + + DF L+ +P V+
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 631 SSSPV 635
Sbjct: 193 KGDAR 197
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.7 bits (159), Expect = 4e-12
Identities = 22/108 (20%), Positives = 40/108 (37%), Gaps = 5/108 (4%)
Query: 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYG-RTPFKGSGNDETL 756
+P R +++APE I + D W+FG+ L+E+ +P+ G DE
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246
Query: 757 SNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804
+ + R + + EP R +E+ +H
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP----TFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 1e-26
Identities = 37/167 (22%), Positives = 63/167 (37%), Gaps = 25/167 (14%)
Query: 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQM--L 527
R L + +G G G V+ + G A+K+ ++ E EI Q L
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGE--EVAVKIFS------SREERSWFREAEIYQTVML 54
Query: 528 DHPFLPTLFAHFTTEKFS----CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLL 583
H + A + + LV +Y G L + + +
Sbjct: 55 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTAS 111
Query: 584 ALEYLHM--------LGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622
L +LHM + +RDLK +NILV+++G ++D L++R
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.5 bits (117), Expect = 8e-07
Identities = 20/123 (16%), Positives = 35/123 (28%), Gaps = 26/123 (21%)
Query: 698 EPTGARSNSFVGTHEYLAPEIIKGEGH------GSSVDWWTFGIFLFELLYGRTPFKGSG 751
+ N VGT Y+APE++ + D + G+ +E+ +
Sbjct: 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222
Query: 752 ND--------------ETLSNVVSQSLRFPGYPV------VSFHARDLIRGLLVKEPDNR 791
+ E + VV + P P ++R R
Sbjct: 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282
Query: 792 LGA 794
L A
Sbjct: 283 LTA 285
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (265), Expect = 2e-25
Identities = 59/376 (15%), Positives = 119/376 (31%), Gaps = 56/376 (14%)
Query: 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPF 531
+ L +KLG G TV+LA+ + + A+K++ D + A+ E +++Q ++
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDAD 70
Query: 532 LPTL--------------FAHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFY 577
F H +++ G +L L +K R +
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 578 VAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVE 636
++LL L+Y+H G+++ D+KPEN+L+ + + + N
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE-NLIQIKIADLGNACWYDEHYTNS 189
Query: 637 EPPPKKASSPCSEASCIEPFCLHPSWQVS---CFTPRLLSVAAKSRKIKSDLAAQVSPMP 693
+ S + S T L + ++ +
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL-FEPDEGHSYTKDDDHIAQII 248
Query: 694 QLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND 753
+L+ E P + G + + + G+ P
Sbjct: 249 ELLGEL----------------PSYLLRNGKYTRTFFNSRGLLRNISKLKFWP------- 285
Query: 754 ETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFF-EGLNW 812
L +V+++ +F + D + +L +P R A + HP+ + L
Sbjct: 286 --LEDVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRA----DAGGLVNHPWLKDTLGM 337
Query: 813 ALIRCAVPPELPRSCD 828
IR D
Sbjct: 338 EEIRVPDRELYGSGSD 353
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 3e-25
Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 9/153 (5%)
Query: 471 HFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML 527
HF + +G G G VY L+ G A+K ++ +G + TE IM+
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGIIMKDF 85
Query: 528 DHPFLPTLF-AHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALE 586
HP + +L +E +V+ Y GDL + + + F +V ++
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMK 144
Query: 587 YLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+L V+RDL N ++ E + ++DF L+
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (172), Expect = 1e-13
Identities = 14/89 (15%), Positives = 33/89 (37%)
Query: 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQ 762
+++A E ++ + + D W+FG+ L+EL+ P N ++ + Q
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 763 SLRFPGYPVVSFHARDLIRGLLVKEPDNR 791
R +++ + + R
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 8e-25
Identities = 34/161 (21%), Positives = 61/161 (37%), Gaps = 15/161 (9%)
Query: 471 HFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ 525
+ ++LG G G VY G A+K ++ + + E +M+
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 78
Query: 526 MLDHPFLPTLFAHFTTEKFSCLVMEYCPGGDLH-VLRQKQPSRF-------FSEQAARFY 577
+ + L + + + ++ME GDL LR +P+ S
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 578 VAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDL 618
E+ + YL+ V+RDL N +V ED + + DF +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (161), Expect = 2e-12
Identities = 22/123 (17%), Positives = 47/123 (38%), Gaps = 4/123 (3%)
Query: 692 MPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELL-YGRTPFKGS 750
+ + + +++PE +K + D W+FG+ L+E+ P++G
Sbjct: 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239
Query: 751 GNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ--HPFFE 808
N++ L V+ +L+R P R ++ + IK+ P F
Sbjct: 240 SNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
Query: 809 GLN 811
++
Sbjct: 299 EVS 301
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 75.2 bits (184), Expect = 4e-16
Identities = 22/157 (14%), Positives = 43/157 (27%), Gaps = 22/157 (14%)
Query: 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKM-------PRAQTEREIMQM 526
+ K +G G V+ +K +K
Sbjct: 4 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 527 LDHPFLPTLFAHFTTEKF----SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVL 582
+ L L + + + ++ME + + +L
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK---------ELYRVRVENPDEVLDMIL 113
Query: 583 LALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLS 619
+ + G+V+ DL N+LV + I + DF S
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 857 | |||
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.44 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.99 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.81 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.91 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.8 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.56 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-60 Score=511.15 Aligned_cols=281 Identities=36% Similarity=0.646 Sum_probs=246.7
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|++++.||+|+||+||+|+++.+++.||||++++.........+.+.+|+++|++++||||++++++|.+++.+||
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 34679999999999999999999999999999999987665556677789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
|||||+||+|..++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+...
T Consensus 86 vmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~-- 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-- 161 (288)
T ss_dssp EECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC--
Confidence 999999999998887653 3999999999999999999999999999999999999999999999999998542110
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.........
T Consensus 162 -----------------------------------------------------------------------~~~~~~~~~ 170 (288)
T d1uu3a_ 162 -----------------------------------------------------------------------SKQARANSF 170 (288)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred -----------------------------------------------------------------------Ccccccccc
Confidence 001122356
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++.++....+.+|. .+++++++||.+||++|
T Consensus 171 ~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~d 248 (288)
T d1uu3a_ 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLLVLD 248 (288)
T ss_dssp CCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT--TCCHHHHHHHHTTSCSS
T ss_pred cCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHHccCC
Confidence 7999999999999999999999999999999999999999998888888898888777764 59999999999999999
Q ss_pred cCCcCCchh--hHHHHHcCCCCCCCChhhhccCCCCCCCC
Q 035930 788 PDNRLGAVK--GAAEIKQHPFFEGLNWALIRCAVPPELPR 825 (857)
Q Consensus 788 Pe~Rpt~~~--~a~ELL~HPfF~~l~w~li~~~~pp~~P~ 825 (857)
|.+|||+.. ....|++||||++++|..++...||.+|.
T Consensus 249 P~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~~ 288 (288)
T d1uu3a_ 249 ATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 288 (288)
T ss_dssp GGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC-
T ss_pred HhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCCC
Confidence 999999533 23458999999999999999999999873
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-59 Score=511.54 Aligned_cols=281 Identities=37% Similarity=0.718 Sum_probs=251.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++||||++++++|.+++.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 45678999999999999999999999999999999998876666667788999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
||||||+||+|..++.... .+++..++.+++||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 82 iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~-- 157 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp EEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred cceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--
Confidence 9999999999999888754 399999999999999999999999999999999999999999999999999853210
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.......
T Consensus 158 -------------------------------------------------------------------------~~~~~~~ 164 (337)
T d1o6la_ 158 -------------------------------------------------------------------------DGATMKT 164 (337)
T ss_dssp -------------------------------------------------------------------------TTCCBCC
T ss_pred -------------------------------------------------------------------------CCccccc
Confidence 0112245
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
++||+.|||||++.+.+|+.++|||||||+||||++|+.||.+.+..+++..+....+.+|. .+++++++||++||++
T Consensus 165 ~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~~L~~ 242 (337)
T d1o6la_ 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKK 242 (337)
T ss_dssp CEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCS
T ss_pred ceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHhhccC
Confidence 68999999999999999999999999999999999999999999988889998888877775 5999999999999999
Q ss_pred CcCCcCCchh-hHHHHHcCCCCCCCChhhh--ccCCCCCCCCC
Q 035930 787 EPDNRLGAVK-GAAEIKQHPFFEGLNWALI--RCAVPPELPRS 826 (857)
Q Consensus 787 DPe~Rpt~~~-~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~ 826 (857)
||.+|+++.. +++||++||||.+++|..+ +...||+.|..
T Consensus 243 dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~ 285 (337)
T d1o6la_ 243 DPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 285 (337)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred CchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCC
Confidence 9999997433 4899999999999999866 45678888854
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-58 Score=500.17 Aligned_cols=277 Identities=34% Similarity=0.718 Sum_probs=247.4
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||+++++|.+++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 35789999999999999999999999999999999987766566677889999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
|||||.||+|..++..... +++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 82 vmE~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~---- 155 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---- 155 (316)
T ss_dssp EECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS----
T ss_pred EeeecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec----
Confidence 9999999999988887643 8999999999999999999999999999999999999999999999999984311
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
....+.
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (316)
T d1fota_ 156 --------------------------------------------------------------------------DVTYTL 161 (316)
T ss_dssp --------------------------------------------------------------------------SCBCCC
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 011245
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..++.....+| +.+++++++||.+||.+|
T Consensus 162 ~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~d 239 (316)
T d1fota_ 162 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVKDLLSRLITRD 239 (316)
T ss_dssp CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSC
T ss_pred cCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHhhhC
Confidence 799999999999999999999999999999999999999999988899999988877766 459999999999999999
Q ss_pred cCCcCCch-hhHHHHHcCCCCCCCChhhh--ccCCCCCCCCC
Q 035930 788 PDNRLGAV-KGAAEIKQHPFFEGLNWALI--RCAVPPELPRS 826 (857)
Q Consensus 788 Pe~Rpt~~-~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~ 826 (857)
|.+|++.. +++++||+||||++++|+.+ +...||+.|..
T Consensus 240 p~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~ 281 (316)
T d1fota_ 240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPI 281 (316)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC
T ss_pred HHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCc
Confidence 99997432 35999999999999999966 45677888753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.7e-58 Score=502.03 Aligned_cols=280 Identities=35% Similarity=0.634 Sum_probs=249.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
..+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+++|+.++|||||+++++|.+...+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 34578999999999999999999999999999999998776666677788999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
+||||+.||+|..++.... .+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 118 ~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~--- 192 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--- 192 (350)
T ss_dssp EEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS---
T ss_pred cccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc---
Confidence 9999999999988887654 39999999999999999999999999999999999999999999999999985421
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.....
T Consensus 193 ---------------------------------------------------------------------------~~~~~ 197 (350)
T d1rdqe_ 193 ---------------------------------------------------------------------------GRTWT 197 (350)
T ss_dssp ---------------------------------------------------------------------------SCBCC
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 01124
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+......+|. .+++++.+||++||.+
T Consensus 198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~ 275 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHHSCS
T ss_pred ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHHhhh
Confidence 57999999999999999999999999999999999999999998888888888888777664 5999999999999999
Q ss_pred CcCCcCC-chhhHHHHHcCCCCCCCChhhhc--cCCCCCCCCCCc
Q 035930 787 EPDNRLG-AVKGAAEIKQHPFFEGLNWALIR--CAVPPELPRSCD 828 (857)
Q Consensus 787 DPe~Rpt-~~~~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~~~ 828 (857)
||.+|+. .++++++||+||||++++|..+. ...||++|...+
T Consensus 276 dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~ 320 (350)
T d1rdqe_ 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKG 320 (350)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred CHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCC
Confidence 9999963 23459999999999999998663 467889987544
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-58 Score=484.86 Aligned_cols=257 Identities=33% Similarity=0.573 Sum_probs=232.1
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
.+++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+++|+.++|||||+++++|.+++.+||
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 35789999999999999999999999999999999987665556667788999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
|||||++|+|..++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|.....
T Consensus 84 vmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 158 (263)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred EEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence 999999999999887654 399999999999999999999999999999999999999999999999999743110
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
......
T Consensus 159 --------------------------------------------------------------------------~~~~~~ 164 (263)
T d2j4za1 159 --------------------------------------------------------------------------SRRTTL 164 (263)
T ss_dssp --------------------------------------------------------------------------CCCEET
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 011245
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+......+|. .+++++++||.+||++|
T Consensus 165 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~d 242 (263)
T d2j4za1 165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISRLLKHN 242 (263)
T ss_dssp TEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHTCSS
T ss_pred CCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHHccCC
Confidence 6999999999999999999999999999999999999999998888888888887777664 59999999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
|.+||| ++|+|+||||++
T Consensus 243 p~~R~t----~~eil~hp~~~~ 260 (263)
T d2j4za1 243 PSQRPM----LREVLEHPWITA 260 (263)
T ss_dssp GGGSCC----HHHHHTCHHHHH
T ss_pred HhHCcC----HHHHHcCcCcCC
Confidence 999999 999999999963
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-57 Score=491.85 Aligned_cols=275 Identities=39% Similarity=0.747 Sum_probs=236.8
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHH-HcCCCCccccceeeeeCCeEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ-MLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr-~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
++|++++.||+|+||+||+|+++.+++.||||++++.........+.+..|..+|. .++|||||+++++|.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999999999999999998765555566677778887765 68999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
||||++|+|..++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||++.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~---- 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML---- 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC----
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc----
Confidence 99999999999987654 389999999999999999999999999999999999999999999999999843210
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........+
T Consensus 156 -----------------------------------------------------------------------~~~~~~~~~ 164 (320)
T d1xjda_ 156 -----------------------------------------------------------------------GDAKTNTFC 164 (320)
T ss_dssp -----------------------------------------------------------------------TTCCBCCCC
T ss_pred -----------------------------------------------------------------------ccccccccC
Confidence 001123457
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCCc
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++..+..+...+|. .+++++++||++||++||
T Consensus 165 gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~~L~~dP 242 (320)
T d1xjda_ 165 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAKDLLVKLFVREP 242 (320)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHSCSSG
T ss_pred CCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHhcccCC
Confidence 999999999999999999999999999999999999999999888888888877766654 589999999999999999
Q ss_pred CCcCCchhhHH-HHHcCCCCCCCChhhhc--cCCCCCCCCCC
Q 035930 789 DNRLGAVKGAA-EIKQHPFFEGLNWALIR--CAVPPELPRSC 827 (857)
Q Consensus 789 e~Rpt~~~~a~-ELL~HPfF~~l~w~li~--~~~pp~~P~~~ 827 (857)
.+||+ +. +|++||||++++|+.+. ...||..|...
T Consensus 243 ~~R~s----~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~ 280 (320)
T d1xjda_ 243 EKRLG----VRGDIRQHPLFREINWEELERKEIDPPFRPKVK 280 (320)
T ss_dssp GGSBT----TBSCGGGSGGGTTCCHHHHHTTCSCC-------
T ss_pred CCCcC----HHHHHHhCchhccCCHHHHHhcCCCCCCCCCCC
Confidence 99999 64 89999999999998663 45677787653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-57 Score=478.07 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=219.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... ....+.+.+|+++|+.++|||||+++++|.+++.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 4689999999999999999999999999999999976532 23345688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
||||+||+|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+....
T Consensus 82 mEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-- 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 157 (271)
T ss_dssp EECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC--
Confidence 99999999999886543 49999999999999999999999999999999999999999999999999985422110
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........+
T Consensus 158 -----------------------------------------------------------------------~~~~~~~~~ 166 (271)
T d1nvra_ 158 -----------------------------------------------------------------------RERLLNKMC 166 (271)
T ss_dssp -----------------------------------------------------------------------EECCBCCCC
T ss_pred -----------------------------------------------------------------------cccccccee
Confidence 011123568
Q ss_pred CCCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCChhhh-HHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 709 GTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETL-SNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 709 GT~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l-~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
||+.|||||++.+..+ +.++|||||||+||||++|+.||......... ..+.......+.+..+++++++||.+||+.
T Consensus 167 GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 246 (271)
T d1nvra_ 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE 246 (271)
T ss_dssp SCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCS
T ss_pred eCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCC
Confidence 9999999999998887 57899999999999999999999876554333 333333334444567899999999999999
Q ss_pred CcCCcCCchhhHHHHHcCCCCCC
Q 035930 787 EPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
||.+||| ++|+|+||||+.
T Consensus 247 dP~~R~t----~~eil~hpwf~~ 265 (271)
T d1nvra_ 247 NPSARIT----IPDIKKDRWYNK 265 (271)
T ss_dssp STTTSCC----HHHHTTCTTTTC
T ss_pred ChhHCcC----HHHHhcCHhhCc
Confidence 9999999 999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=481.71 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=225.6
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++++.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc---ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997542 334567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|||+||+|..++.+. .+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+..
T Consensus 97 Ey~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~----- 168 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP----- 168 (293)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-----
T ss_pred EecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc-----
Confidence 999999999888764 399999999999999999999999999999999999999999999999999854211
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
........+|
T Consensus 169 ----------------------------------------------------------------------~~~~~~~~~g 178 (293)
T d1yhwa1 169 ----------------------------------------------------------------------EQSKRSTMVG 178 (293)
T ss_dssp ----------------------------------------------------------------------TTCCBCCCCS
T ss_pred ----------------------------------------------------------------------cccccccccc
Confidence 0112234579
Q ss_pred CCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-cCCCCCCCCHHHHHHHHhhccCCc
Q 035930 710 THEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL-RFPGYPVVSFHARDLIRGLLVKEP 788 (857)
Q Consensus 710 T~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~-~~p~~~~is~~l~dLI~k~L~~DP 788 (857)
|+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+..... .++.+..+++++++||.+||.+||
T Consensus 179 t~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 258 (293)
T d1yhwa1 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258 (293)
T ss_dssp CGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSST
T ss_pred CCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999999999999999999998877777777665533 344456789999999999999999
Q ss_pred CCcCCchhhHHHHHcCCCCCC
Q 035930 789 DNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 789 e~Rpt~~~~a~ELL~HPfF~~ 809 (857)
.+||+ ++|+|+||||+.
T Consensus 259 ~~R~s----~~eil~Hp~~~~ 275 (293)
T d1yhwa1 259 EKRGS----AKELLQHQFLKI 275 (293)
T ss_dssp TTSCC----HHHHTTCGGGGG
T ss_pred hHCcC----HHHHhcCHhhCC
Confidence 99999 999999999963
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.8e-56 Score=491.75 Aligned_cols=282 Identities=34% Similarity=0.604 Sum_probs=232.1
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHH---HHHHHHcCCCCccccceeeeeCCe
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTE---REIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~E---ieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
.+++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+| +.+|+.++|||||+++++|.+++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 46789999999999999999999999999999999976655444444444555 556666789999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|||||||+||+|..++.... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999999987654 389999999999999999999999999999999999999999999999999843210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
...
T Consensus 160 -----------------------------------------------------------------------------~~~ 162 (364)
T d1omwa3 160 -----------------------------------------------------------------------------KKP 162 (364)
T ss_dssp -----------------------------------------------------------------------------SCC
T ss_pred -----------------------------------------------------------------------------Ccc
Confidence 012
Q ss_pred ccccCCCCccChhhhc-CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhh-ccccCCCCCCCCHHHHHHHHh
Q 035930 705 NSFVGTHEYLAPEIIK-GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVS-QSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~-g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~-~~~~~p~~~~is~~l~dLI~k 782 (857)
...+||+.|||||++. +..|+.++|||||||+||||++|+.||.+....+....... ....++.+..+++++++||.+
T Consensus 163 ~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 242 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 242 (364)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHH
T ss_pred cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHH
Confidence 2457999999999996 56789999999999999999999999987654433221111 122233345699999999999
Q ss_pred hccCCcCCcCCch-hhHHHHHcCCCCCCCChhhh--ccCCCCCCCCCCc
Q 035930 783 LLVKEPDNRLGAV-KGAAEIKQHPFFEGLNWALI--RCAVPPELPRSCD 828 (857)
Q Consensus 783 ~L~~DPe~Rpt~~-~~a~ELL~HPfF~~l~w~li--~~~~pp~~P~~~~ 828 (857)
||++||.+||++. ..++|||+||||++++|..+ +...||++|....
T Consensus 243 ~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~~ 291 (364)
T d1omwa3 243 LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGE 291 (364)
T ss_dssp HTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC-
T ss_pred HcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCCC
Confidence 9999999999953 35799999999999999855 4567888886543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-56 Score=473.38 Aligned_cols=263 Identities=29% Similarity=0.477 Sum_probs=229.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc---cchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR---KKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~---~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
++|++++.||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+++|+.++|||||+++++|.+++.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 579999999999999999999999999999999976544322 23567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC----cEEEecccchhhc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG----HIMLSDFDLSLRC 622 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg----~iKL~DFGLA~r~ 622 (857)
||||||+||+|..++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+| ++||+|||+|...
T Consensus 90 iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999987653 499999999999999999999999999999999999998776 5999999998432
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.. ..
T Consensus 168 ~~----------------------------------------------------------------------------~~ 171 (293)
T d1jksa_ 168 DF----------------------------------------------------------------------------GN 171 (293)
T ss_dssp TT----------------------------------------------------------------------------SC
T ss_pred CC----------------------------------------------------------------------------Cc
Confidence 10 01
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLI 780 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI 780 (857)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+......++. ++.++.++++||
T Consensus 172 ~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 251 (293)
T d1jksa_ 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251 (293)
T ss_dssp BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHH
Confidence 123456899999999999999999999999999999999999999999888888888887766543 356899999999
Q ss_pred HhhccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
++||..||.+||+ ++|+|+||||++.+|..
T Consensus 252 ~~~L~~dP~~R~s----~~eil~hp~~~~~~~~~ 281 (293)
T d1jksa_ 252 RRLLVKDPKKRMT----IQDSLQHPWIKPKDTQQ 281 (293)
T ss_dssp HTTSCSSGGGSCC----HHHHHHSTTTCC-----
T ss_pred HHHccCChhHCcC----HHHHhcCcccCCCChhH
Confidence 9999999999999 99999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=486.17 Aligned_cols=263 Identities=25% Similarity=0.384 Sum_probs=219.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++++.||+|+||+||+|++..+|+.||||+++... .......+.+|+.+|+.++|||||+++++|.+++++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34568999999999999999999999999999999997652 2344567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
||||||+||+|..++.+.. .+++..++.++.||+.||.|||+ +|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 81 iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 9999999999999987653 39999999999999999999996 5999999999999999999999999999854210
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
....
T Consensus 158 ----------------------------------------------------------------------------~~~~ 161 (322)
T d1s9ja_ 158 ----------------------------------------------------------------------------SMAN 161 (322)
T ss_dssp ----------------------------------------------------------------------------HTC-
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0123
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHH---------------------------
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSN--------------------------- 758 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~--------------------------- 758 (857)
+++||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence 56899999999999999999999999999999999999999987654322110
Q ss_pred ---------------HhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 759 ---------------VVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 759 ---------------Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
+............++.+++|||.+||++||++||| ++|+|+||||++.+|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t----a~e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDAEE 308 (322)
T ss_dssp ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHHHHSC
T ss_pred cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcC----HHHHhhCHhhCcCCccc
Confidence 00000000011246889999999999999999999 99999999999877753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-56 Score=475.59 Aligned_cols=258 Identities=29% Similarity=0.430 Sum_probs=225.5
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
+.|++++.||+|+||+||+|+++.+++.||||+++.. .....+.+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 4699999999999999999999999999999999764 2345667899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVV 629 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~ 629 (857)
|||+||+|..++.... ..+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|......
T Consensus 89 Ey~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---- 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 163 (288)
T ss_dssp ECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH----
T ss_pred ecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC----
Confidence 9999999998876543 34999999999999999999999999999999999999999999999999997431100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccC
Q 035930 630 KSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVG 709 (857)
Q Consensus 630 ~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vG 709 (857)
.......+|
T Consensus 164 -----------------------------------------------------------------------~~~~~~~~G 172 (288)
T d2jfla1 164 -----------------------------------------------------------------------IQRRDSFIG 172 (288)
T ss_dssp -----------------------------------------------------------------------HHHHTCCCS
T ss_pred -----------------------------------------------------------------------ccccccccc
Confidence 001234579
Q ss_pred CCCccChhhhc-----CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-CCCCCCCCHHHHHHHHhh
Q 035930 710 THEYLAPEIIK-----GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-FPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 710 T~~YmAPEil~-----g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-~p~~~~is~~l~dLI~k~ 783 (857)
|+.|||||++. +..|+.++|||||||+||||++|+.||.+.+..+.+.++...... ++.+..+++++++||.+|
T Consensus 173 t~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~ 252 (288)
T d2jfla1 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKC 252 (288)
T ss_dssp CCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHH
T ss_pred ccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 99999999984 456899999999999999999999999999888888888876543 334467899999999999
Q ss_pred ccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 784 LVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
|++||.+||| ++|||+||||+.-
T Consensus 253 L~~dp~~R~t----~~ell~hp~~~~~ 275 (288)
T d2jfla1 253 LEKNVDARWT----TSQLLQHPFVTVD 275 (288)
T ss_dssp SCSSTTTSCC----HHHHTTSGGGCCC
T ss_pred ccCChhHCcC----HHHHhcCcccCCC
Confidence 9999999999 9999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-55 Score=484.97 Aligned_cols=265 Identities=29% Similarity=0.447 Sum_probs=233.2
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
+++|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+++|+.|+|||||+++++|.+++.+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999976532 2346688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc--CCcEEEecccchhhcccCc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE--DGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~--dg~iKL~DFGLA~r~~~~~ 626 (857)
||||+||+|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+. +|.+||+|||+|..+..
T Consensus 102 mE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~-- 178 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 178 (350)
T ss_dssp ECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT--
T ss_pred EEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc--
Confidence 99999999998886543 34999999999999999999999999999999999999964 68899999999854210
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 179 --------------------------------------------------------------------------~~~~~~ 184 (350)
T d1koaa2 179 --------------------------------------------------------------------------KQSVKV 184 (350)
T ss_dssp --------------------------------------------------------------------------TSCEEE
T ss_pred --------------------------------------------------------------------------ccccce
Confidence 011234
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLL 784 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L 784 (857)
.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+......++. .+.+++++++||.+||
T Consensus 185 ~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 264 (350)
T d1koaa2 185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 264 (350)
T ss_dssp ECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHC
T ss_pred ecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHc
Confidence 57999999999999999999999999999999999999999999888899998887776654 3568999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCCCCCChhhhcc
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRC 817 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~ 817 (857)
++||.+||| ++|||+||||+..+|.....
T Consensus 265 ~~dP~~R~t----~~eil~hp~~~~~~~~~~~~ 293 (350)
T d1koaa2 265 LADPNTRMT----IHQALEHPWLTPGNAPGRDS 293 (350)
T ss_dssp CSSGGGSCC----HHHHHHSTTTSCTTCCSCCC
T ss_pred cCChhHCcC----HHHHhcCcccCCCCCCCchh
Confidence 999999999 99999999999988754433
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.3e-56 Score=477.79 Aligned_cols=257 Identities=32% Similarity=0.516 Sum_probs=214.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++++.||+|+||+||+|+++.+++.||||++.+.... .....+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5699999999999999999999999999999999876433 22345789999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc---cCCcEEEecccchhhcccCc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR---EDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~---~dg~iKL~DFGLA~r~~~~~ 626 (857)
|||+||+|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||+. .+|.+||+|||+|.....
T Consensus 87 E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~-- 162 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-- 162 (307)
T ss_dssp CCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred eccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC--
Confidence 9999999999987653 499999999999999999999999999999999999994 578999999999843110
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
.....+
T Consensus 163 --------------------------------------------------------------------------~~~~~~ 168 (307)
T d1a06a_ 163 --------------------------------------------------------------------------GSVLST 168 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------CCeeee
Confidence 011234
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--CCCCCCHHHHHHHHhhc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--GYPVVSFHARDLIRGLL 784 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--~~~~is~~l~dLI~k~L 784 (857)
.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....+.+..+......++ ..+.+++++++||.+||
T Consensus 169 ~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 248 (307)
T d1a06a_ 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 248 (307)
T ss_dssp ----CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHS
T ss_pred eeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHc
Confidence 5799999999999999999999999999999999999999999888888888888776654 34679999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.+||.+||| ++|+|+||||++.
T Consensus 249 ~~dP~~R~s----~~eil~hp~~~~~ 270 (307)
T d1a06a_ 249 EKDPEKRFT----CEQALQHPWIAGD 270 (307)
T ss_dssp CSSGGGSCC----HHHHHHSTTTTSS
T ss_pred cCCHhHCcC----HHHHhcCHhhCCC
Confidence 999999999 9999999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-55 Score=476.42 Aligned_cols=254 Identities=28% Similarity=0.368 Sum_probs=226.9
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVME 550 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmE 550 (857)
.|++++.||+|+||+||+|++..+++.||||+++..........+.+.+|+++|+.|+|||||+++++|.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987655555556778999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccccc
Q 035930 551 YCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVK 630 (857)
Q Consensus 551 y~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~ 630 (857)
||.+|+|..++.... .+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|....
T Consensus 96 ~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (309)
T ss_dssp CCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-------
T ss_pred ecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC-------
Confidence 999999987766543 49999999999999999999999999999999999999999999999999974210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCC
Q 035930 631 SSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGT 710 (857)
Q Consensus 631 ~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT 710 (857)
.....+||
T Consensus 167 ------------------------------------------------------------------------~~~~~~GT 174 (309)
T d1u5ra_ 167 ------------------------------------------------------------------------PANSFVGT 174 (309)
T ss_dssp ------------------------------------------------------------------------SBCCCCSC
T ss_pred ------------------------------------------------------------------------CCCccccC
Confidence 01235699
Q ss_pred CCccChhhhcC---CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 711 HEYLAPEIIKG---EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 711 ~~YmAPEil~g---~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.+..+.+..+............+++++++||.+||++|
T Consensus 175 ~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d 254 (309)
T d1u5ra_ 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 254 (309)
T ss_dssp GGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSS
T ss_pred ccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCC
Confidence 99999999975 358999999999999999999999999988888888888777666666679999999999999999
Q ss_pred cCCcCCchhhHHHHHcCCCCCC
Q 035930 788 PDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
|.+||| ++|||+||||..
T Consensus 255 P~~Rpt----~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 255 PQDRPT----SEVLLKHRFVLR 272 (309)
T ss_dssp GGGSCC----HHHHTTCHHHHS
T ss_pred hhHCcC----HHHHHhCHHhcC
Confidence 999999 999999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=466.14 Aligned_cols=257 Identities=23% Similarity=0.367 Sum_probs=213.9
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee--CCeEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT--EKFSCL 547 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~--~~~l~L 547 (857)
++|++++.||+|+||+||+|+++.+|+.||||+++.... .+...+.+.+|+++|++++|||||+++++|.+ ++.+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 579999999999999999999999999999999977643 23345678899999999999999999999865 467899
Q ss_pred EEeecCCCChHHHHhhC--CCCCCcHHHHHHHHHHHHHHHHHHHHcC-----ceeccCCCCcEEEccCCcEEEecccchh
Q 035930 548 VMEYCPGGDLHVLRQKQ--PSRFFSEQAARFYVAEVLLALEYLHMLG-----VVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~--~~~~l~e~~~r~i~~QIl~gL~yLHs~G-----IIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
|||||+||+|.+++.+. ....+++..++.++.||+.||.|||+.| ||||||||+|||++.+|.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999887642 2235999999999999999999999976 9999999999999999999999999986
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
.+...
T Consensus 163 ~~~~~--------------------------------------------------------------------------- 167 (269)
T d2java1 163 ILNHD--------------------------------------------------------------------------- 167 (269)
T ss_dssp HC------------------------------------------------------------------------------
T ss_pred ecccC---------------------------------------------------------------------------
Confidence 53210
Q ss_pred CCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHH
Q 035930 701 GARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLI 780 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI 780 (857)
.......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++..+....... .+..+++++++||
T Consensus 168 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~li 246 (269)
T d2java1 168 TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-IPYRYSDELNEII 246 (269)
T ss_dssp --------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-CCTTSCHHHHHHH
T ss_pred CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-CCcccCHHHHHHH
Confidence 011234579999999999999999999999999999999999999999988888888877765542 2356899999999
Q ss_pred HhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 781 RGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 781 ~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
.+||+.||.+||+ ++|||+|||+
T Consensus 247 ~~~L~~dp~~Rps----~~ell~hp~i 269 (269)
T d2java1 247 TRMLNLKDYHRPS----VEEILENPLI 269 (269)
T ss_dssp HHHTCSSGGGSCC----HHHHHTSTTC
T ss_pred HHHcCCChhHCcC----HHHHHhCCcC
Confidence 9999999999999 9999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9e-55 Score=478.86 Aligned_cols=257 Identities=29% Similarity=0.453 Sum_probs=228.3
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVM 549 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVm 549 (857)
++|++++.||+|+||+||+|++..+|+.||||+++.... .....+.+|+++|++|+|||||+++++|.+++.+||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999976532 23356789999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEc--cCCcEEEecccchhhcccCcc
Q 035930 550 EYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVR--EDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 550 Ey~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~--~dg~iKL~DFGLA~r~~~~~~ 627 (857)
|||+||+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+||||+ .+|.+||+|||+|..+..
T Consensus 106 E~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~--- 181 (352)
T d1koba_ 106 EFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--- 181 (352)
T ss_dssp ECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---
T ss_pred EcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC---
Confidence 9999999988776543 3499999999999999999999999999999999999997 578999999999854211
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.......
T Consensus 182 -------------------------------------------------------------------------~~~~~~~ 188 (352)
T d1koba_ 182 -------------------------------------------------------------------------DEIVKVT 188 (352)
T ss_dssp -------------------------------------------------------------------------TSCEEEE
T ss_pred -------------------------------------------------------------------------CCceeec
Confidence 0112345
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhcc
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLLV 785 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L~ 785 (857)
+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+......++. ++.+++++++||.+||+
T Consensus 189 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 268 (352)
T d1koba_ 189 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQ 268 (352)
T ss_dssp CSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSC
T ss_pred cCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence 6999999999999999999999999999999999999999999888888888887776653 46799999999999999
Q ss_pred CCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 786 KEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 786 ~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+||.+||| +.|+|+||||++.
T Consensus 269 ~dp~~R~s----~~eil~Hp~~~~~ 289 (352)
T d1koba_ 269 KEPRKRLT----VHDALEHPWLKGD 289 (352)
T ss_dssp SSGGGSCC----HHHHHTSTTTSSC
T ss_pred CChhHCcC----HHHHhcCHhhCCC
Confidence 99999999 9999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=459.23 Aligned_cols=253 Identities=23% Similarity=0.410 Sum_probs=213.7
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee----CCeEE
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT----EKFSC 546 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~----~~~l~ 546 (857)
.|++.++||+|+||+||+|.+..++..||+|++..... .....+.+.+|+++|++++|||||+++++|.+ +..+|
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 35788899999999999999999999999999976543 23345678899999999999999999999875 45789
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEc-cCCcEEEecccchhhcc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLG--VVYRDLKPENILVR-EDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~G--IIHRDLKPeNILL~-~dg~iKL~DFGLA~r~~ 623 (857)
||||||++|+|..++.+.. .+++..++.++.||+.||+|||++| ||||||||+|||++ .++.+||+|||+|....
T Consensus 89 ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999999887653 4999999999999999999999998 99999999999996 57999999999984210
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
...
T Consensus 167 -----------------------------------------------------------------------------~~~ 169 (270)
T d1t4ha_ 167 -----------------------------------------------------------------------------ASF 169 (270)
T ss_dssp -----------------------------------------------------------------------------TTS
T ss_pred -----------------------------------------------------------------------------CCc
Confidence 011
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-CCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-FPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-~p~~~~is~~l~dLI~k 782 (857)
....+||+.|||||++.+ +|+.++|||||||+||||++|+.||.+..+...+.+.+..... ......+++++++||.+
T Consensus 170 ~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~ 248 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248 (270)
T ss_dssp BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHH
Confidence 234579999999999876 5999999999999999999999999877665554444433332 22334578999999999
Q ss_pred hccCCcCCcCCchhhHHHHHcCCCCC
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
||.+||++||| ++|||+||||+
T Consensus 249 ~l~~dp~~R~s----~~ell~Hp~fk 270 (270)
T d1t4ha_ 249 CIRQNKDERYS----IKDLLNHAFFQ 270 (270)
T ss_dssp HSCSSGGGSCC----HHHHHTSGGGC
T ss_pred HccCCHhHCcC----HHHHhCCcccC
Confidence 99999999999 99999999995
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-54 Score=465.82 Aligned_cols=256 Identities=23% Similarity=0.396 Sum_probs=226.9
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|++++.||+|+||+||+|.++.+++.||||+++... .....+.+|+++|+.++|||||+++++|.+++.+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997653 2234578999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC--CcEEEecccchhhcccCc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED--GHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d--g~iKL~DFGLA~r~~~~~ 626 (857)
||||+||+|.+++..... .+++..++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||++.....
T Consensus 80 mE~~~gg~L~~~i~~~~~-~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-- 156 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp ECCCCCCBHHHHHTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence 999999999999876542 48999999999999999999999999999999999999854 4899999999743210
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (321)
T d1tkia_ 157 --------------------------------------------------------------------------GDNFRL 162 (321)
T ss_dssp --------------------------------------------------------------------------TCEEEE
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 011224
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCHHHHHHHHhhc
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSFHARDLIRGLL 784 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~~l~dLI~k~L 784 (857)
.+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+.+..+.+..++.....++. ++.+++++++||.+||
T Consensus 163 ~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 242 (321)
T d1tkia_ 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL 242 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTS
T ss_pred cccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHc
Confidence 56899999999999999999999999999999999999999999888999999888777654 3468999999999999
Q ss_pred cCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 785 VKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 785 ~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
.+||.+||+ ++|+|+||||.+
T Consensus 243 ~~dp~~R~s----~~eil~hp~~~~ 263 (321)
T d1tkia_ 243 VKERKSRMT----ASEALQHPWLKQ 263 (321)
T ss_dssp CSSGGGSCC----HHHHHHSHHHHS
T ss_pred cCChhHCcC----HHHHhcCHhhcc
Confidence 999999999 999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.9e-53 Score=450.11 Aligned_cols=258 Identities=31% Similarity=0.448 Sum_probs=225.8
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc------cchhHHHHHHHHHHHcC-CCCccccceeeeeC
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR------KKMPRAQTEREIMQMLD-HPFLPTLFAHFTTE 542 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~------~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~ 542 (857)
++|++++.||+|+||+||+|++..+++.||||++++...... ...+.+.+|+.+|+.++ ||||++++++|.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 689999999999999999999999999999999976533221 12345789999999997 99999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
+++|||||||+||+|..++.... .+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++...
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999997654 4999999999999999999999999999999999999999999999999998432
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.. +.
T Consensus 161 ~~----------------------------------------------------------------------------~~ 164 (277)
T d1phka_ 161 DP----------------------------------------------------------------------------GE 164 (277)
T ss_dssp CT----------------------------------------------------------------------------TC
T ss_pred cC----------------------------------------------------------------------------CC
Confidence 10 01
Q ss_pred ccccccCCCCccChhhhcC------CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC--CCCCCH
Q 035930 703 RSNSFVGTHEYLAPEIIKG------EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG--YPVVSF 774 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g------~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~--~~~is~ 774 (857)
.....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+..++.+...++. ...+++
T Consensus 165 ~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 244 (277)
T d1phka_ 165 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244 (277)
T ss_dssp CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCH
T ss_pred ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCH
Confidence 1234579999999999964 34688999999999999999999999999888888888887765543 457999
Q ss_pred HHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 775 HARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 775 ~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
++++||.+||+.||++||+ ++|||+||||++
T Consensus 245 ~~~~li~~~L~~~p~~R~s----~~eil~h~~~~~ 275 (277)
T d1phka_ 245 TVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHCCSSGGGSCC----HHHHTTSGGGCT
T ss_pred HHHHHHHHHccCChhHCcC----HHHHHcCHHHHH
Confidence 9999999999999999999 999999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=454.75 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=211.9
Q ss_pred EEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccc--ccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEEEee
Q 035930 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVG--RKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLVMEY 551 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~--~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LVmEy 551 (857)
.+++||+|+||+||+|+++.+|+.||||+++...... ......+.+|+++|+.++|||||+++++|.+++++||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999999999999999997653322 22345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcccccC
Q 035930 552 CPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMVVKS 631 (857)
Q Consensus 552 ~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ 631 (857)
+.++++..+.... ..+++..++.+++||+.||+|||++|||||||||+|||++.++.+||+|||+|.....
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~------- 152 (299)
T d1ua2a_ 82 METDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS------- 152 (299)
T ss_dssp CSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS-------
T ss_pred hcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC-------
Confidence 9888777665433 3489999999999999999999999999999999999999999999999999843211
Q ss_pred CCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccccCCC
Q 035930 632 SSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFVGTH 711 (857)
Q Consensus 632 ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~ 711 (857)
........+||+
T Consensus 153 --------------------------------------------------------------------~~~~~~~~~gt~ 164 (299)
T d1ua2a_ 153 --------------------------------------------------------------------PNRAYTHQVVTR 164 (299)
T ss_dssp --------------------------------------------------------------------CCCCCCCSCCCC
T ss_pred --------------------------------------------------------------------CcccccceecCh
Confidence 001123457999
Q ss_pred CccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--------------------C--
Q 035930 712 EYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--------------------G-- 768 (857)
Q Consensus 712 ~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--------------------~-- 768 (857)
.|||||++.+. .|+.++|||||||++|||++|..||.+.+..+.+..+......++ .
T Consensus 165 ~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
T d1ua2a_ 165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP 244 (299)
T ss_dssp TTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCC
T ss_pred hhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCC
Confidence 99999998754 579999999999999999999999999888887777664211110 0
Q ss_pred ----CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCC
Q 035930 769 ----YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLN 811 (857)
Q Consensus 769 ----~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~ 811 (857)
.+.++++++|||.+||++||++||| ++|+|+||||+...
T Consensus 245 ~~~~~~~~s~~~~dll~~~L~~dP~~R~s----a~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 245 LHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRP 287 (299)
T ss_dssp HHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSS
T ss_pred hHHhcccCCHHHHHHHHHHccCChhhCcC----HHHHhCCHhhCCCC
Confidence 1356889999999999999999999 99999999998653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-53 Score=450.15 Aligned_cols=261 Identities=28% Similarity=0.393 Sum_probs=217.0
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
+++|++++.||+|+||+||+|.+..+++.||||+++... ........+.+|+++|++++|||||+++++|.+++++|||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 368999999999999999999999999999999997653 2234467789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+.+ .+..++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--- 155 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--- 155 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC---
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC---
Confidence 999955 5544554444456999999999999999999999999999999999999999999999999998543210
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.......+
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (298)
T d1gz8a_ 156 ------------------------------------------------------------------------VRTYTHEV 163 (298)
T ss_dssp ------------------------------------------------------------------------SBCTTCCB
T ss_pred ------------------------------------------------------------------------cccceeec
Confidence 11123457
Q ss_pred CCCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC------------------C-
Q 035930 709 GTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP------------------G- 768 (857)
Q Consensus 709 GT~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p------------------~- 768 (857)
||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..+.+.++......+. .
T Consensus 164 gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T d1gz8a_ 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243 (298)
T ss_dssp CCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCC
T ss_pred ccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccc
Confidence 9999999999887765 8899999999999999999999998877777666553211110 0
Q ss_pred --------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 769 --------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 769 --------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
.+.++.+++|||++||++||.+||| +.|||+||||+++
T Consensus 244 ~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS----AKAALAHPFFQDV 289 (298)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTC
T ss_pred cccchhhhccCCCHHHHHHHHHHccCChhHCcC----HHHHhCCHhhccC
Confidence 2356789999999999999999999 9999999999877
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=448.00 Aligned_cols=264 Identities=25% Similarity=0.341 Sum_probs=217.0
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCC-CeEEEEEEecccccccccchhHHHHHHHHHHHc---CCCCccccceeeee-
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGT-SCLFALKVMDNDFLVGRKKMPRAQTEREIMQML---DHPFLPTLFAHFTT- 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~t-g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L---~HPnIV~L~~~f~~- 541 (857)
...++|++++.||+|+||+||+|++..+ ++.||||+++..... ......+.+|+.+|+.| +||||++++++|..
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 3457899999999999999999999765 678999999765332 23334567788887766 79999999999853
Q ss_pred ----CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEeccc
Q 035930 542 ----EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFD 617 (857)
Q Consensus 542 ----~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFG 617 (857)
+.++|++|||+.++.+....... ...+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccccCceEEEEEEeccCCchhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence 35789999999887776554433 3459999999999999999999999999999999999999999999999999
Q ss_pred chhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccc
Q 035930 618 LSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVV 697 (857)
Q Consensus 618 LA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~ 697 (857)
++....
T Consensus 162 ~~~~~~-------------------------------------------------------------------------- 167 (305)
T d1blxa_ 162 LARIYS-------------------------------------------------------------------------- 167 (305)
T ss_dssp SCCCCC--------------------------------------------------------------------------
T ss_pred hhhhhc--------------------------------------------------------------------------
Confidence 863210
Q ss_pred cCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcccc-----C------
Q 035930 698 EPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLR-----F------ 766 (857)
Q Consensus 698 ~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~-----~------ 766 (857)
........+||+.|||||++.+.+|+.++|||||||+||||++|+.||.+.+..+.+..++..... +
T Consensus 168 --~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 245 (305)
T d1blxa_ 168 --FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245 (305)
T ss_dssp --GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred --ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence 001123457999999999999999999999999999999999999999998887777776542110 0
Q ss_pred --------------CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 767 --------------PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 767 --------------p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
.....+++.++|||.+||++||++||| ++|+|+||||+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s----a~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLER 301 (305)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCC
T ss_pred hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhcCchh
Confidence 012457889999999999999999999 999999999998864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-52 Score=446.02 Aligned_cols=255 Identities=22% Similarity=0.273 Sum_probs=221.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEE
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~ 546 (857)
+..++|++.+.||+|+||+||+|.+..+++.||||+++.+ ....+.+.+|+++|+.++|||||+++++|.+++.+|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT----CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc----cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 5567899999999999999999999999999999999765 334567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCc
Q 035930 547 LVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNP 626 (857)
Q Consensus 547 LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~ 626 (857)
||||||++|+|..++.......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+....+.
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999999999887666679999999999999999999999999999999999999999999999999985321100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccc
Q 035930 627 MVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNS 706 (857)
Q Consensus 627 ~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s 706 (857)
......
T Consensus 170 --------------------------------------------------------------------------~~~~~~ 175 (287)
T d1opja_ 170 --------------------------------------------------------------------------YTAHAG 175 (287)
T ss_dssp --------------------------------------------------------------------------SEEETT
T ss_pred --------------------------------------------------------------------------ceeecc
Confidence 001123
Q ss_pred ccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 707 FVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 707 ~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
..||+.|||||++.+..|+.++|||||||+||||++|..||........+..++....+++.+..+++++++||.+||+.
T Consensus 176 ~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~ 255 (287)
T d1opja_ 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 255 (287)
T ss_dssp EEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred ccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCC
Confidence 35889999999999999999999999999999999977776655555556666677777777778999999999999999
Q ss_pred CcCCcCCchhhHHHHHc
Q 035930 787 EPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~ 803 (857)
||++||+ +++|++
T Consensus 256 dP~~Rps----~~ei~~ 268 (287)
T d1opja_ 256 NPSDRPS----FAEIHQ 268 (287)
T ss_dssp SGGGSCC----HHHHHH
T ss_pred CHhHCcC----HHHHHH
Confidence 9999999 888865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-53 Score=460.20 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=211.4
Q ss_pred CCCeEEEe-EEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHH-HcCCCCccccceeeee----C
Q 035930 469 MRHFKLHK-KLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQ-MLDHPFLPTLFAHFTT----E 542 (857)
Q Consensus 469 ~~~Y~i~~-~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr-~L~HPnIV~L~~~f~~----~ 542 (857)
.++|.++. .||+|+||+||+|++..+++.||||+++.. ..+.+|++++. .++|||||+++++|.+ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 46898875 699999999999999999999999998643 45678999865 4589999999999976 4
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc---CCcEEEecccch
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE---DGHIMLSDFDLS 619 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~---dg~iKL~DFGLA 619 (857)
.++|||||||+||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 67999999999999999998765556999999999999999999999999999999999999975 567999999998
Q ss_pred hhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccC
Q 035930 620 LRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEP 699 (857)
Q Consensus 620 ~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~ 699 (857)
+.....
T Consensus 162 ~~~~~~-------------------------------------------------------------------------- 167 (335)
T d2ozaa1 162 KETTSH-------------------------------------------------------------------------- 167 (335)
T ss_dssp EECCCC--------------------------------------------------------------------------
T ss_pred eeccCC--------------------------------------------------------------------------
Confidence 542110
Q ss_pred CCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHH----hhccccCCC--CCCCC
Q 035930 700 TGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNV----VSQSLRFPG--YPVVS 773 (857)
Q Consensus 700 ~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~I----v~~~~~~p~--~~~is 773 (857)
......+||+.|||||++.+..|+.++|||||||+||+|+||+.||.+.+..+....+ ......+|. +..++
T Consensus 168 --~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 245 (335)
T d2ozaa1 168 --NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245 (335)
T ss_dssp --CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSC
T ss_pred --CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCC
Confidence 1123457999999999999999999999999999999999999999887665544333 333344443 23589
Q ss_pred HHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 774 FHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 774 ~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
+++++||++||++||.+||+ +.|||+||||.+
T Consensus 246 ~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~ 277 (335)
T d2ozaa1 246 EEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 277 (335)
T ss_dssp HHHHHHHHHHSCSSTTTSCC----HHHHHHSHHHHT
T ss_pred HHHHHHHHHHccCChhHCcC----HHHHHcCHHhhC
Confidence 99999999999999999999 999999999964
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=441.71 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=212.7
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEeccccccccc---chhHHHHHHHHHHHcC--CCCccccceeeeeCCe
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRK---KMPRAQTEREIMQMLD--HPFLPTLFAHFTTEKF 544 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~---~~~~~~~EieILr~L~--HPnIV~L~~~f~~~~~ 544 (857)
++|++++.||+|+||+||+|++..+|+.||||++++....... ...++.+|+.+|+.++ |||||+++++|.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999999999999999999865443222 2234678999999997 8999999999999999
Q ss_pred EEEEEeecCC-CChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccC-CcEEEecccchhhc
Q 035930 545 SCLVMEYCPG-GDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED-GHIMLSDFDLSLRC 622 (857)
Q Consensus 545 l~LVmEy~~g-GsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~d-g~iKL~DFGLA~r~ 622 (857)
.|+||||+.+ +++..++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 57777776543 39999999999999999999999999999999999999854 79999999997431
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
. ..
T Consensus 162 ~-----------------------------------------------------------------------------~~ 164 (273)
T d1xwsa_ 162 K-----------------------------------------------------------------------------DT 164 (273)
T ss_dssp C-----------------------------------------------------------------------------SS
T ss_pred c-----------------------------------------------------------------------------cc
Confidence 1 01
Q ss_pred ccccccCCCCccChhhhcCCCC-CcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGH-GSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~-s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~ 781 (857)
....++||+.|||||++.+..+ +.++|||||||+||||++|+.||.+. ..+......++ ..+++++++||.
T Consensus 165 ~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~--~~~s~~~~~li~ 236 (273)
T d1xwsa_ 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR--QRVSSECQHLIR 236 (273)
T ss_dssp CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS--SCCCHHHHHHHH
T ss_pred cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC--CCCCHHHHHHHH
Confidence 1234579999999999988776 67899999999999999999999753 23455555555 459999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
+||.+||++||| ++|+|+||||+++
T Consensus 237 ~~L~~dp~~R~s----~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 237 WCLALRPSDRPT----FEEIQNHPWMQDV 261 (273)
T ss_dssp HHTCSSGGGSCC----HHHHHTSGGGSSC
T ss_pred HHccCCHhHCcC----HHHHhcCHhhCCC
Confidence 999999999999 9999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-52 Score=448.92 Aligned_cols=259 Identities=20% Similarity=0.299 Sum_probs=221.4
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCC-----eEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTS-----CLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg-----~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~ 540 (857)
+..++|++++.||+|+||+||+|++.+++ ..||+|++.... .......+.+|+.+|+.+ +|||||+++++|.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 55578999999999999999999987654 369999987542 234556788999999988 8999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCC---------------------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCC
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQPS---------------------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLK 599 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~~---------------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLK 599 (857)
+.+.+|||||||++|+|.+++..... ..+++..++.|+.||+.||+|||++||||||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 99999999999999999999876432 248999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhh
Q 035930 600 PENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSR 679 (857)
Q Consensus 600 PeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~ 679 (857)
|+|||++.++++||+|||+|+......
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~----------------------------------------------------- 218 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDS----------------------------------------------------- 218 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCT-----------------------------------------------------
T ss_pred hhccccccCCeEEEeeccccccccCCC-----------------------------------------------------
Confidence 999999999999999999985421110
Q ss_pred hhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHH
Q 035930 680 KIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSN 758 (857)
Q Consensus 680 ~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~ 758 (857)
......+.+||+.|||||++.+..|+.++|||||||+||||++ |+.||.+.+..+.+.+
T Consensus 219 --------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~ 278 (325)
T d1rjba_ 219 --------------------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 278 (325)
T ss_dssp --------------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred --------------------ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 0011234568999999999999999999999999999999997 9999999888888888
Q ss_pred HhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 759 VVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 759 Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
++....+++.+..+++++++||.+||+.||++||| ++||++|
T Consensus 279 ~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~~ 320 (325)
T d1rjba_ 279 LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 320 (325)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 88888888777889999999999999999999999 8888875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-52 Score=448.89 Aligned_cols=285 Identities=39% Similarity=0.708 Sum_probs=237.3
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc---CCCeEEEEEEecccccc-cccchhHHHHHHHHHHHcCC-CCccccceeeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI---GTSCLFALKVMDNDFLV-GRKKMPRAQTEREIMQMLDH-PFLPTLFAHFTT 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~---~tg~~VAVKvi~k~~~~-~~~~~~~~~~EieILr~L~H-PnIV~L~~~f~~ 541 (857)
+++++|++++.||+|+||+||+|++. .+|+.||||++++.... .....+.+.+|+++|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 45678999999999999999999874 47899999999876443 33445678899999999966 899999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhh
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLR 621 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r 621 (857)
...+|+||||+.+|+|..++..... +++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++..
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CCceeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999998877643 78999999999999999999999999999999999999999999999999854
Q ss_pred cccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCC
Q 035930 622 CAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTG 701 (857)
Q Consensus 622 ~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~ 701 (857)
+.... .
T Consensus 179 ~~~~~--------------------------------------------------------------------------~ 184 (322)
T d1vzoa_ 179 FVADE--------------------------------------------------------------------------T 184 (322)
T ss_dssp CCGGG--------------------------------------------------------------------------G
T ss_pred hcccc--------------------------------------------------------------------------c
Confidence 21100 0
Q ss_pred CccccccCCCCccChhhhcCCC--CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc--cCCCCCCCCHHHH
Q 035930 702 ARSNSFVGTHEYLAPEIIKGEG--HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL--RFPGYPVVSFHAR 777 (857)
Q Consensus 702 ~~~~s~vGT~~YmAPEil~g~~--~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~--~~p~~~~is~~l~ 777 (857)
.......||+.|+|||.+.+.. ++.++|||||||+||||++|+.||.+.+..+....+..... .++.+..++++++
T Consensus 185 ~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 264 (322)
T d1vzoa_ 185 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 264 (322)
T ss_dssp GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHH
Confidence 1123456999999999998654 68899999999999999999999998877776666655432 2333456999999
Q ss_pred HHHHhhccCCcCCcCCchh-hHHHHHcCCCCCCCChhhhc--cCCCCCCCCCC
Q 035930 778 DLIRGLLVKEPDNRLGAVK-GAAEIKQHPFFEGLNWALIR--CAVPPELPRSC 827 (857)
Q Consensus 778 dLI~k~L~~DPe~Rpt~~~-~a~ELL~HPfF~~l~w~li~--~~~pp~~P~~~ 827 (857)
+||.+||.+||.+||++.. +++|+|+||||++++|.-+. ...||++|...
T Consensus 265 ~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~ 317 (322)
T d1vzoa_ 265 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIR 317 (322)
T ss_dssp HHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred HHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCC
Confidence 9999999999999997542 48999999999999998663 46678888543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-51 Score=437.08 Aligned_cols=258 Identities=23% Similarity=0.345 Sum_probs=215.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
+++|+++++||+|+||+||+|+++ +|+.||||+++.... .......+.+|+.+|+.++||||++++++|.+++..|+|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 468999999999999999999985 789999999976643 344567889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+.++.+..+.... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++.....
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~---- 152 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI---- 152 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc----
Confidence 9999777776665544 3499999999999999999999999999999999999999999999999999854211
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........+
T Consensus 153 -----------------------------------------------------------------------~~~~~~~~~ 161 (286)
T d1ob3a_ 153 -----------------------------------------------------------------------PVRKYTHEI 161 (286)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -----------------------------------------------------------------------Cccccceec
Confidence 001122446
Q ss_pred CCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccC---------------------
Q 035930 709 GTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRF--------------------- 766 (857)
Q Consensus 709 GT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~--------------------- 766 (857)
|++.|+|||++.+. .++.++|||||||+||||++|+.||.+.+..+.+.++......+
T Consensus 162 ~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T d1ob3a_ 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241 (286)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC
T ss_pred ccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccc
Confidence 89999999999765 46999999999999999999999999887777766654321110
Q ss_pred ------CCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 767 ------PGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 767 ------p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
...+.++++++|||++||++||++||| +.|||+||||++
T Consensus 242 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s----~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKE 286 (286)
T ss_dssp CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC
T ss_pred cCcchhhhcccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCc
Confidence 012457889999999999999999999 999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-51 Score=437.42 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=213.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC----eE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK----FS 545 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~----~l 545 (857)
++|++.+.||+|+||+||+|++..+++.||||+++............+.+|+++|+.++||||+++++++..++ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 57999999999999999999999999999999998775555555677899999999999999999999998654 48
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccC
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~ 625 (857)
|||||||+|++|..++.... .+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||++......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 99999999999998887654 3999999999999999999999999999999999999999999999999986431100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
. .......
T Consensus 165 ~------------------------------------------------------------------------~~~~~~~ 172 (277)
T d1o6ya_ 165 G------------------------------------------------------------------------NSVTQTA 172 (277)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c------------------------------------------------------------------------ccccccc
Confidence 0 0011223
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--CCCCCCHHHHHHHHhh
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--GYPVVSFHARDLIRGL 783 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--~~~~is~~l~dLI~k~ 783 (857)
..+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..+.+.+++.....++ ..+.+++++.+||.+|
T Consensus 173 ~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 252 (277)
T d1o6ya_ 173 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKA 252 (277)
T ss_dssp ------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHH
T ss_pred cccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHH
Confidence 56799999999999999999999999999999999999999999888888888877665543 3467899999999999
Q ss_pred ccCCcCCcCCchhhHHHHH
Q 035930 784 LVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL 802 (857)
|++||.+||++ +++++
T Consensus 253 L~~dp~~R~~s---a~~l~ 268 (277)
T d1o6ya_ 253 LAKNPENRYQT---AAEMR 268 (277)
T ss_dssp TCSSGGGSCSS---HHHHH
T ss_pred ccCCHhHCHhH---HHHHH
Confidence 99999999952 45544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=435.99 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=215.8
Q ss_pred cccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 464 HGCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 464 ~~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
.+.+..++|++++.||+|+||+||+|.++ ++..||||+++.. ....+.+.+|+++|++++|||||++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG----SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC----cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 34466689999999999999999999986 5778999999754 2345678999999999999999999998765 5
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
.+||||||+++|+|.+++.......+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 57899999999999887765444458999999999999999999999999999999999999999999999999985422
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
... ...
T Consensus 161 ~~~--------------------------------------------------------------------------~~~ 166 (272)
T d1qpca_ 161 DNE--------------------------------------------------------------------------YTA 166 (272)
T ss_dssp SSC--------------------------------------------------------------------------EEC
T ss_pred CCc--------------------------------------------------------------------------ccc
Confidence 110 001
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCC-CCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRT-PFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~-PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....||+.|||||++.+..|+.++|||||||+||||+||.. ||...+..+.+..+ ....+++.+..+++++.+||.+
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~ 245 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNCPEELYQLMRL 245 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH-HhcCCCCCcccChHHHHHHHHH
Confidence 123468999999999999999999999999999999999554 55555555555554 4455666667799999999999
Q ss_pred hccCCcCCcCCchhhHHHHHc--CCCCC
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQ--HPFFE 808 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~--HPfF~ 808 (857)
||+.||++||| +++|++ |+||.
T Consensus 246 cl~~~P~~Rpt----~~ei~~~L~~~ft 269 (272)
T d1qpca_ 246 CWKERPEDRPT----FDYLRSVLEDFFT 269 (272)
T ss_dssp HTCSSGGGSCC----HHHHHHHHHHHHH
T ss_pred HcCCCHhHCcC----HHHHHHHhhhhhh
Confidence 99999999999 888887 67775
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=446.15 Aligned_cols=259 Identities=29% Similarity=0.423 Sum_probs=211.2
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC-----
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK----- 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~----- 543 (857)
.++|++++.||+|+||+||+|.+..+|+.||||++++... .....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4689999999999999999999999999999999976432 3344567889999999999999999999998664
Q ss_pred -eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 544 -FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 544 -~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
++||||||+ +++|..+.... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 77887777654 3999999999999999999999999999999999999999999999999997431
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
. .
T Consensus 172 ~------------------------------------------------------------------------------~ 173 (346)
T d1cm8a_ 172 D------------------------------------------------------------------------------S 173 (346)
T ss_dssp C------------------------------------------------------------------------------S
T ss_pred C------------------------------------------------------------------------------C
Confidence 1 0
Q ss_pred ccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC--------------
Q 035930 703 RSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP-------------- 767 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p-------------- 767 (857)
.....+||+.|||||++.+. .++.++|||||||+||||++|+.||.+.+..+.+..+......++
T Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (346)
T d1cm8a_ 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253 (346)
T ss_dssp SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence 11245699999999999875 568999999999999999999999998876666554443211110
Q ss_pred ---------------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhh
Q 035930 768 ---------------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWAL 814 (857)
Q Consensus 768 ---------------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~l 814 (857)
....++++++|||++||.+||.+||| +.|||+||||+++++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~eiL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHDTE 311 (346)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC---
T ss_pred hhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhCcCCCcc
Confidence 12457899999999999999999999 99999999999987543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=436.27 Aligned_cols=257 Identities=21% Similarity=0.310 Sum_probs=212.4
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
|.+..++|.+++.||+|+||+||+|++.+ .||||+++.... .....+.+.+|+++|++++|||||++++++.+ +.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cE
Confidence 34667889999999999999999997643 499999975532 34456788999999999999999999998754 56
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|||||||++|+|.+++..... .+++..+..++.||+.||+|||++|||||||||+||||+.++++||+|||+|+....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 7999999999999999876543 499999999999999999999999999999999999999999999999999843210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
. ......
T Consensus 157 ~-------------------------------------------------------------------------~~~~~~ 163 (276)
T d1uwha_ 157 W-------------------------------------------------------------------------SGSHQF 163 (276)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c-------------------------------------------------------------------------CCcccc
Confidence 0 000112
Q ss_pred ccccCCCCccChhhhcCC---CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCC----CCCCCHHHH
Q 035930 705 NSFVGTHEYLAPEIIKGE---GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPG----YPVVSFHAR 777 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~---~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~----~~~is~~l~ 777 (857)
....||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+....+..++......|. ...+++++.
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~ 243 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHH
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHH
Confidence 355799999999999753 4799999999999999999999999988777777666665554432 356889999
Q ss_pred HHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 778 DLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 778 dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
+||.+||..||.+||| +.+|++|
T Consensus 244 ~li~~cl~~dp~~RPt----~~~il~~ 266 (276)
T d1uwha_ 244 RLMAECLKKKRDERPL----FPQILAS 266 (276)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHcCCCHhHCcC----HHHHHHH
Confidence 9999999999999999 8888875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=427.43 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=207.3
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEE
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~L 547 (857)
..++|++++.||+|+||+||+|++. ++..||||+++.. ....+.+.+|+++|+.++|||||+++++|.+++.+||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC----cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 3468999999999999999999986 5678999999764 2334678999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCcc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPM 627 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~ 627 (857)
|||||++|+|.+++.... ..+++..+..++.||+.||+|||+++||||||||+||||+.++.+||+|||+++.+....
T Consensus 78 v~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~- 155 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 155 (263)
T ss_dssp EEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-
Confidence 999999999999887654 348999999999999999999999999999999999999999999999999985421100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccccc
Q 035930 628 VVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSF 707 (857)
Q Consensus 628 l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~ 707 (857)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (263)
T d1sm2a_ 156 -------------------------------------------------------------------------YTSSTGT 162 (263)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -------------------------------------------------------------------------ceeecce
Confidence 0011234
Q ss_pred cCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccC
Q 035930 708 VGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVK 786 (857)
Q Consensus 708 vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~ 786 (857)
.||+.|||||++.+..|+.++|||||||+||||+| |.+||...+..+.+..+.. ..+.+.+..+++++.+||.+||+.
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~ 241 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIMNHCWKE 241 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHHHHHccC
Confidence 68999999999999999999999999999999999 5666666655566655544 455555567899999999999999
Q ss_pred CcCCcCCchhhHHHHHcC
Q 035930 787 EPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 787 DPe~Rpt~~~~a~ELL~H 804 (857)
||++||+ +++|++|
T Consensus 242 ~p~~Rps----~~~il~~ 255 (263)
T d1sm2a_ 242 RPEDRPA----FSRLLRQ 255 (263)
T ss_dssp SGGGSCC----HHHHHHH
T ss_pred CHhHCcC----HHHHHHH
Confidence 9999999 8888875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.7e-51 Score=437.11 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=208.4
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCCCe---EEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGTSC---LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~---~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
.+...+|++.+.||+|+||+||+|+++.++. .||||++.... .....+.+.+|+++|++++|||||+++++|.++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 3556789999999999999999999976654 68999886542 233456789999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
+.+|||||||++|+|..++..... .+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999999998876543 4899999999999999999999999999999999999999999999999998543
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
...... .+..
T Consensus 179 ~~~~~~----------------------------------------------------------------------~~~~ 188 (299)
T d1jpaa_ 179 EDDTSD----------------------------------------------------------------------PTYT 188 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCCCCc----------------------------------------------------------------------ceee
Confidence 211000 0001
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~ 781 (857)
......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....+.+..+.. ..+++.+..++..+.+||.
T Consensus 189 ~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~ 267 (299)
T d1jpaa_ 189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMDCPSALHQLML 267 (299)
T ss_dssp -------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHH
T ss_pred ecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCccchHHHHHHHH
Confidence 1123458999999999999999999999999999999998 8999998877777666544 4556666779999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHc
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+||+.||.+||+ +.+|++
T Consensus 268 ~cl~~~P~~RPs----~~ei~~ 285 (299)
T d1jpaa_ 268 DCWQKDRNHRPK----FGQIVN 285 (299)
T ss_dssp HHTCSSTTTSCC----HHHHHH
T ss_pred HHcCCCHhHCcC----HHHHHH
Confidence 999999999999 555554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=442.22 Aligned_cols=255 Identities=31% Similarity=0.476 Sum_probs=209.4
Q ss_pred CeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee------CCe
Q 035930 471 HFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT------EKF 544 (857)
Q Consensus 471 ~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~------~~~ 544 (857)
+|+.+++||+|+||+||+|++..+|+.||||++..+. . ...+|+++|+.++||||++++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----R---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----S---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----h---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 6999999999999999999999999999999997642 1 22479999999999999999999854 346
Q ss_pred EEEEEeecCCCChHHHHhh-CCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC-cEEEecccchhhc
Q 035930 545 SCLVMEYCPGGDLHVLRQK-QPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG-HIMLSDFDLSLRC 622 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~-~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg-~iKL~DFGLA~r~ 622 (857)
+|||||||+++.+..+... .....+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||++..+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 8999999976655444321 2234599999999999999999999999999999999999999775 8999999997432
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.. ..
T Consensus 174 ~~----------------------------------------------------------------------------~~ 177 (350)
T d1q5ka_ 174 VR----------------------------------------------------------------------------GE 177 (350)
T ss_dssp CT----------------------------------------------------------------------------TS
T ss_pred cC----------------------------------------------------------------------------Cc
Confidence 10 01
Q ss_pred ccccccCCCCccChhhhcC-CCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhcc-----------------c
Q 035930 703 RSNSFVGTHEYLAPEIIKG-EGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQS-----------------L 764 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g-~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~-----------------~ 764 (857)
...+.+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..++... .
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~ 257 (350)
T d1q5ka_ 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257 (350)
T ss_dssp CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence 1234579999999999876 468999999999999999999999999887777776665311 1
Q ss_pred cCC----------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCCh
Q 035930 765 RFP----------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNW 812 (857)
Q Consensus 765 ~~p----------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w 812 (857)
.++ ..+.+++++++||.+||.+||++||| +.|+|+||||+++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELRD 311 (350)
T ss_dssp CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGGC
T ss_pred cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhccccC
Confidence 111 12457899999999999999999999 999999999987643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-50 Score=434.85 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=209.4
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeee--CCeE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTT--EKFS 545 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~--~~~l 545 (857)
.++|+++++||+|+||+||+|++..+++.||||+++.. ..+++.+|+++|+.+. ||||++++++|.. ..++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 46899999999999999999999999999999999653 3457889999999995 9999999999974 4579
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC-cEEEecccchhhccc
Q 035930 546 CLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG-HIMLSDFDLSLRCAV 624 (857)
Q Consensus 546 ~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg-~iKL~DFGLA~r~~~ 624 (857)
|+|||||.+++|..+. +.+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|..+..
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999999997653 2399999999999999999999999999999999999998655 699999999843210
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
....
T Consensus 183 ----------------------------------------------------------------------------~~~~ 186 (328)
T d3bqca1 183 ----------------------------------------------------------------------------GQEY 186 (328)
T ss_dssp ----------------------------------------------------------------------------TCCC
T ss_pred ----------------------------------------------------------------------------CCcc
Confidence 0112
Q ss_pred ccccCCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCChh-hhHHHhh---------------------
Q 035930 705 NSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDE-TLSNVVS--------------------- 761 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~e-~l~~Iv~--------------------- 761 (857)
...+||+.|+|||++.+.. |+.++|||||||++|||++|+.||....... ....+..
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 3456899999999988754 7999999999999999999999997654322 1111110
Q ss_pred --------------ccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChh
Q 035930 762 --------------QSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWA 813 (857)
Q Consensus 762 --------------~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~ 813 (857)
.....+....++++++|||++||++||.+||| ++|||+||||+.+.|+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVKD 328 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTSCCC
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCCCCCC
Confidence 00011122447889999999999999999999 9999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=431.78 Aligned_cols=264 Identities=22% Similarity=0.313 Sum_probs=216.7
Q ss_pred ccCCCeEEEeE-EccCCceEEEEEEEc--CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHKK-LGCGDIGTVYLAELI--GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~~-LG~G~fGtVyla~~~--~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
+..++|.+... ||+|+||+||+|.++ .++..||||+++... .....+.+.+|+++|++++|||||+++++|.++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~- 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence 34467888885 999999999999875 445689999997652 234456789999999999999999999998754
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
.+|||||||++|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 5799999999999999876543 349999999999999999999999999999999999999999999999999985432
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.... ....
T Consensus 161 ~~~~------------------------------------------------------------------------~~~~ 168 (285)
T d1u59a_ 161 ADDS------------------------------------------------------------------------YYTA 168 (285)
T ss_dssp TCSC------------------------------------------------------------------------EECC
T ss_pred cccc------------------------------------------------------------------------cccc
Confidence 1100 0001
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+++..+.. ..+++.++.+++++.+||.+
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~ 247 (285)
T d1u59a_ 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPECPPELYALMSD 247 (285)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-TCCCCCCTTCCHHHHHHHHH
T ss_pred ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHHHHHHH
Confidence 123468999999999999999999999999999999998 9999999887777666554 44455556799999999999
Q ss_pred hccCCcCCcCCchhhHHHHHcCCCCC
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQHPFFE 808 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~HPfF~ 808 (857)
||..||++||++. .+.+.|+|+|+.
T Consensus 248 cl~~~p~~RPs~~-~i~~~L~~~~~~ 272 (285)
T d1u59a_ 248 CWIYKWEDRPDFL-TVEQRMRACYYS 272 (285)
T ss_dssp TTCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHH-HHHHHHHHHHHH
Confidence 9999999999932 244557788763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-51 Score=432.79 Aligned_cols=260 Identities=24% Similarity=0.315 Sum_probs=210.7
Q ss_pred eEEE-eEEccCCceEEEEEEEc--CCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 472 FKLH-KKLGCGDIGTVYLAELI--GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 472 Y~i~-~~LG~G~fGtVyla~~~--~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
+.+. ++||+|+||+||+|.+. .+++.||||+++... ......+.+.+|+++|++++|||||+++++|.++ ..|||
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lv 85 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLV 85 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEE
Confidence 3443 57999999999999875 456789999997653 2334456789999999999999999999999654 56899
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
||||++|+|.+++.... .+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+......
T Consensus 86 mE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 99999999999988754 3999999999999999999999999999999999999999999999999998543211000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 164 ------------------------------------------------------------------------~~~~~~~~ 171 (277)
T d1xbba_ 164 ------------------------------------------------------------------------YKAQTHGK 171 (277)
T ss_dssp ------------------------------------------------------------------------EEC----C
T ss_pred ------------------------------------------------------------------------cccccccC
Confidence 00112346
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
||+.|||||++.+..|+.++|||||||+||||++ |+.||.+.+..++...+.. ..+++.+..+++++.+||.+||..|
T Consensus 172 gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~d 250 (277)
T d1xbba_ 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDLMNLCWTYD 250 (277)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHHHHHHHcCCC
Confidence 8999999999999999999999999999999997 9999998877766655544 4455555679999999999999999
Q ss_pred cCCcCCchhhHHHH---HcCCCCCCCCh
Q 035930 788 PDNRLGAVKGAAEI---KQHPFFEGLNW 812 (857)
Q Consensus 788 Pe~Rpt~~~~a~EL---L~HPfF~~l~w 812 (857)
|++||+ +++| |+|+||+-+|+
T Consensus 251 p~~RPs----~~~i~~~L~~~~~~~~~e 274 (277)
T d1xbba_ 251 VENRPG----FAAVELRLRNYYYDVVNE 274 (277)
T ss_dssp TTTSCC----HHHHHHHHHHHHHHHHHH
T ss_pred HhHCcC----HHHHHHHhhCHHhhcCCC
Confidence 999999 5554 67887765544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=431.12 Aligned_cols=263 Identities=25% Similarity=0.321 Sum_probs=211.7
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee-------
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT------- 541 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~------- 541 (857)
.++|+++++||+|+||+||+|++..+|+.||||++..... ......++.+|+++|+.++||||++++++|..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 4789999999999999999999999999999999876533 34455678899999999999999999998855
Q ss_pred -CCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchh
Q 035930 542 -EKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSL 620 (857)
Q Consensus 542 -~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~ 620 (857)
++++|+||||+.++.+..+.... ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 45789999999777665444333 348999999999999999999999999999999999999999999999999985
Q ss_pred hcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCC
Q 035930 621 RCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPT 700 (857)
Q Consensus 621 r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~ 700 (857)
....... ..
T Consensus 166 ~~~~~~~-----------------------------------------------------------------------~~ 174 (318)
T d3blha1 166 AFSLAKN-----------------------------------------------------------------------SQ 174 (318)
T ss_dssp ECCC----------------------------------------------------------------------------
T ss_pred ecccccc-----------------------------------------------------------------------cc
Confidence 4211000 00
Q ss_pred CCccccccCCCCccChhhhcCC-CCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCC----------
Q 035930 701 GARSNSFVGTHEYLAPEIIKGE-GHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGY---------- 769 (857)
Q Consensus 701 ~~~~~s~vGT~~YmAPEil~g~-~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~---------- 769 (857)
.......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..+......++..
T Consensus 175 ~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 254 (318)
T d3blha1 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 254 (318)
T ss_dssp CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC--
T ss_pred cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhh
Confidence 1112345799999999999876 68999999999999999999999999887777666655432222110
Q ss_pred --------------------CCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCC
Q 035930 770 --------------------PVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEG 809 (857)
Q Consensus 770 --------------------~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~ 809 (857)
...+++++|||.+||++||++||| ++|+|+||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s----a~elL~Hpff~~ 310 (318)
T d3blha1 255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWS 310 (318)
T ss_dssp -----CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGSS
T ss_pred hhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHHcChhhcc
Confidence 013667899999999999999999 999999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=423.34 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=217.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
.++|+++++||+|+||+||+|+++ +++.||||++++.. ...+.+.+|+.+|++++||||++++++|.+++.+|+|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS----SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc----CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 368999999999999999999985 78899999998653 3446789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
|||+++|+|..++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~--- 153 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--- 153 (258)
T ss_dssp EECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS---
T ss_pred EEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC---
Confidence 999999999888665433 4899999999999999999999999999999999999999999999999997432110
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
.........
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (258)
T d1k2pa_ 154 -----------------------------------------------------------------------EYTSSVGSK 162 (258)
T ss_dssp -----------------------------------------------------------------------SCCCCCCSC
T ss_pred -----------------------------------------------------------------------CceeecccC
Confidence 000112346
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+.. ..+.+.+..++..+.+||.+||+.|
T Consensus 163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~d 241 (258)
T d1k2pa_ 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMYSCWHEK 241 (258)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-CCCCCCcccccHHHHHHHHHHccCC
Confidence 8999999999999999999999999999999998 8999999988887777655 4455566779999999999999999
Q ss_pred cCCcCCchhhHHHHHcC
Q 035930 788 PDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~H 804 (857)
|++||+ +++|++|
T Consensus 242 P~~RPt----~~eil~~ 254 (258)
T d1k2pa_ 242 ADERPT----FKILLSN 254 (258)
T ss_dssp GGGSCC----HHHHHHH
T ss_pred HhHCcC----HHHHHHH
Confidence 999999 8888876
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-50 Score=422.08 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=216.3
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCeEEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~l~LV 548 (857)
+++|+++++||+|+||+||+|++..+++.||||+++... ........+.+|+.+|+.++||||++++++|.+....++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 468999999999999999999999999999999997653 2344567889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
||++.+++|..++.... .+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||+|......
T Consensus 80 ~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--- 154 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--- 154 (292)
T ss_dssp EECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC---
T ss_pred eeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC---
Confidence 99999999988876553 4899999999999999999999999999999999999999999999999998542110
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
........
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (292)
T d1unla_ 155 ------------------------------------------------------------------------VRCYSAEV 162 (292)
T ss_dssp ------------------------------------------------------------------------CSCCCSCC
T ss_pred ------------------------------------------------------------------------Cccceeec
Confidence 00112235
Q ss_pred CCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCC-CChhhhHHHhhcccc---------------------
Q 035930 709 GTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGS-GNDETLSNVVSQSLR--------------------- 765 (857)
Q Consensus 709 GT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~-~~~e~l~~Iv~~~~~--------------------- 765 (857)
+++.|+|||++.+.. ++.++|||||||++|||++|+.||... +..+.+..+......
T Consensus 163 ~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T d1unla_ 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242 (292)
T ss_dssp SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred cccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccc
Confidence 788899999998765 699999999999999999999996544 334444443321111
Q ss_pred ------CCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 766 ------FPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 766 ------~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
....+.+++.+++||++||+.||.+||| ++|||+||||+++
T Consensus 243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s----a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSDF 289 (292)
T ss_dssp CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGSSC
T ss_pred cccchhhhccccCCHHHHHHHHHHccCChhHCcC----HHHHhcChhhcCC
Confidence 0112456889999999999999999999 9999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=426.70 Aligned_cols=261 Identities=24% Similarity=0.288 Sum_probs=214.0
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCCe
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEKF 544 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~~ 544 (857)
|.+..++|++++.||+|+||+||+|++..+ ..||||+++... ...+.+.+|+.+|++++|||||+++++|.+ +.
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 85 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc----CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CC
Confidence 345668999999999999999999999755 579999997552 334678999999999999999999999865 45
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+|+||||+++|+|..++.......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 78999999999998877654444599999999999999999999999999999999999999999999999999853211
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
.. ....
T Consensus 166 ~~--------------------------------------------------------------------------~~~~ 171 (285)
T d1fmka3 166 NE--------------------------------------------------------------------------YTAR 171 (285)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CC--------------------------------------------------------------------------ceee
Confidence 00 0011
Q ss_pred ccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCC-CCChhhhHHHhhccccCCCCCCCCHHHHHHHHhh
Q 035930 705 NSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKG-SGNDETLSNVVSQSLRFPGYPVVSFHARDLIRGL 783 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g-~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~ 783 (857)
....||+.|+|||++.+..++.++|||||||+||||++|..||.. ....+.+..+ ....+.+..+.++.++++||.+|
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~c 250 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQC 250 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-HhcCCCCCCcccCHHHHHHHHHH
Confidence 234689999999999999999999999999999999996555544 4444455444 44556667778999999999999
Q ss_pred ccCCcCCcCCchhhHHHHHc--CCCCCCC
Q 035930 784 LVKEPDNRLGAVKGAAEIKQ--HPFFEGL 810 (857)
Q Consensus 784 L~~DPe~Rpt~~~~a~ELL~--HPfF~~l 810 (857)
|+.||++||+ +++|+. |+||...
T Consensus 251 l~~dP~~Rps----~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 251 WRKEPEERPT----FEYLQAFLEDYFTST 275 (285)
T ss_dssp TCSSGGGSCC----HHHHHHHHHTTTSCS
T ss_pred cccCHhHCcC----HHHHHHHHhhhhcCC
Confidence 9999999999 889887 8899764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=421.91 Aligned_cols=258 Identities=22% Similarity=0.247 Sum_probs=208.1
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCC----eEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTS----CLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg----~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
+....|++.++||+|+||+||+|.++.++ ..||||+++... .......+.+|+++|+.++|||||+++++|.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 44568999999999999999999987654 579999997542 233345688999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
+..++|||||.+++|..++.... ..+++..+..++.||+.||+|||+++||||||||+||||+.++.+||+|||+++.+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999999988776654 34999999999999999999999999999999999999999999999999998543
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
..... ...
T Consensus 161 ~~~~~------------------------------------------------------------------------~~~ 168 (283)
T d1mqba_ 161 EDDPE------------------------------------------------------------------------ATY 168 (283)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCCCc------------------------------------------------------------------------cce
Confidence 21100 000
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
......||+.|||||++.+..|+.++|||||||+||||++|..||........+...+....+++.+..++..+.+||.+
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 248 (283)
T d1mqba_ 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQ 248 (283)
T ss_dssp -----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHH
T ss_pred EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHH
Confidence 11234589999999999999999999999999999999996555544444444444555666777777899999999999
Q ss_pred hccCCcCCcCCchhhHHHHHc
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||..||++||+ +.||++
T Consensus 249 cl~~~p~~RPt----~~eil~ 265 (283)
T d1mqba_ 249 CWQQERARRPK----FADIVS 265 (283)
T ss_dssp HTCSSTTTSCC----HHHHHH
T ss_pred HCcCCHhHCcC----HHHHHH
Confidence 99999999999 777765
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=420.76 Aligned_cols=256 Identities=24% Similarity=0.356 Sum_probs=209.0
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcCC---CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIGT---SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE 542 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~t---g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~ 542 (857)
.+..++|++++.||+|+||+||+|.+..+ +..||||+++.. ......+.+.+|+++|+.++||||++++++|. +
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 35567899999999999999999998654 467899998654 22334567899999999999999999999996 5
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
+.+||||||+++|+|..++..... .+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTT-TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred CeEEEEEEeccCCcHHhhhhccCC-CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 678999999999999988766543 4899999999999999999999999999999999999999999999999998542
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.... ..
T Consensus 159 ~~~~--------------------------------------------------------------------------~~ 164 (273)
T d1mp8a_ 159 EDST--------------------------------------------------------------------------YY 164 (273)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCCc--------------------------------------------------------------------------ce
Confidence 1100 01
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIR 781 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~ 781 (857)
......||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+.+..+.+..+..+ .+++.++.+++.+.+||.
T Consensus 165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~ 243 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMPPNCPPTLYSLMT 243 (273)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTTCCHHHHHHHH
T ss_pred eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHH
Confidence 1123458999999999999999999999999999999997 89999998888888776654 344556789999999999
Q ss_pred hhccCCcCCcCCchhhHHHHHcC
Q 035930 782 GLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 782 k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
+||..||++||+ +.||++|
T Consensus 244 ~cl~~dp~~Rps----~~ei~~~ 262 (273)
T d1mp8a_ 244 KCWAYDPSRRPR----FTELKAQ 262 (273)
T ss_dssp HHTCSSGGGSCC----HHHHHHH
T ss_pred HHcCCCHhHCcC----HHHHHHH
Confidence 999999999999 8888765
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=434.22 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=208.6
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC-----e
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK-----F 544 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~-----~ 544 (857)
.+|++++.||+|+||+||+|.+..+|+.||||++++.. .....+.+.+|+++|+.|+||||+++++++..+. +
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999997542 2334567889999999999999999999997653 3
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhccc
Q 035930 545 SCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAV 624 (857)
Q Consensus 545 l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~ 624 (857)
+||+ +|+.+|+|.+++... .+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|.....
T Consensus 86 ~~l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 4555 556699999998764 399999999999999999999999999999999999999999999999999854211
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcc
Q 035930 625 NPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARS 704 (857)
Q Consensus 625 ~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~ 704 (857)
.. ......
T Consensus 162 ~~------------------------------------------------------------------------~~~~~~ 169 (345)
T d1pmea_ 162 DH------------------------------------------------------------------------DHTGFL 169 (345)
T ss_dssp GG------------------------------------------------------------------------CBCCTT
T ss_pred CC------------------------------------------------------------------------ccceee
Confidence 00 001112
Q ss_pred ccccCCCCccChhhhc-CCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc-------------------
Q 035930 705 NSFVGTHEYLAPEIIK-GEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL------------------- 764 (857)
Q Consensus 705 ~s~vGT~~YmAPEil~-g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~------------------- 764 (857)
...+||+.|+|||++. +..|+.++||||+||++|||++|+.||.+.+..+..........
T Consensus 170 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T d1pmea_ 170 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249 (345)
T ss_dssp CCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHH
T ss_pred ccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhccc
Confidence 3467999999999985 45678999999999999999999999988765555444332110
Q ss_pred -cCC---------CCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 765 -RFP---------GYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 765 -~~p---------~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
..+ ..+.++.++++||.+||++||.+||+ ++|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----a~e~L~hpf~~~~ 301 (345)
T d1pmea_ 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQY 301 (345)
T ss_dssp HTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTT
T ss_pred ccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhccC
Confidence 011 12457889999999999999999999 9999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=433.15 Aligned_cols=256 Identities=26% Similarity=0.381 Sum_probs=211.5
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeC-----C
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTE-----K 543 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~-----~ 543 (857)
.++|+++++||+|+||+||+|++..+|+.||||++++... .....+.+.+|+++|+.++|||||+++++|... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3689999999999999999999999999999999976532 233445788999999999999999999998643 3
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..++||+|+.||+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 345667777899999988653 39999999999999999999999999999999999999999999999999873210
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
..
T Consensus 173 ------------------------------------------------------------------------------~~ 174 (348)
T d2gfsa1 173 ------------------------------------------------------------------------------DE 174 (348)
T ss_dssp ------------------------------------------------------------------------------GG
T ss_pred ------------------------------------------------------------------------------cc
Confidence 01
Q ss_pred cccccCCCCccChhhhcCCC-CCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccccCC---------------
Q 035930 704 SNSFVGTHEYLAPEIIKGEG-HGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSLRFP--------------- 767 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~-~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~~~p--------------- 767 (857)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......++.....++
T Consensus 175 ~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (348)
T d2gfsa1 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254 (348)
T ss_dssp GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence 12456899999999987765 58999999999999999999999998876666666554322111
Q ss_pred --------C------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCC
Q 035930 768 --------G------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGL 810 (857)
Q Consensus 768 --------~------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l 810 (857)
. ...++++++|||++||+.||.+||| ++|||+||||+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~elL~Hp~f~~~ 307 (348)
T d2gfsa1 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQY 307 (348)
T ss_dssp HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTT
T ss_pred hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC----HHHHhcCHhhCCC
Confidence 0 2357899999999999999999999 9999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=436.95 Aligned_cols=270 Identities=26% Similarity=0.393 Sum_probs=209.0
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee------C
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT------E 542 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~------~ 542 (857)
+++|+++++||+|+||+||+|+++.+|+.||||++.+... ......++.+|+.+|+.++||||++++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4789999999999999999999999999999999986643 23445678899999999999999999999964 3
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhc
Q 035930 543 KFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRC 622 (857)
Q Consensus 543 ~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~ 622 (857)
.++|+|||||.++.+. .+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus 95 ~~~~iv~Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp CEEEEEEECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred ceeEEEEeccchHHHH-hhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 6899999999665544 333 23899999999999999999999999999999999999999999999999986321
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
.. ..
T Consensus 170 ~~----------------------------------------------------------------------------~~ 173 (355)
T d2b1pa1 170 GT----------------------------------------------------------------------------SF 173 (355)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc----------------------------------------------------------------------------cc
Confidence 10 01
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHhhccc------------------
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVVSQSL------------------ 764 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv~~~~------------------ 764 (857)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..++....
T Consensus 174 ~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 253 (355)
T d2b1pa1 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253 (355)
T ss_dssp -------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHh
Confidence 12345789999999999999999999999999999999999999998776655554432111
Q ss_pred ----cCCC------------------CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcCCCCCCCChhhhccCCCCC
Q 035930 765 ----RFPG------------------YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQHPFFEGLNWALIRCAVPPE 822 (857)
Q Consensus 765 ----~~p~------------------~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~HPfF~~l~w~li~~~~pp~ 822 (857)
.... ...++++++|||++||.+||++||| |+|||+||||+..-|..-....+|.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----a~elL~Hpw~~~~~~~~~~~~~~~~ 329 (355)
T d2b1pa1 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINVWYDPAEVEAPPPQ 329 (355)
T ss_dssp HTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGGGCCHHHHTCCCC-
T ss_pred hcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccCCCCCcccccCCCCC
Confidence 0000 0124567899999999999999999 9999999999975333333344444
Q ss_pred CC
Q 035930 823 LP 824 (857)
Q Consensus 823 ~P 824 (857)
+.
T Consensus 330 ~~ 331 (355)
T d2b1pa1 330 IY 331 (355)
T ss_dssp --
T ss_pred CC
Confidence 44
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=421.55 Aligned_cols=259 Identities=23% Similarity=0.337 Sum_probs=208.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~ 540 (857)
+..++|+++++||+|+||+||+|.+.. +++.||||+++.... ......+.+|..++.++ +|+||+.+++++.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 555789999999999999999999865 347899999975422 23345567777777666 6899999999876
Q ss_pred eC-CeEEEEEeecCCCChHHHHhhCC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE
Q 035930 541 TE-KFSCLVMEYCPGGDLHVLRQKQP--------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILV 605 (857)
Q Consensus 541 ~~-~~l~LVmEy~~gGsL~~ll~~~~--------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL 605 (857)
.+ ..+|+|||||++|+|.+++.... ...+++..++.++.||+.||.|||++|||||||||+||||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 54 57899999999999999886542 2348999999999999999999999999999999999999
Q ss_pred ccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhh
Q 035930 606 REDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDL 685 (857)
Q Consensus 606 ~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~ 685 (857)
+.++++||+|||+|+.+....
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~----------------------------------------------------------- 188 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDP----------------------------------------------------------- 188 (299)
T ss_dssp CGGGCEEECC------CCSCT-----------------------------------------------------------
T ss_pred CCCCcEEEccCcchhhccccc-----------------------------------------------------------
Confidence 999999999999985421110
Q ss_pred hcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhC-CCCCCCCCChhhhHHHhhccc
Q 035930 686 AAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYG-RTPFKGSGNDETLSNVVSQSL 764 (857)
Q Consensus 686 ~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtG-k~PF~g~~~~e~l~~Iv~~~~ 764 (857)
........+||+.|||||++.+..|+.++|||||||++|||++| ..||.+....+.+..++....
T Consensus 189 --------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~ 254 (299)
T d1ywna1 189 --------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 254 (299)
T ss_dssp --------------TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTC
T ss_pred --------------cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC
Confidence 01112345799999999999999999999999999999999986 568988877777777777777
Q ss_pred cCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 765 RFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 765 ~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
+++.+..+++++++||.+||+.||++||+ ++||++|
T Consensus 255 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~eil~~ 290 (299)
T d1ywna1 255 RMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 290 (299)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 77777779999999999999999999999 8888876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=422.15 Aligned_cols=256 Identities=22% Similarity=0.299 Sum_probs=209.6
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCe----EEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSC----LFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~----~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
...+|++++.||+|+||+||+|.+..+|+ .||+|.++.. ......+.+.+|+++|+.++|||||+++++|.++
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 34579999999999999999999988775 5788877643 2344567789999999999999999999999865
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+|+.+.
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred CeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 4678889999999988777654 349999999999999999999999999999999999999999999999999986532
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
... ....
T Consensus 163 ~~~-------------------------------------------------------------------------~~~~ 169 (317)
T d1xkka_ 163 AEE-------------------------------------------------------------------------KEYH 169 (317)
T ss_dssp TTC-------------------------------------------------------------------------C---
T ss_pred ccc-------------------------------------------------------------------------cccc
Confidence 110 0001
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..++.. ++....+++.++.+++++.+||.+
T Consensus 170 ~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~-~i~~~~~~~~p~~~~~~~~~li~~ 248 (317)
T d1xkka_ 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTIDVYMIMVK 248 (317)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH-HHHHTCCCCCCTTBCHHHHHHHHH
T ss_pred ccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCCCCCcccCHHHHHHHHH
Confidence 123458999999999999999999999999999999998 899998887666554 445556666667899999999999
Q ss_pred hccCCcCCcCCchhhHHHHHcCC
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQHP 805 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~HP 805 (857)
||..||.+||+ +.+|++|.
T Consensus 249 cl~~dP~~RPs----~~eil~~l 267 (317)
T d1xkka_ 249 CWMIDADSRPK----FRELIIEF 267 (317)
T ss_dssp HTCSSGGGSCC----HHHHHHHH
T ss_pred hCCCChhhCcC----HHHHHHHH
Confidence 99999999999 88888873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=421.64 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=210.5
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCC---CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGT---SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~t---g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~~~ 543 (857)
+..++|++++.||+|+||+||+|++... ...||||++++.........+.+.+|+.+|+.++||||++++++|.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 4567899999999999999999987533 34799999987766556667789999999999999999999999976 4
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
..||||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred chheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 67899999999999877665432 49999999999999999999999999999999999999999999999999985432
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
.... ....
T Consensus 163 ~~~~------------------------------------------------------------------------~~~~ 170 (273)
T d1u46a_ 163 QNDD------------------------------------------------------------------------HYVM 170 (273)
T ss_dssp C-CC------------------------------------------------------------------------EEEC
T ss_pred cCCC------------------------------------------------------------------------ccee
Confidence 1100 0001
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....||..|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+.+..+.....+++....++..+++||.+
T Consensus 171 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 250 (273)
T d1u46a_ 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ 250 (273)
T ss_dssp -----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHH
T ss_pred cCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHH
Confidence 123457889999999999999999999999999999997 8999999999999999988888888888899999999999
Q ss_pred hccCCcCCcCCchhhHHHHH
Q 035930 783 LLVKEPDNRLGAVKGAAEIK 802 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL 802 (857)
||..||++||+ +.+|+
T Consensus 251 cl~~dp~~RPt----~~ei~ 266 (273)
T d1u46a_ 251 CWAHKPEDRPT----FVALR 266 (273)
T ss_dssp HTCSSGGGSCC----HHHHH
T ss_pred HcCCChhHCcC----HHHHH
Confidence 99999999999 67765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=412.26 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=208.2
Q ss_pred ccccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee-CC
Q 035930 465 GCMGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT-EK 543 (857)
Q Consensus 465 ~~~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~-~~ 543 (857)
|.+..++|++++.||+|+||+||+|+++ |..||||+++.+ ...+.+.+|+++|++++||||++++++|.+ ++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 3467789999999999999999999984 678999999754 345678999999999999999999999865 46
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcc
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCA 623 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~ 623 (857)
.+||||||+++|+|.+++.......+++..++.++.||+.||.|||+.+||||||||+|||++.+|.+||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 78999999999999999876543458999999999999999999999999999999999999999999999999874311
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCc
Q 035930 624 VNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGAR 703 (857)
Q Consensus 624 ~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~ 703 (857)
. .
T Consensus 155 ~------------------------------------------------------------------------------~ 156 (262)
T d1byga_ 155 S------------------------------------------------------------------------------T 156 (262)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C------------------------------------------------------------------------------C
Confidence 0 0
Q ss_pred cccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhccccCCCCCCCCHHHHHHHHh
Q 035930 704 SNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQSLRFPGYPVVSFHARDLIRG 782 (857)
Q Consensus 704 ~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k 782 (857)
.....+|..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+++..+.. ..+++.++.+++.+++||.+
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~ 235 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEVMKN 235 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCCTTCCHHHHHHHHH
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCccCCHHHHHHHHH
Confidence 112347889999999999999999999999999999998 7999988877777766544 45556667799999999999
Q ss_pred hccCCcCCcCCchhhHHHHHc
Q 035930 783 LLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 783 ~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
||..||.+||+ +.+|++
T Consensus 236 cl~~dP~~Rps----~~~l~~ 252 (262)
T d1byga_ 236 CWHLDAAMRPS----FLQLRE 252 (262)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HcccCHhHCcC----HHHHHH
Confidence 99999999999 666665
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-48 Score=414.13 Aligned_cols=257 Identities=22% Similarity=0.300 Sum_probs=215.8
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT 541 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~ 541 (857)
+..++|++++.||+|+||+||+|++++ ++..||||+++... .......+.+|+++|+.++||||++++++|.+
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 456789999999999999999999864 46789999997642 23345678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCC----------------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCC
Q 035930 542 EKFSCLVMEYCPGGDLHVLRQKQP----------------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLK 599 (857)
Q Consensus 542 ~~~l~LVmEy~~gGsL~~ll~~~~----------------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLK 599 (857)
.+..++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++|||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 999999999999999999886432 1248899999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhh
Q 035930 600 PENILVREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSR 679 (857)
Q Consensus 600 PeNILL~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~ 679 (857)
|+||||+.++++||+|||+|+......
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~----------------------------------------------------- 194 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSAD----------------------------------------------------- 194 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGG-----------------------------------------------------
T ss_pred ccceEECCCCcEEEccchhheeccCCc-----------------------------------------------------
Confidence 999999999999999999985432110
Q ss_pred hhhhhhhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCC-CCCCCCCChhhhHH
Q 035930 680 KIKSDLAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGR-TPFKGSGNDETLSN 758 (857)
Q Consensus 680 ~~~~d~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk-~PF~g~~~~e~l~~ 758 (857)
......+..||+.|||||++.+..|+.++|||||||+||||++|. .||.+.+..+.+..
T Consensus 195 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~ 254 (301)
T d1lufa_ 195 --------------------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 254 (301)
T ss_dssp --------------------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred --------------------cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHH
Confidence 001123456899999999999999999999999999999999985 68888887887777
Q ss_pred HhhccccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 759 VVSQSLRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 759 Iv~~~~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+..+. .++.+..+++++.+||.+||+.||.+||+ +.||++
T Consensus 255 v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt----~~ev~~ 294 (301)
T d1lufa_ 255 VRDGN-ILACPENCPLELYNLMRLCWSKLPADRPS----FCSIHR 294 (301)
T ss_dssp HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 66554 44455679999999999999999999999 777754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-48 Score=413.86 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=212.2
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeE--EEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeeeeCC
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCL--FALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFTTEK 543 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~--VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~~~~ 543 (857)
+..++|++.++||+|+||+||+|.++.++.. ||||.++.. ......+.+.+|+++|+.+ +|||||+++++|.+++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 3457899999999999999999999988865 667776543 2334566789999999998 7999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhC--------------CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCC
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQ--------------PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDG 609 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~--------------~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg 609 (857)
.+||||||+++|+|.++++.. ....+++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999998754 224589999999999999999999999999999999999999999
Q ss_pred cEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhccc
Q 035930 610 HIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQV 689 (857)
Q Consensus 610 ~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~ 689 (857)
.+||+|||+|+.....
T Consensus 165 ~~kl~DfG~a~~~~~~---------------------------------------------------------------- 180 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY---------------------------------------------------------------- 180 (309)
T ss_dssp CEEECCTTCEESSCEE----------------------------------------------------------------
T ss_pred ceEEcccccccccccc----------------------------------------------------------------
Confidence 9999999998431100
Q ss_pred CCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCC-CCCCCCCChhhhHHHhhccccCCC
Q 035930 690 SPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGR-TPFKGSGNDETLSNVVSQSLRFPG 768 (857)
Q Consensus 690 ~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk-~PF~g~~~~e~l~~Iv~~~~~~p~ 768 (857)
.......||..|+|||.+.+..|+.++|||||||+||||++|. +||.+.+..+.+..+.. ..+++.
T Consensus 181 ------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~-~~~~~~ 247 (309)
T d1fvra_ 181 ------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEK 247 (309)
T ss_dssp ------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-TCCCCC
T ss_pred ------------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-cCCCCC
Confidence 0012345899999999999999999999999999999999965 57887777776666554 455666
Q ss_pred CCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHcC
Q 035930 769 YPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 769 ~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~H 804 (857)
+..+++++++||.+||..||++||+ +.||++|
T Consensus 248 ~~~~~~~~~~li~~cl~~dP~~RPs----~~eil~~ 279 (309)
T d1fvra_ 248 PLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 279 (309)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 6779999999999999999999999 8899876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=411.44 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=220.5
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEc-----CCCeEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCccccceeee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELI-----GTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAHFT 540 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~-----~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~f~ 540 (857)
+..++|++++.||+|+||+||+|++. .+++.||||+++.... ......+.+|+.+++.+ +|||||+++++|.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 45578999999999999999999874 4567999999976532 23445688999999999 6999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCC----------------CCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQPS----------------RFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~~~----------------~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNIL 604 (857)
+++.+|||||||++|+|..++..... ..+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 99999999999999999998875431 24899999999999999999999999999999999999
Q ss_pred EccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhh
Q 035930 605 VREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD 684 (857)
Q Consensus 605 L~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d 684 (857)
++.++.++|+|||+++.+....
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~---------------------------------------------------------- 199 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDS---------------------------------------------------------- 199 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCT----------------------------------------------------------
T ss_pred ccccCcccccccchheeccCCC----------------------------------------------------------
Confidence 9999999999999985421100
Q ss_pred hhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhcc
Q 035930 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQS 763 (857)
Q Consensus 685 ~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~ 763 (857)
........+||+.|+|||++.+..++.++|||||||+||||+| |.+||.+.+..+.+.+++...
T Consensus 200 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~ 264 (311)
T d1t46a_ 200 ---------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264 (311)
T ss_dssp ---------------TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT
T ss_pred ---------------cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 0011234579999999999999999999999999999999998 677777777778888888888
Q ss_pred ccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 764 ~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.++..+..++.++.+||.+||..||++||+ +++|++
T Consensus 265 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs----~~~il~ 300 (311)
T d1t46a_ 265 FRMLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQ 300 (311)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCCcccccHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 888777789999999999999999999999 777764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=409.22 Aligned_cols=257 Identities=24% Similarity=0.342 Sum_probs=211.9
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCC-------eEEEEEEecccccccccchhHHHHHHHHHHHc-CCCCcccccee
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTS-------CLFALKVMDNDFLVGRKKMPRAQTEREIMQML-DHPFLPTLFAH 538 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg-------~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L-~HPnIV~L~~~ 538 (857)
+..++|++++.||+|+||+||+|++.+++ ..||||+++.+. .......+.+|..++.++ +|||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 56689999999999999999999987654 479999997653 233456778898888888 79999999999
Q ss_pred eeeCCeEEEEEeecCCCChHHHHhhCC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 035930 539 FTTEKFSCLVMEYCPGGDLHVLRQKQP--------------SRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENIL 604 (857)
Q Consensus 539 f~~~~~l~LVmEy~~gGsL~~ll~~~~--------------~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNIL 604 (857)
|.+++.+|+|||||.+|+|.+++.... ...+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 999999999999999999999987553 234899999999999999999999999999999999999
Q ss_pred EccCCcEEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhh
Q 035930 605 VREDGHIMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSD 684 (857)
Q Consensus 605 L~~dg~iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d 684 (857)
++.++.+||+|||+++.+...
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~----------------------------------------------------------- 188 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHI----------------------------------------------------------- 188 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGC-----------------------------------------------------------
T ss_pred ecCCCCeEeccchhhcccccc-----------------------------------------------------------
Confidence 999999999999997432110
Q ss_pred hhcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhh-CCCCCCCCCChhhhHHHhhcc
Q 035930 685 LAAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLY-GRTPFKGSGNDETLSNVVSQS 763 (857)
Q Consensus 685 ~~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLt-Gk~PF~g~~~~e~l~~Iv~~~ 763 (857)
.........+||+.|+|||++.+..|+.++|||||||+||||++ |..||.+.+..+.+.. +...
T Consensus 189 --------------~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~-i~~~ 253 (299)
T d1fgka_ 189 --------------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL-LKEG 253 (299)
T ss_dssp --------------CTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHTT
T ss_pred --------------ccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH-HHcC
Confidence 01112234568999999999999999999999999999999998 7899988766665544 4455
Q ss_pred ccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 764 LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 764 ~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
.+++.+..+++++.+||.+||+.||.+||+ +.||++
T Consensus 254 ~~~~~p~~~~~~l~~li~~cl~~dP~~Rps----~~eil~ 289 (299)
T d1fgka_ 254 HRMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVE 289 (299)
T ss_dssp CCCCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHccCCHhHCcC----HHHHHH
Confidence 666666779999999999999999999999 777775
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=412.45 Aligned_cols=266 Identities=20% Similarity=0.259 Sum_probs=221.9
Q ss_pred cccCCCeEEEeEEccCCceEEEEEEEcC-----CCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeee
Q 035930 466 CMGMRHFKLHKKLGCGDIGTVYLAELIG-----TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFT 540 (857)
Q Consensus 466 ~~~~~~Y~i~~~LG~G~fGtVyla~~~~-----tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~ 540 (857)
.+..++|.+++.||+|+||+||+|.+.+ ++..||||+++... .......+.+|+++|++++||||++++++|.
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 3556789999999999999999998863 35789999997542 2334456889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhC--------CCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEE
Q 035930 541 TEKFSCLVMEYCPGGDLHVLRQKQ--------PSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIM 612 (857)
Q Consensus 541 ~~~~l~LVmEy~~gGsL~~ll~~~--------~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iK 612 (857)
.++..+|||||+++|+|..++... ....+++..+..++.||+.||.|||+++||||||||+|||++.++++|
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 999999999999999998876532 112468899999999999999999999999999999999999999999
Q ss_pred EecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCC
Q 035930 613 LSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPM 692 (857)
Q Consensus 613 L~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~ 692 (857)
|+|||+|+.......
T Consensus 174 l~DFGla~~~~~~~~----------------------------------------------------------------- 188 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDY----------------------------------------------------------------- 188 (308)
T ss_dssp ECCTTCCCGGGGGGC-----------------------------------------------------------------
T ss_pred EeecccceeccCCcc-----------------------------------------------------------------
Confidence 999999854221100
Q ss_pred CcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhC-CCCCCCCCChhhhHHHhhccccCCCCCC
Q 035930 693 PQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYG-RTPFKGSGNDETLSNVVSQSLRFPGYPV 771 (857)
Q Consensus 693 p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtG-k~PF~g~~~~e~l~~Iv~~~~~~p~~~~ 771 (857)
........||+.|+|||.+.+..++.++|||||||+||||+|| ..||.+.+..+.+..+..+. .++.++.
T Consensus 189 --------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-~~~~p~~ 259 (308)
T d1p4oa_ 189 --------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKPDN 259 (308)
T ss_dssp --------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCCTT
T ss_pred --------eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-CCCCccc
Confidence 0112234689999999999999999999999999999999998 58888888888887776644 4444567
Q ss_pred CCHHHHHHHHhhccCCcCCcCCchhhHHHHHc------CCCCCCCC
Q 035930 772 VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ------HPFFEGLN 811 (857)
Q Consensus 772 is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~------HPfF~~l~ 811 (857)
+++.+.+||.+||+.||.+||+ +.+|++ +|+|++++
T Consensus 260 ~~~~l~~li~~cl~~~P~~RPs----~~~il~~L~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 260 CPDMLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFREVS 301 (308)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHHHC
T ss_pred chHHHHHHHHHHcCCChhHCcC----HHHHHHHHHHhcCCCCcCCC
Confidence 9999999999999999999999 677766 77776554
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=402.52 Aligned_cols=253 Identities=19% Similarity=0.236 Sum_probs=204.9
Q ss_pred EEEeEEccCCceEEEEEEEcCC---CeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCccccceeeee-CCeEEEE
Q 035930 473 KLHKKLGCGDIGTVYLAELIGT---SCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFLPTLFAHFTT-EKFSCLV 548 (857)
Q Consensus 473 ~i~~~LG~G~fGtVyla~~~~t---g~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnIV~L~~~f~~-~~~l~LV 548 (857)
.+.++||+|+||+||+|.+..+ ...||||++++. ........+.+|+++|++++||||+++++++.+ ++.+|+|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 3468999999999999998654 346999999753 234456779999999999999999999999875 5689999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecccchhhcccCccc
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDFDLSLRCAVNPMV 628 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DFGLA~r~~~~~~l 628 (857)
||||++|+|.+++..... .+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~- 185 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF- 185 (311)
T ss_dssp EECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC-
T ss_pred EEEeecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc-
Confidence 999999999998876543 478888999999999999999999999999999999999999999999999854321100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCcccccc
Q 035930 629 VKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSNSFV 708 (857)
Q Consensus 629 ~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~s~v 708 (857)
..........
T Consensus 186 ----------------------------------------------------------------------~~~~~~~~~~ 195 (311)
T d1r0pa_ 186 ----------------------------------------------------------------------DSVHNKTGAK 195 (311)
T ss_dssp ----------------------------------------------------------------------CCTTCTTCSS
T ss_pred ----------------------------------------------------------------------ccceeccccc
Confidence 0001112346
Q ss_pred CCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCC-hhhhHHHhhccccCCCCCCCCHHHHHHHHhhccCC
Q 035930 709 GTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGN-DETLSNVVSQSLRFPGYPVVSFHARDLIRGLLVKE 787 (857)
Q Consensus 709 GT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~-~e~l~~Iv~~~~~~p~~~~is~~l~dLI~k~L~~D 787 (857)
||+.|+|||++.+..++.++|||||||+||||++|..||..... .+....+. ...+++.+..+++.+.+||.+||..|
T Consensus 196 gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~~~~~l~~li~~cl~~d 274 (311)
T d1r0pa_ 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPK 274 (311)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred ccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCcccCcHHHHHHHHHHcCCC
Confidence 89999999999999999999999999999999998887765443 34444444 44555566778999999999999999
Q ss_pred cCCcCCchhhHHHHHcC
Q 035930 788 PDNRLGAVKGAAEIKQH 804 (857)
Q Consensus 788 Pe~Rpt~~~~a~ELL~H 804 (857)
|++||+ +.||++|
T Consensus 275 P~~RPs----~~ei~~~ 287 (311)
T d1r0pa_ 275 AEMRPS----FSELVSR 287 (311)
T ss_dssp GGGSCC----HHHHHHH
T ss_pred HhHCcC----HHHHHHH
Confidence 999999 8888876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-46 Score=398.40 Aligned_cols=262 Identities=19% Similarity=0.254 Sum_probs=201.2
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCc-cccceeeeeCCeEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL-PTLFAHFTTEKFSCLV 548 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnI-V~L~~~f~~~~~l~LV 548 (857)
++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|+++|+.++|+|+ +.+++++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 47999999999999999999999999999999987542 23457889999999987665 4556666788899999
Q ss_pred EeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc---CCcEEEecccchhhcccC
Q 035930 549 MEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE---DGHIMLSDFDLSLRCAVN 625 (857)
Q Consensus 549 mEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~---dg~iKL~DFGLA~r~~~~ 625 (857)
|||+ +++|...+.... ..+++..+..++.||+.||+|||++|||||||||+|||++. +..++|+|||+|+.....
T Consensus 82 me~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999 666665554433 34999999999999999999999999999999999999863 457999999998653211
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCCccc
Q 035930 626 PMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGARSN 705 (857)
Q Consensus 626 ~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~~~~ 705 (857)
... .........
T Consensus 160 ~~~--------------------------------------------------------------------~~~~~~~~~ 171 (299)
T d1ckia_ 160 RTH--------------------------------------------------------------------QHIPYRENK 171 (299)
T ss_dssp TTC--------------------------------------------------------------------CBCCCCBCC
T ss_pred ccc--------------------------------------------------------------------cceeccccC
Confidence 000 000011234
Q ss_pred cccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhhhHHHh---hccccCC---CCCCCCHHHHHH
Q 035930 706 SFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDETLSNVV---SQSLRFP---GYPVVSFHARDL 779 (857)
Q Consensus 706 s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~l~~Iv---~~~~~~p---~~~~is~~l~dL 779 (857)
..+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+. ......+ ....+++++.+|
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~l 251 (299)
T d1ckia_ 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATY 251 (299)
T ss_dssp SCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHH
T ss_pred CcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHH
Confidence 5689999999999999999999999999999999999999998876554433322 2222222 134689999999
Q ss_pred HHhhccCCcCCcCCchhhHHHHHcCCCC
Q 035930 780 IRGLLVKEPDNRLGAVKGAAEIKQHPFF 807 (857)
Q Consensus 780 I~k~L~~DPe~Rpt~~~~a~ELL~HPfF 807 (857)
|..||..||++||++. .+.++|+|+|.
T Consensus 252 i~~cl~~~p~~RP~~~-~i~~~l~~~~~ 278 (299)
T d1ckia_ 252 LNFCRSLRFDDKPDYS-YLRQLFRNLFH 278 (299)
T ss_dssp HHHHHHSCTTCCCCHH-HHHHHHHHHHH
T ss_pred HHHHccCChhHCcCHH-HHHHHHHHHHH
Confidence 9999999999999942 24566777654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-44 Score=384.60 Aligned_cols=251 Identities=18% Similarity=0.233 Sum_probs=204.0
Q ss_pred CCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCC-CCccccceeeeeCCeEEE
Q 035930 469 MRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH-PFLPTLFAHFTTEKFSCL 547 (857)
Q Consensus 469 ~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~H-PnIV~L~~~f~~~~~l~L 547 (857)
.++|+++++||+|+||+||+|++..+|+.||||++... .....+.+|+++++.|.| +||+.+++++..+...|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-----cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 46899999999999999999999999999999998654 223456889999999975 899999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEcc-----CCcEEEecccchhhc
Q 035930 548 VMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE-----DGHIMLSDFDLSLRC 622 (857)
Q Consensus 548 VmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~-----dg~iKL~DFGLA~r~ 622 (857)
||||+ +++|..++.... ..+++..+..++.|++.||+|||++|||||||||+|||++. ++.++|+|||+|+..
T Consensus 79 vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99999 789988887654 34999999999999999999999999999999999999964 578999999998653
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcccccCCCC
Q 035930 623 AVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQLVVEPTGA 702 (857)
Q Consensus 623 ~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l~~~~~~~ 702 (857)
....... .....
T Consensus 157 ~~~~~~~--------------------------------------------------------------------~~~~~ 168 (293)
T d1csna_ 157 RDPVTKQ--------------------------------------------------------------------HIPYR 168 (293)
T ss_dssp BCTTTCC--------------------------------------------------------------------BCCCC
T ss_pred ccCcccc--------------------------------------------------------------------ceeec
Confidence 2110000 00011
Q ss_pred ccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCChhh---hHHHhhccccCC---CCCCCCHHH
Q 035930 703 RSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGNDET---LSNVVSQSLRFP---GYPVVSFHA 776 (857)
Q Consensus 703 ~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~e~---l~~Iv~~~~~~p---~~~~is~~l 776 (857)
....++||+.|||||++.+..++.++|||||||++|||++|+.||.+...... +..+.......+ ..+.+++++
T Consensus 169 ~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (293)
T d1csna_ 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEF 248 (293)
T ss_dssp CCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHH
T ss_pred ccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHH
Confidence 23456899999999999999999999999999999999999999987654332 233332222211 124588999
Q ss_pred HHHHHhhccCCcCCcCCc
Q 035930 777 RDLIRGLLVKEPDNRLGA 794 (857)
Q Consensus 777 ~dLI~k~L~~DPe~Rpt~ 794 (857)
.+||..|+..+|++||+.
T Consensus 249 ~~ii~~~~~~~~~~rP~y 266 (293)
T d1csna_ 249 YKYMHYARNLAFDATPDY 266 (293)
T ss_dssp HHHHHHHHHCCTTCCCCH
T ss_pred HHHHHHHhcCCcccCcCH
Confidence 999999999999999984
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=389.13 Aligned_cols=248 Identities=23% Similarity=0.273 Sum_probs=189.3
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHH--HHHcCCCCccccceeeeeCC----
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREI--MQMLDHPFLPTLFAHFTTEK---- 543 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieI--Lr~L~HPnIV~L~~~f~~~~---- 543 (857)
++|.+.+.||+|+||+||+|++ +|+.||||+++... .....+|.++ +..++||||+++++++.+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 5799999999999999999987 57899999986541 2334445554 45789999999999998654
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH--------cCceeccCCCCcEEEccCCcEEEec
Q 035930 544 FSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM--------LGVVYRDLKPENILVREDGHIMLSD 615 (857)
Q Consensus 544 ~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs--------~GIIHRDLKPeNILL~~dg~iKL~D 615 (857)
.+|||||||++|+|..++++.. +++..+..++.|++.||+|||. +|||||||||+||||+.+|.+||+|
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~~---l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEEecccCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 6899999999999999998753 8999999999999999999996 5999999999999999999999999
Q ss_pred ccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhhhcccCCCCcc
Q 035930 616 FDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDLAAQVSPMPQL 695 (857)
Q Consensus 616 FGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~~~~~~~~p~l 695 (857)
||++..+......
T Consensus 152 FGl~~~~~~~~~~------------------------------------------------------------------- 164 (303)
T d1vjya_ 152 LGLAVRHDSATDT------------------------------------------------------------------- 164 (303)
T ss_dssp CTTCEEEETTTTE-------------------------------------------------------------------
T ss_pred cCccccccCCCcc-------------------------------------------------------------------
Confidence 9998653211100
Q ss_pred cccCCCCccccccCCCCccChhhhcCCC------CCcccceehhhHHHHHHhhCCCCCCCCCC--------------hhh
Q 035930 696 VVEPTGARSNSFVGTHEYLAPEIIKGEG------HGSSVDWWTFGIFLFELLYGRTPFKGSGN--------------DET 755 (857)
Q Consensus 696 ~~~~~~~~~~s~vGT~~YmAPEil~g~~------~s~ksDVWSLGvILyELLtGk~PF~g~~~--------------~e~ 755 (857)
........+||+.|||||++.+.. ++.++|||||||+||||+||..||..... .+.
T Consensus 165 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 165 ----IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp ----ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred ----eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 011123467999999999997653 56789999999999999999988753221 111
Q ss_pred hHHH-hhccccCCCCCC-----CCHHHHHHHHhhccCCcCCcCCchhhHHHHHc
Q 035930 756 LSNV-VSQSLRFPGYPV-----VSFHARDLIRGLLVKEPDNRLGAVKGAAEIKQ 803 (857)
Q Consensus 756 l~~I-v~~~~~~p~~~~-----is~~l~dLI~k~L~~DPe~Rpt~~~~a~ELL~ 803 (857)
+... ..+.++.+.+.. ....+.+||.+||..||++||+ +.||++
T Consensus 241 ~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~ei~~ 290 (303)
T d1vjya_ 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKK 290 (303)
T ss_dssp HHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC----HHHHHH
T ss_pred HHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcC----HHHHHH
Confidence 2222 222332221111 2235889999999999999999 777765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-43 Score=385.90 Aligned_cols=259 Identities=23% Similarity=0.374 Sum_probs=198.5
Q ss_pred ccCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-----------CCCcccc
Q 035930 467 MGMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-----------HPFLPTL 535 (857)
Q Consensus 467 ~~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-----------HPnIV~L 535 (857)
+..++|+++++||+|+||+||+|++..+|+.||||+++++.. ..+.+.+|+.+|+.++ |+||+++
T Consensus 10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 344579999999999999999999999999999999986532 2356688999988875 5789999
Q ss_pred ceeeeeC--CeEEEEEeecCCCCh-HHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEccCCc-
Q 035930 536 FAHFTTE--KFSCLVMEYCPGGDL-HVLRQKQPSRFFSEQAARFYVAEVLLALEYLHM-LGVVYRDLKPENILVREDGH- 610 (857)
Q Consensus 536 ~~~f~~~--~~l~LVmEy~~gGsL-~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs-~GIIHRDLKPeNILL~~dg~- 610 (857)
++++... ...++||+++..+.. ..+........+++..++.++.||+.||+|||+ +||+||||||+||||+.++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 9988653 566777777655543 333344444568999999999999999999997 89999999999999987653
Q ss_pred -----EEEecccchhhcccCcccccCCCCCCCCCCCCCCCCCCCCCcCCCccCCCCCcccccccchhhHHHhhhhhhhhh
Q 035930 611 -----IMLSDFDLSLRCAVNPMVVKSSSPVEEPPPKKASSPCSEASCIEPFCLHPSWQVSCFTPRLLSVAAKSRKIKSDL 685 (857)
Q Consensus 611 -----iKL~DFGLA~r~~~~~~l~~~ss~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~d~ 685 (857)
++|+|||.+....
T Consensus 166 ~~~~~~kl~dfg~s~~~~-------------------------------------------------------------- 183 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYD-------------------------------------------------------------- 183 (362)
T ss_dssp TTEEEEEECCCTTCEETT--------------------------------------------------------------
T ss_pred cccceeeEeecccccccc--------------------------------------------------------------
Confidence 9999999874210
Q ss_pred hcccCCCCcccccCCCCccccccCCCCccChhhhcCCCCCcccceehhhHHHHHHhhCCCCCCCCCCh------hhhHHH
Q 035930 686 AAQVSPMPQLVVEPTGARSNSFVGTHEYLAPEIIKGEGHGSSVDWWTFGIFLFELLYGRTPFKGSGND------ETLSNV 759 (857)
Q Consensus 686 ~~~~~~~p~l~~~~~~~~~~s~vGT~~YmAPEil~g~~~s~ksDVWSLGvILyELLtGk~PF~g~~~~------e~l~~I 759 (857)
......+||+.|+|||++.+..|+.++|||||||++++|++|+.||...... +.+...
T Consensus 184 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 184 ----------------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp ----------------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred ----------------cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 0112456999999999999999999999999999999999999999765321 111111
Q ss_pred hhcc----------------------------------------ccCCCCCCCCHHHHHHHHhhccCCcCCcCCchhhHH
Q 035930 760 VSQS----------------------------------------LRFPGYPVVSFHARDLIRGLLVKEPDNRLGAVKGAA 799 (857)
Q Consensus 760 v~~~----------------------------------------~~~p~~~~is~~l~dLI~k~L~~DPe~Rpt~~~~a~ 799 (857)
+... ..+......+++++|||.+||.+||.+||| ++
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt----a~ 323 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD----AG 323 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----HH
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC----HH
Confidence 1000 000111234578999999999999999999 99
Q ss_pred HHHcCCCCCCCC
Q 035930 800 EIKQHPFFEGLN 811 (857)
Q Consensus 800 ELL~HPfF~~l~ 811 (857)
|||+||||+++.
T Consensus 324 e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 324 GLVNHPWLKDTL 335 (362)
T ss_dssp HHHTCGGGTTCT
T ss_pred HHhcCcccCCCC
Confidence 999999999664
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=3.5e-24 Score=213.16 Aligned_cols=135 Identities=20% Similarity=0.190 Sum_probs=104.9
Q ss_pred eEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccc---------------cchhHHHHHHHHHHHcCCCCccccc
Q 035930 472 FKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGR---------------KKMPRAQTEREIMQMLDHPFLPTLF 536 (857)
Q Consensus 472 Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~---------------~~~~~~~~EieILr~L~HPnIV~L~ 536 (857)
+.++++||+|+||+||+|.+. +|+.||||+++....... ........|..+|..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468999999999999999984 789999999764321100 0012335688889999999999887
Q ss_pred eeeeeCCeEEEEEeecCCCChHHHHhhCCCCCCcHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEccCCcEEEecc
Q 035930 537 AHFTTEKFSCLVMEYCPGGDLHVLRQKQPSRFFSEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIMLSDF 616 (857)
Q Consensus 537 ~~f~~~~~l~LVmEy~~gGsL~~ll~~~~~~~l~e~~~r~i~~QIl~gL~yLHs~GIIHRDLKPeNILL~~dg~iKL~DF 616 (857)
++.. .+|||||++++.+.. +++..+..++.||+.+|+|||++||+||||||+|||++++ .++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 6532 279999998766532 3445567889999999999999999999999999999865 5899999
Q ss_pred cchhh
Q 035930 617 DLSLR 621 (857)
Q Consensus 617 GLA~r 621 (857)
|+|+.
T Consensus 147 G~a~~ 151 (191)
T d1zara2 147 PQSVE 151 (191)
T ss_dssp TTCEE
T ss_pred CCccc
Confidence 99853
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.44 E-value=5.4e-07 Score=90.74 Aligned_cols=85 Identities=18% Similarity=0.222 Sum_probs=61.1
Q ss_pred CCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceeeeeCCeEEEE
Q 035930 470 RHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHFTTEKFSCLV 548 (857)
Q Consensus 470 ~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f~~~~~l~LV 548 (857)
+.|+..+..+-++.+.||+.. ..+..+.||+..... ......+.+|..+|+.|. +--+++++.++..++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~---~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRY---KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGG---TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCc---ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 467777765555567999885 345567888875442 223345688999988875 43467888888889999999
Q ss_pred EeecCCCChHH
Q 035930 549 MEYCPGGDLHV 559 (857)
Q Consensus 549 mEy~~gGsL~~ 559 (857)
|++++|..+..
T Consensus 89 ~~~l~G~~~~~ 99 (263)
T d1j7la_ 89 MSEADGVLCSE 99 (263)
T ss_dssp EECCSSEEHHH
T ss_pred EEecccccccc
Confidence 99999887743
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.99 E-value=2e-05 Score=85.29 Aligned_cols=81 Identities=19% Similarity=0.212 Sum_probs=52.1
Q ss_pred EEeEEccCCceEEEEEEEcCCCeEEEEEEeccc-cccc---ccchhHHHHHHHHHHHcC-C--CCccccceeeeeCCeEE
Q 035930 474 LHKKLGCGDIGTVYLAELIGTSCLFALKVMDND-FLVG---RKKMPRAQTEREIMQMLD-H--PFLPTLFAHFTTEKFSC 546 (857)
Q Consensus 474 i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~-~~~~---~~~~~~~~~EieILr~L~-H--PnIV~L~~~f~~~~~l~ 546 (857)
-.+.||.|....||++.+..+++.|+||.-... .... .....+...|.+.|+.+. + ..+++++.+ ++...+
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence 356799999999999998777888999975321 1111 223456778999888773 2 345666544 444557
Q ss_pred EEEeecCCCC
Q 035930 547 LVMEYCPGGD 556 (857)
Q Consensus 547 LVmEy~~gGs 556 (857)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999997644
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.81 E-value=2.5e-05 Score=77.74 Aligned_cols=136 Identities=15% Similarity=0.045 Sum_probs=83.5
Q ss_pred EEccCCc-eEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCC--CCccccceeeeeCCeEEEEEeecC
Q 035930 477 KLGCGDI-GTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH--PFLPTLFAHFTTEKFSCLVMEYCP 553 (857)
Q Consensus 477 ~LG~G~f-GtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~H--PnIV~L~~~f~~~~~l~LVmEy~~ 553 (857)
.+..|.. +.||+.... .+..+.+|..... ....+..|...|+.|.. -.+++++.+..+++..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCcc------CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 4455553 689998764 4556888876433 23456788888887743 236778888888889999999998
Q ss_pred CCChHH--------------HHhh---CC--CCCC--cHHHH-----HHH---------------HHHHHHHHHHHHHc-
Q 035930 554 GGDLHV--------------LRQK---QP--SRFF--SEQAA-----RFY---------------VAEVLLALEYLHML- 591 (857)
Q Consensus 554 gGsL~~--------------ll~~---~~--~~~l--~e~~~-----r~i---------------~~QIl~gL~yLHs~- 591 (857)
|.++.. .+.+ .. ...+ ..... ..+ .......+..+...
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 866521 1111 00 0000 00000 000 00112233444432
Q ss_pred ------CceeccCCCCcEEEccCCcEEEecccch
Q 035930 592 ------GVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 592 ------GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
.+||+|+.|.|||++.++.+-|+||+.+
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~ 203 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 203 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhc
Confidence 3899999999999997766789999976
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.91 E-value=0.0014 Score=70.01 Aligned_cols=80 Identities=21% Similarity=0.354 Sum_probs=54.5
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcC-------CCeEEEEEEecccccccccchhHHHHHHHHHHHcC-CCCccccceee
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIG-------TSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLD-HPFLPTLFAHF 539 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~-------tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~-HPnIV~L~~~f 539 (857)
..+.+++ +.|+-|-.=.+|++.... ....|.+++.-.. .......+|..+++.+. +.-.++++++|
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~idr~~E~~i~~~ls~~gl~Pkll~~~ 114 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIF 114 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chhhHHHHHHHHHHHHHhCCCCCeEEEEc
Confidence 3344555 578888888999998753 3456888876421 22334568999999885 55556787776
Q ss_pred eeCCeEEEEEeecCCCCh
Q 035930 540 TTEKFSCLVMEYCPGGDL 557 (857)
Q Consensus 540 ~~~~~l~LVmEy~~gGsL 557 (857)
.+ .+||||++|..|
T Consensus 115 ~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 115 SG----GRLEEYIPSRPL 128 (395)
T ss_dssp TT----EEEECCCCEEEC
T ss_pred CC----ceEEEEeccccC
Confidence 53 589999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.80 E-value=0.0015 Score=68.02 Aligned_cols=69 Identities=14% Similarity=0.113 Sum_probs=45.4
Q ss_pred ceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCCCCc-----ccc--ceeeeeCCeEEEEEeecCCC
Q 035930 483 IGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDHPFL-----PTL--FAHFTTEKFSCLVMEYCPGG 555 (857)
Q Consensus 483 fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~HPnI-----V~L--~~~f~~~~~l~LVmEy~~gG 555 (857)
--.||++.. .+|..|++|+.+.. ....+.+..|...|..|....| +.. -..+..++..+.|+++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~----~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPE----RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTT----TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCC----CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 358999977 46778999997654 2334567788888887742222 111 12345567889999999764
Q ss_pred C
Q 035930 556 D 556 (857)
Q Consensus 556 s 556 (857)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.56 E-value=0.0066 Score=62.01 Aligned_cols=145 Identities=15% Similarity=0.060 Sum_probs=78.1
Q ss_pred cCCCeEEEeEEccCCceEEEEEEEcCCCeEEEEEEecccccccccchhHHHHHHHHHHHcCC-----CCcccc-ce--ee
Q 035930 468 GMRHFKLHKKLGCGDIGTVYLAELIGTSCLFALKVMDNDFLVGRKKMPRAQTEREIMQMLDH-----PFLPTL-FA--HF 539 (857)
Q Consensus 468 ~~~~Y~i~~~LG~G~fGtVyla~~~~tg~~VAVKvi~k~~~~~~~~~~~~~~EieILr~L~H-----PnIV~L-~~--~f 539 (857)
++..+.-.+.|..|---+.|+..... | .|++|++... ...+.+..|+++|..|.. |..+.. -+ +.
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~-----~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~ 88 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 88 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred CCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCC-----CCHHHHHHHHHHHHhhhhccccccccceecCCCcce
Confidence 34456666677788888999998653 4 4899998543 223455667777777742 222211 11 22
Q ss_pred eeCCeEEEEEeecCCCChHH-----H---------Hh----hCCC---CCCcHH------------------HHHHHHHH
Q 035930 540 TTEKFSCLVMEYCPGGDLHV-----L---------RQ----KQPS---RFFSEQ------------------AARFYVAE 580 (857)
Q Consensus 540 ~~~~~l~LVmEy~~gGsL~~-----l---------l~----~~~~---~~l~e~------------------~~r~i~~Q 580 (857)
......+.++.++.|..... . ++ .... ...... .....+..
T Consensus 89 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 168 (316)
T d2ppqa1 89 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRP 168 (316)
T ss_dssp EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred eeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHH
Confidence 33456677777776644310 0 00 0000 000000 01111222
Q ss_pred HHHHHHHHH----HcCceeccCCCCcEEEccCCcEEEecccch
Q 035930 581 VLLALEYLH----MLGVVYRDLKPENILVREDGHIMLSDFDLS 619 (857)
Q Consensus 581 Il~gL~yLH----s~GIIHRDLKPeNILL~~dg~iKL~DFGLA 619 (857)
+...+.-.+ ..||||+|+.++|||++.+...-|+||+.+
T Consensus 169 ~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 169 EIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp HHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred HHHhhhccCccccccccccCCcchhhhhcccccceeEeccccc
Confidence 222222222 247999999999999998877789999986
|